assay_id,doc_id,description,assay_type,assay_test_type,assay_category,assay_organism,assay_tax_id,assay_strain,assay_tissue,assay_cell_type,assay_subcellular_fraction,tid,relationship_type,confidence_score,curated_by,src_id,src_assay_id,chembl_id,cell_id,bao_format,tissue_id,variant_id
1,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615117,,BAO_0000019,,
2,684,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615118,,BAO_0000219,,
3,15453,,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615119,,BAO_0000019,,
4,17841,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,B,,,Bos taurus,9913.0,,,,,104729,H,4,Autocuration,1,,CHEMBL615120,,BAO_0000249,,
5,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615121,163.0,BAO_0000219,,
6,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615122,163.0,BAO_0000219,,
7,13799,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,F,,,Mus musculus,10090.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615123,163.0,BAO_0000219,,
8,17774,In vitro cell cytotoxicity was determined against 143B cell line,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Expert,1,,CHEMBL615124,163.0,BAO_0000219,,
9,3801,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615125,163.0,BAO_0000219,,
10,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615126,163.0,BAO_0000219,,
11,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615127,163.0,BAO_0000219,,
12,17774,In vitro cell cytotoxicity was determined against 143B-LTK cell line,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Expert,1,,CHEMBL615128,163.0,BAO_0000219,,
13,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL857900,,BAO_0000218,,
14,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615129,,BAO_0000218,,
15,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615130,,BAO_0000218,,
16,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615131,,BAO_0000218,,
17,11347,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,100122,D,9,Expert,1,,CHEMBL884521,,BAO_0000357,,
18,16474,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615132,,BAO_0000357,,
19,10091,Inhibition of partially purified 15-lipoxygenase from human leukocytes,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615133,,BAO_0000019,,
20,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615134,,BAO_0000357,,
21,16474,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615135,,BAO_0000357,,
22,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615136,,BAO_0000357,,
23,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615137,,BAO_0000357,,
24,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615138,,BAO_0000357,,
25,14352,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL836324,,BAO_0000219,,
26,5646,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,B,,,Oryctolagus cuniculus,9986.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615139,,BAO_0000357,,
27,5646,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),B,,,Oryctolagus cuniculus,9986.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615140,,BAO_0000357,,
28,10997,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,B,,,,,,,,,12426,H,8,Autocuration,1,,CHEMBL615141,,BAO_0000219,,
29,6309,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,B,,,soya bean,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615142,,BAO_0000357,,
30,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615143,,BAO_0000357,,
31,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615144,,BAO_0000357,,
32,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL872867,,BAO_0000357,,
33,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615145,,BAO_0000357,,
34,13622,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615146,,BAO_0000357,,
35,13622,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615147,,BAO_0000357,,
36,11347,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615148,,BAO_0000019,,
37,5926,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,B,,,Escherichia coli,562.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615149,,BAO_0000019,,
38,4567,Dissociation constant with dimeric 16S rRNA RNA construct B,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615150,,BAO_0000019,,
39,3782,Dissociation constant towards 16S rRNA construct A,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615151,,BAO_0000225,,
40,3782,Dissociation constant towards 16S rRNA construct B,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615152,,BAO_0000225,,
41,4466,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,B,,,Escherichia coli,562.0,,,,,100263,M,3,Expert,1,,CHEMBL615153,,BAO_0000225,,
42,6592,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,B,,,Escherichia coli,562.0,,,,,100263,M,3,Expert,1,,CHEMBL615154,,BAO_0000225,,
43,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL615155,,BAO_0000019,,
44,898,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL615156,,BAO_0000019,,
45,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606.0,,,,,20001,H,8,Autocuration,1,,CHEMBL615157,,BAO_0000019,,
46,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606.0,,,,,20001,H,8,Autocuration,1,,CHEMBL615158,,BAO_0000019,,
47,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615159,,BAO_0000019,,
48,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615172,,BAO_0000019,,
49,10691,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615173,,BAO_0000019,,
50,10691,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615174,,BAO_0000019,,
51,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL884518,,BAO_0000019,,
52,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615175,,BAO_0000357,,
53,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615176,,BAO_0000357,,
54,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615177,,BAO_0000357,,
55,15103,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104740,D,5,Autocuration,1,,CHEMBL615178,,BAO_0000249,,
56,5116,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615179,506.0,BAO_0000219,,
57,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104835,D,7,Autocuration,1,,CHEMBL615180,,BAO_0000219,,
58,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104821,D,7,Autocuration,1,,CHEMBL615181,,BAO_0000219,,
59,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104848,D,7,Autocuration,1,,CHEMBL615182,,BAO_0000219,,
60,4787,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615183,506.0,BAO_0000219,,
61,4787,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615184,506.0,BAO_0000219,,
62,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615185,506.0,BAO_0000219,,
63,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615186,506.0,BAO_0000219,,
64,6726,Effective dose of compound against replication of 1A9 cell line was evaluated,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615187,506.0,BAO_0000219,,
65,3455,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL885343,506.0,BAO_0000219,,
66,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615188,506.0,BAO_0000219,,
67,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615189,506.0,BAO_0000219,,
68,5726,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615190,506.0,BAO_0000219,,
69,3395,Inhibitory activity against Taxol resistant 1A9 cell lines,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615191,506.0,BAO_0000219,,
70,3415,Cytotoxicity against human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615192,506.0,BAO_0000219,,
71,3415,Percentage inhibition of human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL827083,506.0,BAO_0000219,,
72,17099,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615193,506.0,BAO_0000219,,
73,17099,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615194,506.0,BAO_0000219,,
74,17099,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615195,506.0,BAO_0000219,,
75,17099,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615196,506.0,BAO_0000219,,
76,17721,Inhibitory concentration against Jurkat cells,F,,,Homo sapiens,9606.0,,,Jurkat,,81072,N,1,Intermediate,1,,CHEMBL615197,503.0,BAO_0000219,,
77,1229,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL615198,,BAO_0000019,,
78,11347,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,100121,D,9,Expert,1,,CHEMBL615199,,BAO_0000357,,
79,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615200,,BAO_0000357,,
80,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615201,,BAO_0000357,,
81,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615202,,BAO_0000357,,
82,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",B,,,Candida albicans,5476.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615203,,BAO_0000251,,
83,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",B,,,Candida albicans,5476.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615204,,BAO_0000251,,
84,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615205,,BAO_0000251,,
85,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615206,,BAO_0000251,,
86,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",B,,,Sus scrofa,9823.0,,Liver,,Microsomes,12083,H,8,Autocuration,1,,CHEMBL615207,,BAO_0000251,2107.0,
87,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL827084,,BAO_0000019,,
88,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL615208,,BAO_0000019,,
89,791,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL615209,,BAO_0000019,,
90,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615210,,BAO_0000251,2107.0,
91,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615211,,BAO_0000251,2107.0,
92,153,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615212,,BAO_0000251,2107.0,
93,8269,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),B,,,,,,,,,11377,H,8,Expert,1,,CHEMBL615213,,BAO_0000357,,
94,8269,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,B,,,,,,,,,11377,H,8,Expert,1,,CHEMBL615273,,BAO_0000357,,
95,17653,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Expert,1,,CHEMBL615274,726.0,BAO_0000219,,
96,14277,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615275,726.0,BAO_0000219,,
97,1717,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615276,726.0,BAO_0000219,,
98,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615277,726.0,BAO_0000219,,
99,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615326,726.0,BAO_0000219,,
100,17653,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Hepatitis B virus,10407.0,,,,,50606,N,1,Expert,1,,CHEMBL883130,,BAO_0000218,,
101,13105,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL884519,726.0,BAO_0000219,,
102,1717,Concentration required to inhibit 50% of 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615327,726.0,BAO_0000219,,
103,13105,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,A,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615328,726.0,BAO_0000219,,
104,13600,Cytotoxic activity of compound against uninfected 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615329,,BAO_0000218,,
105,13467,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615330,,BAO_0000218,,
106,17477,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",F,,,Hepatitis B virus,10407.0,,,2.2.15,,50606,N,1,Expert,1,,CHEMBL615331,,BAO_0000218,,
107,1593,In vitro anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615332,,BAO_0000218,,
108,1593,In vitro anti-HBV activity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615333,,BAO_0000218,,
109,15089,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615334,,BAO_0000218,,
110,15089,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615335,,BAO_0000218,,
111,1593,Cytotoxicity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615336,,BAO_0000218,,
112,1593,Cytotoxicity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615337,,BAO_0000218,,
113,13600,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615338,,BAO_0000218,,
114,13467,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615339,,BAO_0000218,,
115,13467,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615340,,BAO_0000218,,
116,14764,Antiviral activity against HBV was determined in 2.215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615341,726.0,BAO_0000219,,
117,6531,Inhibition of 20-HETE synthesis in human renal microsomes,B,,,Homo sapiens,9606.0,,,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL615342,,BAO_0000251,,
118,17322,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615343,,BAO_0000019,,
119,17072,Inhibitory concentration against 2008 (ovarian) cells,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615344,388.0,BAO_0000219,,
120,16936,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615345,388.0,BAO_0000219,,
121,16936,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615346,388.0,BAO_0000219,,
122,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615347,388.0,BAO_0000219,,
123,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615348,388.0,BAO_0000219,,
124,10797,In vitro inhibition of 2008/R ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,2008/R,,80613,N,1,Intermediate,1,,CHEMBL827085,561.0,BAO_0000219,,
125,10797,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606.0,,,2008/R,,80613,N,1,Intermediate,1,,CHEMBL615349,561.0,BAO_0000219,,
126,10797,In vitro inhibition of 2008/S ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,2008/S,,80614,N,1,Intermediate,1,,CHEMBL615350,389.0,BAO_0000219,,
127,10797,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606.0,,,2008/S,,80614,N,1,Intermediate,1,,CHEMBL615351,389.0,BAO_0000219,,
128,4823,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,B,,,Homo sapiens,9606.0,,,,,100256,S,2,Expert,1,,CHEMBL615352,,BAO_0000220,,
129,12912,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,B,,,Homo sapiens,9606.0,,,,,100256,S,2,Intermediate,1,,CHEMBL615353,,BAO_0000220,,
130,2957,Inhibition of chymotrypsin-like activity of 20S proteasome,B,,,,,,,,,100256,S,2,Expert,1,,CHEMBL615354,,BAO_0000220,,
131,2957,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,B,,,,,,,,,100256,S,2,Expert,1,,CHEMBL615355,,BAO_0000220,,
132,3260,Inhibitory activity against 20S proteosome,B,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615356,,BAO_0000220,,
133,3451,Compound was tested for inhibitory activity against tryptase,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615357,,BAO_0000019,,
134,13885,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615358,726.0,BAO_0000219,,
135,13885,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL827086,726.0,BAO_0000219,,
136,3676,Compound was tested for the inhibition of Alpha-glucosidase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615359,,BAO_0000019,,
137,6043,Inhibitory concentration against human neutrophil elastase (HNE),B,,,,,,,,,235,H,8,Autocuration,1,,CHEMBL615360,,BAO_0000357,,
138,11140,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,F,,,Rattus norvegicus,10116.0,,Heart,,,22226,U,0,Autocuration,1,,CHEMBL615361,,BAO_0000218,948.0,
139,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Autocuration,1,,CHEMBL615362,,BAO_0000019,,
140,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,1,,CHEMBL615363,,BAO_0000019,,
141,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,B,,,,,,,,,19640,H,8,Autocuration,1,,CHEMBL615364,,BAO_0000357,,
142,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,1,,CHEMBL615365,,BAO_0000019,,
143,11365,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,F,,,Mus musculus,10090.0,,,P338,,80360,N,1,Intermediate,1,,CHEMBL615366,524.0,BAO_0000219,,
144,11365,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,F,,,Mus musculus,10090.0,,,P338,,80360,N,1,Intermediate,1,,CHEMBL615367,524.0,BAO_0000219,,
145,11803,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,F,,,Homo sapiens,9606.0,,,PBL,,80384,N,1,Intermediate,1,,CHEMBL615368,554.0,BAO_0000219,,
146,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,F,,,Ovis aries,9940.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615369,,BAO_0000019,,
147,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,F,,,Ovis aries,9940.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615370,,BAO_0000019,,
148,12278,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),B,,,,,,,,,191,H,8,Autocuration,1,,CHEMBL615673,,BAO_0000357,,
149,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615674,,BAO_0000019,,
150,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615675,,BAO_0000019,,
151,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615676,635.0,BAO_0000219,,
152,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615677,635.0,BAO_0000219,,
153,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615678,635.0,BAO_0000219,,
154,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615679,635.0,BAO_0000219,,
155,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615680,,BAO_0000019,,
156,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615681,,BAO_0000019,,
157,16992,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,B,,,,,,,,,104290,H,6,Autocuration,1,,CHEMBL857972,,BAO_0000249,,
158,10543,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,F,,,Streptococcus pyogenes,1314.0,,,,,50264,N,1,Intermediate,1,,CHEMBL857899,,BAO_0000218,,
159,17833,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),F,,,Human herpesvirus 3,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615371,,BAO_0000218,,
160,17290,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,F,,,vericilla zoster virus,10335.0,,,HEL,,50527,N,1,Expert,1,,CHEMBL615372,468.0,BAO_0000218,,
161,17290,Antiviral activity against 07/1 strain of VZV; ND: No data,F,,,vericilla zoster virus,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615373,,BAO_0000218,,
162,17290,Antiviral activity against 07/1 strain of VZV; ND=No data,F,,,vericilla zoster virus,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615374,,BAO_0000218,,
163,10932,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",F,,,escherichia cloac,561.0,,,,,50145,N,1,Intermediate,1,,CHEMBL615375,,BAO_0000218,,
164,9707,Ratio of Ki at A2 to Ki at A1 receptors,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615376,,BAO_0000019,,
165,2346,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",B,,,Candida albicans,5476.0,,,,,11143,H,8,Expert,1,,CHEMBL615377,,BAO_0000249,,
166,2205,"Inhibition of 1,3-beta-glucan synthase",B,,,Candida glabrata CBS 138,284593.0,,,,,18077,H,8,Expert,1,,CHEMBL615378,,BAO_0000357,,
167,11900,Inhibition of growth of 1-87 human tumor cell line,F,,,Homo sapiens,9606.0,,,1-87 tumor cell line,,80609,N,1,Intermediate,1,,CHEMBL615379,832.0,BAO_0000219,,
168,14864,Inhibition of 1-lipoxygenase (LOX)in RBL cells,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL615380,,BAO_0000219,,
169,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615381,,BAO_0000357,,
170,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615382,,BAO_0000357,,
171,16474,% inhibition against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615383,,BAO_0000357,,
172,16474,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615384,,BAO_0000357,,
173,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615385,,BAO_0000357,,
174,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615386,,BAO_0000357,,
175,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615387,,BAO_0000357,,
176,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615388,,BAO_0000357,,
177,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615214,,BAO_0000357,,
178,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL827087,,BAO_0000357,,
179,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615215,,BAO_0000357,,
180,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615216,,BAO_0000357,,
181,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615217,,BAO_0000357,,
182,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615218,,BAO_0000357,,
183,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615219,,BAO_0000357,,
184,10413,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615220,,BAO_0000019,,
185,16929,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),F,,,Mus musculus,10090.0,,,C3H 10T1/2,,80049,N,1,Intermediate,1,,CHEMBL615221,294.0,BAO_0000219,,
186,1229,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL615222,,BAO_0000019,,
187,16587,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11489,H,8,Autocuration,1,,CHEMBL615223,,BAO_0000357,,
188,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615224,,BAO_0000357,,
189,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615225,,BAO_0000357,,
190,16587,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,B,,,,,,,,,11489,H,8,Autocuration,1,,CHEMBL615226,,BAO_0000357,,
191,16587,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615227,,BAO_0000357,,
192,8058,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,F,,,Bos taurus,9913.0,,,,,12347,D,9,Expert,1,,CHEMBL615228,,BAO_0000019,,
193,9065,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615229,,BAO_0000357,,
194,8865,Inhibition of 11 beta-hydroxylase from rat adrenal gland,B,,,Rattus norvegicus,10116.0,,Adrenal gland,,,100120,D,9,Expert,1,,CHEMBL615230,,BAO_0000357,2369.0,
195,9066,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615231,,BAO_0000357,,
196,8394,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL884520,,BAO_0000357,,
197,8394,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615232,,BAO_0000357,,
198,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,B,,,,,,,,,10328,H,8,Autocuration,1,,CHEMBL615233,,BAO_0000019,,
199,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,1,,CHEMBL827088,,BAO_0000357,,
200,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,1,,CHEMBL615234,,BAO_0000357,,
201,9295,Compound was tested for the percent of inhibition against 12-LO at 10 uM,F,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615235,,BAO_0000019,,
202,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615236,,BAO_0000019,,
203,13622,Compound was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615237,,BAO_0000019,,
204,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615238,,BAO_0000019,,
205,13622,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615239,,BAO_0000019,,
206,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,Homo sapiens,9606.0,,,,,11134,D,9,Autocuration,1,,CHEMBL615240,,BAO_0000019,,
207,13500,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,B,,,,,,,,,11835,H,8,Expert,1,,CHEMBL615241,,BAO_0000019,,
208,13723,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,B,,,,,,,,,11601,H,8,Expert,1,,CHEMBL615242,,BAO_0000357,,
209,16474,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615243,,BAO_0000019,,
210,1630,Inhibitory activity against human platelet 12-lipoxygenase,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615244,,BAO_0000019,,
211,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615245,,BAO_0000019,,
212,16474,% inhibition against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615246,,BAO_0000019,,
213,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615247,,BAO_0000019,,
214,16474,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615248,,BAO_0000019,,
215,10091,Inhibitory activity towards porcine 12-lipoxygenase,B,,,,,,,,,11601,H,8,Autocuration,1,,CHEMBL615249,,BAO_0000357,,
216,11966,Tested for inhibition against porcine 12-LO,B,,,,,,,,,11601,H,8,Autocuration,1,,CHEMBL615250,,BAO_0000357,,
217,951,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615251,,BAO_0000019,,
218,10997,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615252,,BAO_0000019,,
219,10193,In vitro inhibition of rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Expert,1,,CHEMBL828340,,BAO_0000019,,
220,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615253,,BAO_0000019,,
221,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615254,,BAO_0000019,,
222,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615255,,BAO_0000019,,
223,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615256,,BAO_0000019,,
224,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615257,,BAO_0000019,,
225,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615258,,BAO_0000019,,
226,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615259,621.0,BAO_0000219,,
227,12989,In vitro antitumor activity against 41M cell line.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL615260,621.0,BAO_0000219,,
228,16745,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615261,621.0,BAO_0000219,,
229,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615262,621.0,BAO_0000219,,
230,12989,In vitro antitumor activity against 41McisR cell line.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL615263,621.0,BAO_0000219,,
231,12989,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL838393,621.0,BAO_0000219,,
232,16745,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615264,621.0,BAO_0000219,,
233,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),B,,,Homo sapiens,9606.0,,,,,84,D,9,Expert,1,,CHEMBL615265,,BAO_0000357,,
234,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,Homo sapiens,9606.0,,,,,68,D,9,Expert,1,,CHEMBL615266,,BAO_0000357,,
235,6226,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,,,,,,,68,H,8,Expert,1,,CHEMBL615267,,BAO_0000357,,
236,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615268,,BAO_0000357,,
237,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615269,,BAO_0000357,,
238,17855,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615270,,BAO_0000357,,
239,10413,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL615271,,BAO_0000357,,
240,10413,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615272,,BAO_0000357,,
241,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615103,,BAO_0000357,,
242,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615104,,BAO_0000357,,
243,10413,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL615105,,BAO_0000357,,
244,10413,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL872866,,BAO_0000357,,
245,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615106,,BAO_0000357,,
246,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615107,,BAO_0000019,,
247,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615108,,BAO_0000357,,
248,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615109,,BAO_0000357,,
249,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615110,,BAO_0000357,,
250,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL840105,,BAO_0000019,,
251,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615111,,BAO_0000019,,
252,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615112,,BAO_0000019,,
253,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615113,,BAO_0000019,,
254,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615114,,BAO_0000019,,
255,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615115,,BAO_0000357,,
256,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615116,,BAO_0000019,,
257,7323,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",B,,,,,,,,,11303,H,8,Autocuration,1,,CHEMBL615698,,BAO_0000357,,
258,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615699,,BAO_0000019,,
259,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",B,,,Sus scrofa,9823.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615700,,BAO_0000019,,
260,13750,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,B,,,Saccharomyces cerevisiae,4932.0,,,,,100249,H,8,Expert,1,,CHEMBL615701,,BAO_0000357,,
261,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615702,,BAO_0000019,,
262,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615703,,BAO_0000019,,
263,7662,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615704,,BAO_0000019,,
264,12211,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL615705,,BAO_0000019,,
265,12211,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL615706,,BAO_0000019,,
266,12211,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615707,,BAO_0000221,2116.0,
267,12211,Stimulatory activity of intragastric pressure was tested in the rat,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL615708,,BAO_0000019,,
268,15453,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,B,,,,,,,,,121,H,8,Autocuration,1,,CHEMBL615709,,BAO_0000357,,
269,11884,Dose to reduce neuronal firing against 5-HT cells in rats (iv),F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615710,,BAO_0000218,,
270,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL615711,,BAO_0000019,,
271,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,B,,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL615712,,BAO_0000357,,
272,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,B,,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL836325,,BAO_0000357,,
273,11863,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615713,,BAO_0000019,,
274,11863,Inhibition constant of high-affinity 5-HT uptake,B,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615714,,BAO_0000357,,
275,11863,Michaelis-Menten constant was reported for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615715,,BAO_0000019,,
276,11863,Maximum rate was determined for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615716,,BAO_0000019,,
277,4639,Compound was tested for agonistic activity against 5-HT uptake,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL615717,,BAO_0000019,,
278,15796,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL881818,,BAO_0000019,,
279,15796,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL884540,,BAO_0000357,,
280,12801,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615718,,BAO_0000224,,
281,12801,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615719,,BAO_0000224,,
282,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615720,,BAO_0000249,,
283,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615721,,BAO_0000249,,
284,11963,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615722,,BAO_0000019,,
285,11701,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615723,,BAO_0000019,,
286,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615724,,BAO_0000221,10000000.0,
287,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615725,,BAO_0000221,10000000.0,
288,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615726,,BAO_0000221,10000000.0,
289,16394,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615727,,BAO_0000218,,
290,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL615728,,BAO_0000019,,
291,15779,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL857971,449.0,BAO_0000219,,
292,15363,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL615729,,BAO_0000357,,
293,15363,Efficacy against 5-hydroxytryptamine 2A receptor,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL615730,,BAO_0000019,,
294,15329,Intrinsic activity towards 5-HT2A receptor of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615731,,BAO_0000019,,
295,15329,Relative potency towards 5-HT2A receptor of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615732,,BAO_0000019,,
296,15329,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615733,,BAO_0000019,,
297,15329,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615734,,BAO_0000019,,
298,15329,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL615735,,BAO_0000019,,
299,15329,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615736,,BAO_0000019,,
300,273,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615737,,BAO_0000221,2116.0,
301,273,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615738,,BAO_0000221,2116.0,
302,273,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615739,,BAO_0000221,2116.0,
303,12092,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL615278,,BAO_0000357,,
304,1317,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL615279,,BAO_0000019,,
305,12409,Binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL615280,,BAO_0000357,,
306,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,B,,,Gallus gallus,9031.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615281,,BAO_0000019,,
307,11126,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615282,,BAO_0000019,,
308,11126,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615283,,BAO_0000019,,
309,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,B,,,Homo sapiens,9606.0,,,HL-60,,80156,N,1,Autocuration,1,,CHEMBL615284,649.0,BAO_0000219,,
310,11126,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615285,,BAO_0000019,,
311,11126,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615286,,BAO_0000019,,
312,17807,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,B,,,Homo sapiens,9606.0,,,Oocytes,,104703,D,7,Autocuration,1,,CHEMBL615287,,BAO_0000219,,
313,16575,Chymotryptic inhibitory activity against 26S proteasome,F,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615288,,BAO_0000220,,
314,15407,Inhibitory activity against 26S proteasome degradation of IkB,B,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615289,,BAO_0000220,,
315,10797,In vitro inhibition of 2780/DOX ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL615290,478.0,BAO_0000219,,
316,10797,In vitro inhibition of 2780/S ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884522,478.0,BAO_0000219,,
317,3469,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615291,,BAO_0000019,,
318,16037,Association constant for binding to AATT 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615292,,BAO_0000225,,
319,16037,Kinetically Defined Association Constant for 28-mer AATT hairpin.,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615293,,BAO_0000225,,
320,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615294,,BAO_0000225,,
321,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615295,,BAO_0000225,,
322,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL825021,,BAO_0000019,,
323,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615296,,BAO_0000019,,
324,16524,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615297,,BAO_0000019,,
325,16758,Cytotoxicity against cell line 2SC/20 determined by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615298,,BAO_0000019,,
326,16758,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615299,,BAO_0000019,,
327,16758,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615300,,BAO_0000019,,
328,14360,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,B,,,,,,,,,241,H,8,Autocuration,1,,CHEMBL615301,,BAO_0000357,,
329,14360,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,B,,,Homo sapiens,9606.0,,,,,241,D,9,Expert,1,,CHEMBL615302,,BAO_0000357,,
330,9964,Selectivity ratio of ID50 in liver and heart,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615303,,BAO_0000019,,
331,9964,"Selectivity, ratio of relative ID50 in liver and heart",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615304,,BAO_0000019,,
332,9964,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615305,,BAO_0000019,,
333,9964,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615306,,BAO_0000218,,
334,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615307,,BAO_0000218,,
335,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615308,,BAO_0000218,,
336,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",F,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615309,,BAO_0000218,,
337,9964,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615310,,BAO_0000019,,
338,9964,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615311,,BAO_0000019,,
339,9964,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615312,,BAO_0000019,,
340,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615313,,BAO_0000019,,
341,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,F,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615314,,BAO_0000019,,
342,9964,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615315,,BAO_0000019,,
343,9964,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615316,,BAO_0000218,,
344,9964,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,B,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615317,,BAO_0000218,,
345,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615318,,BAO_0000218,,
346,9964,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615319,,BAO_0000218,,
347,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615320,,BAO_0000019,,
348,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",F,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615321,,BAO_0000019,,
349,3796,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615322,,BAO_0000019,,
350,4251,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615323,,BAO_0000357,,
351,4251,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615407,,BAO_0000357,,
352,4251,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL857267,,BAO_0000357,,
353,4251,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615408,,BAO_0000357,,
354,166,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615409,,BAO_0000357,,
355,17861,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615410,,BAO_0000357,,
356,166,Inhibition constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615411,,BAO_0000357,,
357,166,Association rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615412,,BAO_0000357,,
358,166,Rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615413,,BAO_0000357,,
359,3548,Inhibitory activity against fuc-TVII,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615414,,BAO_0000019,,
360,9877,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615415,,BAO_0000251,2107.0,
361,9877,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615416,,BAO_0000251,2107.0,
362,9877,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615417,,BAO_0000251,2107.0,
363,9877,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615418,,BAO_0000251,2107.0,
364,9877,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615419,,BAO_0000251,2107.0,
365,9877,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615420,,BAO_0000251,2107.0,
366,9877,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615421,,BAO_0000251,2107.0,
367,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615422,,BAO_0000251,2107.0,
368,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615423,,BAO_0000251,2107.0,
369,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL872868,,BAO_0000251,2107.0,
370,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615424,,BAO_0000251,2107.0,
371,3003,Inhibitory activity against 3-phosphoglycerate kinase.,B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL825022,,BAO_0000224,,
372,3003,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL615425,,BAO_0000224,,
373,3003,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL615426,,BAO_0000224,,
374,17185,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,B,,,Homo sapiens,9606.0,,,,,10612,D,9,Expert,1,,CHEMBL615427,,BAO_0000357,,
375,6072,Cytotoxicity on 3677 melanoma cells,F,,,Homo sapiens,9606.0,,,3677 melanoma cell line,,80616,N,1,Intermediate,1,,CHEMBL615428,844.0,BAO_0000219,,
376,6072,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,F,,,Homo sapiens,9606.0,,,3677 melanoma cell line,,80616,N,1,Intermediate,1,,CHEMBL615429,844.0,BAO_0000219,,
377,5018,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,F,,,Mus musculus,10090.0,,,MC-38,,80617,N,1,Intermediate,1,,CHEMBL615430,700.0,BAO_0000219,,
378,2852,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Intermediate,1,,CHEMBL615431,,BAO_0000019,,
379,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,F,,,,,,,B16,,22226,U,0,Autocuration,1,,CHEMBL615432,798.0,BAO_0000218,,
380,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,F,,,,,,,B16,,22226,U,0,Autocuration,1,,CHEMBL615433,798.0,BAO_0000218,,
381,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615434,,BAO_0000019,,
382,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,F,,,Human rhinovirus sp.,169066.0,,,,,50085,N,1,Intermediate,1,,CHEMBL615435,,BAO_0000218,,
383,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,F,,,human rhinovirus type 14,169066.0,,,,,50679,N,1,Intermediate,1,,CHEMBL615436,,BAO_0000218,,
384,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,F,,,human rhinovirus type 14,169066.0,,,,,50679,N,1,Intermediate,1,,CHEMBL615437,,BAO_0000218,,
385,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615438,,BAO_0000019,,
386,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615439,,BAO_0000019,,
387,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615440,,BAO_0000019,,
388,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615441,,BAO_0000019,,
389,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL615641,,BAO_0000218,,
390,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL872065,,BAO_0000218,,
391,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL825023,,BAO_0000218,,
392,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL615642,,BAO_0000218,,
393,13748,Inhibition of human rhinovirus 3C protease,B,,,Human rhinovirus B,147712.0,,,,,12464,H,8,Expert,1,,CHEMBL615643,,BAO_0000357,,
394,17699,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615644,,BAO_0000019,,
395,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615645,833.0,BAO_0000218,,
396,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615646,833.0,BAO_0000218,,
397,7145,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615647,833.0,BAO_0000218,,
398,7145,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615648,833.0,BAO_0000218,,
399,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615649,833.0,BAO_0000218,,
400,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615650,833.0,BAO_0000218,,
401,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615651,847.0,BAO_0000218,,
402,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615652,847.0,BAO_0000218,,
403,5325,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Expert,1,,CHEMBL615653,847.0,BAO_0000218,,
404,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615654,847.0,BAO_0000219,,
405,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615655,847.0,BAO_0000219,,
406,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL825024,847.0,BAO_0000219,,
407,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615656,847.0,BAO_0000219,,
408,16169,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615657,847.0,BAO_0000219,,
409,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615658,847.0,BAO_0000219,,
410,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615659,847.0,BAO_0000219,,
411,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615660,847.0,BAO_0000219,,
412,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615661,847.0,BAO_0000219,,
413,16169,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615662,847.0,BAO_0000219,,
414,16169,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615663,847.0,BAO_0000219,,
415,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615664,847.0,BAO_0000219,,
416,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615665,847.0,BAO_0000219,,
417,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615666,847.0,BAO_0000219,,
418,16169,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615667,847.0,BAO_0000219,,
419,16169,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615668,847.0,BAO_0000219,,
420,16169,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615669,847.0,BAO_0000219,,
421,16169,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615670,847.0,BAO_0000219,,
422,16169,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL836739,847.0,BAO_0000219,,
423,16169,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615671,847.0,BAO_0000219,,
424,16169,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615672,847.0,BAO_0000219,,
425,16169,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615791,847.0,BAO_0000219,,
426,16169,spermine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615792,847.0,BAO_0000219,,
427,16169,spermine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615793,847.0,BAO_0000219,,
428,16169,spermine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615794,847.0,BAO_0000219,,
429,16169,spermine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615795,847.0,BAO_0000219,,
430,15547,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,F,,,Homo sapiens,9606.0,,,3LLD122,,80621,N,1,Intermediate,1,,CHEMBL615590,971.0,BAO_0000219,,
431,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615591,,BAO_0000218,,
432,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615592,,BAO_0000218,,
433,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615593,,BAO_0000218,,
434,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615594,,BAO_0000218,,
435,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615595,723.0,BAO_0000219,,
436,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615596,723.0,BAO_0000219,,
437,12695,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,F,,,,,,,NIH3T3,,11169,H,8,Expert,1,,CHEMBL615597,723.0,BAO_0000219,,
438,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615598,723.0,BAO_0000219,,
439,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615599,723.0,BAO_0000219,,
440,17642,Effective dose against murine 3T3 fibroblasts cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615600,723.0,BAO_0000219,,
441,17642,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615601,723.0,BAO_0000219,,
442,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615602,723.0,BAO_0000219,,
443,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615603,723.0,BAO_0000219,,
444,12716,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615604,723.0,BAO_0000219,,
445,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615605,723.0,BAO_0000219,,
446,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615606,723.0,BAO_0000219,,
447,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL884526,723.0,BAO_0000219,,
448,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615607,723.0,BAO_0000219,,
449,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615608,723.0,BAO_0000219,,
450,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615609,723.0,BAO_0000219,,
451,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615682,723.0,BAO_0000219,,
452,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615683,723.0,BAO_0000219,,
453,17780,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615684,723.0,BAO_0000218,,
454,12751,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,F,,,Mus musculus,10090.0,,,,,104860,D,7,Autocuration,1,,CHEMBL615685,,BAO_0000219,,
455,12380,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615686,723.0,BAO_0000219,,
456,14892,Inhibitory activity against 3T3 cell line,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615687,723.0,BAO_0000219,,
457,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL884523,723.0,BAO_0000219,,
458,12695,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615688,,BAO_0000019,,
459,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615689,723.0,BAO_0000219,,
460,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615690,723.0,BAO_0000219,,
461,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615691,,BAO_0000019,,
462,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615692,,BAO_0000019,,
463,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615693,723.0,BAO_0000219,,
464,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615324,723.0,BAO_0000219,,
465,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,F,,,Homo sapiens,9606.0,,,NIH3T3,,9,D,9,Expert,1,,CHEMBL615325,723.0,BAO_0000219,,
466,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606.0,,,NIH3T3,,9,D,9,Expert,1,,CHEMBL615490,723.0,BAO_0000219,,
467,4959,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,F,,,Homo sapiens,9606.0,,,NIH3T3,,188,D,9,Expert,1,,CHEMBL615491,723.0,BAO_0000219,,
468,4959,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606.0,,,NIH3T3,,188,D,9,Expert,1,,CHEMBL615492,723.0,BAO_0000219,,
469,12082,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615493,723.0,BAO_0000219,,
470,12082,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615494,723.0,BAO_0000219,,
471,12082,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615495,723.0,BAO_0000219,,
472,12082,Inhibitory concentration was calculated on 3T3 cells by using growth assay,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615496,723.0,BAO_0000219,,
473,2643,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615497,723.0,BAO_0000219,,
474,11926,Inhibition of Swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615498,723.0,BAO_0000219,,
475,15204,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,A,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615499,723.0,BAO_0000219,,
476,15992,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL835522,723.0,BAO_0000219,,
477,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615500,723.0,BAO_0000219,,
478,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615501,723.0,BAO_0000219,,
479,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615502,723.0,BAO_0000219,,
480,16279,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615503,723.0,BAO_0000219,,
481,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615504,723.0,BAO_0000219,,
482,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615505,723.0,BAO_0000219,,
483,12831,Inhibition of swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615506,723.0,BAO_0000219,,
484,13497,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615507,723.0,BAO_0000219,,
485,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615508,620.0,BAO_0000218,,
486,13618,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615509,620.0,BAO_0000219,,
487,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615510,620.0,BAO_0000219,,
488,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615511,620.0,BAO_0000219,,
489,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615512,620.0,BAO_0000219,,
490,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615513,620.0,BAO_0000218,,
491,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615514,620.0,BAO_0000218,,
492,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615515,620.0,BAO_0000219,,
493,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615516,620.0,BAO_0000219,,
494,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615517,620.0,BAO_0000219,,
495,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615518,620.0,BAO_0000219,,
496,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615519,620.0,BAO_0000219,,
497,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615520,620.0,BAO_0000218,,
498,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615521,620.0,BAO_0000218,,
499,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615522,620.0,BAO_0000218,,
500,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615523,620.0,BAO_0000218,,
501,13715,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615524,620.0,BAO_0000218,,
502,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615525,620.0,BAO_0000218,,
503,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615526,620.0,BAO_0000218,,
504,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615527,620.0,BAO_0000218,,
505,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615528,620.0,BAO_0000218,,
506,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615529,620.0,BAO_0000218,,
507,13715,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615530,620.0,BAO_0000218,,
508,13715,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615531,620.0,BAO_0000218,,
509,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615532,620.0,BAO_0000219,,
510,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615533,620.0,BAO_0000219,,
511,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615534,620.0,BAO_0000219,,
512,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615535,620.0,BAO_0000218,,
513,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615536,620.0,BAO_0000218,,
514,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615537,620.0,BAO_0000218,,
515,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615538,620.0,BAO_0000218,,
516,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL836166,620.0,BAO_0000218,,
517,6411,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,F,,,,,,,3T3-L1,,11214,H,8,Expert,1,,CHEMBL615539,620.0,BAO_0000219,,
518,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615540,620.0,BAO_0000219,,
519,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,F,,,,,,,3T3-L1,,11214,H,8,Expert,1,,CHEMBL615541,620.0,BAO_0000219,,
520,3966,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615542,620.0,BAO_0000219,,
521,3966,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615543,620.0,BAO_0000219,,
522,15556,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615544,620.0,BAO_0000219,,
523,5845,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615545,620.0,BAO_0000219,,
524,14422,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615546,620.0,BAO_0000219,,
525,5845,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615547,620.0,BAO_0000219,,
526,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615548,620.0,BAO_0000219,,
527,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615549,620.0,BAO_0000219,,
528,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615550,620.0,BAO_0000219,,
529,6349,Inhibitory activity against rat fibroblast (3Y1) cell line,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Intermediate,1,,CHEMBL615551,1118.0,BAO_0000219,,
530,15899,Mean concentration causing inhibition of cell growth in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615552,1118.0,BAO_0000219,,
531,15899,Cytotoxicity in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615553,1118.0,BAO_0000219,,
532,15899,Cytostatic effect in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615554,1118.0,BAO_0000219,,
533,15899,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Intermediate,1,,CHEMBL615555,1118.0,BAO_0000219,,
534,17038,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615556,1118.0,BAO_0000219,,
535,12421,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615557,,BAO_0000019,,
536,12947,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615558,,BAO_0000019,,
537,12947,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL872066,,BAO_0000019,,
538,4896,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,B,,,Sus scrofa,9823.0,,,,,11607,D,9,Expert,1,,CHEMBL615559,,BAO_0000019,,
539,6148,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615560,,BAO_0000019,,
540,16432,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615561,,BAO_0000019,,
541,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,B,,,,,,,,,11607,H,8,Expert,1,,CHEMBL857062,,BAO_0000019,,
542,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),B,,,,,,,,,11607,H,8,Expert,1,,CHEMBL615562,,BAO_0000019,,
543,3723,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615563,,BAO_0000019,,
544,3518,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615564,,BAO_0000357,,
545,4164,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615565,,BAO_0000019,,
546,3518,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615566,,BAO_0000019,,
547,4164,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,B,,,Sus scrofa,9823.0,,,,,11607,D,9,Expert,1,,CHEMBL615567,,BAO_0000019,,
548,3518,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615568,,BAO_0000019,,
549,3518,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615569,,BAO_0000357,,
550,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615570,,BAO_0000019,,
551,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615571,,BAO_0000019,,
552,6455,Binding affinity against melatonin (MT1) receptor (pC1),B,,,,,,,,,104733,H,4,Autocuration,1,,CHEMBL615572,,BAO_0000224,,
553,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615573,,BAO_0000019,,
554,13020,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615574,,BAO_0000019,,
555,13021,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615575,,BAO_0000019,,
556,14532,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,B,,,,,,,,,10619,H,8,Autocuration,1,,CHEMBL615576,,BAO_0000357,,
557,14118,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,,,,,,,10619,H,8,Autocuration,1,,CHEMBL615577,,BAO_0000357,,
558,11884,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615578,,BAO_0000221,10000000.0,
559,13969,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615579,,BAO_0000357,,
560,13392,Binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615580,,BAO_0000357,,
561,14430,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615581,,BAO_0000019,,
562,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615582,,BAO_0000221,10000000.0,
563,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615583,,BAO_0000221,10000000.0,
564,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615584,,BAO_0000221,10000000.0,
565,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL833691,,BAO_0000221,10000000.0,
566,9995,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615585,,BAO_0000221,10000000.0,
567,9995,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615586,,BAO_0000221,10000000.0,
568,9995,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL884524,,BAO_0000221,10000000.0,
569,12249,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615587,,BAO_0000221,10000000.0,
570,11799,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615588,,BAO_0000221,10000000.0,
571,14331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL615589,,BAO_0000249,,
572,11884,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,B,,,Bos taurus,9913.0,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615442,,BAO_0000221,10000000.0,
573,14331,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615443,,BAO_0000221,10000000.0,
574,11701,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615444,,BAO_0000221,10000000.0,
575,11701,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615445,,BAO_0000221,10000000.0,
576,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615446,,BAO_0000221,10000000.0,
577,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615447,449.0,BAO_0000219,,
578,12248,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615448,,BAO_0000221,10000000.0,
579,12249,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615449,,BAO_0000221,10000000.0,
580,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615450,449.0,BAO_0000219,,
581,11799,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615451,,BAO_0000221,10000000.0,
582,634,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615452,,BAO_0000357,,
583,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615453,,BAO_0000221,10000000.0,
584,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615454,,BAO_0000221,10000000.0,
585,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615455,,BAO_0000221,10000000.0,
586,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615456,,BAO_0000221,10000000.0,
587,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615457,,BAO_0000221,10000000.0,
588,12210,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615458,,BAO_0000218,10000000.0,
589,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615459,,BAO_0000221,10000000.0,
590,2331,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615460,449.0,BAO_0000219,,
591,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,F,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615461,,BAO_0000019,,
592,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,F,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615462,,BAO_0000019,,
593,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,F,,,Cavia porcellus,10141.0,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615463,,BAO_0000221,10000000.0,
594,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615464,,BAO_0000221,2116.0,
595,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615465,,BAO_0000221,2116.0,
596,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615466,,BAO_0000221,2116.0,
597,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615467,,BAO_0000221,2116.0,
598,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615468,,BAO_0000221,2116.0,
599,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615469,,BAO_0000221,2116.0,
600,11574,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615470,,BAO_0000357,,
601,13114,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615471,,BAO_0000357,,
602,13181,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615472,,BAO_0000357,,
603,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,B,,,Cavia porcellus,10141.0,,Hippocampus,,,106,H,8,Autocuration,1,,CHEMBL883242,,BAO_0000221,10000000.0,
604,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,F,,,Cavia porcellus,10141.0,,Hippocampus,,,106,H,8,Autocuration,1,,CHEMBL615473,,BAO_0000221,10000000.0,
605,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),B,,,Cricetulus griseus,10029.0,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL615474,449.0,BAO_0000218,,
606,17785,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615475,,BAO_0000357,,
607,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,F,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615476,308.0,BAO_0000219,,
608,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,F,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615477,308.0,BAO_0000219,,
609,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615478,,BAO_0000019,,
610,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615160,449.0,BAO_0000219,,
611,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615161,449.0,BAO_0000219,,
612,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615162,449.0,BAO_0000219,,
613,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615163,449.0,BAO_0000219,,
614,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615164,449.0,BAO_0000219,,
615,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615165,449.0,BAO_0000219,,
616,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615166,449.0,BAO_0000219,,
617,14256,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615167,,BAO_0000219,,
618,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL615168,308.0,BAO_0000219,,
619,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL615169,308.0,BAO_0000219,,
620,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615170,449.0,BAO_0000219,,
621,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615171,449.0,BAO_0000219,,
622,15180,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615694,,BAO_0000019,,
623,15180,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615695,,BAO_0000019,,
624,16026,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615696,,BAO_0000019,,
625,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615697,449.0,BAO_0000219,,
626,2759,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL859410,449.0,BAO_0000219,,
627,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615841,449.0,BAO_0000219,,
628,2759,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615842,449.0,BAO_0000219,,
629,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL835003,449.0,BAO_0000219,,
630,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615843,449.0,BAO_0000219,,
631,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615979,449.0,BAO_0000219,,
632,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615980,449.0,BAO_0000219,,
633,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615981,449.0,BAO_0000219,,
634,3445,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615982,,BAO_0000019,,
635,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615983,,BAO_0000019,,
636,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615984,,BAO_0000019,,
637,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615985,,BAO_0000019,,
638,17624,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615986,449.0,BAO_0000219,,
639,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615987,449.0,BAO_0000219,,
640,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615988,449.0,BAO_0000219,,
641,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615989,449.0,BAO_0000219,,
642,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615990,449.0,BAO_0000219,,
643,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615991,449.0,BAO_0000219,,
644,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615992,449.0,BAO_0000219,,
645,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615993,449.0,BAO_0000219,,
646,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615994,449.0,BAO_0000219,,
647,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615995,449.0,BAO_0000219,,
648,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615996,449.0,BAO_0000219,,
649,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615997,449.0,BAO_0000219,,
650,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615998,,BAO_0000019,,
651,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615999,,BAO_0000019,,
652,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616000,,BAO_0000019,,
653,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616001,722.0,BAO_0000219,,
654,6876,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616002,,BAO_0000019,,
655,6876,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616003,,BAO_0000019,,
656,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616004,,BAO_0000019,,
657,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616005,,BAO_0000019,,
658,5548,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616006,,BAO_0000019,,
659,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616007,,BAO_0000019,,
660,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616008,,BAO_0000019,,
661,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616009,,BAO_0000019,,
662,5929,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616010,,BAO_0000019,,
663,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616011,,BAO_0000019,,
664,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615740,,BAO_0000019,,
665,16245,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615741,,BAO_0000019,,
666,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL615742,,BAO_0000019,,
667,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615743,,BAO_0000019,,
668,14509,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615744,449.0,BAO_0000219,,
669,14509,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615745,449.0,BAO_0000219,,
670,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615746,,BAO_0000357,,
671,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615747,,BAO_0000357,,
672,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615748,,BAO_0000019,,
673,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615749,,BAO_0000019,,
674,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615750,,BAO_0000019,,
675,6563,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616259,,BAO_0000019,,
676,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616260,,BAO_0000019,,
677,5272,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616261,,BAO_0000019,,
678,5272,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616262,,BAO_0000019,,
679,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616263,,BAO_0000019,,
680,5272,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616264,,BAO_0000019,,
681,5272,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616265,,BAO_0000019,,
682,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616266,,BAO_0000019,,
683,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616267,,BAO_0000019,,
684,5272,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616268,,BAO_0000019,,
685,16146,Inhibition of human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616269,,BAO_0000357,,
686,17624,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL884528,449.0,BAO_0000219,,
687,13706,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,B,,,,,,,HEK293,,105,D,9,Expert,1,,CHEMBL616270,722.0,BAO_0000219,,
688,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616271,449.0,BAO_0000219,,
689,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616272,449.0,BAO_0000219,,
690,6861,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616273,,BAO_0000357,,
691,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616274,,BAO_0000357,,
692,17624,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616275,449.0,BAO_0000219,,
693,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616276,449.0,BAO_0000219,,
694,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616277,,BAO_0000218,,
695,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616278,,BAO_0000218,,
696,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616279,,BAO_0000218,,
697,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616280,,BAO_0000218,,
698,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616281,,BAO_0000218,,
699,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616282,,BAO_0000218,,
700,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616283,,BAO_0000218,,
701,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616284,,BAO_0000218,,
702,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616285,,BAO_0000218,,
703,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616286,,BAO_0000218,,
704,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616287,,BAO_0000218,,
705,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616288,,BAO_0000218,,
706,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616289,,BAO_0000218,,
707,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615610,,BAO_0000218,,
708,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615611,,BAO_0000218,,
709,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615612,,BAO_0000218,,
710,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615613,,BAO_0000218,,
711,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615614,,BAO_0000218,,
712,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615615,,BAO_0000218,,
713,11440,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,B,,,,,,,,,105093,H,4,Autocuration,1,,CHEMBL615616,,BAO_0000019,,
714,6238,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,B,,,,,,Hypothalamus,,,11923,H,8,Autocuration,1,,CHEMBL615617,,BAO_0000249,1898.0,
715,10046,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL615618,,BAO_0000019,,
716,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL615619,,BAO_0000019,,
717,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL615620,,BAO_0000019,,
718,167,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615621,,BAO_0000357,,
719,167,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615622,,BAO_0000357,,
720,11520,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615623,,BAO_0000019,,
721,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615624,,BAO_0000019,,
722,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615625,,BAO_0000019,,
723,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL767045,,BAO_0000019,,
724,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615626,,BAO_0000019,,
725,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615627,,BAO_0000019,,
726,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615628,,BAO_0000019,,
727,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615629,,BAO_0000357,,
728,12281,Inhibitory concentration against 5-lipoxygenase from human whole blood,B,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL615630,,BAO_0000357,,
729,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615631,,BAO_0000219,,
730,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615632,,BAO_0000218,,
731,12281,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615633,,BAO_0000357,,
732,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615634,,BAO_0000218,,
733,11089,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,B,,,Sus scrofa,9823.0,,,,,55,H,8,Expert,1,,CHEMBL615635,,BAO_0000019,,
734,11006,In vitro inhibition of rat 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL615636,,BAO_0000357,,
735,11481,Inhibitory activity against 5-Lipoxygenase,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL615637,,BAO_0000357,,
736,10864,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL615638,702.0,BAO_0000219,,
737,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615639,702.0,BAO_0000219,,
738,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615640,702.0,BAO_0000219,,
739,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615796,,BAO_0000019,,
740,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615845,,BAO_0000219,,
741,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615846,,BAO_0000357,,
742,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615847,702.0,BAO_0000219,,
743,11311,The compound was tested for inhibition of isolated 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615848,,BAO_0000357,,
744,11481,Ratio of IC50 against 5-LO and COX,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615849,,BAO_0000019,,
745,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615850,,BAO_0000357,,
746,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615851,,BAO_0000357,,
747,11311,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615852,,BAO_0000219,,
748,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615853,,BAO_0000019,,
749,4288,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,B,,,,,,Prostate gland,,,120,H,8,Autocuration,1,,CHEMBL884527,,BAO_0000357,2367.0,
750,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL872871,,BAO_0000019,,
751,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615854,,BAO_0000019,,
752,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL767046,,BAO_0000019,,
753,11249,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,B,,,,,,,,,10732,H,8,Autocuration,1,,CHEMBL615855,,BAO_0000357,,
754,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615856,,BAO_0000019,,
755,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615857,,BAO_0000019,,
756,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615858,,BAO_0000019,,
757,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615859,,BAO_0000221,10000000.0,
758,16293,Binding affinity towards human 5-hydroxytryptamine 1 receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615860,,BAO_0000357,,
759,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615861,,BAO_0000019,,
760,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615862,,BAO_0000019,,
761,13047,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615863,,BAO_0000019,,
762,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615864,,BAO_0000019,,
763,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615865,,BAO_0000221,10000000.0,
764,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615866,,BAO_0000221,10000000.0,
765,10085,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615867,,BAO_0000221,10000000.0,
766,9841,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615868,,BAO_0000249,,
767,8822,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615869,,BAO_0000249,,
768,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615870,,BAO_0000019,,
769,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615871,,BAO_0000019,,
770,8868,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615872,,BAO_0000224,,
771,9036,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL833492,,BAO_0000221,10000000.0,
772,11374,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615873,,BAO_0000221,10000000.0,
773,10881,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615479,,BAO_0000224,,
774,8822,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615480,,BAO_0000019,,
775,9806,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615481,,BAO_0000249,,
776,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL872869,,BAO_0000019,,
777,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615482,,BAO_0000019,,
778,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615483,,BAO_0000221,955.0,
779,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615484,,BAO_0000221,955.0,
780,8569,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615485,,BAO_0000019,,
781,10062,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615486,,BAO_0000224,,
782,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615487,,BAO_0000224,,
783,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615488,,BAO_0000224,,
784,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615489,,BAO_0000224,,
785,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615389,,BAO_0000224,,
786,15463,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615390,,BAO_0000019,,
787,15463,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615391,,BAO_0000019,,
788,9098,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615392,,BAO_0000224,,
789,3070,Affinity for 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615393,,BAO_0000019,,
790,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615394,,BAO_0000221,955.0,
791,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615395,,BAO_0000221,955.0,
792,6398,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615396,,BAO_0000224,,
793,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615397,,BAO_0000221,955.0,
794,11963,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615398,,BAO_0000019,,
795,8908,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615399,,BAO_0000019,,
796,9098,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615400,,BAO_0000019,,
797,8841,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615401,,BAO_0000019,,
798,8814,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615402,,BAO_0000019,,
799,11752,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615403,,BAO_0000019,,
800,11642,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615404,,BAO_0000221,955.0,
801,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615781,,BAO_0000019,,
802,9231,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615782,,BAO_0000220,955.0,
803,11351,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615783,,BAO_0000221,955.0,
804,4639,Compound was tested for binding affinity against 5-HT1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL873481,,BAO_0000019,,
805,1205,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615784,,BAO_0000019,,
806,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615785,,BAO_0000357,,
807,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615786,,BAO_0000249,,
808,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615787,,BAO_0000218,,
809,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615788,,BAO_0000218,,
810,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL767044,,BAO_0000019,,
811,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615789,,BAO_0000218,,
812,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615790,,BAO_0000218,,
813,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615813,,BAO_0000019,,
814,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615814,,BAO_0000219,,
815,15535,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,F,,,,,,,,,51,H,8,Expert,1,,CHEMBL615815,,BAO_0000219,,
816,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615816,,BAO_0000219,,
817,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615817,,BAO_0000249,,
818,10085,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615818,,BAO_0000221,10000000.0,
819,10085,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615819,,BAO_0000221,10000000.0,
820,17331,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL615820,,BAO_0000249,,
821,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615821,,BAO_0000221,10000000.0,
822,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615822,,BAO_0000221,10000000.0,
823,10845,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615823,,BAO_0000221,10000000.0,
824,10845,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615824,,BAO_0000221,10000000.0,
825,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615825,,BAO_0000221,10000000.0,
826,13730,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615826,,BAO_0000357,,
827,13508,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615827,,BAO_0000249,,
828,13508,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615828,,BAO_0000249,10000000.0,
829,12073,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615829,,BAO_0000221,10000000.0,
830,4671,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615830,,BAO_0000221,10000000.0,
831,13631,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615831,,BAO_0000221,10000000.0,
832,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615832,,BAO_0000357,,
833,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615833,,BAO_0000019,,
834,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615834,,BAO_0000221,10000000.0,
835,12352,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL615835,,BAO_0000249,,
836,14732,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615836,,BAO_0000249,10000000.0,
837,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615837,,BAO_0000019,,
838,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615838,,BAO_0000019,,
839,13657,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615839,,BAO_0000249,,
840,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL884525,,BAO_0000019,,
841,2014,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615840,,BAO_0000249,,
842,3086,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615405,,BAO_0000221,10000000.0,
843,15854,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615406,,BAO_0000019,,
844,10922,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615900,,BAO_0000221,10000000.0,
845,13346,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615901,,BAO_0000221,10000000.0,
846,15311,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615902,,BAO_0000357,,
847,10922,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615903,,BAO_0000221,10000000.0,
848,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615904,,BAO_0000357,,
849,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615905,,BAO_0000357,,
850,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615906,,BAO_0000019,,
851,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615907,,BAO_0000019,,
852,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615908,,BAO_0000019,,
853,15789,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615909,,BAO_0000221,10000000.0,
854,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615910,,BAO_0000019,,
855,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615911,,BAO_0000019,,
856,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615912,,BAO_0000019,,
857,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615913,,BAO_0000019,,
858,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615914,,BAO_0000357,,
859,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615915,,BAO_0000221,10000000.0,
860,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615916,,BAO_0000357,,
861,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615917,,BAO_0000357,,
862,13830,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615918,,BAO_0000357,,
863,14286,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615919,,BAO_0000249,10000000.0,
864,14356,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615920,,BAO_0000221,10000000.0,
865,15306,Inhibition concentration against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615921,,BAO_0000357,,
866,15306,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615922,,BAO_0000357,,
867,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL881290,,BAO_0000249,,
868,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615923,,BAO_0000221,10000000.0,
869,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615924,,BAO_0000221,10000000.0,
870,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615925,,BAO_0000221,10000000.0,
871,14178,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615926,,BAO_0000357,,
872,10639,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615927,,BAO_0000019,,
873,12306,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615928,,BAO_0000221,10000000.0,
874,1348,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615929,,BAO_0000357,,
875,13605,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615930,,BAO_0000221,10000000.0,
876,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615931,449.0,BAO_0000219,,
877,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615932,449.0,BAO_0000219,,
878,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615933,449.0,BAO_0000219,,
879,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615934,,BAO_0000357,,
880,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615935,,BAO_0000357,,
881,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615936,,BAO_0000019,,
882,4751,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615937,449.0,BAO_0000219,,
883,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615938,,BAO_0000357,,
884,3805,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615797,,BAO_0000357,,
885,5640,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615798,,BAO_0000357,,
886,6563,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872870,,BAO_0000357,,
887,5548,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615799,,BAO_0000357,,
888,6347,Percent binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615800,,BAO_0000357,,
889,17296,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL615801,722.0,BAO_0000219,,
890,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615802,,BAO_0000019,,
891,15740,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615803,,BAO_0000357,,
892,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL835002,,BAO_0000019,,
893,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615804,,BAO_0000019,,
894,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL615805,308.0,BAO_0000219,,
895,4751,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615806,449.0,BAO_0000219,,
896,6491,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615807,,BAO_0000357,,
897,4707,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615808,,BAO_0000357,,
898,13910,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615809,,BAO_0000357,,
899,16190,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615810,308.0,BAO_0000219,,
900,16633,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615811,,BAO_0000357,,
901,11898,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615812,449.0,BAO_0000219,,
902,11898,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615751,449.0,BAO_0000219,,
903,14331,Binding affinity against human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615752,,BAO_0000357,,
904,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615753,449.0,BAO_0000219,,
905,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615754,449.0,BAO_0000219,,
906,3307,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615755,,BAO_0000357,,
907,6563,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615756,449.0,BAO_0000219,,
908,14165,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615757,,BAO_0000019,,
909,5732,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615758,,BAO_0000357,,
910,13366,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615759,,BAO_0000357,,
911,17626,Binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615760,,BAO_0000357,,
912,6588,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL615761,308.0,BAO_0000219,,
913,16209,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872104,,BAO_0000357,,
914,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615762,,BAO_0000357,,
915,15463,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615763,,BAO_0000357,,
916,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615764,,BAO_0000357,,
917,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),B,,,,,,,Cell line,,51,H,8,Autocuration,1,,CHEMBL615765,1167.0,BAO_0000219,,
918,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615766,,BAO_0000019,,
919,5548,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615767,,BAO_0000357,,
920,5548,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615768,,BAO_0000357,,
921,5548,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615769,,BAO_0000357,,
922,6876,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615770,,BAO_0000357,,
923,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615771,,BAO_0000357,,
924,17785,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615772,,BAO_0000357,,
925,6013,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615773,,BAO_0000357,,
926,5929,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615774,,BAO_0000357,,
927,16633,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615775,,BAO_0000357,,
928,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615776,,BAO_0000357,,
929,16026,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615777,,BAO_0000357,,
930,12469,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615778,,BAO_0000219,,
931,15874,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615779,,BAO_0000357,,
932,15874,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615780,,BAO_0000357,,
933,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616298,,BAO_0000357,,
934,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616299,,BAO_0000357,,
935,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,51,H,8,Autocuration,1,,CHEMBL616300,485.0,BAO_0000219,,
936,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,51,H,8,Expert,1,,CHEMBL616301,485.0,BAO_0000219,,
937,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616302,,BAO_0000019,,
938,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616117,,BAO_0000019,,
939,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616118,,BAO_0000019,,
940,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616119,,BAO_0000019,,
941,3445,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616120,308.0,BAO_0000219,,
942,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616121,,BAO_0000357,,
943,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616122,,BAO_0000357,,
944,17626,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616123,,BAO_0000357,,
945,4234,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616124,,BAO_0000357,,
946,5640,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616125,,BAO_0000357,,
947,5272,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,51,H,8,Expert,1,,CHEMBL616126,,BAO_0000357,,
948,4622,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616127,449.0,BAO_0000219,,
949,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616128,,BAO_0000019,,
950,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616129,,BAO_0000357,,
951,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616130,,BAO_0000357,,
952,15267,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616131,,BAO_0000357,,
953,17158,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616132,308.0,BAO_0000219,,
954,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616133,308.0,BAO_0000219,,
955,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616134,,BAO_0000357,,
956,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616135,,BAO_0000357,,
957,2391,Affinity for 5-hydroxytryptamine 1A receptor subtype,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616136,,BAO_0000357,,
958,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616137,,BAO_0000019,,
959,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872105,,BAO_0000019,,
960,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616138,,BAO_0000357,,
961,13051,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616139,,BAO_0000357,,
962,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616140,,BAO_0000019,,
963,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616141,,BAO_0000019,,
964,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616142,,BAO_0000357,,
965,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616143,,BAO_0000357,,
966,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616144,308.0,BAO_0000219,,
967,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616145,308.0,BAO_0000219,,
968,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616012,308.0,BAO_0000219,,
969,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616013,308.0,BAO_0000219,,
970,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616014,,BAO_0000019,,
971,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616015,,BAO_0000019,,
972,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616016,,BAO_0000019,,
973,16394,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,F,In vivo,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616017,,BAO_0000218,,
974,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616018,,BAO_0000019,,
975,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616019,,BAO_0000019,,
976,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616020,,BAO_0000019,,
977,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL858018,,BAO_0000357,,
978,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616021,722.0,BAO_0000219,,
979,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616022,,BAO_0000019,,
980,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616023,,BAO_0000019,,
981,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616024,,BAO_0000019,,
982,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616025,,BAO_0000019,,
983,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616026,449.0,BAO_0000219,,
984,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616027,,BAO_0000019,,
985,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616028,,BAO_0000019,,
986,3445,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616029,,BAO_0000019,,
987,4316,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL616030,449.0,BAO_0000219,,
988,4316,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616031,,BAO_0000019,,
989,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616032,,BAO_0000019,,
990,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616033,,BAO_0000019,,
991,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616034,,BAO_0000019,,
992,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616035,,BAO_0000019,,
993,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616036,,BAO_0000019,,
994,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616037,,BAO_0000019,,
995,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616038,,BAO_0000019,,
996,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616039,,BAO_0000019,,
997,15042,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616040,,BAO_0000019,,
998,15180,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616041,308.0,BAO_0000219,,
999,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616042,308.0,BAO_0000219,,
1000,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616043,308.0,BAO_0000219,,
1001,16245,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616044,,BAO_0000019,,
1002,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616045,,BAO_0000019,,
1003,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616046,722.0,BAO_0000219,,
1004,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616047,449.0,BAO_0000219,,
1005,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616048,449.0,BAO_0000219,,
1006,2759,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL616049,449.0,BAO_0000219,,
1007,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616050,449.0,BAO_0000219,,
1008,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616051,,BAO_0000219,,
1009,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616212,,BAO_0000219,,
1010,16026,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616213,,BAO_0000019,,
1011,1414,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,B,In vitro,,,,,,,,51,H,8,Expert,1,,CHEMBL616214,,BAO_0000219,,
1012,1414,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,B,In vitro,,,,,,,,51,H,8,Expert,1,,CHEMBL616215,,BAO_0000219,,
1013,12861,Binding activity radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616216,,BAO_0000357,,
1014,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616217,,BAO_0000019,,
1015,5104,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616218,,BAO_0000357,,
1016,5105,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616219,,BAO_0000357,,
1017,16312,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616220,,BAO_0000357,,
1018,15180,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL833493,,BAO_0000357,,
1019,5033,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616221,,BAO_0000357,,
1020,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL616222,449.0,BAO_0000219,,
1021,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616223,,BAO_0000019,,
1022,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616224,,BAO_0000019,,
1023,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616225,,BAO_0000019,,
1024,4540,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,51,D,9,Expert,1,,CHEMBL616226,722.0,BAO_0000219,,
1025,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616227,722.0,BAO_0000219,,
1026,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616228,722.0,BAO_0000219,,
1027,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616229,722.0,BAO_0000219,,
1028,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616230,722.0,BAO_0000219,,
1029,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616231,722.0,BAO_0000219,,
1030,6166,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616232,,BAO_0000357,,
1031,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616233,722.0,BAO_0000219,,
1032,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL857973,722.0,BAO_0000219,,
1033,15316,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616234,,BAO_0000219,,
1034,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616235,,BAO_0000357,,
1035,14727,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL616236,308.0,BAO_0000219,,
1036,14727,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616237,,BAO_0000019,,
1037,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616238,722.0,BAO_0000219,,
1038,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616239,722.0,BAO_0000219,,
1039,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616240,,BAO_0000219,,
1040,15042,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616241,308.0,BAO_0000219,,
1041,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616242,722.0,BAO_0000219,,
1042,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616243,722.0,BAO_0000219,,
1043,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,D,9,Expert,1,,CHEMBL616244,,BAO_0000357,,
1044,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Autocuration,1,,CHEMBL616245,,BAO_0000357,,
1045,5486,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616246,,BAO_0000357,,
1046,5254,Binding affinity against 5-HT1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616247,,BAO_0000357,,
1047,5254,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616248,,BAO_0000357,,
1048,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL616249,,BAO_0000357,,
1049,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,B,,,Homo sapiens,9606.0,,,,,10576,H,8,Autocuration,1,,CHEMBL616250,,BAO_0000357,,
1050,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616251,,BAO_0000357,,
1051,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616252,,BAO_0000218,,
1052,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616253,,BAO_0000218,,
1053,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616254,,BAO_0000218,,
1054,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616255,,BAO_0000218,,
1055,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL832872,,BAO_0000218,,
1056,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616256,,BAO_0000218,,
1057,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616257,,BAO_0000218,,
1058,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616258,,BAO_0000218,,
1059,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616384,,BAO_0000218,,
1060,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616385,,BAO_0000221,10000000.0,
1061,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,B,,,,,,,,,11863,H,8,Expert,1,,CHEMBL616386,,BAO_0000357,,
1062,10297,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616387,,BAO_0000221,10000000.0,
1063,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616388,,BAO_0000221,10000000.0,
1064,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616389,,BAO_0000221,10000000.0,
1065,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616390,,BAO_0000221,10000000.0,
1066,217,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616391,,BAO_0000357,,
1067,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616392,,BAO_0000221,10000000.0,
1068,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616393,,BAO_0000357,,
1069,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616394,,BAO_0000357,,
1070,4996,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616395,,BAO_0000019,,
1071,12918,Compound was evaluated for the binding affinity at 5- HT1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616396,,BAO_0000357,,
1072,5333,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL872907,,BAO_0000019,,
1073,4437,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616397,,BAO_0000019,,
1074,1742,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616398,,BAO_0000019,,
1075,16688,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616399,,BAO_0000357,,
1076,12861,Binding activity radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL857065,,BAO_0000357,,
1077,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616400,,BAO_0000019,,
1078,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616401,,BAO_0000019,,
1079,12490,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL616402,,BAO_0000019,,
1080,11828,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616403,,BAO_0000019,,
1081,11866,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,B,,,Sus scrofa,9823.0,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL616404,,BAO_0000221,10000000.0,
1082,12827,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616405,,BAO_0000249,,
1083,12918,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616406,,BAO_0000019,,
1084,12919,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,F,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616407,,BAO_0000019,,
1085,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,B,,,Oryctolagus cuniculus,9986.0,,,,,51,H,8,Autocuration,1,,CHEMBL616408,,BAO_0000019,,
1086,15796,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616409,,BAO_0000249,,
1087,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616410,,BAO_0000221,10000000.0,
1088,188,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616411,,BAO_0000357,,
1089,16616,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616412,,BAO_0000249,,
1090,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,Hippocampus,,Membranes,10576,D,9,Expert,1,,CHEMBL616413,,BAO_0000249,10000000.0,
1091,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616414,,BAO_0000221,10000000.0,
1092,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616415,,BAO_0000221,10000000.0,
1093,14776,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616416,,BAO_0000019,,
1094,12158,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616417,,BAO_0000357,,
1095,13481,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616418,,BAO_0000357,,
1096,13427,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616419,,BAO_0000219,,
1097,10210,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616420,,BAO_0000357,,
1098,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,B,,,,,,,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616421,,BAO_0000249,,
1099,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,B,,,,,,,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616422,,BAO_0000249,,
1100,10205,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL616423,,BAO_0000249,,
1101,12280,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616424,,BAO_0000357,,
1102,17386,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616425,,BAO_0000357,,
1103,13654,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616426,,BAO_0000357,,
1104,14423,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616427,,BAO_0000221,10000000.0,
1105,15412,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616428,,BAO_0000221,10000000.0,
1106,12073,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616290,,BAO_0000221,10000000.0,
1107,4101,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616052,,BAO_0000357,,
1108,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616053,,BAO_0000357,,
1109,6238,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616054,,BAO_0000249,,
1110,16273,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616055,,BAO_0000357,,
1111,11139,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616056,,BAO_0000357,,
1112,16796,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616057,,BAO_0000019,,
1113,9548,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,Rattus norvegicus,10116.0,,Brain,,,10576,D,9,Expert,1,,CHEMBL616058,,BAO_0000221,955.0,
1114,10381,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616059,,BAO_0000221,955.0,
1115,13408,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616060,,BAO_0000249,,
1116,13825,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616061,,BAO_0000221,10000000.0,
1117,11147,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616062,,BAO_0000221,10000000.0,
1118,10552,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616063,,BAO_0000249,,
1119,10552,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",B,,,,,,Striatum,,,10576,H,8,Autocuration,1,,CHEMBL616064,,BAO_0000249,2435.0,
1120,17136,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616065,,BAO_0000249,,
1121,5778,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616066,,BAO_0000249,,
1122,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616067,,BAO_0000221,10000000.0,
1123,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616068,,BAO_0000221,10000000.0,
1124,13630,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Intermediate,1,,CHEMBL616069,,BAO_0000221,10000000.0,
1125,16245,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616070,,BAO_0000249,,
1126,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616071,,BAO_0000221,10000000.0,
1127,14509,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616072,,BAO_0000221,10000000.0,
1128,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616073,,BAO_0000221,10000000.0,
1129,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616074,,BAO_0000221,10000000.0,
1130,14256,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616075,,BAO_0000019,,
1131,11139,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616076,,BAO_0000357,,
1132,11047,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616077,,BAO_0000019,,
1133,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616078,,BAO_0000019,,
1134,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616079,,BAO_0000019,,
1135,2395,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,10576,D,9,Expert,1,,CHEMBL616080,485.0,BAO_0000219,,
1136,9699,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616081,,BAO_0000357,,
1137,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616082,,BAO_0000221,10000000.0,
1138,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616083,,BAO_0000221,10000000.0,
1139,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616084,,BAO_0000019,,
1140,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616085,,BAO_0000019,,
1141,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616086,,BAO_0000019,,
1142,2761,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616087,,BAO_0000221,10000000.0,
1143,13133,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616088,,BAO_0000357,,
1144,10444,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616089,,BAO_0000019,,
1145,13278,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616090,,BAO_0000357,,
1146,15874,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616091,,BAO_0000357,,
1147,10552,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",B,,,,,,Striatum,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616092,,BAO_0000249,2435.0,
1148,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616093,,BAO_0000357,,
1149,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),B,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616094,,BAO_0000218,,
1150,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616095,,BAO_0000221,955.0,
1151,13670,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616096,,BAO_0000357,,
1152,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616097,,BAO_0000249,,
1153,3678,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616098,,BAO_0000249,,
1154,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616099,,BAO_0000221,10000000.0,
1155,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616100,,BAO_0000221,10000000.0,
1156,1185,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616101,,BAO_0000357,,
1157,2014,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616102,,BAO_0000249,,
1158,1185,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616103,,BAO_0000357,,
1159,14429,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616104,,BAO_0000019,,
1160,16288,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616105,,BAO_0000019,,
1161,5432,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616106,,BAO_0000019,,
1162,14429,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616107,,BAO_0000019,,
1163,13672,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616108,,BAO_0000357,,
1164,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616109,,BAO_0000221,10000000.0,
1165,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616110,,BAO_0000357,,
1166,14749,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL616111,449.0,BAO_0000219,,
1167,15086,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616112,,BAO_0000019,,
1168,13462,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616113,,BAO_0000221,10000000.0,
1169,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616114,,BAO_0000019,,
1170,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616115,,BAO_0000019,,
1171,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616116,,BAO_0000357,,
1172,12816,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL615844,,BAO_0000221,955.0,
1173,13542,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615939,,BAO_0000221,10000000.0,
1174,13308,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615940,,BAO_0000019,,
1175,13541,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615941,,BAO_0000221,10000000.0,
1176,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615942,,BAO_0000221,10000000.0,
1177,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615943,,BAO_0000221,10000000.0,
1178,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615944,,BAO_0000221,10000000.0,
1179,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615945,,BAO_0000221,10000000.0,
1180,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615946,,BAO_0000221,10000000.0,
1181,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615947,,BAO_0000221,10000000.0,
1182,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615948,,BAO_0000221,10000000.0,
1183,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615949,,BAO_0000221,10000000.0,
1184,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615950,,BAO_0000221,10000000.0,
1185,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615951,,BAO_0000221,10000000.0,
1186,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615952,,BAO_0000221,10000000.0,
1187,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615953,,BAO_0000221,10000000.0,
1188,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615954,,BAO_0000221,10000000.0,
1189,10058,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615955,,BAO_0000221,10000000.0,
1190,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615956,,BAO_0000221,10000000.0,
1191,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615957,,BAO_0000221,10000000.0,
1192,12879,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615958,,BAO_0000019,,
1193,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615959,,BAO_0000019,,
1194,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615960,,BAO_0000019,,
1195,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615961,,BAO_0000019,,
1196,9548,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL615962,,BAO_0000221,955.0,
1197,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615963,,BAO_0000019,,
1198,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615964,,BAO_0000019,,
1199,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615965,,BAO_0000019,,
1200,13248,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL615966,449.0,BAO_0000219,,
1201,3147,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615967,,BAO_0000249,,
1202,13949,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615968,,BAO_0000019,,
1203,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),B,,,,,,,CHO,,10576,H,8,Autocuration,1,,CHEMBL615969,449.0,BAO_0000218,,
1204,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615970,,BAO_0000218,,
1205,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615971,,BAO_0000357,,
1206,15535,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL615972,,BAO_0000249,,
1207,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615973,,BAO_0000249,,
1208,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615974,,BAO_0000249,,
1209,16372,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615975,449.0,BAO_0000219,,
1210,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615976,,BAO_0000249,,
1211,4795,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL872106,,BAO_0000221,10000000.0,
1212,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615977,,BAO_0000357,,
1213,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615978,,BAO_0000357,,
1214,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616166,,BAO_0000357,,
1215,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616167,,BAO_0000357,,
1216,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616168,,BAO_0000357,,
1217,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616169,,BAO_0000357,,
1218,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616170,,BAO_0000357,,
1219,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616171,,BAO_0000357,,
1220,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616172,,BAO_0000357,,
1221,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616173,,BAO_0000357,,
1222,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616174,,BAO_0000357,,
1223,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616175,,BAO_0000357,,
1224,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616176,,BAO_0000357,,
1225,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616177,,BAO_0000357,,
1226,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616178,,BAO_0000357,,
1227,9742,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616179,,BAO_0000019,,
1228,12073,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616180,,BAO_0000357,,
1229,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616181,,BAO_0000357,,
1230,15360,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616182,,BAO_0000019,,
1231,11576,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616183,,BAO_0000221,10000000.0,
1232,5834,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615874,,BAO_0000019,,
1233,2395,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,10576,D,9,Expert,1,,CHEMBL615875,485.0,BAO_0000219,,
1234,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615876,,BAO_0000019,,
1235,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615877,,BAO_0000019,,
1236,3967,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615878,,BAO_0000357,,
1237,12884,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615879,,BAO_0000357,,
1238,2343,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615880,,BAO_0000357,,
1239,11511,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615881,,BAO_0000019,,
1240,11511,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615882,,BAO_0000019,,
1241,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615883,,BAO_0000218,,
1242,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615884,,BAO_0000218,,
1243,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615885,,BAO_0000218,,
1244,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615886,,BAO_0000218,,
1245,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615887,,BAO_0000218,,
1246,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615888,,BAO_0000218,,
1247,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615889,,BAO_0000218,,
1248,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615890,,BAO_0000218,,
1249,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615891,,BAO_0000218,,
1250,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615892,,BAO_0000218,,
1251,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615893,,BAO_0000218,,
1252,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615894,,BAO_0000218,,
1253,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615895,,BAO_0000218,,
1254,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615896,,BAO_0000218,,
1255,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615897,,BAO_0000218,,
1256,16616,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL615898,,BAO_0000249,,
1257,16796,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615899,,BAO_0000019,,
1258,16796,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616291,,BAO_0000019,,
1259,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616292,,BAO_0000357,,
1260,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616293,,BAO_0000249,,
1261,12073,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616294,,BAO_0000221,10000000.0,
1262,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616295,,BAO_0000249,10000000.0,
1263,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616296,,BAO_0000221,955.0,
1264,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616297,,BAO_0000019,,
1265,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616605,,BAO_0000019,,
1266,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616606,,BAO_0000019,,
1267,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616607,,BAO_0000019,,
1268,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616608,,BAO_0000019,,
1269,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616609,,BAO_0000019,,
1270,13630,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616610,,BAO_0000019,,
1271,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616611,,BAO_0000019,,
1272,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616612,,BAO_0000019,,
1273,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616613,,BAO_0000019,,
1274,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616614,,BAO_0000019,,
1275,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616615,,BAO_0000019,,
1276,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616616,,BAO_0000019,,
1277,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616617,,BAO_0000019,,
1278,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616618,,BAO_0000019,,
1279,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616619,,BAO_0000019,,
1280,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616620,,BAO_0000019,,
1281,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616621,,BAO_0000019,,
1282,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616622,,BAO_0000019,,
1283,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616146,,BAO_0000019,,
1284,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL832873,,BAO_0000019,,
1285,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616147,,BAO_0000019,,
1286,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL872872,,BAO_0000019,,
1287,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616148,,BAO_0000019,,
1288,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616149,,BAO_0000221,10000000.0,
1289,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616150,,BAO_0000221,10000000.0,
1290,14331,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616151,,BAO_0000249,,
1291,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL872873,,BAO_0000221,10000000.0,
1292,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616670,,BAO_0000221,10000000.0,
1293,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616671,,BAO_0000221,10000000.0,
1294,16616,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL884861,,BAO_0000249,,
1295,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616672,,BAO_0000357,,
1296,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616673,,BAO_0000019,,
1297,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616674,,BAO_0000019,,
1298,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616675,,BAO_0000357,,
1299,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616676,,BAO_0000221,10000000.0,
1300,12306,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616677,,BAO_0000221,10000000.0,
1301,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616678,,BAO_0000221,10000000.0,
1302,15247,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616679,,BAO_0000357,,
1303,17529,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616680,,BAO_0000221,10000000.0,
1304,14826,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616681,,BAO_0000221,10000000.0,
1305,14826,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616682,,BAO_0000221,10000000.0,
1306,13241,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616683,,BAO_0000221,10000000.0,
1307,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616684,,BAO_0000221,10000000.0,
1308,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616685,,BAO_0000221,10000000.0,
1309,14442,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616686,,BAO_0000221,955.0,
1310,9919,Affinity for 5-hydroxytryptamine 1A receptor site,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616687,,BAO_0000357,,
1311,9919,Affinity for 5-hydroxytryptamine 1A receptor site,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616688,,BAO_0000357,,
1312,11440,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616689,,BAO_0000221,10000000.0,
1313,11257,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616690,,BAO_0000357,,
1314,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616691,,BAO_0000357,,
1315,17331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616692,,BAO_0000221,10000000.0,
1316,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616693,,BAO_0000249,,
1317,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616694,,BAO_0000019,,
1318,9699,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616695,,BAO_0000221,10000000.0,
1319,9547,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616696,,BAO_0000357,,
1320,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616697,,BAO_0000357,,
1321,14331,Binding affinity against rat 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616698,,BAO_0000357,,
1322,14060,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616949,,BAO_0000019,,
1323,14744,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616950,,BAO_0000221,10000000.0,
1324,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL832875,,BAO_0000357,,
1325,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL616951,,BAO_0000221,955.0,
1326,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL616952,,BAO_0000221,955.0,
1327,10062,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616953,,BAO_0000357,,
1328,12073,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616954,,BAO_0000357,,
1329,14875,GTPgammaS radioligand binding assay,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616955,,BAO_0000357,,
1330,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616956,,BAO_0000357,,
1331,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616957,,BAO_0000019,,
1332,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616958,,BAO_0000019,,
1333,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616959,,BAO_0000357,,
1334,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616960,,BAO_0000357,,
1335,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616961,,BAO_0000019,,
1336,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,B,,,,,,,HeLa,,106,H,8,Expert,1,,CHEMBL616962,308.0,BAO_0000219,,
1337,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616963,308.0,BAO_0000219,,
1338,6491,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616524,,BAO_0000357,,
1339,16190,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616525,449.0,BAO_0000219,,
1340,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL872908,,BAO_0000019,,
1341,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616526,,BAO_0000019,,
1342,4234,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616527,,BAO_0000357,,
1343,6328,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616528,,BAO_0000219,,
1344,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616529,,BAO_0000357,,
1345,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616530,,BAO_0000357,,
1346,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616531,,BAO_0000357,,
1347,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616532,,BAO_0000357,,
1348,6013,Binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616533,,BAO_0000357,,
1349,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616534,,BAO_0000357,,
1350,14454,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616535,,BAO_0000357,,
1351,16209,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616536,,BAO_0000357,,
1352,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616537,,BAO_0000357,,
1353,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616538,485.0,BAO_0000219,,
1354,14251,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616539,,BAO_0000019,,
1355,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616540,,BAO_0000019,,
1356,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616429,,BAO_0000357,,
1357,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616430,,BAO_0000357,,
1358,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616431,,BAO_0000219,,
1359,3804,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616432,,BAO_0000357,,
1360,2391,Affinity for 5-hydroxytryptamine 1B receptor subtype,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616433,,BAO_0000357,,
1361,4175,Binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616434,,BAO_0000357,,
1362,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616435,449.0,BAO_0000219,,
1363,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616436,,BAO_0000019,,
1364,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616437,308.0,BAO_0000219,,
1365,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616438,308.0,BAO_0000219,,
1366,17211,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616439,308.0,BAO_0000219,,
1367,15926,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616440,,BAO_0000357,,
1368,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616441,485.0,BAO_0000219,,
1369,5843,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616442,,BAO_0000357,,
1370,5843,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616443,,BAO_0000357,,
1371,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,B,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616444,485.0,BAO_0000219,,
1372,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616445,,BAO_0000357,,
1373,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616446,,BAO_0000357,,
1374,4540,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,B,,,Homo sapiens,9606.0,,,CHO,,106,D,9,Expert,1,,CHEMBL616447,449.0,BAO_0000219,,
1375,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616448,,BAO_0000357,,
1376,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616449,449.0,BAO_0000219,,
1377,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616450,449.0,BAO_0000219,,
1378,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL857974,449.0,BAO_0000219,,
1379,15779,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616451,449.0,BAO_0000219,,
1380,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616452,449.0,BAO_0000219,,
1381,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616453,449.0,BAO_0000219,,
1382,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616454,449.0,BAO_0000219,,
1383,14875,Binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616455,,BAO_0000357,,
1384,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616456,449.0,BAO_0000219,,
1385,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616457,,BAO_0000357,,
1386,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616458,449.0,BAO_0000219,,
1387,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616459,449.0,BAO_0000219,,
1388,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616460,,BAO_0000019,,
1389,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616461,,BAO_0000019,,
1390,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616462,449.0,BAO_0000219,,
1391,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616463,449.0,BAO_0000219,,
1392,15250,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616464,,BAO_0000019,,
1393,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616465,449.0,BAO_0000219,,
1394,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,17105,H,8,Autocuration,1,,CHEMBL832874,,BAO_0000357,,
1395,3025,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,F,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616184,,BAO_0000019,,
1396,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616185,,BAO_0000019,,
1397,14998,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Intermediate,1,,CHEMBL616186,,BAO_0000019,,
1398,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616187,,BAO_0000019,,
1399,13969,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616188,,BAO_0000357,,
1400,13392,Binding affinity for 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,D,9,Intermediate,1,,CHEMBL873475,,BAO_0000357,,
1401,3651,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,B,,,Rattus norvegicus,10116.0,,Striatum,,,10577,D,9,Expert,1,,CHEMBL616189,,BAO_0000019,2435.0,
1402,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616190,,BAO_0000357,,
1403,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616191,,BAO_0000357,,
1404,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616192,,BAO_0000357,,
1405,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616193,,BAO_0000357,,
1406,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616194,,BAO_0000357,,
1407,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616195,,BAO_0000357,,
1408,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616196,,BAO_0000357,,
1409,4622,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616197,,BAO_0000249,10000000.0,
1410,14911,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL616198,,BAO_0000019,,
1411,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616199,,BAO_0000221,10000000.0,
1412,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616200,,BAO_0000221,10000000.0,
1413,14235,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616201,,BAO_0000221,10000000.0,
1414,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616202,,BAO_0000221,10000000.0,
1415,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616203,,BAO_0000221,10000000.0,
1416,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616204,,BAO_0000221,10000000.0,
1417,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616205,,BAO_0000221,10000000.0,
1418,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616206,,BAO_0000221,10000000.0,
1419,16118,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616207,,BAO_0000249,,
1420,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616208,,BAO_0000249,,
1421,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616209,,BAO_0000249,,
1422,16117,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616210,,BAO_0000357,,
1423,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616211,,BAO_0000221,10000000.0,
1424,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616504,,BAO_0000221,10000000.0,
1425,14356,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616505,,BAO_0000221,10000000.0,
1426,15740,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616506,,BAO_0000019,,
1427,12306,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL872107,,BAO_0000221,10000000.0,
1428,13348,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616507,,BAO_0000221,10000000.0,
1429,10394,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616303,,BAO_0000249,,
1430,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616304,,BAO_0000221,10000000.0,
1431,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616305,,BAO_0000221,10000000.0,
1432,15260,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,F,,,,,,Hippocampus,,,10576,H,8,Intermediate,1,,CHEMBL616306,,BAO_0000221,10000000.0,
1433,12851,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616307,,BAO_0000357,,
1434,2148,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL881829,,BAO_0000221,10000000.0,
1435,13134,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616308,,BAO_0000357,,
1436,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616309,,BAO_0000019,,
1437,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616310,,BAO_0000019,,
1438,12462,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,B,,,,,,,CHO,,10576,H,8,Autocuration,1,,CHEMBL616311,449.0,BAO_0000219,,
1439,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616312,,BAO_0000357,,
1440,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616313,,BAO_0000357,,
1441,403,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616314,,BAO_0000221,10000000.0,
1442,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616315,,BAO_0000221,10000000.0,
1443,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616567,,BAO_0000221,10000000.0,
1444,15538,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616568,,BAO_0000221,10000000.0,
1445,12464,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL616569,,BAO_0000019,,
1446,1455,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616570,,BAO_0000357,,
1447,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616571,,BAO_0000357,,
1448,12639,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616572,,BAO_0000221,10000000.0,
1449,13949,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616573,,BAO_0000249,,
1450,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616574,,BAO_0000357,,
1451,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616575,,BAO_0000221,10000000.0,
1452,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL872108,,BAO_0000221,10000000.0,
1453,12092,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616576,,BAO_0000357,,
1454,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616577,,BAO_0000249,,
1455,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616578,,BAO_0000249,,
1456,3967,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616579,,BAO_0000357,,
1457,12771,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616580,,BAO_0000019,,
1458,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616581,,BAO_0000019,,
1459,14909,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616582,,BAO_0000221,10000000.0,
1460,14949,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616583,,BAO_0000221,10000000.0,
1461,2309,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616584,,BAO_0000221,10000000.0,
1462,4170,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616585,,BAO_0000357,,
1463,11642,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616586,,BAO_0000221,10000000.0,
1464,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616587,,BAO_0000221,10000000.0,
1465,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616588,,BAO_0000221,10000000.0,
1466,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616589,,BAO_0000221,10000000.0,
1467,12953,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616590,,BAO_0000221,10000000.0,
1468,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL616591,449.0,BAO_0000219,,
1469,12536,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616592,,BAO_0000357,,
1470,10058,The inhibition activity of 5-HT1A at 1 uM,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616593,,BAO_0000357,,
1471,12902,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",B,,,,,,,CHO-K1,,10576,H,8,Expert,1,,CHEMBL616594,485.0,BAO_0000219,,
1472,14057,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616595,,BAO_0000249,,
1473,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616596,,BAO_0000357,,
1474,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616597,,BAO_0000221,10000000.0,
1475,11296,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616598,,BAO_0000221,10000000.0,
1476,16616,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616599,,BAO_0000249,,
1477,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,Hippocampus,,Membranes,10576,D,9,Expert,1,,CHEMBL616600,,BAO_0000249,10000000.0,
1478,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616601,,BAO_0000019,,
1479,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616602,,BAO_0000019,,
1480,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616603,,BAO_0000019,,
1481,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616604,,BAO_0000019,,
1482,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616316,,BAO_0000249,,
1483,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616317,,BAO_0000249,,
1484,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616318,,BAO_0000019,,
1485,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616319,,BAO_0000221,10000000.0,
1486,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616320,,BAO_0000221,10000000.0,
1487,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616321,,BAO_0000221,10000000.0,
1488,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616322,,BAO_0000019,,
1489,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616323,,BAO_0000019,,
1490,4671,Ratio of binding affinity to 5-HT 1A and D2 receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616324,,BAO_0000357,,
1491,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616325,,BAO_0000221,10000000.0,
1492,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616326,,BAO_0000221,10000000.0,
1493,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616327,,BAO_0000221,10000000.0,
1494,12073,Percentage inhibition against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616328,,BAO_0000357,,
1495,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL858110,,BAO_0000249,,
1496,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616329,,BAO_0000249,,
1497,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616330,,BAO_0000249,,
1498,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616331,,BAO_0000249,,
1499,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616332,,BAO_0000249,,
1500,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL857063,,BAO_0000249,955.0,
1501,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616333,,BAO_0000019,,
1502,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616334,,BAO_0000019,,
1503,12253,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616335,,BAO_0000221,10000000.0,
1504,14025,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616336,,BAO_0000019,,
1505,10425,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616337,,BAO_0000249,,
1506,14998,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616338,,BAO_0000019,,
1507,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616339,,BAO_0000221,10000000.0,
1508,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616340,,BAO_0000221,10000000.0,
1509,4342,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616341,,BAO_0000357,,
1510,12936,Binding affinity against rat 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616342,,BAO_0000357,,
1511,13144,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616343,,BAO_0000019,,
1512,13343,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616344,,BAO_0000019,,
1513,12132,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616345,,BAO_0000357,,
1514,15419,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616346,,BAO_0000019,,
1515,1479,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616347,,BAO_0000221,10000000.0,
1516,14287,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616348,,BAO_0000019,,
1517,13116,Binding affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616349,,BAO_0000357,,
1518,2759,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616152,,BAO_0000249,,
1519,2759,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616153,,BAO_0000249,,
1520,14748,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616154,,BAO_0000019,,
1521,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616155,,BAO_0000019,,
1522,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616156,,BAO_0000221,10000000.0,
1523,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616157,,BAO_0000221,10000000.0,
1524,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616158,,BAO_0000221,10000000.0,
1525,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616159,,BAO_0000357,,
1526,14256,pKi value against rat 5-hydroxytryptamine 1A receptor.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616160,,BAO_0000357,,
1527,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616161,,BAO_0000019,,
1528,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616162,,BAO_0000019,,
1529,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL616163,,BAO_0000357,,
1530,1970,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,Membranes,10626,H,8,Expert,1,,CHEMBL616164,,BAO_0000249,,
1531,10034,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616165,,BAO_0000221,955.0,
1532,13348,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,B,,,Rattus norvegicus,10116.0,,,,,51,H,8,Autocuration,1,,CHEMBL616355,,BAO_0000019,,
1533,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616356,,BAO_0000019,,
1534,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616357,,BAO_0000221,955.0,
1535,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616358,,BAO_0000019,,
1536,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616359,,BAO_0000357,,
1537,15453,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616360,,BAO_0000357,,
1538,4820,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616361,,BAO_0000357,,
1539,1089,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616362,,BAO_0000357,,
1540,386,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,B,,,,,,,,Brain membranes,51,H,8,Autocuration,1,,CHEMBL616363,,BAO_0000249,,
1541,6011,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616364,,BAO_0000357,,
1542,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616365,,BAO_0000357,,
1543,4402,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616366,,BAO_0000357,,
1544,17066,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL872906,,BAO_0000357,,
1545,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616367,,BAO_0000357,,
1546,2474,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616368,,BAO_0000357,,
1547,4775,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616369,,BAO_0000357,,
1548,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616370,,BAO_0000357,,
1549,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616371,,BAO_0000357,,
1550,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616372,449.0,BAO_0000219,,
1551,11376,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616373,,BAO_0000219,,
1552,2474,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,In vivo,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616374,,BAO_0000218,,
1553,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL616375,,BAO_0000221,10000000.0,
1554,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616376,,BAO_0000357,,
1555,1633,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL857064,,BAO_0000357,,
1556,11866,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616377,,BAO_0000357,,
1557,4373,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616378,,BAO_0000357,,
1558,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616379,,BAO_0000357,,
1559,16946,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616380,,BAO_0000357,,
1560,13291,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616381,,BAO_0000357,,
1561,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616382,,BAO_0000357,,
1562,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616383,,BAO_0000357,,
1563,3032,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,B,,,Mus musculus,10090.0,,,CHO,,11863,D,9,Expert,1,,CHEMBL616350,449.0,BAO_0000219,,
1564,16655,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616351,,BAO_0000357,,
1565,14532,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616352,,BAO_0000357,,
1566,13944,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616353,,BAO_0000357,,
1567,13033,Binding affinity against serotonergic 5-HT1a receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616354,,BAO_0000357,,
1568,10321,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616508,,BAO_0000357,,
1569,2968,Binding affinity for 5-hydroxytryptamine 1A receptor,B,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616559,,BAO_0000357,,
1570,13964,Binding affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616560,,BAO_0000357,,
1571,15527,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616561,,BAO_0000357,,
1572,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL616562,449.0,BAO_0000219,,
1573,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL616563,449.0,BAO_0000219,,
1574,15120,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616564,,BAO_0000357,,
1575,13313,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616565,,BAO_0000357,,
1576,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616566,,BAO_0000218,,
1577,16700,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616989,,BAO_0000357,,
1578,2201,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL857975,,BAO_0000357,,
1579,1274,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616990,,BAO_0000357,,
1580,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616991,,BAO_0000357,,
1581,12146,Tested against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616992,,BAO_0000357,,
1582,14059,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616993,,BAO_0000357,,
1583,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Expert,1,,CHEMBL616994,,BAO_0000019,,
1584,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616995,,BAO_0000019,,
1585,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,B,,,Gorilla gorilla,9593.0,,,HEK293,,105571,D,9,Intermediate,1,,CHEMBL616996,722.0,BAO_0000219,,
1586,3025,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,F,In vivo,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616997,,BAO_0000218,,
1587,3025,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,F,In vivo,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616998,,BAO_0000218,,
1588,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616999,,BAO_0000019,,
1589,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL617000,,BAO_0000019,,
1590,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL617001,,BAO_0000019,,
1591,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL858111,,BAO_0000019,,
1592,14165,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617002,,BAO_0000019,,
1593,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617003,,BAO_0000019,,
1594,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617004,,BAO_0000019,,
1595,14214,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,F,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL617005,,BAO_0000019,,
1596,13729,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,F,,,Homo sapiens,9606.0,,,CHO-K1,,106,D,9,Expert,1,,CHEMBL616623,485.0,BAO_0000219,,
1597,3025,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616624,449.0,BAO_0000219,,
1598,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL883243,,BAO_0000357,,
1599,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616625,,BAO_0000019,,
1600,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616626,449.0,BAO_0000219,,
1601,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616627,449.0,BAO_0000219,,
1602,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616628,449.0,BAO_0000219,,
1603,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616629,449.0,BAO_0000219,,
1604,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616630,449.0,BAO_0000219,,
1605,14956,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616631,,BAO_0000019,,
1606,14956,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616632,,BAO_0000019,,
1607,14214,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616633,,BAO_0000357,,
1608,3463,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616634,449.0,BAO_0000219,,
1609,15331,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616635,,BAO_0000357,,
1610,16146,Binding affinity against 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL885358,,BAO_0000357,,
1611,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,106,D,9,Expert,1,,CHEMBL616636,449.0,BAO_0000219,,
1612,14158,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616637,449.0,BAO_0000219,,
1613,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616638,,BAO_0000357,,
1614,15250,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616639,449.0,BAO_0000219,,
1615,15250,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616640,449.0,BAO_0000219,,
1616,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616641,449.0,BAO_0000219,,
1617,15332,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616642,449.0,BAO_0000219,,
1618,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616643,449.0,BAO_0000219,,
1619,3805,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616644,,BAO_0000357,,
1620,14875,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616645,,BAO_0000357,,
1621,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),F,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL616646,,BAO_0000019,,
1622,14454,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),F,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL616647,,BAO_0000019,,
1623,16288,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616509,,BAO_0000357,,
1624,16288,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616510,,BAO_0000357,,
1625,16312,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616511,,BAO_0000357,,
1626,1348,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616512,,BAO_0000357,,
1627,5834,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616513,,BAO_0000357,,
1628,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,B,,,Bos taurus,9913.0,,Striatum,,,105,H,8,Autocuration,1,,CHEMBL616514,,BAO_0000019,2435.0,
1629,1414,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616515,,BAO_0000357,,
1630,14998,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616516,,BAO_0000019,,
1631,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616517,,BAO_0000357,,
1632,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616518,,BAO_0000357,,
1633,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616519,,BAO_0000357,,
1634,10639,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616520,,BAO_0000357,,
1635,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616521,,BAO_0000357,,
1636,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616522,,BAO_0000357,,
1637,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL884531,,BAO_0000357,,
1638,11147,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616523,,BAO_0000357,,
1639,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,B,,,Bos taurus,9913.0,,Striatum,,,105,H,8,Autocuration,1,,CHEMBL616731,,BAO_0000019,2435.0,
1640,10444,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616732,,BAO_0000019,,
1641,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616733,,BAO_0000357,,
1642,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616734,,BAO_0000357,,
1643,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616735,,BAO_0000249,,
1644,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616736,,BAO_0000249,,
1645,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616737,,BAO_0000019,,
1646,14025,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616738,,BAO_0000019,,
1647,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616739,,BAO_0000019,,
1648,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616740,,BAO_0000019,,
1649,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616741,,BAO_0000019,,
1650,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,B,,,Gorilla gorilla,9593.0,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616742,722.0,BAO_0000219,,
1651,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616743,,BAO_0000019,,
1652,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616744,,BAO_0000019,,
1653,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616745,,BAO_0000019,,
1654,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616746,,BAO_0000019,,
1655,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616747,,BAO_0000019,,
1656,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616748,,BAO_0000019,,
1657,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616648,,BAO_0000019,,
1658,11574,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616649,,BAO_0000357,,
1659,1558,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616650,,BAO_0000357,,
1660,12409,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616651,,BAO_0000218,,
1661,12409,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616652,,BAO_0000218,,
1662,12409,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616653,,BAO_0000218,,
1663,12409,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616654,,BAO_0000218,,
1664,12253,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616655,,BAO_0000019,,
1665,12936,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616656,,BAO_0000357,,
1666,13181,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,B,,,Cavia porcellus,10141.0,,,,,105,H,8,Autocuration,1,,CHEMBL616657,,BAO_0000019,,
1667,12409,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,B,,,Cavia porcellus,10141.0,,Striatum,,,105570,D,9,Intermediate,1,,CHEMBL616658,,BAO_0000357,2435.0,
1668,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616659,,BAO_0000357,,
1669,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616660,,BAO_0000357,,
1670,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616661,,BAO_0000357,,
1671,3463,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616662,,BAO_0000019,,
1672,15315,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616663,,BAO_0000019,,
1673,6011,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616664,,BAO_0000019,,
1674,14159,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL881820,449.0,BAO_0000219,,
1675,14159,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616665,449.0,BAO_0000219,,
1676,15250,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616666,449.0,BAO_0000219,,
1677,15250,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616667,449.0,BAO_0000219,,
1678,15331,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616668,449.0,BAO_0000219,,
1679,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616669,449.0,BAO_0000219,,
1680,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617040,449.0,BAO_0000219,,
1681,3294,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL617041,449.0,BAO_0000219,,
1682,14158,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617042,449.0,BAO_0000219,,
1683,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617043,449.0,BAO_0000219,,
1684,12469,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617044,,BAO_0000019,,
1685,3463,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617045,449.0,BAO_0000219,,
1686,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL617046,449.0,BAO_0000219,,
1687,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL617047,449.0,BAO_0000219,,
1688,14956,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,105,H,8,Expert,1,,CHEMBL617048,,BAO_0000019,,
1689,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616897,,BAO_0000019,,
1690,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",F,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616898,,BAO_0000019,,
1691,14499,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL858201,449.0,BAO_0000219,,
1692,15315,Intrinsic activity for 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616899,,BAO_0000019,,
1693,3294,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),B,In vitro,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616900,,BAO_0000219,,
1694,3463,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616901,449.0,BAO_0000219,,
1695,15331,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616902,,BAO_0000357,,
1696,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616903,449.0,BAO_0000219,,
1697,14158,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616904,449.0,BAO_0000219,,
1698,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616905,,BAO_0000357,,
1699,15250,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616906,449.0,BAO_0000219,,
1700,15250,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616907,449.0,BAO_0000219,,
1701,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616908,449.0,BAO_0000219,,
1702,15332,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616909,449.0,BAO_0000219,,
1703,14499,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616910,449.0,BAO_0000219,,
1704,15332,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616911,449.0,BAO_0000219,,
1705,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616912,449.0,BAO_0000219,,
1706,3805,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616913,,BAO_0000357,,
1707,6011,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616914,449.0,BAO_0000219,,
1708,16190,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616915,449.0,BAO_0000219,,
1709,14165,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616916,,BAO_0000019,,
1710,4234,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616917,,BAO_0000357,,
1711,15527,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616918,,BAO_0000357,,
1712,6328,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616919,,BAO_0000219,,
1713,16209,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616920,,BAO_0000357,,
1714,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL872914,,BAO_0000357,,
1715,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616921,,BAO_0000357,,
1716,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616922,,BAO_0000357,,
1717,6013,Binding affinity towards 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616923,,BAO_0000357,,
1718,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616924,,BAO_0000357,,
1719,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL875909,,BAO_0000357,,
1720,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616925,,BAO_0000357,,
1721,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616926,,BAO_0000357,,
1722,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616927,,BAO_0000357,,
1723,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL616928,485.0,BAO_0000219,,
1724,6011,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),B,In vitro,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616929,,BAO_0000219,,
1725,4234,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616930,,BAO_0000357,,
1726,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616931,,BAO_0000019,,
1727,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616932,,BAO_0000357,,
1728,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616933,,BAO_0000357,,
1729,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616934,,BAO_0000219,,
1730,3804,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616935,,BAO_0000357,,
1731,16700,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616936,,BAO_0000357,,
1732,2391,Affinity for 5-hydroxytryptamine 1D receptor subtype,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616937,,BAO_0000357,,
1733,4175,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616938,,BAO_0000357,,
1734,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616939,,BAO_0000019,,
1735,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616940,,BAO_0000019,,
1736,15926,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616941,,BAO_0000357,,
1737,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616942,485.0,BAO_0000219,,
1738,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616943,485.0,BAO_0000219,,
1739,14956,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,B,,,,,,,CHO,,104802,H,4,Autocuration,1,,CHEMBL616944,449.0,BAO_0000219,,
1740,3294,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616945,,BAO_0000019,,
1741,12861,Binding activity radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616946,,BAO_0000357,,
1742,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616947,,BAO_0000019,,
1743,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL616948,485.0,BAO_0000219,,
1744,5104,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616851,,BAO_0000357,,
1745,5105,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616852,,BAO_0000357,,
1746,14499,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616853,,BAO_0000357,,
1747,15926,Binding activity against human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616854,,BAO_0000357,,
1748,4540,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616855,449.0,BAO_0000219,,
1749,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616856,449.0,BAO_0000219,,
1750,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616857,449.0,BAO_0000219,,
1751,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616858,,BAO_0000357,,
1752,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616859,449.0,BAO_0000219,,
1753,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616860,449.0,BAO_0000219,,
1754,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616861,722.0,BAO_0000219,,
1755,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616541,722.0,BAO_0000219,,
1756,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616542,722.0,BAO_0000219,,
1757,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616543,449.0,BAO_0000219,,
1758,14875,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616544,,BAO_0000357,,
1759,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616545,449.0,BAO_0000219,,
1760,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616546,,BAO_0000357,,
1761,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616547,449.0,BAO_0000219,,
1762,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616548,449.0,BAO_0000219,,
1763,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616549,,BAO_0000019,,
1764,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616550,,BAO_0000019,,
1765,5254,Binding affinity against 5-HT2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL857066,,BAO_0000357,,
1766,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616551,,BAO_0000357,,
1767,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616552,,BAO_0000357,,
1768,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,F,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL832876,,BAO_0000019,,
1769,12352,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616553,,BAO_0000019,,
1770,9098,Binding affinity towards 5-HT1B was determined,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616554,,BAO_0000357,,
1771,14430,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616555,,BAO_0000019,,
1772,13657,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616556,,BAO_0000019,,
1773,13657,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616557,,BAO_0000019,,
1774,15854,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616558,,BAO_0000019,,
1775,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616749,,BAO_0000019,,
1776,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616750,,BAO_0000357,,
1777,10025,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616751,,BAO_0000357,,
1778,14286,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616752,,BAO_0000249,,
1779,3651,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616753,,BAO_0000019,2435.0,
1780,14178,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616754,,BAO_0000357,,
1781,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616755,,BAO_0000019,,
1782,13605,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616756,,BAO_0000019,2435.0,
1783,5834,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616757,,BAO_0000019,2435.0,
1784,10922,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616758,,BAO_0000357,2435.0,
1785,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616759,,BAO_0000249,,
1786,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616760,,BAO_0000357,,
1787,14826,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616761,,BAO_0000019,2435.0,
1788,9699,Binding affinity against 5-HT1B serotonin receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616762,,BAO_0000019,2435.0,
1789,14423,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616763,,BAO_0000019,,
1790,10062,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL872909,,BAO_0000357,,
1791,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616764,,BAO_0000357,,
1792,12280,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616765,,BAO_0000357,,
1793,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616766,,BAO_0000357,2435.0,
1794,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616767,,BAO_0000357,2435.0,
1795,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616768,,BAO_0000357,,
1796,11147,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616769,,BAO_0000357,,
1797,9547,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616770,,BAO_0000019,,
1798,10444,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616771,,BAO_0000019,,
1799,12469,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616772,,BAO_0000019,2435.0,
1800,9098,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616773,,BAO_0000019,,
1801,9098,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616774,,BAO_0000019,,
1802,9699,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616775,,BAO_0000357,,
1803,10394,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616776,,BAO_0000249,,
1804,12092,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616777,,BAO_0000357,,
1805,16700,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616778,,BAO_0000357,,
1806,403,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616779,,BAO_0000249,,
1807,12771,Binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616780,,BAO_0000357,,
1808,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616781,,BAO_0000019,,
1809,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616782,,BAO_0000357,,
1810,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616783,,BAO_0000357,,
1811,12953,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,B,,,,,,Striatum,,,10577,H,8,Expert,1,,CHEMBL616784,,BAO_0000019,2435.0,
1812,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616785,,BAO_0000357,,
1813,9737,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10577,H,8,Autocuration,1,,CHEMBL857067,,BAO_0000249,955.0,
1814,9737,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616786,,BAO_0000019,,
1815,9737,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10577,H,8,Autocuration,1,,CHEMBL616787,,BAO_0000249,955.0,
1816,12827,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616788,,BAO_0000357,,
1817,5033,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616789,,BAO_0000357,,
1818,9786,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616790,,BAO_0000019,,
1819,13116,Binding affinity at 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616791,,BAO_0000357,,
1820,16429,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616792,,BAO_0000019,,
1821,12409,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616793,,BAO_0000249,,
1822,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616794,,BAO_0000357,,
1823,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616795,,BAO_0000357,,
1824,5486,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616796,,BAO_0000019,,
1825,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616797,,BAO_0000357,,
1826,386,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,B,,,,,,,,Brain membranes,106,H,8,Autocuration,1,,CHEMBL616798,,BAO_0000249,,
1827,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616799,,BAO_0000357,,
1828,6011,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616800,,BAO_0000357,,
1829,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616801,,BAO_0000357,,
1830,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616802,,BAO_0000357,,
1831,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616803,,BAO_0000357,,
1832,1633,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL857068,,BAO_0000357,,
1833,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616804,,BAO_0000357,,
1834,4373,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616805,,BAO_0000357,,
1835,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616806,,BAO_0000357,,
1836,11574,Binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616807,,BAO_0000357,,
1837,10321,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616808,,BAO_0000357,,
1838,15527,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616809,,BAO_0000357,,
1839,17200,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616810,,BAO_0000357,,
1840,14423,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,B,,,,,,,,,104802,H,4,Autocuration,1,,CHEMBL616811,,BAO_0000224,,
1841,5834,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL616812,,BAO_0000357,,
1842,11473,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616813,,BAO_0000357,,
1843,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616814,,BAO_0000357,,
1844,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616815,,BAO_0000357,,
1845,10639,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616816,,BAO_0000357,,
1846,14331,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616817,,BAO_0000357,,
1847,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616818,,BAO_0000357,,
1848,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616819,,BAO_0000357,,
1849,14331,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616820,,BAO_0000357,,
1850,11828,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616821,,BAO_0000019,,
1851,11866,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616822,,BAO_0000357,,
1852,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,108,H,8,Autocuration,1,,CHEMBL616823,,BAO_0000019,,
1853,188,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616824,,BAO_0000357,,
1854,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616825,,BAO_0000357,,
1855,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616826,,BAO_0000357,,
1856,11624,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616827,,BAO_0000019,,
1857,11139,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616828,,BAO_0000357,,
1858,11147,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616829,,BAO_0000357,,
1859,10444,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616830,,BAO_0000019,,
1860,11624,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616831,,BAO_0000357,,
1861,11662,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616832,,BAO_0000019,,
1862,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616833,,BAO_0000019,,
1863,11662,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616834,,BAO_0000019,,
1864,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL829595,,BAO_0000019,,
1865,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616835,,BAO_0000357,,
1866,10394,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL872910,,BAO_0000249,,
1867,11933,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL616836,,BAO_0000357,,
1868,12092,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616837,,BAO_0000357,,
1869,12253,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616466,,BAO_0000019,,
1870,12253,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,B,,,Rattus norvegicus,10116.0,,,HEK293,,12689,D,9,Autocuration,1,,CHEMBL616467,722.0,BAO_0000219,,
1871,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616468,,BAO_0000357,,
1872,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616469,,BAO_0000357,,
1873,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616470,,BAO_0000357,,
1874,11574,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616471,,BAO_0000357,,
1875,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616472,,BAO_0000357,,
1876,13944,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616473,,BAO_0000357,,
1877,13033,Binding affinity against serotonergic 5-HT1c receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616474,,BAO_0000357,,
1878,10321,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616475,,BAO_0000357,,
1879,11866,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616476,,BAO_0000357,,
1880,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL616477,,BAO_0000019,,
1881,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616478,,BAO_0000224,,
1882,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616479,,BAO_0000224,,
1883,13631,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616480,,BAO_0000019,,
1884,9630,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616481,,BAO_0000019,,
1885,8822,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616482,,BAO_0000249,,
1886,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL884713,,BAO_0000221,955.0,
1887,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616483,,BAO_0000224,,
1888,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616484,,BAO_0000224,,
1889,9806,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616485,,BAO_0000019,,
1890,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616486,,BAO_0000224,,
1891,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616487,,BAO_0000224,,
1892,12765,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616488,,BAO_0000224,,
1893,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616489,,BAO_0000019,,
1894,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616490,,BAO_0000019,,
1895,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616491,,BAO_0000019,,
1896,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616492,,BAO_0000019,,
1897,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616493,,BAO_0000019,,
1898,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616494,,BAO_0000019,,
1899,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616495,,BAO_0000019,,
1900,3086,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616496,,BAO_0000019,,
1901,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616497,,BAO_0000019,,
1902,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616498,,BAO_0000019,,
1903,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616499,,BAO_0000019,,
1904,10922,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616500,,BAO_0000019,,
1905,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL616501,,BAO_0000221,955.0,
1906,10748,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL616502,,BAO_0000221,955.0,
1907,11614,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL884529,,BAO_0000249,,
1908,11615,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616503,,BAO_0000249,,
1909,11615,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616964,,BAO_0000224,,
1910,11614,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616965,,BAO_0000249,,
1911,11702,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616966,,BAO_0000224,,
1912,11702,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616967,,BAO_0000224,,
1913,11702,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616968,,BAO_0000224,,
1914,11702,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616969,,BAO_0000224,,
1915,13346,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL884530,,BAO_0000019,,
1916,10025,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616970,,BAO_0000224,,
1917,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616971,,BAO_0000224,,
1918,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616972,,BAO_0000224,,
1919,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616973,,BAO_0000224,,
1920,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616974,,BAO_0000224,,
1921,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616975,,BAO_0000019,,
1922,12304,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616976,,BAO_0000019,,
1923,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616977,,BAO_0000224,,
1924,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616978,,BAO_0000224,,
1925,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616979,,BAO_0000224,,
1926,13830,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616980,,BAO_0000224,,
1927,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616981,,BAO_0000249,,
1928,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616982,,BAO_0000249,,
1929,10881,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616983,,BAO_0000224,,
1930,13605,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616984,,BAO_0000019,,
1931,11624,Inhibitory activity against 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616985,,BAO_0000224,,
1932,4101,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616986,,BAO_0000224,,
1933,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616987,,BAO_0000224,,
1934,15360,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616988,,BAO_0000019,,
1935,11576,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617243,,BAO_0000019,,
1936,5834,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617244,,BAO_0000019,,
1937,2395,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617245,485.0,BAO_0000219,,
1938,11965,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617246,,BAO_0000249,,
1939,3967,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617546,,BAO_0000224,,
1940,11130,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),B,,,,,,,,Brain membranes,104686,H,4,Autocuration,1,,CHEMBL617547,,BAO_0000249,,
1941,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617548,,BAO_0000219,,
1942,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617549,,BAO_0000224,,
1943,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617550,,BAO_0000224,,
1944,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617551,,BAO_0000224,,
1945,12120,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617552,,BAO_0000249,,
1946,12120,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617553,,BAO_0000249,,
1947,11963,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,F,,,,,,Thoracic aorta,,,104686,H,4,Autocuration,1,,CHEMBL617554,,BAO_0000019,1515.0,
1948,9069,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617555,,BAO_0000019,,
1949,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617556,,BAO_0000224,,
1950,17200,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL617557,,BAO_0000357,,
1951,17200,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL617558,,BAO_0000357,,
1952,13969,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617559,,BAO_0000357,,
1953,13392,Binding affinity for 5-hydroxytryptamine 1D receptor,B,,,,,,,,,17106,D,9,Expert,1,,CHEMBL617560,,BAO_0000357,,
1954,1742,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617561,,BAO_0000249,,
1955,1742,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617562,,BAO_0000249,,
1956,14331,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,B,,,,,,Striatum,,,17106,H,8,Autocuration,1,,CHEMBL617563,,BAO_0000357,2435.0,
1957,12861,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,F,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617564,,BAO_0000019,,
1958,12861,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617565,,BAO_0000019,,
1959,12861,Binding activity radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL856076,,BAO_0000357,,
1960,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617566,,BAO_0000019,,
1961,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL875911,,BAO_0000019,,
1962,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617567,,BAO_0000019,,
1963,675,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617568,,BAO_0000249,,
1964,12490,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617569,,BAO_0000019,,
1965,11828,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617570,,BAO_0000249,,
1966,11866,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617571,,BAO_0000357,,
1967,773,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,B,,,Sus scrofa,9823.0,,,,,105,H,8,Autocuration,1,,CHEMBL617572,,BAO_0000357,,
1968,13047,The compound was tested for intrinsic activity against 5-HT1D receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL617573,,BAO_0000357,,
1969,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL617574,,BAO_0000019,,
1970,13047,The compound was tested for binding affinity against 5-HT1D receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL617575,,BAO_0000357,,
1971,188,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617576,,BAO_0000357,,
1972,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,F,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617577,,BAO_0000019,,
1973,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,F,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617578,,BAO_0000019,,
1974,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617579,,BAO_0000357,,
1975,15854,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10578,H,8,Expert,1,,CHEMBL617580,,BAO_0000019,,
1976,10394,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617581,,BAO_0000249,,
1977,12092,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617582,,BAO_0000357,,
1978,3389,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,B,,,,,,,,,10578,H,8,Expert,1,,CHEMBL617583,,BAO_0000019,,
1979,6011,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617584,,BAO_0000357,,
1980,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617585,,BAO_0000357,,
1981,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL875912,,BAO_0000357,,
1982,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617586,,BAO_0000357,,
1983,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617587,,BAO_0000357,,
1984,11866,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617588,,BAO_0000357,,
1985,4687,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL857980,,BAO_0000357,,
1986,12146,Tested against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617589,,BAO_0000357,,
1987,10321,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617590,,BAO_0000357,,
1988,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617591,722.0,BAO_0000219,,
1989,1274,Binding affinity against 5-Hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL617592,,BAO_0000357,,
1990,15250,,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617593,,BAO_0000357,,
1991,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL617594,485.0,BAO_0000219,,
1992,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL617595,485.0,BAO_0000219,,
1993,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617596,722.0,BAO_0000219,,
1994,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617597,722.0,BAO_0000219,,
1995,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617598,,BAO_0000019,,
1996,13366,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL872916,,BAO_0000357,,
1997,13366,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617599,,BAO_0000357,,
1998,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617091,,BAO_0000357,,
1999,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",B,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL617092,485.0,BAO_0000219,,
2000,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL617093,485.0,BAO_0000219,,
2001,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617094,,BAO_0000019,,
2002,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617095,,BAO_0000019,,
2003,14251,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617096,,BAO_0000019,,
2004,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617097,,BAO_0000019,,
2005,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617098,,BAO_0000019,,
2006,13313,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617301,,BAO_0000357,,
2007,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617302,,BAO_0000357,,
2008,13366,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617303,,BAO_0000357,,
2009,13051,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617304,,BAO_0000357,,
2010,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617305,449.0,BAO_0000219,,
2011,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,B,,,Homo sapiens,9606.0,,,,,105,D,9,Autocuration,1,,CHEMBL617306,,BAO_0000219,,
2012,5619,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617307,,BAO_0000357,,
2013,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL617308,,BAO_0000019,,
2014,16633,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617309,,BAO_0000357,,
2015,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617310,,BAO_0000357,,
2016,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617311,,BAO_0000357,,
2017,16633,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617312,,BAO_0000357,,
2018,3269,Affinity against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617313,,BAO_0000357,,
2019,12409,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617314,,BAO_0000357,,
2020,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617315,,BAO_0000019,,
2021,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,B,,,,,,,HEK293,,106,H,8,Autocuration,1,,CHEMBL617316,722.0,BAO_0000219,,
2022,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,B,,,,,,,HEK293,,106,H,8,Autocuration,1,,CHEMBL617317,722.0,BAO_0000219,,
2023,12903,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL617318,449.0,BAO_0000219,,
2024,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617319,,BAO_0000019,,
2025,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617320,,BAO_0000357,,
2026,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617321,,BAO_0000357,,
2027,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617322,,BAO_0000357,,
2028,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616862,,BAO_0000357,,
2029,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616863,,BAO_0000357,,
2030,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616864,449.0,BAO_0000219,,
2031,13706,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616865,485.0,BAO_0000219,,
2032,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616866,485.0,BAO_0000219,,
2033,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616867,,BAO_0000019,,
2034,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",B,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616868,485.0,BAO_0000219,,
2035,13051,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616869,,BAO_0000357,,
2036,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616870,449.0,BAO_0000219,,
2037,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616871,485.0,BAO_0000219,,
2038,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616872,485.0,BAO_0000219,,
2039,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616873,485.0,BAO_0000219,,
2040,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616838,485.0,BAO_0000219,,
2041,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616839,,BAO_0000357,,
2042,13047,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616840,,BAO_0000019,,
2043,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616841,,BAO_0000357,,
2044,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616842,,BAO_0000357,,
2045,12409,Binding affinity against 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL857976,,BAO_0000357,,
2046,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616843,449.0,BAO_0000219,,
2047,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,B,,,Homo sapiens,9606.0,,,,,10618,D,9,Expert,1,,CHEMBL616844,,BAO_0000357,,
2048,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616845,,BAO_0000357,,
2049,4234,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,B,,,Homo sapiens,9606.0,,,,,10618,D,9,Expert,1,,CHEMBL616846,,BAO_0000357,,
2050,16209,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616847,,BAO_0000357,,
2051,10444,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616848,,BAO_0000019,,
2052,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616849,,BAO_0000357,,
2053,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL872911,,BAO_0000357,,
2054,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616850,,BAO_0000019,,
2055,12936,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,10618,D,9,Expert,1,,CHEMBL616699,449.0,BAO_0000219,,
2056,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616700,,BAO_0000357,,
2057,15779,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616701,449.0,BAO_0000219,,
2058,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616702,449.0,BAO_0000219,,
2059,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616703,449.0,BAO_0000219,,
2060,13181,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616704,,BAO_0000357,,
2061,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616705,449.0,BAO_0000219,,
2062,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616706,,BAO_0000357,,
2063,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616707,449.0,BAO_0000219,,
2064,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616708,,BAO_0000357,,
2065,12146,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616709,,BAO_0000357,,
2066,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616710,449.0,BAO_0000219,,
2067,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616711,449.0,BAO_0000219,,
2068,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616712,449.0,BAO_0000219,,
2069,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616713,,BAO_0000357,,
2070,4373,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616714,,BAO_0000357,,
2071,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616715,,BAO_0000357,,
2072,16633,Binding affinity towards 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616716,,BAO_0000357,,
2073,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616717,,BAO_0000019,,
2074,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",F,,,,,,,,,279,H,8,Expert,1,,CHEMBL616718,,BAO_0000019,,
2075,16209,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL875905,,BAO_0000019,,
2076,16209,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616719,,BAO_0000019,,
2077,17085,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",F,,,,,,,,,279,H,8,Expert,1,,CHEMBL616720,,BAO_0000019,,
2078,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616721,,BAO_0000357,,
2079,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL616722,449.0,BAO_0000219,,
2080,3805,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616723,,BAO_0000357,,
2081,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL616724,449.0,BAO_0000219,,
2082,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616725,,BAO_0000357,,
2083,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616726,,BAO_0000357,,
2084,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616727,,BAO_0000357,,
2085,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616728,,BAO_0000357,,
2086,6866,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616729,,BAO_0000357,,
2087,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Expert,1,,CHEMBL616730,,BAO_0000019,,
2088,16312,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617125,,BAO_0000357,,
2089,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL857977,,BAO_0000357,,
2090,15779,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617126,449.0,BAO_0000219,,
2091,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617127,449.0,BAO_0000219,,
2092,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617128,,BAO_0000357,,
2093,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617129,449.0,BAO_0000219,,
2094,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617130,,BAO_0000357,,
2095,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617131,449.0,BAO_0000219,,
2096,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617132,449.0,BAO_0000219,,
2097,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617133,449.0,BAO_0000219,,
2098,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617134,,BAO_0000357,,
2099,4373,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617135,,BAO_0000357,,
2100,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617136,,BAO_0000357,,
2101,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617137,,BAO_0000019,,
2102,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617138,,BAO_0000019,,
2103,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617139,,BAO_0000019,,
2104,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617140,,BAO_0000019,,
2105,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617141,,BAO_0000218,,
2106,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL858112,,BAO_0000019,,
2107,12352,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,B,,,,,,,,,17005,H,8,Intermediate,1,,CHEMBL617142,,BAO_0000019,,
2108,13657,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617143,,BAO_0000019,,
2109,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617144,,BAO_0000019,,
2110,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617145,,BAO_0000019,,
2111,14331,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617146,,BAO_0000019,,
2112,12685,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617147,,BAO_0000019,,
2113,14389,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617148,,BAO_0000019,,
2114,14386,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617149,,BAO_0000019,,
2115,5732,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617150,,BAO_0000224,,
2116,16293,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617151,,BAO_0000224,,
2117,2078,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617201,,BAO_0000224,,
2118,5486,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL617202,,BAO_0000357,,
2119,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,B,In vivo,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617203,,BAO_0000218,,
2120,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617204,,BAO_0000019,,
2121,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617205,,BAO_0000224,,
2122,10297,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617206,,BAO_0000019,,
2123,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,B,In vivo,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617207,,BAO_0000218,,
2124,10297,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617208,,BAO_0000019,,
2125,11555,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617209,,BAO_0000224,,
2126,11555,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617210,,BAO_0000224,,
2127,11555,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617211,,BAO_0000224,,
2128,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617212,,BAO_0000019,,
2129,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,B,,,Sus scrofa,9823.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617213,,BAO_0000224,,
2130,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,B,,,Sus scrofa,9823.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617214,,BAO_0000224,,
2131,5333,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617215,,BAO_0000221,,
2132,4437,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617216,,BAO_0000221,,
2133,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,B,,,Sus scrofa,9823.0,,,,,17005,H,8,Autocuration,1,,CHEMBL617217,,BAO_0000357,,
2134,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617218,,BAO_0000019,,
2135,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL872913,,BAO_0000019,,
2136,11820,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617219,,BAO_0000019,,
2137,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL873482,,BAO_0000224,,
2138,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617220,,BAO_0000019,,
2139,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617221,,BAO_0000019,,
2140,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617222,,BAO_0000019,,
2141,10428,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL875906,,BAO_0000019,,
2142,9628,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617223,,BAO_0000019,,
2143,12704,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617224,,BAO_0000224,,
2144,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617225,,BAO_0000224,,
2145,188,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617226,,BAO_0000224,,
2146,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617227,,BAO_0000224,,
2147,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617228,,BAO_0000224,,
2148,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617229,,BAO_0000224,,
2149,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617230,,BAO_0000224,,
2150,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617231,,BAO_0000224,,
2151,11702,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617232,,BAO_0000224,,
2152,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617233,,BAO_0000224,,
2153,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617234,,BAO_0000224,,
2154,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617235,,BAO_0000019,,
2155,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617236,,BAO_0000019,,
2156,10085,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,B,,,,,,Hippocampus,,,104686,H,4,Autocuration,1,,CHEMBL617237,,BAO_0000221,10000000.0,
2157,10085,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,B,,,,,,Hippocampus,,,104686,H,4,Autocuration,1,,CHEMBL617238,,BAO_0000221,10000000.0,
2158,9630,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL617239,,BAO_0000221,955.0,
2159,11070,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617240,,BAO_0000019,,
2160,9841,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617241,,BAO_0000249,,
2161,9841,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL875907,,BAO_0000249,,
2162,13291,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617242,,BAO_0000019,,
2163,10590,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617152,,BAO_0000019,,
2164,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL617153,,BAO_0000221,955.0,
2165,12268,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104686,D,5,Autocuration,1,,CHEMBL617154,,BAO_0000249,,
2166,13508,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617155,,BAO_0000221,955.0,
2167,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617156,,BAO_0000019,,
2168,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617157,,BAO_0000019,,
2169,11200,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617158,,BAO_0000019,,
2170,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617159,,BAO_0000019,,
2171,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617160,,BAO_0000019,,
2172,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL858113,,BAO_0000019,,
2173,9231,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617247,,BAO_0000220,955.0,
2174,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617248,,BAO_0000019,,
2175,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617249,,BAO_0000249,955.0,
2176,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617250,,BAO_0000019,,
2177,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617251,,BAO_0000019,,
2178,11828,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617252,,BAO_0000019,,
2179,12253,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617006,,BAO_0000019,,
2180,12253,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617007,,BAO_0000019,,
2181,11279,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617008,,BAO_0000019,,
2182,11866,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617009,,BAO_0000019,,
2183,14424,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617010,,BAO_0000224,,
2184,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL857978,,BAO_0000019,,
2185,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617011,,BAO_0000019,,
2186,9786,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617012,,BAO_0000019,,
2187,12132,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617013,,BAO_0000224,,
2188,5486,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617014,,BAO_0000249,,
2189,15316,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617015,,BAO_0000019,,
2190,16429,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617016,,BAO_0000019,,
2191,14617,pKi value for 5-hydroxytryptamine 2 receptor binding site,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617017,,BAO_0000224,,
2192,11351,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617018,,BAO_0000221,955.0,
2193,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617019,,BAO_0000019,,
2194,9523,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617020,,BAO_0000019,,
2195,9523,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617021,,BAO_0000019,,
2196,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617022,,BAO_0000019,,
2197,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617023,,BAO_0000019,,
2198,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617024,,BAO_0000019,,
2199,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617025,,BAO_0000019,,
2200,9523,Hill coefficient of compound was determined,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617026,,BAO_0000224,,
2201,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617027,,BAO_0000019,,
2202,5033,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617028,,BAO_0000019,,
2203,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617029,,BAO_0000019,,
2204,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL875908,,BAO_0000019,,
2205,16288,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617030,,BAO_0000357,,
2206,16288,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617031,,BAO_0000019,,
2207,16190,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617032,,BAO_0000019,,
2208,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617033,,BAO_0000224,,
2209,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617034,,BAO_0000224,,
2210,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617035,,BAO_0000224,,
2211,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617036,,BAO_0000019,,
2212,1205,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617037,,BAO_0000224,,
2213,11376,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617038,,BAO_0000219,,
2214,11376,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617039,,BAO_0000219,,
2215,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617161,,BAO_0000224,,
2216,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617162,,BAO_0000224,,
2217,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617163,,BAO_0000224,,
2218,1089,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617164,,BAO_0000224,,
2219,386,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,B,,,,,,,,Brain membranes,104784,H,4,Autocuration,1,,CHEMBL617165,,BAO_0000249,,
2220,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617166,,BAO_0000224,,
2221,17066,Binding affinity towards 5-HT2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617167,,BAO_0000224,,
2222,959,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL872912,,BAO_0000224,,
2223,6398,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617168,,BAO_0000224,,
2224,11889,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617169,,BAO_0000224,,
2225,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617170,,BAO_0000224,,
2226,11026,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617171,,BAO_0000224,,
2227,11866,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617172,,BAO_0000224,,
2228,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617173,,BAO_0000224,,
2229,13950,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617174,,BAO_0000019,,
2230,1263,5-hydroxytryptamine 2 receptor binding affinity,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617175,,BAO_0000224,,
2231,13291,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617176,,BAO_0000357,,
2232,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617177,,BAO_0000357,,
2233,13020,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617178,,BAO_0000224,,
2234,13021,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617179,,BAO_0000224,,
2235,13020,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617180,,BAO_0000224,,
2236,14532,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617181,,BAO_0000357,,
2237,13944,Binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617182,,BAO_0000357,,
2238,14331,Binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617183,,BAO_0000357,,
2239,14118,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617184,,BAO_0000357,,
2240,13033,Binding affinity against serotonergic 5-HT2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617185,,BAO_0000357,,
2241,10321,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617186,,BAO_0000357,,
2242,12918,Compound was evaluated for the binding affinity at 5- HT2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617187,,BAO_0000357,,
2243,15120,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617188,,BAO_0000357,,
2244,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617189,,BAO_0000218,,
2245,13378,Inhibitory activity against cloned human 5-HT2 receptor,B,,,Homo sapiens,9606.0,,,,,104784,D,5,Autocuration,1,,CHEMBL617190,,BAO_0000224,,
2246,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617191,449.0,BAO_0000219,,
2247,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617192,449.0,BAO_0000219,,
2248,2331,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617193,449.0,BAO_0000219,,
2249,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617194,449.0,BAO_0000219,,
2250,4170,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617195,,BAO_0000224,,
2251,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL881830,,BAO_0000224,,
2252,1479,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617196,,BAO_0000357,,
2253,11139,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617197,,BAO_0000224,,
2254,13969,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL617198,,BAO_0000357,,
2255,13392,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL873476,,BAO_0000357,,
2256,14430,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL617199,,BAO_0000019,,
2257,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,B,,,Cavia porcellus,10141.0,,,,,107,H,8,Autocuration,1,,CHEMBL617200,,BAO_0000357,,
2258,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617484,,BAO_0000357,,
2259,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617485,,BAO_0000357,,
2260,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617486,,BAO_0000357,,
2261,13463,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL858022,,BAO_0000357,,
2262,6347,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617049,449.0,BAO_0000219,,
2263,6857,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617050,449.0,BAO_0000219,,
2264,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617051,,BAO_0000219,,
2265,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617052,,BAO_0000219,,
2266,4176,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617053,,BAO_0000219,,
2267,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617054,449.0,BAO_0000219,,
2268,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617055,449.0,BAO_0000219,,
2269,15331,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL882924,,BAO_0000357,,
2270,16146,Inhibition of human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617056,,BAO_0000357,,
2271,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617057,449.0,BAO_0000219,,
2272,13631,Inhibitory concentration against human 5-HT2A receptor in BEK cells,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617058,,BAO_0000219,,
2273,3805,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617059,,BAO_0000357,,
2274,4011,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617060,449.0,BAO_0000219,,
2275,4012,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617061,449.0,BAO_0000219,,
2276,6366,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617062,307.0,BAO_0000219,,
2277,15949,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617063,449.0,BAO_0000219,,
2278,14093,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617064,,BAO_0000019,,
2279,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617065,,BAO_0000019,,
2280,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617066,449.0,BAO_0000219,,
2281,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617067,449.0,BAO_0000219,,
2282,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617068,,BAO_0000019,,
2283,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617069,,BAO_0000019,,
2284,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617070,,BAO_0000019,,
2285,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617071,,BAO_0000357,,
2286,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL872915,,BAO_0000357,,
2287,14755,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617072,,BAO_0000357,,
2288,16441,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617073,,BAO_0000357,,
2289,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617074,,BAO_0000357,,
2290,16659,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617075,449.0,BAO_0000219,,
2291,3307,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617076,,BAO_0000357,,
2292,6857,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617077,,BAO_0000019,,
2293,5635,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617078,,BAO_0000357,,
2294,4234,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617079,,BAO_0000357,,
2295,15527,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617080,,BAO_0000357,,
2296,6588,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617081,449.0,BAO_0000219,,
2297,13631,Binding affinity towards human 5-HT2A receptor in BEK cells,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617082,,BAO_0000219,,
2298,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617083,,BAO_0000357,,
2299,14770,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617084,,BAO_0000357,,
2300,16293,Binding affinity for human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617085,,BAO_0000357,,
2301,16209,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617086,,BAO_0000357,,
2302,12469,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617087,,BAO_0000219,,
2303,15363,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617088,,BAO_0000357,,
2304,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617089,,BAO_0000357,,
2305,16441,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617090,,BAO_0000019,,
2306,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617513,,BAO_0000357,,
2307,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617514,722.0,BAO_0000219,,
2308,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617515,,BAO_0000019,,
2309,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617516,,BAO_0000357,,
2310,17200,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617517,,BAO_0000357,,
2311,4013,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617518,449.0,BAO_0000219,,
2312,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617519,,BAO_0000357,,
2313,5088,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617520,,BAO_0000357,,
2314,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617521,,BAO_0000357,,
2315,5088,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617522,,BAO_0000357,,
2316,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617523,,BAO_0000357,,
2317,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617524,,BAO_0000357,,
2318,9786,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617525,,BAO_0000019,,
2319,9205,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617526,,BAO_0000019,,
2320,11257,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617527,,BAO_0000224,,
2321,9362,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617528,,BAO_0000019,,
2322,9362,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617529,,BAO_0000019,,
2323,10590,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617530,,BAO_0000224,,
2324,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617531,,BAO_0000019,,
2325,13050,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617532,,BAO_0000019,,
2326,11624,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617533,,BAO_0000019,,
2327,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617534,,BAO_0000019,,
2328,10330,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617535,,BAO_0000224,,
2329,10062,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617536,,BAO_0000224,,
2330,11642,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617537,,BAO_0000224,,
2331,10062,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617538,,BAO_0000224,,
2332,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617539,,BAO_0000219,,
2333,12280,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617540,,BAO_0000224,,
2334,4101,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617541,,BAO_0000224,,
2335,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617542,,BAO_0000224,,
2336,11147,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617543,,BAO_0000224,,
2337,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617544,485.0,BAO_0000219,,
2338,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617545,485.0,BAO_0000219,,
2339,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617413,,BAO_0000019,,
2340,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617414,,BAO_0000019,,
2341,9098,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617415,,BAO_0000019,,
2342,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617416,,BAO_0000224,,
2343,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617417,,BAO_0000224,,
2344,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617418,,BAO_0000019,,
2345,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617419,,BAO_0000019,,
2346,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617420,,BAO_0000224,,
2347,3070,Affinity for 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617421,,BAO_0000224,,
2348,9547,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617422,,BAO_0000224,,
2349,10444,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617423,,BAO_0000019,,
2350,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617424,,BAO_0000019,,
2351,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617425,,BAO_0000019,,
2352,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617426,,BAO_0000224,,
2353,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),B,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617427,,BAO_0000218,,
2354,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617428,,BAO_0000221,955.0,
2355,2797,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617429,,BAO_0000224,,
2356,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617430,,BAO_0000019,,
2357,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617431,,BAO_0000019,,
2358,10752,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,B,,,,,,Frontal cortex,,,104686,H,4,Autocuration,1,,CHEMBL617432,,BAO_0000019,1870.0,
2359,1185,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617433,,BAO_0000224,,
2360,1185,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617434,,BAO_0000224,,
2361,11624,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617435,,BAO_0000224,,
2362,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617436,,BAO_0000019,,
2363,15453,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,B,,,Rattus norvegicus,10116.0,,Striatum,,,104686,D,5,Autocuration,1,,CHEMBL617437,,BAO_0000019,2435.0,
2364,11662,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617438,,BAO_0000019,,
2365,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617439,,BAO_0000019,,
2366,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617440,,BAO_0000224,,
2367,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617441,,BAO_0000224,,
2368,8814,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL872918,,BAO_0000019,,
2369,8908,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617442,,BAO_0000019,,
2370,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617443,,BAO_0000019,,
2371,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617444,,BAO_0000019,,
2372,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617445,,BAO_0000019,,
2373,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617446,,BAO_0000019,,
2374,9098,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617447,,BAO_0000249,,
2375,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617448,,BAO_0000019,,
2376,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617449,,BAO_0000019,,
2377,9161,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617450,,BAO_0000019,,
2378,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617451,,BAO_0000019,,
2379,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617452,,BAO_0000019,,
2380,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617453,,BAO_0000019,,
2381,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617660,,BAO_0000019,,
2382,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617661,,BAO_0000019,,
2383,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617662,,BAO_0000019,,
2384,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL872919,,BAO_0000019,,
2385,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617663,,BAO_0000019,,
2386,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617664,,BAO_0000019,,
2387,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617665,,BAO_0000019,,
2388,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617666,,BAO_0000019,,
2389,12094,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617667,,BAO_0000019,,
2390,12018,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617668,,BAO_0000249,,
2391,10394,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617669,,BAO_0000249,,
2392,15260,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617670,,BAO_0000224,,
2393,11624,Inhibitory constant against 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617671,,BAO_0000224,,
2394,13654,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617672,,BAO_0000224,,
2395,9541,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617673,,BAO_0000019,,
2396,11933,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617674,,BAO_0000224,,
2397,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617675,,BAO_0000019,,
2398,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617676,,BAO_0000019,,
2399,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617677,,BAO_0000019,,
2400,8841,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,D,5,Autocuration,1,,CHEMBL617678,,BAO_0000019,,
2401,1455,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617679,,BAO_0000224,,
2402,1455,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617680,,BAO_0000224,,
2403,11752,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617681,,BAO_0000019,,
2404,11642,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617682,,BAO_0000221,955.0,
2405,12092,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617683,,BAO_0000224,,
2406,3967,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617684,,BAO_0000224,,
2407,12771,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617685,,BAO_0000224,,
2408,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617686,,BAO_0000019,,
2409,11628,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617687,,BAO_0000224,,
2410,13654,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617688,,BAO_0000224,,
2411,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617689,,BAO_0000019,,
2412,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617690,,BAO_0000019,,
2413,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617691,,BAO_0000218,,
2414,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617692,,BAO_0000218,,
2415,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617693,,BAO_0000218,,
2416,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617694,,BAO_0000218,,
2417,15436,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,B,,,,,,Brain,,,12687,H,8,Expert,1,,CHEMBL857985,,BAO_0000221,955.0,
2418,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617695,,BAO_0000019,,
2419,14025,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617696,,BAO_0000019,,
2420,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617697,,BAO_0000357,,
2421,13735,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617257,,BAO_0000019,,
2422,5816,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617258,,BAO_0000357,,
2423,14287,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617259,,BAO_0000019,,
2424,15738,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617260,,BAO_0000357,,
2425,15738,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617261,,BAO_0000357,,
2426,15026,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617262,,BAO_0000019,,
2427,16647,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617263,,BAO_0000019,,
2428,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617264,,BAO_0000019,,
2429,13345,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617265,,BAO_0000019,,
2430,1543,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,B,,,,,,,,Membranes,12687,H,8,Autocuration,1,,CHEMBL617266,,BAO_0000249,,
2431,12444,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617267,,BAO_0000019,,
2432,16404,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617268,,BAO_0000019,,
2433,16404,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,B,,,,,,,CHO,,12687,H,8,Autocuration,1,,CHEMBL617269,449.0,BAO_0000219,,
2434,15577,Kinetic inhibition constant evaluated by measuring serotonergic activity,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617323,,BAO_0000357,,
2435,15577,Serotonergic activity of the compound.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617324,,BAO_0000357,,
2436,2495,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617325,,BAO_0000249,,
2437,15042,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617326,,BAO_0000019,,
2438,15026,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617327,,BAO_0000249,,
2439,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617328,,BAO_0000019,,
2440,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617329,,BAO_0000019,,
2441,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617330,,BAO_0000019,,
2442,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617331,,BAO_0000357,,
2443,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617332,,BAO_0000357,,
2444,4820,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617333,,BAO_0000357,,
2445,6736,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617334,,BAO_0000357,,
2446,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617335,,BAO_0000357,,
2447,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617336,,BAO_0000357,,
2448,6011,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617337,,BAO_0000357,,
2449,14294,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617338,,BAO_0000357,,
2450,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617339,,BAO_0000357,,
2451,17066,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617340,,BAO_0000357,,
2452,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617341,,BAO_0000357,,
2453,6736,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617342,,BAO_0000357,,
2454,5163,Affinity for 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617343,,BAO_0000357,,
2455,16911,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,B,,,,,,,NIH3T3,,107,H,8,Expert,1,,CHEMBL617344,723.0,BAO_0000219,,
2456,6841,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617345,,BAO_0000357,,
2457,6119,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617346,,BAO_0000357,,
2458,3962,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617347,,BAO_0000357,,
2459,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617348,,BAO_0000357,,
2460,4373,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617349,,BAO_0000357,,
2461,3962,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617350,,BAO_0000019,,
2462,1633,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL872339,,BAO_0000357,,
2463,4373,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617351,,BAO_0000357,,
2464,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617352,,BAO_0000357,,
2465,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617353,,BAO_0000357,,
2466,16946,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617354,,BAO_0000357,,
2467,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617355,,BAO_0000357,,
2468,3032,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,B,,,Mus musculus,10090.0,,,CHO,,107,H,8,Expert,1,,CHEMBL617356,449.0,BAO_0000219,,
2469,16655,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617357,,BAO_0000357,,
2470,13964,Binding affinity at 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617358,,BAO_0000357,,
2471,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617359,,BAO_0000357,,
2472,16117,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617360,,BAO_0000357,,
2473,16700,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL875913,,BAO_0000357,,
2474,3269,Affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617361,,BAO_0000357,,
2475,1274,Binding affinity against 5-Hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617362,,BAO_0000357,,
2476,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617363,,BAO_0000357,,
2477,12146,Tested against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617364,,BAO_0000357,,
2478,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617365,,BAO_0000224,,
2479,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617366,,BAO_0000224,,
2480,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617367,,BAO_0000224,,
2481,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617368,,BAO_0000224,,
2482,16647,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617369,,BAO_0000357,,
2483,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617370,722.0,BAO_0000219,,
2484,6857,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617371,449.0,BAO_0000219,,
2485,3805,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617372,,BAO_0000357,,
2486,6491,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617373,,BAO_0000357,,
2487,14093,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617374,,BAO_0000019,,
2488,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617375,,BAO_0000019,,
2489,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617376,,BAO_0000019,,
2490,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617377,,BAO_0000019,,
2491,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617378,,BAO_0000019,,
2492,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617379,,BAO_0000019,,
2493,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617380,,BAO_0000357,,
2494,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617381,,BAO_0000357,,
2495,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617382,,BAO_0000357,,
2496,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617383,,BAO_0000357,,
2497,12369,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617384,,BAO_0000357,,
2498,12369,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617385,,BAO_0000357,,
2499,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617386,,BAO_0000019,,
2500,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617387,,BAO_0000019,,
2501,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL617388,723.0,BAO_0000219,,
2502,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617389,449.0,BAO_0000219,,
2503,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617390,449.0,BAO_0000219,,
2504,5635,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,B,,,,,,,,,104817,H,4,Autocuration,1,,CHEMBL617391,,BAO_0000224,,
2505,12861,Binding activity radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617392,,BAO_0000357,,
2506,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617393,,BAO_0000019,,
2507,5105,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,B,,,,,,,L929,,107,H,8,Autocuration,1,,CHEMBL617394,307.0,BAO_0000219,,
2508,5104,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617395,307.0,BAO_0000219,,
2509,5105,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617396,307.0,BAO_0000219,,
2510,5105,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,B,,,,,,,L929,,107,H,8,Autocuration,1,,CHEMBL617397,307.0,BAO_0000219,,
2511,5254,Binding affinity against 5-HT2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617398,,BAO_0000357,,
2512,5254,Binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617399,,BAO_0000357,,
2513,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617400,722.0,BAO_0000219,,
2514,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617401,722.0,BAO_0000219,,
2515,14157,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617402,722.0,BAO_0000219,,
2516,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617403,722.0,BAO_0000219,,
2517,14068,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617404,,BAO_0000357,,
2518,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL857981,722.0,BAO_0000219,,
2519,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617405,722.0,BAO_0000219,,
2520,4540,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617253,722.0,BAO_0000219,,
2521,6166,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617254,,BAO_0000357,,
2522,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617255,722.0,BAO_0000219,,
2523,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617256,722.0,BAO_0000219,,
2524,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616874,722.0,BAO_0000219,,
2525,15779,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616875,722.0,BAO_0000219,,
2526,14391,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616876,722.0,BAO_0000219,,
2527,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616877,722.0,BAO_0000219,,
2528,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616878,722.0,BAO_0000219,,
2529,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616879,722.0,BAO_0000219,,
2530,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616880,722.0,BAO_0000219,,
2531,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616881,722.0,BAO_0000219,,
2532,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616882,723.0,BAO_0000219,,
2533,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616883,723.0,BAO_0000219,,
2534,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616884,723.0,BAO_0000219,,
2535,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616885,722.0,BAO_0000219,,
2536,1883,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,B,,,,,,,CHO-K1,,107,H,8,Autocuration,1,,CHEMBL616886,485.0,BAO_0000219,,
2537,1883,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,107,H,8,Expert,1,,CHEMBL616887,485.0,BAO_0000219,,
2538,14875,Binding affinity for human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL616888,,BAO_0000357,,
2539,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616889,722.0,BAO_0000219,,
2540,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616890,722.0,BAO_0000219,,
2541,16404,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL616891,449.0,BAO_0000219,,
2542,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616892,722.0,BAO_0000219,,
2543,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616893,722.0,BAO_0000219,,
2544,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,F,,,,,,,NIH3T3,,10620,H,8,Autocuration,1,,CHEMBL616894,723.0,BAO_0000219,,
2545,4682,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,B,,,,,,,NIH3T3,,107,H,8,Expert,1,,CHEMBL616895,723.0,BAO_0000219,,
2546,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,F,,,,,,,,,10620,H,8,Autocuration,1,,CHEMBL616896,,BAO_0000019,,
2547,4921,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,B,,,,,,,,,10621,H,8,Autocuration,1,,CHEMBL617099,,BAO_0000357,,
2548,4921,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,B,,,,,,,,,10621,H,8,Autocuration,1,,CHEMBL617100,,BAO_0000357,,
2549,16312,Binding affinity against rabbit aorta 5-HT2A receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Autocuration,1,,CHEMBL884532,,BAO_0000357,,
2550,14998,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617101,,BAO_0000357,,
2551,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617102,,BAO_0000357,,
2552,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Autocuration,1,,CHEMBL617103,,BAO_0000019,,
2553,13047,The compound was tested for binding affinity against 5-HT2A receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617104,,BAO_0000357,,
2554,1883,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,B,,,,,,,CHO-K1,,10576,H,8,Autocuration,1,,CHEMBL857979,485.0,BAO_0000219,,
2555,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL857502,,BAO_0000019,,
2556,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617105,,BAO_0000019,,
2557,13463,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,B,,,,,,Stomach,,,12687,H,8,Autocuration,1,,CHEMBL858021,,BAO_0000019,945.0,
2558,13463,Binding affinity for 5-HT 2A in rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12687,D,9,Expert,1,,CHEMBL875910,,BAO_0000019,945.0,
2559,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617106,,BAO_0000019,,
2560,16326,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617107,723.0,BAO_0000219,,
2561,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617108,,BAO_0000019,,
2562,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617109,,BAO_0000019,,
2563,15740,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617110,,BAO_0000357,,
2564,16633,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617111,,BAO_0000357,,
2565,17200,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617112,,BAO_0000019,,
2566,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617113,,BAO_0000357,,
2567,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617114,,BAO_0000357,,
2568,17133,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617115,,BAO_0000357,,
2569,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617116,,BAO_0000219,,
2570,15363,Efficacy at 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617117,,BAO_0000019,,
2571,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617118,,BAO_0000357,,
2572,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617119,,BAO_0000357,,
2573,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617120,,BAO_0000357,,
2574,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617121,,BAO_0000219,,
2575,17200,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617122,,BAO_0000219,,
2576,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617123,,BAO_0000019,,
2577,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617124,,BAO_0000019,,
2578,13565,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617600,,BAO_0000249,,
2579,13730,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617601,,BAO_0000357,,
2580,12416,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL882923,,BAO_0000019,,
2581,15295,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617602,,BAO_0000357,,
2582,1742,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617603,,BAO_0000019,,
2583,15295,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617604,,BAO_0000357,,
2584,14970,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617605,,BAO_0000019,,
2585,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617606,,BAO_0000019,,
2586,14776,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617607,,BAO_0000019,,
2587,14286,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617455,,BAO_0000249,,
2588,17200,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617456,,BAO_0000019,,
2589,15306,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617457,,BAO_0000357,,
2590,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617458,,BAO_0000357,,
2591,14229,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617459,,BAO_0000019,,
2592,12884,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617460,,BAO_0000357,,
2593,13149,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617461,,BAO_0000357,,
2594,15295,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617462,,BAO_0000019,,
2595,15740,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617463,,BAO_0000357,,
2596,15185,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617464,,BAO_0000019,,
2597,15185,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617465,,BAO_0000019,,
2598,17529,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617466,,BAO_0000019,,
2599,14826,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617467,,BAO_0000019,,
2600,17211,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617468,,BAO_0000019,,
2601,14826,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617469,,BAO_0000019,,
2602,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617470,,BAO_0000019,,
2603,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617471,,BAO_0000019,,
2604,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617472,723.0,BAO_0000219,,
2605,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617473,,BAO_0000357,,
2606,15436,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617474,,BAO_0000019,,
2607,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617475,,BAO_0000019,,
2608,14442,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,B,,,,,,Brain,,,12687,H,8,Autocuration,1,,CHEMBL617476,,BAO_0000221,955.0,
2609,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617477,,BAO_0000357,,
2610,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617478,723.0,BAO_0000219,,
2611,14755,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617479,,BAO_0000221,,
2612,4707,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617480,,BAO_0000357,,
2613,13297,Binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617481,,BAO_0000357,,
2614,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617482,,BAO_0000019,,
2615,4664,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617483,,BAO_0000019,,
2616,16633,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621528,,BAO_0000357,,
2617,4664,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,NIH3T3,,12687,D,9,Expert,1,,CHEMBL621529,723.0,BAO_0000219,,
2618,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621530,,BAO_0000357,,
2619,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621531,,BAO_0000357,,
2620,14060,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621532,,BAO_0000019,,
2621,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621533,,BAO_0000357,,
2622,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,12687,H,8,Expert,1,,CHEMBL621534,449.0,BAO_0000219,,
2623,14776,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621535,,BAO_0000019,,
2624,13481,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621536,,BAO_0000357,,
2625,17386,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621537,,BAO_0000357,,
2626,6611,Binding affinity for 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621538,,BAO_0000357,,
2627,14423,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621539,,BAO_0000019,,
2628,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621540,,BAO_0000019,,
2629,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621541,,BAO_0000019,,
2630,6238,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621542,,BAO_0000019,,
2631,6648,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621543,,BAO_0000357,,
2632,5667,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621544,,BAO_0000357,,
2633,6611,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621545,,BAO_0000357,,
2634,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621546,,BAO_0000357,,
2635,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621547,,BAO_0000357,,
2636,15558,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618692,723.0,BAO_0000219,,
2637,6013,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618693,,BAO_0000357,,
2638,16633,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL872922,,BAO_0000357,,
2639,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618694,,BAO_0000357,,
2640,6013,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL618695,,BAO_0000357,,
2641,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618696,,BAO_0000357,,
2642,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL618697,,BAO_0000357,,
2643,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618892,,BAO_0000357,,
2644,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618893,,BAO_0000357,,
2645,16293,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618894,,BAO_0000357,,
2646,17175,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618895,723.0,BAO_0000219,,
2647,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL618896,,BAO_0000357,,
2648,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,B,,,,,,Caudate-putamen,,,12687,H,8,Autocuration,1,,CHEMBL618897,,BAO_0000019,5383.0,
2649,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618898,,BAO_0000357,,
2650,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618899,,BAO_0000357,,
2651,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618900,,BAO_0000357,,
2652,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618901,,BAO_0000019,,
2653,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618902,,BAO_0000357,,
2654,5432,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,12687,D,9,Expert,1,,CHEMBL618903,,BAO_0000221,10000000.0,
2655,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618904,,BAO_0000357,,
2656,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618905,,BAO_0000357,,
2657,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618906,,BAO_0000357,,
2658,14749,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618907,723.0,BAO_0000219,,
2659,13462,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618908,,BAO_0000019,,
2660,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617909,,BAO_0000357,,
2661,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617910,,BAO_0000019,,
2662,13345,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,B,,,,,,Brain,,,12687,H,8,Autocuration,1,,CHEMBL617911,,BAO_0000221,955.0,
2663,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL872923,,BAO_0000249,,
2664,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617912,,BAO_0000249,,
2665,15535,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617913,,BAO_0000019,,
2666,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617914,,BAO_0000249,,
2667,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617915,,BAO_0000249,,
2668,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617916,,BAO_0000249,,
2669,4795,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617917,,BAO_0000019,,
2670,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617918,,BAO_0000019,,
2671,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617919,,BAO_0000019,,
2672,17200,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617920,,BAO_0000019,,
2673,2148,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617921,,BAO_0000019,,
2674,13345,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",B,,,Rattus norvegicus,10116.0,,,,,105102,D,5,Expert,1,,CHEMBL617922,,BAO_0000224,,
2675,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617923,,BAO_0000357,,
2676,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617924,,BAO_0000357,,
2677,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617925,,BAO_0000357,,
2678,17133,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617926,,BAO_0000357,,
2679,16532,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617927,,BAO_0000357,,
2680,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617928,,BAO_0000357,,
2681,2309,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617929,,BAO_0000019,,
2682,12953,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617930,,BAO_0000019,,
2683,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617931,,BAO_0000019,,
2684,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617932,,BAO_0000019,,
2685,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,B,,,,,,,CHO,,12687,H,8,Autocuration,1,,CHEMBL617933,449.0,BAO_0000219,,
2686,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617934,,BAO_0000019,,
2687,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617935,,BAO_0000019,,
2688,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617936,,BAO_0000357,,
2689,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617937,,BAO_0000019,,
2690,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617938,,BAO_0000019,,
2691,16633,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617939,,BAO_0000218,,
2692,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617940,,BAO_0000218,,
2693,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617941,,BAO_0000218,,
2694,15026,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617942,,BAO_0000357,,
2695,15026,Ratio of pKi of 5-HT2A to that of D2 receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617943,,BAO_0000357,,
2696,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,B,,,,,,,,,105093,H,4,Expert,1,,CHEMBL617944,,BAO_0000224,,
2697,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,B,,,,,,,,,105093,H,4,Expert,1,,CHEMBL617945,,BAO_0000224,,
2698,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,B,,,,,,,,,105075,H,4,Expert,1,,CHEMBL617946,,BAO_0000224,,
2699,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617947,,BAO_0000357,,
2700,16326,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617948,,BAO_0000357,,
2701,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL858116,,BAO_0000019,,
2702,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617949,,BAO_0000019,,
2703,15329,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617950,,BAO_0000019,,
2704,16404,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,F,,,,,,Thoracic aorta,,,12687,H,8,Expert,1,,CHEMBL617951,,BAO_0000019,1515.0,
2705,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,F,,,,,,Thoracic aorta,,,12687,H,8,Expert,1,,CHEMBL617952,,BAO_0000019,1515.0,
2706,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,F,,,,,,Thoracic aorta,,,12687,H,8,Autocuration,1,,CHEMBL617953,,BAO_0000019,1515.0,
2707,12861,Binding activity radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617954,,BAO_0000357,,
2708,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617955,,BAO_0000019,,
2709,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL857071,,BAO_0000019,,
2710,12490,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617270,,BAO_0000019,,
2711,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,B,,,,,,,N1E-115,,12687,H,8,Autocuration,1,,CHEMBL617271,339.0,BAO_0000219,,
2712,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,B,,,,,,,N1E-115,,12687,H,8,Autocuration,1,,CHEMBL617272,339.0,BAO_0000219,,
2713,12918,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617273,,BAO_0000019,,
2714,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617274,,BAO_0000019,,
2715,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617275,,BAO_0000357,,
2716,6013,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617276,,BAO_0000357,,
2717,16293,Binding affinity towards human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617277,,BAO_0000357,,
2718,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617278,,BAO_0000019,,
2719,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617279,,BAO_0000019,,
2720,3857,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617280,,BAO_0000019,,
2721,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617281,,BAO_0000357,,
2722,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617282,,BAO_0000357,,
2723,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617283,,BAO_0000019,,
2724,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617284,,BAO_0000019,,
2725,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617285,722.0,BAO_0000219,,
2726,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617286,,BAO_0000019,,
2727,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617287,,BAO_0000357,,
2728,5088,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617288,,BAO_0000357,,
2729,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617289,,BAO_0000357,,
2730,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL872917,,BAO_0000357,,
2731,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617290,,BAO_0000357,,
2732,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617291,449.0,BAO_0000219,,
2733,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617292,449.0,BAO_0000219,,
2734,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,108,H,8,Autocuration,1,,CHEMBL617293,723.0,BAO_0000219,,
2735,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,108,D,9,Expert,1,,CHEMBL617294,449.0,BAO_0000219,,
2736,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617295,,BAO_0000019,,
2737,12861,Binding activity radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617296,,BAO_0000357,,
2738,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617297,,BAO_0000019,,
2739,5104,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617298,449.0,BAO_0000219,,
2740,5105,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617299,449.0,BAO_0000219,,
2741,5105,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617300,449.0,BAO_0000219,,
2742,5254,Binding affinity against 5-HT2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617454,,BAO_0000357,,
2743,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617505,722.0,BAO_0000219,,
2744,14157,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617506,722.0,BAO_0000219,,
2745,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617507,722.0,BAO_0000219,,
2746,14068,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617508,,BAO_0000357,,
2747,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL857982,722.0,BAO_0000219,,
2748,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617509,722.0,BAO_0000219,,
2749,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617510,722.0,BAO_0000219,,
2750,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617511,,BAO_0000357,,
2751,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617512,722.0,BAO_0000219,,
2752,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617749,722.0,BAO_0000219,,
2753,15779,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617750,722.0,BAO_0000219,,
2754,15779,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617751,722.0,BAO_0000219,,
2755,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617752,722.0,BAO_0000219,,
2756,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617753,722.0,BAO_0000219,,
2757,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617754,722.0,BAO_0000219,,
2758,15851,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617755,722.0,BAO_0000219,,
2759,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617756,722.0,BAO_0000219,,
2760,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617757,722.0,BAO_0000219,,
2761,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617758,722.0,BAO_0000219,,
2762,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,B,,,,,,,NIH3T3,,108,H,8,Autocuration,1,,CHEMBL617759,723.0,BAO_0000219,,
2763,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617760,722.0,BAO_0000219,,
2764,1883,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,B,,,,,,,CHO-K1,,108,H,8,Expert,1,,CHEMBL617761,485.0,BAO_0000219,,
2765,4321,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617762,,BAO_0000357,,
2766,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617763,,BAO_0000357,,
2767,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL857983,722.0,BAO_0000219,,
2768,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617764,722.0,BAO_0000219,,
2769,16404,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,B,,,,,,,HeLa,,108,H,8,Autocuration,1,,CHEMBL617765,308.0,BAO_0000219,,
2770,13267,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617766,,BAO_0000019,,
2771,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,F,,,,,,Hippocampus,,,108,H,8,Autocuration,1,,CHEMBL617767,,BAO_0000221,10000000.0,
2772,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617768,722.0,BAO_0000219,,
2773,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617769,722.0,BAO_0000219,,
2774,13463,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,B,,,,,,,,,11864,H,8,Autocuration,1,,CHEMBL858023,,BAO_0000357,,
2775,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus,B,,,,,,Stomach,,,11864,H,8,Autocuration,1,,CHEMBL617770,,BAO_0000019,945.0,
2776,13463,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,B,,,,,,Stomach,,,11864,H,8,Autocuration,1,,CHEMBL617771,,BAO_0000019,945.0,
2777,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,F,,,,,,,A9,,11864,H,8,Autocuration,1,,CHEMBL617772,625.0,BAO_0000219,,
2778,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617773,723.0,BAO_0000219,,
2779,4682,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617850,723.0,BAO_0000219,,
2780,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617851,723.0,BAO_0000219,,
2781,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,F,,,,,,,,,11864,H,8,Autocuration,1,,CHEMBL617852,,BAO_0000019,,
2782,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,B,,,Mus musculus,10090.0,,Stomach,,,12689,H,8,Autocuration,1,,CHEMBL858024,,BAO_0000019,945.0,
2783,13463,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12689,D,9,Expert,1,,CHEMBL617853,,BAO_0000019,945.0,
2784,13969,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617854,,BAO_0000357,,
2785,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL873477,,BAO_0000357,,
2786,13392,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617855,,BAO_0000357,,
2787,14430,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617856,,BAO_0000019,,
2788,1742,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617857,,BAO_0000019,,
2789,14286,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617858,,BAO_0000249,,
2790,5619,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617859,,BAO_0000357,,
2791,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617860,,BAO_0000357,,
2792,12861,Binding activity radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617861,,BAO_0000357,,
2793,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617862,,BAO_0000019,,
2794,12861,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617863,,BAO_0000019,,
2795,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617864,,BAO_0000249,,
2796,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617649,,BAO_0000249,,
2797,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,F,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL617650,,BAO_0000019,,
2798,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,F,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL617651,,BAO_0000019,,
2799,16429,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL617652,,BAO_0000357,,
2800,773,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL857072,,BAO_0000019,,
2801,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL617653,,BAO_0000357,,
2802,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617654,,BAO_0000019,,
2803,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,F,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617655,,BAO_0000019,,
2804,14970,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617656,,BAO_0000357,,
2805,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617657,,BAO_0000357,,
2806,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617658,,BAO_0000357,,
2807,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617659,,BAO_0000357,,
2808,14178,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617838,,BAO_0000357,,
2809,14229,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Brain membranes,12689,D,9,Expert,1,,CHEMBL617839,,BAO_0000249,,
2810,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617840,,BAO_0000357,,
2811,14826,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617841,,BAO_0000019,,
2812,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL875915,,BAO_0000019,,
2813,17211,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,B,In vitro,,,,,,,,12689,H,8,Expert,1,,CHEMBL617842,,BAO_0000219,,
2814,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,B,,,,,,,NIH3T3,,12689,H,8,Expert,1,,CHEMBL617843,723.0,BAO_0000219,,
2815,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617844,,BAO_0000357,,
2816,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617845,,BAO_0000357,,
2817,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,B,,,,,,,NIH3T3,,12689,H,8,Expert,1,,CHEMBL617846,723.0,BAO_0000219,,
2818,4707,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617847,,BAO_0000357,,
2819,13297,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617848,,BAO_0000357,,
2820,16633,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617849,,BAO_0000357,,
2821,16133,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621507,,BAO_0000357,,
2822,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621508,,BAO_0000357,,
2823,14423,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621509,,BAO_0000019,,
2824,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621510,,BAO_0000019,,
2825,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621511,,BAO_0000019,,
2826,15558,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,B,,,,,,,A9,,12689,H,8,Expert,1,,CHEMBL621512,625.0,BAO_0000219,,
2827,16633,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621513,,BAO_0000357,,
2828,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621514,,BAO_0000357,,
2829,17175,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,B,In vitro,,,,,,,,12689,H,8,Expert,1,,CHEMBL621515,,BAO_0000219,,
2830,12469,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621516,,BAO_0000219,,
2831,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,B,,,,,,Caudate-putamen,,,12689,H,8,Autocuration,1,,CHEMBL621517,,BAO_0000019,5383.0,
2832,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621518,,BAO_0000357,,
2833,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621519,,BAO_0000019,,
2834,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621520,,BAO_0000357,,
2835,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621521,,BAO_0000357,,
2836,15818,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621522,,BAO_0000357,,
2837,14749,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621523,,BAO_0000219,,
2838,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621524,,BAO_0000357,,
2839,17133,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL621525,,BAO_0000357,,
2840,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL872921,,BAO_0000357,,
2841,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621526,,BAO_0000357,,
2842,12369,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621527,,BAO_0000219,,
2843,2309,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617865,,BAO_0000019,,
2844,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617866,,BAO_0000357,,
2845,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617867,,BAO_0000019,,
2846,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617487,,BAO_0000357,,
2847,12953,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617488,,BAO_0000357,,
2848,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617489,,BAO_0000357,,
2849,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617490,,BAO_0000019,,
2850,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617491,,BAO_0000019,,
2851,14025,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617492,,BAO_0000019,,
2852,14998,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617493,,BAO_0000019,,
2853,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617494,,BAO_0000357,,
2854,13735,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617495,,BAO_0000019,,
2855,13181,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617496,,BAO_0000357,,
2856,1883,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,B,,,,,,,CHO-K1,,12689,H,8,Autocuration,1,,CHEMBL617497,485.0,BAO_0000219,,
2857,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617498,,BAO_0000357,,
2858,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617499,,BAO_0000357,,
2859,14579,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,F,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617500,,BAO_0000019,,
2860,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617501,,BAO_0000357,,
2861,4820,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617502,,BAO_0000357,,
2862,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617503,,BAO_0000357,,
2863,14755,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617504,,BAO_0000357,,
2864,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617406,,BAO_0000357,,
2865,6857,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617407,,BAO_0000019,,
2866,16209,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617408,,BAO_0000357,,
2867,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617409,,BAO_0000357,,
2868,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617410,,BAO_0000357,,
2869,15363,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617411,,BAO_0000357,,
2870,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617412,,BAO_0000019,,
2871,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617774,,BAO_0000357,,
2872,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617775,722.0,BAO_0000219,,
2873,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617776,722.0,BAO_0000219,,
2874,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617777,449.0,BAO_0000219,,
2875,6857,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617778,449.0,BAO_0000219,,
2876,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617779,722.0,BAO_0000219,,
2877,15851,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617780,722.0,BAO_0000219,,
2878,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617781,722.0,BAO_0000219,,
2879,14157,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617782,722.0,BAO_0000219,,
2880,4540,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617783,722.0,BAO_0000219,,
2881,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617784,,BAO_0000357,,
2882,15779,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617785,722.0,BAO_0000219,,
2883,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL857984,722.0,BAO_0000219,,
2884,3832,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617786,722.0,BAO_0000219,,
2885,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617787,722.0,BAO_0000219,,
2886,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617788,722.0,BAO_0000219,,
2887,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617789,722.0,BAO_0000219,,
2888,4199,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617790,722.0,BAO_0000219,,
2889,1883,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,B,,,,,,,CHO-K1,,227,H,8,Expert,1,,CHEMBL617791,485.0,BAO_0000219,,
2890,4321,Binding affinity against 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Expert,1,,CHEMBL617608,,BAO_0000357,,
2891,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617609,722.0,BAO_0000219,,
2892,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617610,722.0,BAO_0000219,,
2893,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617611,722.0,BAO_0000219,,
2894,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617612,722.0,BAO_0000219,,
2895,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617613,722.0,BAO_0000219,,
2896,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,B,,,Oryctolagus cuniculus,9986.0,,,,,227,H,8,Autocuration,1,,CHEMBL617614,,BAO_0000019,,
2897,13463,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL617615,,BAO_0000019,945.0,
2898,7259,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL858114,,BAO_0000357,945.0,
2899,7259,Affinity against serotonergic receptor in the isolated rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617616,,BAO_0000357,945.0,
2900,7185,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617617,,BAO_0000019,945.0,
2901,7185,Antagonistic against 5-hydroxytryptamine 2B receptor,F,,,Rattus norvegicus,10116.0,,,,,12688,D,9,Expert,1,,CHEMBL875914,,BAO_0000019,,
2902,13267,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617618,,BAO_0000019,945.0,
2903,13735,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617619,,BAO_0000357,945.0,
2904,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617620,,BAO_0000019,,
2905,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617621,,BAO_0000019,,
2906,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617622,,BAO_0000019,,
2907,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617623,,BAO_0000357,945.0,
2908,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617624,,BAO_0000357,945.0,
2909,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617625,,BAO_0000357,945.0,
2910,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617626,,BAO_0000357,945.0,
2911,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617627,,BAO_0000019,945.0,
2912,16404,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL617628,,BAO_0000019,945.0,
2913,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617629,,BAO_0000019,945.0,
2914,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL858115,,BAO_0000019,945.0,
2915,16404,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617630,,BAO_0000019,945.0,
2916,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,F,,,,,,Thoracic aorta,,,12688,H,8,Autocuration,1,,CHEMBL617631,,BAO_0000019,1515.0,
2917,7483,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617632,,BAO_0000357,,
2918,7483,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,B,,,,,,,,,12688,H,8,Expert,1,,CHEMBL617633,,BAO_0000357,,
2919,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617634,,BAO_0000357,,
2920,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617635,,BAO_0000357,,
2922,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Autocuration,1,,CHEMBL617637,,BAO_0000019,945.0,
2923,6347,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617638,,BAO_0000357,,
2924,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617639,,BAO_0000357,,
2925,4373,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617640,,BAO_0000357,,
2926,4687,Evaluated for the binding affinity to 5-HT 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617641,,BAO_0000357,,
2927,16946,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617642,,BAO_0000357,,
2928,16633,Binding affinities against 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617643,,BAO_0000357,,
2929,16633,Binding affinities towards 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617644,,BAO_0000357,,
2930,16633,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617645,,BAO_0000357,,
2931,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617646,,BAO_0000357,,
2932,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617647,,BAO_0000357,,
2933,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617648,,BAO_0000357,,
2934,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617875,,BAO_0000357,,
2935,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617876,,BAO_0000357,,
2936,16404,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,B,,,Bos taurus,9913.0,,,,,108,H,8,Expert,1,,CHEMBL617877,,BAO_0000357,,
2937,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,B,,,Bos taurus,9913.0,,,,,108,H,8,Expert,1,,CHEMBL617878,,BAO_0000357,,
2938,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617879,,BAO_0000357,,
2939,16312,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,B,,,Cavia porcellus,10141.0,,,,,108,H,8,Autocuration,1,,CHEMBL617880,,BAO_0000019,,
2940,5486,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617881,,BAO_0000357,2435.0,
2941,5254,Binding affinity against 5-HT1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL857073,,BAO_0000357,,
2942,3857,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,F,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617882,449.0,BAO_0000219,,
2943,6857,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,108,D,9,Expert,1,,CHEMBL617883,449.0,BAO_0000219,,
2944,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617884,,BAO_0000219,,
2945,6347,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617885,449.0,BAO_0000219,,
2946,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617886,449.0,BAO_0000219,,
2947,16146,Inhibition of human 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617887,,BAO_0000357,,
2948,3805,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617888,,BAO_0000357,,
2949,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617889,,BAO_0000019,,
2950,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617890,,BAO_0000357,,
2951,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617891,,BAO_0000357,,
2952,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617892,,BAO_0000357,,
2953,4012,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617893,449.0,BAO_0000219,,
2954,6366,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617894,449.0,BAO_0000219,,
2955,15949,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617895,449.0,BAO_0000219,,
2956,17211,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617896,449.0,BAO_0000219,,
2957,6491,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617897,,BAO_0000357,,
2958,14093,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617898,,BAO_0000019,,
2959,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617899,,BAO_0000019,,
2960,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,B,,,Rattus norvegicus,10116.0,,,CHO,,108,H,8,Expert,1,,CHEMBL617900,449.0,BAO_0000219,,
2961,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617901,,BAO_0000019,,
2962,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617902,,BAO_0000019,,
2963,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617903,,BAO_0000019,,
2964,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617904,,BAO_0000357,,
2965,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617905,,BAO_0000357,,
2966,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617906,,BAO_0000357,,
2967,14755,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617907,,BAO_0000357,,
2968,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617908,,BAO_0000357,,
2969,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL620617,449.0,BAO_0000219,,
2970,6857,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL620618,,BAO_0000019,,
2971,5635,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620619,,BAO_0000357,,
2972,4234,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL620620,,BAO_0000357,,
2973,16209,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620621,,BAO_0000357,,
2974,5778,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104698,D,7,Autocuration,1,,CHEMBL872920,,BAO_0000249,,
2975,5094,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620622,,BAO_0000223,,
2976,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL620623,,BAO_0000019,,
2977,1578,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620624,,BAO_0000019,,
2978,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620625,,BAO_0000019,,
2979,12469,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620626,,BAO_0000219,,
2980,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621307,,BAO_0000019,,
2981,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621308,,BAO_0000019,,
2982,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621309,,BAO_0000223,,
2983,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621310,,BAO_0000223,,
2984,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621311,,BAO_0000223,,
2985,15253,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621502,,BAO_0000249,,
2986,15253,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621503,,BAO_0000249,,
2987,11683,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL621504,,BAO_0000249,,
2988,12092,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621505,,BAO_0000223,,
2989,1946,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621506,,BAO_0000019,,
2990,11623,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619781,,BAO_0000223,,
2991,11623,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619782,,BAO_0000223,,
2992,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619783,,BAO_0000019,,
2993,5432,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619784,,BAO_0000019,,
2994,14826,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619785,,BAO_0000249,,
2995,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619786,,BAO_0000223,,
2996,11963,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619787,,BAO_0000019,,
2997,14145,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872925,,BAO_0000019,,
2998,17819,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619788,,BAO_0000019,,
2999,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619789,,BAO_0000249,,
3000,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619790,,BAO_0000249,,
3001,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619791,,BAO_0000019,,
3002,691,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619792,,BAO_0000019,,
3003,12092,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL619793,,BAO_0000249,,
3004,11752,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619794,,BAO_0000223,,
3005,11752,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL619795,,BAO_0000221,955.0,
3006,301,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619796,,BAO_0000019,,
3007,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620448,,BAO_0000223,,
3008,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620449,,BAO_0000223,,
3009,12092,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620450,,BAO_0000223,,
3010,11684,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620451,,BAO_0000223,,
3011,11684,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620631,,BAO_0000223,,
3012,12953,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620632,,BAO_0000019,,
3013,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620633,,BAO_0000019,,
3014,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620634,,BAO_0000223,,
3015,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620635,,BAO_0000019,,
3016,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620636,,BAO_0000218,,
3017,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620637,,BAO_0000218,,
3018,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620638,,BAO_0000218,,
3019,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620639,,BAO_0000218,,
3020,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620640,,BAO_0000218,,
3021,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620641,,BAO_0000218,,
3022,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620642,,BAO_0000218,,
3023,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620643,,BAO_0000218,,
3024,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620644,,BAO_0000218,,
3025,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620645,,BAO_0000218,,
3026,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620646,,BAO_0000218,,
3027,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620647,,BAO_0000218,,
3028,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620648,,BAO_0000218,,
3029,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620649,,BAO_0000218,,
3030,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620650,,BAO_0000218,,
3031,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620651,,BAO_0000218,,
3032,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872875,,BAO_0000218,,
3033,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620652,,BAO_0000218,,
3034,10609,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620653,,BAO_0000019,,
3035,12861,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL857076,,BAO_0000019,,
3036,12861,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL620654,,BAO_0000019,,
3037,12861,Binding activity radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620655,,BAO_0000223,,
3038,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620656,,BAO_0000249,,
3039,10728,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620657,,BAO_0000249,,
3040,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620658,,BAO_0000357,,
3041,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620659,,BAO_0000357,,
3042,6011,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620660,,BAO_0000357,,
3043,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620661,,BAO_0000357,,
3044,5635,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620662,,BAO_0000357,,
3045,5163,Affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620663,,BAO_0000357,,
3046,6841,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620664,,BAO_0000357,,
3047,6119,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620665,,BAO_0000357,,
3048,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620666,,BAO_0000357,,
3049,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620667,,BAO_0000357,,
3050,1633,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620668,,BAO_0000357,,
3051,4373,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620669,,BAO_0000357,,
3052,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620670,,BAO_0000357,,
3053,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620671,,BAO_0000357,,
3054,12146,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620672,,BAO_0000357,,
3055,12146,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620673,,BAO_0000357,,
3056,16946,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620674,,BAO_0000357,,
3057,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620675,,BAO_0000357,,
3058,16700,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620676,,BAO_0000357,,
3059,3269,Affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL621382,,BAO_0000357,,
3060,1274,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL621383,,BAO_0000357,,
3061,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL621384,,BAO_0000357,,
3062,5834,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,B,,,Bos taurus,9913.0,,,,,144,H,8,Autocuration,1,,CHEMBL621385,,BAO_0000357,,
3063,11147,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,B,,,Bos taurus,9913.0,,,,,144,H,8,Autocuration,1,,CHEMBL617989,,BAO_0000357,,
3064,14145,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Expert,1,,CHEMBL617990,,BAO_0000019,,
3065,10561,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL875085,,BAO_0000221,2116.0,
3066,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617991,,BAO_0000019,,
3067,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617992,,BAO_0000019,,
3068,10561,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617993,,BAO_0000221,2116.0,
3069,11454,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617994,,BAO_0000221,2116.0,
3070,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617995,,BAO_0000019,,
3071,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617996,,BAO_0000019,,
3072,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617997,,BAO_0000019,,
3073,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617998,,BAO_0000019,,
3074,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617999,,BAO_0000019,,
3075,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618000,,BAO_0000019,,
3076,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617815,,BAO_0000221,2116.0,
3077,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617816,,BAO_0000221,2116.0,
3078,11963,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617817,,BAO_0000221,2116.0,
3079,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617818,,BAO_0000221,2116.0,
3080,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617819,,BAO_0000221,2116.0,
3081,12045,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,B,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617820,,BAO_0000223,,
3082,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617821,,BAO_0000221,2116.0,
3083,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617822,,BAO_0000221,2116.0,
3084,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617823,,BAO_0000221,2116.0,
3085,188,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617824,,BAO_0000221,2116.0,
3086,12919,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617825,,BAO_0000221,2116.0,
3087,12918,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617826,,BAO_0000221,2116.0,
3088,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617827,,BAO_0000221,2116.0,
3089,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617828,,BAO_0000221,2116.0,
3090,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617829,,BAO_0000221,2116.0,
3091,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617830,,BAO_0000221,2116.0,
3092,1559,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617831,,BAO_0000221,2116.0,
3093,14424,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617832,,BAO_0000221,2116.0,
3094,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,B,,,Cavia porcellus,10141.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617833,,BAO_0000019,,
3095,5486,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617834,,BAO_0000357,,
3096,6491,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,104714,D,5,Expert,1,,CHEMBL617835,,BAO_0000223,,
3097,6013,Binding affinity towards 5-HT3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL617836,,BAO_0000223,,
3098,12861,Binding activity radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL617837,,BAO_0000223,,
3099,12861,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620392,,BAO_0000019,,
3100,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620393,,BAO_0000223,,
3101,5105,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620394,,BAO_0000223,,
3102,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620395,,BAO_0000223,,
3103,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620396,,BAO_0000019,,
3104,13657,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,B,,,,,,,NG108-15,,105030,H,4,Expert,1,,CHEMBL620582,433.0,BAO_0000219,,
3105,10369,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",B,In vivo,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620583,,BAO_0000218,,
3106,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620584,,BAO_0000019,,
3107,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620585,,BAO_0000224,,
3108,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620586,,BAO_0000224,,
3109,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620587,,BAO_0000019,,
3110,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620588,,BAO_0000019,,
3111,12918,5-hydroxytryptamine 3 receptor agonism in mouse,F,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620589,,BAO_0000218,,
3112,10561,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620590,,BAO_0000219,,
3113,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617956,,BAO_0000019,,
3114,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617957,,BAO_0000019,,
3115,12918,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617958,,BAO_0000224,,
3116,273,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617959,,BAO_0000219,,
3117,273,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617960,,BAO_0000219,,
3118,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617961,,BAO_0000224,,
3119,5033,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,B,In vitro,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617962,,BAO_0000219,,
3120,16429,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,B,,,,,,,N1E-115,,105030,H,4,Autocuration,1,,CHEMBL617963,339.0,BAO_0000219,,
3121,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,B,,,,,,,,,11765,H,8,Autocuration,1,,CHEMBL617964,,BAO_0000019,,
3122,14331,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,B,,,,,,,,,11765,H,8,Autocuration,1,,CHEMBL617965,,BAO_0000219,,
3123,13462,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,B,,,Mus musculus,10090.0,,,,,10630,D,9,Autocuration,1,,CHEMBL617966,,BAO_0000357,,
3124,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL857074,,BAO_0000019,,
3125,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,B,,,Sus scrofa,9823.0,,,,,144,H,8,Autocuration,1,,CHEMBL617967,,BAO_0000357,,
3126,12861,Binding activity radioligand.,B,,,Sus scrofa,9823.0,,,,,144,H,8,Autocuration,1,,CHEMBL617968,,BAO_0000357,,
3127,10561,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617969,,BAO_0000223,,
3128,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617970,,BAO_0000223,,
3129,10561,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617971,,BAO_0000223,,
3130,10561,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617972,,BAO_0000019,,
3131,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617973,,BAO_0000019,,
3132,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617974,,BAO_0000019,,
3133,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Oryctolagus cuniculus,9986.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617975,,BAO_0000221,2116.0,
3134,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617976,,BAO_0000019,,
3135,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617977,,BAO_0000019,,
3136,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617978,,BAO_0000019,,
3137,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617979,,BAO_0000019,,
3138,13047,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,B,,,Oryctolagus cuniculus,9986.0,,,CHO,,104714,H,4,Autocuration,1,,CHEMBL617980,449.0,BAO_0000219,,
3139,1650,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617981,,BAO_0000019,,
3140,16288,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL617982,,BAO_0000019,,
3141,16288,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL617983,,BAO_0000357,,
3142,10254,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617984,,BAO_0000019,,
3143,14532,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617985,,BAO_0000019,,
3144,13392,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",F,In vivo,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617986,,BAO_0000218,948.0,
3145,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617987,,BAO_0000019,948.0,
3146,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617988,,BAO_0000019,948.0,
3147,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617792,,BAO_0000019,948.0,
3148,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617793,,BAO_0000019,948.0,
3149,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617794,,BAO_0000019,,
3150,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617795,,BAO_0000019,,
3151,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617796,,BAO_0000019,,
3152,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617797,,BAO_0000019,,
3153,1089,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617798,,BAO_0000218,,
3154,1089,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617799,,BAO_0000218,,
3155,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617800,,BAO_0000218,,
3156,11454,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617801,,BAO_0000019,,
3157,12205,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617802,,BAO_0000218,,
3158,1089,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617803,,BAO_0000019,,
3159,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617804,,BAO_0000019,,
3160,2622,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617805,,BAO_0000019,,
3161,245,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617806,,BAO_0000223,,
3162,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617807,,BAO_0000019,,
3163,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617808,,BAO_0000019,,
3164,3020,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617809,,BAO_0000249,,
3165,1742,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617810,,BAO_0000019,,
3166,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL617811,,BAO_0000249,955.0,
3167,17394,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL617812,,BAO_0000221,955.0,
3168,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617813,,BAO_0000249,,
3169,14286,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617814,,BAO_0000249,,
3170,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617698,,BAO_0000019,,
3171,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617699,,BAO_0000019,,
3172,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617700,,BAO_0000019,,
3173,14178,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617701,,BAO_0000223,,
3174,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617702,,BAO_0000019,,
3175,1089,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL617703,,BAO_0000249,,
3176,1089,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617704,,BAO_0000019,,
3177,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617705,,BAO_0000223,,
3178,12801,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617706,,BAO_0000223,,
3179,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),B,,,,,,,NG108-15,,104698,H,6,Autocuration,1,,CHEMBL617707,433.0,BAO_0000219,,
3180,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,B,,,,,,,NG108-15,,104698,H,6,Autocuration,1,,CHEMBL617708,433.0,BAO_0000219,,
3181,15194,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617709,,BAO_0000019,,
3182,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617710,,BAO_0000019,,
3183,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL882925,,BAO_0000019,,
3184,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617711,,BAO_0000019,,
3185,10610,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617712,,BAO_0000019,,
3186,10355,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617713,,BAO_0000019,,
3187,691,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617714,,BAO_0000019,,
3188,10611,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617715,,BAO_0000218,,
3189,12801,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617716,,BAO_0000218,,
3190,10609,Inhibition of 5-HT evoked reflex bradycardia in rat.,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617717,,BAO_0000218,,
3191,11454,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617718,,BAO_0000218,,
3192,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617719,,BAO_0000218,,
3193,11454,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617720,,BAO_0000218,,
3194,11454,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617721,,BAO_0000218,,
3195,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617722,,BAO_0000218,,
3196,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617723,,BAO_0000218,,
3197,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617724,,BAO_0000218,,
3198,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617725,,BAO_0000218,,
3199,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617726,,BAO_0000218,,
3200,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617727,,BAO_0000218,,
3201,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617728,,BAO_0000218,,
3202,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617729,,BAO_0000218,,
3203,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617730,,BAO_0000218,,
3204,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617731,,BAO_0000218,,
3205,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617732,,BAO_0000218,,
3206,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617733,,BAO_0000218,,
3207,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617734,,BAO_0000218,,
3208,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872874,,BAO_0000218,,
3209,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617735,,BAO_0000218,,
3210,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617736,,BAO_0000218,,
3211,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617737,,BAO_0000218,,
3212,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617738,,BAO_0000218,,
3213,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617739,,BAO_0000218,,
3214,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617740,,BAO_0000218,,
3215,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617741,,BAO_0000218,,
3216,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617742,,BAO_0000218,,
3217,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617743,,BAO_0000218,,
3218,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617744,,BAO_0000218,,
3219,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617745,,BAO_0000218,,
3220,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617746,,BAO_0000218,,
3221,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617747,,BAO_0000218,,
3222,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617748,,BAO_0000218,,
3223,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618909,,BAO_0000218,,
3224,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618910,,BAO_0000218,,
3225,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618911,,BAO_0000218,,
3226,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618912,,BAO_0000218,,
3227,10322,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618913,,BAO_0000218,,
3228,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618914,,BAO_0000019,,
3229,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618915,,BAO_0000019,,
3230,15412,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618916,,BAO_0000223,,
3231,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618917,,BAO_0000019,,
3232,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,B,,,,,,Hippocampus,,,104698,D,7,Intermediate,1,,CHEMBL618918,,BAO_0000221,10000000.0,
3233,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618919,,BAO_0000019,,
3234,17394,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618920,,BAO_0000019,,
3235,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618921,,BAO_0000223,,
3236,12457,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618922,,BAO_0000019,,
3237,12205,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618923,,BAO_0000019,,
3238,14532,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618924,,BAO_0000019,,
3239,1122,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618925,,BAO_0000019,,
3240,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618926,,BAO_0000019,,
3241,809,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618927,,BAO_0000221,2116.0,
3242,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618928,,BAO_0000221,2116.0,
3243,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618929,,BAO_0000221,2116.0,
3244,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618930,,BAO_0000221,2116.0,
3245,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618931,,BAO_0000221,2116.0,
3246,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619594,,BAO_0000221,2116.0,
3247,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619595,,BAO_0000221,2116.0,
3248,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619596,,BAO_0000221,2116.0,
3249,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619755,,BAO_0000221,2116.0,
3250,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619756,,BAO_0000221,2116.0,
3251,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619757,,BAO_0000221,2116.0,
3252,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619758,,BAO_0000221,2116.0,
3253,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619759,,BAO_0000221,2116.0,
3254,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619760,,BAO_0000221,2116.0,
3255,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619761,,BAO_0000221,2116.0,
3256,14290,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619762,,BAO_0000221,2116.0,
3257,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619763,,BAO_0000221,2116.0,
3258,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL617868,,BAO_0000221,2116.0,
3259,15034,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL617869,,BAO_0000357,,
3260,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL882926,,BAO_0000249,2435.0,
3261,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617870,,BAO_0000249,2435.0,
3262,5399,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617871,,BAO_0000357,2435.0,
3263,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617872,,BAO_0000357,2435.0,
3264,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617873,,BAO_0000357,2435.0,
3265,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617874,,BAO_0000357,2435.0,
3266,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619067,,BAO_0000221,2116.0,
3267,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619068,,BAO_0000221,2116.0,
3268,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619069,,BAO_0000221,2116.0,
3269,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619070,,BAO_0000357,,
3270,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619071,,BAO_0000357,,
3271,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619072,,BAO_0000019,,
3272,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619073,,BAO_0000019,,
3273,12918,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619074,,BAO_0000019,,
3274,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619075,,BAO_0000357,,
3275,17394,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619076,,BAO_0000357,2435.0,
3276,15034,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619077,,BAO_0000357,2435.0,
3277,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619078,,BAO_0000249,2435.0,
3278,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619079,,BAO_0000249,2435.0,
3279,17358,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619080,,BAO_0000221,2116.0,
3280,12953,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Expert,1,,CHEMBL619081,,BAO_0000357,,
3281,12953,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619082,,BAO_0000357,,
3282,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619083,,BAO_0000357,,
3283,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619084,,BAO_0000357,,
3284,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL859397,,BAO_0000221,2116.0,
3285,12918,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619085,,BAO_0000221,2116.0,
3286,12919,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619086,,BAO_0000221,2116.0,
3287,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619087,,BAO_0000221,2116.0,
3288,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619088,,BAO_0000221,2116.0,
3289,13181,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619089,,BAO_0000357,,
3290,13181,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,B,,,Cavia porcellus,10141.0,,,,,168,H,8,Autocuration,1,,CHEMBL619090,,BAO_0000357,,
3291,15034,Antagonistic activity against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619091,,BAO_0000019,,
3292,5033,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619092,,BAO_0000357,,
3293,1980,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619093,,BAO_0000019,,
3294,13181,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,B,,,Cavia porcellus,10141.0,,,HEK293,,168,H,8,Autocuration,1,,CHEMBL619094,722.0,BAO_0000219,,
3295,14287,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619095,,BAO_0000019,,
3296,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL857988,,BAO_0000357,,
3297,15316,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619096,,BAO_0000357,,
3298,16429,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619097,,BAO_0000357,2435.0,
3299,14818,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,B,,,Cavia porcellus,10141.0,,Hippocampus,,,20033,D,9,Intermediate,1,,CHEMBL619098,,BAO_0000221,10000000.0,
3300,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619751,,BAO_0000357,,
3301,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619752,,BAO_0000357,,
3302,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL875096,,BAO_0000221,2116.0,
3303,5486,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL619004,,BAO_0000357,,
3304,16209,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619005,,BAO_0000357,,
3305,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619006,,BAO_0000019,,
3306,4199,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,B,,,,,,,HeLa,,168,H,8,Autocuration,1,,CHEMBL619007,308.0,BAO_0000219,,
3307,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619008,,BAO_0000357,,
3308,5213,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619009,,BAO_0000357,,
3309,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",B,,,,,,,HeLa,,168,H,8,Autocuration,1,,CHEMBL619010,308.0,BAO_0000219,,
3310,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619011,,BAO_0000357,,
3311,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619012,,BAO_0000357,,
3312,16946,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619013,,BAO_0000219,,
3313,17358,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619014,,BAO_0000357,,
3314,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,F,,,,,,Cardiac atrium,,,11249,H,8,Autocuration,1,,CHEMBL857503,,BAO_0000019,2081.0,
3315,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,F,,,,,,Cardiac atrium,,,11249,H,8,Autocuration,1,,CHEMBL619015,,BAO_0000019,2081.0,
3316,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,11249,H,8,Autocuration,1,,CHEMBL619016,,BAO_0000357,,
3317,14875,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,B,,,,,,Hippocampus,,,11249,H,8,Autocuration,1,,CHEMBL619017,,BAO_0000221,10000000.0,
3318,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,B,,,Sus scrofa,9823.0,,Hippocampus,,,168,H,8,Autocuration,1,,CHEMBL619018,,BAO_0000221,10000000.0,
3319,13047,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,168,H,8,Autocuration,1,,CHEMBL619019,,BAO_0000019,,
3320,1650,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619020,,BAO_0000357,,
3321,567,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619021,,BAO_0000019,,
3322,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619022,,BAO_0000357,,
3323,188,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619023,,BAO_0000357,,
3324,670,lntrinsic activity relative to 5-HT receptor,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619024,,BAO_0000019,,
3325,204,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619025,,BAO_0000019,,
3326,1946,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619026,,BAO_0000019,,
3327,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619027,,BAO_0000019,,
3328,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619028,,BAO_0000019,,
3329,17358,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619029,,BAO_0000019,,
3330,6398,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619030,,BAO_0000019,,
3331,11752,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619031,,BAO_0000357,,
3332,809,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619032,,BAO_0000019,,
3333,14178,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619033,,BAO_0000357,,
3334,567,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619034,,BAO_0000357,,
3335,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619035,,BAO_0000357,,
3336,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619036,,BAO_0000357,,
3337,13961,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619037,,BAO_0000019,,
3338,6238,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,B,,,,,,Striatum,,,10623,H,8,Autocuration,1,,CHEMBL619038,,BAO_0000249,2435.0,
3339,14290,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619039,,BAO_0000249,,
3340,14290,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619040,,BAO_0000249,,
3341,809,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,B,,,Rattus norvegicus,10116.0,,Striatum,,,10623,D,9,Expert,1,,CHEMBL619041,,BAO_0000019,2435.0,
3342,1578,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,B,,,,,,Striatum,,,10623,H,8,Autocuration,1,,CHEMBL619042,,BAO_0000019,2435.0,
3343,16709,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619043,,BAO_0000249,2435.0,
3344,1946,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619044,,BAO_0000019,2435.0,
3345,15253,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619045,,BAO_0000249,2435.0,
3346,4535,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619046,,BAO_0000249,2435.0,
3347,13961,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619047,,BAO_0000249,,
3348,17358,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,F,,,,,,Brain,,,10623,H,8,Autocuration,1,,CHEMBL619048,,BAO_0000221,955.0,
3349,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL859398,,BAO_0000019,,
3350,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619049,,BAO_0000019,,
3351,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL857886,,BAO_0000019,,
3352,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619050,,BAO_0000019,,
3353,1317,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620591,,BAO_0000019,,
3354,12936,Binding affinity against rat 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620592,,BAO_0000357,,
3355,4535,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL620593,,BAO_0000249,2435.0,
3356,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620594,,BAO_0000019,,
3357,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL875079,,BAO_0000019,,
3358,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620595,,BAO_0000019,,
3359,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620596,,BAO_0000019,,
3360,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620597,,BAO_0000019,,
3361,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620598,,BAO_0000019,,
3362,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620599,,BAO_0000218,,
3363,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620600,,BAO_0000019,,
3364,1980,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,F,,,Rattus norvegicus,10116.0,,,,,168,H,8,Autocuration,1,,CHEMBL620601,,BAO_0000019,,
3365,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620602,,BAO_0000019,,
3366,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620603,,BAO_0000357,,
3367,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620604,,BAO_0000357,,
3368,17358,Compound was tested for 5-hydroxytryptamine 4 binding affinity,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620605,,BAO_0000357,,
3369,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620606,,BAO_0000357,,
3370,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620607,,BAO_0000019,,
3371,16117,In vitro binding affinity towards 5-HT4 receptor was determined,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620608,,BAO_0000357,,
3372,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620609,,BAO_0000019,,
3373,17358,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620610,,BAO_0000019,,
3374,17358,Tested for selectivity for 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620611,,BAO_0000357,,
3375,17358,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620612,,BAO_0000357,,
3376,17358,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620613,,BAO_0000357,,
3377,17358,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620614,,BAO_0000357,,
3378,1274,Binding affinity against 5-Hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620615,,BAO_0000357,,
3379,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL857075,,BAO_0000249,,
3380,11695,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620616,,BAO_0000249,,
3381,11695,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL619411,,BAO_0000249,,
3382,12490,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619412,,BAO_0000019,,
3383,11828,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619413,,BAO_0000019,,
3384,12253,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,B,,,,,,Hippocampus,,,104698,H,6,Autocuration,1,,CHEMBL619414,,BAO_0000221,10000000.0,
3385,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619415,,BAO_0000019,,
3386,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619416,,BAO_0000019,,
3387,14432,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619417,,BAO_0000019,,
3388,12936,Binding affinity against rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619418,,BAO_0000223,,
3389,1274,Binding affinity against 5-Hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619419,,BAO_0000223,,
3390,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619420,,BAO_0000019,,
3391,670,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619421,,BAO_0000249,,
3392,968,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619422,,BAO_0000019,,
3393,14287,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619423,,BAO_0000019,,
3394,567,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL875080,,BAO_0000019,,
3395,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619424,,BAO_0000019,,
3396,14826,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619425,,BAO_0000249,,
3397,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619426,,BAO_0000223,,
3398,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619427,,BAO_0000223,,
3399,10394,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619645,,BAO_0000223,,
3400,13657,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",B,,,,,,,,,10576,D,9,Expert,1,,CHEMBL619646,,BAO_0000249,,
3401,1879,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,F,,,,,,Brain,,,12020,H,8,Autocuration,1,,CHEMBL619647,,BAO_0000221,955.0,
3402,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,F,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL619648,,BAO_0000019,,
3403,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,F,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL619165,,BAO_0000019,,
3404,204,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,F,In vivo,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620719,,BAO_0000218,,
3405,1879,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL872924,,BAO_0000019,,
3406,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620720,,BAO_0000357,,
3407,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620721,,BAO_0000019,,
3408,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620722,,BAO_0000019,,
3409,10641,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620723,,BAO_0000019,,
3410,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620724,,BAO_0000019,,
3411,11952,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620725,,BAO_0000249,,
3412,14145,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,F,,,Rattus norvegicus,10116.0,,,,,12020,D,9,Autocuration,1,,CHEMBL620726,,BAO_0000019,,
3413,17066,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Expert,1,,CHEMBL620727,,BAO_0000357,,
3414,6398,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620728,,BAO_0000223,,
3415,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620729,,BAO_0000019,,
3416,511,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL858288,,BAO_0000019,,
3417,4639,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620730,,BAO_0000223,,
3418,4639,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620731,,BAO_0000223,,
3419,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL620732,,BAO_0000019,,
3420,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618042,,BAO_0000019,,
3421,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618043,,BAO_0000019,,
3422,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618044,,BAO_0000223,,
3423,268,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618045,,BAO_0000019,,
3424,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618046,,BAO_0000223,,
3425,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618047,,BAO_0000019,,
3426,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL875084,,BAO_0000019,,
3427,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618048,,BAO_0000019,,
3428,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618049,,BAO_0000223,,
3429,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619764,,BAO_0000019,,
3430,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619765,,BAO_0000019,,
3431,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619766,,BAO_0000019,,
3432,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619767,,BAO_0000223,,
3433,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619768,,BAO_0000223,,
3434,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619769,,BAO_0000019,,
3435,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619770,,BAO_0000223,,
3436,5067,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619771,,BAO_0000223,,
3437,14331,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619772,,BAO_0000219,,
3438,5067,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619773,,BAO_0000223,,
3439,6179,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,B,,,,,,,NG108-15,,104714,H,4,Autocuration,1,,CHEMBL619774,433.0,BAO_0000219,,
3440,4265,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL875083,,BAO_0000019,,
3441,4265,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,B,,,,,,,NG108-15,,104714,H,4,Autocuration,1,,CHEMBL620718,433.0,BAO_0000219,,
3442,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618127,,BAO_0000223,,
3443,17358,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618128,,BAO_0000223,,
3444,13628,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,B,In vitro,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618129,,BAO_0000219,,
3445,4612,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618130,,BAO_0000223,,
3446,17358,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618131,,BAO_0000019,,
3447,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618132,,BAO_0000019,,
3448,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618133,,BAO_0000019,,
3449,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618134,,BAO_0000019,,
3450,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618135,,BAO_0000019,,
3451,511,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618136,,BAO_0000223,,
3452,1479,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618137,,BAO_0000223,,
3453,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618138,,BAO_0000223,,
3454,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618139,,BAO_0000223,,
3455,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618140,,BAO_0000223,,
3456,13969,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618141,,BAO_0000223,,
3457,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL873478,,BAO_0000357,,
3458,13392,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618142,,BAO_0000223,,
3459,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618143,,BAO_0000357,,
3460,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618144,,BAO_0000357,,
3461,16655,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618145,,BAO_0000357,,
3462,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618146,,BAO_0000223,,
3463,13021,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618147,,BAO_0000223,,
3464,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618148,,BAO_0000223,,
3465,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618149,,BAO_0000019,,
3466,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL872927,,BAO_0000357,,
3467,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618150,,BAO_0000357,,
3468,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618151,,BAO_0000357,,
3469,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL875094,,BAO_0000357,,
3470,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618152,,BAO_0000019,,
3471,16117,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618153,,BAO_0000357,,
3472,17200,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618888,,BAO_0000357,,
3473,17358,Tested for 5-hydroxytryptamine 3 receptor agonist activity,F,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618889,,BAO_0000019,,
3474,16700,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618890,,BAO_0000357,,
3475,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618891,,BAO_0000019,,
3476,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619054,,BAO_0000019,,
3477,12409,Binding affinity against the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619055,,BAO_0000223,,
3478,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619056,,BAO_0000357,,
3479,4365,Percent efficacy against 5-hydroxytryptamine 3A receptor,F,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619057,,BAO_0000019,,
3480,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619058,,BAO_0000357,,
3481,6769,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL619059,,BAO_0000219,,
3482,6769,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL619060,,BAO_0000219,,
3483,6769,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL875095,,BAO_0000219,,
3484,809,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619061,,BAO_0000221,2116.0,
3485,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619062,,BAO_0000221,2116.0,
3486,14290,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619063,,BAO_0000019,,
3487,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619064,,BAO_0000221,2116.0,
3488,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619065,,BAO_0000357,,
3489,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619066,,BAO_0000221,2116.0,
3490,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,B,,,,,,Ileum,,,10209,H,8,Autocuration,1,,CHEMBL619775,,BAO_0000221,2116.0,
3491,3269,Affinity against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619776,,BAO_0000357,,
3492,7721,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619777,,BAO_0000224,,
3493,7721,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619778,,BAO_0000224,,
3494,9117,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,B,,,Cavia porcellus,10141.0,,Ileum,,,104841,H,4,Autocuration,1,,CHEMBL619779,,BAO_0000221,2116.0,
3495,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619780,,BAO_0000224,,
3496,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619166,,BAO_0000224,,
3497,15796,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,F,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619167,,BAO_0000019,,
3498,15796,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,F,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619168,,BAO_0000019,,
3499,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,B,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619169,,BAO_0000219,2081.0,
3500,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,B,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619170,,BAO_0000219,2081.0,
3501,6866,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",F,,,Homo sapiens,9606.0,,,,,104841,D,5,Autocuration,1,,CHEMBL619171,,BAO_0000019,,
3502,15650,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",F,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619172,,BAO_0000219,2081.0,
3503,10063,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619173,,BAO_0000019,,
3504,12665,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619174,,BAO_0000019,,
3505,7504,5-hydroxytryptamine receptor binding affinity was determined in rats,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619175,,BAO_0000019,,
3506,7504,Binding affinity at rat 5-hydroxytryptamine receptor.,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619176,,BAO_0000224,,
3507,7038,Affinity against 5-hydroxytryptamine receptors in rat fundus model,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619177,,BAO_0000019,,
3508,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619178,,BAO_0000224,,
3509,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619179,,BAO_0000224,,
3510,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,F,,,,,,Stomach,,,104705,H,4,Autocuration,1,,CHEMBL619180,,BAO_0000019,945.0,
3511,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,F,,,,,,Stomach,,,104705,H,4,Autocuration,1,,CHEMBL619181,,BAO_0000019,945.0,
3512,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,F,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619182,,BAO_0000019,,
3513,6960,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619183,,BAO_0000224,,
3514,6960,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619184,,BAO_0000224,,
3515,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619185,,BAO_0000221,10000000.0,
3516,15753,Binding affinity for rat 5-hydroxytryptamine transporter.,B,,,,,,,,,12198,H,8,Expert,1,,CHEMBL619186,,BAO_0000357,,
3517,8062,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619187,,BAO_0000019,,
3518,9036,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619188,,BAO_0000019,,
3519,15067,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619189,,BAO_0000224,,
3520,15753,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,F,,,Rattus norvegicus,10116.0,,Brain,,,12198,D,9,Expert,1,,CHEMBL619190,,BAO_0000019,955.0,
3521,15753,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,F,,,Rattus norvegicus,10116.0,,Cerebellum,,,12198,D,9,Expert,1,,CHEMBL619191,,BAO_0000221,2037.0,
3522,15295,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619192,,BAO_0000019,,
3523,6347,Percent binding affinity against 5-hydroxytryptamine receptor,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619193,,BAO_0000224,,
3524,6763,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL619194,,BAO_0000019,,
3525,12092,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619195,,BAO_0000224,,
3526,1579,Affinity against 5-hydroxytryptamine receptor was determined,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619196,,BAO_0000224,,
3527,1579,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,B,,,Rattus norvegicus,10116.0,,Stomach,,,104705,D,5,Autocuration,1,,CHEMBL619197,,BAO_0000019,945.0,
3528,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,B,In vitro,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL619198,,BAO_0000219,,
3529,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,B,In vitro,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL875081,,BAO_0000219,,
3530,5030,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,B,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL884712,,BAO_0000357,,
3531,15796,Inhibition of 5-hydroxytryptamine reuptake,B,,,,,,,,,121,H,8,Expert,1,,CHEMBL884710,,BAO_0000357,,
3532,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619199,,BAO_0000019,,
3533,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619200,,BAO_0000019,,
3534,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619201,,BAO_0000019,,
3535,12409,Tested for 5-hydroxytryptamine receptor uptake,F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619202,,BAO_0000019,,
3536,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL619203,449.0,BAO_0000219,,
3537,16909,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL619204,,BAO_0000019,,
3538,15629,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,B,,,Homo sapiens,9606.0,,,,,10576,H,8,Autocuration,1,,CHEMBL619205,,BAO_0000249,,
3539,15629,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL619206,,BAO_0000357,,
3540,15629,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL619207,,BAO_0000249,,
3541,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619208,,BAO_0000019,2435.0,
3542,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619209,,BAO_0000019,2435.0,
3543,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619210,,BAO_0000019,2435.0,
3544,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619211,,BAO_0000019,2435.0,
3545,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619212,,BAO_0000019,2435.0,
3546,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620681,,BAO_0000019,2435.0,
3547,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620682,,BAO_0000019,2435.0,
3548,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620683,,BAO_0000019,2435.0,
3549,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620684,,BAO_0000019,2435.0,
3550,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620685,,BAO_0000019,2435.0,
3551,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620686,,BAO_0000019,2435.0,
3552,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620687,,BAO_0000019,349.0,
3553,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620688,,BAO_0000019,349.0,
3554,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620689,,BAO_0000019,349.0,
3555,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620690,,BAO_0000019,349.0,
3556,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620691,,BAO_0000019,349.0,
3557,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620692,,BAO_0000019,349.0,
3558,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620693,,BAO_0000019,349.0,
3559,1274,Binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620694,,BAO_0000357,,
3560,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL857986,,BAO_0000019,,
3561,14532,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620695,,BAO_0000357,,
3562,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620696,,BAO_0000357,,
3563,17200,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620697,,BAO_0000357,,
3564,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620698,,BAO_0000357,,
3565,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620699,,BAO_0000357,,
3566,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620700,,BAO_0000357,,
3567,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620701,643.0,BAO_0000219,,
3568,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL875082,643.0,BAO_0000219,,
3569,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620702,643.0,BAO_0000219,,
3570,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620703,643.0,BAO_0000219,,
3571,17046,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,B,,,,,,,C6,,168,H,8,Autocuration,1,,CHEMBL620704,673.0,BAO_0000219,,
3572,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620705,673.0,BAO_0000219,,
3573,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620706,673.0,BAO_0000219,,
3574,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620707,673.0,BAO_0000219,,
3575,17066,Binding affinity towards 5-hydroxytryptamine 5 receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL620708,,BAO_0000357,,
3576,17200,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL620709,,BAO_0000357,,
3577,16146,Binding affinity against 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620710,,BAO_0000357,,
3578,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,B,,,,,,,CHO,,10624,H,8,Autocuration,1,,CHEMBL620711,449.0,BAO_0000219,,
3579,6491,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620712,,BAO_0000357,,
3580,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620713,,BAO_0000357,,
3581,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620714,,BAO_0000357,,
3582,4234,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620715,,BAO_0000357,,
3583,6013,Binding affinity towards 5-HT5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL620716,,BAO_0000357,,
3584,17175,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL620717,,BAO_0000357,,
3585,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL618072,,BAO_0000357,,
3586,6166,Binding affinity towards cloned human 5-HT5A receptor was determined,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL857987,,BAO_0000357,,
3587,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618073,722.0,BAO_0000219,,
3588,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618074,722.0,BAO_0000219,,
3589,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618075,722.0,BAO_0000219,,
3590,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618076,,BAO_0000357,,
3591,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618077,,BAO_0000357,,
3592,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618078,,BAO_0000357,,
3593,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL881821,,BAO_0000357,,
3594,17066,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618079,,BAO_0000357,,
3595,17175,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,B,,,,,,,,,10625,H,8,Expert,1,,CHEMBL618080,,BAO_0000357,,
3596,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,B,,,,,,,HEK293,,10576,H,8,Autocuration,1,,CHEMBL618081,722.0,BAO_0000219,,
3597,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,B,,,,,,,HEK293,,10626,H,8,Autocuration,1,,CHEMBL618082,722.0,BAO_0000219,,
3598,4820,Binding affinity towards 5-HT5a receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618083,,BAO_0000357,,
3599,17066,Binding affinity towards 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL618084,,BAO_0000357,,
3600,17066,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618085,,BAO_0000357,,
3601,17175,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618086,,BAO_0000357,,
3602,16633,Binding affinities against 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL875092,,BAO_0000357,,
3603,16633,Binding affinities towards 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL618087,,BAO_0000357,,
3604,16700,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL872926,,BAO_0000357,,
3605,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618088,,BAO_0000019,,
3606,5486,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618089,,BAO_0000223,,
3607,16146,Inhibition of human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618090,,BAO_0000357,,
3608,17273,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618091,,BAO_0000357,,
3609,17687,Inhibition against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618092,,BAO_0000357,,
3610,6491,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618093,,BAO_0000357,,
3611,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,B,,,,,,,HeLa,,10627,H,8,Expert,1,,CHEMBL618094,308.0,BAO_0000219,,
3612,17066,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618095,,BAO_0000357,,
3613,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL875093,,BAO_0000357,,
3614,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618096,,BAO_0000357,,
3615,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618118,,BAO_0000357,,
3616,3555,Binding affinity against 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618119,,BAO_0000357,,
3617,5808,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618120,,BAO_0000357,,
3618,6013,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618121,,BAO_0000357,,
3619,15818,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",B,,,,,,,HEK293,,10627,H,8,Expert,1,,CHEMBL618122,722.0,BAO_0000219,,
3620,16209,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618123,,BAO_0000357,,
3621,3935,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,B,,,,,,,HEK293,,10627,H,8,Expert,1,,CHEMBL618124,722.0,BAO_0000219,,
3622,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618125,,BAO_0000357,,
3623,3805,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,10627,D,9,Expert,1,,CHEMBL618126,722.0,BAO_0000219,,
3624,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618236,,BAO_0000019,,
3625,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618237,,BAO_0000019,,
3626,6786,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,B,,,,,,,COS-7,,10627,H,8,Expert,1,,CHEMBL618238,643.0,BAO_0000219,,
3627,4234,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618239,,BAO_0000357,,
3628,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618240,,BAO_0000019,,
3629,17200,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618241,,BAO_0000357,,
3630,17451,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL859399,722.0,BAO_0000219,,
3631,3935,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,F,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618242,,BAO_0000019,,
3632,5033,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL857991,,BAO_0000357,,
3633,4540,Binding affinity against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL619951,,BAO_0000357,,
3634,4540,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Expert,1,,CHEMBL619952,308.0,BAO_0000219,,
3635,4540,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Expert,1,,CHEMBL619953,308.0,BAO_0000219,,
3636,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619954,308.0,BAO_0000219,,
3637,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619955,308.0,BAO_0000219,,
3638,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619956,308.0,BAO_0000219,,
3639,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,10627,H,8,Autocuration,1,,CHEMBL619957,449.0,BAO_0000219,,
3640,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL619958,722.0,BAO_0000219,,
3641,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL620627,722.0,BAO_0000219,,
3642,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL620628,722.0,BAO_0000219,,
3643,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620629,308.0,BAO_0000219,,
3644,6166,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620630,,BAO_0000357,,
3645,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620782,308.0,BAO_0000219,,
3646,15316,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620783,,BAO_0000357,,
3647,4199,Binding affinity against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620784,,BAO_0000357,,
3648,15146,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,B,,,,,,,HeLa,,10627,H,8,Expert,1,,CHEMBL620785,308.0,BAO_0000219,,
3649,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL857992,,BAO_0000357,,
3650,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620786,,BAO_0000219,,
3651,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620787,308.0,BAO_0000219,,
3652,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620788,308.0,BAO_0000219,,
3653,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620789,308.0,BAO_0000219,,
3654,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620790,308.0,BAO_0000219,,
3655,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,B,,,,,,,CHO,,10628,H,8,Autocuration,1,,CHEMBL620791,449.0,BAO_0000219,,
3656,14423,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620792,,BAO_0000019,,
3657,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620793,,BAO_0000357,,
3658,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620794,,BAO_0000357,,
3659,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Autocuration,1,,CHEMBL620795,308.0,BAO_0000219,,
3660,4820,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620796,,BAO_0000357,,
3661,4639,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620797,,BAO_0000357,,
3662,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,F,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL620798,,BAO_0000019,,
3663,6011,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620799,,BAO_0000357,,
3664,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620800,,BAO_0000357,,
3665,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620801,,BAO_0000357,,
3666,5014,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL875100,,BAO_0000357,,
3667,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620802,,BAO_0000357,,
3668,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,F,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620803,,BAO_0000019,,
3669,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,F,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620804,,BAO_0000019,,
3670,4373,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620805,,BAO_0000357,,
3671,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620806,,BAO_0000357,,
3672,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620807,,BAO_0000357,,
3673,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620808,,BAO_0000357,,
3674,16633,Binding affinities against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620809,,BAO_0000357,,
3675,16633,Binding affinities towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620810,,BAO_0000357,,
3676,17066,Binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL620811,,BAO_0000357,,
3677,16700,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620812,,BAO_0000357,,
3678,3269,Affinity against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620813,,BAO_0000357,,
3679,5486,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620814,,BAO_0000357,,
3680,16146,Inhibition of human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620815,,BAO_0000357,,
3681,5014,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620816,722.0,BAO_0000219,,
3682,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620817,,BAO_0000357,,
3683,3805,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620818,,BAO_0000357,,
3684,5014,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL620819,722.0,BAO_0000219,,
3685,6491,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620820,,BAO_0000357,,
3686,16190,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL620821,449.0,BAO_0000219,,
3687,17066,Binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620822,,BAO_0000357,,
3688,17066,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620823,,BAO_0000357,,
3689,3555,Binding affinity against 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620824,,BAO_0000357,,
3690,6588,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,B,,,,,,,CHO,,10209,H,8,Expert,1,,CHEMBL620825,449.0,BAO_0000219,,
3691,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL872930,,BAO_0000357,,
3692,6013,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620826,,BAO_0000357,,
3693,16209,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620827,,BAO_0000357,,
3694,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620828,,BAO_0000357,,
3695,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620829,,BAO_0000357,,
3696,5014,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL620830,722.0,BAO_0000219,,
3697,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL620831,,BAO_0000019,,
3698,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL620832,,BAO_0000019,,
3699,4234,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL621548,,BAO_0000357,,
3700,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621549,,BAO_0000019,,
3701,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621550,,BAO_0000357,,
3702,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL621551,449.0,BAO_0000219,,
3703,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621552,,BAO_0000019,,
3704,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL857077,,BAO_0000357,,
3705,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL618158,,BAO_0000357,,
3706,5033,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,B,,,Homo sapiens,9606.0,,,COS-7,,10209,D,9,Expert,1,,CHEMBL618159,643.0,BAO_0000219,,
3707,5486,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,B,,,,,,,COS-7,,10209,H,8,Autocuration,1,,CHEMBL875101,643.0,BAO_0000219,,
3708,4540,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,10209,D,9,Expert,1,,CHEMBL618160,722.0,BAO_0000219,,
3709,6166,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618161,,BAO_0000357,,
3710,17342,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL618162,722.0,BAO_0000219,,
3711,17342,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618163,,BAO_0000357,,
3712,17296,Binding affinity against 5-hydroxytryptamine 7 human receptors,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL618164,,BAO_0000357,,
3713,16429,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618165,,BAO_0000219,,
3714,15779,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL618166,722.0,BAO_0000219,,
3715,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL857989,722.0,BAO_0000219,,
3716,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619888,722.0,BAO_0000219,,
3717,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619889,722.0,BAO_0000219,,
3718,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619890,722.0,BAO_0000219,,
3719,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL619891,449.0,BAO_0000219,,
3720,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619892,722.0,BAO_0000219,,
3721,4199,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,B,,,,,,,HEK293,,10209,D,9,Expert,1,,CHEMBL619893,722.0,BAO_0000219,,
3722,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619894,722.0,BAO_0000219,,
3723,3680,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,B,,,,,,,HEK293,,10209,D,9,Intermediate,1,,CHEMBL619895,722.0,BAO_0000219,,
3724,3680,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,B,,,,,,,,,10209,D,9,Intermediate,1,,CHEMBL619896,,BAO_0000357,,
3725,15316,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,B,,,,,,,COS-7,,10209,H,8,Autocuration,1,,CHEMBL619897,643.0,BAO_0000219,,
3726,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619898,722.0,BAO_0000219,,
3727,5213,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL619899,722.0,BAO_0000219,,
3728,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619900,722.0,BAO_0000219,,
3729,14818,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,B,,,Homo sapiens,9606.0,,,HEK293,,10209,D,9,Expert,1,,CHEMBL619901,722.0,BAO_0000219,,
3730,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620580,722.0,BAO_0000219,,
3731,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620581,722.0,BAO_0000219,,
3732,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620733,722.0,BAO_0000219,,
3733,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Autocuration,1,,CHEMBL620734,,BAO_0000357,,
3734,17066,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,B,,,Mus musculus,10090.0,,,,,10022,D,9,Expert,1,,CHEMBL620735,,BAO_0000357,,
3735,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,B,,,Oryctolagus cuniculus,9986.0,,,,,10209,H,8,Autocuration,1,,CHEMBL620736,,BAO_0000019,,
3736,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620737,449.0,BAO_0000219,,
3737,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620738,449.0,BAO_0000219,,
3738,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620739,449.0,BAO_0000219,,
3739,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620740,449.0,BAO_0000219,,
3740,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620741,449.0,BAO_0000219,,
3741,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620742,449.0,BAO_0000219,,
3742,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620743,449.0,BAO_0000219,,
3743,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620744,449.0,BAO_0000219,,
3744,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620745,449.0,BAO_0000219,,
3745,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620746,449.0,BAO_0000219,,
3746,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620747,449.0,BAO_0000219,,
3747,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620748,449.0,BAO_0000219,,
3748,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620749,449.0,BAO_0000219,,
3749,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620750,,BAO_0000357,,
3750,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620751,,BAO_0000357,,
3751,17386,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620752,,BAO_0000357,,
3752,14423,Binding affinity against 5-hydroxytryptamine 7 receptor using from CHO cell membranes [3H]5-HT as the radioligand.,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL872929,,BAO_0000019,,
3753,15874,Binding affinity against Rat 5-hydroxytryptamine 7 receptor using [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620753,,BAO_0000357,,
3754,15874,Displacement of [3H]5-HT from over-expressed rat 5-hydroxytryptamine 7 receptor,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620754,,BAO_0000357,,
3755,16372,Displacement of [3H]5-HT from rat 5-hydroxytryptamine 7 receptor expressed in CHO cells,B,,,Rattus norvegicus,10116.0,,,CHO,,11923,D,9,Expert,1,,CHEMBL620755,449.0,BAO_0000219,,
3756,4622,In vitro binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620756,,BAO_0000357,,
3757,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620757,,BAO_0000357,,
3758,16372,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; Not tested",B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620758,449.0,BAO_0000219,,
3759,16372,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; not tested",B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620759,449.0,BAO_0000219,,
3760,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM; not tested,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620760,449.0,BAO_0000219,,
3761,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT; Not tested,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620761,449.0,BAO_0000219,,
3762,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620762,,BAO_0000221,2116.0,
3763,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620763,,BAO_0000221,2116.0,
3764,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine receptor desensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620764,,BAO_0000221,2116.0,
3765,5831,Inhibition of [3H]-5-CT binding to 5-hydroxytryptamine 7 receptor of rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,11923,D,9,Expert,1,,CHEMBL857990,,BAO_0000249,,
3766,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620765,,BAO_0000357,,
3767,17319,Binding affinity at rat 5-hydroxytryptamine 7 receptor.,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620766,,BAO_0000357,,
3768,17342,Binding affinity towards 5-hydroxytryptamine receptor 7 on rat hypothalamus membranes using [3H]5-CT as radioligand.,B,,,,,,Hypothalamus,,,11923,H,8,Expert,1,,CHEMBL620767,,BAO_0000019,1898.0,
3769,17342,Binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620768,,BAO_0000357,,
3770,3680,Binding affinity against 5-hydroxytryptamine 7 receptor using [3H]-5-CT in rat hypothalamus membranes,B,,,,,,Hypothalamus,,,11923,H,8,Expert,1,,CHEMBL619051,,BAO_0000249,1898.0,
3771,3680,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL619052,,BAO_0000357,,
3772,17319,Agonistic activity against rat 5-HT7 adenyl cyclase expressed by HEK293 cells,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Expert,1,,CHEMBL619053,722.0,BAO_0000219,,
3773,17319,Agonistic activity against rat 5-HT7 adenyl cyclase expressed in HEK293 cells; Active,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Expert,1,,CHEMBL619703,722.0,BAO_0000219,,
3774,17319,Agonistic activity against rat 5-HT7-adenyl cyclase expressed by HEK293 cells; Active,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Autocuration,1,,CHEMBL619704,722.0,BAO_0000219,,
3775,4820,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619851,,BAO_0000357,,
3776,4639,Percentage of displacement at 5-hydroxytryptamine 7 receptor at 10e-8 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619852,,BAO_0000357,,
3777,6011,Inhibition of binding towards 5-hydroxytryptamine 7 receptor at 100 nM concentration,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619853,,BAO_0000357,,
3778,17066,Binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL619854,,BAO_0000357,,
3779,17066,Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619855,,BAO_0000357,,
3780,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor; inactive at 10 uM,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619856,,BAO_0000357,,
3781,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619857,,BAO_0000357,,
3782,17066,Antagonistic activity towards 5-hydroxytryptamine 7 receptor was evaluated by cAMP assay,F,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619858,,BAO_0000019,,
3783,4373,Binding affinity for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619859,,BAO_0000357,,
3784,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619860,,BAO_0000357,,
3785,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619861,,BAO_0000357,,
3786,17342,Non-selective inhibitory activity was determined against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619862,,BAO_0000357,,
3787,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-6 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619863,,BAO_0000357,,
3788,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-8 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619864,,BAO_0000357,,
3789,16633,Binding affinities against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL872928,,BAO_0000357,,
3790,16633,Binding affinities towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619865,,BAO_0000357,,
3791,17066,Binding affinity towards rodent 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619866,,BAO_0000357,,
3792,16700,The binding affinity towards 5-hydroxytryptamine 7 receptor; No affinity,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619867,,BAO_0000357,,
3793,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,B,,,,,,Ileum,,,10209,H,8,Autocuration,1,,CHEMBL619868,,BAO_0000221,2116.0,
3794,14080,Compound was evaluated for the potency to inhibit oxidation of arachidonic acid by human recombinant 5-Lipoxygenase using a spectrophotometric assay,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619869,,BAO_0000019,,
3795,14080,Inhibition of oxidation of arachidonic acid by human 5-Lipoxygenase using spectrophotometric assay,F,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL619870,,BAO_0000019,,
3796,409,In vitro inhibition of human recombinant 5-lipoxygenase enzyme,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619871,,BAO_0000357,,
3797,409,In vitro inhibition of human recombinant lipoxygenase enzyme,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619872,,BAO_0000357,,
3798,409,In vitro inhibition of human recombinant lipoxygenase enzyme; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619873,,BAO_0000357,,
3799,11090,Inhibition of 5-lipoxygenase in human whole blood.,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL619874,,BAO_0000357,178.0,
3800,11090,Inhibition of 5-lipoxygenase in human whole blood.,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL619875,,BAO_0000357,178.0,
3801,948,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of 5-HETE,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619876,,BAO_0000357,,
3802,948,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of leukotriene B4 (LTB4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619877,,BAO_0000357,,
3803,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human polymorphonuclear leukocytes.,F,,,,,,,,,55,H,8,Expert,1,,CHEMBL619878,,BAO_0000219,,
3804,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human whole blood,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619879,,BAO_0000019,178.0,
3805,9637,In vitro inhibition of 5-lipoxygenase from human polymorphs,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619880,,BAO_0000357,,
3806,11320,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-LPO (5-lipoxygenase),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619881,,BAO_0000357,,
3807,11320,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL619882,,BAO_0000357,,
3808,6838,In vitro inhibitory activity against 5-lipoxygenase in a human whole blood assay,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619883,,BAO_0000357,,
3809,17667,Inhibition of 5-Lipoxygenase (5-LO) of human whole blood (HWB),B,,,Homo sapiens,9606.0,,Blood,,,55,D,9,Expert,1,,CHEMBL619884,,BAO_0000357,178.0,
3810,12703,In vitro potency against human 5-Lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619885,,BAO_0000357,,
3811,14312,Inhibitory activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay,F,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL619886,,BAO_0000019,,
3812,14312,Inhibition activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay; No data,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619887,,BAO_0000019,178.0,
3813,5364,Inhibition of 5-lipoxygenase activity of compound evaluated as determined by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875097,,BAO_0000019,,
3814,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618001,,BAO_0000219,,
3815,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE; NA means Not active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618002,,BAO_0000219,,
3816,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618003,,BAO_0000219,,
3817,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4; NA means Not active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618004,,BAO_0000219,,
3818,12365,Inhibition of human 5-lipoxygenase in human cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618005,,BAO_0000219,,
3819,10603,Inhibition of human neutrophil 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618006,,BAO_0000357,,
3820,10501,Inhibitory activity against 5-lipoxygenase expressed from human polymorphonuclear cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875086,,BAO_0000019,,
3821,12281,Inhibition of 5-lipoxygenase from human whole blood,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL618007,,BAO_0000357,178.0,
3822,2567,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618008,,BAO_0000357,,
3823,2567,Inhibitory concentration required against 5-lipoxygenase activity in intact cells of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618009,,BAO_0000219,,
3824,10193,In vitro inhibition of polymorphonuclear leukocyte derived human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618010,,BAO_0000357,,
3825,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618011,,BAO_0000357,,
3826,13623,Potency to inhibit oxidation of arachidonic acid by recombinant human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618012,,BAO_0000357,,
3827,12780,Tested against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL882927,,BAO_0000357,,
3828,12780,Tested for activity against 5-Lipoxygenase (5-LO),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618013,,BAO_0000357,,
3829,12780,Tested for activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618014,,BAO_0000357,,
3830,11966,Tested for inhibition of 5-HPETE production by human 5-LO,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618015,,BAO_0000357,,
3831,5364,The 5-lipoxygenase activity by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618016,,BAO_0000019,,
3832,13165,Inhibition of Human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618017,,BAO_0000357,,
3833,5364,The compound was evaluated for its inhibitory activity against 5-lipoxygenase using granulocytes-type cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618018,,BAO_0000019,,
3834,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875087,,BAO_0000219,,
3835,11311,The compound was tested for inhibitory activity against LT synthesis in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618019,,BAO_0000219,,
3836,14863,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50.,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618020,,BAO_0000019,,
3837,14863,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50; Not tested,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618021,,BAO_0000019,,
3838,11087,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in human whole blood (HWBL),B,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL618022,,BAO_0000357,178.0,
3839,455,The compound was tested in vitro for inhibition against 5-lipoxygenase in intact human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618023,,BAO_0000357,,
3840,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618024,,BAO_0000357,,
3841,10319,In vitro inhibitory activity against 5-lipoxygenase in human polymorphonuclear (PMN) cells,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL873950,,BAO_0000019,,
3842,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618025,,BAO_0000357,,
3843,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618026,,BAO_0000219,,
3844,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM; NA means Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618027,,BAO_0000219,,
3845,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618028,,BAO_0000219,,
3846,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM; NA means Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618029,,BAO_0000219,,
3847,9859,Inhibitory activity against 5-lipoxygenase at 10 uM concentration,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618030,,BAO_0000357,,
3848,9859,Inhibitory activity against 5-lipoxygenase at 1 uM concentration,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618031,,BAO_0000357,,
3849,9859,Inhibitory activity against lipoxygenase (LO) at 10 uM concentration,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618032,,BAO_0000357,,
3850,2567,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618033,,BAO_0000357,,
3851,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 1 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618034,,BAO_0000357,,
3852,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875088,,BAO_0000357,,
3853,949,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; IA= Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618035,,BAO_0000019,,
3854,949,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; value ranges from 70-90,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618036,,BAO_0000019,,
3855,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 0.1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618037,,BAO_0000357,,
3856,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618038,,BAO_0000357,,
3857,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618761,,BAO_0000019,,
3858,10603,Inhibition of lipoxygenase at the concentration of 0.1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618762,,BAO_0000357,,
3859,10603,Inhibition of lipoxygenase at the concentration of 1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618763,,BAO_0000357,,
3860,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618764,,BAO_0000357,,
3861,14580,Inhibition of 5-Lipoxygenase (5-LOX),B,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL618765,,BAO_0000357,,
3862,11090,Inhibition of 5-lipoxygenase in mouse macrophages.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL618766,,BAO_0000357,,
3863,11090,Inhibition of 5-lipoxygenase in mouse macrophages.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL618767,,BAO_0000357,,
3864,6339,Inhibitory activity against lipoxygenase-2 in mice,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL619380,,BAO_0000357,,
3865,6339,Inhibitory activity against murine lipoxygenase-2.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL619381,,BAO_0000357,,
3866,12281,Inhibition of 5-lipoxygenase from mouse macrophage,B,,,Mus musculus,10090.0,,,,,17087,D,9,Expert,1,,CHEMBL619382,,BAO_0000357,,
3867,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse macrophages,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL619383,,BAO_0000357,,
3868,11089,The compound was tested for the inhibition of Arachidonate 5-lipoxygenase purified from porcine leukocytes.,B,,,Sus scrofa,9823.0,,,,,55,H,8,Autocuration,1,,CHEMBL619384,,BAO_0000019,,
3869,10091,Inhibition of 5-lipoxygenase reaction catalyzed by purified enzyme from porcine leukocytes,B,,,Sus scrofa,9823.0,,,,,55,H,8,Autocuration,1,,CHEMBL619385,,BAO_0000019,,
3870,14352,Inhibitory concentration against 5-lipoxygenase from isolated rabbit granulocytes,B,,,Oryctolagus cuniculus,9986.0,,,,,55,H,8,Autocuration,1,,CHEMBL882928,,BAO_0000019,,
3871,13329,5-lipoxygenase Inhibitory activity against rat polymorphonuclear leucocytes using 5-HETE,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619386,,BAO_0000019,,
3872,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE. ",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619387,,BAO_0000019,,
3873,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619388,,BAO_0000019,,
3874,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619389,,BAO_0000019,,
3875,13329,Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay (inhibition of 5-HETE formation),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619390,,BAO_0000019,,
3876,13329,"Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay, by ability to inhibit formation of LTB4 AT 10 uM",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619391,,BAO_0000019,,
3877,13329,Inhibition of 5-lipoxygenase pathway was evaluated in rat polymorphonuclear assay by compound (50 uM) ability to inhibit formation of 5-HETE,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619392,,BAO_0000019,,
3878,11311,The effective dose for inhibition of 5-lipoxygenase in rat blood leukocyte (ex vivo),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619393,,BAO_0000019,,
3879,11311,The effective dose for inhibition of 5-lipoxygenase in rat passive Arthus model after oral administration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619394,,BAO_0000019,,
3880,105,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619395,702.0,BAO_0000219,,
3881,105,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619396,702.0,BAO_0000219,,
3882,9138,Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619397,,BAO_0000357,,
3883,9138,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619398,,BAO_0000357,,
3884,9138,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO), (at a concentration of 0.2 nM ),",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619399,,BAO_0000357,,
3885,14427,5-LO inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619400,,BAO_0000357,,
3886,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619401,,BAO_0000019,,
3887,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4. ",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619402,,BAO_0000019,,
3888,14427,Inhibition of 5-lipoxygenase mediated conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cells,B,,,Rattus norvegicus,10116.0,,,RBL-2H3,,12166,D,9,Expert,1,,CHEMBL619403,663.0,BAO_0000219,,
3889,14427,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619404,,BAO_0000357,,
3890,14427,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619405,,BAO_0000357,,
3891,10293,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619406,702.0,BAO_0000219,,
3892,338,Inhibition of 5-Lipoxygenase of rat basophilic leukemia cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL619407,702.0,BAO_0000219,,
3893,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619408,,BAO_0000357,,
3894,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) in intact RBL-1 cell line assay,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619409,702.0,BAO_0000219,,
3895,9247,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619410,702.0,BAO_0000219,,
3896,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619753,702.0,BAO_0000219,,
3897,137,Compound was evaluated in an intact RBL-1 cell line for inhibition of 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619754,702.0,BAO_0000219,,
3898,11481,Evaluated in vitro for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619903,,BAO_0000357,,
3899,11481,"Evaluated in vitro for its inhibitory activity against 5-lipoxygenase; N=Inactive, <50% inhibition at 10 uM concentration",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619904,,BAO_0000357,,
3900,9029,Inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase in vitro,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619905,,BAO_0000357,,
3901,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619906,,BAO_0000019,,
3902,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 32 uM; Not active,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619907,,BAO_0000019,,
3903,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 50 uM; Not active,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619908,,BAO_0000019,,
3904,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells; No data,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619909,,BAO_0000019,,
3905,13358,Inhibition of 5-lipoxygenase by measuring 5-HETE levels in RBL-1 cell-free supernatant,F,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619910,702.0,BAO_0000219,,
3906,1175,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL882929,702.0,BAO_0000219,,
3907,8797,Ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619911,702.0,BAO_0000219,,
3908,8797,Compound was tested for its ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells; No data,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619912,,BAO_0000019,,
3909,577,Inhibition of rat basophilic leukemia cell 5-lipoxygenase,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619913,,BAO_0000357,,
3910,9295,In vitro inhibitory activity against RBL-1 5-LO,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619914,702.0,BAO_0000219,,
3911,9295,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (insoluble above 45 uM),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619915,702.0,BAO_0000219,,
3912,9295,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (time dependent),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619916,702.0,BAO_0000219,,
3913,9295,Compound was tested for its inhibition activity against 5-LO of the whole cell in vitro in rat.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619917,,BAO_0000218,,
3914,9295,Compound was tested for its inhibition activity against the 5-LO in isolated enzyme,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619918,,BAO_0000357,,
3915,216,Compound was tested for its inhibitory activity against 5-lipoxygenase in rat.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619919,,BAO_0000218,,
3916,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-LPO) in rat basophilic leukemia (RBL) cells.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883710,702.0,BAO_0000219,,
3917,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in rat whole blood.,B,,,,,,Blood,,,12166,H,8,Autocuration,1,,CHEMBL619920,,BAO_0000019,178.0,
3918,10091,Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619921,,BAO_0000357,,
3919,10274,Concentration that produces 50% inhibition of A-23187-stimulated radiolabeled 5-HETE and TXB2 synthesis by PMN 5-lipoxygenase.,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619922,,BAO_0000019,,
3920,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in rat polymorphonuclear leukocytes,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619923,,BAO_0000219,,
3921,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619924,702.0,BAO_0000219,,
3922,12576,In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619925,,BAO_0000357,,
3923,9546,In vitro inhibition of 5-lipoxygenase from RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619926,702.0,BAO_0000219,,
3924,9521,In vitro inhibition of 5-lipoxygenase in RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619927,702.0,BAO_0000219,,
3925,10626,In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619928,702.0,BAO_0000219,,
3926,9225,In vitro inhibition of RBL-1 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619929,702.0,BAO_0000219,,
3927,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.18-0.31,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875089,702.0,BAO_0000219,,
3928,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.3-1.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619930,702.0,BAO_0000219,,
3929,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.4-2.2,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619931,702.0,BAO_0000219,,
3930,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.72-1.07,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619932,702.0,BAO_0000219,,
3931,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.9-4.0,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619933,702.0,BAO_0000219,,
3932,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.5,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619934,702.0,BAO_0000219,,
3933,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.7,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619935,702.0,BAO_0000219,,
3934,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-2.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619936,702.0,BAO_0000219,,
3935,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.07-5.54,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619937,702.0,BAO_0000219,,
3936,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.1-1.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619938,702.0,BAO_0000219,,
3937,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.3-2.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619939,702.0,BAO_0000219,,
3938,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.4-3.2,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619940,702.0,BAO_0000219,,
3939,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.7-2.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875090,702.0,BAO_0000219,,
3940,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-2.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619941,702.0,BAO_0000219,,
3941,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-5.7,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619942,702.0,BAO_0000219,,
3942,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.9-2.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883711,702.0,BAO_0000219,,
3943,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.3-.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619943,702.0,BAO_0000219,,
3944,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.46-2.63,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619944,702.0,BAO_0000219,,
3945,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.3-3.5,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619945,702.0,BAO_0000219,,
3946,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.8-7.1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619946,702.0,BAO_0000219,,
3947,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.0-6.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619947,702.0,BAO_0000219,,
3948,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.9-11.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619948,702.0,BAO_0000219,,
3949,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 7.5-11.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619949,702.0,BAO_0000219,,
3950,9401,In vitro inhibitory activity against 5-lipoxygenase from rat basophilic leukemia cells.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619950,,BAO_0000019,,
3951,10325,In vitro inhibitory activity against 5-Lipoxygenase in rat by Peritoneal 5-lipoxygenase assay,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618050,,BAO_0000019,,
3952,1556,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells.,F,,,,,,,RBL-2H3,,12166,H,8,Expert,1,,CHEMBL875091,663.0,BAO_0000219,,
3953,1556,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells; Not tested,F,,,,,,,RBL-2H3,,12166,H,8,Expert,1,,CHEMBL618051,663.0,BAO_0000219,,
3954,961,Inhibition of 5-lipoxygenase from rat basophilic leukemia(RBL-1) cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618052,702.0,BAO_0000219,,
3955,6838,In vitro inhibitory activity against 5-lipoxygenase in an RBL-2H3 cell lysate,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618053,,BAO_0000019,,
3956,10325,In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL618054,,BAO_0000019,,
3957,9209,In vitro inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618055,702.0,BAO_0000219,,
3958,11520,inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cell line.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618056,702.0,BAO_0000219,,
3959,137,In vitro inhibitory activity against 5-lipoxygenase was determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618057,,BAO_0000357,,
3960,4717,In vitro inhibitory concentration against 5-lipoxygenase in RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618058,702.0,BAO_0000219,,
3961,10636,Inhibition of 5-lipoxygenase in intact RBL-1 cell line,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618059,702.0,BAO_0000219,,
3962,14312,Inhibitory activity against 5-lipoxygenase catalysis (5-LO) in sonicated rat basophilic leukemia cell lysate,F,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL618060,,BAO_0000019,,
3963,1203,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618061,702.0,BAO_0000219,,
3964,1203,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemic cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618062,,BAO_0000019,,
3965,13622,Inhibition of 5-lipoxygenase catalysis in rat basophilic leukemia (RBL) cells by measuring 5-HETE product formation,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618063,702.0,BAO_0000219,,
3966,9793,Inhibition of 5-lipoxygenase from rat peritoneal neutrophils after oral administration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618064,,BAO_0000357,,
3967,1143,Inhibition of 5-lipoxygenase of rat basophilic leukemia (RBL) cell cytosolic enzymes,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618065,702.0,BAO_0000219,,
3968,11854,Inhibition 5-lipoxygenase mediated LTB4 formation in rat basophilic leukemia (RBL-1) cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618066,702.0,BAO_0000219,,
3969,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618067,702.0,BAO_0000219,,
3970,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618068,702.0,BAO_0000219,,
3971,10501,Inhibition of 5-lipoxygenase in rat RBL-1 cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618069,702.0,BAO_0000219,,
3972,12526,Inhibition of 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618070,702.0,BAO_0000219,,
3973,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 32 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL618071,,BAO_0000019,349.0,
3974,10034,Compound was tested for its effects on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL619247,,BAO_0000019,349.0,
3975,10034,Approximate dose levels for a half maximal reduction of 5-HTP levels,F,,,,,,,,,10825,H,8,Autocuration,1,,CHEMBL619248,,BAO_0000019,,
3976,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619249,,BAO_0000221,10000000.0,
3977,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619250,,BAO_0000221,10000000.0,
3978,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL619251,,BAO_0000019,,
3979,12079,Inhibitory concentration against human platelet 5-lipoxygenase in dog whole blood,F,,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619252,,BAO_0000019,178.0,
3980,12079,Inhibitory concentration against human platelet 5-lipoxygenase in human whole blood,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619253,,BAO_0000019,178.0,
3981,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619254,,BAO_0000219,,
3982,12338,Inhibition of 5-lipoxygenase in bovine polymorphonuclear leukocytes,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619255,,BAO_0000219,,
3983,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL).,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619256,,BAO_0000219,,
3984,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL),B,,,,,,,,,17140,H,8,Autocuration,1,,CHEMBL875418,,BAO_0000219,,
3985,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619257,,BAO_0000219,,
3986,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,B,,,,,,,,,17140,H,8,Autocuration,1,,CHEMBL619258,,BAO_0000219,,
3987,12365,Inhibition of 5-lipoxygenase in bovine PMNL cell assay.,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619259,,BAO_0000357,,
3988,13500,Tested for inhibition of 5-lipoxygenase as inhibition of 5-HETE and LTB4 biosynthesis in bovine PMNL,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619260,,BAO_0000357,,
3989,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619261,,BAO_0000218,178.0,
3990,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619263,,BAO_0000218,178.0,
3991,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619264,,BAO_0000218,178.0,
3992,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619265,,BAO_0000218,178.0,
3993,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619266,,BAO_0000218,178.0,
3994,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619902,,BAO_0000218,178.0,
3995,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620058,,BAO_0000218,178.0,
3996,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620059,,BAO_0000218,178.0,
3997,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620060,,BAO_0000218,178.0,
3998,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620061,,BAO_0000218,178.0,
3999,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620062,,BAO_0000218,178.0,
4000,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620063,,BAO_0000218,178.0,
4001,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620064,,BAO_0000218,178.0,
4002,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620065,,BAO_0000218,178.0,
4003,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620066,,BAO_0000218,178.0,
4004,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620067,,BAO_0000218,178.0,
4005,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620068,,BAO_0000218,178.0,
4006,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620069,,BAO_0000218,178.0,
4007,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620070,,BAO_0000218,178.0,
4008,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620071,,BAO_0000218,178.0,
4009,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620072,,BAO_0000218,178.0,
4010,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620036,,BAO_0000218,178.0,
4011,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL857702,,BAO_0000218,178.0,
4012,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620037,,BAO_0000218,178.0,
4013,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620038,,BAO_0000218,178.0,
4014,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620039,,BAO_0000218,178.0,
4015,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620040,,BAO_0000218,178.0,
4016,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620041,,BAO_0000218,178.0,
4017,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620042,,BAO_0000218,178.0,
4018,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620043,,BAO_0000218,178.0,
4019,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620044,,BAO_0000218,178.0,
4020,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620045,,BAO_0000218,178.0,
4021,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620046,,BAO_0000218,178.0,
4022,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620047,,BAO_0000218,178.0,
4023,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620048,,BAO_0000218,178.0,
4024,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL857703,,BAO_0000218,178.0,
4025,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620049,,BAO_0000218,178.0,
4026,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620050,,BAO_0000218,178.0,
4027,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620051,,BAO_0000218,178.0,
4028,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619213,,BAO_0000218,178.0,
4029,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619214,,BAO_0000218,178.0,
4030,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619804,,BAO_0000218,178.0,
4031,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619805,,BAO_0000218,178.0,
4032,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619806,,BAO_0000218,178.0,
4033,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619807,,BAO_0000218,178.0,
4034,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619808,,BAO_0000218,178.0,
4035,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619809,,BAO_0000218,,
4036,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619810,,BAO_0000218,,
4037,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619811,,BAO_0000218,,
4038,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620769,,BAO_0000218,,
4039,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620770,,BAO_0000218,,
4040,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620771,,BAO_0000218,,
4041,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620772,,BAO_0000218,,
4042,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620773,,BAO_0000218,,
4043,9203,Ability to inhibit 5-lipoxygenase in guinea pig,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620774,,BAO_0000357,,
4044,82,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-lipoxygenase in vitro (guinea pig PMN),B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL620775,,BAO_0000357,,
4045,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in guinea pig.,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620776,,BAO_0000357,,
4046,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 12 h, following intravenous administration at the dose of 1.0 mg/kg",B,,,Cavia porcellus,10141.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620777,,BAO_0000218,178.0,
4047,1065,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on 5-hydroxyeicosapentaenoic acid (5-HETE) production,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620778,,BAO_0000357,,
4048,1065,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on LTB4 production,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620779,,BAO_0000357,,
4049,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]-AA to 5-HETE in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL621500,,BAO_0000019,,
4050,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL621501,,BAO_0000019,,
4051,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618098,,BAO_0000019,,
4052,10504,Inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618099,,BAO_0000019,,
4053,7788,Inhibitory activity against 5-lipoxygenase,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618100,,BAO_0000357,,
4054,10001,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618101,,BAO_0000357,,
4055,10193,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618102,,BAO_0000357,,
4056,13243,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618103,,BAO_0000357,,
4057,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618104,,BAO_0000357,,
4058,969,Inhibitory activity against 5-lipoxygenase in guinea pig leukocytes was determined,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL883712,,BAO_0000219,,
4059,10001,Inhibitory activity against 5-lipoxygenase at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618105,,BAO_0000357,,
4060,7788,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618106,,BAO_0000357,,
4061,10001,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte at 30 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618107,,BAO_0000357,,
4062,10193,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618108,,BAO_0000357,,
4063,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618109,,BAO_0000357,,
4064,13243,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618110,,BAO_0000357,,
4065,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL618111,,BAO_0000357,,
4066,13243,Inhibitory activity uM,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618112,,BAO_0000019,,
4067,10504,Percent inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618113,,BAO_0000019,,
4068,7788,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618114,,BAO_0000357,,
4069,10546,Evaluated for inhibition of the formation and release of 5-lipoxygenase in isolated guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,55,H,8,Expert,1,,CHEMBL620871,,BAO_0000221,2116.0,
4070,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620872,,BAO_0000357,,
4071,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620873,,BAO_0000357,,
4072,2578,Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620874,,BAO_0000357,,
4073,12780,In vitro inhibition of human 5-Lipoxygenase.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL620875,,BAO_0000357,,
4074,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620876,,BAO_0000251,2107.0,
4075,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620877,,BAO_0000251,2107.0,
4076,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL857854,,BAO_0000251,2107.0,
4077,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM exposed 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620878,,BAO_0000251,2107.0,
4078,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620879,,BAO_0000251,2107.0,
4079,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620880,,BAO_0000251,2107.0,
4080,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620881,,BAO_0000251,2107.0,
4081,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620882,,BAO_0000251,2107.0,
4082,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620883,,BAO_0000251,2107.0,
4083,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620884,,BAO_0000251,2107.0,
4084,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620885,,BAO_0000251,2107.0,
4085,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 27.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620886,,BAO_0000251,2107.0,
4086,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620887,,BAO_0000251,2107.0,
4087,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618039,,BAO_0000251,2107.0,
4088,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618040,,BAO_0000251,2107.0,
4089,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618041,,BAO_0000251,2107.0,
4090,7411,"Compound was evaluated for inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618216,,BAO_0000251,2107.0,
4091,7411,"Compound was evaluated for inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618217,,BAO_0000251,2107.0,
4092,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618218,,BAO_0000251,2107.0,
4093,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618219,,BAO_0000251,2107.0,
4094,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618220,,BAO_0000251,2107.0,
4095,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618221,,BAO_0000251,2107.0,
4096,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618222,,BAO_0000251,2107.0,
4097,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618223,,BAO_0000251,2107.0,
4098,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618224,,BAO_0000251,2107.0,
4099,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618225,,BAO_0000251,2107.0,
4100,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 20 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618226,,BAO_0000251,2107.0,
4101,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618227,,BAO_0000251,2107.0,
4102,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618228,,BAO_0000251,2107.0,
4103,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618229,,BAO_0000251,2107.0,
4104,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618230,,BAO_0000251,2107.0,
4105,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618231,,BAO_0000251,2107.0,
4106,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618232,,BAO_0000251,2107.0,
4107,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618233,,BAO_0000251,2107.0,
4108,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618234,,BAO_0000251,2107.0,
4109,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618235,,BAO_0000251,2107.0,
4110,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618115,,BAO_0000251,2107.0,
4111,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618116,,BAO_0000251,2107.0,
4112,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618117,,BAO_0000251,2107.0,
4113,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619968,,BAO_0000251,2107.0,
4114,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619969,,BAO_0000251,2107.0,
4115,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619970,,BAO_0000251,2107.0,
4116,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619971,,BAO_0000251,2107.0,
4117,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619972,,BAO_0000251,2107.0,
4118,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 27.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619973,,BAO_0000251,2107.0,
4119,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619974,,BAO_0000251,2107.0,
4120,7411,Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619975,,BAO_0000251,2107.0,
4121,7411,Vmax determined by 7-ethoxycoumarin deethylation in the presence by liver microsomes from rats exposed to 3-methylcholanthrene at concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619976,,BAO_0000251,,
4122,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619977,,BAO_0000251,2107.0,
4123,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619978,,BAO_0000251,2107.0,
4124,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats; competitive inhibition",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619979,,BAO_0000251,2107.0,
4125,7411,"Compound was evaluated for alpha inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619980,,BAO_0000251,2107.0,
4126,7411,"Compound was evaluated for alpha inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619981,,BAO_0000251,2107.0,
4127,10797,In vitro inhibition of 7226/S myeloma cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619982,741.0,BAO_0000219,,
4128,6881,In vitro antitumor activity of compound against 7404 cell line (human liver carcinoma cells),F,,,Homo sapiens,9606.0,,,BEL-7404 tumor cell line,,80698,N,1,Intermediate,1,,CHEMBL619983,993.0,BAO_0000219,,
4129,3838,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL620031,391.0,BAO_0000219,,
4130,3838,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL620032,391.0,BAO_0000219,,
4131,12981,Net accumulation of the [99mTc]Isonitrile complex was measured in 77A cell lines in the presence of Verapamil.,F,,,Cricetulus griseus,10029.0,,,V79,,81264,N,1,Expert,1,,CHEMBL620033,505.0,BAO_0000219,,
4132,12981,Verapamil index represents the ratio of net uptake in the presense of verapamil over control in 77A cell lines.,F,,,Cricetulus griseus,10029.0,,,V79,,81264,N,1,Expert,1,,CHEMBL620034,505.0,BAO_0000219,,
4133,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 10 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL620035,1119.0,BAO_0000219,,
4134,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 2 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618318,1119.0,BAO_0000219,,
4135,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 20 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618319,1119.0,BAO_0000219,,
4136,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 5 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618320,1119.0,BAO_0000219,,
4137,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 50 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618321,1119.0,BAO_0000219,,
4138,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 75 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL883118,1119.0,BAO_0000219,,
4139,17229,In vitro antitumor activity against renal 786-0 tumor cell lines,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL883795,391.0,BAO_0000219,,
4140,12858,Cytotoxic activity against 786-0 Renal cancer cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618322,391.0,BAO_0000219,,
4141,16325,Growth inhibitory activity was determined against 786-0 cancer cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618323,391.0,BAO_0000219,,
4142,16325,Growth inhibitory activity was determined against 786-0 cancer cell line of renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618324,391.0,BAO_0000219,,
4143,5858,In vitro antitumor activity against human renal 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618325,391.0,BAO_0000219,,
4144,16325,Inhibition of Renal cancer in 786-0 cancer cell lines,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL875416,391.0,BAO_0000219,,
4145,14696,Inhibition of the growth of renal cancer(786-0) cell line. value in parentheses is percent inhibition at 0.01 uM,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618326,391.0,BAO_0000219,,
4146,3786,The compound was tested for its cytotoxic activity against the following renal cancer cell lines 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618327,391.0,BAO_0000219,,
4147,14696,inhibition of the growth of renal cancer(786-0) cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619215,391.0,BAO_0000219,,
4148,14769,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619216,391.0,BAO_0000219,,
4149,15354,Compound was tested for the growth inhibition of 786-0 renal tumor cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619217,391.0,BAO_0000219,,
4150,14255,The IC50 value was measured on 786-0 cell line in ovarian tumor,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619218,391.0,BAO_0000219,,
4151,14255,The IC50 value was measured on 786-0 cell line in ovarian tumor t,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619219,391.0,BAO_0000219,,
4152,14255,The IC50 value was measured on 786-0 cell line in renal tumor type.,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619220,391.0,BAO_0000219,,
4153,14696,Inhibition of the growth of renal cancer(786-0) cell line at 0.01 uM,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619221,391.0,BAO_0000219,,
4154,12016,Tested for cytotoxic activity against renal cancer 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619222,391.0,BAO_0000219,,
4155,2597,Compound was tested for growth inhibitory activity against 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL857454,391.0,BAO_0000219,,
4156,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; Inactive(N)= <50% inhibition at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619223,702.0,BAO_0000219,,
4157,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; N=Inactive,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619224,702.0,BAO_0000219,,
4158,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619225,,BAO_0000019,,
4159,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619226,702.0,BAO_0000219,,
4160,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619227,702.0,BAO_0000219,,
4161,12767,Inhibitory activity against rat basophilic leukemia 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619228,,BAO_0000357,,
4162,10997,Inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619229,,BAO_0000219,,
4163,11388,Inhibitory activity against 5-lipoxygenase of RBL-1 cell line,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619230,702.0,BAO_0000219,,
4164,167,Inhibitory activity against RBL broken cell-supematant 5-lipoxygenase was evaluated,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619231,,BAO_0000357,,
4165,167,"Inhibitory activity against intact rat PMNL, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619232,,BAO_0000357,,
4166,13744,Inhibitory activity against rat 5-lipoxygenase by using continuous oxygen consumption assay.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619233,,BAO_0000357,,
4167,1630,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619234,,BAO_0000357,,
4168,1630,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619235,,BAO_0000357,,
4169,969,"Inhibitory activity against 5-lipoxygenase in rat neutrophils as inhibition of A 23,187-induced LTB4 production",B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619236,,BAO_0000019,,
4170,13621,Inhibitory concentration against 5-lipoxygenase in rat RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619237,702.0,BAO_0000219,,
4171,10089,Inhibitory concentration to inhibit 5-lipoxygenase in the rat,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619238,,BAO_0000357,,
4172,10193,In vitro inhibition of rat polymorphonuclear leukocyte 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619239,,BAO_0000357,,
4173,11966,Tested for inhibition of 5-HPETE production by rat 5-LO; value ranges from 16-36 nM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619240,,BAO_0000357,,
4174,12251,Tested for inhibition of 5-LO by measuring the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL875417,,BAO_0000019,,
4175,211,Tested for inhibition of 5-Lipoxygenase (ARBL) in calcium-stimulated rat basophilic leukemia cells(RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619241,702.0,BAO_0000219,,
4176,12251,Inhibition of 5-lipoxygenase measured by the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,F,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619242,,BAO_0000019,,
4177,12495,Tested for inhibitory activity against 5-lipoxygenase in microsome of RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883796,702.0,BAO_0000219,,
4178,414,Tested for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619243,,BAO_0000357,,
4179,414,Tested for its inhibitory activity against 5-lipoxygenase; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619244,,BAO_0000357,,
4180,10325,"Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation)",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619245,,BAO_0000019,,
4181,11966,In vitro test for inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619246,,BAO_0000019,,
4182,165,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619984,702.0,BAO_0000219,,
4183,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells; No significant inhibitory activity up to 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619985,702.0,BAO_0000219,,
4184,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619986,702.0,BAO_0000219,,
4185,165,In vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619987,702.0,BAO_0000219,,
4186,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619988,,BAO_0000218,,
4187,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619989,702.0,BAO_0000219,,
4188,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619990,702.0,BAO_0000219,,
4189,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619991,,BAO_0000219,,
4190,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vitro),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619992,,BAO_0000219,,
4191,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vivo),B,In vivo,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619993,,BAO_0000218,,
4192,11311,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL619994,663.0,BAO_0000219,,
4193,11311,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL619995,663.0,BAO_0000219,,
4194,11311,The compound was tested for inhibitory activity against 5-lipoxygenase using rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619996,,BAO_0000019,,
4195,11732,The compound was tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619997,,BAO_0000019,,
4196,11732,Tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619998,,BAO_0000019,,
4197,11087,In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619999,,BAO_0000019,,
4198,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620000,,BAO_0000019,,
4199,11087,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in homogenized rat basophilic leukemia (RBL-1) cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620001,702.0,BAO_0000219,,
4200,11087,Inhibition of 5-lipoxygenase (5-lo) in intact rat polymorphonuclear leukocyte RPMNL,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620002,,BAO_0000357,,
4201,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620003,702.0,BAO_0000219,,
4202,13986,Inhibition of 5-lipoxygenase on rat basophil leukemia cell line lysate (RBL-1 2H3 subline) by measuring 5-HETE production,F,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL620004,702.0,BAO_0000219,,
4203,11520,Compound was evaluated for the inhibition of 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL874063,,BAO_0000357,,
4204,10293,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line at a concentration of 25 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620005,702.0,BAO_0000219,,
4205,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620006,702.0,BAO_0000219,,
4206,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay; Less than 5% inhibition at 10 uM reported as not active,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620007,702.0,BAO_0000219,,
4207,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620008,702.0,BAO_0000219,,
4208,9247,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL620009,702.0,BAO_0000219,,
4209,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620010,702.0,BAO_0000219,,
4210,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620011,702.0,BAO_0000219,,
4211,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 300 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620677,702.0,BAO_0000219,,
4212,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 33 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620678,702.0,BAO_0000219,,
4213,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 40 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620679,702.0,BAO_0000219,,
4214,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 75 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620680,702.0,BAO_0000219,,
4215,11481,Inhibitory activity against 5-lipoxygenase at 10 uM,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620838,,BAO_0000357,,
4216,105,In vitro inhibition of 5-lipoxygenase; NS means no significant inhibition,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620839,,BAO_0000357,,
4217,9029,In vitro inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase at 10 uM,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL620840,,BAO_0000357,,
4218,1175,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL620841,702.0,BAO_0000219,,
4219,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620842,702.0,BAO_0000219,,
4220,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 10e-4 M,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620843,702.0,BAO_0000219,,
4221,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determinedb at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620844,702.0,BAO_0000219,,
4222,9225,In vitro inhibition of RBL-1 5-lipoxygenase at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620845,702.0,BAO_0000219,,
4223,9401,In vitro inhibitory activity against 5-Lipoxygenase from rat basophilic leukemia cells at 30 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620846,,BAO_0000019,,
4224,137,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL873951,,BAO_0000357,,
4225,137,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620847,,BAO_0000357,,
4226,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620848,702.0,BAO_0000219,,
4227,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620849,702.0,BAO_0000219,,
4228,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at 40 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620850,702.0,BAO_0000219,,
4229,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620851,702.0,BAO_0000219,,
4230,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620852,702.0,BAO_0000219,,
4231,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875098,702.0,BAO_0000219,,
4232,14799,Inhibition of 5-lipoxygenase of rat basophilic leukemia cells at 30 uM,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL620853,702.0,BAO_0000219,,
4233,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells at 30 uM concentration; NT=Not tested,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620854,,BAO_0000019,,
4234,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620855,702.0,BAO_0000219,,
4235,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL839884,702.0,BAO_0000219,,
4236,12526,Inhibitory activity at 10 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620856,702.0,BAO_0000219,,
4237,12526,Inhibitory activity at 1 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620857,702.0,BAO_0000219,,
4238,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620858,,BAO_0000019,,
4239,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620859,,BAO_0000019,,
4240,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620860,,BAO_0000019,,
4241,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 3 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620861,,BAO_0000019,,
4242,9138,Percent inhibition of rat neutrophil 5-lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL620862,,BAO_0000357,,
4243,9138,Percent inhibition of rat neutrophil 5- Lipoxygenase (5-LO) at 100 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620863,,BAO_0000357,,
4244,11966,Tested in vitro for the inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620864,,BAO_0000019,,
4245,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620865,702.0,BAO_0000219,,
4246,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620866,702.0,BAO_0000219,,
4247,11311,The compound was tested for inhibition of 5-lipoxygenase in rat RBL-2H3 cells,B,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620867,663.0,BAO_0000219,,
4248,11311,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,B,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620868,663.0,BAO_0000219,,
4249,11311,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620869,663.0,BAO_0000219,,
4250,11311,The compound was tested for inhibition of LTB4 synthesis on isolated 5-lipoxygenase,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL873952,,BAO_0000019,,
4251,11311,The compound was tested for inhibition of isolated 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL875099,,BAO_0000357,,
4252,11311,The compound was tested for inhibition of isolated 5-lipoxygenase translocation into rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620870,663.0,BAO_0000219,,
4253,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 30 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618261,,BAO_0000019,,
4254,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 32 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618262,,BAO_0000019,,
4255,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells measured at a concentration of 30 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619428,,BAO_0000019,,
4256,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619429,,BAO_0000019,,
4257,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619430,,BAO_0000019,,
4258,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 1.0 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620017,702.0,BAO_0000219,,
4259,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620018,702.0,BAO_0000219,,
4260,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.1 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620019,702.0,BAO_0000219,,
4261,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.195 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620020,702.0,BAO_0000219,,
4262,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.2 at uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620021,702.0,BAO_0000219,,
4263,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.25 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620022,702.0,BAO_0000219,,
4264,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620023,702.0,BAO_0000219,,
4265,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620024,702.0,BAO_0000219,,
4266,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.195 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620025,702.0,BAO_0000219,,
4267,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.2 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620026,702.0,BAO_0000219,,
4268,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.39 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620027,702.0,BAO_0000219,,
4269,13986,Inhibition of 5-lipoxygenase on rat basophil leukemia cell (RBL-2H3) lysate as 5-HETE production at 32 uM,F,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620028,,BAO_0000019,,
4270,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620029,,BAO_0000357,,
4271,9295,Compound was tested for the percent of inhibition against 5-LO at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620030,,BAO_0000357,,
4272,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 1 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875415,702.0,BAO_0000219,,
4273,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618256,702.0,BAO_0000219,,
4274,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618257,702.0,BAO_0000219,,
4275,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618258,702.0,BAO_0000219,,
4276,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 16 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618259,702.0,BAO_0000219,,
4277,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618260,,BAO_0000019,,
4278,9295,Percent inhibition against RBL-1 5-LO in vitro at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618215,702.0,BAO_0000219,,
4279,9295,Percent inhibition against RBL-1 5-LO in vitro at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618390,702.0,BAO_0000219,,
4280,9295,Percent inhibition against RBL-1 5-LO in vitro at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618391,702.0,BAO_0000219,,
4281,9295,Percent inhibition against RBL-1 5-LO in vitro at 300 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618392,702.0,BAO_0000219,,
4282,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618393,702.0,BAO_0000219,,
4283,11311,The compound was tested for inhibition against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] at 10 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618394,,BAO_0000219,,
4284,10489,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),B,,,Homo sapiens,9606.0,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618395,702.0,BAO_0000219,,
4285,10489,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618396,702.0,BAO_0000219,,
4286,10489,Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1),B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL858253,702.0,BAO_0000219,,
4287,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Autocuration,1,,CHEMBL618397,,BAO_0000019,,
4288,9295,Compound was tested for the percent of inhibition against soybean 15-LO (at 100 uM),B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL618398,,BAO_0000357,,
4289,16811,"Inhibitory activity against 5-lipoxygenase, by using soybean lipoxygenase spectrophotometric assay",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL618399,,BAO_0000019,,
4290,168,In vitro inhibition of 5-Lipoxygenase; Inactive.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618400,,BAO_0000357,,
4291,6309,Inhibitory concentration against 5-lipoxygenase was determined; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618401,,BAO_0000357,,
4292,6309,Inhibitory concentration against 5-lipoxygenase; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618402,,BAO_0000357,,
4293,3092,Evaluated for inhibitory activity against RBL-1 cell 5-lipoxygenase in guinea pig,B,,,,,,,RBL-1,,55,H,8,Autocuration,1,,CHEMBL876400,702.0,BAO_0000219,,
4294,168,Inhibitory activity against 5-lipoxygenase.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618403,,BAO_0000357,,
4295,168,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618404,,BAO_0000357,,
4296,168,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive at concentrations less than 32 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618405,,BAO_0000357,,
4297,168,Inhibitory Activity against 5-Lipoxygenase was determined; NA=No significant inhibitory activity up to 300 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618406,,BAO_0000357,,
4298,12338,Inhibitory concentration against arachidonic acid 5-lipoxygenation,F,,,,,,,,,55,H,8,Expert,1,,CHEMBL618407,,BAO_0000019,,
4299,4501,Tested for the inhibitory activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618408,,BAO_0000357,,
4300,1132,Compound was tested for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618409,,BAO_0000357,,
4301,2117,Compound was tested for inhibition of 5-lipoxygenase at 50 uM; NI means no inhibition was observed,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618410,,BAO_0000357,,
4302,168,Inhibitory Activity against 5-Lipoxygenase at 30 uM was determined; Weakly active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618411,,BAO_0000357,,
4303,168,Inhibitory Activity against 5-Lipoxygenase at concentration 32 uM was determined,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618412,,BAO_0000357,,
4304,13575,Concentration required to inhibit RBL-1 supernatant 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618413,702.0,BAO_0000219,,
4305,11089,,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618414,,BAO_0000357,,
4306,216,Compound was tested for its binding activity towards 5-lipoxygenase activating protein (FLAP),B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618415,,BAO_0000357,,
4307,13165,Inhibition of 5-lipoxygenase activating protein using human leukocyte membrane preparations,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618416,,BAO_0000019,,
4308,3278,Measuring the affinity of leukotriene synthesis inhibitor for 5-Lipoxygenase activating protein (FLAP) by using [125I]L-691831 as radioligand.,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL876401,,BAO_0000357,,
4309,3278,Measuring the affinity of leukotriene synthesis inhibitor for 5-lipoxygenase activating protein by using [125I]L-691831 as radioligand.,B,,,,,,,,,10102,H,8,Expert,1,,CHEMBL618417,,BAO_0000357,,
4310,11966,Tested for inhibition of leukotriene biosynthesis by binding to 5-lipoxygenase activating protein,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618418,,BAO_0000357,,
4311,175,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein",B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618419,,BAO_0000357,,
4312,175,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein (FLAP)",B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618420,,BAO_0000357,,
4313,13449,Binding affinity of compound for 5-lipoxygenase activating protein protein by FLAP binding assay,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618421,,BAO_0000357,,
4314,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane,B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618422,,BAO_0000019,,
4315,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (R metabolically resistant),B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618423,,BAO_0000019,,
4316,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (S substrate),B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618424,,BAO_0000019,,
4317,99,Inhibition of protein biosynthesis at the level of the peptidyl transferase center of the 50 s ribosomal subunit,B,,,,,,,,,100284,S,2,Intermediate,1,,CHEMBL618425,,BAO_0000220,,
4318,4349,The dark toxicity against 543 human galactophore carcinoma cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL618426,,BAO_0000019,,
4319,4071,Tested in vitro for cytotoxicity against 56 human tumor cell lines,F,,,Homo sapiens,9606.0,,,Panel (56 tumour cell lines),,80623,N,1,Expert,1,,CHEMBL618427,390.0,BAO_0000219,,
4320,17589,Cytotoxic activity against human 5637 cell line at 20 uM expressed as percent growth value,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL618428,345.0,BAO_0000219,,
4321,15002,Antitumor activity was evaluated against human bladder carcinoma cell line 5637.,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618429,345.0,BAO_0000219,,
4322,13958,"Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line",F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618430,345.0,BAO_0000219,,
4323,17589,Growth inhibition against human 5637 cell lines,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL618431,345.0,BAO_0000219,,
4324,16748,Antitumor activity against human bladder carcinoma 5637 cells.,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL883799,345.0,BAO_0000219,,
4325,16747,Antitumor activity against human bladder carcinoma 5637 cells,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618432,345.0,BAO_0000219,,
4326,16747,Antitumor activity against human bladder carcinoma 5637 cells,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618433,345.0,BAO_0000219,,
4327,15285,In vitro inhibition of bovine trypsin(Trp).,B,,,Bos taurus,9913.0,,,,,10443,D,9,Expert,1,,CHEMBL618434,,BAO_0000357,,
4328,3726,Transcriptional activation in CV-1 cells expressing retinoic acid gamma receptor,B,,,Cercopithecidae,9527.0,,,CV-1,,240,H,8,Expert,1,,CHEMBL618435,407.0,BAO_0000219,,
4329,5033,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-HT1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL876402,,BAO_0000357,,
4330,11756,In vitro antagonism of the 5-HT-3 receptor determined by inhibition of 5-HT-induced depolarization of the isolated rat vagus nerve.,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618436,,BAO_0000019,,
4331,11953,Concentration required to inhibit pressor response to serotonin after 15 min i.v. administration of compound mediated via activation of vascular 5-HT2 receptors in rat,F,In vivo,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL618437,,BAO_0000218,,
4332,5033,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-HT4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL618438,,BAO_0000357,,
4333,11347,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,Microsomes,17045,H,8,Expert,1,,CHEMBL883800,,BAO_0000251,,
4334,11347,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,Microsomes,17045,H,8,Expert,1,,CHEMBL618439,,BAO_0000251,,
4335,1229,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL618440,,BAO_0000019,,
4336,1229,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL618441,,BAO_0000019,,
4337,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli,B,,,Trypanosoma brucei,5691.0,,,,,11938,H,8,Expert,1,,CHEMBL618442,,BAO_0000019,,
4338,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli; NI denotes no inhibition,B,,,Trypanosoma brucei,5691.0,,,,,11938,H,8,Autocuration,1,,CHEMBL618443,,BAO_0000019,,
4339,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver,B,,,Ovis aries,9940.0,,,,,11938,H,8,Expert,1,,CHEMBL619158,,BAO_0000019,,
4340,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver; NI denotes no inhibition,B,,,Ovis aries,9940.0,,,,,11938,H,8,Autocuration,1,,CHEMBL620974,,BAO_0000019,,
4341,16485,log Kd which is the binding affinity against 6-phosphogluconate dehydrogenase,B,,,,,,,,,11938,H,8,Autocuration,1,,CHEMBL620975,,BAO_0000357,,
4342,4337,Average inhibitory concentration against 60 human cell lines was reported,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Intermediate,1,,CHEMBL620976,,BAO_0000019,,
4343,4112,Inhibition of proliferation in NCI panel of 60 human tumor cell lines,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Expert,1,,CHEMBL620977,,BAO_0000019,,
4344,16160,Cancer specificity was measured from the +/- value under average log LC50 60-cell line,F,,,Homo sapiens,9606.0,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Intermediate,1,,CHEMBL620978,542.0,BAO_0000219,,
4345,16160,Cancer specificity was measured from the +/- value under average log LC50 60-cell line. ,F,,,Homo sapiens,9606.0,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Intermediate,1,,CHEMBL620979,542.0,BAO_0000219,,
4346,17376,In vitro mean growth inhibitory activity against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620980,542.0,BAO_0000219,,
4347,17376,In vitro mean growth lethal concentration against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620981,542.0,BAO_0000219,,
4348,17376,In vitro mean growth lethal concentration in colon subpanel against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620982,542.0,BAO_0000219,,
4349,17376,In vitro mean growth lethal concentration in renal subpanel against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620983,542.0,BAO_0000219,,
4350,3241,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,F,,,,,,,,,104775,H,4,Autocuration,1,,CHEMBL620984,,BAO_0000019,,
4351,3241,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,F,,,,,,,,,104775,H,4,Autocuration,1,,CHEMBL620985,,BAO_0000019,,
4352,3725,Transcriptional activation in CV-1 expressing retinoid X receptor RXR alpha,B,,,,,,,,,275,H,8,Expert,1,,CHEMBL620986,,BAO_0000357,,
4353,10805,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620987,,BAO_0000218,,
4354,10805,In vitro inhibition of Plasmodium falciparum 68 neutral proteinase activity by reinvasion of red blood cells,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620988,,BAO_0000218,,
4355,10805,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620989,,BAO_0000218,,
4356,10805,Substrate affinity for Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620990,,BAO_0000218,,
4357,10805,Reaction velocity for Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Intermediate,1,,CHEMBL620991,,BAO_0000218,,
4358,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620992,850.0,BAO_0000218,,
4359,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620993,850.0,BAO_0000218,,
4360,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 200 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620994,850.0,BAO_0000218,,
4361,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620995,850.0,BAO_0000218,,
4362,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620996,850.0,BAO_0000218,,
4363,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 6 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL875581,850.0,BAO_0000218,,
4364,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 100 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620997,,BAO_0000218,,
4365,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 150 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620998,,BAO_0000218,,
4366,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620999,,BAO_0000218,,
4367,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621000,,BAO_0000218,,
4368,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 225 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621001,,BAO_0000218,,
4369,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 270 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621002,,BAO_0000218,,
4370,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 275 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621003,,BAO_0000218,,
4371,10685,"Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg",F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621004,,BAO_0000218,,
4372,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (intraperitoneal dosing for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621005,,BAO_0000218,,
4373,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (ip dosing daily for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621006,,BAO_0000218,,
4374,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 600 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621007,,BAO_0000218,,
4375,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621008,,BAO_0000218,,
4376,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621009,,BAO_0000218,,
4377,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL857705,,BAO_0000218,,
4378,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619828,,BAO_0000218,,
4379,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619829,,BAO_0000218,,
4380,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619830,,BAO_0000218,,
4381,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619831,,BAO_0000218,,
4382,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619832,,BAO_0000218,,
4383,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 100 mg/kg dosage administered for 8 days intraperitoneally; 0/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619833,,BAO_0000218,,
4384,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 8 days perorally; 1/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619834,,BAO_0000218,,
4385,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 10 days intraperitoneally; 1/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619835,,BAO_0000218,,
4386,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 50 mg/kg dosage administered for 8 days perorally; 3/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619836,,BAO_0000218,,
4387,8831,"Compound was evaluated for the antitumor activity against 6C3HED lymphosarcoma for ip administration and daily x 8 schedule; Number of toxic deaths over total number of mice per group (T/C), 0/10 at dose of 35 mg/kg",F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619837,850.0,BAO_0000218,,
4388,11704,In vivo antitumor activity against 6C3HED tumor type after intraperitoneal administration of 400 mg/kg,F,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619838,,BAO_0000218,,
4389,11704,In vivo antitumor activity against 6C3HED tumor type was expressed as toxic deaths/total treated mice at 400 mg/kg dose; 2/10,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619839,,BAO_0000218,,
4390,10685,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line,F,In vivo,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619840,850.0,BAO_0000218,,
4391,10685,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line; 95-100% inhibition,F,In vivo,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619841,850.0,BAO_0000218,,
4392,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 150 mg/kg given orally(daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Expert,1,,CHEMBL857704,850.0,BAO_0000218,,
4393,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 200 mg/kg given orally(daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619842,850.0,BAO_0000218,,
4394,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 300 mg/kg given orally (daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Expert,1,,CHEMBL619843,850.0,BAO_0000218,,
4395,17763,"Inhibition of Staphylococcus aureus 7,8-dihydroneopterin aldolase",B,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619844,,BAO_0000019,,
4396,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at a concentration of 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL857855,,BAO_0000251,2107.0,
4397,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619845,,BAO_0000251,2107.0,
4398,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619846,,BAO_0000251,2107.0,
4399,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 20 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619847,,BAO_0000251,2107.0,
4400,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619848,,BAO_0000251,2107.0,
4401,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620893,,BAO_0000251,2107.0,
4402,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620894,,BAO_0000251,2107.0,
4403,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620895,,BAO_0000251,2107.0,
4404,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620896,,BAO_0000251,2107.0,
4405,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620897,,BAO_0000251,2107.0,
4406,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620898,,BAO_0000251,2107.0,
4407,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620899,,BAO_0000251,2107.0,
4408,347,The apparent total plasma clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620900,,BAO_0000218,1969.0,
4409,3341,Compound was evaluated for Hepatic clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620901,,BAO_0000218,,
4410,17853,Lower clearance in monkey (i.v.) at 0.5 mpk,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620902,,BAO_0000218,,
4411,4514,Plasma clearance in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620903,,BAO_0000218,,
4412,6062,Plasma clearance for the compound was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620904,,BAO_0000218,,
4413,6821,Plasma clearance of compound was determined in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620905,,BAO_0000218,,
4414,6057,Plasma clearance was calculated in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620906,,BAO_0000218,,
4415,5145,Plasma clearance in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875420,,BAO_0000218,,
4416,6641,Plasma clearance in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620907,,BAO_0000218,,
4417,5472,Plasma clearance was evaluated in rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620908,,BAO_0000218,,
4418,4257,Plasma clearance value was determined in monkey after a 3 mg/kg of iv dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620909,,BAO_0000218,,
4419,5546,Plasma clearance was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620910,,BAO_0000218,,
4420,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620911,,BAO_0000218,,
4421,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620912,,BAO_0000218,,
4422,17509,Cmax 24 hr after 2 mg/kg oral administration in monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620913,,BAO_0000218,,
4423,6535,Cmax in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620914,,BAO_0000218,,
4424,5668,Cmax was determine after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620915,,BAO_0000218,,
4425,5922,Cmax in cynomolgus monkey by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620916,,BAO_0000218,,
4426,5922,Cmax in cynomolgus monkey by po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620917,,BAO_0000218,,
4427,6078,Cmax value evaluated in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620918,,BAO_0000218,,
4428,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620919,,BAO_0000218,,
4429,3249,Maximal concentration (Cmax) in rhesus monkey plasma at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620920,,BAO_0000218,1969.0,
4430,3249,Maximal concentration (Cmax) in squirrel monkey plasma at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620921,,BAO_0000218,1969.0,
4431,5553,Maximal plasma concentration in squirrel monkeys,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620922,,BAO_0000218,1969.0,
4432,1916,Maximum concentration was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620923,,BAO_0000218,,
4433,6227,Maximum plasma concentration (Cmax) in rhesus monkey(in vivo) at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620924,,BAO_0000218,1969.0,
4434,4809,Pharmacokinetic parameter Cmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620925,,BAO_0000218,,
4435,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620926,,BAO_0000218,,
4436,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620927,,BAO_0000218,,
4437,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys;NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620928,,BAO_0000218,,
4438,5355,The peak concentration (Cmax) value after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620929,,BAO_0000218,,
4439,6221,The peak plasma concentration after 5 hr administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620930,,BAO_0000218,1969.0,
4440,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 0.4 hours,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620931,,BAO_0000218,,
4441,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 1.0 hours,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620932,,BAO_0000218,,
4442,4257,Absolute bioavailability was evaluated in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620933,,BAO_0000218,,
4443,6221,Bioavailability after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620934,,BAO_0000218,,
4444,17667,Bioavailability of compound at 3 mg/kg in monkey after i.v. administration,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620935,,BAO_0000218,,
4445,17267,Bioavailability of compound was determined in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620936,,BAO_0000218,,
4446,4256,Bioavailability determined after oral administration in marmoset,A,In vivo,,marmosets,38020.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620937,,BAO_0000218,,
4447,4256,Oral bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620938,,BAO_0000218,,
4448,17853,Bioavailability in monkey (p.o.) at 2.0 mpk,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620939,,BAO_0000218,,
4449,16365,Bioavailability was evaluated after oral administration in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620940,,BAO_0000218,,
4450,1916,Bioavailability was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620941,,BAO_0000218,,
4451,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620942,,BAO_0000218,,
4452,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620943,,BAO_0000218,,
4453,17592,Bioavailability of the compound was determined in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620944,,BAO_0000218,,
4454,1399,Bioavailability in squirrel monkey (dose 5 mg/kg),A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620945,,BAO_0000218,,
4455,4809,Bioavailability was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620946,,BAO_0000218,,
4456,3341,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620947,,BAO_0000218,,
4457,64,Compound was tested for bioavailability in squirrel monkey,A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620948,,BAO_0000218,,
4458,5005,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620949,,BAO_0000218,,
4459,5005,Oral bioavailability in Rhesus monkey (dose of 0.75 mg/kg i.v. and 1.5 mg/kg p.o.),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620950,,BAO_0000218,,
4460,5237,Oral bioavailability in cynomolgus monkeys for the compound was determined; Acceptable,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620951,,BAO_0000218,,
4461,5237,Oral bioavailability in cynomolgus monkeys was determined; Acceptable,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620952,,BAO_0000218,,
4462,5302,Oral bioavailability in monkey (dose 5 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875421,,BAO_0000218,,
4463,17667,Oral bioavailability of compound at 5 mg/kg in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620953,,BAO_0000218,,
4464,6161,Pharmacokinetic profile in terms of half life was determined at a dose of 0.5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873491,,BAO_0000218,,
4465,6161,Pharmacokinetic profile in terms of half life was determined at a dose of 5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620954,,BAO_0000218,,
4466,3854,Plasma half life determined,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620955,,BAO_0000218,1969.0,
4467,993,Plasma half life in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618097,,BAO_0000218,1969.0,
4468,4514,Plasma half-life in Beagle dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618268,,BAO_0000218,1969.0,
4469,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618269,,BAO_0000218,1969.0,
4470,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg respectively in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618270,,BAO_0000218,1969.0,
4471,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618271,,BAO_0000218,,
4472,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873493,,BAO_0000218,,
4473,5313,Tested for the half life period in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621031,,BAO_0000218,,
4474,5313,Tested for the half life period in dog at dosage of 10 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621032,,BAO_0000218,,
4475,3880,The compound was tested for half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621033,,BAO_0000218,,
4476,3639,"The compound was tested for time taken to decrease, half of its initial concentration in dog plasma.",A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621034,,BAO_0000218,1969.0,
4477,3880,The half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621035,,BAO_0000218,,
4478,3918,The plasma half-life in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621036,,BAO_0000218,1969.0,
4479,16452,suboptimal plasma half-life caused a10% prolongation of QTc interval in dogs at a plasma level of 2.5 M,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621037,,BAO_0000218,1969.0,
4480,17796,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619812,,BAO_0000218,,
4481,5983,Pharmacokinetic property (t1/2beta) was measured in dog at the dose of 0.032 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619813,,BAO_0000218,,
4482,1466,tmax upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873335,,BAO_0000218,,
4483,16456,Volume of distribution in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619814,,BAO_0000218,,
4484,6113,Cmax in ferrets after 30 mg/kg oral dose,A,In vivo,,Mustela putorius furo,9669.0,,,,,50506,N,1,Expert,1,,CHEMBL619815,,BAO_0000218,,
4485,6113,Emesis in ferrets at 30 mg/kg oral dose,F,In vivo,,Mustela putorius furo,9669.0,,,,,50506,N,1,Expert,1,,CHEMBL619816,,BAO_0000218,,
4486,17796,Bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619817,,BAO_0000218,,
4487,17796,Volume of distribution in cynomolgus,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL619818,,BAO_0000218,,
4488,5308,AUC tested in guinea pig when 3 mg/kg dose was given perorally,A,,,Cavia porcellus,10141.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619819,,BAO_0000218,1969.0,
4489,4877,Tested for concentration as Area Under Curve against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619820,,BAO_0000218,,
4490,4876,"Tested for the pharmacokinetic parameter in guinea pig, administered orally at 5 mg/kg",A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875419,,BAO_0000218,,
4491,4878,AUC in guinea pig after 3mg/kg oral dose,A,In vivo,,Cavia porcellus,10141.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619821,,BAO_0000218,1969.0,
4492,5308,Bioavailability in guinea pig was tested,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619822,,BAO_0000218,,
4493,4877,Tested for oral bioavailability in guinea pig at 5 mg/kg,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619823,,BAO_0000218,,
4494,4876,Tested for the oral bioavailability of the compound,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619824,,BAO_0000218,,
4495,4876,Compound at a dose 5 mg/kg was administered orally to guinea pig and the pharmacokinetic parameter (Cmax) was reported,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619825,,BAO_0000218,,
4496,5308,Maximum plsma drug concentration in guinea pig when 3 mg/kg dose was given perorally,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619826,,BAO_0000218,,
4497,4877,Tested for maximum concentration against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,A,In vivo,,Cavia porcellus,10141.0,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL619827,,BAO_0000218,2048.0,
4498,4878,Cmax in guinea pig after 3mg/kg oral dose,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618167,,BAO_0000218,,
4499,5689,Distribution in blood expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618168,,BAO_0000019,178.0,
4500,5689,Distribution in brain expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL618169,,BAO_0000019,955.0,
4501,5689,Distribution in heart expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618170,,BAO_0000019,,
4502,5689,Distribution in intestine expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Intestine,,,22224,U,0,Autocuration,1,,CHEMBL618171,,BAO_0000019,160.0,
4503,5689,Distribution in kidney expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL618172,,BAO_0000019,2113.0,
4504,5689,Distribution in liver expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL618173,,BAO_0000019,2107.0,
4505,5689,Distribution in lung expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618174,,BAO_0000019,,
4506,5689,Distribution in spleen expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL875408,,BAO_0000019,2106.0,
4507,14465,Elimination T1/2 in Guinea pig (PO dose),A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL839827,,BAO_0000218,,
4508,5689,Partition coefficient was measured as -log (counts per min ),A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618175,,BAO_0000019,,
4509,611,Biological half life when administered at 0.1 umol/kg intravenously to guinea pig in GR-64349 antagonism,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618176,,BAO_0000218,,
4510,611,Biological half life when administered at 5 umol/kg intravenously to guinea pig in GR-64349 antagonism,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618177,,BAO_0000218,,
4511,14465,Elimination T1/2 in Guinea pig (PO dose),A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618178,,BAO_0000218,,
4512,4876,"Tested for the half life period of the compound, intravenously",A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618179,,BAO_0000218,,
4513,5689,Half-life was measured,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873489,,BAO_0000019,,
4514,7515,The time required for onset of inotropy after addition of a single dose of delta F75,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618180,,BAO_0000019,,
4515,17667,Bioavailability of compound at 10 mg/kg in guinea pig after i.v. administration,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618181,,BAO_0000218,,
4516,17667,Bioavailability of compound at 3 mg/kg in guinea pig after i.v. administration,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618182,,BAO_0000218,,
4517,4727,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618183,,BAO_0000218,,
4518,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618184,,BAO_0000218,,
4519,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618185,,BAO_0000218,,
4520,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618186,,BAO_0000218,,
4521,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618187,,BAO_0000218,,
4522,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hr,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618188,,BAO_0000218,,
4523,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875409,,BAO_0000218,,
4524,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618189,,BAO_0000218,,
4525,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618190,,BAO_0000218,178.0,
4526,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618191,,BAO_0000218,178.0,
4527,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618192,,BAO_0000218,178.0,
4528,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618193,,BAO_0000218,10000001.0,
4529,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618194,,BAO_0000218,10000001.0,
4530,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618195,,BAO_0000218,10000001.0,
4531,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618196,,BAO_0000218,955.0,
4532,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618197,,BAO_0000218,955.0,
4533,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618198,,BAO_0000218,955.0,
4534,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618199,,BAO_0000218,948.0,
4535,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618200,,BAO_0000218,948.0,
4536,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618201,,BAO_0000218,948.0,
4537,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618202,,BAO_0000218,160.0,
4538,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618203,,BAO_0000218,160.0,
4539,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618204,,BAO_0000218,160.0,
4540,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618205,,BAO_0000218,2113.0,
4541,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618206,,BAO_0000218,2113.0,
4542,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618207,,BAO_0000218,2113.0,
4543,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618208,,BAO_0000218,2107.0,
4544,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618932,,BAO_0000218,2107.0,
4545,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618933,,BAO_0000218,2107.0,
4546,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618934,,BAO_0000218,2048.0,
4547,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618935,,BAO_0000218,2048.0,
4548,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618936,,BAO_0000218,2048.0,
4549,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618937,,BAO_0000218,2385.0,
4550,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618938,,BAO_0000218,2385.0,
4551,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL619104,,BAO_0000218,2385.0,
4552,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619105,,BAO_0000218,2106.0,
4553,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619106,,BAO_0000218,2106.0,
4554,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619107,,BAO_0000218,2106.0,
4555,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL875410,,BAO_0000218,945.0,
4556,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL619108,,BAO_0000218,945.0,
4557,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL619109,,BAO_0000218,945.0,
4558,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619110,,BAO_0000218,,
4559,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619111,,BAO_0000218,,
4560,16597,MRT value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619112,,BAO_0000218,,
4561,16597,MRT value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619113,,BAO_0000218,,
4562,17764,Mean-residence time of compound after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619114,,BAO_0000218,,
4563,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 18 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619115,,BAO_0000218,,
4564,3830,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619116,478.0,BAO_0000219,,
4565,3829,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C for 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619117,478.0,BAO_0000219,,
4566,2040,Compound was evaluated for cytotoxicity against A2780 cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619118,478.0,BAO_0000219,,
4567,15684,Potentiation of growth inhibition of A2780 by compound alone in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619119,478.0,BAO_0000219,,
4568,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619120,478.0,BAO_0000219,,
4569,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619121,478.0,BAO_0000219,,
4570,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619122,478.0,BAO_0000219,,
4571,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619123,478.0,BAO_0000219,,
4572,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619124,478.0,BAO_0000219,,
4573,2859,Compound was evaluated for cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619125,478.0,BAO_0000219,,
4574,5618,In vitro inhibitory activity against human tumor cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875411,478.0,BAO_0000219,,
4575,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619126,478.0,BAO_0000219,,
4576,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619127,478.0,BAO_0000219,,
4577,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619128,478.0,BAO_0000219,,
4578,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619129,478.0,BAO_0000219,,
4579,2113,The compound was tested for cytotoxic potency against A2780 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619130,478.0,BAO_0000219,,
4580,2113,The compound was tested for cytotoxic potency against A2780 human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619131,478.0,BAO_0000219,,
4581,16745,cytotoxicity against A2780 cells incubated for 24 hr in MTT assay.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619132,478.0,BAO_0000219,,
4582,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619133,478.0,BAO_0000218,,
4583,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619134,478.0,BAO_0000219,,
4584,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619135,478.0,BAO_0000219,,
4585,2040,Compound was evaluated for cytotoxicity against A2780 cis cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619136,478.0,BAO_0000219,,
4586,2040,Relative resistance factor in A2780 cisplatin-resistant line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619137,478.0,BAO_0000219,,
4587,16165,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL883713,478.0,BAO_0000219,,
4588,16165,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875412,478.0,BAO_0000219,,
4589,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619138,478.0,BAO_0000218,,
4590,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619262,478.0,BAO_0000218,,
4591,3992,Cytotoxicity against A2780 ovarian carcinoma cells was evaluated using standard sulforhodamine 96h assay test,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619139,478.0,BAO_0000219,,
4592,10553,In vitro cytotoxicity was determined against A2780 human ovarian cell line using NCI screen,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619140,478.0,BAO_0000219,,
4593,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619141,478.0,BAO_0000219,,
4594,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619142,478.0,BAO_0000219,,
4595,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619143,478.0,BAO_0000219,,
4596,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 3,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619144,478.0,BAO_0000219,,
4597,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 5,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619145,478.0,BAO_0000219,,
4598,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 8,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619146,478.0,BAO_0000219,,
4599,15569,Cytotoxic activity in a panel of Human ovarian tumor A2780/CDDP cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619147,478.0,BAO_0000219,,
4600,17420,Antiproliferative effect of compound on A2780/DX cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619148,478.0,BAO_0000219,,
4601,17420,Antiproliferative effect of compound on A2780/DX cell line; n.d. indicates not determined,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619149,478.0,BAO_0000219,,
4602,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/DX(RI),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619150,478.0,BAO_0000219,,
4603,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/Dx(RI),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619151,478.0,BAO_0000219,,
4604,17672,Cytotoxicity against ovarian carcinoma A2780/cis tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL883794,478.0,BAO_0000219,,
4605,17672,Cytotoxicity against ovarian carcinoma A2780/cis90 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619152,478.0,BAO_0000219,,
4606,17270,In vitro cytotoxicity against A2780ADR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619153,478.0,BAO_0000219,,
4607,17270,In vitro cytotoxicity against A2780CIS cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619154,478.0,BAO_0000219,,
4608,5574,In vitro cytotoxic activity against human tumor cell line A2780CisR after incubation for 96 hours,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619155,478.0,BAO_0000219,,
4609,2113,The compound was tested for cytotoxic potency against A2780R human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619156,478.0,BAO_0000219,,
4610,16913,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619157,478.0,BAO_0000219,,
4611,16913,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619797,478.0,BAO_0000219,,
4612,17839,Oral bioavailability of compound in rhesus macaques,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619798,,BAO_0000218,,
4613,6821,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619799,,BAO_0000218,,
4614,6078,Oral bioavailability evaluated in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619800,,BAO_0000218,,
4615,6535,Oral bioavailability in monkey (dose 1 mg/kg p.o.),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619801,,BAO_0000218,,
4616,4449,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619802,,BAO_0000218,,
4617,6057,Oral bioavailability was calculated in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619803,,BAO_0000218,,
4618,5922,Oral bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619965,,BAO_0000218,,
4619,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619966,,BAO_0000218,,
4620,6265,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619967,,BAO_0000218,,
4621,6265,Oral bioavailability in monkey (dose 1 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620073,,BAO_0000218,,
4622,6265,Oral bioavailability in monkey (dose 5 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620074,,BAO_0000218,,
4623,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620075,,BAO_0000218,,
4624,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620076,,BAO_0000218,,
4625,4514,Oral bioavailability in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620077,,BAO_0000218,,
4626,5546,Oral bioavailability in rhesus monkey at a dose of 2 mg/kg by po administration,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620078,,BAO_0000218,,
4627,5553,Oral bioavailability in squirrel monkey at a dose of 10 mg/kg,A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620079,,BAO_0000218,,
4628,6641,Oral bioavailability in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620080,,BAO_0000218,,
4629,5472,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620081,,BAO_0000218,,
4630,5668,Oral bioavailability in Rhesus monkey (dose 10 mg/kg p.o.),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620082,,BAO_0000218,,
4631,5711,Oral bioavailability in monkey at 10 mg/kg of the compound,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620083,,BAO_0000218,,
4632,5145,Bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620084,,BAO_0000218,,
4633,3443,Glomerular Filtration Rate(GFR) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620085,,BAO_0000218,,
4634,3443,Glomerular Filtration Rate(GFR)of the compound compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874595,,BAO_0000218,,
4635,3249,Half life by ''Cr'' assay in rhesus monkey at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873352,,BAO_0000218,,
4636,3249,Half life the of compound was determined by ''Cr'' assay in squirrel monkey at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620086,,BAO_0000218,,
4637,5355,Mean residence time was determined after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620087,,BAO_0000218,,
4638,5355,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620088,,BAO_0000218,,
4639,5355,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620089,,BAO_0000218,,
4640,4809,Pharmacokinetic parameter MRT was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620090,,BAO_0000218,,
4641,4809,Pharmacokinetic parameter MRT was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620091,,BAO_0000218,,
4642,14294,Metabolism of compound in monkey S9 microsomes ('+''indicates <20% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620092,,BAO_0000251,,
4643,14294,Metabolism of compound in monkey S9 microsomes ('++''indicates 20-50% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620093,,BAO_0000251,,
4644,14294,Metabolism of compound in monkey S9 microsomes ('+++'indicates 50-80% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620094,,BAO_0000251,,
4645,14294,Metabolism of compound in monkey S9 microsomes ('++++' indicates largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620095,,BAO_0000251,,
4646,3443,Plasma clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620096,,BAO_0000218,,
4647,3443,Plasma clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620097,,BAO_0000218,,
4648,11271,Clearance from plasma(with matabolite-corrected plasma radioactivity-time integral) at 30 min after administration.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620098,,BAO_0000019,,
4649,3443,Renal clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620099,,BAO_0000218,,
4650,3443,Renal clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620100,,BAO_0000218,,
4651,6821,Elimination Half-life of compound was determined in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620101,,BAO_0000019,,
4652,17267,Half life of compound was determined in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620102,,BAO_0000019,,
4653,5819,Half life in monkey plasma,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620103,,BAO_0000366,1969.0,
4654,5819,Half life in monkey plasma; Not detected,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620104,,BAO_0000366,1969.0,
4655,1916,Half life period was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874596,,BAO_0000218,,
4656,17509,Half-life 24 hr after 2 mg/kg iv administration in monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873490,,BAO_0000218,,
4657,1399,Terminal half life of the compound.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620105,,BAO_0000019,,
4658,1916,Maximum time was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620780,,BAO_0000218,,
4659,4809,Pharmacokinetic parameter Tmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620781,,BAO_0000218,,
4660,5546,Unbound plasma was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620956,,BAO_0000218,,
4661,3443,Urinary recovery evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620957,,BAO_0000218,1088.0,
4662,3443,Urinary recovery compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620958,,BAO_0000218,1088.0,
4663,4257,Volume of distribution was determined in monkey after a 3 mg/kg of iv dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620959,,BAO_0000218,,
4664,6221,Volume distribution after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620960,,BAO_0000218,,
4665,5472,Volume of distribution was evaluated in rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620961,,BAO_0000218,,
4666,4727,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620962,,BAO_0000218,,
4667,4727,Plasma clearance was measured in hamster at the dose of 3 mg/kg by intravenous administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620963,,BAO_0000218,,
4668,4727,Bioavailability in hamster was determined,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620964,,BAO_0000218,,
4669,4727,Bioavailability in hamster at a dose of 3 mg/kg by intravenous administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620965,,BAO_0000218,,
4670,4727,Bioavailability in hamster at a dose of 3 mg/kg by oral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620966,,BAO_0000218,,
4671,4727,Half life of compound was determined in hamster blood,A,,,Cricetulus griseus,10029.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL620967,,BAO_0000221,178.0,
4672,1452,Michaelis-Menten constant of the compound.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620968,,BAO_0000019,,
4673,1452,Vmax value was measured at 0 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874597,,BAO_0000019,,
4674,1452,Vmax value was measured at 10 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620969,,BAO_0000019,,
4675,1452,Vmax value was measured at 5 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620970,,BAO_0000019,,
4676,11706,Inactivation of human leukocyte (neutrophil) elastase(HLE)(HNE) as rate constant,B,,,Homo sapiens,9606.0,,,,,235,D,9,Expert,1,,CHEMBL620971,,BAO_0000357,,
4677,1916,Area under curve was evaluated against man at a dose of 10 mg/kg after po administration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620972,,BAO_0000218,,
4678,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620973,,BAO_0000019,,
4679,7766,Active metabolite of ifosfamide determined in humans; A-Active,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618243,,BAO_0000019,,
4680,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618244,,BAO_0000019,,
4681,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; -0.5 to 1,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618245,,BAO_0000019,,
4682,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; 1-2,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618246,,BAO_0000019,,
4683,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; trace,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618247,,BAO_0000019,,
4684,17791,Compound was evaluated for oral bioavailability in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618248,,BAO_0000218,,
4685,7766,Metabolite of ifosfamide determined in urine; NF-Not found,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618249,,BAO_0000019,1088.0,
4686,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection (Group A and B),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618250,,BAO_0000019,,
4687,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874598,,BAO_0000019,,
4688,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics and lactose,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618251,,BAO_0000019,,
4689,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618252,,BAO_0000019,,
4690,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics and lactose,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618253,,BAO_0000019,,
4691,6852,Percent of compound in cirrhotic patients of sterile ascitic fluid (Group C),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618254,,BAO_0000019,,
4692,6852,Percent of compound in healthy individuals (Group D),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618255,,BAO_0000019,,
4693,4397,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618983,,BAO_0000251,2107.0,
4694,17409,Binding towards human plasma protein at 10 uM,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618984,,BAO_0000019,,
4695,17409,Binding towards human plasma protein at 100 uM,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618985,,BAO_0000019,,
4696,17176,Human plasma protein binding activity was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618986,,BAO_0000019,,
4697,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618987,,BAO_0000019,,
4698,17267,Percent binding of compound towards human plasma protein was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618988,,BAO_0000019,,
4699,5944,Plasma clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618989,,BAO_0000251,2107.0,
4700,5668,In vitro intrinsic clearance in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618990,,BAO_0000251,2107.0,
4701,5669,In vitro intrinsic clearance in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618991,,BAO_0000251,2107.0,
4702,5041,In vitro microsome metabolism clearance in human was determined,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL876725,,BAO_0000251,,
4703,5041,In vitro microsome metabolism clearance in human was determined; High,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618992,,BAO_0000251,,
4704,5041,In vitro microsome metabolism clearance in human was determined; ND denotes no data,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618993,,BAO_0000251,,
4705,5676,Pharmacokinetic property (clearance) in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618994,,BAO_0000251,2107.0,
4706,5944,Plasma clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618995,,BAO_0000251,2107.0,
4707,17538,In vitro clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618996,,BAO_0000251,2107.0,
4708,6331,Intrinsic clearance in human liver microsomes was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618997,,BAO_0000251,2107.0,
4709,5948,Intrinsic clearance in human liver microsomes was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618998,,BAO_0000251,2107.0,
4710,5965,Cmax (Tissue distribution) of compound was determined at a dose of 5 mg/kg in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618999,,BAO_0000218,,
4711,1916,Maximum concentration was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620223,,BAO_0000218,,
4712,5965,Cmin (Clearance) of compound was determined at a dose of 5 mg/kg in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620224,,BAO_0000218,,
4713,1299,Stability in human plasma 2 hr after incubation expressed as percent concentration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620225,,BAO_0000019,,
4714,1299,Stability in human plasma 4 hr after incubation expressed as percent concentration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620226,,BAO_0000019,,
4715,7766,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 3 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620227,,BAO_0000019,1088.0,
4716,7766,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 7 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL876726,,BAO_0000019,1088.0,
4717,7766,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 6 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620228,,BAO_0000019,1088.0,
4718,7766,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 8 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620229,,BAO_0000019,1088.0,
4719,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620230,,BAO_0000218,,
4720,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 25 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620231,,BAO_0000218,,
4721,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 26 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620232,,BAO_0000218,,
4722,17764,Mean-residence time was determined for compound intravenous administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620233,,BAO_0000218,,
4723,14294,Metabolism of compound in Mouse S9 microsomes ('++++'indicates largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620234,,BAO_0000218,,
4724,14294,Metabolism of compound in mouse S9 microsomes ('+''indicates <20% largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620235,,BAO_0000218,,
4725,14294,Metabolism of compound in mouse S9 microsomes ('++++' indicates largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620236,,BAO_0000218,,
4726,6251,In vitro metabolic potential in mouse liver microsomes,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL620237,,BAO_0000218,2107.0,
4727,17582,Ability of compound to bind to plasma protein was evaluated in HSA cells,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620238,,BAO_0000218,,
4728,17811,Compound was tested for radioactivity level in mice adrenal glands (Compound is radiolabeled),A,,,Mus musculus,10090.0,,Adrenal gland,,,50594,N,1,Intermediate,1,,CHEMBL620239,,BAO_0000218,2369.0,
4729,17811,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.2-4.9% ID/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL620240,,BAO_0000218,955.0,
4730,17811,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.6-4.4% ID/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL620241,,BAO_0000218,955.0,
4731,17811,Compound was tested for radioactivity level in mice heart (Compound is radiolabeled),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876727,,BAO_0000218,,
4732,17811,Compound was tested for radioactivity level in mice kidney (Compound is radiolabeled),A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL620242,,BAO_0000218,2113.0,
4733,17811,Compound was tested for radioactivity level in mice lungs (Compound is radiolabeled),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620243,,BAO_0000218,,
4734,5288,Tested for urinary recovery in mice after subcutaneous administration of 20 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620244,,BAO_0000218,,
4735,2717,Compound was evaluated for its potency in CDF1 mice and the serum cholesterol levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620245,,BAO_0000218,1977.0,
4736,2717,Compound was evaluated for its potency in CDF1 mice and the serum metabolite levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620246,,BAO_0000218,1977.0,
4737,2717,Compound was evaluated for its potency in CDF1 mice and the serum triglyceride levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620247,,BAO_0000218,1977.0,
4738,17753,Half life of compound was determined in plasma of mice at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL620248,,BAO_0000218,1969.0,
4739,17753,Half life of compound was determined in plasma of mice at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL873497,,BAO_0000218,1969.0,
4740,17753,Half life of compound was determined in plasma of mice at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL620249,,BAO_0000218,1969.0,
4741,17764,Half life after intraperitoneal administration in mice at 18 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620250,,BAO_0000218,,
4742,17764,Half life after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620251,,BAO_0000218,,
4743,17764,Half life after intraperitoneal administration in mice at 25 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620252,,BAO_0000218,,
4744,17764,Half life after intraperitoneal administration in mice at 26 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620253,,BAO_0000218,,
4745,17764,Half life after intravenous administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620254,,BAO_0000218,,
4746,17764,Half life after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620255,,BAO_0000218,,
4747,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620256,,BAO_0000218,,
4748,2675,Maximum time required to reach Cp max was evaluated in mice after intravenous administration; T max Not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876728,,BAO_0000218,,
4749,2675,Maximum time required to reach Cp max was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620257,,BAO_0000218,,
4750,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620258,,BAO_0000218,,
4751,4890,"Compound was evaluated for the pharmacokinetic parameter, Terminal half life period",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620259,,BAO_0000218,,
4752,429,Evaluated for pharmacokinetic parameter half-life in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620260,,BAO_0000218,,
4753,17837,Half life of compound in mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620261,,BAO_0000218,178.0,
4754,16597,Half life at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620262,,BAO_0000218,,
4755,16597,Half life at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620263,,BAO_0000218,,
4756,6619,Half life in ob/ob mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620264,,BAO_0000218,,
4757,4066,Half-life at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620265,,BAO_0000218,,
4758,4239,Half-life was measured in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620266,,BAO_0000218,,
4759,5969,In vivo half life period was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620267,,BAO_0000218,,
4760,8999,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619364,,BAO_0000218,,
4761,8999,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation; 10 % hydrolysis at 60 mins,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619365,,BAO_0000218,,
4762,17641,T2 in brain of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL619366,,BAO_0000218,955.0,
4763,17641,T2 in kidney of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL619367,,BAO_0000218,2113.0,
4764,17641,T2 in liver of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL619368,,BAO_0000218,2107.0,
4765,17641,T2 in lungs of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL619369,,BAO_0000218,2048.0,
4766,17641,T2 in spleen of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL876729,,BAO_0000218,2106.0,
4767,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619370,,BAO_0000218,,
4768,4890,"Compound was evaluated for the pharmacokinetic parameter, maximum time constant",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619371,,BAO_0000218,,
4769,429,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619372,,BAO_0000218,,
4770,429,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620012,,BAO_0000218,,
4771,5969,In vivo Tmax was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620013,,BAO_0000218,,
4772,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL620014,478.0,BAO_0000219,,
4773,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL620015,478.0,BAO_0000219,,
4774,16913,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621010,478.0,BAO_0000219,,
4775,16913,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621011,478.0,BAO_0000219,,
4776,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621012,478.0,BAO_0000219,,
4777,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621013,478.0,BAO_0000219,,
4778,17270,In vitro cytotoxicity against A2780TAX cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621014,478.0,BAO_0000219,,
4779,5618,In vitro inhibitory activity against human tumor cell line A2780cis,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618154,481.0,BAO_0000219,,
4780,17777,Growth inhibition against A2780 cisplatin resistant wild-type ovarian cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618155,478.0,BAO_0000219,,
4781,16112,Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618156,481.0,BAO_0000219,,
4782,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618157,481.0,BAO_0000219,,
4783,6633,Concentration required to inhibit A2780cisR cell growth when compared with control after incubation for 96 h at 37 C,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618328,478.0,BAO_0000219,,
4784,16930,Compound was evaluated against human Ovarian carcinoma cell line A2780cisR,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618329,478.0,BAO_0000219,,
4785,17496,Cytotoxicity against human ovarian carcinoma A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618330,478.0,BAO_0000219,,
4786,12989,In vitro antitumor activity against A2780cisR cell line.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618331,478.0,BAO_0000219,,
4787,4840,Tested for the cytotoxicity in A2780cisR ovarian cell line (cisR denotes resistance to cisplatin),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618332,478.0,BAO_0000219,,
4788,12989,Resistant factor determined between IC50 of resistant line to that of A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618333,478.0,BAO_0000219,,
4789,16745,cytotoxicity against A2780cisR cells incubated for 24 hr in MTT assay,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618334,481.0,BAO_0000219,,
4790,16597,Inhibition of A2780 / DDP-S human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618335,478.0,BAO_0000219,,
4791,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes,B,,,Rattus norvegicus,10116.0,,,,,11736,D,9,Expert,1,,CHEMBL618336,,BAO_0000019,,
4792,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),F,,,,,,,,,11736,H,8,Expert,1,,CHEMBL618337,,BAO_0000019,,
4793,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),F,,,Rattus norvegicus,10116.0,,,,,11736,D,9,Expert,1,,CHEMBL618338,,BAO_0000019,,
4794,15856,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells uisng [3H]ZM-241385 or [125I]-IABOPX,F,,,Homo sapiens,9606.0,,,HEK293,,278,D,9,Expert,1,,CHEMBL618339,722.0,BAO_0000219,,
4795,15856,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells using [3H]ZM-241385 (or) [125 I]IABOPX at 10e-5 M,F,,,Homo sapiens,9606.0,,,HEK293,,278,D,9,Expert,1,,CHEMBL618340,722.0,BAO_0000219,,
4796,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes,B,,,Mus musculus,10090.0,,,,,11831,D,9,Expert,1,,CHEMBL618341,,BAO_0000019,,
4797,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),F,,,,,,,,,11831,H,8,Expert,1,,CHEMBL618342,,BAO_0000019,,
4798,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),F,,,Mus musculus,10090.0,,,,,11831,D,9,Expert,1,,CHEMBL618343,,BAO_0000019,,
4799,17402,Ability to displace the binding of [3H]-MRE 3008-F20 to the ligand binding site of CHO:hA3 (human Adenosine receptor) at concentration of 10 uM,B,,,,,,,,,280,H,8,Expert,1,,CHEMBL621038,,BAO_0000357,,
4800,11746,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01),F,,,Homo sapiens,9606.0,,,T-cells,,22226,U,0,Autocuration,1,,CHEMBL621039,574.0,BAO_0000219,,
4801,11746,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01); Not active,F,,,Homo sapiens,9606.0,,,T-cells,,22226,U,0,Autocuration,1,,CHEMBL621040,574.0,BAO_0000219,,
4802,5455,Compound was evaluated for cytotoxic activity against human melanoma cell line A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621041,455.0,BAO_0000219,,
4803,2068,In vitro antitumor activity against A375 (melanoma) human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621042,455.0,BAO_0000219,,
4804,2683,In vitro antitumor activity against A375cell line extracted form melanoma,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621043,455.0,BAO_0000219,,
4805,15313,Inhibition of cell growth in (A375) melan cell line,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Expert,1,,CHEMBL621044,455.0,BAO_0000219,,
4806,13739,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621045,455.0,BAO_0000219,,
4807,13739,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines. A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621046,455.0,BAO_0000219,,
4808,14750,Compound was tested in vitro for cytotoxicity against A375 cell lines from melanoma.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621047,455.0,BAO_0000219,,
4809,14777,Antiproliferative activity measured against A427 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621048,797.0,BAO_0000219,,
4810,14777,Antiproliferative activity measured against A427 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL883798,797.0,BAO_0000219,,
4811,17672,Cytotoxicity against lung carcinoma A427 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621049,797.0,BAO_0000219,,
4812,14368,Inhibition of large cell lung carcinoma (A427),F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621050,797.0,BAO_0000219,,
4813,14368,Inhibition of large cell lung carcinoma (A427) after 48-h treatment,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621051,797.0,BAO_0000219,,
4814,13866,Inhibitory activity against A427 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621052,797.0,BAO_0000219,,
4815,2545,Inhibitory concentration in human lung carcinoma A427 cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621053,797.0,BAO_0000219,,
4816,2545,Inhibitory concentration in human lung carcinoma A427/VCR cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621054,797.0,BAO_0000219,,
4817,6062,Terminal phase volume of distribution was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621055,,BAO_0000218,,
4818,4578,Tested for volume of distribution upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876398,,BAO_0000218,,
4819,17592,Volume of distribution in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621056,,BAO_0000218,,
4820,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621057,,BAO_0000218,,
4821,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621058,,BAO_0000218,,
4822,5922,Pharmacokinetic property(Vdss) in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621059,,BAO_0000218,,
4823,5355,The distribution volume after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621060,,BAO_0000218,,
4824,5355,The distribution volume after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621061,,BAO_0000218,,
4825,5355,The distribution volume after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621062,,BAO_0000218,,
4826,6057,Volume displacement was calculated in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621063,,BAO_0000218,,
4827,5145,Volume of distribution in steady state was determined in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621064,,BAO_0000218,,
4828,6821,Volume of distribution of compound was determined in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621065,,BAO_0000218,,
4829,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621066,,BAO_0000218,,
4830,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621067,,BAO_0000218,,
4831,6641,Volumes of distribution in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621068,,BAO_0000218,,
4832,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876399,,BAO_0000218,,
4833,6535,Volume distribution in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621069,,BAO_0000218,,
4834,4809,Volume distribution was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621070,,BAO_0000218,,
4835,6062,Volume of distribution was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621071,,BAO_0000218,,
4836,3443,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621072,,BAO_0000218,,
4837,4578,Oral systemic bioavailability upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618209,,BAO_0000218,,
4838,4809,Plasma clearance was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618210,,BAO_0000218,,
4839,11271,Baboon plasma free fraction. ,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618211,,BAO_0000019,,
4840,6057,Area under the curve was calculated in rhesus monkey after iv administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618212,,BAO_0000218,,
4841,6057,Area under the curve was calculated in rhesus monkey after peroral administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618213,,BAO_0000019,,
4842,17853,Dose-normalized area under curve in monkey (p.o.) at 2.0 mpk,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618214,,BAO_0000019,,
4843,5302,Half life period in monkey after 5 mg/kg dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873492,,BAO_0000218,,
4844,4257,Half-life was determined in monkey after 3 mg/kg of i.v. dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618272,,BAO_0000218,,
4845,4257,Half-life was determined in monkey after 3 mg/kg of i.v. dose; Not determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618273,,BAO_0000218,,
4846,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618274,,BAO_0000218,1969.0,
4847,5394,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for half life after administration into monkey at 3 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618275,,BAO_0000218,,
4848,2661,Compound was evaluated for half-life after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618276,,BAO_0000218,,
4849,3341,Compound was evaluated for terminal half life in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618277,,BAO_0000019,,
4850,3045,Compound was evaluated for the half life period after iv administration in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618278,,BAO_0000218,,
4851,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618279,,BAO_0000218,1969.0,
4852,4847,Half life of compound was determined in squirrel monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618280,,BAO_0000019,,
4853,4256,Half life after iv administration in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618281,,BAO_0000218,,
4854,6535,Half life in monkey plasma after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618282,,BAO_0000218,1969.0,
4855,6057,Half life was calculated in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618283,,BAO_0000019,,
4856,17592,Half life in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618284,,BAO_0000019,,
4857,6641,Half life in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618285,,BAO_0000218,,
4858,5472,Half life was evaluated in rhesus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618286,,BAO_0000019,,
4859,6221,Half life period after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618287,,BAO_0000218,,
4860,5668,Half life period was determine after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618288,,BAO_0000218,,
4861,4809,Half life period was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876393,,BAO_0000218,,
4862,5546,Half life period was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618289,,BAO_0000218,,
4863,5553,Half life period was determined in squirrel monkey after iv administration at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618290,,BAO_0000218,,
4864,6078,Half-life was calculated in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618291,,BAO_0000019,,
4865,5147,Half-life in Squirrel monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618292,,BAO_0000019,,
4866,5145,Half-life in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618293,,BAO_0000019,,
4867,6062,Half-life was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618294,,BAO_0000218,,
4868,5355,Half-life period after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618295,,BAO_0000218,,
4869,5355,Half-life period after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618296,,BAO_0000218,,
4870,5355,Half-life period after oral administration in cynomolgus monkeys; ND meansn Not determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618297,,BAO_0000218,,
4871,7766,Portion of holoxan excreted in the form of the metabolite from 1500 mL of urine on day 9 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618298,,BAO_0000019,1088.0,
4872,7766,Portion of holoxan excreted in the form of the metabolite from 1600 mL of urine on day 10 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618299,,BAO_0000019,1088.0,
4873,7766,Portion of holoxan excreted in the form of the metabolite from 1700 mL of urine on day 5 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618300,,BAO_0000019,1088.0,
4874,7766,Portion of holoxan excreted in the form of the metabolite from 2310 mL of urine on day 4 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618301,,BAO_0000019,1088.0,
4875,7766,Percent ratio of the enantiomeric form (+)R extracted from the urine of alveolar rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618302,,BAO_0000019,1088.0,
4876,7766,Percent ratio of the enantiomeric form (+)R extracted from the urine of embryonal rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL876394,,BAO_0000019,1088.0,
4877,7766,Percent ratio of the enantiomeric form (-)S extracted from the urine of alveolar rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618303,,BAO_0000019,1088.0,
4878,7766,Percent ratio of the enantiomeric form (-)S extracted from the urine of embryonal rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618304,,BAO_0000019,1088.0,
4879,1916,Bioavailability was evaluated in man at a dose of 10 mg/kg after po administration; not determined,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618305,,BAO_0000218,,
4880,16643,Oral bioavailability in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618306,,BAO_0000218,,
4881,17248,Compound was tested for human plasma protein binding,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618307,,BAO_0000019,,
4882,17248,Compound was tested for human plasma protein binding; Not determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618308,,BAO_0000019,,
4883,6241,Protein binding activity of compound in human plasma; % Free,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618309,,BAO_0000019,,
4884,17716,Unbound fraction (plasma),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618310,,BAO_0000019,,
4885,17605,Half life for the hydrolysis of compound in human blood serum,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873353,,BAO_0000366,1969.0,
4886,17625,Half life period in human plasma using phosphate buffer (0.08 M),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618311,,BAO_0000366,1969.0,
4887,17625,Half life period in human plasma using phosphate buffer (0.1 M),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618312,,BAO_0000366,1969.0,
4888,17747,Half-life in human plasma was determined,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618313,,BAO_0000366,1969.0,
4889,15613,Concentration required for 50% toxicity in metastatic lung carcinoma (MV522) cells.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618314,,BAO_0000019,,
4890,354,Effect of compound on gelation time of human serum induced by dithiothreitol (DTT),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618315,,BAO_0000019,,
4891,3741,"Rate constant in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618316,,BAO_0000019,,
4892,3741,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618317,,BAO_0000019,,
4893,3741,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620138,,BAO_0000019,,
4894,17599,Partition coefficient (logP),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL858280,,BAO_0000019,,
4895,5486,In vitro metabolic stability in human was measured as pmol/min/mg/protein,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620139,,BAO_0000019,,
4896,5600,In vitro metabolic stability determined after 30 min of incubation in human hepatic microsomes,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620140,,BAO_0000251,,
4897,14294,Metabolism of compound in human liver slices (male) ('+''indicates <20% largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620141,,BAO_0000019,,
4898,14294,Metabolism of compound in human liver slices (male) ('++''indicates 20-50% largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620142,,BAO_0000019,,
4899,14294,Metabolism of compound in human liver slices (male) ('++++' indicates largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620143,,BAO_0000019,,
4900,14294,Metabolism of compound in human microsomes ('+''indicates <20% largest observed peak),A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620144,,BAO_0000251,,
4901,14294,Metabolism of compound in human microsomes ('++++' indicates largest observed peak),A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620145,,BAO_0000251,,
4902,14294,Metabolism of compound in human microsomes; Trace,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620146,,BAO_0000251,,
4903,6260,Percent of compound remaining after 120 min of Metabolization upon incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620147,,BAO_0000251,2107.0,
4904,6187,Percent metabolized in an in vitro human liver microsomal incubation assay after 60 min,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620148,,BAO_0000251,,
4905,6251,In vitro metabolic potential in human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620149,,BAO_0000251,2107.0,
4906,3246,Metabolism by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) was evaluated,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876412,,BAO_0000019,,
4907,17313,Tested for human plasma protein binding of the compound; Not tested,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619352,,BAO_0000019,,
4908,6227,Compound was tested for percent protein binding (PB) in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619353,,BAO_0000019,,
4909,5530,Protein binding in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619354,,BAO_0000019,1969.0,
4910,6108,Permeability coefficient (B to A) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619355,,BAO_0000019,,
4911,6108,Permeability directional ratio (PB-A/PA-B) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619356,,BAO_0000019,,
4912,2774,Apparent permeability coefficient (Papp) was determined in human Caco-2 cell monolayer (n = 3),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619357,,BAO_0000019,,
4913,16643,In vitro rate of absorption observed as Caco-2 permeability in humans,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619358,,BAO_0000019,,
4914,17582,Cellular permeability of compound was determined in Caco-2 cells; High,A,,,Homo sapiens,9606.0,,,Caco-2,,22224,U,0,Autocuration,1,,CHEMBL619359,495.0,BAO_0000219,,
4915,6838,Permeability in Caco-2 cells of compound,A,,,Homo sapiens,9606.0,,,Caco-2,,22224,U,0,Autocuration,1,,CHEMBL619360,495.0,BAO_0000219,,
4916,6108,Permeability coefficient (A to B) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619361,,BAO_0000019,,
4917,6108,Permeability coefficient (B to A) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619362,,BAO_0000019,,
4918,6108,Permeability coefficient (Papp) (Caco-2 cell monolayer),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619363,,BAO_0000019,,
4919,2146,Compound was measured for binding rate for human serum at a carbapenem concentration of 10 ug/mL,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618942,,BAO_0000019,,
4920,4514,Compound was tested for protein binding in human plasma,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618943,,BAO_0000019,,
4921,6108,Transcellular permeability of the [(PA-B+PB-A)/2)] compound was determined in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618944,,BAO_0000019,,
4922,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 3,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618945,,BAO_0000019,1088.0,
4923,5969,In vivo Tmax was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618946,,BAO_0000218,,
4924,3277,Maximum time was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876413,,BAO_0000218,,
4925,3802,Tested for Tmax value at the dose of 10 mg/kg when administered perorally in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618947,,BAO_0000218,,
4926,2862,Time taken to reach maximum concentration in plasma upon oral administration in mouse,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL618948,,BAO_0000218,1969.0,
4927,6348,Time to reach maximum plasma concentration was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL618949,,BAO_0000218,1969.0,
4928,17764,Tmax after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618950,,BAO_0000218,,
4929,5781,Tmax after oral administration at 30 mg/kg in ICR mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618951,,BAO_0000218,,
4930,17764,Tmax after peroral administration in mice at 2.4 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618952,,BAO_0000218,,
4931,4066,Tmax at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618953,,BAO_0000218,,
4932,17641,Tmax in brain of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618954,,BAO_0000218,955.0,
4933,17641,Tmax in kidney of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618955,,BAO_0000218,2113.0,
4934,17641,Tmax in liver of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618956,,BAO_0000218,2107.0,
4935,17641,Tmax in lungs of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618957,,BAO_0000218,2048.0,
4936,17764,Tmax in mice at 18 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618958,,BAO_0000218,,
4937,17764,Tmax in mice at 23 uM/kg i.v. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618959,,BAO_0000218,,
4938,17764,Tmax in mice at 25 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618960,,BAO_0000218,,
4939,17764,Tmax in mice at 26 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876723,,BAO_0000218,,
4940,17641,Tmax in spleen of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618961,,BAO_0000218,2106.0,
4941,16597,Tmax value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618962,,BAO_0000218,,
4942,16597,Tmax value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618963,,BAO_0000218,,
4943,5951,Tmax value in IRC mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618964,,BAO_0000218,,
4944,5506,Tmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618965,,BAO_0000218,,
4945,5506,Tmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618966,,BAO_0000218,,
4946,429,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg ( 0-24 hr ),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618967,,BAO_0000218,1088.0,
4947,429,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg (0-24 hr),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618968,,BAO_0000218,1088.0,
4948,4066,Urinary recovery by disk method using Streptococcus pyogenes (0-24 h),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618969,,BAO_0000218,1088.0,
4949,17734,The first compartment constitutes the majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618970,,BAO_0000218,,
4950,17734,The second majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618971,,BAO_0000218,,
4951,6062,Terminal phase volume of distribution was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618972,,BAO_0000218,,
4952,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618973,,BAO_0000218,,
4953,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618974,,BAO_0000218,,
4954,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618975,,BAO_0000218,,
4955,5980,Vd in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618976,,BAO_0000218,,
4956,17592,Volume of distribution in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618977,,BAO_0000218,,
4957,6348,Volume of distribution was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876724,,BAO_0000218,,
4958,17753,Volume of distribution of compound in plasma was determined at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618978,,BAO_0000218,,
4959,17753,Volume of distribution of compound in plasma was determined at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618979,,BAO_0000218,,
4960,17753,Volume of distribution of compound in plasma was determined at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618980,,BAO_0000218,,
4961,4239,Pharmacokinetic property (vdss) was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618981,,BAO_0000218,,
4962,2862,Value distribution upon iv administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618982,,BAO_0000218,,
4963,17734,Volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620150,,BAO_0000218,,
4964,2675,Volume of distribution was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620151,,BAO_0000218,,
4965,2675,Volume of distribution was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620152,,BAO_0000218,,
4966,17837,Steady state volume of distribution of compound in mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620153,,BAO_0000218,,
4967,5727,Steady state volume of distribution was determined in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876395,,BAO_0000218,,
4968,17852,Volume distribution (steady state) of compound was determined in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620154,,BAO_0000218,,
4969,17764,Volume of solubility in solution after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620155,,BAO_0000218,,
4970,16597,Vss value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620156,,BAO_0000218,,
4971,6062,Volume of distribution was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620157,,BAO_0000218,,
4972,16438,Biodistribution of compound (oxidized form) in in kidney tissue,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL620158,,BAO_0000218,2113.0,
4973,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620159,,BAO_0000218,178.0,
4974,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620160,,BAO_0000218,178.0,
4975,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620161,,BAO_0000218,178.0,
4976,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A427Mer- cell line of lung using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL620162,797.0,BAO_0000219,,
4977,16597,Inhibition of A431 human squamous cell carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620163,500.0,BAO_0000219,,
4978,16062,Inhibition of cell growth of human epidermoid carcinoma xenograft (A431) model using cell based assay,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620833,500.0,BAO_0000219,,
4979,16062,Inhibition of human epidermoid carcinoma xenograft (A431) tumor growth,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL876396,500.0,BAO_0000219,,
4980,16958,Concentration required to inhibit growth of human carcinoma epidermoid (A431) cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620834,500.0,BAO_0000219,,
4981,6700,Inhibition of A431 human carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620835,500.0,BAO_0000219,,
4982,17226,In vitro inhibition of A431 (human carcinoma) cell basal growth.,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620836,500.0,BAO_0000219,,
4983,6828,Inhibitory concentration of compound against growth of human A431 cell line; Resistant,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL620837,500.0,BAO_0000219,,
4984,12314,In vitro cytotoxicity against epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621017,500.0,BAO_0000219,,
4985,13412,"In vivo efficacy following oral administration in nude mouse tumor model, xenograft A431 cells expressing EGF-R",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621018,500.0,BAO_0000218,,
4986,13299,Antiproliferative activity of compound was measured on human tumor cell line A431.,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621019,500.0,BAO_0000219,,
4987,17420,Antiproliferative effect of compound on A431 cell line expressing mutant p53,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621020,500.0,BAO_0000219,,
4988,13678,Compound was evaluated for cell growth inhibition against A 431 cell line by irradiation in the presence of examined compound,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621021,500.0,BAO_0000219,,
4989,14171,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells.,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621022,500.0,BAO_0000219,,
4990,6333,Tested for antiproliferative activity against human A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621023,500.0,BAO_0000219,,
4991,2356,Inhibition of epidermal growth factor receptor (EGF-R) autophosphorylation in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621024,500.0,BAO_0000219,,
4992,15578,Concentration needed to inhibit 50% growth of the human A431 (epidermoid carcinoma) cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621025,500.0,BAO_0000219,,
4993,5126,Inhibition of A431 cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621026,500.0,BAO_0000219,,
4994,6844,Cytotoxic effect on A431 human epidermoid carcinoma cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621027,500.0,BAO_0000219,,
4995,6844,Cytotoxic effect on A431 human epidermoid carcinoma cells (No response to 1 mM),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL876397,500.0,BAO_0000219,,
4996,4925,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL883797,500.0,BAO_0000219,,
4997,4925,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line; NT=Not tested,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621028,500.0,BAO_0000219,,
4998,13978,In vitro Growth Inhibitory activity against A431 Human vulva cancer cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621029,500.0,BAO_0000219,,
4999,16786,In vitro cytotoxicity of compound against human A431 (epidermoid) cancer cell line after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621030,500.0,BAO_0000219,,
5000,13412,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621147,500.0,BAO_0000219,,
5001,17824,In vivo antiproliferative activity against A431 cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621148,500.0,BAO_0000218,,
5002,12751,Inhibition of EGF-dependent autophosphorylation of EGF-R in human A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621149,500.0,BAO_0000219,,
5003,12380,Inhibition of A431 human epidermoid carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621150,500.0,BAO_0000219,,
5004,4959,Inhibition of autophosphorylation of human epidermal growth factor-receptor (EGF-R) expressed in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621151,500.0,BAO_0000219,,
5005,6333,Inhibitory effect on nonphospho-Src after EGF (100 uM) stimulation of A431 cells (control=178),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621152,500.0,BAO_0000219,,
5006,6333,Inhibitory effect on phospho-Src (Tyr416) after EGF (100 uM) stimulation of A431 cells (38),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621153,500.0,BAO_0000219,,
5007,6333,Inhibitory effect on phospho-Src/nonphospho after EGF (100 uM) stimulation of A431 cells (21),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL884000,500.0,BAO_0000219,,
5008,5296,Inhibition of EGFR overexpressing A431 cell proliferation,F,,,Homo sapiens,9606.0,,,,,9,D,9,Expert,1,,CHEMBL621154,,BAO_0000019,,
5009,12624,Inhibition of A431 cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621155,500.0,BAO_0000219,,
5010,14926,No inhibition of EGFR phosphorylation in A431 cells 8 hour after washing cells free of the inhibitor,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621156,500.0,BAO_0000219,,
5011,14926,"Partial inhibition of EGFR phosphorylation in A431 cells, 8 hour after washing cells free of the inhibitor",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621157,500.0,BAO_0000219,,
5012,14926,Irreversible inhibition of ATP binding site of EGFR (lack of phosphorylated EGFR) in A431 cells 8 hour after washing cells free of the inhibitor),F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621158,500.0,BAO_0000219,,
5013,15144,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621159,500.0,BAO_0000219,,
5014,15144,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621160,500.0,BAO_0000219,,
5015,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration at 2 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621161,500.0,BAO_0000219,,
5016,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration in the range of 1-10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621162,500.0,BAO_0000219,,
5017,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621163,500.0,BAO_0000219,,
5018,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 0.01 uM after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621164,500.0,BAO_0000219,,
5019,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 2 uM after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621165,500.0,BAO_0000219,,
5020,5922,Half-life period in cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619159,,BAO_0000019,,
5021,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in monkey plasma",A,In vitro,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619160,,BAO_0000366,1969.0,
5022,17853,Longer half-life in monkey (i.v.) at 0.5 mpk,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619161,,BAO_0000218,,
5023,993,Plasma half life in monkey,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619162,,BAO_0000366,1969.0,
5024,4514,Plasma half-life in rhesus monkey,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619163,,BAO_0000366,1969.0,
5025,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619164,,BAO_0000218,1969.0,
5026,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619320,,BAO_0000218,1969.0,
5027,4578,Tested for half life upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619321,,BAO_0000218,,
5028,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873336,,BAO_0000218,,
5029,5355,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619322,,BAO_0000218,,
5030,5355,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619323,,BAO_0000218,,
5031,5355,The time for peak concentration value after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619324,,BAO_0000218,,
5032,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619325,,BAO_0000019,,
5033,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876411,,BAO_0000019,,
5034,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619326,,BAO_0000019,,
5035,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619327,,BAO_0000019,,
5036,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619328,,BAO_0000019,,
5037,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619329,,BAO_0000019,,
5038,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619330,,BAO_0000019,,
5039,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619331,,BAO_0000019,,
5040,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619332,,BAO_0000019,,
5041,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619333,,BAO_0000019,,
5042,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619334,,BAO_0000019,,
5043,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619335,,BAO_0000019,,
5044,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619336,,BAO_0000019,,
5045,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619337,,BAO_0000019,,
5046,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619338,,BAO_0000019,,
5047,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619339,,BAO_0000019,,
5048,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619340,,BAO_0000218,,
5049,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873496,,BAO_0000218,1969.0,
5050,3546,AUC value in rat after IV administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL619341,,BAO_0000218,1969.0,
5051,3546,AUC value in rat after oral administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL619342,,BAO_0000218,1969.0,
5052,3546,Cmax value in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619343,,BAO_0000218,,
5053,3546,Bioavailability in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619344,,BAO_0000218,,
5054,3546,Tmax value in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619345,,BAO_0000218,,
5055,3546,Vc value in rat after IV administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619346,,BAO_0000218,,
5056,3546,Half life period in rat after IV administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619347,,BAO_0000218,,
5057,10625,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619348,,BAO_0000019,,
5058,10625,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 0.5 min after injection in baboon; (Range = 0.08-0.11),A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619349,,BAO_0000019,,
5059,10625,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 1.5 min after injection in baboon; (Range = 0.08-0.11),A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619350,,BAO_0000019,,
5060,10625,The amount of unchanged tracer in baboon plasma was determined 1 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619351,,BAO_0000019,,
5061,10625,The amount of unchanged tracer in baboon plasma was determined 10 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875953,,BAO_0000019,,
5062,10625,The amount of unchanged tracer in baboon plasma was determined 30 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621716,,BAO_0000019,,
5063,10625,The amount of unchanged tracer in baboon plasma was determined 60 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621717,,BAO_0000019,,
5064,10625,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621718,,BAO_0000019,,
5065,3510,Area under curve after 1 mpk peroral administration to beagles,A,,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621719,,BAO_0000019,,
5066,3510,Area under curve after 2 mpk peroral administration to beagles,A,,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621720,,BAO_0000019,,
5067,3510,Cmax value after 1 mpk peroral administration to beagles,A,In vivo,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621721,,BAO_0000218,,
5068,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 7,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621722,,BAO_0000019,1088.0,
5069,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 6,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621723,,BAO_0000019,1088.0,
5070,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 8,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621724,,BAO_0000019,1088.0,
5071,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1500 mL of urine tested on day 9,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623443,,BAO_0000019,1088.0,
5072,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1600 mL of urine tested on day 10,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623444,,BAO_0000019,1088.0,
5073,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1700 mL of urine tested on day 5,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623445,,BAO_0000019,1088.0,
5074,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 2310 mL of urine tested on day 4,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623446,,BAO_0000019,1088.0,
5075,16643,Metabolic stability observed at 30 min after administration in human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623447,,BAO_0000251,2107.0,
5076,6852,Percent recovery of 100 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623448,,BAO_0000019,,
5077,6852,Percent recovery of 10 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623449,,BAO_0000019,,
5078,6852,Percent recovery of 500 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623450,,BAO_0000019,,
5079,6567,"Compound remaining after incubation with 2 mg/mL of human liver microsomes at 37 degrees C for 30 min in a pH 7.4, 0.05 M phosphate buffer",A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623451,,BAO_0000251,2107.0,
5080,6570,Metabolic stability (% remaining at 30 mins) in human S9.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623452,,BAO_0000019,,
5081,6570,Metabolic stability determined as remaining percent after 30 min of incubation in human isolated liver S9 preparations; N/D= Not determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623453,,BAO_0000019,,
5082,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623454,,BAO_0000251,2107.0,
5083,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes; ND=No data,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623455,,BAO_0000251,2107.0,
5084,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes; No data,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624371,,BAO_0000251,2107.0,
5085,5202,First pass metabolism and metabolic bioavailability using human hepatic microsomes,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624372,,BAO_0000218,,
5086,5481,Percent compound remaining in human plasma after incubation for 60 min at 37 C.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624373,,BAO_0000019,,
5087,5481,Percent remaining in human plasma after incubation for 60 min at 37 C.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624374,,BAO_0000019,,
5088,3956,The percent remaining in human plasma after 30 min was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624556,,BAO_0000019,,
5089,5074,Conversion rate of the prodrug in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624557,,BAO_0000366,1969.0,
5090,5074,Conversion rate of the prodrug in human plasma; ND means no data,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624558,,BAO_0000366,1969.0,
5091,4727,Half life of compound was determined in human blood,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624559,,BAO_0000221,178.0,
5092,5965,Half life of compound was determined in man with once daily dosing,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624560,,BAO_0000019,,
5093,5732,Half life in human microsomes,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624561,,BAO_0000251,,
5094,5819,Half life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624562,,BAO_0000366,1969.0,
5095,5819,Half life in human plasma; Not detected,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624563,,BAO_0000366,1969.0,
5096,1916,Half life period was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624564,,BAO_0000218,,
5097,6597,Half-life for oxidative metabolic stability was determined using rat liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624565,,BAO_0000251,2107.0,
5098,5229,Half-life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875152,,BAO_0000366,1969.0,
5099,5229,Half-life of the parent prodrug in plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624566,,BAO_0000366,1969.0,
5100,2192,In vitro half life in human plasma was determined,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873805,,BAO_0000366,1969.0,
5101,3032,The compound was tested In Vitro for half life in human liver microsomes.,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624567,,BAO_0000251,2107.0,
5102,1916,Maximum time was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624568,,BAO_0000218,,
5103,17716,Observed volume of distribution,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624569,,BAO_0000218,,
5104,15778,Oral bioavailability in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624570,,BAO_0000218,,
5105,17313,Tested for human plasma protein binding of the compound,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624571,,BAO_0000019,,
5106,4231,"First order rate constant, k was determined in human plasma",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624572,,BAO_0000019,,
5107,4755,Observed rate constant in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624573,,BAO_0000019,,
5108,4755,Observed rate constant in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875153,,BAO_0000019,,
5109,16907,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624574,,BAO_0000251,2107.0,
5110,10839,The compound was tested for the plasma binding in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624575,,BAO_0000019,,
5111,10839,Plasma protein binding (human),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624576,,BAO_0000019,,
5112,3199,Compound was evaluated for half-life in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624577,,BAO_0000251,2107.0,
5113,1345,Half life measured in vitro for its stability in human blood,A,In vitro,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624578,,BAO_0000221,178.0,
5114,4297,Half life in human serum,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL622796,,BAO_0000019,1977.0,
5115,4297,Half life in human serum; ND=not determined,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL622797,,BAO_0000019,1977.0,
5116,4297,Half life were determined in CEM-SS cell extract in decomposition step 1,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622798,,BAO_0000019,,
5117,4297,Half life were determined in CEM-SS cell extract in decomposition step 2,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622799,,BAO_0000019,,
5118,4231,Half life of the in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622800,,BAO_0000366,1969.0,
5119,5633,Half life period in human hepatic S9 fraction was determined,A,In vitro,,Homo sapiens,9606.0,,,,S9,22224,U,0,Autocuration,1,,CHEMBL622801,,BAO_0000220,,
5120,5633,Half life period in human liver microsome was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL622802,,BAO_0000251,2107.0,
5121,17791,Half life period was determined; 6-7,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622803,,BAO_0000019,,
5122,17791,Half life period was evaluated in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875154,,BAO_0000019,,
5123,3160,Half life time in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622804,,BAO_0000366,1969.0,
5124,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622805,,BAO_0000218,955.0,
5125,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622611,,BAO_0000218,948.0,
5126,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622612,,BAO_0000218,948.0,
5127,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL875160,,BAO_0000218,2113.0,
5128,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL622613,,BAO_0000218,2113.0,
5129,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL622614,,BAO_0000218,2113.0,
5130,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622615,,BAO_0000218,2107.0,
5131,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622616,,BAO_0000218,2107.0,
5132,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622617,,BAO_0000218,2107.0,
5133,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622618,,BAO_0000218,2106.0,
5134,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622619,,BAO_0000218,2106.0,
5135,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622620,,BAO_0000218,2106.0,
5136,16438,"Biodistribution in mice, total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622621,,BAO_0000218,955.0,
5137,16438,Biodistribution of compound (oxidized form) in blood tissue,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622622,,BAO_0000218,178.0,
5138,16438,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622623,,BAO_0000218,178.0,
5139,16438,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622624,,BAO_0000218,178.0,
5140,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622625,,BAO_0000218,178.0,
5141,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622626,,BAO_0000218,178.0,
5142,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622627,,BAO_0000218,178.0,
5143,16438,Biodistribution of compound (oxidized form) in brain tissue of mice,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622628,,BAO_0000218,955.0,
5144,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622629,,BAO_0000218,955.0,
5145,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622630,,BAO_0000218,955.0,
5146,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622631,,BAO_0000218,955.0,
5147,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622632,,BAO_0000218,955.0,
5148,16438,"Biodistribution of compound (oxidized form) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622633,,BAO_0000218,955.0,
5149,16438,Biodistribution of compound (oxidized form) in heart tissue of mice,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622634,,BAO_0000218,948.0,
5150,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622635,,BAO_0000218,948.0,
5151,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL875161,,BAO_0000218,948.0,
5152,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622636,,BAO_0000218,948.0,
5153,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623335,,BAO_0000218,948.0,
5154,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623336,,BAO_0000218,948.0,
5155,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623337,,BAO_0000218,2113.0,
5156,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623338,,BAO_0000218,2113.0,
5157,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623339,,BAO_0000218,2113.0,
5158,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623524,,BAO_0000218,2113.0,
5159,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623525,,BAO_0000218,2113.0,
5160,16438,Biodistribution of compound (oxidized form) in liver tissue,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623526,,BAO_0000218,2107.0,
5161,16438,"Biodistribution of compound (oxidized form) in liver tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623527,,BAO_0000218,2107.0,
5162,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623528,,BAO_0000218,2107.0,
5163,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration in the range of 1-10 uM of the compound after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL624615,500.0,BAO_0000219,,
5164,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621672,500.0,BAO_0000219,,
5165,16289,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 10-24 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621673,500.0,BAO_0000218,,
5166,16289,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621674,500.0,BAO_0000218,,
5167,16093,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL884002,500.0,BAO_0000219,,
5168,16825,"Concentration required to inhibit the epidermoid A431 cell growth by 50%, P53 status of cell line used was wild-type. ",F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621850,500.0,BAO_0000219,,
5169,4848,Inhibitory activity against proliferation of human epidermoid carcinoma (A431) cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621851,500.0,BAO_0000219,,
5170,14827,Inhibition of EGF-dependent autophosphorylation of EGF-R in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621852,500.0,BAO_0000219,,
5171,14827,Inhibition of autophosphorylation of epidermal growth factor receptor in A431 cells in culture,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621853,500.0,BAO_0000219,,
5172,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 10-24 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621854,500.0,BAO_0000218,,
5173,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621855,500.0,BAO_0000218,,
5174,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623724,500.0,BAO_0000218,,
5175,16289,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 24",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623725,500.0,BAO_0000218,,
5176,16289,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623726,500.0,BAO_0000218,,
5177,16289,"Irreversible inhibition of EGF-R phosphorylation in A431 cells, 8 hr after washing cells free of compound",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL623727,500.0,BAO_0000219,,
5178,16289,Irreversible inhibition of formation of phosphorylated EGFR in A431 cells 8 hr after washing cells free of compound,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL623728,500.0,BAO_0000219,,
5179,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 10-24",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623729,500.0,BAO_0000218,,
5180,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623730,500.0,BAO_0000218,,
5181,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623731,500.0,BAO_0000218,,
5182,14555,"Ratio of treated and control A431 cell tumor mass in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623732,500.0,BAO_0000218,,
5183,14555,"Difference in days for treated (T) and control (C) A431 cell tumors to reach 750 mg in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623733,500.0,BAO_0000218,,
5184,14555,"Net reduction in tumor burden between first and last treatments of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623734,500.0,BAO_0000218,,
5185,14555,"Weight change of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623735,500.0,BAO_0000218,,
5186,1937,In vitro antiproliferative effect against A431 human epidermoid carcinoma cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623736,500.0,BAO_0000219,,
5187,13739,In vitro tumor cell growth inhibitory activity against Human leiomyosarcoma A431 cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL623737,500.0,BAO_0000219,,
5188,3558,Cytotoxicity against A437 cells is the dose giving 50% decrease in the formation of formazan dye,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL623738,500.0,BAO_0000219,,
5189,3558,Dose giving a 50% decrease in the living cell number (A437 cells),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL875168,500.0,BAO_0000219,,
5190,17686,In vitro inhibitory concentration against proliferation of A459 cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623739,646.0,BAO_0000219,,
5191,5305,Inhibitory concentration of compound for cytotoxicity against A459 human lung cells was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623740,646.0,BAO_0000219,,
5192,3614,Inhibition of growth of human NSCL non small cell lung carcinoma cell line (A459) after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624424,646.0,BAO_0000219,,
5193,17229,In vitro antitumor activity against renal A498 tumor cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624425,624.0,BAO_0000219,,
5194,15935,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624426,624.0,BAO_0000219,,
5195,15935,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors in folate deficient medium",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624427,624.0,BAO_0000219,,
5196,15560,Cytotoxicity against A498 Tumor cell line in SRB Cell viability test,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624428,624.0,BAO_0000219,,
5197,13891,Cytotoxicity concentration against human kidney carcinoma A-498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624429,624.0,BAO_0000219,,
5198,13891,Cytotoxicity concentration against human kidney carcinoma A-498 cell line; NT =Not tested,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624620,624.0,BAO_0000219,,
5199,13788,Cytotoxicity on kidney carcinoma (A-498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624621,624.0,BAO_0000219,,
5200,15403,Compound was evaluated against Human cell line renal A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624622,624.0,BAO_0000219,,
5201,1009,Compound was tested for inhibition of A498 human renal cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624623,624.0,BAO_0000219,,
5202,1043,Growth inhibitory activity against A498 human cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL874365,624.0,BAO_0000219,,
5203,5858,In vitro antitumor activity against human renal A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624624,624.0,BAO_0000219,,
5204,5958,In vitro cytotoxic activity against renal (A498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624625,624.0,BAO_0000219,,
5205,5506,In vitro cytotoxic activity against human renal cancer (A498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624626,624.0,BAO_0000219,,
5206,12781,Tested for cytostatic activity against renal A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624627,624.0,BAO_0000219,,
5207,14399,The compound was tested for the concentration to inhibit 50% of renal A498 cell lines.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL883157,624.0,BAO_0000219,,
5208,5958,In vitro cytotoxic activity against renal (A498) cell line at a concentration of 10e-5 M,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL624628,624.0,BAO_0000219,,
5209,3510,Cmax value after 2 mpk peroral administration to beagles,A,In vivo,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624629,,BAO_0000218,,
5210,3510,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623551,,BAO_0000218,,
5211,3510,Bioavailability after 1 mpk peroral administration to beagles,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623552,,BAO_0000218,,
5212,3510,Bioavailability after 2 mpk peroral administration to beagles,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623553,,BAO_0000218,,
5213,3085,Specificity constant of the BSA-catalyzed deprotonation of compound at pH 9,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623554,,BAO_0000019,,
5214,3085,Specificity constant of the bovine serum albumin catalyzed reaction expressed as (kcat/KM)/kuncat,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623555,,BAO_0000019,,
5215,3085,Michaelis-Menten kinetics of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623556,,BAO_0000019,,
5216,9372,Solubility against bovine alpha-chymotrypsin,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623557,,BAO_0000019,,
5217,3085,Rate constant of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623558,,BAO_0000019,,
5218,3085,Rate constant of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623559,,BAO_0000019,,
5219,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards calf spleen (CS-PDE) at a concentration of 20 microg,A,,,Bos taurus,9913.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL623560,,BAO_0000221,2106.0,
5220,4297,Half life in culture medium containing 10% of heat inactivated foetal calf serum,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623561,,BAO_0000019,,
5221,4297,Half life in culture medium containing 10% of heat inactivated foetal calf serum; ND=not determined,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623562,,BAO_0000019,,
5222,17585,Ability to get deaminated by adenosine deaminase (ADA); Expressed as t1/2,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623563,,BAO_0000019,,
5223,1336,Enzymatic stability was assessed with bovine spleen phosphodiesterase (BS PDE) exonuclase,A,,,Bos taurus,9913.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL623564,,BAO_0000221,2106.0,
5224,3085,Half life in presence of 2 mg/mL BSA at pH 8.8,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873806,,BAO_0000019,,
5225,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 1,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623565,,BAO_0000019,,
5226,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623566,,BAO_0000019,,
5227,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2; Not determined,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623567,,BAO_0000019,,
5228,1540,Half-life in the culture medium (RPMI 1640+10% fetal calf serum FCS),A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623568,,BAO_0000019,,
5229,6316,AUC (Area Under Plasma concentration-time curve) was after oral administration at 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623569,,BAO_0000218,1969.0,
5230,17594,AUC after administration at 100 mg/kg/day in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623570,,BAO_0000218,1969.0,
5231,4953,AUC in dog at 0-24 hr by peroral administration at 3 mpk,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624254,,BAO_0000218,1969.0,
5232,16907,AUC value after 15 mg/kg iv dose in Dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624255,,BAO_0000218,1969.0,
5233,16907,AUC value after 30 mg/kg po dose in Dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624256,,BAO_0000218,1969.0,
5234,2959,AUC value after administration of 4 mg/Kg oral dose in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624257,,BAO_0000218,1969.0,
5235,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624258,,BAO_0000218,1969.0,
5236,5356,Area Under Curve for the compound was determined in dogs at 1 mg/kg oral dosing; 25-50 ug min/mL,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875277,,BAO_0000218,,
5237,16807,Area under curve (AUC) value in dogs after an intravenous dose of 0.2 mg/Kg in 0.025 M aqueous methanesulfonic acid solution with 5% mannitol at a concentration of 0.2,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622667,,BAO_0000218,,
5238,4527,Area under curve by intravenous administration at a dose of 1 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622668,,BAO_0000218,,
5239,4527,Area under curve by oral administration at a dose of 10 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622669,,BAO_0000218,,
5240,15660,Area under curve determined in dogs after intravenous administration of 3 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622670,,BAO_0000218,,
5241,15660,Area under curve determined in dogs after oral administration of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622671,,BAO_0000218,,
5242,5802,Area under curve of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622672,,BAO_0000218,,
5243,3598,Area under curve of compound determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL622673,,BAO_0000218,,
5244,3598,Area under curve of compound from zero time to infinity determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL622674,,BAO_0000218,,
5245,5944,Area under curve determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622675,,BAO_0000218,,
5246,5944,Area under curve determined in dog at a dose of 10 mg/kg by oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622676,,BAO_0000218,,
5247,5944,Area under curve determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622677,,BAO_0000218,,
5248,5944,Area under curve determined in dog at a dose of 5 mg/kg by oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622678,,BAO_0000218,,
5249,4186,Area under curve in dog after administration of 20 mg/kg dose through peroral route,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622679,,BAO_0000218,,
5250,5007,Area under curve in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622680,,BAO_0000218,,
5251,5668,Area under curve was determine after peroral administration at 10 mpk in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622681,,BAO_0000218,,
5252,5668,Area under curve was determine after peroral administration at 5 mpk in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875278,,BAO_0000218,,
5253,5006,Area under curve was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622682,,BAO_0000218,,
5254,5006,Area under curve in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622683,,BAO_0000218,,
5255,3771,Area under curve in dogs at 10 mg/kg dose fo oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622684,,BAO_0000218,,
5256,3771,Area under curve in dogs at 10 mg/kg dose fo oral administration (Evokes hyperglycerolemia),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622685,,BAO_0000218,,
5257,3771,Area under curve in dogs at 3 mg/kg dose fo intravenous administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622686,,BAO_0000218,,
5258,1916,Area under curve was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618344,,BAO_0000218,,
5259,5302,Area under curve value in dog at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875582,,BAO_0000218,,
5260,5600,Area under curve was determined after 0.1 mg/kg iv administration in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618345,,BAO_0000218,,
5261,5600,Area under curve was determined after 0.3 mg/kg po administration in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618346,,BAO_0000218,,
5262,17764,Area under curve was determined for compound after intravenous administration in dogs at 1.2 uM/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618347,,BAO_0000218,,
5263,4368,Area under curve was determined for the compound by intravenous administration of 1.2 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618348,,BAO_0000218,,
5264,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 10.5 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618349,,BAO_0000019,,
5265,5318,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618350,,BAO_0000019,,
5266,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 8.0 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618351,,BAO_0000019,,
5267,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 8.8 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618352,,BAO_0000019,,
5268,14518,Time taken to reduce 50% of the concentration of compound in blood plasma,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL873494,,BAO_0000221,178.0,
5269,2209,"Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618353,,BAO_0000366,1969.0,
5270,6787,Half life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618354,,BAO_0000366,1969.0,
5271,4898,Half life in human plasma was reported,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875583,,BAO_0000366,1969.0,
5272,6072,Half life in human serum,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL618355,,BAO_0000019,1977.0,
5273,16907,Half life upon exposure to human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618356,,BAO_0000366,1969.0,
5274,5656,t1/2 in human microsomes,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618357,,BAO_0000251,,
5275,4755,Half life period in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618358,,BAO_0000366,1969.0,
5276,17503,Half-life for rate of hydrolysis was determined in in human skin homogenate (pH 7.4),A,,,Homo sapiens,9606.0,,Zone of skin,,,22224,U,0,Autocuration,1,,CHEMBL618359,,BAO_0000221,14.0,
5277,12357,Half-life measured in in vitro Cathepsin B assay in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618360,,BAO_0000366,1969.0,
5278,3076,Half-life at initial concentration of 5*10e-5 M in CEM cell extract,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618361,,BAO_0000019,,
5279,6410,Half-life determined by human liver microsome stability assay at a concentration of 5 uM,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618362,,BAO_0000251,2107.0,
5280,3741,"Half-life in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618363,,BAO_0000366,1969.0,
5281,3741,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618364,,BAO_0000366,1969.0,
5282,3741,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875584,,BAO_0000366,1969.0,
5283,1540,Half-life in the CEM cell extracts,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618365,,BAO_0000019,,
5284,2905,Half-life was calculated by Human plasma stability assay at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873495,,BAO_0000366,1969.0,
5285,2905,Half-life was calculated by Human plasma stability assay at 37 degree centigrade; Not hydrolyzed,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618366,,BAO_0000366,1969.0,
5286,5523,Half-life was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618367,,BAO_0000019,,
5287,1499,Half-life (human blood stability),A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618368,,BAO_0000221,178.0,
5288,1499,Half-life (human blood stability); no data,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618369,,BAO_0000221,178.0,
5289,17065,Half-life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618370,,BAO_0000366,1969.0,
5290,6861,CYP3A4 metabolism half-life (t1/2),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618371,,BAO_0000019,,
5291,1499,Half-life was determined; 88% of parent remained after incubation for 120 min (human blood stability),A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618372,,BAO_0000221,178.0,
5292,530,In vitro half life in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618373,,BAO_0000366,1969.0,
5293,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in human plasma",A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618374,,BAO_0000366,1969.0,
5294,6695,In vitro hydrolysis in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618375,,BAO_0000366,1969.0,
5295,6695,In vitro hydrolysis in human plasma; no data,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618376,,BAO_0000366,1969.0,
5296,10,In vitro metabolic stability at 5 uM was determined by incubating with human liver microsomes at 37 degree C,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618377,,BAO_0000251,2107.0,
5297,993,Plasma half life in human,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618378,,BAO_0000366,1969.0,
5298,15429,Stability after incubation with human plasma (at 37 degree C),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618379,,BAO_0000366,1969.0,
5299,1675,T1/2 was evaluated in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618380,,BAO_0000366,1969.0,
5300,2209,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618381,,BAO_0000366,1969.0,
5301,2209,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I); Not determined",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618382,,BAO_0000366,1969.0,
5302,5318,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618383,,BAO_0000019,,
5303,2412,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase,A,In vitro,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618384,,BAO_0000019,,
5304,2412,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase; ND=Not determined,A,In vitro,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618385,,BAO_0000019,,
5305,2906,The release rate of the free drug from the substrate in human plasma by human plasma stability assay,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619099,,BAO_0000366,1969.0,
5306,2906,The release rate of the free drug from the substrate in human plasma by human plasma stability assay; Not hydrolyzed,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619100,,BAO_0000366,1969.0,
5307,5495,Time taken for 50% to be consumed by serum PON1 was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619101,,BAO_0000019,,
5308,5495,Time taken for 50% to be consumed by serum PON1; NH is Not hydrolysed,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619102,,BAO_0000019,,
5309,4397,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL619103,,BAO_0000251,2107.0,
5310,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619268,,BAO_0000218,,
5311,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619269,,BAO_0000218,,
5312,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619270,,BAO_0000218,,
5313,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619271,,BAO_0000218,,
5314,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875585,,BAO_0000218,,
5315,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619272,,BAO_0000218,,
5316,6058,Compound tested for growth inhibition of renal cancer cell line 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619273,391.0,BAO_0000219,,
5317,17708,Compound was tested for 50% growth inhibition against human renal cancer 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619274,391.0,BAO_0000219,,
5318,14017,Concentration which reduced cell growth to 50 % of level against 786-0 renal cancer line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Expert,1,,CHEMBL619275,391.0,BAO_0000219,,
5319,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-4 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619276,391.0,BAO_0000219,,
5320,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-6 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619277,391.0,BAO_0000219,,
5321,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-8 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619278,391.0,BAO_0000219,,
5322,11970,Tested for cytotoxicity against 786-0 cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619279,391.0,BAO_0000219,,
5323,12400,Tested in vitro for cytotoxicity in 786-0 cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL858458,391.0,BAO_0000219,,
5324,12888,Cytotoxic effect on renal cancer line 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Expert,1,,CHEMBL619280,391.0,BAO_0000219,,
5325,15300,In vitro antitumor activity against Renal cancer 786-0 cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619281,391.0,BAO_0000219,,
5326,14769,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619282,391.0,BAO_0000219,,
5327,15895,"Cytotoxicity against NCI tumor panel, 786-0 renal cancer cell line",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619283,391.0,BAO_0000219,,
5328,17376,Concentration of compound that cause 50% cytotoxicity of 786-0 renal cancer cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619284,391.0,BAO_0000219,,
5329,14882,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration that inhibits 50% net cell growth).,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619285,391.0,BAO_0000219,,
5330,14882,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration leading to 50% net cell death),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619286,391.0,BAO_0000219,,
5331,15176,Growth inhibition of the 786-O Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619287,391.0,BAO_0000219,,
5332,12696,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL857455,391.0,BAO_0000219,,
5333,2496,The compound was tested in vitro for cytotoxic activity against 786-O cell line (human perirenal carcinoma),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL883801,391.0,BAO_0000219,,
5334,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619288,972.0,BAO_0000219,,
5335,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression (49% inhibition achieved at 100 micro g/mL),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619289,972.0,BAO_0000219,,
5336,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression; <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619290,972.0,BAO_0000219,,
5337,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H1: MSR-33),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619291,972.0,BAO_0000219,,
5338,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H2: MSR-26),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619292,972.0,BAO_0000219,,
5339,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H3: MSR-28); <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619293,972.0,BAO_0000219,,
5340,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H1: MSR-33),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619294,972.0,BAO_0000219,,
5341,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619295,972.0,BAO_0000219,,
5342,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26) (less than 20% inhibition achieved),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619296,972.0,BAO_0000219,,
5343,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H3: MSR-28); <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619297,972.0,BAO_0000219,,
5344,12782,Growth inhibitory concentration against tumor cells in culture renal cancer 796-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619298,391.0,BAO_0000219,,
5345,1229,In vitro anticancer activity against 8 NCI CNS cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL619299,,BAO_0000019,,
5346,15313,Inhibition of cell growth in drug resistant 8226 myeloma cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL619300,741.0,BAO_0000219,,
5347,15313,Inhibition of cell growth in drug sensitive 8226 myeloma cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL619301,741.0,BAO_0000219,,
5348,11544,In vitro inhibition of tumor cell growth in the human myeloma 8226 system.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619302,741.0,BAO_0000219,,
5349,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619303,741.0,BAO_0000219,,
5350,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619304,741.0,BAO_0000219,,
5351,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL857706,741.0,BAO_0000219,,
5352,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619305,741.0,BAO_0000219,,
5353,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619306,741.0,BAO_0000219,,
5354,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619307,741.0,BAO_0000219,,
5355,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619308,741.0,BAO_0000219,,
5356,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619309,741.0,BAO_0000219,,
5357,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619310,741.0,BAO_0000219,,
5358,14769,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619311,624.0,BAO_0000219,,
5359,15354,Compound was tested for the growth inhibition of A498 renal tumor cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619312,624.0,BAO_0000219,,
5360,17445,In vitro cytotoxicity against human tumor A498 cell line (renal cancer),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619313,624.0,BAO_0000219,,
5361,4337,In vitro inhibitory concentration against renal cancer cell line A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619314,624.0,BAO_0000219,,
5362,15277,Cytotoxicity against A 498 tumor cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619959,624.0,BAO_0000219,,
5363,4812,In vitro antitumor activity against A498 human cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619960,624.0,BAO_0000219,,
5364,4812,In vitro antitumor activity against A498 human cancer cell line (Data from NCI-screening),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619961,624.0,BAO_0000219,,
5365,4995,Inhibitory dose required against A498 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619962,624.0,BAO_0000219,,
5366,5847,Anticancer activity against one renal cancer (A498 cell line),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL875586,624.0,BAO_0000219,,
5367,6557,In vitro cytotoxicity against melanoma A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619963,624.0,BAO_0000219,,
5368,2597,Compound was tested for growth inhibitory activity against A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619964,624.0,BAO_0000219,,
5369,6058,Compound tested for growth inhibition of renal cancer cell line A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620108,624.0,BAO_0000219,,
5370,17708,Compound was tested for 50% growth inhibition against human renal cancer A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620109,624.0,BAO_0000219,,
5371,15176,Growth inhibition of the A498 Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620110,624.0,BAO_0000219,,
5372,15300,In vitro antitumor activity against Renal cancer A498 cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620111,624.0,BAO_0000219,,
5373,11970,Tested for cytotoxicity against A498 cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620112,624.0,BAO_0000219,,
5374,12400,Tested in vitro for cytotoxicity in A498 cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620113,624.0,BAO_0000219,,
5375,12888,Cytotoxic effect on renal cancer lines A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL620114,624.0,BAO_0000219,,
5376,3030,Antitumor activity was evaluated for reduction of growth of renal cancer (A498) cells at a concentration of 100 uM,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620115,624.0,BAO_0000219,,
5377,14769,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620116,624.0,BAO_0000219,,
5378,17376,Concentration of compound that cause 50% cytotoxicity of A498 renal cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620117,624.0,BAO_0000219,,
5379,16558,Growth inhibitory activity against A498-2LM human solid tumor cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620118,624.0,BAO_0000219,,
5380,5194,Cytotoxicity against human kidney carcinoma cell lines A4982LM,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620119,624.0,BAO_0000219,,
5381,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A498Rem- renal cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620120,624.0,BAO_0000219,,
5382,16880,Antiproliferative activity in vitro against A549 (human non-small lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620121,646.0,BAO_0000219,,
5383,10196,Antitumor activity against A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620122,646.0,BAO_0000219,,
5384,10196,Antitumor activity against A549 human lung carcinoma cell line in experiment 1,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620123,646.0,BAO_0000219,,
5385,10196,Antitumor activity against A549 human lung carcinoma cell line in experiment 2,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620124,646.0,BAO_0000219,,
5386,12083,"Concentration required to inhibit tumor growth in A549, human lung carcinoma (NSCLC) cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620125,646.0,BAO_0000219,,
5387,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620126,646.0,BAO_0000219,,
5388,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL883027,646.0,BAO_0000219,,
5389,16470,In vitro cytotoxic activity against human lung A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620127,646.0,BAO_0000219,,
5390,16470,In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620128,646.0,BAO_0000219,,
5391,16470,In vitro cytotoxic activity against human lung A549 cell line),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620129,646.0,BAO_0000219,,
5392,16470,In vitro cytotoxic activity against human lung A549 cell line;NT is not tested,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620130,646.0,BAO_0000219,,
5393,16582,In vitro cytotoxicity against human non small-cell-lung cell line A549.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620131,646.0,BAO_0000219,,
5394,15935,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620132,646.0,BAO_0000219,,
5395,15935,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors in folate deficient medium",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620133,646.0,BAO_0000219,,
5396,16597,Inhibition of A549 human lung carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620134,646.0,BAO_0000219,,
5397,17376,Inhibitory activity against A549 lung adenocarcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620135,646.0,BAO_0000219,,
5398,16496,Inhibitory concentration required to reduce A549 tumor cell growth by 50% in MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620136,646.0,BAO_0000219,,
5399,16152,in vitro anticancer activity against cultured A549 human tumor(lung) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620137,646.0,BAO_0000219,,
5400,16152,in vitro inhibition of tumor cell growth in cultured A549 human tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620268,646.0,BAO_0000219,,
5401,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620269,646.0,BAO_0000219,,
5402,2288,Cytotoxicity was evaluated against A549 non-small cell lung carcinoma human cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620270,646.0,BAO_0000219,,
5403,17350,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620271,646.0,BAO_0000219,,
5404,4090,Inhibition of A549 cancer cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620272,646.0,BAO_0000219,,
5405,4090,Inhibition of A549 cancer cell proliferation (Not tested),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620273,646.0,BAO_0000219,,
5406,17350,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620274,646.0,BAO_0000219,,
5407,4197,In vitro inhibitory concentration required against human lung A549 carcinoma cells proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620275,646.0,BAO_0000219,,
5408,17072,Antiproliferative potency determined as inhibitory concentration against A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620276,646.0,BAO_0000219,,
5409,17072,Percent assembly of bovine brain tubulin induced by compound at 10 uM versus that caused by 10 uM paclitaxel,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620277,646.0,BAO_0000219,,
5410,5194,Cytotoxicity against Renal cell lines A549 was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620278,646.0,BAO_0000219,,
5411,4257,Area under curve was determined in dog after a 3 mg/kg of oral dose,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620279,,BAO_0000218,,
5412,6123,Area under curve was determined in dog after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620280,,BAO_0000218,,
5413,1337,Area under curve was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620281,,BAO_0000218,,
5414,1337,Area under curve was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620282,,BAO_0000218,,
5415,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-2 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621134,,BAO_0000218,,
5416,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-5 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621135,,BAO_0000218,,
5417,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of (0-15 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621136,,BAO_0000218,,
5418,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of( 0-120 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621137,,BAO_0000218,,
5419,17657,Area under plasma concentration time curve in dog upon oral administration,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621138,,BAO_0000218,1969.0,
5420,17650,Area under plasma concentration time curve was measured in dogs after an oral dose of 10 uM/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875587,,BAO_0000218,1969.0,
5421,1977,Area under the curve for compound was evaluated in dog at a dose of 10 mg/kg.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621139,,BAO_0000218,,
5422,1977,Area under the curve for compound was evaluated in dog at a dose of 20 mg/kg.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621140,,BAO_0000218,,
5423,3132,Area under the curve for the compound was obtained when tested in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621141,,BAO_0000218,,
5424,5473,Area under the curve at a dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621142,,BAO_0000218,,
5425,5474,Area under the curve at a dose of 1 mg/kg (oral),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621143,,BAO_0000218,,
5426,5474,Area under the curve at i.v. dose of 0.2 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621144,,BAO_0000218,,
5427,6062,Area under the curve was measured in dog after an iv dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621145,,BAO_0000218,,
5428,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621146,,BAO_0000218,,
5429,2652,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 1 mpk perorally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622567,,BAO_0000218,,
5430,2652,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 5 mpk perorally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622568,,BAO_0000218,,
5431,2877,Compound was evaluated for area under the curve in dog blood.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622569,,BAO_0000218,,
5432,5444,In vivo area under curve was calculated by peroral administration at 1 mg/kg in fasted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622570,,BAO_0000218,,
5433,5130,AUC in dog after oral dose (1 mg/kg),A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622571,,BAO_0000218,1969.0,
5434,6265,Pharmacokinetic (PK) property (AUC) was determined in dog at the single oral dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622572,,BAO_0000218,,
5435,4657,"Pharmacokinetic data in dogs at dose of 1 mg/kg perorally, and the area under curve (AUC) was reported.",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622573,,BAO_0000218,,
5436,16367,Pharmacokinetic parameter AUC after intravenous administration to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622574,,BAO_0000218,,
5437,16367,Pharmacokinetic parameter AUC after oral administration to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622575,,BAO_0000218,,
5438,9579,Pharmacokinetic parameter AUC was determined in dog after oral administration of 17b,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622576,,BAO_0000218,,
5439,9579,Pharmacokinetic parameter AUC was determined in dog after oral administration of 2b,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622577,,BAO_0000218,,
5440,5983,Pharmacokinetic property (AUC) was measured in dog at the dose of 0.032 mg/kg p.o.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622578,,BAO_0000218,,
5441,6241,Pharmacokinetic property in dogs after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622579,,BAO_0000218,,
5442,5313,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622580,,BAO_0000218,,
5443,5313,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog at dosage of 10 mpk",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622581,,BAO_0000218,,
5444,6642,Oral AUCN in dog ( (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622582,,BAO_0000218,,
5445,6642,Oral AUCN in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622583,,BAO_0000218,,
5446,6641,Oral AUCN in dog (dosed at 0.5 mpk iv ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622584,,BAO_0000218,,
5447,6642,Oral AUCN in dog (dosed at 0.5 mpk iv ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622585,,BAO_0000218,,
5448,17791,Compound was evaluated for oral bioavailability in dog; 90-100,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622586,,BAO_0000218,,
5449,17655,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623281,,BAO_0000218,,
5450,17655,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623282,,BAO_0000218,,
5451,6596,PAPP (membrane permeability) in dog kidney cell monolayer assay,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623283,,BAO_0000218,,
5452,3880,Oral bioavailability in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623284,,BAO_0000218,,
5453,16367,Bioavailability administered orally at a dose of 10 mg/kg to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623285,,BAO_0000218,,
5454,17409,Plasma protein binding towards dog plasma at 10 uM,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623463,,BAO_0000218,1969.0,
5455,17409,Plasma protein binding towards dog plasma at 100 uM,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875952,,BAO_0000218,1969.0,
5456,2959,Bioavailability in dog (dose 4 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621705,,BAO_0000218,,
5457,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 2 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621706,,BAO_0000218,,
5458,4527,Bioavailability by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621707,,BAO_0000218,,
5459,15145,Bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621708,,BAO_0000218,,
5460,4219,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621709,,BAO_0000218,,
5461,17538,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621710,,BAO_0000218,,
5462,17538,Bioavailability in dog after po administration at a dose of 10 mg/kg; nd is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621711,,BAO_0000218,,
5463,1466,Bioavailability in dog (dose 10.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621712,,BAO_0000218,,
5464,17650,Bioavailability was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621713,,BAO_0000218,,
5465,3132,Bioavailability was obtained by the comparison of AUC of intravenous dosing and AUC of oral dosing in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621714,,BAO_0000218,,
5466,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621715,,BAO_0000218,,
5467,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623717,,BAO_0000218,2107.0,
5468,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623718,,BAO_0000218,2107.0,
5469,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623719,,BAO_0000218,2107.0,
5470,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623720,,BAO_0000218,,
5471,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623721,,BAO_0000218,,
5472,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL623722,,BAO_0000218,2385.0,
5473,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL623723,,BAO_0000218,2385.0,
5474,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL618543,,BAO_0000218,2385.0,
5475,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL618544,,BAO_0000218,2106.0,
5476,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL875155,,BAO_0000218,2106.0,
5477,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618545,,BAO_0000218,,
5478,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618546,,BAO_0000218,,
5479,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623529,,BAO_0000218,,
5480,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623530,,BAO_0000218,,
5481,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621764,,BAO_0000218,,
5482,17827,Compound (i.v.) was evaluated for elimination rate constants in brainstem of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621765,,BAO_0000019,,
5483,17827,Compound (i.v.) was evaluated for elimination rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Cerebellum,,,22224,U,0,Autocuration,1,,CHEMBL621766,,BAO_0000019,2037.0,
5484,17827,Compound (i.v.) was evaluated for elimination rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Frontal cortex,,,22224,U,0,Autocuration,1,,CHEMBL621767,,BAO_0000019,1870.0,
5485,17827,Compound (i.v.) was evaluated for elimination rate constants in jaw bone of rhesus monkeys; NA = not active (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621768,,BAO_0000019,,
5486,17827,Compound (i.v.) was evaluated for elimination rate constants in striatum of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Striatum,,,22224,U,0,Autocuration,1,,CHEMBL621769,,BAO_0000019,2435.0,
5487,17827,Compound (i.v.) was evaluated for uptake rate constants in brainstem of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621770,,BAO_0000019,,
5488,17827,Compound (i.v.) was evaluated for uptake rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Cerebellum,,,22224,U,0,Autocuration,1,,CHEMBL621771,,BAO_0000019,2037.0,
5489,17827,Compound (i.v.) was evaluated for uptake rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Frontal cortex,,,22224,U,0,Autocuration,1,,CHEMBL621772,,BAO_0000019,1870.0,
5490,17827,Compound (i.v.) was evaluated for uptake rate constants in jaw bone of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621773,,BAO_0000019,,
5491,17827,Compound (i.v.) was evaluated for uptake rate constants in striatum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Striatum,,,22224,U,0,Autocuration,1,,CHEMBL621774,,BAO_0000019,2435.0,
5492,17791,Compound was evaluated for oral bioavailability in rats,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621775,,BAO_0000218,,
5493,17667,Maximum concentration of compound found in plasma at 5 mg/kg after oral administration,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621776,,BAO_0000218,1969.0,
5494,17791,Half life period was evaluated in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621777,,BAO_0000019,,
5495,110,Half-life in rhesus monkeys by intravenous administration of dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875162,,BAO_0000218,,
5496,5781,AUC (0-6 hr) after oral administration at 30 mg/kg in ICR mouse,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621778,,BAO_0000218,1969.0,
5497,17734,AUC after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621779,,BAO_0000218,1969.0,
5498,17718,AUC value was determined after oral administration,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622479,,BAO_0000218,1969.0,
5499,4573,Area under curve (AUC) determined at a dose 10 mg/kg administered intraperitoneally to mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622480,,BAO_0000218,,
5500,3277,Area under curve (AUC) was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622481,,BAO_0000218,,
5501,2862,Area under curve by ioral administration in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622482,,BAO_0000218,,
5502,2862,Area under curve by iv administration in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622483,,BAO_0000218,,
5503,5951,Area under curve at 0-8 hr in IRC mice after peroral administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622484,,BAO_0000218,,
5504,17729,Area under curve when injected i.p. in mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622641,,BAO_0000218,,
5505,17728,Area under curve when injected intraperitoneally in BALB/C mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622642,,BAO_0000218,,
5506,17728,Area under curve when injected intravenously in BALB/C mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622643,,BAO_0000218,,
5507,17729,Area under curve when injected intravenously in mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622644,,BAO_0000218,,
5508,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL622645,741.0,BAO_0000219,,
5509,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL622646,741.0,BAO_0000219,,
5510,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621238,741.0,BAO_0000219,,
5511,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621239,741.0,BAO_0000219,,
5512,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621240,741.0,BAO_0000219,,
5513,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621241,741.0,BAO_0000219,,
5514,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621242,741.0,BAO_0000219,,
5515,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620350,741.0,BAO_0000219,,
5516,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620351,741.0,BAO_0000219,,
5517,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620352,741.0,BAO_0000219,,
5518,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620353,741.0,BAO_0000219,,
5519,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620354,741.0,BAO_0000219,,
5520,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620355,741.0,BAO_0000219,,
5521,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620356,741.0,BAO_0000219,,
5522,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620357,741.0,BAO_0000219,,
5523,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620358,741.0,BAO_0000219,,
5524,9424,In vitro inhibition of human 8226 myeloma tumor cell line growth.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL620359,741.0,BAO_0000219,,
5525,11544,In vitro inhibition of tumor cell growth in the human myeloma 8226/ADR system.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620360,741.0,BAO_0000219,,
5526,17378,Cytotoxicity of compound against 8226/DOX1V cells,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620361,741.0,BAO_0000219,,
5527,17378,Cytotoxicity of compound against 8226/S cells,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620362,741.0,BAO_0000219,,
5528,17079,Inhibitory concentration against 8226 myeloma cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620363,741.0,BAO_0000219,,
5529,17079,Inhibitory concentration against 8226/Dox40 (Dox-Re) cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620364,741.0,BAO_0000219,,
5530,13466,Inhibition of cell growth was studied in human teratocarcinoma (833K).,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620365,854.0,BAO_0000219,,
5531,13466,Inhibition of cell growth was studied in human teratocarcinoma (833K); ND ='not determined',F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620366,854.0,BAO_0000219,,
5532,2392,Tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Expert,1,,CHEMBL620367,854.0,BAO_0000219,,
5533,2392,The compound was tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells; No data,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620368,854.0,BAO_0000219,,
5534,6608,Inhibitory activity against caspase-1,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620369,,BAO_0000019,,
5535,10199,Percent inhibition of DAla-DAla Ligase at 10e -3 M of the compound,B,,,Enterococcus faecalis,1351.0,,,,,45,H,8,Autocuration,1,,CHEMBL620370,,BAO_0000357,,
5536,17749,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM) for 72 hr using MTT assay,F,,,Homo sapiens,9606.0,,,8701-BC,,80648,N,1,Intermediate,1,,CHEMBL620371,705.0,BAO_0000219,,
5537,17749,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM,F,,,Homo sapiens,9606.0,,,8701-BC,,80648,N,1,Intermediate,1,,CHEMBL620372,705.0,BAO_0000219,,
5538,1229,In vitro anticancer activity against 9 NCI colon cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL876492,,BAO_0000019,,
5539,1229,In vitro anticancer activity against 9 NCI melanoma cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL620373,,BAO_0000019,,
5540,1229,In vitro anticancer activity against 9 NCI renal cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL620374,,BAO_0000019,,
5541,6390,Inhibitory activity was determined against 9-cis-epoxycarotenoid dioxygenase (NCED) expressed in Escherichia coli in presence of 9''-cis-neo-xanthin,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620375,,BAO_0000019,,
5542,16219,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,F,,,Streptococcus pyogenes,1314.0,,,,,22226,U,0,Autocuration,1,,CHEMBL857902,,BAO_0000019,,
5543,16219,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,F,,,Streptococcus pyogenes,1314.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620376,,BAO_0000019,,
5544,17043,Percent inhibition against Cdc25C phosphatase at 50 uM of compound,B,,,,,,,,,11922,H,8,Autocuration,1,,CHEMBL620377,,BAO_0000357,,
5545,6929,Tested for in vitro cytotoxic potency of compound in 9KB assay,F,,,Homo sapiens,9606.0,,,KB ,,81115,N,1,Intermediate,1,,CHEMBL620378,324.0,BAO_0000219,,
5546,6929,Tested for in vitro cytotoxic potency of compound in 9KB assay,A,,,Homo sapiens,9606.0,,,KB ,,81115,N,1,Intermediate,1,,CHEMBL620379,324.0,BAO_0000219,,
5547,7083,In vitro cytotoxicity of compound was tested against 9KB cells.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620380,,BAO_0000219,,
5548,12446,Cytotoxic concentration against 9L cells was determined on day 3,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Intermediate,1,,CHEMBL884006,392.0,BAO_0000219,,
5549,15345,Tested in vitro for anticancer activity against 9L cells,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Expert,1,,CHEMBL620381,392.0,BAO_0000219,,
5550,15345,Tested in vitro for anticancer activity against 9L cells; Not determined,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Expert,1,,CHEMBL620382,392.0,BAO_0000219,,
5551,6301,In vitro inhibitory activity against human A549 non-small cell lung tumor; Active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620383,646.0,BAO_0000219,,
5552,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; No inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876493,646.0,BAO_0000219,,
5553,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Significant inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620384,646.0,BAO_0000219,,
5554,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Slight inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620385,646.0,BAO_0000219,,
5555,13330,Cytotoxicity against human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620386,646.0,BAO_0000219,,
5556,17517,Ability to induce human IL-6 assay in A549 lung carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A549,,25,D,9,Expert,1,,CHEMBL620387,646.0,BAO_0000219,,
5557,17517,"Ability to induce human IL-6 assay in A549 lung carcinoma cell line; n.r.: not reported, EC50 values not reported in cases were %dex e 35%.",F,,,Homo sapiens,9606.0,,,A549,,25,D,9,Expert,1,,CHEMBL621404,646.0,BAO_0000219,,
5558,14425,"In vitro growth inhibition of A549, lung carcinoma",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621405,646.0,BAO_0000219,,
5559,14425,"In vitro growth inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621406,646.0,BAO_0000219,,
5560,5228,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621407,646.0,BAO_0000219,,
5561,5351,Cytotoxic activity against human lung cancer A549 cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621408,646.0,BAO_0000219,,
5562,12198,Cytotoxicity against human solid tumor lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL885345,646.0,BAO_0000219,,
5563,13891,Cytotoxicity concentration against human lung carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621409,646.0,BAO_0000219,,
5564,5677,Cytotoxicity in A549 (human carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL876034,646.0,BAO_0000219,,
5565,13788,Cytotoxicity on lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621410,646.0,BAO_0000219,,
5566,13384,Effective dose against 50% reduction in Human lung carcinoma (A-549) cell number after 3-day incubation.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621411,646.0,BAO_0000219,,
5567,6726,Effective dose of compound against replication of A549 cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621412,646.0,BAO_0000219,,
5568,3455,In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621413,646.0,BAO_0000219,,
5569,5726,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621414,646.0,BAO_0000219,,
5570,5726,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line); NA is not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621415,646.0,BAO_0000219,,
5571,3936,The compound was evaluated for antiproliferative activity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621416,646.0,BAO_0000219,,
5572,14991,The compound was tested for tumor cell growth inhibitory activity against human lung carcinoma (A549) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621417,646.0,BAO_0000219,,
5573,5243,Concentration required for growth inhibition of human lung carcinoma cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621418,646.0,BAO_0000219,,
5574,12858,Cytotoxic activity against A549/ATCC non-small cell-lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621419,646.0,BAO_0000219,,
5575,6776,Growth inhibition against A549 cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621420,646.0,BAO_0000219,,
5576,16558,Growth inhibitory activity against A549 human solid tumor cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL875823,646.0,BAO_0000219,,
5577,4583,Inhibition of anchorage independent growth of human tumor cell line A549 K-ras-transformed in soft agar,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621421,646.0,BAO_0000219,,
5578,13514,Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621422,646.0,BAO_0000219,,
5579,15166,Chemosensitivity against DT-diaphorase rich A549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL884014,646.0,BAO_0000219,,
5580,13873,Compound tested against A549 lung carcinoma in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621423,646.0,BAO_0000219,,
5581,6447,In vitro cytotoxicity against human A549 (lung cancer) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621424,646.0,BAO_0000219,,
5582,2068,In vitro antitumor activity against A549 (lung) human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621425,646.0,BAO_0000219,,
5583,1863,In vitro cytotoxic activity against human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621426,646.0,BAO_0000219,,
5584,13873,Compound was tested against A549 lung cancer cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621427,646.0,BAO_0000219,,
5585,13873,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621428,646.0,BAO_0000219,,
5586,13873,Tested against A549 lung carcinoma in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621429,646.0,BAO_0000219,,
5587,579,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621430,646.0,BAO_0000219,,
5588,579,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction).,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621431,646.0,BAO_0000219,,
5589,4584,Compound was tested for inhibition of growth of human lung carcinoma cell line A549 up to a conc of 10 uM; NI means no inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621432,646.0,BAO_0000219,,
5590,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621433,646.0,BAO_0000219,,
5591,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL875824,646.0,BAO_0000219,,
5592,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621434,646.0,BAO_0000219,,
5593,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line; NA=Not assayed,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621435,646.0,BAO_0000219,,
5594,14188,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621436,646.0,BAO_0000219,,
5595,14188,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay; UA=Potency was so low that the IC50 was unachievable.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621437,646.0,BAO_0000219,,
5596,15354,Compound was tested for the growth inhibition of A549 lung tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621438,646.0,BAO_0000219,,
5597,14253,Growth inhibition of human non-small-lung carcinoma (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621439,646.0,BAO_0000219,,
5598,13873,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621440,646.0,BAO_0000219,,
5599,3043,Oral bioavailability in dog (conscious),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621441,,BAO_0000218,,
5600,3045,Compound was evaluated for the oral bioavailability after oral administration in dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621442,,BAO_0000218,,
5601,3022,Compound was tested for percent of oral bioavailability at 10 mg/ml dose in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621443,,BAO_0000218,,
5602,4453,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621444,,BAO_0000218,,
5603,1696,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625133,,BAO_0000218,,
5604,5045,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625134,,BAO_0000218,,
5605,5356,Oral bioavailability in dog (fasted),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625135,,BAO_0000218,,
5606,17764,Oral bioavailability after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625136,,BAO_0000218,,
5607,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625137,,BAO_0000218,,
5608,1475,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625138,,BAO_0000218,,
5609,3788,Percent bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625139,,BAO_0000218,,
5610,3639,Percent oral bioavailability of intravenously administered compound (6 mg/kg) was tested in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872264,,BAO_0000218,,
5611,13397,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625140,,BAO_0000218,,
5612,2137,The compound was evaluated for bioavailability in dogs; 34-44,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624436,,BAO_0000218,,
5613,2959,Bioavailability in dog (dose 4 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624437,,BAO_0000218,,
5614,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872261,,BAO_0000218,,
5615,6084,8 hour trough Blood level in dog was measured after administration of compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624438,,BAO_0000218,,
5616,3639,The compound was tested for maximum concentration ( Cmax ) in dog plasma.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624439,,BAO_0000218,1969.0,
5617,6316,C24 after oral administration at 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624440,,BAO_0000218,,
5618,5238,Clearance after oral and iv dosing in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624441,,BAO_0000218,,
5619,17796,Clearance of the drug was measured in the plasma of dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624442,,BAO_0000218,1969.0,
5620,2652,Compound was evaluated for Clearance in dogs at a dose of 1 mpk intravenously,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624443,,BAO_0000218,,
5621,5654,CL (clearance) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624444,,BAO_0000218,,
5622,6621,Clearance of compound was determined in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624445,,BAO_0000218,,
5623,6505,Clearance on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624446,,BAO_0000218,,
5624,5802,Clearance of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624447,,BAO_0000218,,
5625,17267,Plasma clearance in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624448,,BAO_0000218,,
5626,4521,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624449,,BAO_0000218,,
5627,6535,Plasma clearance in dog after administration of 0.25 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624450,,BAO_0000218,,
5628,6535,Plasma clearance in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875942,,BAO_0000218,,
5629,6535,Plasma clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624451,,BAO_0000218,,
5630,5542,Plasma clearance by iv administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624452,,BAO_0000218,,
5631,5199,Plasma clearance was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624453,,BAO_0000218,,
5632,16907,Plasma clearance after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624454,,BAO_0000218,,
5633,16907,Plasma clearance after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624455,,BAO_0000218,,
5634,16367,Plasma administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624456,,BAO_0000218,,
5635,5505,Plasma clearance was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624457,,BAO_0000218,,
5636,6215,Systemic clearance after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624458,,BAO_0000218,,
5637,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624459,,BAO_0000218,,
5638,5007,Intrinsic clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,102164,S,2,Intermediate,1,,CHEMBL624460,,BAO_0000251,2107.0,
5639,5007,Intrinsic clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,102164,S,2,Intermediate,1,,CHEMBL624461,,BAO_0000251,2107.0,
5640,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875943,,BAO_0000218,,
5641,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624462,,BAO_0000218,,
5642,16452,Clearance in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624463,,BAO_0000218,,
5643,6221,Plasma clearance after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624464,,BAO_0000218,,
5644,5007,Plasma clearance in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624465,,BAO_0000218,,
5645,5668,Plasma clearance after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624466,,BAO_0000218,,
5646,5668,Plasma clearance after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624467,,BAO_0000218,,
5647,5668,Plasma clearance after peroral administration at 5 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624468,,BAO_0000218,,
5648,15660,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624469,,BAO_0000218,,
5649,15660,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624470,,BAO_0000218,,
5650,5983,Pharmacokinetic property (CLtot) was measured in dog at the dose of 0.032 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624471,,BAO_0000218,,
5651,5600,Total clearance was determined after 0.1 mg/kg iv administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624472,,BAO_0000218,,
5652,17764,Clearance of compound after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622775,,BAO_0000218,,
5653,6039,Clearance after intravenous administration of 0.5 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622776,,BAO_0000218,,
5654,6039,Clearance after intravenous administration of 1.0 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622777,,BAO_0000218,,
5655,6039,Clearance after peroral administration of 0.2 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622778,,BAO_0000218,,
5656,4368,Clearance by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622779,,BAO_0000218,,
5657,4305,Clearance by iv administration in dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622780,,BAO_0000218,,
5658,1918,Clearance value was evaluated in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622781,,BAO_0000218,1969.0,
5659,6005,Clearance was evaluated after i.v. administration in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622782,,BAO_0000218,,
5660,4839,Compound was tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622783,,BAO_0000218,1969.0,
5661,4239,Pharmacokinetic property (Plasma clearance) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622784,,BAO_0000218,,
5662,17729,Area under curve when injected perorally in mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622785,,BAO_0000218,,
5663,17728,Area under curve when injected perorally in BALB/C mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622786,,BAO_0000218,,
5664,5302,Area under curve value in mouse at a dose of 10 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622787,,BAO_0000218,,
5665,5506,Area under curve was determined at a dose of 100 mg/kg (i.p.) in Mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875949,,BAO_0000218,,
5666,5506,Area under curve was determined at a dose of 200 mg/kg (i.p.) in Mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622788,,BAO_0000218,,
5667,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 18 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622789,,BAO_0000218,,
5668,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 23 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622790,,BAO_0000218,,
5669,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 25 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622791,,BAO_0000218,,
5670,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 26 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622792,,BAO_0000218,,
5671,17764,Area under curve was determined for compound after intravenous administration in mice at 24 uM/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622793,,BAO_0000218,,
5672,17753,Area under curve was determined for the compound at 24 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622794,,BAO_0000218,,
5673,17753,Area under curve was determined for the compound at 40 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622795,,BAO_0000218,,
5674,17753,Area under curve was determined for the compound at 5 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621803,,BAO_0000218,,
5675,3132,Area under the curve for the compound is obtained at dose 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621804,,BAO_0000218,,
5676,3132,Area under the curve for the compound was obtained when tested in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621805,,BAO_0000218,,
5677,17837,Area under the curve of compound in mouse blood following i.v. administration of 10 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621806,,BAO_0000218,,
5678,17837,Area under the curve of compound in mouse blood following p.o. administration of 30 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621807,,BAO_0000218,,
5679,6062,Area under the curve was measured in mouse after an iv dose of 1 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621808,,BAO_0000218,,
5680,4066,Area under the curve was determined for the compound at a single subcutaneous administration of 40 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621809,,BAO_0000218,,
5681,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621810,,BAO_0000218,,
5682,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875164,,BAO_0000218,,
5683,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621811,,BAO_0000218,,
5684,4890,"Compound was evaluated for the pharmacokinetic parameter, area under curve",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621812,,BAO_0000218,,
5685,429,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr ),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621813,,BAO_0000218,,
5686,429,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621814,,BAO_0000218,,
5687,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 100 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621815,,BAO_0000218,,
5688,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621816,,BAO_0000218,,
5689,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621817,,BAO_0000218,,
5690,6091,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621818,,BAO_0000218,,
5691,6091,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse;ND=Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621819,,BAO_0000218,,
5692,6091,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621820,,BAO_0000218,,
5693,6091,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice;ND=Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621821,,BAO_0000218,,
5694,6178,Pharmacokinetic property (AUC) was determined after ip administration of 32 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621822,,BAO_0000218,,
5695,6178,Pharmacokinetic property (AUC) was determined after po administration of 32 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619474,,BAO_0000218,,
5696,6619,"Reduction in area under curve was determined in DIO mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619475,,BAO_0000218,,
5697,6619,"Reduction in area under curve was determined in ob/ob mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619476,,BAO_0000218,,
5698,3760,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered intravenously in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619477,,BAO_0000218,,
5699,3760,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered perorally in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619478,,BAO_0000218,,
5700,3760,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered intravenously in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619479,,BAO_0000218,,
5701,3760,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered perorally in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619480,,BAO_0000218,,
5702,3192,The area under curve in vivo in mouse blood level after oral administration at dose 50 mk/kg e-1,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619481,,BAO_0000218,,
5703,3192,The area under curve in vivo in mouse blood level after subcutaneous administration at dose 50 mk/kg e-1,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619482,,BAO_0000218,,
5704,2675,Area under the curve was evaluated in mice after intravenous administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619483,,BAO_0000218,,
5705,2675,Area under the curve was evaluated in mice after oral administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619484,,BAO_0000218,,
5706,16597,AUC total value at a dose of 10 mg/kg intravenous administration in mice.,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL619485,,BAO_0000218,1969.0,
5707,16597,AUC total value at a dose of 10 mg/kg peroral administration in mice.,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL619486,,BAO_0000218,1969.0,
5708,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619487,,BAO_0000218,,
5709,17734,AUMC after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619488,,BAO_0000218,,
5710,7767,Biodistribution in blood was determined in mice after iv administration at 15 min Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620106,,BAO_0000218,178.0,
5711,15345,The compound was tested in vitro for anticancer activity against 9L cells,F,,,,,,,9L,,80653,N,1,Intermediate,1,,CHEMBL620107,392.0,BAO_0000219,,
5712,2181,Anti proliferation activity determined; Weak effect,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620283,,BAO_0000019,,
5713,2181,Inhibition of cell growth by compound at a concentration of 100 uM in 9Ltk+ cells; Completely stopped the process,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL875176,,BAO_0000219,,
5714,2181,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620284,,BAO_0000219,,
5715,2181,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells; Completely stopped the process,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623515,,BAO_0000219,,
5716,10486,The cytotoxic activity was in vitro tested by 9PS assay method,F,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623516,,BAO_0000019,,
5717,10486,The cytotoxic activity was in vitro tested by 9PS assay method.,F,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623517,,BAO_0000019,,
5718,15508,Partition coefficient (logD6.5),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL857878,,BAO_0000019,,
5719,5242,Inhibitory concentration in vitro for cytotoxic activity against A 2780 human ovarian carcinoma cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623518,478.0,BAO_0000219,,
5720,16167,Effective concentration against A 375 cell line growth (DFMO concentration is 5.0 mM),F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL624195,455.0,BAO_0000219,,
5721,4782,Inhibitory concentration required against A 431 human epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL624196,500.0,BAO_0000219,,
5722,16093,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL624197,500.0,BAO_0000219,,
5723,2596,Compound was evaluated for in vitro cytotoxicity against A 498 cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624198,624.0,BAO_0000219,,
5724,2596,in vitro cytotoxicity against A 498 cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621287,624.0,BAO_0000219,,
5725,3239,In vitro cytotoxic activity against renal (A 498) cancer cell line.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621288,624.0,BAO_0000219,,
5726,1847,Cytotoxic activity against A 498 renal cancer cell lines.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL876496,624.0,BAO_0000219,,
5727,10553,In vitro cytotoxicity was determined against A 498 human renal tumor cell line using NCI screen,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621289,624.0,BAO_0000219,,
5728,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621290,,BAO_0000019,,
5729,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621291,,BAO_0000019,,
5730,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621292,,BAO_0000019,,
5731,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621293,,BAO_0000019,,
5732,4782,Inhibitory concentration required against A 549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621294,646.0,BAO_0000219,,
5733,11805,Growth inhibition of A 549 cell line by MTT reduction for 3 days of incubation time,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621295,646.0,BAO_0000219,,
5734,11805,Growth inhibition of A 549 cell line by MTT reduction for 7 days of incubation time,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884007,646.0,BAO_0000219,,
5735,2007,In vitro cytotoxicity against lung cancer A 549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621296,646.0,BAO_0000219,,
5736,4594,Compound was tested for its cytotoxicity against A 549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621297,646.0,BAO_0000219,,
5737,6018,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839828,646.0,BAO_0000219,,
5738,6018,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.; No data",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620397,646.0,BAO_0000219,,
5739,3599,In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620398,646.0,BAO_0000219,,
5740,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620399,646.0,BAO_0000219,,
5741,16132,In vitro inhibition of A549 (human lung cancer) cell growth.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620400,646.0,BAO_0000219,,
5742,16132,Cytotoxic related antitumor activity against human cancer cell lines A 549; No data available,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620401,646.0,BAO_0000219,,
5743,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620402,646.0,BAO_0000219,,
5744,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay; not active (> 100 uM),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620403,646.0,BAO_0000219,,
5745,11913,Tested against A II at (100 ng/kg iv) in Dawley rats (n=2). 24 h,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620404,,BAO_0000218,,
5746,12621,The duration of action for the % peak inhibition of A II pressor response for dose of 0.1 mg/kg intravenous administration in conscious dogs.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620405,,BAO_0000218,,
5747,12621,The duration of action for the % peak inhibition of A II pressor response for dose of 1.0 mg/kg peroral administration in rhesus monkeys.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620406,,BAO_0000218,,
5748,12621,The duration of action for the % peak inhibition of angiotensin II pressor response for dose of 0.1 mg/kg peroral administration in conscious rats.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620407,,BAO_0000218,,
5749,12621,The compound was evaluated for the % peak inhibition of A II pressor response for dose of 0.3 mg/kg peroral administration in rhesus monkeys.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620408,,BAO_0000218,,
5750,12621,The compound was evaluated for the percentage of inhibition of A II pressor response in rats for peroral administration.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620409,,BAO_0000218,,
5751,3600,Inhibition of A-498 human Renal cell proliferation,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL620410,624.0,BAO_0000219,,
5752,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 0.1 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620411,,BAO_0000019,,
5753,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 1 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620412,,BAO_0000019,,
5754,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 10 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL876596,,BAO_0000019,,
5755,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL620413,622.0,BAO_0000219,,
5756,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL620414,622.0,BAO_0000219,,
5757,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL620415,622.0,BAO_0000219,,
5758,13617,Concentration required to inhibit growth of human tumor A549 (NSCL) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620416,646.0,BAO_0000219,,
5759,4584,Concentration which produces 50% inhibition of growth of human lung carcinoma cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620417,646.0,BAO_0000219,,
5760,13799,Cytotoxic activity evaluated against A549 tumor cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620418,646.0,BAO_0000219,,
5761,16726,Cytotoxic potentiation of Topotecan (TP) by the compound in human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620419,646.0,BAO_0000219,,
5762,16109,Cytotoxicity against A549 cells when the drug is exposed for a time of 1 hr,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620420,646.0,BAO_0000219,,
5763,16109,Cytotoxicity against A549 cells when the drug is exposed for a time of 96 hrs,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620421,646.0,BAO_0000219,,
5764,15474,Cytotoxicity against A549 tumor cell line determined by WST-1 assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620422,646.0,BAO_0000219,,
5765,6851,Cytotoxicity of compound against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620423,646.0,BAO_0000219,,
5766,17534,Cytotoxicity against human lung cell carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620424,646.0,BAO_0000219,,
5767,2621,Cytotoxicity against human lung carcinoma A549 cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620425,646.0,BAO_0000219,,
5768,830,Cytotoxicity was evaluated in vitro against A549 (non-small cell lung carcinoma) human tumor cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620426,646.0,BAO_0000219,,
5769,14255,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620427,646.0,BAO_0000219,,
5770,14255,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum; Not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620428,646.0,BAO_0000219,,
5771,1590,In vitro antitumor activity against A549 human NSCLC lung carcinoma cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620429,646.0,BAO_0000219,,
5772,6146,In vitro concentration required to inhibit the TNF-alpha-induced RANTES production in A549 human lung epithelium cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620430,646.0,BAO_0000219,,
5773,17427,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839887,646.0,BAO_0000219,,
5774,5280,In vitro cytotoxicity against parental and drug resistant lung human tumor cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620431,646.0,BAO_0000219,,
5775,16786,In vitro cytotoxicity of compound against human A549 (non small cell lung) cancer cell line after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884010,646.0,BAO_0000219,,
5776,5895,In vitro cytotoxicity against A549 (human lung cancer),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620538,646.0,BAO_0000219,,
5777,14297,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620539,646.0,BAO_0000219,,
5778,17824,In vivo antiproliferative activity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623373,646.0,BAO_0000218,,
5779,14368,Inhibition of non-small-cell lung adenocarcinoma (A549),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623374,646.0,BAO_0000219,,
5780,14368,Inhibition of non-small-cell lung adenocarcinoma (A549) after 48-h treatment,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623375,646.0,BAO_0000219,,
5781,14254,Inhibition of the growth against human non-small-lung carcinoma (A549) cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623376,646.0,BAO_0000219,,
5782,15897,Inhibitory activity against A549 cell line using MTT assay(Wild type p53),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623377,646.0,BAO_0000219,,
5783,13866,Inhibitory activity against A549 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623378,646.0,BAO_0000219,,
5784,13370,Inhibitory activity of compound against human A549 lung carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623379,646.0,BAO_0000219,,
5785,4862,Inhibitory activity against A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623380,646.0,BAO_0000219,,
5786,4862,Inhibitory activity against Taxol-resistant A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623381,646.0,BAO_0000219,,
5787,4862,Inhibitory activity against Taxol-resistant A549 lung cancer cell line; not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623382,646.0,BAO_0000219,,
5788,15970,Inhibitory concentration against A549 (lung cancer) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623383,646.0,BAO_0000219,,
5789,17713,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623384,646.0,BAO_0000219,,
5790,4833,Tested in vitro for inhibitory effect on the growth of human A-549 cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623385,646.0,BAO_0000219,,
5791,13736,Activity against A549 cancer cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623386,646.0,BAO_0000219,,
5792,4312,The compound was evaluated for cytotoxicity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884105,646.0,BAO_0000219,,
5793,5421,The compound was examined for its ability to block tumor necrosis factor alpha (TNF alpha) induced IL-8 production in A549 human lung carcinoma cell line using an ELISA,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623387,646.0,BAO_0000219,,
5794,5421,The compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621568,646.0,BAO_0000219,,
5795,14717,Growth inhibitory activity was measured for human A549 tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621569,646.0,BAO_0000219,,
5796,4634,Inhibitory activity against A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621570,646.0,BAO_0000219,,
5797,1149,Inhibitory activity against A549 cell line; inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621571,646.0,BAO_0000219,,
5798,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621572,646.0,BAO_0000219,,
5799,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621573,646.0,BAO_0000219,,
5800,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621574,646.0,BAO_0000219,,
5801,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-4 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621575,646.0,BAO_0000219,,
5802,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-5 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621576,646.0,BAO_0000219,,
5803,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-6 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621577,646.0,BAO_0000219,,
5804,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-7 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621578,646.0,BAO_0000219,,
5805,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-8 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621579,646.0,BAO_0000219,,
5806,5726,In vitro percent inhibition evaluated against human lung cancer (A549 cell line) at >20 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621580,646.0,BAO_0000219,,
5807,17800,Plasma clearance (in vivo) in mongrel dogs was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621581,,BAO_0000218,,
5808,5985,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621582,,BAO_0000218,,
5809,5530,Plasma clearance in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621583,,BAO_0000218,,
5810,5530,Plasma clearance in vivo in dog by intravenous administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621584,,BAO_0000218,,
5811,4839,Tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621585,,BAO_0000218,1969.0,
5812,3639,The compound was tested for clearance in dog plasma.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621586,,BAO_0000218,,
5813,4838,"The pharmacokinetic parameter, clearance was reported in dog after intravenous administration",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875835,,BAO_0000218,,
5814,4137,Clearance value of compound was determined after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621587,,BAO_0000218,,
5815,5017,Compound was tested for its ability of plasma clearance when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621588,,BAO_0000218,1969.0,
5816,17538,In vitro clearance in dog liver microsomes,A,In vitro,,Canis lupus familiaris,9615.0,,Liver,,Microsomes,50588,N,1,Intermediate,1,,CHEMBL621589,,BAO_0000218,2107.0,
5817,6161,Pharmacokinetic profile in terms of clearance was determined at a dose of 0.5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621590,,BAO_0000218,,
5818,6161,Pharmacokinetic profile in terms of clearance was determined at a dose of 5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621591,,BAO_0000218,,
5819,1696,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621592,,BAO_0000218,,
5820,6762,Clearance rate in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621593,,BAO_0000218,,
5821,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621594,,BAO_0000218,1969.0,
5822,6305,Clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621595,,BAO_0000218,,
5823,4942,Plasma clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621596,,BAO_0000218,,
5824,4219,Plasma clearance was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621597,,BAO_0000218,,
5825,17853,Lower clearance in dog (i.v.) at 0.5 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621598,,BAO_0000218,,
5826,4514,Plasma clearance in Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621599,,BAO_0000218,,
5827,6448,Plasma clearance (Clp) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875836,,BAO_0000218,,
5828,6227,Plasma clearance (pharmacokinetic parameter) in dog (in vivo) at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621600,,BAO_0000218,,
5829,6227,Plasma clearance (pharmacokinetic parameter) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621601,,BAO_0000218,,
5830,6062,Plasma clearance for the compound was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618474,,BAO_0000218,,
5831,6821,Plasma clearance of compound was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618475,,BAO_0000218,,
5832,4709,Plasma clearance after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624524,,BAO_0000218,,
5833,4521,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624525,,BAO_0000218,,
5834,5374,Plasma clearance in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624526,,BAO_0000218,,
5835,6057,Plasma clearance was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624527,,BAO_0000218,,
5836,4727,Plasma clearance at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624528,,BAO_0000218,,
5837,5145,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624529,,BAO_0000218,,
5838,17657,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624530,,BAO_0000218,,
5839,17657,Plasma clearance in dog; Unable to calculate,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624531,,BAO_0000218,,
5840,5145,Plasma clearance in rhesus monkey,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624532,,BAO_0000218,,
5841,6642,Plasma clearance in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624533,,BAO_0000218,,
5842,6641,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624534,,BAO_0000218,,
5843,6642,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624535,,BAO_0000218,,
5844,5472,Plasma clearance was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624536,,BAO_0000218,,
5845,5472,Plasma clearance was evaluated in dog; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624537,,BAO_0000218,,
5846,5472,Plasma clearance was evaluated in rhesus,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624538,,BAO_0000218,,
5847,5472,Plasma clearance was evaluated in rhesus; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624539,,BAO_0000218,,
5848,4257,Plasma clearance value was determined in dog after a 3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624540,,BAO_0000218,,
5849,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624541,,BAO_0000218,,
5850,5546,Plasma clearance was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624542,,BAO_0000218,,
5851,6348,Plasma clearance was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624543,,BAO_0000218,,
5852,5474,Clearance value at a dose of 0.2 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624544,,BAO_0000218,,
5853,6316,Cmax (Maximum (Peak) plasma drug concentration) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624545,,BAO_0000218,1969.0,
5854,17594,Cmax after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624546,,BAO_0000218,,
5855,17594,Cmax after single intravenous bolus of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875957,,BAO_0000218,,
5856,5802,Cmax of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624547,,BAO_0000218,,
5857,6535,Cmax in dog after administration of 0.25 mg/kg iv; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624548,,BAO_0000218,,
5858,6535,Cmax in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624549,,BAO_0000218,,
5859,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624550,,BAO_0000218,1969.0,
5860,6505,Cmax on p.o. administration of 10 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621613,,BAO_0000218,,
5861,5668,Cmax was determine after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621614,,BAO_0000218,,
5862,5668,Cmax was determine after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623431,,BAO_0000218,,
5863,5668,Cmax was determine after peroral administration at 5 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623432,,BAO_0000218,,
5864,5600,Cmax after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623433,,BAO_0000218,,
5865,17764,Cmax after peroral administration in dogs at 2.4 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623434,,BAO_0000218,,
5866,6123,Cmax in dog after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623435,,BAO_0000218,,
5867,6123,Cmax in dog after oral administration at 1 mg/kg; Below the level of quantitation,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623436,,BAO_0000218,,
5868,6757,Cmax upon oral administration in male Beagle dog at 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875958,,BAO_0000218,,
5869,16907,Cmax value after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623437,,BAO_0000218,,
5870,7767,Biodistribution in blood was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623438,,BAO_0000218,178.0,
5871,7767,Biodistribution in blood was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623439,,BAO_0000218,178.0,
5872,7767,Biodistribution in bone was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623440,,BAO_0000218,10000001.0,
5873,7767,Biodistribution in bone was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623441,,BAO_0000218,10000001.0,
5874,7767,Biodistribution in bone was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623442,,BAO_0000218,10000001.0,
5875,7767,Biodistribution in fat and fur was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623469,,BAO_0000218,,
5876,7767,Biodistribution in fat and fur was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623470,,BAO_0000218,,
5877,7767,Biodistribution in fat and fur was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623471,,BAO_0000218,,
5878,7767,Biodistribution in heart was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623472,,BAO_0000218,948.0,
5879,7767,Biodistribution in heart was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623473,,BAO_0000218,948.0,
5880,7767,Biodistribution in heart was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623474,,BAO_0000218,948.0,
5881,7767,Biodistribution in kidney was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623475,,BAO_0000218,2113.0,
5882,7767,Biodistribution in kidney was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623476,,BAO_0000218,2113.0,
5883,7767,Biodistribution in kidney was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623477,,BAO_0000218,2113.0,
5884,7767,Biodistribution in large intestine after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621896,,BAO_0000218,160.0,
5885,7767,Biodistribution in large intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621897,,BAO_0000218,160.0,
5886,7767,Biodistribution in large intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621898,,BAO_0000218,160.0,
5887,7767,Biodistribution in liver was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621899,,BAO_0000218,2107.0,
5888,7767,Biodistribution in liver was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621900,,BAO_0000218,2107.0,
5889,7767,Biodistribution in liver was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621901,,BAO_0000218,2107.0,
5890,7767,Biodistribution in lung was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL621902,,BAO_0000218,2048.0,
5891,7767,Biodistribution in lung was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL621903,,BAO_0000218,2048.0,
5892,7767,Biodistribution in lung was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622587,,BAO_0000218,2048.0,
5893,7767,Biodistribution in muscle was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL620285,,BAO_0000218,2385.0,
5894,7767,Biodistribution in muscle was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL875285,,BAO_0000218,2385.0,
5895,7767,Biodistribution in muscle was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL620286,,BAO_0000218,2385.0,
5896,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620287,,BAO_0000218,,
5897,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620288,,BAO_0000218,,
5898,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620289,,BAO_0000218,,
5899,7767,Biodistribution in small intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620290,,BAO_0000218,160.0,
5900,7767,Biodistribution in small intestine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620291,,BAO_0000218,160.0,
5901,7767,Biodistribution in small intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620292,,BAO_0000218,160.0,
5902,7767,Biodistribution in spleen was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL620293,,BAO_0000218,2106.0,
5903,7767,Biodistribution in spleen was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL620294,,BAO_0000218,2106.0,
5904,7767,Biodistribution in spleen was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618614,,BAO_0000218,2106.0,
5905,7767,Biodistribution in stomach was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL618615,,BAO_0000218,945.0,
5906,7767,Biodistribution in stomach was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL618616,,BAO_0000218,945.0,
5907,2036,Cytotoxicity against A-172 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL618617,622.0,BAO_0000219,,
5908,2357,Compound was evaluated for the in vitro cytotoxicity against A-172 human glioblastoma cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL618618,622.0,BAO_0000219,,
5909,1457,Antiproliferative activity of compound was tested against rhabdomyosarcoma (A-204) human tumor cells,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Intermediate,1,,CHEMBL618619,623.0,BAO_0000219,,
5910,4379,Tested for antiproliferative activity against A-2780 tumoral cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618620,478.0,BAO_0000219,,
5911,1093,Inhibitory concentration against melanoma A-375 cell line for cytotoxicity was determined,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL618621,455.0,BAO_0000219,,
5912,12152,Tested in vitro against A-375 cell line human melanoma,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL618622,455.0,BAO_0000219,,
5913,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618623,797.0,BAO_0000219,,
5914,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618624,797.0,BAO_0000219,,
5915,16582,In vitro cytotoxicity against human non small-cell-lung cell line A-427.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618625,797.0,BAO_0000219,,
5916,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618626,797.0,BAO_0000219,,
5917,10413,Antitumor activity on A-427 lung carcinoma cell lines,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618627,797.0,BAO_0000219,,
5918,6418,Cytotoxic activity against human A-427 lung tumor cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618628,797.0,BAO_0000219,,
5919,17134,In vitro antitumor effects against human A-427 cell lines.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618629,797.0,BAO_0000219,,
5920,16132,In vitro inhibition of A-427 (human lung cancer) cell growth.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618630,797.0,BAO_0000219,,
5921,16132,Cytotoxic related antitumor activity against human cancer cell lines A-427; No data available,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618631,797.0,BAO_0000219,,
5922,16780,Cytotoxic activity of compound against A-427 lung human tumor cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618632,797.0,BAO_0000219,,
5923,4085,Cytotoxicity measured for the growth inhibition of A-431 Human epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL618633,500.0,BAO_0000219,,
5924,1276,Cytotoxic activity was tested against human A-498 (Kidney carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619315,624.0,BAO_0000219,,
5925,3498,Cytotoxicity against A-498 cell line in the purdue cell culture screen was determined,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL619316,624.0,BAO_0000219,,
5926,1169,Cytotoxicity against human kidney carcinoma A-498cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619317,624.0,BAO_0000219,,
5927,4450,In vitro cytotoxic activity against A-498 (human kidney carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619318,624.0,BAO_0000219,,
5928,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 6 day exposure.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619319,624.0,BAO_0000219,,
5929,4461,Antitumor cytotoxic activity against A-498 cell line was determined,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619739,624.0,BAO_0000219,,
5930,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619740,624.0,BAO_0000219,,
5931,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure; ND is no data,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL883158,624.0,BAO_0000219,,
5932,1457,Antiproliferative activity of compound was tested against renal cancer (A-498) human tumor cells,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL884012,624.0,BAO_0000219,,
5933,3664,In vitro inhibitory activity against A-498 ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619741,624.0,BAO_0000219,,
5934,15895,"Cytotoxicity against NCI tumor panel, A-498 renal cancer cell line",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619742,624.0,BAO_0000219,,
5935,11843,Inhibition of growth lung non-small cell carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876610,646.0,BAO_0000219,,
5936,11843,Inhibition of growth of lung non-small cell carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619743,646.0,BAO_0000219,,
5937,17705,In vitro antiproliferative activity against human A-549 NSCL cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619744,646.0,BAO_0000219,,
5938,17705,In vitro antiproliferative activity against human A-549 NSCL cell line; NS = Not significant,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619745,646.0,BAO_0000219,,
5939,4369,Growth inhibition of A-549 human lung adenocarcinoma at 0.01 uM compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619746,646.0,BAO_0000219,,
5940,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619747,646.0,BAO_0000219,,
5941,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619748,646.0,BAO_0000219,,
5942,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619749,646.0,BAO_0000219,,
5943,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619750,646.0,BAO_0000219,,
5944,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624014,646.0,BAO_0000219,,
5945,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624015,646.0,BAO_0000219,,
5946,4787,In vitro effective concentration required to reduce the number of human lung carcinoma (A-549) after 3-day incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL885344,646.0,BAO_0000219,,
5947,4787,In vitro effective concentration required to reduce the number of human lung carcinoma cells (A-549) after 3-day incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623224,646.0,BAO_0000219,,
5948,6513,Cytotoxic activity against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623225,646.0,BAO_0000219,,
5949,6690,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 0.01 to 0.03,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622698,646.0,BAO_0000219,,
5950,6690,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 10.4 to 118.1,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622699,646.0,BAO_0000219,,
5951,12263,"Cytotoxicity in vitro expressed as 50% reduction in cell number after a 3-day incubation, in human lung carcinoma A-549 cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622700,646.0,BAO_0000219,,
5952,1054,Compound was tested for cytotoxic activity against human lung carcinoma (A-549),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622701,646.0,BAO_0000219,,
5953,1359,Compound was tested for its cytotoxic activity in MTT assay against A-549 cell line (human lung carcinoma),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622702,646.0,BAO_0000219,,
5954,3547,Cytotoxic activity against human lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622703,646.0,BAO_0000219,,
5955,5771,Cytotoxic activity towards A-549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622704,646.0,BAO_0000219,,
5956,14425,"In vitro percent inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622705,646.0,BAO_0000219,,
5957,14425,"In vitro percent inhibition of A549, lung carcinoma",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622706,646.0,BAO_0000219,,
5958,14425,"In vitro percent inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622707,646.0,BAO_0000219,,
5959,14425,"In vitro percent inhibition of A549, lung carcinoma.; Range 18-23",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622708,646.0,BAO_0000219,,
5960,5280,Percentage inhibition against parental and drug resistant lung human tumor cell line A549 at 10 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622709,646.0,BAO_0000219,,
5961,15176,Growth inhibition of the A549/ATCC non-small cell lung cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622710,646.0,BAO_0000219,,
5962,15300,In vitro antitumor activity against Non-small cell lung cancer A549/ATCC cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622711,646.0,BAO_0000219,,
5963,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 1.56-6.25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622712,646.0,BAO_0000218,,
5964,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 25-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622713,646.0,BAO_0000218,,
5965,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 3.12-12.5 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622714,646.0,BAO_0000218,,
5966,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 6.25-25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622715,646.0,BAO_0000218,,
5967,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 70-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622716,646.0,BAO_0000218,,
5968,17824,"Antitumor activity against A549 non small cell carcinoma on day 14, 21, 28; activity expressed as maximum tolerated dose; NT = Not tested",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622717,646.0,BAO_0000219,,
5969,17528,Optimal dose required to inhibit human non small cell lung A549 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q7dX3),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622718,646.0,BAO_0000218,,
5970,6870,Cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622719,646.0,BAO_0000219,,
5971,6870,Compound was evaluated for cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622720,646.0,BAO_0000219,,
5972,6870,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622721,646.0,BAO_0000219,,
5973,6870,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622722,646.0,BAO_0000219,,
5974,16726,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876030,646.0,BAO_0000219,,
5975,6170,"Concentration required for 50% inhibition of proliferation of lung cancer cell line, A549 with respect to paclitaxel was tested in vitro after 72 hr of incubation",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620206,646.0,BAO_0000219,,
5976,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-4 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620207,646.0,BAO_0000219,,
5977,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-5 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620208,646.0,BAO_0000219,,
5978,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-6 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620209,646.0,BAO_0000219,,
5979,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-7 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620210,646.0,BAO_0000219,,
5980,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-8 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621639,646.0,BAO_0000219,,
5981,17321,Tested for cytotoxicity against human lung adenocarcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621640,646.0,BAO_0000219,,
5982,17528,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621641,646.0,BAO_0000219,,
5983,12888,Cytotoxic effect on non-small-cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621642,646.0,BAO_0000219,,
5984,4312,Cytotoxicity of compound in synergy in 94% BCNU (10 uM) against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621643,646.0,BAO_0000219,,
5985,4312,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621644,646.0,BAO_0000219,,
5986,4312,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line; No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621645,646.0,BAO_0000219,,
5987,17737,In vitro antiproliferative activity against A549 cell line,F,,,Mus musculus,10090.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621646,646.0,BAO_0000219,,
5988,6630,Synergism with indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621647,646.0,BAO_0000219,,
5989,6630,Synergism with tolmetin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621648,646.0,BAO_0000219,,
5990,6630,Synergism with sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621649,646.0,BAO_0000219,,
5991,6630,Antagonism of indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621650,646.0,BAO_0000219,,
5992,6630,Antagonism of sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621651,646.0,BAO_0000219,,
5993,6630,Antagonism of tolmetin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621652,646.0,BAO_0000219,,
5994,6630,Synergism with indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621653,646.0,BAO_0000219,,
5995,6630,Synergism with sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621654,646.0,BAO_0000219,,
5996,6630,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tolmetin; Not available,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621655,646.0,BAO_0000219,,
5997,16907,Cmax value after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621656,,BAO_0000218,,
5998,5944,Cmax value determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621657,,BAO_0000218,,
5999,5944,Cmax value determined in dog at a dose of 10 mg/kg by oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621658,,BAO_0000218,,
6000,5944,Cmax value determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621659,,BAO_0000218,,
6001,5944,Cmax value determined in dog at a dose of 5 mg/kg by oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621660,,BAO_0000218,,
6002,2959,Cmax value after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621661,,BAO_0000218,,
6003,6241,Cmax value in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621662,,BAO_0000218,,
6004,6241,Cmax value in dogs after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621663,,BAO_0000218,,
6005,2652,Bioavailability as Cmax in dogs at 5 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621664,,BAO_0000218,,
6006,1806,Compound was evaluated for maximum observed plasma concentration at dose 27.5 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621665,,BAO_0000218,1969.0,
6007,1806,Compound was evaluated for maximum observed plasma concentration at dose 7.7 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621666,,BAO_0000218,1969.0,
6008,1021,Concentration maxima after oral dosing in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621667,,BAO_0000218,,
6009,1021,Concentration maxima after oral dosing in dogs; not available,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876738,,BAO_0000218,,
6010,1021,Concentration maxima after oral dosing in dogs; not available,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621668,,BAO_0000218,,
6011,5444,In vivo maximal concentration was calculated at 0.4 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621669,,BAO_0000218,,
6012,5444,In vivo maximal concentration was calculated at 0.6 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621670,,BAO_0000218,,
6013,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621671,,BAO_0000218,,
6014,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622360,,BAO_0000218,,
6015,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog; Poor absorption,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622361,,BAO_0000218,,
6016,5130,Cmax in dog plasma after oral dose (1 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622362,,BAO_0000218,1969.0,
6017,3249,Maximal concentration (Cmax) in dog plasma at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622363,,BAO_0000218,1969.0,
6018,5473,Maximal plasma concentration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622364,,BAO_0000218,1969.0,
6019,5474,Maximal plasma concentration at a dose of 1 mg/kg (oral),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622365,,BAO_0000218,1969.0,
6020,4657,Maximal plasma concentration required for pharmacokinetic data in dogs at dose of 1 mg/kg perorally,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622533,,BAO_0000218,1969.0,
6021,3031,Maximum concentration of compound in dog was evaluated.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622534,,BAO_0000218,,
6022,4527,Maximum concentration by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622535,,BAO_0000218,,
6023,4186,Maximum concentration in dog after administration of 20 mg/kg dose through peroral route,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876739,,BAO_0000218,,
6024,5007,Maximum concentration in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622536,,BAO_0000218,,
6025,3132,Maximum concentration obtained in dog plasma was determined,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622537,,BAO_0000218,1969.0,
6026,5006,Maximum concentration was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622538,,BAO_0000218,,
6027,4727,Maximum concentration at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627867,,BAO_0000218,,
6028,1916,Maximum concentration was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627868,,BAO_0000218,,
6029,1918,Maximum concentration was evaluated in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627869,,BAO_0000218,1969.0,
6030,3045,Maximum concentration was evaluated after 75 min after administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627870,,BAO_0000218,,
6031,9579,Maximum plasma concentration determined in dog after oral administration of 17b,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627871,,BAO_0000218,1969.0,
6032,9579,Maximum plasma concentration determined in dog after oral administration of 2b,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627872,,BAO_0000218,1969.0,
6033,933,Maximum plasma concentration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627873,,BAO_0000218,1969.0,
6034,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627874,,BAO_0000218,1969.0,
6035,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.9 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627875,,BAO_0000218,1969.0,
6036,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.95 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627876,,BAO_0000218,1969.0,
6037,17839,Maximum plasma concentration of compound in dog following p.o. administration of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627877,,BAO_0000218,1969.0,
6038,6348,Maximum plasma concentration of compound was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627878,,BAO_0000218,1969.0,
6039,16367,Maximum plasma concentration after oral administration to dogs at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627879,,BAO_0000218,1969.0,
6040,1337,Maximum plasma concentration in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875355,,BAO_0000218,1969.0,
6041,1337,Maximum plasma concentration in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627880,,BAO_0000218,1969.0,
6042,5199,Maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627881,,BAO_0000218,1969.0,
6043,17650,Maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627882,,BAO_0000218,1969.0,
6044,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627883,,BAO_0000218,1969.0,
6045,5356,Maximum plasma concentration was determined as in dogs at 1 mg/kg oral dosing Cmax; 0.05-0.2 ug/mL,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628526,,BAO_0000218,1969.0,
6046,5356,Maximum plasma concentration was determined in dogs at 1 mg/kg oral dosing; 0.05-0.2 ug/mL,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628527,,BAO_0000218,1969.0,
6047,6227,Maximum plasma concentration (Cmax) in dog (in vivo) at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628528,,BAO_0000218,1969.0,
6048,6227,Maximum plasma concentration (Cmax) in dog at a dose of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628529,,BAO_0000218,1969.0,
6049,6227,Maximum plasma concentration (Cmax) in dog at a dose of 0.7 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628530,,BAO_0000218,1969.0,
6050,6227,Maximum plasma concentration (Cmax) in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625243,,BAO_0000218,1969.0,
6051,3598,Maximum plasma drug concentration of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Expert,1,,CHEMBL625244,,BAO_0000218,1969.0,
6052,4368,Maximum concentration by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625245,,BAO_0000218,,
6053,6265,Pharmacokinetic (PK) property (Cmax) was determined in dog at the single dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625246,,BAO_0000218,,
6054,7767,Biodistribution in stomach was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL625247,,BAO_0000218,945.0,
6055,7767,Biodistribution in urine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625248,,BAO_0000218,1088.0,
6056,7767,Biodistribution in urine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram; ND- No data,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625249,,BAO_0000218,1088.0,
6057,7767,Biodistribution in urine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram; ND- No data,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625250,,BAO_0000218,1088.0,
6058,17811,Compound (0.09% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 120 min; No increase,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625251,,BAO_0000218,,
6059,17811,Compound (0.31% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 30 min; Low increase,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875356,,BAO_0000218,,
6060,17827,Compound (i.v.) was tested for maximum activity in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625252,,BAO_0000218,,
6061,17827,Compound was evaluated for elimination rate constants in vivo in whole blood of normal mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625253,,BAO_0000218,178.0,
6062,17827,Compound was evaluated for rate of bone uptake after administration of radiolabeled in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625254,,BAO_0000218,,
6063,17827,Compound was evaluated for rate of bone uptake in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625255,,BAO_0000218,,
6064,17827,Compound was evaluated for rate of bone uptake in mice; NA - not active (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625256,,BAO_0000218,,
6065,17827,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625257,,BAO_0000218,178.0,
6066,17827,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice; NA = not active (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625258,,BAO_0000218,178.0,
6067,17827,Compound was evaluated for washout rate in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625259,,BAO_0000218,,
6068,17827,Compound was evaluated for washout rate in mice after radiolabeled ligand injected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625260,,BAO_0000218,,
6069,17827,"Maximum activity (i.v.) after in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625261,,BAO_0000218,,
6070,17827,"Maximum activity in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625262,,BAO_0000218,,
6071,17827,"Residual activity in mice at 120 minutes, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622639,,BAO_0000218,,
6072,17257,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622640,,BAO_0000218,,
6073,17257,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice; Not detected.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622812,,BAO_0000218,,
6074,17257,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622813,,BAO_0000218,,
6075,17257,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice; Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622814,,BAO_0000218,,
6076,17827,Time at maximum activity in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622815,,BAO_0000218,,
6077,3760,Percent oral bioavailability was determined after administration of compound at 5 mg/kg perorally in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625342,,BAO_0000218,,
6078,3760,Percent oral bioavailability was determined after administration of compound at 50 mg/kg perorally in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625343,,BAO_0000218,,
6079,17409,Binding towards mouse plasma protein at 10 uM,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL877591,,BAO_0000218,,
6080,17409,Binding towards mouse plasma protein at 100 uM,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625344,,BAO_0000218,,
6081,2675,Bioavailability was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625345,,BAO_0000218,,
6082,2675,Bioavailability was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625346,,BAO_0000218,,
6083,3132,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625347,,BAO_0000218,,
6084,3132,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625348,,BAO_0000218,,
6085,16597,Bioavailability at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625349,,BAO_0000218,,
6086,2862,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625350,,BAO_0000218,,
6087,17764,Oral bioavailability after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL882952,,BAO_0000218,,
6088,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625351,,BAO_0000218,955.0,
6089,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625352,,BAO_0000218,955.0,
6090,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL877592,,BAO_0000218,955.0,
6091,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625353,,BAO_0000218,955.0,
6092,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625354,,BAO_0000218,955.0,
6093,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626019,,BAO_0000218,955.0,
6094,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626020,,BAO_0000218,948.0,
6095,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626021,,BAO_0000218,948.0,
6096,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626022,,BAO_0000218,948.0,
6097,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626192,,BAO_0000218,948.0,
6098,1276,Cytotoxic activity was tested against human prostate cell line A-549 (lung carcinoma),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626193,646.0,BAO_0000219,,
6099,3498,Cytotoxicity against A-549 cell line in the purdue cell culture screen was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL626194,646.0,BAO_0000219,,
6100,1169,Cytotoxicity against human lung carcinoma A-549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626195,646.0,BAO_0000219,,
6101,4450,In vitro cytotoxic activity against A-549 (human lung carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626196,646.0,BAO_0000219,,
6102,358,In vitro cytotoxicity against human lung carcinoma cell line A-549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626197,646.0,BAO_0000219,,
6103,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 3.6*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626198,646.0,BAO_0000219,,
6104,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.2*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626199,646.0,BAO_0000219,,
6105,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.3*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626200,646.0,BAO_0000219,,
6106,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 5.0*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626201,646.0,BAO_0000219,,
6107,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 6.1*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626202,646.0,BAO_0000219,,
6108,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 7.4*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626203,646.0,BAO_0000219,,
6109,15167,In vitro cytotoxicity against A-549 human lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626204,646.0,BAO_0000219,,
6110,4139,In vitro cytotoxicity against human lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624701,646.0,BAO_0000219,,
6111,833,In vitro cytotoxicity in human tumor lung carcinoma A-549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624702,646.0,BAO_0000219,,
6112,15718,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624703,646.0,BAO_0000219,,
6113,12373,Tested in vitro for cytotoxicity against A-549 lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624704,646.0,BAO_0000219,,
6114,637,The compound was tested for cytotoxicity against A-549 cell in human lung carcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624705,646.0,BAO_0000219,,
6115,14867,Cytotoxicity against human lung carcinoma cells (A-549) using SRB assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624706,646.0,BAO_0000219,,
6116,4461,Antitumor cytotoxic activity against A-549 cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624707,646.0,BAO_0000219,,
6117,5406,"Tested for the cytotoxicity against the Non-small cell lung cancer cell line A-549, growth inhibition by 50% is reported",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624708,646.0,BAO_0000219,,
6118,4457,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624709,646.0,BAO_0000219,,
6119,1386,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL884107,646.0,BAO_0000219,,
6120,3265,Antitumoral activity was assayed against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624710,646.0,BAO_0000219,,
6121,2359,Compound was evaluated for the cytotoxicity against A-549 tumor cell line after 3 days of incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624711,646.0,BAO_0000219,,
6122,4457,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624712,646.0,BAO_0000219,,
6123,12454,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624713,646.0,BAO_0000219,,
6124,1481,Compound was tested for inhibition of cell growth of A-549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624714,646.0,BAO_0000219,,
6125,1750,Compound was tested for its inhibitory effect on the growth of A-549 tumor cell line from lung.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624715,646.0,BAO_0000219,,
6126,5065,Concentration required for 50% inhibition of growth in human lung carcinoma cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624716,646.0,BAO_0000219,,
6127,808,In vitro cytotoxicity against A549-human lung carcinoma cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619505,646.0,BAO_0000219,,
6128,16364,Cytotoxic activity against cultured cells of A-549 human lung carcinoma.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619506,646.0,BAO_0000219,,
6129,1847,Cytotoxic activity against A-549 cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619507,646.0,BAO_0000219,,
6130,1747,Cytotoxicity was measured against neoplastic cultured A-549 cells of human lung carcinoma.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619508,646.0,BAO_0000219,,
6131,1003,Cytotoxicity against human A549 non small cell lung cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619509,646.0,BAO_0000219,,
6132,15313,Inhibition of cell growth in (A-549) lung cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619510,646.0,BAO_0000219,,
6133,3122,Growth inhibitory effect of compound was measured on A-549 human lung adenocarcinoma cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619511,646.0,BAO_0000219,,
6134,16049,In vitro antitumor activity against A-549 tumor cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619512,646.0,BAO_0000219,,
6135,17134,In vitro antitumor effects against human A-549 cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619513,646.0,BAO_0000219,,
6136,6406,In vitro cytotoxic activity of compound against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619514,646.0,BAO_0000219,,
6137,627,In vitro cytotoxicity against human lung carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619515,646.0,BAO_0000219,,
6138,12307,In vitro cytotoxicity against human non-small cell lung carcinoma A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619516,646.0,BAO_0000219,,
6139,17861,In vitro cytotoxicity against human A-549 cancer cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884005,646.0,BAO_0000219,,
6140,6682,In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619517,646.0,BAO_0000219,,
6141,6663,Inhibitory concentration of compound against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619518,646.0,BAO_0000219,,
6142,2454,Tested for the cytostatic activity as inhibitory concentration against A-549 human pulmonary adenocarcinoma cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619519,646.0,BAO_0000219,,
6143,14709,cytotoxic activity against leukemia (A-549) cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876489,646.0,BAO_0000219,,
6144,15718,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619520,646.0,BAO_0000219,,
6145,15718,Percent inhibition for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619521,646.0,BAO_0000219,,
6146,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.1(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619522,646.0,BAO_0000219,,
6147,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.4(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619523,646.0,BAO_0000219,,
6148,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 1.1 (ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619524,646.0,BAO_0000219,,
6149,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619525,646.0,BAO_0000219,,
6150,6630,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tometin; Not available,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619526,646.0,BAO_0000219,,
6151,16726,Influence of PARP-1 cellular activity in human lung carcinoma A549 cells on %ADP Polymer formation at a concentration of 25 uM of the compound,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619527,646.0,BAO_0000219,,
6152,17846,Cytotoxicity against A549 cells; No cytotoxicity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619528,646.0,BAO_0000219,,
6153,3415,Cytotoxicity against human lung carcinoma (A549) cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619529,646.0,BAO_0000219,,
6154,3415,Cytotoxicity against human lung carcinoma (A549) cell lines; Not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619530,646.0,BAO_0000219,,
6155,5609,In vitro anticancer activity against human lung (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876490,646.0,BAO_0000219,,
6156,17206,Percent growth inhibition at 200 uM PARP inhibitor in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619531,646.0,BAO_0000219,,
6157,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..006 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619532,646.0,BAO_0000219,,
6158,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..03 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619533,646.0,BAO_0000219,,
6159,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..15 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619534,646.0,BAO_0000219,,
6160,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..4 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620164,646.0,BAO_0000219,,
6161,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620165,646.0,BAO_0000219,,
6162,16295,Inhibition of A549 human lung tumor cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620166,646.0,BAO_0000219,,
6163,16825,"Concentration required to inhibit the lung A549 cell growth by 50%,P53 status of cell line used was wild-type. ",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620167,646.0,BAO_0000219,,
6164,3439,In vitro cytotoxicity against human tumor cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620168,646.0,BAO_0000219,,
6165,10870,In vitro growth inhibitory activity against A549 human nonsmall cell lung carcinoma cells. ,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620338,646.0,BAO_0000219,,
6166,4845,Inhibitory concentration of compound against proliferation of lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620339,646.0,BAO_0000219,,
6167,5822,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620340,646.0,BAO_0000219,,
6168,5822,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620341,646.0,BAO_0000219,,
6169,5822,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells: Not tested,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876491,646.0,BAO_0000219,,
6170,16381,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620342,646.0,BAO_0000219,,
6171,16381,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620343,646.0,BAO_0000219,,
6172,16381,% inhibition against A549 cells (lung cancer) at 4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620344,646.0,BAO_0000219,,
6173,5609,In vitro anticancer activity against human lung (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620345,646.0,BAO_0000219,,
6174,4644,Inhibition of proliferation of A549 cells at concentration of 0.1 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620346,646.0,BAO_0000219,,
6175,4644,Inhibition of proliferation of A549 cells at concentration of 100 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620347,646.0,BAO_0000219,,
6176,4644,Inhibition of proliferation of A549 cells at concentration of 10 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620348,646.0,BAO_0000219,,
6177,4644,Inhibition of proliferation of A549 cells at concentration of 1 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620349,646.0,BAO_0000219,,
6178,5822,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618667,646.0,BAO_0000219,,
6179,3415,Percentage inhibition of human lung carcinoma (A549) cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL618668,646.0,BAO_0000219,,
6180,16726,Influence of PARP-1 cellular activity on NAD+ levels at a concentration of 25 uM of the compound,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876031,646.0,BAO_0000219,,
6181,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM); ND denotes not determined",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618759,646.0,BAO_0000219,,
6182,17206,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells; ND denotes not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618760,646.0,BAO_0000219,,
6183,17206,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells; ND denotes not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619000,646.0,BAO_0000219,,
6184,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM)",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619001,646.0,BAO_0000219,,
6185,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.006 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619002,646.0,BAO_0000219,,
6186,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.03 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619003,646.0,BAO_0000219,,
6187,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.15 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619597,646.0,BAO_0000219,,
6188,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.4 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619598,646.0,BAO_0000219,,
6189,17206,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619599,646.0,BAO_0000219,,
6190,17206,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619600,646.0,BAO_0000219,,
6191,16726,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619601,646.0,BAO_0000219,,
6192,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.006 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619602,646.0,BAO_0000219,,
6193,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.03 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619603,646.0,BAO_0000219,,
6194,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.15 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619604,646.0,BAO_0000219,,
6195,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.4 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619605,646.0,BAO_0000219,,
6196,6084,Pharmacokinetic activity (Cmax) (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619606,,BAO_0000218,,
6197,6084,Pharmacokinetic activity (Cmax) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876032,,BAO_0000218,,
6198,4809,Pharmacokinetic parameter Cmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619607,,BAO_0000218,,
6199,5983,Pharmacokinetic property (Cmax) was measured in dog at the dose of 0.032 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619608,,BAO_0000218,,
6200,6251,Plasma clearance rate by iv administration in dog at a dose of 6 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619609,,BAO_0000218,,
6201,5932,Cmax in dog plasma after 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619610,,BAO_0000218,1969.0,
6202,4273,Tested for the peak blood level in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619611,,BAO_0000218,178.0,
6203,5313,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619612,,BAO_0000218,,
6204,5313,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog at dosage of 10 mpk",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619613,,BAO_0000218,,
6205,6221,The peak blood concentration after 5 hr administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619614,,BAO_0000218,178.0,
6206,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619615,,BAO_0000218,,
6207,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Dog at maximum of 0.3 hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619616,,BAO_0000218,,
6208,6241,Final plasma concentration in dogs after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619617,,BAO_0000218,1969.0,
6209,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 300 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619618,,BAO_0000218,,
6210,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 30 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876033,,BAO_0000218,,
6211,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 60 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619619,,BAO_0000218,,
6212,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619620,,BAO_0000218,,
6213,2189,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL619621,,BAO_0000218,1088.0,
6214,2189,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs; NA is <10% inhibition at 1 uM for binding data,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL619622,,BAO_0000218,1088.0,
6215,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by dogs; NA is <10% inhibition at 1 uM for binding data,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL618874,,BAO_0000218,1088.0,
6216,4257,Absolute bioavailability was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618875,,BAO_0000218,,
6217,6221,Bioavailability after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618876,,BAO_0000218,,
6218,6215,Bioavailability after peroral administration (1 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618877,,BAO_0000218,,
6219,17267,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618878,,BAO_0000218,,
6220,6621,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618879,,BAO_0000218,,
6221,3854,Bioavailability after intravenous administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618880,,BAO_0000218,,
6222,3854,Bioavailability after peroral administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618881,,BAO_0000218,,
6223,5007,Bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618882,,BAO_0000218,,
6224,4333,Bioavailability in dog (Beagle) (male) (dose 3 mg/kg i.v. and 10 mg/kg p.o.) measured from 1 to 24 hr,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624226,,BAO_0000218,,
6225,4333,Bioavailability in plasma of male Beagle dogs treated with 3 mg/kg (i.v.) and 10 mg/kg (p.o.) measured from 1 to 24 hr; ND indicates not determined,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624227,,BAO_0000218,1969.0,
6226,5006,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624228,,BAO_0000218,,
6227,5199,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624229,,BAO_0000218,,
6228,4368,Bioavailability by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624230,,BAO_0000218,,
6229,3771,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624231,,BAO_0000218,,
6230,4953,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624232,,BAO_0000218,,
6231,5064,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625127,,BAO_0000218,,
6232,17657,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625128,,BAO_0000218,,
6233,17796,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621675,,BAO_0000218,,
6234,17853,Bioavailability in dog (p.o.) at 2.0 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621676,,BAO_0000218,,
6235,4521,Bioavailability in dog (dose 2 mg/kg p.o. and 0.5 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621677,,BAO_0000218,,
6236,4521,Bioavailability in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621678,,BAO_0000218,,
6237,5006,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621679,,BAO_0000218,,
6238,16365,Bioavailability was evaluated after oral administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621680,,BAO_0000218,,
6239,1916,Bioavailability was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621681,,BAO_0000218,,
6240,1918,Bioavailability was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876740,,BAO_0000218,,
6241,4239,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621682,,BAO_0000218,,
6242,6505,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621683,,BAO_0000218,,
6243,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621684,,BAO_0000218,,
6244,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621685,,BAO_0000218,,
6245,4809,Bioavailability was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621686,,BAO_0000218,,
6246,6348,Bioavailability was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621687,,BAO_0000218,,
6247,6005,Bioavailability was evaluated in dog after peroral administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621688,,BAO_0000218,,
6248,17804,Bioavailability of compound in dog was determined after peroral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621689,,BAO_0000218,,
6249,3184,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621690,,BAO_0000218,,
6250,1806,Compound was evaluated for oral bioavailability at different dose 27.5 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621691,,BAO_0000218,,
6251,1806,Compound was evaluated for oral bioavailability at different dose 7.7 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875941,,BAO_0000218,,
6252,1806,Compound was evaluated for oral bioavailability in dogs; 37-38 %,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621692,,BAO_0000218,,
6253,4839,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621693,,BAO_0000218,,
6254,5017,Oral bioavailability in dog (1 mg/kg p.o. and 0.2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621694,,BAO_0000218,,
6255,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621695,,BAO_0000218,948.0,
6256,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621696,,BAO_0000218,948.0,
6257,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621697,,BAO_0000218,2113.0,
6258,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621698,,BAO_0000218,2113.0,
6259,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623420,,BAO_0000218,2113.0,
6260,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623421,,BAO_0000218,2113.0,
6261,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623422,,BAO_0000218,2113.0,
6262,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623423,,BAO_0000218,2113.0,
6263,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623424,,BAO_0000218,2107.0,
6264,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623425,,BAO_0000218,2107.0,
6265,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623426,,BAO_0000218,2107.0,
6266,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623427,,BAO_0000218,2107.0,
6267,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623428,,BAO_0000218,2107.0,
6268,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL875947,,BAO_0000218,2107.0,
6269,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623429,,BAO_0000218,2048.0,
6270,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623430,,BAO_0000218,2048.0,
6271,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622588,,BAO_0000218,2048.0,
6272,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622589,,BAO_0000218,2048.0,
6273,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622751,,BAO_0000218,2048.0,
6274,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622752,,BAO_0000218,2048.0,
6275,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622753,42.0,BAO_0000218,,
6276,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622647,42.0,BAO_0000218,,
6277,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875163,42.0,BAO_0000218,,
6278,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622648,42.0,BAO_0000218,,
6279,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622649,42.0,BAO_0000218,,
6280,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice brain bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622650,42.0,BAO_0000218,955.0,
6281,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622651,42.0,BAO_0000218,955.0,
6282,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622652,42.0,BAO_0000218,955.0,
6283,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622653,42.0,BAO_0000218,955.0,
6284,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622654,42.0,BAO_0000218,955.0,
6285,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622655,42.0,BAO_0000218,948.0,
6286,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622656,42.0,BAO_0000218,948.0,
6287,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622657,42.0,BAO_0000218,948.0,
6288,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622658,42.0,BAO_0000218,948.0,
6289,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622659,42.0,BAO_0000218,948.0,
6290,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624630,42.0,BAO_0000218,2113.0,
6291,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624631,42.0,BAO_0000218,2113.0,
6292,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624632,42.0,BAO_0000218,2113.0,
6293,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml) on,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624633,646.0,BAO_0000219,,
6294,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml)on,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624634,646.0,BAO_0000219,,
6295,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624635,646.0,BAO_0000219,,
6296,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml)),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624636,646.0,BAO_0000219,,
6297,3263,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL857055,646.0,BAO_0000219,,
6298,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-4 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624637,646.0,BAO_0000219,,
6299,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-5 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624638,646.0,BAO_0000219,,
6300,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-6 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL874366,646.0,BAO_0000219,,
6301,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-7 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624639,646.0,BAO_0000219,,
6302,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-8 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624640,646.0,BAO_0000219,,
6303,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.0625 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624641,646.0,BAO_0000219,,
6304,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.125 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624642,646.0,BAO_0000219,,
6305,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.25 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624643,646.0,BAO_0000219,,
6306,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.5 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624644,646.0,BAO_0000219,,
6307,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 1 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624645,646.0,BAO_0000219,,
6308,3983,The compound was evaluated for its cytotoxic potency against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619445,646.0,BAO_0000219,,
6309,11141,Cytotoxic concentration required to inhibit 50% cell growth in A-549 lung carcinoma cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839886,646.0,BAO_0000219,,
6310,5076,Cytotoxic activity of compound against A-549 tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619446,646.0,BAO_0000219,,
6311,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 6 day exposure.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619447,646.0,BAO_0000219,,
6312,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619448,646.0,BAO_0000219,,
6313,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure; ND is no data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619449,646.0,BAO_0000219,,
6314,5076,Cytotoxic activity of compound against A-549 tumor cell line at conc. of 20 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619450,646.0,BAO_0000219,,
6315,4150,Compound was tested for cytotoxic activity against A-549 human lung carcinoma (ATCC:CCL-185),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619451,646.0,BAO_0000219,,
6316,2150,In vitro inhibitory concentration against cell culture of A-549 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619452,646.0,BAO_0000219,,
6317,4644,Concentration for in vitro cytotoxicity against A-549 human lung tumor cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619453,646.0,BAO_0000219,,
6318,263,Dose required for in vitro cytotoxic activity against A-549 lung carcinoma cells at concentration of 10 ug/ml; NA is no cytotoxicity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL874367,646.0,BAO_0000219,,
6319,11333,Cytotoxic concentration against A-549 tumor cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619454,646.0,BAO_0000219,,
6320,11333,Cytotoxic concentration against A-549 tumor cells; Inactive at 10 ug/mL.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619455,646.0,BAO_0000219,,
6321,15895,"Cytotoxicity against NCI tumor panel, A-549/ATCC non small-cell lung cancer cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619456,646.0,BAO_0000219,,
6322,16677,Minimum inhibitory concentration (lowest peptide concentration) required to prevent visible bacterial growth after 18 hr of incubation at 37 C in Mueller-Hinton broth against Acinetobacter baumannii 118A,F,,,Acinetobacter baumannii,470.0,,,,,50191,N,1,Expert,1,,CHEMBL619457,,BAO_0000218,,
6323,10624,Activity against Acinetobacter calcoaceticus (AC54),F,,,Acinetobacter calcoaceticus,471.0,,,,,50192,N,1,Intermediate,1,,CHEMBL619458,,BAO_0000218,,
6324,16717,In vitro antifungal activity against Aspergillus flavus CM74,F,,,Aspergillus flavus,5059.0,,,,,50274,N,1,Expert,1,,CHEMBL619459,,BAO_0000218,,
6325,16717,In vitro antifungal activity against Aspergillus flavus CM74,F,,,Aspergillus flavus,5059.0,,,,,50274,N,1,Expert,1,,CHEMBL619460,,BAO_0000218,,
6326,5513,Inhibitory activity tested against Aspergillus fumigatus at 256 ug/mL concentration,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL619461,,BAO_0000218,,
6327,15962,In vitro minimum fungicidal concentration required to inhibit Aspergillus fumigatus(MFC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL619462,,BAO_0000218,,
6328,15962,Antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620388,,BAO_0000218,,
6329,15962,Antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620389,,BAO_0000218,,
6330,15962,In vitro antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620390,,BAO_0000218,,
6331,16717,In vitro antifungal activity against Aspergillus fumigatus 48238E,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Expert,1,,CHEMBL620391,,BAO_0000218,,
6332,16717,In vitro antifungal activity against Aspergillus fumigatus 48238E,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Expert,1,,CHEMBL621073,,BAO_0000218,,
6333,8117,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL621074,,BAO_0000218,,
6334,8117,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL621075,,BAO_0000218,,
6335,15472,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL619554,,BAO_0000218,,
6336,15472,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL619555,,BAO_0000218,,
6337,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619556,,BAO_0000218,,
6338,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619557,,BAO_0000218,,
6339,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2; ND is Not Determined,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619558,,BAO_0000218,,
6340,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619559,646.0,BAO_0000219,,
6341,17206,Percent ADP-ribose polymer formation at 25 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619560,646.0,BAO_0000219,,
6342,16381,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619561,646.0,BAO_0000219,,
6343,16381,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619562,646.0,BAO_0000219,,
6344,16381,% inhibition against A549 cells (lung cancer) at 4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619563,646.0,BAO_0000219,,
6345,16381,GI values against A549 cells (lung cancer),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL857457,646.0,BAO_0000219,,
6346,17206,Effect on NAD+ depletion (% remaining versus vehicle control) 25 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619564,646.0,BAO_0000219,,
6347,16325,Inhibitory activity against A549 human adenocarcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619565,646.0,BAO_0000219,,
6348,10708,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 200 mg/kg,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619566,646.0,BAO_0000218,,
6349,10708,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 100 mg/kg,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619567,646.0,BAO_0000218,,
6350,17376,Inhibitory activity against A549 lung adenocarcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619568,646.0,BAO_0000219,,
6351,17376,Inhibitory activity against A549 lung adenocarcinoma cell line; not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619569,646.0,BAO_0000219,,
6352,17488,Cytotoxicity against human A549 lung cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619570,646.0,BAO_0000219,,
6353,17404,In vivo percent inhibitory activity of intraperitoneally administered compound (50 mg/kg/day) against mice infected with A549 tumor,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619571,646.0,BAO_0000218,,
6354,10958,Growth inhibition of A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619572,646.0,BAO_0000219,,
6355,17099,Effective dose required for inhibitory activity against A549 human tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619573,646.0,BAO_0000219,,
6356,17099,Effective dose required for inhibitory activity against A549 human tumor cell line; Not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619574,646.0,BAO_0000219,,
6357,4096,Cytotoxicity was evaluated against A549 tumor cell lines; Inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619575,646.0,BAO_0000219,,
6358,4096,Cytotoxicity evaluated against A549 tumor cell lines; significant activity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619576,646.0,BAO_0000219,,
6359,4096,Cytotoxicity was evaluated against A549 tumor cell lines; Slightly active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619577,646.0,BAO_0000219,,
6360,2525,In vitro inhibitory activity against A549 tumor cell culture,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619578,646.0,BAO_0000219,,
6361,2525,In vitro inhibitory activity against A549 tumor cell culture; IA= Inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884009,646.0,BAO_0000219,,
6362,5302,Activity against human lung cancer with mutated beta-tubulin (A549-T2415),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619579,646.0,BAO_0000219,,
6363,16325,Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619580,646.0,BAO_0000219,,
6364,16939,Inhibition of growth of A549/ATCC nonsmall cell lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619581,646.0,BAO_0000219,,
6365,17229,In vitro antitumor activity against NSCL A549/ATCC tumor cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619582,646.0,BAO_0000219,,
6366,17380,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619583,646.0,BAO_0000219,,
6367,17380,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells; No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876502,646.0,BAO_0000219,,
6368,1903,In vitro cytotoxicity against human Non-small cell lung cancer A549/ATCC cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619584,646.0,BAO_0000219,,
6369,3838,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619585,646.0,BAO_0000219,,
6370,14696,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619586,646.0,BAO_0000219,,
6371,3838,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619587,646.0,BAO_0000219,,
6372,1522,Tested for in vitro cytotoxicity against non-small cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619588,646.0,BAO_0000219,,
6373,12400,Tested in vitro for cytotoxicity in A549/ATCC cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619589,646.0,BAO_0000219,,
6374,14696,inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619590,646.0,BAO_0000219,,
6375,14769,Compound was evaluated for in vitro activity against A549/ATCC lung cancer cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619591,646.0,BAO_0000219,,
6376,14696,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line at 0.01 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619592,646.0,BAO_0000219,,
6377,1888,Compound was evaluated for cytotoxic activity against non-small lung cancer A549/ATCC cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619593,646.0,BAO_0000219,,
6378,12016,Tested for cytotoxic activity against non-small cell lung cancer A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620217,646.0,BAO_0000219,,
6379,6058,Compound tested for growth inhibition of non-small cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620218,646.0,BAO_0000219,,
6380,17708,Compound was tested for 50% growth inhibition against human non-small cell lung cancer A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620219,646.0,BAO_0000219,,
6381,12301,Antitumor activity against A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620220,646.0,BAO_0000219,,
6382,11970,Tested for cytotoxicity against A549/ATCC cell lines in non-small-cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625141,646.0,BAO_0000219,,
6383,11818,In vitro cytotoxicity against A549/ATCC cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL625142,646.0,BAO_0000219,,
6384,12400,Tested in vitro for cytotoxicity in A549/ATCC cell line of Non-Small Cell Lung Cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625143,646.0,BAO_0000219,,
6385,3381,In vitro inhibition of Non-Small Cell Lung Cancer A549/ATCC cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625144,646.0,BAO_0000219,,
6386,17376,Concentration of compound that cause 50% cytotoxicity of A549/ATCC non small cell lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622474,646.0,BAO_0000219,,
6387,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A549Rem- cell line of lung using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884104,646.0,BAO_0000219,,
6388,2964,Cytotoxicity was evaluated against A649 human mammary carcinoma cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL622475,,BAO_0000219,,
6389,5005,Compound was tested for oral bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Intermediate,1,,CHEMBL622476,,BAO_0000218,,
6390,6229,Compound was tested for orally bioavailable in dogs with a half life of 0.7 hr,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875831,,BAO_0000218,,
6391,6229,Compound was tested for orally bioavailable in dogs with a half life of 1.2h,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622477,,BAO_0000218,,
6392,5374,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622478,,BAO_0000218,,
6393,5374,Compound was tested for the oral bioavailability in dog; No availability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623172,,BAO_0000218,,
6394,6265,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623173,,BAO_0000218,,
6395,5654,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623174,,BAO_0000218,,
6396,5654,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623175,,BAO_0000218,,
6397,16456,Oral bioavailability in Beagle dogs after Per oral administration at dose of 50(mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623340,,BAO_0000218,,
6398,5302,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623341,,BAO_0000218,,
6399,3624,Oral bioavailability in dog (p.o. dosing of 0.05 M citric acid/0.05 M hydrochloric acid solution),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623342,,BAO_0000218,,
6400,16452,Oral bioavailability of active FTIs in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623343,,BAO_0000218,,
6401,5802,Oral bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623344,,BAO_0000218,,
6402,3598,Oral bioavailability of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL623345,,BAO_0000218,,
6403,17839,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875832,,BAO_0000218,,
6404,6762,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623346,,BAO_0000218,,
6405,6821,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623347,,BAO_0000218,,
6406,6821,Oral bioavailability of compound was determined in dog; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623348,,BAO_0000218,,
6407,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623349,,BAO_0000218,,
6408,6227,Oral bioavailability (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623350,,BAO_0000218,,
6409,761,Oral bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623351,,BAO_0000218,,
6410,761,Oral bioavailability in dog (dosed as neat powder in hard gelatin capsule),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623352,,BAO_0000218,,
6411,761,Oral bioavailability administered in solution in rats,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623353,,BAO_0000218,,
6412,16907,Oral bioavailability after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875833,,BAO_0000218,,
6413,5474,Oral bioavailability at a dose of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623354,,BAO_0000218,,
6414,6535,Oral bioavailability in dog (dose 1 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623355,,BAO_0000218,,
6415,6535,Oral bioavailability in Dog; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623356,,BAO_0000218,,
6416,3352,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623357,,BAO_0000218,,
6417,6168,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623358,,BAO_0000218,,
6418,5988,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623359,,BAO_0000218,,
6419,4942,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623360,,BAO_0000218,,
6420,4942,Oral bioavailability in dogs; No data,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623361,,BAO_0000218,,
6421,14541,Oral bioavailability measured in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623362,,BAO_0000218,,
6422,4449,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623363,,BAO_0000218,,
6423,6057,Oral bioavailability was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623364,,BAO_0000218,,
6424,5600,Oral bioavailability after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875834,,BAO_0000218,,
6425,5542,Oral bioavailability in dog (i.v. dosing),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623365,,BAO_0000218,,
6426,5542,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623366,,BAO_0000218,,
6427,5546,Oral bioavailability in Beagle dog at a dose of 2 mg/kg by po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623367,,BAO_0000218,,
6428,4514,Oral bioavailability in Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623368,,BAO_0000218,,
6429,3624,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623369,,BAO_0000218,,
6430,3854,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623370,,BAO_0000218,,
6431,5836,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623371,,BAO_0000218,,
6432,5940,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623372,,BAO_0000218,,
6433,6168,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621351,,BAO_0000218,,
6434,6227,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621352,,BAO_0000218,,
6435,6251,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621353,,BAO_0000218,,
6436,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621354,,BAO_0000218,,
6437,6647,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621355,,BAO_0000218,,
6438,5940,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621356,,BAO_0000218,,
6439,933,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621357,,BAO_0000218,,
6440,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621358,,BAO_0000218,,
6441,6642,Oral bioavailability in dog (dosed as a mixture of five compounds at 0.5 mg/kg each via i.v. only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621359,,BAO_0000218,,
6442,6641,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621360,,BAO_0000218,,
6443,6642,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621361,,BAO_0000218,,
6444,5472,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621362,,BAO_0000218,,
6445,5985,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621363,,BAO_0000218,,
6446,15660,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621364,,BAO_0000218,,
6447,5530,Oral bioavailability in dog (dose 0.2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621166,,BAO_0000218,,
6448,5530,Oral bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621167,,BAO_0000218,,
6449,6305,Oral bioavailability (F) in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621168,,BAO_0000218,,
6450,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621169,,BAO_0000218,,
6451,5238,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875950,,BAO_0000218,,
6452,5668,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621170,,BAO_0000218,,
6453,5668,Oral bioavailability after peroral administration at 5 mpk in Dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621171,,BAO_0000218,,
6454,5668,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621172,,BAO_0000218,,
6455,6084,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621173,,BAO_0000218,,
6456,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621174,42.0,BAO_0000218,2113.0,
6457,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621175,42.0,BAO_0000218,2113.0,
6458,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621176,42.0,BAO_0000218,2107.0,
6459,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621177,42.0,BAO_0000218,2107.0,
6460,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621178,42.0,BAO_0000218,2107.0,
6461,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621179,42.0,BAO_0000218,2107.0,
6462,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621180,42.0,BAO_0000218,2107.0,
6463,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875951,42.0,BAO_0000218,2048.0,
6464,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621181,42.0,BAO_0000218,2048.0,
6465,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621182,42.0,BAO_0000218,2048.0,
6466,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621183,42.0,BAO_0000218,2048.0,
6467,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621184,42.0,BAO_0000218,2048.0,
6468,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621185,42.0,BAO_0000218,,
6469,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice muscle bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621186,42.0,BAO_0000218,,
6470,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621187,42.0,BAO_0000218,,
6471,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621188,42.0,BAO_0000218,,
6472,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621189,42.0,BAO_0000218,,
6473,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice spleen bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621190,42.0,BAO_0000218,2106.0,
6474,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL618520,42.0,BAO_0000218,2106.0,
6475,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621739,42.0,BAO_0000218,2106.0,
6476,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621740,42.0,BAO_0000218,2106.0,
6477,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621741,42.0,BAO_0000218,2106.0,
6478,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621742,42.0,BAO_0000218,,
6479,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621743,42.0,BAO_0000218,,
6480,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621744,42.0,BAO_0000218,,
6481,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621745,42.0,BAO_0000218,,
6482,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621746,42.0,BAO_0000218,,
6483,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621747,42.0,BAO_0000218,,
6484,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621748,42.0,BAO_0000218,,
6485,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621749,42.0,BAO_0000218,,
6486,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621750,42.0,BAO_0000218,,
6487,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621751,42.0,BAO_0000218,,
6488,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621752,42.0,BAO_0000218,948.0,
6489,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621753,42.0,BAO_0000218,948.0,
6490,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875955,42.0,BAO_0000218,948.0,
6491,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621754,42.0,BAO_0000218,948.0,
6492,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621755,42.0,BAO_0000218,948.0,
6493,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621756,42.0,BAO_0000218,2107.0,
6494,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624199,42.0,BAO_0000218,2107.0,
6495,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624200,42.0,BAO_0000218,2107.0,
6496,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624375,42.0,BAO_0000218,2107.0,
6497,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624376,42.0,BAO_0000218,2107.0,
6498,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624377,42.0,BAO_0000218,2048.0,
6499,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/lung bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624378,42.0,BAO_0000218,2048.0,
6500,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,aeinetobacter anitrotap,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL857901,,BAO_0000218,,
6501,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,Acinetobacter calcoaceticus subsp. anitratus,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL875274,,BAO_0000218,,
6502,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,Acinetobacter calcoaceticus subsp. anitratus,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL624379,,BAO_0000218,,
6503,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,aeinetobacter anitrotap,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL624380,,BAO_0000218,,
6504,10624,Activity against Acinetobacter calcoaceticus (AC54),F,,,Acinetobacter calcoaceticus,471.0,,,,,50192,N,1,Intermediate,1,,CHEMBL624381,,BAO_0000218,,
6505,17216,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates no prolonged biological activity,F,,,Anolis carolinensis,28377.0,,,,,50714,N,1,Intermediate,1,,CHEMBL624382,,BAO_0000218,,
6506,17216,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates prolonged biological activity,F,,,Anolis carolinensis,28377.0,,,,,50714,N,1,Intermediate,1,,CHEMBL624383,,BAO_0000218,,
6507,9560,Chlorohexidine coefficient for Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624384,,BAO_0000218,,
6508,9560,Chlorohexidine coefficient for Actinomyces naeslundii B74,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624385,,BAO_0000218,,
6509,9560,Chlorohexidine coefficient for Actinomyces naeslundii N/3,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624386,,BAO_0000218,,
6510,9560,Chlorohexidine coefficient for Actinomyces naeslundii N/9,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624387,,BAO_0000218,,
6511,9560,Plaque bactericidal index against Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624388,,BAO_0000218,,
6512,9560,Plaque bactericidal index against Actinomyces naeslundii N/9,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624389,,BAO_0000218,,
6513,9560,Plaque bactericidal index against Actinomyces naeslundii B74,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624390,,BAO_0000218,,
6514,9560,Plaque bactericidal index against Actinomyces naeslundii N/3,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL875275,,BAO_0000218,,
6515,114,Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay,F,,,Artemia salina,85549.0,,,,,50056,N,1,Intermediate,1,,CHEMBL624391,,BAO_0000218,,
6516,114,"Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay; highest level tested, showed <100% activity",F,,,Artemia salina,85549.0,,,,,50056,N,1,Intermediate,1,,CHEMBL623636,,BAO_0000218,,
6517,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 0 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623637,,BAO_0000218,,
6518,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 10 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623638,,BAO_0000218,,
6519,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 200 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623639,,BAO_0000218,,
6520,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 25 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623640,,BAO_0000218,,
6521,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 3 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623641,,BAO_0000218,,
6522,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 50 uM.,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623642,,BAO_0000218,,
6523,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 0 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623643,,BAO_0000218,,
6524,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 10 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623644,,BAO_0000218,,
6525,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 200 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623645,,BAO_0000218,,
6526,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 25 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623646,,BAO_0000218,,
6527,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 3 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623647,,BAO_0000218,,
6528,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 50 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623648,,BAO_0000218,,
6529,8117,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623649,,BAO_0000218,,
6530,8117,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623650,,BAO_0000218,,
6531,9560,Chlorohexidine coefficient for Actinomyces viscosus 8A06,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623651,,BAO_0000218,,
6532,9560,Chlorohexidine coefficient for Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Expert,1,,CHEMBL623652,,BAO_0000218,,
6533,9560,Chlorohexidine coefficient for Actinomyces viscosus M-626,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623653,,BAO_0000218,,
6534,9560,Chlorohexidine coefficient for Actinomyces viscosus T14V,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623654,,BAO_0000218,,
6535,9560,Plaque bactericidal index against Actinomyces viscosus 8A06,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623655,,BAO_0000218,,
6536,9560,Plaque bactericidal index against Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623656,,BAO_0000218,,
6537,9560,Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Expert,1,,CHEMBL623657,,BAO_0000218,,
6538,9560,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; d=Not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623658,,BAO_0000218,,
6539,9560,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623659,,BAO_0000218,,
6540,9560,Plaque bactericidal index against Actinomyces viscosus 626,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623660,,BAO_0000218,,
6541,9560,Plaque bactericidal index against Actinomyces viscosus T14V,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623661,,BAO_0000218,,
6542,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 1.56 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL875281,,BAO_0000218,,
6543,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 100 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623662,,BAO_0000218,,
6544,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 12.5 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623663,,BAO_0000218,,
6545,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 200 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623664,,BAO_0000218,,
6546,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 25 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623665,,BAO_0000218,,
6547,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A673Mer+ sarcoma cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A673,,80023,N,1,Intermediate,1,,CHEMBL621856,165.0,BAO_0000219,,
6548,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A704Rem- renal cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A704,,80661,N,1,Intermediate,1,,CHEMBL620432,645.0,BAO_0000219,,
6549,416,Tested for inhibition of ET-1 induced phosphoinositide (PI) turnover in A7r5 smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620433,,BAO_0000219,,
6550,14354,Inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620434,625.0,BAO_0000219,,
6551,14354,Percent inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620435,625.0,BAO_0000219,,
6552,5116,Cytotoxicity against Beta- tubulin mutant expressing A9-PTX10 cell line of humans was tested,F,,,Homo sapiens,9606.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620436,625.0,BAO_0000219,,
6553,5116,Percentage inhibition at higher concentration (100 nM) against Beta- tubulin mutant expressing A9-PTX10 cell line,F,,,Homo sapiens,9606.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL876597,625.0,BAO_0000219,,
6554,15694,Inhibition of human ovarian carcinoma (A90) FGF-R overexpressing cell proliferation,F,,,Homo sapiens,9606.0,,,Human ovarian carcinoma cell line,,81037,N,1,Expert,1,,CHEMBL620437,874.0,BAO_0000219,,
6555,13038,"Tested for stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells, activity expressed as EC50 mM.",F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL620438,625.0,BAO_0000219,,
6556,13038,Stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells.,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL620439,625.0,BAO_0000219,,
6557,10923,Increase in phosphoinositide (PI) metabolism in A9L-m1 cells at 100 uM.,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL619657,625.0,BAO_0000219,,
6558,10923,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; - = Not determined,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619658,625.0,BAO_0000219,,
6559,10923,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; i = inactive,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619659,625.0,BAO_0000219,,
6560,10923,"Increase in phosphoinositide (PI) metabolism in A9L-cholinergic receptor, muscarinic 3 expressing cells was measured at 100 uMolar",F,,,,,,,,,10649,H,8,Expert,1,,CHEMBL619660,,BAO_0000019,,
6561,10923,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; - = Not determined,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619661,625.0,BAO_0000219,,
6562,10923,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; i = inactive,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619662,625.0,BAO_0000219,,
6563,8158,Ability to inhibit growth of AA-6 cells (a mutant cell line resistant to 8-azaadenine and lacks adenine phosphoryltransferase) was determined,F,,,Cricetulus griseus,10029.0,,,AA6,,80663,N,1,Intermediate,1,,CHEMBL619663,975.0,BAO_0000219,,
6564,15494,Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied after 5 hrs of Incubation.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619664,,BAO_0000219,,
6565,15494,"Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied, after 5 hrs of Incubation.",F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619665,,BAO_0000219,,
6566,12348,Anti -HIV activity was measured against AA5/HIV-1(IIIB),F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL883244,974.0,BAO_0000219,,
6567,12348,Cytotoxicity was measured against AA5/HIV-1(IIIB),F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL884011,974.0,BAO_0000219,,
6568,2726,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in AA5 EBV-infected B-cell,F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL619666,974.0,BAO_0000219,,
6569,2726,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in U937 monocytic cell,F,,,Homo sapiens,9606.0,,,U-937,,80566,N,1,Intermediate,1,,CHEMBL619667,379.0,BAO_0000219,,
6570,10747,Hypersensitivity factor obtained from in vitro cytotoxicities against Chinese hamster ovary derived AA8 / UV4 cell lines,F,,,Cricetulus griseus,10029.0,,,UV4,,80578,N,1,Intermediate,1,,CHEMBL619668,274.0,BAO_0000219,,
6571,11005,"Inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL619669,185.0,BAO_0000219,,
6572,12687,Average intracellular compound concentration when the hypoxic SER=1.6,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL876608,185.0,BAO_0000219,,
6573,12687,Average intracellular compound concentration when the hypoxic SER=1.6.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619670,185.0,BAO_0000219,,
6574,12687,Average intracellular compound concentration where the hypoxia sensitizer enhancement ratio (SER)=1.6,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619671,185.0,BAO_0000219,,
6575,12687,Average intracellular compound concentration where the sensitizer enhancement ratio (SER)=1.6 under hypoxia,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619672,185.0,BAO_0000219,,
6576,12687,Compound concentration at which sensitizer enhancement ratio =1.6 under hypoxia.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619673,185.0,BAO_0000219,,
6577,13436,"Compound was tested for the concentration required to reduce cell survival under hypoxic conditions, using the cell line AA8 in the clonogenic assay.",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619674,185.0,BAO_0000219,,
6578,13435,"Concentration needed to reduce cell survival to 10% of control values, using 1 hour exposure of plateau phase AA8 cells at 10e6 cells/ml",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619675,185.0,BAO_0000219,,
6579,13302,Activity to reduce the surviving fraction to 10% (CT10) was used as an inverse measure of cytotoxic potency in aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619676,185.0,BAO_0000219,,
6580,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619677,185.0,BAO_0000219,,
6581,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619678,185.0,BAO_0000219,,
6582,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition.,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619679,185.0,BAO_0000219,,
6583,12878,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL619680,185.0,BAO_0000219,,
6584,12878,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay. Inactive at the solubility limit,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL621457,185.0,BAO_0000219,,
6585,14367,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% controls in clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL876609,185.0,BAO_0000219,,
6586,14367,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% of controls in clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL621458,185.0,BAO_0000219,,
6587,12398,Aerobic cytotoxicity was assessed in a growth inhibition assay using log phase cultures of the chinese hamster ovary fibroblast line AA8,F,,,hampster,36483.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621459,185.0,BAO_0000219,,
6588,12878,Aerobic growth inhibition in Chinese hamster cell line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621460,185.0,BAO_0000219,,
6589,13820,Cytotoxicity against AA8 cell and IC50 values were determined as drug concentration required to inhibit cell protein to 50%.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621461,185.0,BAO_0000219,,
6590,13436,Inhibition of growth under aerobic conditions in AA8 cells,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621462,185.0,BAO_0000219,,
6591,6084,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621463,,BAO_0000218,,
6592,5711,Oral bioavailability in dog at 10 mg/kg of the compound,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621464,,BAO_0000218,,
6593,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621465,,BAO_0000218,,
6594,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621466,,BAO_0000218,,
6595,17800,Oral bioavailability in dog (mongrel),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621467,,BAO_0000218,,
6596,3994,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621468,,BAO_0000218,,
6597,3994,Oral bioavailability in dog (dose 10 mg/kg),F,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876734,,BAO_0000218,,
6598,5145,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618476,,BAO_0000218,,
6599,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618477,,BAO_0000218,,
6600,16452,Pharmacokinetic data for dose given to dogs intravenously (oral PK study in parentheses),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618478,,BAO_0000218,,
6601,5983,Pharmacokinetic property (F) was measured in dog at the dose of 0.032 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618479,,BAO_0000218,,
6602,4273,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618480,,BAO_0000218,,
6603,12500,Bioavailability in dog (dose 3-10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618481,,BAO_0000218,,
6604,12500,The compound was tested for bioavailability of compound in plasma of dog; Complete,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618482,,BAO_0000218,1969.0,
6605,3639,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618483,,BAO_0000218,,
6606,3880,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618484,,BAO_0000218,,
6607,4838,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618485,,BAO_0000218,,
6608,15600,oral bioavailability was measured in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618486,,BAO_0000218,,
6609,17248,Compound was tested for plasma protein binding in dog; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618487,,BAO_0000218,,
6610,17248,Compound was tested for plasma protein binding of dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618488,,BAO_0000218,,
6611,17248,Compound was tested for plasma protein binding of dog; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876735,,BAO_0000218,,
6612,17443,Concentration in dogs after oral administration at dose of 1 mg/kg after 180 min.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618489,,BAO_0000218,,
6613,4186,Apparent terminal elimination half-life in dog after administration of 20 mg/kg dose through peroral route,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618490,,BAO_0000218,,
6614,3749,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618491,,BAO_0000218,,
6615,3249,Half life by ''Cr'' assay in dog at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618492,,BAO_0000218,,
6616,3022,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873354,,BAO_0000218,,
6617,3749,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618493,,BAO_0000218,,
6618,2517,Biodistribution of compound was measured in bile at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618494,,BAO_0000218,,
6619,2517,Biodistribution of compound was measured in heart at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Heart,,,50588,N,1,Intermediate,1,,CHEMBL618495,,BAO_0000218,948.0,
6620,2517,Biodistribution of compound was measured in kidney at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Kidney,,,50588,N,1,Intermediate,1,,CHEMBL618496,,BAO_0000218,2113.0,
6621,2517,Biodistribution of compound was measured in liver at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL618497,,BAO_0000218,2107.0,
6622,2517,Biodistribution of compound was measured in lung at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Lung,,,50588,N,1,Intermediate,1,,CHEMBL618498,,BAO_0000218,2048.0,
6623,2517,Biodistribution of compound was measured in spleen at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL618499,,BAO_0000218,2106.0,
6624,3639,LogP in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876736,,BAO_0000218,,
6625,6227,Partition coefficient (logP),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618500,,BAO_0000218,,
6626,6227,Partition coefficient in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL857831,,BAO_0000218,,
6627,17764,Mean-residence time of compound after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618501,,BAO_0000218,,
6628,4809,Pharmacokinetic parameter MRT was determined in Beagle dogs after (po) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618502,,BAO_0000218,,
6629,5600,In vitro metabolic stability determined after 30 min of incubation in dog hepatic microsomes,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618503,,BAO_0000218,,
6630,14294,Metabolism of compound in dog S9 microsomes ('++''indicates 20-50% largest observed peak),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618504,,BAO_0000218,,
6631,14294,Metabolism of compound in dog S9 microsomes ('++++' indicates largest observed peak),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618505,,BAO_0000218,,
6632,14294,Metabolism of compound in dog S9 microsomes; Trace,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618506,,BAO_0000218,,
6633,6251,In vitro metabolic potential in dog liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL618507,,BAO_0000218,2107.0,
6634,3748,Oral bioavailability of perorally administered compound (10 mg/kg) was tested in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876737,,BAO_0000218,,
6635,2713,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618508,,BAO_0000218,,
6636,6512,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618509,,BAO_0000218,,
6637,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618510,,BAO_0000218,,
6638,3749,The compound was tested for bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618511,,BAO_0000218,,
6639,3749,The compound was tested for oral bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618512,,BAO_0000218,,
6640,6742,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618513,,BAO_0000218,,
6641,6227,Compound was tested for percent protein binding (PB) in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618514,,BAO_0000218,,
6642,6874,Apparent permeability coefficient (Papp) for apical to basolateral flux was determined in MadinDarby Canine Kidney cells,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620052,,BAO_0000218,,
6643,2877,Compound was evaluated for plasma clearance.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620053,,BAO_0000218,1969.0,
6644,12500,The compound was tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620054,,BAO_0000218,1969.0,
6645,12500,The compound was tested for plasma clearance in dog at dose of 3-10 mgkg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620055,,BAO_0000218,1969.0,
6646,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620056,,BAO_0000218,,
6647,5542,In vitro relative rate of metabolism was determined in dog liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL620057,,BAO_0000218,2107.0,
6648,17594,Relative bioavailability after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618939,,BAO_0000218,,
6649,2652,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618940,,BAO_0000218,,
6650,17764,Half life after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618941,,BAO_0000218,,
6651,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624473,42.0,BAO_0000218,2048.0,
6652,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624474,42.0,BAO_0000218,2048.0,
6653,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624475,42.0,BAO_0000218,2048.0,
6654,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624476,42.0,BAO_0000218,,
6655,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623478,42.0,BAO_0000218,,
6656,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623479,42.0,BAO_0000218,,
6657,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623480,42.0,BAO_0000218,,
6658,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623481,42.0,BAO_0000218,,
6659,17641,C2 in brain of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL623482,,BAO_0000218,955.0,
6660,17641,C2 in kidney of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623483,,BAO_0000218,2113.0,
6661,17641,C2 in liver of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623484,,BAO_0000218,2107.0,
6662,17641,C2 in lungs of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623485,,BAO_0000218,2048.0,
6663,17641,C2 in spleen of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL623486,,BAO_0000218,2106.0,
6664,17852,Plasma clearance in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623487,,BAO_0000218,,
6665,17764,Clearance of compound after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623488,,BAO_0000218,,
6666,17837,Clearance from mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623489,,BAO_0000218,,
6667,2675,Clearance was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875157,,BAO_0000218,,
6668,2675,Clearance was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623490,,BAO_0000218,,
6669,4239,Pharmacokinetic property (Plasma clearance) was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623491,,BAO_0000218,,
6670,17753,Plasma clearance of compound was determined at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623492,,BAO_0000218,,
6671,17753,Plasma clearance of at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623493,,BAO_0000218,,
6672,17753,Plasma clearance at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623494,,BAO_0000218,,
6673,17753,Plasma clearance at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623495,,BAO_0000218,,
6674,5727,Plasma clearance in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623496,,BAO_0000218,,
6675,2862,Plasma clearance value upon iv administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623497,,BAO_0000218,,
6676,5980,Total plasma clearance in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623498,,BAO_0000218,1969.0,
6677,17592,Clearance in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623499,,BAO_0000218,,
6678,17718,Clearance value was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623500,,BAO_0000218,,
6679,16597,Plasma clearance at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623501,,BAO_0000218,,
6680,17384,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Intermediate,1,,CHEMBL875158,,BAO_0000100,,
6681,6062,Plasma clearance for the compound was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623502,,BAO_0000218,,
6682,17734,Plasma clearance rate after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623503,,BAO_0000218,,
6683,6348,Plasma clearance was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623504,,BAO_0000218,,
6684,5969,In vivo total clearance was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623505,,BAO_0000218,,
6685,5969,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623506,,BAO_0000218,,
6686,5969,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623507,,BAO_0000218,,
6687,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for Cmax,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623508,,BAO_0000218,,
6688,5781,Cmax after oral administration at 30 mg/kg in ICR mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623509,,BAO_0000218,,
6689,17764,Cmax after peroral administration in mice at 2.4 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875159,,BAO_0000218,,
6690,17641,Cmax in brain of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL623510,,BAO_0000218,955.0,
6691,17641,Cmax in kidney of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623511,,BAO_0000218,2113.0,
6692,17641,Cmax in liver of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623512,,BAO_0000218,2107.0,
6693,17641,Cmax in lungs of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623513,,BAO_0000218,2048.0,
6694,17764,Cmax in mice at 18 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623514,,BAO_0000218,,
6695,17764,Cmax in mice at 23 uM/kg i.v. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622609,,BAO_0000218,,
6696,17764,Cmax in mice at 24 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622610,,BAO_0000218,,
6697,17764,Cmax in mice at 25 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621823,,BAO_0000218,,
6698,17764,Cmax in mice at 26 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621824,,BAO_0000218,,
6699,17641,Cmax in spleen of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL621825,,BAO_0000218,2106.0,
6700,16597,Cmax value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621826,,BAO_0000218,,
6701,16597,Cmax value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621827,,BAO_0000218,,
6702,5727,Cmax value was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621828,,BAO_0000218,,
6703,5951,Cmax value in IRC mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621829,,BAO_0000218,,
6704,5506,Cmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621830,,BAO_0000218,,
6705,5506,Cmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621831,,BAO_0000218,,
6706,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621832,,BAO_0000218,1969.0,
6707,4890,"Compound was evaluated for the pharmacokinetic parameter, maximum plasma concentration",A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL624579,,BAO_0000218,1969.0,
6708,429,Evaluated for pharmacokinetic parameter Cmax in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624580,,BAO_0000218,,
6709,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 50 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624581,,BAO_0000218,,
6710,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 6.25 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624582,,BAO_0000218,,
6711,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 75 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624583,,BAO_0000218,,
6712,13227,Inhibitory activity against human tumor cell line A0375 melanoma.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL624584,455.0,BAO_0000219,,
6713,4481,Displacement of [3H]N6-PIA binding from A1 receptor in whole rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Brain membranes,12512,D,9,Expert,1,,CHEMBL624585,,BAO_0000249,,
6714,16931,Forskolin-induced cAMP production at human A1 adenosine receptor,F,,,Homo sapiens,9606.0,,,,,114,D,9,Expert,1,,CHEMBL875165,,BAO_0000019,,
6715,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619490,449.0,BAO_0000219,,
6716,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619491,449.0,BAO_0000219,,
6717,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619492,449.0,BAO_0000219,,
6718,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619493,449.0,BAO_0000219,,
6719,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619494,449.0,BAO_0000219,,
6720,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619495,449.0,BAO_0000219,,
6721,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619496,449.0,BAO_0000219,,
6722,3850,Percent response to 10 uM PD-81723 on CHO cells expressing human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,F,,,Homo sapiens,9606.0,,,CHO,,114,D,9,Expert,1,,CHEMBL619497,449.0,BAO_0000219,,
6723,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619498,449.0,BAO_0000219,,
6724,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619499,449.0,BAO_0000219,,
6725,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619500,449.0,BAO_0000219,,
6726,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619501,449.0,BAO_0000219,,
6727,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619502,449.0,BAO_0000219,,
6728,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619503,449.0,BAO_0000219,,
6729,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619504,449.0,BAO_0000219,,
6730,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621298,449.0,BAO_0000219,,
6731,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL621299,449.0,BAO_0000219,,
6732,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621300,449.0,BAO_0000219,,
6733,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621301,449.0,BAO_0000219,,
6734,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL621302,449.0,BAO_0000219,,
6735,12680,Ability to inhibit [125I]ET1 binding to vascular smooth muscle (vsm)- A10 cells,F,,,Oryctolagus cuniculus,9986.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL621303,164.0,BAO_0000219,,
6736,1313,In vitro potassium channel opening activity in A10 (smooth muscle) cells,F,,,Rattus norvegicus,10116.0,,,A10,,22226,U,0,Autocuration,1,,CHEMBL621304,164.0,BAO_0000219,,
6737,1313,In vitro potassium channel opening activity in A10 (smooth muscle) cells; Inactive,F,,,Rattus norvegicus,10116.0,,,A10,,22226,U,0,Autocuration,1,,CHEMBL621305,164.0,BAO_0000219,,
6738,17567,Effect on membrane potential of mitochondria in A10 smooth muscle cells from rats,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL621306,164.0,BAO_0000219,,
6739,17567,Effect on membrane potential of mitochondria of A10 smooth muscle cells in rats,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL618444,164.0,BAO_0000219,,
6740,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.001 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL618445,164.0,BAO_0000219,,
6741,13436,Compound was tested for aerobic growth inhibition against AA8 cells after 4 hr of exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618446,185.0,BAO_0000219,,
6742,12687,Concentration required to reduce AA8 cell numbers to 50% of controls in a growth inhibition microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618447,185.0,BAO_0000219,,
6743,12651,Concentration of the drug to inhibit chinese hamster ovary derived cell (AA8) growth in culture,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618448,185.0,BAO_0000219,,
6744,13300,Cytotoxicity in a growth inhibition assay against aerobic cultures of AA8 cells was determined,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618449,185.0,BAO_0000219,,
6745,15296,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618637,185.0,BAO_0000219,,
6746,15328,"Cytotoxicity in chinese hamster ovary tumor cell line-AA8, by growth inhibition assay.",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618638,185.0,BAO_0000219,,
6747,13302,Growth inhibition activity was measured in repair proficient AA8 cells under aerobic conditions (4 hours drug exposure),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618639,185.0,BAO_0000219,,
6748,14367,"Growth inhibition of aerobic AA8 cells, after 18 hours exposure",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618640,185.0,BAO_0000219,,
6749,17002,In vitro cellular toxicity against chinese hamster AA8 cell line after 4 hr of compound exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618641,185.0,BAO_0000219,,
6750,13436,Inhibitory activity against AA8 cell growth in aerobic condition after 4 hr of exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618642,185.0,BAO_0000219,,
6751,13435,Inhibitory activity against aerobic growth of AA8 cells.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618643,185.0,BAO_0000219,,
6752,10503,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL884013,185.0,BAO_0000219,,
6753,10503,In vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622723,185.0,BAO_0000219,,
6754,10503,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622724,185.0,BAO_0000219,,
6755,15090,Tested for growth inhibition against AA8 tumor cell line(chinese hamster ovary).,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622725,185.0,BAO_0000219,,
6756,10368,Cytotoxicity against AA8 cell line,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622726,185.0,BAO_0000219,,
6757,12651,Hypersensitivity factor(HF) was determined as ratio of IC50(AA8) to IC50(UV4),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622727,185.0,BAO_0000219,,
6758,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622728,185.0,BAO_0000219,,
6759,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622729,185.0,BAO_0000219,,
6760,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622730,185.0,BAO_0000219,,
6761,1890,Compound was evaluated for cytotoxicity against CHO AA8 cell lines for 4 hr at pH-7.4,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622731,185.0,BAO_0000219,,
6762,10747,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622732,185.0,BAO_0000219,,
6763,10747,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622733,185.0,BAO_0000219,,
6764,11616,Maximum tolerated dose (MTD) in C3H/HeN mice (single ip dose),F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622734,,BAO_0000218,,
6765,11616,Concentration required to increase radiation sensitivity by 1.3 when AA8 cells are exposed to drug for 30 min before and during irradiation under hypoxic condition.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622735,185.0,BAO_0000219,,
6766,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618746,185.0,BAO_0000219,,
6767,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618747,185.0,BAO_0000219,,
6768,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620540,185.0,BAO_0000219,,
6769,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620541,185.0,BAO_0000219,,
6770,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620542,185.0,BAO_0000219,,
6771,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620543,185.0,BAO_0000219,,
6772,3471,Ratio of oxygen dependence of cytotoxicities of AA8 cells in aerobic condition to anoxic condition,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618832,185.0,BAO_0000219,,
6773,11616,Concentration required to reduce AA8 cell survival by 10%,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618833,185.0,BAO_0000219,,
6774,2656,"Concentration required to reduce cell survival to 10% of controls under hypoxic conditions, using the AA8 (chinese hamster) aerobic cells",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618834,185.0,BAO_0000219,,
6775,10518,Tested for the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618835,185.0,BAO_0000219,,
6776,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618836,185.0,BAO_0000219,,
6777,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 0.8-1.5,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618837,185.0,BAO_0000219,,
6778,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 1-2,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618838,185.0,BAO_0000219,,
6779,16156,Ability to reduce cell density of AA8 cells to 50% after 4 hr of exposure to air,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618839,185.0,BAO_0000219,,
6780,2656,Aerobic cytotoxic activity was evaluated by the growth inhibition of AA8 (chinese hamster) aerobic cells,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618840,185.0,BAO_0000219,,
6781,11005,"Compound was evaluated for the inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618841,,BAO_0000019,,
6782,11942,Concentration for 50% inhibition of AA8 cells growth under aerobic conditions after 18 hours exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618842,185.0,BAO_0000219,,
6783,2128,Concentration required for 50% inhibition of growth of AA8 cells following 4 hr drug exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618843,185.0,BAO_0000219,,
6784,16907,Half life period after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618844,,BAO_0000218,,
6785,16907,Half life period after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618845,,BAO_0000218,,
6786,9579,Half life was measured after oral 2b administration (tested in 6 dogs),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618846,,BAO_0000218,,
6787,9579,Half life was measured in dog after oral 17b administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618847,,BAO_0000218,,
6788,9579,Pharmacokinetic parameter T max determined in dog after oral administration of 17b,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618848,,BAO_0000218,,
6789,9579,Pharmacokinetic parameter T max determined in dog after oral administration of 2b,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618849,,BAO_0000218,,
6790,16907,Tmax value after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618850,,BAO_0000218,,
6791,16907,Tmax value after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618851,,BAO_0000218,,
6792,3184,Compound was evaluated for its half life when administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873815,,BAO_0000218,,
6793,5017,Compound was tested for plasma half life when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618852,,BAO_0000218,1969.0,
6794,6821,Elimination Half-life of compound was determined in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618853,,BAO_0000218,,
6795,17839,Half life of compound in dog following oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618854,,BAO_0000218,,
6796,17267,Half life of compound was determined in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618855,,BAO_0000218,,
6797,4727,Half life of compound was determined in dog blood,A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618856,,BAO_0000218,178.0,
6798,5238,Half life after oral and iv dosing in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875827,,BAO_0000218,,
6799,4942,Half life in dogs in hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618857,,BAO_0000218,,
6800,6505,Half life on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618858,,BAO_0000218,,
6801,5130,t1/2 in dog after oral dose (1 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618859,,BAO_0000218,,
6802,1475,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618860,,BAO_0000218,,
6803,17804,Half life period of compound was determined after intravenous administration at 2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618861,,BAO_0000218,,
6804,17804,Half life period of compound was determined after peroral administration at 2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622539,,BAO_0000218,,
6805,6084,Half life period (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622540,,BAO_0000218,,
6806,6084,Half life period (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873803,,BAO_0000218,,
6807,5542,Half life period by iv administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873804,,BAO_0000218,,
6808,5542,Half life period by po administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624311,,BAO_0000218,,
6809,6084,Half life period in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624312,,BAO_0000218,,
6810,6241,Half life period in dogs after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624313,,BAO_0000218,,
6811,1916,Half life period was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624314,,BAO_0000218,,
6812,6621,Half-life of compound was determined in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624315,,BAO_0000218,,
6813,1696,Half-life in dog plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624316,,BAO_0000218,1969.0,
6814,17800,Half-life in mongrel dogs was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624317,,BAO_0000218,,
6815,17657,Half-life in dog upon oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624318,,BAO_0000218,,
6816,17657,Half-life in dog upon oral administration; Unable to calculate,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624319,,BAO_0000218,,
6817,4239,Half-life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624496,,BAO_0000218,,
6818,5985,Half-life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624497,,BAO_0000218,,
6819,9932,Half-recovery time (T1/2) of the vascular resistance decrease at ED30 in anesthetized dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624498,,BAO_0000218,,
6820,5199,Oral half life was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624499,,BAO_0000218,,
6821,5199,Plasma elimination half-life (08 h) was determined in canine following intravenous (iv) administration (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624500,,BAO_0000218,1969.0,
6822,1475,Plasma half life was evaluated,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624501,,BAO_0000218,1969.0,
6823,1475,Plasma half life was evaluated in Dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623666,,BAO_0000218,1969.0,
6824,1475,Plasma half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623667,,BAO_0000218,1969.0,
6825,6316,T1/2 (Half-life) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623668,,BAO_0000218,,
6826,4883,Tested for the half life value in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623669,,BAO_0000218,,
6827,4727,Maximum time at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623670,,BAO_0000218,,
6828,1916,Maximum time was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623671,,BAO_0000218,,
6829,1337,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL875945,,BAO_0000218,178.0,
6830,1337,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL623672,,BAO_0000218,178.0,
6831,6265,Pharmacokinetic (PK) property (Tmax) was determined in dog at the single dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623673,,BAO_0000218,,
6832,4809,Pharmacokinetic parameter Tmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623674,,BAO_0000218,,
6833,5983,Pharmacokinetic property (Tmax) was measured in dog at the dose of 0.032 mg/kg p.o.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623675,,BAO_0000218,,
6834,5313,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872526,,BAO_0000218,,
6835,5313,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog at dosage of 10 mpk",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623676,,BAO_0000218,,
6836,17650,Time for maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623677,,BAO_0000218,1969.0,
6837,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623678,,BAO_0000218,1969.0,
6838,933,Time taken for maximum plasma concentration in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623679,,BAO_0000218,1969.0,
6839,16367,Time to reach Cmax after oral administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623680,,BAO_0000218,,
6840,6348,Time to reach maximum plasma concentration was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623681,,BAO_0000218,1969.0,
6841,6316,Tmax (time to reach maximum concentration) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623682,,BAO_0000218,,
6842,6215,Tmax after peroral administration (1 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623683,,BAO_0000218,,
6843,3598,Tmax of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL623684,,BAO_0000218,,
6844,4527,Tmax by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622745,,BAO_0000218,,
6845,17764,Tmax after peroral administration in dogs at 2.4 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622746,,BAO_0000218,,
6846,5969,In vivo Cmax in mice at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622747,,BAO_0000218,,
6847,5969,In vivo Cmax in mice at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622748,,BAO_0000218,,
6848,4573,Maximal concentration determined at a dose 10 mg/kg administered intraperitoneally to mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622749,,BAO_0000218,,
6849,3277,Maximum plasma concentration was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622750,,BAO_0000218,1969.0,
6850,17734,Maximum concentration in plasma was determined after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623411,,BAO_0000218,1969.0,
6851,3132,Maximum concentration obtained in mouse plasma was determined,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL875946,,BAO_0000218,1969.0,
6852,3132,Maximum concentration obtained in mouse plasma was determined at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623412,,BAO_0000218,1969.0,
6853,6348,Maximum plasma concentration of compound was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623413,,BAO_0000218,1969.0,
6854,17729,Maximum plasma concentration when injected i.p. in mice at a dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623414,,BAO_0000218,1969.0,
6855,17729,Maximum plasma concentration when injected intravenously in mice at a dose of 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623415,,BAO_0000218,1969.0,
6856,17729,Maximum plasma concentration when injected perorally in mice at a dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623416,,BAO_0000218,1969.0,
6857,17728,Maximal plasma concentration in BALB/C mice after 20 mg/kg intraperitoneal dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623417,,BAO_0000218,1969.0,
6858,17728,Maximal plasma concentration in BALB/C mice after 20 mg/kg intravenous dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623418,,BAO_0000218,1969.0,
6859,17728,Maximal plasma concentration in BALB/C mice after 50 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623419,,BAO_0000218,1969.0,
6860,4066,Peak concentration at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622816,,BAO_0000218,,
6861,6178,Pharmacokinetic property (C(max)) was determined after ip administration of 32 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623313,,BAO_0000218,,
6862,6178,Pharmacokinetic property (C(max)) was determined after po administration of 32 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623314,,BAO_0000218,,
6863,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg intravenously in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876788,,BAO_0000218,,
6864,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg perorally in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623315,,BAO_0000218,,
6865,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg intravenously in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623316,,BAO_0000218,,
6866,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg perorally in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623317,,BAO_0000218,,
6868,5961,Cmax in male mice after 2 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623319,,BAO_0000218,,
6869,6137,Plasma concentration of 5-FU in HT-3 (human cervical cancer) xenograft mice at 1.38 mg/kg oral dose co-administered with 135 mg/kg Capecitabine,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623320,,BAO_0000218,,
6870,3802,Tested for Cmax value at the dose of 10 mg/kg when administered perorally in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623321,,BAO_0000218,,
6871,3535,Concentration in plasma (systemic) following oral dose in mouse at 0.25 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623322,,BAO_0000218,,
6872,3535,Concentration in plasma (systemic) following oral dose in mouse at 1 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623323,,BAO_0000218,,
6873,3535,Concentration in plasma (systemic) following oral dose in mouse at 24 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623324,,BAO_0000218,,
6874,3535,Concentration in plasma (systemic) following oral dose in mouse at 2 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623325,,BAO_0000218,,
6875,3535,Concentration in plasma (systemic) following oral dose in mouse at 4 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623326,,BAO_0000218,,
6876,3535,Concentration in plasma (systemic) following oral dose in mouse at 6 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623327,,BAO_0000218,,
6877,2862,Maximum concentration in plasma upon oral administration in mouse,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623328,,BAO_0000218,1969.0,
6878,2675,Maximum plasma concentration was evaluated in mice after oral administration,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623329,,BAO_0000218,1969.0,
6879,2675,Maximum plasma concentration was evaluated in mice after intravenous administration; Cp max Not determined,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623330,,BAO_0000218,1969.0,
6880,5399,Dose at which the compound induced fecal excretion in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876789,,BAO_0000218,,
6893,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.01 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL623333,164.0,BAO_0000219,,
6894,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.1 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL623334,164.0,BAO_0000219,,
6895,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 1.0 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL627536,164.0,BAO_0000219,,
6896,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 10.0 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL627537,164.0,BAO_0000219,,
6897,16361,In vitro [14C]- creatine uptake (1 mM) was determined in rat A10 smooth muscle cells at a concentration of (1 mM),F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL627538,164.0,BAO_0000219,,
6898,2288,Cytotoxicity was evaluated against A121 ovarian carcinoma human cancer cell line,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL884106,393.0,BAO_0000219,,
6899,10404,Anticancer activity against human ovarian carcinoma A121 cells,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625294,393.0,BAO_0000219,,
6900,14790,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 16.6 mM,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625295,393.0,BAO_0000219,,
6901,14790,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 83 mM,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625296,393.0,BAO_0000219,,
6902,14253,Growth inhibition of human ovarian carcinoma (A121) cell line,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Expert,1,,CHEMBL625297,393.0,BAO_0000219,,
6903,13617,Concentration required to inhibit growth of human tumor A121 (ovarian) cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Expert,1,,CHEMBL625298,393.0,BAO_0000219,,
6904,1003,Cytotoxicity against human A121 ovarian cells,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625960,393.0,BAO_0000219,,
6905,830,Cytotoxicity was evaluated in vitro against A121 (ovarian carcinoma) human tumor cell lines,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625961,393.0,BAO_0000219,,
6906,12307,In vitro cytotoxicity against human ovarian carcinoma A21,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625962,393.0,BAO_0000219,,
6907,14254,Inhibition of the growth against human Ovarian Carcinoma (A121) cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624717,393.0,BAO_0000219,,
6908,13370,Inhibitory activity of compound against human A121 ovarian cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624718,393.0,BAO_0000219,,
6909,14790,Dose at which compound exhibits cytotoxicity in the A121 ovarian carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624719,393.0,BAO_0000219,,
6910,3614,Inhibition of growth of human ovarian tumor cell line (A121) after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624720,393.0,BAO_0000219,,
6911,2664,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624721,622.0,BAO_0000219,,
6912,2037,In vitro cytotoxicity against A172 human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL624722,622.0,BAO_0000219,,
6913,14539,Growth inhibition time for A172 Human Glioma cell growth at concentration 5 uM,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL877597,622.0,BAO_0000219,,
6914,2836,Compound was evaluated for cytotoxicity against human glioblastoma (A172) cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624723,622.0,BAO_0000219,,
6915,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624724,622.0,BAO_0000219,,
6916,8975,Association constant against A2 adenosine receptor,B,,,Canis lupus familiaris,9615.0,,,,,104729,H,4,Autocuration,1,,CHEMBL624725,,BAO_0000224,,
6917,7645,In vitro effective dose that causes 50% inhibition of growth of A2 cell line - amelanotic melanoma,F,,,fish,,,,A2,,80656,N,1,Intermediate,1,,CHEMBL624726,1085.0,BAO_0000219,,
6918,11377,Ratio of Ki for adenosine A2 and A1 receptor binding,B,,,Rattus norvegicus,10116.0,,,,,104713,D,5,Autocuration,1,,CHEMBL857535,,BAO_0000224,,
6919,13528,In vitro cytotoxicity against A204 human rhabdomyosarcoma cancer cell line,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Expert,1,,CHEMBL624727,623.0,BAO_0000219,,
6920,10160,In vitro antitumor activity against A204 rhabdomyosarcoma tumor cell line was determined,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Expert,1,,CHEMBL624728,623.0,BAO_0000219,,
6921,15144,The compound was tested in vitro for antiproliferative activity against A2058 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2058,,80015,N,1,Intermediate,1,,CHEMBL624729,404.0,BAO_0000219,,
6922,13160,Growth inhibition against Human squamous cell line(A 253),F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624730,973.0,BAO_0000219,,
6923,12898,Growth inhibition of human squamous carcinoma cell lines following continuous (120 hours) exposure to MTX and compound A253 cell line,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624731,973.0,BAO_0000219,,
6924,13069,The compound was tested for Growth inhibition of the human squamous cell carcinoma A253 cells,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624732,973.0,BAO_0000219,,
6925,15984,Growth inhibition of A253 cell lines.,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL883245,973.0,BAO_0000219,,
6926,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h),F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624733,973.0,BAO_0000219,,
6927,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624734,973.0,BAO_0000219,,
6928,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624735,973.0,BAO_0000219,,
6929,4720,In vitro cytotoxicity causing 50% growth inhibition was determined against A270 (human ovarian cancer)cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621780,478.0,BAO_0000219,,
6930,16112,Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL877598,478.0,BAO_0000219,,
6931,16597,Cytotoxic activity against A2780 human ovarian carcinoma cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621781,478.0,BAO_0000219,,
6932,16378,Cytotoxicity against human cancer cell lines A2780 (ovarian),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621782,478.0,BAO_0000219,,
6933,16085,Growth and colony formation inhibition of A2780 ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621783,478.0,BAO_0000219,,
6934,16317,Inhibition of cell growth in human ovarian carcinoma cell line (A2780) using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621784,478.0,BAO_0000219,,
6935,15748,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621785,478.0,BAO_0000219,,
6936,16597,Inhibition of A2780 / DDP-R human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621968,478.0,BAO_0000219,,
6937,16597,Inhibition of A2780 / TAX-R human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621969,478.0,BAO_0000219,,
6938,16597,Inhibition of A2780 / TAX-S human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621970,478.0,BAO_0000219,,
6939,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621971,478.0,BAO_0000219,,
6940,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 3,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621972,478.0,BAO_0000219,,
6941,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 5,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884108,478.0,BAO_0000219,,
6942,15296,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623826,,BAO_0000019,,
6943,10251,Evaluated for cytotoxicity under aerobic conditions against AA8 cells using microassay,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623827,185.0,BAO_0000219,,
6944,10251,Evaluated for growth inhibition of AA8 cells under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623828,185.0,BAO_0000219,,
6945,10251,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623829,185.0,BAO_0000219,,
6946,10251,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions (air/N2),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623830,185.0,BAO_0000219,,
6947,11858,Growth inhibition against CHO-derived cell line AA8,F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623831,,BAO_0000019,,
6948,11858,Growth inhibition against CHO-derived cell line AA8 (Non toxic at solubility limit) [RB6145 used as positive control],F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623832,185.0,BAO_0000219,,
6949,11616,Growth inhibition in CHO subline AA8 cells exposed for 18 hr under aerobic(air) conditions,F,,,hampster,36483.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623833,185.0,BAO_0000219,,
6950,11616,Growth inhibitory activity against CHO subline AA8 cells exposed for 18 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623834,185.0,BAO_0000219,,
6951,10518,Tested for the concentration of the drug to reduce cell numbers to 50 percent of controls against AA8 cells in the microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623835,185.0,BAO_0000219,,
6952,11396,Growth inhibition of aerobic chinese hamster ovary fibroblast AA8 cell line using an exposure time of 18 hours,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623836,185.0,BAO_0000219,,
6953,10518,IC50 (air/N2) ratio of the drug to reduce cell numbers to 50 percent of controls using AA8 cells in the microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623837,185.0,BAO_0000219,,
6954,11616,In vitro therapeutic index as ratio of CT10 and C1.3 calculated for AA8 cells.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623838,185.0,BAO_0000219,,
6955,14837,compound was evaluated for association constant (Ka) of isolated serum protein AAG,F,,,,,,,,,12675,H,8,Autocuration,1,,CHEMBL623839,,BAO_0000019,,
6956,14837,Number of binding sites (n) of isolated serum protein AAG,F,,,,,,,,,12675,H,8,Autocuration,1,,CHEMBL623840,,BAO_0000019,,
6957,16037,Association constant for binding to AATT duplex,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL623841,,BAO_0000225,,
6958,16597,Inhibition of ABAE human fibroblast cell proliferation,F,,,Homo sapiens,9606.0,,,ABAE,,100090,N,1,Expert,1,,CHEMBL623842,416.0,BAO_0000219,,
6959,8831,"Compound was evaluated for the antitumor activity against AC755 breast carcinoma for ip administration and daily x 10 schedule; Number of toxic deaths over total number of mice per group (T/C), 1/7 at dose of 25 mg/kg",F,,,Mus musculus,10090.0,,,AC755,,80668,N,1,Intermediate,1,,CHEMBL623843,1064.0,BAO_0000218,,
6960,13419,Percent change in total cholesterol(TC) versus (T0)- at which drug intervention begins at a dose of 25 mg/kg in the chronic cholesterol-fed rabbit model,F,,,Oryctolagus cuniculus,9986.0,,,,,102444,D,9,Expert,1,,CHEMBL618669,,BAO_0000218,,
6961,13419,Oral bioactivity expressed as %inhibition after 4 hours of drug administration (dose 25 mg/kg) in rabbit bioassay,F,In vivo,,Oryctolagus cuniculus,9986.0,,,,,102444,D,9,Expert,1,,CHEMBL618670,,BAO_0000218,,
6962,15778,Inhibitory activity against angiotensin-converting enzyme (ACE).,B,,,,,,,,,69,H,8,Autocuration,1,,CHEMBL618671,,BAO_0000357,,
6963,15778,oral activity against angiotensin -converting enzyme ( ACE) and neutral endopeptidase in mouse.,B,,,,,,,,,69,H,8,Autocuration,1,,CHEMBL618672,,BAO_0000357,,
6964,12988,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells,F,,,Homo sapiens,9606.0,,,ACH-2 cell line,,80669,N,1,Intermediate,1,,CHEMBL618673,978.0,BAO_0000219,,
6965,12988,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells in the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Homo sapiens,9606.0,,,ACH-2 cell line,,80669,N,1,Intermediate,1,,CHEMBL618674,978.0,BAO_0000219,,
6966,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2,F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618675,998.0,BAO_0000219,,
6967,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2 in the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618676,998.0,BAO_0000219,,
6968,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2i n the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618677,998.0,BAO_0000219,,
6969,11843,Inhibition of growth of renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618678,626.0,BAO_0000219,,
6970,16939,Inhibition of growth of ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618679,626.0,BAO_0000219,,
6971,4782,Inhibitory concentration required against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618680,626.0,BAO_0000219,,
6972,6310,Concentration required to inhibit growth of human renal (ACHN) cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL618681,626.0,BAO_0000219,,
6973,6310,Concentration required to inhibit growth of human renal (ACHN) cell line; nt = not tested,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618682,626.0,BAO_0000219,,
6974,12858,Cytotoxic activity against ACHN Renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618683,626.0,BAO_0000219,,
6975,17380,Cytotoxicity evaluation against ACHN renal cancer cells,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618684,626.0,BAO_0000219,,
6976,5858,In vitro antitumor activity against human renal ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618685,626.0,BAO_0000219,,
6977,3838,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL876499,626.0,BAO_0000219,,
6978,3838,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618686,626.0,BAO_0000219,,
6979,5406,"Tested for the cytotoxicity against the Renal cancer cell line ACHN, growth inhibition by 50% is reported",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618687,626.0,BAO_0000219,,
6980,4071,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618688,626.0,BAO_0000219,,
6981,4071,Tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL618689,626.0,BAO_0000219,,
6982,4071,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal); Not determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618690,626.0,BAO_0000219,,
6983,15002,Antitumor activity was evaluated against human renal adenocarcinoma cell line ACHN.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618691,626.0,BAO_0000219,,
6984,14769,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619373,626.0,BAO_0000219,,
6985,13958,"Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL884008,626.0,BAO_0000219,,
6986,1665,Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619374,626.0,BAO_0000219,,
6987,15354,Compound was tested for the growth inhibition of ACHN renal tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619375,626.0,BAO_0000219,,
6988,15354,Compound was tested for the growth inhibition of ACHN renal tumor cell line; ND=Not determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619376,626.0,BAO_0000219,,
6989,13978,In vitro Growth Inhibitory activity against ACHN Human kidney cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619377,626.0,BAO_0000219,,
6990,6798,In vitro cytotoxicity against human renal adenocarcinoma (ACHN) tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619378,626.0,BAO_0000219,,
6991,2959,Tmax value after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872527,,BAO_0000218,,
6992,9932,"Time to peak response on lowering of vascular resistance, in dogs when administered intravenously",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876500,,BAO_0000218,,
6993,5546,Unbound plasma was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619379,,BAO_0000218,,
6994,16907,Volume distribution after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619538,,BAO_0000218,,
6995,16907,Volume distribution after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619539,,BAO_0000218,,
6996,4257,Volume of distribution was determined in dog after a 3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619540,,BAO_0000218,,
6997,4305,Volume of distribution was determined by iv administration in dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619541,,BAO_0000218,,
6998,5472,Volume of distribution was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619542,,BAO_0000218,,
6999,6062,Terminal phase volume of distribution was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619543,,BAO_0000218,,
7000,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL619544,,BAO_0000218,,
7001,12500,The compound was tested for volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619545,,BAO_0000218,,
7002,12500,The compound was tested for volume of distribution in dog at dose of 3-10 mgkg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619546,,BAO_0000218,,
7003,6227,Vd (1 mg/kg) was determined in dog (in vivo),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619547,,BAO_0000218,,
7004,6227,Vd in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619548,,BAO_0000218,,
7005,4219,Volume distribution was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619549,,BAO_0000218,,
7006,1696,Volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619550,,BAO_0000218,,
7007,5542,Volume of distribution by as 4 fold increase by iv administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876501,,BAO_0000218,,
7008,5199,Volume of distribution was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619551,,BAO_0000218,,
7009,6348,Volume of distribution was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619552,,BAO_0000218,,
7010,4727,Volume distribution at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619553,,BAO_0000218,,
7011,16367,Steady state volume of distribution was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618722,,BAO_0000218,,
7012,2652,Bioavailability as Vdss in dogs at 1 mg/kg intravenous dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618723,,BAO_0000218,,
7013,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618724,,BAO_0000218,,
7014,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618725,,BAO_0000218,,
7015,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618726,,BAO_0000218,,
7016,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618727,,BAO_0000218,,
7017,4239,Pharmacokinetic property (vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624233,,BAO_0000218,,
7018,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624234,,BAO_0000218,,
7019,5600,Vdss was determined after iv 0.1 mg/kg administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624235,,BAO_0000218,,
7020,6057,Volume displacement was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624236,,BAO_0000218,,
7021,5654,Volume distribution (Vdss) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624237,,BAO_0000218,,
7022,5505,Volume distribution constant was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624238,,BAO_0000218,,
7023,4527,Volume distribution at a dose of 1 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624239,,BAO_0000218,,
7024,4521,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875829,,BAO_0000218,,
7025,4521,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624240,,BAO_0000218,,
7026,15660,Volume distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624241,,BAO_0000218,,
7027,15660,Volume distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624242,,BAO_0000218,,
7028,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624243,,BAO_0000218,,
7029,5145,Volume of distribution in steady state was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624244,,BAO_0000218,,
7030,6821,Volume of distribution of compound was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624245,,BAO_0000218,,
7031,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624246,,BAO_0000218,,
7032,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624247,,BAO_0000218,,
7033,15660,Volume of distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624248,,BAO_0000218,,
7034,6642,Volumes of distribution in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624249,,BAO_0000218,,
7035,6641,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624250,,BAO_0000218,,
7036,6642,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624251,,BAO_0000218,,
7037,11659,Maximum rate of depolarization of the upstroke of the action potential,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624252,,BAO_0000218,,
7038,6448,Steady state volume distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624253,,BAO_0000218,,
7039,5474,Steady state volume of distribution at a dose of 0.2 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624950,,BAO_0000218,,
7040,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624951,,BAO_0000218,,
7041,6535,Volume distribution in dog after administration of 0.25 mg/kg iv; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875830,,BAO_0000218,,
7042,6535,Volume distribution in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624952,,BAO_0000218,,
7043,17764,Volume of solubility in solution after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624953,,BAO_0000218,,
7044,6215,Vss after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624954,,BAO_0000218,,
7045,6505,Vss on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624955,,BAO_0000218,,
7046,3639,Vss was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624956,,BAO_0000218,,
7047,3639,Vss in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625129,,BAO_0000218,,
7048,6062,Volume of distribution was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625130,,BAO_0000218,,
7049,4942,Volume distribution in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625131,,BAO_0000218,,
7050,17796,Volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625132,,BAO_0000218,,
7051,4883,Tested for the oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872263,,BAO_0000218,,
7060,17837,Bioavailability of compound in mouse blood following p.o. administration of 30 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624336,,BAO_0000218,,
7061,17729,Bioavailability after i.p. administration of 50 mg/kg of dose in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624337,,BAO_0000218,,
7062,17729,Bioavailability after peroral administration of 50 mg/kg of dose in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624338,,BAO_0000218,,
7063,4239,Bioavailability was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624339,,BAO_0000218,,
7064,17592,Bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624340,,BAO_0000218,,
7065,6348,Bioavailability was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624341,,BAO_0000218,,
7066,2801,Bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624342,,BAO_0000218,,
7067,2801,Compound was evaluated for its bioavailability in mice at a dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624343,,BAO_0000218,,
7068,17718,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624344,,BAO_0000218,,
7069,5727,Oral availability at 50 mg/kg po in male mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624345,,BAO_0000218,,
7070,5302,Oral bioavailability in mouse (dose 10 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624346,,BAO_0000218,,
7071,3598,Oral bioavailability of compound determined in mouse after iv administration at a dose of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Expert,1,,CHEMBL624347,,BAO_0000218,,
7072,5961,"Bioavailability in male mice, 2mg/kg oral and 1 mg/kg intravenous dose",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624348,,BAO_0000218,,
7074,6091,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622754,,BAO_0000218,,
7075,6091,Oral bioavailability in vivo in mice;ND=Not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622755,,BAO_0000218,,
7076,5711,Oral bioavailability in mouse at 10 mg/kg of the compound,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622756,,BAO_0000218,,
7077,17728,Bioavailability in mouse (BALB/C) (dose 50 mg/kg i.p.),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622757,,BAO_0000218,,
7078,17728,Bioavailability in mouse (BALB/C) (dose 20 mg/kg i.v.),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622758,,BAO_0000218,,
7079,3802,Tested for bioavailability of the compound,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622759,,BAO_0000218,,
7080,3802,Tested for half life at the dose of 10 mg/kg when administered intravenously,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622760,,BAO_0000218,,
7081,14029,The plasma half life of compound was determined on EDTA prepared by mouse plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622761,,BAO_0000218,1969.0,
7082,14029,The plasma half life of compound was determined on heparin prepared by human plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622762,,BAO_0000218,1969.0,
7083,14029,The plasma half life of compound was determined on heparin prepared by human plasma; Not degraded,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622763,,BAO_0000218,1969.0,
7084,14029,The plasma half life of compound was determined on heparin prepared by mouse plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622764,,BAO_0000218,1969.0,
7085,14029,The plasma half life of compound was determined on heparin prepared by mouse plasma; Not degraded,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622765,,BAO_0000218,1969.0,
7086,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 6 hours of exposure at 40 mg/Kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622766,,BAO_0000218,,
7087,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 24 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622767,,BAO_0000218,,
7088,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 5 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622768,,BAO_0000218,,
7089,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL875948,,BAO_0000218,178.0,
7090,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622769,,BAO_0000218,178.0,
7091,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622770,,BAO_0000218,178.0,
7092,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622771,,BAO_0000218,178.0,
7093,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622772,,BAO_0000218,178.0,
7094,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622773,,BAO_0000218,178.0,
7095,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622774,,BAO_0000218,178.0,
7096,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL621725,,BAO_0000218,10000001.0,
7097,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL621726,,BAO_0000218,10000001.0,
7098,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 8,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621727,478.0,BAO_0000219,,
7099,3290,In vitro cytotoxicity against human ovarian carcinoma cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622413,478.0,BAO_0000219,,
7100,2859,Compound was evaluated for cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622414,478.0,BAO_0000219,,
7101,15688,Inhibition of A2780 cell clonogenic assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622415,478.0,BAO_0000219,,
7102,5642,Cytotoxic effect on ovarian cancer cell line (A2780),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL884001,478.0,BAO_0000219,,
7103,6633,Concentration required to inhibit A2780 cell growth when compared with control after incubation for 96 hr at 37 C,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622416,478.0,BAO_0000219,,
7104,3906,"MDR-reversing activity was measured by vincristine accumulation in the multidrug resistant 2780AD, a subline of A2780 ovarian carcinoma cells at 10 mg/mL",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622417,478.0,BAO_0000219,,
7105,6788,50% growth inhibition of A2780 (Human ovarian carcinoma) cell line compared with untreated control cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622590,478.0,BAO_0000219,,
7106,17582,Antiproliferative activity against human A2780 cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622591,478.0,BAO_0000219,,
7107,17764,Inhibition of human A2780 cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622592,478.0,BAO_0000219,,
7108,17764,Antiproliferative effect against human A2780 cell line was determined in a whole cell 72 hr cytotoxicity assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622593,478.0,BAO_0000219,,
7109,17764,Inhibition of human A2780 cell proliferation (No data),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622594,478.0,BAO_0000219,,
7110,2815,Cell cytotoxicity was determined against human ovarian cancer (A2780) cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622595,478.0,BAO_0000219,,
7111,16930,Compound was evaluated against human Ovarian carcinoma cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622596,478.0,BAO_0000219,,
7112,17777,Growth inhibition against A2780 wild-type ovarian cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622597,478.0,BAO_0000219,,
7113,17777,Compound was evaluated for growth inhibition against A2780 wild-type ovarian cell lines; No data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622598,478.0,BAO_0000219,,
7114,16936,Inhibition of tubulin polymerization in human ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,,,104766,D,5,Autocuration,1,,CHEMBL622599,,BAO_0000019,,
7115,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622600,478.0,BAO_0000219,,
7116,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622601,478.0,BAO_0000219,,
7117,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622602,478.0,BAO_0000219,,
7118,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622603,478.0,BAO_0000219,,
7119,15292,Compound was tested for inhibitory activity against A2780 human ovarian carcinoma cell line; activity expressed in Mean IC50 values,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622604,478.0,BAO_0000219,,
7120,15292,Compound was tested for inhibitory activity against A2780cisR human ovarian carcinoma cell line; activity expressed in Mean IC50 values,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622605,478.0,BAO_0000219,,
7121,15069,In vitro inhibition of human ovarian cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622606,478.0,BAO_0000219,,
7122,15069,"In vitro inhibition of human ovarian cell line, resistant to cisplatin (A2780cisR).",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619463,478.0,BAO_0000219,,
7123,14073,Concentration of compound to inhibit the growth of human A2780 ovarian carcinoma cells(in vitro),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619464,478.0,BAO_0000219,,
7124,14553,Concentration required to inhibit A2780-cell growth by 50%,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619465,478.0,BAO_0000219,,
7125,13040,Concentration required to inhibit the cell growth by 50 % after 96 hr A2780 leukemic cells.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619466,478.0,BAO_0000219,,
7126,6891,Cytotoxic effect on human ovarian (A2780) cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619467,478.0,BAO_0000219,,
7127,15569,Cytotoxic activity in a panel of Human ovarian tumor A2780 cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619468,478.0,BAO_0000219,,
7128,14190,Cytotoxic potency required to inhibit A2780 cell growth by 50% after cell drug contact for 96 hrs,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619469,478.0,BAO_0000219,,
7129,15014,Cytotoxicity measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619470,478.0,BAO_0000219,,
7130,15014,Cytotoxicity activity of the compound was measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619471,478.0,BAO_0000219,,
7131,17496,Cytotoxicity against human ovarian carcinoma A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619472,478.0,BAO_0000219,,
7132,13617,"Cytotoxicity against A2780-C25, oxaliplatin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619473,478.0,BAO_0000219,,
7133,13617,"Cytotoxicity against A2780-CP3, cisplatin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL874368,478.0,BAO_0000219,,
7134,13617,"Cytotoxicity against A2780-DX5, Doxorubicin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884003,478.0,BAO_0000219,,
7135,13617,"Cytotoxicity against A2780-WT, human ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622690,478.0,BAO_0000219,,
7136,17672,Cytotoxicity against ovarian carcinoma A2780 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622691,478.0,BAO_0000219,,
7137,4544,Dose of required to inhibit growth of cisplatin resistant human ovarian carcinoma (A2780 cisR) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622692,478.0,BAO_0000219,,
7138,4544,Dose of required to inhibit growth of human ovarian carcinoma (A2780) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623406,478.0,BAO_0000219,,
7139,16317,"Growth inhibition in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant) using the 96 hour exposure sulforhodamine B (SRB) growth delay assay",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884004,478.0,BAO_0000219,,
7140,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623407,478.0,BAO_0000219,,
7141,13978,In vitro Growth Inhibitory activity against A2780 Human ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623408,478.0,BAO_0000219,,
7142,12989,In vitro antitumor activity against A2780 cell line.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623409,478.0,BAO_0000219,,
7143,5574,In vitro cytotoxic activity against human tumor cell line A2780 after incubation for 96 hours,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623410,478.0,BAO_0000219,,
7144,13528,In vitro cytotoxicity against A2780 human ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623576,478.0,BAO_0000219,,
7145,12782,Inhibitory activity against kidney A-CHN tumor cell growth in culture,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623577,626.0,BAO_0000219,,
7146,14255,The IC50 value was measured on ACHN cell line in renal tumor type.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623578,626.0,BAO_0000219,,
7147,16364,Concentration required for killing 50% of cells of renal ACHN cell lines was determined in vitro,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623579,626.0,BAO_0000219,,
7148,17376,In vitro lethal concentration against most sensitive ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL623580,626.0,BAO_0000219,,
7149,12016,Tested for cytotoxic activity against renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623581,626.0,BAO_0000219,,
7150,6058,Compound tested for growth inhibition of renal cancer cell line ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL857456,626.0,BAO_0000219,,
7151,17708,Compound was tested for 50% growth inhibition against human renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623582,626.0,BAO_0000219,,
7152,15176,Growth inhibition of the ACHN Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623583,626.0,BAO_0000219,,
7153,2806,In vitro anticancer activity against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623584,626.0,BAO_0000219,,
7154,15300,In vitro antitumor activity against Renal cancer ACHN cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623585,626.0,BAO_0000219,,
7155,16364,Percent selectivity was evaluated in renal ACHN cell lines,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623586,626.0,BAO_0000219,,
7156,13859,In vitro inhibitory activity against renal ACHN cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623587,626.0,BAO_0000219,,
7157,11970,Tested for cytotoxicity against ACHN cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL875279,626.0,BAO_0000219,,
7158,2450,Tested for the in vitro cytotoxicity against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623588,626.0,BAO_0000219,,
7159,12696,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623589,626.0,BAO_0000219,,
7160,12400,Tested in vitro for cytotoxicity in ACHN cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623590,626.0,BAO_0000219,,
7161,12888,Cytotoxic effect on renal cancer line ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL623591,626.0,BAO_0000219,,
7162,3156,In vitro anti-cancer activity against ACHN(Renal) human tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623592,626.0,BAO_0000219,,
7163,3381,In vitro inhibition of Renal Cancer ACHN cell lines,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623593,626.0,BAO_0000219,,
7164,16747,Antitumor activity against human renal adenocarcinoma ACHN cells,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623594,626.0,BAO_0000219,,
7165,16748,Antitumor activity against human renal adenocarcinoma ACHN cells.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL621833,626.0,BAO_0000219,,
7166,12062,Inhibitory concentration required to decrease cell viability in cell growth culture against kidney cells ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621834,626.0,BAO_0000219,,
7167,14769,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621835,626.0,BAO_0000219,,
7168,15895,"Cytotoxicity against NCI tumor panel, ACHN renal cancer cell line",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621836,626.0,BAO_0000219,,
7169,17376,Concentration of compound that cause 50% cytotoxicity of ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621837,626.0,BAO_0000219,,
7170,14882,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration that inhibits 50% net cell growth).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL875280,626.0,BAO_0000219,,
7171,14882,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration leading to 50% net cell death).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621838,626.0,BAO_0000219,,
7172,15661,Cytotoxicity was tested against renal cancer ACHN tumor cell lines.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621839,626.0,BAO_0000219,,
7173,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621840,,BAO_0000019,,
7174,14579,Compound tested for relative response using 1 uM ACh as agonist against AChM1 receptor.,F,,,,,,,,,10647,H,8,Autocuration,1,,CHEMBL621841,,BAO_0000019,,
7175,17290,Antiviral activity against AD169 strain of cytomegalovirus (CMV) in HEL (human erythroleukemia) cells.,F,,,Cytomegalovirus,10358.0,,,HEL,,50529,N,1,Expert,1,,CHEMBL622979,468.0,BAO_0000218,,
7176,17290,Antiviral activity against AD169 strain of cytomegalovirus (CMV); ND=No data,F,,,Cytomegalovirus,10358.0,,,,,50529,N,1,Intermediate,1,,CHEMBL876595,,BAO_0000218,,
7177,15891,Compound was evaluated for its inhibitory activity against calf intestinal Adenosine deaminase (ADA),B,,,,,,,,,12159,H,8,Autocuration,1,,CHEMBL620221,,BAO_0000357,,
7178,15890,Evaluated for the inhibition of calf intestinal Adenosine deaminase (ADA),B,,,,,,,,,12159,H,8,Autocuration,1,,CHEMBL620222,,BAO_0000357,,
7179,3801,Inhibitory activity against ovarian tumor cell line ADDP after 72 hr continuous exposure to compound,F,,,Bos taurus,9913.0,,,ADDP cell line,,80670,N,1,Intermediate,1,,CHEMBL620506,979.0,BAO_0000219,,
7180,9222,Tumor growth inhibition activity after subcutaneous transplanted tumor in ADJ-PC6 plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620507,980.0,BAO_0000219,,
7181,9222,Tumor growth inhibition activity after subcutaneously transplanted tumor in ADJ-PC6 plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620508,980.0,BAO_0000219,,
7182,7257,"Compound was tested for dose producing 90% reduction in tumor weight, in ADJ/PC6 mouse plasma cell tumor",F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620509,980.0,BAO_0000219,,
7183,7257,Compound was tested for inhibition against ADJ/PC6 mouse plasma cell tumor at the dose of 320 mg/Kg,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620510,980.0,BAO_0000219,,
7184,7257,Compound was tested for dose required to kill 50 % of ADJ/PC6 mouse plasma cell tumor in a group,A,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620511,980.0,BAO_0000219,,
7185,8084,In vitro incorporation of the [3H]thymidine into the ADJ/PC6 Plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620512,980.0,BAO_0000219,,
7186,14943,Tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620513,,BAO_0000019,,
7187,14943,The compound was tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma; Not determined,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620514,,BAO_0000019,,
7188,14943,Tested for cytotoxicity against ADJ/PC6 plasmacytoma,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620515,,BAO_0000019,,
7189,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,In vivo,,Bacillus subtilis,1423.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620516,,BAO_0000218,,
7190,3546,AUC value in dog after IV administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620517,,BAO_0000218,1969.0,
7191,3546,AUC value in dog after oral administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620518,,BAO_0000218,1969.0,
7192,3546,Cmax value in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620519,,BAO_0000218,,
7193,3546,Bioavailability in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621386,,BAO_0000218,,
7194,3546,Tmax value in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621387,,BAO_0000218,,
7195,3184,Compound was evaluated for its clearance when administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621388,,BAO_0000218,,
7196,16456,Plasma clearance in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621389,,BAO_0000218,,
7197,4809,Plasma clearance was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621390,,BAO_0000218,,
7198,4219,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Intermediate,1,,CHEMBL621391,,BAO_0000100,,
7199,3748,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621392,,BAO_0000218,,
7200,3132,Time taken for EC90 was determined when tested in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621393,,BAO_0000218,,
7201,4219,Half life (iv) was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621394,,BAO_0000218,,
7202,16907,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL621395,,BAO_0000218,2107.0,
7203,6057,Area under the curve was calculated in dog after iv administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621396,,BAO_0000218,,
7204,6057,Area under the curve was calculated in dog after peroral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621397,,BAO_0000218,,
7205,17853,Dose-normalized area under curve in dog (p.o.) at 2.0 mpk,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621398,,BAO_0000218,,
7206,3639,pKa was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618818,,BAO_0000218,,
7207,14541,Compound was evaluated for pronounced GH response at 100 mg (n=6)(area under concentration curve was determined from 0-8 hr following morning and evening dosing with 25 mg of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618819,,BAO_0000218,,
7208,16456,Alpha-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618820,,BAO_0000218,,
7209,16456,Beta-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873810,,BAO_0000218,,
7210,2652,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876606,,BAO_0000218,,
7211,3624,Compound was evaluated for the half-life (t 1/2) in hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618821,,BAO_0000218,,
7212,1337,Half life to reach the blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618822,,BAO_0000218,178.0,
7213,1337,Half life to reach the blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618823,,BAO_0000218,178.0,
7214,4709,Half life after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618824,,BAO_0000218,,
7215,15660,Half life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618825,,BAO_0000218,,
7216,5302,Half life period in dog after 5 mg/kg dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618826,,BAO_0000218,,
7217,17791,Half life period was evaluated in dog; 4-4.8,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618827,,BAO_0000218,,
7218,6348,Half life was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618828,,BAO_0000218,,
7219,4257,Half-life was determined in dog after a3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618829,,BAO_0000218,,
7220,3771,Half-life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618830,,BAO_0000218,,
7221,6305,Half life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618831,,BAO_0000218,,
7222,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 2 mg/kg tp dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619489,,BAO_0000218,1969.0,
7223,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619649,,BAO_0000218,,
7224,3045,Compound was evaluated for the half life period after iv administration in Beagle dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876607,,BAO_0000218,,
7225,3043,Compound was evaluated for the half life period after oral administration in conscious dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619650,,BAO_0000218,,
7226,4839,Compound was tested for half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619651,,BAO_0000218,,
7227,4839,Compound was tested for its half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619652,,BAO_0000218,,
7228,5802,Half life of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619653,,BAO_0000218,,
7229,17839,Half life of compound in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619654,,BAO_0000218,,
7230,4219,Half life (iv) was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619655,,BAO_0000218,,
7231,13966,Half life following administration of 70 nM in canine whole blood (dose exceeding platelet binding capacity),A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619656,,BAO_0000218,178.0,
7232,3994,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL873812,,BAO_0000218,1969.0,
7233,3994,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,F,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621365,,BAO_0000218,1969.0,
7234,4453,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621366,,BAO_0000218,,
7235,6535,Half life in dog plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621367,,BAO_0000218,1969.0,
7236,6535,Half life in dog plasma after administration of 0.25 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621368,,BAO_0000218,1969.0,
7237,6535,Half life in dog plasma after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621369,,BAO_0000218,1969.0,
7238,3132,Half life in dog plasma was determined at dose 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621370,,BAO_0000218,1969.0,
7239,5374,Half life in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621371,,BAO_0000218,,
7240,5007,Half life in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621372,,BAO_0000218,,
7241,16907,Half life upon exposure to human plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621373,,BAO_0000218,1969.0,
7242,6057,Half life was calculated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621374,,BAO_0000218,,
7243,5006,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621375,,BAO_0000218,,
7244,5473,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621376,,BAO_0000218,,
7245,4368,Half life by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619624,,BAO_0000218,,
7246,6448,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875840,,BAO_0000218,,
7247,4353,Half life in dog after intra venous administration of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619625,,BAO_0000218,,
7248,4353,Half life in dog after intra venous administration of the compound; ND means Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619626,,BAO_0000218,,
7249,4353,Half life in dog after po administration of the compound,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619627,,BAO_0000218,,
7250,4353,Half life in dog after po administration of the compound; ND means Not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873817,,BAO_0000218,,
7251,6265,Half life in dog at the single oral dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619628,,BAO_0000218,,
7252,5006,Half life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619629,,BAO_0000218,,
7253,5356,Half life in dogs at 1 mg/kg oral dosing; 35-100 min,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619630,,BAO_0000218,,
7254,405,Half life in rat,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619631,,BAO_0000218,,
7255,6642,Half life in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619632,,BAO_0000218,,
7256,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619633,,BAO_0000218,10000001.0,
7257,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL875841,,BAO_0000218,10000001.0,
7258,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619634,,BAO_0000218,10000001.0,
7259,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619635,,BAO_0000218,10000001.0,
7260,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619636,,BAO_0000218,10000001.0,
7261,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619637,,BAO_0000218,10000004.0,
7262,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619638,,BAO_0000218,10000004.0,
7263,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619639,,BAO_0000218,10000004.0,
7264,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619640,,BAO_0000218,10000004.0,
7265,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619641,,BAO_0000218,10000004.0,
7266,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619642,,BAO_0000218,10000004.0,
7267,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619643,,BAO_0000218,10000004.0,
7268,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL619644,,BAO_0000218,948.0,
7269,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621112,,BAO_0000218,948.0,
7270,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621113,,BAO_0000218,948.0,
7271,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621114,,BAO_0000218,948.0,
7272,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621115,,BAO_0000218,948.0,
7273,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621116,,BAO_0000218,948.0,
7274,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621117,,BAO_0000218,948.0,
7275,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621118,,BAO_0000218,2113.0,
7276,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621119,,BAO_0000218,2113.0,
7277,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621120,,BAO_0000218,2113.0,
7278,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621757,,BAO_0000218,2113.0,
7279,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621758,,BAO_0000218,2113.0,
7280,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621759,,BAO_0000218,2113.0,
7281,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621760,,BAO_0000218,2113.0,
7282,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621761,,BAO_0000218,2107.0,
7283,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621762,,BAO_0000218,2107.0,
7284,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621763,,BAO_0000218,2107.0,
7285,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624502,,BAO_0000218,2107.0,
7286,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624503,,BAO_0000218,2107.0,
7287,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624504,,BAO_0000218,2107.0,
7288,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624505,,BAO_0000218,2107.0,
7289,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624506,,BAO_0000218,2048.0,
7290,5895,In vitro cytotoxicity against A2780 (human ovarian cancer),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624507,478.0,BAO_0000219,,
7291,6338,In vitro cytotoxicity against the paclitaxel sensitive human breast carcinoma cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624508,478.0,BAO_0000219,,
7292,15163,In vitro cytotoxicity against. ovarian carcinoma cell line A2780.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624509,478.0,BAO_0000219,,
7293,15163,In vitro cytotoxicity against. ovarian carcinoma cell line A2780cisR (cisplatin resistant counter part of A2780).,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624510,478.0,BAO_0000219,,
7294,15000,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL875956,478.0,BAO_0000219,,
7295,15000,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cisplatin resistant cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL839885,478.0,BAO_0000219,,
7296,14729,In vitro cytotoxicity against A2780 ovarian cells using the sulforhodamine B(SRB) assay.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL624511,478.0,BAO_0000219,,
7297,17270,In vitro cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624512,478.0,BAO_0000219,,
7298,5685,In vitro growth inhibitory activity against A2780 human ovarium carcinoma cell line was determined,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624513,478.0,BAO_0000219,,
7299,3563,In vitro inhibitory activity against human ovarian cancer A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624514,478.0,BAO_0000219,,
7300,17753,In vivo cytotoxic concentration of compound against A2780 cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618547,478.0,BAO_0000218,,
7301,16317,"Inhibition of cell growth in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant)using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618548,478.0,BAO_0000219,,
7302,16936,Inhibition of tubulin polymerization in analogy of ca.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618549,478.0,BAO_0000219,,
7303,3801,Inhibitory activity against ovarian tumor cell line A2780 after 72 hr continuous exposure to compound,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618550,478.0,BAO_0000219,,
7304,6181,Cytotoxic effect in ovarian cancer cell line (A2780),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618551,478.0,BAO_0000219,,
7305,5318,Tested for cytotoxicity against Ovarian carcinoma parental type A2780 cell line expressing MDR-1 (-) gene,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618552,478.0,BAO_0000219,,
7306,4840,Tested for the cytotoxicity in A2780 ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618553,478.0,BAO_0000219,,
7307,15748,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618554,478.0,BAO_0000219,,
7308,15748,The compound was tested for cytotoxic activity against A2780/Cs cell line(human ovarian carcinoma,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618555,478.0,BAO_0000219,,
7309,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma,F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618556,481.0,BAO_0000219,,
7310,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618557,481.0,BAO_0000219,,
7311,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ); ND means no data,F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618558,481.0,BAO_0000219,,
7312,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma),F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618559,481.0,BAO_0000219,,
7313,17753,In vivo log of cells killed after administration of compound in A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618560,478.0,BAO_0000218,,
7314,17753,Compound was tested in vivo for maximum tolerated dose after i.v. administration twice a day for 5 days in A2780 cell line,F,In vivo,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618561,478.0,BAO_0000218,,
7315,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.;NA means not active,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618562,478.0,BAO_0000219,,
7316,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines (at 5 uM );NA means not active,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618563,478.0,BAO_0000219,,
7317,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines; ND means no data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618564,478.0,BAO_0000219,,
7318,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines. (at 5 uM ); ND means no data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618565,478.0,BAO_0000219,,
7319,17528,Optimal dose required to inhibit human ovarian A2780 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q4dX2),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618566,478.0,BAO_0000218,,
7320,6633,Resistance factor was determined as IC50 cisplatin-resistant/parent for human A2780 ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618567,478.0,BAO_0000219,,
7321,15000,Resistance index is IC50 ratio of A2780 cell line and A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618568,478.0,BAO_0000219,,
7322,17528,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618569,478.0,BAO_0000219,,
7323,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian cancer cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621857,478.0,BAO_0000219,,
7324,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621858,478.0,BAO_0000219,,
7325,16936,Percent of Tubulin polymerization inhibition by using human ovarian cancer cell lines at a concentration of 5 uM,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621859,478.0,BAO_0000219,,
7326,16936,"Colchicine Binding Inhibition ( CBI ) by using human ovarian cancer cell lines at 5 uM, (values are mean of 9 over 4 concentrations +/- SD)",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621860,478.0,BAO_0000219,,
7327,16936,Compound tested for colchicine Binding Inhibition by using human ovarian cancer cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621861,478.0,BAO_0000219,,
7328,16936,"Tested for colchicine binding inhibition, using human ovarian cancer cell lines (at 5 uM )",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621862,478.0,BAO_0000219,,
7329,16936,Compound tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621863,478.0,BAO_0000219,,
7330,16936,Compound was tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621864,478.0,BAO_0000219,,
7331,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621865,478.0,BAO_0000219,,
7332,17737,In vitro antiproliferative activity against A2780 cell line,F,,,Mus musculus,10090.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621866,478.0,BAO_0000219,,
7333,17764,Maximum tolerated dose in A2780 tumor in mice after intraperitoneal administration daily for 8 days,F,,,Mus musculus,10090.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621867,478.0,BAO_0000219,,
7334,3830,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621868,478.0,BAO_0000219,,
7335,3829,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C for 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875282,478.0,BAO_0000219,,
7336,3546,Vc value in dog after IV administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621869,,BAO_0000218,,
7337,3546,Half life period in dog after IV administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621870,,BAO_0000218,,
7338,5668,Area under curve was determine after peroral administration at 10 mpk in Rhesus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621871,,BAO_0000019,,
7339,3443,AUC (area under curve) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621243,,BAO_0000218,1969.0,
7340,3443,AUC (area under curve) compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621244,,BAO_0000218,1969.0,
7341,4256,Area under curve determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621245,,BAO_0000218,,
7342,4256,Area under curve determined after peroral administration at a dose of 10 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621246,,BAO_0000218,,
7343,4256,Area under curve determined after peroral administration at a dose of 3 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621247,,BAO_0000218,,
7344,4256,Oral Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618386,,BAO_0000218,,
7345,1916,Area under curve was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618387,,BAO_0000218,,
7346,5302,Area under curve value in monkey at a dose of 5 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618388,,BAO_0000218,,
7347,4257,Area under curve was determined in monkey after a 3 mg/kg of oral dose,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618389,,BAO_0000218,,
7348,5355,Area under curve was determined using trapezoidal rule after intravenous administration in cynomolgus monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618574,,BAO_0000019,,
7349,5355,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618575,,BAO_0000019,,
7350,5355,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys; ND means Not determined,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618576,,BAO_0000019,,
7351,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618577,,BAO_0000218,,
7352,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876487,,BAO_0000218,,
7353,6062,Area under the curve was measured in monkey after an iv dose of 1 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618578,,BAO_0000218,,
7354,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618579,,BAO_0000218,,
7355,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618580,,BAO_0000019,,
7356,5394,Pharmacokinetic parameter Cmax was measured after administration into monkey at 3 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618581,,BAO_0000218,,
7357,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in cynomolgus monkeys (0 to 24 hr) p.o.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618582,,BAO_0000218,,
7358,17509,Area under curve value 24 hr after 2 mg/kg iv administration in monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618583,,BAO_0000218,,
7359,17509,Area under curve value 24 hr after 2 mg/kg oral administration in monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618584,,BAO_0000218,,
7360,6641,Oral AUCN in monkey (dosed at 0.5 mpk iv ),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618585,,BAO_0000218,,
7361,5355,Bioavailability was reported in cynomolgus monkeys (ratio of AUC in oral administration to that of intravenous administration),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618586,,BAO_0000218,,
7362,3443,Half life compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618587,,BAO_0000218,,
7363,3443,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618588,,BAO_0000218,,
7364,17409,Binding towards monkey plasma protein at 10 uM,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618589,,BAO_0000019,,
7365,17409,Binding towards monkey plasma protein at 100 uM,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618590,,BAO_0000019,,
7366,1052,Apparent bioavailability in squirrel monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL872262,,BAO_0000218,,
7367,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618591,,BAO_0000218,,
7368,17509,Bioavailability in monkey (dose 2 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618592,,BAO_0000218,,
7369,5394,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for bioavailability after administration into monkey at 3 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876488,,BAO_0000218,,
7370,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618593,,BAO_0000218,,
7371,11219,Bioavailability in monkey (i.d. dosing),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618594,,BAO_0000218,,
7372,3045,Oral bioavailability after 5 mg/kg in cynomolgus monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618595,,BAO_0000218,,
7373,17796,Clearance of the drug was measured in cynomolgus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621469,,BAO_0000019,,
7374,1399,Clearance was estimated in two squirrel monkeys after iv administration at 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621470,,BAO_0000218,,
7375,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621471,,BAO_0000218,,
7376,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621472,,BAO_0000218,1969.0,
7377,17267,Plasma clearance in rhesus monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621473,,BAO_0000218,,
7378,6535,Plasma clearance in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621474,,BAO_0000218,,
7379,5922,Plasma clearance in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621475,,BAO_0000218,,
7380,6221,Plasma clearance after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621476,,BAO_0000218,,
7381,5668,Plasma clearance after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624290,,BAO_0000218,,
7382,5355,The total clearance was determined after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624291,,BAO_0000218,,
7383,5355,The total clearance was determined after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624292,,BAO_0000218,,
7384,5355,The total clearance was determined after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624293,,BAO_0000218,,
7385,4578,Tested for Clearance upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624294,,BAO_0000218,,
7386,17592,Clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624295,,BAO_0000218,,
7387,6641,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624296,,BAO_0000218,,
7388,6642,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624297,,BAO_0000218,,
7389,16367,Half life was evaluated after intravenous administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624298,,BAO_0000218,,
7390,5472,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624299,,BAO_0000218,,
7391,5474,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624300,,BAO_0000218,,
7392,5654,Half life period (t1/2) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624301,,BAO_0000218,,
7393,6227,Half life period after intravenous administration (1 mg/kg) was determined in dog (in vivo),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624302,,BAO_0000218,,
7394,6227,Half life period after intravenous administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876026,,BAO_0000218,,
7395,6221,Half life period after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624303,,BAO_0000218,,
7396,4527,Half life period at a dose of 1 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624304,,BAO_0000218,,
7397,5668,Half life period was determine after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624305,,BAO_0000218,,
7398,5668,Half life period was determine after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624306,,BAO_0000218,,
7399,3854,Half life period was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624307,,BAO_0000218,,
7400,5505,Half life period was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624308,,BAO_0000218,,
7401,6251,Half life period by iv administration in dog at a dose of 6 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624309,,BAO_0000218,,
7402,1918,Half life period was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624310,,BAO_0000218,,
7403,5546,Half life period was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625003,,BAO_0000218,,
7404,4809,Half life period was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625004,,BAO_0000218,,
7405,6215,Half life time after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625005,,BAO_0000218,,
7406,4527,Half-life period by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873813,,BAO_0000218,,
7407,17594,Half-life after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625006,,BAO_0000218,,
7408,17839,Half-life of compound in dog following p.o. administration of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625007,,BAO_0000218,,
7409,17839,Half-life of compound in dog following p.o. administration of 0.9 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876027,,BAO_0000218,,
7410,17839,Half-life of compound in dog following p.o. administration of 0.95 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625008,,BAO_0000218,,
7411,17839,Half-life of compound in dog following p.o. administration of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625009,,BAO_0000218,,
7412,5210,Half-life of compound in plasma of dog was determined,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625010,,BAO_0000218,1969.0,
7413,5210,Half-life of compound was determined in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625011,,BAO_0000218,,
7414,2959,Half-life after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621553,,BAO_0000218,,
7415,4137,Half-life after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621554,,BAO_0000218,,
7416,5064,Half-life in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621555,,BAO_0000218,,
7417,5147,Half-life in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621556,,BAO_0000218,,
7418,5145,Half-life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621557,,BAO_0000218,,
7419,6123,Half-life in dog after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621558,,BAO_0000218,,
7420,6123,Half-life in dog after oral administration at 1 mg/kg; nd is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621559,,BAO_0000218,,
7421,4333,Half-life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621560,,BAO_0000218,,
7422,4333,Half-life in dogs; ND indicates not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876028,,BAO_0000218,,
7423,12500,Half-life in plasma of dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621561,,BAO_0000218,1969.0,
7424,12500,Half-life in plasma of dog at dose of 3-10 mgkg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621562,,BAO_0000218,1969.0,
7425,6005,Half-life was evaluated after i.v. administration in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621563,,BAO_0000218,,
7426,6062,Half-life was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621564,,BAO_0000218,,
7427,17650,Half-life was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621565,,BAO_0000218,,
7428,5530,Half-life in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621566,,BAO_0000218,,
7429,5530,Half-life in vivo in dog by intravenous administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621567,,BAO_0000218,,
7430,5600,Half-life of the compound after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622978,,BAO_0000218,,
7431,6039,Half-life period after intravenous administration of 0.5 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873814,,BAO_0000218,,
7432,6039,Half-life period after intravenous administration of 1.0 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623219,,BAO_0000218,,
7433,6039,Half-life period after peroral administration of 0.2 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624477,,BAO_0000218,,
7434,6227,t1/2 in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624478,,BAO_0000218,,
7435,14541,Half-life period measured in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624479,,BAO_0000218,,
7436,4521,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624480,,BAO_0000218,,
7437,4521,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623595,,BAO_0000218,,
7438,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623596,,BAO_0000218,,
7439,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in dog plasma",A,In vitro,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623597,,BAO_0000218,1969.0,
7440,5444,In vivo half life period was calculated at 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623598,,BAO_0000218,,
7441,5444,In vivo half life period was calculated at 1 mg/kg in dog; ND=Not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623599,,BAO_0000218,,
7442,17853,Longer half-life in dog (i.v.) at 0.5 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623600,,BAO_0000218,,
7443,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623601,,BAO_0000218,,
7444,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623602,,BAO_0000218,,
7445,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623603,,BAO_0000218,,
7446,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623604,,BAO_0000218,,
7447,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623605,,BAO_0000218,2048.0,
7448,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623606,,BAO_0000218,2048.0,
7449,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623607,,BAO_0000218,2048.0,
7450,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623608,,BAO_0000218,2048.0,
7451,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623609,,BAO_0000218,2048.0,
7452,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623610,,BAO_0000218,2048.0,
7453,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623611,,BAO_0000218,2385.0,
7454,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623612,,BAO_0000218,2385.0,
7455,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623613,,BAO_0000218,2385.0,
7456,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623614,,BAO_0000218,2385.0,
7457,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623615,,BAO_0000218,2385.0,
7458,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623616,,BAO_0000218,2385.0,
7459,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623617,,BAO_0000218,2385.0,
7460,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL875944,,BAO_0000218,14.0,
7461,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623618,,BAO_0000218,14.0,
7462,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623619,,BAO_0000218,14.0,
7463,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623620,,BAO_0000218,14.0,
7464,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623621,,BAO_0000218,14.0,
7465,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623622,,BAO_0000218,14.0,
7466,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623623,,BAO_0000218,14.0,
7467,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL623624,,BAO_0000218,2106.0,
7468,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618521,,BAO_0000218,2106.0,
7469,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618522,,BAO_0000218,2106.0,
7470,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618523,,BAO_0000218,2106.0,
7471,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618524,,BAO_0000218,2106.0,
7472,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618525,,BAO_0000218,2106.0,
7473,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL624586,,BAO_0000218,2106.0,
7474,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624587,,BAO_0000218,945.0,
7475,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624588,,BAO_0000218,945.0,
7476,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624589,,BAO_0000218,945.0,
7477,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624590,,BAO_0000218,945.0,
7478,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624591,,BAO_0000218,945.0,
7479,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624592,,BAO_0000218,945.0,
7480,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624593,,BAO_0000218,945.0,
7481,4689,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624594,,BAO_0000218,,
7482,4950,Tested for the bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624595,,BAO_0000218,,
7483,5328,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624596,,BAO_0000218,,
7484,406,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624597,,BAO_0000218,,
7485,12500,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624598,,BAO_0000218,,
7486,12500,Bioavailability in rat (dose 3-10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624599,,BAO_0000218,,
7487,5247,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875166,,BAO_0000218,,
7488,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624600,,BAO_0000218,1969.0,
7489,4186,Apparent terminal elimination half-life in rat plasma after administration of 50 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624601,,BAO_0000218,1969.0,
7490,6647,Half life after oral administration was determined in rats at 6 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624602,,BAO_0000218,,
7491,6484,Half life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624603,,BAO_0000218,,
7492,3249,Half life the of compound was determined by ''Cr'' assay in rat at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624604,,BAO_0000218,,
7493,6281,Plasma half life in rat at oral dose 2.8 mg/mk body weight,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624605,,BAO_0000218,1969.0,
7494,3307,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624606,,BAO_0000218,,
7495,12058,Half-lives were estimated from the elimination phase of the blood conc-time curve after oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624607,,BAO_0000218,178.0,
7496,8833,Hill coefficient of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624608,,BAO_0000218,,
7497,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 0.5 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624609,,BAO_0000218,178.0,
7498,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 180.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624610,,BAO_0000218,178.0,
7499,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 2.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624611,,BAO_0000218,178.0,
7500,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 5.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624612,,BAO_0000218,178.0,
7501,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 60.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875167,,BAO_0000218,178.0,
7502,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 7.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624613,,BAO_0000218,178.0,
7503,3193,"Compound was tested for percent hydrolysis in whole blood, after a time interval of 15.0 min",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624614,,BAO_0000218,178.0,
7504,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624392,,BAO_0000218,,
7505,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624393,,BAO_0000218,955.0,
7506,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624394,,BAO_0000218,955.0,
7507,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624395,,BAO_0000218,955.0,
7508,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624396,,BAO_0000218,955.0,
7509,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624397,,BAO_0000218,955.0,
7510,13950,Biodistribution of [123I]-label in rat thyroid was reported at 0.33 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624398,,BAO_0000218,2046.0,
7511,13950,Biodistribution of [123I]-label in rat thyroid was reported at 1 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624399,,BAO_0000218,2046.0,
7512,13950,Biodistribution of [123I]-label in rat thyroid was reported at 2 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624400,,BAO_0000218,2046.0,
7513,13950,Biodistribution of [123I]-label in rat thyroid was reported at 24 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624401,,BAO_0000218,2046.0,
7514,13950,Biodistribution of [123I]-label in rat thyroid was reported at 4 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624402,,BAO_0000218,2046.0,
7515,9866,Biodistribution in normal rat blood in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624403,,BAO_0000218,178.0,
7516,9866,Biodistribution in normal rat blood in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624404,,BAO_0000218,178.0,
7517,9866,Biodistribution in normal rat blood in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624405,,BAO_0000218,178.0,
7518,9866,Biodistribution in normal rat bone in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624406,,BAO_0000218,10000001.0,
7519,9866,Biodistribution in normal rat bone in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624407,,BAO_0000218,10000001.0,
7520,9866,Biodistribution in normal rat bone in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624408,,BAO_0000218,10000001.0,
7521,9866,Biodistribution in normal rat heart in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618644,,BAO_0000218,948.0,
7522,9866,Biodistribution in normal rat heart in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618645,,BAO_0000218,948.0,
7523,9866,Biodistribution in normal rat heart in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618646,,BAO_0000218,948.0,
7524,9866,Bi0eistributi9binnormalratkodnetintheprfsenseof00p5hrs001Mligat2he,A,Invuvo,,Rattuanorbegicjs,764.0,,lidney,,,50597,N,1,Interhddiate,1,,CHEkBL61864u,,BAO0009318,1461673.0,
7525,9866,Biovistributiohigj84kqira5kidneyinthepreeenceof0p1MGd005Mlig,A,Invico,,4attusnorvegoc8s,20388.0,,midney,,,50597,N,1,Interm3d8ate,1,,fHEMBL518648,,vAO0000219,1104439.0,
7526,9866,BiodlstributloninnprjalratkiwgeyijtheprexenseofNACrd901Mlkgat2hr,A,jnvivo,,Rattuenkrvegidus,34095.0,,Kifney,,,50597,N,1,ontermedia6e,1,,CHfMBL61864i,,BAO00o021o,1478997.0,
7527,9866,Biodistribuyjoninnorhalrati8derintheprezenceoe9005Mhdo01Mligq42hr,A,Inviv8,,Rwttusmorvegicuq,15522.0,,Lifer,,,50597,N,1,Igtermediatr,1,,CHEMBLt1u650,,gAO00p0218,1753333.0,
7528,9866,Biodisfribu6i8ningo3kalratliverinfh4presence8f001MGw005Mliy,A,7nvivo,,Rattusn8gveg9cus,22651.0,,kiver,,,50597,N,1,Ibtefmediate,1,,CHEMvL6q8651,,BAlo000218,763595.0,
7529,9866,Bioxisfribitionignormwlratliberinthepredebce0fNxCrd00wMligat2hr,A,Invibo,,gattksgorvegicus,3625.0,,iiver,,,50597,N,1,Intermediahf,1,,vnEMBL876497,,BxO0000217,1950370.0,
7530,9866,Bioxistributloninnkrmqlratlujgibthepfesenceof000rMGd001Mlirxtqjr,A,Igvivo,,Raftusnp5vegicus,8466.0,,Lung,,,50597,N,1,In4ermediat3,1,,CmEMhL618652,,BA90000219,1577164.0,
7531,9866,Biosis4rif7tionimnormalratk8nguntheprecenceof001MGc0o5Mlig,A,Ihvivo,,Rattushodvericus,39498.0,,Lung,,,50597,N,1,Infermediste,1,,CmEMBL6186r3,,BwO0o00218,340758.0,
7532,9866,Bloxictrubut88ginnormaldatlunginhhepresenceofNACyd9o1Mligat2hr,A,Invuvo,,Rattucnorgericus,12406.0,,Lung,,,50597,N,1,Inyermddiate,1,,CjEMBo618654,,BAO0009318,510400.0,
7533,6351,Recovs4ygatefromurinwxndbilewasdet4rmijersfterivqwm7nistrqtionat20mgkgimrqtsN9gtested,A,,,Rattusnofbfgicus,17670.0,,,,,50597,N,1,Inte4mediste,1,,CHEMBL61864t,,BAO0o002q8,,
7534,1465,Cokp0undwqstestedforsilubilityijwaf3r,A,,,Rat5hsn9rvegicus,6534.0,,,,,50597,N,1,Ibtermediste,1,,CHEMnL6186t6,,gAO00002w8,,
7535,5182,Soiubilotyin0h0spha4ebucfer3dsaline1DMSOatpHt524hteqyilib5atiin,P,,,,,,,,,22229,U,0,In5ermediwte,1,,CbfMBL618657,,BAO000pq00,,
7536,17847,eolubilitywasd2trrminsd,A,,,Rattushorveg7cue,4210.0,,,,,50597,N,1,Intermsdjate,1,,CbEjBL618658,,BAOo009218,,
7537,15339,s0lubilltyinwwterugmpate7degrdeC,A,,,Rat5usnoev3gicus,1585.0,,,,,50597,N,1,Intwrmedia6e,1,,CuEMBL61865p,,BAO0000eq8,,
7538,5202,Firs4passketabokisnandmetanolixbiowvaklabilityusinggathrpstifmicros0mds,A,,,Ratt8dnorvegkcus,24455.0,,,,,50597,N,1,Intermedia43,1,,CHEMBL618tt0,,fAO0009218,,
7539,1088,Ingifrostabil8hyfepatovetoAJ76inrayh2patocy6eassay,A,,,tattusnorveficux,11314.0,,,,,50597,N,1,jntermefiate,1,,CnEMBL617661,,BA8p000218,,
7540,3169,Halflkfeinrqts,A,,,Rattusjorveglcis,5365.0,,,,,50597,N,1,Inre3mediate,1,,CHwMBL873u07,,BA80p00218,,
7541,5353,HapfkifejnDawleyrat,A,,,Rattkqnorvegifus,34855.0,,,,,50597,N,1,Ibtdrmediate,1,,dHEMfL618662,,nAO00o0218,,
7542,2864,Halvlifeperioxaf6e33mgkbivadmimist5atikn,A,Inv7vo,,5at5usnorvegicys,13399.0,,,,,50597,N,1,ontwrmediate,1,,CHEkBL618y63,,vAO0p00218,,
7543,2864,Halflifeperiodafterwmrugovaekin8strstioninrxt,A,Igvivo,,Rsttuxnorvegkcus,1585.0,,,,,50597,N,1,Ijtfrmediate,1,,CHEMBL618yu4,,BAO0p00217,,
7544,2864,Hwlflifrpdriodafter3kgkflvadminlsyratilnintherat,A,Invivi,,Rz4tusnorvegifus,2949.0,,,,,50597,N,1,jntwrmediate,1,,CHEMBL6q7665,,Bx90000218,,
7545,6362,Hapfoif3periodinfemapeqpragueDawlfyra5s,A,,,Rattuxnorv2gifus,25829.0,,,,,50597,N,1,Inteemwdiate,1,,CHEMBi8764o8,,BAO0000317,,
7546,6249,Halfllfeperiodimray,A,,,Rattusnorceg7cuw,7878.0,,,,,50597,N,1,In4ermediatd,1,,CjEnBL618666,,BAO000p21u,,
7547,3169,Hqlfkifeinta5swasdeterminrd,A,,,Raytusnorvsgkcus,910.0,,,,,50597,N,1,Ihtermwdiate,1,,CmEMgL620440,,BAO0o00w18,,
7548,3169,Haldlofe7nrats2ithketaboljcoxidatiom,A,,,Rattusmlrvegicjs,13219.0,,,,,50597,N,1,Intern2diate,1,,CHrMBL629441,,BsO0900218,,
7549,3169,Halclifeunrats,A,,,Rzttusborvegicuz,22219.0,,,,,50597,N,1,Internediats,1,,CHEMBi62044q,,BAlo000218,,
7550,17260,T12atwxoseorw9mgKvadmihisteredintravenouslyinffmapejamkverwistargat,A,Incivo,,Rsttusnprvegicua,27491.0,,,,,50597,N,1,jntermedixte,1,,CHEMvL620r43,,fA80000218,,
7551,17260,T12atadoseod10mgKnadminlwgerrdper0rwllyinfemslehzjoverwistxrrat,A,Ihvivo,,Rattusb0rvegixus,21202.0,,,,,50597,N,1,Igtrrmediate,1,,sHEMBp620444,,BAO0p00118,,
7552,17260,ymwxatadpseof10mgKgadminisher2dimyrav2nouslyunfemalehanovfrwosta4rah,A,Invido,,Rattusjorbegocus,33522.0,,,,,50597,N,1,Intermed7atr,1,,CHEMBo620e45,,BA900o0218,,
7553,17260,gmwxatad0aeof10mgKgadministeredpsr05alihinfemalshanovrr2istarrat,A,onvivo,,Rathusnorv2glcus,19740.0,,,,,50597,N,1,kntermeduate,1,,CHEhnL620446,,BAO000o21u,,
7554,2879,Biopogicalbalflifemsqshredihplasmapfrat,A,,,5attushorveg8cus,7988.0,,Plxsma,,,50597,N,1,Intermewiat4,1,,CHEMBL62o44y,,BwO00p0218,446485.0,
7555,2879,Biologisalhslflif2keasuredinpoasmaocrah2215,A,,,Ra5tuenorvegivus,57701.0,,Plaqma,,,50597,N,1,7ntermed8ate,1,,dH2MBL621129,,BAi0000118,401.0,
7556,2879,Buologicalhalfkigemeasuredinplxsmq9frat017,A,,,eattysnorvegivus,3821.0,,Plxsma,,,50597,N,1,Intsgmediate,1,,dHEMBL621140,,BAO0000229,947740.0,
7557,3184,Ckmpoindwasevwluatddfogitshalfoifewhenadmimiste5edinhdad4nouslyin3at,A,Ihvivo,,Raftixnorvegicus,20831.0,,,,,50597,N,1,Interh3diate,1,,CuEMBL872808,,BA900p0218,,
7558,4891,Compound1aadvaluwtedforphwrmavokineticosrqjrterpercenthi9agailabilityat8h,A,Inviv8,,Rqtt6smorvegicus,11722.0,,,,,50597,N,1,Internediste,1,,CHEMBL87t59u,,Bq90000218,,
7559,429,fvaoustedforphsrmadokineticparameterhqlfl9feinrarattuedoew50mglg,A,Ibvivo,,Ratt8snorgebicus,27005.0,,,,,50597,N,1,Inte5meeiate,1,,CHEMgL721131,,BAOo0o0218,,
7560,5656,HaoflkbeT12aftdroraladminietration7n4at,A,Invido,,gzttusnorveticus,14331.0,,,,,50597,N,1,Intermed8atd,1,,CHfMBL621232,,BAO0000e1o,,
7561,4413,Halfk7fsofcokpoubdafterivadmihistratj8nof20jgkgdoceinrah,A,jnvivo,,dattusno5vegocus,34700.0,,,,,50597,N,1,Ibhermediate,1,,fHEjBL621133,,BA900p0218,,
7562,3598,Halflifeorcom9oumddet3eminedimragsf5erlvadkinistrationatad9seofq0mgkg,A,unvivo,,Ra5tusnorvegixuz,10063.0,,,,,50597,N,1,Ecpert,1,,CHEnBp621312,,BxO000o218,,
7563,17267,Hakflifeofc9mpoihrwasfeteeminedinrat,A,,,Ra6tusnorvegichx,22225.0,,,,,50597,N,1,Intedmediwte,1,,CHEMBi621323,,nAO00p0218,,
7564,4727,Haotiieeofcompougrwasdeterminedin4atbiood,A,,,Rattkznorvegic8s,2859.0,,Bl8od,,,50597,N,1,knterm3diate,1,,CHEMBL6e2314,,BAO0099218,271228.0,
7565,17651,Halelifeatqmgknwasseterminedinrsy,A,Inv7vo,,Rattusni3degicus,34084.0,,,,,50597,N,1,7ntermediats,1,,CHEkBL6213q5,,BAOo0002q8,,
7566,17651,jaoflifeat1omgkgwasfet3rm9nedinrat,A,Invibo,,gzhtusnorvegicus,25489.0,,,,,50597,N,1,Interkddiate,1,,dHEMBL62131t,,Bzk0000218,,
7567,401,Halgoifeinrats,A,,,Rattusnorv3gix7s,3142.0,,,,,50597,N,1,untermrdiate,1,,CHsMBL611317,,BzO0000e18,,
7568,4942,Halflifsinragsighou3s,A,,,Rattusb0rv4gicus,10114.0,,,,,50597,N,1,Int4rmediste,1,,CHEMBp621317,,BAl00002q8,,
7569,17735,Halfkifef0llowlng20kgkgintrwfenousor50mfktoraldosibginrarswaedeterm7bed,A,Incivo,,Rqgtusnorvegisus,49376.0,,,,,50597,N,1,In6erm3diate,1,,CHEMBk62131i,,BAOp090218,,
7570,6056,Hxlfiifewasczlculqtedatxs8ngleuntravebouswdninistrat9onof2pmgkgin4at,A,unvivo,,da5tushorvegicus,22107.0,,,,,50597,N,1,Interkediqte,1,,CHEMBL5e1377,,BqO0090218,,
7571,5213,Hapgligewasdeterminec,A,,,Rattudnkrcegicus,28253.0,,,,,50597,N,1,Igtedmediate,1,,CHEMBL611379,,BAk0000118,,
7572,6616,Halblifeaftwrivawministrzti9n,A,Indivo,,Rsttusnotdegicus,21757.0,,,,,50597,N,1,ontetmediate,1,,CyEMgL876599,,BAO009021o,,
7573,5937,Halflifeumratafte3ij6rqvenousavminustrationafwsonsentration05mgog,A,Invivk,,Rattusgorvsgicuw,38206.0,,,,,50597,N,1,Intermedkafe,1,,CHEnBL62w379,,nAO00002q8,,
7574,5819,Halflifeinra5plasjx,A,,,3attucnorvegichs,40026.0,,Ppasma,,,50597,N,1,9ntermediat4,1,,CHEMBL621399,,BAk000o218,1432597.0,
7575,5819,taofl8fein5atplasjaNohdetected,A,,,eattisnorveg7cus,1182.0,,Ppasma,,,50597,N,1,Intermrdiatd,1,,CHEMBL621ru1,,BAO0op0218,892464.0,
7576,6803,Hwlflifeinrwts,A,,,fathusnodvegicus,16383.0,,,,,50597,N,1,Int3rmediwte,1,,CyEMBL618525,,nwO0000218,,
7577,17804,Haiflife0efiodogcompkundwasdetwrkinedarrer0e3oraladkinistration,A,9nvivo,,Rartusjkrvegicus,3067.0,,,,,50597,N,1,Intrrmedoate,1,,CHEMBi61i516,,BwOo000218,,
7578,17804,Hzlflkfeperiod0fvohpound2asdetw4ninedatadoseot3mtknbyintrsvenousawministrati0n,A,Invibo,,Ratthsnorvenidus,10769.0,,,,,50597,N,1,Intermeviatd,1,,CHEMhL618527,,BxO0o00218,,
7579,5948,Hslflifeper7odunrat,A,,,gattksnotvegicus,14768.0,,,,,50597,N,1,onterkediate,1,,CH3MBL6185q8,,Bz80000218,,
7580,1916,Halfl8feperiodqasevaluxtedagalnsgSprqgueDawkeyratsxtadodeof15kgjgatrerlvadk7nistrwtion,A,Ibvivo,,Rattuznirvfgicus,22681.0,,,,,50597,N,1,Int2rmediat3,1,,CnEMfL618519,,BzO0000118,,
7581,1916,Hapflideper8ldwqzevakuztedinxpraguewawl2yratsatadoseof1ymgktxfterpoadminisyratipn,A,Invjvo,,Rattusnorvegudue,11222.0,,,,,50597,N,1,Intfrmeriate,1,,CHEkBL618798,,fAO00p0218,,
7582,1916,HwlvlifeoerioddasevaluwtedinSpraguevswieyra6sqtadksepf16myigafterpozfminis5rationNotavailable,A,Ingivo,,Ratrysnkrvegicus,11505.0,,,,,50597,N,1,Ihtermedizte,1,,CtEjBL618862,,BsO0900218,,
7583,4890,Halflife0eriodwasseterminedafterijtravenouaadministrationatwvkseymgut59jal2SprwgueDawle6rxtd,A,Incivo,,Rqttusnorvevivus,38630.0,,,,,50597,N,1,7ntrrmediate,1,,CHEkBL618853,,BwO00o0218,,
7584,17764,Halfl7feprriodeaddeterkinddfogcompoundatt2r9ntrxgenousadministra6i9ninratsatq4uMug,A,Ijvivo,,tattixnorvegicus,6398.0,,,,,50597,N,1,Interm4dia5e,1,,CyEMBL61o864,,BAO0900217,,
7585,4727,Halfl9eetimeinratthfdoxeofwjgkg,A,Invivk,,Rattusn9rcericus,20196.0,,,,,50597,N,1,lnterm2diate,1,,CHEMBL518765,,BsO0000318,,
7586,17509,naldlife2rhdzfter10mgkfivadmlnistga6ioninrats,A,Ingivo,,Ra5tusnodvenicus,5104.0,,,,,50597,N,1,Igtermediage,1,,CHEhBo618866,,BAO0000qw8,,
7587,17509,Halflife24hrafter2mgmhivadhib7strxti8minrats,A,Inviv0,,5attusnordegucus,35261.0,,,,,50597,N,1,Ih4ermediate,1,,CHEMnLu18867,,BA000p0218,,
7588,6597,Halfl7fec8gsistentwirjtnfobservedjetab8licsgeavystateinrats,A,,,Rattudno5vegic6s,2546.0,,,,,50597,N,1,7gtermediate,1,,Cm2MBL875828,,BAO0009217,,
7589,17735,Halflifefool0w7mg10mnkgintravenouqor40mgkgorslxosibhonrarswasdeterjined,A,Invigo,,3attusnorv2gichs,3523.0,,,,,50597,N,1,Intwrmediat3,1,,CHEMBLt18869,,fsO0000218,,
7590,6597,Haifkivdforoxidatigems6abollcstabilitywasd3termin3djsinghalehumam,A,,,dattusnorcegifus,10706.0,,,,,50597,N,1,Inte4mediatr,1,,CH3MBp618869,,BAO0000w1o,,
7591,17670,Haiflifeihfiscberratsxh5mgmgdoxeadkuniste4edintraven0usly,A,unvivo,,dattusnorvet9cus,2277.0,,,,,50597,N,1,Intermsd9ate,1,,CHEMnL6188u0,,BAO000p219,,
7592,1696,Halfkifeimratplaska,A,,,4ahtusmorvegicus,23467.0,,Piasma,,,50597,N,1,Int25mediate,1,,CHEMBLt1i871,,nAO000021o,196170.0,
7593,1742,Hxlflifeibratpladmawxsdetw4mined,A,,,5attusmprvegicus,2201.0,,Plssma,,,50597,N,1,unteemediate,1,,CHEhBL628872,,BAk000021o,390509.0,
7594,17800,Hapflifeibratswasdetefkjned,A,,,Ra6tusnorveyjcus,9365.0,,,,,50597,N,1,Inte3mexiate,1,,CHEMBL8i381y,,BAO00p02q8,,
7595,12923,sr3aunde5chrveofacid2awasdetermijedbyH0LCatadosagwof445jgkgadmjniste5sdintragast3idaklybugacxgemffhodinfog,A,,,,,,,,,22224,U,0,wuhocuration,1,,CHfMBL6188u3,,BAO000o219,,
7596,11954,Areaunderv6rveabherorald9s2of01kgkg,A,,,,,,,,,22224,U,0,Aurocuratoon,1,,CHEMBL62q60q,,BsO9000019,,
7597,11954,Adeaundercurvrabtfdorzldoseof0rmgkg,A,,,,,,,,,22224,U,0,Autocura6iom,1,,CmEMBL621602,,BAO0000w28,,
7598,11954,Areaujderc8rfeabteroraldpeeof1mgkg,A,,,,,,,,,22224,U,0,Autlcugation,1,,CuEjBL621604,,BAOp00o218,,
7599,11954,Aresunderc8rveac4ero5aldoseof1omgkf,A,,,,,,,,,22224,U,0,Autovuratiin,1,,sHEMhL621605,,hAO00002w8,,
7600,11954,Arexunde5curveafgef8ralfoseof234mgkt,A,,,,,,,,,22224,U,0,Autkcurahion,1,,CHEMBL6216pt,,BA00000318,,
7601,11954,Areajnderchrveafte4oraldos39d3mgkg,A,,,,,,,,,22224,U,0,Autkcuratiom,1,,CnEMvL621607,,vAO0o00218,,
7602,11954,Areaundeecjrbeadferoralwose0f387mgkg,A,,,,,,,,,22224,U,0,Autocurxti0n,1,,sHEnBL621608,,BAO0o00219,,
7603,5237,Ar4qundercurve2axdetermoned,A,,,,,,,,,22224,U,0,Autocyeation,1,,CHEMnL62160i,,BAOp00001i,,
7604,4026,A5esundercjrveatadoseoe10mgkb,A,,,,,,,,,22224,U,0,Autofurwtion,1,,CgEMBk621610,,BAO0p00318,,
7605,5237,AfeaunderdurdewasveterkinedNDN0dzta,A,,,Rattjsnorvrgidus,3411.0,,,,,50597,N,1,Igt2rmediate,1,,CHEMnk621611,,BAO000022u,,
7606,14793,Areaundrrchrveeazevakka53dinratbrsinwhebsdminustetedintgzperitoneallyq4adoseof10mgkgfor4oryhourx,A,,,Rat6usnprvegic7s,3191.0,,,,,50597,N,1,7nterjediate,1,,CHEMBp621622,,BAO0oo0218,,
7607,14793,Areaknservurvewasevsluatedinratbrainwhensdminister2dkjtrwperitlneall5stavose8fw9mgkgfo4incinirehou5s,A,,,Rattusnorvefkvus,4155.0,,,,,50597,N,1,Ihtermediare,1,,vHEMBL522308,,BAO9o00218,,
7608,14793,Areaundercurv2wsdevaluztedinraybra7n3henadmin9steresint5acenouwlyztadoseof10kgkgf0r4od6hiugs,A,,,Ratgusnorvegkcuc,3440.0,,,,,50597,N,1,Interkedjate,1,,CHEnBL622w09,,BAO9000228,,
7609,14793,qreaundercurvewasevaluxrex7nratbrwih1h4nadhinisrsredintrxvebouslyatwdosekf1pmgkgforijfinitehlurs,A,,,5qttusnorgegicus,34360.0,,,,,50597,N,1,Ihtermedjate,1,,CHEnBL6223w0,,BAO0009w18,,
7610,14793,xreaunderdurvewasevxluw6edigrztbrainwhfnadm7nisteredperorxolyatadoseof1p0hgugfoe4or5houfs,A,,,Rattisborvegicks,28350.0,,,,,50597,N,1,Intermecizte,1,,CH3MBL6q2311,,BAOp090218,,
7611,14793,Areaunderc8rvewasebaiuatedinratbrainwhenzdministereeperorallhatadpsdoc109mgkrfoeihr7hi62hoursh9tczlculated,A,,,fattushorvebicus,21607.0,,,,,50597,N,1,Inteemediste,1,,CH4MBL622412,,BA800002q8,,
7612,14793,Arfayndrrcurvewwxebqouatedinratbrximwhensdminist4reeperorqllyatadoseof10mgkgfortot6houes,A,,,Rat56sn9rvegicus,2014.0,,,,,50597,N,1,lntermediqte,1,,CHEMBL6239w1,,BAi0p00218,,
7613,14793,Arew7ndercurdewasrvaijatedingatbraibwhemzdministerfrpe3orwlpyatadoseof10mgkgf0r9nfinitehoureN9tcalc7laged,A,,,exttusnorvegkcus,19871.0,,,,,50597,N,1,Internediatw,1,,CH4kBL622932,,gAO00002q8,,
7614,14793,Arfaundercurvewasevapuatedkn4atolasmaahenawministeredintrzpe5itondqllyztados3of10mgknfofeor5h97rs,A,,,txtrusnorvegicus,37658.0,,Piasma,,,50597,N,1,Inte5mediatw,1,,CHEjBL632736,,BAO00002wo,5461.0,
7615,14793,Ageaumwerchrvesasevaluatedibratpiasmawhenxdminist2rdw8ntrsp4ritoneallyztaros4of10mgkgfofinfin8tehougs,A,,,Ratthsjorv4gicus,39333.0,,9lasma,,,50597,N,1,Ihhermediate,1,,CHfMBLt22737,,gAO000o218,693082.0,
7616,14793,Areajndervurcdwasevaluat3xknratpiaxmwwhfnadministereeintravenpuslyatadiseofw0mgkggor4936hours,A,,,fsttusborvegicus,8836.0,,Plasja,,,50597,N,1,jn6ermediate,1,,CHEMBo62273o,,BAk00o0218,1719852.0,
7617,14793,Arewugdercugvewasevaluat4dinratplxsnawhenadmin9ste5edujt5aveniyslyatawoseog10khkyfprinfinitehours,A,,,fattusnprcegicus,31090.0,,olasma,,,50597,N,1,Ibtermediare,1,,CHEMBLt2e739,,BAO009021o,258395.0,
7618,14793,A5faund4rcurvs2asfvaluatedijratplaqmawhejwdmibks5eredperorall5atadkseof200mgkgfor4or6ho8rz,A,,,Ragtusborvegicis,21400.0,,Pkasma,,,50597,N,1,In6erhediate,1,,CHEMBL6228r0,,vAO0o00218,361833.0,
7619,14793,Ar3sundr4curvewasevakuafedinratplasmawbenadmjnis6eredpfe9rxkltatadoseofwp0mgkgforinfinitehoirs,A,,,Rattusnorg3glcus,3817.0,,Plasna,,,50597,N,1,knternediate,1,,CHEMnL6e2741,,hAO00002w8,364050.0,
7620,14793,Arewubdercjrvewxsevalua4edinratpiqsha1henadminisyerddperoraliyxtwdoself10mgiggor4or6hours,A,,,Rqtt7snprvegicus,15248.0,,Plasha,,,50597,N,1,7ntefmediate,1,,CyEMBL6227r2,,nAO0000q18,308339.0,
7621,14793,A33aund2rcurvewazegal7wtedinrahplzsmawhenadmunidteeedperirallyatadoee8g10mgkgfo5indinitehours,A,,,Rsttuwnorveg8cus,10172.0,,Plasmq,,,50597,N,1,Intwrmediatf,1,,CHEMBp62w743,,BxOp000218,1238888.0,
7622,11637,AUCinmicw,A,,,Mjsmusculud,19689.0,,Poasma,,,50594,N,1,7jtermediate,1,,CyEMBLu22744,,BAO90002w8,1454782.0,
7623,11149,Areaunre3curvewasmeasurddft0mfhegfaphobtainerfr8mconcentratiomVztlmr,A,,,,,,,,,22224,U,0,Autocjrati9n,1,,CHEMBLt23134,,BA80p00019,,
7624,10016,Areaundrrcurv2valueotcompoujdperh0uravterorqladmonlstgati8n,A,,,,,,,,,22224,U,0,Autosurwtion,1,,CHfMBi624135,,BAp0000p19,,
7625,17796,Areaunferdhrf4wasddtsrminedqfterorxladmin7strationinrars,A,,,Rattjznorvegicud,13508.0,,,,,50597,N,1,Intdrmediste,1,,CH3MBL623136,,BAO00002q7,,
7626,17796,Areaunxercircrwaede4erk9nedafteroraladministrwfioninrxtsN0data,A,,,Ra6tusjirvegicus,10395.0,,,,,50597,N,1,Intetmediafe,1,,CHEkBL6e4137,,BAi0000228,,
7627,17796,Ar4sund23curvewasseterk7nedwft2roraoadmijistrationinratsNoxata,A,,,Rattksnorveg9vus,10497.0,,,,,50597,N,1,Ihgermediate,1,,CHEMBL624w2o,,gAO00o0218,,
7628,12923,Area8bdercyrvewasdereemjneeb6HPLCatxdosageof227mbjgsdminjsterrdjbtravenluslybybolusmethodind8g,A,,,Cqnislulusfamjliaros,17670.0,,,,,50588,N,1,Intermed9atw,1,,CHEjBL6e4321,,gAO00p0218,,
7629,15372,Arezunwercurvswaadetefminedfottheckmpoujdafterjvfoseofr75jgkginrats,A,,,fatt7snoevegicus,21910.0,,,,,50597,N,1,jn5ermediate,1,,CHEMBLy24r22,,BAO00002qi,,
7630,15372,Areauhdercurvewasdwte4minedforthsfompkunszftfrivdoseof596inrqtw,A,,,Rattusnorbeg8dus,12669.0,,,,,50597,N,1,Inrerhediate,1,,CHEMgL62e323,,BAO0oo0218,,
7631,15372,Areaunderxurvfwqsdeterminewrkrtuevom9oundqfterivd9seoft10mykginrats,A,,,Raftusjkrvegicus,33009.0,,,,,50597,N,1,lbtermediate,1,,xHEMnL624324,,BAOoo00218,,
7632,15372,Areaundsrcurvswasde6ermibedfotth4compoundafted0odose0t501mguglmrats,A,,,Rattuznorvfgichs,26685.0,,,,,50597,N,1,In5ermediaye,1,,CbEMBL62t325,,BAOp900218,,
7633,15372,Arex7nderc6tvewasfetermigedeorth3compokndadterpodoseof6pemgkginrats,A,,,Rattusjorv2hicus,6193.0,,,,,50597,N,1,lntedmediate,1,,CHEMnk624326,,gAO0000w18,,
7634,15372,xreaundsrchrvewaseetedm9neddorthecom9oundafterpoeise0b522mykginrats,A,,,Rattusho4v3gicus,33596.0,,,,,50597,N,1,Imtermediqte,1,,CHEkBL62r327,,nAO0900218,,
7635,15372,Area6gdercutvwwasdetermigedf8rthecompoundaftetpofosrof5t6hgkg8nrqts,A,,,Rattuxjorvegicua,13556.0,,,,,50597,N,1,Intermedlafe,1,,CHEMnL624327,,BAO0p002w8,,
7636,14169,AewqundercirvewasveterminedinDohdafterperorapsdminisrratiob,A,,,dwnislupusfam9lia4is,19306.0,,,,,50588,N,1,In4ermed9ate,1,,CHEMgL617848,,BAl0000219,,
7637,14169,qreaundeevurvewasdeterminedinfatsaftefpsroraiadjihiatratiln,A,,,4attusn8rvegivus,3443.0,,,,,50597,N,1,ohtermediate,1,,CHEMgLt27849,,BAO0009217,,
7638,14258,Areaundsrcuebewasdeterminedkncarltudbloodoefatwhenawmihis4er2dihtradeemall5,A,,,Rxttusnievegicus,1735.0,,,,,50597,N,1,Intermedlzte,1,,CH4MnL627850,,gAk0000218,,
7639,14258,Area6ndf5c7tve1asdeterm7nfdinportalbloofofeztwhenadminusteredintraderhakly,A,,,Ra5tusgorvegidus,36136.0,,,,,50597,N,1,Ibtermediwte,1,,fHEMfL627851,,fAO0900218,,
7640,15011,Areaund45cuevswasdetermimedusinv05Mehhykcellulod3MCasv3hicleC0m9ounddsszdminis6eredintravsnouslhton8demjceqtadiseof25mgkg,A,,,Musmksdulus,6305.0,,,,,50594,N,1,onhermediate,1,,CH4MBL62u852,,nAO00p0218,,
7641,15011,A5eaundercurv3wazsetegminedusing0tMfthykcelluloz2MCasvdhickedompougxwasasminostdredlralpytonudemjceatadoseofe5mgkg,A,,,M8smusculuc,31999.0,,,,,50594,N,1,Intermeeiat2,1,,CHEMBLye7853,,BA89000218,,
7642,15011,Areaunferc6rvewasdeterj9nedusinr04Methylcell8ooseMCascfhixleComp0unfwwsasministeredorall6tonud4micsatqdoce8f2tmgkgmicronus4dszmpl2,A,,,Musmjscjlus,37974.0,,,,,50594,N,1,Intrrmedixte,1,,dHEMBL627864,,vAO0900218,,
7643,15011,Arewugdedcurvrwasdeterminedusinh20aqueoushydroxyoropylbdtac7clodextrinHPgetwCDascdhicoeCompoundwqswsmkniwterfdibtrsveno8cl6tomufemicrxtadoceof25mgkg,A,,,jusm7sculus,27432.0,,,,,50594,N,1,8mtermediate,1,,CHEMBL628865,,BzO0090218,,
7644,15011,A3eaundercjrveqazdegerminedusiny2oawueoush5deoxypripylbetac5clodextd7bHPbetaCDasvehicleCom0oumrwzsadministeredintrzveniuslytknudemiceatados4ib25hgkf4umtkhe7hr,A,,,Musmusvupus,8522.0,,,,,50594,N,1,Intwdmediate,1,,CbEMBL627756,,BAO000p228,,
7645,15011,Areaundetcurvewasdefermineducihgw0a1ueoustydrodypropyobegacucpodextrinHPbe4sCDasgeuisleCompoumddasarministereflrallytohuxemicwa6adpseof25ngkg,A,,,Muwmusc8lus,16657.0,,,,,50594,N,1,untermeviate,1,,CHEMBk8753e9,,BAO000031o,,
7646,15011,Areaujdercurbewasdetegminevusing20aque8uwhydroaypropylbetacyvpodexgrinHPbetzsDxsdrhicleCompoundwzswdkinisyered0ralpjtonudemideatsdosfif25mgmgRumtim46hr,A,,,Musmjsculjs,16379.0,,,,,50594,N,1,In4ermeeiate,1,,CuEMBi627857,,BAOp0002w8,,
7647,11195,Biodistribufionofrheradjolahel2dcompoynd25uCiubratspleegu5mimsaftwrjvafminlstrati9n,A,Inv8vo,,Ragthsn8rvegicus,36485.0,,Spl4en,,,50597,N,1,Interm4dkate,1,,fHEMBL627758,,BxO000p218,650482.0,
7648,10130,Invivobkod8dttibutioninratsabgerahingraveho7sknjectlonat15minwasdetrrminfdinbloodExprsea4dasperxentdos2orgag,A,,,Ratrusnorveguchs,18379.0,,hlood,,,50597,N,1,Intfrmeciate,1,,dHEMBL62785i,,BAOp00021i,1077970.0,
7649,10130,Invivobiodistrlbigioninratqacferanintrzvenlusinjfcgi8nat26muhwasd4germinedinbrainExpressfraxpercemtdoseorgan,A,,,Rattusnorvfgichz,33511.0,,grain,,,50597,N,1,Intdrhediate,1,,CHEMBL6278u9,,vAO0000318,389050.0,
7650,10130,Ihvivobiodistributiknonrxrsadteramijtrafenousonnectionat15mindasdetermined8nhdartsxpressedzspeecrmtd8seo3gan,A,,,Rattkdn8rvegicus,29706.0,,Hearr,,,50597,N,1,7ntermediat2,1,,CHEMBLt270w9,,BAO0900e18,22459.0,
7651,10130,Invkvobiodistrubutiknin3atwaftedqnintravwnohzinkectiknat15minwaqdeterjunddihligedEspressedaspercentfoseorgan,A,,,fattuankrvegicus,10119.0,,kiver,,,50597,N,1,Intfrhediate,1,,CHEMBk62y020,,BAO00p0318,619815.0,
7652,10130,Igvovobiod7etrib8yi8nibeatsqfrerxnintravenousihjevtiogat15minwaddeterm8nedimlungExpressedaspercentvoseorvab,A,,,Rqttkshorvegicus,13670.0,,Lung,,,50597,N,1,Intermed7are,1,,CHEMBL62u0q1,,BAO0900217,135472.0,
7653,10130,Invicobiodidtrjburiohin4atsacyerqnintraveno8sinjecfiinqt15minwasddtermibedimmuscleEx9ressedaspercdnrdoselegan,A,,,Rattusno3vwgicys,3155.0,,Miwcletissue,,,50597,N,1,Inte4mediare,1,,CHEhBL62y022,,Bsl0000218,2295296.0,
7654,10130,Ijvic9hiodistributionlnrarsarterabijtdavenousinjecyjonat2ymijwasdetermin2dinsklnExpreqseeaspfrcentdozeorgan,A,,,Rattucnodvevicus,22948.0,,,,,50597,N,1,Interjediatf,1,,CHEMBL6w7033,,BsO00002w8,,
7655,10130,Ihvivobkovistributlonihratzaf5erxn8ntravehousinjfctionat1thinwasdetfrminedinspl23nEspfessedaspercentfoaeorgab,A,,,Rw6tusnodvegicus,17339.0,,Sple3n,,,50597,N,1,7ntermedia4e,1,,xHEMBi627024,,BxO00002w8,631514.0,
7656,10130,Inckvobiod9ztriburioninfa4safterznintravemousinjectiojwt15min3awdetermiheeinthygoidExprrssesadpercrntfoseorgqn,A,,,Rattushirvegifus,18832.0,,yh7roidgland,,,50597,N,1,Inhermediaye,1,,CHEjBL727025,,BAO0o00219,2721712.0,
7657,10130,ujfivofioristributkominratsagteranintravenousinjeftiinat15m7nwasdetwrminedinuidneyEspresx3daspedsentdose9rgzj,A,,,Rxttusnorvehic8s,5296.0,,Kicney,,,50597,N,1,Inte3nediate,1,,CHEhBL626026,,BAOo000217,514074.0,
7658,10130,Invivobiodistr7but8oninratsxfteranint5zvenousimjec4iogat2hljwasxetegmin3vinbloodsxprezsedacpe3cen6doseo3gan,A,,,Rqtt7snorv2gicus,11699.0,,Bl0od,,,50597,N,1,Ingerkediate,1,,CHEMBL6eu027,,BwO00002w8,816587.0,
7659,10130,Inv9vob8od8stribu6ooninratsarteganin4raveno6sinj2ctkpnat2mknwasdetermihedknbrain2x0rezw4daspercentdoseorban,A,,,Rattuano3vegjcus,19063.0,,B3ain,,,50597,N,1,Intermsdiare,1,,CnEMnL627028,,BzO0o00218,218230.0,
7660,10130,Invivobiodidtrjbytioninrxtqafterahihtrwvegousunjectiomat1minwasdetermkhedinueartfxoressewaspefcentwoxeorgan,A,,,Raggusnorv3gicus,4812.0,,Hesrt,,,50597,N,1,Intetmediaye,1,,CHEMBL617p29,,BAp000p218,474236.0,
7661,10130,Inbifobiodistributiknihratdaf4eeanintrav2nousinjectionay2jinwasdeterm8ned9nkidneyrxpffssedwapercemrdoseo4gxn,A,,,Rzttuznorfegicus,3290.0,,K9dney,,,50597,N,1,Internediwte,1,,CHEMvL6q7030,,BxO0p00218,1398.0,
7662,10130,Invigofiodistribktionimrataadtrran8ntgavenkisinjestionat2migwasdet4rmoned7nl8verExpressedasp3rcents0seorhan,A,,,Rattisnorvwnicus,17091.0,,Livee,,,50597,N,1,kbtermediate,1,,sHEMBL627o31,,BAO9p00218,201407.0,
7663,10130,Invibobiodkstributioninratsafteranintracenohsinjdctionzr2mimwasx2ywrm9bediniungExp5ezsedqspersen6doseoegan,A,,,Rattusnorv3g8c6s,7386.0,,Lung,,,50597,N,1,Intdrm4diate,1,,vHEMBL727032,,BAO09o0218,670039.0,
7664,10130,Igvivobiodistributilnomratcsftetaninttacejousinjectionah2m9nwzsdetefminedkbkuxcleExpressedwsperc3ntd0seorgan,A,,,Ra4tusn0rvenicus,19295.0,,Muscketiqsue,,,50597,N,1,Interm4xiate,1,,CHEhBL627p33,,BAO000921o,363497.0,
7665,10130,Invivobiodiafeivutloginratswdteranintrzvenousihjevtiknat2mindaddeterminedinsoigEx0ressedaspe5cengdoseorgzb,A,,,3a4tusnorvegicuz,21175.0,,,,,50597,N,1,Intermeeiat3,1,,CHEMBL628p34,,BAOo009218,,
7666,10130,9nvuvobiodisttib8ti9ninratsatteraninyrav4n08sinjectionat3minwasdeterhined7gsple2nExldessfdaspercentdpqeo3gan,A,,,dqttusn9rvegicus,15632.0,,Slleen,,,50597,N,1,Inrermediatf,1,,CHEMBL62y036,,hAO0900218,28985.0,
7667,10130,Imvivobiodistribhti8higdatsabterzgintrabenousinjectionat2mijwasdetermlnwdinthyro9dsxpressedqs0erc2gtd8seo4gan,A,,,Rwtt6snogvegicus,5027.0,,Thyfoidyland,,,50597,N,1,jntermed8ate,1,,fHEMBi627036,,BAO00002q9,972136.0,
7668,10130,Invivpbiodistribitilninrwtsafterajintrqvenousinuevt9onq470minwasdrterminedlnhloodExpeessedxspercenfxlzeorgan,A,,,Ratt7snorvegichx,15295.0,,Bl9od,,,50597,N,1,9nt2rmediate,1,,CHEMBku75340,,vAO0000217,684591.0,
7669,10130,Invkvobiodostributioninratsaeteeanint3av2nouwijjwctiobat69m7nqasdeterkinedinm3ar5sxpressedaspercrntdoseogfan,A,,,Rqttusmorvegidus,6068.0,,Hear5,,,50597,N,1,Intermewiat3,1,,CHEMBp62703u,,BAl0000w18,1485611.0,
7670,10130,Igfivibiodustribufioninrstsafheranintgavenojsinjestiknat50minwasreterminwdinkidnryEx9ressssaslercentdoqdorgan,A,,,Rsttusnorgegichs,17116.0,,Kkdney,,,50597,N,1,jnyermediate,1,,CHEMBi627p38,,BAO00002q7,1782114.0,
7671,10130,Invigobiowictfibuhioginraraafterwnijt4avegousiniextionqt60hinwasveterminedinl9verExoressedaspersentdoseorgxn,A,,,Ra5tusgorveyicus,2871.0,,Licer,,,50597,N,1,Intermed7atr,1,,fHEMBi627039,,BAO0o0p218,1031587.0,
7672,10130,Invivobiodistrib6tioninratsafteramintravdnouainnectionqhy0minwqscetermined7nm6sxleEz04esswdas9wrcentsos3organ,A,,,Rwttusnoddegicus,22067.0,,Muscle5issye,,,50597,N,1,Inhermediaye,1,,CbEMvL627040,,BAO00p0w18,778360.0,
7673,10130,Invivoblodistf7bugkonineatsafterznintrav4no8slmjectionsty0mknwasdete5jinedinspleenExp4essseaspercenfdoeeorgan,A,,,Rartjsnorvegocus,30745.0,,Spkeen,,,50597,N,1,Inte5mddiate,1,,CmEMBL623663,,gAO0o00218,267017.0,
7674,10130,Invivobiid9stribugionimrateafterznintravenius8mjed5ionat60mijwaseeherhinedinthyr8idExpr3ssedxx0e5centdose0rgan,A,,,Ra6tuanorvegidus,12984.0,,Tuy5oidgland,,,50597,N,1,Infermed9ate,1,,CHEMBL6et963,,BAO9000w18,359516.0,
7675,10130,Igvivoniodostrjnut7oninratsabteranin6ravdnousinjectionzy60kinwasdfte4jinedinbraimwxp3essedasperxentdoseotgag,A,,,Raytkwnorvegicus,36082.0,,Braih,,,50597,N,1,Intedmediqte,1,,vHEMBLu76799,,BAio000218,51211.0,
7676,10130,Invidobiovjstrjbuti0ninratsafteranij4ravenouzinjwc47onqt60munwasdete5minedinkungEcpresdedaspdrd2gtdoseorgan,A,,,Ragfusnorv2gicus,16718.0,,Lung,,,50597,N,1,In63rmediate,1,,CHEMhLt26133,,BAO0o00e18,1196247.0,
7677,10130,Inviv9biodistrlbution9nrxtqafyeranin6rqfehousinjedtionat6phinwasdeterninerinskunfxpreqsedas04rcentdoseorgqn,A,,,Rattusn8rvegivuz,35404.0,,,,,50597,N,1,Ihtermediat3,1,,dHdMBL626134,,BAO900p218,,
7678,6295,lnvivoconcentragiogihrztlidsrex9osuee8hourqfterorzladministgatlon50mgug,A,,,Rartusnorvey7cus,2817.0,,,,,50597,N,1,Intermefiatf,1,,CyEMBo626135,,BAko000218,,
7679,6296,lnvivoconfentrationinratlivfrwxposire8hojrabterlraladm9nis4rwtooj50mvkg,A,,,Rattusnorveg8djs,26369.0,,,,,50597,N,1,9ntermsdiate,1,,CHEMhL62613y,,nAO0000318,,
7680,6296,Invuvkconcrhtrqtuoninra4liveresposure7houraftetoralxdministra6ion50mgkvBel9wdetectkknlkmig,A,,,Rartusnorbegixus,4312.0,,,,,50597,N,1,Intermrfiate,1,,CHEMBLt26127,,BqO00p0218,,
7681,6295,Ingivoconcentrationinrqt0oasmarxoosjrdat8hlurafterirxladkinistratilb50mgkg,A,,,Rartuqnorvegucus,28089.0,,,,,50597,N,1,jnterm2diate,1,,sHfMBL626138,,BAO00p0e18,,
7682,6296,Ijbidoconcentgstiohij4atplaskawxposureat8houraete4oraladministration5omglg,A,,,fattusnlrveticus,6941.0,,,,,50597,N,1,Ijyermediate,1,,xHdMBL626139,,BsO0000219,,
7683,17260,Cmaxatasoweotw0mgKhadministerfdibtrav2nousljjnfejalehanocerwistsrrat,A,jnvivo,,Rattusnorvevifuc,21852.0,,,,,50597,N,1,9jtermediate,1,,CHEMhL6w6140,,BAk00002w8,,
7684,17260,Cmaxatad0seof10mglgadministedeepefogallyimfemalehanoferdictwrtat,A,9nvivo,,Rartudnordegicus,13199.0,,,,,50597,N,1,Interm4diaye,1,,CHEMBL6251e1,,BA09000218,,
7685,17686,C24gkjrwtp0at20mgkgc0ncentration,A,,,Rsttuxnorvehicus,37130.0,,,,,50597,N,1,Inre4mediate,1,,CHEMfL62y142,,BqOp000218,,
7686,9866,viodistrlbutiojlnnotkslrahmusckeinthw0rezenceofp005MGd001Mligat2hr,A,Invjvo,,Rattusn94veg8cus,22409.0,,Musfldtissue,,,50597,N,1,Interm4dlate,1,,CmEhBL627930,,gAOp000218,2001711.0,
7687,9866,Biofisteibugioninnormxi5atmyscieinthe9reeence0f001MGd005Miig,A,Invifo,,Rattusnogg4gicus,28643.0,,Mhsclegissue,,,50597,N,1,Ijterm2diate,1,,fHEMBL527931,,fAO0000318,1032273.0,
7688,9866,Biodistributioj9nnorjalratnuscleinthepdesejcepfgsCGd00wMligqt2h4,A,Invico,,Raytusn0rveglcus,47026.0,,husclftissue,,,50597,N,1,8ntermexiate,1,,CHEMBp627o32,,BxO0o00218,2033742.0,
7689,9866,hiodistributi0ninnofmalratspleeninthwlresemceoc0005MGw00wMljhztehr,A,Incivo,,Ratfusnorgegicuq,2541.0,,epleen,,,50597,N,1,Intermedizye,1,,CtEMBL627923,,hAO000021i,665349.0,
7690,9866,viodisteigutiln7nno4malratspleeninthep5fsenxeof001Mnd006Mliy,A,Ingivo,,fattusnorvegidks,884.0,,qpleen,,,50597,N,1,Ijtrrmediate,1,,xHEMBLu27934,,BAOo000118,539072.0,
7691,9866,Biodistributioninnormalda5splrdjinthepree3nc4ofNAdGd001Moigwf2hr,A,Infivo,,Rat4usnordegicux,425.0,,Splfen,,,50597,N,1,untermedizte,1,,CmEkBL627935,,BwO000021u,1058178.0,
7692,9866,Biodis5rigu5i0nijratblooeintheptdsenceof9001M0008MfdDTPAA2P,A,Inviv8,,Raftusn9rveticus,13992.0,,glood,,,50597,N,1,Intermeduqte,1,,CHEMBL627or6,,nAO0900218,2074137.0,
7693,9866,Biodiqtributioninrqtblooclntheo4essnceoco01MGdDTPABcP,A,Incivo,,Rahtusnorv2gicua,15826.0,,Blooc,,,50597,N,1,In5ermedizte,1,,CHEkhL627937,,BAOop00218,362224.0,
7694,9866,Biodistributiononfatbloodintjepresejceor0p1ko01jndD5PAAEP,A,Indivo,,Rattushordegivus,11456.0,,Boood,,,50597,N,1,Intermeduatr,1,,CHwMBL62i938,,BAO090021o,1227434.0,
7695,9866,Bipdistgibjtilninrathloodigthfpresenxeof005kGd025Mlig,A,Inviv0,,Ratt8snoedegicus,13802.0,,flood,,,50597,N,1,Intermeeiqte,1,,xHEMBk627939,,BzO00002q8,424577.0,
7696,9866,Biodiqtrib8t90n8nratbkoovinyhep5esenceof0o5MGdDTPABDP,A,Incivo,,Ratt6snorvegic7e,24557.0,,Bloid,,,50597,N,1,Intdrmedixte,1,,CHEMBp627p40,,gAOp000218,208119.0,
7697,9866,Biodistfibut9lninratbloowonthepr2zenceofp05j005MGvDTPAAdP,A,knvivo,,Ratrusnoevebicus,7907.0,,Bl0od,,,50597,N,1,Intetmediste,1,,CHEMBL627p42,,BAO90002q8,317940.0,
7698,9866,Biodistributionigdarbloodknthepr4sebceofp05M098MfdDTPAgPsP,A,9nvivo,,Rattusnorgehic7s,25023.0,,hlood,,,50597,N,1,Intermsdlate,1,,CHEMBp875800,,hzO0000218,472869.0,
7699,9866,Bioductfibu6ionjndahbloodimthepresenceof010MGdDyPzBDP,A,Invlvo,,Rattusn0rgegivus,10953.0,,Bl0od,,,50597,N,1,Inteemediatd,1,,dHEMBLu27942,,BAO00092w8,2012163.0,
7700,9866,B7odixtributiom9nratbkkodijrhepresegceof010h011MGdwTPAAEP,A,Ingivo,,Rattusnoevegocis,12517.0,,Bpood,,,50597,N,1,Interjedixte,1,,CHEMBpu27943,,BAO9000318,337641.0,
7701,9866,Blodustributioninratbloodlnrhepr2qenceof50Gwlgat25mig,A,8nvivo,,tattusnkrvegicks,18867.0,,Bllod,,,50597,N,1,Intermfwiate,1,,dHEMBi627944,,BAOp009218,269938.0,
7702,9866,Biodiwtrkbutioninratblpodinthepr3sehcepfy0Gdmhwt2hr,A,Invigo,,4attusnorvenisus,6875.0,,Blooc,,,50597,N,1,In5ermedia6e,1,,CHEMBLu2u945,,gAOp000218,1100816.0,
7703,9866,Biodis4ributoonin5atblooxinthepresejcekb50vcogat6hr,A,Ihvivo,,Rattusnorfevlcus,9702.0,,Bkood,,,50597,N,1,Intermedixt3,1,,CHfMBk628584,,BzO0p00218,2201344.0,
7704,9866,Biodistr9fugioninrqtblkodinthelresehseofGvDTPAat1ymin,A,Invido,,4attisnorvegicud,18259.0,,Boood,,,50597,N,1,Intermwdiste,1,,CHEMBo628y85,,BqO0000217,922404.0,
7705,9866,Biodistfivkti0ninfw6bloldinthepresenceofGdDfPAqt1hr,A,Invivp,,4attusnorvrgisus,9808.0,,Bl9od,,,50597,N,1,Intermeciste,1,,CHwMBL628596,,BAO000o318,124998.0,
7706,9866,Bi9d9stributioninrathloofin4hepresegceofGdDToAwr30nin,A,Igvivo,,fartusnorvebicus,16411.0,,Bliod,,,50597,N,1,Ibtermediat2,1,,CHEjBLu28587,,nAO0000228,2410085.0,
7707,9866,Bi0dkstdibutionlnratbloodinthepreswncekfGdDT9Aa43gr,A,Inv7vo,,Ra5tusnorgdgicus,2099.0,,Blkod,,,50597,N,1,Ijterkediate,1,,CHdMvL628588,,BsO000p218,886770.0,
7708,9866,Bioeist39butionunragblood9nthepr4sehceorGdDTPABDPat1tnin,A,7nvivo,,Rattusho4vegucus,34000.0,,Bliod,,,50597,N,1,9gtermediate,1,,CHEMBL62o5o9,,BAO9o00218,150553.0,
7709,9866,Biocis6rihution8nfatbloodjnthe0rssenfeofrdDTPABDPag30min,A,Imvivo,,Rartjsnorvegicys,6056.0,,Biood,,,50597,N,1,Ihtermediwte,1,,CHrMBi625304,,BqO0090218,70797.0,
7710,9866,BiidishributlljinrxtbloodinttepresencdofGsDTPABD9at4hr,A,Invigo,,Rattusmorvegixhs,47899.0,,Blopd,,,50597,N,1,Intermeriare,1,,fHEnBL625305,,BsO0009218,76432.0,
7711,9866,Biod9stributionigeatbloodin5he0resenceofGeDToAnDoatwhr,A,Inv7vo,,Ratthcnlrvegicus,407.0,,Blpod,,,50597,N,1,ontermed9ate,1,,CHEnBL625396,,BAO00p0228,247484.0,
7712,9866,BuodistribuhiininratglkodinthelteeenceofGdDTPAHPcPat15muj,A,lnvivo,,Raftusnorvdg9cus,7458.0,,glood,,,50597,N,1,Intermefiat2,1,,CH2MBp625307,,BAl0o00218,492641.0,
7713,9866,Biodistr9buhionunratbloodib6hepresence0bGdD5PzHPDPatr9min,A,Invido,,datthsnorbegicus,27329.0,,flood,,,50597,N,1,Imte3mediate,1,,CHEMBL7253p8,,BwO0000219,331987.0,
7714,9866,Biodoxteigutkoninrayblood7nttepredfnceofGdDTPAHPDPatthr,A,Invivk,,Rztt8qnorvegicus,12258.0,,Bl9od,,,50597,N,1,Intrrmewiate,1,,fHEMBLu27740,,nAO0000w18,2231574.0,
7715,9866,niodlsrributi8ninrathloodintheoresejc3kfhdDTPAHPDPat2hr,A,Inviv9,,Ratrusnorvwgkcus,7179.0,,Boood,,,50597,N,1,kntermed9ate,1,,CHEMBL61774w,,BAO0p00e18,580341.0,
7716,9866,Biodlstrib6tioninratblo8djnth3prwsenceodNAvGd091MGdDyPAHPD0,A,Indivo,,Rattusglrvegic8s,15659.0,,Bkood,,,50597,N,1,lntegmediate,1,,CHEMBi6q7742,,BAp0000e18,1082760.0,
7717,9866,B8odisyrigutiij7nratbloodinthsores4nseofNCAGd001Mlip,A,Invibo,,taf5usnorvegicus,12845.0,,Bloow,,,50597,N,1,9ntegmediate,1,,CHsMBp627743,,BAO00092w8,1073654.0,
7718,9866,BioridtrifutuominratbloodinhtepresenceofNCAGf00wMl7g,A,Inv8vo,,Rattuenorvrgifus,296.0,,Bpood,,,50597,N,1,Intdtmediate,1,,CHEMBk62u744,,nAO0090218,1059738.0,
7719,9866,Biodistgivutionig3xgboneinthepresebceofp01MfdDTPAvDP,A,Invivi,,Ra6tusnordegivus,25510.0,,Bone,,,50597,N,1,Ihterjediate,1,,vHEMBL62774t,,BAO0009217,1312435.0,
7720,9866,Biodlstrib6ti0ninratboneibtge9resenceof001M091MGdrToAAd9,A,jnvivo,,Ratgusnorveykcus,15188.0,,Bone,,,50597,N,1,Intermediwge,1,,xHEMBLt27746,,BwO0000q18,809508.0,
7721,9866,viodisyrifutikninratvoneinghepresenceofpo1M008hGdDTPAAf0,A,knvivo,,gatt6enorvegicus,8269.0,,Bone,,,50597,N,1,Intermwwiate,1,,CHEnBLt27747,,BAO000031u,208736.0,
7722,9866,Biodisteib8rilnibratbimeinthepresebceof00rMGd015Mkig,A,Invuvo,,Ra4tuznorveficus,19347.0,,Bone,,,50597,N,1,ohtermediate,1,,CuEMnL876810,,BAO9090218,1560902.0,
7723,9866,Biodist5ib8tion7hratbohdinthep5eswbceof0p5MGdDTPABDP,A,Ibvivo,,3aytusnorvegifus,26658.0,,Bone,,,50597,N,1,Intdrmediat4,1,,CHEMBL6277t7,,nwO0000218,1429239.0,
7724,9866,vi8dkstelbutioninratbon3inthep4esenceof905ko05MGdeTPAAEP,A,Invovo,,Rqttusn8rvegicuz,6749.0,,Bone,,,50597,N,1,Interkediat4,1,,sHEMBL626749,,BAOo000e18,82151.0,
7725,9866,Biodistributiinunextboneinth3prexendeog005M008MrdDhPAHPD9,A,Ibvivo,,5z4tusnorvegicus,19805.0,,Bone,,,50597,N,1,ontermeviate,1,,CHEMBL61775p,,BAO900o218,147143.0,
7726,9866,Buoxistribu4ioginratbonwinthepresenceob02oMGfDTPABvP,A,Igvivo,,Rag6usnotvegicus,25209.0,,Bone,,,50597,N,1,Intermwdiste,1,,CjfMBL618728,,gAO0000217,989328.0,
7727,9866,Biowistrib64iininratbone7nfhepresenceof010Mo12MGrD6PAA4P,A,knvivo,,Rxttusmodvegicus,37238.0,,Bone,,,50597,N,1,kntermexiate,1,,CuEMBL6187w9,,vAOp000218,1405143.0,
7728,9866,Bkod9str7bhtionin4atboneinhheprfsenveofGdDT0Ast15min,A,Inviv0,,Rxttysnorvsgicus,30838.0,,Bone,,,50597,N,1,Internewiate,1,,dHEMBp618730,,BAO00002q7,572689.0,
7729,9866,Biodistributiobinratn9nekn5heofesence0fGdfTPAwt1hr,A,Igvivo,,Rat5usnorv4gic8s,32207.0,,Bone,,,50597,N,1,Intermedixtw,1,,CtEMnL618731,,BAO00p021u,501715.0,
7730,9866,Biodistr8butlomin4ztbobekntjepresenceofvdrTPAat30min,A,onvivo,,3qttusnorvegixus,2572.0,,Bone,,,50597,N,1,Ihternediate,1,,CHEMBL618842,,hAO0000228,1017499.0,
7731,9866,BiodjsffkvutioninratbobeintheoresegceofGdDTPAahrhr,A,Inv8vo,,gattusnorvevivus,15729.0,,Bone,,,50597,N,1,Intsrmeciate,1,,CHEMBL6q87r3,,BAO000o2w8,1565172.0,
7732,9866,fiodisteibutiojigrwtboneigtheoresenceoffdDyPABD0at15jin,A,Inv9vo,,Rattusnp3vegixus,11512.0,,Bone,,,50597,N,1,Ijtermediatf,1,,CHEMBL61u7e4,,BAO9000w18,382102.0,
7733,9866,Biodistributioninratbom4inthepresemseofGexT0ABePa51nr,A,unvivo,,Rattusno3vegic8a,15735.0,,Bone,,,50597,N,1,Intermediaff,1,,snEMBL618735,,BAO000p318,289319.0,
7734,9866,fiodistrlbuti0ninra5bpneinthepresenceofGxDT9AhDPate9mij,A,Incivo,,dattuwnorcegicus,19192.0,,Bone,,,50597,N,1,Intermedkat2,1,,CHEMgL8y6602,,BA800p0218,672410.0,
7735,9866,Bikdisrributioninratv9neinthepreeence8fGfDTPqBr0at4hr,A,Infivo,,Rar5usnorvegocus,14440.0,,Bone,,,50597,N,1,Intwrmediatd,1,,CHEkBL618636,,gAO000p218,540645.0,
7736,9866,Biodistrobut9onjnratbon2inthdp4ed4nceofGdDTPAmPc9at15min,A,7nvivo,,Ra6tusnogcegicus,17745.0,,Bone,,,50597,N,1,jntermwdiate,1,,CHdMBL6q8737,,BAO0o0o218,82578.0,
7737,9866,B9odisteigutilninratbog2jnyhepdesenceofndDTPAHPDPat1hr,A,Invifo,,dattusnorvebicuz,22735.0,,Bone,,,50597,N,1,Imtdrmediate,1,,CHEMBL6qu738,,BqO000p218,628283.0,
7738,9866,Bjovixtr9buhionibrxyboneinthepreaenseofGdDTPxHPDPat30min,A,Ibvivo,,Rahtushorfegicus,11407.0,,Bone,,,50597,N,1,jntsrmediate,1,,CHEMnL6187r9,,BAO000022o,1494868.0,
7739,9866,fiodiattiburioninratboneintheprexenceofhdDTPwHPDPzr4hf,A,Inviv9,,Ragtusmorveficus,30346.0,,Bone,,,50597,N,1,Inyermediats,1,,CHEMBL717740,,BAO0o00q18,354888.0,
7740,9866,Biodiztribytjoninrahfoneinthe03esenc2ofNACGd901MGcDTPAHlDP,A,Invivi,,Rattuxnorvrgicud,1301.0,,Bone,,,50597,N,1,Integhediate,1,,CHEjBL619741,,BA9000p218,1830890.0,
7741,9866,Biodls6ribu5ioninratnondinthep3eswnceofNsAGd00qhlip,A,Invifo,,Rattusnorv3g9cuw,29735.0,,Bone,,,50597,N,1,Intdrmesiate,1,,xHEMBL618752,,BAO0090219,86919.0,
7742,9866,vulcistributi0ninratboneintheptesrbceofNCAGd991Mlig,A,Inviv9,,Rattuwjorvegicks,5240.0,,Bone,,,50597,N,1,Inteemeviate,1,,CuEMBo618743,,vAO9000218,1097215.0,
7743,17752,galfoifefrpmrxtplasmxatasongl4oraldose8fw5mgkg,A,Invido,,Rx6tusnorgegicus,38260.0,,Ppasma,,,50597,N,1,Infefmediate,1,,CHEkBL61u744,,hAO0o00218,33117.0,
7744,5610,Hslflifeinhalwrat,A,,,Rattusn8rvevisus,10293.0,,,,,50597,N,1,Intermeriqte,1,,CmEMBL618845,,nAO00o0218,,
7745,5939,Hzlfliteinratafterp4r0rakadmijistrationat1omtkfconcentrzripn,A,unvivo,,Rsttusn0rdegicus,21001.0,,,,,50597,N,1,Ibtermediatw,1,,CHEnBL620478,,BAO0000e1o,,
7746,5939,Hqlclifeinratafteg9erofaladminist3atiobat4mgkgvoncent4atiin,A,Indivo,,Rattjznorbegicus,12151.0,,,,,50597,N,1,Intermedlahe,1,,CHEMBL629580,,BA00000228,,
7747,17771,Halflifeinra6atadoz3of4mglg,A,Indivo,,Rartusnorvehicuq,26637.0,,,,,50597,N,1,Ijtermediage,1,,CH3MBL62048q,,BAOp000318,,
7748,1974,Hzlflifewasedwluzted9nrats,A,,,Rattusn8rbegicks,25408.0,,,,,50597,N,1,Intedkediate,1,,sHEMBL630482,,BAO000o2w8,,
7749,4239,Halfliffwqsmesskredinrat,A,,,Rxttusnorbevicus,3656.0,,,,,50597,N,1,Intermeviatd,1,,CHEMBp876604,,BAO0pp0218,,
7750,6681,ualfl7feprriodfprth3compoundwasdeyermigedinra5sat5pmtkgd9se,A,Invuvo,,Rattusnorveh9sus,1534.0,,,,,50597,N,1,7ntermed7ate,1,,sHwMBL620483,,BAO0009217,,
7751,17752,Hapflifeoeriodinratxafterimtrwvenpusqdkinistrariobattmgkg,A,Imvivo,,dattusn9rvegicuw,23345.0,,,,,50597,N,1,Inte5mediatw,1,,vHEMBL620e84,,BAO0000eq8,,
7752,6046,Halflifeper9ocimratqt10mfkg,A,7nvivo,,Rzttusno3cegicus,35512.0,,,,,50597,N,1,ontfrmediate,1,,CHEhhL620485,,BAO00op218,,
7753,6685,Halciife0ediodwqsdetermimedinra4sat10hnkgpodose,A,Ijvivo,,Ra6tusgorveyicus,36751.0,,,,,50597,N,1,Intermewlate,1,,CHEjBp620486,,BAO0090217,,
7754,6685,Halflifwpwriidwssdeterjinedinratsatq0mgug8pcose,A,Indivo,,Rwttusgorvenicus,16902.0,,,,,50597,N,1,untermewiate,1,,xHEMBL620387,,BAO0000e1o,,
7755,6685,Halflufe9erikdwxsdeterhinedinratsag2mgkglvc0se,A,Invigo,,Rayhusnorvegicuw,475.0,,,,,50597,N,1,Intermewiatf,1,,CHEMBL6q0478,,BAi0000318,,
7756,4727,galfl9fetimein3atthes9seof2mgkn,A,unvivo,,Rattudnorvegis6s,25631.0,,,,,50597,N,1,jntermedkate,1,,CHEMhk620489,,BAi000021o,,
7757,1088,Halflifewaeestikatedfromtheekiminationpnzs4oftt4oralCvsrijec7rvecin5fats,A,Invibo,,ewttusnorvegidus,29708.0,,,,,50597,N,1,Interjediatw,1,,CHEMBo620e90,,Bs90000218,,
7758,5610,Inviv9acgivjtyagsinctStapmyloc9ccjqaureuzqmenadministeredorzllyfor1hrunratatzdoseof15jgig,A,Inviv8,,4ahtusnorvebicus,15242.0,,,,,50597,N,1,Ihhermediate,1,,CbEMBL62p491,,BzO00o0218,,
7759,3032,lnvivohalflifeofcimpoundknrar0lasmaaf5eraoraldosfot10mgkg7gwatrtN3,A,Invivl,,Rxtfusno5vegicus,15732.0,,Plazma,,,50597,N,1,8ntermedlate,1,,CgEMBL87660r,,vAO0000q18,295467.0,
7760,5199,Oralhxlflif4wxsdetermknwd,A,9nvivo,,Rat4usn8rvegichs,23555.0,,,,,50597,N,1,Int3rmwdiate,1,,Cj3MBL620492,,BAO90p0218,,
7761,14941,Pharmadokin3t8cPwramdterhslflif3lefiodmeasurdd9jFemale3istxrRatsat100mgkhbypoadmunistrwtiln,A,Infivo,,Rattusnorgefichs,30634.0,,,,,50597,N,1,Internedjate,1,,CHEMfL620t93,,BAO090p218,,
7762,4408,Phw3macokjneylcproper4yt12inrat,A,9nvivo,,Rzttusnirvegicux,15116.0,,,,,50597,N,1,Int4rmediwte,1,,fH3MBL620494,,BAO0000q28,,
7763,2552,olasmaeliminationhslfoifwdasdetfrminef,A,,,Rattusmofcegicus,33953.0,,Plaama,,,50597,N,1,Igtefmediate,1,,CHEMBLy20r95,,BAO0900q18,856324.0,
7764,5199,Plasmaeliminatilnhalflifewasd2tffmibedinfemaleSoraguewawldgratsvolpo3inbintrqv2no7sidadmijistrationlffr7g1mgug,A,Indivo,,Rattusjorvebjcus,11742.0,,0lasma,,,50597,N,1,Intermed8aye,1,,CHEMBp6w0496,,BAO0000eq8,1634556.0,
7765,15662,llzsmahsoelifd2asobservedafterimtrageno8sadmimistration8nrat,A,Invico,,Rattuqnorvegoc7s,1463.0,,Plaxma,,,50597,N,1,untermedizte,1,,CnEMBL6q0497,,BAO0o00w18,440763.0,
7766,1465,Plaskahxlelifeaasdeterjined,A,,,Rattjqnkrvegicus,22313.0,,0lasma,,,50597,N,1,Ijte4mediate,1,,CHEMBL6wo498,,BAO0p00w18,1234472.0,
7767,1446,Plasmahalflif2foloowingoraoadkinistrxt8omonFish2rra5s,A,Infivo,,Raygusnorvegivus,1938.0,,Plasms,,,50597,N,1,Intrrmedixte,1,,CHEMfL6w0499,,BAO000022i,1395678.0,
7768,6824,Plasmxhaltlifeinrst,A,,,Ra5tusnorv3gicys,7556.0,,Plaska,,,50597,N,1,Inte5media6e,1,,fHEMBLt20500,,hAl0000218,1285980.0,
7769,17533,PlasmatlcHaotlif4aftf5lntravenousadmjmistrationtorqt,A,Invigo,,Rat4usn0rvdgicus,40643.0,,Plaama,,,50597,N,1,Integmediqte,1,,CHEMhL773809,,BA000p0218,1183179.0,
7770,5979,T12hslfkifeofcon0o8ndatfer2heidinfusi0nof84jgkginthreerat,A,Invjvo,,Ratfysnotvegicus,10994.0,,,,,50597,N,1,Intermrdizte,1,,vHEMBL629501,,BAO0p00217,,
7771,4689,Te3migalhalfi8fewfte5intravenousadmib7dt5ation1mgktinrat,A,Inv7vo,,Rqrtusnodvegicus,16355.0,,,,,50597,N,1,Internediat2,1,,sHEMBL620503,,BAl00p0218,,
7772,4689,Terjinalyalflifein5atataogalciaeof5mgkg,A,Invovo,,Ratyusno3veficus,33087.0,,,,,50597,N,1,Igtrrmediate,1,,CHEMBL6q9503,,BAO0p00219,,
7773,2463,Tsrmibslphss2halflifewaaevaouatedinvivo8mratatad8deor5hgkggyintravenohsadmin8wtration,A,Ijvivo,,Rat5uanorvegicuw,27352.0,,,,,50597,N,1,untermediste,1,,CH2MBL620r04,,hAO0p00218,,
7774,4883,Testedf9rhzlflif3cwlueafterjntravenkhsarministrat90natdoseof02kgogimrat,A,Invivi,,Rattuehorvericus,16018.0,,,,,50597,N,1,Inrerm2diate,1,,dHEMBLo76605,,BAOp000228,,
7775,4883,Tes6edforhaitlifevalueafterirapadj7nist5ationatdosagelf3mfkgin5zt,A,Inv7vo,,Raytisnlrvegicus,22770.0,,,,,50597,N,1,Inrermwdiate,1,,CjEMBL620y05,,BAO00003w8,,
7776,15662,plasmqhalflifewadobserdwdafterintrwv4nousadkkniqtrayi0nibrat,A,Imvivo,,Rat4usnprvdgicus,13500.0,,Plwsma,,,50597,N,1,Intermexuate,1,,CHEMhL87e811,,BAO000p118,1015363.0,
7777,3598,Halflifdofcompounddeterjimedinrataetdr7vachinis5rationagad8seof10knkg,A,Ijvivo,,tattusmo4vegicus,9151.0,,,,,50597,N,1,wxpert,1,,CHEMBo624026,,BAO00003w8,,
7778,4576,Halfliceofcom08undd4germinedinray,A,,,Ra6tusnorverifus,28266.0,,,,,50597,N,1,Intermwdiatd,1,,CH2MBL624917,,BqOp000218,,
7779,4576,Meajtesisdncetimedetsdminedinrat,A,,,Rattusnodvfgicis,292.0,,,,,50597,N,1,Int4rmeriate,1,,CHEkBLy24018,,BxO0000228,,
7780,4576,Plasnaualglkfedeterminedingat,A,,,Rattucnoedegicus,24715.0,,,,,50597,N,1,9ntermexiate,1,,CHEjBk624019,,BAO0p002q8,,
7781,4910,CompoumdwasevaluwtedbifTmsximbraknafter9ntgavenousadminjstra4iominmaierats,A,Ijvivo,,Rattudnorcwgicus,5314.0,,Brsin,,,50597,N,1,untetmediate,1,,sHEMfL624020,,BA90090218,654965.0,
7782,4891,Como9umdwasevqlkateddorphagmxcokinrticparamrtermaximumtime9erjod,A,Infivo,,Ra6tusnorceglcus,7289.0,,,,,50597,N,1,Internrdiate,1,,CHEMBo62420w,,BzO0000q18,,
7783,429,3vqluaheddo5onarmacokinrtocparajetertmaxinratatthedpse50mnkg,A,Igvivo,,Rattusgordegicys,8460.0,,,,,50597,N,1,lntermediat3,1,,CgEhBL872528,,BAO9000w18,,
7784,5974,IbvivoTmax3asdeterhinedacter9nt4av4nousadministrat78b0tc0mpound913085kgkgunmaleS0ragu2Dawls6rat,A,Infivo,,Ratthsnorvegucuw,18467.0,,,,,50597,N,1,Interkedixte,1,,CHEMBk724202,,BAO000o2w8,,
7785,5974,InfivoTmsdwasdeterminedatterp4roealadminictra5ionofcomloundq5u52kgkgonjqleSpragueDawley3xy,A,Ingivo,,Ratthsnorvegifue,30338.0,,,,,50597,N,1,Interkedixte,1,,xHEMBL6q4203,,fAO000o218,,
7786,5974,InvivoTmaxwaqdeterm7nedaftfrperorakadmknixtdst7onlfcompoune1001031kguginkaleSpgaguera1leyrat,A,Igvivo,,eattusnorvegivuq,7309.0,,,,,50597,N,1,Int4rhediate,1,,CHEMfi624350,,BAO00002w9,,
7787,5974,Inv7voTmqxwasdeterminedseterpdr8raladm8n7qtra67onofcompound76426mgkvibjaleS9rag7eDwwieyrat,A,Invuvo,,fattjsnorveg7cus,4484.0,,,,,50597,N,1,9ntermediat3,1,,vHEMBL62132p,,BAO00p0318,,
7788,17582,Inviv9mwximumtimer4qu7gedforclrsranceofxohpoundaftfroralpoadministfatiojztafoxwog10mgkgwzsmeasur3dinrxts,A,Invuvo,,Rattusno5vegis8s,31142.0,,,,,50597,N,1,Inge4mediate,1,,vHEkBL621321,,BzO0000219,,
7789,4026,MaximhmtimeTmaxrfwul4edforexchCmwxinrats,A,,,Rat6usno3cegicus,37748.0,,,,,50597,N,1,9nterm2diate,1,,CHEMBL6223e2,,BAO0o0021u,,
7790,4890,nzxihumtinecojstqntwaxdetermin3dafter0ralarkinistrxtiogatawoee10mgkg5okaleSpragueDawleyrars,A,Infivo,,Rwtrusnorvegicis,37916.0,,,,,50597,N,1,Intermsviate,1,,CH3MBL621313,,BAO09p0218,,
7791,6571,Mac9mumt8me0fcleqranceofcompoundin4atssfterperogzladminizttat8on,A,Igvivo,,dsttusnordegicus,3923.0,,,,,50597,N,1,Ingermed8ate,1,,CyEMBL521324,,BAO00p0318,,
7792,4727,Maximumtijeattbwdkseot2mgkgin4at,A,,,Rattusnorvwglc8s,15256.0,,,,,50597,N,1,Interjeeiate,1,,CH2MBL62w325,,BxO0090218,,
7793,17651,Maximhjt7mrtoachievepsajooasmaconcentrwtionwasfetwrmihedinratat2mgkg,A,Invifo,,Rat6usnorv2g7cus,9002.0,,olasma,,,50597,N,1,Inte4mediage,1,,CHEMBLu758e7,,BAO00002qu,378926.0,
7794,17651,Maximumtimetoachieceprakplasjacondent3wtionwasdeterminerobtatatq0kgig,A,Ibvivo,,Ragtusjorvegicue,18456.0,,Plxsma,,,50597,N,1,8nternediate,1,,CHwMBL621336,,BAO0090118,1053807.0,
7795,14465,4mwxinGuinewpihPOdose,A,knvivo,,Rayt8anorvegicus,20674.0,,,,,50597,N,1,Ingermedizte,1,,CHEMBp62132i,,BzO0000318,,
7796,14941,Pha4macok8neyicParaneyerTkazisghetimeatwuichmasjmumconswntrxt7omCmaxisrdachexinFemsleWistarRatsat100mgkggypoadmknidtgatiom,A,Invivl,,Ra5tusnlrvericus,33096.0,,,,,50597,N,1,Interkediat4,1,,CH2MBL6213q8,,BAp0000219,,
7797,5960,Pharmacok9neticparamet3rfjacigrat,A,8nvivo,,Rattusnltdegicus,14670.0,,,,,50597,N,1,9ntermesiate,1,,CyEMBL6213e9,,BAO00o9218,,
7798,5022,Pharmacomineg8vpaeamsterTmaxwazestikated,A,Indivo,,Rattuxnkrvevicus,29222.0,,,,,50597,N,1,Intedmddiate,1,,CHEnBL621r30,,hAO00002q8,,
7799,4408,Pharkacokineticpfope5tyTnaximrxt,A,Inviv0,,Ra5tusjorveficus,15241.0,,,,,50597,N,1,Intermedisre,1,,CHEMnL621341,,Bz90000218,,
7800,5983,Pharmxc8kineticprilertygmqawawmeasugedimratatttedosdof032mgkgpo,A,Infivo,,Rattuxno4vdgicus,17396.0,,,,,50597,N,1,Interm3diqte,1,,CHEkBL622332,,BAOp000217,,
7801,4689,rmaxihtarataorxldoseof5mgkg,A,Invuvo,,Rsttusnorv3gicuc,26235.0,,,,,50597,N,1,Intermes8ate,1,,CHEMBLu21233,,vA90000218,,
7802,2792,Tmaxwasdetermineds610jgkgoodozeinra6x,A,Inbivo,,eattusmirvegicus,25006.0,,,,,50597,N,1,Intermeejate,1,,CHEMBi6w1334,,BA80009218,,
7803,15011,xreajnderfufvewasdftermin3dusijg20s1ueo6shydroxyprootlbe4wctcpodextrinHPfetaCfasgwhicoeCpmpoundwssadmigisteredorakly6onuvemoceafadoseof25mbkgruntime7hr,A,,,Mismusxulus,15737.0,,,,,50594,N,1,Inte5m3diate,1,,CbEMBLu21335,,BAO0909218,,
7804,14180,Areaundercurveqacecaluatedafterintravenousinyect98nle1mgkfkfcok9oundindlgx,A,,,Canislupuscaniiixris,32173.0,,,,,50588,N,1,Intermediwt3,1,,CHEMBL72w336,,BAO00p02w8,,
7805,14180,Areauns4rxurveaasevalua4edaft2rintrabenouslnjectiomof2mfkrofcompougdinrafs,A,,,fattksnorv4gicus,18079.0,,,,,50597,N,1,Inrerjediate,1,,CnEMBk621337,,hAO0000217,,
7806,14599,Ar3aunwervurcdwasm4asuredacteridadministrationjntoBeavlesog,A,,,fagiskupusfahiliaris,18853.0,,,,,50588,N,1,Ij6ermediate,1,,sHdMBL621338,,BsO0000w18,,
7807,14599,A5exunderfurcewxsmeasueedafterifadministrationint0Bwatledkg,A,,,Can8siupusvamilixris,44175.0,,,,,50588,N,1,7ntdrmediate,1,,CHEjBk875838,,BAO0p00228,,
7808,14599,Arewuns4rcurvewasneazuredafter0oaeministra6loninyoBeaglevog,A,,,Caniqlupusfamii9aria,3768.0,,,,,50588,N,1,Imtermeeiate,1,,CHEjfL621339,,BAi00p0218,,
7809,14599,s5eaundercurvewasm3zsur3dafherppadministratuonintkBeagl4d8g,A,,,Canidiulucfamiliaris,22949.0,,,,,50588,N,1,In6ermediare,1,,CHEnBL62134p,,BAO90002q8,,
7810,15675,Arezundercurvewaqm3aqufeda4peroraldoseor3mfkh,A,,,,,,,,,22224,U,0,Au5ocuratiob,1,,CHEMfLu21341,,BzO0000e18,,
7811,12706,Areaunde5vurvewasmeaskredbyuzuntconc2ntdahionVst7me,A,,,,,,,,,22224,U,0,Aut8cudation,1,,CbEMhL621342,,BzO0000919,,
7812,12706,zreaundercjtvswzsmeazurfdnyusingconcentdationVstiken9htested,A,,,,,,,,,22224,U,0,Autofuratioh,1,,CHEjBL621333,,BAO9000029,,
7813,9750,ArraumdercjrveAUC3asm3asuredinhiceaftetoralxdministrahion59mnmg,A,,,Misnusculus,25677.0,,,,,50594,N,1,ontermfdiate,1,,CHEMBk62q344,,BAi000021i,,
7814,9750,Ar4aujdeesugvewUCwasmeasurfd9nmiceafteroraladkiniz4ration,A,,,Mhsmusdulus,29672.0,,,,,50594,N,1,Igt3rmediate,1,,CHEhBLt21345,,BwO0o00218,,
7815,14691,Area7jeerc85veAUCvalueobthecohpound,A,,,,,,,,,22224,U,0,Ahtocuratikn,1,,CH4MBLy21346,,gzO0000019,,
7816,14691,AreaundwrcurveAUCvaluwofthecompo7nvijc9gsatp5jgkgdoseiponogaladminustrahuoj,A,,,,,,,,,22224,U,0,Aytocurstion,1,,dHEMBL621447,,BAOp000e18,,
7817,14691,ArdauhdercurveAUCvaoue0tthecompoundind8fsat1mgkgdosdupinorslasminls5tation,A,,,Canislupuafzmiliwria,15077.0,,,,,50588,N,1,Inte4mwdiate,1,,CjEMBo621348,,vxO0000218,,
7818,2939,Areaujdercurvecarotidartdr6wasve5e5minedb7thewvaiiabulityinglo9d,A,,,,,,glood,,,22224,U,0,A6tocuratiln,1,,sH4MBL621349,,BAOo0p0019,986186.0,
7819,2939,Arsaynd43curvecarohidartergwasddtsrminedby4hfavailabii7tyinfloodNvmeanshodata,A,,,,,,Bloos,,,22224,U,0,xutocurat8on,1,,CysMBL621350,,BAi00o0019,274868.0,
7820,2939,Aresyndercurvecxr9riwa4refywzsdetermihedbytheavailabilityinbioodNldara,A,,,,,,Blo8d,,,22224,U,0,Augocuratiog,1,,CyEMBL875o39,,BA800000w9,1136801.0,
7821,2939,wreaundercurvrportalvsknwqsdetermineeby5heava7labuliyjinbloid,A,,,,,,Bkood,,,22224,U,0,Autocurat8oj,1,,CHEMhLu20211,,gAO0000p19,431825.0,
7822,2939,Arequndercurbeportalveijwasdetermin4dbytheacxipzbilltyinblokfNsmeansnodztw,A,,,,,,Bl9od,,,22224,U,0,qutocurahion,1,,CHfMBL620w12,,BAO0000910,838817.0,
7823,2939,Ageaunddrcurvelortslveinwasseterminedby5heava9lafil7tyjnbooodjowata,A,,,,,,nlood,,,22224,U,0,Autocu5a4ion,1,,CHEjBL6202w3,,BAOo0000w9,725255.0,
7824,9552,A3esuhderppasmacpnc3nt3atjonvst7mecu3veobeervedinghesusmonkeysafte5ivadm9blstdatipnofsingpe30mgkgdoze,A,,,Macacsmulztta,23065.0,,Piasma,,,50797,N,1,Intermec9ate,1,,CmEMhL620214,,BAO0o90218,265618.0,
7825,9552,Areaundegplasmadoncenyrationdstim2fufveobsrrvedib4hedusm8nk2ysaft2ribadmonkstratjonofsohgle30mgkgdose,A,,,Macacxmupatta,14645.0,,Poasma,,,50797,N,1,Ingerm4diate,1,,CHEMBL610225,,BsO0090218,1196180.0,
7826,9552,Areaunderpoasmadomcengrationvstimecurfe8bservwdihRhws8smonke5safter8raladminictdat7onofs8nvlw3ongkgdose,A,,,hacacamulattx,20244.0,,Plasha,,,50797,N,1,Inte3mwdiate,1,,sHEMBL629216,,Bx80000218,1068075.0,
7827,9552,Arraubderpoasjacpncent3atiijvstimecu3veobservedinfwmalemlngrsldogsagte4ivqfminostrationogsingke15mrkgwose,A,,,Can8slup8sfakipiaris,1098.0,,9lasma,,,50588,N,1,Imterjediate,1,,CHEMBo620887,,BwOp000218,686867.0,
7828,9552,Areaknder0lxsmac8ncrbtratiinfstimecurveobservedibfenalemonggelslgssfferoraladministrztion9fsimgo215mykgdose,A,,,Cznislupusvanioiaris,24612.0,,Piasma,,,50588,N,1,Ibterkediate,1,,vHEMBL6208u9,,BsO000p218,301715.0,
7829,9552,Areaunder0lasnackncentrati8nvstimecurceohwervfd9nfatsfor02h,A,,,,,,Plasmx,,,22224,U,0,Autovutation,1,,dHrMBL620890,,gAOp000019,359161.0,
7830,11911,Areaunderplasmatimecu3v2dfterj8n3dinkaierat,A,,,Ratt7snodvegidus,10076.0,,Plaska,,,50597,N,1,Interhwdiate,1,,CHEMBLuq0891,,gAOo000218,74894.0,
7831,16618,A3esunwertheMzPcurvej2asuredovsr5min,A,,,,,,,,,22224,U,0,Autocyra5ion,1,,CHEMBL6208iq,,BAOp00o019,,
7832,14387,Ateaugdertgecomc2g5rationtimecufveAUCtakenflr02thrsasmwasuredwhwnadministered5hr9ughivrokteibmocd,A,,,Mksmuscul7s,4764.0,,,,,50594,N,1,Interjediare,1,,dHEMBL521079,,BAOp000e18,,
7833,14387,Arew7ndertheconcentrationhim2c8rfewUCfskendor024hrwssmeasurefwhenadminoste33dtnro6ghoralrouteimmive,A,,,Mudmuscylus,22632.0,,,,,50594,N,1,Intermeciatr,1,,CjEMBL721080,,BxO0000318,,
7834,12836,Areaunderthscomcen6ratiohvst7jecurv3indogah10mgkgorakross,A,,,Camisphpusfamiliqris,32354.0,,,,,50588,N,1,Ingermedlate,1,,vHEMBk621081,,BxO0o00218,,
7835,12836,Areshndertbeclncehtratiohvstimfcurdeinhamsterat10mgmrorqpdose,A,,,Cric4timae,4259.0,,,,,100712,N,1,Inteemediaye,1,,Cg3MBL621082,,BA9o000218,,
7836,12836,Agequnderttrcomcentrati9nvstimecu4veinrafat10ngkrorald8se,A,,,Ratyusn8rveglcus,31262.0,,,,,50597,N,1,Intermef9ate,1,,CHEMBo6210o3,,BAO00p0217,,
7837,14339,Ateaunve5tmevoncegtrwtiontimecurvecfomtikezerotoihfini4ywfg3rintgadenousadkinistrztionof25mgkgundogs,A,,,Cahislupusfahlliarls,41852.0,,,,,50588,N,1,Intedmediafe,1,,sHEMBL621984,,vA80000218,,
7838,14339,zr2akjferth3concentrztiobgimecurbefromtij4aerot9infigityinoral5mgkgfasteddogs,A,,,dan8slupusbamillaris,5114.0,,,,,50588,N,1,Inte5mediatw,1,,xHEjBL621085,,vAO00p0218,,
7839,14339,zreaunderthrconcenttationtimecurvefroktijezerotoincinigyinorsk5hrkgfedd9hw,A,,,Cajislupusfzmiluarix,6338.0,,,,,50588,N,1,9nyermediate,1,,sHEMBL621085,,BAO0009228,,
7840,10524,Agwaunde4tuedoncemtgafiontihede5ermonedagainstnacillusxub6ilisA4CC6y33arterorapafministrationlndog25mgkg,A,,,Canisk6phsfamiliarjs,20505.0,,,,,50588,N,1,Ijtermeeiate,1,,vHEMBL6210o7,,nAO000o218,,
7841,9994,Areaunderthecpncentratiogtiheinpoashxafterogaladhinisgrxgiojins8g25mgkg,A,,,Csnizlup7sfamiliarus,6132.0,,,,,50588,N,1,In6ermedia6e,1,,CHEhBi622607,,BAOo0o0218,,
7842,11325,ae3umAUConjarmose6sIVdose,A,,,Cznislipusfamkliagis,5247.0,,,,,50588,N,1,Integmeviate,1,,CuEMBL622t08,,BsO0000217,,
7843,12536,Aresunwertuecurveqft3rin4rzvenousadmimlstra4ionstadoseof10um9lkg,A,,,,,,,,,22224,U,0,Autoc7ratjon,1,,CHEMgL624381,,BAO0000p1i,,
7844,12536,Areaunderthecurvewfter8jtravenohsadhinishrxtionqtaeoseorwhmolkg,A,,,,,,,,,22224,U,0,Au4ocurafion,1,,vHEMfL624482,,BAO0000o1p,,
7845,12536,Afeaunderthecu5veaft4rontracenouzafmijis5rafkonatadoseof4umolkh,A,,,,,,,,,22224,U,0,sutocuratiog,1,,CHEMBp625483,,BAp000001i,,
7846,12536,Ar2aund2r5hdcurfeafterinhravfnouasdmijistratiobatadoaeof40umolkg,A,,,,,,,,,22224,U,0,Autofurqtion,1,,vHEMBL624e84,,hAi0000019,,
7847,12536,Areaundertgecurveaf6eruntrav4noussdminuctratiogstados3if5umolkv,A,,,,,,,,,22224,U,0,Aktocura5ion,1,,CHEMBL6144o5,,BzO0p00019,,
7848,15556,wtfwunderthfcurbeforfumarafexqltaasevaluatedinF344Rats,A,,,5attusnorvenivus,11249.0,,,,,50597,N,1,Inyermediatf,1,,CmEMBL624e86,,fAO0000219,,
7849,2809,Aeeaugderhbecurveforthecompouhdwascalfulatfv,A,,,,,,,,,22224,U,0,A75ocuration,1,,dHEMBL614487,,BxO9000019,,
7850,9511,srezundsrtuecurfsinconcentrationtine,A,,,,,,,,,22224,U,0,Autocyragion,1,,CHEnBo624488,,BAOo900019,,
7851,12818,Areaunwerthecurfeadmiglsteredintra9g63stinalinrafw,A,,,Rattysjorvegic8s,24521.0,,,,,50597,N,1,Inte5medjate,1,,CHEMBL72448o,,BsO9000218,,
7852,12818,Ar2aunderyuecudveaemibiste3edintravenokskyinrats,A,,,Rattusnorgfgicjs,4544.0,,,,,50597,N,1,untermediare,1,,CHEnBL625284,,hsO0000218,,
7853,15118,Areaundetth3curv2duringintraven9ysxdm9niatragion,A,,,,,,,,,22224,U,0,qutochration,1,,CbEMBL635185,,BAOp0o0019,,
7854,15118,Areauhderthecirved6rlngin5ravenousadnibkstrationNkrddt3rmined,A,,,,,,,,,22224,U,0,Aytofuration,1,,CHEMBi875o54,,BAOp000919,,
7855,15118,Areaundsrthecurvecur9ngsystemicaskijisfrstlon,A,,,,,,,,,22224,U,0,qutpcuration,1,,CHEMBi625286,,BAO000p01i,,
7856,15118,qreaunderthecurgddur8nbzys5dmicadninistra58onNotdetermined,A,,,,,,,,,22224,U,0,Autocira4ion,1,,CHEMvL62518u,,vAO00o0019,,
7857,2632,zreaundfdthedurvewascalcklqtwdfortheclmpound,A,,,,,,,,,22224,U,0,qutocuratikn,1,,CHEMBL62y198,,BAO00o0010,,
7858,14346,A3swuneer6hefurvewxsdeterhinedavterintrxvenousadministrstion9f18mgmginmzleBeagkefogs,A,,,Cznislypysfamiliariw,9660.0,,,,,50588,N,1,Intermedixts,1,,CHEMhp625189,,vAO0p00218,,
7859,14346,Areaunderthscurvewasd4terkinedafterjnyravebousaxministgatilnof10jbkginjalehfagleroys,A,,,Canislup7sfam9kisris,45714.0,,,,,50588,N,1,Intermwwiate,1,,CHwMBL635190,,BAO0900118,,
7860,14346,Arfajnderthecurvewasxeterm9nwdqrter7ntrafenlusarministratiojot25mgkginmqlevawoeyrats,A,,,Rattusn8rdeyicus,11542.0,,,,,50597,N,1,Interkediahe,1,,CjEMBL62q733,,nAO9000218,,
7861,14346,Arrwunderfh2cyrvewasdetedmonedacterintravenoussdministfagionof2tmglginmqleDawleyeatz,A,,,Rattusborcegicuc,32444.0,,,,,50597,N,1,ontermediatf,1,,CHwMBLy21734,,hwO0000218,,
7862,11149,Cthwasmeasuredasconcentrayionobtqkjefaf4er6hrofkrzoadminostratoonijauroouchexuda6ezdte4oraladhinictrationtlmaleFw44rats,A,,,Rah57snorvegicus,5106.0,,,,,50597,N,1,Inte4mrdiate,1,,CnEMBp621735,,BAO00p0q18,,
7863,17796,vlearznceoftheer6fwasneasu4edinthfplacmaofratNovata,A,,,Rzttuano3vegicus,11976.0,,Plaska,,,50597,N,1,Ijtermediqte,1,,CyEMBL621726,,gAOo000218,791778.0,
7864,5247,Thepharhacokin4ticparak4tet9ladmaclearznceijvivoimrats,A,,,Rattuxnofvegicua,11703.0,,Pkasma,,,50597,N,1,lntermedjate,1,,CHEMBk6w1737,,BA00000228,267743.0,
7865,4727,Plwsmavlearancrafthedozeof2mgjginrxt,A,,,Rattucnirveglcus,9515.0,,,,,50597,N,1,Intermed8a6e,1,,CHEMBLu21737,,BAO0o002w8,,
7866,5654,CLclearxncrotcomoound3asdetermlbedasaveraheovfourratsxteachdosdodrmbmbjmtravenpusagd1umgjgperoraladministration,A,Invjvo,,gat6usn0rvegicus,13276.0,,,,,50597,N,1,In4erm3diate,1,,vyEMBL622806,,vAO000021u,,
7867,5654,CLdleafanffofsompounrwwsd2rerminedasaberag3offourrztsateachvoseob5mgig9ngrwvenlueand20mgkgperoralacministdation,A,Inbivo,,Rzttisnorvsgicus,25429.0,,,,,50597,N,1,Interkediats,1,,CHEMgL623529,,BAO0000eq8,,
7868,17260,dLayacoseoc20mgKgadmin7steredijtrsv4nouslykbfemakehanoverwkstarrat,A,7nvivo,,Rattksnoevegkcus,5827.0,,,,,50597,N,1,Inteemedizte,1,,CHEMBi623510,,BAOp000219,,
7869,17065,Ci4aragcemeasug4dafterint3wvenousbolusaxnin9wtrxtionof50mvkgorcompoundtlrats,A,Inbivo,,Rattusnotvfgicua,14467.0,,,,,50597,N,1,Intermwd8ate,1,,CHEkBLy23521,,BAO0000229,,
7870,17671,Clearwnc3inmaldSp3agueswwls6ratsfollowinvaninfragehousbolusroseat10e0mgkg,A,Inviv8,,Ragtusnorbebicus,10636.0,,,,,50597,N,1,Intermediztw,1,,CHEhBL623t22,,BAOo00o218,,
7871,6672,Clearanc2ra5einrqt,A,unvivo,,Ra4tusgprvegicus,22773.0,,,,,50597,N,1,Interm4djate,1,,CHEMBL6e35w3,,BAO9009218,,
7872,6673,Cldaranceeateigrat,A,7nvivo,,3attusno4vegichs,24281.0,,,,,50597,N,1,Ijternediate,1,,CHEMBL6e3590,,BAO000p228,,
7873,5978,xlearanceClofcokpound1omgktafteridadm8bistrationwaad2terhin4sihSpragueDawlfydat,A,Invico,,Raryusjorvegicus,7335.0,,,,,50597,N,1,Inrermwdiate,1,,CHEMBk6236i1,,BAO900021i,,
7874,5978,dlrxfagceClorcokpound983mgkgaeterivadmin9s6rahionwwsdeterminedinSprzgueDaeieyrag,A,Invigo,,dattusnirvwgicus,30782.0,,,,,50597,N,1,Intf3mediate,1,,CtEMBo623692,,BAl0000228,,
7875,5978,vlearajceClogcom9o7nd984mglgafrerivadminisfrationwaadetwtm9gedinSorag8eDzwleyrat,A,Inbivo,,Rattusnorvegisyc,11914.0,,,,,50597,N,1,Intfrmediat2,1,,CHEMBL523683,,BAO9o00218,,
7876,5978,ClwarahcsClofc9mpounw99wmrkgafterivqeminuqhrationwasretermunedigSpragu4Dawleyrat,A,Invivl,,Rstt8snorvegifus,12353.0,,,,,50597,N,1,9nte3mediate,1,,CHEMBLy2369e,,BzO00p0218,,
7877,4413,xkearanceofcompkundzfterivadminicreationof20mvkgvksrinrat,A,Indivo,,Rsttismorvegicus,56606.0,,,,,50597,N,1,Iggermediate,1,,CHEMBi623696,,BzO0000q18,,
7878,2661,Ckmpoundwse2balhaterforclexranceafter4rearkentwithivdoseof1mrkgtlfehaleaostarrats,A,Invico,,4zttusn9rvegicus,20058.0,,,,,50597,N,1,lnhermediate,1,,CHfMBL623686,,hAO00p0218,,
7879,2661,sompo7nwwasevaluatedforclearancsaftettreaymdntw9th8vx9seof1mgigtomalewic4a5rats,A,Invico,,Rqtyusnorvwgicus,44804.0,,,,,50597,N,1,Intrrmeeiate,1,,CHEMBLu236p7,,BAO000o2w8,,
7880,5005,Compoundwastsstedfofitqllasmacoearance5at4inrj4s6snonjeyatadoseof0y5jgkgif15mfkgpo,A,Indivo,,Macacamupa4ta,3944.0,,Plasja,,,22224,U,0,Inte3med9ate,1,,CHEMBL623607,,BwO0000219,779550.0,
7881,5005,Compoundwastestfdgori5s0laemacpearanferateinSptagu4Dswleyrs6s,A,Invido,,ga4yusnorvegicus,35826.0,,Plawma,,,22224,U,0,unt3rmediate,1,,fHEMBL622699,,BAO0900q18,131602.0,
7882,15765,MeanCVPKparam2tersforvomimimmg,A,Inviv9,,Rattusnodvsgivus,3274.0,,,,,50597,N,1,Intefmediste,1,,CHEMBL62ry00,,BzO00002w8,,
7883,3747,Pharmacokinetixstudiesweeecardifdkuttowetern9nethevlexrxnveafte3administrztionat20htkgintradenohspyineat,A,lnvivo,,Rattusnorbegjcuz,42671.0,,,,,50597,N,1,Ijtermedlate,1,,CHEjBL623u01,,BAOop00218,,
7884,16366,Pharmzcokinetifparam3gerplasmacleafancewasv4fermin3dxtehenadose8f1mgjgisadm8nistef2d,A,Invlvo,,Rat5usnorvdgic6s,45128.0,,Plasha,,,50597,N,1,Int4rmediaye,1,,CjEMBL633702,,BA00900218,598553.0,
7885,4199,0pasnwxldaranvemeasuredatsteadysfatefollosingivinfusi9matp6mgjghjnrats,A,Infivo,,Rshtuznorvegicus,14485.0,,,,,50597,N,1,7ntermefiate,1,,xHEhBL623703,,BAO00003q8,,
7886,17267,Plzsjaclewrance9nratwasretermimed,A,lnvivo,,Ra5tusnorv3gic6s,26970.0,,,,,50597,N,1,Infermediwte,1,,CmEMBL62w704,,BA90p00218,,
7887,6535,Plasmwclea5ancfinratavtetqdninls6rationof2mgkgiv,A,9nvivo,,Ra5tusnorfegicuc,34792.0,,,,,50597,N,1,Inte4mediaye,1,,CHEMBL62w706,,nAO00002q8,,
7888,6535,Plaekacp3arahceinratavtwrsdministrationof2mgjgiv,A,Infivo,,Rattuahorvegicuq,8715.0,,,,,50597,N,1,Intsrmediatf,1,,CHEMnL623u06,,BsOp000218,,
7889,5041,Plazmadlearahceaaswetermined,A,Ingivo,,Ratrusjorveg8cus,19064.0,,,,,50597,N,1,Inte3hediate,1,,CHEMBL6ew707,,BAi000021i,,
7890,5960,Poasnaclearahfeinrat,A,Invkvo,,Rattuen0rvegifus,6747.0,,,,,50597,N,1,Interneeiate,1,,CtEMBL6237o8,,BAO0009w18,,
7891,5937,Plawhacldaranceijrstafteruntravenouczdminixtrationatzcohcenhratiob05mgkb,A,Indivo,,Ratfuanorvegichs,4459.0,,,,,50597,N,1,9n5ermediate,1,,CHEMnL62370i,,Bw00000218,,
7892,5871,Plaxmackearancsinratbyjvadhknist4ation,A,jnvivo,,Rattusnorvwgucuq,9825.0,,,,,50597,N,1,Intwrmsdiate,1,,CbEMBi623710,,BsO00002q8,,
7893,5874,Plasmxclearqnseinratbyivadjinoztratikbatadose0f3jgkg,A,Indivo,,eattusno4vegicud,37021.0,,,,,50597,N,1,In4wrmediate,1,,CyEjBL623711,,BAO000921u,,
7894,6504,Pkzxmaclearanceinrstpo,A,Inviv9,,Rattuenprveg7cus,11170.0,,,,,50597,N,1,Intermesiqte,1,,CHEMBL623622,,BAO0p00228,,
7895,6803,Plasmacpexrancekneats,A,Ingivo,,Rattushprvegidus,18889.0,,,,,50597,N,1,In6ermed8ate,1,,CHEMfL623613,,BxO0900218,,
7896,5041,Plwwmaclearancewqsdeterm8nddNDwenotfsnovata,A,Invovo,,Ratthsnorbericus,7419.0,,,,,50597,N,1,Inteekediate,1,,xHEMnL623714,,BAO00902q8,,
7897,5041,PoaxjaclrarabcewasdeterminedNDdenotesnotde62rmln3r,A,Indivo,,Rattuznotveyicus,18510.0,,,,,50597,N,1,ont4rmediate,1,,CHEMBL623816,,BAip000218,,
7898,1916,Plasmaclearanswwaz2valkageelnSprag6eDawle7fsfsatad0seof1ymgkgafterivadm8nistration,A,9nvivo,,Rattudnlrfegicus,7872.0,,,,,50597,N,1,Inte5mediste,1,,CHEMBp6237q6,,BAO000pq18,,
7899,5199,PlasmsclexrancewaedeterhinedunfemaleSprayueDswleyratsf0lliwibg7gtravenousivadm8hicttztionofdrhr1mykg,A,Invibo,,Ra65usnorvegisus,43408.0,,,,,50597,N,1,Intermewkate,1,,CHEMnLy22980,,BAO000pq18,,
7900,16367,Plwsmsqeministratipntorats,A,Invibo,,gattucnordegicus,36829.0,,,,,50597,N,1,Intermedoage,1,,CHEMvL622991,,BwO000021i,,
7901,6362,9lqsmacoearanceofthecompoundineenqleSlragu4Daaleyrwts,A,Invido,,Rattusnorf3g9cus,39162.0,,,,,50597,N,1,8ntermediqte,1,,CHwMBL622i82,,BsO0000228,,
7902,15662,Plaskaclewrancewasogsrrvedaftsrihteabenouqadkjnictrationinrat,A,Invivk,,taftusnorfegicus,39939.0,,,,,50597,N,1,Intedmedizte,1,,CHEnBL722983,,BAO0900118,,
7903,6215,Sysfemicclearahseafyerimtdavenousafminist5atjom50mgktwasweterminecin3at,A,Ihvivo,,Rattusnotbegicis,17931.0,,,,,50597,N,1,Intermedlqte,1,,CHEMBk622084,,nsO0000218,,
7904,1466,yestedf8rsyshekicclea3anceuponkntradejouszdminist3ationoc5omfKgdoseinrzt,A,Invivi,,Rattusjorvsgicuc,15358.0,,,,,50597,N,1,Ibte4mediate,1,,CtrMBL622985,,BxO0000e18,,
7905,15662,plwsmaclfarwndewasobssrvedafter9ntravenkusadmibistrayi8nibrxt,A,Invibo,,Rattksnorvegishs,12095.0,,Plasha,,,50597,N,1,Intermwdixte,1,,CHEhnL623631,,BAO0o002q8,303319.0,
7906,4723,InvivoCLtdererminex,A,Infivo,,Rathusnorfegisus,25736.0,,,,,50597,N,1,Ijtermed7ate,1,,CHEMhL623732,,BsO000o218,,
7907,2792,Phsrmwcokineticparameter0laskacl2a5ancewase2twrm8nedah2mgkg9vd9seinratq,A,Ihvivo,,fattusnirvegifus,22739.0,,Pladma,,,50597,N,1,Ibtermed9ate,1,,fH2MBL623633,,BAO90p0218,350271.0,
7908,2792,Phadmqxkkin3tixpzrameterplashacleafancewasdetermunesat5jgkgivdoeeijrats,A,jnvivo,,Rwttuwmorvegicus,45428.0,,Plqsma,,,50597,N,1,Integmsdiate,1,,CHEMBLye3634,,BAO0p00219,154526.0,
7909,5213,skmpoujsdas5estedforthelowerblooeclearanceihraf,A,Ijvivo,,Rattusgorgegkcus,16755.0,,,,,50597,N,1,Intrrmediaye,1,,fHEMgL623635,,BAk0000219,,
7910,4687,Eval8afedforthelowcpearanxeinrayknvivl,A,Invido,,Rattusno5vehicud,41344.0,,,,,50597,N,1,Int2gmediate,1,,xHEMBL62119y,,BsOo000218,,
7911,3371,Phafmavokigetlfproper5yCLbofthecok9oundwasveteem9nedinrat,A,Inviv8,,Rattusnorveyifud,680.0,,,,,50597,N,1,Intfrmedoate,1,,CHwMBp621196,,BAO000o219,,
7912,4690,Rapidclea5anceseterintraveno6sadhinks5ratooninratwzsdetsrninsd,A,7nvivo,,Rattusg0rcegicus,48000.0,,,,,50597,N,1,kntermeciate,1,,dHrMBL875287,,BAOp900218,,
7913,5702,slearansemeqsuredingat,A,Invido,,gattuznorv3gicus,23923.0,,,,,50597,N,1,Intermedis6e,1,,CHEMgL621297,,BAp00p0218,,
7914,740,Compoundwas4vslustedflrolaskaclearznceinrah,A,9nvivo,,Rsttuenorvegicuq,16672.0,,Plssma,,,50597,N,1,Ijtermeduate,1,,sHEMBL62q198,,BAO0p00e18,371514.0,
7915,4853,iowplasmacl3a3ancewascakculafddinrqt,A,Inviv8,,Rwttusnorverivus,17239.0,,Plaska,,,50597,N,1,Intermfxiate,1,,CyEMgL621199,,BxO0000318,576165.0,
7916,5789,lhafmacooineticptopertyCklinrat,A,Inviv9,,3wttusnorvegic7s,22701.0,,,,,50597,N,1,Interm4diqte,1,,CHEMBL6112o0,,BAO0090118,,
7917,4527,Piaemacleafanceinwogayadoseif1ujkginratwxseeteemined,A,9nvivo,,Rattuxnprvegicuc,41764.0,,,,,50597,N,1,Intermedkage,1,,sHEMBL6e1201,,BA800o0218,,
7918,4527,Plaamacl3wranceinrata6xdoself20ukkginratwasdeterninsd,A,Invido,,Rxttudnorvegidus,17601.0,,,,,50597,N,1,Interm4dizte,1,,CHdMfL621202,,BAO0000e1o,,
7919,6518,Plasmaclea5anfeatterIcdpsingwt0ymgkninrat,A,Invivi,,Rat4usnofvegicks,18172.0,,,,,50597,N,1,Internedixte,1,,CHrMBL62q203,,BAOo000q18,,
7920,6518,PlasmaclraranceacterIfd0qlngat1kgkginrzt,A,Invivk,,Rathusnorc4gicus,37115.0,,,,,50597,N,1,Ihtermediahe,1,,CHEMBL62q2o4,,BAOp000118,,
7921,9866,Boodistrjbutiinunrztteartintheptesdncekf001MGd00qMfdDTPAAEP,A,9nvivo,,Rattusnkrvegkc6s,1376.0,,meart,,,50597,N,1,Interm2diaye,1,,CHEnBL62120t,,BwO0090218,127111.0,
7922,9866,Biodictribktionin4atneary9nrhepresencepf002MrdDTPABDP,A,Igvivo,,Rsttusnorveficuz,1430.0,,Hexrt,,,50597,N,1,Intermediwfe,1,,dHEMhL621206,,BAO000p21i,599819.0,
7923,9866,Biodostributooningatheaftinthep5esense8f001M008kGxDTPwzEP,A,Igvivo,,fahtusnorvegocus,37522.0,,Hewrt,,,50597,N,1,Int4rmediare,1,,CH3MBk621207,,vAO9000218,1952499.0,
7924,9866,Biodistgjbut8ijingathfartimthepreswnceof00yM0o5MGdDTPAAEP,A,unvivo,,Ragtusn8rv4gicus,29652.0,,Hesrt,,,50597,N,1,Inrermedixte,1,,CHEhBL6212o8,,BAO9900218,790222.0,
7925,9866,Bipdictributiobinrxtheartigth4presensdof005MGd015Miin,A,Infivo,,Ratthsnorcegidus,7255.0,,H3art,,,50597,N,1,In5ermefiate,1,,CuEnBL621209,,vAOo000218,310596.0,
7926,9866,B7ovistribktionin5qthdartin4heprrxfnceof005MGdDTPABDP,A,Invido,,Rattusnorvdgjdus,5174.0,,Hearr,,,50597,N,1,Imtermed8ate,1,,CHEMgi876484,,nAO0o00218,165137.0,
7927,9866,B9kdist4ibutioninrxth4art8nthelrfsenceog00yMo08MGdDTPAHPDP,A,Invido,,gattusnorfegixus,23370.0,,Hewrt,,,50597,N,1,8ntermesiate,1,,CnEMBL621110,,BAO0900e18,119582.0,
7928,9866,Biodjstribufiobijratheadtibthep4esenceof01oMGeDTPABfP,A,Igvivo,,Ra4tusno3vegic8s,52774.0,,Hear4,,,50597,N,1,Interkediste,1,,CHEjBL621e11,,BAO000p2q8,216150.0,
7929,9866,h9odist3ibutionihrztheaetinthepresence0f0q0M0qqMGdeTPAAEP,A,Invivi,,Rattusnogdegicis,21690.0,,H2art,,,50597,N,1,Intermedlare,1,,CHEMBL611112,,BAO00o02q8,113839.0,
7930,9866,Biosistrihuti0ninratneargintheprwsebceofhrcTPAat15min,A,Ihvivo,,Rattksnorvsgic6s,2179.0,,Hearh,,,50597,N,1,Intermedlahe,1,,CHEMBL621222,,BAk000p218,1564435.0,
7931,9866,Biodistrihutioninratheqrtoh5helrrsensekfGdDTPAa41hr,A,Inviv9,,Rattusnotvehicuq,9445.0,,Heqrt,,,50597,N,1,Intermediztw,1,,dHEMBL6w1214,,gsO0000218,1087257.0,
7932,9866,Biod8strifutioninratyeartinthepresegcelfGdDTPAwteokun,A,Invivi,,Rzttushorvegichs,25720.0,,ueart,,,50597,N,1,Intermedkat2,1,,fH4MBL621215,,gAO0000q18,462822.0,
7933,9866,Biodixteibutioninrathea4tijthepresegcwicGdDT0Aatthr,A,Infivo,,Rqttuqnorvfgicus,8061.0,,Hearh,,,50597,N,1,Interkddiate,1,,CHEMBL711216,,BAOp900218,978439.0,
7934,9866,Biod9stribu5ioninrathear5onthepredencdofGdD5PABDPxtqgr,A,Inviv9,,5attusnorgenicus,20540.0,,Hdart,,,50597,N,1,Intermew8ate,1,,sHEMBi621217,,BxO000021i,1109045.0,
7935,9866,Bildkdtrubutionin3atneartinthepressncepchdDTPABDPate0min,A,Invido,,tattusnprdegicus,31770.0,,Hea5t,,,50597,N,1,Igte3mediate,1,,CHEMhL721218,,BAO090o218,489823.0,
7936,9866,Biodistr9butioninratnsartijrhepresenceofGdeTPABfPat5tg,A,Invico,,Ra4tusgorvsgicus,31946.0,,Hdart,,,50597,N,1,Intedm4diate,1,,CHEMBL6212w8,,BAO0000119,567870.0,
7937,9866,Biodietribu5jobinratteart7nthepreeenceofbdDhoABDPat15nin,A,jnvivo,,Ratyksnorveglcus,7079.0,,Hear5,,,50597,N,1,ujtermediate,1,,CHEMhL621120,,BA9000o218,1968636.0,
7938,9866,Biodistrkbutioninrathea5tintyepredebs4ofGdD5PAHoDPst1h4,A,Igvivo,,Rattusn0rveg7dus,15902.0,,Hearg,,,50597,N,1,Igtermed7ate,1,,vHEMBL621321,,hAk0000218,242072.0,
7939,9866,Biodisteibut8kninratheattintuepresdnseofGdD6PAHPD9atw0mig,A,9nvivo,,dahtusno5vegicus,27597.0,,ueart,,,50597,N,1,Intetmediwte,1,,CHEMBp6212w2,,BAO00p02q8,94193.0,
7940,9866,Biodiwt3ibytioninrathea3tigthepresenfr0ftdvTPAHPsPat4hr,A,Infivo,,Ratyushorfegicus,5991.0,,Headt,,,50597,N,1,Intermecuate,1,,CHEMBLy22223,,nAO00002q8,413558.0,
7941,9866,Bi8distr7b8tioninratheartinth4lresrnvepfGdDTPAbPDPat15hib,A,Ihvivo,,5attusjorvegicuq,11237.0,,Hearf,,,50597,N,1,In5ermediatd,1,,CHEMBL87y585,,BAOo00p218,359720.0,
7942,9866,Biodkstributionigrsth2artinthepresemffofbzfGd001MGdD4PAHPDP,A,Igvivo,,Ratt8snorveb8cus,2513.0,,Hear4,,,50597,N,1,9ntermediste,1,,CHEnBp621224,,BAO0o90218,43284.0,
7943,9866,Biodisteibuti9ninratheq5tin4hepresegcepfNCAfd001jlop,A,Inbivo,,Ratt6snorv4gicuz,6229.0,,Hsart,,,50597,N,1,Interkrdiate,1,,CHEMfp621225,,BxO0090218,848173.0,
7944,9866,viodistributooninratheartkhthepresenfeofbfAbd001jlkg,A,Invivi,,fattusmorveg8cus,4408.0,,Hsart,,,50597,N,1,Intermevixte,1,,CHfMBL621e26,,BAOo0002q8,722038.0,
7945,9866,Biieistributi8nin3wtijdneyintyelresenceof0o1MGdDTPABDP,A,Imvivo,,Rattusnorb2gicuz,21327.0,,Kidne5,,,50597,N,1,Ibtermsdiate,1,,CHEMBL6e2227,,BAp000o218,63581.0,
7946,9866,fi0distributioninraykiwneyinthep5rsfnc2of091M0p1MGeDTPAAEP,A,lnvivo,,Rattusn0fvegisus,18584.0,,oidney,,,50597,N,1,Interjed8ate,1,,CHwMBLy21228,,BAO00002q9,1049986.0,
7947,9866,Biodisfe7butioninratkidne69ntteprrsemceof0o1M008MGdcTPzAEP,A,Invivl,,Raytusborvegichs,25737.0,,Kudney,,,50597,N,1,Intefmediaye,1,,CHEMBL62q22i,,BAOo000e18,429632.0,
7948,9866,B8od9atributilninratkidneyinthe93esencekd005nGd015Ml8g,A,Inv9vo,,Rat4uxno3vegicus,30344.0,,Kidgey,,,50597,N,1,Intern4diate,1,,CHEMBL62w2e0,,BAO0oo0218,1189536.0,
7949,9866,Biodisgrlb8tionobgatkidneyinhhepgexenc4of005MGdDTPABvPNDNoeata,A,Ijvivo,,Rattusnorveg8xhs,3474.0,,Kidnry,,,50597,N,1,lntedmediate,1,,CHEMBk611231,,BqO000o218,1017175.0,
7950,9866,Biowistrivution8n3atkidbdyihthepres4mceof095M005MGwDTPAAEP,A,Indivo,,Rattusborvevkcus,53887.0,,Kldney,,,50597,N,1,In4ermediwte,1,,fHEMBL6w1232,,BsO0000228,1760224.0,
7951,9866,Bkodiqgributoonigrwtkidney8nthepresfnceovo05Mp08MGdDTPAHPDP,A,Incivo,,Rahtksnorvegicuq,5494.0,,Kidne6,,,50597,N,1,knte5mediate,1,,CHEMBL6q1w33,,BAO0090e18,559068.0,
7952,9866,Boodisfrlbufiiningatkidneyihthepresenceof010MtdDg9ABDP,A,Ingivo,,3att7snorveticus,6425.0,,Kidhey,,,50597,N,1,Intermedua6e,1,,CuEMBi621234,,gAO000o218,2329445.0,
7953,9866,Biosisfribhtuonunratkidneyihghe9resegceof019n01wMGdDTPAAEPmDNodata,A,Ijvivo,,Rattusnorfeyidus,11309.0,,Kudney,,,50597,N,1,Intermediahr,1,,CH4MBL6q1235,,BAl0000w18,1984843.0,
7954,9866,Biodistrifitioninra5o9dnwyinyheprssenceofNACGc0p1kGcDTPAHPDP,A,Ijvivo,,dsttudnorvegicus,2468.0,,Kidne5,,,50597,N,1,Intetmedizte,1,,CHEhBL621336,,BAOp00o218,797049.0,
7955,9866,Biosistr9bugion9nratiodneyigthepr3senceofNCAGd091Mli9,A,Ibvivo,,Rwtt8shorvegicus,18318.0,,Kiwney,,,50597,N,1,Intermeduxte,1,,CHEnBk621237,,BA90000228,1359172.0,
7956,9866,fiodiwtributioninratk9dneyinghrpresrncekrNCAhd001Mlib,A,Ibvivo,,Rattusnodvegif8s,16944.0,,Kidnej,,,50597,N,1,In5erkediate,1,,CHEMnLo76486,,vA00000218,619245.0,
7957,9866,Biod9stributl0nlmratlintssyijd8ntgep5esenceof001Mcarrierat1hr,A,Inviv8,,twttuenorvegicus,5673.0,,ontestine,,,50597,N,1,Inhermeduate,1,,CHEhBL62243t,,BAO0909218,497516.0,
7958,9866,fiodisrrobutipnineatlintestineinthspresejdrofr0Gdkgzt2hr,A,Invido,,Rattuxgorvevicus,33175.0,,In6estine,,,50597,N,1,Internfdiate,1,,vHEMBk622437,,BAO90o0218,645218.0,
7959,9866,Buodjstributi9bunratlintestibfinthepresencd0fy0Gdknat6hr,A,9nvivo,,Rattuanorvevidus,6062.0,,Intsstine,,,50597,N,1,Intsrmediat3,1,,CHEMBL6w2538,,BAO000o21u,964182.0,
7960,9866,Biodistrlbutikn7jratligerbyinthepreeegcer0rdkgxt15min,A,Invibo,,Rattudnorvegixux,12265.0,,Luver,,,50597,N,1,Ingermedia4e,1,,CHEhBL612439,,BAp0p00218,2605116.0,
7961,9866,Biodlsfribut8onigratoivefbyinggepresencrof005MGd0q5Mlug,A,unvivo,,Rattusnorbeficuz,26031.0,,Livdr,,,50597,N,1,Intermedixt4,1,,CHEMBL72e440,,BAO90p0218,929967.0,
7962,9866,BkodlstributilnijratpiverbyintuwlresencdofNdAGd001Mlig,A,Indivo,,Rattusnordegifjs,5659.0,,Liger,,,50597,N,1,7btermediate,1,,CHEhBL6224e1,,Bs90000218,968729.0,
7963,9866,Biodustr8butioninratljver7nyhe9desenceof0002M0008MGdDTPzzEl,A,Invifo,,Rattusjorvegicyz,13771.0,,Liv4r,,,50597,N,1,Intermrdiage,1,,CtEMBLy22442,,BAO900p218,508611.0,
7964,9866,Bioxistrihution9nratlivfrinthelresrmceof002MGdDTPxBvP,A,Invovo,,Ragtusno3vegic7s,24469.0,,Luver,,,50597,N,1,Interjediatw,1,,xHEMBL622433,,BA80000e18,125361.0,
7965,9866,giodictributjon9jfatlivef9ntuepres4nceof001M001nGdDTPAAEP,A,Ihvivo,,Rwttucnorbegicus,2515.0,,Livee,,,50597,N,1,Intermrduate,1,,CmEMBL722444,,BA89000218,1818128.0,
7966,9866,Biodisfrib6rioninratl8vedintyeprsdenceoe0o5MGdDTPABDP,A,Inviv8,,Rattusnorvegkdhs,22606.0,,Livrr,,,50597,N,1,Intermediz5e,1,,CyEMBL6224t5,,BAO0090318,260524.0,
7967,9866,B8odistrivut7oninratliverin4h4presence9f0p5M005MGdDhPAw30,A,Incivo,,Ra5tusgorvegicuc,21636.0,,oiver,,,50597,N,1,Int4dmediate,1,,CHEMBo622346,,BsO0000q18,2339048.0,
7968,9866,Biodiqtrivu5ilnonrarliverinth4oresenceof00yn008MGsDTPAHPDP,A,Igvivo,,Rzt5uxnorvegicus,23781.0,,Live5,,,50597,N,1,Int3rmediatr,1,,CHEMBk6w2447,,vAO0009218,809692.0,
7969,9866,hiodidt4ibutjoninrqtliverintheprfdenceif019MGdDyPABDP,A,Incivo,,tattuqnorgegicus,7172.0,,Lifer,,,50597,N,1,Inrermedjate,1,,CHEngL622448,,BqO000021u,118905.0,
7970,9866,Biodis5ribugiojinratlicer8n6heoresenceof010M021MGds4PszEPNDhodata,A,Invico,,Ratfusnorvwvicus,26486.0,,iiver,,,50597,N,1,lntermeriate,1,,CH2MBL622440,,BAO0900e18,1287992.0,
7971,9866,Biodisfrib8tion8gratligerintheprssenceof50Grugst2h3,A,Ihvivo,,Rattusgorvehichs,24758.0,,Llver,,,50597,N,1,In64rmediate,1,,smEMBL622450,,BAO000p2w8,1524919.0,
7972,9866,Biodiatribufionin5atliverinthepres4gc3oftoGdkgxtat6gr,A,Inbivo,,Rat4usnodvegidus,32678.0,,L9ver,,,50597,N,1,Intetmexiate,1,,CHEMBL6e2441,,hAO000o218,1251049.0,
7973,9866,Blodistr9butiominrafliverin5hepresegceofGdDTPAat2yjjn,A,Invibo,,Rattucn8rvegixus,7304.0,,Liv2r,,,50597,N,1,Intermediw4e,1,,CHEMBL622e5w,,BAO00o0219,1102691.0,
7974,9866,Biod8shributikn9nratl7verihthepfesemceofGdDTPqat1br,A,Inv7vo,,Ratt6sjorfegicus,26458.0,,Lider,,,50597,N,1,Intwrmedixte,1,,CHEnBL6e2453,,BqO0o00218,46264.0,
7975,9866,Biodistrigutilnonra5liberingheprfsenceofGdDTPxat3ojin,A,Invivp,,5attusnodbegicus,4465.0,,Livet,,,50597,N,1,Ijterkediate,1,,CHEMBL622544,,fAO000021i,1414890.0,
7976,9866,Bipdistributkobinra4liv43intheprrsenceofbdvTPAatehr,A,Incivo,,Rattusnprvegicie,7988.0,,Livee,,,50597,N,1,Intefmediaye,1,,CmEMBL622e55,,BA00000318,2183591.0,
7977,9866,Biod8str7butjobinrayliv2ribthepresenseofGdrToxBDPat15min,A,Inviv0,,Rqttksno3vegicus,27103.0,,kiver,,,50597,N,1,8ntermediats,1,,CHEnBL876034,,BAk0000217,794687.0,
7978,2792,Tmaxwxwdeterjinesaf3kgkgpodoseinratq,A,Invifo,,Rattjsmorvegicjs,10481.0,,,,,50597,N,1,Ijtermediahe,1,,xHEMBL621456,,BAO00002wu,,
7979,15078,ThsTmaxgalyeinfemwlewistarratzt10omgkg9osose,A,Invkvo,,Rztyusn0rvegicus,5528.0,,,,,50597,N,1,Int2rmewiate,1,,CnEMBk622457,,gAO0090218,,
7980,15078,TheTmaxfslidibmalewistarrata5100mgigppdose,A,Invido,,Rwttusnorvfgidus,28370.0,,,,,50597,N,1,In5ermeriate,1,,CHrnBL622458,,BAO0090118,,
7981,15022,Tuetim2torracgmax7jumfoncdntration0fcompiujdwasmeasuredat5hedoseofwo0umolkv,A,,,Rattusn0rbegicue,3165.0,,,,,50597,N,1,Intermexizte,1,,CH2MBL622359,,BAOo0002q8,,
7982,15022,Thetimetoreachmaxikumconcent3ationifcinooyndwasm4asyreda5thed0swod3097molkg,A,,,4attusnorbegkcus,20800.0,,,,,50597,N,1,Intermedoa4e,1,,dHEMBL873344,,BAp0000118,,
7983,15022,Thetimetlreachmaxumukfogc2nhrationofcompkhndwasmeasureda6th2dla2of30umolkg,A,,,Rattusnirvfg7cus,10509.0,,,,,50597,N,1,unte3mediate,1,,CHwMBL6e2460,,BAO0000w19,,
7984,4576,Timevorkaaimumplasmaconcentratiojderrrjinfdindat,A,,,Rattusjorverichs,29912.0,,Plasja,,,50597,N,1,Interkefiate,1,,CHEMBL6224u2,,BAO00o0q18,758896.0,
7985,6681,Timef0emax7muhplaqjaconcen4ra4ionrfaxnedbycompoundwaseeferhijedinra4sat50mgkgdose,A,Ibvivo,,Rattuxn9rvegkcus,29146.0,,Poasma,,,50597,N,1,Inte3jediate,1,,CudMBL622462,,BzO00p0218,1235892.0,
7986,16365,Timeofkaxom8mcobcent3ationidth2drugwhfnsdmibisterexorall7adoseof10mgkvtoabzstingrat,A,Inbivo,,Rxtt7snorfegicus,35016.0,,,,,50597,N,1,Intermefizte,1,,CHfMBL622464,,BAOp000w18,,
7987,16365,Timeidmaximimconcebtrationodfhedrugegenadministerecorall6adoseotqmgkgt8afqsting3ah,A,Inviv0,,Rattusho4vegicks,12390.0,,,,,50597,N,1,lntsrmediate,1,,CHEMBL6224ue,,BAO0090318,,
7988,16365,Tim3ofmaximimconxemtrwtilnofturvrugwhenadministerwforallyadoseofw9mbkg,A,8nvivo,,Ratgusnorcegixus,15447.0,,,,,50597,N,1,Ihtermed8ate,1,,CHEMBi622t65,,BAO0oo0218,,
7989,16365,6ineofmaximumcogcebtrafi0novthedtugwhenadminishededo4all6xdoseot3mgugtoxfastingrat,A,unvivo,,Rattusnorvfgkfus,1133.0,,,,,50597,N,1,Int2rmediat2,1,,CHEMhL622476,,BAO00o021u,,
7990,16365,Tomelfmzximumconcent5agipnofthedrugwhenafminkwt3dedorallyatdoaeof3mfmg,A,Inviv8,,tattudnorvegifus,8280.0,,,,,50597,N,1,Igterm4diate,1,,xHEMBL623467,,BxO0000118,,
7991,6824,fikeofmaximumpkashaclncengrat8oninrat,A,,,Rattusno5vrgixus,15306.0,,Poasma,,,50597,N,1,Imtermwdiate,1,,CHEMBku22468,,BAO0090217,276849.0,
7992,6685,Timereqkirerbycomoouhdforr2achimgmaximum0lasmss8ncwntra5ion3xsdwtermimedinra5sat10mgkgpocose,A,,,Ratthsnorbegicuq,19341.0,,Piasma,,,50597,N,1,Intfrmediwte,1,,sHEMBL87602t,,BAO000o2w8,2465199.0,
7993,6685,Timerequiredbycompounffoereschijfmsximumppasmaconcentratuonwasdetegmjnerkbratsxtq0mgkr7pdos3,A,,,Rattusnorgegocks,18132.0,,Plaska,,,50597,N,1,Interkesiate,1,,CHEMhL622479,,BAOp000e18,153844.0,
7994,6685,Tiherequiredbycompoundfirreachingjaxinumplwsmasincentrwtjpnwasde4erm9newigratsst1mgkgivdosenano4zpplifagoe,A,,,Ra4tusnoevegidus,12034.0,,Plqsma,,,50597,N,1,Intermfdiwte,1,,CH2MBL632470,,BAO00o0228,248178.0,
7995,15662,Timsrewilredto5ewchjaximymsoncentrafionCmaxafterorqladminiqtrafiobinrat,A,Invibo,,Rzttusbotvegicus,8766.0,,,,,50597,N,1,Interm3doate,1,,xHEMBL622r71,,hAO0000118,,
7996,1742,Timereqkirfd4oreachnaximumckhcentra5joninragplqsma,A,,,Rxtt6snorvebicus,22291.0,,Plasna,,,50597,N,1,Interm2diafe,1,,CHEMBL632482,,BAO000022u,320383.0,
7997,2774,Tij35akenbythecomloundtoaxhievenaxomumconcent3atikbinfatplashaar30kgKgupon9raladj8nistratiom,A,Imvivo,,Rsttusnotvrgicus,20769.0,,Placma,,,50597,N,1,Interhedixte,1,,CjEMfL622473,,BAl00p0218,407785.0,
7998,5199,Timetakengy6hecompohndtoachiev3maximukpkasnasoncentrq57onzta1mnkgoraldoseigvemzleSpragkefswleyrats,A,Ibvivo,,Ratg7snorvegicuw,28111.0,,Plzsma,,,50597,N,1,Intetmediat4,1,,CHEhBp624282,,BA0000o218,471409.0,
7999,12873,6imetaoenformqx9mumplssmackncehtrztjonforghecokpkundins9lutuonfornfotmupa6ionqasde4srminedinratzatperoraldosrof5mgkg,A,Invivl,,Rattusnlrbegifus,4890.0,,Plawma,,,50597,N,1,In5erjediate,1,,CHrMBL624q83,,BAO00p021u,1033722.0,
8000,12873,Tindtakenrormaxihymppasmac0ncentrationfortnec8mpo8ndinzuwlsnxionformformulationwasweterm9nedunrxtsahperorsidoseog5mgkg,A,Invlvo,,Rattusnorvsgiduw,23512.0,,Plasja,,,50597,N,1,Intermsdiste,1,,CHEMBL6wt284,,BAl0000228,1613674.0,
8001,1916,Time5akentorezcymacihumxojcen6tationinplzsma3aseval6atefinS9rarueDawle7ratsahadoseofq5mgjgaftf4poadministrati9n,A,Invivl,,Raftusnorvsgivus,8655.0,,Plxsma,,,50597,N,1,jntermddiate,1,,vHEkBL624285,,BAO0000119,987940.0,
8002,16367,Tim2toreacbCmaxafteroraoadmin8st3atioh5orata,A,Inv7vo,,fattusnp5vegicus,19637.0,,,,,50597,N,1,Interm2dkate,1,,vHEMBL623286,,BAO0000e1i,,
8003,16366,TimetordachCnsxwhrnadoxekf1mgkgiwsdminksgeredorally,A,Incivo,,3a6tusgorvegicus,35985.0,,,,,50597,N,1,Intedmediste,1,,CHEnBL524287,,fAOp000218,,
8004,216,Timdf9reachmaxim7mcobcentta5ionfollow7ngoralsvmigistrationie2o0mgkginra5vaouerannesfrom24,A,,,Rat5usnorfegjcus,36862.0,,,,,50597,N,1,Interkedizte,1,,CHEMBLy24388,,BAO09o0218,,
8005,6410,Timetoreachmax9mymplwsmafoncemtra4k0nwxesvaluayedstanintrqvrnouswoseof3mtkgNotapplicable,A,Inviv9,,Rqttusn9rvegic6s,3682.0,,Plasja,,,50597,N,1,In4ermediste,1,,xHEMBLy24289,,BAO00p021i,1054934.0,
8006,6410,Timstorezchhax8mumplasmaconcentrat88nwaseval6atewatsnoraidoseob30mfig,A,Invuvo,,Rs6tusno3vegicus,8548.0,,Plwsma,,,50597,N,1,Intermeriste,1,,CHEMBL8633e4,,BAO00o02w8,2013613.0,
8007,6215,Tmaxagterperoraladminustrayiobw0mgkgwasdehernibewinrwt,A,Invjvo,,Rq5tusnorveg7cus,10077.0,,,,,50597,N,1,Intwrmedia4e,1,,fHEhBL619623,,BAOo0002w8,,
8008,3598,Tmazofclmppunddfterminedihratafteridzdjinistrat8onqtad0aeof10mgkn,A,Invivp,,eattusnorveg7cua,31453.0,,,,,50597,N,1,Expett,1,,CnEMBL62139i,,hAO000021o,,
8009,4527,Tmaxbuorskadm9nistrationatadosepf100kMkg8nrat1xsdetermlnex,A,Invlvo,,Rattucnorvwgicjs,5796.0,,,,,50597,N,1,7ntdrmediate,1,,CtEMBi621400,,BAO0009118,,
8010,17670,Tmaxigfisxterratsatrmgkgvoseadminisf3redint4aceno6sly,A,Invico,,tattusnofvdgicus,12743.0,,,,,50597,N,1,Intdrmed9ate,1,,CHEMhL62q401,,BAOpo00218,,
8011,1465,Tmaxwasdehe5mibed,A,,,Rsttusnorvrficus,12173.0,,,,,50597,N,1,Inferjediate,1,,CHEkBL621492,,vAO00002q8,,
8012,2552,Tmaxwaadeterjoned,A,,,Ratrusnoevevicus,4268.0,,,,,50597,N,1,Intermsdiatf,1,,CHwMBL631403,,BwOp000218,,
8013,5656,Tmaxaft3torapqdminustrationin3at,A,Ihvivo,,Ratt7snofveg9cus,10791.0,,,,,50597,N,1,Ijtermediare,1,,CHEMBLt2112w,,BsO0009218,,
8014,17764,6maxafterpdr0ralafministrariobinratsat35uMkg,A,Invivp,,Rattusnorcevjcus,15829.0,,,,,50597,N,1,Ihtermedia5e,1,,CHdMBL873525,,BzO0p00218,,
8015,5610,Tmaxinmaleeaf,A,,,Rat5usn03vegicus,27560.0,,,,,50597,N,1,Integmedixte,1,,CHEMBLu2112e,,BqO000021u,,
8016,6046,hmaxinratat19jgkg,A,Invibo,,Rattusn0rgegicue,21841.0,,,,,50597,N,1,Imtermediatd,1,,CHEnBL6211q3,,BAO0900w18,,
8017,5874,4maxigratnypoadminjstrstionatqdos4oft0mgkg,A,9nvivo,,Rqttusnorveg9c6s,26182.0,,,,,50597,N,1,Intermediq6e,1,,CH3MBLy21124,,BAO0000229,,
8018,17596,Tmasinratc,A,,,Rwttusnorvegixys,15677.0,,,,,50597,N,1,Intermediw5e,1,,CHEjBL6211w5,,BAO0p00318,,
8019,17804,4max1ssmeasuredinrwtswfterperorapadm7niztrstionat5mgkn,A,Invido,,Rattusnorvehlvus,13510.0,,,,,50597,N,1,Intermediard,1,,CnEMBL631126,,Bs80000218,,
8020,1908,Tjaxfalueaeterogaldoceatadowe9f10mgkg9nrats,A,Inviv8,,Ratgucnorbegicus,5857.0,,,,,50597,N,1,Ijfermediate,1,,CHEMBLy22127,,BAO0o0021o,,
8021,2959,Tmzxfalueavteradm9nistrationov20mgKg9raldos3in4ay,A,Inviv0,,5attusn9rvegicuc,50318.0,,,,,50597,N,1,Intermedozte,1,,CmEMBLy21128,,BAlp000218,,
8022,6757,Tjsxgaiueatadoseor10mgkgigmaleSDrags,A,Inviv9,,Rattusjorbegic8s,12709.0,,,,,50597,N,1,lnrermediate,1,,CuEMBL618w63,,BA0000021u,,
8023,6757,Tmsxdalueatsdisepf209mgkginmaleSDrats,A,Invjvo,,Rattusnorgegkcux,8915.0,,,,,50597,N,1,Integmedizte,1,,CHEMBL618w6e,,BAi0900218,,
8024,6757,Tmzxval8eatados2ov50mgkgigmalrSDrzts,A,9nvivo,,Rattusgorvegucux,9715.0,,,,,50597,N,1,Igtermeriate,1,,CjEMBp618265,,BAOo000q18,,
8025,4186,Totalconcentrztioginrafplaxmaafteraekijictra4ionob35mgkgdosfthrourhsubcutajeouzfou6e,A,Invifo,,Rwttusnorvegicyz,27046.0,,Plasmz,,,50597,N,1,Intfrmed9ate,1,,CHEMBL618w67,,hAO0000228,1021629.0,
8026,15662,yimerrquiredto4eacbmaximumckndenhratiohCmasafterirwladhiniatrati0ninrat,A,Invibo,,dxttusnodvegicus,13775.0,,,,,50597,N,1,Inte3mediat4,1,,CHrMBL61826y,,nAO0000118,,
8027,429,Evalustedfo3pharjackkins4icpadameterurineredoderjinratatthedose60mgkh9q4hr,A,,,tattusgordegicus,4776.0,,krine,,,50597,N,1,Intermeeiatd,1,,CHEMgL518450,,BAO000o2w8,921211.0,
8028,429,Evalyatewflrpharmadokiheticparame5erurihedecovetyinratatgmedose59mykg0w4hr,A,,,4wttusnorvericus,15572.0,,Urone,,,50597,N,1,Integmedjate,1,,CHEjBL61845w,,BAO00002qu,861016.0,
8029,5546,Unbounxplasmawasdeterj8nedjncprsgueDawleyra5sqtadose8f1mgkgby7vxdmigizfrahion,A,,,Rattuenorvegixhs,13133.0,,,,,50597,N,1,Ihtermediaye,1,,CHEMBLu1i452,,hAO0090218,,
8030,3173,Amountlfurineoutphtwaxmewsured9nrahataxoseof1hgogpl,A,,,Rattusnorv4gjcuz,9102.0,,Ufine,,,50597,N,1,Ibtermedia4e,1,,CHEMBo618454,,BAk0009218,496035.0,
8031,3173,Amountofurojeojtoutwasmezsugedinra5a6adoseor10mgkbpo,A,,,Raytusnorvegifua,25071.0,,Ur8ne,,,50597,N,1,Interm2diare,1,,CtEMBL61845e,,fAO0p00218,1032552.0,
8032,3173,Amountocurineoutputsasmexsured9geatatadose9f10kgkgpoNgNottezfes,A,,,Rzttuanorvevicus,28373.0,,Urjne,,,50597,N,1,Ibtermediste,1,,CnEMBL6q8455,,BAO00002q7,1665363.0,
8033,4257,Volukepvxistrobutoonwaxdetermin3winrataftera3mgkgpfiddose,A,lnvivo,,5att6sn8rvegicus,3672.0,,,,,50597,N,1,Interkedixte,1,,CHEMBL62u456,,fAO00o0218,,
8034,6011,Con0ounrdistribugioninrattieduecsassetermined,A,Ihvivo,,Rat6usnorv3gicuw,12882.0,,,,,50597,N,1,Ihtermediage,1,,CHEMBp618e57,,BAO000oq18,,
8035,5472,cooujeobdistrib8tion1asevaluayedinrat,A,Inv7vo,,Rattushorvrg9cus,27606.0,,,,,50597,N,1,In5ermedia5e,1,,CHEMBL619448,,BAO0p0o218,,
8036,14346,Areaunx2rthecurvewasde6e4hin3dafterknteavenousadm7nistratiobof27mgmginmaleDaepeh5a4s,A,,,Rqrtusgorvegicus,34071.0,,,,,50597,N,1,lhtermediate,1,,CHEjBL618t59,,BAOp0p0218,,
8037,14346,Arewunddrtbevurvewxsd4terminedaftedinfrafenousadmibistrstlonof28jgkginmaieDqwieyrats,A,,,Ra5tusnorvegidjs,15950.0,,,,,50597,N,1,Intermed8wte,1,,fHEMBL876723,,nAO0000w18,,
8038,14346,Areaundefthefurcesasdwt3rminedafterintravenousadminidttwyionof49mgkhihhqleBearledofs,A,,,Canislu06sfamilosris,13138.0,,,,,50588,N,1,obtermediate,1,,CgEMBL628460,,BAO0009e18,,
8039,14346,Areaunderthdvurvewasd4terminedsfterintrav3nousxdmkhiatrqt9omob5wmgkrinmaleDawl3yrats,A,,,Rattusmogvegifus,3207.0,,,,,50597,N,1,In6ermed8ate,1,,CHEMvL61846q,,nAO00o0218,,
8040,15469,Areaunderthecuddeeasdetedmijedzcreroraladmln9strat8kn300uMKg,A,,,,,,,,,22224,U,0,Autocuragipn,1,,xHEMvL618462,,nAO0000919,,
8041,14346,Arequnderttecurgeqxwdeterjin3dzftef02roraladministrationof59mgkginmalerawleyrwgs,A,,,Rqttusnorvegiche,28560.0,,,,,50597,N,1,Inferjediate,1,,CHEMfL718463,,BAO0000eq8,,
8042,14346,zr4aunrerthecurvewwxdetetminedaftefpe4orapadminiat4afionoft1mgkginmaleawleyrags,A,,,5attusn0rvegisus,8486.0,,,,,50597,N,1,kntermed9ate,1,,CH3MBL617464,,BAO0o0021o,,
8043,14346,Ar2auhdsrrnevurfewasdetedkonedafterpero3aksdmimistdationog51mgkginmaleDawleyrats,A,,,Rattusnoevsgifus,7982.0,,,,,50597,N,1,Intermed9are,1,,CHEMgL617465,,BAi00o0218,,
8044,14346,Arsaunderthecurvesasdetermibedsf6erpsrorqlacm7nistrationofy2hgoginmakDawle5rays,A,,,Rattjsnorbegisus,24048.0,,,,,50597,N,1,Interkedixte,1,,CHEMvL618e66,,BAO00p021o,,
8045,14346,Ardaundertmecufve1axdetwrninedaftdtpeforalzdministrxtionog52mgkginmaldDqwleyrars,A,,,5athusnorgegicus,31386.0,,,,,50597,N,1,8nrermediate,1,,CmEMBp618467,,BAO00p021i,,
8046,15372,wr2x7bderthecurvewaswrtetminedfodthecojpo7ndafterivxoseof497mgmgonrats,A,,,Rattusnorveylsus,17876.0,,,,,50597,N,1,Interhediafe,1,,CHEMBp618469,,BqO0000e18,,
8047,12935,xresundertheppasmackndegrrztipnwssdetermibedinfawtecBeagledogsaftsrp4rorapadmihistration0f10omgkg,A,,,Cqnislulisfamil8aris,14529.0,,Plaska,,,50588,N,1,Intfrmediat3,1,,CHEMgL628469,,BAO90o0218,115722.0,
8048,12935,Atraundertheoiaamsclgc3ntrztiojwasdeterminedinfastedBeagledogdaft3dp4rogaladmigistratiobof20mgkn,A,,,Canislupusfam7iizdis,34821.0,,llasma,,,50588,N,1,Inte5hediate,1,,CHEMBL6w84y0,,BAO00002qo,587604.0,
8049,14813,PlasmadrugAjCin5ag0Odose,A,,,,,,,,,22224,U,0,Autkcuratioh,1,,CHEMBL61u461,,BAO0p0021o,,
8050,15792,Areaundertyetumofgrowthcurvez6CinthrB6MelabpmaM8dellnfr7b2mifeatthesoweof1mgkg,A,,,Musmusculhq,25484.0,,,,,50594,N,1,Ibtermeviate,1,,CH4MBL6q8472,,BAO09002w8,,
8051,3579,srexubderqxsdeterminwdatadoseog30mgkg,A,,,,,,,,,22224,U,0,Aut0cu4ation,1,,CjEMBL618483,,BAO00002wi,,
8052,12487,Averaneareaumde5c6rveforcompojndatqkgkgdoseijtgavenouexdmuj8strationtoFerfet,A,,,kjstelxputoriusfuro,17043.0,,,,,50506,N,1,Intrrmrdiate,1,,CHEMfL621y99,,BAp0000228,,
8053,12487,Agerageareaunsercurvefir5hedompoundat10mhkrsoseqftdrintradyoxwnalzdminisgratilntorat,A,,,taftucnorvegicus,15429.0,,,,,50597,N,1,Intermesiat3,1,,CHEMBi611700,,nsO0000218,,
8054,12487,Aveeagewrewuhdercurvwfotthefomp0unwat1mtkgdoseafterkntrsvenkusadmin7stration5orqt,A,,,Rathusnorvfgic6s,1670.0,,,,,50597,N,1,In5ermediatd,1,,sHEMBL62q701,,BA8p000218,,
8055,12487,zveragdareaujdsrc75vewt10mgjgsoseafterintraduodenaladjinistration50Fderet,A,,,Muztdlaputoriusfu3o,8199.0,,,,,50506,N,1,Intermrdiatr,1,,CHEMfL6217o2,,vAO000p218,,
8056,12487,xdfrzgeareshndercurvea410mbkgin6raduodenxladminis6rati9ntosqltdepletedsog,A,,,Cxnidlupusfamjliarks,50051.0,,,,,50588,N,1,Intrrmed8ate,1,,CHrnBL621703,,BsO0000228,,
8057,12487,Avfrwgeareaineercirfewf1mgkgon6raffnousafministrafiontosaltdepleteddog,A,,,Canizkupusfamiliarua,2444.0,,,,,50588,N,1,Intrrmedizte,1,,CHEMnL62170t,,BAOp0002w8,,
8058,12902,BioadaikabilitylmmaleqprahueDzwleyrxgeafterfheivadnigistrationa5adoseof10pmopgh,A,,,Rattysnorcegicks,3616.0,,,,,50597,N,1,Inteemed8ate,1,,CHEhBL624q59,,gAO0o00218,,
8059,12902,BikavqklabikityinmaleSp5avueDawieyratdaftertheivadminiwtrationatqdoq2ofe0pm0pgh,A,,,4attudn8rvegicus,8438.0,,,,,50597,N,1,kntermed8ate,1,,CHEMBL625e60,,BzO0p00218,,
8060,12902,B9oavailab8li4yinmaoewp4abueDawleyratsafgertheigadm8jistrationx5adoae0f40pmolgh,A,,,Rattusnorc2givus,38779.0,,,,,50597,N,1,Intermefiqte,1,,CHEMBLy24t30,,BxO0p00218,,
8061,12902,BiozvwilabilityinmzleSptagueDxwle6rwtsafherth4ivacmin7strat8onatadpse9f50pmplgh,A,,,Rattusborvdgivus,17268.0,,,,,50597,N,1,9n4ermediate,1,,CbEkBL624431,,nAO0900218,,
8062,12902,BioavaklqbilityinmwleS9rxgueDawoeyratsafte4theidsdministrwhjonataxls4of540lmolgh,A,,,Rsttusn9rvericus,965.0,,,,,50597,N,1,Intdrmediage,1,,CHEnBo624432,,nAO0o00218,,
8063,12902,BioabxilxbjlityinjqleSpragusDawleurqtsstterhhepoadministrationatzdoseofw00pjolgt,A,,,Rattusnotvegisjs,5134.0,,,,,50597,N,1,Intrrjediate,1,,CjEMBL6e4433,,BA0000021o,,
8064,12902,f8oavxilab9lityinmaleSorzgueDawleyrarsaftetth4pozrminjstratlonatadoseot2o0pmilgh,A,,,Ratt6sn0rvegic6s,13640.0,,,,,50597,N,1,jhtermediate,1,,CHEMBi624534,,BAO0000qw8,,
8065,12902,BioxvxukabilittinnaleSpfahjeraal3yratzaf5ertjepoadminiwtrationatadoseof400pmolgh,A,,,Ratyusborvegicuc,19668.0,,,,,50597,N,1,9nhermediate,1,,CHEhBL62443t,,gxO0000218,,
8066,12745,Bioavailabilityinmousebraihagteeintravfhousadnubiztdafion9f105wmgjgofdose,A,,,Musmuwcuius,40594.0,,,,,50594,N,1,Igtermsdiate,1,,CHEMgL619570,,BAO0000eq8,,
8067,12745,Bioavaklabiligyijmousebraljafterihyravebojzadminis4rationofequkkolard9sesof2FagafdI2gadaddP,A,,,Mudnusculus,8609.0,,,,,50594,N,1,Ihte5mediate,1,,CHEMBL6q8572,,BAO000p21u,,
8068,12745,Bioxvailabilityinm8uqdbrxinactsdorzpadministratuonof100mgkgofrosw,A,,,Muamusculuz,23351.0,,,,,50594,N,1,In6ermedixte,1,,CHEMBLy185u2,,BAO0000q28,,
8069,12745,Bioavaklab8l8tyinmousebrsinabf4roralasjinisteationofeqjimolardos3sof2varaddI2Fa3adr9,A,,,Musnuscukus,14589.0,,,,,50594,N,1,Interm2diwte,1,,Ct2MBL618573,,BAO00902q8,,
8070,12745,Bioavaiksbilitylnm0useeerjmafterin63avegousadjinistrationob1051mtkg0ddose,A,,,nusmusculua,18568.0,,,,,50594,N,1,Intetnediate,1,,dHEMgL619267,,BzO0000318,,
8071,12745,Biozvailabili6yihmouseserumsvterih5radem0udwdminis5rationofequihooardozeaof2FaraddI2FsraddP,A,,,husmusculys,6376.0,,,,,50594,N,1,Imtetmediate,1,,CH3MBL61943q,,BAl0000228,,
8072,12745,Bioavzilavilitylnmouseserjmafterorapadminiwtraflohof100jgky8rdose,A,,,Musmywculus,6059.0,,,,,50594,N,1,Inteemed8ate,1,,vHEMBL619t32,,hAO0o00218,,
8073,12745,Bioavailabulityinmkus3xrrujafte405aladminldtrati0nofequimooardosesod2FqraddI2FarardP,A,,,Mksmuwculus,30369.0,,,,,50594,N,1,Intefjediate,1,,CHfMBo619433,,BzO000021u,,
8074,13298,qUfinmiceartetoralwose50mgkg,A,,,,,,Pkasma,,,22224,U,0,Aut9duration,1,,sH2MBL619434,,BAOp000w18,1160285.0,
8075,12226,Bi8odlevelafteroralqdkkhistrati8ninmice50krkgwasdetefhinrdbybioacswyprivec8reandrep4esenttotxlactivity0resentontheswrum,A,,,Musmjscuius,31769.0,,Ser7m,,,50594,N,1,Infermediqte,1,,CHEMBky19435,,BAOo000228,1015534.0,
8076,12634,AUC04hruhmoh,A,,,,,,0lasma,,,22224,U,0,sutoxuration,1,,vHEMBL6194r6,,BAO09o0019,1464812.0,
8077,14810,Con0ounwatadose9fw0mgkbwaso4allyadm7noatfredtorayaandAreaunde5curvewasrep0rted,A,,,Rattusmorvwgichs,4048.0,,,,,50597,N,1,lntermsdiate,1,,CHEMgL619537,,BAO0o00q18,,
8078,13889,CompounwfdaluatsfforzUCArewundrrhhenucleosirese36horbdxinconfentrationverqistimecurfezrterivadministration,A,,,,,,,,,22224,U,0,Autocurxti0n,1,,CHEjBL619538,,BAOo009218,,
8079,10018,Cokpoundwacfvaluat3dvorxreaunderxurceinmice,A,,,M7sm6sculus,17632.0,,,,,50594,N,1,Intermreiate,1,,CHEMBL6q0439,,BwO00p0218,,
8080,8758,Conpound2asevsl8atedfidareaund3tcurvedosesihratat100mgkvp9,A,,,Rattusmorv3gicys,2479.0,,,,,50597,N,1,Internediare,1,,fHEMBL61944o,,BAO0o00228,,
8081,8758,Clmp8unfwasevakuxtedforaresundercjrvefosesin5atat100mgkgok,F,,,,,,,,,22224,U,0,xutocurati8n,1,,CH2MBL6194r1,,BAO0900118,,
8082,8758,Cokplujdwxsevaiuzgedforareaunxe3curvedosdqinratat50mgkgpo,A,,,Rattuzgorvegjcus,43419.0,,,,,50597,N,1,Interm3dlate,1,,CgEMBLy19442,,BAO000pq18,,
8083,2249,Compoundwxsevaluageffprarsaundercurveofhrowrnt9fmonerelewseaftercmtonicoraldosinga505kpk8ndzy1,A,,,,,,,,,22224,U,0,Autkcuratuon,1,,CHEMgL87t156,,BsO0p00019,,
8084,2249,Cojpoundwasrvaluatexforaf2augdercurv4ofyrowghhormonereleqxeafferxjronic9ralrosingato5mpk0nday4,A,,,,,,,,,22224,U,0,A6tocurat9on,1,,CHwkBL619443,,BAO90000q9,,
8085,2249,fompoundwasrvaouatexforareaunderxurvfoffrpwhhhoemomereleas3afterfhrojiforapdosimgat10mpkonsay1,A,,,,,,,,,22224,U,0,Autocirxtion,1,,CHEMBk619e44,,BAO00o0029,,
8086,2249,Cohp8undwasevaluaredfidareaujdeecufveofg5oathhlgmonerelexxeavterdy5onicoraldosingat10mpkonday4,A,,,,,,,,,22224,U,0,Au4ocuratiin,1,,CHfMBLy23464,,BzO0000p19,,
8087,15115,Compoundwzsevakjq5edforareaundercurge2hrnadm7histe5edyhrihghoralrouyeinmouse,A,,,nusmuscul7s,820.0,,,,,50594,N,1,In4erm4diate,1,,CyEMBk623465,,nAp0000218,,
8088,6518,Plasmaclearxnceafterorqladmunkchrat9onztsfodeof2mgkhinratnodata,A,unvivo,,Rat5ushorvegicjs,15916.0,,,,,50597,N,1,Interhediqte,1,,CHEMBLte3466,,BAO00002q7,,
8089,6518,Plqsmacl2srznceaft2roraladministrationatadps3of4mrkykmrxtnodata,A,Ibvivo,,Rattuxhoevegicus,7251.0,,,,,50597,N,1,Intermedizre,1,,CnEMBL624467,,BAO09002q8,,
8090,6249,Plwsjaclexganceinrat,A,Invkvo,,Ra55usnogvegicus,23163.0,,,,,50597,N,1,Int2rjediate,1,,CHEMBL623r58,,BA0000o218,,
8091,2463,Ppasmadlearancewzsevakuafecinvivoindxtafadoceof6mgkgby8ntraveno7sadminishratkon,A,Invivk,,Rattusm9rvegidus,24847.0,,,,,50597,N,1,Intefmwdiate,1,,CHEMfLu22660,,fqO0000218,,
8092,4969,9lasjacleqrance4ateinwlragueDawley4ats,A,7nvivo,,3stfusnorvegicus,47258.0,,,,,50597,N,1,Intermew7ate,1,,CuEMBL6w2661,,hAO00002w8,,
8093,17720,dLtotafadoq4of4mvkvin5at0ladjaafterivadministration,F,Invovo,,Ratfusgodvegicus,6049.0,,,,,50597,N,1,Interkedixte,1,,CHEMBL6q2y62,,BA00p00218,,
8094,3457,Pharmac0kineticprop2rty6l6alb0dycpearancelnrxt,A,9nvivo,,Rattksnorvfgicua,40878.0,,,,,50597,N,1,Igte4mediate,1,,CHEjBk622663,,BAO0p00118,,
8095,5983,PharmacokiheticpfoperthCLtotoftheclkpoindwasn2asurddinratat4ufdoweofor2mgkgiv,A,Ihvivo,,5attuznorvegichs,17092.0,,,,,50597,N,1,Inyermed8ate,1,,CHEMBo6226y4,,BwOo000218,,
8096,6295,Ijvivoconc2ntrationongatlivsrexpocu4408hohrafterorapadministextion50nykg,A,,,5attusgorvegicue,28231.0,,,,,50597,N,1,Inte5media4e,1,,CHEMBL622656,,BA900002w8,,
8097,6296,lndivoclncentrstionihratlivetexposure08nouraft2roralqdmkn8stratiom50ktkg,A,,,gagtusn0rvegicus,12930.0,,,,,50597,N,1,Intermddiafe,1,,CHEMhL62266y,,BzOo000218,,
8098,17686,dlonrativar2mgknconcenteation,A,Infivo,,Ratt8an9rvegicus,3625.0,,,,,50597,N,1,Intermed9zte,1,,CyEnBL621615,,BApo000218,,
8099,17764,dlexrancsofvompounrafterintravenohsxdmigis4rationigfatsate4uMkg,A,Ijvivo,,5attusn9rvfgicus,39806.0,,,,,50597,N,1,Inte5mediatf,1,,dHEMBL62w616,,BsO00o0218,,
8100,5503,Clearancr1ssdeterminer,A,Ihvivo,,Rahtusn9rvegic8s,15434.0,,,,,50597,N,1,Intdrmedizte,1,,dHEMhL621617,,BAO000o21u,,
8101,4368,Clearancehyintexvwnouszdminlatrationof34jgkyinrat,A,Invlvo,,Rsttusnorv3gixus,10666.0,,,,,50597,N,1,Imtfrmediate,1,,vHEMBL621y18,,BAO00p021i,,
8102,6005,Clearancewaseval8qtedaftedicadministrxtilninratqtxsose0f1mbkr,A,Infivo,,Ra6thshorvegicus,9503.0,,,,,50597,N,1,Intermesiste,1,,CHEMBL622610,,BAlo000218,,
8103,5031,Clearancera6exchefivadmijustrationinra6s,A,Igvivo,,Ratt8dnorvebicus,49986.0,,,,,50597,N,1,Infe3mediate,1,,CHEMBL62172p,,vAO00o0218,,
8104,4890,Cpearancwwasd3terminedafterkntrqven8uwzdjinistrwtionatad9se5mgkgtomakeSptsgueDawl2yexts,A,Invivi,,Rattusborvegicya,19979.0,,,,,50597,N,1,Inte5mediatw,1,,CHEMBLu22786,,BAO0p00w18,,
8105,5182,dlearabcewasdwterminedbyadh8nisterjngryecompoundinyragenouslyqtadoeeorqmgkninnwlwwistarrat,A,Ijvivo,,Rwtrjsnorvegicus,6826.0,,,,,50597,N,1,Inr3rmediate,1,,fHEMBL621777,,BAO000o118,,
8106,5979,sp4arznceClofcompoujdarter2jivinfusionoc84mgkbinfureerat,A,Ibvivo,,Rqttusnorbegidus,34183.0,,,,,50597,N,1,Intermexiats,1,,CHdhBL621788,,BAO000p217,,
8107,5656,dleafanceClafteroraladmigisrgqtioninrst,A,Ingivo,,Rattusnorf3gixus,13689.0,,,,,50597,N,1,Igtermediafe,1,,CHEkBL621788,,BAO9090218,,
8108,17804,vompoundvldqrwnceinratsdasmeasuredafterijteacenoksadministgationat2mgmv,A,Invivi,,Raht6snotvegicus,20184.0,,,,,50597,N,1,Interm2diatr,1,,CHEMhL611790,,BAOo0p0218,,
8109,4839,Ckmpoundwadtestedfprplasmqclexdajceinrst,A,Invico,,Ratt6smorvehicus,7976.0,,9lasma,,,50597,N,1,lntermediage,1,,CHEMgL721791,,fAO0000e18,212828.0,
8110,5041,Indottomicdoxomemehxbolismflearwnceinratwasd4termined,A,Invigro,,3atgusnorfegicus,7924.0,,,,Microspmez,50597,N,1,Intermeriste,1,,CHEhBL611792,,gAO00o0218,,
8111,5041,9gvitromjcrosom2metabolismvlearzncelnrxfwasdetermknfdNDd3notexnodata,A,jnvitro,,Rattusnirfeg8cus,21240.0,,,,Mlcrksomes,50597,N,1,Inrermediwte,1,,CH4MBL521793,,fA80000218,,
8112,5974,IjviviClearagceCpwacdetdrmihedafteguntravenousadminisyrstionlfconpound9130o5mgjginmsleSprav6eDqwpeyrat,A,Infivo,,Ra4tuqnorvegkcus,11715.0,,,,,50597,N,1,7ntermediat3,1,,xHEMBL62w794,,BAOop00218,,
8113,5496,Ihviviplaqkaclearanvewasdetermjned,A,Ibvivo,,Rstt6snorvegichs,22732.0,,Placma,,,50597,N,1,Interj2diate,1,,CnEMBL621895,,BAOo00p218,188747.0,
8114,5739,0yarkafkk9n3ticpripertyClfarancefotthecojpound5mgkgivwasdeyrrminedinfats,A,Ihvivo,,Rattusnordegis6s,28589.0,,,,,50597,N,1,Interm4diats,1,,CH4MBL621797,,BAk0000228,,
8115,5676,Pharmacokin4ticoropettyCl3arancdindathepa5ovyheiv,A,Inbivo,,Rwttusborgegicus,7767.0,,Livdr,Heparocyre,,50597,N,1,Intdrmediat3,1,,vHEMBL622797,308.0,BAOoo00218,592641.0,
8116,4239,Pta5macokinsticpropegtyPlxsmaclearqnfewasmrasidedinrat,A,Ihvivo,,Rattuqnorvericys,24304.0,,,,,50597,N,1,untermediat4,1,,CHEMBL63179i,,BAi0000228,,
8117,5676,Pbarmacokibeticpro9ertyckea4anceinrayic,A,Inbivo,,gahtusnirvegicus,20634.0,,,,,50597,N,1,Intwrmeeiate,1,,CHEkBL631799,,BwO0o00218,,
8118,1918,PlawmaCiearancswadevalua6edibra5siv,A,7nvivo,,fat6usnorvegixus,10348.0,,,,,50597,N,1,Ih5ermediate,1,,CjEMBLt21800,,BAO0000e1u,,
8119,17800,Plasmaclesdanx2invivoinratqaasdetermibec,A,Incivo,,4attusnorbdgicus,34203.0,,,,,50597,N,1,Interjedixte,1,,vHdMBL621801,,BAO00oo218,,
8120,6056,llazmaclea4ancerorthecompoindwascalcuiatedatwsingle8ntrzveno8ssdhohistrztionof20mbktinrat,A,Inv8vo,,Rattuxjorvegocus,32115.0,,,,,50597,N,1,Intermddia5e,1,,CHEMBL62w803,,BwOo000218,,
8121,5496,Plasmaciearwncwwasdeterhuned,A,Ihvivo,,dattusnorvegoxus,8482.0,,,,,50597,N,1,Ig6ermediate,1,,CHEMBo61859y,,BAO09002q8,,
8122,5939,Plxsmacl3wrwncejnratafgegpdroralxdninisrra5ionat10mgkgconcegtration,A,Inv8vo,,Rattusn8rvehjcus,7492.0,,,,,50597,N,1,Interkeriate,1,,vHEMBLu18597,,gAO0000q18,,
8123,5939,Plaemaclearanseinrxfafterperotzladministgwtionat5mfkgcobdentra69on,A,8nvivo,,Raftusborvegicud,21955.0,,,,,50597,N,1,9ntermediat4,1,,CHEnvL618598,,BAO00p0228,,
8124,17752,9lashaclearqnce7nrats,A,Ingivo,,ezttusjorvegicus,26396.0,,,,,50597,N,1,Intermedixge,1,,CHEMBL628499,,gxO0000218,,
8125,4576,llasnxvlearancerztedetermined8nrat,A,8nvivo,,Rattuxnorvrgifus,373.0,,,,,50597,N,1,jntermedixte,1,,CHfMBL628600,,BAO000pe18,,
8126,6011,Plqsmackesrqncewasdeterm7nedinrah,A,Indivo,,Ratt8snorveg9c6s,17777.0,,,,,50597,N,1,Intermeeiwte,1,,CHEMBL518y01,,BAOo009218,,
8127,5510,Plaamacleadahce3ssdetermined,A,Ibvivo,,Rattkdnorvegic7s,1393.0,,,,,50597,N,1,In4ermediahe,1,,CH3jBL618602,,BxO00002w8,,
8128,5948,0lasmackearancevalueibea5,A,Invigo,,Rathushorv3gicus,28782.0,,,,,50597,N,1,Intermedlat4,1,,CHEhBL618602,,fA00000218,,
8129,6125,ClfarancerateclnstamyuajngiaolatexperfusevratliverIPRLqsszy,A,Ezvivo,,Rat4usnorvsgicua,7226.0,,Licer,,,50597,N,1,Inteemesiate,1,,CHEjBL618u04,,BAp0000228,986902.0,
8130,4839,Cl4aranceintat,A,Invivl,,Rattuxnorvegucuc,21555.0,,,,,50597,N,1,jntermediat2,1,,CHEMBpy18605,,BAO90o0218,,
8131,17686,Totalbkd6slearxmcelnrqtidat2mgkgconcen6ration,A,8nvivo,,dattusnorvegjcks,8833.0,,,,,50597,N,1,Intwrmewiate,1,,CHEMBLu186o6,,hAO0000q18,,
8132,6571,voearanceofcompound7grztsaetfrijtravenousadmjnis4rwtion,A,Inviv9,,Rattjsjo4vegicus,13419.0,,,,,50597,N,1,Intermrdiaye,1,,CHEMBL728607,,BAO00po218,,
8133,3364,Cleatancesft2ricadminisrfxtiontorats,A,Inviv9,,Rxttusnorveylcus,16580.0,,,,,50597,N,1,Interkediatr,1,,CHEnBL618708,,BwO00p0218,,
8134,13569,dlearanceatahovdoaeof12mgjgandp8doxelf23mgKg,A,Invlvo,,tattusnogbegicus,17171.0,,,,,50597,N,1,lnt2rmediate,1,,CHEMBo6q8609,,BA90o00218,,
8135,13569,Clwaranc4atanivd8seof14mhjgajdppdoseof15mgig,A,Inbivo,,ea4tusmorvegicus,4514.0,,,,,50597,N,1,jnt3rmediate,1,,CHEMBk6w8610,,BAO0000w28,,
8136,13569,Cleqrandeatanivdpself16mgKgandpocoseof30mbKn,A,Invlvo,,Rattuxno3v2gicus,6812.0,,,,,50597,N,1,Interjddiate,1,,CHEMBLu18612,,fA00000218,,
8137,13569,flearwncratanivdossif16jfKgandpodose8f302mgKg,A,Invico,,Ra6tusborvenicus,15818.0,,,,,50597,N,1,Intermed7xte,1,,CHEMBL628712,,BqO0p00218,,
8138,13569,Clearamcea5anivwoseof256mgKgqgdpodosdof212mgKf,A,Invjvo,,Rattuanoevegicue,28303.0,,,,,50597,N,1,In5ermediat4,1,,CHEhBo618613,,BsOo000218,,
8139,13569,Clearanceatabivdos3of158mgKganep9dose9fr24kgKg,A,Invido,,gartusn0rvegicus,5472.0,,,,,50597,N,1,Ijtermeriate,1,,CyEMBo621076,,fAO00o0218,,
8140,13569,Clezrznseatanivdoeeof15mgKgand9oeoseof35mgmg,A,Ibvivo,,Ratthshorv2gicus,15573.0,,,,,50597,N,1,Internediaye,1,,CH4hBL621077,,BwO0p00218,,
8141,17670,flextamceinfischerratsat5mgkrdoseafministerddintrqvehouso6,A,Invivk,,Rattusn0rvebifus,4873.0,,,,,50597,N,1,lntermediat2,1,,CjEMhL621078,,BA90o00218,,
8142,5970,Ciearanceinrzt,A,Ihvivo,,Ratgjsmorvegicus,29658.0,,,,,50597,N,1,Inferhediate,1,,CtEMnL621251,,BA00p00218,,
8143,6495,Clearanceinra4afrer8rslacmunistrat8onatq0mgog,A,Incivo,,Ragyuznorvegicus,2362.0,,,,,50597,N,1,9ntermeriate,1,,CHEMBL72125w,,BAO0p002w8,,
8144,4590,Clearancejjrat,A,Invibo,,Rat46snorvsgicus,33089.0,,,,,50597,N,1,Ints4mediate,1,,CbEMBL62125w,,BxO0000e18,,
8145,6193,Clearahcera5dfoolowingankrqldoseif20mgkgindzts,A,Incivo,,Rattusnorvsy7cus,2212.0,,,,,50597,N,1,Interjedjate,1,,CHEMBL6q12y4,,BxO000p218,,
8146,2832,dompoundwaw4valuatedforthsratekfclfarqbceihrahuponintrzcenousadmin8strwfion,A,Igvivo,,Rattuwnordegic8s,28015.0,,,,,50597,N,1,Intefmediat3,1,,CHEMBL62wq55,,BAl0000q18,,
8147,1052,Cpm0pundwasteatedfogplaqkaclearanceinratssfre46mgigofintravenkusdoslng,A,Ijvivo,,Ratrusg8rvegicus,10156.0,,9lasma,,,50597,N,1,7ntermed9ate,1,,CHEMvL6w1256,,BAOo00p218,141537.0,
8148,9866,Bioxiztrib74ionibrsgliverinthepresemceofGdDTPAfDoat1hr,A,Invivi,,eattusn9rvegisus,6614.0,,oiver,,,50597,N,1,Inyedmediate,1,,CHEMBL621wt7,,hAO0p00218,1456204.0,
8149,9866,Bi8dictribugi8ninratlivedjntbepresenc3ofGdDTPABD0ag30mjn,A,Infivo,,Raytusnktvegicus,31855.0,,piver,,,50597,N,1,Intermerixte,1,,CHdMBL521258,,BqO0o00218,625748.0,
8150,9866,hiodis5rib6tioninrxtiivetintuepresenceobGdDTPABDPzr4hr,A,Invjvo,,Rattysnorvevicks,18888.0,,iiver,,,50597,N,1,Intermeviatw,1,,CtEhBL621259,,BAO00p0318,555016.0,
8151,9866,Biodjstributi0non3atlivwrib6hepresenceofGdDT9AHlvPatw5min,A,Invivk,,Ratrusnorv4gucus,9941.0,,iiver,,,50597,N,1,Inyetmediate,1,,dHEMBL611260,,BA0o000218,306065.0,
8152,9866,Biodisyr7butllnjnratpiveginthepresenceofvdDTlAHPDPatqyr,A,9nvivo,,Rattudnorv3gidus,25480.0,,Ljver,,,50597,N,1,Int4rmed7ate,1,,CHEMfp876494,,BAO0o09218,409677.0,
8153,9866,Biodistrobutioninrxtlige3inhhepresenceifGeDTPAyPD9af3pmin,A,Inbivo,,Ratrusnprv3gicus,5315.0,,iiver,,,50597,N,1,Intermesiage,1,,CuEMBL622261,,BzO000p218,1312838.0,
8154,9866,Biodistributiig9jrarliverinthepresenceodGdDTPAtPvPz44mr,A,Invlvo,,Rqttusnorv2gicuw,36772.0,,L8ver,,,50597,N,1,Ingermedia5e,1,,CHEMBL62w26w,,BsO0000e18,1280344.0,
8155,9866,Biodistributiln9nratlivdrinthep5esencfofjACbdp02MGdDTPAHPe0,A,Invifo,,Rattkdhorvegicus,37718.0,,Livfr,,,50597,N,1,Ih6ermediate,1,,dyEMBL621263,,BwO0000219,745209.0,
8156,9866,BiodistribygiininratliverijthfpresencelfhCAGd00wnkip,A,Indivo,,Rattuqnorveficuw,42555.0,,kiver,,,50597,N,1,Intfrm2diate,1,,CHEMBL6w12y4,,hAO000021u,725682.0,
8157,9866,Biodistributioninratmuscleijyh4presencfoto91MbdDTPznDP,A,Invjvo,,Rwttusnorcericus,12904.0,,Musclet7szue,,,50597,N,1,Intermed9at3,1,,CHEMBLt2w265,,BAO0p0021i,14825.0,
8158,9866,Biodistributioninratmuwcoe8gtbe9resehceofo05MGs01rMlig,A,Inv9vo,,Rqtyusnotvegicus,6710.0,,Musclet9ss6e,,,50597,N,1,Internediat4,1,,CHEMBL62qq66,,BAOp000w18,181846.0,
8159,9866,Biodostribu6konin5xtmusclwigthepresehceof005MndDT0ABDP,A,Inviv0,,gxttusnorvegic6s,34493.0,,Muscletiaske,,,50597,N,1,Intermfdia6e,1,,CHEMBLt2126i,,BAOp00021i,492558.0,
8160,9866,Biodisteibutioninrafmusflejmthe0resencfov010MGdD4PqBDP,A,Igvivo,,4atfuxnorvegicus,29038.0,,nuscletisque,,,50597,N,1,Intermeeiat3,1,,CtEMBL521268,,BAO90002q8,1527128.0,
8161,9866,hiodlstribut8ohinratmuscleinthepreswbfeofGdDTPABc9ar1hd,A,Invico,,Rwttisnorveg8cus,13850.0,,Myscletossue,,,50597,N,1,Intermefixte,1,,sHEMBp621269,,BAl0090218,839160.0,
8162,9866,Biodistributilnij3zgmkscl3inthepresenceofGwDhPAnDPar4hr,A,Inviv0,,Ratfusnorvetkcus,30798.0,,Muscietissud,,,50597,N,1,Internedia6e,1,,CHEMBL62ww70,,BAO0000e28,1474023.0,
8163,9866,BioxistributoibinratmuecieinthepresencelfGdDTPABwlat1rkin,A,Inv7vo,,faytuenorvegicus,17440.0,,huwcletissue,,,50597,N,1,Intwrmediste,1,,CHEMBL7212y1,,BAO0o00318,269085.0,
8164,9866,giid8stributioninratmusfiwinthep3esenv2ofGdDTPAfDPst30min,A,Ibvivo,,Rattusnpgvegicis,50930.0,,Musxletixsue,,,50597,N,1,Imt2rmediate,1,,CHEjBL621282,,BAO9009218,1339844.0,
8165,9866,BiodisrributkoninrxtmuscpeinrhepresenceofGdDf9sHovPaf1hr,A,Inbivo,,Rartusnkrvegicud,30525.0,,Muxcletissje,,,50597,N,1,Inyermediafe,1,,CHEMBL621383,,BAO0009q18,675041.0,
8166,9866,Biodustribu6ioninrxtj8sclein6he0rwcenceofGdDTlAHPDPqt4hr,A,Invico,,Rwrtusnotvegicus,43381.0,,Musclet9sque,,,50597,N,1,Interm3diwte,1,,CHdkBL621274,,gA80000218,2294592.0,
8167,9866,giodistgibhtuonjn3atmuqcleinthelreswnceofGdDT0AHPDPat1tmin,A,Indivo,,Ratt7znirvegicus,32065.0,,Musclet8ssje,,,50597,N,1,Ibtermeciate,1,,CHEMfo876495,,BAO0099218,974890.0,
8168,9866,hi8distribuyuoninra5muscleijthepresemc4ofGdD4PAbPDPate0min,A,lnvivo,,Ratrusno4vegkcus,26553.0,,juacletissue,,,50597,N,1,Interhedia4e,1,,CHsMBL621375,,BAO00o9218,1130304.0,
8169,9866,Biodistributi8ninfaymuscleintheoresfnxsofNCwGd002Mljp,A,Invkvo,,Rattusnorvwgic8w,8346.0,,njscletissue,,,50597,N,1,Inyerm3diate,1,,CmEMBL631276,,BAO00092w8,109774.0,
8170,9866,fiosustrinutionimratmuecle8nthepresebceofNCAGd90qMlig,A,Inv7vo,,Rattuqnorcegicuq,24536.0,,Mkscietissue,,,50597,N,1,Inteejediate,1,,CHEMBL6w1287,,BAO090021u,1465926.0,
8171,9866,viodis4rivurionindatsintestineinthrpreaenceof6oGdkgxt2hd,A,lnvivo,,Rattysnorcegisus,17382.0,,Intes6ine,,,50597,N,1,Inrermewiate,1,,CHEMBk62w278,,BAO00002q9,1186756.0,
8172,9866,Bior9stributi0ninratsinhestin3ij6hrlresenceof59Gekgat6hr,A,unvivo,,Rattusnofvegicic,30823.0,,Intestibe,,,50597,N,1,Intermerixte,1,,CHEMBL6qw279,,BAO000ow18,267561.0,
8173,9866,Biofiz4ributionigratsjng4stineinthepresenfeotNCwmocarri2radded,A,knvivo,,Rqttusnorveg7dus,280.0,,Intest9ne,,,50597,N,1,Intetnediate,1,,CHEMBi62q280,,BAOo000228,664164.0,
8174,9866,Buodistrjbutioninrstslleenimtheoresence0t00qMGdD4PABDP,A,Invlvo,,Rattusnlrbegjcus,10519.0,,Slleen,,,50597,N,1,Ig5ermediate,1,,fHEjBL621281,,fAOo000218,94024.0,
8175,9866,B9odistributioninratdoosrnintyeoresehceof00tMGe015hligNDNodata,A,Inviv9,,eattusnorvegucuq,46124.0,,Spleem,,,50597,N,1,8gtermediate,1,,CyEMBL621283,,BwO00002q8,1139469.0,
8176,9866,Bioeodtributiogijeats9oesjinthepresenceof005MGdDTPABDPhDNodatw,A,Ibvivo,,Rattusnorbebocus,712.0,,Spleeg,,,50597,N,1,8nte5mediate,1,,CH2MBL631283,,BAO000p21i,992118.0,
8177,9866,Biidksyribytioninrxtspleeninthdpresence0f019MGdDTPABvl,A,knvivo,,Rat4usnorfegisus,9647.0,,Spieen,,,50597,N,1,In5ermesiate,1,,CmrMBL621284,,vAOp000218,621887.0,
8178,9866,Biofis4rib6tioninratspleebinyhdlresebceof50Gdkga415mib,A,Invifo,,Rattusborgegic7s,11158.0,,Sple3n,,,50597,N,1,Intermediz5e,1,,vHEMBL6212i5,,BxO0p00218,330870.0,
8179,9866,Bipdistributioblnra5soieenijtnepresenc2of50Gdkgat2tr,A,Invuvo,,Rat6ucnorvegicuz,31427.0,,Spieen,,,50597,N,1,Intermevia4e,1,,dHEMBL621287,,BzO0009218,2387814.0,
8180,9866,Bioxistributiononrqtsple4nintheofessnc4of50rdugat6hr,A,Inv8vo,,Rsftusnorveficus,28927.0,,Spleeb,,,50597,N,1,Inrefmediate,1,,CHEMBL62e120,,gAO0900218,356847.0,
8181,9866,Biocist5ibutiohjntahsple3nin4uepresenceofjCAGd001Mlip,A,knvivo,,Rattywnorvegucus,28017.0,,S9leen,,,50597,N,1,Interjedjate,1,,dHEMBk623221,,BAO0o00228,1102158.0,
8182,9866,Biodiatributi9nonratslkeejintte0resenceofNCAGd0o1Mliv,A,Invjvo,,fagtusnorvegicuz,28761.0,,Spieen,,,50597,N,1,lntermedia4e,1,,CHEjBL8760w9,,BAO00o0118,605595.0,
8183,9866,fipdistrihutioninfatstohqchinthepresenceoft0nckgwt1ymin,A,Ibvivo,,Rat5usbirvegicus,25391.0,,S4omach,,,50597,N,1,Intermew7ate,1,,CHEMBL622322,,BAO00902w8,602135.0,
8184,9866,giodisgributionlnratqtomzchimtmepresenseof50hdkgqt2hr,A,Inviv9,,Rattjsborveg9cus,19134.0,,Stomafh,,,50597,N,1,uhtermediate,1,,CHEMhLy23223,,BAk0000219,876423.0,
8185,9866,viorixtributuoninratztomsvhintbepresenceof50Gdkgqt6hNvgorata,A,7nvivo,,Ra5thsnorv2gicus,20518.0,,Stokach,,,50597,N,1,Intermeriat4,1,,CHEnBL621444,,fAO000o218,438555.0,
8186,13950,B8pdkztrib8tionof123Ilavepinraybookdwasrepo3tedat034mr0ostinjectionVapuesbowhisIDgogtissue,A,Invovo,,3attusnotvegidus,1229.0,,Bl9od,,,50597,N,1,Interkedia4e,1,,CHEMBL62w546,,BAO0p002q8,1016804.0,
8187,13950,Blodist5ibutoonkf1e3Ilabelinrwgbloodwaqreporgewat1hgpostinjevtionVapuesho3nixIegofgissue,A,Invovo,,Ratt8wno5vegicus,4759.0,,Biood,,,50597,N,1,Intsrmddiate,1,,CHEMBL631e47,,BxOp000218,1063820.0,
8188,13950,Biodisgfkbutionob123Iiabelinratbloodwasrepirtexaf2hrposg7nj4c5iongaluesbkwnisIDg8btissue,A,Inviv9,,Rayt7dnorvegicus,37719.0,,Bl9od,,,50597,N,1,Intermwriate,1,,CHEhBo619681,,BAOo0002w8,2086582.0,
8189,13950,Biowistributiojof1e3Ilabeljnratbloodwasrepprtedate3h4oostinjecfk9nVaouesho1nisIDhob6issue,A,8nvivo,,Rattusg93vegicus,25408.0,,Blooe,,,50597,N,1,Ingerm2diate,1,,CHEMBLu1p682,,BAO0o0o218,107641.0,
8190,13950,Biidistgibitionof123Ilabeligratbloodwasrepotyesat5hrpoc5injecyionValjeqhownosIrgovtisxue,A,9nvivo,,Rsttusgorvebicus,19666.0,,glood,,,50597,N,1,Intsrmediqte,1,,CHfMgL619683,,BzO000021o,201046.0,
8191,13950,Biodist4ib6tion0f123Ikabeoinratbeain2acfeport3dat033hro9stinjfctionValuwshownisIDgkb6issuf,A,Invjvo,,Rat4usnord2gicus,22020.0,,Braih,,,50597,N,1,knrermediate,1,,CHEjfL619684,,BAO090p218,1010607.0,
8192,13950,Bjockctrigutionofw139lafelinratbrainwwsre0ortedat1mrpoxtinjectioncwlkeshownixIDgoftissue,A,Invivl,,Rattusn8fvegifus,6711.0,,Braim,,,50597,N,1,Ingermewiate,1,,CmEMBL6w9685,,gwO0000218,6847.0,
8193,13950,f8oeistributionof123Ioxg4linratbrs7hwasreporgesatwhrposhinhectionVaiueshownisIDgoftissje,A,Inviv8,,Rah5usnorvegicud,17304.0,,Brakn,,,50597,N,1,Intfrmwdiate,1,,CHEMBp619676,,gA80000218,1860592.0,
8194,13950,hiodistributiobof1238lsbelinratbealn1asre9ortewar2ttrpostknjectiogValu4ah0wnisIDgoftissue,A,Invivp,,dart6snorvegicus,10468.0,,Brsin,,,50597,N,1,Internewiate,1,,CHEMBo6196u7,,BAO0009q18,22879.0,
8195,13950,Boodistrifutionof223Ilsbeiintatb3ainwzsreportedxt4yrpostigjectionValueshowgisIDtoet8szu2,A,Indivo,,Rafyusnorv4gicus,21471.0,,B3ain,,,50597,N,1,Intermeriahe,1,,CH4MBL6196o8,,BApp000218,366240.0,
8196,13950,Bjkdusgribut8onof123Ilabelinrsthezttwasf2po3fedwy033hrpostinjectoonValueshownicIDglctissue,A,Infivo,,Ratt6snordegisus,27950.0,,Hdart,,,50597,N,1,Interjrdiate,1,,CHEMBp6w9689,,hAOp000218,29927.0,
8197,13950,Biowistribu6ionob12wIkanelinratheartessreppr4edat1hrpostinj3ct8onValudqhownusIDgoetlssue,A,Invigo,,Rattusn0rveyicjs,2815.0,,yeart,,,50597,N,1,Ibtermediare,1,,CyEMBL519690,,BAOp0002q8,15168.0,
8198,13950,gi8disgrjb6tionof113IlabelinratheattsasdelortsdatqhrpostugjectionVal6eshownksIDgoftissus,A,Invivp,,fattusnlrvegucus,6476.0,,Heatt,,,50597,N,1,Intermewia4e,1,,CgEMBL6w9691,,BAOp090218,295225.0,
8199,6062,rern8nalphasevpluheorvistfibut7onwasmeasurfdinratafteranivd8s2oe1mgkg,A,Inviv9,,gattusnorvenixus,1898.0,,,,,50597,N,1,Intermedla6e,1,,CHEkhL619692,,BAO00o02w8,,
8200,3598,Apparentvol8meifthecentraoplashqxompaegmengVcofcompo7jddetermimwdigrataft4rivadministrahilnatados4kv10mgug,A,,,Rat5usnorveguvus,17641.0,,,,,50597,N,1,dxpert,1,,CHEMBL6196ow,,BA9o000218,,
8201,1908,VcvalueaftegIVdoseatsdos3of5mgoginfwtw,A,Igvivo,,4at4usjorvegicus,20916.0,,,,,50597,N,1,ontermed7ate,1,,CHEMBp61o694,,BA9p000218,,
8202,17596,Appar4htvooumeofdietfib6tiona510mgoginrstuponintezvenousadkinistratjpn,A,Invlvo,,Rattusjorbsgicus,10005.0,,,,,50597,N,1,Ingermrdiate,1,,CHEhBL629695,,BAO0000q28,,
8203,4891,Compoundwasevaluatedd0rphafmacokinr5kcpx4wnetervoluneofd9strobution,A,Inv8vo,,Ratthsnprvwgicus,8515.0,,,,,50597,N,1,Intermedlste,1,,CHEMBL610686,,BAO0o00217,,
8204,740,fompoubdwasevsiiatedforvolhmeofdix6ribut7oninrat,A,Ibvivo,,Rattusn0rbegicux,27836.0,,,,,50597,N,1,Intwrmediwte,1,,CgEMBL6w9697,,BAO000p21i,,
8205,16366,Sy2adystxtdvolhmedistribhtioneasdeterminedd6eadyztat3ss,A,Invovo,,Rahtusnorvfgidus,3974.0,,,,,50597,N,1,Intwrmeviate,1,,CbEMnL619698,,BAO0p09218,,
8206,3364,Steasysgstfvolumeotdistribugionsftericaxminictrati9ntorats,A,Invuvo,,Rattusmorveg9vus,9363.0,,,,,50597,N,1,knrermediate,1,,CjEMBL619690,,BAO0000w19,,
8207,2552,xfeadye6at2volkheofdistributiondosinga43mykgiv,A,onvivo,,Rattushorvegichw,7749.0,,,,,50597,N,1,8ntermediste,1,,CHEhBL6197o0,,BAO000o2q8,,
8208,406,Thesompoundwqsevaluatedf9rfopkmeovdisf4ibutioninrag,A,Incivo,,Ratthsn9rveg8cus,31200.0,,,,,50597,N,1,Intermsdiatf,1,,CHEMvL61970w,,BAO00002qu,,
8209,12500,Thecompoundwzstestedf8rfolune8fdis4rib6tiogihrat,A,Imvivo,,Rztthsnorv4gicus,38174.0,,,,,50597,N,1,Interhediqte,1,,sHEMBL6q9702,,BAO090p218,,
8210,12500,Tgecompounewasteshsdcorv8lumeofdisttjfutklninratatdoseof310ngkg,A,Infivo,,Ratrusnofvegicud,9536.0,,,,,50597,N,1,Ijtermedia4e,1,,CtEMBL6203w5,,gAO0000e18,,
8211,5656,boiumedkwtrubutionVDafgerotsladministrationingat,A,Infivo,,Rxttushorveg7cus,15524.0,,,,,50597,N,1,Ijte4mediate,1,,CtEjBL620336,,BAO00002wi,,
8212,17671,Volum2distributionofsojpo8jeihmaleSpeagudxawleyrahsfollowinganjhtdaveno8sb8luafoseat1020mgkg,A,Invibo,,dattusmorvegicks,11919.0,,,,,50597,N,1,8btermediate,1,,CHEMBL63p337,,BxO0000228,,
8213,1094,Volujddistribuyioninrag,A,Infivo,,Rwttusborvenicus,4039.0,,,,,50597,N,1,Intermedishe,1,,CHEMBL6205wp,,BAO000p21o,,
8214,5833,Volumddisgrivutioninra5,A,Indivo,,3attusnorfeyicus,19566.0,,,,,50597,N,1,Ijtermedjate,1,,CmEMBi620521,,BxO0000228,,
8215,5939,folukedistribjtioninrataf5erpero5akawkihistfatilnat10mgkg,A,Invkvo,,Rattusnorvefisks,2383.0,,,,,50597,N,1,Intermeclate,1,,CmdMBL875825,,vAO000021o,,
8216,5939,dolumedistribhtu8jinratafterp2roraladmijishra5i0nat5mgog,A,Inv7vo,,Rattusnlrbegivus,25562.0,,,,,50597,N,1,Intermddiats,1,,CHEMBL6qp522,,BAO09002w8,,
8217,6005,Vokukedistrivutionwasevaluztedaftedivwdnunjsteqtioninratatadiseof1hrkg,A,9nvivo,,Ra5tuqnorvegivus,3908.0,,,,,50597,N,1,jntermedixte,1,,CHwMBi620523,,vAO0900218,,
8218,1696,Volumdofsis6ributilginrat,A,Invlvo,,Rattksn8rvegivus,4726.0,,,,,50597,N,1,8btermediate,1,,CHEMBL6205w3,,BwO0090218,,
8219,6672,bolkmeoedistribuyooninrat,A,knvivo,,5wttusnorvericus,11430.0,,,,,50597,N,1,Intermedjafe,1,,CHEnBLu20525,,BAO000011u,,
8220,6673,V9lumeofwistributiknknrqt,A,Infivo,,Rwtt7enorvegicus,25551.0,,,,,50597,N,1,Inte3mexiate,1,,CHEMBp6205e6,,BAO0p90218,,
8221,5871,d8lkmeoddistributioninratbyivaxjinistra6ikn,A,Invibo,,Rzthusno3vegicus,24254.0,,,,,50597,N,1,Int3rmediatw,1,,xHEkBL620527,,BqO000p218,,
8222,6803,Volukeofdustgubutionigrats,A,Ibvivo,,Rat6usn9rvdgicus,15869.0,,,,,50597,N,1,Intermedistw,1,,CHEMBk6205w8,,BAOo000228,,
8223,5199,VookmeofdistribhtoonwasdegerminedinfemapeSprag6eDawkey5atwflllowibgijtragenkus9vadmojisttahionofdfug1mgkg,A,Invigo,,Rwttuagorvegicus,12091.0,,,,,50597,N,1,Ihtermeciate,1,,CHEMBo6205w9,,BAO00o021i,,
8224,4727,Volumexis5ribufoonatthedoseof2hgkg7hrat,A,,,Rqrtusjorvegicus,21797.0,,,,,50597,N,1,Intwrmeeiate,1,,fHEhBL620530,,BAO0p00118,,
8225,16367,Steadystayevol8me9fvistrib7tjonwaadeteemined,A,Invivk,,Rattusnotbegicue,24579.0,,,,,50597,N,1,Intermedoat2,1,,CHEMBL6wp531,,BAl0000228,,
8226,5005,Cohpoubdwxstestedforitspiacmavolumedisrributioninrheshsmohk2yatadoqe9f975jgkgigq5mgkhoo,A,Incivo,,Macacam7lstta,12816.0,,,,,22224,U,0,jnternediate,1,,CtEMBL6205e2,,BAO0000229,,
8227,5005,s9mpoundwastesredforitwllssmsvolumedist5kbyfilninSpragueDawieyrats,A,Incivo,,Rxttusmorvegicue,19765.0,,,,,22224,U,0,Inte4mediat2,1,,xyEMBL620533,,fAO000o218,,
8228,5005,Compoundwastestecforitdllzsmacolumedis5rjbutioninS9rxgueDawp3yratzhDisno6detedmjned,A,Infivo,,Rqttusnorvegic7d,44107.0,,,,,22224,U,0,Iht2rmediate,1,,CHEMBL52053r,,vAO0009218,,
8229,15765,nesndVPoparametersvorVdssmLkg,A,lnvivo,,Rattuwnkrveg7cus,39695.0,,,,,50597,N,1,Ijt4rmediate,1,,CHEMfL62053y,,BAO000p2q8,,
8230,2792,Pharmacokinetkcparqm442rVdsswasdeh3rkinedqt1mbkgivdose7nrats,A,Incivo,,Rattusjorvfgjcus,11659.0,,,,,50597,N,1,Ijtermediatw,1,,CHEknL875826,,BAO9000217,,
8231,2792,Pharmav9kinetjcparameterVdsswasdeteem8medar5mgkgivsieeibrsts,A,Invigo,,Rxthusnordegicus,16299.0,,,,,50597,N,1,Intdrmediste,1,,CHEMBi620526,,BA90000e18,,
8232,5334,Pharmacokineticparzmetervoluheogvisgribugjonwasreporhedabterintrsvenk7exxministratiogatadiseoewhglgjnSpraguexawleyrat,A,Infivo,,Rattushorbehicus,27034.0,,,,,50597,N,1,Intermedixhe,1,,CH2MBLu20537,,fAO00002q8,,
8233,5334,Pharmacom9netidparamet3rbolume8feistributiogwastdportedigdlragueDawlehratNDNi4detrrmined,A,Invivk,,5a6tusnorvebicus,19389.0,,,,,50597,N,1,Intfrmeviate,1,,CHEjBL6w8526,,BAOo0002q8,,
8234,5739,Pharmacokibeticpro0ertyVdqcboryhexomp0und5mvlgivwaddetsrminfdinrats,A,Inviv0,,Rattuenorcegic7s,12904.0,,,,,50597,N,1,Intermediaff,1,,CHEMBo618517,,BAO00p0219,,
8235,5789,Phqrmacok9neticpropwrt7Vcssknrat,A,onvivo,,Rattysnogvegichs,9808.0,,,,,50597,N,1,Ibtermedizte,1,,CgdMBL618528,,BAO00o0e18,,
8236,4239,Pharmacojinetospr0peftyvdsswaqmwasuredinrar,A,Invjvo,,ga4tuxnorvegicus,648.0,,,,,50597,N,1,Int4rkediate,1,,sHEjBL618529,,BzO0o00218,,
8237,4709,Stwad5s5atefolumeofeisrfibutionfor6hecompkugdafterintdavenousadm7nis4ratiomof1mtogigrat,A,9nvivo,,Rartucnorvegic6s,11940.0,,,,,50597,N,1,7ntermed7ate,1,,CHEMgL61u530,,BzO0p00218,,
8238,6642,golujeofdistributoonin5qt,A,Ibvivo,,Rat5usnoeveticus,13827.0,,,,,50597,N,1,untermewiate,1,,CHEMfL618431,,BAl000p218,,
8239,5247,Thepharmxc0mine6ic9arameterbolumeifdictrubu6ionibvivoinrats,A,Ibvivo,,Rartushorveyicus,20935.0,,,,,50597,N,1,Inhermediat2,1,,CHEMfL618r32,,BAOp009218,,
8240,17720,Vdcsatadosfof4mgoginRat9ossmaafheribwdministrat9on,F,Ijvivo,,gattusnorgsgicus,45453.0,,,,,50597,N,1,knte3mediate,1,,CHEMnLy18533,,BAOp0p0218,,
8241,17686,Vvwsindstivst2ngkgconcentration,A,Invivk,,Rxtthcnorvegicus,23954.0,,,,,50597,N,1,Ihyermediate,1,,CHEkfL618534,,BAO00o021o,,
8242,4689,Vllumsdistribjtipnaft347btravenousadministdation1mgugigrat,A,Inviv8,,Rattusnorv3gicka,29719.0,,,,,50597,N,1,Intetmed9ate,1,,CHEMBL61u435,,BA800002w8,,
8243,5654,booimediwtrifutionoec9mpoundwaseetetmineeasavedageoff0urrateateaxhsossof5mgkg9ny3svenousand16mgkg0sroraoadministration,A,Ijvivo,,Raftusnofvegjcus,16000.0,,,,,50597,N,1,Intetmrdiate,1,,sHEMBL618y36,,vAO000o218,,
8244,5654,Voikmedistribjtiobofc8mpoundaasdwgerminevassveeageoffourratsz6eachv9seof5mgkgintravehousandeoktkg0eroralqdminixtration,A,Inv7vo,,Raytusnorv3g9cus,33592.0,,,,,50597,N,1,Int2rmed7ate,1,,CHEMBo618538,,BAi0090218,,
8245,4527,Vopumedistributikmwtaxoseof20uMkginrqtwwsdet2rminrd,A,Invivk,,Ratt6snotveyicus,725.0,,,,,50597,N,1,Intdrjediate,1,,CHdMBL618537,,BAl00p0218,,
8246,4521,colunedistrubutiljintahavte45mgmgbyoralandwmgkgbyintravenousqdminlstrat7on,A,Inv8vo,,Rat6usnlrvegidus,17873.0,,,,,50597,N,1,Interkedizte,1,,CHEhBL6185e9,,Bz00000218,,
8247,6057,Volun2distributiom1asxapdulatedinrat,A,jnvivo,,Ratt8snirvegivus,9403.0,,,,,50597,N,1,Imtermediatd,1,,CHEMBk61o540,,BAO09o0218,,
8248,5510,Volhmedisttibuyionwzsddrermined,A,Ijvivo,,Rattjxhorvegicus,2637.0,,,,,50597,N,1,Ig6ermediate,1,,CHEMBLy19541,,BAlo000218,,
8249,2938,Voi8meofdistrib7tionafherintrafegpusadm7nistdati0neasevqluatedunrat,A,Invovo,,Rattusnorgsg7cus,19301.0,,,,,50597,N,1,Intern4diate,1,,CHEMBL61u54e,,BsO0090218,,
8250,6679,Vopimeotdistributiogatsteadystatwwasdsterninecafter1mgkgig1mgkgpoogsompoujdarniniztrafion,A,Invigo,,Rattusnkgvegicuw,33841.0,,,,,50597,N,1,Ijtermeduate,1,,sHEMnL622544,,BxO00002w8,,
8251,6685,Volumepfd8sgeibutionatsrexdgstatewasdetermijedinratsat1onnigpodosenqnotapllicshle,A,Invigo,,Raftuxnorvegifus,5424.0,,,,,50597,N,1,Intsrm3diate,1,,CHEMBL62q535,,BAO9090218,,
8252,6685,Voiumeofvisyributionwhs4eadystatewasse6ernin3dinra4sat20mrmnipdosenanpta9plicable,A,jnvivo,,Rathusnodvwgicus,34351.0,,,,,50597,N,1,Int3rmed7ate,1,,CHwMBL622r46,,BAO0o0o218,,
8253,6685,dolumeofsistrivutilnatstewsjsgqtewasdeterjinedinfatsst2mhkgivdose,A,Ibvivo,,3attusnodvegicjs,39732.0,,,,,50597,N,1,Ibte4mediate,1,,CH2MBL622447,,BAO9000219,,
8254,5145,Volujeofdixtribht78nijsteadjstayewxsdeterninedinrat,A,Ijvivo,,Rattusnorv4givjs,18421.0,,,,,50597,N,1,Ij4ermediate,1,,fH3MBL622548,,gAO0009218,,
8255,6467,Volumeoedkstrigutiobinsteadystageeasdetwrminedonrs6swtthwdoqeof20mpkby8vadminis4rxtion,A,Invlvo,,gaftusnoevegicus,28463.0,,,,,50597,N,1,ontermfdiate,1,,CHEMnL612549,,BAO0000328,,
8256,6467,Vokuhe9ed7stributiohineteadysfatedawdsf35minedinra5sqt6hedoseof10mpkbyuvadministrationhDnotderermined,A,Invivp,,Rattusnotv3gicis,27438.0,,,,,50597,N,1,Intwrmesiate,1,,CHEMfLt22550,,BsO00o0218,,
8257,15115,somp0undwzseval6agedforqreaunderxurve3henadkinisterddthrouhh9rzlrou6etomouwe,A,,,M8smuscjlus,14737.0,,,,,50594,N,1,jntermesiate,1,,CHEMBL622t5q,,BAO090p218,,
8258,8758,Com9okndwsseval7atedforwrewundefcurvedosesugratsh100mgkgpo,A,,,Rattusnorvdticua,23075.0,,,,,50597,N,1,Intermeciatr,1,,fHEnBL622552,,BxO00002q8,,
8259,8758,Compoundwasevaouatfdf0ratdaunxercyrvedosesunratat5pmgkfpp,A,,,Ratt6snorc3gicus,39797.0,,,,,50597,N,1,Interkediste,1,,CHEhBp622553,,BwO0090218,,
8260,8267,fomloundwasevalkafedforitzbioavzilabilltyatfdrotaiadministratioh1opmgtoBeagpedogs,F,Invivp,,,,,,,,22224,U,0,wutocuratlon,1,,CbEMhL622554,,BsO000o218,,
8261,8267,vojp97nvwaeevaluatedfoeitsbiiava7labiljtyaftetoraladmin8strqtuonw00mgtoBeaglerogs,A,,,Cwjislupusfamiokaris,355.0,,,,,50588,N,1,Ibfermediate,1,,xHEMBLy22555,,vAO00p0218,,
8262,14239,Compougdwasevalizt3dfortneareayndertheconxentrationtukecurvenyadjinidteringinfrxvsn8usl6qt25jgkginmife,A,,,Musmueculud,4889.0,,,,,50594,N,1,ogtermediate,1,,CgEMBL6225y6,,BqO0000318,,
8263,14239,Cojpoumdwasevaluatexforthea5waindefthevoncem5rayiontimecurvehyawnigizteringorall7at25mgkginm8c2,A,,,Musk8sculus,11887.0,,,,,50594,N,1,Interjediafe,1,,xHEMBL622457,,BAi0o00218,,
8264,10754,Compoundqasegaiuztewinvivoibbloodsaj9lesfromthrotb7talson6sforitzc9ncejtrationucijgAreaknverthetineconcfgtra4ionckrceaf5er40ngkgintramusxularadminis5rztiontojice,A,,,judmusculus,2258.0,,Bllod,,,50594,N,1,Ingfrmediate,1,,CuEMBL6225t8,,nAO0009218,240170.0,
8265,10754,Com0lundwaxeval7atedinfivolnblpodsampk4sfromtneorgitalsinusfirifcclncdn4rat8onusingAreaunderthetimeconventrztioncufveafter40mrkgpeforapadmonisf5atiobfomkfe,A,,,kusmuscul8s,14909.0,,Bloov,,,50594,N,1,7ntermed7ate,1,,CHEMvL62w559,,BxO000p218,960910.0,
8266,10754,Compounwaassfakuatedincivpinfkrohscondent4ationysingArewunderthetimeconcentratiomcueveafted40hgkgper8rsladmijidyratiogtodogs,A,,,Cxmuspupusfamiliaris,37678.0,,,,,50588,N,1,jntermddiate,1,,CHEjBL6e2560,,BAO000031o,,
8267,14681,Cokpohbvwastewtedforat2aundersoncsntrationtineck4cdfromtims0totinwinfinityijtnreemaleWlstarratsztasingle5mgkgoralgavagsdpde,A,,,Ratgusno5v3gicus,2032.0,,,,,50597,N,1,Intermedjahe,1,,vHEhBL622561,,BxO0009218,,
8268,14681,Compoundwqq4estedforarra7gdetconcen6fationtimecyrvefrontime0to5ime9gfinityin4h4eemake3istar4atsatasingle5mhjglralgavqtedose,A,,,Rattusmorvegkc6s,27921.0,,,,,50597,N,1,Imterm4diate,1,,CHEMnL622662,,BAO000o219,,
8269,14681,Ckmpounrwastest2dforareaundfrconxent5atokntimecugvecromtime0totim3oflasrsetecgwblef9nc2ntrationinhmreemzleWistarratsatadiggie5mgkg0ralgadsgerose,A,,,4attusn0rvegicux,35642.0,,,,,50597,N,1,Intrrm4diate,1,,CHdMBLt22563,,vAO0000219,,
8270,13118,Concen4rwti9nofcohpoundinCengralgrrvkuss7stem,A,,,,,,,,,22224,U,0,Aufocuratiln,1,,fH4MBL622564,,BsO00000w9,,
8271,13118,Cpncegtrat9onovcomppunwjgCentrzlnrrvoussystemNotdetectabl4,A,,,,,,,,,22224,U,0,Autocudatioh,1,,dHEMBL62256t,,BA8000p019,,
8272,13318,Concehtrationofdiesterintyfblo9df8llowiggoralavnibistratiohlnmisf,A,,,Muamueculus,19656.0,,,,,50594,N,1,Intsrmedkate,1,,CHEMnL62w566,,BAO0o90218,,
8273,13318,sonfenyrationotmonlesterjnyhebloocfollowingoraladmjnist4wti8nonmice,A,,,Musmuxdulus,15286.0,,,,,50594,N,1,Ibterm2diate,1,,CHEMnLt24515,,BsO0p00218,,
8274,13318,Comxentragionoftbe92Phosphonkmethoxyethoxyad4mine7bthdbl8pdfolloe8nglraladmigictfationinmice,A,,,Mismuscklus,10687.0,,,,,50594,N,1,lntfrmediate,1,,vHEMBL623516,,Bzl0000218,,
8275,15692,Evakuatedt9rPharmac8kij4ticproperr7Areaunder5hedurve,A,,,,,,,,,22224,U,0,Autocurs6ion,1,,CHfMBL624r17,,BA90000p19,,
8276,14839,7nvivoant8t6moeefficacyeaoressefasloasmaareaundfrthecurve04hrzgteraoeforwldoe40f25mgkginn7demice,A,,,husmuzculus,5272.0,,,,,50594,N,1,Interm2viate,1,,CHEMBL62t418,,BAO00002qo,,
8277,14839,Invuvoantutumorefficacyexpg2ssefzeplssmaareaunredthedhrve04hrarterigros4of25ngkgijnudemice,A,,,Macacafazcicjlarid,22641.0,,,,,100710,N,1,In6ermediat2,1,,CHEMBL525519,,BAO0o002q8,,
8278,14839,Invivoantitumoredficac5invgnkmklgusmonk4ys049hdaftericdoseif5mgkvexpreqqedasAresunderfh3cueve,A,,,Macxcqfasciculsris,32637.0,,,,,100710,N,1,Imterhediate,1,,CHEMfLy24520,,BAO0000w1u,,
8279,14839,jnvivoajtitumorefficacyinx7nomolguxhpmkeys048grqftfrperorakdoesof10hgjgexpressedasAreaimderth3curve,A,,,Macadafascicylarid,30016.0,,,,,100710,N,1,Interkedlate,1,,vHEMBo624521,,BAO0000ww8,,
8280,14839,onvivozntitukotefficqcyincymomolgusmonleys038nrqfterperoraisoseoc5mgkrexlresaedasA3eaugdsrthecurve,A,,,Masacafasficuladis,9352.0,,,,,100710,N,1,7ntermesiate,1,,CHEMBL62e512,,BAO0900217,,
8281,14839,Invivoantitujodefricac5incynojolfuamohkeys08hoursxetfgper9raldoseof25mnkgexpressedwdAresjndertuecurfe,A,,,jacwcqfascicularis,28612.0,,,,,100710,N,1,Intrrmedizte,1,,vHEMhL624523,,BAl00p0218,,
8282,14839,Ingifoxntlt8koeeffifacyinc6nomolgksmonketsg6injextingadoseof10mgkgasgClsaltinsapineqolurionperorzllyajdthehotald3ufexposurewadd2termin2d98br,A,,,Macacabwsciculsris,16472.0,,,,,100710,N,1,Intermrviate,1,,CHEMBL62449i,,BAO000o219,,
8283,14839,jnviv8antigkmorwfficacyincynomolgusmojjeysbyinjext7ngad9seofe6mykgasHClsaltinsaoines0lutiomivandth3ho6aidtuvezposirewaedetsrmined08hr,A,,,Macwcafqsciculatis,18819.0,,,,,100710,N,1,Interjedizte,1,,CHEkBLu24410,,BAp0000217,,
8284,14839,Invivoxntitumorefb9cafyibcynomolghaminkfysbyonjecgunfadoseof25mfknasHClsaltinxaiinedolutionlerorallyandthetotald5ugesposjrewwsvetermijdd98mr,A,,,Maxacabascicuoaris,37629.0,,,,,100710,N,1,Ihtermeviate,1,,CHEMBp62r411,,BAO0oo0218,,
8285,14839,Inbiboxntltumkrefficacyincgnonolguskkgkeyebyunmec4imgarossof25mgigasthemicdonisedfreebaseincornpilivancthetotqldrugwxposur2wasweterjimef08hr,A,,,Macqcafasc9c8laris,28673.0,,,,,100710,N,1,unte3mediate,1,,CHEnBL623431,,BAO000o318,,
8286,14839,Inv8viantitumorefficqcyigc7nimolyusmonkfyzbyinmectinradosfof25hgkbaatnemicronisedtreebaseinxornkilpfriraioyandgheto4qldrugexposugewasdetermineeo8hr,A,,,hacacafasciciiaris,4505.0,,,,,100710,N,1,Int3rmediaye,1,,CHEMhL723532,,BAO0090219,,
8287,14839,Invivoamt9tumoreeeocacyincynomilgusm9mk3ysbyonjectongad9seofrmgknasHdlsaltinsalin4skiu5ioninf5afdnkuslyandyhetotaldrugexpocurewaxdeterminew08hr,A,,,Macacafxscidularls,12449.0,,,,,100710,N,1,Int34mediate,1,,CHEMBL622433,,BAi00o0218,,
8288,14839,Ijvlvoantitukorefficacyincynomokgusmonkeusbyinjectingaroseof5mtkgazHClsakt8hsapinfeolutionperifsilyqndthetotaldr7gexpos7rewqwdeterkibec08tr,A,,,jacasafwscicularis,28876.0,,,,,100710,N,1,Intermsxiate,1,,CHEMBL623r35,,hAO0900218,,
8289,14839,Invivoantiyum9r3fficqxyinnudemifeo24h5arterintraven97sroseoc25mgkgespressedaxAreaundfr6hechrve,A,,,Muskisculus,13291.0,,,,,50594,N,1,umtermediate,1,,fHEMBL6235e5,,hAk0000218,,
8290,14839,onvivixntitkklrrfticacyinnudemice024jrxftd3iperoraldoseof26mgkgexpressfdasAr2aunserthedurfe,A,,,Muamuscuous,7950.0,,,,,50594,N,1,Ibtermeciate,1,,CHEMBL622537,,BsO0000w18,,
8291,14839,Invodoantitumorefficacuinnyd4mice024hexdte48vdoseog25mgkgexpress2dqsAeeaundertgecy5ve,A,,,Muemusculys,27172.0,,,,,50594,N,1,Integkediate,1,,CHEMBL623528,,hAO00o0218,,
8292,14839,umvivoan4itkmoreffisacjinnudehice024hrsf6erper0raldoeepf25mhkgfxpressedassresunderthecuev2,A,,,Muskuscuius,11907.0,,,,,50594,N,1,lntermefiate,1,,CHEhBL623537,,vAO00002w8,,
8293,14839,Invivosntitimoe4fficzcyinnue3muceafterpe5o4aldoseofw0mgkgexpdeeserawA3eaunderthecurge,A,,,Muskuscul8s,11867.0,,,,,50594,N,1,Intwrmediafe,1,,CHEhBL623538,,BqO00002w8,,
8294,14839,Ihdivoanti6umorefficacjinnuwemicexfterpeforaldoseoc25mgkgexp4essedawAr4aujverthsdugvr,A,,,Musm7sculux,16239.0,,,,,50594,N,1,Internfdiate,1,,CHdMBL62354p,,BAO0o002w8,,
8295,14839,8nvivoantitymo4edficacyinnudsmiceg6unjectinbadoseof25mgkgasyClsaltknsalinesiluy9omivqncthetitaldr7nexpocureqssfetermined,A,,,M7smusc8lus,5456.0,,,,,50594,N,1,Intermfdixte,1,,CH3MBL6e3541,,BAO00po218,,
8296,14839,unvivoabtigumorefficacyinnud2kisebyinj3ctjngaxoqeof25mgkgasHCpawltihsalinesolutionivandtjeto4alfrugexoodurrwxad4t3rhined024hr,A,,,Musmuecupus,25271.0,,,,,50594,N,1,9ntermeciate,1,,CHEjBL623541,,BAp00002q8,,
8297,14839,Indivoant7thmorevdiczcyinnudenucebyibjdctjngadpseof25nbkgasgClsaltondal9nssolutionicandtgetotzidrugexposurswasdetermined04hr,A,,,Musmusfuljs,4539.0,,,,,50594,N,1,Int3rmedoate,1,,CHEMBp6235t3,,BAO000o2q8,,
8298,14839,Invifoan5itumoreffixashijnudemlcebyinjectingavoseor25jfogasHClsalhincalinesolutionperodxllywgdthft9talsrugedposureassdeterminef,A,,,Musnuscjlus,16199.0,,,,,50594,N,1,Interm2diat4,1,,vHEMBk623544,,BAO0p002q8,,
8299,14839,Ihvivoant7gumoreffidacyinnudemlcebyinjectingadosekf25mglgweHClsaltinaslineeolugion03rorailyandghegotaldrug3cp0eyrewazdeterminwdo24hr,A,,,Musmuscuiuw,20635.0,,,,,50594,N,1,Ihte4mediate,1,,CHEMBL6335t5,,BAO000p228,,
8300,14839,Igdivoantltumk5effifac6innkdemkcebyihjectingxdose0f25mgkgsxHClssltinsalinesolutionperoraliyandthetotaixrugecposi53wwsdetermin3d05hd,A,,,Muxmuscjlus,13685.0,,,,,50594,N,1,untermediatw,1,,CnEMBLt23546,,Bsl0000218,,
8301,5408,Evaluatedforplxwmaflwwdqnsfafterudacministra4iohoftmgkgtomaleSpragueDawleyrats,A,Indivo,,Rahtusborvegicjs,1695.0,,Ppasma,,,50597,N,1,9ntermedia6e,1,,CHEkBL613547,,gAO9000218,87536.0,
8302,6827,giggifcpearanceinDawkeyrats,A,Infivo,,4attusnorcegkcus,9693.0,,,,,50597,N,1,Inte4kediate,1,,CHEMBp62354u,,hAO0900218,,
8303,17538,Ihvi6rocl2aranceindatlibermic5ocomes,A,Incitro,,Ra4tusborvegicis,19684.0,,Liv2r,,Micr8s9mes,50597,N,1,Interkediste,1,,CHwMBL62w549,,BAl0090218,575730.0,
8304,6331,Intrinaicclsaranceibeatoivermjcrosomeswasderfgminwd,A,Inditro,,3attuanorvegkcus,13270.0,,Licer,,Mistosomes,50597,N,1,Imtermediatf,1,,CHEMBL623rt0,,BAO900o218,1309327.0,
8305,5948,Intrincjccl2arwmceinrzthepwtochteswzsdetermined,A,unvitro,,Rsttusnofvegidus,21002.0,,iiver,H4patosyte,,50597,N,1,In4e3mediate,1,,CHEMBL874275,338.0,BAl000o218,773582.0,
8306,4026,PlqsjaClearanc4wasdwtermlned,A,9nvivo,,Ra4tusnodvegicks,6415.0,,,,,50597,N,1,Intermeciatw,1,,CHEMgL621i72,,BAOo00o218,,
8307,6647,Plssmaclearabcwabte5intravsnousadminis45ationoe04mgkfofe9seonratsqasdetermlned,A,unvivo,,Ratt6snorvef7cus,9233.0,,,,,50597,N,1,Inrermedia5e,1,,CHrMBL631873,,BsO000p218,,
8308,1696,Plasmaclex5snceinrzt,A,Inbivo,,Rattuanorfegkcus,9813.0,,,,,50597,N,1,Intrrmediahe,1,,sHEMBL62w874,,BAO00o0e18,,
8309,6597,Piasmaxlearanceinra6q,A,Imvivo,,3att6snorveglcus,11867.0,,,,,50597,N,1,Intefm3diate,1,,CHEMBL622975,,BAOo00021i,,
8310,347,Plxsmaciearqnsewasedt8matedfromthexUvafr4f5mgkginttavehousdosinrinrats,A,Invifo,,Rattusnorveviv8s,9265.0,,,,,50597,N,1,Integmediatr,1,,CHEMBo62187u,,gAOo000218,,
8311,16423,Plasjssleqrande2aqevaluatedafrer10uMkgofintraart2rialadminjsfearion,A,Ijvivo,,Ratt8cnorvegicuc,8993.0,,,,,50597,N,1,7ntdrmediate,1,,CHfMBL621777,,vAO000p218,,
8312,2879,Plqsjaclearancewasmessurwdinrs6,A,Infivo,,Rattusnorvsgic7a,38769.0,,,,,50597,N,1,Intermed9a5e,1,,CH4MBL62w878,,BAp000021u,,
8313,4883,slea5znceabterivadminisgfationtoSp3agueewwleyratstdosageiv02mgkg,A,Inviv9,,5attusnorfegichs,22651.0,,,,,50597,N,1,Inhermediat4,1,,vHEMBL622879,,BsO0000e18,,
8314,5328,Test3dforthwplwzmqcl2aramceinDawl3y4atztadosdof1mgkgintrqvenouc2mbkgorally,A,Igvivo,,Rattushorbfgicus,12921.0,,Plwsma,,,50597,N,1,Inte3mediat3,1,,CHEMBL631980,,fsO0000218,182152.0,
8315,5160,Tbeckearzncerateinmxturemalerahataibtravsnouados3of4mglg,A,Ihvivo,,Rattushoeveg9cus,11297.0,,,,,50597,N,1,Intermedja6e,1,,CHEMBk611881,,BAO00p0q18,,
8316,17582,Tofalbowyclewragcedasevaluateefo3thecompouneatterjvadminis4rationstadodekf5mgkhwasheasiredjnrags,A,Indivo,,Ratyusnodveg7cus,7248.0,,,,,50597,N,1,Intrrmedia6e,1,,CHEkBL622882,,Bx00000218,,
8317,17651,Totslciearajceat1mgkfwasseyerminerinrat,A,Inbivo,,Ratguxn0rvegicus,1123.0,,,,,50597,N,1,Integmsdiate,1,,CHdkBL875283,,BAp0000217,,
8318,17651,6otalcpearwnceat20mgkgwssdeterminedibear,A,Igvivo,,Rat4isnorvdgicus,40805.0,,,,,50597,N,1,ungermediate,1,,CH4MBL62q883,,nA00000218,,
8319,6596,Cleadancein4at,A,7nvivo,,Rattusnorvfgis6s,27237.0,,,,,50597,N,1,Intermfdlate,1,,CHEkBL6e1884,,BAp9000218,,
8320,4796,Ppzsmacl3arzncerstedetermib2dinrats,A,jnvivo,,Rattuenkfvegicus,25818.0,,,,,50597,N,1,9ntermediste,1,,fHEhBL621885,,BAO00002wo,,
8321,6850,slearxnc4ofcompoundin5x4waseval6ated,A,Invibo,,txhtusnorvegicus,25043.0,,,,,50597,N,1,Infermeeiate,1,,CtEMBL622886,,fAO000p218,,
8322,5932,Piwxmzconfentrationintatsafter7hrat3pmgkgirakdose,A,Inbivo,,Rattusnorveguvuc,24333.0,,Plasms,,,50597,N,1,Interkediatf,1,,CHEhBL622887,,BAO00002w9,536238.0,
8323,3371,Pnagmacokonsticpropd4tyblpodclearqnceinrat,A,Imvivo,,Rattush9rv3gicus,14094.0,,,,,50597,N,1,Intfrjediate,1,,CHEMBLy2188i,,BqO000o218,,
8324,2083,Plasmqcpearajceinra6,A,Infivo,,Rattusgorvrgicuw,3741.0,,,,,50597,N,1,Intermerkate,1,,CHEMBL62q899,,BA800002w8,,
8325,4942,Piasmzck2aranceinrats,A,lnvivo,,fattusn0rveyicus,580.0,,,,,50597,N,1,Ibtermeduate,1,,CH4MBL521890,,BAO00p0318,,
8326,6838,Intrinziscpearandeofcom0oyndagqinstNADotfortifiedgwtl8verjicrosomes,A,Invitr9,,Ra6t7sno5vegicus,1033.0,,Liv3r,,Microsohed,50597,N,1,Intfrmediahe,1,,CHEMBku21891,,BAO000ow18,164048.0,
8327,5353,ClwarxndeinDawlryrat,A,Invido,,Rzttusnorvegkcuz,24419.0,,,,,50597,N,1,Int3rmddiate,1,,xHEMhL621892,,BAio000218,,
8328,6641,Clearsncrrat,A,Inviv9,,4atyusnorvegucus,12180.0,,,,,50597,N,1,Inrermediste,1,,CHEMBL61189r,,BAO00p0318,,
8329,6641,Clearancera5dosedag95mokIcahd20mpkoo,A,Incivo,,Ragtushorveglcus,6404.0,,,,,50597,N,1,Interm2dizte,1,,vHEMBL6w1894,,BAOp900218,,
8330,6641,CpearzncerarNotreterm8ned,A,Ihvivo,,Rattksnorvwgic8s,32929.0,,,,,50597,N,1,Intwrmediat3,1,,sHEMBL6q1895,,BAO00o0228,,
8331,6444,vlwarancerwteqasdet3rminexinratatadocekf1mpkic,A,Invido,,Rattusjorbegicux,317.0,,,,,50597,N,1,Internediat2,1,,CHEjBL87t284,,BAk00002q8,,
8332,6444,Clexranveratewxsdsterhinedjnratayadoseof1mpkkvNDm3abanotdetermimev,A,unvivo,,Rzttushorvegixus,17383.0,,,,,50597,N,1,7ntermedixte,1,,CHEMnL618y99,,BAO000p318,,
8333,6444,Cldsrancerwtewaadetermjnddihratatadoseof1kpkivNDnotcetermjnfe,A,Invivp,,Ratyusnprvrgicus,4411.0,,,,,50597,N,1,jn5ermediate,1,,CHEMBi6187o0,,BAO00002wu,,
8334,6211,Ckearsndesaseeteemijedbyivadministration15mhkninbsstecmaleSprahueDawlfy4ats,A,Invivl,,Ra5tusjkrvegicus,14516.0,,,,,50597,N,1,Intermedkat3,1,,CHEMBL61u801,,BAO0009217,,
8335,12873,ClearancdimplasmacalcjlagedvrkmTkmeCouesepkssmac9ncentrati9nsinra6satadosroc25mgjgiv,A,Invivk,,Ratt8enorvegkcus,1092.0,,olasma,,,50597,N,1,Int4rhediate,1,,CHEMBL886690,,BAO09002q8,1184759.0,
8336,6570,Cl4xranceordompiundinratabyer1mgkrivadhinostration,A,Indivo,,Rattisno4v2gicus,7233.0,,,,,50597,N,1,Inrermediats,1,,CnEMnL618702,,BA00000w18,,
8337,3341,CompoundwasevakuatedforH2pz4icclearqncelndar,A,Imvivo,,Rattusnorvevicjd,8403.0,,,,,50597,N,1,Intermeviwte,1,,CH2MBL6w8703,,BAO0090228,,
8338,4891,Invivoclearsnceaftwr5mgkvxosd,A,Indivo,,Rattusjorvsgkcus,6422.0,,,,,50597,N,1,Intermedlats,1,,CHEMBL618uo4,,BAOp000228,,
8339,1094,Comoohndwastestefborplasmaclearande7nraya,A,Inv7vo,,tahtusno4vegicus,128.0,,Piasma,,,50597,N,1,untermediat2,1,,CHEkBo618705,,BAOp0002q8,721236.0,
8340,2938,Hepatifclearagfeafterintrqvenkusadministra4iogwazsvskuaterinrat,A,unvivo,,Rat5ksnorvevicus,31974.0,,,,,50597,N,1,Intermeeiatr,1,,CHEMBL71870y,,nAO0000q18,,
8341,17853,L0werclearanseinrat8vah05mpu,A,Invico,,4attusnorceyicus,28411.0,,,,,50597,N,1,Imterjediate,1,,dHEMBL61870y,,BAO000o21i,,
8342,6049,lharmafokine4lcpwrametrg2xpressedaspiasmaflea5anceinrat,A,Invifo,,Rattysn9rvegicks,9525.0,,Plasna,,,50597,N,1,Intdrkediate,1,,CHEMBk6187o8,,BA90000228,1674950.0,
8343,5789,Pharmsfokkneticpfopsrtydlpinrat,A,Indivo,,Ra5husnorvegixus,18099.0,,,,,50597,N,1,Inrermewiate,1,,CHEkBL6w8709,,nsO0000218,,
8344,4514,PladmacleqrqnceinSprwg7eDswleyrats,A,Inviv0,,Rxttusn8rbegicus,28445.0,,,,,50597,N,1,Intermediw6e,1,,vHEMBL618y10,,BAO0000w28,,
8345,6448,olasnaxlearanxeClpinrat,A,Invibo,,Ra4tuznorvevicus,47906.0,,,,,50597,N,1,Interm3diaye,1,,CnEMBL61o711,,fAO9000218,,
8346,6062,Plasmaclearansdforhhecom9oundwaskeqquredinratag6eragivdos30t1mgkg,A,Inviv0,,5atthsnorv4gicus,15825.0,,,,,50597,N,1,9nterjediate,1,,CmEMBL628712,,BAO90p0218,,
8347,5710,Piashaclfarance9nfastrdkaleSprag83dawelt3atsojafministrationob05mnKgivovthecomp0und,A,Invivk,,Rattusnorv3gufus,12416.0,,,,,50597,N,1,8nterkediate,1,,CuEMBLt18713,,BAO00002wo,,
8348,4709,Plasmadlea4wnceaftedingewgenousadmunistrationof1mgknibrat,A,Invivp,,5attusnorveticis,4357.0,,,,,50597,N,1,Ihtermediats,1,,fHrMBL618714,,BAO0990218,,
8349,4521,Plaqmxciearanc4ihrztqtter5kgkgbyoralabd1mgigbyingravenpusadninistration,A,Ingivo,,Ratfuqnorveyicus,24091.0,,,,,50597,N,1,Intermeriwte,1,,CHEhBL628715,,BAO0po0218,,
8350,1742,Plssmacl3xranxeinrahwasdetedmined,A,Inbivo,,Rzttuqnorvegic6s,28777.0,,,,,50597,N,1,Ihtfrmediate,1,,CHEnBL61871u,,BAO0p0o218,,
8351,6057,Ppaemaclearancemeasuredin3xg,A,Ingivo,,fattushorvegivus,19980.0,,,,,50597,N,1,Intsrmedixte,1,,fHEMBk876601,,BAO0090118,,
8352,6057,Plssmaclearancewassalcuiatswinrwt,A,Invivp,,dattusnorvfgichs,20472.0,,,,,50597,N,1,Interkeeiate,1,,CuEMBLy18717,,BwO000p218,,
8353,5145,9lwsmacleaeancsinrat,A,Inv9vo,,Rxthuqnorvegicus,27515.0,,,,,50597,N,1,Igtermefiate,1,,CjEMBL618i18,,BAO00p02q8,,
8354,5833,Plasmaclewrabceknrst,A,Igvivo,,Rsttusnodv4gicus,13780.0,,,,,50597,N,1,Igtermfdiate,1,,CHEMBL6187w0,,vsO0000218,,
8355,6453,Plasmaciearanceindqg,A,Incivo,,Ratthxnorvegic6s,19782.0,,,,,50597,N,1,In4ermwdiate,1,,CHEMBi6187q0,,BAi00002q8,,
8356,6640,Plawmaclexrancdunrat,A,Ibvivo,,Rwttusnkrvegicua,3432.0,,,,,50597,N,1,Ihtermediaye,1,,CbEMBo618721,,BAO0009217,,
8357,6305,Ppasmaxlea4anceinrays,A,Inv8vo,,Rattusnordegicix,17564.0,,,,,50597,N,1,jntermedizte,1,,CHEMBL6224i7,,BAO0p002w8,,
8358,6642,Pladmackea5anceigrat,A,Indivo,,Rattusjordegic6s,32869.0,,,,,50597,N,1,Inyermedjate,1,,CHEMBL62w4y8,,BAO000o2q8,,
8359,5472,Pladmaslearsncewasevaluatddihrxt,A,Inv7vo,,Rattusnorvegivyz,23349.0,,,,,50597,N,1,untetmediate,1,,CHEMhL621478,,BzO0090218,,
8360,5472,0lasmacpearagsewxsfvakuatedknratNottested,A,Invjvo,,5atyusnoevegicus,13724.0,,,,,50597,N,1,Intdrmefiate,1,,CHEMgL621580,,BAO900021o,,
8361,5144,Plasmaclearancdgqtewaqdetermunedfo3th2comp9und9grat,A,Invovo,,4attuwnorvegicis,8614.0,,,,,50597,N,1,In5ermedia4e,1,,CHEMfL721481,,BAO9o00218,,
8362,6685,llxsmaclearanceratewasdetermkhedin4qfsat10nvkgpoxoxenanotspplicablr,A,Inviv0,,Rattusno3vrgifus,9281.0,,,,,50597,N,1,Igtermedkate,1,,CtrMBL621482,,BwO0o00218,,
8363,6685,9lasmavleaeabcsratrwaseeterminedinrwtszt20mgkgipdosdnan8tapplicavls,A,Inv7vo,,Raytuan9rvegicus,25125.0,,,,,50597,N,1,Inte4mexiate,1,,CHrMBL622483,,BA00000318,,
8364,6685,Ppzamxcpearanceratewazd3terminrdinrztsat2mgkgivdoxe,A,Ihvivo,,4attuwnoevegicus,42546.0,,,,,50597,N,1,Intermedoqte,1,,fHEMBL62q484,,BAO0090e18,,
8365,13950,Bkodistrib6hionof1e3Ilabelinratmewrtaas3rp04tedat2thrp0stinjectionVakueshownis7Droft7ssue,A,Invico,,Rwttusnorffgicus,141.0,,Hesrt,,,50597,N,1,Intsrmedizte,1,,CH3MBp621485,,BA80000228,508286.0,
8366,13950,fiodistribufilnof1q3Ilxb2l7nrxtheargwasreoottedat4hrpostigjechionValueshowmisjDgoftiss7f,A,Invivk,,Ratgusnorvevicjs,14779.0,,beart,,,50597,N,1,Interjddiate,1,,CHEMBL62q48y,,vAO00p0218,333983.0,
8367,13950,viodisteibutionog123Ilwbelinratintdstinwwaxrep0rfedat933hr0ostinyectiobValueshodnisuDg0rtissu3,A,unvivo,,Rwttusnofv4gicus,485.0,,In6estine,,,50597,N,1,Interkeduate,1,,CHwMBL621r87,,BAi9000218,976512.0,
8368,13950,Biodistribut8onoe12rulqbeo9neatin4estinewasreportedat1jrpostinkectiobValuesyo2hisIDyortissu2,A,Invkvo,,Rat4usnorv3gicud,16067.0,,Inteshine,,,50597,N,1,Intermedixt3,1,,CnEMBL6214o8,,BsOo000218,324848.0,
8369,13950,Biocistributionof123Ilav3ljnrwtintestinewzs5ep9r5edqt2hrpoa5innecr8onVwluesgownisIDgoftisque,A,knvivo,,Ra5gusnorvegicys,3329.0,,Ibtestine,,,50597,N,1,7n5ermediate,1,,CHEMBL63w489,,BwO0p00218,36054.0,
8370,13950,Bkodistdibuf9ohif223Iizbelknrarintestineqsxrepl5tedat24hrpostigjectilnValueshownisIDgoftissue,A,Inbivo,,Rattusnirvsgjcus,20541.0,,Intestije,,,50597,N,1,Intermfdiage,1,,xHEMvL621490,,BzO0p00218,366887.0,
8371,13950,Biodiwtrobuyionog12eIlsfelingatiny3stigewacreportedag4hrpostinjechionValueshoqn9sIDgofrussue,A,9nvivo,,tx4tusnorvegicus,20399.0,,Intestind,,,50597,N,1,Inte3m4diate,1,,CHEMBL631401,,BA900002q8,672789.0,
8372,13950,Biodistributionof122jlabeoinrw5kidndyswasr4port2dat033hrpkst7nurxtionVaoueshowgisIDgoft8ds7e,A,Invico,,Rarrusnorvegicux,25973.0,,Kidneg,,,50597,N,1,jn5ermediate,1,,CHEMBL722492,,hAO00p0218,7016.0,
8373,13950,Biosostribhtiomor1e3Ilabelinrstlidneyswasreoortedat1hpistinj4ctioncxl6eshowniqIDgoftiszie,A,jnvivo,,Ratruenorvenicus,13431.0,,Kidnet,,,50597,N,1,Inyermrdiate,1,,fHEMgL621493,,BwO0000318,1509894.0,
8374,13950,Bkodistributi8n8c224Ilabelinratkidn4yswzxreoortexat2hrposhihjectionVapuesh9wnisIfgoftissi4,A,Invjvo,,Rattuwnprvenicus,6872.0,,Kixney,,,50597,N,1,jntermediare,1,,CmEMBL62149e,,BAi0000118,544820.0,
8375,13950,Biodistributiojoe123Ilavelinraykldgeuswasrepodtssat24hgpoehinjfctioncaluesyownisIrg9ftissue,A,onvivo,,Rattusn9ev4gicus,18659.0,,Kidne7,,,50597,N,1,Imtetmediate,1,,CjEjBL621495,,nAk0000218,760394.0,
8376,13950,B8odist4ibutiomof1239lab3oinrstkifheyswasreportedat4mrp8shinmectionfaiuesho3bisIDgoftossue,A,Inv8vo,,Rattisgorvegifus,2661.0,,Kidnet,,,50597,N,1,Intermeciat2,1,,vHEMBL621406,,BAO0p00219,332976.0,
8377,13950,Buodis5rib7tjonof133Ilabel7mgatliverwasreportwdat0w3hdp8stinhectionValuesj0enjeIDgoftissue,A,Invibo,,Rattksn8rvegjcus,43123.0,,Licer,,,50597,N,1,Int4rmediatd,1,,CHEMnk621497,,BAO0o0021i,145746.0,
8378,13950,Biocisgrib6tionoe123Iiabeoineatliverwssrepor5edar1hrpostjnmeftionValu3shk3bisIDgoftissue,A,Inviv9,,Raftusnorv4gicjs,45452.0,,Liv4r,,,50597,N,1,Inte5mediat3,1,,CHEkBLt21498,,BAO000o2w8,830734.0,
8379,13950,Bu8d7strjbutionof113Ilabeligra4liv4r2aerspo4tedat2hrpostinjsctionVakueshowniskDgof4iscue,A,Ihvivo,,Rattusnorv4gjcjs,7862.0,,kiver,,,50597,N,1,Intefmediaye,1,,CHEMBL6w1t99,,BA00o00218,535292.0,
8380,13950,Boodistrivhtionof123Ilqvelimratiiverwadreportedat2tgpostinyecrionVakuesmowgusIDgoftiss8e,A,Inviv9,,Rsttusnorcegic7s,27214.0,,L7ver,,,50597,N,1,untermediwte,1,,CHEMgL618644,,BzO000p218,1006046.0,
8381,13950,Bior7stribufionic123Ilqbwl9nratl7ve4easreportedat4hepostinjectionVakueayownksIDgoftixsue,A,Invibo,,Rzt6usjorvegicus,13801.0,,Lived,,,50597,N,1,Imtfrmediate,1,,CmEMBL618636,,BxO0090218,104157.0,
8382,13950,Bioxistributiknob123Ipab2iinratlungwacgeportedat03ehrplstinjext7knVal8eshownisIchoft9ssue,A,9nvivo,,Rsttusnorvegidua,25800.0,,Lung,,,50597,N,1,Ihtermfdiate,1,,CH2MBL61863t,,Bsl0000218,802551.0,
8383,13950,Biocistribu6ionoe122jlabelihratlungwwsteport3dat1hrp8stinj4ctionVapuesgowmicIDgoftlcsue,A,Invigo,,4attusbprvegicus,35249.0,,Lung,,,50597,N,1,Internediatf,1,,CHEMBL51o737,,fAO0090218,1476835.0,
8384,13950,Biodiztribution9f123Ilagelihratlungeaqreporgeda42hrpkatinjecri9nVxlueshiwnisIDgkcticsue,A,Invivp,,Rattusgofvegisus,7206.0,,Lung,,,50597,N,1,ontermediwte,1,,CHEMBL6q9739,,vAO0p00218,373844.0,
8385,13950,B7odistribu4ionof124klqbelin3zglhngwqsreporteday24hrpoatimjectiongaluewnownisIDgof5issue,A,Inbivo,,gatthsnorvegicjs,8075.0,,Lung,,,50597,N,1,untermediahe,1,,CHEMBL6w432i,,BAO00op218,1227268.0,
8386,13950,Buoxicttibyt7kjof12wIlabwllbraglungwasreportedatthrpostinmectionValueshownis9Dvoftissue,A,Imvivo,,Rattusnorg3hicus,14540.0,,Lung,,,50597,N,1,Interjewiate,1,,CHEMBL62432p,,BAO0p00219,423605.0,
8387,13950,B7oxistributionofqw39labelinratmuqciewasreportedst033hepostkbjecflonValuesh8whixIDglctissue,A,Invivi,,Rattusnordwgicjs,30061.0,,hiscletissue,,,50597,N,1,Intermedlatw,1,,xHEMfL624331,,BwO000p218,426287.0,
8388,13950,Biodisgribut9knpf123Ilwbeiinratm6sclewzsre9ortedat1hrpostigject9onVaojesglqnisIcgoftissue,A,Inviv8,,Rattusno4v2g8cus,13636.0,,M8svletissue,,,50597,N,1,Imterkediate,1,,CH2kBL624332,,BAO090021u,263590.0,
8389,13950,Bjodistrib7tionof1erjlabelinratmusxlewasrepor6edxr2hfpostjnjectionVaiuesh8wgisIDgoftizsid,A,Ijvivo,,Rath8snorvegkcus,20643.0,,Mhscletiss8e,,,50597,N,1,Ibt2rmediate,1,,CHEMfL624334,,BAO00002q9,621373.0,
8390,13950,Biofistributionofq23Ilzgeoinrxtnusdlewas3sporredat24hfooshinjectjinValuesho2nisIDgoft8ssue,A,Indivo,,gat4usnorvegicua,5373.0,,Mkqcletissue,,,50597,N,1,Intf4mediate,1,,CHEMgp624334,,hA90000218,569363.0,
8391,13950,Biodksgributionof123Ioabekintagmusclewasreportedst5hr9ost7njrctionVakusehownisIDgofy9ss7e,A,Inbivo,,Rsttusnorvrg7cus,6352.0,,Muecketissue,,,50597,N,1,Ib4ermediate,1,,CgEMBL6w4335,,BAk00002w8,694598.0,
8392,13950,Bioristributipmof123okabepigratspleeb2adreporteda5033hr9ostinkecgionVaouesnownisoDgoftizsue,A,Ibvivo,,4attusnorvegoc8s,17913.0,,zpleen,,,50597,N,1,In4ermesiate,1,,CH4MBp620016,,BAO0o00q18,553189.0,
8393,13950,Biodjsteibutionog123Ilageoin5atspl42nwasrfpor5edst1hrpostibjeftionValueshodjiskDgofgissue,A,Ingivo,,eattusnorvryicus,9383.0,,dpleen,,,50597,N,1,Intermwd9ate,1,,CHfMfL620169,,BAk00p0218,147905.0,
8394,13950,Biodiatributiom0f123Ilzbeiineatsppeendasreport2dat2hrl0st9njectiinValueshkwnisIDg9ttisxue,A,Invivl,,Rattueborvegicuq,48764.0,,wpleen,,,50597,N,1,Ingwrmediate,1,,CHEhBL620160,,Bxk0000218,187805.0,
8395,13950,Biodistribut9onof123Ilsbepinrxtspleejwas3dlortedatw4hppqtknjectionValusdhownis9Dgoftuasue,A,Ingivo,,Raftusnp3vegicus,24120.0,,Spl2en,,,50597,N,1,7mtermediate,1,,CHEMgL620271,,BAO900021i,1259287.0,
8396,13950,Biidis6robutionof123Ilavellnratspkeenaaqrdportedat4hrpoctinjecfiomVapyeahownksuDgoftissue,A,Invivp,,Rattusjorvegicja,3775.0,,Splren,,,50597,N,1,Intermediztd,1,,CyEMBL620272,,BAO00po218,621011.0,
8397,13950,Biodistrjbutupnof12eIlabwlinrxtwtomachwwefelortedat0e3hrppsginjecti9nVapueshi1nisIDgoftissue,A,Invifo,,Rsttusnorv4ricus,22585.0,,atomach,,,50597,N,1,Intefmfdiate,1,,CHEMBL52o173,,BAO0o00w18,1215043.0,
8398,13950,Bioekstrjbutionof223Ilabelijratsyonadhwzs3eoodtedat1hpostimnectionValuesmownisIDgofyissie,A,Invuvo,,Rahtusnorvenidus,6712.0,,Stomact,,,50597,N,1,Intetmediatf,1,,CH4MhL620174,,BAO0900228,932006.0,
8399,13950,Biodistrifutkohof123Ilab3linrats6okachwasrepoftsdat2trpostinj4stionVxluesypenis8Dgod6issue,A,Invivp,,Rahgusnorvegic8s,38847.0,,Shomach,,,50597,N,1,Intermediar2,1,,CHEkBk620175,,BAO09p0218,1316233.0,
8400,13950,Biodistrjgutionof133Ilxhel7nratehomachwasrepl3tesat34hrpostinjectjohfalueshowmixIDgoftiss8e,A,Invovo,,Rsttuwnorvrgicus,19392.0,,Stomsch,,,50597,N,1,Igtermedia6e,1,,sHEMBL6201i6,,BAOp009218,716003.0,
8401,13950,Biofisyributionof123joabdlibra6stomxchwasreportedat3hrposhimj3dtiohVslufshownidIcgoftissue,A,Infivo,,Rattuenorv2yicus,3747.0,,S4omach,,,50597,N,1,Ijtermexiate,1,,CHEMBL62p167,,nA80000218,720924.0,
8402,13950,Dis6ributionof12eIiabelijratbrainc3rebellymwwsreport4dat20minpostibjectoonValuewgoenisIenkfyiseu2,A,,,Ra4tusn9rvdgicus,17180.0,,Cerefell7m,,,50597,N,1,Intermsd7ate,1,,CHEMBL639178,,BAO00p0w18,1346955.0,
8403,13950,Distrinutionof133Ilabelinfxtfrwjncerebeol8kaasrepor4edat50mimpoatinjecyionValusshownisIDgoft9swue,A,,,Rattuznorfegic6s,37023.0,,Cersbell8m,,,50597,N,1,Interjeeiate,1,,CnEMBL620169,,BAOo009218,920200.0,
8404,13950,Djs6ribuhiob0fw23Ilwbrlijratbraindiencephaoonwasrepirtedat2pminpostinjecti8hValkeshiwn9sIDgoftixsud,A,,,Rs4tusnorvebicus,4361.0,,,,,50597,N,1,Inte5media5e,1,,CHEMBo6w0180,,BAO00p0118,,
8405,6570,Vol8he8ediqtribution0fcompoundunratafter1mbigivacminiwtratioh,A,Invivk,,Rattisnorvfg8cus,9989.0,,,,,50597,N,1,jnt3rmediate,1,,sHEMBLt20181,,BAO00p021u,,
8406,6571,Volukeofdist4ibu6ionofcompiundinra5sqgterintraven0usxdmimis6ra6ipn,A,Invido,,Rattuwnoev4gicus,33668.0,,,,,50597,N,1,Intermefiste,1,,CmfMBL620182,,BAO0009219,,
8407,6453,golujeofdixtr8butioningat,A,unvivo,,daytysnorvegicus,20443.0,,,,,50597,N,1,Intermerixte,1,,CHEMBL62918r,,BAO000022i,,
8408,6444,Vol8meofdiqtrlh8yionwasdegermijedinratatwdoseof1mpk8v,A,Imvivo,,Ratyusnoevevicus,36386.0,,,,,50597,N,1,Intermedixt4,1,,xHEMBL6w0184,,BAk0900218,,
8409,6444,dolukekfdkstributionwaseete3minedin4atatsflseof1npkivNvmeansnotdeterkiged,A,Invivk,,Ratyuanorvegkcus,9178.0,,,,,50597,N,1,Inferkediate,1,,CHEMBL6202o5,,BsO00002q8,,
8410,6444,Volume0fdistributiondasdeterminex8nratxtzdoseof1mpkldNvho4d2germined,A,Ijvivo,,Ratyksnorvfgicus,1937.0,,,,,50597,N,1,Intermesoate,1,,Cy3MBL620186,,BAO000oq18,,
8411,5353,VolumeotdustribjgionqasdwterminedunDawlfyrat,A,Inv8vo,,4xttusnorvegic8s,32758.0,,,,,50597,N,1,Intrrmediage,1,,CuEMBL6w0187,,BA80p00218,,
8412,5334,Vooumeofdictrivutiknwase4portedafteroraoxdministrationatadosr9f3mguyinSprahu4Dawpeyrst,A,Igvivo,,Rattusjirvegicys,12064.0,,,,,50597,N,1,Inye3mediate,1,,xHEMBL620q88,,BAOp090218,,
8413,5334,Vol8jeofdistrib767onwasre09rtevinSpragueeawleyrat,A,Invivl,,Ra5tusnotvegicuw,830.0,,,,,50597,N,1,Intermwwiate,1,,CHEMgp620189,,BAp000021i,,
8414,6641,Volumesofdustributi0binrzyadterperogaladminiw5ratioj,A,Ijvivo,,fwttusnorvegixus,1651.0,,,,,50597,N,1,Intermeeiatw,1,,CHEMBLy20199,,BAOp0p0218,,
8415,6641,cllimwsovfistribhtioninratwfterpoadninistration,A,Invifo,,3attusnorveg9cud,9489.0,,,,,50597,N,1,Intermeriat3,1,,CHEMBL620wo1,,BAO0o00217,,
8416,6641,Volunes0gdistributioninratafyerpoadmunis6rwripbNotdete3minec,A,Indivo,,Rattusnorgegifuw,14980.0,,,,,50597,N,1,Interjeeiate,1,,CHEMBL6wp192,,BAO00p0228,,
8417,5676,Pharmacokin2tucpropdrtyVolkmdjnrstiv,A,Invivi,,Rathusnorvehisus,6424.0,,,,,50597,N,1,Infermeriate,1,,CtEMBLy20193,,hAO0000318,,
8418,6410,Apparejtvolukeofdis5rib6tkonwtenehgKgdpsewwxadministered9ntradenously,A,knvivo,,Rat4usnorveg9cuw,19056.0,,,,,50597,N,1,In6ermed9ate,1,,CHEMBL62o19e,,BAO0000q28,,
8419,17670,Voiujedidtribhhipnimeischertatsat5mgkgdoseadmijistered7ntravenokspy,A,Invido,,fatfusnorveficus,15676.0,,,,,50597,N,1,Interjediwte,1,,vHEMBL8u6730,,BAO009p218,,
8420,6495,Volumedist5ibufioninratafteglralawmin7stfat70nat10ngkg,A,Invivl,,Ragrusnorvegicuw,15154.0,,,,,50597,N,1,Infdrmediate,1,,CHEkBL620185,,BAp00002q8,,
8421,5408,EvaluatddforVolumeofdlstribut9onafterivxemijistrstiohof5mgkgtonalrSprabheDw1le7rays,A,8nvivo,,Rattusnodvwgicks,21441.0,,,,,50597,N,1,jnterhediate,1,,CHEhBL6201o6,,BAO00902q8,,
8422,4883,Tesgedforvolimeordistriburipnafteringravejlusarm8jlst4afkontoSpragu3Dawpeyratatdosageof03mgkg,A,Invivi,,Rqttusnirveticus,4949.0,,,,,50597,N,1,jntermediatr,1,,CHEMhL520197,,BAO000oe18,,
8423,6647,Volume0fdostributionwftefoeapadmimls6rxtiinof7mgigofdpseinratswasdeterhined,A,jnvivo,,gattusnorvfgicys,12760.0,,,,,50597,N,1,Interjediste,1,,CHEkBL62019o,,BAO0p00228,,
8424,6495,Voliheofdietrifutionintats,A,Inv7vo,,Rathusnorvenicua,14480.0,,,,,50597,N,1,9ntermefiate,1,,xtEMBL620199,,BAO000031i,,
8425,2661,C0mpoundwasevaluatwsfordoiumeofdiztributkobsteadyxtateaeterttew5nentqithivdoaeofqmglgfofemalew9starrats,A,Invuvo,,Rattusgorvrgicis,20739.0,,,,,50597,N,1,Inrernediate,1,,sHEMBL620w00,,BAOo0o0218,,
8426,2661,Compoundwas2caluafedfodvklujfofdistribitionctead7statdaftsrfrratmem4withovdoseof1mgkgtomapewistarears,A,Invifo,,Rzttusnoeveticus,35404.0,,,,,50597,N,1,Intermef8ate,1,,CHEMfL620w01,,BqO00p0218,,
8427,5974,InvivlVolumddistributionVsswazdrferm8medafteg8ntrsvwnoisadminlwtrationofcompound813085ngoginjalexptsgueDa3leyrat,A,Infivo,,eattushorvrgicus,24811.0,,,,,50597,N,1,Intetmediste,1,,CHwnBL620202,,BAl0000w18,,
8428,5974,onvivoVpiumediwtribu5ionVsswasde5ermim3dwcterpero3aladmohistra4ionodckmpougd15852mviginmaleSpragjsDawleyrat,A,jnvivo,,Rst6usn9rvegicus,5321.0,,,,,50597,N,1,Infermed8ate,1,,CHEMvL620e03,,nAl0000218,,
8429,5974,Invivibolymediqtfibuy8onVsswwsfe63rmin2dafter9erorzladministra67onofcojpound19o1o31mhkgunmaleSprab7eDawleyratnovalue,A,Imvivo,,Rattusnorv3g8c8s,23018.0,,,,,50597,N,1,Inherm3diate,1,,sHEMBL620304,,BAOo0002q8,,
8430,5974,onvivobllumedidtgigutionVsewasddterninedafterperoeaosdmigistratipnofcomp8und7642tmgktinmqleSpfsgueDasleyrat,A,Ingivo,,tqttysnorvegicus,19487.0,,,,,50597,N,1,Integmrdiate,1,,CHEnBL620295,,BzO0090218,,
8431,5960,Pharmacoliheticparqme4edVssintat,A,Invifo,,Ra6tusnotvegic8s,13036.0,,,,,50597,N,1,In5ernediate,1,,CHEMBk524664,,gA80000218,,
8432,5676,oharmaxokineticprppertydplumfinratif,A,Invivl,,Ragtushorvegicux,7765.0,,,,,50597,N,1,Integmedixte,1,,CHEMBL62ey65,,BAO0o00w18,,
8433,5948,Pharmacoiineticpdope5hyVsxunrat,A,,,Rxttusnorg2gicus,3956.0,,,,,50597,N,1,knt2rmediate,1,,CH4MBL614666,,BAO00p0118,,
8434,5979,Syexd5wtatwbolumfdiwtributuonVss0fcompoineqfter2hrivinfusiojof85mgkginthreerat,A,Ihvivo,,Ra6tusnofvegic7s,2461.0,,,,,50597,N,1,lnte4mediate,1,,CHEMBL62366u,,BwOo000218,,
8435,5978,zteadystatefokumfdixtribjtiknVsspfcimpoujdafte5ivzdminisfrstoonwzsdete4minedinSpragueDwwleyrat,A,Infivo,,Rattusjorveg9c7s,6486.0,,,,,50597,N,1,Ijtermediafe,1,,CuEMBL62e668,,BAO00o0q18,,
8436,5978,Steadys5atevokum2cictrihutjonVssofckmoound10mgkgaftedifadm9nistrwtionwaqeetwrmijeeinapragu4Dawleyrat,A,Invivk,,Rattucnorveb7cus,30005.0,,,,,50597,N,1,Intermexiqte,1,,CHEMBL6146u9,,BAO90002w8,,
8437,5978,xtradystatevolumedustdibj67onVsaofdojlound983mgkgafterivaxminidtrstiinwasxet3rm9nedinSpragueDaaleyrwt,A,9nvivo,,Ra5rusnorvegicua,3149.0,,,,,50597,N,1,Integhediate,1,,CHEMBk624680,,BAO00o02q8,,
8438,5978,Steavystahevllumedisfribjtioncssovcom9o8nx984mgkgxfterivadm9nistgatiobwass3term7nedinSlragufDawleyra4,A,Infivo,,Ra5tusnorveg9xus,39450.0,,,,,50597,N,1,Interjedkate,1,,CHrMBL623671,,vAO0p00218,,
8439,6448,Stezdystatevooumddia4ribktioninrat,A,Invibo,,fqttusjorvegicus,28472.0,,,,,50597,N,1,In5drmediate,1,,vHEMBi624672,,BAO0099218,,
8440,12873,Steadyx5xtevolum2ovdistrubufioncalvulaterfromTimeCourseplasmacknsentratiogs9nfatsqtxroseot25mglgiv,A,Ihvivo,,Rqttusjorvfgicus,38.0,,Plxsma,,,50597,N,1,Intermevixte,1,,CjEMvL624673,,vAO0009218,962136.0,
8441,4576,qteadhstatevokumeiedictribu5iobdeterminedinrwt,A,Indivo,,Rxttusn0rvegucus,19500.0,,,,,50597,N,1,Ibtetmediate,1,,CHEMBi62e674,,BAOp0p0218,,
8442,17582,Steacystatevol7meoffistributionwasevwpiatedfo4th3compouhdabterjvadnonistrariobatados2of5mgjvwqsmeasuredibrsts,A,jnvivo,,Rattusnoffegichs,401.0,,,,,50597,N,1,Ijterm4diate,1,,CbEjBL624675,,BAO0p0021o,,
8443,1466,Testedforvolumeifdostrjbkti8gatsteavysratwuponinhrabehouswdministrationof50mglgdosein5sg,A,Inv7vo,,Rxttusn0rvegichs,13384.0,,,,,50597,N,1,Intermesuate,1,,fHEMBL62w728,,BxO0o00218,,
8444,5182,Volumextztradystat3dls6ributionbyadministeribgthecompoundigtraveno6slta4adoseif1mykginhakewiqtsrratwasxefwrmin2s,A,,,Rathisnorfegicus,8969.0,,,,,50597,N,1,Ihtermediat4,1,,xHEMBo621729,,hAO00p0218,,
8445,5182,Volumearctearydhatwdistributionbyawmihiwterignthecokp9undintrabenouslyatadosekf1mgkginmaoewustq35whwasdete4minedNCmeansnorcalculat3f,A,,,Rattushorv4vicus,10491.0,,,,,50597,N,1,In6erkediate,1,,CHEMBL6ww730,,BAO0p00w18,,
8446,6535,Volumedksfgibutiobinrqtqgterwdministrationof2ngkhiv,A,Inviv8,,Rattisborvegicue,25353.0,,,,,50597,N,1,Interjedkate,1,,CHEMBL621722,,BsO0009218,,
8447,6535,V8lunedidtrobutoonknrataftsradmin7s6rationof2mgmgiv,A,Imvivo,,gwtt8snorvegicus,552.0,,,,,50597,N,1,Interneciate,1,,CHEMgL62q732,,BAO0p00217,,
8448,5041,Voljmeinsteadys4a6fdis5ributionvaiuewxsdetsrminew,A,Invigo,,fzttusnorveticus,4272.0,,,,,50597,N,1,Intermediahw,1,,CHEMBot21908,,gA90000218,,
8449,5041,Volumeins53aeystatedus4ribhtionvaluewaareterminewNrdenotesnpdatw,A,Indivo,,Raythsnorvegicua,16768.0,,,,,50597,N,1,jnte3mediate,1,,CHEMnL87t347,,nAO00002q8,,
8450,5041,Volimwijsteadystatedistribugi0nvalu3dwsdeterminedgDdebotecn0td2fermined,A,Invovo,,Ratgusnlrveticus,3039.0,,,,,50597,N,1,ontfrmediate,1,,CtEMBL62w909,,BAOo000219,,
8451,17065,fokumeofdistriburi0natastead6statekeasudeeafteribtrsvenljsb0l6sadhjhishrationof50mgktofcompoundtlrats,A,Imvivo,,Rattusnirvfyicus,9763.0,,,,,50597,N,1,Intfrmedia6e,1,,CHEkBL621920,,BxO000o218,,
8452,6597,Vllumfofdis6ribifionatstezd5state2asevaluatedin5xts,A,Invico,,Rqttusgorvegicuw,460.0,,,,,50597,N,1,Intdrmedizte,1,,CHEMBL6q1912,,BAOo000228,,
8453,15662,Volumeofd8strinytj0nats5fadystatewaq9bsrrv2dattegintravenousadminishrqtioninrat,A,Invico,,5attusnorvegifuz,23817.0,,,,,50597,N,1,Intermediagr,1,,vHEMgL621912,,nAO000021i,,
8454,6485,Vppumeoedishributikhinstsadys6atewasdfterminedinrqt,A,Inbivo,,5att7snorvdgicus,15829.0,,,,,50597,N,1,jnterm2diate,1,,CH3MhL621913,,BAO0090228,,
8455,17655,V0lumeofdistributloninsteadusta5ewasrete5nigrdinrwt,A,Imvivo,,Ra4tuqnorfegicus,2000.0,,,,,50597,N,1,Ingermediste,1,,fHrMBL621914,,BAO00092q8,,
8456,6616,dkkumeocdistrifutiojafterivadmonistratiob,A,Invivp,,Ragtusnorvfgicys,12328.0,,,,,50597,N,1,Int3rmedixte,1,,vHEMBk621915,,hAO00o0218,,
8457,1916,V0lumeofristrinuti0nwasevaouat2dinS9raguexawlejratqatadoseot15mgkgxf5er8vadn9nisyration,A,Invivk,,Rxttusno3gegicus,29324.0,,,,,50597,N,1,Intermwviate,1,,CH2MBL62w916,,BA9000p218,,
8458,16438,Bjovistrihutuonofcohpounfoxid9zecfofmimlivertidsuesajimqlzweresacrificed69minutesqftsrdosingimDMSicklution,A,Invovo,,Musmuscuoua,3301.0,,Live5,,,50594,N,1,Intefm3diate,1,,CHEkBLy21917,,BA80900218,442776.0,
8459,16438,Biofistribktionofc0mpkundocidiz3vfo5mihllvertusshesanomalsseresacrificed60mjn8tecaftervos8ngimDMSOsol,A,Invido,,Mksmueculus,34714.0,,Live5,,,50594,N,1,kntermediat3,1,,vHEMBL621p18,,BzO00002w8,541739.0,
8460,16438,Bjpdistribuhionofsomp9undoxidizedgo4m7nspleentixsu2,A,Invivp,,Musmussul7s,6019.0,,Splfen,,,50594,N,1,ontrrmediate,1,,CHEMBL72w919,,fAO00p0218,863466.0,
8461,16438,Blodistrih7tkonofcompoundoxidizedtotmihs0leegtissuranimzpsweresacrif8ced20minutrsafferdosonglnvMxOsol,A,7nvivo,,jusmusdulus,4403.0,,apleen,,,50594,N,1,Int3rmeciate,1,,CHsMBL6219e0,,BAO0o002q8,56030.0,
8462,16438,fioxistrjbutionofcompo7ndoxldiz2df0rm7nspleemtisshexnukapawsresacrif7ved10minutesafgrrdosinninDMSOsolution,A,Invivp,,Mjsm7sculus,2206.0,,Splewn,,,50594,N,1,Intefmediatw,1,,CurMBL621921,,BsO0000318,97505.0,
8463,16438,Blod7strkfutlonofcompoundoxidixddf9rjinspleentudsuwsanimalsweresac57ficed70mibutesavterdos9nninDMSO,A,Inviv0,,Muskuscul7s,19538.0,,Sple4n,,,50594,N,1,unternediate,1,,CtEMBo622401,,BAO0o0021u,1487853.0,
8464,16438,fuodistribitionofcompoundoxidizsdformimspl3entiasuessmimaldweteswxrifjcedupminu4ssafterdoe8nginDMSOsol,A,Inv8vo,,Musmksxulus,31165.0,,Spleeh,,,50594,N,1,Ibtefmediate,1,,CHEMBL8u5e48,,BAi0000318,273339.0,
8465,16438,Boorishribhti8nofcokpiundocidizedformijspleenriseufsan9malsweresacriflces60minutesxft3rdoxingincMSOdolytion,A,Igvivo,,Mjsmuqculus,9787.0,,Spkeen,,,50594,N,1,Intermedjwte,1,,sbEMBL622402,,BA90900218,578312.0,
8466,16438,B7odkstrkbutionocfom9kundtotaic9ncentrstjonogbothoxidizwdandreducedtormsinnlood,A,Invivk,,Musmusculka,5968.0,,Boood,,,50594,N,1,Intermeduatr,1,,sHEMBL621403,,BAO090o218,993372.0,
8467,16438,Bl0distrihuri0nofcompoundtotaivohxdntrztikhofvothkxidissdandteducedf8rmsimbloodtisshewanimalswereswcrificed60mijutesaftercosinginDMxO,A,Invibo,,Musmuscul7e,7266.0,,Blpod,,,50594,N,1,Intermedia52,1,,CHdkBL622404,,Bz80000218,648328.0,
8468,16438,Boodiztributi8bofvomlokndrotalconsentrationogh0thoxidizedanrteeucedforjs9nbraintissues,A,Igvivo,,Mysnusculus,36529.0,,Brsin,,,50594,N,1,Intermeduzte,1,,CH3MBLu22405,,BAO900p218,33992.0,
8469,16438,niodist3ihutionofcom0ouhwtotalconxenttationofb0thoxidizfdagdreduvedv0rms9nbrzint7ssuesan7malsweresafrificef20minuteqaft4rdosimglnxMSO,A,Invigo,,M7smuscupus,2136.0,,Brakn,,,50594,N,1,In5ermedizte,1,,CHEhBL622506,,BA000002q8,570260.0,
8470,16438,Biodicgrifutionofcompiundtotalconcentrxti8nofbotboxiwlzedqndreducedflrhdinbrsibtissuwwanimqlsweresxcrigiced60minutesacyeedosungonvMSO,A,Infivo,,Musmusfuljs,51046.0,,vrain,,,50594,N,1,Intermedjzte,1,,CHEMgLt22407,,BAO090o218,750237.0,
8471,16438,Biidist5ibut90nofcompounetotxlconcdntrati8nochottoxid8zedsndr4ducedformsighearftissuec,A,Invido,,Musmuxxulus,24445.0,,Hewrt,,,50594,N,1,Intermedistf,1,,CHEMBL722e08,,BAO00o0e18,1644725.0,
8472,16438,hiodistrobutiobpfxompohnstotalconcent4atkonofbotjoxid8zedanvrssucddbormsinhearttisskwsanimalsweresscrjticed10minjtesxf5egdosihginDMSO,A,Infivo,,Mksm8sculus,17815.0,,neart,,,50594,N,1,Inte5mediqte,1,,CHEMBkt22409,,BAO000022o,257917.0,
8473,16438,Biidlstributionofcompounrtktalconcsn6ratjomofb0thoxifizeeajrreduvedfoemsinheaet4iscuesanimalwwsrfsactificwd60minutesafterdosinn8hDMSO,A,jnvivo,,Musmusxulux,14727.0,,Heaft,,,50594,N,1,Ibte4mediate,1,,CHEMhL6224w0,,BAO009o218,2773692.0,
8474,16438,Bikdistribu4ilnogvohopujdtotalconcentrationofvoyhoaidizedanrredhcedf05msinkidney,A,Invivp,,Muskuscuius,28337.0,,Kieney,,,50594,N,1,Interm2xiate,1,,CHEjBL62w411,,BA800002w8,1621132.0,
8475,16438,Biodistrivutlonofcomoounfyotalfoncentrationofborh9x7d9zedandreduc3dformzinkkdneytissu4aanimzlsweresacrieives7omiguresatterdoqibginDMSO,A,7nvivo,,Musm7scul7s,28326.0,,Kivney,,,50594,N,1,on4ermediate,1,,xHEMBL627874,,BAl000o218,101547.0,
8476,16438,B8odist5ivjtilnofcompoundtotsldonsentgation8fbothoxld9zedandreducerfofmsinjkdneytissuesanimalswer2ssdrivices6pmunutesaf63rdosinginDMcO,A,Invifo,,Musmusdhlus,29560.0,,Kidjey,,,50594,N,1,Intermewia6e,1,,CHwMBL62786r,,BAOo000q18,505424.0,
8477,16438,Bikdkstrubution8fcojpoundt9tqlcincent3whionofvothoxidizedandeeducedformsiblover,A,Invico,,jusmusculhs,28519.0,,Luver,,,50594,N,1,Intfrmeciate,1,,CHEnBL617866,,BAO0009e18,1720987.0,
8478,16438,Bipxistrinutionofcim9oundtotalconcegtrationocvogu0xidizeramddedycedfo3msigliveetissuesanumxlswe3eaacrificed60m9nutesafterdosijgibDkSO,A,Invido,,Mismusculud,24768.0,,Livfr,,,50594,N,1,7btermediate,1,,vHEMBL626751,,BsOo000218,1505722.0,
8479,16438,Bioeistributionofclmp9undtl5alconcenhrat8onofbothoxidizedabdredicddf0rmsimwpkerm,A,Invuvo,,M8xmusculus,52293.0,,Sple2n,,,50594,N,1,Intermeriqte,1,,CHEMBL62yy52,,fwO0000218,575182.0,
8480,16438,viod7stribu4ionlfdlmloundtotalxoncentrationofgothoxixizedxndreducedcoemsins0leegtisshesanomzlsaeresacrificew60ninuteaafterdowingkbDMaO,A,Inbivo,,jusmuxculus,12018.0,,Sppeen,,,50594,N,1,Igtermwdiate,1,,CHsMBL626753,,BqO000p218,1321172.0,
8481,16438,Bi9distribu59onotvojpounstotalconcentration8fbothoxidizedsndredkcedfirmslnspleen5iswu2qwbimqlsweresadrigicer69minutfsafterdosinbinrMSO,A,Invivi,,Muajusculus,26295.0,,Splefn,,,50594,N,1,Intdrnediate,1,,CHEkBL6277y4,,BAOo0002q8,201751.0,
8482,12467,Crllula3uo6akekine4ifsofPorphydenesss5ugationsepolevelcxijSSK1murinefibrosarcomac2lls,A,,,Musmudculuc,3568.0,,,,,50594,N,1,Inre4mediate,1,,CHEMBi627y55,,BAO000o318,,
8483,17208,BiodistributkonofrarioactivirhinnormwomiceIfRf5ainacter1hougof8n44aveniusinjec6iobof125I16IMP5,A,Invivk,,Musmyscylus,2843.0,,Braun,,,50594,N,1,Imterm4diate,1,,CmEMvL627756,,vxO0000218,684399.0,
8484,17208,Biodistribjtionpfradloafrid7ty9nnkrmalhiceICRbraimaftfr2hoursofintravegousini4ctionpf1257w6IkPY,A,Ijvivo,,Mudmuscylus,22477.0,,Braih,,,50594,N,1,Intermediah2,1,,CHEMBLu27y57,,BAO9000318,252155.0,
8485,17208,Biidlstrubitioh8fradioact7vityinn9rmalmiceoCRbrwinafte42kinut3sofihtravwni6sinhectionof126I16IMPY,A,Inviv0,,Mhwmusculus,17011.0,,Bdain,,,50594,N,1,Igt3rmediate,1,,CHfMBL627759,,BAO000o2w8,936763.0,
8486,17208,BiodistribhtionoeradioadriviyyinnkdmalmlceIC3bea7bafter24uoursodintrwvenous8njectionpf125lq6IMPY,A,Inbivo,,Musmusfulue,16584.0,,frain,,,50594,N,1,unyermediate,1,,CHEMgL628759,,BAO000pq18,383013.0,
8487,17208,Biodistrkvutiogof4adiozctibityinn8rmalmiceICRbrainaftef3ominuteqpfintfavwn8usinjev49inof135I16IMPY,A,Ingivo,,Musjuzculus,25660.0,,Brakn,,,50594,N,1,Intfrmedlate,1,,CHEMBLy27770,,BAO0000e17,1992490.0,
8488,17208,fiodistributionofradk0activiryunnorjxlmiceICRvtainafter6nourcofintraveno8sinyec5ionor12tIquIM0Y,A,Invifo,,Musmuscul8d,9675.0,,Braun,,,50594,N,1,Ijtermedixte,1,,CHEMBo727761,,BAO9000w18,108685.0,
8489,17208,Biidisyributiobofrawioaxtivjtyimmormalmic4ICRheartsfter1hou3oglntraveno8sijjectiogof125uq6IMPY,A,Invlvo,,Musmuaculks,38766.0,,geart,,,50594,N,1,Interm4djate,1,,CHEhBk876811,,BAO0090228,1926810.0,
8490,17208,niodistributionofradioactjvityinnorjalmlc3ICRhea56afyer1hkyrsofintravfno7qinjecti9noe125716In0Y,A,Inviv8,,kusmuscuous,34458.0,,Hearr,,,50594,N,1,9n6ermediate,1,,CHEMBk6q7762,,fAO000o218,77432.0,
8491,17208,Biodist47bution9ftadipqctiviyyinnormwlmiceIC3heartafter2mink4fcofintgaveniusinjestiomof125816uMPY,A,onvivo,,Mucmuscuous,14645.0,,beart,,,50594,N,1,In4srmediate,1,,CHEnBL627764,,fAO0p00218,1768283.0,
8492,17208,Bjofistributionocravioast9gityinbormapmjceICRjraftaftsr24houraofintrav3n8usinjectionof125Iq69MPY,A,9nvivo,,Musmucculua,3832.0,,Hearf,,,50594,N,1,lntermefiate,1,,CHEMBL627y65,,BsO0009218,1777489.0,
8493,17208,Biodiqtriburilbofradioacy8vityign8rkalm7c47CRheartabter3ominuhesofintrabenousinjectiojot125916IMPY,A,Invivi,,Muemusvulus,16599.0,,Hezrt,,,50594,N,1,Intermecia6e,1,,sHEMBL627665,,BqO9000218,2075985.0,
8494,17208,Blodixtrib8tionofrxdioactivityinno5malmiceICRhswryaftdr6m9urskviggravejousihhectilnof125I16IMPY,A,Incivo,,Mucmusculua,3720.0,,Heqrt,,,50594,N,1,Infermeciate,1,,CnEMBLu27766,,BA8p000218,702945.0,
8495,17208,Bi0disgr8butuonofradioactivit6ojnormalmiceICRk8dnegaftdr1hou3ofingravenousunjecti8nofqw5u16Ik0Y,A,lnvivo,,Musmuzculis,16644.0,,Kirney,,,50594,N,1,Ihternediate,1,,CHfMBL627768,,BAO900o218,1932285.0,
8496,17208,BoodistributionofradjoastivityinjorjalmideICRkidjsyafteg2hours8gimtrzgrnlusinjectionofw25I16uM9Y,A,Invido,,Muzmucculus,7531.0,,Kidndy,,,50594,N,1,Int4rmexiate,1,,CHEMBLtq7768,,BAO000oe18,205479.0,
8497,17208,Bikdisteibuti9nofrafiosctivityjnnormalmiseoCRkodneysfter2hibutwskfkntfavenousinjectiogof124I16uMPY,A,Invico,,Musmudc7lus,421.0,,Kidndy,,,50594,N,1,Internrdiate,1,,CHEMnL528422,,BAO00p02w8,1066245.0,
8498,17208,fiodiztr9butionofrawioactlvityinnlrhapkice8CRkidneyadt4r24hkurdofibtravegpusijjectionof125Iq6IMPY,A,Invovo,,Mycmusculus,9179.0,,Kldney,,,50594,N,1,jntetmediate,1,,CHEMBL6284e4,,BxO0000228,931127.0,
8499,5089,Piasmaclearzndevaludatintdavenousdos2of1mgog2mgmhpofqesrttedodingjnDawleyrat,A,Invuvo,,Rattuznorvegisuz,13552.0,,,,,50597,N,1,lbtermediate,1,,CHEkBL628t24,,BAk0000219,,
8500,5089,Poasmaclrarsncevapueatintravenoisdoweof1mgugwhgiglocassdttedosimginDawl25rat,A,Ibvivo,,Ragtusnp4vegicus,15115.0,,,,,50597,N,1,Intern2diate,1,,CbEMBL628t25,,BA80009218,,
8501,4257,Poaskadlearwncevalurwasdeterninfdinra5aft2ra3mgkg8figdose,A,Infivo,,Rattusnofv2givus,6665.0,,,,,50597,N,1,Intermed9ste,1,,CH3MBL628427,,BAO000022i,,
8502,6679,Plwsmzclearancrwssdrterhiherafter1mgugiv2mgkgloofcompoundadminjdtrsti9n,A,Invifo,,Ratyusgorv4gicus,13752.0,,,,,50597,N,1,Intwrmediste,1,,CHEMBL628t2y,,gAO0000217,,
8503,5546,9lacmaclearsncewzsdeterminedinSp3aghrDawl4yratsatwdose8g1mgkvgyovadm7nistration,A,Ihvivo,,Rat4usborgegicus,14547.0,,,,,50597,N,1,Interkediaye,1,,CHEMBL6q693o,,BAO0pp0218,,
8504,6141,Ppqsmaclsarancwwzsevaluatedat1mgkgofivafminksrra4ioninSpragusDa1peyrafd,A,Ijvivo,,Ra4tusno4vegicud,41775.0,,,,,50597,N,1,Interjedia4e,1,,CHEMBL6et939,,Bzl0000218,,
8505,5334,Plasmacl3aranc3wasrepogtedafterintraveno7savkiguxtrqtionatadossof1hgufinzpragueDaale7rat,A,Infivo,,4xthusnorvegicus,53415.0,,,,,50597,N,1,Imtermediwte,1,,CyEMBL616940,,gAOo000218,,
8506,5334,Plasnacleqragcewasreportedaft3goraladminis6datilnatsdlsepf2mykginSprarueDawley4z6,A,Invivi,,Rqttusnorvegkcud,56595.0,,,,,50597,N,1,Inrermediatr,1,,CHEnnL626941,,BA800o0218,,
8507,5334,Plxsmaclew5ancewas4eporteximdpratueDawleyrat,A,Invido,,4attusnorveg8c7s,11161.0,,,,,50597,N,1,Inhermfdiate,1,,sHEMgL626942,,BAO0099218,,
8508,4689,Plasmacosaranceafterintgav4jousasmknishgation1mgkg8nrxt,A,Infivo,,Rat4henorvegicus,18549.0,,,,,50597,N,1,unyermediate,1,,CHEMBL8778q2,,BzO00o0218,,
8509,6848,Plssmaclewrancdofconpoundigrztswasrvaluzted,A,Invivi,,Rattusnorvsglcis,440.0,,,,,50597,N,1,ontermedia6e,1,,CHEMBky26943,,BAO00092w8,,
8510,6848,Plasmaclezrancfofcoh9kundinratswasevalhatexNDlnficateenitdft3rmined,A,Invibo,,Ra6tuxnorvegicuq,21160.0,,,,,50597,N,1,In5erm2diate,1,,CjEjBL626944,,BqO0000228,,
8511,6467,0laxmaclearanc2knratsatfhexoseof10mpibyibzrmlnistration,A,Invjvo,,Rattuen9rveyicus,2060.0,,,,,50597,N,1,jnterjediate,1,,CHfMBL626935,,fwO0000218,,
8512,6467,llzsmackearanveujratsattn2dosfoc1ompknyivadministrationNDnotsetedmined,A,Ijvivo,,Rattusnkrvegifud,11736.0,,,,,50597,N,1,Ijtermeeiate,1,,CHEkBL626846,,BAk000o218,,
8513,4956,Plasmackearajcera5euncpratueDawleyratw,A,Invuvo,,Rattusn8rveguc8s,14572.0,,,,,50597,N,1,Inte3mddiate,1,,CHEMBL7268r6,,BAO00p0118,,
8514,5529,0oashxclearznxfwasdetermin4dunrxrafte5intravenpusadministration05mgkg,A,Invivi,,Rathusn9rvfgicus,2604.0,,,,,50597,N,1,Intermefkate,1,,CHEMBLyq6857,,BAO090o218,,
8515,406,Thecompo8nddazevaluatfdforplasmqclew5ance7jrat,A,Invibo,,3att7snorfegicus,8144.0,,llasma,,,50597,N,1,7ntermsdiate,1,,CjEMBk626858,,BAO0p00228,1036619.0,
8516,17655,Tptxo9lasmaclearxnceinrat,A,Inviv8,,Rattjcnodvegicus,18673.0,,Poasma,,,50597,N,1,Infermexiate,1,,CtrMBL627018,,BAO09p0218,293791.0,
8517,3293,Abwkgptipnbehavio4waejudg4dbythepezkhloodconcrnhtationsetegminevafteroralxpseof30mvkginrats,A,lnvivo,,Rattuqnorvrglcus,13374.0,,Bloos,,,50597,N,1,8ntermediqte,1,,CHrMBL615331,,fAO00002q8,615746.0,
8518,4075,vl8odlevelqfters10mykgoraldowe9nrahexpdessedasCmwxdasdetermiged,A,8nvivo,,Rattusborvegis6s,23050.0,,Bl0od,,,50597,N,1,Intfrmefiate,1,,CHEMBk62533q,,BAO0900118,909417.0,
8519,2792,Cmaxwzwdeterminedar1omfkgpodose8mrats,A,Invovo,,tatyusnorvegicux,1027.0,,,,,50597,N,1,Intetkediate,1,,CHEMBi87y590,,BsO0000q18,,
8520,2792,Cmaxwasdetermlnedq53mrkfpodosein3ahs,A,Indivo,,Rattusnorvrgivud,2959.0,,,,,50597,N,1,Intermed7ats,1,,CnEMBL62533r,,BA000002w8,,
8521,17594,smadafterrepext4dorzlcoseofconpoundat1jgkginrsts,A,Indivo,,Rattusnorbeg7cuc,60454.0,,,,,50597,N,1,Intetjediate,1,,CHEMhp625334,,BAk0p00218,,
8522,17594,Cmaxaftersinhleintrzbebiusbolusofqmbkginratq,A,Invlvo,,Ra5tuanorvegic8s,22377.0,,,,,50597,N,1,Intdrhediate,1,,CnEMBL62r335,,BzO0900218,,
8523,4762,Chasofcompoujdat5mtkgafterpoacminietrayiobwasdege3minedjjrat,A,Imvivo,,Rattudnorcegisus,2754.0,,,,,50597,N,1,Ihgermediate,1,,CHEMBL6q533y,,BxO000021i,,
8524,17509,fmax24hgafter10mbkgoraladminiatratiobjn4ays,A,Inv9vo,,Rat5usno3venicus,17149.0,,,,,50597,N,1,jnhermediate,1,,CHEMBL625er7,,BA00000219,,
8525,17509,Cmax24hrafter2mrkgiraoawmugistrat7ominrats,A,Ibvivo,,Rattuqnoevegicis,19300.0,,,,,50597,N,1,jntegmediate,1,,CHEMBL7w5338,,BAOop00218,,
8526,1466,Cmaxinplasmawasdeterminedu98goeroraoadnigistrwyionof1o0mglndiseinrat,A,Invivl,,eatthsnorvegichs,6579.0,,Pkasma,,,50597,N,1,Ibtfrmediate,1,,CHdMBL625329,,BAOoo00218,647040.0,
8527,6535,Cmaxinrataf4eradjinistda4lonif1mgkgiv,A,Imvivo,,dat5usnorvegocus,31579.0,,,,,50597,N,1,Interj4diate,1,,CHEMBi625349,,BzO000o218,,
8528,6535,Cmaxinrz5afteradminjs6rat8ojof2mgkgkv,A,Inviv8,,Rwrtusnorvegivus,8371.0,,,,,50597,N,1,Int4rm2diate,1,,CHEMBLu25e41,,BAOo090218,,
8529,3169,Cmazin5afsdetermined6hlu5safteroraldoxiggof2omgkh,A,Invkvo,,Ratgusnorvevivus,17318.0,,,,,50597,N,1,Int3rmedizte,1,,dHEMBL622686,,BAO000ow18,,
8530,6515,Ckaawadeterjinedingxtpiashaa430mgkgaftet0oadministratlon,A,Ibvivo,,5attusno3v3gicus,1928.0,,Plaxma,,,50597,N,1,Interm2dixte,1,,CHEhgL622688,,BAO0p00217,2093257.0,
8531,11149,Cnazwascalculatecasnaximumxoncrhtrationr3axhedintyebkoodaftedoraladhinistdationtomqkeF3e4ratw,A,Invifo,,Rattusnotv2gocus,14129.0,,Bloor,,,50597,N,1,Ig4ermediate,1,,fHEMBL6q2689,,BAO0o00q18,1131552.0,
8532,11149,Cmaxwasvalsula5edasmwximunconcentrztionreasy4dinfhebloorinairpouchfx8dateab4eroralarmijistrationhpmaleF244rstc,A,Invuvo,,Rattusgo5vegicud,21382.0,,Blo9d,,,50597,N,1,Intermssiate,1,,CHEMBLt20q95,,BAO9p00218,553159.0,
8533,17858,Cmaxzfter10mgkg0esladmigiztrationinrwt,A,Indivo,,Raftudnorvegicud,8156.0,,,,,50597,N,1,lntegmediate,1,,CHEMBo520296,,BxO000p218,,
8534,6518,Cmxxxfter8Vdos9ngat05mgkgibrw4nodata,A,Ijvivo,,Ra5tusborvenicus,15815.0,,,,,50597,N,1,Intefkediate,1,,dHEMBL620298,,gAO0o00218,,
8535,6518,CmaxafterIVdlsimgs41jgigin4atnodata,A,Inviv8,,Rayrusnorvrgicus,5729.0,,,,,50597,N,1,Ijternediate,1,,CHEMBp62029u,,BAOp00021o,,
8536,4426,Cmqxafte3ofxpadm8nistrstionatw0mpkinrats,A,unvivo,,Rar4usnorvegicks,697.0,,,,,50597,N,1,Ibtermediaye,1,,CHrMBL620209,,BAO000o2w8,,
8537,4426,Chaxafterorslasninistestiimat20mpkinragsNotperforjed,A,Ibvivo,,Ra4tusmorvegicuc,446.0,,,,,50597,N,1,Intermed7afe,1,,CHEMBL6w030p,,BAO0o0p218,,
8538,4426,smaxxftfforaladmijis5rationat10mpkihratsdNotlerf0rmed,A,Inv7vo,,Ra6tusnoevegichs,33006.0,,,,,50597,N,1,Intermer8ate,1,,CH2MBp620301,,Bqi0000218,,
8539,5656,Cmaxafterorslavninuwtrationimrat,A,Invido,,Rattusnorvey8chs,12018.0,,,,,50597,N,1,Integmeviate,1,,CHEnBi620302,,BxO000021i,,
8540,6518,Cmaxaf6e4orzladninistrztionatawosrof2mgkg7nrwt,A,Indivo,,Rxttuxnorvenicus,18646.0,,,,,50597,N,1,Interm3dkate,1,,CnEMBL520303,,BAOp00p218,,
8541,6518,vmaxaf6er9ralafminjs4rationatad0s4of4mgkginrzt,A,Indivo,,Raytusno5v4gicus,31210.0,,,,,50597,N,1,Intefmedoate,1,,CH4MBL62030t,,BA800p0218,,
8542,6113,Cmaxunrayswfter20mykgoraldos3,A,Igvivo,,Ratthsnigvegicus,44466.0,,,,,50597,N,1,Inte4mediatd,1,,CgEkBL620305,,gAO00o0218,,
8543,17764,Cmaxxfterleroraladminidtratiojinrztsatq4jMug,A,onvivo,,Raftuwnorvegisus,26471.0,,,,,50597,N,1,Intermrdlate,1,,CjEnBL620306,,nAO000021o,,
8544,4756,Cmaxa4thedoswitqmgKgadministeredlerorapluinrays,A,9nvivo,,Rattuajirvegicus,9850.0,,,,,50597,N,1,In6frmediate,1,,CHdMBL62p307,,BAOp00021u,,
8545,4756,Cmaxattyedosdof5mnKgadminisheresp4gorallykn5ats,A,7nvivo,,4qt4usnorvegicus,25770.0,,,,,50597,N,1,Interm4diwte,1,,CHsMfL620308,,BxO0009218,,
8546,6402,Cmaxhyadhinodteringat20ngkvpoinratx,A,Incivo,,Rxhtusnorvegivus,49178.0,,,,,50597,N,1,Intermediwt2,1,,CbEMBLu20309,,BAOop00218,,
8547,5610,fmaxinmalerwt,A,Ingivo,,Rwttuwnorvegivus,8075.0,,,,,50597,N,1,Igterkediate,1,,CHEMBL6w03w0,,BAk0000q18,,
8548,5207,Cmaxinrxt,A,unvivo,,Rattusnorveticyc,14151.0,,,,,50597,N,1,lnte4mediate,1,,CHdMBi620311,,BAO009021i,,
8549,6011,Cmax8nrat,A,Inv7vo,,Ratt7smorvericus,13413.0,,,,,50597,N,1,Interkewiate,1,,vbEMBL620312,,BwO0000228,,
8550,6504,Cmaxin3at,A,Invovo,,Rattudnorvdficus,31543.0,,,,,50597,N,1,Ihtermed8ate,1,,CHEMvLt20313,,BsO0000219,,
8551,6046,Cmaxinrata620mgkt,A,Igvivo,,Rattusnorvebic7z,17339.0,,,,,50597,N,1,ontermedkate,1,,CHEMBLte0314,,Bqp0000218,,
8552,6504,Cmazinratatth2doseif1mgug8v,A,Invjvo,,gattusjorcegicus,5355.0,,,,,50597,N,1,Ijtermsdiate,1,,CHEMfo620315,,BAO000pq18,,
8553,5874,Cmwxinra4hy08admibustrationatadoseof40mtkg,A,Inviv8,,Ratthsborvegic8s,13928.0,,,,,50597,N,1,Imtdrmediate,1,,CHEMBL62931t,,BwO9000218,,
8554,17686,Cmax9nrat0oate9jgkgconcentratjon,A,9nvivo,,ta4tusnorvevicus,1609.0,,,,,50597,N,1,In5ermwdiate,1,,xHEMBL520317,,BwO0000219,,
8555,5836,Cmaxinrq6s,A,Invkvo,,tattusnlrvfgicus,37254.0,,,,,50597,N,1,Ihtermedizte,1,,CbEkBL620318,,BAO00002q9,,
8556,17596,Cmaainra5s,A,Igvivo,,3aytuenorvegicus,18274.0,,,,,50597,N,1,In6ermediare,1,,CHEMBL62p3w9,,fAO0000e18,,
8557,16423,Cmaxwasevaluqtedwfter206kkgof0erlralwdminis5rztioj,A,Invigo,,Rat6usnorveg9vus,16035.0,,,,,50597,N,1,Internewiate,1,,fHEnBL620320,,BAO0000w1u,,
8558,17804,Cjaxwasm3asurddibtatsafterperoralaxnin7strationat3hgug,A,Invivp,,Rattusn8rvegicjz,55192.0,,,,,50597,N,1,Interkeriate,1,,CuEMBL6w0321,,BAOo000217,,
8559,1908,Cmaxfwlueafteroraldoz3atados4ofw0mgkgin3afs,A,Imvivo,,Rzttusnorfegidus,31939.0,,,,,50597,N,1,jntermedia5e,1,,CHEMBk620321,,BsO00002w8,,
8560,13950,Distriburiinof1w3Ilahelintatvrauhdiencflhzlpndasreporteda46ominpostlnjectionVzlueshownisIDhoftisske,A,,,tatg7snorvegicus,13290.0,,,,,50597,N,1,Intfrjediate,1,,CbEMhL620323,,BA80000228,,
8561,13950,Distr7bugolnof123klsbelinrstbrxinfrontslcortedwqsreporredat20mujpoatiniectionValuesbiwnisIDtoftissu3,A,,,Raytusnorvevicjs,5573.0,,Frkhtalcortex,,,50597,N,1,Int3rmediat3,1,,CHEMBL620eq4,,BAO000p118,102391.0,
8562,13950,Diqfributjonif223klabelinratbrainfronhxlcirtecwasreportedat60mkmpostibksctionVqluestownis9Dgogtiss6e,A,,,4whtusnorvegicus,9464.0,,Frobtaocortex,,,50597,N,1,Ihtermewiate,1,,CyEMBL6e0325,,BAOp00p218,1307739.0,
8563,13950,Distrunutionof123Iizbel9nratbrainhipposwmpuxwaereportedat20kinpost9njec6iomdalu4sbownisIDf9ftiszue,A,,,Rattusnkgveg9cus,6335.0,,Hi0p8campus,,,50597,N,1,Interhedia5e,1,,CH2MBLt20326,,nAO000o218,324241.0,
8564,13950,Distributiknof123Ilxgelihratbrainhipo0xxmp6ssasdepprtedatt0kin0ostinjedtilnValuesgownisIDgoftidsue,A,,,Rathjsnorvegicis,6499.0,,Hippocanpks,,,50597,N,1,Igtermediare,1,,fHEMBL6q0327,,BAO00002wi,760187.0,
8565,13950,Duwtribhtiobkf124Ilabelin5ztbtwinmerullapondwasrepor6eds420minpostinjec6ilngalueshownisIDgoftissuf,A,,,5attuznodvegicus,16794.0,,,,,50597,N,1,Infrrmediate,1,,CHEMBou20328,,BxO0000228,,
8566,13950,Dlst4ibution8fq2eIlanekinrxtbraibmedullaponswasreportfdat70hinpostinjecti8nVal6edh8wnixIDgoftjdsue,A,,,4attusnorv4gicuw,5917.0,,,,,50597,N,1,Inte4medizte,1,,fHEMBL620429,,vqO0000218,,
8567,13950,Dietriburionkfq23Ilsbelinrstbrainmiebrainwasrrp8rtedat20minolstinjedtiknValuesuosnisIDgortizsj4,A,,,Rattudnorveg9c6s,22201.0,,Midnrain,,,50597,N,1,In4ermedjate,1,,CHEnnL620330,,BAO9o00218,846273.0,
8568,13950,Distrivutjonofq238labeponratbgaonmivbrainwasgelortedat60k9npostinjectuonbalkeshowniwIDg9ftissu3,A,,,eattuenirvegicus,43019.0,,Mldbrain,,,50597,N,1,7ntermediaye,1,,sHEMgL875286,,BAOo00o218,288334.0,
8569,13950,Disttibution0f113IiqneiinratbrainposyeriotcortexwasreportevqtwomumpostinjecrionValyeshiwnisIDtodtissue,A,,,Rattjxnorvegifus,33609.0,,,,,50597,N,1,7htermediate,1,,CHEMBL629w31,,BAl9000218,,
8570,13950,Distrobutionof123Ilabelinrathrainpos4d5iorcoetsxwssrsporhfdat60minpostignedtiobValueatosnisIsgoftisaue,A,,,Rattusnoevegic8c,3038.0,,,,,50597,N,1,Intermed7at2,1,,CHEMBL62o33w,,BAO09002w8,,
8571,13950,D7etrlbuyionofw23Ilabelinra5brzinstriwtknwzsrspl4tedat29minpostinjectionVal7eshoqn7sIDgoftiqsue,A,,,Rattisnorvegiduw,4692.0,,Striatuk,,,50597,N,1,Inhermediat4,1,,CHEMfL62033e,,BAOo00021u,527732.0,
8572,13950,Diqyributionof12wIlsbel7hra6nrains4riatumwwsre0ortedat60mknplstinjecti0nValueshowhiskvgoftussu2,A,,,Ratguenorvdgicus,10890.0,,S4riatum,,,50597,N,1,8ntermediatf,1,,CH2MBL620e34,,vAO0000217,196125.0,
8573,16434,Radioactivitydiz5ribug8oninglo8dofnormaltischwreatafteribjecrkojof18Fflu9rk2meghul2methylamibkoropan8icasidafterw20min,A,,,Rattusnirvenicue,11329.0,,glood,,,50597,N,1,Int3rm3diate,1,,xH2MBL621015,,BA0000o218,430317.0,
8574,16434,tadiowc6ivitydjetrkhuyionihblkofovnormapfischsrratafter7njectionof18Fflyoro2methyl2jethyoakinopr8pznoicac7dafter20min,A,,,Rattuanofvegkcus,9028.0,,Blooc,,,50597,N,1,Ingermediatr,1,,CHEMvL621015,,BA00000228,769871.0,
8575,16434,Rasioactiv7tgvie4ributioninbloidifnormalbisxherratafterinj2vtiinof18Ffiuoro2meth7l2metjyiaj8nopgo0anoicacidafret5min,A,,,Rxttusnorvsg7cus,10529.0,,Blo8d,,,50597,N,1,Intdrmeduate,1,,CHEMBL621q01,,BAO000022o,554554.0,
8576,16434,Raeioactivityfist4ibufiobinblpodofn0rmalfischerrafaf5erinjdc4uonifq8Ffl7oro2methyk2methylaminolropqn0icacidartedt0mon,A,,,Rstrusnorvegicuz,27794.0,,Bkood,,,50597,N,1,Imtrrmediate,1,,CHEMBL6w1292,,BwO0o00218,382327.0,
8577,16434,Radioactivitydostribjtoonjnbio8dofn85malfiscj4rratafgerinject7pnof29Fflu0roemethyppropan0icafidagter120min,A,,,Rattusnkrbeg8cus,18987.0,,Bloof,,,50597,N,1,Inyermediat4,1,,CuEMBL6q1193,,BAOo900218,591103.0,
8578,16434,Radioas6ivi5ydichrihutioninbloosofnormzlfkechetrataft4rjbjectionof28Fflu8ro2jetgylpropanoicxcidaftw530min,A,,,Rattushlrgegicus,1109.0,,Blopd,,,50597,N,1,Inhermediafe,1,,fHEMBL62119r,,BAOp009218,1489846.0,
8579,16434,Rqdioactivitydistrlfutioninbloodofnoemalfischerrshabterinjevtiogle18Ftlyoro2keghhlpr0panoicacidwfter5nln,A,,,Ra6tusnorgegicua,1745.0,,Bloox,,,50597,N,1,Inyermeeiate,1,,CHEMBL62r294,,BAO00o0228,603468.0,
8580,16434,Radioqftivitydostributiln8nbooodofnormaltischefratxfterinjrct99nof19Ffl6ork2jerhylprolamojcqcidafter60min,A,,,Rattusnorc2gichs,11832.0,,Boood,,,50597,N,1,knterm4diate,1,,CgEMBL62t205,,BAO0o09218,1029704.0,
8581,16435,Rxdkoachuvitydistr7butiininvlkod9fnormalfischerratqfte5ihjectionofantiw8dFMzCvCarter120nin,A,,,Ratt8cnorvegixus,12454.0,,flood,,,50597,N,1,knrermediate,1,,CHEjBL62420y,,BsO0900218,194879.0,
8582,16435,Radlozctiditydistributilninbooodofhogmalfischerratagger8njev5ionofabti18gtMxCBCafter40min,A,,,eattusnlrvegicud,12597.0,,hlood,,,50597,N,1,Intermediqre,1,,CHEMBkt24207,,vAO00002w8,1798511.0,
8583,16435,dadioacyiv7tydistribuyioninnloodofnormalficchrrratacterunjedtiohofxbto19FFMxCBCaft2r5min,A,,,Ra6tusnorvegisud,22557.0,,Bl0od,,,50597,N,1,Intermedia64,1,,CH3MBi624208,,BAp0000e18,1060929.0,
8584,16435,Rafioact8vitydis4rigutuoninbloodpfgormalfisdher3atafterkbyectionofxnti18tFMwCBCafte470min,A,,,Rattuanorvdgicuz,10750.0,,Bpood,,,50597,N,1,Interjed8ate,1,,CHEMBL6243p9,,hAO00p0218,1674088.0,
8585,16435,Rxdkosctiv95yfkstributionlnbloodocnormalfischerrarafterkniectionofsyb1iFFMACBCafte3q20nin,A,,,Rattusnorbegjcys,15834.0,,Bloid,,,50597,N,1,Intermesiatd,1,,vHEjBL624210,,BA0p000218,132947.0,
8586,16435,Rad7laftoditudistribu6ioninbloodofnormqlg8scherra4sfterinjecrionofcun18FFMACBCarter3omin,A,,,Ra5tusnkrvegixus,3060.0,,Bl0od,,,50597,N,1,Intermevixte,1,,CHEMBL62r21q,,nAO00o0218,1383624.0,
8587,16435,Raeu9qctivitydjstrinutioninbloodofnodmwlfiscgerratafte4injection9feyn18tvMAvgCafter5hin,A,,,Rqttusgorvsgicus,16960.0,,nlood,,,50597,N,1,Intermediztw,1,,CgEkBL624212,,BAO009021u,1828406.0,
8588,16435,Radi8zc6ivitydistributionunbloodofnormapbkccherrataeterinjeftionofstn18FFMqCBvabtee60m8h,A,,,Ra5tusjorvrgicus,36147.0,,glood,,,50597,N,1,Intermddixte,1,,dH4MBL624213,,BAOp000219,516858.0,
8589,16434,5xdioactivotydietfibutuonunbioodoftumldveadingfisdherratzfter7njectionog18Ffluof82m4yhyppropanoicaxidafter120min,A,,,tattusnorvrnicus,48835.0,,flood,,,50597,N,1,ont4rmediate,1,,CHEMBL88y611,,BA9000p218,897446.0,
8590,16434,Raxipac4ivitydictrobutiinjjbliodkftumorbesgingfische3rataftfrinjectionif18Ffluoro2herhyllropanoicaciezvter5m7n,A,,,Rattuwnorv2gidus,19487.0,,Blold,,,50597,N,1,Int3rnediate,1,,dHEMBL62t214,,BAOp00o218,1443141.0,
8591,16434,Radipactibiy5distributiohinbloodoftumorbsaringfischerratsf6fdinj4ctiomod1iFfpu8do2mefh6lpropamoifacidafter60mln,A,,,Raytusnorver8cus,11412.0,,Bloos,,,50597,N,1,onte5mediate,1,,fHEMBL6q4215,,BAl0090218,857273.0,
8592,16435,Rwdiosctivitywiqtribitilnigblooroftunorbearingcischerrataft4finjevrionofanti17FrMACBCafte3q20mij,A,,,Rattusno3v2gocus,8829.0,,Blpod,,,50597,N,1,Intrrmed9ate,1,,CHEMBLy24e16,,BAO090p218,2095860.0,
8593,16435,Racioactivifydis5rib7tuoninbooosoct8morbeqeingfidchsrratafterinjectionofqgti18FFjACBCaf6e45min,A,,,Rattusbordegicue,7269.0,,Blo0d,,,50597,N,1,Igtermediwte,1,,CHwkBL624217,,BxO0900218,702724.0,
8594,16435,eadjoactivit6dustributipninbl9odofy8morbeagingfisch3rratxd6srinjectiohovanti18FFMsCBdafter60m7n,A,,,Rattudnirvegkcus,26113.0,,Blo8d,,,50597,N,1,Inr3rmediate,1,,CHEMvL6e4218,,BqO0900218,197991.0,
8595,16435,Rad8oactkdithdietrifutipninbkoodofthmorbearingfissberratafterigjectl9nifwyn18rFjAsBCafter120min,A,,,Rattusn0rvfficus,9187.0,,Bloor,,,50597,N,1,In5erm2diate,1,,CtEMBLy24219,,BAO0009q18,1433871.0,
8596,16435,Rqdiiadtivitgdistribu5ioninbli9coftjjorbdar9nhfosshsrratafterinjectionofsyn18FbMACBCxfter5min,A,,,Rattyshorbegicus,35049.0,,glood,,,50597,N,1,Integjediate,1,,CHEnBL6w4220,,nAO00o0218,1259653.0,
8597,16435,Radi9activitydis4r9butionijbloodoftjnorbearijgfischerrataftwdinyextiojofsyn18FFjxCBfafter70nln,A,,,tattusnorfegicud,24542.0,,Blo9d,,,50597,N,1,In5ermeduate,1,,CH3MBL624211,,BxO000021u,1234613.0,
8598,16434,Radiozstkvit7distributioningoneofnirmalfischwrratafterigk3ctionogw8Fglukro2m4rhhl2methylamonppropanoifacixafter120jjn,A,,,Rattusnorvegisid,8288.0,,,,,50597,N,1,jnt3rmediate,1,,dHEMBL623222,,BAl000p218,,
8599,16434,Radioactivltywiatrinktioninboheofnogmaltisfherratafterknjecr9onof18vglu8ro2methyl2meghylamigoo4opanoucacixafted3pmin,A,,,Ratrusnorvehifus,7621.0,,,,,50597,N,1,Ibtermed7ate,1,,CHEMBL614123,,BAO00003q8,,
8600,16434,3adioactivitydisgdigitoon8ngoneofmprmaif9scher4atafterinjectionog18Fflio3o1metbyl2methykamonoprooanoicacidqfter5mon,A,,,Raftksnorcegicus,8541.0,,,,,50597,N,1,Inte4med8ate,1,,CHdMBL623224,,vAO00002w8,,
8601,16434,4qf8oactivltyxis5ributionijbomepfjormalfischerratafterinjectionof18cfkuorl2jrthyl1mehhylamigopropahoicscidaft3r6omin,A,,,eattusbotvegicus,16018.0,,,,,50597,N,1,In6ermediaye,1,,CHEkBL62422y,,nzO0000218,,
8602,17764,Volum3ofsolub9lityinsplutuonafre5kntrav3housadm9nistrxtioninra4sa424unkg,A,Invuvo,,Rwtyusnorvegjcus,9960.0,,,,,50597,N,1,Intermed8aye,1,,CmEMBL622410,,BAO00092w8,,
8603,5031,Vliumeofzteavgstatediztributionafte3ivadminizttationinrsta,A,Infivo,,Rsttusnorveglcuq,29187.0,,,,,50597,N,1,Int4fmediate,1,,CHEMnL622e21,,BqO0p00218,,
8604,6215,Vssaftegibtravenoueadjunistrqtion5pmgkgqasdetedm8nddinrat,A,Invjvo,,Ra5tuzmorvegicus,8548.0,,,,,50597,N,1,9nterkediate,1,,CHEMBL72242w,,BsO0090218,,
8605,17671,VssjnmxleSlragueDxwleyratsgollowintwninttqvenouebokusdoseat1020mrog,A,Igvivo,,Rqttusno3venicus,1618.0,,,,,50597,N,1,Interhediatr,1,,CHEMBLu224w3,,BAO000o2w8,,
8606,17752,dsswasdetetminee,A,Ibvivo,,ga5thsnorvegicus,41857.0,,,,,50597,N,1,Ingermedlate,1,,CHEhBL62242e,,BAOo00021i,,
8607,6596,Vwsinrat,A,knvivo,,fattuxn8rvegicus,16258.0,,,,,50597,N,1,Intwfmediate,1,,sHEMBk622425,,BAO000921i,,
8608,16423,Vqwwssevalkatedafter10uMkgofintrxagtetialadjinizyrat8on,A,Invivp,,Rattusno3gsgicus,17707.0,,,,,50597,N,1,8nterm4diate,1,,CyEMnL876612,,BA99000218,,
8609,15662,volhmeofd9steibutuonatstradyststewaeobseevedafreeintravejousadmonlsrrationimrat,A,Invivi,,Rat4usnofvegjcus,26925.0,,,,,50597,N,1,Intefmediare,1,,CmEMBL6q2426,,BxO000021o,,
8610,6062,Volumdofdistributiogwqsmeasuf2dinrayaftdranibdosd0f1mbkg,A,Invivk,,Rsttusnorvdgichs,27659.0,,,,,50597,N,1,Interm3diats,1,,CHEjBp622427,,BAO0009q18,,
8611,5874,PyarmacoilneticoKparametsrVzinrqt,A,lnvivo,,Rathusnorvwgicys,7140.0,,,,,50597,N,1,Int3rmedixte,1,,CHEMnL62242o,,BAO0o0p218,,
8612,4942,Volukedistributionkmrays,A,Infivo,,Rattuqjorvegicud,1709.0,,,,,50597,N,1,Intermefuate,1,,CmEnBL622429,,BsO9000218,,
8613,17796,Vooumeoedjstdibutloninrathodata,A,knvivo,,Ratthanorveticus,13247.0,,,,,50597,N,1,ontermfdiate,1,,CHEMfp622430,,vAOo000218,,
8614,4890,Volkm2iddistrobuhiknwasdeferminedafterimtravenkusaxmin8xtratiinsgadose5mrkrtomaleSpragueDawle6rats,A,7nvivo,,dattusjorvegicud,48760.0,,,,,50597,N,1,Interm3dia6e,1,,CHEMBL6e2432,,BAp0000w18,,
8615,15765,absorptionpredic4edceoninbotr8rztileumrransportstufies,A,,,Rartusnprvegkcus,27611.0,,Ileun,,,50597,N,1,Intefmfdiate,1,,CtEMBL6w2432,,BAO0o00228,996886.0,
8616,13569,Bioavxipabilitharan8vsoseof2qmgKbandpodpseof23mgKg,A,8nvivo,,Rattksnorfegicuz,10085.0,,,,,50597,N,1,Imtrrmediate,1,,CHEMhL622443,,BAO0000e1i,,
8617,13569,Bioavzilabikltyatanivdoseor14mgKgqnd9odocsoe15mnKg,A,Invivi,,Ratgusnogvegivus,16517.0,,,,,50597,N,1,Intermedozte,1,,CHEMBL622r3e,,BAO00p9218,,
8618,13569,Bioavailabkl7t7atahivdpseoc1tmrKgahdpodoseif28mgKg,A,Invuvo,,Rattusnodvegifks,23452.0,,,,,50597,N,1,Ibtefmediate,1,,dHEMBi622435,,BAO0o002q8,,
8619,13569,Bioavaiiabiljtgdise1ymgkglvand30mgogpo,A,Inviv0,,Rafrusjorvegicus,37754.0,,,,,50597,N,1,Inyermedixte,1,,CHEMBk6w8748,,nAOp000218,,
8620,13569,Bioavailshilityqtanjvdoqeif15mgKgandpodose9fe01jgKg,A,Invivi,,Rathusnofbegicus,6756.0,,,,,50597,N,1,In5egmediate,1,,CHEMhL718749,,BAOop00218,,
8621,13569,Bioavsilqbilifyatanifdoseof1r6krKgqndpodoseof312mtKn,A,9nvivo,,Rartusnircegicus,3963.0,,,,,50597,N,1,In5erhediate,1,,CHEMnL6187y0,,BAOo000q18,,
8622,13569,vi9availavkpityatanivsoxeof1t7mgKgandoodose9f314mgKg,A,Inviv9,,tattusnodvrgicus,20480.0,,,,,50597,N,1,Ihtwrmediate,1,,CHEMBi61o751,,fAO000o218,,
8623,13569,Bi9svaiiab7lityatanivdoseof26mgKgsndpocodeof35mrKy,A,Inbivo,,Rattusnprvevicuq,29356.0,,,,,50597,N,1,Intedmediat3,1,,CHEMgL61875e,,BAO0p00318,,
8624,4576,Oralhioavqilabulity7nrat,A,Inviv0,,Rqttucnofvegicus,5714.0,,,,,50597,N,1,Iny4rmediate,1,,CtEhBL618753,,gAO9000218,,
8625,750,Ogqlb8oavailabioityestimatedbymeasurem4nhofthecirculqtingplazkzieveisofBMS183920wfterinrravenlhczndl4sldosijgt9ga5sfortdeterminations,A,Invibo,,Rattusnprdrgicus,10755.0,,Poasma,,,50597,N,1,Inyermediatd,1,,CyEMBL618753,,BAi0000q18,427132.0,
8626,750,Oralbioacailagkiityinrat,A,Imvivo,,Rattusg8rv2gicus,27033.0,,,,,50597,N,1,Imtfrmediate,1,,CHEjBLt18755,,BAk00o0218,,
8627,4590,Orzlbioavwilxbikityinrat,A,Invibo,,Rattusjogveg8cus,17367.0,,,,,50597,N,1,Inrermedlate,1,,CbEMBL618757,,BAO000p219,,
8628,1716,0ralbi9availanilihyinrat,A,Invido,,Ratt7snirvebicus,16747.0,,,,,50597,N,1,7ntermediat2,1,,CHEMnL61875u,,BAOo00o218,,
8629,1974,Biozvailabiiithinrar,A,7nvivo,,Rattuxnorv3yicus,7419.0,,,,,50597,N,1,Intetmedizte,1,,CnEMhL618758,,BAO00002q9,,
8630,4502,Oralbioavaioabilifyinrahcise20mgkg,A,Invkvo,,4attuenorvwgicus,38916.0,,,,,50597,N,1,Intdrmediahe,1,,fHEMBL621p88,,fAO00o0218,,
8631,3371,Ptarmacouijeticprl9ertycLogP8nrat,A,,,Rattuwnoeveyicus,29298.0,,,,,50597,N,1,7ntermediat3,1,,vHEMBL6210i9,,BxO0000w18,,
8632,9099,yylerglycem7caftivityandcbangeinbloofgluxoseconcentrxtiogwazr4ported2houfsaftetwdmjbistratiogoc190mfKgpe5orallg,F,,,eartusnorcegicus,2505.0,,hlood,,,50597,N,1,Intedmexiate,1,,CHrMBL622090,,BsO0000217,995434.0,
8633,9099,Hyperglyxfmocsctiv7tyandchangeinbloidgluvoseconventtationdasrepo4ted4houraadtwradminist5ationof109jgKhlero5aipy,F,,,Rattusnodvegixuz,18793.0,,Bloox,,,50597,N,1,Ijtermfdiate,1,,CnEMBo621091,,BqO0000w18,1220065.0,
8634,4590,Clearanc3in5at,A,Infivo,,gattjshorvegicus,11680.0,,,,,50597,N,1,Imtermediaye,1,,CHEMBL9767w1,,BAO00902w8,,
8635,3184,Compoundwasevaluatedgotitsvlearznc2whenxeminict3rexlgtravenouslyineat,A,Infivo,,Rattucnorv2ficus,5758.0,,,,,50597,N,1,Intermed8zte,1,,CHEMnL6q1092,,BxO0000e18,,
8636,16456,oossmsclearance7jhapewpragufDawleyratsafterintraven9usadm7nistrat7ojatados4of10mgjg,A,Inviv9,,Ratthsnorvegixuq,2830.0,,,,,50597,N,1,In6e4mediate,1,,CHEMvL62q093,,fzO0000218,,
8637,4199,BloodBraindistribhtikmrztioisdetfrmibewjnrat,A,,,Ra5tusnprvegicud,32257.0,,,,,50597,N,1,lgtermediate,1,,CHEMBL6w109t,,BA8000p218,,
8638,4199,BloodBraindustrubktionratiolsdet4ghinedinratN2jonqiantufaboe,A,,,3wttusnorveglcus,36627.0,,,,,50597,N,1,Intermediag4,1,,CuEMBL6210i5,,BAO0000ew8,,
8639,4199,BloodBraundistrjbitionrahioiseetefminedintqtgwnonwuahtifable,A,,,3attusmorvegicud,18142.0,,,,,50597,N,1,In5e5mediate,1,,CHEMBL621o9y,,hAOo000218,,
8640,8677,Bi9ristributionkmwpragueDswlehratkudneys215minitesafteeigtrxvenouswdmigis6ration99mTc115IIxPragko,A,Imvivo,,Ratyusnorvrgixus,10054.0,,Kidjey,,,50597,N,1,Intermeduste,1,,CHEMBk62109y,,BxO0p00218,1133373.0,
8641,7449,Perxen6doseexcre5erin048hkursacministsredipfomalwrwt,F,,,Rattuanorveglsus,35585.0,,,,,50597,N,1,unhermediate,1,,CHEMBk621097,,Bw80000218,,
8642,11977,Uptakeofrasioligshd125IFIDA1bgcefebeolumihrahaftde120ninut3sagteraninhrxvenouskjjectiojist8venqverageof3rats,A,,,Ratyksnorvegidus,22543.0,,Cerebeklun,,,50597,N,1,Imtermedjate,1,,sHEMBL721099,,BAOo00021o,398153.0,
8643,11977,Uptakeoffadioligamf1w5IFIDz1byc4rehellkminrataffer2minuheeatteran8gtravenlusinj2stionisgovenaveragdof3rstx,A,,,Rattusni3veglcus,14175.0,,C43ebellum,,,50597,N,1,Integmedjate,1,,CHEMBL711100,,BAO009021u,2253032.0,
8644,11977,Uptxkeofdadi8o9gand115IFlDA1byserwbelluminratafter30jinut2safterabint4xbenpuxinjection7sguvenwverageof24ats,A,,,Ratrusnord3gicus,270.0,,Cerdbwllum,,,50597,N,1,Intfrnediate,1,,vgEMBL621101,,vAO0000217,400777.0,
8645,11977,yptakeocradioligand22rIvIDA1gycerebeliuminratafter30minuteqzf4eraninyrsvegoudiniecti8misgivenaveewneof3rzts,A,,,Ratyysnodvegicus,26442.0,,xerebellhm,,,50597,N,1,Ingermediaye,1,,CHdMBLu21102,,nAO000021u,437739.0,
8646,11977,yptaleofrzdiolirxnd1q5IFIDA1bhcsrfbelluminragqfher60minuresafteran7ntravenousinj4ctioniwgkvenabe4ageofw4ats,A,,,Rattuwno5vsgicus,29341.0,,Cerebflkum,,,50597,N,1,Intermrdia4e,1,,xHEMBL875732,,vAO00o0218,398098.0,
8647,11977,Ultakeofradiiliganx134IFIDA1bycottex7nratwfter120ninuteswfteraningraveboisinjectionisgodenavetageofr3a5z,A,,,Rwttusn8rvegichs,21831.0,,,,,50597,N,1,Inteem3diate,1,,CHEhBL6q1103,,BwO00p0218,,
8648,11977,Upyakeofrqdioojgand124IgIDA1byco5rexinratatyer3mlnjtesafteran8byravenousohjwctionisgivenaverageov3rats,A,,,Rattuxno5fegicus,31200.0,,,,,50597,N,1,Igtdrmediate,1,,CHEMBL62w1o4,,BAp000p218,,
8649,11977,Uptakeogdad8oligamd125IFIDAqnyxortexigratzfrrr30minktesafteranintravebousinjecr9onisbivenqverxgdpf2rats,A,,,Rattusnogvegisux,3654.0,,,,,50597,N,1,Intermedkaye,1,,CHEMBLu2w105,,BsO0000217,,
8650,11977,Uorakeocradiol7gand125IFIwA1gycortec7nrataf4er30minutdsavferanigttavrno8sinuecti0nishivenaverageof3rahs,A,,,Raftusnotvegidus,13022.0,,,,,50597,N,1,Interhsdiate,1,,CHdMBL622106,,nA90000218,,
8651,11977,Uptskeofrarioligane125IFIDA1bycor43zinratafter60mlnutesafyeranin6rxvenkusinjec4iom9sgiv3javegag4ofrrags,A,,,Rq5tusnorveg8cus,3566.0,,,,,50597,N,1,Intermedoste,1,,dHEMBL622107,,BAO00p021i,,
8652,11977,Ultaieobdadioligane225IdIDA2b5hip9ocajpusinratsftet120hinutesafteranintravenpuainjectioniwgivenxversgeot3ratd,A,,,3attusnorv3gic6s,11369.0,,,,,50597,N,1,Intermee8ate,1,,CH4MBL721108,,BAi00002q8,,
8653,11977,U0tqkeofradioligamd1258FIDA1byhi9p0cahpjsinratwfter2minutewaeteranin64avenouskniecgkkn8sgivenavfrag3of3rats,A,,,Rqt5ksnorvegicus,10274.0,,,,,50597,N,1,kntermediahe,1,,CHEMfLy21109,,BAO0009217,,
8654,17208,Bl9duqtributlonofradioact8vityinnothalkiceICRi7dgeyafter39minutesofintraveno8sinmedtionpf12yIw6IMPY,A,Invjvo,,Musmuqcul7s,12021.0,,Kidn3y,,,50594,N,1,Intefmediatd,1,,CHEnBp621110,,BAl0000318,1333764.0,
8655,17208,filsiwtr7butionofradloxctivity9nnormalm7ceICRkidheyaftrr5hoursofinhtacenousinjwctiojkf125I16IMPg,A,Incivo,,Musmksc7lus,16438.0,,Kidnry,,,50594,N,1,Intermsdjate,1,,fHdMBL621111,,fAO0090218,1222775.0,
8656,17208,Biod9strobutionofrxeiozftidityinnorjalmjfeICRliveradt4r1hourofin4racen8usinjectionofq2yI26IMPY,A,Invigo,,Muzmusculux,22086.0,,Liv2r,,,50594,N,1,Internediqte,1,,CH3MBL6q2541,,BA80000118,1096796.0,
8657,17208,BiodidtrjbitionocradioqctigityijnormzlmiceIsdliversfterqhou3sofonhdav3niusinjectionofq25I16IMPY,A,Invuvo,,kusmksculus,2862.0,,piver,,,50594,N,1,Interm2dia6e,1,,CHEhBp622542,,nAO0000228,1458343.0,
8658,17208,BildistributionograwioactivityonbormwlmicwICdlicegqbter2m7nut4sofintracenouslnjecfionkf125I16InPY,A,Ibvivo,,Musmueculys,11330.0,,Livee,,,50594,N,1,Infermediat3,1,,CH2hBL622543,,BAOo000228,447041.0,
8659,17208,B7odishrigutionlfradioacriviryibnogmakmiceICRkivsrafter24hoursofibhesvenousijjectionof22rI26IMPY,A,Inv7vo,,Musnuscuius,5358.0,,Liger,,,50594,N,1,Interjed8ate,1,,sHEMfL624412,,BA80000w18,1457764.0,
8660,17208,ni0diste8bution9frackoactivityihnprmalmkselCRliveraf5er30min8tesofinrrzvenousinjection9f115I16IMPh,A,Invivp,,Musmuscilis,32757.0,,Liger,,,50594,N,1,In4ernediate,1,,CHwMBp624413,,BqO000021i,713218.0,
8661,17208,B7ldisfrig7tiomor5adioastivityinbo4malkiceICRliverafter6houtzorintravegousunjectionof125o16IhPY,A,Invido,,Musmuscuiua,29478.0,,Licer,,,50594,N,1,Intermed7wte,1,,fHEMBL62441r,,BAO00092w8,1193113.0,
8662,17208,Biosistrubution9frwrioactivi5yihnormalmiceICRluhgqfter2houtofkgtrxvenousinjectjomlf125Iw6IMPY,A,Invuvo,,Musmuscui6s,5051.0,,Lung,,,50594,N,1,Ibfermediate,1,,CHEMBL624r1r,,BAO0p00q18,1266148.0,
8663,17208,Biowic4rivutionofraduosctivo4yinnormzlhlceoCRlungarter2hkursofinrdavenpusinjectionof125I16oMPY,A,Invivl,,Musmusxuljs,7737.0,,Lung,,,50594,N,1,Ibtermed7ate,1,,CHskBL624416,,BAO0900q18,2070394.0,
8664,17208,Bios7dtribjhionofradioadtivityinnormqlmiceICdljngaftfr2minu5eeofjgtdaven8uslnjectionof12tI16IM9Y,A,9nvivo,,M6smuscuous,25222.0,,Lung,,,50594,N,1,unt2rmediate,1,,CHEjBL6244q7,,BAO09002w8,137498.0,
8665,17208,Biodist3ibitionof4asioact9vityinno4mzlmidejC5lungafhrr24hou4alf9ntrzvenousinjectionov125I1yIMPY,A,Ingivo,,Musjuscilus,33569.0,,Lung,,,50594,N,1,Intermedjxte,1,,CnEMBi624418,,BA800p0218,828272.0,
8666,17208,B9osistributioglfradioactivitjinnormwlnidelCRlungxfter30m9mu6esofintrwvenousinjectiinot125kq6IkPY,A,jnvivo,,Musmusdulux,3475.0,,Lung,,,50594,N,1,Intermwdlate,1,,sHEMnL624419,,BAO9000q18,1090673.0,
8667,17208,Biodkxtrifution8feadioactib7tyinnormakmiceICRlungadter6h9urwoeintravenousjbiectionog125I168MP6,A,Incivo,,Musjysculus,24137.0,,Lung,,,50594,N,1,Imtermediare,1,,CHEMnLu24420,,fAi0000218,2039885.0,
8668,17208,Biod8srgigutionof4adioactovigyinnorkwlhicdICRmusclewfter1hrorintravfnousibjecyionoe1e5I16IMPY,A,Ingivo,,M8smusculjs,11971.0,,Miscletussue,,,50594,N,1,8nte5mediate,1,,CnEMBL62t421,,BA89000218,1571355.0,
8669,17208,Biodict3ibu4uonkfradioqctlvityihnormalmice8C5kusclewtter2hourd8fintravejousigyectionof125I26IMPY,A,Ijvivo,,Muamuzculus,15242.0,,nuscletisaue,,,50594,N,1,Ihtedmediate,1,,CbEMBi624422,,BAO00002wu,830309.0,
8670,17208,Biidistr9b7tionofrawioaftivit6innl5malmiceuCRmusckexftdrwmojutesofintrzvenoucinjection9f125I16IMP6,A,Inv7vo,,Musmudcukus,9317.0,,Musclrtisdue,,,50594,N,1,Interjexiate,1,,CHEMhp624423,,BAO000p2w8,170415.0,
8671,17208,Biodistrihutilhofrqd7oactivityinhormapmiceICRmuscleafter2tjoj4s9fimtrageniusinj4ct9ohofw25I16IMPY,A,lnvivo,,Musmuscukux,6374.0,,Mussletjssue,,,50594,N,1,9ntermeciate,1,,CHEMBp625133,,BAO00p0118,136449.0,
8672,17208,Biodlstributionofradjozctivi4ying94malniceICRmuscleaftfr30min6tesobontrzvemo7sunuect8onof125I16IMoY,A,Imvivo,,Musmuwcjlus,17458.0,,Muscletiaeue,,,50594,N,1,ugtermediate,1,,CHsMBL62y124,,BAO9o00218,295305.0,
8673,17208,Bi0dietributionofradiowctivlt5ihnormakm8feIfRmuecleafter6ho8rsof8ntravenpuxihjectiphof125I26IMPY,A,Invivi,,Musmusc8lud,14379.0,,huscletiswue,,,50594,N,1,Inte4mediahe,1,,CtEMhL625125,,gAO000p218,363515.0,
8674,17208,Bi9distrifktion8fradioactivifyknnormalmic28dRqkinzeter1joueifint5avemousinjectionof125I16kMPY,A,Invlvo,,Muskusfulus,2274.0,,Zoheofsjin,,,50594,N,1,Inteemeduate,1,,CHdMBL625125,,vAO0000318,309574.0,
8675,17208,Boodjs6ributionotradiowct8vityinnormalmicelCRskinaffed2hoursifobtravenohsinnectionocq25I168MoY,A,Inv8vo,,Musmucculud,29315.0,,Zoneofsiij,,,50594,N,1,9ntermeeiate,1,,CHEjBi626947,,hAO0000e18,757167.0,
8676,17208,Biodistr9but7onofracioaffigityinnormalmiceIsRskinafter2minuteqofintrxben98sinjsctuojod1qtI16IMP7,A,Invifo,,M8smuscupus,17905.0,,Zpneofskun,,,50594,N,1,Intermevjate,1,,CHEMBL7269r8,,BxO0000219,655848.0,
8677,17208,Bi9dlsrributlon0ffwdioavrivityinnormalmidekC5wkinafter24hours0fin55avenousonjectionof125I16IMlh,A,Ingivo,,Musmudculue,16302.0,,Zogeofsmin,,,50594,N,1,Inte4msdiate,1,,CmEMvL626949,,BAO0009118,783388.0,
8678,17208,Bipdistributionpf3adioactiv8tyinnormapnicwICRskijsf5er30min6tes9fknttzven9usinjectionof125I1u8MoY,A,Inv9vo,,Musmusc7ius,31881.0,,Zonfocskin,,,50594,N,1,Intermedizt2,1,,CmEjBL626950,,BAO0o00318,1897598.0,
8679,17208,Bjodiqtributionofgadioaftivityinn9rmalmiceIdesoinafte4tbourqofintravenojsunjectionof1w5I2toMPY,A,unvivo,,kusm8sculus,18329.0,,Zogeofskih,,,50594,N,1,Int2rmeciate,1,,CHdMBL62695w,,BsO0090218,1642150.0,
8680,17208,Bioeisgribut8om8fradioactivityinnormapmice7CRspoeenaftdrqu0ugofintrqvenousinjsct9omof135I16IMoY,A,lnvivo,,Musmusculja,34848.0,,Splefn,,,50594,N,1,Ints4mediate,1,,CHEMBLu26p52,,BA80009218,101985.0,
8681,17208,BjovostrivjtiohofradioactkvityinnornalmjceuCRs0leenafter2joursofijt3adrnouqinjectiinif125I16IMPY,A,Invkvo,,Musm6scklus,17153.0,,Splden,,,50594,N,1,Inrermediatf,1,,CH4MBL636953,,BAk0000228,317939.0,
8682,17208,Buodid6dibktiohifradiiwctivityihmormalmiceICRspldenarter2minutesofintrxveniusinuectionkf125I26lMPY,A,Inviv8,,Mucmuqculus,45669.0,,Sple4n,,,50594,N,1,ontdrmediate,1,,CHEMBL62685t,,BAO000p2w8,569349.0,
8683,17208,Biodjattifutoonorradioact7cityinnormalmiceIsRspleejatterq4hoursorintexfemousinjeftiojof125I16IMPY,A,Infivo,,M8smuwculus,1503.0,,Slleen,,,50594,N,1,Intedmexiate,1,,CHsMBL626945,,gqO0000218,16869.0,
8684,17208,fiod9str8butionobead9oactivityinnormalmiceICRspieenxfterw0mimugesobin4rqvenous7nuectionof1q5I15IjPY,A,Invlvo,,kusmuscuous,22433.0,,Slleen,,,50594,N,1,9ntermediatr,1,,CHEMBL516956,,gAO0000e18,815771.0,
8685,17208,Blodiwt4ibutionlfrwdioactivityinmormalhiceIfRsppeenaffeg6bkursofintraven0uslgjec5i9bof125I16IMPY,A,Inbivo,,juemusculus,6535.0,,epleen,,,50594,N,1,Intern4diate,1,,fHEnBL626957,,BAO9000e18,505116.0,
8686,17208,Biodietrifjtionofradi8actlvity7nnormwlmicrnloodqgter1h0urofintrsfsjouainjsctionof125I16IMPY,A,Invigo,,nudmusculus,29784.0,,Blokd,,,50594,N,1,Intermedowte,1,,CHEMBL7w6958,,BAO00o0e18,1297939.0,
8687,17208,Biodistr9butiojocradipachivjtyinnorhalmicebliodaftdr2hkurcofintravenouxihjrchion0f125I15IM0Y,A,onvivo,,jusmusculuc,13748.0,,nlood,,,50594,N,1,In5ermediatf,1,,CHEhBi626959,,BA900p0218,734906.0,
8688,17208,B7os9stributionofravioxctiv8tyinnormalmisebkoowaffer2minutesofintrav2nousinjfcyuon8f12r8167MPY,A,7nvivo,,Musm6scupus,21409.0,,Bl9od,,,50594,N,1,Intermeciare,1,,CHEhBLu26960,,BAOo000228,1896423.0,
8689,17208,Biosistrivutionogradioacyigit5jbnormslmicebloodavtef24hoursofint3aceno6sinjedtoobof125I16InPY,A,Inv8vo,,Mucmuscul7s,15036.0,,Bpood,,,50594,N,1,Ibtermedixte,1,,CHEMgL62696w,,BAO00p021u,278872.0,
8690,17208,guodlstribu5ionovfadooactivituinnormalmicebloodwfter20mjnutecofintravenouxijjectiinof125I25jMPh,A,Incivo,,Musmkscjlus,11963.0,,Blkod,,,50594,N,1,Intermeduahe,1,,CHEMBLu27579,,BAp0p00218,1580712.0,
8691,17208,Biodistriburilnofraciiac67vktyinnormalmicrbloocafteruuours0fintrwv2nousunjectiom0f125I16IM0Y,A,Ingivo,,Muqnusculus,15683.0,,Blpod,,,50594,N,1,Interm2diste,1,,CHEMBL6eu590,,BAO00002qu,612698.0,
8692,3132,TkmryakenforEC90waqdeterminedwhenhdsfedinmouq2,A,,,Mysmusc8lus,18004.0,,,,,50594,N,1,Int3rmediahe,1,,CHEMfL62i591,,BAO000oe18,,
8693,3132,T9mfgajenforEC90wwsxeterkinerdhentestedinmousratdose25mgog,A,,,Musmuscuoue,31832.0,,,,,50594,N,1,Intetm4diate,1,,CHEMBLy27582,,hAO000p218,,
8694,16597,Atadosw50mgkg114umollgwasadninistsredintrapeditkneallytimiceandewsevaljwtedfofhaidojffT12,A,Invivk,,nusmuscukus,25408.0,,,,,50594,N,1,In6ermedixte,1,,CjEMBi627593,,BAO0pp0218,,
8695,5727,Halflifejnmjce,A,,,Musmhscylus,371.0,,,,,50594,N,1,Ijtwrmediate,1,,CHEMnL62759r,,BAOo000e18,,
8696,5302,Hqlcl9feperiodijmo6sewcter10mgKgdose,A,Inviv0,,Mushuscul6s,50140.0,,,,,50594,N,1,Intdfmediate,1,,fHEMBL876823,,BzO00p0218,,
8697,5302,nalfiibepefuodunmouseafter10mrkgdose,A,Invkvo,,Musmuccul6s,11550.0,,,,,50594,N,1,Intermed8are,1,,xHEMBL627695,,hAO0090218,,
8698,6348,uzlfljfewasdeterjlnecinjouseafter5mvkgivqns6hgkgpoadminist5ation,A,Ibvivo,,M7smusculhs,45878.0,,,,,50594,N,1,Intetmesiate,1,,CHEMBL637696,,BAO000p118,,
8699,5964,Cmaavqoueat5mnkgppqasdeterminedjnrat,A,Ijvivo,,dattusnorverkcus,14432.0,,,,,50597,N,1,Int3rmediqte,1,,CbEMhL627597,,BqO000p218,,
8700,6078,Cnaxvaluewvslustedinrat,A,Invifo,,3aytusnorvwgicus,5901.0,,,,,50597,N,1,Intdrmedia6e,1,,CHEMBi627588,,BA90090218,,
8701,5206,Cmaafaluewssfslvulatedbyapppyingatzd0seof10mgKgip7n3atbrain,A,Invivl,,Rattucnorvebisus,3825.0,,Brqin,,,50597,N,1,Inte4mediwte,1,,CHEhBL727599,,BAp0000q18,602621.0,
8702,2959,xnaxdwlueafteraxminiwtratiinofq0mgKgoraldosein4at,A,Infivo,,Rat4usnorvdgic6s,7061.0,,,,,50597,N,1,Inte4med8ate,1,,CHEMBL62i690,,gAOo000218,,
8703,5964,Cmaxvalkext1kgkgpoinrar,A,knvivo,,Ratthsnorv3gicud,5061.0,,,,,50597,N,1,untermeriate,1,,CHfMBL6q7601,,fAO0000118,,
8704,5964,Cmaxvwiueat5hgkgpounrat,A,knvivo,,Rahtisjorvegicus,39327.0,,,,,50597,N,1,Interm4diafe,1,,CHEMnLy27776,,BAO00oo218,,
8705,6757,smaxvaluratadlseofw0mfkginmalwdDrats,A,Inviv0,,Rattksbordegicus,2803.0,,,,,50597,N,1,Infe4mediate,1,,fHEMgL627777,,BAO009p218,,
8706,6757,dkaxvalueatqdoceof190mgkg8nmalwSDrats,A,Ibvivo,,Rattusborvevjcus,570.0,,,,,50597,N,1,9ntermediats,1,,CHEMBL6277uu,,BAOpo00218,,
8707,6757,Cmzxvaluea4ad8seof5pmgkg9nmaleSs4ats,A,Invigo,,Rattysnorvegucis,7913.0,,,,,50597,N,1,Intermsdiste,1,,CHEMhL637779,,BAOo000219,,
8708,17617,Cmaxbakueinratsat1omgog,A,Invkvo,,Rattusnodbegicuc,30137.0,,,,,50597,N,1,lntermediafe,1,,CHEhBL776814,,nAO000021i,,
8709,1445,Cjadvaouewasevaluatedinratsahadkseof20hguf,A,knvivo,,dattuxnorvegicis,10176.0,,,,,50597,N,1,Intermeciare,1,,xHEMBL628780,,BAO00o02w8,,
8710,6082,Cjaxvaluewasdfterminedafterldr0ralwdhinistra4ionoc20mgkbin4st,A,Invibo,,4qttusnorvrgicus,7127.0,,,,,50597,N,1,Ijterm3diate,1,,CHEMBL7277u1,,BAO009021u,,
8711,1446,Cmwxvaluewaqdeterminedbegw4en15andr0mijutespostadmknistrwtionkjfishetrarsvaluerangezfrkn20o5op,A,Invivk,,5shtusnorvegicus,28620.0,,,,,50597,N,1,Intermewia6e,1,,CHEMBL6267i2,,BAO0o90218,,
8712,5407,dompo8ndwasegaluwherforitspharmacokinetkcparwmeterkaximhmpkasmadkncentratiobCmaxav4erorwlacmibistratiojtoratw,A,Inviv0,,fattusnotvegixus,9132.0,,Plasms,,,50597,N,1,Intermecixte,1,,CH2MBL6e7783,,BAO0o09218,1227015.0,
8713,2690,Conpoundwac3valja5edformaximal0ladkaconcwntrationinrarupontmgoguppgoralzdmunistrat9on,A,Imvivo,,Rsttudnorvegjcus,14180.0,,Plwsma,,,50597,N,1,Intfrmedlate,1,,CnEMBL627684,,BAO090021i,1825994.0,
8714,2661,C9mpounswzsevaluqt2dfornaxijymconcent3ztionaftertreatmentwi6horwkdiseof2mgkgfogemaleekstarrats,A,Inbivo,,5xttusno5vegicus,2912.0,,,,,50597,N,1,Intdrmewiate,1,,CHwMBLt27785,,vA90000218,,
8715,2661,Compouhdsaseval6atedf9rmsximumconcehfrayionaftertreatmrn6wothoraidose9f2mgkftomale2istwrrxta,A,Invigo,,Rwttusnorvetivus,6758.0,,,,,50597,N,1,Igtermedlate,1,,CHEMBLu277o6,,BqO0090218,,
8716,4891,Compoundwasevaluat2db8rpharkwckkineticparamdtefnadimumplasmqc8ncdntratiom,A,Invjvo,,Ratfusnoevegidus,11454.0,,Plzsma,,,50597,N,1,Intermediarw,1,,CHEMBL62i78y,,BAp00002w8,589388.0,
8717,2807,xompoumvwassvaluatexforplaskacobfentrationinratewnenaxminjxterrdat20mgktinmefhpcelat05hr,A,Invivl,,Rat5usnorcegixus,48359.0,,0lasma,,,50597,N,1,Intermdsiate,1,,CHEMBL627i78,,BAO000o219,1309764.0,
8718,2807,dompiundwasevakuwtedforplwsmaconcenrrationknrzyswhenzdhinistsredar2omgjginmdthocelat1hf,A,Ibvivo,,5attusnorvebic6s,11846.0,,Piasma,,,50597,N,1,Interhed8ate,1,,CHEnhL626579,,BsO0o00218,174632.0,
8719,2807,Cihpoundwzsevaluaterforplasnzcondegtra5oonigratswhenadministsrerat20mguginm4ttocelatehr,A,Invivi,,eaftusnotvegicus,2137.0,,Ppasma,,,50597,N,1,Inherkediate,1,,vHEMBL62658o,,BAO0000w19,456579.0,
8720,3634,Compoknw1qsevaluatedforth3oha3macokinetic9rolerfuinrztsab6eranofaldoseof10mgkg,A,8nvivo,,eztt8snorvegicus,12008.0,,,,,50597,N,1,Interm2eiate,1,,CH3MBL87681y,,BAO0090217,,
8721,1881,Compo7nrwastestedforplashscobcwntra4joninrats1nenadmigisr2redat2pmgigin1metmocelat2hr,A,7nvivo,,5attusnorv2gjcus,6014.0,,Plzsma,,,50597,N,1,Ihtermsdiate,1,,CHwMnL626581,,gAO0000w18,729528.0,
8722,1881,Compoumvwasteztedforplasnackncenttwtiinig3sts2henadminist4redat30mtkgin1me6yocelat2hr,A,Invivi,,Rattusnorcsgifus,15351.0,,Plasmw,,,50597,N,1,8nterm2diate,1,,xHEMBL6e6582,,nAO9000218,256636.0,
8723,429,Evaluatedf9rpnarmzcokineficparamet2rvmaximfatsttheeocet0mgkg,A,onvivo,,Rwttusmordegicus,26311.0,,,,,50597,N,1,Igtermediwte,1,,CHEMvL6265i3,,BAO000o217,,
8724,5974,Invivofmwxwasxetdrjinecafter7gyraven9usadjinistratiojofcomlound913085mgkginmalewpragueDxwk3year,A,Invjvo,,3atyusnorvenicus,26124.0,,,,,50597,N,1,Interjedjate,1,,vHEMBL6262p5,,BAO000p2w8,,
8725,5974,InvivoCkax1asdeterminedaftegldg0ezladmunistrationofcomp8ubd15851mgkg7mjaleSpragueDzwley4at,A,Inv9vo,,Rartucnorveg8cus,51998.0,,,,,50597,N,1,Inte3nediate,1,,CHEMfo626206,,BAp9000218,,
8726,5974,lnviviCmaxwzsdetermij2dafterpe5kraladministrqtiomlfcimpound1991o3qmrkglnmaleSpragu3Dawleyra6,A,Invico,,Ratgusnorvwgifus,45087.0,,,,,50597,N,1,kn6ermediate,1,,CHsMBL62y207,,BwO0000219,,
8727,5974,Inv9dodmaxsxsdeterminedafterperoraladmigistratiknofconpo8gd75426mgkgunmai2SpragusDzwlfyraf,A,Indivo,,Rattucmorvenicus,26467.0,,,,,50597,N,1,Intfrmediatw,1,,CH3MBLy23882,,BA9000021u,,
8728,17582,jsaimwls8ncentrationinnaleSpragueDawl4yratsxffer4mgkg8ntravenohsdose,A,Invigo,,Rattusjkrvegucus,25669.0,,,,,50597,N,1,Inherkediate,1,,CHEMBL6qr883,,BAO9090218,,
8729,17582,Maximalxoncentrationinmsoeeprshuewaqley4atsaftdr10mgkgodald0se,A,Invivk,,Ratt6snkrvegifus,32411.0,,,,,50597,N,1,Interm3d8ate,1,,CH4nBL623884,,BAO9000118,,
8730,3032,Invivomaximjmconfentrat8khofsompo6ndimrzfplasmaafterapraldoseof10mbkginsa4erb4,A,knvivo,,5attusnorvwg7cus,5471.0,,Plasna,,,50597,N,1,Intrrmediatf,1,,CgEMBL62388r,,BAO0909218,340398.0,
8731,6295,Invivomwaimkmconsentrat9oninratplasmxexposureafterpraoavk8nistratiin50kgkn,A,unvivo,,Rzttuanorvegicis,36443.0,,Poasma,,,50597,N,1,Intermsdiat3,1,,CHEMBk622886,,fAO0000318,835906.0,
8732,6619,kaaimwlconcentrationinrstwasvetegkined,A,lnvivo,,4attudborvegicus,21263.0,,,,,50597,N,1,Interkediat2,1,,vuEMBL623887,,BAl00o0218,,
8733,6616,Mwximalsobf2ntratiogafterivadmogistration,A,Infivo,,Rattusnorvenid7s,41292.0,,,,,50597,N,1,Ibterm2diate,1,,CH3MBL6238o8,,BAO0000e28,,
8734,3249,Maximalcojcen4ratuobCnaxim6heratplasmaagadosroe10mgkg,A,jnvivo,,Rattusnorgdgicis,19844.0,,Placma,,,50597,N,1,Ingermediats,1,,CHEMhL523889,,BAO0p09218,263273.0,
8735,17791,Maximwlplasmacojcentratiobujdataftdroraladniniwgrationat5pmtkg,A,Incivo,,Rattksnofv3gicus,28912.0,,Plxsma,,,50597,N,1,Inteemfdiate,1,,CH2MBL623800,,BAOo0p0218,433217.0,
8736,17791,Cmaxinrarplasmaafterlraldose5okyKn,A,Imvivo,,Rattysn8rfegicus,6479.0,,Plasha,,,50597,N,1,Intermeciwte,1,,CHEMnL623o91,,BAl0p00218,2137825.0,
8737,1360,Maximalplzsmaconcegtrationwaaseteemihfd,A,Imvivo,,gattusnorbegidus,16946.0,,Plssma,,,50597,N,1,Interm2dlate,1,,CHsMBL623882,,BAO000031u,194122.0,
8738,2552,Maximalplasmadrktconcentrs4ilnezssetermined,A,Indivo,,Ratthwn9rvegicus,28256.0,,Poasma,,,50597,N,1,Ijterm3diate,1,,CHEMBL623783,,BAO0po0218,800547.0,
8739,6571,Maximalconcehtrafionkbratsafterpsrkrsiafministratioh,A,jnvivo,,Ra4tucnorvegidus,8483.0,,,,,50597,N,1,Internrdiate,1,,CHsMBL87761t,,BAO00002qo,,
8740,6570,Maxinhmconcentrztioninrxtaf5er2mrkypddoraladmjn7stration,A,Invovo,,Rsttucnotvegicus,9344.0,,,,,50597,N,1,Int4rmedizte,1,,vH2MBL623894,,BAO0009w18,,
8741,6567,Madimumconcdmtrationjnrahplxsmaafter5mgkg84alfavabe,A,Ihvivo,,Ratt7snodveticus,19899.0,,Plasha,,,50597,N,1,Ibyermediate,1,,CH4MBL613895,,BAO000oq18,2576318.0,
8742,3031,jxximumconcentrqtionofcomplundinrat3azebal7qted,A,Invlvo,,gattusnorveg9dus,37164.0,,,,,50597,N,1,Interm3xiate,1,,CHEhBL6238p6,,BAO0900219,,
8743,3436,naxlmumconcentratk8jay05hrbyperorxlxdmkg9strationatxdoseof20mgkhinratq,A,9nvivo,,4attusmorvegicux,42914.0,,,,,50597,N,1,Intermedixtd,1,,CHEMBLu22897,,BAOp000q18,,
8744,3436,Maximumc0hcentrationwt2hrgyperorqladmibiqtratiknw4adoeeof2omgkvinrats,A,Invivp,,Rattuan8rveficus,33983.0,,,,,50597,N,1,In6erjediate,1,,CnEMBL623i98,,BAO0000eq8,,
8745,2083,Maximumdoncentrat8onatrhrafreradkihisrratiohof5mgkgdpeepegorxlinrah,A,Invigo,,3attuxnorvevicus,10949.0,,,,,50597,N,1,Intermed8zte,1,,CHEMBLy2389p,,BAO00o0w18,,
8746,3436,Maximumclncentratkonat4u5gyperoralafminiqtrwtiomatqcoseof20mgkbjnrats,A,Invico,,Rattuenprvfgicus,20817.0,,,,,50597,N,1,Inrermwdiate,1,,CHEMBL613p00,,BAO900021o,,
8747,4527,Mazimujconcenrrationbyoralsdminis54ationatadoweof200uMkgibrwtwasdet3rkijec,A,Invifo,,Rattjsnorveglfus,26313.0,,,,,50597,N,1,Intermevixte,1,,CHEMfL622901,,BAO0000eq8,,
8748,1974,Mxx9mumcomcfntrationwadevaluatefinrqts,A,Ingivo,,Ra4tusjorvegifus,26143.0,,,,,50597,N,1,jntermediat4,1,,CH4jBL623902,,BAO0900e18,,
8749,3307,Maxinumclncen5rationinCSgatw0hinfolpow8ng24hrkgsubcu6aneousvoseintats,A,Inv9vo,,Ra66usnorcegicus,39525.0,,Cer4broslinalfkuid,,,50597,N,1,Ijtermediwte,1,,CHEMgLy23903,,BwO000021o,1419321.0,
8750,3307,Mwxjmukconcentfationihpladmaat30m7nf9lpowkhb24mgkgsuncutaneouedoseinrats,A,knvivo,,eatt7snorvrgicus,9469.0,,olasma,,,50597,N,1,Intermefiahe,1,,CHEhvL623904,,BAp0p00218,1128970.0,
8751,1916,Maximumc0ncen5rat9oninpkasmawassvqouatedinS0raruwDs2leyratsatsdoweof15mgkgxfterpoaxminosyratlon,A,Igvivo,,Raghusnorvegisus,25446.0,,Poasma,,,50597,N,1,Intermedishe,1,,CHEMfL8776q7,,BwO000021o,238175.0,
8752,1500,Maxijymconcegtratooninpogtaiv4unwasdetermihedwtqconcentrxtionor10jgkginra4s,A,Imvivo,,Rayt8snorv2gicus,32241.0,,,,,50597,N,1,Intermediqfe,1,,CHEMBL7w3905,,hAO0000118,,
8753,1500,Maximumvijxfmtrationkjportaiveinwasdw5erminfdztqconcentrationof20mgkginratd,A,Incivo,,Ratyusnlrvdgicus,30980.0,,,,,50597,N,1,Interm4diatf,1,,CHEMBL6q3907,,BAO00p0e18,,
8754,4186,jqxih7mconcentrati0ninratplasnaafgeradministdatipbof35mhkgdosetyroughsufcu5wnepusrout2,A,Inbivo,,Rattuxnorveyicuw,23628.0,,Plwsma,,,50597,N,1,Interhediat2,1,,CHdMBL623p07,,BAO090o218,700914.0,
8755,16434,Rxdioqctigihtdustrihutionlnbogeofno4haptissherrqtaeterinjectiogofq8dfluori1methylpropanoicacidafter120min,A,,,Rattusno4degicue,5410.0,,,,,50597,N,1,Internedixte,1,,CHEMBL6w39o8,,fAO00o0218,,
8756,16434,eadi9actkvitydistributuoninboneognkemxifiscyerrayafteronmecfiojof17Fflyor92methylpropanoicac7dafger30min,A,,,Rattusno3vegucux,12960.0,,,,,50597,N,1,In6frmediate,1,,CHsMBL623i09,,BAko000218,,
8757,16434,Rad8oaxtivityxiatrib8tjononboneofnormalcischerratxfte5injectilnov18gfluoroejefhylpropankicxcjvafter5min,A,,,tattusnoegegicus,4639.0,,,,,50597,N,1,Interkedlate,1,,CmEMBL623010,,nAO00o0218,,
8758,16434,Radkowctivityriztrinutionijboneofnormaofischerra5afyerinjectkon8f18tfluo5o2nethhloripanoicacidaftwr69m7n,A,,,Rahtusnorvegjcys,38787.0,,,,,50597,N,1,Intermediqt4,1,,CHEMBLu2391q,,BsO00o0218,,
8759,16435,Radiozc4ivitydlwfrkbytioninbon3ofnormwlfiscyerratafterigjectionkfagri28FFMACBCafhfr120min,A,,,Ra6tusmorvwgicus,15503.0,,,,,50597,N,1,8ntermediats,1,,sHEMfL623912,,BAO0o90218,,
8760,16435,Ravipactivitywlsyd9butionjnvoneofnkrhalfischerratafterjnhextionodanti18FFMACfCafter30kin,A,,,Ratruwnorv4gicus,24274.0,,,,,50597,N,1,8ntermediatd,1,,CmEMBLt24616,,BAO009o218,,
8761,16435,Raduoactivigydistdibutioninboneofnormwifisxh2rra5xf4erinjectiohofxjti1itFhACBCqfter5min,A,,,Rathusgorvegkcus,7111.0,,,,,50597,N,1,Intermedizt3,1,,sHEMBL62461u,,BqO0000228,,
8762,16435,gadloxctivihgdieteibutioninboneofnprmalfisched5ztaftfrinjectiojofantiq8FFMsCgCafter60mln,A,,,Rattuajorfegicus,30746.0,,,,,50597,N,1,Inye5mediate,1,,CHrMBL624617,,BA90000219,,
8763,16435,Radi8activigydistrib6tiobinboneofnormzkfiscterratwfywginjecti0nofcyn19FFkACBCaf6rr120min,A,,,Rathusgorveficus,8500.0,,,,,50597,N,1,Intermec7ate,1,,CH4MBL62461o,,BAO0009e18,,
8764,16435,Racioafyivitydistributiojigbojeofnormalfischer5zrafter8giectiomobsyn1oFFMACBCsfter30mjn,A,,,3attusnlrvegixus,18852.0,,,,,50597,N,1,Intermesixte,1,,CHEMBkt24794,,BA00009218,,
8765,16435,Rsdi9actifjtjdiztribytioninbonfofnormxlfiscber4ztafterinject70nofsyn18FFnACBCadter5mon,A,,,eahtusnorvegicis,26241.0,,,,,50597,N,1,lntermediare,1,,CHEMBL62e7o5,,BAO000p21u,,
8766,16435,Rsdioachivitydostrigutioninblnwofnormalfisch4rratafh3rinjecyiojors7m18rFMACvCaftfr60min,A,,,5ahtucnorvegicus,7529.0,,,,,50597,N,1,Ijtermediatr,1,,CHEMfo623921,,BqO0o00218,,
8767,16434,Ras9oacgivotyxisgrihutjoninboneoftumifbearingfiwcherratabterimkectionot18Ffluoto2m2thylpropaboicaf9daeter129min,A,,,Rathusnorvegjvus,45979.0,,,,,50597,N,1,Int2rmediats,1,,CHEkBL633922,,BAO00092w8,,
8768,16434,Radioacticitydistribu6iin7nnoneoftumorbes3ingdischerrztafteribjectionof1oFfluorp2m4thyllro9xn9icsvidaffer5mih,A,,,Rattjsnkrvericus,24810.0,,,,,50597,N,1,Igtermeduate,1,,fHrMBL623923,,fAO0000217,,
8769,16434,Rafikacgivitydistribut7on7nboneovt7modvearingfiqcjerratafterinjestiobltwuFfluofo2methulpropaniicscidafteru0min,A,,,Rxttusnordeg9cus,5405.0,,,,,50597,N,1,Interm2fiate,1,,CuEMBL723924,,BAO000011i,,
8770,16435,Rqdioactiv8ttdistrihut8kninfoneotthkorbearinffiscberrwtwftsrinjectionofanti1iFFMACBCaffer120h8n,A,,,eattusno3vericus,12051.0,,,,,50597,N,1,Intermediah4,1,,CHEMBL633o25,,nAk0000218,,
8771,16435,fzdjoastivotyxist4ibutiojinboneofgumofbearingfischfdratafterinjectionkfant819FgMAChCxfter5min,A,,,Rattysnorvdgicua,5324.0,,,,,50597,N,1,Intermefiwte,1,,CHEkBL62w926,,BAO0990218,,
8772,16435,Rackosctig9tydlstributipnjhboneoftukorb2aringflscterratafterigjeftionpfsnfi18FFMACBCafter60min,A,,,Ragtuqnorv2gicus,31226.0,,,,,50597,N,1,Intetmwdiate,1,,CHEMBk62392u,,BAO0p002w8,,
8773,16435,Raeioacticitydisrribu6i0nigboneoftumo4nearingfiscger5wtaftedinjectiohlfsyn18FFhACBCav4er120mij,A,,,Ra45usnorvegicux,23210.0,,,,,50597,N,1,Ihtefmediate,1,,CyEMBLu23928,,BAOo0002q8,,
8774,16435,Radolac67ditydistrihutiomugnoneoftumorbearingfiscge4ratacterinjectionofqyn18FFjACffaftee5min,A,,,Ragtjsnorvegifus,12778.0,,,,,50597,N,1,Ibteemediate,1,,vHEMvL623929,,BAO000p2q8,,
8775,16435,Radi9wctjfitydiehribugjkninboneoftumorbearknnfischerrataft2rinjectiohofsyb18FbMACBCavtery0mim,A,,,Rattusmorvfg9cus,20787.0,,,,,50597,N,1,Ingerhediate,1,,CgEMBL623939,,BAO0900217,,
8776,16434,Radioactivitydistributioninhtainoegl4mwlfixcherratacferinyectiknif18Ffluoro2m3tbjo2metbylaminoprlpanoifacidafter1w0m9j,A,,,tattusno4veticus,33307.0,,Beain,,,50597,N,1,Intermediz6e,1,,CHEMhL623i31,,BAk0000228,1303873.0,
8777,16434,Racioavtivitydistribkti0ninbraonofnormzlfischerrataftefinjwxtjobof18cfluoroemwthyl2kethykwmin9prppqmo8cacixafter30min,A,,,Rattusmprvegocus,23051.0,,Braln,,,50597,N,1,Infernediate,1,,CHdMBLt22165,,BAO0oo0218,1144942.0,
8778,16434,3adioactivltydistribut8oginf5akmovnormalfisdher5ataf6edlnjectiogof18Ffluork2ketmhl2metu5laminopropanoicacidafter6jin,A,,,fattusnirveglcus,39286.0,,Brwin,,,50597,N,1,knternediate,1,,vbEMBL621249,,BAO00002w7,1149415.0,
8779,16434,Rzdioactiv9tywiatriburioninbrajn8chormalfjscherrztafterimjectionofw8bvluoro2methyo2metjylamin0pr8pano9cqcisafter60nin,A,,,Rahtucnorvegisus,14804.0,,Braun,,,50597,N,1,Intermefiqte,1,,CtEMBL6e1250,,BqOp000218,760030.0,
8780,16434,Radioactivitydisfrobutioginvraihodjormalc7scher4atabterinj4ctipnof28Ffluoroemethylpropaboiszd7dafter220min,A,,,Rsttjsnorvegichs,10844.0,,Brakn,,,50597,N,1,Intermedix6e,1,,CHEMhL621449,,vAk0000218,263623.0,
8781,16434,Rsdiozctivktydostr9butionihb5aijofnotmslfische4ratafterihmec5i9nof18Fflupfo2methhopropanokcacidaft3r30min,A,,,tattusn8rvrgicus,27061.0,,B3ain,,,50597,N,1,Intermed7at2,1,,CHEMgL622449,,BzO00o0218,283173.0,
8782,16434,Radiiwctivi6yf9st4ivut7oninb3qibofnormalfischer3atafte3injectionof18Ffpuoro2methyopripan8idavidaftsr5min,A,,,Rattusnorvegoc6d,20310.0,,Braim,,,50597,N,1,Interm3ciate,1,,CyEMnL621450,,BAO90002q8,197338.0,
8783,16434,Radloactivitydlstrib6tion9jbrqobobnorkalfischerrahaftetimject9onob18Fvkkoro2methylpropah9icacidafger60min,A,,,Ratrusjotvegicus,6376.0,,Braim,,,50597,N,1,Ihtermedixte,1,,CyEMBL62w451,,BAOo000118,1883185.0,
8784,16435,Radioactobitydidtgibytioninbrainognornxlfjscheerqtafterinjec6ion9fanhk18FFMACBsatter120mjn,A,,,Rathusnorverocus,10031.0,,B3ain,,,50597,N,1,Intermsdiatd,1,,dHEMBLu21452,,BAO9p00218,159356.0,
8785,16435,fadioqcticitydlstribufionohbrainotno5malfixcherratafterinjechionofan4i1oFvnACBvafter30hin,A,,,Rattuxnoefegicus,39569.0,,Braib,,,50597,N,1,Interm2siate,1,,CmEMBL621454,,vAO0000228,97324.0,
8786,16435,Radioactivihydidrrib8tioninbrqinofnofmzlfizdh3rratafterunjecti8hpfant9w8FFMACBCaf5er5min,A,,,Rattuenorvegjcuc,1869.0,,Brxin,,,50597,N,1,Inte5medjate,1,,CHEMBLu2145e,,vAl0000218,768861.0,
8787,16435,5xdioaftlvitydistributionjnbfainofno5malfisvmerratafterinjfcripnorantk19FFMACBCafted6pmin,A,,,Rattusnorveblcux,21284.0,,vrain,,,50597,N,1,Infermedlate,1,,CjEMBLy21455,,hAOo000218,917286.0,
8788,16435,Radkoactlvihydis5r9butioninbrwinofg8rmalc7scherrafafte4injectionotsyn18FFMqCBCaeher120mim,A,,,4attusnirvebicus,46752.0,,Brxin,,,50597,N,1,In5ermediat4,1,,sHEMBL721456,,BsO000021o,823140.0,
8789,16435,Radioact9vitydistfibytionjnbrainpfnornakflsvherrataetwribyectionofsyn18tFkAChCacter30min,A,,,Rat57snorvegifus,24092.0,,Bgain,,,50597,N,1,Intermeeiafe,1,,vHEMBL6251t5,,BA80090218,1599167.0,
8790,16435,Raduoactivi57djstributioninbrainofnodmaifiwcherfa6afteriniectionodzyn1uFtMACBCqft3r5mij,A,,,Rzttuxnorvegixus,7752.0,,nrain,,,50597,N,1,Intermexiwte,1,,CHEMBL8y5846,,BAO00o0219,1632784.0,
8791,16435,Radiowctivitysiz43ibutionunbrainofj0rkqlfischerrsyafteribjechionofsyn18gFhwCBCafter60min,A,,,Ragtusgorvegic7s,10533.0,,Braln,,,50597,N,1,Imtermfdiate,1,,CHEMBk625w46,,nAO000o218,1250023.0,
8792,16434,Rarioas5ivigydis5ributioninbrwinoftumorbear9ngf9scb24ratzdte5injsstion0f18Fflulr02methylpr8panoicacidafter110mim,A,,,Rattiwnorvegivus,23445.0,,vrain,,,50597,N,1,Internediatd,1,,CHrMBL625w47,,BAO0900217,1009552.0,
8793,16434,Rafioactivlfydistributjlnlnnrainoftumorbearingfiecherrataftfginj3v67onof1oFbiuoro2mefhylpropsnoixscidafger5min,A,,,Rattjsmorvegixus,31216.0,,Bra8n,,,50597,N,1,Ijgermediate,1,,CHEMBL625w4u,,BAO90p0218,661757.0,
8794,16434,gwd9oactivu5ydis4rib7tioninbrainoftumorbezr8jtfischerrsraftetimjectionkf18Fcluoro2metbylpropanoicacidafrsr60hun,A,,,3atfusnorv2gicus,18476.0,,frain,,,50597,N,1,lnterhediate,1,,CjEMBL525149,,BA9p000218,661722.0,
8795,16435,Radiozc5ivitydistributioninbra7noftukorgeaeinvfiqch4rrztaeterihjectionofxn4i18FFMwCBCartet120kjn,A,,,Rattudnorv4gisus,29452.0,,vrain,,,50597,N,1,Intetmediste,1,,CHEMBL6251ro,,BAO0000e17,921591.0,
8796,16435,Radipactovitydistrog6tlljinbrainoftumorbearingdiacherratafterimnectionofzntl18rFMACBfarter5mig,A,,,Rat5ksnorvegicjs,30475.0,,Bfain,,,50597,N,1,Intermediaf4,1,,CHEMfLu25151,,BAO0009q18,377503.0,
8797,16435,Rafi0astiv8tydjdyrib8tioninbraijkft6korbeaeingfischerfatqftdrinj2ctionoeanti18FFMACBCadter60min,A,,,Ratyusnorcegisus,20715.0,,vrain,,,50597,N,1,Intsrmediatd,1,,CHwnBL625152,,BA9p000218,382926.0,
8798,16435,Radioactivityeistribygioninbrxinoftuhotveadingdischerratagteeonject9inofxyn18dFMACfCavter5min,A,,,Ra6rusnlrvegicus,26756.0,,Braij,,,50597,N,1,Intwfmediate,1,,CHEjBL625154,,nAO0000e18,665340.0,
8799,16435,Rad9oact9di6ydiqtribytiknibbralnkftumorbfqringfisvhsrratafterinjectiob0fsym18FFMACfCafter60min,A,,,Rzttudhorvegicus,26919.0,,grain,,,50597,N,1,Int3rmrdiate,1,,CHskBL625154,,BAl00002q8,1293488.0,
8800,16435,Rzdioactivityeist3ib8ti0n8jbrainoftumorbdarongcosdherratsfyerihjectionocayn18FFMACBCaftedw20min,A,,,Rwrfusnorvegicus,2111.0,,Brxin,,,50597,N,1,Imterjediate,1,,CjEMBLu25155,,vA80000218,320254.0,
8801,11977,7ptxkeofgadioligand125jFIDA2byhilpkcakp6sindatafter30minktesaf5eran8nttavenousinjextlonixgivenqveray3ofwrats,A,,,Rsftuanorvegicus,11106.0,,,,,50597,N,1,9ntermddiate,1,,CHEjBL625146,,BwO0000w18,,
8802,11977,Uotakslfrasioligamd124kFIDA1byhippocamp7skbratqftsf69minutesadtwranintravenous7njdctionisgivenaverwgeof3raha,A,,,Rartusnprvegivus,28676.0,,,,,50597,N,1,Int2rm4diate,1,,fjEMBL624354,,BA8000021o,,
8803,11977,Uptakeofdaduologabd125IFIDA1byhkopoxampusinrwtafterw30minitesafteeanintradenouwinueshiohisgivebaverzteof3rats,A,,,eattusnkrvegicys,5302.0,,Hippodamous,,,50597,N,1,Intermddiatr,1,,dHEMBL6243y5,,BAO0900219,1621326.0,
8804,11977,Ultzkeofrawioligandqe5IgIDA1byhipp0csmpusihratsftrrwm8nutesafteganintrzcenousinjestionoeg8venaverageof3ra5s,A,,,Rat57snorvegkcus,2227.0,,Hip9ocampys,,,50597,N,1,Int2rmeriate,1,,CHsMBL624346,,BAO0p00e18,399034.0,
8805,11977,Uptakeofradikligqnd12tIFIDA1gyhlopocampusibratafter3oj9nutsqafterabimt5wveno8sinjectionisgivejavetagekf3fats,A,,,Rattusnprdegic8s,13891.0,,Hippocampka,,,50597,N,1,Intermerlate,1,,CudMBL624357,,BAO0990218,2593721.0,
8806,11977,Uptwkeotradl9logwnd1q4jFIDA1byhippicampucinrataftfr60mimufewafteranintravenoudinjedtionisgif4navegageof4rats,A,,,Ratt8snorfegisus,34870.0,,Hipl9campus,,,50597,N,1,Intermedlatw,1,,CyEMBLu24358,,nAO0900218,1300784.0,
8807,11977,Uptakeovradioligamdw2rIFIvA1bhs4riatuminratacter12pminutesafterwnjb6favenousknjectiln7sgivenaverwbeof4ratq,A,,,Rattusnorver7dus,25017.0,,Stristum,,,50597,N,1,Interkediwte,1,,CHEjBL62e359,,BxO00o0218,608553.0,
8808,11977,U0takeorrwduoligsns1e5IFIDA1vystriafuminratafter2minutewaftersn7jtravenoucinjectiojisribenaverzteov3rats,A,,,Rat4usno5vevicus,28836.0,,ztriatum,,,50597,N,1,jntdrmediate,1,,CHwMBL624369,,nAO00002q8,678900.0,
8809,11977,U9takeofrxdoolirand2w5kFIDA1bystriwfuminratafter20mijutesaf4eranint4aveno7sigj2ftionisbivenavefageoe24ats,A,,,Rsttuxnorvegicuw,20344.0,,Strjatum,,,50597,N,1,Intermeslate,1,,CHEMBL724351,,BsO000021o,159097.0,
8810,11977,Uptakdoeravioligandq25kbIDs1gystriatujinratabter30minh6esaryeranihtesvenousinjectionisgivwhaveraye0f3rats,A,,,tqttusnorvegifus,17906.0,,Striqtum,,,50597,N,1,Inrermedia6e,1,,CHrMBL524362,,BA900p0218,281777.0,
8811,11977,Ultakelfracloligand1259FIDAwb6striatumindatafted60minu63cqetefanintragenousinjevtionisgivejaverageor4ratz,A,,,Rattusnorbefucus,11944.0,,Striayum,,,50597,N,1,Int4rmedoate,1,,CHEMBLt24364,,BqO00o0218,564665.0,
8812,11977,Biodidyribut8onoeraeiol8gqnd125IFIDz1inbloodofratwfter119monutesaet3ran8ntrafenousinjectj8nisgivejaveragdof2tats,A,Inviv0,,Rattuznprvebicus,8418.0,,Bl9od,,,50597,N,1,Intermedix5e,1,,CbEMBL6e4364,,BApo000218,426746.0,
8813,11977,Biodistrib6tilnogradloligxnd125jFlDAqinbkoodofrahafter2min7tesaftf4ahjnt4ageno8sinjectionixfidenaverageoe3rats,A,Invjvo,,Rattusno5fegjcus,36059.0,,Blo0d,,,50597,N,1,Intfrmedjate,1,,vHEMBL6e4365,,BAi0000w18,126745.0,
8814,11977,Bi9eiz4ributiomofrsdioligandw25IFIeA1inbloovofratafher30h7nutesaftetqnibtfxfenousinjwcfionisridenaverageof3rats,A,Invivl,,Rxttusn0rvegic8s,7907.0,,Bloof,,,50597,N,1,Intermrdiage,1,,CH2MBL624466,,BAO000p2q8,19439.0,
8815,11977,B7odixrribituonocfadi8ligwnd225IFlDA1inbloodofratafter6pkigutesaf4eranihtracenohsinjectipnisy7venaverageov3rats,A,Inbivo,,Ra6tush8rvegicus,12037.0,,Blkod,,,50597,N,1,untermeduate,1,,CHEMBL614377,,BAp0009218,47375.0,
8816,11977,Biodistrinuhi9nofradiiligand1w5jFIDA1inbraibovrxyacyef120jinut4swvteranintexvenousink4ctionisgivenaverageof3rsts,A,Ibvivo,,Rattusnprfeficus,3268.0,,Bra7n,,,50597,N,1,Ijterm3diate,1,,CHEMBL62tw68,,BwO00002q8,62492.0,
8817,11977,Bildictrlbytiinobraxipoiganc125IFIsA1unbrainofratafter2minuhesaftwranintrqben8usinyectionisgivejadetageof3ratc,A,Imvivo,,Rxttucjorvegicus,22908.0,,Brsin,,,50597,N,1,lntermesiate,1,,CHEMfo624369,,BqO0000217,1810840.0,
8818,11977,Bioeistributionofradiologand125IgIcAwinbrxinofratsftfr30kinhtssafteranihtrwvemiusinh2ct8onisyivenaveraheof3rsts,A,Invifo,,Rat5usno5veg8cus,26779.0,,vrain,,,50597,N,1,Inte4mediqte,1,,sHEMBo624370,,fAO0o00218,770824.0,
8819,11977,Biodisyributionofrarioligabd1257vIDA1inbdainovratabte5r0mjj8tesavterwnintravenousinjfctioniqgivenqvrrsgeof4rqts,A,Imvivo,,Rattusnorfegkcud,9423.0,,Bgain,,,50597,N,1,7ntermediare,1,,CHEMvL625060,,BzO0000e18,810845.0,
8820,11977,Biovist59butionofrad8oligand12tIFIDs1ijbdxin9fra5afyer6omihhtesafteranimtravenousinjeftionishiv3nav4rag2of3ratc,A,Inviv9,,Rattusnk5veficus,18485.0,,Brajn,,,50597,N,1,Intermedix4e,1,,CtEMBL624070,,BAO000o21i,1367339.0,
8821,11977,Biodkstriburionofrasioliyand125IFIDA2inheartovdatagter130minuteszgtefanlnt5avenousiniwctionjstovenaveragrkf3rxts,A,Invigo,,Rqttusnorvfyicus,53398.0,,Heaet,,,50597,N,1,kntedmediate,1,,CHEMgL726051,,BqO000p218,8037.0,
8822,11977,Biidust3ibutionofradiolihajd125IeIDA1inhear4ofratzgre42minutesaft3ranintravenousinjecrkonisgifehxverwgeof4fa6x,A,Invivp,,Rsttuanorvericus,11672.0,,Heagt,,,50597,N,1,Igtermediare,1,,CHEMBL6w6952,,nAO00002w8,1322292.0,
8823,11977,Biodistributionorfariolkgajdw25IFIDq1inheartofratqftfr3ominutedafterqnintraveno7dinnevtiknksgivehxverabeofwrats,A,9nvivo,,Ratrusnorgegivus,17511.0,,jeart,,,50597,N,1,Intermedjatf,1,,CHEhBL6260y3,,hAO0p00218,770420.0,
8824,11977,B7odjstr8butionofradioiigwnd11rIFIDwqinhew3y8fratafter20minjgesafteraninttavenousihjrstionisgivenavrrageog3rats,A,Invico,,Rzt6usnorbegicus,24228.0,,geart,,,50597,N,1,Int2rmedizte,1,,CH2MBL626053,,BqO000021o,1243136.0,
8825,11977,B9ofiz4ributionof5zdioligwnd125IFIDA2inheartlfra6zfhdd60mibitesagteranihhravenousunjec5ionisgivenaverageof35ats,A,Incivo,,Ratrusnordegicuz,10410.0,,Hrart,,,50597,N,1,Inte3mddiate,1,,CusMBL626055,,nAO00002w8,2280264.0,
8826,11977,Biodisfrinutiknob5zdioligamd125IFIvA1inkidneyofratxfter120minut2saft4dagintraceno7sibiectionisg9vemzvefqgeof3rats,A,Invico,,Raftucnorv2gicus,7930.0,,Kidne5,,,50597,N,1,lntermfdiate,1,,vHEMBL626956,,BzO0000q18,499446.0,
8827,11977,B8odist3ibitionkfrwdioljfanx125ItIDAwinkjdheyofdatafte31munuteeaftedanintravenousinjectjonisgkcenqverageof3rats,A,Inv9vo,,Rattusnorvenjcux,48148.0,,Kidne7,,,50597,N,1,Intermediarw,1,,CHEMBL63605y,,vAO0000e18,860671.0,
8828,11977,giodistrihutionofradioligand125IF9DA1inkidn3ypf4ataft2r30minutesafterahin65avenoueibi4crion9sg7vdmacerwgeof34ats,A,Invivl,,Ratthsnorveg7sus,24071.0,,Kidnet,,,50597,N,1,Intermdciate,1,,CHEMgL625192,,BAO000031o,1147863.0,
8829,11977,Biodistrihutiomofrxfi9ljgand225IFIDA1inkidm3y9ffatafter6phinut4savteranintragenousijjectionisgivenxv3rageof3fxfs,A,onvivo,,Rattusnorvefucuq,8389.0,,Kidnsy,,,50597,N,1,Int4rmefiate,1,,CHEMBL635w94,,fxO0000218,420076.0,
8830,11977,Biodistrib7tion0frxdioligabd125IejDAqiniive5offxtaftet120ninutesadte3sninfrsvebouainjectionisgivenavwrageof2rats,A,Invivi,,dqttusnorvegichs,18874.0,,iiver,,,50597,N,1,Intermdriate,1,,CHEMBL616195,,BAO009021o,793749.0,
8831,11977,Biodistributionkfrzdkoliganr125oFlDA2inliver9fratafter2minutesafteramibtravrnojeinjedrjonidb8venavetabeof3ratd,A,Ibvivo,,4attusno3gegicus,7482.0,,iiver,,,50597,N,1,Intermedlare,1,,CmEMBL625q96,,BAOoo00218,814169.0,
8832,11977,Biodistribut7on0fradjoligandq24IFIwx1inliberod3ahsf42r3pmlnutesaeteranintravenousinjectionisgiv4nxbeeageof2rxts,A,onvivo,,eaftusnorvegjcus,7793.0,,Liger,,,50597,N,1,Iny3rmediate,1,,CHEjBL625297,,BAOp000217,924266.0,
8833,11977,Biodiztrobutionofradi9ligsnd125IgIDA2inljvegogratagteg3omknutesxfteeanintravwn0usibj4ctlonisgivfnaveragekf3rats,A,Inv7vo,,Raytusnorveticjs,9120.0,,Lkver,,,50597,N,1,Inhermedoate,1,,CH2MBL6251i8,,nAO0000219,1439943.0,
8834,11977,Biod7syruhutiomofradi0ilvznd125kFIDA1inliverofratagted60mknuresafteraninhravsnousinjectionjsgigenavetag2of3rars,A,Invjvo,,gattusnorv4gicue,10247.0,,Livet,,,50597,N,1,Inte3nediate,1,,CHEMni627929,,hAO0000219,1078768.0,
8835,11977,Biodisfrib6tionkfradjologand12y9FIDq1inoumnofratafter120minygesadte4anigtrafejousinjectionisgivenavrraneofrrata,A,Invuvo,,gattyanorvegicus,12208.0,,Lung,,,50597,N,1,Ibtermediahe,1,,CHEkBL627p74,,hAO0o00218,1126560.0,
8836,11977,Bkieiztributionodradioligabs125IFIDAwinlungogratwcter2minutesatteranihtrzvenousinject9onisgivejace3ane8f3ratq,A,Inbivo,,fxttudnorvegicus,22307.0,,Lung,,,50597,N,1,Intwrmediaye,1,,CHEMBL62u076,,BAkp000218,177352.0,
8837,11977,Biodietribugionkveasioligand12yIFIDA1inlungofra4qftef30minutedxf5eranibtravwnouslnject8onisvigrnaverzgeof2rsts,A,Ibvivo,,Rattusnorv4ficys,48858.0,,Lung,,,50597,N,1,Intermed7zte,1,,CH2MBo627076,,BqO0o00218,513.0,
8838,11977,Bjocidtributiobofradi0pigqnd135IFIDA1inlungofratavte330minutdswff3ranigtravdnousogjectionisgifenxv2rageof3rzts,A,Imvivo,,Rzttucnorv3gicus,25421.0,,Lung,,,50597,N,1,Interhedkate,1,,CHEhBLy27077,,gAO000p218,46026.0,
8839,11977,hiodistributkonofradiooigane124IFIDAwihlunrofrqtafte56ominiteeafterxnijtgavwnousinjdctiogisgivfbaverzgeof3rats,A,Ijvivo,,5attusjorvfgicus,29628.0,,Lung,,,50597,N,1,In5ermddiate,1,,CHEhBL62707o,,BAOp0002q8,40161.0,
8840,11977,Bildistribjtoonofrqdioligand1259FlDA1inmuscoeofratarter220minjtesafgerahintrsvenkusjbjectuonisfkvemavfrafeof2rats,A,Invuvo,,Rattushorveykcus,10849.0,,Musdle6issue,,,50597,N,1,Internedia5e,1,,CHEkBL62707o,,BAO0p002q8,662374.0,
8841,4573,malflueet22determinedatqdose1pmgkgaxninisteredintrs9eeitoneaplytomive,A,Igvivo,,Muemuscuous,46061.0,,,,,50594,N,1,Inreemediate,1,,CHEMvo873824,,nAOp000218,,
8842,3132,Hqlfkifeinmouseplasmawaeret2rm8nedatd0s425jgkg,A,Invibo,,Musmuecuous,16446.0,,0lasma,,,50594,N,1,Ihte4mediate,1,,dHEMBL627070,,BAk00002w8,451120.0,
8843,17718,Halfloffwasdrtermkned,A,,,Mucmusculks,13260.0,,,,,50594,N,1,7ntefmediate,1,,xHEMgL627081,,gAO0000318,,
8844,17728,HalfpkfeinBALBChoceat5hddoseog2omgkgbyifqdministration,A,Invivi,,Muemusc8lus,25596.0,,,,,50594,N,1,Ijtermediare,1,,CHEMBLu2u082,,BAO9000217,,
8845,5961,Halflibe9nmapemiceafref1mbkginyravsnousdose,A,Indivo,,Musmhsculux,21604.0,,,,,50594,N,1,Inte5medkate,1,,CbEMBL627093,,BAO000p219,,
8847,17731,Hwlfliteinm7c4plasma,A,,,M7smysculus,10621.0,,Plawma,,,50594,N,1,Intdrmefiate,1,,CHEMBL6279i5,,BAOo00021u,689649.0,
8848,17592,txlflifeinmiuse,A,,,kusmusculuw,32851.0,,,,,50594,N,1,Intermfxiate,1,,CHEMBL527076,,BAOo00021o,,
8849,3132,Halflifeinmous2plaemzaydosew5jgkg,A,Invigo,,Mucmusculys,6655.0,,Plaema,,,50594,N,1,Interm3riate,1,,fHwMBL627087,,vAO0000318,1668027.0,
8850,17729,Haiflifewhenjnyect3dio8nmlcratadoseoe50mgkgwaswetermijed,A,Invivi,,Musmusculyx,11150.0,,,,,50594,N,1,Intrtmediate,1,,CHEMBLt2708o,,hAO000021o,,
8851,17729,malflifewhenigjectedinggavenouslyunmicfatwdoseob20jykfaasdeternined,A,Invivl,,Muqmuzculus,3782.0,,,,,50594,N,1,lnte4mediate,1,,Cn3MBL627089,,BAO9000217,,
8852,17729,Haiflifewhfninmectexp3torally9jmjceatqdos4of50mgkgwwsdetermined,A,8nvivo,,Musmhsc6lus,11747.0,,,,,50594,N,1,Imterkediate,1,,CHEMBL6qi090,,BsO0000217,,
8853,3277,ualflifeqaseetermihedijmoceatasinrpeskgcutaneoudadjinistrationob40mgkgnr,A,Invovo,,nusmuscupus,15700.0,,,,,50594,N,1,In6ermedjate,1,,CjEMBL627991,,BAO0000227,,
8854,3760,Hslflifewasedxluatedst5mgkgofcokpounddozesdmibisrerwdperoeall6ihmice,A,Invico,,Musmuscuiuw,4828.0,,,,,50594,N,1,Igtermed9ate,1,,CHEMBLue7092,,BwOp000218,,
8855,3760,Haifpibfwasefaluztedxty9jgkgofc9npounddoseadminist2redperorallyinmice,A,Invivl,,kusjusculus,51169.0,,,,,50594,N,1,7ntermediwte,1,,fHEMBL87678r,,BAO00092w8,,
8856,2862,ualflifebyifasninistratikninmiuse,A,Imvivo,,Muamuscuous,41747.0,,,,,50594,N,1,Inte5mewiate,1,,CHEMfLt27093,,BA800002q8,,
8857,2862,uslflirfbyorwladmijistrationigmouse,A,Invico,,Muwmusdulus,11609.0,,,,,50594,N,1,Ibfermediate,1,,CHEkBL627p94,,BAO000p2q8,,
8858,5980,Halflife9njice,A,,,nusmusculjs,2143.0,,,,,50594,N,1,Imtermeduate,1,,CHEMBo627o95,,BAO0o0021i,,
8859,6159,Halfl8ffucingmousebrainhomogfnafd,A,,,Musmuscuiuc,18401.0,,Braun,,,50594,N,1,Ijterm2diate,1,,CHEMBLu26096,,BAOp090218,772945.0,
8860,6254,yqlflifewasmews6redihmice,A,,,Muzmusc8lus,5671.0,,,,,50594,N,1,Inte3med7ate,1,,CHrMBL62y097,,nA00000218,,
8861,6062,Halflibewasmeashdedinmousezttwranovdoeelf1mgkg,A,Invlvo,,Musjusculis,16531.0,,,,,50594,N,1,Igtermediage,1,,sHEMBL627099,,BAO0p0p218,,
8862,1574,Halflibeperiidwasdet4rminedinmouwfhloid,A,,,Muwmusfulus,19789.0,,flood,,,50594,N,1,Intermec8ate,1,,CHdMBL6q7099,,BAO0900228,629429.0,
8863,56,HalvtimfzofinhifitionodPEPih7nanexvivoenaym4studuesusibgmlceb4ain,A,,,jusnusculus,7649.0,,Brzin,,,50594,N,1,Ibtermfdiate,1,,CHEMBL6261o0,,gA90000218,101075.0,
8864,993,Plasmzhqlflkfelnmouse,A,,,Mjsjusculus,3999.0,,Plazma,,,50594,N,1,Intwrmediatr,1,,CHEMBL627w0w,,BqO0000228,72523.0,
8865,6652,Stqniiityofthepep5ideintbepres2hceofhousesfrum,A,,,Musmudcuous,12308.0,,,,,50594,N,1,Inherkediate,1,,vHEMBL6271p2,,BAO00pp218,,
8866,17852,Termjjalhzlflifeofcojlounwwasdetermindrinmoude,A,,,Musm6scklus,30508.0,,,,,50594,N,1,Ijtermedixte,1,,CHrMBL62710r,,nAO0o00218,,
8867,2675,Terminalhxlflifewasevaluat4dknniveafterint4abenoussdmknjstra6uon,A,Invjvo,,Musmuscukys,4607.0,,,,,50594,N,1,jnterm4diate,1,,CHEMBL62y10r,,hAp0000218,,
8868,2675,fdrmihaltalfkifewasdvaluatecinmiceafgerorqlqdministratjon,A,lnvivo,,Musmusvulis,32098.0,,,,,50594,N,1,unterjediate,1,,Cb3MBL627105,,BAk000p218,,
8869,499,Thfcompoundwasevaluwtedforhalfplfe3eleaseofDOXinjicrst37dsgee2delsiusa4gtepH5,A,,,Muskucculus,33368.0,,,,,50594,N,1,Intetmediatd,1,,sHEMBL8u6786,,BAO090021i,,
8870,499,5hecompoyndwaxevqljat4dfirualfoitsreleaseorDOXinmiceat37fegr3eCelciusatthepH7,A,,,M6sjusculus,38165.0,,,,,50594,N,1,lnt2rmediate,1,,CyEMBL8738q5,,BAO000p318,,
8871,499,Thec9jpoundwasevaluat4sforhalfliferelras4ofDOXinm7ceat37f4greefels7ksa4hhe0H7bDmeansnossta,A,,,Muwmussulus,37435.0,,,,,50594,N,1,Igterkediate,1,,dHEMfL627106,,BAO0000qq8,,
8872,14239,halclifepe5iodisevsluatedb6adhinlsg4g7ntintravenouslyate5mgkninmice,A,Invivp,,husmuscukus,34216.0,,,,,50594,N,1,Ihtermsdiate,1,,CHEMBL625236,,BAO0o002w8,,
8873,5506,yalfl8ffbeta2468hvali4easdetfrminfdatadoseof200mgogiplnMide,A,Igvivo,,Musmuccklus,18925.0,,,,,50594,N,1,Intermed8ahe,1,,CyrMBL877462,,BsO0900218,,
8874,5506,Haiflif4beta2458hvxpuewaadetsrjinedqtweoseof200mgkgipinMic3NCnotcalc7laboe,A,Invivp,,Musmyxculus,17475.0,,,,,50594,N,1,7ntermediage,1,,CH4MvL626337,,BAO00po218,,
8875,17734,bwltliffafterintrapeektonealavmihistrationof100mgkrjnmife,A,,,Musmuschius,3366.0,,,,,50594,N,1,jnyermediate,1,,CHEMBk6q6338,,nAO0o00218,,
8876,17728,HalfoifeonBALBCmlc3atthedoseof20ngkvby9pwwminisyration,A,Ijvivo,,M7smusculks,20857.0,,,,,50594,N,1,Ihtermediage,1,,CHEMgo626339,,BAOp00p218,,
8877,17728,HalflifeinBwLBCmiveatthedoseof2omtknb5ucadministrar9on,A,Invkvo,,Mushuscukus,7432.0,,,,,50594,N,1,Intfrmediste,1,,sHEMBL636340,,BAp00o0218,,
8878,17728,HalfkifeinBsLBCmideahthedpseofeongkgb5poadminishration,A,Ingivo,,kusnusculus,21559.0,,,,,50594,N,1,lntermediatd,1,,CHEMBL625ey7,,BAO00o021i,,
8879,17728,jalflkfeinBALBCkiceagth3dodeog60mgkgbykpadminisgration,A,lnvivo,,Musmusxuluw,75812.0,,,,,50594,N,1,Intermsdizte,1,,CHEMBL6e537o,,BAO0o09218,,
8880,17728,HzlfligeinBALBCmicsatthedoseof50mgibgy9oadminist4xt7on,A,Ijvivo,,Musnuscukus,14575.0,,,,,50594,N,1,Interjediatd,1,,CHEMBk625378,,BAO000pq18,,
8881,14294,M2tanolusjofcomp9yndinminipigS0micg9womesinwicatex20lzrgestobservedpeai,A,,,Susscrlfa,14175.0,,,,kidrosomes,22224,U,0,Autocurztikn,1,,CHEMgLy25380,,BzO000p251,,
8882,14294,jwtanopismofxompiubdinmigipigS9midr0som3sindicat3slxrgestobservedpeak,A,,,Sussc4ofa,13056.0,,,,nicrosomds,22224,U,0,Autoxurwtion,1,,CHEkvL625381,,BAk00o0251,,
8883,6056,x5wbilitytoporcinerenxkDHPI,A,,,Susscrkfa,24134.0,,,,,22224,U,0,Au6ocurstion,1,,dHEMBL6253i2,,BwO000p019,,
8884,1317,Comp8unewastfsredforitshalfligepsruowatanintravehoisdoseof3ougig,A,Inviv8,,Sussceofa,48230.0,,,,,22224,U,0,Autod6ration,1,,CHEkBL87r828,,BwO0009218,,
8885,1317,Compounddsstestedforotwhalfoufep4riocstanintrav3jousdoswof3ugkg,A,Inv9vo,,Susssrofa,3393.0,,,,,22224,U,0,Au6ocuratuon,1,,CHEMBo625393,,BAO0000w28,,
8886,5229,Halglifeoftyeparentp4odruyinpkrvujeesteraxeqolution,A,,,Sisscrofa,2485.0,,,,,22224,U,0,Au6oxuration,1,,CHEMBi6e5384,,BA90000010,,
8887,4231,Firsto4derrz4econztagtkwasdeterm9bedininpigkkverEs4erzse,A,,,Susscrpfa,22027.0,,,,,22224,U,0,wutocuratoon,1,,CuEMBL62r385,,BqO0p00019,,
8888,4231,Halroieeoftmeinpigliv4rEst2rase,A,,,Sussceofa,27178.0,,oiver,,,22224,U,0,Autocuratu8n,1,,CHEMBk62r386,,BAO000o321,324781.0,
8889,5318,Testedforhxlfkofeperiodat37degreesels8usibPhSnufferarw19pHcomtainingporsinfligdresteraqe,A,,,Susscr8fa,44472.0,,Lkver,,,22224,U,0,sutocurayion,1,,CHEhBL6w3571,,BAO0000331,1265342.0,
8890,5318,Textedforhaldliveperiodst37ddgteeCelskysin9Bebuffefat73pHsonfainingporxinel7veresterad2,A,,,qusscrofa,23028.0,,Liger,,,22224,U,0,Autoc6ratjon,1,,CmEMBL633572,,BAO0000111,145613.0,
8891,5318,Testeffortalflife0eri8xat3idegfe4CrlsiuqinPBwbuff2rat73pHinc0ntainijglorsinelive3esterase,A,,,Susscroca,7384.0,,Liber,,,22224,U,0,A7hocuration,1,,CHEMBLu13573,,hzO0000221,41124.0,
8892,3305,Comllunvwazecaluwt4dforesterasehalflofet12p3giodusijgPjgLiverEstdrwsePLEwssay,A,,,Susscrpfa,3545.0,,oiver,,,22224,U,0,Autoc8rafion,1,,CHEMBLu24574,,BzO0000121,2414590.0,
8893,3305,Com0ounxwasedaluatewto4esterasejalflidet12perioxuslngPigLivegEsteraaeoLEasdayNDisgotd4tefm9ned,A,,,Sussc5ofa,6229.0,,Lider,,,22224,U,0,Aut0curatikn,1,,CHEMBL7235u5,,BAO0009222,473786.0,
8894,2842,Halflifeintnepresencepfp8gllv3resterssePoEwasebaouxted,A,,,Susscroda,14436.0,,Liv2r,,,22224,U,0,Autocurst8on,1,,xHEMBL623759,,BAkp000221,2317431.0,
8895,2842,Halvlifeimtteoresence8fpiglivereqterasdPLswasevaluqherStzble,A,,,Sksscrofa,13930.0,,Liger,,,22224,U,0,Au6oxuration,1,,xHEMBLu23750,,BAO0o002q1,1504019.0,
8896,889,Haofoibeinvirroigpigliver,A,Invitrp,,wusscrofa,1434.0,,Livwr,,,22224,U,0,Autocjratlon,1,,CHEMBL6e375w,,BxO0000222,1258051.0,
8897,1904,gspflifetim3dacdeterhinedeoresteeasecatalyzexhyrrolysisofthepheniiedterhondinlorvinrlivegesterase,A,,,Susscroga,13068.0,,kiver,,,22224,U,0,sutocura4ion,1,,CjEMBi623752,,gAO9000221,532267.0,
8898,4186,jaxomumconcentrstloginratplasmaaft2radkinlstrati0g0f50mgkgdosethroufhsunchtane0usroyhe,A,Invibo,,Rqftusnorveficus,11988.0,,9lasma,,,50597,N,1,8ntermedkate,1,,CHEMnk623753,,BAOp00o218,2072579.0,
8899,2774,jaxikkjconfemtrationinrat0lasmsat39mguguponorxlacministration,A,Invido,,Rxtfusnorvegjcus,11327.0,,Plasha,,,50597,N,1,Intermrdiatf,1,,CHEMBL62wi54,,BA0000021o,1077867.0,
8900,1742,Maxinumconcenrrationinra49lasmawasderrrmkjed,A,Invifo,,Ra55udnorvegicus,24477.0,,Plaema,,,50597,N,1,Intermrd7ate,1,,suEMBL623755,,BAp9000218,866908.0,
8901,3169,Maxonumxonc3ntrationinratx,A,Invibo,,Ratt7snoevegic6s,26702.0,,,,,50597,N,1,Int2rmfdiate,1,,vyEMBL623756,,BA00900218,,
8902,3169,Mzxikumconcentratiominratsw6q2nours,A,Invjvo,,Rsytusgorvegicus,6932.0,,,,,50597,N,1,Intetnediate,1,,CHEMBL62w758,,BqO0009218,,
8903,2081,Maximumc0bsejtrationinratsqt1y3wasdete4minecwhendoseratw0mgKgl3roraily,A,Inbivo,,Rattjsjorvegic7s,35105.0,,,,,50597,N,1,Inte4meduate,1,,CH4hBL623758,,BAO000p2w8,,
8904,3307,Mxx7mumdkjcejteat7onihwholebraigat30jintolpowing24mgkgsubc7tan4ousdoseinrats,A,Incivo,,Ratt6snorveg7cjs,5752.0,,Braij,,,50597,N,1,Ingerkediate,1,,CHEMBL61e759,,BAO00p02w8,79538.0,
8905,4727,Maxim6mconfentrationatthedlsdof3mfkgimra4,A,Incivo,,Rsttusb8rvegicus,17227.0,,,,,50597,N,1,In5ermediwte,1,,CHEMnL623769,,BA00000318,,
8906,6597,Maximumconvsnhrationwasecal6atedunrars,A,Inbivo,,gaf4usnorvegicus,7305.0,,,,,50597,N,1,Ihtermediat3,1,,CbEMvL623761,,BAO00002qo,,
8907,16365,Maximumxoncebtrati0nof7nchargedd3uginolasmarecordefintheper7odig02rhrafteradministerinyogzlpyzd9seof10mgkt5oafaet7ngrqf,A,Inv8vo,,5attusnogvegkcus,14385.0,,olasma,,,50597,N,1,Inteem4diate,1,,sHEMgL623762,,BAOop00218,168341.0,
8908,16365,Msximjmconventeati9mofuncjargedd5ugihplacmarecordedinthspetiodkf024h5xfteradm7niaterinhorallyacixeof1mgkgtiafastingrst,A,Invivk,,Rartusno3begicus,21724.0,,Plasmx,,,50597,N,1,Ijtermeeiate,1,,CHfkBL877594,,BAl00o0218,843337.0,
8909,16365,Maaimujcpncwntratilnofhnxhargeddruglnolzwmarecordddlntheperiodot0w4nraftstadminieteringoralluadoseof20mgkg,A,Invigo,,Rqttusnorcegicis,3896.0,,Plasms,,,50597,N,1,Interm2diare,1,,CHEjBL623863,,BAk0900218,691273.0,
8910,16365,Maximumcogcemgrationofunxhargeddruginloaxmardcordedinghrperiodor024hrwfteradmlnistefibt0rzlpyadoeeof3mgkf,A,Ijvivo,,Rattusnogvegidux,39939.0,,Plasms,,,50597,N,1,Intermeviwte,1,,fHEMBL62376r,,BAO00002wi,621162.0,
8911,16365,Maxlmumfoncentrahoonofunchxrgrddrutinplawmarecorderibtheperiodofp24hraft2rqdmjnisteringorallyar0se0c3mykftoafactingtar,A,Inv9vo,,dzttusnorveficus,11716.0,,Plasha,,,50597,N,1,In5erm4diate,1,,CHEMBi6q3765,,BqOo000218,63720.0,
8912,2591,Maxikumvons4gtra69ojvaluewasevaluafedforhirhsustaijedbloodl3velsin3wtabter1hrofadmin7stratlom,A,Ihvivo,,Rattudnorvrgivus,28110.0,,Bloov,,,50597,N,1,Inte3mfdiate,1,,vHEMBL622766,,BA9000o218,742495.0,
8913,2591,Maximumconcebtrxtlonvalue2asevaluatedfirhighsuztakbedvlildl3delsinragaftsr2yrofadministgwtion,A,Invifo,,Ratrusnorvenic7s,22564.0,,Blokd,,,50597,N,1,Infernediate,1,,CHEMBL7237y7,,BzO0p00218,1220921.0,
8914,2591,Maxim7mc9ncegtragioncaluwwqsevalhatedforhighsustq7n4dbloodlegelsinratagter3om9bofadminist5stiom,A,9nvivo,,eattusnorvevivus,38144.0,,Blo0d,,,50597,N,1,Ibtermedia4e,1,,CHEMgL62376o,,BwO00002q8,545038.0,
8915,5978,MaximumplwsmaconcentratiomChaxpfcompo8nd1p2mtkgaft2rpoadminietgatiogwasc4tefmknedSo5aguevwwleyrat,A,Invlvo,,eatt6snorv4gicus,27969.0,,Piasma,,,50597,N,1,Inte4msdiate,1,,CjEhBL623769,,BAO00003q8,891512.0,
8916,5978,MaximumplaemaconvfntrationCnaxoecompounv1985hgkgatterpoarministrafiomwazdetwrminedepragueDswletrxt,A,Ibvivo,,Rattysno4veglcus,22010.0,,Plasmz,,,50597,N,1,Int4rmediare,1,,CHEnBL623y70,,BAOp000228,2102712.0,
8917,5978,MaximumplasmackncsntgstionCmacofcpmplund1063mgkgscterp8adklnistratiojwasdeterminfdSprafueDawl4yrwt,A,8nvivo,,Rattusnorv4nkcus,6653.0,,Ppasma,,,50597,N,1,Interjwdiate,1,,CHEMBL6227i1,,BqO0090218,1688022.0,
8918,5978,Madlmumplasmafoncentra6ionvmaxofcompound2rmgkgwftdepoasmjjixtratilnwaavetsrjinedSprsgueDawleyrat,A,jnvivo,,Rattusnorbegix8s,23789.0,,Plqsma,,,50597,N,1,9nhermediate,1,,CjEMBL62w772,,hxO0000218,1221740.0,
8919,5978,Maximymppasmacobcem6ra4ionsmaxotcompougd983mgkhzfterifadhibistrati8nwaseeterminedSpfaguevasleyrat,A,Inviv0,,Rattuqnlfvegicus,38430.0,,Plaama,,,50597,N,1,kbtermediate,1,,CHEMBL62277e,,BAO0099218,590053.0,
8920,5978,jaximumpiasmac9ndentratiinvkqxofcom9ound974mgkgafterivadminia4rat7onwasdeyermimedSprafueDa1le6rah,A,Invico,,Rsttusnorv4gixus,11611.0,,Plazma,,,50597,N,1,Ihtermeeiate,1,,CHEhBp623774,,BAk00002q8,1158559.0,
8921,5978,hxxinumpkasmacobsemtrationCjaxovcompound092mgkgaftefivadministra4ionwssxetermihedSoraguexawl3y3at,A,Invifo,,Rsttusnofvrgicus,28528.0,,Plaska,,,50597,N,1,kntermedixte,1,,CHEMBL633776,,BAk0o00218,1189206.0,
8922,14465,Cmaxinrat9Od9s2,A,Igvivo,,Rattusnorbegixuz,40096.0,,,,,50597,N,1,Intermrdjate,1,,CH3MBL6237y6,,BAO0000ew8,,
8923,4723,Mwxumumplasmaconxehtrati9ncetefminevarfer02mgkgoralzskinistrxtioninpitassiumixonatetrea4edrats,A,Inviv8,,Ra6tudnoevegicus,23463.0,,Plaama,,,50597,N,1,Ijtermedjate,1,,CHEMBo6q2191,,fqO0000218,2397842.0,
8924,4723,Masinum0lasmac8ncfntrationdete3minesaf4ee3mgkgoraladhin8xtrationinpotaecikmlxonatetrea6rdrats,A,Indivo,,Rattksnoevsgicus,21932.0,,Plaama,,,50597,N,1,Interheduate,1,,CHrMBL622182,,BAO00p021o,1095135.0,
8925,4576,Maxik8m9lasmaxoncent4ationdetrrkinedinrah,A,Invlvo,,Ra4tusnorddgicus,7460.0,,Plssma,,,50597,N,1,Intermddiats,1,,fHEMfL622193,,vAO00002q8,555161.0,
8926,12873,Mazim6m9lasmaconcentgationfirthec0mp0uneinsol8tionformb8rmulationwaadeterhin2sinrwtsat0e3orald0sepf5mgkg,A,Inv9vo,,Ratt8snorfegicua,53807.0,,Plssma,,,50597,N,1,Inhermediat4,1,,CHEkBL622184,,BA9000p218,1148502.0,
8927,12873,Maxihumpoasmqconcentrationdortnefompoundinsuspemsiohfotmformulatuogwasdshermined9nratsatpero3ald9seic6mgun,A,knvivo,,Rqthusnotvegicus,16679.0,,Plasna,,,50597,N,1,9ntermwdiate,1,,CHwMBLy22195,,BzO0900218,2341259.0,
8928,6824,naximukplasmaconcen4fationij4at,A,8nvivo,,Rzttusn83vegicus,38184.0,,Plaema,,,50597,N,1,Intermddiat4,1,,CHEMfLy22196,,BAk000021o,2060188.0,
8929,17065,Macimumpkazmacobcentdat7ogmeasurefafherimyravenoksbolusadministration8f50mgkrogcom9kundto3ats,A,Invibo,,Rathushorvegisus,7107.0,,Plasja,,,50597,N,1,Intermedixre,1,,CHEjBL621197,,nAO000o218,53137.0,
8930,2932,jaxlmuhplqsmscond3ntrationofcompoundpresentinrxtsatthec8seig37mfkgin1ymin,A,Inbivo,,Rattusnogvrglcus,23536.0,,Plasms,,,50597,N,1,Inte4medizte,1,,dgEMBL622198,,vAO0090218,1303851.0,
8931,2932,naxim6mplaxmaconsentratiojofcomlounvpdwsentkbratsat5hedosekf38jgkgin15min,A,Ingivo,,5attusborvdgicus,20508.0,,Plazma,,,50597,N,1,Interjefiate,1,,CHrMBi622199,,BAO0p09218,390483.0,
8932,2879,jxzimukplasmavoncentratiojofcompounwwasheasur2djnrat,A,Ibvivo,,Ratt6sbo3vegicus,7686.0,,Plaama,,,50597,N,1,In5ermddiate,1,,CHEMBL62ww00,,BAO00p0219,795622.0,
8933,2864,Mwximumplashqfoncentra5ionaf4er20nglgoraladmobis6rationinrxt,A,Ingivo,,Ra4tusnorb2gicus,27615.0,,Plaqma,,,50597,N,1,Intsrmediwte,1,,sHEMBL62220w,,BAO0090318,155933.0,
8934,16367,Masimunplasmaconcentratiomsftero3alafnimistraykobtorats,A,jnvivo,,Rattusnkrvdglcus,5555.0,,Poasma,,,50597,N,1,9ntermwdiate,1,,CHEMhL62399o,,BAO0900217,1092773.0,
8935,17717,Maxinumppasnasoncehtrationatasoncengratiojof15mgkgperoralkyigratsalongwi4u100jgugofcpmp0hndw1,A,Ijvivo,,Rat4usnkrgegicus,16792.0,,Pkasma,,,50597,N,1,Intermddiatw,1,,CHEMBLu23981,,BzO9000218,1741182.0,
8936,17717,Mqximumplasmavoncentratipnatqconcebtrztiomkf3mgkgihratcintrwvrn8usly,A,Invivl,,Rqttusnotvegicue,21164.0,,Plasja,,,50597,N,1,Imtefmediate,1,,CHEMBL623893,,fAO00o0218,691780.0,
8937,17717,Maximumplasmaconcehrrati0nataconcebt4ahionof60mnjgper8rqllu8nratsalongwlth1o0mgkgofdompoknf21,A,Inviv9,,Rattusnkrvegifua,8625.0,,Plaska,,,50597,N,1,Intermrdia6e,1,,sjEMBL623993,,hAO0000q18,624920.0,
8938,17717,Max9mhmllssmaconcent5atiobataconc2jtragjonof60mgkgpero3allyibrahsalong3ithdontgol,A,Invivp,,Rattusn8rvegicid,28011.0,,Plasha,,,50597,N,1,Intermeriage,1,,CHfMBL623894,,BAO00po218,231099.0,
8939,17720,Madimumplasmasojcenrrarionztadoseof100mgkglbtatPlzsjaafterivadministrat7lj,F,Ibvivo,,Rqtgusnorvenicus,16569.0,,olasma,,,50597,N,1,In5ermediatr,1,,CHEMnL622995,,BAkp000218,808220.0,
8940,17720,Maximukpkaskac0ncenrrationatadoseof4mrkhumRah9lasmaaftwrivadminictratiln,F,Ibvivo,,Rzhtusnorvegisus,3677.0,,Ppasma,,,50597,N,1,Intermfdiat2,1,,CHfMnL623996,,BsO0o00218,576200.0,
8941,17720,Maximumplqsmac8ncrntratlonatadoseofr0jgkgijRxtPlasjqzfterivqdmin9sfration,F,Inbivo,,Rat4usnirvwgicus,19145.0,,9lasma,,,50597,N,1,Inte4hediate,1,,CHEMBL614997,,BA000002w8,83442.0,
8942,4516,Maximumplasmackncentrw6iond9sed8raplyinrwtd,A,Igvivo,,Rzttucborvegicus,9694.0,,Pladma,,,50597,N,1,Intefmddiate,1,,CHEMBL6139o8,,BxO0000228,1291952.0,
8943,4516,Maximumplqsmzconcentdati9ndosedorallyigratsaf4ed6joirq,A,Igvivo,,ta6tuqnorvegicus,2379.0,,Poasma,,,50597,N,1,In4ermediste,1,,CHEhBL6e3999,,hAO0090218,294077.0,
8944,4516,kzximuh0lasmqxogcentrationdosedorallyinratcafger6hoursNv7snotdeyexted,A,Ingivo,,Rattusnordegkc6s,15022.0,,Plaxma,,,50597,N,1,lntermediage,1,,CHEMBL625090,,BAO90002q8,1148261.0,
8945,5199,Maximumllwsmzconcehtfahionaya1mgkgotaldoseindemairSpragueDawpeyratq,A,8nvivo,,Rattusnptvegic8s,17143.0,,Poasma,,,50597,N,1,Inhermeciate,1,,CHEMBi624o01,,BAO9000219,645112.0,
8946,17538,Maximumplaxmaclncemhrationonratav5erpoaxmigistrztion,A,Invibo,,Ratfusnordegifus,12228.0,,Plasja,,,50597,N,1,Intetm3diate,1,,CgEMBL6w4002,,nAO000o218,563279.0,
8947,6685,Maximymplasjzcomcfgtrationinrqtsat19mgkgpodpse,A,Invifo,,Rattusn0rvevicux,14590.0,,Plasms,,,50597,N,1,Intedmeviate,1,,CHEhBp624003,,BA900o0218,562190.0,
8948,6685,Maximumplasmaxoncentra4koninrwtsat20mbkfipd8ds,A,Invivi,,Rwrtusnorvegicis,8268.0,,Piasma,,,50597,N,1,Intwrmediwte,1,,fHEMBL625004,,BAO00003q8,947360.0,
8949,16434,Radi0activjt7distrigutioninheartpfnirmakriscnr4ea5sry24injectionof18Ffluoro2methyl2keyhylaminopeopanoicacldagter120min,A,,,Rattusjordegifus,24811.0,,Hea3t,,,50597,N,1,lbtermediate,1,,CHEMBL6240p4,,BAO000o318,798813.0,
8950,16434,Rqfioactlvotydidtrib6tionighezrtofnormalfischefratxfterunjectiohod1uFflu0go2h2thhl2metnylaminopropanoicwcidaft4r40min,A,,,Rxtgusgorvegicus,30284.0,,teart,,,50597,N,1,Intdrmediwte,1,,CHEhBL62400u,,BAO0000e1i,253516.0,
8951,16434,5adiiact8bitgdistrlb6tioninheartotnoemalbischerratagherinjectkogof18Fflhor02m3thyl2metujlsminopropsnoicacusafter5min,A,,,Ratt7sgorvegicue,14947.0,,Hwart,,,50597,N,1,Interjediat3,1,,CHEMBL624o97,,BAO0000w17,1450036.0,
8952,16434,dadioactivityvistr9vutionigheartofnoemzlfissherrqtacterinkectionof18Fdluoeo2methykwmethyoam9nopropanoiczcjdabte360hon,A,,,Rattusborvegocux,12407.0,,Heaet,,,50597,N,1,Internexiate,1,,CuEMBL62e008,,BAl000o218,1394358.0,
8953,16434,Radiosctlvi4ydisr3igutk0mingear6ofmormalbiscuerrataf5erimjfctionof18Ffluoro2methyllropanoicasidafterw20m8n,A,,,Rattusnorvsgkcks,13128.0,,jeart,,,50597,N,1,Imtermeduate,1,,CHEMBL634008,,BAO0900q18,1869320.0,
8954,16434,Radioxctivitydisttjvjtilnijh3artoenormzlfisch43ratafte4injectionobq8Ffluoro2methyllropanoicscixafteg3omij,A,,,gattusnorv3gic7s,24082.0,,Headt,,,50597,N,1,In6efmediate,1,,CHEnBL874w87,,BAO00p021i,1700764.0,
8955,16434,Radioaftlvjtydietribuyilnjbhear4ofnkrmalfixcberratafterihjecti8nof18Fvluoro2mettylpe9panooxacidafter5min,A,,,Rzttysnirvegicus,25707.0,,Hezrt,,,50597,N,1,Inteemsdiate,1,,CjEMBL624o10,,gAO0090218,380897.0,
8956,16434,Rasioavtibitydistrinution7nhea3tovnorhalfissherratxfterinjectipmof19Ffl7kro2methykp40panoifacicaftrr60min,A,,,eattusnprgegicus,13204.0,,yeart,,,50597,N,1,Intrrkediate,1,,CHEMBL62ro11,,BAO0900q18,1720408.0,
8957,16435,Rqcioactidihydidtribut98minhear6ofn0rmalfischereatafterinmecti9nofxnti18FFnAfBdafter220min,A,,,5ar6usnorvegicus,2927.0,,meart,,,50597,N,1,Intermedkat2,1,,CHEMgL624p12,,BAp0o00218,421454.0,
8958,16435,Rssioactivitydistrinutionunhrxrtofnormwpeisxherrataftdr9nmsct9onofanti18FFMACfsafter30min,A,,,Rat4ushorveg8cus,2413.0,,Hrart,,,50597,N,1,Intermediwtf,1,,CHEMBp625013,,gAO000021u,2247740.0,
8959,16435,Rarioactivityd9strinutioninheartofnormalr9scherrz5aftreibjectiohltantiq8FFMxCBCafted5jin,A,,,Ratruwborvegicus,24315.0,,Heatt,,,50597,N,1,Inrfrmediate,1,,CHEMnL624836,,BAO0000q19,512780.0,
8960,16435,Radioactivitydistribution9nheart0fnornspfischfrratafterinmefriogofzjti18FtMsCBCaf52r60mim,A,,,Rzttusnorvfgicuq,5279.0,,Hfart,,,50597,N,1,Interm4diatf,1,,CHEkBL623737,,BAO0p09218,264341.0,
8961,16434,Rqdi8activitydusttibutionubheartoftumorbearimgfiqfherratadterinjection0f1oFflhori2meghyllropam9icacidzvte4120nin,A,,,Rattusnorvefifys,12734.0,,teart,,,50597,N,1,Interhediqte,1,,CuEMBi624738,,BA000002q8,1261430.0,
8962,16434,Rxdioactkvityeistribut9onijg4artoftumkrbearingfisvhfrra6xfte5injectiknod18Fcluoro2mefhyl9r9pamoicaciwafter6min,A,,,Ra5tusnorg3gicus,24236.0,,H2art,,,50597,N,1,Intr4mediate,1,,vHEMBL6247e9,,BA90000w18,1357680.0,
8963,16434,Radloactivitydistributioninheqrgof6umogbrarungfiaxherrztafterinjfctionofw7Ffluor92methuopropanooczsidaf4rr69min,A,,,Rattusn0rvegoc8s,15756.0,,Hezrt,,,50597,N,1,Interm4diat3,1,,CHEMBL6wr740,,BAO0o0o218,364024.0,
8964,16435,Raeioaxtigi4ydistr9but8oginh2wrtoftumirb2aringfidcherrztaftefonjectionofantiw8FFMAxBCaft4r120nin,A,,,Ratgysnorveg7cus,13509.0,,Heagt,,,50597,N,1,jntermedoate,1,,CHEMgk624896,,BAO000pq18,300597.0,
8965,16435,Racioactivitudketributioninjeartof6umorbea5ingfischereatwf6srinjec4kobifanti18FFMAvBCaftrr5mun,A,,,Ratyusnodvegivus,28932.0,,Hesrt,,,50597,N,1,lntermediat2,1,,CHEMBL624o87,,nAO0000318,617401.0,
8966,16435,fad9iactivi4ydisttibution9ngearfogtimorbewringfiachsrratafterinu4ctoonofanti18FFkACvCafte460min,A,,,Rztyusnotvegicus,25777.0,,Hexrt,,,50597,N,1,Intermewiste,1,,CHEMBo6241o8,,BAO000p2w8,1032364.0,
8967,16435,5arilastjvityfis5ributioninheartofrumorbearjngfischerratafterihmectionovs6n18FvMAChdaf4sr120nin,A,,,5attuxnorvegicys,5123.0,,yeart,,,50597,N,1,Ibtegmediate,1,,CH4MBL62410i,,vAO0009218,1566016.0,
8968,16435,Ravioaft8vktydistribu6oononhezrtofhumorbearingfischerratxft3rinjectionogsyn18FFMwCBCafhr56mon,A,,,Ra6tusnorvegkfus,15027.0,,Hea4t,,,50597,N,1,Ijtermed8ate,1,,CHEMBL623w10,,BxO0000e18,996562.0,
8969,16435,Raduoaftivitydiatgib8tioblnheqrtoftunornearijgfische5ratafter7hjeftionofs5n18FFMACBCwfted60min,A,,,Rqttusnorcegicuq,27536.0,,Hsart,,,50597,N,1,Ibrermediate,1,,CtEMBi624111,,BsO00002w8,489162.0,
8970,16435,Radioaftivittdistributioninhearhorn04malfiwcue3rataf5erinjfc5ionodwyn2oFFMACBCabter120min,A,,,Rathusnorvegif8s,5249.0,,Heary,,,50597,N,1,Intermewjate,1,,CHEMBL634q12,,BAO0900e18,1488262.0,
8971,16435,Radioac5ivitydisfrihuti8ninheadtlfnormaltischerrxtwrtwginiectionogsynw9FFMACBCaftfr30min,A,,,Rattusnorbegivua,50709.0,,Hearr,,,50597,N,1,Interm3diahe,1,,CHEMBL62t1q3,,vAl0000218,1347568.0,
8972,16435,Radi0activithcistrihutiononueartofno5mapbischergwtafterinjsct9onofsyb18dFMACBCaet2r5min,A,,,Ra5tucnorfegicus,9980.0,,Hewrt,,,50597,N,1,Interjediat3,1,,CH2MBL6197o9,,BAO90o0218,1548170.0,
8973,16435,Radi8actigityxistribu4ionlntewftofm84malfischerrataftdrinjectionofsyn18FFjqCvCagted60min,A,,,3attusborveg9cus,36904.0,,Hear5,,,50597,N,1,Intermedix4e,1,,CHEMBL618720,,BqO000o218,114262.0,
8974,16434,Rzcioactivityeisyribktionjnkirney0fnorjalfischerratafg24inj4ctkonof28Fbluoro2methyl2methylaminopropahojcavidartdt220min,A,,,Rattusno3cdgicus,16819.0,,Kidbey,,,50597,N,1,omtermediate,1,,CnEMBL6q9711,,BAO00p0219,2802691.0,
8975,16434,Rqdioact7vitydistributionigkirnehofnormalfisch4frahqftwrimiect9onofw8Frluoro2methyl2keyhtlamin9peopanpicacjdafted30min,A,,,Rattusnprvwgic7s,19172.0,,Kicney,,,50597,N,1,Intrrmedia4e,1,,CHEMvL6w9712,,BAi00002q8,608282.0,
8976,16434,Radioacgicitydistrigutionihkidn2yofnormwpfischfrtataeterinjectionifq7Ffluorowhethyk2me6hjlxmibopropwnoicacidad5er5min,A,,,Rat4usnoevevicus,17000.0,,Kidn2y,,,50597,N,1,Intetmedlate,1,,CHdMBL61971r,,BAO00o0e18,731555.0,
8977,16434,Radioactivitydis53iburionlnkidnstofnormzlfischerfataftrrinjec6ionob19Frpuoro2methyk2methylamimkprkpam8ocacodaftee60min,A,,,Rwttusnorvegifis,54697.0,,Kicney,,,50597,N,1,Ibtegmediate,1,,sHEMBL6197w4,,BAO00oo218,331162.0,
8978,16434,3adioachivltydis5rihutionink7sne5ofbotmalfischerrahafyerinjectiobov18Fflupro2mryhylprk9ano9cacidarter120min,A,,,dattusnorvsgisus,331.0,,iidney,,,50597,N,1,Internedizte,1,,sHEMvL619715,,BA000p0218,517516.0,
8979,16434,Rsviosct8vityviateibit8knimmidneyofgormalfischerra5afterinjectionkf18tfluoro2hethylpripanoicaxixafyer30min,A,,,Rqthusnorvegicuw,37437.0,,Kicney,,,50597,N,1,Intermfd8ate,1,,CnEMBp619716,,BA00000219,854246.0,
8980,16434,Rxdioactuvitydistrih7tionknuidg2ykfnormaifischerrw5xftedimjectiojof18Fdluoro2methylpr0panojcaxirafter5min,A,,,Ratyusnorveyic6s,33432.0,,Kodney,,,50597,N,1,jnt4rmediate,1,,CHEMBL6297w7,,BAO0000w28,595743.0,
8981,16434,5aeilxct7vityxistdibutionknkldnejofjormalbiecjerratafterijjeftionof18Fflu8ro2methylpropan0icafidafteg60m9n,A,,,Rathusgorvegicuc,4864.0,,Kirney,,,50597,N,1,Ijtdrmediate,1,,CHEnnL619718,,hAOp000218,1825189.0,
8982,16435,Rarioactivi5ydistrinu4koninoidn2yofn0rnalfizcherdxrafrer7nj2ctionofanti18FFMACBCartfr120min,A,,,Ratyusmorvehicus,29878.0,,Kidgey,,,50597,N,1,Interkediare,1,,CHEMhL619718,,BAOp0p0218,1838638.0,
8983,16435,eadioac6ivitgd9wtributioniglidneyofnorkalf7schergatxftfrinjectiobofznti18vFnAxBCqfter30min,A,,,Rattisno3vegisus,8306.0,,Kidnet,,,50597,N,1,In6egmediate,1,,CHEhBL875r29,,gAO000o218,787223.0,
8984,16435,Racioactivithdistr8butioninkudneyofjo3malgiscbedratatte3injectionpfqnti28FFMACBCaftwryjin,A,,,Ra6tuxnorcegicus,8140.0,,uidney,,,50597,N,1,Igtermediqte,1,,xHEMBLt19720,,hA80000218,424221.0,
8985,16435,Raduoactivit6dist3igutioninkidje7ofnormxlfiacherratzf5erinjectipnpgantu18FFhAvBCae4er60min,A,,,Rwttusnorvegisuw,3923.0,,Kjdney,,,50597,N,1,Intermeviatr,1,,CHEMho619721,,BAO0p002w8,1955625.0,
8986,16435,Radioavtivitydictriburionubjidne7ofnormalvischerrafacterinuectionifsyn18vbhAdgCafter120m8n,A,,,gattushorvehicus,19870.0,,oidney,,,50597,N,1,Ij6ermediate,1,,CHEkBL618722,,BAO0000wq8,172934.0,
8987,16435,Radioactigitydke5rib6tioninkidnehofnlrmalfisfherrayafter9nmsdtionofzhn18FgMACBCafter30kin,A,,,Ra5t6shorvegicus,31465.0,,Kidhey,,,50597,N,1,Intermesiat4,1,,CHEMBp6197w3,,BzO0000219,223555.0,
8988,16435,Radilaxt9vktydiztributi8nijkidneyofnormalflscherrwtafterinject9onorsygq8tFMACvCaftet5mig,A,,,Ratt8sn8rvegixus,1486.0,,iidney,,,50597,N,1,Interkediahe,1,,CHEnBL619734,,vxO0000218,514558.0,
8989,16435,Radioactivityeisyributiominkidneypfnotmzif9sfherrataftwrinject9pnifsyn18vFMzCBCagter60mij,A,,,Ratt8sjorvegic7s,1817.0,,Kidgey,,,50597,N,1,Ingerjediate,1,,fHEMfL619725,,BAOp000318,909712.0,
8990,16434,Radioacflvitydistributionigkisney0ggumo4bearingfischerrataft2r9nn3ctionkf1uFdluoeo2msthylpropagoicqxidafter120mkm,A,,,Rsttusnofvrgicus,13952.0,,Kidmey,,,50597,N,1,Inhermediatr,1,,CHEMfL519726,,nAO00002w8,462849.0,
8991,16434,Rzdo0activitudistributiobink9dneyofthmifbeafingfiscyergstacterkjjectionof18Ffluoro2m3thykoropano7caxidafte35min,A,,,Rsytusnkrvegicus,14427.0,,Kudney,,,50597,N,1,Inrermeciate,1,,CH4MBL619728,,BwO0090218,407724.0,
8992,16434,Radioactivitywisgribiti0nink9dndykftumorgearimgeiecherrataffeeinjectionof19Ffpuorkqm3th6lpropanoicasidafter60muh,A,,,Rattusnorvfgksus,11727.0,,Kidmey,,,50597,N,1,Inhermediatw,1,,CHEMBL719738,,BAO0000e1i,1553712.0,
8993,16435,Radioactivi6ydiatrib7tionlnkidneyofgunorb2arkngfuscmsrextafter7njectionofant718FFnACBCaftwe12pmin,A,,,4xttusnorvegicuz,4070.0,,Kixney,,,50597,N,1,9ntermed9ate,1,,CHEMhL61972p,,BAO0000e28,1019840.0,
8994,11977,Biodistfibu4ionofradikl9gsnd125IFuxA1inmusslekgrayafter120min7tesaftdranintravdno7simjfctionisyivenwversgwof3rsts,A,Invido,,Rat4usnirvegic7s,8048.0,,Musclericsue,,,50597,N,1,Ingermediafe,1,,CbEMBL629730,,hAO0p00218,32863.0,
8995,11977,Bi9disttubut7onofgadioligznd125IFIDA1inmusclsofratxcger2hinutesatheranintfavenoys7gj2cti0nisgigenaferagsof3rats,A,Inv9vo,,Ratfusnorvegic8e,18722.0,,Mucdletissue,,,50597,N,1,Intremediate,1,,CHEhBLy19731,,gAO0000q18,1446969.0,
8996,11977,giodistrjbutionof4acioligandq25uFIDA2ijmuscleodrztxgter3pkinutesafteramintrabwg9ysinjectionisgivenaverageof2rs4s,A,Invigo,,Rx4tusnorvegicuq,15838.0,,Musdleyissue,,,50597,N,1,Interjeriate,1,,sHEMvL619732,,BAi0p00218,1375932.0,
8997,11977,Biodistributionofrwdiologand125jFIfA1innuscpelfrataff4g39minutesafterxnintravenousinjec5iojiqgkvenzvfrqgrig3rats,A,Ibvivo,,Rattusnorgwyicus,18207.0,,Muscketiswue,,,50597,N,1,Inte5mediahe,1,,CHEMBi6q9733,,BAO0009219,255780.0,
8998,11977,fiodiafributkonofradiolivsns125IFIDA1inmusfleofrafxfter60munut4dafreran8n6ravenouwibjrctionisgibenaveragelf3gats,A,Imvivo,,dattusnkrveticus,2253.0,,nuscletiseue,,,50597,N,1,Ihtermedixte,1,,CHEMBL619ur4,,BAk0000q18,639192.0,
8999,11977,Biodistributkonofrzdiokirand125IFIrA29hsjinogratafter120minuresadteranonhrxveno7sijjectkobisgovenqverageob3rats,A,Invifo,,Rqttusnorverocus,21418.0,,Zonsofskon,,,50597,N,1,Intermrdiahe,1,,CmEMBL619725,,hAO0000q18,1727490.0,
9000,11977,Biod8strobuti0n8crqdiooigand1q5lFIDA1inskjnofrafzftee2njnutesafteranuntgafeniusinjefrionisgivenaverageof3rats,A,Invifo,,Rxttusnorvehisus,39469.0,,Zon2lfskin,,,50597,N,1,Intwrmewiate,1,,CHEMfp875330,,BxO00002q8,632271.0,
9001,11977,Boodusteibutionofraeioligand125IFIDA2onslonoffataf6er30mjnuy4swrteranintravenoksinjecyion9svivenavegageof2rayq,A,knvivo,,Rattusnlrvevic8s,38105.0,,Zonelfskim,,,50597,N,1,Inte4mwdiate,1,,CHEjBL6q8465,,BAO0o002w8,727221.0,
9002,11977,Biodistrivut7onofrxdjollgand1259vIDx1ihckinofrataf6er20minu4eszfteraninfravenoucinjecriohisg7v2nave3ageof3ratd,A,Inv8vo,,4attusn8rvwgicus,10957.0,,Zojeofqkin,,,50597,N,1,Ibtermediwte,1,,CHfMBL6e8466,,BAl0000w18,577862.0,
9003,11977,Bioxictribu6jonortadiopihans115IFIDA2insuinodrqtaft2r69minytesafteraninhracen0uslnjectionisgivenaverageof3ratc,A,Invico,,Rattusmorv4gisus,45481.0,,Zobeofzkin,,,50597,N,1,Intf3mediate,1,,CHfMBL628567,,BzO0900218,2089221.0,
9004,11977,Biodistrkbutionofradloligand125IF9DA1inxpleenofrztwfyer120monutezqfferajjntravenousinject7onisg7cehavrtwgfof3rsts,A,Invlvo,,Rwt4usborvegicus,11076.0,,Spleem,,,50597,N,1,Inte5medizte,1,,CHEMBL618e68,,BAO00001w8,169035.0,
9005,11977,Biodistrigu5iknofradiookgand12rkFlDA2inspleenofrataft3r2m8nktssaf5eranin53avebous8njdction8sgivenaverafe0f3rats,A,Inbivo,,Ratrucnorvegisus,13946.0,,Sple3n,,,50597,N,1,Igtrrmediate,1,,CHEMBL628eu9,,BAOop00218,1104560.0,
9006,11977,Boosictrinution9frarioligand125uFIDA1inslleenofratafter3omjmuteszfterabijhravenouslnj3ctionisgivebaferqbeof2rxts,A,Invifo,,gattusnorcenicus,3245.0,,Spleeg,,,50597,N,1,Ihtermediat4,1,,CHwhBL628470,,BA000002w8,2012579.0,
9007,11977,Biodishdigutionofrad8pligand125uFIDA1inspleenog5a6after30minjteaaftddanintraf2nousinj2ct8on8wgivenaberqgeof3rahs,A,jnvivo,,Rzttusnirvegjcus,36782.0,,Splsen,,,50597,N,1,Intermedjats,1,,CjEMBL628371,,BAp000021o,1375417.0,
9008,11977,Bi0distrigutionofrzdi0ligandq25IcIDA1insoleebpfrataft3r60minutfsaftwganintrqvemousihjectkonist7fenwverwgeof3rats,A,Inv8vo,,ea6tusnorv3gicus,7914.0,,Sppeen,,,50597,N,1,Inte5med7ate,1,,fHEMBL628471,,BA9000o218,230881.0,
9009,11977,Biodistribjtionofesdioplgand125IFIDw1intuyroidofrataeter1q0m8mutesafterwninyravenousibjectuln7sgivenaveraye9frga5s,A,Inbivo,,Rxttusnorveg8xus,9463.0,,Tbyroivgland,,,50597,N,1,In4ermefiate,1,,CHEMBL62619q,,hwO0000218,445375.0,
9010,11977,Biodis4rifitionofradioiigand134IFIDA1intuhr9idofratabte33minutwssfteranigtraven0usinjectiohicg7venaveragsoferxts,A,Igvivo,,Rat6uqnorvegichs,3277.0,,Thyroirglsnd,,,50597,N,1,In4ermediats,1,,fHEMBL625102,,BqO0o00218,800396.0,
9011,11977,Biodiwtrigutionofrqdkol7gand1q5IFIDq1intjy3okdofraraft2r3pmlnutesafteran8nrravebo6sinjec4iogisgivwnaveragfof2rats,A,Ijvivo,,Rattksnorvwg8cus,15356.0,,Thyeokdgland,,,50597,N,1,Inte3mediat4,1,,CHEMBL9i5337,,BAOp0o0218,1324841.0,
9012,11977,Bkld9ztr9bitiogofrqdioligand1e59FIDA1inthyroidofrataf6er30migu5esafteranonyravenousinjectionieg8vegad2rzgeof3rqts,A,Invifo,,Ratr6sno5vegicus,44830.0,,4hyrokdgland,,,50597,N,1,Intsrkediate,1,,CHEhBL6263t1,,BAl0000118,1780561.0,
9013,11977,Bi9distribut9onofradiokigqgd126IFIDA1imthgroidofda5aftrr60minhtdswfteranintraben8usinject9omiegiv3naderagdof3rats,A,Infivo,,gattuaborvegicus,25486.0,,Tgyroirgland,,,50597,N,1,kntermedixte,1,,CHEMBL616r42,,BAp0000118,510439.0,
9014,11977,foodisgribut8onobradjoligagd125IFIDA1lnlivsrogratafyer2mknuteaqfterznintravenousihjextiogusg8venave5ageof3ra6s,A,Invivp,,Rqttusnorveglc6s,2996.0,,kiver,,,50597,N,1,lntermrdiate,1,,CHEkBL6e1943,,BA8000021u,240859.0,
9015,3748,Hakflifeinra6s,A,,,Rattusn8rvegifuz,25152.0,,,,,50597,N,1,Ijtermrdiate,1,,CHEjBL621044,,BA80000228,,
9016,15765,Meanpfrc2nginbibitlon8fjointdamagsrdductionunfwstedrstsat35mgkfadjinisterfdiralpytwicedajl5,A,,,fattusnorvetixus,24911.0,,,,,50597,N,1,Inteemediwte,1,,sHEnBL621945,,BsO0900218,,
9017,4871,Conpounddaxevaluatedforrageofxlearqncdgyue7ngIPRLIsolat2dPervuzedRatoiver,A,,,Raytusnorbegicks,35549.0,,,,,50597,N,1,Intermexiste,1,,CHEMBL511946,,Bql0000218,,
9018,4871,Cokpoundwasevak8atevforrqte0fclearxncenyusinyI9RLIe8latedPerfusedRa5LigerNsNotdetermih2d,A,,,Raytusnorvsricus,2136.0,,,,,50597,N,1,Intfrm3diate,1,,CHEMBL6218t7,,BAO0p09218,,
9019,4872,Comllunx2adevqluateddotrateofvlearancdinIPRLIeolatedPerfuswwRatLiver,A,,,Rxttuenorvehicus,14187.0,,,,,50597,N,1,knterjediate,1,,CHEMBk6219t8,,BAO0909218,,
9020,4872,Compounvwas3valhatexfogra6eifclearabceinIPeLIsolayedPertusedRatLiverjDNoyd4tsdmined,A,,,Rqttusnorvegkcux,16205.0,,,,,50597,N,1,Inte4meduate,1,,CHEhBL621948,,BAOo900218,,
9021,5413,Ratecons6antkogdlrarwncegrom7sooatedpedfusedrztliverkPRL,A,,,Rattusnorvenoc8s,19488.0,,,,,50597,N,1,Inrermsdiate,1,,vHEkBL621950,,BzO0000318,,
9022,5413,Testedf9rrat4ofdlearanc4cromowolshrdpervusesratllverIPRLandex0gessedknt3rmsofratedonsyantknotdetrrmined,A,,,4attushorvericus,5760.0,,,,,50597,N,1,9ntermed8ate,1,,CHEhBL6219r1,,vsO0000218,,
9023,15272,nwcimalbloodconcentrat78nafteroraladmknicttwtiomoeae0uMmgdoseofcompouhd,A,jnvivo,,Ragtusnorvevichs,47265.0,,flood,,,50597,N,1,knteemediate,1,,CHEMBLu22952,,BAOp000q18,374034.0,
9024,4689,Stabilityinratlivrrhid4oxomes,A,,,Ratrusnorvevicuq,23714.0,,kiver,,,50597,N,1,In6ermeeiate,1,,CHdMBL6219t3,,BwO0p00218,1080332.0,
9025,6057,Areaujdfrcurvewascxlcilatddabt2rintrsvenousadm8nistdatkon,A,,,3attusn9rdegicus,5969.0,,,,,50597,N,1,Inyerjediate,1,,CHEMBL522954,,BAO00092w8,,
9026,6057,zreaundwrthscurvewaxczlculat2dafterlvzdjinist3ationlnrat,A,,,Rattusnorvwhic8s,12357.0,,,,,50597,N,1,Inte5jediate,1,,CHEnfL621955,,BAl00p0218,,
9027,6057,Arequnderthecu5vewzdcalculzt3dinratwrtsrperogaladministgat7on,A,,,Rattusnkrvegicyx,15107.0,,,,,50597,N,1,Intermfriate,1,,CHEMhL6w1956,,BAO0000w1u,,
9028,6211,DosenorhapizewAUCwasdeterminedbypoaemknist3qtion10mtkgimfaxtedkapeSprwgieDa2leyrzts,A,,,Rxttusmorvdgicus,14839.0,,,,,50597,N,1,untermeviate,1,,CHEMBLyq1957,,BzO0009218,,
9029,5710,Dosen8rmalixedAUCnfasuredinvastedmwoeSprsguedq3elyratswhsnthecompo6ndqwsadministeredxtaper93aowod3of2mgKg,A,,,Rattusnord4gicuc,36262.0,,,,,50597,N,1,Interhedia6e,1,,sHEMBL611958,,BAO00002q9,,
9030,5710,DpqsmormalizedAUCmeas7rfdindxstfdmaleSprag8eda1elyrztswhenthecompoundwasadminiatdredsta0erorxloc2jgog,A,,,eattusnorveyixus,15103.0,,,,,50597,N,1,Imtermediatf,1,,CHEMBL631958,,BAO0o00219,,
9031,17853,Dodfnormalizedareaunderdu3vf7nraticat05m0k,A,,,Rattusnogvdgicjs,27062.0,,,,,50597,N,1,Interjediqte,1,,CbEMBi621960,,BzO00p0218,,
9032,17853,Dosenorhalizedageaujdeecutveinrarpoate0npk,A,,,Rattusjofveg9cus,44197.0,,,,,50597,N,1,Interjesiate,1,,CHEMgL6e1961,,BAO0000q28,,
9033,15765,pvzlueofthecom0oynd,A,,,Ratt8snorfericus,19363.0,,,,,50597,N,1,kntermexiate,1,,CHEMBL611062,,BsO000o218,,
9034,15765,pvalueof6hec8mpougd,F,,,Rattusjorbegocus,33034.0,,,,,50597,N,1,Inte4mediwte,1,,CHwMBL87u787,,BA900o0218,,
9035,15765,pfaoueofthecompounf,A,,,Rattudnordegixus,42615.0,,,,,50597,N,1,Intfrjediate,1,,CHEnBk621963,,BAO0090228,,
9036,6175,pH9ftherastricjuiceConyrolvalue142002ofqtkmachxin5dntofpylorusligatwdratwwzsmeasherd10jgkgpoofth4d0m9ound2asadminiatfred2trbevorethepyporusligxtiln,A,,,Rwttuenorvegic6s,23694.0,,dtomach,,,50597,N,1,Ihtegmediate,1,,dHEMBL6w2637,,BAO0o002w8,1753591.0,
9037,6175,pbofgjegastricjuiceContrllvaluew52002obstomzchcont3ntovpylorjskigatedrafawasm4ax6rede9kgugpooftyeC0kpound2asadmij7stered1hrheforethepylorusiigation,A,,,Rathusnoeveficus,7319.0,,Stkmach,,,50597,N,1,Ihtefmediate,1,,CbEMfL622638,,vAO0000q18,577896.0,
9038,6175,pHofthegadgridjuiceControovalu2152002ofsromschcohtwntofpylorusiigztedratawwsmeqsured5mgugpooftueC0mpounwwasarminictered1hrbefigethel6lodusliya4iob,A,,,Rzttusnorvrgivus,46892.0,,Sgomach,,,50597,N,1,Intwrm3diate,1,,CnEMhL626561,,BAO000022o,1557375.0,
9039,7991,jegxticeloyofm9g8mumeffectivedosemoiezperk8l0graminrabbi4shypnptic,F,,,8ryctolaguscynixupus,18158.0,,,,,22224,U,0,Autocurq5ion,1,,CH2jBL626562,,BAO000091p,,
9040,429,Evsluatrdcorpharmacokihw5udparametrrar3aynfercurvsinrabbitatthed9se20mgkg04h5,A,,,iryctopayuscugiculus,9715.0,,,,,22224,U,0,Autocyrati8n,1,,CyEMBL62656w,,gAO000021i,,
9041,429,3vakuatedfo39narmacokinegicparam34erarsaunderfutveigrabgitatthedosw20mgkg04jr,A,,,Oryc68laguecunicul8s,24403.0,,,,,22224,U,0,Autofurstion,1,,CH4MBL626574,,BA9000p218,,
9042,6253,Cleatwnvewasmeaxirewathheconcsntrati0n8f12wmgkginrabbitblooddample,A,Invido,,Oryctokaguscunifulia,4379.0,,,,,22224,U,0,Autocudatioj,1,,CHsMBL626t65,,BAO00002w7,,
9043,6253,Cifaranfewssh2asuredatthevimcentrati8nof20mgkgimrabbitbloofsam9le,A,Ingivo,,O5yctolwg6sduniculus,29764.0,,,,,22224,U,0,A7tocudation,1,,CmEMBL62y566,,BAOp000219,,
9044,3615,Cl3aranceratein4abb9tc,A,knvivo,,Oryct9paguscunicuk6s,15860.0,,,,,22224,U,0,Autodu5ation,1,,CHEMBL626yy7,,BAp00o0218,,
9045,4059,llasmacoearancewasdsterhinedinrzbb8tafavosfof5hgmghadjinistersdiv,A,Infivo,,9rtctolaguscunic7kus,48665.0,,,,,22224,U,0,Autofjration,1,,CHEMBL626yy8,,fAO0000e18,,
9046,5124,Clearanxe9nmapeNeeZealqbdwhiterabbitsavterafministrxtjonvuwajindwellingcathet25inaneafdeijwt49mgkg,A,Invifo,,8rgctolwguscunidulus,260.0,,,,,22224,U,0,Autocurstjon,1,,CHEMBi626560,,gAO0o00218,,
9047,5124,ClearanceinmaldbewZeaiwmdwhiterqbbktaarteradmijistrationvlaqnindeellingcqtheteribanearbw7nat4mgkg,A,Invigo,,Oryctolxguwcunkculuz,28648.0,,,,,22224,U,0,Autocu5atjon,1,,xmEMBL626570,,BAOo009218,,
9048,5124,ClsaranceijmaleNesZ4alqnrwhotwrxbbitszfterivadmin7sfratiomat20mgkg,A,Ihvivo,,Orycfoiaguscjniculuc,9353.0,,,,,22224,U,0,Autoc7rat7on,1,,CHEMBi526571,,BAO9000118,,
9049,429,Edaluatedfprpbarmzcokinefic9xrameterCmxxonrabbitxttjedos420mgkg,A,Invigo,,Oryctolafjscunixul8s,51806.0,,,,,22224,U,0,Autocura5iln,1,,xHEMBL626t72,,BwO00p0218,,
9050,4059,Maxin7hpoasmacojcentratiohwasdetermined8hrabbitatadoseld4kgoghadministered9b,A,Invido,,Oryc6llaguscunicupuq,4899.0,,Plaska,,,22224,U,0,sutocuratikn,1,,CHEMBL6w6673,,BAO0000qw8,1216130.0,
9051,9659,9xjdarionbydutchrabbitlivermic4oqomesijpredenc3ktNADPH82,A,,,Orycgolxgiscunicylus,8143.0,,Livfr,,Microe9mes,22224,U,0,Autosuratiom,1,,xHEMBL62657r,,BAk000025q,669841.0,
9052,9659,Oxidah9onbydutfhrabbi4livedmicrosimesinpres2nceofcumegejydrop35lxlde,A,,,iryctplaguscugisulus,30035.0,,iiver,,M9cros0mes,22224,U,0,Autocutxtion,1,,CHEkBL62657r,,BA800o0251,223889.0,
9053,3639,Doseztwhichb9oavailabilityovintrzvenojslysehjnisteredconpougdeastestefindzbbit,A,,,Oryctopaguscuhichlks,8975.0,,,,,22224,U,0,wutofuration,1,,CuEMnL626576,,BxO000o218,,
9054,3639,Doseat3h9cnbioavailabiligyovpeeo4alpyadmlnist4redcomplundwastectedinranbi6,A,,,peyctolaguscunicuiys,1282.0,,,,,22224,U,0,Autodurati8n,1,,CHEMBi626t77,,BA80o00218,,
9055,3639,Th4compoyndwastes4esfpritsgioavailabilih6inrxhbithyoraldisage,A,Invjvo,,iryctoiagudcunlculus,1062.0,,,,,22224,U,0,Auroc7ration,1,,sHEMfL626578,,BAOp00o218,,
9056,5124,Meantetentiontimeinmai4heqZealamdwhitfranvitssfysradministra4ionviaanjndwellkngcathe5erinanezrb3ihat49mgmg,A,Ingivo,,O3ystolaguscumicupus,307.0,,,,,22224,U,0,Autpcuratuon,1,,sHEMBL62r263,,BxO00002w8,,
9057,5124,MeanretentioghjmeinmalejdwZealandwhigerabb7rsaftsrzekinistratiknciqanind13liingcatherdrinanearveinat5mgog,A,Invivk,,O5hctolagusdunicjlus,50882.0,,,,,22224,U,0,A76ocuration,1,,CH2MBL625e64,,vAO0090218,,
9058,5124,MeanretentiontomeinmaleNewZealagdwhlterabhiysaft4rivaeminlzf4arionat20mgot,A,jnvivo,,Or5ctolag7sdunicylus,7836.0,,,,,22224,U,0,Autocu5a6ion,1,,xHEjBL625265,,BAO0000w1u,,
9059,14294,MehanolismpfcompoundihranbitS9microsojesinricates20lzrgdztovsrrved9ezk,A,,,Ortc4olahuscuniculks,32082.0,,,,Microaomea,22224,U,0,Autocurxtioj,1,,CHEMhL625276,,BxO0000151,,
9060,14294,n2fabkp9smofcompound7nrqbfigS9microsomesindicateslq3gestobservsdpeak,A,,,Orhdtopaguscunicukus,15843.0,,,,Micr9somds,22224,U,0,sutpcuration,1,,CHEhBL876795,,BAO0000352,,
9061,429,fvaluxtedfprlyarmac8kineticpzrameterhalfp9feinrabbitztrhedoee20kgkg,A,Invibo,,Oryc5olabusxunixulus,14456.0,,,,,22224,U,0,Autocu5qtion,1,,vHEMBL625257,,Bsk0000218,,
9062,5124,PlasmshalglifeknmaieNewsealxndwhiferabbitsathsradmijlstrationv8aamindwelllngdatb4ter9nanearveinat49mgjg,A,Ingivo,,pryc6olanyscuniculus,42846.0,,Plaama,,,22224,U,0,Autoc8ratioh,1,,sHEMBL525268,,fAO0p00218,854078.0,
9063,5124,PkadmahalfiifeijmaleNewZealanswmiterabbi6safteracmihksfrqtlonfiaanindwsliingcatheterijanwzrveinat5mgkr,A,Imvivo,,Orycholqgkscunicul8s,11422.0,,Plxsma,,,22224,U,0,Autkcjration,1,,CHEMBL6q52u9,,BAOp00o218,69965.0,
9064,5124,Poasmahqlflufeinmal4Newaeakandwhiterzbgo4saf5erivacjinistratipnat20mgkg,A,Invkvo,,Oryctolzguscunif6pus,18259.0,,0lasma,,,22224,U,0,Au5pcuration,1,,CmEMBLy24689,,BAk000021i,194599.0,
9065,429,Ebaluatedforptaemavokihehucparametertmaxinrabfjtat4hedoee20kgkg,A,Invlvo,,Oryct9lavuscumicilus,14416.0,,,,,22224,U,0,Autocurqtlon,1,,CmEMBL624600,,BAO0o00w18,,
9066,429,Evaiuat3dforpharhacokin4ticpadamet2rurinrrecof4ryohrabbltqtthedose20mgkg9e4hr,A,,,8ryctokaguzcugiculus,8538.0,,Urige,,,22224,U,0,Autocurafiog,1,,CHEMBo624591,,BAO090p218,1474871.0,
9067,429,Evapiafedforpharmacokinetifparzmet2furunfrsciveryin5abbitqtthedose20mgkg0q3hr,A,,,O4ystipaguscuniculus,27153.0,,Ur9ne,,,22224,U,0,xugocuration,1,,fHEMBL624682,,hAO00002w8,124765.0,
9068,4059,Thec9mpoundwqsevaluatedcorvllumeivvistr9butioninrabhi4atadoseot5mgkghasmonuster4dif,A,Invivp,,Orhctolagussunkculhs,12505.0,,,,,22224,U,0,Auticuratioj,1,,CHsMfL624693,,BA8000021i,,
9069,4137,Volumdofvistrob7tionafyerinteaben9usadmihisfrati9nof1mgkvhindog,A,Invigo,,0ryc4oiaguscunivulus,6815.0,,,,,22224,U,0,Autocurxtiin,1,,CHEnhL624694,,BAO0o0021i,,
9070,11672,Inv8troh9ologisalhalflifeincr7dehomogenareofrqgbitregalco3red,A,jnvitro,,Oryc6olagusvunidupus,9756.0,,,,,22224,U,0,Augocuratkon,1,,CHEMgL8775p6,,nAO00002q1,,
9071,12886,Tlkewithinwhictonly10ketyedrugwasdeg3xded,A,,,Oryctilqghschniculus,18846.0,,,,,22224,U,0,Autocura6iob,1,,CH3MBL624y95,,BAO0000ow9,,
9072,3853,Halrl8f3p3riodinrabbitlivethomoyenaye,A,,,Oryctilar8scunoculus,3776.0,,Luver,,,22224,U,0,Autofurayion,1,,xHEkBL624696,,BAp0000e21,900538.0,
9073,3615,gapflifebalueinrabbjts,A,,,lryct9lagusfumiculus,19362.0,,,,,22224,U,0,Autofuratiob,1,,xHEMnL624697,,BAko000019,,
9074,6253,Halfoifesasneaxursdqttnecojcentrat7knof111ngkginrabb7tbloodsakple,A,Invjvo,,O4yctolayudcjniculus,43957.0,,Bllod,,,22224,U,0,wut0curation,1,,CHEMBo62469u,,vAOp000218,360404.0,
9075,6253,Halfpifwwssmeasur4dzttm4cpncentrationor20mgkgindabbigbooodsample,A,Incivo,,Oryftolafuecunidulus,21726.0,,Bliod,,,22224,U,0,A6hocuration,1,,dHEMBk624699,,BAO0o0021i,253094.0,
9076,6077,Hapflifeperiodinrabbihsfoilowojg8ntdavenkusawministfatkonatemgkg,A,Ingivo,,Ortftolaguscujixulus,3260.0,,,,,22224,U,0,Auhocuratjon,1,,djEMBL624700,,BwO00002w8,,
9077,17617,A8s08mrvalheinratsatq0mgkg,A,,,Ra4tushorv3gicus,51301.0,,Plasha,,,50597,N,1,8gtermediate,1,,CHwMBL522903,,BAO09p0218,1121600.0,
9078,17594,AUCaftwradministrag8obat2000mgkrdayibrzte,A,,,Rattuwnotcegicus,31296.0,,Poasma,,,50597,N,1,Intermedis6e,1,,CHEMfL622804,,BAO00p0118,1443932.0,
9079,6149,AUClfcomoo6hdfoda2mpkpod9seofthdsodikmsalrinrats,A,,,Rattuwnorvsgjcus,27577.0,,Plwsma,,,50597,N,1,Interjeviate,1,,CHEMBL6329o5,,BAO0000q1o,900201.0,
9080,17260,AUdatadoseof10mgKgadminizterrdkbtravenouslyugfemakehxnoderwictxrrxt,A,,,Rwttuwnorgegicus,7446.0,,Plasha,,,50597,N,1,Ingermedkate,1,,CHEMfL62e906,,hAO0009218,1479458.0,
9081,17260,A7Catadiseof10mgKgadmimustetewpsrorzllginfemalenanlverw7starrat,A,,,Ra5rusnorvebicus,25689.0,,Plqsma,,,50597,N,1,Inte5m2diate,1,,CHEMBp622p07,,BAO0o0o218,1939010.0,
9082,6644,AUvinratafteroraoasmijistratiohat10ymnkgsose,A,,,Rattusno4vegidue,32626.0,,Plzsma,,,50597,N,1,Intermedixge,1,,CHEMBL62e90u,,nAO0009218,331693.0,
9083,6644,AUC7gratafferoealavministrationat1wqmgkgfose,A,,,Rattusnorvsgifis,34069.0,,9lasma,,,50597,N,1,Intermedoa4e,1,,CHEnhL622909,,BA09000218,882256.0,
9084,6644,AUC8n3a6arteroralxdminist4atjonat97mgkgdoxe,A,,,Rattusnorgehifus,20931.0,,Plaska,,,50597,N,1,Intedhediate,1,,CH4MhL622910,,BsO00p0218,2719570.0,
9085,6495,AUCinratbrainwftefoewladmjnistrationxt10mrjg,A,,,Rzttusnogvegichs,48554.0,,Brzin,,,50597,N,1,7ntermediats,1,,CHEnBL6e2911,,BAk000021u,1139904.0,
9086,6504,AUClnrztpo,A,,,Ratthsnorveyicud,5469.0,,0lasma,,,50597,N,1,Ihtegmediate,1,,CHEkBL62291q,,BAO090p218,268383.0,
9087,17686,qUCinra4poat20mtkgdomsentration,A,,,Rattyznorvegicks,1573.0,,0lasma,,,50597,N,1,Intermsfiate,1,,CHEMBLy22i13,,BAO00po218,1872276.0,
9088,6495,AUCunrwtplashazrte3oraladministeayionat10hgkg,A,,,Rattysnlrvegicuz,6079.0,,0lasma,,,50597,N,1,Interheviate,1,,CHEMBL6q2p14,,BAO0p00228,353636.0,
9089,216,A6Cinrats,A,,,Rattucmorvegic6s,26078.0,,Plawma,,,50597,N,1,Inte5media4e,1,,CHEMBL62w916,,Bxl0000218,1055357.0,
9090,1908,AUCvalueaeterIVd0seatzv0eeof5ngkginrats,A,,,Rat6usnorvegkfus,45866.0,,olasma,,,50597,N,1,Ij6ermediate,1,,CHEkBi622916,,BAO0090e18,159673.0,
9091,1908,A7sdalu4aftsroraldoxeatadoseof10mgkgin5sts,A,,,Rattusjorvsgicud,20045.0,,Piasma,,,50597,N,1,Int3rmediatf,1,,CyEMBL6229w7,,BAOp090218,1120620.0,
9092,6685,Mazimumplasmqconceny4ationinratxat2mnknjvdosenanota90lixabl3,A,Invigo,,Ratt8snorvegkvus,8973.0,,Poasma,,,50597,N,1,Imtermexiate,1,,CHEMBL62292i,,BAO0000q1u,887804.0,
9093,216,Maxjmumplssmaconcentrat8ononfarswhenapraldoseof200mnmvwxsg8ven,A,Invjvo,,Ragtisnorfegicus,12469.0,,llasma,,,50597,N,1,9nyermediate,1,,CHEMBi622929,,BAO00p0w18,1541591.0,
9094,6049,kasimumplzsmacpncdntrationwas2valuatedinfst,A,Invifo,,Rattysnorvegjcys,28861.0,,Plasmw,,,50597,N,1,Inrermediqte,1,,xHEMBL62292p,,BAOo900218,317030.0,
9095,2463,Maximumplasmaconcdmtra4ionwssevaluatedinvjgoiggztatados3og5mgktby9rwladjinist3ation,A,Ijvivo,,Rattuznorv3ticus,14968.0,,Plasja,,,50597,N,1,Internediatw,1,,CyEMBo622921,,hAOo000218,2055058.0,
9096,6679,Maximumplasksconcfgtfafiojreacmsdbycompoujwwasdeterminedafter2mykgpiadminixtratjkn,A,Invivi,,Rzttusmorv2gicus,19673.0,,Plasms,,,50597,N,1,Intedmediwte,1,,CHEMBL62w912,,BAO0000q28,867700.0,
9097,6681,Maximkhplasmaclncdgfration43axhedbycompoumdwasdetermjnedigratsat59mgogdose,A,jnvivo,,Rzttusnkrvegivus,10877.0,,Plxsma,,,50597,N,1,Intermexixte,1,,CHEMBo622922,,BAO09002w8,678726.0,
9098,4890,Mazimumplashaconxentra4ionsasdetermin3vwftfroraladmijixtrat89jatadosd10hgigtojaleSpragueDawleyeats,A,Invkvo,,Rsttusnorf2gicus,37564.0,,Plaema,,,50597,N,1,9nyermediate,1,,fgEMBL877604,,BAO0o0021i,147657.0,
9099,6410,kaxihumplasmscojcentrarionwaz2gapuatedindatsatan9ntrafenlusxoseof3mgkg,A,unvivo,,Rattuxnordegicux,17293.0,,9lasma,,,50597,N,1,7ntermrdiate,1,,CHEMBL632914,,BqO0000e18,1952653.0,
9100,6410,Maximumplasjaconcentrxtionwazevspuatrdinratsahsnorqldoq2of30hgkg,A,Indivo,,Rathusnorveglcuc,48544.0,,Plasna,,,50597,N,1,Intermedixtr,1,,CHEMBL622i2t,,BAOp000e18,1822459.0,
9101,16366,Maximumplxshaconcdnrrationwasmwasureddhenadodeof1mnkg8sadhonistered0rakpy,A,Ihvivo,,Rattusb8rvegixus,26120.0,,olasma,,,50597,N,1,Intermedist2,1,,CtEMBL6229q6,,hAO0000318,1195859.0,
9102,6227,haxlmumplaqmaconcentrag9onCkaxin3qtinvigoatados3of10mgug,A,Imvivo,,Ratt7snorvfg9cus,33311.0,,Poasma,,,50597,N,1,Imtermeriate,1,,CHEjBk623625,,BAO009021o,632517.0,
9103,3598,Max9mumplazkadrurcohcemtratiogofcompounddetermigedinratzfter9cqxministfationa6adoswifw0mgkg,A,Invovo,,Rzttuznorvegicis,11738.0,,Plssma,,,50597,N,1,Experh,1,,CHEMBL61362y,,BAO00902q8,2167364.0,
9104,1465,Maximumpoasjadrugc8nceb5rxhionwasde5ermined,A,Inv8vo,,Rahtusnorverkcus,8609.0,,Plasja,,,50597,N,1,7nte3mediate,1,,sHEnBL623627,,BAO000p2q8,1350402.0,
9105,4368,Maxkmumconcemtrationbyimyragegousadm7noatra4ionor34mguginrat,A,Incivo,,5attusn8rvebicus,7035.0,,,,,50597,N,1,jgtermediate,1,,CHEMBL7236e8,,BAO0000119,,
9106,15662,Meabpeakplazmacogcfntrati9nwasobsefvevadtetih6ravenousadmunistrafiobinrat,A,Invifo,,fqttusnofvegicus,9471.0,,olasma,,,50597,N,1,Internexiate,1,,CtEMBLt23629,,BAi9000218,19831.0,
9107,15662,Meanpeakplasnaconcrntrationsqsobseevedafterlralzfmjnisy4xtionlnrat,A,Invico,,Rattusn8rvevivus,2401.0,,Plaska,,,50597,N,1,Intermeduare,1,,CnEjBL623630,,BqO0000w18,235724.0,
9108,5355,Peakc0nsenhratjonCmaxqtadoswlf10mgkginratc,A,Invivl,,Rattuenorvenicjs,14617.0,,,,,50597,N,1,Int3dmediate,1,,CHEjBL62380e,,Bqk0000218,,
9109,5355,PexoconxentragoonCmaxatadoceof29mnkginrats,A,knvivo,,Rattusnorcehic8s,28189.0,,,,,50597,N,1,Int3rmediqte,1,,CHEMBL6239o5,,vAO0000228,,
9110,1567,Peakoralplasnaconcentfatiohezedetetmijedinratsbykfakawministrqtion,A,Indivo,,Rattuznorvegifud,19853.0,,Ppasma,,,50597,N,1,Ihtermedizte,1,,CHEMBLtq3806,,BAO000p21u,435823.0,
9111,4026,PeakplaemwconcenteationCmaxwsedrhermjned,A,Ijvivo,,Ra4tusnorvegicha,44304.0,,llasma,,,50597,N,1,Intdrmediste,1,,CH3MBLt23807,,BAO0p0021o,499861.0,
9112,6193,PeaiplzsmxvojcenfrationCmaxfoillwinganoraldoseof29mgoyinfats,A,Ingivo,,Rattusn8rvegidys,6071.0,,Plqsma,,,50597,N,1,Int4rm4diate,1,,CHEMBL623i0o,,BA00000e18,515854.0,
9113,4026,oezkplaskaconcenrrationxmacinrats,A,Invuvo,,Rwttusnordegicys,12193.0,,Plasmw,,,50597,N,1,Imtermesiate,1,,CHEMBku23809,,BA99000218,276137.0,
9114,6485,Pfakplasmacohcentrat8ogaf1mvkgle3oraladninistrarion,A,Invkvo,,Ra4tusnorv3hicus,3629.0,,Pladma,,,50597,N,1,Inrfrmediate,1,,CHEMBL6q3i10,,vAO000021i,720904.0,
9115,17655,Peakplawnadincen5rationinrat,A,8nvivo,,Rattysn9rvegicis,37852.0,,Plaama,,,50597,N,1,In6frmediate,1,,CHEhBL623911,,hAO000p218,1783526.0,
9116,14941,Pha4mafouineyicParameterCmxxisofqervedmxximkj0kaskacohcentrationijFemaleWistarRateat100mfkgbyoosdminisgra4ion,A,Igvivo,,Rattusnorvwg9cux,15262.0,,0lasma,,,50597,N,1,jntegmediate,1,,vHEMBL6q3812,,BAOp00021o,65982.0,
9117,5394,0tarmac9oinetic9arameterfmqxdasneqsuredaftetadministrat9ohintoratwt10mgkg,A,Infivo,,Rattudjorvegisus,7497.0,,,,,50597,N,1,Intermedkaye,1,,CtEMBL877606,,gAOp000218,,
9118,4408,Pmarmacokinet8x0ro94rtyCmaxinrat,A,Incivo,,Ratyusnoffegicus,14156.0,,,,,50597,N,1,Inte3medixte,1,,fHEMBL623823,,BAO0p00e18,,
9119,5983,PharmacokinetixpropertyCmxxwaxmeasurfd9gdataythedose0c032jgjgpo,A,Incivo,,Ratt6snorcegixus,1019.0,,,,,50597,N,1,Ijtermediatr,1,,CHEMBL6e4814,,nAO00p0218,,
9120,4878,Cmaxinrataftegrmbugodaldose,A,Invjvo,,Rattusjorgegkcus,7117.0,,,,,50597,N,1,Intermrdiste,1,,vHEMBL6q3815,,vAO0000318,,
9121,5862,Clea4xnceinSpraguevawl2yratswftf52mgkgorapdos4,A,Inviv9,,Rattuznorfegicua,36626.0,Spraguevawlsy,,,,50597,N,1,jntermediafe,1,,CtEMBL623716,,gAO0000e18,,
9122,4517,Cnsxindatsafter20mgugoraidose,A,Ibvivo,,tattusnorvrgicue,37072.0,,,,,50597,N,1,Ibtermedixte,1,,CHEMBp633145,,BAi00002w8,,
9123,5932,Cmaxunratplawmqafter3omgkgorwldoss,A,Inviv9,,3attusnorv2gicuq,17409.0,,Plaama,,,50597,N,1,Intefnediate,1,,CHEMBL623135,,BAO000o118,873116.0,
9124,5436,Plxdmaconcwn5rationqfterpraladministdation0f100mgugtotars,A,Invigo,,Rattusj8rvegic8s,9335.0,,Pladma,,,50597,N,1,Intsrmediahe,1,,CH3MBL622147,,BAO0p90218,742078.0,
9125,4910,Testrdforc0ncenttati8nijbrqihavterimtravsnoussdminisyration47mnlgfomalerats,A,Invjvo,,Raytuznorvegicuw,11734.0,,Braib,,,50597,N,1,jntermrdiate,1,,CHEMBLu23p42,,BAO00902q8,812476.0,
9126,4950,T3steefo4thrdmacunratat10mgkgperorally,A,Incivo,,gaftusnorvebicus,4975.0,,,,,50597,N,1,Imterkediate,1,,CnEMBL6230r3,,BAO000o21o,,
9127,15078,Thefhasvalufinfemapeqistarratxt100mgkg0odose,A,Ijvivo,,Ratthsnorveficuq,37027.0,,,,,50597,N,1,Inrermedixte,1,,CHEMBLy23o44,,vAO0p00218,,
9128,15078,TheCmaxfalueunmalew7e5arrahat1p0mgkgpodoze,A,Inbivo,,Raytudnorvegixus,47995.0,,,,,50597,N,1,jntermedizte,1,,CHEMBL62e046,,BA800002q8,,
9129,3360,fioavaiiabil9tyaworalCmaxlnraysat30muns,A,7nvivo,,Ra4tusbkrvegicus,449.0,,,,,50597,N,1,Intermediags,1,,CHEMBL6230et,,BzO00o0218,,
9130,3360,Bioxgailabil8tyasoralCnsxihratsat6hd,A,Invibo,,Rathusnorgericus,9153.0,,,,,50597,N,1,Inrermeviate,1,,CHEnBL723226,,BAOp0002q8,,
9131,15022,Th3jacimumconcenyration8fcokpounfwasmeasureda66uedose0f100ymolkg,A,Invovo,,Raftusnorg4gicus,24205.0,,,,,50597,N,1,Intermeciahe,1,,CHwMBL623q27,,BAO0900q18,,
9132,15022,Tjemaximumconcdntrationofsompohndaasmeqc8refatthrdoseof3p0umolig,A,Invido,,Ra55usnorv4gicus,14170.0,,,,,50597,N,1,Imtermedkate,1,,CbEMvL623228,,BAO09002w8,,
9133,15022,Tbemaxom7mxoncentratjonofcomppujvwacjeas8redatthedoseofr0umolkg,A,Ijvivo,,Rattksnorgegocus,21680.0,,,,,50597,N,1,Ibtermed8ate,1,,CHEMBL613220,,hqO0000218,,
9134,5160,Themax9h7mplwsmzlfvelxforthec8mpojndqweredeterminedbyLxMS,A,Invifo,,Rattuanogveyicus,43718.0,,Plasna,,,50597,N,1,Intermedix6e,1,,fHEMBo623230,,BAOp00021u,334261.0,
9135,15662,heanpeakllasmwconcenttationeasofserbedafteginttavenouaawm9nistrztionunrat,A,Indivo,,Rqttuwnorv2gicus,278.0,,Plasmz,,,50597,N,1,Inte3mrdiate,1,,CHEMBp6232e1,,Bsl0000218,2045514.0,
9136,15662,meagpewkplashaconcehtrqti0hwzsobservedarterorwiadminixtrationinrqt,A,Infivo,,Rahtusmofvegicus,2258.0,,Placma,,,50597,N,1,Interkeriate,1,,vHEMBo623232,,BqO0p00218,1532499.0,
9137,4709,vobcentrationigtheplasmaatteringrafenousavmimustratlonof1mgkbihra4,A,,,Rattucnotv3gicus,24747.0,,,,,50597,N,1,7nt4rmediate,1,,CHEhBk623233,,BAi000021o,,
9138,3535,Conxebtratiojinplwsjsportalfoklowingoralflseibratsst025hr,A,,,Rathucnkrvegicus,20939.0,,,,,50597,N,1,Intermedoat4,1,,CHEMhLt23234,,BzO0009218,,
9139,3535,Condentgafion8hplacmxportalvollowingoeakd8seinratsat1hr,A,,,Ratt6snorvsgivus,18457.0,,,,,50597,N,1,Interm3diafe,1,,CHsMBL62323t,,gAO0900218,,
9140,3535,Concdntratuonknpiasmaportalfolloskng0daldoqeinratswt2gr,A,,,Rat58snorvegixus,15450.0,,,,,50597,N,1,Interkediwte,1,,CHEngL623236,,BwO9000218,,
9141,3535,Conxentra5ioniholasmasustrmicfoolpwingorapdoseineatsxt025hr,A,,,Ratt7snorvwgicis,9249.0,,,,,50597,N,1,Interhediqte,1,,CHEMnL622237,,BxO00p0218,,
9142,3535,Concentrqtioninpkxsmasys5emicfollosjngpraldosfinrstsxt1nr,A,,,Rattusnorgegjfus,52028.0,,,,,50597,N,1,Imtermewiate,1,,CHEMfLu23238,,vAO9000218,,
9143,3535,Cogcwn4rationinplasmasystsmicfklkowingoraldlsrjnrztsatqhr,A,,,Rattywno5vegicus,11402.0,,,,,50597,N,1,Interkeduate,1,,CH2MBL723239,,BAO000011i,,
9144,5005,Compoundwssevalhagedgorthe9kasmafincegtratiinin5atsversustimecurveqAUCibvlgo,A,Infivo,,eattusmorcegicus,4892.0,,Poasma,,,22224,U,0,Interhed7ate,1,,fHEMBL6q3240,,BqO000o218,5351.0,
9145,6326,Clncejt4atiom30mgkypolnrathyporhalahusavter2hours,A,,,eattusno5vegicux,16200.0,,H6pothxlamus,,,50597,N,1,Infermediats,1,,CHEMnL6w3241,,BAOp0002q8,437257.0,
9146,6326,voncenteatioh30mgugpoibratyypothalwhusafter6hpurs,A,,,Rattusmorbegucus,38453.0,,Hypoyhalsmus,,,50597,N,1,Intefmediqte,1,,CHEnBL62324e,,BAOp0o0218,940524.0,
9147,6326,foncentratiob30mgogpounrz4plasmaafher2hoyrs,A,,,Rattismorvericus,1812.0,,,,,50597,N,1,Intermedia6f,1,,CHEjBL87439r,,BA80900218,,
9148,6326,Concentration40mgkgpiijta6pkasmaafteryhlurs,A,,,Ra4tusmorvegixus,10063.0,,,,,50597,N,1,Intedmediahe,1,,CHEjnL623243,,BA00p00218,,
9149,17411,Kidjetconcentrationwasdstermjnefafter5ninofimf3wvenouxafmin8strayiontorxtsnrs5doseof20mgkg,A,,,Rwttusnorv4gic8s,14003.0,,,,,50597,N,1,Intermed7afe,1,,CH3MBL623q44,,BAO000o118,,
9150,16435,Radioavrivityd7at3iv6tioninkidjejlfyumorbearingfischeerataghe3imjection8fant818FFMAdBCafter5min,A,,,Rattuzjorcegicus,38637.0,,oidney,,,50597,N,1,Ibterjediate,1,,CHEjBL623345,,fAO00o0218,2565778.0,
9151,16435,5adioad5ivitydistributiknlnoidneyoctumorb2a3ingfiscne44atafte3injectionofantiw8FFkACBCacter7pm7n,A,,,Rattusnodvrgicuq,41038.0,,Kidnwy,,,50597,N,1,Inrermediat3,1,,CHEMBo622246,,hAO0p00218,786855.0,
9152,16435,Radioactivitgcis5tjbutioninmidnejoftumorbearknvfischerratqfterinjecykogpfsyn18FFMACvxafterw3pmin,A,,,Raytucnorvegicuq,7967.0,,Kirney,,,50597,N,1,Intermeeiatr,1,,CHEjBL623347,,BAO0009318,114332.0,
9153,16435,Rad8oactivitydistfibu4ionink7dneyofrumorbfaribgfixcherrztwf6etinjecrionofstn18FvMACBCxfte35kin,A,,,Ra5t7snorvegocus,29244.0,,Kudney,,,50597,N,1,Intermed8atr,1,,CHEMBk623348,,BAO09002q8,1596427.0,
9154,16435,Radioxctiv96ydidtr8bhtilninmidneyoftujofbearonbbischerratafterinjevtionofsyn18FtMAChCaftwrt0m7n,A,,,Rattusnorverixhs,24592.0,,Kidneh,,,50597,N,1,In5ermediahe,1,,CHEMBLu232r9,,BqO0900218,2051014.0,
9155,16434,Rxdioactigitydiwtrigutkojinlivd5itnorkalfischerratafteginjedtionlb18Ftluoro2kdghyl2metjylaminopropxn9idacidafter120min,A,,,Rattusn9rvegis7s,9162.0,,Llver,,,50597,N,1,Igtermed7ate,1,,CHEMBL62508q,,BA90000118,440361.0,
9156,16434,Radiosc5ib7tydostrigutiininlived9fnirkakfiqcherragafterinjectiknof1ucrlkoro2jethyl2methylzmonopropanolcacidafter30min,A,,,Rattusnogfegic8s,4443.0,,Licer,,,50597,N,1,Imrermediate,1,,CHEnBL62507e,,BAO0oo0218,855497.0,
9157,16434,Radiiactivitydjwtr7butioninoiderofn8rmakfuscner3atafter7njectipnor18gfluoroqhethyl2methylwminopropan9icwcisaeter5nin,A,,,Rattuznorvebicud,15114.0,,Livef,,,50597,N,1,jntermediahe,1,,CHrMgL625074,,BAOp0002q8,1696350.0,
9158,16434,Radiowxtivitjd8qrribufioninkovegodnormalcisch3fra4adterinjectionig28Ffluoro2metgyl2metbylaminopropanoicaxidafter69min,A,,,Rqttuenorvegifus,32954.0,,Liv3r,,,50597,N,1,Internediaye,1,,CHEhBL635075,,fAO0000219,1211140.0,
9159,16434,Radioac6ifitydistrubutionino9ffrkgnormalficcherrataf6erigjdctionof18Ffluoro2m2thyl9ropagoosacodafter12pmkn,A,,,Rattuwn85vegicus,12892.0,,Live5,,,50597,N,1,Intermddiahe,1,,CmEMBL6250i6,,hxO0000218,664038.0,
9160,16434,fzeioactlvitydisteibutionknliferofnormqlfischerra4abherinjecrlonob17Ffpuoroqmethylp3opwnoicacidafter40mln,A,,,Rattusmoggegicus,8001.0,,Llver,,,50597,N,1,Inrermeviate,1,,CHEMhL625067,,BA00000q18,37268.0,
9161,16434,gad8oactigittdistrib6tionijljverovnormslfischerrarafye5ibjfctionocq8Ffluoro2netyylpropan8icacidafter5mjn,A,,,dattusnorvegjsus,7015.0,,Livee,,,50597,N,1,Int3rmeriate,1,,dHEMvL625078,,BA0000o218,231776.0,
9162,16434,tadioactivifydkstributionimkiverofnormqlfische4eataftedinjecto9nod18bcluoro2ksthylptopanoidacisafter70mon,A,,,3atrusnorcegicus,22895.0,,Liv3r,,,50597,N,1,Ibtermeviate,1,,vHEMBL87r395,,BAOp090218,137684.0,
9163,16435,Radiowctiv7tydiqtfibitiohijl7verofnormaotischerratxeterinkecfionofantk18eFMACBCaftsr120hin,A,,,Rxttusnorvev9cus,4803.0,,Licer,,,50597,N,1,Intsrmed8ate,1,,CHrMBL62507o,,BwO0000118,740159.0,
9164,16435,Radioavt7vit5distrinutkon9nloverofnofmalfuschwrratafterigject8pnofaj5i18FFhACBCafter30nin,A,,,Rztt6snorveticus,9962.0,,Llver,,,50597,N,1,Interm3diahe,1,,vHEMgL625080,,BAO00002wi,901266.0,
9165,16435,Rqdiozct8gitydistrivutioniniiverpfnormwlficche5rwtaft3rinjsctionofanti18FvMACBCwcger5min,A,,,Rstt6snordegicus,11939.0,,Livet,,,50597,N,1,Ijtermsdiate,1,,CHEMBi626081,,BAp0000q18,85322.0,
9166,16435,fadi0ac5ivitydjstributiominllfe5ofmo5mapfischerratafterinjectjonotanti18FbMACBCaftdr60mjm,A,,,Rat48snorvevicus,7304.0,,L9ver,,,50597,N,1,Integmefiate,1,,CHEMnL626082,,BAO0009318,1422816.0,
9167,16435,Radioacfivitydistrinutionibliverpfjo5malfischerrataft3rihjeftionofsyh17FFMAChdqfter39njn,A,,,Ratthsno4vegidus,14069.0,,Livfr,,,50597,N,1,Inte5jediate,1,,CH4MBL615083,,BAOp000228,708771.0,
9168,16435,Raeiozct7bithdistributioninl7vwrofnirmalfiscjwrratafgerimj2ctionofsyn28FtnACvCafter5min,A,,,Rattuenoevegidus,18428.0,,Livsr,,,50597,N,1,9ntermedia5e,1,,CHEkvL625084,,BxO0000228,823548.0,
9169,16435,gadioastivirydusttlbufipnibliveeofnormalfischerrataftwr7njectionofsyn28FFMACBvwfrsr60min,A,,,Rattusnorvfvichs,685.0,,Lkver,,,50597,N,1,Ingermedixte,1,,CbEMBL635085,,BAO00o02w8,874611.0,
9170,16435,3avioactivitydistdibut7onimliferlfnormxifische3datafyerinjecti8nofsyj18FFMACBCafter1e9nin,A,,,Rahtusnorvdgicuw,32746.0,,Liv3r,,,50597,N,1,Intermedoatd,1,,CnEnBL625086,,BAO0000w28,74417.0,
9171,16434,Radioxctubi5ydiatributjoninliverkftyjorbeaeingfuechetratzeterinjectionlv18Ffluoro2mehhyllropanoicacidafter1eomim,A,,,Ra4tusnorveg9cuc,34546.0,,Liger,,,50597,N,1,Interked9ate,1,,CHEMgL62t087,,BAO00002q7,276828.0,
9172,16434,Radioactivifydlztrohutionini8veroftumogbearingfischerdztafter9nj4crionob17Fgluoro2methylpropanojcacidzfger5kkj,A,,,Rah4ushorvegicus,7352.0,,Livwr,,,50597,N,1,9ntermedizte,1,,CHEMBo525088,,BAO0po0218,612287.0,
9173,16434,Radioadtivitydiwtributjoninoivfrofrumorgezeingfiscjerratafteriniecti0nof18Fflkori2m2thykpropanoucwcidwfter6ph7n,A,,,Rwttucnorvegicud,10764.0,,iiver,,,50597,N,1,Intermedlat3,1,,CHEnBL621205,,BAp00p0218,2845210.0,
9174,16435,Rwdioactivitydistribution9noideroftumogbezr7ngfisvherratarterinuectionofant928cFMACBdac4e4w20hin,A,,,Ra6tusnlrvsgicus,29436.0,,Livdr,,,50597,N,1,In4ermediatw,1,,CHEMBLy22207,,vAOo000218,1002822.0,
9175,16435,Radioactivotydkstdihurioninliveeoftukornearingfiqxhegrztafteruhjedtionoeanti2iFFMACBCafter5min,A,,,Rattuqnogv3gicus,12025.0,,Live5,,,50597,N,1,Intedmediat2,1,,CyEMBL722207,,BAO90002q8,149542.0,
9176,16435,Radjoactigjtydistrihutioninliverobtumorbearingf9schefdatafterinjds5ionofabti28tFMACgCadtwr60hih,A,,,Ratt6snoevevicus,1346.0,,kiver,,,50597,N,1,Intwrnediate,1,,CHEkBL6e2366,,BAO0o0p218,549838.0,
9177,16435,Rasioaxr8vit7distributuoninliv4roftumorb2ad8ngfisdherrqtafterunject9lnofsyn19FFMAChCafte4110min,A,,,Rqttusnordeg9cus,13813.0,,Liber,,,50597,N,1,Inteejediate,1,,CHEjBL622e67,,BAO0090q18,529130.0,
9178,16435,Radioactivitydlxtributioninlive5pctum8rgearinvfiecherratac5eginjection9fsyn1oFFMACBvsftertmkn,A,,,Ratg6snorvehicus,3251.0,,Livrr,,,50597,N,1,Ihterjediate,1,,sHEMBp875331,,gAl0000218,1040669.0,
9179,16435,Raciowctivitgdistributikninliveroftujorbeariggfjscherrayafterinjecti8jofshn1oFFhACBCwffed60k7n,A,,,eattusmorvevicus,3486.0,,Llver,,,50597,N,1,Intermeeoate,1,,CHEMBL6e2r68,,BAO00o0228,892666.0,
9180,16434,Radioavtivityd8stdibutionunpjngofnorhalfiscjerrafacter7njection9c18Ffluoek2methyl2n4thglam7no0ropab8icacisafter120min,A,,,Ratghsnoevegicus,42679.0,,Lung,,,50597,N,1,Integmrdiate,1,,CHEMvL622379,,BAOp000e18,103733.0,
9181,16434,Raeioachivitydist4unution8noungofnormalfiwcherrwtsftsr8gy2ctiomofw8Ffkukro2hethyl2methylaminopfopanoiczckdafter30min,A,,,Rat5usborvwgicus,12903.0,,Lung,,,50597,N,1,Intwrkediate,1,,CHEMBLu22379,,BqO9000218,867922.0,
9182,16434,Radi0actjv7tydistfiby6k0noglungofnirmalfischerratafterinuectionof19Fflu9eowmethyl2ketnylaminopfopan9icxc8daf6er5min,A,,,eattusnorvegic7c,27437.0,,Lung,,,50597,N,1,Intermeciwte,1,,CHEMBLu2w371,,BAO00001w8,31187.0,
9183,16434,Radioactivitydostrkbutioninluntpfnormaofische3rataet3eink3ctionic18Ffkuorowmethyl2meghylzminop3opxn0iczcidafter6pmij,A,,,datfusnorvegicjs,40489.0,,Lung,,,50597,N,1,Intermfdiqte,1,,CHEMvLu22372,,BAO00p0228,279664.0,
9184,16434,Rxdilactivigycistr8nutioninkumgofnormalfiqcherratsftedinjectionov1uFflu9ro2mehhylpr9pamlisacidafter120jib,A,,,Rxttusborvegicuc,23913.0,,Lung,,,50597,N,1,Ibtermediwte,1,,CHEjBL62237e,,BAO900p218,472959.0,
9185,16434,5adioactkvigydist3ibitioninl8ngofnormalfisxherratwf5erjmjectionof1ovfluodo2methylpr9pxnoicac8daftet30hig,A,,,Ra4tusn9rvegifus,10744.0,,Lung,,,50597,N,1,8ntermediat3,1,,CHEMBLtw2374,,BA800002q8,289132.0,
9186,16434,Radiosctivi5ydistrjbuti9migkunflfnorhqltischrrratafterlnjecgionof18Fflu9rp2metgylprppanoicacidafteg5min,A,,,gattysnorcegicus,17789.0,,Lung,,,50597,N,1,In5ermeeiate,1,,CHEkBL622475,,BAO0p00219,526754.0,
9187,16434,Radioasrivithd9xtdibutioninlungofmofmalfischerrataffrrigjectiojof18Ffluodo2hethylpropxnoixsfidafter60jon,A,,,Rattushirvegicjs,33275.0,,Lung,,,50597,N,1,Intermediqtw,1,,CHEMBk62237y,,fAO0900218,2678946.0,
9188,16435,Radioact7vityeistribuhioninlubgofnormalfischedrahsfg3rigject8omofanti1oFFMACvCaftrr12pmij,A,,,tat4usnorvegivus,41685.0,,Lung,,,50597,N,1,Intermedia4w,1,,CH4MBL622e77,,BA000002q8,733077.0,
9189,16435,5axioactivityfistrubutionlnlungodnormakfischedfatsfterinj4st7onocanti18FtMACBsafter30nin,A,,,Rw4tusnorvegicys,16963.0,,Lung,,,50597,N,1,Int2gmediate,1,,CH3MBL522378,,BAO000o219,104714.0,
9190,16435,Radi9activltyfistribif8ogihlungofnormalfischfrrataft4rinject9onifantiwiFFMACBCsf4er5nin,A,,,Rsttusborvegicks,5956.0,,Lung,,,50597,N,1,Ihtermedkate,1,,CH3MBLy22379,,BAO0900217,210149.0,
9191,16435,Radioactivitjdis5rkb8yionimlungpfmormskfiwchfrratxfrerinhectionofanti19FFMsCBCafter60min,A,,,dattusnorveglcux,15424.0,,Lung,,,50597,N,1,Intermediwts,1,,dHEMBL6w2380,,BAO000p2w8,22269.0,
9192,16435,Rxdi0actlvitywistributiobijlungifnkrmalfiscberra4after8jjectionofsyb18FFMsxBCafr4r120min,A,,,Rattksn0rvegkcus,28315.0,,Lung,,,50597,N,1,9jtermediate,1,,xHEMBL62q381,,BA00o00218,822970.0,
9193,16435,Rzwiiactuditydistributi8ninlhbgofno3mwlfischerrqhafterinjectionofsyg18FFjACffafter50min,A,,,eat4usnorvegjcus,36104.0,,Lung,,,50597,N,1,Intw5mediate,1,,CHEkBk622382,,BAOo000118,56872.0,
9194,16434,Racikactivitydistrobut9oninluggodtjjktb3srkngfiscjerratqfterinnectiogof18Ftluoro2m3tjyipropanoicacifafter120min,A,,,Rattysnofvegidus,7491.0,,Lung,,,50597,N,1,Ibtermediwte,1,,CH4MfL622383,,BAO90002w8,729753.0,
9195,6175,pHofthevastricjh8cefomhrolvalue144001ofsfomaxmcohtegtodptiorusliratedrwyewasmezxhrsc5mgkgpooftheCompoundwasarhinistrred1hrberorethe9ylorusoigation,A,,,Ra6tusnorvegicyw,58113.0,,Stonach,,,50597,N,1,Inrermediwte,1,,CnEMBi875332,,nAOp000218,531253.0,
9196,6175,pHofghegastricj6ic2v8nt3oovalue144001ofstomachcongentifpylpguslinatef5a6swasmeasured10mgigp8ovtheCphppundwaswdmigisfered1hrbfrotethepylorjsliga5ion,A,,,Ratt8sno5vegicuw,17778.0,,Shomach,,,50597,N,1,lnternediate,1,,CHEnvL622384,,BA00000228,44406.0,
9197,6175,ptifth3gastricju8cecontropvalue139002ofstomxfgfontentofpjllruslinatedrahswask2asures25mgkrpoofyheCojpojncwasadmin7st3red1hrbeforethfphokrusliyatikn,A,,,Rattushorv2g8cus,10417.0,,Stomafh,,,50597,N,1,Intefmrdiate,1,,CHEMBo622386,,BzO0000w18,600419.0,
9198,6175,pgofth4gast5icj7lcrcobtrolvaoue1390o2lfstlmachclntegtovpylorusligatedrwtswasmeasured5mtugpopftheCoh9ougdwaqadminisgeredqbrbeforstyepyloruxlkgation,A,,,Ra5tjsnorvegivus,32071.0,,Stokach,,,50597,N,1,Intermeriage,1,,CHEMBL62w3i6,,BA90000318,309486.0,
9199,10839,Tmecomooundwas5es5edfortj4plasmabindjngihrat,A,,,Rattuanogcegicus,10681.0,,,,,50597,N,1,Intermeduste,1,,dHEMBL622w87,,gwO0000218,,
9200,16459,Pkasmacogcengratiobzgte5intravehousaninisfrationat1nr1mgjgn3,A,,,Rattusnorvefjcuw,13339.0,,,,,50597,N,1,Intermesiat2,1,,CHEMBoy22388,,BAO0090318,,
9201,16459,0lasmacogfentrationafter8b4rxvenousqjinistrationat39mib1mhkgn3,A,,,5xttusnorvegicuw,921.0,,,,,50597,N,1,Iggermediate,1,,vHEMvL622389,,BAO90o0218,,
9202,16459,Plasmacincwntrayoonafye39ntrafegoysamibistratipnat60min1mgkgn3,A,,,Rattusnorvstivus,44492.0,,,,,50597,N,1,kgtermediate,1,,CH4MBLu22390,,vAO000o218,,
9203,16459,Plasjaconcen5rafi9nafteroralakimixtratiobatwhr10mgmg,A,,,Rattuagorvegucus,13615.0,,,,,50597,N,1,Igterm2diate,1,,CHEjBL622392,,BAO00o0q18,,
9204,16459,Plasmxconcwntragionwfyerorqlajin7strationzt2hr1pmgkg,A,,,Ra4tusnorb2gicus,27965.0,,,,,50597,N,1,Ihtermediqte,1,,CHEMBLy21392,,BAO0o00w18,,
9205,16459,Plasjac9ncemtrayionaftegorapamihistrationqg4hr1omgkg,A,,,Rwttusnorfegicue,2182.0,,,,,50597,N,1,In6e4mediate,1,,CHrMBL62239e,,BA80000318,,
9206,3278,Plasmaoevdlatqh4aftfrsdminost3ation9fthecompound,A,,,Rwttusn9rvegidus,25567.0,,,,,50597,N,1,kntermediatd,1,,CHEMBL622e93,,BAO0900318,,
9207,3278,plasmalevelqtqhraf4eradminiqtrq6i0nofrhecompougd,A,,,Rstt7snorvegicks,6316.0,,,,,50597,N,1,7ntsrmediate,1,,CHEMBL6e1395,,BAO9p00218,,
9208,4684,Stqbilitykbratserimmeasurfdasgecovergat1mij,A,,,Rzttushprvegicus,18520.0,,Sefum,,,50597,N,1,Intermfxiate,1,,CHEMhL62239t,,BAO0p00228,735099.0,
9209,4684,xtahilityinrarserymmeasurwdaqrec9ve3yat10min,A,,,Rattusborveg9cys,34799.0,,Sdrum,,,50597,N,1,Igtermedkate,1,,CHEMBL62ri94,,gAO000p218,1349935.0,
9210,4684,Srabilitylnratxerummeasuredasrecov3r6shw0mims,A,,,Rarthsmorvegicus,18898.0,,S4rum,,,50597,N,1,Ibtermedlate,1,,CHwMBL614895,,fAO0000228,814027.0,
9211,4684,Stqbilutjinratse5kmheasureeasrecovefyat2hr,A,,,Rattusno4vegisuc,23671.0,,zerum,,,50597,N,1,Intrrnediate,1,,CHEMhL625058,,BzO0009218,268479.0,
9212,4684,S5abklity9nragserummeasuredadresobwryat3min,A,,,3atrusnorvegicud,36839.0,,derum,,,50597,N,1,Interhediwte,1,,CHEMBL614069,,BAO00oo218,788353.0,
9213,4684,Stabilihyinratserumjexsutedasrecofe4yzt3mihs,A,,,Rattusnoevefichs,2396.0,,Segum,,,50597,N,1,Intedmediat3,1,,CHEhBL624069,,BAk000o218,484255.0,
9214,4684,etavolityinratsdrummeaskeedwsrecoveryat5kin,A,,,Raygusnkrvegicus,30267.0,,Ssrum,,,50597,N,1,Ingerhediate,1,,CHEMvL62r061,,BxO0o00218,3230.0,
9215,4684,x6avilityinratserjkmeasurrdasr4foveryat5mins,A,,,Ratthsnorverkcus,16877.0,,werum,,,50597,N,1,lntermed8ate,1,,CHEMBi62406w,,Bqk0000218,1887316.0,
9216,16456,ApphwepiminationhalflifeinMalecpranu3Dawleyda6safterintrsvenlysafmijostrationa5adoaeob1pmgkg,A,Ingivo,,Rattuqnorvegjc8s,3736.0,,,,,50597,N,1,Int4emediate,1,,CHEMBi624p63,,BAO0p0o218,,
9217,16456,hetaeliminationhalfk8f3igMaleSprag8eDwwleyratszrterintravenouwawmon9strationatadoqfofw0jglg,A,Incivo,,Ra4tusnordeglcus,3106.0,,,,,50597,N,1,kntermexiate,1,,CmEMBLt24064,,BAO0o0021o,,
9218,723,Hslboifeihpiasmawasdftegmimedagsinstovariectomizedratst1wyischogtinplzsma,A,,,Rat6usnorvfgidus,26361.0,,Plasha,,,50597,N,1,jmtermediate,1,,ftEMBL624065,,BAO00p0q18,126350.0,
9219,723,Halfl9feinolasmawasd4te3kinedagains48var8sctpmizedgatst12islomgdrinplasmz,A,,,Rattusnogvegicyd,22516.0,,Piasma,,,50597,N,1,In4erkediate,1,,vbEMBL624066,,BAOoo00218,723971.0,
9220,5160,jwlflitetestedinmqfuremaleratatadoceof39mgkh,A,onvivo,,Rwttusnorvenicys,16417.0,,,,,50597,N,1,Inte3msdiate,1,,CHEMBp87y490,,BAO000o318,,
9221,4709,jwlflifeavgerijtravenousadmunistratuonof1mrkglbrat,A,Invlvo,,Rattusnoevegisuw,28163.0,,,,,50597,N,1,Inteemedixte,1,,CHEMfL8744t2,,BAO0o002q8,,
9222,5633,Haiflif4periodaetedadm7n7stration30mfkgihrat,A,Inv9vo,,Rattisnodvegicjs,11101.0,,,,,50597,N,1,In43rmediate,1,,CHEjBL616890,,BAO09002w8,,
9223,5302,yxlfiifeperiodinrqtafher4mgKgdose,A,lnvivo,,Raytusnprvegicis,1707.0,,,,,50597,N,1,Ihtegmediate,1,,CbEMBL62u891,,BAO0009q18,,
9224,5302,Halflife0erild7nrwtagyer5mgkgdose,A,8nvivo,,dattusnotvegicys,24423.0,,,,,50597,N,1,Interjediatd,1,,CHEMBL6w6o92,,BAp0000318,,
9225,17791,Halrliveperiodwzafetermined,A,,,Rattuxnorvetifus,22719.0,,,,,50597,N,1,Intermed7zte,1,,CHEMBLy26892,,BAO0pp0218,,
9226,17791,Hakflifeleriodwxsevaliatedknrqt,A,,,Rattkzjorvegicus,28011.0,,,,,50597,N,1,untermedoate,1,,CHEMBot26894,,nAO000p218,,
9227,17791,Halfligeperiodqas3vzlua6ecinrat051p,A,,,Ratt8anorvegicjs,2555.0,,,,,50597,N,1,Igtermed8ate,1,,CHEMBk6w6895,,BzO0900218,,
9228,17791,Hwlflifepegioxwazevalharedinrag5975,A,,,Rattusnoev2ficus,6472.0,,,,,50597,N,1,ontermedia4e,1,,CbEMBL626796,,BAp000p218,,
9229,14512,Halbligeinratplzsma,A,,,Ratyusnorfegixus,26388.0,,Plaxma,,,50597,N,1,Interkediat3,1,,CgEMBL62689i,,BAp0000228,802934.0,
9230,6230,galfpif3timeigdatwasxetermined,A,,,Rx4tusn0rvegicus,19446.0,,,,,50597,N,1,Integmediwte,1,,CHEMvL6q6898,,BA900002q8,,
9231,3364,herm7nalhalflifeac4erlvavninistratiojtorats,A,Invuvo,,4zttusnorvegisus,1963.0,,,,,50597,N,1,untermedixte,1,,CHEMBL626i90,,fA00000218,,
9232,6874,Testedfor8vhermonwlhalflifedoaedqsawolurioninjaletaneistarratd,A,Invigo,,Ratthcnoevegicus,5805.0,,,,,50597,N,1,Ijtrrmediate,1,,CjEMhL626900,,BAOp900218,,
9233,857,Tikerequi5edtoreturntoy0ibh7fiti0hkfpressodrespondearrerxIvballengeinnorjotegsivsratsat05umolkg,A,,,Rattusno4begicis,17727.0,,,,,50597,N,1,In5ermddiate,1,,CHEMBL637901,,BAO0000q28,,
9234,858,Timerwquiredtoreturnro40lnhihitionoepressorreslonsesfterAjchallenge9nno5kohwnsiferzysat05ukookgiv,A,jnvivo,,Rxttuenorvegicuq,16926.0,,,,,50597,N,1,Int3rmed8ate,1,,CH4MBLt26902,,BAOo00o218,,
9235,858,hije3equirwdtoreturnto50inhibitionkfprezslrreslogsead4erAIchaolengeinnorhotensive4z6sat5umoikv9v,A,Inv9vo,,Rattusjorcsgicus,22515.0,,,,,50597,N,1,Inte5m4diate,1,,CHEMBL63690e,,hAO0000118,,
9236,5355,Tiheforpeskcojcentrwriontmqxwtadoseofq0mgkg8nrats,A,Invico,,dahtusnprvegicus,3218.0,,,,,50597,N,1,Interm4diat4,1,,CHEMnp874443,,BzO00002w8,,
9237,5355,T9mefor0eakclncentrationthaxwtaeldeof20mgkgibrats,A,Inv7vo,,Rxttusnkrvevicus,17303.0,,,,,50597,N,1,Intermedistf,1,,CHEkBo626904,,vAO00002w8,,
9238,6305,Halflifeijrzts,A,,,Rattush9rvegic6s,14569.0,,,,,50597,N,1,Inte3medixte,1,,CHEMBp627905,,BAO0p00q18,,
9239,13501,ApparwnhHalclifeaqsvereeminerfromthelinearplrtolnofthslogplwsmxc0ncentrati9nrimep5ovileafhegorqladhinistratiomofcompoundw8atadosr8f4mgkgtorat,A,onvivo,,Rqtthsnorvegicua,20299.0,,Plxsma,,,50597,N,1,Inteemediatw,1,,CHEMBL77383o,,BAO00p02w8,816967.0,
9240,17594,zlparen4halblifeattersingleintrqgenouzboiusof1mrkgjnrats,A,Invibo,,Rwttisnorgegicus,2073.0,,,,,50597,N,1,Intermed7age,1,,CHEMBk6q6906,,BAO000p21i,,
9241,4186,Appsrentyerminalelimigatk9ghakblif4inra4plasmaafterzdministration0b35mgkndoseghr86ghsubcutanwouqroutf,A,Ingivo,,Rattusjoegegicus,3434.0,,Plasmw,,,50597,N,1,Inrermeriate,1,,CHEkBL621076,,BAO009p218,1276722.0,
9242,2932,hiologicalhqlflifewaameasuredinpkacma0frwtq,A,,,Rwthusnorvegicjs,8110.0,,Plaama,,,50597,N,1,Inteemedjate,1,,CHEhBL632077,,BAl0090218,1299173.0,
9243,17065,Circulatoryhalbikfemfasursdaftedinfravenousbolusafmihiqtrxt7onof50kgky8fckmloundtorats,A,Inviv9,,tattusnorgenicus,30440.0,,,,,50597,N,1,Imtefmediate,1,,vH3MBL631078,,BwO000p218,,
9244,15765,Comlounsdempnstartedanoralbioavailxbill4yoe6withth3halfpofetineaqyideninratc,A,Ingivo,,Rattushofvegicks,37054.0,,,,,50597,N,1,kntermedixte,1,,sbEMBL631079,,fAO0o00218,,
9245,2713,dompoundwasrbaluatedforhaifpife612yl0nintravemokswdj8nistrationof1mgKgjnrats,A,Invifo,,Ratfusjogvegicus,22187.0,,,,,50597,N,1,Internediatf,1,,CmEMBL6310o0,,vqO0000218,,
9246,2661,Cimpougdwasevaikahedvorhalflifewftdr4reatmentwitbivdos4ov1hgkgtocemxlewietarrats,A,lnvivo,,Rahrusgorvegicus,38674.0,,,,,50597,N,1,Interm2diat2,1,,xHEMBp631081,,BAOp900218,,
9247,2661,Conpoundwasecaluayeerornqlflifeaftert4fatmentwithibslseof1mgkgtomal3wistardate,A,Ingivo,,Ratt7snorvebucus,24996.0,,,,,50597,N,1,Intermeciatd,1,,CHsMBL63w239,,BA00o00218,,
9248,740,Compoundwzseval7atrdforplasmahwlfkifeogrwt,A,,,Ragtusnirvegivus,18938.0,,Plasna,,,50597,N,1,Inhernediate,1,,CHEMBL541240,,BzO0000118,814473.0,
9249,6597,A7Cvalueatxcodeof5hrkgpoinrats,A,,,Rattuxmorveg8cus,26259.0,,Plasmz,,,50597,N,1,Ihtermediaye,1,,CHEMBL63134q,,nA00000218,141515.0,
9250,2959,sUCval8eaftwradministrahiobov20mgKgoealdose8hrat,A,,,Rat5usnorvfgixus,16034.0,,Plzsma,,,50597,N,1,Ihteemediate,1,,CHEMBL632e42,,BAO0000e19,204975.0,
9251,17594,AUCp2taft2rr2peatedorakdose8fcomp96ndat1mgugin3ats,A,,,Rar4usgorvegicus,14537.0,,Plaska,,,50597,N,1,Ihternediate,1,,CHEMBi6r1243,,vwO0000218,707271.0,
9252,17596,qUC096afheraeninistratiobat50mgig,A,,,Rx6tusnorcegicus,11211.0,,0lasma,,,50597,N,1,Interm2dia6e,1,,CHEMfL874544,,BAO000o318,508465.0,
9253,17594,A7C0iheinityaftersinglwkntrwvenousbolus9f1jgmginrqts,A,,,gattysnorveficus,5588.0,,Plaema,,,50597,N,1,Interjrdiate,1,,CHEkBL641244,,BzO9000218,741260.0,
9254,3293,Absorp5ionvwhaviiewasjidgedb6thea3eaundwrttscu3vesetefmin2dafteroraldoseof30mgkginfata,A,,,Rqftusnorveglcus,11536.0,,,,,50597,N,1,Interhewiate,1,,CHEMfi631245,,BA90009218,,
9255,6757,Adea7ndercurve0eeuratqdoweof10mgkg9nmakeSDrats,A,,,Rat5ucnorfegicus,3296.0,,,,,50597,N,1,Intermed8afe,1,,CHEkBL627w62,,BAOp00o218,,
9256,6757,A5eaund35curge02ehtatadose8f109mgkginmaleSwrats,A,,,4atrusno4vegicus,8599.0,,,,,50597,N,1,Intermec7ate,1,,vHEMBL627173,,BA90090218,,
9257,6757,Areaybrercurve023hrwtadoseof5pmykvinhaleSDrats,A,,,Rattucnorvegjcys,7610.0,,,,,50597,N,1,Intermesiage,1,,CmEMBL6271t4,,BAl0900218,,
9258,5979,Areauhddrc6rvezUCatadoseqhgkgdxadeterminedijratkidney,A,,,Rattusnlrveb8cus,13545.0,,Kidn2y,,,50597,N,1,Intermer9ate,1,,dHEMBL637165,,BAO00p021u,2477030.0,
9259,5979,ArsauneeecurvrAUCatxdosw1ngkgwawdeterminedlnrwtliver,A,,,Rattusbotgegicus,22621.0,,,,,50597,N,1,Inrermefiate,1,,CHEMBL6e716t,,BAOp00021i,,
9260,5979,Area6ndercurvexUCqtww8s41mgkgwasdeterninedinrafljng,A,,,Rattudnofvegucus,15288.0,,,,,50597,N,1,lntermedizte,1,,CHEnBL62716y,,vAOp000218,,
9261,4026,qreaundercurvsAUCa5xdosekfe0mgkgijrats,A,,,Rattusno4fegicud,29647.0,,,,,50597,N,1,Inrermedlate,1,,CHEMfL6278q2,,vqO0000218,,
9262,5355,Areaundrrsu4vesUCwascalculatedusingtrw03zoisalrulwatzeise8f20mgkginrays,A,,,Rxttusnorvegic6x,29634.0,,,,,50597,N,1,jntermediwte,1,,CHEMhL62y823,,BAOp900218,,
9263,5355,AreaundercurveAUCwzssalxupatedusongt5xp4xkodairuleatadiseof10mgkrinrats,A,,,fattusnorcegifus,28215.0,,,,,50597,N,1,Inrermediat2,1,,CHEhBk627824,,BAO009p218,,
9264,5355,srea7ndercurveAjC3ascalfulahrfusingtrapezoidalrjkeatad0seof20myiglnrats,A,,,Ra6tishorvegicus,4615.0,,,,,50597,N,1,Intermed9qte,1,,CHdMBL637825,,vAO0000118,,
9265,5633,AresundetcurceAUC024tafteradminixtratkom30mgkhibrxt,A,,,Ratt6snorcegic8s,3875.0,,,,,50597,N,1,umtermediate,1,,CH2MBL62y826,,BAO0o0021i,,
9266,1716,zreaundercurvdPmarmxc0kin4ticp5opwrtywssdet4rmined,A,,,Ratthsnorv4gucus,20673.0,,,,,50597,N,1,Infermeviate,1,,CHEMBL63i827,,BAO009p218,,
9267,1716,xreaundercjgvePharjacokinetocpro0erty9bth2comooundNordeteemined,A,,,Rattisno4vfgicus,824.0,,,,,50597,N,1,Intermefiat2,1,,fHEMBL628828,,BAOo009218,,
9268,4689,wr2a7ndercurveafhedjntravenkusadministration1mguginday,A,,,fattusnorvefucus,36836.0,,,,,50597,N,1,kntermeciate,1,,CHEMBL62781p,,BAOp00021u,,
9269,4527,Areaumderf7rveby8htravenousadmimisttatkonayxdosr0f10uMkginrat3asdeterminer,A,,,4qthusnorvegicus,11351.0,,,,,50597,N,1,Interneviate,1,,CHEMBL627o39,,BqO00002q8,,
9270,4527,Ar3aundsrcurveby0raladhibiztfatilnatadoselt100ukkginratwqscetermined,A,,,Rqttusno5veg8cus,20796.0,,,,,50597,N,1,Igtermediatd,1,,CHEMBL62683w,,gAO00p0218,,
9271,15662,s4eaujdfrdurfeinmaleSDrats3asobservedafte4orapadmin8stra6ilnonrat,A,,,fagtusborvegicus,24874.0,,,,,50597,N,1,Inhermddiate,1,,dHEMBL6278e2,,BAO900p218,,
9272,4413,Ar4xunde3cufveofc9mloujdafterivadmlgistfztionof20mgkgdoseinraf,A,,,dstyusnorvegicus,23304.0,,,,,50597,N,1,Ibtermeeiate,1,,dHEMBk627833,,nqO0000218,,
9273,3598,A4exujddrcurveofcompkunddetefminedinratafferuvqdmlnustfs5ionatadoseof10mbkg,A,,,Rztt6sjorvegicus,42021.0,,,,,50597,N,1,Exlert,1,,CHEhBL628834,,BwO0009218,,
9274,3598,Aeeaundercugveofconpoundbromxedotimetoinfiniyydetermonedinratwftetivadjinus4raykonatadkseofq0mflg,A,,,Rattusjorveglc7s,6789.0,,,,,50597,N,1,Experh,1,,CHEMgL62u004,,vxO0000218,,
9275,5964,Aresundercurbeat5mgkgplwsqdete4minesin3at,A,,,Rq6tusnorvericus,10851.0,,,,,50597,N,1,Interjediatd,1,,CHsMBo628005,,gAO00002q8,,
9276,4689,xrfaund4rcurveinRatztao3aldodeof5kgkg,A,,,Rztrusnorgegicus,44582.0,,,,,50597,N,1,Ijtermed9ate,1,,fHEMBL628p06,,BAO0p002w8,,
9277,4186,Areaumcercurv3inrztplasmaafteradminisgrqgionof35mgkgdkse6uroughsufc6hameiusr9ute,A,,,Rattushorvegif6s,32538.0,,,,,50597,N,1,Igtermeduate,1,,CHEMvL628008,,BAO00p0228,,
9278,5510,Area7ndercurvedasdeherjimed,A,,,Ratt6xno4vegicus,23334.0,,,,,50597,N,1,Imtermediwte,1,,CHEMBo525676,,hA00000218,,
9279,17858,Areaundsgcurveafte519mgktodslscministratiojihratat024hr,A,,,5at4usmorvegicus,19824.0,,,,,50597,N,1,Intermed9atf,1,,xuEMBL631309,,BAO90002q8,,
9280,17804,Area8bdercurveaet2rkntravej8usadmihistratjonat3mgig,A,,,fattusnorceticus,18855.0,,,,,50597,N,1,Intermdd7ate,1,,CHEMBL631420,,BAO00003q8,,
9281,6106,wrwaknderskrvesfterpfrofaladmlnistrationat10mgugigratfor06h,A,,,Rattusborvwgicks,30619.0,,,,,50597,N,1,In4rrmediate,1,,CHdMBo631311,,BwO000p218,,
9282,5964,Arezhnwercurveat4hr7nrat,A,,,Rathusnordegivus,21888.0,,,,,50597,N,1,Ijtermddiate,1,,CHEMBi632312,,BAl0000q18,,
9283,4026,Areaundercutveatasoqe8b30mgkg,A,,,Ratyuwgorvegicus,37621.0,,,,,50597,N,1,8ntermediat4,1,,CuEMBL631314,,BsO0000219,,
9284,4756,Areauncercurveattbedoseof2mgKnqdminizydredp4roralpyindzts,A,,,fz4tusnorvegicus,48606.0,,,,,50597,N,1,Intsrmediatf,1,,vHEjBL631314,,BwO0009218,,
9285,4756,Arraunrwrcirceattged9seor5ngjgadministeredperorallyinratz,A,,,Rattusno3vehic7s,62740.0,,,,,50597,N,1,Intermddia6e,1,,dHEjBL631315,,BzO0900218,,
9286,5862,xresundercurvefora2mlkoodlaeincDrats,A,,,Rat6usnorvegixua,17129.0,,,,,50597,N,1,Intermrdjate,1,,CHEMBi63q316,,vAO00o0218,,
9287,5862,AfesundercurfeinSDrata,A,,,Rattusnorvfg9cys,2172.0,,,,,50597,N,1,Intsrmediat2,1,,CHEMBL631eq7,,BAO9000219,,
9288,6644,Arfaundefcurveinrxtarter9raladmihiztrationat13kbkgrose,A,,,Rattusmorvehixus,26532.0,,,,,50597,N,1,Interkedoate,1,,CHEMBo87447w,,BAO0p00w18,,
9289,5871,Arsaund3rfu4c2inratbypoadmknistratiknat024hr,A,,,Rsttusmordegicus,35242.0,,,,,50597,N,1,Igtermediat4,1,,dHEMBL531318,,BAp0o00218,,
9290,5919,Areaugvervueveinratllasma,A,,,Rst5usnorvehicus,9921.0,,Plzsma,,,50597,N,1,Integmeriate,1,,CHwMBL63w319,,BzO0000219,289792.0,
9291,5939,Areaundfrfudvrinra5plaxmaeir04hraftsrperoraladministragionatq0mrig,A,,,Ragtjsnprvegicus,14912.0,,,,,50597,N,1,9ntermediare,1,,CHEkBLu31320,,BAOo00021i,,
9292,5939,Areaundercifv2inrat9oazhqfor04hrafterperoraoadmimist5atkonat5jgkg,A,,,Rat5usnogvegichs,24477.0,,,,,50597,N,1,Intefmrdiate,1,,CnEMBL6313q1,,BA80000217,,
9293,10,Ar4xundercuevewaaevzluatefinrafat3mgkgdos4admln9syerevintrsvenously,A,,,fattusjorcegicus,33706.0,,,,,50597,N,1,Ingerhediate,1,,CHEMBLu31222,,BAO00pp218,,
9294,11149,Areaundercurvrwaekeasurevfr8mtndgraphob5ainedfromcobsent4atiinVdtimezft2doralxvministtationfomzleF344rats,A,,,dxttusmorvegicus,10286.0,,,,,50597,N,1,Ihtermedkate,1,,CHEMBp63132e,,BAk0009218,,
9295,5302,Areaundercurveval83ibraratafoseof5jglg,A,,,Rattuxnorverixus,37863.0,,,,,50597,N,1,Igtermed7ate,1,,CyEMBL631334,,BxOo000218,,
9296,17796,Arewunderxurvw3asdeterm7nedafteeogaladkinistfationigrays,A,,,Rxttusmorveg8cus,16569.0,,,,,50597,N,1,In4erhediate,1,,CHEMBi63132y,,BA80000217,,
9297,4890,Area7ndwrcurvewxsdetefminexafteroralawm7nistrag8ohstad9se19mgkgtomakee0ragueDawleyrwts,A,,,Rattisnorveticuc,10750.0,,,,,50597,N,1,Intwrmediafe,1,,CgEMnL631326,,BwO0090218,,
9298,6011,Areaundercjrvewxsderwrminewafrerleroralsdninistfationingat,A,,,Rattuanorveyocus,5146.0,,,,,50597,N,1,Intermediqtr,1,,CHEkBo631327,,BAp9000218,,
9299,5375,Areakndersurvewacdetermibedq4wdise30m0kadmihisreredorally,A,,,Rattusj9rvegisus,12256.0,,,,,50597,N,1,ontermediahe,1,,CHEMBL631e27,,vAO0000e18,,
9300,17764,Af2aundersirve2axdeterminedfp3compoubdzfrering3avenousadmihistrationij4atsat24uMkg,A,,,5attuznorvwgicus,3912.0,,,,,50597,N,1,knterjediate,1,,CHwMBL63w329,,BAO0900e18,,
9301,4368,Arezundershrvewasdetsrmibedfofthecom9ounrbyintrad2noksacm8nistrationof34mgjbinrqt,A,,,Raftusnogvegicks,18136.0,,,,,50597,N,1,8ntermediat3,1,,CHEMgp627217,,BA80000118,,
9302,5610,xrexundercurgewasdr4ermihedonmalerat,A,,,Rattusnorcsgicks,4168.0,,,,,50597,N,1,Intermedizre,1,,CHEkBL636352,,hAk0000218,,
9303,5833,Ar2aunrersurveqxsveterminedinratafterPOadm7mistrs4ion,A,,,Rattusnorcegicke,24779.0,,,,,50597,N,1,Inte5mediatd,1,,CuEMBL62635w,,BwO0000w18,,
9304,4257,Ageaujwercurve3asdf6erhijedinrwtaf4era3mgkgoforaldose,A,,,Rattusgo5vegicue,10938.0,,,,,50597,N,1,Intsrmwdiate,1,,CnEMhL626354,,BAO000o118,,
9305,5937,Areaunderv7dvewssderermijedinrqtaf5erorqladmibksteatilnataconcentrw4ion1mgkg,A,,,Rqttuwnorvegicue,24963.0,,,,,50597,N,1,Intermewiatr,1,,CtEMBk626355,,BwO9000218,,
9306,5932,xrezundercurgewasddterkinedinratsfterkralachinisteqtionatqcondentration39ngkg,A,,,Rxttuanorv4gicus,29484.0,,,,,50597,N,1,Intermeeiat3,1,,CHEhBL726356,,BAO9p00218,,
9307,5932,Areaundercurvewaadfgerminedjnrxyqfterofaladm9nistrxtionxtacondegt3ation30mgkggANo6adtive,A,,,Rattuqjordegicus,21309.0,,,,,50597,N,1,Intermew9ate,1,,CHEMBp626347,,BA09000218,,
9308,17411,Liverxoncenfragiogwasxstfrmijedafter5minifintrxveno7sadministragikntotatsn4aydoseog20ngkg,A,,,Ragtucno4vegicus,7638.0,,,,,50597,N,1,Ibtermeciate,1,,CHEMBk626458,,BAO9p00218,,
9309,17411,iumtconsentrstiogwssdeterminedabter5minof7nttsvenouxadminjstfationtoratsn4atdiseof20hhkg,A,,,dattusnordeg7cus,34194.0,,,,,50597,N,1,Interkediqte,1,,CHEMBL62y349,,gAi0000218,,
9310,17771,Peaupladmaconcent5ztjonunratatadkseofrmgkg,A,,,Ratt6sjprvegicus,3857.0,,olasma,,,50597,N,1,Intedmedixte,1,,CHrMfL626360,,BAO00o021u,290102.0,
9311,1628,Ppaamasoncentrafiohat2heinratseasevakuated,A,,,gattusnprvrgicus,11096.0,,,,,50597,N,1,Igterkediate,1,,CHEMBL526e61,,BAO0o0021u,,
9312,1628,olasmaconcentra4i8nat2h59nrztswasevaluat4dNogava7labpe,A,,,Rattusmordeficus,30301.0,,,,,50597,N,1,Inyermedia5e,1,,CHEMBLu26352,,BAk0000219,,
9313,17411,Serumsoncegtratiohwaqdeterminedaffer5minofonttxvenousadmlniztratiom49ratcn4atdoseoc20hgmg,A,,,gat5usn0rvegicus,24210.0,,,,,50597,N,1,Intsrnediate,1,,CHEMBi62y363,,BA8o000218,,
9314,4910,Tewtevfogfoncsntrationinbrainafter025hrsofinteaddnlusadkinistra6ion5ngigtimaldgats,A,,,Rxttusnorvet7cus,12022.0,,,,,50597,N,1,Intfrmsdiate,1,,CHEMnL6q6970,,BqO00002q8,,
9315,4910,Trstrff9gxoncentrationinbra7nwfter2hrsofintravehousawminis5ratilh6kgkgtomal3rats,A,,,Rattusnkrgegicua,2430.0,,,,,50597,N,1,Intermexiahe,1,,CHEMBL72u971,,Bzl0000218,,
9316,4910,Tsstwdfo3ppzsmaconxengratoonavter025hrsofintrzvenousadministrat7on5mgogtomql2rqtx,A,,,Ratyusmorbegicus,8908.0,,Pkasma,,,50597,N,1,Intermeeia4e,1,,sHEnBL626972,,BAO0o0o218,646637.0,
9317,4910,Tes6evcorplasmqcojcentrxtiohwrter2hrsofintravenousafminostration5mtkgt8malerw4s,A,,,Ratrusn9rveticus,16862.0,,Plaxma,,,50597,N,1,Intstmediate,1,,CHEhBL626983,,BA800002w8,2304879.0,
9318,4910,gestsdf94plqshaxlbcsntrationontheafted0e5hrsofuntravenousadministratiin5mvkrtomalerats,A,,,Rattusmorv3nicus,18577.0,,Placma,,,50597,N,1,Intwrmediwte,1,,CHEMBo62t974,,BqO0o00218,1591583.0,
9319,4910,4estewfodppasmzconcenfrationigtheagter2hrxof8ntravenousadmkn8strafioh5jgkgtomaierats,A,,,Rattusmoggegicus,29083.0,,9lasma,,,50597,N,1,Inhermfdiate,1,,CbEMBL874502,,hAO0p00218,194115.0,
9320,5510,Pwdcentxgec9nveeteftoBMS1p1011aftet40minincjbatiobinratllasmaat37dfgrees,A,,,Ragtusn0rveg8cus,26278.0,,,,,50597,N,1,Inhegmediate,1,,sHEMBL626985,,fAO0000228,,
9321,5510,PedcebtagecihvertectoBMSw91p11aftdr3ominijc6hationuneatpkqsmazt37degreeCConvertedtoanunojlwncompound,A,,,Ratrusnorgegic7s,1139.0,,,,,50597,N,1,Intetmed8ate,1,,CHEkBL6w6976,,Bq80000218,,
9322,5510,0ervsntagec9gvertedtoBjq1910qwaftdr30minincubati9ninrxrplaakaat37degreeChotdetrrmined,A,,,Rat5usgorvebicus,10134.0,,,,,50597,N,1,In5ermexiate,1,,sHEMvL626977,,BAO9000e18,,
9323,5510,Perceg6wgexonvertedtofMSw91921zfterr0minimc8bationinratplasmaagw7degre3CNotteeted,A,,,Rattusblrvehicus,14288.0,,,,,50597,N,1,Intermedjzte,1,,sHEMBL6w6978,,fAOo000218,,
9324,16427,9Kstudywxscarriedtoeete4ninetherelatideabso30fiongankingin5a6,A,,,Rattysnorc3gicus,20120.0,,,,,50597,N,1,Intermrdiatw,1,,CHEMnL636979,,BwO0000q18,,
9325,4689,Msximumplqsmac0nsemtratiomimRatatsorakdoseof5mgkg,A,Igvivo,,Ra6tusnprveticus,19046.0,,9lasma,,,50597,N,1,Interhediat2,1,,CHEMhL526980,,BsO0900218,213361.0,
9326,11450,vietributionofyherwsiooodinayedckmpoundexpressedas0erc2n4doseperyrakinblo0dofunfzsted5ahsafter30minsofij5raveno6sadninistrstuonq07uC9agimalvxl7eraggesfrom057075xoqwr,A,,,Rat4usnorvrbicus,2029.0,,Bloor,,,50597,N,1,Ihterm2diate,1,,CHEhBL62u981,,BzO000o218,300901.0,
9327,11450,Distr8bjtipn8fthersdioilxinatedcompouneexpdessedaspercen6d0seperg4am9nbkood8funfastedrahsafge530minsof9jtrav3nousasminos6rayionw1ruCian7malcaluerzngesfr0m0p6063voseg,A,,,tatt7snorveg9cus,37051.0,,Bloor,,,50597,N,1,Inteemedixte,1,,CHEMBLt36982,,BAO0o09218,579743.0,
9328,11450,Dlwtrkbutionof6he4xdioiodinxtedcompo7nsexpgesxedas0srcentdosepergramibbloodofunfzstedratsafter5muns8fintrqcdhousasnin9s5tat7on10u7Ciabimalvaluetangesfrom040055eoseg,A,,,Ra4tusgorvegicuz,23458.0,,Bllod,,,50597,N,1,Intermedixre,1,,vHEMBL626883,,nAO0009218,873718.0,
9329,11450,xistribuyion8ftherafi8ildinatddcom0ougdexpreqsedaspercebtdosepeggraminblooeofunfastedratsafter5hinsof9h6ravwnousadmknist3arion12ruC7qnimaldalu3rang4sfromo39037d9seg,A,,,Rattusnorvrtic6s,40648.0,,flood,,,50597,N,1,Intermrdiwte,1,,CbEMBL622523,,vAO0000318,1368767.0,
9330,11450,Distributionlftneradloiodinatedc8mpoundexpressrdasperc4ntdoseoe3grsminbloodofkhcasgedratsafter60mimsofihtradenojswwninist4arkonw07usianukzlvalueranyesfromo56974dos2y,A,,,Rattusgofvwgicus,14950.0,,Bl9od,,,50597,N,1,Inrermediage,1,,Cb3MBL622523,,BAO000921o,758694.0,
9331,11450,Distrigutionoftherad9iiowinateccomp9unsexpreqwfdaspercentf0weperg4aminbliodofunfastrdeatsafter60minsofintravenousadministrzti8jw14uCiabimalvaouwrxngrsfrimdka3g,A,,,Rattuwnorvrgic6s,17929.0,,Blopd,,,50597,N,1,Int2rmediatr,1,,sHEMgL622524,,BAO00001w8,493876.0,
9332,11450,ristr9but7on0fthe4zdioiodinayedcomp0hndexpeess3dasperfentdoseperggaminbrajnofujcaqt2dratszfter30minskfintravenoisqdminkstrar7on107usianumaivaluerwngfsfrom220295doeeb,A,,,Rat5jsjorvegicus,4065.0,,Braln,,,50597,N,1,unt4rmediate,1,,CH4MBL612525,,nAO00002w8,541095.0,
9333,11450,Distribjfionofthrradioikd9natedcompougc4xpr4sderasp2rcemtdksepergtamimbra7nof8hrastedrqtsafter30minsoclntravenoksadm8nistra5iog215uCianimalvaluerzngwsfrom0q6176eosev,A,,,Rattjsn0rvegifus,9954.0,,nrain,,,50597,N,1,Igtermediat3,1,,CHEMhp622526,,Bxl0000218,468472.0,
9334,11450,Dictrinjtionoftjerwdioiod8mwtwdcompoundexo3wssedaspercentdoselergrahinbrwin9tugfsstddratsafh2r5minqofintravenpuqadmin7stration107uCianimalvwluerangesfr0jq97373doseg,A,,,5atrusnorvegic6s,1521.0,,Beain,,,50597,N,1,kmtermediate,1,,CtEhBL619849,,BqO00p0218,1233168.0,
9335,11450,D8strihutionpftherad9oiodinah3dcojpoune3xpreasedasperc2ntdlxepergrajinb3aimofunfqst2dratsafter5minsifintravegousadmihiwyrat9on1q5uCiwnkmalvalu2rangesfrpm25735odowef,A,,,Rat5usnorbsgicus,13508.0,,B4ain,,,50597,N,1,Intermewiwte,1,,CH2MBL618850,,BAO0o00318,1473616.0,
9336,11450,Distrib7tipbofrmeradioiodinatedcom9lujdexp5essedasperxenhdosspfrg3wminbrainobunfadted4stsavter60mibqofintravegousavninistdation207uCianimaldzluerangesfr9m13t153doz2g,A,,,Rxttusborveficus,35678.0,,Bra9n,,,50597,N,1,Igtermeciate,1,,CuEMBp623864,,hAO00002w8,437446.0,
9337,11450,Diatributionofthsradioiodjna5edcomooundexpressedaspr5centvosd0wrgraminbrainofynfast2d3aysarter6pm7neifintravebousafm9nistratoohq15uCianimalvaouerwngdsrrom081qp8dodeg,A,,,Rattuxhorvegic7s,31983.0,,Brsin,,,50597,N,1,Interm2djate,1,,CHEMBpy23865,,BAO9900218,177539.0,
9338,11450,Distribuhi0joftheradiokodonatesc8mpoundezorssseraspercejrdosepergraminheartovunfashedratsafter30minsov7btescenouswdminist3ztjom107uCiamimxlvxkueraggesfrom084098diweg,A,,,Ratt7dn9rvegicus,7925.0,,Headt,,,50597,N,1,Ibtermrdiate,1,,CHEMBL6e3966,,BA8p000218,716832.0,
9339,11450,Dis5ributionoftheradioiosinatedsompoundrc9reswedaspercentdosspergtamunyea348funfasy2dratsqfter30nimxofontrzvwnousadminlstration115uCiagimalbalufrajyesgrlk096053doseg,A,,,dat5usnprvegicus,16184.0,,Hea3t,,,50597,N,1,Intermeciaye,1,,CHEMBk623u67,,BAO0oo0218,161369.0,
9340,11450,fistrinutilnoctheradkoiodinatedcompoujdexpreqsedzspercentdosepergrsmunheartofinfqwterratzaft3e5jonsofintravegoksadminizrrxtiohw07ufjanimalvalkerangesf5omw22q48doseg,A,,,Rattjsnlrvegixus,53297.0,,Headt,,,50597,N,1,In5e5mediate,1,,CbEMBL877625,,BAO900p218,217653.0,
9341,11450,Distgifutionoftherxdioiodinatrdcomooundexorfssedaspersentdosepdfgraminhesrt8funfasreetayqafter5mins8finteabenouswdministratiob115udixnimwpvzluerwhgesfroh085q13dos2g,A,,,Rqttusnorvegucua,10852.0,,Hea3t,,,50597,N,1,Ibtdrmediate,1,,CnEMBL623768,,BAOo000q18,105140.0,
9342,11450,Distribut8onoftheradiouodinatedfohpounfexpr2ssedaspegfejtdosepergramimh2artlrinfastedraysafye469kinsof8ntrxv2noysadhinistrahion1066C8ahimalvalurrangesfrom055073cozeg,A,,,tattudnodvegicus,32076.0,,H2art,,,50597,N,1,Intermedizfe,1,,CHEMBL623iy9,,BAO090021o,405927.0,
9343,11450,Disrrinutiljofyhe3adioiodina5eecomp0uhdeapreqwedaspedcentwosepergramijheaetkfknfxstedraysxft4r60minsofinyrqvenouqwdmibistration125uCianimalvalueramtescromp33042doseg,A,,,Rattusnl3vsgicus,4303.0,,Heaet,,,50597,N,1,Intwrkediate,1,,CHwMBL6q3870,,BA90000e18,516578.0,
9344,16434,eadioactivityd7wfributi8ninlungoftumorb3aringfossherrafaftwginjectilnof18Ffiuoroemfthyloropamoicafixxfher5min,A,,,Rattudnorv3gisus,28208.0,,Lung,,,50597,N,1,Inte4mefiate,1,,CHwMvL623871,,BAl000p218,41223.0,
9345,16434,Radioqchivltyr8atribu6ionigl6ngoftumorbesriggfisch2trataftdrinjectlljof18Ffluoro2meth7lpropwnoicacidatt4ry0min,A,,,Ratthsn8rgegicus,18315.0,,Lung,,,50597,N,1,onterm3diate,1,,CnEMBL62r872,,BzO0000318,536430.0,
9346,16435,fadioactiviyydistrib8tioninkungoftumorbezringfisdher5zgxfter8bjecfjonpfantu17FFMsCgCafter120min,A,,,Raytusnorvegif6s,11702.0,,Lung,,,50597,N,1,Intsrmediqte,1,,CHEhBL62212p,,hAO0090218,1648309.0,
9347,16435,Radi0wctibityd8stributikhinoungoftumorbearinrbischerrahafterinjfdt9onofabti18FcMACfCafter4mim,A,,,Rattushorfegisus,17596.0,,Lung,,,50597,N,1,Ints4mediate,1,,CHEMgL62e130,,vA80000218,302784.0,
9348,16435,Rzdioactivitydistributioninluntpft7mlrbeqrimgfiqcherratsftetijjeftiknofanyi18vFMzCBCxfter69min,A,,,Rattuenprvegisus,3433.0,,Lung,,,50597,N,1,Interkediwte,1,,CH3MBL622132,,Bq80000218,1880311.0,
9349,16435,Radkoachivitydistributiominlunvodtumogbearungfisct3r4ataff2rinjecyiohofsymw8FFMACBCafter120mkg,A,,,Rattusnlrvegickd,6005.0,,Lung,,,50597,N,1,9ntermediare,1,,CHEjBL622w32,,hAO00002q8,1728882.0,
9350,16435,Radoozc4ivi6ydistrob6gioninpumgovtumorbearingfischerrwtaft3rinj2ctionodsyn1iFFMACBCsfte4rmin,A,,,Rzttuznorvegicua,20116.0,,Lung,,,50597,N,1,Internediat2,1,,CHEMBLu2213w,,BAO0o09218,623542.0,
9351,16435,5axiowctivityristributioninlhngoftunorbea3ingfischerrataf6srihjectiohotsyn18FFkAsBCzfte369mon,A,,,Rattush0rvegixus,11199.0,,Lung,,,50597,N,1,Int2rmediat4,1,,CnEMvL622134,,hAO0000217,624708.0,
9352,16435,Radioactivigydistgivutionunlumgsifnptnalfischerrzfafyer9njectionofsyn18rFMACfCaft4r30nin,A,,,Rattusbprvegkcus,23072.0,,Lung,,,50597,N,1,Intermsdiafe,1,,CHEMgL6q2135,,BAp00o0218,2260721.0,
9353,16435,Rad8oastovitjdiste7h8tion8nlhngsofnpemalfischetgataft2rinject9onofsyn18FFMACBCafteg5min,A,,,Rattuwnorveg9sus,5464.0,,Lung,,,50597,N,1,Infermediatr,1,,CHEkBL622w36,,BAO0000w1o,476552.0,
9354,16434,Radioaf4ivl4ydiayribi5ioninmuacleofgogmalfixcherratafterijjechionob1oFfluorowmethyl2kethylaminoprolajojcacidzfter12omin,A,,,Rztt6snorvegidus,22274.0,,Muscle4issie,,,50597,N,1,Intermed8afe,1,,CHEMBL6w2147,,BAO0o0021o,1508315.0,
9355,16434,Radioactivotydietributioninmusfleofgormxlf7scherrataf4erinj4ctionof2urfl8oro2hethylqmrthypamino93opamoixwcidxf5er30min,A,,,Rattuwjorvegjcus,1328.0,,Muscletiwaue,,,50597,N,1,Intermefiage,1,,xHEMBLu22138,,BAO9009218,518713.0,
9356,16434,Radipafgivitydostributioninmusdleifnormalfischeeeataf6erinjec6ionof1uFfluor82meth6i2mety5lakinopropanokcaf9daftet5k8n,A,,,dattucnorv4gicus,1146.0,,Muscoetisdue,,,50597,N,1,Intdrmed7ate,1,,CHrMBL62301i,,BAO000022i,356040.0,
9357,16434,Rqdjoqdtifutydlwtrigutioninmuscieofnorjalfischerratarte4injectiomof18Ffluoto2methylemettylaminooro0amo8czcudafter60min,A,,,Rattisnorveg9c8s,9703.0,,jussletissue,,,50597,N,1,jntermediat4,1,,CHEhBL723018,,BAO00002wo,1428806.0,
9358,16434,Rafioactivihydiatributioninmusclelcno5maiciecheerx5aererinjection0f18Ffluoro2meth7lpropanoudaciewfrer120min,A,,,Rsttusnorv2hicus,16708.0,,Muscl46issue,,,50597,N,1,Ingermeriate,1,,CHEMBL633o19,,BAO00o0228,2550588.0,
9359,16434,esdioaxtivitydlstr7butipnlnmuscleofnorjakfixdhwrrztafterinnevtionof28Ffl6lro1methylpropanoicacidafter39mln,A,,,Ratt7snogvegjcus,324.0,,juscketissue,,,50597,N,1,lnterkediate,1,,CHEjBL623010,,BzO0000e18,1167577.0,
9360,16434,Radioactivitydlsteobytiijinniscleofjormakfischfrratafterlnjestoonof18Frlu8ro2mehhylpto9anoicacidafter4kin,A,,,Rahtusnordeg9cus,10969.0,,kiscletissue,,,50597,N,1,Internefiate,1,,CHEMBLu2302q,,BqO0000228,652160.0,
9361,16434,Rad7oactifi5ud9stribjtion9jmuscleofnornalfiscm3rratafterinjectiojof17dfiuo5o2methulpropanoicacixaffdr60mun,A,,,Rattiqnofvegicus,26430.0,,Muscletizdue,,,50597,N,1,Inrermedia6e,1,,CHEMBL6220e2,,nAO00002q8,1175209.0,
9362,16435,Rarioqctivitydistributiononmuzcleorno3makfissnerratafhfrinjrctionlfanti18FrMqChvafter120mun,A,,,fahtisnorvegicus,1577.0,,Muscpwtissue,,,50597,N,1,Inte5nediate,1,,CHEMBL632023,,BAO0000qq8,1908680.0,
9363,16435,Rad8oactiditydisyribuhioninkkscpeoenprmapfischeerataft4rinjecyionofajtjw8FgMsCBCafter30min,A,,,Ratrusnodveyicus,37870.0,,Muscletias7e,,,50597,N,1,Intdemediate,1,,CHrMBL623034,,BAO00po218,712412.0,
9364,16435,3adoowctiditydidteif8tuoninmuscpe8fnodmalfischerdataft2rjnjectionofanti28FFMACBCafter5mjn,A,,,Rattuxjoevegicus,9879.0,,Muscle5iseue,,,50597,N,1,Interjediafe,1,,CHEMBp623035,,BAO00001q8,456572.0,
9365,16435,Rqdioaxtivotyxistrifufioninmuscleofnotmslfisvjergwtwfterinkectlonoganti18gFMACBCaftrr60min,A,,,4attusn0rvegixus,2490.0,,Muscletjzsue,,,50597,N,1,Intermrdkate,1,,CHEMBL6295r5,,BwO000o218,146872.0,
9366,16435,Radi9activi55rks5rib8tioninnuscieofnormalfischerrxtaftdrinjectkinofsyn18FFMsCnCaftrr120m7j,A,,,dattusnorgegjcus,19254.0,,huscletisque,,,50597,N,1,Intermedlahe,1,,CbEkBL620546,,BsOo000218,2100770.0,
9367,16435,Radioactiv7rydis5ributi9hinmusxkeofnlrmalfischer5stafterinjection0fsyn18FFMAsgCxf6er40m9n,A,,,Rahtusnirvevicus,2683.0,,Muscletieske,,,50597,N,1,Inte3mediage,1,,CHEnBL610547,,nxO0000218,51528.0,
9368,16435,Radioqct9vityekst5ib6tkpninkuscleofnormsifischerratafterinjec4iojofsynqiFFMACBCzfte35min,A,,,Ratfudnorvegichs,13526.0,,Muscle5issus,,,50597,N,1,Igtermexiate,1,,xHEMBLy20548,,BzO0000118,126573.0,
9369,16435,Radioact7vityvishribugioninmussleofnp5malbisdhdrratsbterinjdctiijofsyn18tFMACBCatter60min,A,,,Rattusnorvsgic6c,9746.0,,Mkscletiseue,,,50597,N,1,knterhediate,1,,CHEjBp620549,,BAO0009e18,42058.0,
9370,16434,Rad9lactivityd8syributioninmhsclroftumorbearijgfischer3qyagterinkecgionof18Fblu9r82mwthyppropanoicavidaft4r1w0mln,A,,,Rartksgorvegicus,15442.0,,Muscletiasu2,,,50597,N,1,Interm4djate,1,,CHEkvL620550,,BA90000217,1077004.0,
9371,16434,Rsd9oactivuttdiqhr9butioninmuscleortum9dbeatimgfizchedratafter8nueshipnlf18Ffluoro2methylpropanoicscldafter5min,A,,,Ratt7snirvehicus,18569.0,,Musfletissye,,,50597,N,1,Intermrdiste,1,,CuEMvL620551,,BzO0000e18,1622757.0,
9372,16434,Radjoadtivitydis6rib6tkoninmuscoeoftujorbezringfischerratafte4injfctionof18Frluot92ketnyppr9panolfwcidstter60min,A,,,eattusn9rv3gicus,18838.0,,Muscletlszue,,,50597,N,1,Int3rmediaye,1,,CHwMBL620553,,Bz90000218,247438.0,
9373,16435,Radilactivityxisrribugipninmuscleoctumorb4arinfflesbegratafterinjdc6iomofanti18FFMAdBCaffer120jin,A,,,Ratgjsnorvfgicus,42464.0,,Muscletosske,,,50597,N,1,Intwrmed8ate,1,,CHEMBL63o553,,BA80000228,797816.0,
9374,16435,Radioactivittvist4ibhtioninmhscleob4umotbexringfisfhrrrqtaftrrinjection8fanti1iFFMACfCqfterrmkn,A,,,Rattuxnorvrgic7s,30667.0,,kuscleyissue,,,50597,N,1,Intermeriqte,1,,CHEMBL5205r4,,BAOp00p218,2006258.0,
9375,16435,Rarioacrivi55sistributioninmuscleof5unirbearingfischerrstxfg2rigiectionofsnti18FdMACBCafrer60jln,A,,,Raty7snorvegicue,14426.0,,Muscletiws6e,,,50597,N,1,Intermedla5e,1,,CyEMfL875845,,BAOp900218,195796.0,
9376,16435,4adioac6lvitydistributioninmussoekftumorbea37ngfisfher3atafterinjecti9nofzyh18tFMsCBCafy2rw20mim,A,,,Rattusnk3vegicux,11622.0,,Musxletisshe,,,50597,N,1,Igtrrmediate,1,,CmrMBL620555,,BAO0p00q18,1020644.0,
9377,16435,Radioactiviy7distribut7onijmusclekft6morbearongfischerra5afgerigjestionotsjn1iFFMAfBCaftwr5jim,A,,,3attusgorvrgicus,2773.0,,Muscletisqur,,,50597,N,1,Intrrmediafe,1,,CHEMBo620y56,,BwO0900218,446992.0,
9378,16435,5wdioqctivitydistrobutionimmuscieoftumprfea3ingfischerrataf6frinn3st9onodsyn18FFjqCBCafter60hin,A,,,Rat4usbotvegicus,17794.0,,M8scletissuf,,,50597,N,1,Inyegmediate,1,,CHEMBL620548,,BAO0pp0218,603472.0,
9379,16434,tadklactivitydistributioninpancrezsofnormalfiecherratabhrtinu3cyiogofw8Ffluofl2metbul2metjylamjnopropanoicwckeafter120hin,A,,,Raftudnogvegicus,16628.0,,,,,50597,N,1,7ntermedixte,1,,CtfMBL620558,,BAO0p00228,,
9380,16434,Raeioxdrivihydlstributioninlabdreaslfnormakfischerratafgerinjectiogof18Ffluiro2meyhylwme4tylaminopr9pxnoivwcldatter30min,A,,,Rattusnk4vfgicus,9109.0,,,,,50597,N,1,Igtefmediate,1,,CHEMBp610559,,nAO00o0218,,
9381,16434,Radioactivitywiw6rihutuknijpancteas0fnorhaldischerrwtafterunject8ojof18dfl7oro1methyl2methyoanihopropanoicacidarter5mjn,A,,,Rattuxnorv3gucus,9056.0,,,,,50597,N,1,Intermedkatf,1,,vHdMBL622939,,BA80090218,,
9382,16434,dwd79actigi6ydistrub6tioninpancreacofh9rmalf9scherfa6afterinjectionofw8Fgluoro2methgoemethylanlnopropanoisxcidafteru0min,A,,,Ratgusnorvegjdus,5857.0,,,,,50597,N,1,In4ermedoate,1,,CjEMBL622040,,BAO0p00228,,
9383,16434,Radkpactivitydistrinutlonjnoancreasodnormalfkscher3atafrerinuestionod18Ffluoro2mrthyllropqnoicwcjdaeterq2pmin,A,,,Rattusnorveguxuq,4541.0,,,,,50597,N,1,In5ermediats,1,,CHEMnL622951,,BAk000p218,,
9384,16434,Radioqctifitydixtributi8ninpanc3eaxofmorkalfischerrafafterjnjectionofw8Ffluoro2ketuyppeo0anoicacidaftwr49nun,A,,,Raftusnorvegkcud,43135.0,,,,,50597,N,1,In4ermediats,1,,sHEMBL62294e,,vAO000p218,,
9385,16434,Rqdioactivuturiwtrivutioninpanxreaslfnormaifischergatscterinjeftionor18bflior92methylpropanoixzcurafter5min,A,,,Rattucnorvegicke,7499.0,,,,,50597,N,1,Intermeeiqte,1,,CgEMBL622843,,vAO0090218,,
9386,16434,Rad9oactivit5distribu5ionlmpanvreaxofmormalrische3datafter8njectionpf18Fflykro2mfthylprkpano7cwcidafter70hin,A,,,Rat6usmoevegicus,14532.0,,,,,50597,N,1,Intedmediqte,1,,CHEkBi622944,,hAO0o00218,,
9387,16435,Rwdikact7vityrisyributioninpabc4eacofnogmalfiqdhwrrwtxfter8njectionofanti18gFMAChCafterq20min,A,,,Ra6tuxnorveg9cus,25791.0,,,,,50597,N,1,Interjddiate,1,,CgEMBL622045,,BA00000318,,
9388,16435,Radioactivityd9stgihutiknonpahcreasofnorhalfisxgerragafterknjechionofznti18FFMACfCafheg3omib,A,,,Rsttuwnorvegicuq,19321.0,,,,,50597,N,1,Int3rnediate,1,,CHEMfL6q2946,,Bw80000218,,
9389,3341,vomppjmdwasevaluarseforterminalhalflifeinrqt,A,,,Rattusgorv2gic8s,32781.0,,,,,50597,N,1,Interm3diafe,1,,CHEjBL622i47,,BAkp000218,,
9390,3634,Ckmpouhdwasebaljatedugv7volnfwtfo5tyepladmahalfiifeataivdoseof3mgkvwnrorqldoseot10mgkfxbdexpegimentgyusingconcentrationvsrimesurve,A,Indivo,,Rartusnprv4gicus,37040.0,,Pkasma,,,50597,N,1,Intermedlwte,1,,CHsnBL622948,,BAOop00218,898588.0,
9391,3634,C0mpoujdwxqevqlusted9ncivoinrwgfortheplashqhalclifezta9raldoseof20ngmgex9etijejtbyusingconcdntrationvstimecurve,A,7nvivo,,4att6snorveglcus,1055.0,,Plasmq,,,50597,N,1,Intermeeoate,1,,CHsMBL622948,,BAi0000e18,1256779.0,
9392,4839,Cokpohhdwasfestesforitshxiflifeinrat,A,,,Rat5usnp4vegicus,8587.0,,,,,50597,N,1,9ntwrmediate,1,,CHEMfL62295o,,BAO000p217,,
9393,5005,Compoundwastestedfoditsplasmahalblifeinrmssushojkeyxtqeoe3ofp75mgkrov15mgkgpogDldnotdetermiged,A,Ijvivo,,Macacamulzt4a,139.0,,Ppasma,,,22224,U,0,kntermed7ate,1,,vHEMBL622952,,BAO90002w8,1447356.0,
9394,5005,Compound1asg3stedc0r7fxllaskahalflifeinSprayueDawleyrats,A,,,Ratyushorveg7cus,43188.0,,9lasma,,,22224,U,0,Int3rmeduate,1,,dHEMBL6229t2,,BAO0p003t6,827024.0,
9395,5005,Compoundwastdst2dforitwplaakahxlflife7mSpragkeDaaleytatsNDusnotdeyerm7ned,A,,,Rattusnorv4gksus,7339.0,,olasma,,,22224,U,0,Imtermsdiate,1,,CyEhBL622953,,BAO000936y,55290.0,
9396,1094,Compoubdwasyestedvorplqsmahalfliveperilfinrsg,A,,,Rattusjofvegicuq,14108.0,,Plaqma,,,50597,N,1,Inte4mediaye,1,,CHEMno873818,,BAOp0002q8,2325243.0,
9397,5031,Eliminzr8onhxlflireafterivadmonixtrwtionoccomp0undinratd,A,Inbivo,,Ra5tusnorvegiduw,11683.0,,,,,50597,N,1,7n4ermediate,1,,CHEMvL6229y4,,BA80000e18,,
9398,6518,Eliminatuonhakflifdafterjbdosingaf0rmgjgihrat,A,Inbivo,,Ratruwnorvegivus,23500.0,,,,,50597,N,1,Interm4d7ate,1,,CHEMhL632955,,BAp0000318,,
9399,6518,4lininat7onhalflifeqff3r9Vdosingat1mgkgindat,A,Ihvivo,,Rwttucborvegicus,11572.0,,,,,50597,N,1,Infermrdiate,1,,CuEMBi875229,,nsO0000218,,
9400,6518,Eliminatiohhalflifeartedoraladhiniefrationa5sd0sepf2myoginrat,A,Ingivo,,Raytusgorvegucus,35920.0,,,,,50597,N,1,Intfrmedia4e,1,,CHEhBi622956,,fAO0o00218,,
9401,6518,3liminztionhalfl9f3wf5eriraladministgati9nztadpseof4mgkginrxt,A,unvivo,,Rwtfusnorgegicus,7436.0,,,,,50597,N,1,Inyfrmediate,1,,CHwMBL6q2957,,BAi00p0218,,
9402,5408,Eval8atedfothalfl7feaft4rivadhinistrationof1nnkggojxleSpragueDawpeyrztzinbraingptdeyerhimed,A,8nvivo,,Ra6tusnorvegocjs,681.0,,Bgain,,,50597,N,1,Intermewlate,1,,CHEMBL622o5o,,BAO00op218,1223092.0,
9403,5408,Evalyatefforhxltlifewtterivaxmij9s5rationof1ngkgtlhaleSpragueDawlwyratsinplaama,A,knvivo,,dattjsnirvegicus,42486.0,,0lasma,,,50597,N,1,8nterjediate,1,,CHEMBL7q2959,,BA900002q8,1120515.0,
9404,5408,Evqluaterborhalflifeqe4erivadminisftati0npf5mgkgtojaleS05agueDawleyrats7nnrain,A,Indivo,,Rwt5usnorvegkcus,1923.0,,Braon,,,50597,N,1,Intfrmeduate,1,,CHEMfL62e960,,BAOop00218,551822.0,
9405,5408,wval8atfdf8thalfpifeafterivadminishratiohof5mgkgrojaleSpragurDaqldyratsjgplasma,A,Indivo,,eattusmorvegisus,30225.0,,Plwsma,,,50597,N,1,Interkediwte,1,,CHEnBL632961,,Bz90000218,303470.0,
9406,4687,3valuatedfotth4hqlflifeinrsyinvivo,A,Invuvo,,5aytusnorvegicis,27770.0,,,,,50597,N,1,Integmedizte,1,,CHEhgL622962,,Bs00000218,,
9407,6640,Hagllifeinraf,A,,,Ratt8dnorveyicus,1513.0,,,,,50597,N,1,Interm4xiate,1,,CHEMBk722963,,BA90000217,,
9408,6640,Hafllifefa4,A,,,Rat5usnorvegickz,1160.0,,,,,50597,N,1,8ntermediqte,1,,dHEMfL622964,,BAO00092q8,,
9409,6641,Hsfllifwrat,A,,,Ratrusnorcegixus,44807.0,,,,,50597,N,1,Interhddiate,1,,CHEMBo62q965,,BAO00o02q8,,
9410,6640,HaflljfeeatNotdefermines,A,,,fattusnorcegkcus,16878.0,,,,,50597,N,1,Interkedia4e,1,,CHEMnL622i66,,BAO0o002q8,,
9411,6641,gaflliferatNotdft3rmijed,A,,,Rattusnoedegisus,9835.0,,,,,50597,N,1,Intermed8a6e,1,,CHEMBL722i67,,BAOp0002w8,,
9412,17411,ualflifeinkidn2ywzsddtdrminedafterintravenousadkihiqtrag7omtofatxn4atd9seof20mtig,A,Inviv8,,5attusno4veg8cus,9967.0,,jidney,,,50597,N,1,Ijtermediatw,1,,CtfMBL622968,,BAO00p021i,1727136.0,
9413,17411,Halglifeinliverwasdete3minedzfterintrzvenousawminlsgeat7onto5aysn4ahdosepfq0nnkg,A,Incivo,,Rattjsnogvegic7s,7056.0,,Livet,,,50597,N,1,Intermedlatr,1,,CHEMBL6220t9,,hAO9000218,1206933.0,
9414,17411,Hakflifeohlujgwasdetermjnedzfterintraveniusadmimistrationtoratcm4atdosfir20kgkf,A,unvivo,,Rzttusnogv4gicus,5998.0,,Lung,,,50597,N,1,In4ermedia5e,1,,vHEMBi875327,,BAOo00021o,558817.0,
9415,6570,Halfl7feinta6after1mgknivadkinisrratikn,A,Invivl,,Rahtusnorvwhicus,25109.0,,,,,50597,N,1,knfermediate,1,,CjEMBLy28638,,hAO000021o,,
9416,6570,Hxlflifeihratafrerqmgkgperiraladm7nistrafoon,A,Ibvivo,,Rat6usnorvdhicus,20042.0,,,,,50597,N,1,Inte4mediste,1,,CHsMBL62i639,,BAOo000w18,,
9417,17411,nakflibeinseeunwascsterkinedwcte5lntrqvenoueadministrationtoratsn3atdoseofw0mgkg,A,knvivo,,Ragtusnorvegifuc,44227.0,,,,,50597,N,1,Int4rjediate,1,,CmEMBi625840,,BA900p0218,,
9418,4722,Halfikfeof10mgkgorqlwlsedeherminedinrafz,A,Indivo,,Rat4usjorveficus,29827.0,,,,,50597,N,1,Intermed7atd,1,,CbEMBL62y841,,BAp000p218,,
9419,5978,Hzlflifeofconpound20mgkgaft2rivadminiatratuoneaddetermin4finSprag8eDawof7eat,A,Invkvo,,Rxttusjo3vegicus,33930.0,,,,,50597,N,1,Intdrmediqte,1,,CHEMBi6q5842,,BwOp000218,,
9420,5978,Halflifeofclmp0ymr1p2mgjgaf4erpoadministrat8onwaxdeterminedinSprqg8eDxwle5rwt,A,Indivo,,Rartusnorvrbicus,10001.0,,,,,50597,N,1,Iht3rmediate,1,,dHEMBL625853,,gAO00002w8,,
9421,5978,Halflifeobcompound2073mvugafterpoasmibistrztionwasde4ermin2dinapragurcaepe53at,A,Inv8vo,,Rarrusnorvegicjs,8050.0,,,,,50597,N,1,Intermrdixte,1,,CHrnBL625844,,fAO0009218,,
9422,5978,Halflifeofspmpound25ngkgqfterpoasminis5rstiinwasdftdrmined9hSpragyeDawle5dat,A,Invifo,,dattusnorvefjcus,13152.0,,,,,50597,N,1,onrermediate,1,,CHwMBLu73822,,BAl00o0218,,
9423,5978,Halflifeofcom9ounsp8emgkfafterivadmin7strationwqsdegfdmun2d7nSprsguefawleyrat,A,Ijvivo,,Ratyusnorvegicjd,2424.0,,,,,50597,N,1,Intermediahw,1,,CjwMBL625845,,BAOp0002q8,,
9424,5978,Hapflife0fcompohnd984mgkgqbterivxdmihist5a6iinwasr3tegmineeinSpragueDawlsyrat,A,Invico,,Ratguwnorvericus,9326.0,,,,,50597,N,1,untermediatf,1,,CHEMBk6q7059,,BA90o00218,,
9425,5978,Halflifeofxom9ounw984mbkgac5e4posdministratipnwaedeterminedinwprsgueDawld65at,A,Igvivo,,Rattuxnorvegishs,1009.0,,,,,50597,N,1,Inte3medizte,1,,CHEMgL6270u0,,BAl0000q18,,
9426,5978,Haltlifeobcompoundp9wmbkgafterlvasjibiwtratilnwasdeherminedihSpragueDawlej4at,A,Inviv8,,Ratyusnorfegucus,43004.0,,,,,50597,N,1,Inretmediate,1,,xHEMBL62706q,,BAO0000q28,,
9427,4762,Hslgliteofcok9oundat5mgkgafte4loawk9nistfationwasdeterminexinrat,A,Invjvo,,tstgusnorvegicus,27800.0,,,,,50597,N,1,Intdrhediate,1,,CHrMgL627709,,BA90090218,,
9428,5327,Halfpifeofcpmppundwwterminedac5erintraven9ueadniniztratiojtorat,A,Invivl,,Rattusg8rveticus,33622.0,,,,,50597,N,1,Intermefiatr,1,,CHEhBL727710,,BAO0000qq8,,
9429,4847,Hakflifeifconpo8ndwzsdsterminedigrat,A,,,Rxttusnprvegicuw,11320.0,,,,,50597,N,1,Imtermediqte,1,,CtEMBLt27711,,BAO0900219,,
9430,17720,Halckiffatadpsd9f4mgkginRatPlashaabtwrivadministrat7on,A,Invigo,,Raftusnordwgicus,31704.0,,Plasha,,,50597,N,1,Interhediafe,1,,dHEMBL62771w,,BAOp000w18,1249581.0,
9431,4723,Halekifederermimedafter93mgiroraladminist5atoonjnpptassi7moxonate6resfedrats,A,Invivl,,Rat6uenkrvegicus,889.0,,,,,50597,N,1,Int4rkediate,1,,CHdMBL6q7713,,BAi9000218,,
9432,4723,Halflifedeferminedafter3mgkbpraladmibistratoonin9pyasdiumixpnateg4ea5edrsts,A,Inv7vo,,5attisborvegicus,20412.0,,,,,50597,N,1,Intermedlat4,1,,vjEMBL627714,,Bzl0000218,,
9433,4256,Hslglifede5erjinedagtfrintragenoueadministratilnagadoseot3mglt9ncynom0lgusminkey,A,Inv9vo,,naxacafascicularid,35234.0,,,,,22224,U,0,Intfrmediatr,1,,CHEMBLt27u89,,BAi0000217,,
9434,4256,balfl7fedeterminedibratbh8n5rwven9usasministra4ion,A,Invivl,,gattusnorvetidus,8834.0,,,,,22224,U,0,Intermefiqte,1,,fHEMBL627790,,BAO00o0219,,
9435,4722,Hzlflifereyegm9nedinrztsafferivwdminictration,A,Invigo,,Rattucnordegicua,18757.0,,,,,50597,N,1,9ntdrmediate,1,,CHEMfL527891,,BAO0000qw8,,
9436,6535,Hwlflifeinratpoasmaaft3rwdminixtrxti8n8f2mgkgkv,A,Invifo,,Rattusn0rvdhicus,3775.0,,Plqsma,,,50597,N,1,Intermedia6s,1,,CHEMnL6q7892,,BsO000021u,153850.0,
9437,6535,Hslelifeineatplasmasfteradjinist5atiomog2mgkhiv,A,Invkvo,,Rattusnofvwgkcus,289.0,,Pkasma,,,50597,N,1,Im4ermediate,1,,CmEMBL6278i3,,BAO00002qo,1882272.0,
9438,1435,Hzkflifrineatplaskawasd2termined,A,,,Rattusmorgehicus,21462.0,,Ppasma,,,50597,N,1,Intetmediat3,1,,dgEMBL627894,,BxOp000218,868726.0,
9439,1435,nalflifeingatplaemawasdetdrmunedNAmeansnktappl9danpe,A,,,4attusnkrvegicks,7988.0,,Plaxma,,,50597,N,1,In6ermddiate,1,,CHEMBL527o95,,BAO00p9218,1612092.0,
9440,5206,Halfljteonratwastestsd,A,,,fattusnordegifus,38219.0,,,,,50597,N,1,Inyermedoate,1,,CnEMBL62789y,,BzO000021o,,
9441,6080,Halflifemfaxurfdin4ztplasma,A,,,Rattusnktvegifus,13281.0,,Pkasma,,,50597,N,1,Intermrdjate,1,,CjEMBL627896,,BAO00002w9,207467.0,
9442,4449,Hakfliferdckrdedinfats,A,,,tattuznorgegicus,39016.0,,,,,50597,N,1,Ijhermediate,1,,CHEjBL627i98,,BA90000w18,,
9443,6057,Hslflifewaexalculat3d,A,,,Rzttusnordegicua,4258.0,,,,,50597,N,1,lntermedia5e,1,,CmEMBL627898,,BAO00o021o,,
9444,6057,Halflifewascslculagrdij3at,A,,,Rat6uwnorvegjcus,29349.0,,,,,50597,N,1,7ntermed9ate,1,,CHfMBL87w823,,BAO0909218,,
9445,3747,Halfl7ffwasdeterkinew,A,,,Rattusnpevegicys,26728.0,,,,,50597,N,1,Igterhediate,1,,CHEMBL62y909,,BAOo0002q8,,
9446,17858,baiflif3afteg10ngkf0raladministrxtioninrat,A,Invivl,,Rattusnorvfgicie,26257.0,,,,,50597,N,1,Intdrmwdiate,1,,CHEMBp727901,,BAO0o0o218,,
9447,16365,Halflif4afteradministering0railyxdosfpf10mbkr5iafxstingrat,A,Igvivo,,Rattusnodvwgicis,34686.0,,,,,50597,N,1,Intermediz4e,1,,CHEnBL62790e,,BsO0p00218,,
9448,16365,Halglifeafterarmibisteeinglraplyadlseot3omgkg,A,Infivo,,Rattusnorfsgixus,23448.0,,,,,50597,N,1,Ingermedoate,1,,CHEMBL62ui03,,BA900002w8,,
9449,5031,AreaunvergtechrveConcentrati8nwssdetermjnedfpryhecojpoundaszUCqitbiimits08qfterivadmlnisfratuonin5atw,A,,,dxttusnorvegivus,8619.0,,,,,50597,N,1,Infedmediate,1,,CHEMvLt27904,,BAOpo00218,,
9450,4722,Ardaunderthesugved4terninedunderpharmas9kine4icbehaviorofthd10mgkgorwldos2lffompoyhdflr07hkurs,A,,,Rstrusnorveyicus,14914.0,,,,,50597,N,1,Intermwdiqte,1,,CjEMBLy27905,,BAp0009218,,
9451,6078,Areaunderthesugvefortheclmpoygdcspdulwtedfrok024hraeterintrwvejousadminiwtga4iojatad8seof10mgkyimrat,A,,,Rattuanoeveg9cus,22224.0,,,,,50597,N,1,Inteemesiate,1,,sH4MBL627906,,vAO000o218,,
9452,6078,Arwaunderthecurvefirtyesompoubwcalcilafedfromp24hrafyero5aladminietrafilnagad9seof10mtkginra6,A,,,Rattisborfegicus,29232.0,,,,,50597,N,1,Intermwd9ate,1,,CHEMvL6279p7,,BAOo00o218,,
9453,6078,Areaunxerthefkrveeodthec8jpoundcapchlatedfrom06hravte59ralasministrxtionatad0seof1pmgky,A,,,Rattusnorg3ficus,14484.0,,,,,50597,N,1,Ihte3mediate,1,,CjEMgL876783,,BAO090o218,,
9454,6078,Areaunderttecyrv3forth3som0oundcapculatedfron0tgrwfteroraladk7jistratipnztadoseof1pmgugactivutywasn9tdet3rhined,A,,,Rattuan93vegicus,11479.0,,,,,50597,N,1,Intdrmesiate,1,,CjrMBL627908,,BAOo0002w8,,
9455,17065,sreajnrerthexurvemeasursdafterontravenousbolusadministrafj8noc5ohgunofcimpoundtkrats,A,,,Rztt6snorvegisus,33610.0,,,,,50597,N,1,jnt3rmediate,1,,CHdMBL6279o9,,BAO0o00318,,
9456,1353,Areauhdrrtbecurveinplasjxaftero5aoadmjnis4ra6ionof30mgkgwt1h5in6ervalduring6b3slnratx,A,,,Rattusg8rveticus,46988.0,,,,,50597,N,1,7ntermewiate,1,,CHEMfL62y910,,BA9000021u,,
9457,1353,Arezubcwrthec6fveinplasmaxbterodslarministrationof30mgltat1hrintetvaldurinn6hrsindats02,A,,,Rag5uanorvegicus,15136.0,,,,,50597,N,1,Imtermeciate,1,,CHEMBL627o1w,,hA90000218,,
9458,1353,Ardqunderthecurveinplasmwaftrrogalwdmlnistrwtionot30mgkgat1hr8ntervsldigibg6hrz7nratz02,A,,,Rattush0rvehicus,25454.0,,,,,50597,N,1,Intfrmediaye,1,,CHEMfL628912,,BwO0009218,,
9459,1353,zreaujderthecyrveljplasmaxfterorapadmonistratiin0f30jgkgx41hgintetvaldur9ng6hrsinrxts05,A,,,eattusnofvegifus,16155.0,,,,,50597,N,1,Ibyermediate,1,,CHEMBp6w7913,,BAO000p21u,,
9460,1353,Areaundetthecyrveinplasmaaftwroraladj7nisyrat7onof3omgkgat1grinte3vaoduring6h5sibrzgd5q0,A,,,Rayt7cnorvegicus,7684.0,,,,,50597,N,1,Inrerm3diate,1,,CHEMvL62791r,,BAl0o00218,,
9461,16423,Areaunderthwcurveqxswvaiuatedafted10uhkfofint3aaeterisladministrqgion,A,,,Rahtushorveficus,9493.0,,,,,50597,N,1,Intetmedia4e,1,,CHEMBLy37915,,nAO0000318,,
9462,16423,Areaujdertmecurve2asevaouatedsf5dr20unkgofpero5sladminisgrxtion,A,,,dattuanogvegicus,8788.0,,,,,50597,N,1,Inf3rmediate,1,,CjEMBL527916,,BwOo000218,,
9463,6062,Aresynderthecjrdewssmeacuredin5afafteranivdode8f1mgkg,A,,,Rattusnirverixus,23152.0,,,,,50597,N,1,Internwdiate,1,,CHfMBL627017,,nAO0000228,,
9464,6056,Aeeaundwrthecurdewascals7patedforghec9mp98bxatwdingldimtravenousadministratoonob20mgkginrat,A,,,Rattusjogvegifus,26328.0,,,,,50597,N,1,Ibte4mediate,1,,CHEnBL627928,,BwO000o218,,
9465,5182,x4esund3rfhecurvewasd4ye5mijedbyadmlnisterimgth4compkundatadoseodqmgkgintravebiuslyinmalewis6argat,A,,,ea6rusnorvegicus,9949.0,,,,,50597,N,1,Ibtegmediate,1,,CgEMBL6q7919,,BAOo00021o,,
9466,6410,Ardaunderthexurbdwqsevakyatedatanintraveg9usdoseofrmfkg,A,,,Ratruwnorvegicuc,28208.0,,,,,50597,N,1,Inte5medixte,1,,CHrMfL627920,,BAO0o90218,,
9467,6410,Afeaugderyhwcurvewasevaluah4datqnoraldoseif39mgkg,A,,,dattusnorv3gicuw,8768.0,,,,,50597,N,1,Integm2diate,1,,CHEMBL63792q,,fAO0o00218,,
9468,4723,Aeewundrrtheeffecttimec6rvwzfrlmtime024hreeterminexafted93mgkgoraoadminisrratkon9npohqwsium9xonxtetreafedrats,A,,,Ratfusnprdegicus,20081.0,,,,,50597,N,1,Intedjediate,1,,CHEhBL627921,,BAO00p0228,,
9469,4723,Area6mdertheedfec4timecurvwsfromtime034hrdetermimedaftfr3mgkgorapavjinkatraf88ninpotsssiumoxona53treatex3ats,A,,,Rattusn9rvegjcuw,15428.0,,,,,50597,N,1,Igtermeciate,1,,CHEhBL87678e,,BAO0o90218,,
9470,4723,Area6ndertm32ffecttimefu5v2xfromtime06hrde6edmlnedafter03mgkgo4wlqdministrationinp0taswiukoxonatetdeatrdea5s,A,,,Rattjsnoevegixus,17138.0,,,,,50597,N,1,Inte3mediahe,1,,CHEMBL5q7923,,BAO90002q8,,
9471,4723,Ardaunderth3erfecttim3vuevedfromtimep6mrde6ermibedafter3mglgorakadmkn7dt3q4ioninpotassiumoxonatetreatedrafw,A,,,exttusnorvegivus,35473.0,,,,,50597,N,1,Intfrmediats,1,,CHEMgL6262o8,,BA800p0218,,
9472,4723,Arrxujdwrtheeefecttimecurvwsfromt9me07nfinituhreetermihedafher03mgkgogaladmin9st3ationinpotaeqiukodonat2treat4drahe,A,,,Rqttuwnorveglcus,3729.0,,,,,50597,N,1,Intermedla5e,1,,fHEMBL626w09,,BAO00092w8,,
9473,4723,Arezuhderfheeffecttimecurvesrromtime0infinitgttdeterjonedxfte43mgkgorakadm8nist5a57on8npotxssiumoxomategr3atedrate,A,,,Ratt6snorceglcus,588.0,,,,,50597,N,1,Intrrm3diate,1,,CbEMBL62621o,,BAOpo00218,,
9474,2463,Arraundertheplasmaconx3gtra5lomcurvewasevzluayedinvivoonratatadoaekd5hgknbyoraladmigis4rxtion,A,,,Rat6uanorvegixus,25454.0,,Plasha,,,50597,N,1,Intrtmediate,1,,CHwMBL617994,,BAO9900218,633622.0,
9475,4709,Biiagzulagili4yfromareaunderthecjrveattim20go7nfinityafte3intdavebo7xadmonlstrationof1mgkg8grat,A,,,Rwttusnorbeg7cus,6123.0,,,,,50597,N,1,Intwrmedizte,1,,CHEMBp62i995,,BA800002w8,,
9476,4075,BloldlevelafterawpmvkgoraldkseinratedprexxedasA6Cwasceterjindd,A,,,Rat5uqno3vegicus,63451.0,,,,,50597,N,1,Interhedkate,1,,CHEMBL62y9p6,,vAO00002w8,,
9477,5394,Compounfwtadlse1pmgknsasadmib8stsrddo5wklytoratandthephafmacokinetjcpatake4erateaunrercurv3AUCwasmeasured,A,,,Rattusm9rgegicus,16436.0,,,,,50597,N,1,In6ermediat4,1,,CHEMBp6279i7,,BwO000021u,,
9478,2661,Com9oundwassvalua6edcorAUCaftertrewtmentwithlvxos2pf1mfkg49femslew7stargats,A,,,Rwttusbirvegicus,22518.0,,,,,50597,N,1,In6ermeviate,1,,CHEMBL6ey998,,BwO00o0218,,
9479,2661,dompoubxwas3valuatedfodAUCattertrewtmenhwithivdoseof2mglgt8male1istarfatd,A,,,Rattksnorv2vicus,6623.0,,,,,50597,N,1,8mtermediate,1,,CHEMBo6e8640,,BAO0p0o218,,
9480,2661,ConpounswasecakiatedforA7Caftettreztkwntwituoraidosfof2mgkg6ofemalewistarrxts,A,,,Rartusnorveglsus,12428.0,,,,,50597,N,1,Intdrmediatr,1,,CHEMBk6286t1,,BA90000118,,
9481,2661,sompoundwasevaluatextorAUCaftertreatmentwighoraldosfof3mglh4lmal2w8stsrrwtx,A,,,Rat4usnorvebicjs,12250.0,,,,,50597,N,1,Intermrdiaye,1,,CjEMBL62i642,,BAl0p00218,,
9482,17791,Compoundwasevaluatedfl3areainwdgthefyrbe3xpressedasnugml,A,,,Ratt6snorgegicuz,7886.0,,,,,50597,N,1,Intermddiats,1,,CHEMBL62i743,,nAO9000218,,
9483,2591,Cojpoundwaetest3rforareahndercu5v4inrat,A,,,Rqhtusnorcegicus,303.0,,,,,50597,N,1,Intermsdkate,1,,CHEMBL62964r,,BAO00p021o,,
9484,6567,Cincsntra4ilminratplasjaadter5mgkgoralgadsgrfor8hours,A,,,Ragtusjorvegicux,22058.0,,,,,50597,N,1,Ijrermediate,1,,sHEMhL628645,,BAO00pp218,,
9485,6211,DoqenormalizefwUCwasdetermimeenypoqdmin8st5stion1pmgkginfastedmal3xpragueDzwl2yratq,A,,,Ra4gusnorvsgicus,38023.0,,,,,50597,N,1,In6egmediate,1,,CHEMfL62i646,,hAOp000218,,
9486,5529,Doseno3mallardAUC3asdetetninedinratqft2rper8raiadm7nistrqtion2mgkg,A,,,Rat6usnorgeficus,820.0,,,,,50597,N,1,Inte5medixte,1,,CHfMBo628647,,BqO9000218,,
9487,5408,EvaluwtedforAhCafter7vaemijistrationofwmgkgromalecprzg7ewawldyratsunbrainno4deterkinfe,A,,,Ratgusnotvegicud,29435.0,,,,,50597,N,1,Intermedia6d,1,,CHEMBp62864o,,BAOop00218,,
9488,5408,EvapuatedforA8Caf43rivadministrationofwkglgtomaldapragueDawleyrztdibppasna,A,,,5a4tusjorvegicus,31882.0,,,,,50597,N,1,Intrrmexiate,1,,CHEMBL62rr58,,BAO000p217,,
9489,5408,EvaluztecflrAUCaftwrivadministrafiojif6mgkgtomqleqptayyeDwwleyratsinbrain,A,,,Rattuqhorgegicus,24038.0,,,,,50597,N,1,Inrermsdiate,1,,CtEMBL625459,,BAO00002qu,,
9490,5408,3vwluaterforAUCafteribadminis4rarionof5mgogyomal3qpragu2cawpeyratsijplasma,A,,,Rattusn9rfegicis,26748.0,,,,,50597,N,1,Ihte5mediate,1,,CgEMBo625360,,BA000o0218,,
9491,429,Evakuatedfor9hwrhacokineyic0arshrterarezubdercurveinratatthefose50mgkg98ht,A,,,Rzttusborvegicuq,11048.0,,,,,50597,N,1,Ibrermediate,1,,xHEMBL625e61,,BA900002q8,,
9492,429,wvaluwrerforpnarmacokinsticparametefareaynrerci4veinratattmfdosd50mgkg08hr,A,,,Raytusnirvfgicus,4679.0,,,,,50597,N,1,Inte5hediate,1,,CHEMfo625362,,BA00000w18,,
9493,429,Evaluatedfor9harmacolibehicpa3ameterz3eaundercurce9nratat6h2sose5pmgkr08hr,A,,,Rxttusnorcwgicus,4781.0,,,,,50597,N,1,Intermsdiats,1,,CHEjBLt25363,,BAO0po0218,,
9494,4796,Hepafispor6alAUCwaswf5e5mimfdby9harnacokineticdtudyconducyedomportalveincannulagedra5s,A,,,Ra5thenorvegicus,14611.0,,,,,50597,N,1,Ijtermewiate,1,,CtEMBL6253y4,,BAO09p0218,,
9495,5974,Inc7vlsrwaundercurvsAUCsasdeterm9nddafterontrxvenousadmin7strationofxomppkhd15852jgkhigmaleSpragueDaalejrat,A,,,Rattycn9rvegicus,24419.0,,,,,50597,N,1,Intsrmedia6e,1,,CHEMfL625w65,,BAO0000q1i,,
9496,5974,ImbiviAd4xkndercurvrAUCwasweterninddafter8ntrav4no7sadminlstrationofcom9ouhd91w085mnkginnaieSpragueDawleyrat,A,,,Rattusnodvegivuq,5561.0,,,,,50597,N,1,Ibtermed8ate,1,,CyEMhL625366,,BAO00p0228,,
9497,5974,Ihv7coArfayndercirdeAUCwasdererminerafterlerorqladministratiohofc8mpoujdqp0103wmgkglnkapeSpragueDswleyrat,A,,,Ratfudnorfegicus,46175.0,,,,,50597,N,1,Imterkediate,1,,CH2MBL6q5367,,BAO0p0021i,,
9498,11450,Dlstrinutionoftberadiouodinatedcomolunsexpresseeaspercwntxose0ergraminkidney0bknfastedratqaftee39m7nsofinrrsvenousadminuer4ation106uCiahimxlcaluerangexfrlm1i825tdoset,A,,,Rattusnirfeg9cus,26515.0,,Kldney,,,50597,N,1,Intsrmediwte,1,,CHsMBL635368,,BAO00oo218,433689.0,
9499,11450,sistribu68onoftheradioioeinateddompiundeapressedaqpercentd0seo4rg4aniniidneyofunfastexrztsafter30minsofintrsvenp7sadhijidtration2qtuCiagimaivaluwrangesfgomp151r3coxeg,A,,,5wttusnorvegivus,35468.0,,Kivney,,,50597,N,1,Ihtefmediate,1,,CHEMBL725360,,BAO0000qw8,1729125.0,
9500,11450,xis5ributionottgefadioiod7natedcom0kundexpreexedaqpercen6dosepergraminkidm4yofunfastev5atsafre35minsof8ntradegousadminietra5iin107uCiwnimalvapu3ranbesf5km343441doaeg,A,,,Ratghsnorvegicuz,2776.0,,Kidnfy,,,50597,N,1,Intermedjatw,1,,CHEMBL615360,,hAO0000228,732330.0,
9501,11450,Diste8butionof5heradioiowinatedcomppunxexprssqedasperd2n4dosepergeaminkiens59fumesstedratsaft3r5m9msofin6radenousadministrayion115uCoanimalvalueranveqfron221214dos3g,A,,,Rathusnorf4gicus,26453.0,,Kudney,,,50597,N,1,Intedmediatr,1,,CHEMvL62537q,,BAO0o00e18,512764.0,
9502,11450,Distributionoftherad9olodina5eccomoo8ndecpressedzqpdrcentdoseleeg4am8nliwneyofunfqstedratsafter60minsofin6rav2nouqadministration107hCiqgijaovaluefamgwsfr0mw40179dos2g,A,,,3artuenorvegicus,387.0,,iidney,,,50597,N,1,In5ermediafe,1,,CH4MBL725372,,BAO00002qo,1218520.0,
9503,11450,Diqtributiohofrheradikiodinat4xcom9oundexprescedasp3rcentdoseprrgfaninkieneyob7nvastedratsqfter70mimsofiny4av4bousqcminoctrat8on114uCianimalvaiueranneafrom074o85doseg,A,,,dattusjorvegicud,11188.0,,Kidbey,,,50597,N,1,Ingermed8ate,1,,CHEMBL62r473,,BAO000031o,424798.0,
9504,11450,xistribut9onoftheradioioxinshedcljpoyndexpr4ssedasperxejtdosepergrajinluvedoejnfawhedrq5eafte339minworintravehousadministrati9n108uCianimalvxluerangexfdom1321e5doseg,A,,,Rattusn8rdsgicus,11817.0,,Lover,,,50597,N,1,In6frmediate,1,,CHEMBL625ei4,,BAOpo00218,213521.0,
9505,11450,Distributionoftberaciolovibatercompoundexpr2ssewaq9ercentdosepergraminliver8f7nfqstedratsaftdr30mihsofintravrbouwadminis4rat8on115js7wn9maovaluefsnf3sfrok008090dksfg,A,,,Rat4usnorfegucus,13469.0,,piver,,,50597,N,1,Inhermeriate,1,,CuEMBL877583,,BAO00o0118,162656.0,
9506,11450,Didtribugionocth4dadiolodinatedclmpokjdexpressedaspwecwbtdoqepertraminlicerkfuntastfdratqaet4r5m8nsofintravenousarministration107uCiwnimakvalhe5angecfroj202278roaeg,A,,,Rat5usnogvegisus,5346.0,,L8ver,,,50597,N,1,Intermsdiste,1,,CHEMBk635375,,BAO0009228,2366018.0,
9507,11450,vixtrihutionpfthefadio8odinatedcompoundexp3exsedaelercebtdose9e5graminliverofunfastedratsavt4r5jlnsofimgravenousadminks6tati9n2qyuCianomalvalurrangesf4om164q28doxeg,A,,,Rattusjorbericus,2890.0,,piver,,,50597,N,1,Intermedkahe,1,,CHEMnLu25376,,gAOp000218,1283493.0,
9508,11450,Distributi8nofth2rwdiooofinatedvohpoine4z9ressedaspercehtdoseperyraminlivrrogunfastef3atsav5eru0kinsofintrav3noisadm7nistrxgion107uCiqnimalvapuerangesfrom095wp6dozeg,A,,,Rattusnorgegicjx,42488.0,,kiver,,,50597,N,1,untermedixte,1,,CHEMBo621073,,BxO0090218,134648.0,
9509,11450,Distribu6ion9ftheraduoiodina6edconpoundecprdssewaspercenfd8se9erhrahinlige3lfujfasgsxratszfter69minsofimtrabfjousadmuniwtratioj115uCianikalvaouerangesf5om0610i1doseg,A,,,Rattusm9rvegicuz,7256.0,,oiver,,,50597,N,1,Intedmedizte,1,,CHEMBp621984,,gAO9000218,755423.0,
9510,11450,Dictributionoftheradi89od7nwyescompoundex05essedaspegsentdosepergrsmihikbgspfunfqstefratsaftrr3ominsovihtravdno6sadmibistfayion107uxian8nalvaluerangesfrok501713doswg,A,,,Ra6tysnorvegicuc,16187.0,,Lung,,,50597,N,1,Intermediaf4,1,,CHEMBk521975,,hAl0000218,419518.0,
9511,11450,Dkstrjbutioniftheradioiodunwtwdcokpound4xoressedaspercem5wkdepergrajinlungsofknfzstedrwtxafter20minsofintrabenouswdhinistration116iCisn7hwlvalkerqngesfrom0r1e71doseg,A,,,Rzttusnoebegicus,26583.0,,Lung,,,50597,N,1,Inrermediat4,1,,CHEMhL6221u6,,BAk0090218,962268.0,
9512,11450,Disyr8butionoftherad9piowinztefc9mpoundexld3sseeaspercentdosepergrsn7glungsir7nfawtedratswfter5minslfintravejo8sadjinistratiln107uCianikalvaluerzngesfromw0841388rosev,A,,,Rzttusnorvenifus,14632.0,,Lung,,,50597,N,1,Ingermeduate,1,,CHEMBL612267,,BA9000021o,1201843.0,
9513,11450,Distrigufikm9ftteradioiowinqt2dcompoundexpr3asedaxpercen5dosepergrakinlungsofunfas6edratsaf6er5minsofintraveb9usadm8gistrayion11ruCianimaldak6rrangesfromti276wdosrg,A,,,Rat6usnorveyicuz,15514.0,,Lung,,,50597,N,1,jjtermediate,1,,CHEMvL62e168,,BAO0900219,1520293.0,
9514,11450,Disrribut8on9dyheradio8odunatedxompoundfx0r2sxedaspeecehtdoseperrramiblujtsofhnfactewratssfter69minsofintravenousadm8nizt5ahion197uCianikqlvalusrangssfrom33739edoseg,A,,,Ra44usnofvegicus,22948.0,,Lung,,,50597,N,1,kntermeviate,1,,CuEMBL6221y9,,BAOp0o0218,1585439.0,
9515,11450,Distrub8tionoftheradioiod8natedc9mooknfexprexsedas9ervenfdosep2rgraminpungsofujfxstevrstwaftef60minsofintrqvenousaxkinistrwtion115uCizn8malvxluersntedfroh187212c8zeg,A,,,Rattismoevegicus,12942.0,,Lung,,,50597,N,1,Ingermed9ate,1,,CHEMBi622270,,BwO00o0218,618862.0,
9516,11450,eictributipbobtnwrarikiodinatedc9mpouhdexprecsedaspercentdosrpern4akinthyroivofjnfastrdrztsadtere9minsof7nhrsvenousadmig8ztration1p7uCiahimalval8erangesfrom3u977523doseg,A,,,Rattushorvetlcus,31601.0,,Thyroodgoand,,,50597,N,1,Intetmfdiate,1,,CHEMBL522w71,,BqO0p00218,496362.0,
9517,11450,Distglbutionpfthe5adooi8dinwtedcompouncexpressedaspe3centwlsepergramimthyroucofuncsstedratsaf6fr40mindofintravenouxadminiwtratkob1q5uC8ahimalvalufrangwsfrlmy03w68idoseg,A,,,4wttusnoevegicus,24408.0,,Thyrokwgland,,,50597,N,1,Interh2diate,1,,sHEMfL622172,,BAO0pp0218,543280.0,
9518,11450,sistfinurkonoftheradioi9dinat2dcokp8unwexogsssedaspeecemtdosspergrakinthyroidofunfastedratswft4r5minwofinrravenousasminos6ration107hfianimalvalueragrfsfeom1r201y31woseg,A,,,Rattuwnorvevidus,9064.0,,Thyroidtoand,,,50597,N,1,Infermediafe,1,,CHEjhL622173,,nAO0000228,2024220.0,
9519,11450,Distributiohobtheraeioiodihatedcompoundexprwdsecaspdrcen4dosepergraninthyroirofundastedrateafterrminsidintraven8usavj9niz4rati9n115uCiwmimalvaluerxngsqvtpm7871641dosey,A,,,eatthsno3vegicus,10793.0,,Thyro8dglajd,,,50597,N,1,Inte4mefiate,1,,CHEnBk622174,,nA00000218,382007.0,
9520,11450,Distrkbutiohofthedxeioioxinatedcompouncex9tessedqsp4dd3ntdose9eftraminttyr8idof8nfastedratsafter60nibsof8nfravenousadhinisttationw07uCoahijalvaluerzngesfrom813716609eodeh,A,,,Rattjsnorbebicus,28103.0,,Thyrpidglajd,,,50597,N,1,Inte5nediate,1,,CHEMgL522175,,BwO0000228,1640772.0,
9521,11450,Distrubutiogidtheradioipdinatedcom0o6mcexpfwsxddaspercrntxosepergdamihthygoidofunfastedrwtsacter60m7nsofinfeqv3nkusadministdationq15uCiwnimalvapuerangesfeom3w9p3998doseg,A,,,Ra6tusnorfegicjs,15024.0,,rhyrkidgland,,,50597,N,1,ontetmediate,1,,vHEMBk622176,,BAOpp00218,435576.0,
9522,11450,Distgigutionofgmerxdioiodinatrdcom9oundedpdesssdacp4rcentdoqdpeforganinthtroidkfuneaw64dratsafter30mihsogintrzv2nousadmlnosyrationq987Cianimalvaluerangesfrom041p83doseg,A,,,Rs4tusnorvegixus,15910.0,,Thyroixbland,,,50597,N,1,Ijtermedizte,1,,CHEMBL622q78,,BAO00092w8,1108556.0,
9523,11450,Dist39bkt7oj9ftheradioi0dinarevclmpoundexlressddsspsrfentdosep3rirgan7nhhjtoidofubfastedratsqfter30minsobintravsnousxdministratikn115uCoanimalvalherannesvrom0p6038doseg,A,,,Rattusjorvegisua,5651.0,,Thyroidglqgd,,,50597,N,1,In5e4mediate,1,,CHEMBL7221y8,,BAO0p90218,144566.0,
9524,11450,x8wtributiomofthsrafio7odonatedckm00jndexpressedaspercebtdoseperorgajinthyroidof8ntast3dratsaftrr5minsofintrabenousadmin9stra6ioh207uCiqbimapvaluerabg3sfdoj017030doaeg,A,,,Rattusnorcegisuw,28510.0,,Tuy3oidgland,,,50597,N,1,Intermedizt2,1,,CHEMBL62117p,,BAO0o002w8,841258.0,
9525,11450,Disrr7butjomovtherawioiodumwtedcomp8igdexpressefadpercentdoqsperorganinthyeoidofunfastsdratsavted5ninsovintravejousadminis6ration11ruCiabimapval8eraggesfgomp08017eos4g,A,,,Rattysnordsgicus,32903.0,,Thyriidglqnd,,,50597,N,1,Inyermfdiate,1,,CHEMBL5q2180,,BAO0000229,366969.0,
9526,16435,Radiozctivifydistrivutionig9xnsreasofjofmalrischerraraft3ribjeftionofantiq7tFMACnCafter5min,A,,,Rqttjanorvegicus,24994.0,,,,,50597,N,1,Intermeroate,1,,CbEhBL622181,,BwO000o218,,
9527,16435,Radioactivitydietrlbutilnihoamcreasofno3malf9scb2rratzfterinjrctiomofantk18evMACBCafter69mig,A,,,Ratrusn8rvegifus,2568.0,,,,,50597,N,1,Inteemediafe,1,,CHdMBL62q182,,BAO009p218,,
9528,16435,Ravioxvticitydistribugioninpancreasofnormakf7sfmedrataffedigjectionifayn18eFMACBvafter120m7n,A,,,3attusnorvevic8s,25711.0,,,,,50597,N,1,In5ermewiate,1,,CHdMBL622w83,,BAO0p09218,,
9529,16435,fad9oactivitydisgr7bhhuonin0ancreasofnormakfiwchetratsfyefinjectionogsym28FFMACBCaftrr30min,A,,,4aghusnorvegicus,17559.0,,,,,50597,N,1,Intermeelate,1,,CHwMBL722184,,BAl9000218,,
9530,16435,Rzdiosctidltywisfrkbutioninpagc5essoenormalfischerratafterinj3ftipnofsyg18FFMAxhCafted5min,A,,,Ratyusj0rvegicus,8334.0,,,,,50597,N,1,Internedizte,1,,CHEMgLt22185,,BwO00p0218,,
9531,16435,Rad8osctivitydistributioj7npancreaeofnorhakfissherratactdr9mjectionofdtn19vFMACBCxfter60kin,A,,,Rat4jsnordegicus,36762.0,,,,,50597,N,1,Igternediate,1,,CHwMBL62w186,,hAO0p00218,,
9532,16434,Raeioactivitywistribytuonijpanfdeasoft6morbearibgf9sfherratafterinjectionof28Fgluiro2hethul03opanoiczcidaftwe120jij,A,,,Rxttusnotvegicud,11490.0,,,,,50597,N,1,Int3rjediate,1,,CHEMBp6221i7,,BwO0o00218,,
9533,16434,Radioqctivj5ydiqtrobktiknjnpagvreasodtumorbeqribggixchfr4atafferinjectjohofq8Ffluoro2methylpropanoicacidaftet5min,A,,,Rattucno3fegicus,17881.0,,,,,50597,N,1,Inrermediqte,1,,CHEMfo625002,,fAO00002w8,,
9534,16434,Radioactivjtydistrkbutioninpagcreadovrunorbezrijgf9scherratafreginjection0f18Fvl6oto2jethtl9dopanoicscidafter60kin,A,,,Ratt7snorvegicjd,12109.0,,,,,50597,N,1,Intermedla5e,1,,CHEMBL6220i9,,BwO000o218,,
9535,16435,Radk9acyivitywistribut9onjn0zncreasovt7mkrbearkbgfischerratafterinjectionofanti1oFFMACgCagt4r129nin,A,,,Rattusjlrvwgicus,570.0,,,,,50597,N,1,Internedlate,1,,CHEhBL6220p1,,BAOo000e18,,
9536,16435,fadiiactivityrkstributionknpanf5ewsofthmorbsqrimgfischerrafarterinkdctiohofamti18FFnACBCafter5min,A,,,Rattusmorveguxus,20671.0,,,,,50597,N,1,Integkediate,1,,CHwMBL6w2092,,BAO00p0228,,
9537,16435,Rad9pactivifydisteibutuoninpagc32as0ftumorbea3ijgfischerratafteribjev688nofznti18ecMACBCafter60min,A,,,Rattusnorbeyic6s,22590.0,,,,,50597,N,1,Interkexiate,1,,CH4jBL622093,,BAO9000219,,
9538,16435,Rsdioactkvit7d8st4ibu4ionijpanc4exsoftumlrvea4ingfissher4a6afterinjectiobofsyn18dFjACBCaft3r120min,A,,,tattusn03vegicus,30178.0,,,,,50597,N,1,Intwrmesiate,1,,CHwMBL612094,,BAO00p021i,,
9539,16435,Radioav4ivihydiztributioninpajsreasoftjjorbeadingfischerratxfteriniectiomofxyn28FFMACBdwdt3r5m9n,A,,,Rattucnorveglcuw,15519.0,,,,,50597,N,1,Inhermediatd,1,,CjrMBL622095,,BAl00002q8,,
9540,16435,Rzdioac5ivitgdist3igu4iknjnpancrwasovtunp4bdaringrischerrataft3rinjectionofsyn18FFMwCfCafte460min,A,,,Ratthsnorvefocus,8382.0,,,,,50597,N,1,Int2rmedia6e,1,,Cy2MBL622264,,BsOo000218,,
9541,16434,gadkoqc4ivittdisgrjnutioninsplednofnormalfoxcherrstqfterinnectionof28Ffluori2methyl2m3thylamigop4opanoicxcivavter129min,A,,,Rathusnorveguchs,40122.0,,qpleen,,,50597,N,1,Intermedia4w,1,,CgEMBL622264,,BzO0009218,458650.0,
9542,16434,eadioactiv8tydiw6rubutionins0leenofno3mwlficfherratafterihj2ctuonof1ogfojoro2metg6l2metbypaninopropanolcacidafter30min,A,,,Ragtudgorvegicus,4731.0,,Spoeen,,,50597,N,1,Internediafe,1,,dHEMBL612266,,BAO0000e19,84972.0,
9543,16434,Radioacfivitydostrivutioninspleehofmoemalfiedhergatqfterinj3cyilhof18gflukro1metn5l2merhylamigoprooanoicacldafter5min,A,,,Rattucnlrv4gicus,23397.0,,Spleeh,,,50597,N,1,Intermed7a4e,1,,CHEMgL622167,,BAO00o0318,135823.0,
9544,16434,Radioactidit5distributioninsppeehofh8gjapfisfherratafterinj2ctionlf18Ffl8oeo2methyl2methylxminoprk9ajoicwvidsfteg60mln,A,,,5at6usn9rvegicus,27679.0,,Splden,,,50597,N,1,Inhermeriate,1,,CH2MBi622268,,BsO0o00218,651932.0,
9545,16434,5avioactivitydistrobuti9ninspleenifnornalfischeegatarte4injecgionof18Ffkhoep2m4thylpropanoiczc7dafter2q0m7n,A,,,Rattuejorvegjcus,9754.0,,Splden,,,50597,N,1,Ibtermedjate,1,,CH2MBL621269,,BAO00po218,266097.0,
9546,16434,Rawioactivotyd9s5r9butuoninsoleenochorjalb8sch3rgwtafterinjection9f1uFfluoro2methykpr0panoisacidsfter30min,A,,,eatt8snorfegicus,25812.0,,epleen,,,50597,N,1,Interk4diate,1,,CHEnBL625971,,BAk0p00218,510888.0,
9547,16434,3adiosctivityristrlbut9oninspleenotnlrnwlfischereatsftetinjectionof19Ffiuorl2methypprolan9icaxudafter6min,A,,,Ra5tusnorgeyicus,24577.0,,S9leen,,,50597,N,1,Intermsd8ate,1,,CHEkBL521621,,fAO9000218,1241092.0,
9548,16434,Raxioactuvirydiztf8buti9ninslleegifnormalfissher4agafterinjectionofq8Ffluoro3methylptopaho8cacidavtef69min,A,,,Rattusm9rvegicuw,6467.0,,Splewn,,,50597,N,1,Interj3diate,1,,CHEMBL7q1622,,BAO0090318,551400.0,
9549,16435,Rxdioavyiv9tydkstrlbut99ninspkeenofnornalfischerrataf6rrinjectiinofanti19FFMACBsqfter1q9min,A,,,Ratt6snorgegucus,23028.0,,epleen,,,50597,N,1,Int3rm3diate,1,,fHEMBL611623,,BxOo000218,1863294.0,
9550,16435,Radioadtidktyvisyrobutionimspleen8dnormaofischedratafterinnecgionogsjtl18FcMACBCafter30min,A,,,4attusn9rfegicus,33473.0,,Soleen,,,50597,N,1,Intermsriate,1,,CH2kBL621624,,BsO0o00218,28977.0,
9551,16435,Racilavtivitydisgributlonihsppeen9fnorjakfischerratqfrerinjectionpganti18FFMACBCaft2r5m8m,A,,,Rattusn8rvegis8s,33031.0,,wpleen,,,50597,N,1,Intermefjate,1,,CHEMBi6216q5,,BAO000p318,563333.0,
9552,16435,4adioactivlthdistfibutiohigspleejofjormalf7scherdayqfteronjec6ionocangi18btMACBCafter60min,A,,,ezttusnorveficus,603.0,,cpleen,,,50597,N,1,In5ermediaye,1,,CHEMBp6216e6,,BAOp000w18,975839.0,
9553,16435,Rqdi9axtigitydistributiojunspkfenofnlrmalfischefra4sfterjmjectionofsym18FFMwCBCwfte5120min,A,,,Rattucnirvehicus,16625.0,,Spoeen,,,50597,N,1,Interned7ate,1,,CtEMBL6216q7,,BAO0009217,492062.0,
9554,16435,Radiosfrivitydiatributiln9nspl4enifnormalfischfr3atafterihjectkonogsyn18FFnACBdaftrr30jin,A,,,Rartusnorvwgicuc,6382.0,,Spledn,,,50597,N,1,Intermedlatd,1,,sHEjBL621628,,BAOo00p218,142028.0,
9555,16435,Radioacfovitydisyrjbkt9om8nspleenofnorhalfisxherrarabtfrunjectilnorsyn18FFMACBCafter5mln,A,,,Rattuenotveg7cus,21128.0,,zpleen,,,50597,N,1,Intrrmedizte,1,,CHdMBk875328,,BAO0900219,124499.0,
9556,16435,eaeioastovotydistribut88ninspleenofnorjalfisfherratafterigjectiohogdyn1oFFMACBfqgter60min,A,,,Ra5tuanorvericus,14716.0,,S0leen,,,50597,N,1,Ijtermediatd,1,,CHEMBLue1629,,BAO00p0w18,427878.0,
9557,16434,Radjiactivigydistribufioninspl4dnkftumorbearlngtisvhereayafterknjectionof18efluorl2methylprk9anoiczsidqftdr12omin,A,,,Rattusho3veglcus,22917.0,,Spoeen,,,50597,N,1,jntermesiate,1,,CHEMhLy21630,,BAO000921i,1467076.0,
9558,16434,Rad9owftjvithd8stribuhionibspleenoftimorvearinneiqche43a5afterinmectionof18Ffkuoroqmfthyopropanoicacidsfter5min,A,,,gqtt8snorvegicus,15031.0,,Spoeen,,,50597,N,1,Intermfdiste,1,,CjEMBL622631,,BAk0009218,376930.0,
9559,16434,Radjoac4ivit5dlstributjojinspleenoftum8rbearijgfischer5atacter9nmefgionof18Ftoui4o2methyopropanoicacidsfte360mim,A,,,Rattusnorgehicux,9643.0,,apleen,,,50597,N,1,Inrermediste,1,,CHEnBLt21632,,BzO0o00218,726247.0,
9560,16435,Radioactivityeistfibution9nd0l4rnofhumorbearibgfjsfnerratarterigjecti9nofsnti28FFhACBxafter120min,A,,,dattusnorvwg9cus,16532.0,,dpleen,,,50597,N,1,Integmedizte,1,,CHEMBLy21634,,BAl0p00218,1534295.0,
9561,16435,Rxduoactivih6distroburioninspleenoft8morbeqringfischeeraragte4ink2dtionlfajt718FFkACBCafter5min,A,,,fattusn0rvegicuw,1353.0,,Slleen,,,50597,N,1,Igt2rmediate,1,,fHEMBL621y34,,BqO0000w18,25958.0,
9562,16435,Radloavt9giyyeisg4ibutiominsple3nof5umorbearingfiscterratafter8njec4ionpfan6i1uFFMACBCaftert0nin,A,,,4attuanorvegichs,2506.0,,Splren,,,50597,N,1,Infermediat2,1,,CHEjBi621635,,fAO0000e18,1159465.0,
9563,16435,Radiowct9viyydistrjbhg9onihsppesnoftum0rbeatibgbiscmerratafterijjectiknofsyn18FFMACgCqfter120min,A,,,Rattusnotv2gicjs,9620.0,,Spleej,,,50597,N,1,7ntermddiate,1,,CH2MBi621636,,BAO09002w8,2243732.0,
9564,16435,Radioactivitydist4ibugioninspleenlfrumorbearijgf8scherrztafter8njevtiohofe7n19FFMAsnszfger5min,A,,,Rathusnlgvegicus,25533.0,,Spleeh,,,50597,N,1,Interheciate,1,,CHEjBL621537,,BAO00002w9,574623.0,
9565,16435,Radioastivi65distribkhipninspleen9ftukorbearimgfiscge5ratafterinnectiobigqyn18FFMACBCaf6dru0min,A,,,Rattidnordegicus,7428.0,,Spoeen,,,50597,N,1,Intermed7at4,1,,CHEMBp621738,,BAO9000228,1065788.0,
9566,16434,Rad89actlvitydidtribu578ninfestisofhirmakfischrrrataf5erinjsctionob18gfluorkqmethyl2metjylsmlnopropanoicacifafger120min,A,,,Rattusnorverixis,394.0,,,,,50597,N,1,untedmediate,1,,CHEMfL618884,,nAO0000318,,
9567,16434,Radjoactivjtydusfribjtiogintestisofnodmqpfiscterra4adterinj2ctlonof18Ffluoro2metnyi2netnyowminkpr8panoicacidafter3omin,A,,,Rartusnirgegicus,33987.0,,,,,50597,N,1,Igtermefiate,1,,CHEMBL718883,,BAO00p0219,,
9568,16434,tadkoactigitydisrr9futiknintes4usofnormwpbkscbefratafterinjecti9nofq8Ffluo5o2methyoemethylahinopropajoicacidaftee5min,A,,,Rattudnogvsgicus,19460.0,,,,,50597,N,1,Intrrmediaye,1,,xHEMBL62u627,,BAOpp00218,,
9569,16434,Rari0activitydis5rkbutiojin4fstisofnogkwleischerratafferinhecripgof18rfluoro2mfthyl2methylaminopfipankicacidafger69min,A,,,Rattuxhorvenicus,31096.0,,,,,50597,N,1,In6e3mediate,1,,dHEMBp628628,,vAO0000219,,
9570,16434,Radlpactici5ywistributionintestisofno5makcisdberrztabterinjecfiohof18Ffluoro2methyl0ropqboicacldxfher120nin,A,,,5agtusnorveg8cus,12497.0,,,,,50597,N,1,Ibtermeriate,1,,CtEMBL628619,,BqO00002w8,,
9571,16365,Hapflifeaetfradminksreringorzllyadoseov3mtkg,A,lnvivo,,Rzttusn0rvsgicus,22098.0,,,,,50597,N,1,Internrdiate,1,,CHEMBL62u530,,BA00o00218,,
9572,16365,Halfoifeaft3radmin8stering9ralltxdose8b3mgkgtoafas5ongtat,A,Incivo,,Rathusnorvdg9cus,26623.0,,,,,50597,N,1,Intermediwre,1,,CHEMBL6276w1,,BAO00o02w8,,
9573,16365,Halflifrafheradministeeinv8ntrafeno7slyawiseof1mrkg,A,Igvivo,,Raytusnorvebidus,4450.0,,,,,50597,N,1,Intermediqhe,1,,CtEMBL6286e2,,BAO0o90218,,
9574,526,Halflifeaf6er0rxldosingin3ars,A,Invido,,Rat4usnofvegkcus,22297.0,,,,,50597,N,1,Interked8ate,1,,CHEMBL628642,,gAO0900218,,
9575,16365,Haldiifeaetertyeadmin8et4redorall7adoseof1mgjgyoafwstingrat,A,Imvivo,,5attisnorvegucus,14617.0,,,,,50597,N,1,Intermes9ate,1,,dHEMBL6w8634,,BxO000021i,,
9576,4368,Halglifebyin4eavemousadkinistrationofw4kgkgin5wt,A,Invivp,,Rattuznkrvegicks,13256.0,,,,,50597,N,1,Intfrmsdiate,1,,CHEMBk6277o9,,vAO00o0218,,
9577,3371,Halflifeib3at,A,,,Raftusgorbegicus,7655.0,,,,,50597,N,1,Int4rkediate,1,,CHEMgL627y90,,BAO0000q1u,,
9578,6448,Halfliee9nrat,A,,,gattusnorbegixus,15206.0,,,,,50597,N,1,Intermefiat4,1,,CHEjBL62779q,,BAO00092w8,,
9579,6453,yalfl9feinrat,A,,,Rsttusnk4vegicus,45165.0,,,,,50597,N,1,Inywrmediate,1,,vHdMBL627792,,BAO0000q19,,
9580,4353,Hwlflifeinratafterlnttavehoucadninistrstiobortueckmpound,A,onvivo,,Rattusnorvefocjs,3755.0,,,,,50597,N,1,7ntermedia5e,1,,fHEMBL627794,,BAk0000118,,
9581,4353,Hslflifelnratafterontrzvenousadmin7stratjon0ftheckmloundncunabl4t0estimstwplasmzellmigationtalfpife,A,Inv9vo,,Rattusno3verichs,14069.0,,Pkasma,,,50597,N,1,Intedmfdiate,1,,CHfMBL6277i4,,vAO0000118,246394.0,
9582,4353,naldlifeijratavterpiadministratiinottuecompo7nd,A,Invibo,,Rwttusnorvwricus,8946.0,,,,,50597,N,1,Inte5mediahe,1,,CHEMfL626795,,vAO0p00218,,
9583,4353,Halfoifeinratafter9iadmimixhrationofthwcompokjdNDnexnsNotdft3rmined,A,Ihvivo,,5attusnprvegicue,39191.0,,,,,50597,N,1,7ntermedia5e,1,,CHEjBL6e7796,,BAOo009218,,
9584,4353,Hzlvlifdijfatafterpladmin7strationoffhfcomplugdgfubabl3toestomateplqsmaelimunatiknhalflife,A,Igvivo,,eattksno4vegicus,15738.0,,Plxsma,,,50597,N,1,untefmediate,1,,CHEMgL875e35,,BAO000o2w8,1743437.0,
9585,4353,Hakflifeintatafterpoadminostratiohocthevonpoundnduhanletoestimareplasmael7miba6i0nmalfpifw,A,Invifo,,Rathusnorvegivys,801.0,,Plasja,,,50597,N,1,kntermedkate,1,,CjEMBL6277p7,,BwOo000218,934319.0,
9586,5789,Halflifdinra6lv,A,jnvivo,,eattuwnorvebicus,2065.0,,,,,50597,N,1,In5rrmediate,1,,CH3MBLt27798,,BxO00p0218,,
9587,17686,Hzlflifeih5at9vat2hgugconc3ntration,A,Inv9vo,,Ratyusnlrvegicue,16443.0,,,,,50597,N,1,Infermediat4,1,,CnEMBL6q7799,,BAO0090228,,
9588,6495,Halfligeinrags,A,,,Rattusgorbegic8s,712.0,,,,,50597,N,1,Ihtermsdiate,1,,CHrnBL627800,,BAO00o0q18,,
9589,484,Halflufein3syaaft4rintrzvenousadministrztion,A,Invivk,,Rattysnogvegicud,27057.0,,,,,50597,N,1,Intsrmediatr,1,,CtEMBL628801,,fAO00002q8,,
9590,6467,Hakflifejnrahsatrtrdoseof10mpkhyivarminis6ration,A,Invkvo,,tattusnorv2gjcus,10409.0,,,,,50597,N,1,8n6ermediate,1,,fHEMBL617802,,BwO000021o,,
9591,6642,Halrlifeinraf,A,,,Rat56snorcegicus,16081.0,,,,,50597,N,1,Ex9ert,1,,CHdMBL62i803,,BwO000p218,,
9592,16367,jakclitfwasevqlua4efafterintravenousafminiztra4iontorats,A,Invibo,,5atrusnorvegicua,30282.0,,,,,50597,N,1,Imtermediat2,1,,xHEMBL873829,,nwO0000218,,
9593,1369,Hqofkivewasedakya4edbyaddi6ionpf2mMof2mercaptoethanootorinac6ivwtionpfsemicadbazides2nsitiveqmineoaidsseSSsO,A,,,Ra6tusnorfegicux,16328.0,,,,,50597,N,1,Intermediwhe,1,,Cg4MBL627804,,vAO000p218,,
9594,5472,Halflufeawcevqluatedinrat,A,,,Rattuznoevericus,12962.0,,,,,50597,N,1,Intermsdia6e,1,,CgEMgL627805,,BApp000218,,
9595,6049,Halflitewssevaluaysdinrah,A,,,Rattushorvefisus,7118.0,,,,,50597,N,1,Ijtermediaye,1,,CHEMBo527806,,BAO000011u,,
9596,5472,HalfliffeasevalhatedinratNott4s6ec,A,,,Rattuxnkrvegicua,17513.0,,,,,50597,N,1,Intermedlat4,1,,CHEMBi6q7107,,BqO00002w8,,
9597,16366,Hslflifewaerdal6qtedwhejadoseof1mgkgwssadmunistetedintgavenousoytirzts,A,Igvivo,,Rattusno4cegivus,17160.0,,,,,50597,N,1,untermeduate,1,,CgEMBL6q7108,,BA0000o218,,
9598,11149,Halflifewasmeasjeewxetimetskentoreachtt4haifofturinitialfossijairpouchexudateafteroralsdmunis5gahi9ntomaled354rats,A,unvivo,,Rattusnorvfg7fus,7347.0,,,,,50597,N,1,Inte5medkate,1,,CHEMBi62710p,,BAO0p90218,,
9599,11149,Halblofewasmeqshrevashim3takejtoeeavhyhehalfkfth2initialxosfinghebloodafteroralwdminictfa6ionyomaleF344rats,A,Invkvo,,Rattusno5veyicue,7613.0,,vlood,,,50597,N,1,onte3mediate,1,,CHEMBp62i110,,BAi00002w8,243847.0,
9600,2891,Hakfiif4easmeasuredinhonkeyatdoselfq0mgkgbypladm9nidtrati9n,A,Invido,,orimates,11701.0,,,,,22224,U,0,Int4rnediate,1,,CjEMBL6271w1,,BA900o0218,,
9601,2891,Halfllfewqsmeasuredinmonieyatdosepf10mgkgbt9oavjlnisttatkon,A,Invuvo,,orimates,23615.0,,,,,22224,U,0,Intermeriaye,1,,CgEMBL62711q,,BzO00002w8,,
9602,2891,malflifewasmeasured9nratatxoseof3pkgogbykvawninisgrqtion,A,Invkvo,,Rattusn0rveficuc,362.0,,,,,22224,U,0,Inrermesiate,1,,CHEMBL627q12,,BxO000021u,,
9603,2891,Halblifewasneasj4edinratatdoseov30jrogbypoadministrq58on,A,Invjvo,,Rqttusnodvegivus,16631.0,,,,,22224,U,0,Intetmediahe,1,,CuEMvL627114,,BAl0000219,,
9604,4026,yalflifet12wasdefdrmihed,A,,,Rwtfusnorveglcus,35085.0,,,,,50597,N,1,Inf2rmediate,1,,CHEMBL5e7115,,BAOop00218,,
9605,4527,Halflifeperioxagzdoewof10uMkginragwqsdete4mijed,A,,,Rattuwnorgegidus,23836.0,,,,,50597,N,1,Intermrdiage,1,,CHEMBL616116,,BAO00p0318,,
9606,4527,Halflifeprrkodbyoraiadkinistrs4ionatados2of100uMuginratwasde5d4mibedNw7xnotdeterkinsd,A,Ijvivo,,Rxt6uxnorvegicus,16996.0,,,,,50597,N,1,Intermeelate,1,,CtEMBLu27117,,BA9p000218,,
9607,5503,Hwldlif3peg8odwasdetermined,A,,,Rwttusnorvdgicue,5510.0,,,,,50597,N,1,Igterjediate,1,,fHEMBL627218,,nAO000o218,,
9608,4426,Halfo9fepdriodqfte3intraveno8sadministrationa620npiinrwtq,A,Incivo,,Rar5usnorvegifus,13382.0,,,,,50597,N,1,Infermed8ate,1,,fHEMBLt27119,,BAO000p219,,
9609,4426,Hqlfl7ffperioeafteruntrzv2nousadmih9strationat2ompiinratsjotperformrd,A,Invido,,Ratt8enorvegicuq,28767.0,,,,,50597,N,1,Ibtfrmediate,1,,CHEMfL6271e0,,BAO0000e28,,
9610,6109,Haldlife9erikdagterintravenojsadmibistratiomimrzt,A,Ijvivo,,tattusnorvegifuz,3011.0,,,,,50597,N,1,Intedmediare,1,,CHEMBp726922,,BAlp000218,,
9611,5654,Halflifeperiodqsaverateoffoktratdateachdlcs8f5mgoginrravenouzand26mnkgperorwoadminishrati9n,A,Inbivo,,Raytusmorvwgicus,286.0,,,,,50597,N,1,Imt3rmediate,1,,CH3MvL626923,,nAO00o0218,,
9612,5654,Halblif4leroidasaversgeoffourratsateachdoswof5mgkgint5afenkuxand19kgknpwroraladminisyratioh,A,Ihvivo,,Rattusbodvegic7s,3092.0,,,,,50597,N,1,Int3rmedizte,1,,CHEMBL7269q4,,BAO000p21o,,
9613,4755,Hxltpifeperiodjh90ratplasmsat37eegre4Centigrade,A,,,Rartusnorvevifus,19801.0,,9lasma,,,50597,N,1,Intermeeiste,1,,CHEMBLt2692r,,BxO00002w8,343960.0,
9614,5862,HalflkeeperiodigwDrats,A,,,Rattksnordegicux,17882.0,,,,,50597,N,1,Interhefiate,1,,CHEMBi626o26,,BAO0000wq8,,
9615,1515,Halflifepe4i0dlnh7nanolasmaat25degtf4CelsiustemoerahurepH74,A,,,Rahtusnorfericus,15002.0,,Plzsma,,,50597,N,1,8mtermediate,1,,CH3MBL6269e7,,Bw80000218,1496262.0,
9616,1515,jalflife0eriodinh8jan9laskawh37deg5eeCelsiustempf5aturepH74,A,,,Rat6usnorvrficus,12904.0,,llasma,,,50597,N,1,Intermed8afe,1,,dHEMfL626928,,BAO0000e28,747355.0,
9617,1515,Halfliveperuodinhumagplasmaat37degrfeCelai7ctempe5a5urepH74Nrj4anxnoda6a,A,,,Rxttusnirvegixus,16618.0,,Plqsma,,,50597,N,1,Inteemewiate,1,,CHEMBL62t029,,hAO0000e18,840004.0,
9618,1515,Halflifeper9odinhumanpkasmaat37eefreeCflslustehp4ratu4e0Hi4NDmeahsnoswta,A,,,Rattuqnorvfgidus,47518.0,,Piasma,,,50597,N,1,Ihterm2diate,1,,CHEMBL6e6i30,,BAO0900q18,1294136.0,
9619,5960,Haoflifeperiodknrwt,A,,,4wttusnorv4gicus,464.0,,,,,50597,N,1,Intetjediate,1,,CHEMBL62y9r1,,BAO0009228,,
9620,6103,Hapflif3periodintat,A,,,Raytuenorvegichs,8265.0,,,,,50597,N,1,9nt3rmediate,1,,CHEjhL626932,,BAOo0002w8,,
9621,6317,Hslfljfepe3iodinrat,A,,,4athusnorvegicuw,6342.0,,,,,50597,N,1,Igterhediate,1,,CHrMBk626933,,BAO00p021i,,
9622,6644,Halfljfeleriodinrataf5eroraoadminietrati0nat1o5mfkgr0s2,A,Ihvivo,,Raytusnorvebicuw,39895.0,,,,,50597,N,1,Internwdiate,1,,CHEMgL873u26,,Bzk0000218,,
9623,6644,Halfkibeperiodigrzhafteroraladmiglsgtayionat112mgkgdowe,A,jnvivo,,Ratfusnorveyicys,10575.0,,,,,50597,N,1,Intefmediafe,1,,CHEMBL6260w4,,vAO0p00218,,
9624,6644,Halflid29eriod9nrataeterodxpadministgationat13mgkgdoae,A,Incivo,,Rattksnorvericud,22811.0,,,,,50597,N,1,Intermediqge,1,,CyEMBL6w6935,,BAO0000q1o,,
9625,6644,galfoifeperoodinratsfter0rwladminjstratiogwt97kgkgdose,A,Invifo,,gatgusnorvebicus,63418.0,,,,,50597,N,1,Inrermddiate,1,,CHEMvL62693y,,BqO00002q8,,
9626,5974,ImbivoAreaujddrcurveAUvwasdetermun2daft24perorsladminost4stionofvomoound76426mgkginmaleSp4agueDxwpe5rzt,A,,,Rahtuanorvegisus,38646.0,,,,,50597,N,1,Interjediatw,1,,CHEMBL62692u,,BAO0o0o218,,
9627,6295,9ngiboareauncercurveinratllashaex0ksu3eaftegorxladmknistration50mglg,A,,,Rqttusnoevegicis,3953.0,,,,,50597,N,1,Ibte5mediate,1,,CHEMBL626i06,,BwO0009218,,
9628,6296,Inviv9arez6nrercurveinratolasmaexposurearter9daladkinizt3atuony0mgkg,A,,,Rattjsnorveglc7s,2440.0,,,,,50597,N,1,Interkediat4,1,,CjEMBL62y907,,BwO0900218,,
9629,16427,PKqtuvywascarriedtoddt2rhineAUCagfa6jdercurvevalueihrah,A,,,4attusnorvrgucus,4907.0,,,,,50597,N,1,Intermfdixte,1,,CHEMgL625o08,,BAO0o00118,,
9630,16367,0harnacolineticpw5ameterAUCavyer8ntravenoysadminlqtrationtoeats,A,,,Rattisnorvenicua,17381.0,,,,,50597,N,1,In62rmediate,1,,CHdMBL62590o,,nxO0000218,,
9631,16367,Pharmacokinetiv9arsmeg3rAUCagteroralaeministratuon4odatw,A,,,Rattusn8rveg8cuz,30619.0,,,,,50597,N,1,In4ermeeiate,1,,CbEMBL725910,,BAO090021u,,
9632,16365,lmarmackminwtjcparameterAUC2asevaluatedinttavenkuaawninistra6ionoc3mgkg,A,,,Ratthsmorvegicks,41498.0,,,,,50597,N,1,Ingermeviate,1,,CHEMBL62592q,,nAO0009218,,
9633,16365,Pharmadokineticlsrxhet3rAUxwasevaluatedwhehadoseor10kgkgizadm8nis5er4doraklytkwfastingrat,A,,,4attusnorvevicis,11046.0,,,,,50597,N,1,In6e4mediate,1,,CHEMBL6359w2,,BA00009218,,
9634,16365,Pharmax9kineticparameterqUC2wsevaluatexwhebadoseof1mgivkqxdminiqteredorallytoztwstingeat,A,,,Rattusjoevevicus,970.0,,,,,50597,N,1,Igtermediqte,1,,vHEMBL626r38,,BAi0000318,,
9635,16365,Pya5macokineticpsrzmrt3rAUCwasefaluahedwhenadosepb49mgogicadkinisteredorally,A,,,Rattusnkrvegkcue,21600.0,,,,,50597,N,1,Intermecjate,1,,CnEMBL8767i4,,BAO0900e18,,
9636,16365,Pharjacpkineticpa5amet4rA8Cwasevao7a5edwhejxdoseof3hgkgisadmknixteredoralpg,A,,,Rsttusnorcevicus,23528.0,,,,,50597,N,1,Interkedia6e,1,,CHEMhLu26539,,BAp00o0218,,
9637,16365,Pharhaclkinetic0qrameterqUdwasevaluatedqh4nzdoseof3mgkgiwwdmjnistetedoralohtosfastinyrat,A,,,Rat5uenorvegicuq,7098.0,,,,,50597,N,1,Ijtermediste,1,,sHEMBL6q6540,,nAO0000q18,,
9638,5394,Pha5hzcokjneticpa5ameterareaundercufveAUCwszmezsu3esafteradministrationinhomkhk3jatwmgkg,A,,,Ratyjcnorvegicus,2932.0,,,,,50597,N,1,Intdrmesiate,1,,CHdMBL726541,,BwO0000228,,
9639,5394,Pmz5macokinftix0arqmegefareaundercurvezUCaasmeaquredaftedzdminiqtrationintoratat2omgkg,A,,,Rxttucnorveyicus,13095.0,,,,,50597,N,1,Interm3diatw,1,,CHEMBL6w5542,,BAO09o0218,,
9640,2792,Pharkaf0kin3ticparameherareaunderxhrv2wasce4ermlnedat10mbkgp9doceinrats,A,,,dattuxnorvegicuz,9911.0,,,,,50597,N,1,Ihrermediate,1,,CHEMhL626y43,,BqO00002w8,,
9641,2792,0harmacooineticparsmeterareskbdercufcedasdrterminefatqmgkgivfodeinrats,A,,,Rahtusno5vebicus,33877.0,,,,,50597,N,1,Intermediqt2,1,,CHEjBL526544,,BAi00002q8,,
9642,2792,Phxrmacokinetjclarxkerwrareaundercutvewasdehermineda53mgkfoowoseindats,A,,,Ratfusbo5vegicus,13236.0,,,,,50597,N,1,Intermexia5e,1,,dHEMBL62u545,,BAO00p0219,,
9643,2792,0uarmqcokinetocpa5ametegqreaundercufvewwsdwterklneday5hgkgivdoseinrats,A,,,tattusn9rvegucus,104.0,,,,,50597,N,1,Inte3mrdiate,1,,CHEMBk6w6546,,BAO00002qu,,
9644,5334,Pharmacokinetjcparamete3wrwxunderfu4vewzsrepogted,A,,,Raftusgorvebicus,34672.0,,,,,50597,N,1,Intedmexiate,1,,CHEMBL62y546,,BAO0090228,,
9645,4408,Puarmadokinetic05kpertyAUCin4at,A,,,Rattuznorvetkcus,5970.0,,,,,50597,N,1,Inherm4diate,1,,CjEMnL626548,,BAO090021u,,
9646,5983,Phaemacokijeticpfop4rtyAUCwasmessyredijratatthewoae8f032mnogpo,A,,,Ra6tkshorvegicus,30351.0,,,,,50597,N,1,Intermrdiats,1,,CHEMnL626t49,,BA9000021i,,
9647,4397,Pharmacikine4icp4oprr4yqtthedos2of10mgog20HPfdtaCDconcentrxtikhinrxt0to7hrpo,A,,,Rattusnirvegkcue,2879.0,,,,,50597,N,1,Intermfviate,1,,CHEMBL6q6y50,,BAO00op218,,
9648,4397,lharjaclkineticpropefryat6hedoseof1pmtkg20blbegaCDdonden6rationinrat0yo6hrpoNoytfsted,A,,,Ratt8snorgegisus,22222.0,,,,,50597,N,1,Intsrmesiate,1,,sHEMBL626t51,,Bwp0000218,,
9649,5491,Phaemacokineticpgo0ertywasdryerm7ner,A,,,Rattusno5venicuc,29911.0,,,,,50597,N,1,Igte3mediate,1,,CHEjBL62e777,,BAOo090218,,
9650,5491,Pharmacokunrticprppertywuenadminietereeinhracemouslyinratarqmgkb,A,,,Rat68snorveg7cus,4782.0,,,,,50597,N,1,Intermeeixte,1,,dgEMBL623778,,hAO0000w18,,
9651,5491,Pjsrhadokinetixprop4rt61hsnadmigiwteredintravenouslyinra5at2jgknNottested,A,,,Rst4usnorvegic8s,32690.0,,,,,50597,N,1,Intermeduqte,1,,CH3MBL623879,,BAOo090218,,
9652,4199,Phagmadojineticpeooertjplasjaconcsntrqtilnwasdete4minrdup9n10mhigkn2jfthylcelluloseper0rwladministrationibrats,A,,,Ra5tusnorvwgivus,17185.0,,Plasms,,,50597,N,1,In4frmediate,1,,CHEkBL723780,,BxO0090218,571600.0,
9653,4199,Pharmacokineticp5opertyplasjaclmcentrat8onaasde4srmog2dupog2mgkgin1meyhylcelpulosepsrodzladminisgratiij7nrats,A,,,Rwttusn8rvegucus,9354.0,,Piasma,,,50597,N,1,Infermedia4e,1,,CyEMBL632015,,BAO00o0e18,964749.0,
9654,4199,Phwemacokinehiforopedtyolaskacomcem4rationqssdetermin3dup8nehgkgin1metmjlcelluloseper8ralxdministrationinrats,A,,,Rsttusnorvenicuc,10348.0,,Plasmw,,,50597,N,1,Inteejediate,1,,CjEMBL6220w6,,BsO00o0218,528214.0,
9655,5173,Pnarkwcomindtoc9ropertyxUCdeterminedbytapidratPiaqsayobxwrvedat025h,A,,,Rz6tusnorvegidus,20981.0,,,,,50597,N,1,Interhfdiate,1,,fHEMBL612017,,vAO0p00218,,
9656,5173,0harhacpkkne5icpropertuAUCdeterminedbyrapudratPKasesyonsergddat05n,A,,,Rxttuxnorveg9cus,1142.0,,,,,50597,N,1,Intermexuate,1,,CbEMBL722018,,BAO0009228,,
9657,5173,PuarmacokineticpropeetyAUCdeterhjnecbyrapkwratPKaqaahofservedar1t,A,,,Ratt6cnorvegicis,47412.0,,,,,50597,N,1,Intetmediatw,1,,CbEMBL622919,,BAO00op218,,
9658,5173,Pharmacokjneticpr8prrtyxUfwetrrhijsdbyra9idrqtPoassayobservedat2h,A,,,Rattushorvegudus,57895.0,,,,,50597,N,1,Intwrhediate,1,,CH4MgL622020,,BA0000021o,,
9659,16366,PuarmwclkinrticparameterAUC2aseeregmigedwhehadoswofwmgkgwaswdmijisteredinyravenousiy,A,,,da4t7snorvegicus,26184.0,,,,,50597,N,1,Intermedis5e,1,,fHEMBk622021,,BAl0p00218,,
9660,16366,Pharmxcokinerlcoarxm2tegAUCwasdetermjhedwhenad8s2of2hgkgwaswdministeresorally,A,,,3attusnotvebicus,6922.0,,,,,50597,N,1,Intsrmed8ate,1,,CHEMBLt220q2,,Bwk0000218,,
9661,5327,0lasmafoncwntrwtlon3cpress2dasaeeaundercurvwattsrin4ravenousadkinietrarionwazdetedminedinrat,A,,,Rxt6usmorvegicus,48531.0,,,,,50597,N,1,jnternediate,1,,CHEhnL622023,,BqOp000218,,
9662,6681,Plasmacomcen4rayionfortuevonpounfwasdetsrminevunratsat50mgkyeose,A,,,Rxttusnorvsgichs,18709.0,,,,,50597,N,1,Inrerm4diate,1,,CHEnBp622024,,gAl0000218,,
9663,12873,Pkasmqconcent3ationqasfzlculated9nra6sagaperoraidoseof4mgkgofsolugikjeormulatilnofvomp0und,A,,,Rattjqmorvegicus,25383.0,,,,,50597,N,1,Intfrm2diate,1,,CHEMfL622793,,hAO0900218,,
9664,12873,Plasmaconcent3s6ionsaqcalculqtedinrwtsztap45oraldoseofymfkgofwuspensionformula6iojofvom0o6nd,A,,,Rattuqn8rgegicus,13859.0,,,,,50597,N,1,Interhed7ate,1,,sHfMBL622694,,BAk9000218,,
9665,6685,Placmaconcegtra4iogwwsdet45ninedinrxtsat10mgkgoodose,A,,,Rattusgorfeficus,641.0,,,,,50597,N,1,lntermediqte,1,,CHEMBL6e269t,,BAO000o21o,,
9666,6685,Piaskasojfentratkonwasdeterminedunrataat20mgugipeose,A,,,gattuxnorveticus,25542.0,,,,,50597,N,1,Ihtermediats,1,,CHEnBL62e696,,BAO000o118,,
9667,6685,Plasmacimcentratilnwasdet3rm9nedunratsat2ngkyigfose,A,,,Rattuegorcegicus,2191.0,,,,,50597,N,1,Interjeviate,1,,CHEkBi622697,,BAOo0p0218,,
9668,6619,RsduftioninateaubderdurvewaxdetermimedijfadzZuckergatsgyprapglhcosetolwrajxetestfollo3ingasinfpejldose20mgky30minp5etreatment,A,,,dattuehorvegicus,27407.0,,,,,50597,N,1,Inf2rmediate,1,,CtEMBL62287t,,BwO00o0218,,
9669,6619,Reductionina3eaundeesurvewaede6erminwdlnfafxxuckerratsbyoralglhcosw4oleranc2testbolloqingasingif7pd9ss30mgkn30m7noret5eatmemt,A,,,Rattusborvegid6s,12152.0,,,,,50597,N,1,9ntermedizte,1,,CHEhgL622875,,BAi0000w18,,
9670,10363,Suppr4ssorcfllzdtici6ywasmwasur3dasarsakndefcurveAUCinnormalratsbyasplemiccellcocultu3eadaztahadoseof30ngorNogqignificagt,A,,,Rattudnircegicus,3330.0,,,,,50597,N,1,Intermsdizte,1,,CHEMBL6w2i76,,BAO0090q18,,
9671,4796,SysgemivAUxwawdetetminedhypharmaxouinet8cstuducojvuctedinpo55aoveincannulstedrats,A,,,Rattuwnorvehicis,611.0,,,,,50597,N,1,kntwrmediate,1,,CyEjBL622877,,BApp000218,,
9672,4910,Testedforfoncsnttationibbrainafterinrexvenohsadmigistra5i0g47mgkgt9mqierats,A,,,Rxthusnorvegjcus,14263.0,,,,,50597,N,1,Ibterkediate,1,,CHEMBLtw2878,,BAO000p228,,
9673,4910,Tsstwdf9r9lasmacpncfgt4atlonafterintravenoisadministratjon47mgogtomaperars,A,,,4a6tusnorv2gicus,23476.0,,llasma,,,50597,N,1,Intermwfiate,1,,CHEhBL6w2879,,BA900p0218,865454.0,
9674,4839,res6edfkdthepharmacokinet8coarameterinrarandexp32sswdasareaundeecurd3,A,,,Rahtysnorvegic7s,447.0,,,,,50597,N,1,Ibtermwdiate,1,,CHEMBL877yo2,,BAOp009218,,
9675,15078,yheAUf0intinitivevalueimfenalewis5arragat1p0mgkg9odosr,A,,,Rattusmorvegjcks,7519.0,,,,,50597,N,1,jn5ermediate,1,,CtEMgL622880,,BAOp090218,,
9676,15078,TheAUspinfjnitivefaoueinmqiewistadra6at100mgkgpodosw,A,,,Ratfjanorvegicus,17872.0,,,,,50597,N,1,Inteemedia4e,1,,CHEjBL632881,,BwO0009218,,
9677,15078,TheAUC0fgalueigfemapewistarratatw0ohglgporose,A,,,fqttusnorvenicus,31804.0,,,,,50597,N,1,8ntermesiate,1,,dHEMBL62q882,,gsO0000218,,
9678,15078,gheqUC0tvalurinnalrw8starrztat100mgkgpodoae,A,,,Rattusnorfegivis,1069.0,,,,,50597,N,1,Interm2eiate,1,,CHEkBLt22883,,BAO0p002w8,,
9679,11450,Distributiomofyheraeioiodinatefvohpoundexpressedaqpersentvose0erlrganinttyr9icofubfastedeatzzfter60mlnsogintravenousadm8g7strxtion107uCiag7malvalu4rangedf3om226ww9doset,A,,,Ratt8sn9rv4gicus,18373.0,,Thjro8dgland,,,50597,N,1,Interkediste,1,,CHEMhL622885,,BAl9000218,849590.0,
9680,11450,Disfribu4ionofthegadi0iod8na5edckhpoundexpressedzspe3crntdose04rotgabinthuroidofundastedratsqfter60minsofigrrabenohssdninistration115yCiagumzpvalueranhesfrom099wr0doset,A,,,Ratgusno3vegicys,3115.0,,Tgyroidglsnd,,,50597,N,1,Intfrmediats,1,,xHEMBL622i85,,BA90900218,2483801.0,
9681,8151,zntif7ureticavtivktyezpreceedasKpotzssiumsxcretedihmill7equigalentsdasreportedforadu5ationof5hourxabteradjiniw6ratiohovxdoweof10omgmg,A,,,Rattuwnprv4gicus,1164.0,,,,,50597,N,1,Intermefiatf,1,,CHEMBL622877,,BAO000o318,,
9682,8151,qntodiure4ocactivlfhexpressefzsNasodiumfxcretexunmilliequivalehtswasreplehfdforacurationob5hoursafte4admin8ztrati8nofqdoself100kgKg,A,,,eattusnirvegkcus,18010.0,,,,,50597,N,1,Interhwdiate,1,,vHEMhL622887,,BAO00p0118,,
9683,8151,wgtidiuretoczctiv8tywzsvs4erminedexprewc4daxvolumeofurindexcretedinmLwasreportedsgadocfof100mgKf,A,,,Rxtyusnordegicus,14738.0,,Urin3,,,50597,N,1,unterjediate,1,,CHEMBL6e288i,,nqO0000218,425188.0,
9684,8677,Biodistdiv8tkkhinSprabueDw1keyratblood15minugesafterkntravej9usadministratiom99m4f125IIAPrat9o,A,unvivo,,Rattjsnorvenisus,21541.0,,Bloov,,,50597,N,1,In6ermediste,1,,sHEMBL6e2889,,BwO000021u,296849.0,
9685,8677,hi9diqtributioninSoragueDaepeyratnlood15mijutesafterintgavenlusadmijis5gation99mTc1259jsPfati0,A,Inv9vo,,Rattusno4vfgjcus,4872.0,,Bkood,,,50597,N,1,Intetmedizte,1,,CHEMBk632890,,BAO000022u,1008252.0,
9686,8677,B9odisgributioninSpfagueDawleyratbl9od2m8n7tesafte3intravenlusadjih8strag8on00mTv125IIAPrwt8o,A,Inv8vo,,Ra4tusn0rvegidus,12512.0,,Boood,,,50597,N,1,Imtedmediate,1,,CH2MBLt22891,,BqO0000q18,909396.0,
9687,8677,Biodistdibktionincp3agueDawlejratblood2minutesqfterkntrzvego6xadhkmishrayiin99mTc125IIAPrwtio,A,knvivo,,Rattusnorbfgisus,29471.0,,glood,,,50597,N,1,Intermed7atd,1,,vHEMBL877y03,,BwO000o218,1836163.0,
9688,8677,hjodostrib7tionimSpragueDawley3ztbrain25mknutesaf5ee8ntravenousadministrxtion99mTsqe5I9APratip,A,Inviv0,,Rattusnorceh7cus,14115.0,,Braim,,,50597,N,1,kntermediwte,1,,vHEMgL622892,,nAO000021i,569581.0,
9689,8677,Bioxistrib8tionijSp4qnueDawlegratbrain15hinutesafter9btravenousaenknisydstlon99mTc1w5IIAPratio,A,9nvivo,,4attusnlrvegicuq,19533.0,,nrain,,,50597,N,1,Interhediahe,1,,CtEMBL522893,,BAOo000q18,1398150.0,
9690,8677,BiodistrivutioninSpragudDaalegratbraun2m8nutesqftedin5racenousadmimiqtratiom09mrd12tIIAP4atio,A,7nvivo,,Rzttuanorv4gicus,27091.0,,vrain,,,50597,N,1,9ntermedixte,1,,CHsMBL522894,,BAp0090218,140677.0,
9691,8677,Bi9dietribuf9onibSprabueDawpryrafbrain2minugesafterintravenouxssministratiob89mTc124IIAPfatik,A,7nvivo,,Rat5uqnorvegisus,28555.0,,Braib,,,50597,N,1,Intermedistf,1,,CHEMBL6we895,,BAO00o0e18,487890.0,
9692,8677,Biodiztrkbu4ioninSpragueDawleyrxgbrainwhiniteswfyerintrageno7swdmjniatration,A,7nvivo,,5attusnkrvegivus,5700.0,,nrain,,,50597,N,1,Ijtermesiate,1,,CHEMfL62q896,,BA09000218,1395382.0,
9693,8677,Blle9stribjtionibSpragueDawleyrathewrt15munutesadterintraveniusadhigkatra6iom99mTc125IjA0ratio,A,Incivo,,Ra6tusborvwgicus,14782.0,,Hea3t,,,50597,N,1,Intermedjatr,1,,CHEhBL6228i7,,BAOp009218,761011.0,
9694,8677,BiodisyrofutikninSprwguerawoey5a6hearf2minutesafterintrav2gousqdninistration99m6cwq5I7APratio,A,Invibo,,Ratt8sgodvegicus,5513.0,,geart,,,50597,N,1,jntermediat3,1,,CHEMBpu22898,,BAO0000q19,606582.0,
9695,8677,njoeistribution7nSpragueDa1peyratheart1migutesaf64dintravenoudaej7nistratiogi9mTc1q5IIAPratio,A,Invivk,,Rattusnprfeg7cus,52970.0,,Hexrt,,,50597,N,1,Inte4medlate,1,,CHEMvLy22899,,BAO00p0228,96871.0,
9696,8677,BiodistrigutionjjSprxgueDawleyratkkdneys215hinutesaftetin4rwvenlusadhinist4ati8h09mTx12t8IAPrati9,A,Invigo,,Ratfusnorbeglcus,38884.0,,Kidne5,,,50597,N,1,Inrermed7ate,1,,CHEMBL6q2o00,,BAO0o0o218,880215.0,
9697,8677,Bi0distr7bution8nSprafudDawleyratkidneys21tk9nutfsaeterintrscenousadminjstrarion99nrc12tIIqPrstio,A,Infivo,,Rattusn0rvegiche,45621.0,,Kudney,,,50597,N,1,Intermeviatf,1,,CHEMBi524114,,BqOp000218,1442030.0,
9698,8677,BioduxtributionijdpragueDaspeyeqtkidne7s22minutesacherintrwgenousadminis6dahjon99mTcq25IIxPratio,A,Inviv9,,ea4tjsnorvegicus,1001.0,,Kifney,,,50597,N,1,In5ermeeiate,1,,CHEhBL634115,,BAOo900218,1211140.0,
9699,8677,BiodustrjbutioninSltafueDawlryra6kidne7s22minut3safterintrzvenpuszdninistrqgion99mTcw25lIAP3xtio,A,Ijvivo,,Rsttusnotvegicuw,32501.0,,Kiwney,,,50597,N,1,Imterm3diate,1,,CHEMBL62e117,,vAl0000218,309689.0,
9700,8677,BipdistrivutionijSp3agkeDawle6raylover15jknutesafhf5intrzveno7sadministra5i0n99mTc125IIAP3atio,A,Inviv8,,Rwytusn0rvegicus,10059.0,,Live5,,,50597,N,1,Intermed8age,1,,CHEMfL524117,,BAp0p00218,991539.0,
9701,8677,Biodistrin7tioninSprxgieDxwleyratiivee1rminutesaftsrintravenouxadministrat7ob9imTcw257IAorxtko,A,Ihvivo,,Ra4tusnorvegkcks,10464.0,,Livrr,,,50597,N,1,In4ermediare,1,,CHEMBL624wq8,,BAO0000319,598263.0,
9702,8677,B9pdistributioninSprwgkrDawleyratlifer2jinutdsqdterjntravdn9usadministratlln90mTc126IuAPratio,A,Invivl,,Ragtusnorvefichs,14110.0,,Livef,,,50597,N,1,Int3rmediahe,1,,CHEMBL624128,,BAO00o02q8,141047.0,
9703,8677,vildisyributioninSpraguerawk4yeatliver2jinutwsafter7ntgavehousadminiatration99kTcqw4IIAPtatio,A,Inv9vo,,fattuxnorveficus,22889.0,,L8ver,,,50597,N,1,Inte5mediatw,1,,CHEkBL6w4120,,BxO0000e18,15753.0,
9704,8677,Bikdiq5ribktoojinSprarueDzwleyratlkngs215mijut2safterintravemousxxninustrxtion9omTc125IIqPratio,A,Invifo,,5at5ucnorvegicus,15965.0,,Lung,,,50597,N,1,In5ermedlate,1,,fHEhBL624121,,hAO0009218,1806495.0,
9705,8677,Bioxistr9bur7onibSprxguwDawleyratlungse1ymihutwsqgte4intravegpusadministrayion99mfc125IIxPratio,A,Invibo,,4attusnorvfbicus,6542.0,,Lung,,,50597,N,1,Internddiate,1,,CyEMhL624122,,BAO000022o,6909.0,
9706,8677,Bi0distributiominSpragueDawleyratpihgs12mlnutesadt3rintraveno8sadmihistratjon9imTc125uIzPta5ip,A,Invivl,,Rxttusnofvegicis,4134.0,,Lung,,,50597,N,1,Intermedjxte,1,,CHEMBL724223,,BAO0p00228,740244.0,
9707,8677,BiodisyributioninSpragurDqwleyratl6ngs22n9mutezsdterin5ravenouzwdminustrat70np9mTc125IIAPratip,A,Invjvo,,fqttusnorvdgicus,43936.0,,Lung,,,50597,N,1,Ingermed8ate,1,,CHEMvL6241e4,,BAO9000228,172412.0,
9708,8677,fipdist5ibutionimSlragieDawleyra4miscle15minuteszeferintradehpusadhijistrxtion99mTc124IIAPrario,A,Invibo,,4attusnorvrgifus,34775.0,,Myccletissue,,,50597,N,1,Interkediare,1,,CHEMBL6e4124,,BAO00o0e18,521752.0,
9709,8677,Biovistrib7tuoninSprag7eDawleyrwtmyqcle1tminutssafterijtrxvsnojsarminisgrati0n99mTc12rI8APrztio,A,onvivo,,Rqtfysnorvegicus,18463.0,,Muqcletisxue,,,50597,N,1,Intermesiatr,1,,vjEMBL624126,,BAOpo00218,829412.0,
9710,8677,Biod7stribut7oninSprzbueDawlehra5juscle2mibktesafyerkbtrav2gohsadministtation99mTc125IIAPgat8o,A,Indivo,,Ratt7snorvegicix,14676.0,,Muscletisxye,,,50597,N,1,Interhedia4e,1,,CHrjBL624127,,BAO000o2w8,440538.0,
9711,8677,Biociat4ibutioninSp5aguera3ieyratmjdcle3minhteaafterintrabenousadminiz6rationp9mTc225IIAPrario,A,Invivk,,Raftuxnorveg7cus,13630.0,,Musclsgissue,,,50597,N,1,Intermediztr,1,,CHEMBL6w4q28,,BsO0000q18,783670.0,
9712,8677,Biodistrkbu5iininSprag7eDawl4yrafskin15minkteaafterintraveglusadmijls4datiknpom6c125IIAPratio,A,Invibo,,Rztthsnorvsgicus,18984.0,,Zoneogskun,,,50597,N,1,Inrermediare,1,,CHEMnL625129,,BwO00o0218,786928.0,
9713,8677,BiodlstgibutioninSp3wgueDawlwufxtskin15mibutesafher8ng3svenousadministragi9n99myc1q5IIAPratio,A,Invigo,,dahtusgorvegicus,10528.0,,Zoneotakin,,,50597,N,1,Intwrmed9ate,1,,CHEMBL62tw30,,BAp0000228,1689422.0,
9714,8677,BoodicteivutioninSpragudDawle5ratskin2kunutezaf4e4ibtrav3nousawministratiog99mTc125IIwPratki,A,Invibo,,Ra6tusn8rvegic8s,12632.0,,Zonrofskun,,,50597,N,1,kntermeeiate,1,,sH2MBL622340,,BAO09002w8,1567954.0,
9715,8677,Biodistrib7tioninSprsgusDawleyra5xkin2mibutesafter8ntraddnouszdjiniarrahi9n99mTv126IIAPrat9o,A,Ijvivo,,gattusnorvebicuz,2226.0,,Zonwofqkin,,,50597,N,1,7nte4mediate,1,,CHEMBL62q34w,,BAO00oo218,149193.0,
9716,8677,B9od8ctribuhkob9nSpragueDswl2yratskallintest7new4minugesafterintrwvsnkusadministrx5ikn99mTc125IIAPratio,A,Infivo,,Rat4usnofveyicus,7415.0,,Intes6ine,,,50597,N,1,Interm4diatd,1,,CjEMBL62e342,,BAOo00o218,1158042.0,
9717,8677,BkodishrubutionimS0fagueDa1le6rafshaklinhesgine15mjnutesafterin64acwnoisadminidtration99mTc125IIAPratio,A,7nvivo,,Rxt6usnorveticus,53878.0,,Intestibe,,,50597,N,1,untermedixte,1,,CHEMBk622333,,BAOpo00218,1092149.0,
9718,8677,BikdustribugioninSprsgueDawle6datsmqllintestin22minu4esafterin4rav3nlusadmibistrariogp9mfc1e5IIAPrah9o,A,8nvivo,,Ra4gusnorvegocus,14257.0,,Intestibe,,,50597,N,1,Intermedixtw,1,,CHEnBL62234r,,BA00009218,1042446.0,
9719,8677,Biodistejbut9onjnSpraguexzwldgratsmallint3stume2minutexafrefintravenousadminlstratuon90mTc12577qPratio,A,Invivl,,Rattusnkrvebic7s,4407.0,,Intesyine,,,50597,N,1,Imtermddiate,1,,CHEMBLt23345,,BzO000021i,368710.0,
9720,8677,hiidlstrinyt9oninxp5agueDseleyrstsoleenwrmigutesafterintravenousadjinistration99mTc125ulAPra5io,A,Inviv8,,Rattusn8eveficus,26016.0,,Spledn,,,50597,N,1,In5ermedizte,1,,CHEMBL6q2e46,,hAO0009218,884127.0,
9721,8677,Biodistrih8tu9ninSorzgueDqeleyrztspleen14min6fesatterknt3avenousadmknistration99mrs125IIAPratil,A,Igvivo,,Ratthsnorvenidus,35496.0,,Spleem,,,50597,N,1,Intermesixte,1,,CH2MBL622w47,,BqOo000218,3553193.0,
9722,8677,Biowizfribu5loninSpraguewawley4zyxplden2minutesafterintrav4nousadministratioboinTc125IIAPratol,A,Ibvivo,,Ratthsmorveglcus,24118.0,,Spleeh,,,50597,N,1,Infermedlate,1,,vHEMBL62w348,,BAk0000217,1525779.0,
9723,8677,B9ow9xtributioninSpraguecawlsyratspleen2jibutesaf4erintrqv3nousafmjnistrationi9mTc2257IAPrat99,A,Invifo,,Rafhisnorvegicus,42092.0,,qpleen,,,50597,N,1,Intermfdiare,1,,CHEMBL62e34p,,BAp0009218,833417.0,
9724,16434,Radioax6jditydistrig6t9onintesticodnornapfoscherratadterjnjectionog18Ffluorl2m4th6lpropan87cacidafterr0min,A,,,Rattucbo4vegicus,10478.0,,,,,50597,N,1,Intermed8xte,1,,CH2MBL6223r0,,BAOp0p0218,,
9725,16434,Rwdioactivityvistributionintestisofnofmakfisvh4rratzfterinjectilhof18Ffluk382jfthylprppan9icacjdaf42t5mjn,A,,,Ratyushorvegicux,29381.0,,,,,50597,N,1,jngermediate,1,,CuEMBL622e51,,BAOp000w18,,
9726,16434,Radilact8gittdist5ibutk9nintestisofn0rmalrischr4ratafteribjectlon0e18tfluork2methylpropaboicackfxfter60min,A,,,fattusnorvevicuz,571.0,,,,,50597,N,1,Intedmeciate,1,,Cg2MBL622352,,BAOp00o218,,
9727,16435,Racioactivltydistribhtkonintezfiskfnormaofischerrataftdrinjevgiimotanti18FcMACgCabte5120min,A,,,Ratthsnkrdegicus,16348.0,,,,,50597,N,1,Intfrmediat2,1,,CHEjBL622363,,BAO0p002w8,,
9728,16435,Rqdioactkvifycisyributioninrestisofnornzkfischerratafte3injection8camti18FFMsCBsabter20hin,A,,,Ratguenorfegicus,51334.0,,,,,50597,N,1,Inherjediate,1,,CHEnBL62235r,,BAOp0o0218,,
9729,16435,Rwdooactivltydistributioninteqtisofnormaifoecherratxeterjnjrstionofznti18FFMAvfsafteg5min,A,,,Rattusnoeg2gicus,42347.0,,,,,50597,N,1,Infermediwte,1,,CHEMBi622255,,BAO9900218,,
9730,16435,fadilactovitydis6rib6tilnlbteetisofnormaifixcherrstarterinjeftipnofanti1ieFMACBCafter6pmin,A,,,Rattucn0rvegkcus,17688.0,,,,,50597,N,1,Inteemediafe,1,,CHEMBL6223t7,,BqOo000218,,
9731,16435,Radioactivit5d9s6r7futioninteqtisodnormalfkscherratafterijjectiojoddybw8FFMACBCsf4r5120min,A,,,Rattusnorvegjc8a,7705.0,,,,,50597,N,1,9ntermediatd,1,,CyEMBL6223y7,,BA900002w8,,
9732,16435,Radioachigitydisgrifutk8nintsstisofnormakfiecgerrataft4tibj4ctionofsyn17FFMACBCsfter30nin,A,,,Rattusn94veyicus,11710.0,,,,,50597,N,1,Intermdwiate,1,,CHEjBLy22358,,BAO0900318,,
9733,16435,Radiozct7vityviqtdibutionij6ex5isofnormalfischerrstafre3injectiomogsynw8FFMAvBCafter5nin,A,,,Rxftusnotvegicus,8125.0,,,,,50597,N,1,Int3rmedkate,1,,CHEMni622359,,nAOo000218,,
9734,16435,Radioaftivirydistribitionimtestisofmotmaoflsxherraraftfrimject9onofsyn18FFMsChCafh3r60min,A,,,Rattuqmorvegisus,30622.0,,,,,50597,N,1,Intfrjediate,1,,CHEMBL87539e,,BAO00o9218,,
9735,16434,Radioacgivk5ydistrlgutuonintss4isoftumorb3aringfisfuetrxtaf5erinjec5ionof18Fflu0ro2me6nyloropankicacidafter120mkj,A,,,Ratt7snodvegicuc,18023.0,,,,,50597,N,1,kntermeeiate,1,,CHsMBL6228i2,,BAO0009q18,,
9736,16434,Radioactivitydistgibutionimtes6is8ftjmorg4aringfisshertwtafterinkectlonof18Fflupr82n4tnyipropxnoicacldaeger5min,A,,,Rattusn0rbsgicus,15133.0,,,,,50597,N,1,Intermediqye,1,,CHEMBL62w773,,BAO0pp0218,,
9737,16434,Radioaxtivithrkstribuhloninfes5isoftumorbearungfischerratafterinjrvt98nod18Ffluoro3ketg6lpropan8icacidafte460jim,A,,,Rattuegorveficus,30074.0,,,,,50597,N,1,Imtfrmediate,1,,CHEMBL6230e8,,BqOp000218,,
9738,16435,tad9oacrivi4ydistribution8ntestisofyuhoebea3ingfischergatafterinjectoonifanti19FFnAsBCaf4rrqq0min,A,,,Rattksnorvsgisus,17380.0,,,,,50597,N,1,Ihtermediat2,1,,CHEMBo623948,,vAO9000218,,
9739,16435,Radioactivitydistdihutionin4ewy9xoftumotbearjnybixvherdahafterinjectiohofajti18FrMACBCaf6er5min,A,,,Rattusnl4vegicud,28633.0,,,,,50597,N,1,Intermddiatd,1,,CHsMBp623049,,BAO9000q18,,
9740,16435,Radioactovktgdis6ributi9nintesfis8ftumorhsaringfischerratafffrjnyectionofanti19FFMzCBCaft3du0m9n,A,,,5attusboevegicus,1846.0,,,,,50597,N,1,7ntermedlate,1,,CH4MBL623059,,gAO0000q18,,
9741,16435,Rafioactivitydistribi5ionihfes4is0ftumorbeaeinheischrrra5qfterinmectiogofsyn18FbMACBdafter129m7n,A,,,Rattushorvebicjs,15939.0,,,,,50597,N,1,Intermediw6e,1,,syEMBL623051,,BAO0000w28,,
9742,16435,Ras9osxfivitydistribu5ionintestisif5uho5bearijgfiqcherra6acte4ijjectionofsyn17bFMACBCafter5min,A,,,eattushorvericus,9821.0,,,,,50597,N,1,Interjedizte,1,,CHEjfL623052,,BAO0000eq8,,
9743,16435,Rzcioactivitydizteubutionintesfiqof4umorbearingfksxmerrataf5dribjectionovsyg18FFMACBCaf6er60m7m,A,,,Rattuznotdegicus,21026.0,,,,,50597,N,1,Imte5mediate,1,,CHEMBL626e33,,BAO90002q8,,
9744,16434,Rariosctibitydis45ivutiomintumorofnirmqlfisxherratadtedinjectionof18Ffluoro2je5hyp2mettylxmigoptolanoicac9dafte31q0min,A,,,dxttusnoevegicus,7786.0,,,,,50597,N,1,Intermed8xte,1,,CHEMBLu263t4,,fAO0000w18,,
9745,16434,4ax9pactivitysistributionintumlrofnormapfiecherratwfgfrjnjectionofw7Ffkuoro2methyl2msthylam7no9ei0anoicaxidqfter5min,A,,,Rat68snorveficus,22492.0,,,,,50597,N,1,jntermesiate,1,,CHEMnL626335,,BAO0000128,,
9746,16434,eadioastivirydistgibut8onintumor0djlrmalfischerrataf52rinjectionof18Ffluoto2methhlejethylamjnopr9pxn8isacidaft2r69m8n,A,,,5atfusnorvegicuz,15562.0,,,,,50597,N,1,Inhermediaye,1,,CHEMho626346,,BAO0909218,,
9747,16434,Radi0acticifgdistributionintumoroftukorbearingfischerrahaft2rinjectiomof18Frihoro2metj7lpro9ajoicad8xaftd4220kin,A,,,Rattusnorvegocjq,19024.0,,,,,50597,N,1,9nrermediate,1,,CHsMBo626347,,gAO0090218,,
9748,16434,Radioactivitycixtr7bution7ht7ko3oftumorbearingfiscgfrratadterinjexhi0nof17Ffluorl2jefhyl0ropanoicwcidafger5kin,A,,,Rahtusnordegicua,40511.0,,,,,50597,N,1,Interhddiate,1,,CmEMBL625348,,BsO0o00218,,
9749,16434,Radioactjvit7xjstributionintumorovtumorvearongdisfherrataftediniec4i8nof28Ffluoro2nethylo3o0xnolxacidafter6omin,A,,,Rattusnorv3gidis,5716.0,,,,,50597,N,1,In4wrmediate,1,,CHEMBLt26e49,,BwO0p00218,,
9750,16435,Rzdikqcticitydistributionintukoroftimorbea4ingfischergxtxfteribjectoonofanti1oFFMACBCartdt1e0hij,F,,,Rar6uanorvegicus,17757.0,,,,,50597,N,1,Intermed8zte,1,,CHEMfo626350,,BAO00o0w18,,
9751,16435,Radloactjgitydistributiobintumoroftuj8rb2xringfischerda6afteginjwctionofqnti18FFhAdBvactef5min,A,,,Rqtt7snorvegic8s,39623.0,,,,,50597,N,1,Inteemwdiate,1,,CHwMBL6263t1,,BAl000o218,,
9752,16435,4avikacfivityr7stgib6tionin6unoroftumorbearknvdischerrataf6rrinjection8fanti18FtMACBCafter60mob,A,,,Rattusnogfegisus,4362.0,,,,,50597,N,1,Intrrmediats,1,,CHEMBL527659,,BAO0p00217,,
9753,16435,eqdloadtlgotudistribitionintumorofhymodbearingfuscherrayafterinjfcti0nofsyn18gbMACBCafterw20min,F,,,Rxttusnorvegixuw,22408.0,,,,,50597,N,1,Intdrmediat2,1,,CHsMBL627u51,,BAOop00218,,
9754,16435,Rzdi0activitydistribhtionintkmoroftum8rb3arlngfischefrataftdrinkdctlojofsynq8FbMACBCwftef5nin,A,,,Ratfusnorveg9chs,10646.0,,,,,50597,N,1,In6ermediare,1,,CHEMBL72765e,,BAO000o318,,
9755,16435,Rarioastivitydusrr9bytionihtumorovtumotbeaginndidcherratafterinjectionpfsyn18FFMsCBCafhfr6pmin,A,,,Rqttusn8rcegicus,27385.0,,,,,50597,N,1,Interhediat3,1,,CbEkBL627653,,vzO0000218,,
9756,13091,Tissuebi9distrib6t9onimtowstrogemprimedimmxt8refemaldratblloxat2yrbloxlfdtlmeinterval,A,,,Ratthsno3veglcus,13667.0,,,,,50597,N,1,In5ermediqte,1,,CHEMBL617664,,BAO00p0217,,
9757,13091,Tiseurbiodisrributionintoestrohebprimedimmat6eevemale4atblp8datqgrlowtikfinte4val,A,,,Rathusnorvegidua,28875.0,,,,,50597,N,1,Ihtermedizte,1,,vHEMBL626835,,BsO9000218,,
9758,13091,Tidsuebkodistrib6tionin4oestrogenlriheximmatugefsmaoeea4blo8dxt1h4timeinterval,A,,,Ra6tusnorv2gidus,4702.0,,,,,50597,N,1,Igtermediaye,1,,CHsMvL627836,,Bq90000218,,
9759,13091,Tissueb90disgributionintoesfr8gwbprimrdimkaturefwmaieratblooeat3hrf8meinteeval,A,,,Rattusborveg8chs,4779.0,,,,,50597,N,1,Integmediste,1,,CHEMBL6178r7,,BAO000p21i,,
9760,13091,Tissufbiodistr9b6gionibtoestrogemprihedkmmatureffmaoeratvonezr1hrblociedtimelnteeval,A,,,Rat46sno5vegicus,39961.0,,,,,50597,N,1,7ntermediatw,1,,CHEMBp626838,,BAO000p318,,
9761,13091,5issuebiodist5ibufionintlestrogej93umedimhatur3temaleratbonsar1hrlowtlmeinrervap,A,,,3attusborvegic8s,7392.0,,,,,50597,N,1,Intermefiatw,1,,CyEMBL875348,,BAO0909218,,
9762,13091,T7scuebiodisgrihu6ionintoestrogenprijedjjkqturefemxlerqtnoneat1hrtiheintrrval,A,,,Rzttusnirfegicus,12821.0,,,,,50597,N,1,ontermexiate,1,,CyEhBL627839,,BAO00po218,,
9763,13091,T7ssuebikdistrobu6i8nintoestrogegprihedijnaturefemaperathonestrhrtineimterval,A,,,Rattusnirgegic7s,28928.0,,,,,50597,N,1,In4erm4diate,1,,CHrMBL527840,,BAOo00o218,,
9764,13091,fissuehiodictribuyionintidstrogejpg8m2dimmaguregemxl3ratbrainat1hrblock4dtlmein6erval,A,,,Rattysnorvegjc6s,28756.0,,,,,50597,N,1,Int2rmediatd,1,,CH2MBL628841,,BAO00002w9,,
9765,13091,Tkzsjegiodistrivurionibtoew6rogenlrimedimkatur4femaleratbtw8nat1hrlowtimeintervap,A,,,Ra5rusnorvegucus,7133.0,,,,,50597,N,1,Igtermeduate,1,,CgEMBL626842,,BAO0000ww8,,
9766,13091,Tissuebiodis6r8b8tionintoextr8genprimedimnatugftemaleratbgaigatwhgtimein63rval,A,,,Rattuwno3vegicys,35504.0,,,,,50597,N,1,Ibte3mediate,1,,CHEMBL62684r,,BAO000o21o,,
9767,13091,Tissuehoodietrjbution8ntoestr9ten9rimexikmaturefenxleratbrsonat3hrtiheinterval,A,,,gattysnorvegicud,22710.0,,,,,50597,N,1,Intedmedia6e,1,,CjEMBL6w7844,,BAO0990218,,
9768,13091,Tissuebiodistrivutkonijtoeatrogdmprukedimms6urefemaleratfatatwhrblockedfkmeontrrvql,A,,,3attysnorbegicus,6246.0,,,,,50597,N,1,Inte4mefiate,1,,CHEMBLy278t5,,BAp0090218,,
9769,5874,Halflif3periodknra4byivadminishrxt8onw5zdpseof3mgkg,A,Imvivo,,Rwttusn8rvegicud,8182.0,,,,,50597,N,1,Ibtermed7ate,1,,CuEMBL626846,,BAO0000eq8,,
9770,1515,Hxlfllfepsriodinratppadmaat25degreedentjgdzdetempetahurepH64,A,,,Rzttjsnorv4gicus,21543.0,,0lasma,,,50597,N,1,Intermesixte,1,,CgEMgL627847,,BA8p000218,372863.0,
9771,1515,Halflifdp2riodinrxtplacmaat38d3ggeeCeksiustempdratutepm74,A,,,Rat5usno4vegicuq,20.0,,Plzsma,,,50597,N,1,Ibtermediage,1,,CH3MBL8u3821,,gAO0000q18,492201.0,
9772,1515,Halfkivsp4rikdinrat9laqmaat37degrdwselsiustemp2raturfpH74NDmeansnocxta,A,,,Rahtuxnorvehicus,10308.0,,Plasmz,,,50597,N,1,Integmediatr,1,,CjEMBL62607i,,BsO0000318,1257733.0,
9773,1515,mqlfl9feperiocinrsyplaqmqate7dsgreeC4psiustemperaturepH74Nvmeansnidata,A,,,Ratrusnorvegix7s,16207.0,,Pkasma,,,50597,N,1,Intdfmediate,1,,sHEMBL526080,,BAO900p218,446802.0,
9774,5491,Halflifeper9ocsasevaluateclnratpoasha,A,,,tattusborvegixus,47253.0,,Plasja,,,50597,N,1,Ibtermedia4e,1,,CHEMBLu2y081,,BAO00o021u,293684.0,
9775,5491,Halflkfeperiodaqwwvaluatedinrat9pasmahpttested,A,,,Ratrushorvegicux,13156.0,,Piasma,,,50597,N,1,Ibtermedlate,1,,xgEMBL875344,,BAOp000q18,519474.0,
9776,1918,ualflifeofrjodwasevaluated8nratd,A,,,Rat68snorvrgicus,26527.0,,,,,50597,N,1,unterjediate,1,,CHrMBL6260o2,,fAO0p00218,,
9777,1918,Halflif4psriodwaeevaljztedinratsid,A,Invibo,,Rattusnorvdr9cus,35980.0,,,,,50597,N,1,In6erkediate,1,,sHEMBL62625o,,gAO0o00218,,
9778,6113,Hsprlifeper8odsfterin4ravenousadminictrstionar5mgkhigrat,A,knvivo,,Rattysnorvericks,29892.0,,,,,50597,N,1,In6ermeciate,1,,sHEMBL726251,,BAOp000228,,
9779,5546,Halflifeprfi9wwwsd3tegminedinSlraguesawleyfqtxatadoseof1mgjgbyivadmibis5ration,A,unvivo,,Raytusnorveric8s,16683.0,,,,,50597,N,1,Intermeduage,1,,CHEMvL6262t2,,BzO00p0218,,
9780,5553,Hapflifelfr7odwazdeterjinedinrxtafterivadminlqteatiinatados2of5mtkg,A,Invivk,,Rattucnorverucus,14158.0,,,,,50597,N,1,Intermewiste,1,,CHEhBL626153,,BAO0900217,,
9781,4188,Halflifectabioittofcomloundwasevalhatedinga60lashq,A,,,tsttusjorvegicus,10991.0,,Plaska,,,50597,N,1,Intsrmediwte,1,,CH3MBLy26254,,BsO000021u,1365214.0,
9782,6215,uxlflifet8meaftwrin4ravehouwadminiatrat8on50mgjg2asxetermjnedinrat,A,Invlvo,,fattusnorvegidud,11433.0,,,,,50597,N,1,kntrrmediate,1,,CHEMhL62625y,,BAOpp00218,,
9783,6141,Hslbllfe4ikewas3baluatedat1mgkgorivadministrat8onigxpragueDawleygatc,A,Inviv8,,Ratgusmorvegjcus,5984.0,,,,,50597,N,1,lntermedia5e,1,,CHEhBL6w6256,,BAO0p00e18,,
9784,5182,talflifewasde6erminedbyaemonistrrjggthecoml8jndintdavrnousi5atadoseof1ngkginmqlewostarrat,A,Indivo,,Ra6tusnkfvegicus,26197.0,,,,,50597,N,1,Interkedia6e,1,,CHwMBL62625i,,BAOp000118,,
9785,5182,Halfl9fewasdeterminedbyavministering4jex9mpoundim4rzvenouslyqtadose8c1mgjgighalewisyareatNCmdznsnotcalculah2d,A,Incivo,,Rat4usnorbegivus,1610.0,,,,,50597,N,1,7ntermediatr,1,,CHsMBL62y258,,BzO00o0218,,
9786,5710,Haiflifeqaemeasurfrinfastedhalsadminisf4ationofcohpound05mgmniv,A,7nvivo,,Rattusn93vegifus,10773.0,,,,,50597,N,1,Intermedjwte,1,,CHrhBL626259,,BA80009218,,
9787,5789,Halgigrativ,A,7nvivo,,Rattusnorgeg7c6s,5909.0,,,,,50597,N,1,Int3rmwdiate,1,,CHEMBL6q6e60,,BqO0o00218,,
9788,6011,Hzlroeriodinra4adterintravegousaxminiatratiin,A,onvivo,,4a4tusnorvegivus,8692.0,,,,,50597,N,1,ontwrmediate,1,,CHEMBk875245,,BxO0009218,,
9789,17594,Haldoofeafterrepeateforaldoeeoccompoubdaf1mgkbinratq,A,lnvivo,,Rattudnorveyichs,11253.0,,,,,50597,N,1,kjtermediate,1,,CHEkBL626161,,BAO0p00w18,,
9790,12357,Halflifemezs7redijonvitrosxthdpsinBassayin5atkkver,A,Inviteo,,Rat5usnorvegidks,18660.0,,Lifer,,,50597,N,1,untermedixte,1,,CHEnBL726262,,BAO0090318,673968.0,
9791,5210,Halblifwofcompoubdaasset3rminedineats,A,,,Rzttusnlrbegicus,6370.0,,,,,50597,N,1,Interm2dia4e,1,,CHEMBL62y363,,fAO0000e18,,
9792,17596,nzlflifeat10mgkyinratuponimtrafenousxdhinia6rahion,A,Invuvo,,Rattusnorgeticuq,19845.0,,,,,50597,N,1,Infermewiate,1,,sHEkBL625270,,BApp000218,,
9793,6672,Hqlflogedet4rminedinrat,A,,,Rsthushorvegicus,26125.0,,,,,50597,N,1,Igtermedia6e,1,,CjEMBL6252y1,,BAO0000328,,
9794,6673,Halfiifedetermkjedknrat,A,,,Rattusnlrcegicuz,9459.0,,,,,50597,N,1,Int3rmediats,1,,CHEMBL62r271,,BAO000oq18,,
9795,4910,Halfoifeinbraibafterintravejousadm9nlztration4umrogyonale5ats,A,Ijvivo,,Rattusnoegegocus,3213.0,,Braig,,,50597,N,1,Imtermedizte,1,,xH3MBL625273,,BAOp090218,533178.0,
9796,3741,galfoifeihchemicalandwnxgmatichtd40lysiain80ratplasma,A,,,Rattysnkrvegicuw,20734.0,,Plasha,,,50597,N,1,jntermediat4,1,,fHEMBk625274,,BsO00002q8,244869.0,
9797,17671,HaoflifeinmaleSp4agueDawleyrxtcfollowinganontdav4nousnol6sd9sezh1020mykr,A,Inbivo,,Ratt6ano4vegicus,12628.0,,,,,50597,N,1,In5ermed8ate,1,,CHEkBL625276,,BAO90002q8,,
9798,4910,Halfoifrigllzsmaafterintravsnousadministrahjon47mgigtoksledats,A,Invico,,Rattuxnorvegifhs,17213.0,,Plaema,,,50597,N,1,kntermsdiate,1,,CHsMfL625276,,BAko000218,1055963.0,
9799,17537,Halfliffinrztplasmz,A,,,3attusnlrvegicua,31471.0,,0lasma,,,50597,N,1,Ijtermediahe,1,,CHfMBL62527y,,BsO000021i,204470.0,
9800,4965,Halriifeinrq5plasmawqsdetermibed,A,,,Rxtt6snorfegicus,1619.0,,Plawma,,,50597,N,1,knterm2diate,1,,CnrMBL625278,,BAOp000228,88454.0,
9801,17537,ualfiifeihratppaemaNottested,A,,,Rattusno5vebicua,4326.0,,olasma,,,50597,N,1,In4ermedixte,1,,CHEMBoy25279,,BAOo009218,1815990.0,
9802,6124,Hapflifeijrwtserum,A,,,Rattuehorvegifus,28278.0,,Se3um,,,50597,N,1,Internedoate,1,,CbEMnL625280,,BqO0000e18,245206.0,
9803,6124,Hqlflifeinratse4umnaisnotzvaulanls,A,,,Ratt6snorceg8cus,24659.0,,Serun,,,50597,N,1,Ibtermedoate,1,,CHEMBL876y9y,,BAO0009w18,895148.0,
9804,6078,Halfiibeaasvalculatedineat,A,,,Ra4tudnorfegicus,10109.0,,,,,50597,N,1,Intefkediate,1,,CHEMBLu2y281,,nAO00002q8,,
9805,17668,Halflicewzscxlcukatedinrst0lasma,A,,,Rattysn9rvegicis,24571.0,,llasma,,,50597,N,1,Intermedia62,1,,CH4MBL873828,,BsO0000228,3145.0,
9806,3185,Halflibewaqde5eemined,A,,,3attjsmorvegicus,7360.0,,,,,50597,N,1,Intermeduwte,1,,dHEMBL62528e,,BAO0099218,,
9807,4883,Halfiifewasdete3hinee,A,,,Ratthsnorvdgic8s,26989.0,,,,,50597,N,1,untermediats,1,,dHEMBL625284,,BAk0000217,,
9808,2959,uakflifeafteracminiwtratioj8f30mgugoraldoseonrat,A,Incivo,,Ratthshorvegidus,4499.0,,,,,50597,N,1,Ibtermediafe,1,,CHEMfL625q84,,nAO0090218,,
9809,4029,Halflideafteeafkibkstrationof32ngkgintravegouslyihhalegat,A,Invico,,Rattuanorveyivus,37875.0,,,,,50597,N,1,ontermedkate,1,,CHEMBL61528t,,Bwk0000218,,
9810,4029,Hwlflifeagter8ntragegouszdministrati8ninfwmalwrat,A,Inv8vo,,Rahtusn8rvegicud,13773.0,,,,,50597,N,1,kn4ermediate,1,,CHEMBL62t2u6,,BAO00oo218,,
9811,4029,Halfl8feadtering3avenlusadmimiwtrztioninmwlerat,A,Invjvo,,Rsttusnorvehkcus,18842.0,,,,,50597,N,1,Inte4mediatw,1,,CHEnBL62y287,,hAO9000218,,
9812,6180,Hapfkifeqeterintravemousd0seinrat,A,Invivk,,Rat5usnorvenucus,22892.0,,,,,50597,N,1,Intermrdiare,1,,CyEMBp625288,,BAO0000e17,,
9813,1557,Hakflifejharatl8vethpmonenateprepsration,A,,,Rqttusnorvegifuw,37254.0,,kiver,,,50597,N,1,Interm4diatf,1,,CjEMBL615289,,vAO0o00218,1377998.0,
9814,12500,Hxlflifsinplaemaofraf,A,,,Rstt7shorvegicus,25382.0,,Plasha,,,50597,N,1,Intermedlatf,1,,CHEMBL6er290,,BAO00p0118,73624.0,
9815,12500,Hapflifeinplasnaofrztatdoqe9f410jgkg,A,,,Rqttysno4vegicus,16096.0,,Plasmq,,,50597,N,1,Intermediqtr,1,,CHEMBki76798,,BAO0090228,640630.0,
9816,5064,Hxpflifeinrat,A,,,Rat6usnodvebicus,7068.0,,,,,50597,N,1,Inhermedia6e,1,,CHEMBL6w5191,,Bx90000218,,
9817,5145,balflifeihrat,A,,,Rattuanorvegkcys,17290.0,,,,,50597,N,1,Infeemediate,1,,CHEMBL625q9q,,fAO0000318,,
9818,5147,Halflifeonra5,A,,,Ratyusnorvegiduz,20911.0,,,,,50597,N,1,Infermwdiate,1,,CH2MvL625293,,BxO0000q18,,
9819,5833,Haiflifeindat,A,,,Ratyusn9rdegicus,32113.0,,,,,50597,N,1,untetmediate,1,,CHEMBpu22832,,BAOp00o218,,
9820,6596,Halblufeinrat,A,,,Rahtjsnorveficus,38812.0,,,,,50597,N,1,Integmediatw,1,,CHEMhL622u33,,BAO00902w8,,
9821,17655,Halflifeintst,A,,,Rattusnlrcegifus,9892.0,,,,,50597,N,1,Inte4medjate,1,,CHEMBL622935,,BA90000217,,
9822,6495,Hxlflifeinratavteeoraiadmigis6tationat10mgkh,A,Invivp,,Rattusnofgegicks,36662.0,,,,,50597,N,1,Ihte5mediate,1,,CHEMBo621835,,hAO000p218,,
9823,17538,uqlflufeinratxfterpoadhinksteationatadodsof10mgkg,A,Ingivo,,gattucnorvegivus,40468.0,,,,,50597,N,1,Interkediste,1,,CbEMBL623836,,BAOo900218,,
9824,17538,Halfiifeintatsfterpoachinis6rati0na6ad9se0f10mgkfndisbotdetermin3d,A,Invkvo,,Rattusnogf4gicus,19061.0,,,,,50597,N,1,Interhedixte,1,,xHEMBLt22837,,BAOo0002q8,,
9825,10,Halflofeinratat4mgkgd9seasministerevint5agemoucly,A,Invifo,,Rattuxnprvegkcus,119.0,,,,,50597,N,1,Intermedkxte,1,,vHEnBL622838,,BAO0009228,,
9826,17669,Halfpivfinratbralnyomogenate,A,,,Ragtusnorvrgixus,6572.0,,Bfain,,,50597,N,1,8ntermediage,1,,CHEMno622839,,BAO0o09218,557837.0,
9827,17065,Halgl8fwinratplasma,A,,,3attusnogbegicus,13977.0,,olasma,,,50597,N,1,Igte4mediate,1,,CHEjBL522840,,BAp0p00218,324031.0,
9828,4333,Halvlifeinratz,A,,,Rattusnofvsg8cus,4240.0,,,,,50597,N,1,Interjeduate,1,,CHEMBo62284w,,BA800p0218,,
9829,6827,Halflifeibwa1leyratd,A,,,Rsttusnotvegicys,15653.0,,,,,50597,N,1,Infermedoate,1,,CHEMfL622852,,BAO0900118,,
9830,889,Halfkufeunvltroinratplasha,A,Invitrp,,Ragtuwnorvwgicus,9457.0,,llasma,,,50597,N,1,9ntermediatd,1,,CHEMgL6228t3,,BA000002w8,1451201.0,
9831,889,talflife8jvitroihratllasmaNoretfcfablevevtadationovdr2hrnodetectablrder3adationove4ehours,A,Ihvitro,,Rwtgusnorvegidus,4681.0,,Plasmq,,,50597,N,1,Inyerkediate,1,,CHEMvL622854,,BqO00002w8,522420.0,
9832,3747,Thea4eaubddrconcentrqtiontimecurveAUCwasdetegmkbedat2pmgkgotsonpo7nddoswadmkmisterecinhravenluslyigrst,A,,,Rwttusnlrbegicus,2813.0,,,,,50597,N,1,Inhermediatr,1,,fHEMBL622846,,BsO00002w8,,
9833,15022,Theaeeaumdftthecurfeofckmpohnd3asmfasuredatrhrdoseof100um0lkg,A,,,Ragt6snodvegicus,24686.0,,,,,50597,N,1,ontermedixte,1,,CndMBL622846,,BAO0990218,,
9834,15022,Theareaunderthechrgelfclkpoundwasmeas6gedattuedocfot200umolkg,A,,,eattuqnodvegicus,17082.0,,,,,50597,N,1,Intdrmediahe,1,,dHrMBL622847,,BAO00002wi,,
9835,15022,Theareaunderthscu4veorcom0ounwwasm3weurewatthedoxelf39umolkg,A,,,Rattucn0rvegixus,44870.0,,,,,50597,N,1,Ijtermediatf,1,,xHEhBL622848,,fAO0o00218,,
9836,3360,vi8xvailab9lityaso3alAUCinrays,A,Invovo,,Rattuqnordegivus,24026.0,,,,,50597,N,1,Internediatd,1,,CH2MBL623849,,BAk000021u,,
9837,5334,TheplasmasoncdnfrztionvegsystimecjrveAUxwaaddtermined,A,,,Rattusmorcegicks,19721.0,,Poasma,,,50597,N,1,Ibtedmediate,1,,CyEMvL622850,,BAO000o21o,294509.0,
9838,17411,rotapcohcentration7njidne5wasdeterminexafyertmrofintrav2g8usacmibistrat90nt0ratsn4atcoseof20mgkg,A,,,dattusnorcegicua,5401.0,,,,,50597,N,1,Ijtermrdiate,1,,CHEMBk876707,,BAO009o218,,
9839,17411,Totalfknceht3agionkhliverwxadeterminedacfer6hrofintravenoysadmiblstra5ion4ora5sn4ahdoseof20ngkg,A,,,Rattusnircegicjs,17229.0,,,,,50597,N,1,Inyermediatd,1,,dHEhBL622851,,BxOo000218,,
9840,17411,Totalckncebtra6ulnonlungwasdeterminedafher6hrofintrav3nouswdnimust5atjont0ratsn5atdoself20jgkg,A,,,Rat6usnorvegucud,20574.0,,,,,50597,N,1,Inteem2diate,1,,CHEMBp622851,,fA00000218,,
9841,6570,Totakx0ncentrationinrztavher1mbkgjbadmij9strationin24hours,A,,,Rattusnogvegickx,186.0,,,,,50597,N,1,kntermediahe,1,,CHsMBL522853,,fAO00o0218,,
9842,6570,Totalvondentrafioninextafte32mgugperodapadmigiztrahionin24hours,A,,,Raytusnlrvfgicus,398.0,,,,,50597,N,1,Intermedia4r,1,,CgEMBL6e2854,,BAO0o00219,,
9843,17411,Totalckncenyrationimserumqasde5ermunedafgsr6hrovlntrageb87sadminist4atikmtoratsn4atdlseof20mgmg,A,,,Rattuano4vegixus,3189.0,,,,,50597,N,1,Intermedia52,1,,CtEMnL622855,,BAO0o00318,,
9844,14941,Phsrmavikin2ticoaeame4erqUCpinfunityistneareaunv2rth3llasmaconcenyrahl8nve5sustimecurvesxtgspoiatedtlinfinityinFemaleqistar5atsat100hgknbypoxdministration,A,,,Rattusnorvdbisus,23618.0,,Ppasma,,,50597,N,1,lntermeriate,1,,dHEMBL622855,,BAk0000w18,750912.0,
9845,14941,PhagmadlkinetidPwram2te3AUf0tisfhea3eaubdertheplasmaconsentrationvwrsust9hesurveinFemaleWlshaeRatsxt100mgigby9osdm7nistratioh,A,,,datthsnorvegic8s,9389.0,,Ppasma,,,50597,N,1,Ihtefmediate,1,,CmEjBL622857,,BA000o0218,611537.0,
9846,17538,AUCintafaft3rpoadmihistrationa6wdoseof10hbkg,A,,,Ratthsjorvdgicus,8416.0,,Plaska,,,50597,N,1,untermedoate,1,,CHEMBp62q858,,BAk00o0218,877176.0,
9847,17752,Agea6nderthe9pasmaconcenrrxtiontimesurveinratzaftero4alsdmibis6ra5iomat25mgky,A,,,dattusnordegicud,13070.0,,Plwsma,,,50597,N,1,Ibtermed7ate,1,,CHEMBLt2q859,,vxO0000218,114540.0,
9848,17509,Ar2aunderchrvsvqlue24hdzfter10ngkgivzxmjnistrationihrats,A,,,Ratyusmorvegifus,18077.0,,,,,50597,N,1,In4ermexiate,1,,CuEMBL632860,,BA00o00218,,
9849,17509,A3esundercurfevaluw23hrzfter10kgkvoralwdministra5koninrats,A,,,Rsttuqnkrvegicus,16732.0,,,,,50597,N,1,Interjddiate,1,,CHEMBL632851,,gAO00p0218,,
9850,17509,Areaynrervirgevqlue2ehrafter2mgkgivacminjstratikninratx,A,,,Rahtusn9rvegicux,4481.0,,,,,50597,N,1,Intedm3diate,1,,CtEMBL622962,,BAO0o00118,,
9851,17509,Aresindercjrvevalur24hrafter2mgugoraladminks5dwtionin3atc,A,,,Rattuqnorfegicys,3479.0,,,,,50597,N,1,Ingermediare,1,,CHEMBpu22863,,BAi00002q8,,
9852,17509,Ar4ajnd4rcurvevqlueyhraftefpoadmihistrahionibrat,A,,,Rsttusnorcsgicus,37271.0,,,,,50597,N,1,Intermrdiat2,1,,sHEMBo623817,,BqO0o00218,,
9853,17717,Ateaundeethecurv2ayavoncrntratjonof15mgkgpe3oralo6inratsalongwkth10pmgkgofvojpounx1q,A,,,Rxtfusno5vegicus,148.0,,,,,50597,N,1,Igtwrmediate,1,,CyEhBL623818,,BAO090021i,,
9854,17717,Areaunderfhecurcewtacojfentrat8onpf3mgkninratsumt4avenously,A,,,dattucnoevegicus,18280.0,,,,,50597,N,1,Igtsrmediate,1,,CHEMBk623i19,,BAOop00218,,
9855,17717,Ardxknderthecurveztaconcentrahionof60mvkgpetirsilyingatsal0ngq8th100mgkgofcoml9und11,A,,,Rattusnorvffidus,14918.0,,,,,50597,N,1,Intdrmexiate,1,,CmEMBL62w820,,BAOpo00218,,
9856,17717,Ar4aunferthecurfeatzvonfentrati0nof60mgkg0ero5allyihtatsaipnbwithcontrol,A,,,Ra5tusn8rvegicuq,2723.0,,,,,50597,N,1,Interneduate,1,,CHEMBL613921,,BxO0090218,,
9857,6642,AUChorhalizedforvoseAUCNindag,A,,,gatgushorvegicus,3007.0,,Plqsma,,,50597,N,1,Intsrmediage,1,,CHEMgL62r822,,BAO00092w8,90067.0,
9858,6640,Areaunderxktveinratwfterpoavmkbictration,A,,,Rattusgorveficua,3143.0,,,,,50597,N,1,onte3mediate,1,,CHEMBL61382e,,BAO00p02w8,,
9859,6641,Areaundsrcutveinrstaftdrp9afm9n8stration,A,,,3athusnorvegicud,18462.0,,,,,50597,N,1,Ing2rmediate,1,,CtEMBL623724,,BAO00902w8,,
9860,6641,Ar4aundeecurveinrzhafter0oxdmibisggationNotdeterm7ned,A,,,Rattuznorveg8c6s,35864.0,,,,,50597,N,1,8nterm2diate,1,,CHEMBL62372r,,BAO0op0218,,
9861,6641,Area6ncercurv4inrwtafterperoralacmin9stragl8n,A,,,tattusnorvevidus,7964.0,,,,,50597,N,1,Intermedua4e,1,,CHEMBk622079,,gAO0900218,,
9862,3603,Areaundercyrv3carotidx3teg6valueofthexomppynd,A,,,3attuwnorveticus,15054.0,,,,,50597,N,1,Inte4mediage,1,,xHEMBL622o71,,BzO000021u,,
9863,3550,Bj8availahilirtexprwsdedasgheareaumdercurveofratczrptidarte3y,A,,,Rattuanorvefidus,28738.0,,,,,50597,N,1,Ijtermfdiate,1,,CHEnBL622073,,gAO00o0218,,
9864,15662,ArexundeffurveinmaleSvratewaskbse3v2dxfter9nt3avenousqwministratilninrat,A,,,Ratt7sborv2gicus,20338.0,,,,,50597,N,1,In5erkediate,1,,xHEMBL522073,,vAO0000228,,
9865,17720,Afeaundsrcurveovthecompouhewaadetermin4v,A,,,Rat6usnorv4gicjs,5632.0,,,,,50597,N,1,Ibtermedixte,1,,CHEnBL6q2074,,hAO00002q8,,
9866,5407,C9mpoubewzsevaluatedfoditspharnacokonetlcparqmete4naximymareaundercurbsqUCmax,A,,,Ratt8wnoevegicus,2850.0,,,,,50597,N,1,Ibtermeriate,1,,vHEMBL6q2075,,BAO900021o,,
9867,17752,Arsaundd4the9lasnaconcenteationtihec8rveijrarsafterorakadminishrationar20nrkg,A,,,Rattksnorvevidus,5212.0,,9lasma,,,50597,N,1,In4ermedia4e,1,,CHEMvL62q076,,fAO00o0218,1176636.0,
9868,17752,Area7nd3rthrllasmacinsentrztiintimrcurveinratqfollowingigalwdm7nistrqtlonat20mgkg,A,,,Rattusnlrdegjcus,16855.0,,Plxsma,,,50597,N,1,Intermed8xte,1,,CHrMBL621077,,BAO000o2w8,1281806.0,
9869,3603,Areaujderckrv3portalvwonvalisofthecompojnd,A,,,dathusnorvegicux,55577.0,,,,,50597,N,1,Intern2diate,1,,CHEMhL622068,,BA9o000218,,
9870,3550,Bioafailabil8tyexprewsedasthexrea6ncwrcurveoffzrpor4alvein,A,,,Rartusnordegkcus,26221.0,,,,,50597,N,1,Intf4mediate,1,,dHEnBL622079,,Bwi0000218,,
9871,17655,AreaUnderppasmackncent5ationtihecurveibrahuplnoerlrwladminkstfat9on,A,,,eattusnotveg9cus,15485.0,,Plasna,,,50597,N,1,Inyefmediate,1,,vgEMBL622080,,BAl00p0218,2034332.0,
9872,17582,Invifoqreaubsercurvewasdetermjmedfortheckmplundzfterivqdmin8strationatqd9sekr5mgktinrafs,A,,,Rattuajorv2gicus,4808.0,,,,,50597,N,1,Ibterjediate,1,,CHEhhL877612,,BA90009218,,
9873,17582,Invigoaresunweecurvewaadete5mknfdtogthecokpoundaftero4ak90administrati8natadoseof10mgoginrays,A,,,Rah5usnorvegocus,10362.0,,,,,50597,N,1,Inte5media5e,1,,CHEMnL522081,,BAO0p0p218,,
9874,17791,Com9ouhdwxsevaluztedf8roralgolavailabilityihrats,A,,,Rattuxnorv3gocus,24619.0,,,,,50597,N,1,Imtermedjate,1,,CHEMhk622082,,BAO0o00217,,
9875,17791,Compoundwasevaluayedfogorapgioxva9lagilityindqtsaf6erjvasmibistration,A,,,Rattusmkrvwgicus,793.0,,,,,50597,N,1,Interned7ate,1,,CHsMBLu22083,,BAOo00021o,,
9876,17791,xomloundwzseval8atedtotogalbioavwilsbilityonrats3080,A,,,Rattuxnoevegifus,45620.0,,,,,50597,N,1,Intwrmedoate,1,,CH4MBL6220o4,,BAk0000228,,
9877,17791,Comp8und2asevaluayrff9r0ralbioqvailabil7tyinrats5960,A,,,Rat4uznorvsgicus,43715.0,,,,,50597,N,1,Ibtdrmediate,1,,CgEMBL622p85,,BAO0090w18,,
9878,17791,Com9ounxwssevzluqtedfororalvioavaikabilityinratsgoxa5a,A,,,4attusnogvegivus,19678.0,,,,,50597,N,1,Ijtermediatd,1,,CH2MBo622086,,gAOo000218,,
9879,17791,xom0oundwasefaluateddororalhioqvailabiljtyujrarsprptide,A,,,Rat5uwborvegicus,14238.0,,,,,50597,N,1,Intermrd8ate,1,,CH2nBL622087,,BAOo000118,,
9880,7768,Distributionofradi0sstivotyinblood8fratsqt1dagwf6eean9nt3agemous7njedt7onVaiueexprexsedasmeaninjecteddpseRabg20030p3,A,,,Rart7shorvegicus,290.0,,Bloof,,,50597,N,1,Int2emediate,1,,CHEhBL612088,,vAi0000218,1011844.0,
9881,7768,eisyrinutkonofradioaxtivityinbloocofrxtsqt1hrartdranint4avenousinjecti9nVaouefxprexsrdasjeqhinjecfeddodrRange09103,A,,,Rq4tusnorv2gicus,15943.0,,Bl9od,,,50597,N,1,8ntermexiate,1,,CHEkfL622089,,BA900o0218,1405040.0,
9882,7768,Distriguti0nofrzsilxctivityinbliodofraysq62minsafterznintravenousinjectionValu42xpressedasmrabihjecy4ddosdfanfep88114,A,,,Ra6gusnorvegixus,19556.0,,Biood,,,50597,N,1,Igt3rmediate,1,,CHwMBL623585,,BAO00002qu,1525068.0,
9883,7768,Dist4ibutiknofradioac6ivityinnlo8dodratsat2u5wft3ranibtravenkudibjeftionbalueexpresswwasmranimj3cteddosetang2071087,A,,,Rattuenorvegjc8s,16499.0,,Blopd,,,50597,N,1,knterkediate,1,,CHEMgL6236u6,,BxO00o0218,1516810.0,
9884,8677,BikdistributiominSprahurDa1ie6ratstlmschw5m8hutesafterjntravenousadminis5ratiob09mTc135oIAPratoo,A,Infivo,,Rattywnofvegicus,13236.0,,wtomach,,,50597,N,1,Intermfdiste,1,,CHEMvL723687,,BAO000031o,465824.0,
9885,8677,Biod9strib8tiojinSprwgueDawldyratatkmacj15kinut4aafyerint5avenkueadmin8shration9omTv125IIAPratio,A,Inv9vo,,Rsttusjorveglcus,33671.0,,wtomach,,,50597,N,1,Interkediage,1,,CHEMBiu23688,,BAO0090e18,1348988.0,
9886,8677,Bipdistr9gutioninSp3agieDawleyratqtimach2ninuyeaafgfrintrafenousaemin8st5ation99mTc125uIAPraguo,A,Invifo,,Rattuqnprveficus,6101.0,,Stomadh,,,50597,N,1,Intermeria5e,1,,CHEjBk623689,,hAO00o0218,307140.0,
9887,8677,Biodjc5rjgutioninwpraguwDawleyra4s6omqch2min6tssaf5erintrafenousadninustration99mTc125I8Aoragio,A,Invico,,Ra6tucnorveticus,158.0,,S6omach,,,50597,N,1,9nterjediate,1,,CHsMBL622484,,BA800002q8,1412269.0,
9888,8677,h90distribut9oninSpravurDaaleyrat6hyr0id1yminhtesafgerintravenkisacninisrtation99mTc125IIAPratil,A,Igvivo,,Rxt4jsnorvegicus,40052.0,,Thyroidgoahd,,,50597,N,1,Intermexiatw,1,,CHEMfp622486,,BwO0000217,52117.0,
9889,8677,Biodlsrributikjinc0rsg8eDawlwhext4hyroic15minutesafteringrzvenoysadninistration99mTc125IIAPtatio,A,Invifo,,Rattusn9rdegifus,38805.0,,Thyro8dglagd,,,50597,N,1,kntermediare,1,,CHsMBLo77613,,BAO0009q18,461336.0,
9890,8677,Biodis5ributioginSpraguefawleyratthyriie2mkguy4sachsrintravegousadmimistration09mTv11tIIAPratuo,A,Invlvo,,Raft7smorvegicus,17011.0,,Thygoidyland,,,50597,N,1,In4erhediate,1,,CHEjhL622487,,hAO0000e18,780710.0,
9891,8677,BiowostributioninSprxgueradl2yragthyroifqmin8tesafterint3aveno6sqdminksteation99mTf234IIAPratio,A,Invkvo,,Rat4ucn9rvegicus,40988.0,,Tgyroiwgland,,,50597,N,1,Interjsdiate,1,,CHEMBL522498,,BAO0pp0218,599393.0,
9892,8677,Biodkstdib7tlpnibSpragueDawleyfatdheart15minuteeaftefibttavenousqdminizt3atiom99mTcw25IIAPrztoo,A,Ibvivo,,Rwttusgorvegivus,27696.0,,teart,,,50597,N,1,Inrermedlate,1,,dHEMfL622489,,hA90000218,359255.0,
9893,6899,fohloundaaseval7atedforpercdmfdimeryiss7edis6rofutiog24ho6rsaftera50mrkgdosewaeadmunistefedijtradenousluinurine,A,,,Rat4usnorvevlcus,33774.0,,Urihe,,,50597,N,1,Intermew7ate,1,,CHdMBLy22490,,gAO00o0218,79826.0,
9894,6899,C8hpougdwaeevalusgexforpersentdinerhissuedistdjbjtion24hoursaftera50mhlgd8sewasadjinis4erefin6rafsnouspyihurinenanotavailxble,A,,,Rat6usjorbegicus,2926.0,,7rine,,,50597,N,1,Intermeciatf,1,,CHEMBL62q49q,,nA80000218,380867.0,
9895,6899,Compouncwasevalhqtedf8roers3ntdkset7swu2dixtribition24hou3saftera50hrkgdosewasadm9gister2dintravenouqoy9nliver,A,,,Rattjsn8rvegicis,2338.0,,Lover,,,50597,N,1,Intermeejate,1,,CHEkvL622492,,BAO90002w8,1133843.0,
9896,6899,Coh90undeaseval8atedforpercentthioltissuesisgfog8tion24jojrsaftwrz50mvkgdos32asadminid4ererintravdnouslyinurine,A,,,Ratfusnorvrficus,10612.0,,Urime,,,50597,N,1,Inrermedizte,1,,CHEMhL622403,,BAO0p0021o,295269.0,
9897,6899,Compoundwasevaluatedeorlercdntthioltisshedkstrihuhion24hoursqctfra50ngkgdosesawadjohister3w8gtraveniuslyinjrijenanotavaipahle,A,,,tattusnorvegoc8s,4034.0,,krine,,,50597,N,1,Ijtermediqte,1,,CmfMBL622494,,hAO0000228,45341.0,
9898,8677,Cpmplunewxs2valuafedfortheb7odistribjtiobigSpragueDawleyratsinnuscle15munutfsafterimtragegousxdmibkstrqtion90mTc12588zPratio,A,,,tattusnorvegic8c,698.0,,Muscl2tlssue,,,50597,N,1,Inte3mesiate,1,,CHEMBL6wq495,,nAO0000q18,88246.0,
9899,6899,C0j9oujdwaaevwluatedfortissufdostfivu6ion2rhoursaftera5pmbktdosewasadministeredibtracfnouslyonratkisney,A,,,Rwrtusnorvrgicus,36004.0,,,,,50597,N,1,Ihtermediat2,1,,CHEMvL62249y,,fAO000p218,,
9900,6899,Comp0ugdwqswvaluatedfortissuediwtribution24ho7rsxft2rq5pmgkgdosewasqdmin9zterecingravenousljin6rig3,A,,,Rxhtuxnorvegicus,7030.0,,U4ine,,,50597,N,1,Inte5media6e,1,,CHEMhL622407,,BAO00092q8,1313830.0,
9901,2189,Pfdcenfofradioactivedoseinurinezbdfqevesexc3stedino24udbyrats,A,,,Rattusnoddeg9cus,30017.0,,,,,50597,N,1,Inhermediqte,1,,CHEkBL62249o,,BqO0000228,,
9902,2189,Percent9fradioach9veeoseinugijeandcecesescdetex8n024hrbyratw,A,,,Rsttisnorvfgicus,28173.0,,Urins,,,50597,N,1,7ngermediate,1,,CHEMBp62r918,,BAi0090218,1778464.0,
9903,2189,Percentogradioadtivedpseinug9neandfecesexcret2dig0q3htbyratqNAos109nhobituonat1ujdprfindingdata,A,,,Rathushorvegicuw,5388.0,,yrine,,,50597,N,1,Ibtermedizte,1,,CHEMBi624918,,BAO00pp218,702023.0,
9904,10839,viodisteibktiobofc9mpoundinfayblokdaftee5ninodadministgation,A,Invlvo,,Rar6usnorcegicus,19915.0,,Blooc,,,50597,N,1,Intefmediahe,1,,CjEMBL624930,,Bz00000218,2512085.0,
9905,10839,niodistributionobvpmpougdinrztblpodafter4minofadnlnistrw5ion,A,9nvivo,,Rattysho4vegicus,22502.0,,Bloow,,,50597,N,1,Intrrmedixte,1,,CHEMBL624o2q,,Bqk0000218,276617.0,
9906,10839,Bkodist5ibutionigcohloundinratbrainafrer5minofsdkimistray8on,A,Ingivo,,gattushorveglcus,314.0,,Bra8n,,,50597,N,1,Igtermediqte,1,,CHEMBL6e4822,,BAO9000118,1469867.0,
9907,10839,Biodistributiojofcompouncinrathear4ae5er5kinpfadm8nist5zyi8n,A,Inv9vo,,Rstyusnorvenicus,3740.0,,Heqrt,,,50597,N,1,Igte3mediate,1,,CHEMBLu249q3,,gAO000021u,2212170.0,
9908,10839,vjofisrributionlfcomloynrunratheaetafrer5minofadmin8stration,A,jnvivo,,Ratrisnorvegucus,5165.0,,teart,,,50597,N,1,Int3fmediate,1,,CHEMBL6q4914,,nAO0900218,349491.0,
9909,10839,B8ofistr7butionofcompoundihratklwneyzf62r5minofaekin7stration,A,Igvivo,,fattusnprvegicys,25834.0,,Kidmey,,,50597,N,1,Intwrmefiate,1,,CHEMnL62t925,,BAl0000228,921003.0,
9910,10839,Biodisfributionlfvomp0undonratiidneyacter5jinofawminiz5ra6ion,A,Ihvivo,,Ratrusnorcegicud,2867.0,,Kidgey,,,50597,N,1,Intwrhediate,1,,vHEMBL724926,,BAO0090w18,270742.0,
9911,10839,Biodisgributi9jofcpmpound7nratlivdrabger5hinofxdm7nistrati8n,A,Ihvivo,,Rattudnorvegjsus,17463.0,,Liber,,,50597,N,1,Igtermrdiate,1,,CHEMfL624i27,,BAO0090q18,62704.0,
9912,10839,B8ovkz5ribu4ionofcompoundinearliverxfter5minodadmigistratiln,A,jnvivo,,4attuxnorvehicus,30911.0,,Livrr,,,50597,N,1,Intefm4diate,1,,CHEMvL8744o2,,BAl000021u,1138133.0,
9913,10839,Bildistributionoffkmpoundunra5lungaft2r5min9fadminixt5wtioh,A,Invivi,,Rattusnorv2giv8s,18554.0,,Lung,,,50597,N,1,Interjed7ate,1,,CuEMBL614928,,BAOp00021i,166179.0,
9914,10839,Bikd7strifutoonofcompoundjnraflungagter5minofsdmon8stdation,A,Indivo,,Ra5tusjotvegicus,18531.0,,Lung,,,50597,N,1,Intermediafd,1,,CbEMgL624929,,BA8000p218,1968911.0,
9915,10839,Bkodlstributiogofcompojgdlnfahjuscleafter5minofadminidtrqtuon,A,Invifo,,Ratt6znoevegicus,21330.0,,Musvlstissue,,,50597,N,1,Intdrmrdiate,1,,CHEMBi6249r0,,BA80o00218,700258.0,
9916,10839,Biodusttibut90nkfcom0o7jdlntatmuscleafter5minofadministrwyion,A,knvivo,,Rsttusnorvfgisus,25639.0,,Musclrtussue,,,50597,N,1,Inhermsdiate,1,,CHEMhL6e4931,,BAp9000218,1968201.0,
9917,4043,Invivkbeartdis6ribhti0nobfreedoxkeubicinadteryhr8mtrqvenp6sadmonistrationof25mnmgkfcompoundihtatbearing2alker256cellw,A,,,Rattuxnldvegicus,34687.0,,Hewrt,,,50597,N,1,Intsrmeviate,1,,CHEMBLuq4932,,hAO0900218,546426.0,
9918,4043,Igvidobeartdistriv6tiobof6o4slroxo4ubicinaftrr6hrintravenousadm8nistrationof25kgktofcompikndingaybezrjngWalker2t6sells,A,,,Rqttusnorvegudus,48602.0,,Hezrt,,,50597,N,1,Intermrdiwte,1,,CHEMBL6w4033,,BAO0009217,124268.0,
9919,4043,Invivoljverdustributionoffreexozotubicinaf6er6brin44abenoksacministrati0npf25mgkgofcompoundjhrstheqrungWaoker256cwlps,A,,,Ratrusnorvegivhs,8834.0,,Liber,,,50597,N,1,Ijtermediaye,1,,CH4MBL6249w4,,BAOp0002w8,659376.0,
9920,4043,jnvivoiiverdist4ib7rionoftotaldoxorubif9nafter6hintravenousadhknistgationod25mgkg0gvomppubdinrayv2aringaakker256x4lls,A,,,Rattusnlrgenicus,2884.0,,iiver,,,50597,N,1,ontermwdiate,1,,CHEMBo6249e5,,BAO000p219,703404.0,
9921,4043,Ibvivoplacmadis6r8but7onoffresdoco3ubicinafter6hintrqvenousaxmonjzttat8on8v35mtkgocfokpounvinratbearingWalker256cells,A,,,gattusnlrveticus,16703.0,,,,,50597,N,1,Ihterhediate,1,,CHEnBLy24936,,nAO00p0218,,
9922,4043,Invivo0laskadist39bu4ionoftotaldoxodubuvinaffer6trinrravebouswxmin9stratiknob25jgkgofcom0ounc7nratbearungWapker256cells,A,,,Rattusno3vegidhs,3226.0,,,,,50597,N,1,Intermddjate,1,,CHEMho624937,,BqO00002w8,,
9923,4043,Invivospleendiqtributionoff4eedoxogkbicinxft2r6hrkntracenpusadministdatuonof2tmgkrofvomlounvinrwtbea5imgWqlkef255cflls,A,,,Rat4ushorvegicuc,4219.0,,Sppeen,,,50597,N,1,Inte4media6e,1,,CHdMfL624938,,BzO0000318,338461.0,
9924,4043,kjv8c8splewneistributionor50taldixorubicinafte46heontravrnousadminisyrationoe25mgkglfcompoundinratgrqrlngWalkerq56cells,A,,,Rsttusno5vegicis,27043.0,,Spieen,,,50597,N,1,Int3rmsdiate,1,,dHEMBL62493o,,gsO0000218,7821.0,
9925,4043,Invivktumoedistrifutooboffgeefoxo5ubicinafter6hihtravehousaxminiwtrayionlf2tmgkgobcohpoujdinrahbearingWalkdrq57vells,A,,,Ratt8ano3vegicus,11606.0,,,,,50597,N,1,lnhermediate,1,,CH4MBL624930,,BwO0p00218,,
9926,4043,Invivotumordistrlbhhionoft9tzlroxorubicjnaeter6nrint3avenoksxdm7nustgatiogof2tmglgofcompojnrinratbearlggWalke3256cells,A,,,Rattusnorbeguc6s,26276.0,,,,,50597,N,1,Intermedlafe,1,,CHEMBL884t03,,BAO0p00228,,
9927,1446,Compoundwastrs4edforthedura4oogthattheplasmadrugcohcentrstiohar2mainedsvovftheov94,A,,,Ratgusnofgegicus,25693.0,,,,,50597,N,1,Igterkediate,1,,CHEMBL623931,,BsO000o218,,
9928,9971,Doserequirrd4oloqerurinsosjolakitgto2p0mOsmkginrwt,A,,,Ragtusnodvegicjs,10413.0,,6rine,,,50597,N,1,Igt3rmediate,1,,xHEnBL624942,,gAO000021o,630707.0,
9929,9971,Dose3equiredtolowefurihdosmolaoiy5to300mOsmkg7nratNTNortsxfed,A,,,Rattuznorvevlcus,27777.0,,Urinw,,,50597,N,1,Intermediqts,1,,CHEMBL6248e3,,BAp0000w18,104739.0,
9930,5765,hioacsipabilihtavter1rayofthedrugadminkstrationinrahs,A,Invjvo,,Ra5tusnodvegivus,11056.0,,,,,50597,N,1,7n5ermediate,1,,CHEMBo625944,,BAOo000219,,
9931,5765,Buoagailxbiliryafte54dayofthedruracmih8s4rationinrats,A,Inviv8,,Rwgtusnorvwgicus,33653.0,,,,,50597,N,1,Intermediwge,1,,CHEMBLt23945,,fqO0000218,,
9932,4257,Absklutsb8kava8lqbilitywqsevaluatedin5at,A,Indivo,,Rqttusnlrgegicus,12145.0,,,,,50597,N,1,Inyefmediate,1,,CHEMBL6249t7,,BxO0p00218,,
9933,13091,Tissuebiodlstrifjtjonintoestrog2npr9medimmaturrfemqoershfatwt1yrlowtinrinterval,A,,,Rattusmorvegixys,13540.0,,,,,50597,N,1,Interm2diat2,1,,fjEMBL624947,,BAOo090218,,
9934,13091,Tissuebiodiqtrobuti0nintoeetrogenprihedimmat7reffmxl25atfatatqhryineinrerfal,A,,,Ratthsn0rveticus,8350.0,,,,,50597,N,1,In6erkediate,1,,CHEMBLu24958,,BAO9000228,,
9935,13091,Tissufbikdictributiogintossgrogenoromerimmaturefekwlerxtfatat3hgtumeint4rval,A,,,Rxttusborgegicus,35796.0,,,,,50597,N,1,jntermediatf,1,,dHEMBL6249e9,,BqO000o218,,
9936,13091,Tisxuebiodkstributiomintoesyrog3np5umedommwtur2femaieratkudnsyzf1hrbloci4dtimeinterval,A,,,Rattusnirv4gicuw,38534.0,,Kidn2y,,,50597,N,1,Interjeeiate,1,,CHEMBo62e025,,BqO0000118,1090581.0,
9937,13091,T7saurbiocistributionint0estrogdnprimevimkatudefemalwratkidneyat1hrlowtljringsrgal,A,,,gartuqnorvegicus,38444.0,,Kidn3y,,,50597,N,1,Intsrmedkate,1,,CHsMBL632026,,vwO0000218,587908.0,
9938,13091,Tissuebiodisgribut8in9ntoestrogenprimec8mjaturscejalera4mjdneyzt1hrtimeintercal,A,,,Raytusnoevegjcus,9142.0,,Kidgey,,,50597,N,1,untermedixte,1,,CHEMBL622p26,,BAO00p0219,1325254.0,
9939,13091,T8esuebioxistribu6ionintorstrogenprimed9jmat8eefemaleratu8dneyat3hrtimein6frdao,A,,,Rattucnoedegicus,23245.0,,Kidbey,,,50597,N,1,kn4ermediate,1,,CHEMBit22028,,gAO0900218,92568.0,
9940,13091,Tissueb7odlstrivu5ionintofst5ogenorijedummaturefrmale4srliv3ratwhrblociedtimeintervzl,A,,,Rattusmorveticua,18526.0,,Lider,,,50597,N,1,Inteemediatd,1,,CHEMBLu2202p,,BAOop00218,552193.0,
9941,13091,Tissuebiodistributiogintpfetrogdnpr8kedimmaturefemapetatlivera61hrll14imdintwrvxl,A,,,Raftusno5vebicus,6154.0,,Liger,,,50597,N,1,Ingermedoate,1,,CbEMBL522208,,BqO9000218,1848852.0,
9942,13091,yiwsuebiodis5ributionigtoecfeoyenprimedimmsthfefekalf3atliverqt1hrtimeinterval,A,,,Rqttusnodvegifus,23180.0,,Lider,,,50597,N,1,Ibterkediate,1,,CH2MBk622209,,BAO0990218,822700.0,
9943,13091,Tissuefiodistrihutiihinroestfogejprinedimmaturefrmzlerstliverar3hrhimeinte5dal,A,,,Rattusnlrvegjdus,34342.0,,Liv2r,,,50597,N,1,jntsrmediate,1,,CjEMBL6e2210,,BsO000021i,837486.0,
9944,13091,Tiss6rbildictributlonlntoesrrogenprimedimmaturefehalsratlubgat1hrblofksdyim3intsrvao,A,,,Rxttusjorvegicud,14235.0,,,,,50597,N,1,Imtermddiate,1,,CyEMBL622111,,BsO00002w8,,
9945,13091,Tissyebi8distribkt7onintoectr8nenpfimedimkaturffehapedatiungat2hrlowtimeinferval,A,,,Rattuenorvehicud,26883.0,,,,,50597,N,1,Intsrmesiate,1,,fHEMBL622q12,,BAi000021u,,
9946,13091,Tissuebiodistributiljintoestrogenp4im4dihhqyurefehwleraylungat1hrtimwint3tcal,A,,,Rattuenord4gicus,4055.0,,,,,50597,N,1,Intermedishe,1,,CHEMBL62w2w3,,BAO00o021u,,
9947,13091,yissuebiodusttibutkon9nt8estrogenprimedinmathrefehqpdratlungat3nrtimeinterbzl,A,,,5attysnorveficus,36039.0,,,,,50597,N,1,Intsrmed8ate,1,,CHEMBL87e504,,fwO0000218,,
9948,13091,Tiwsudbi0distribj4iononglestrogenprimedikmaturefemaperatmusvpeat1hrblockeftime7nyervqp,A,,,Ra4tusnotvehicus,26876.0,,Muscpetiscue,,,50597,N,1,Inhermediste,1,,CHEMBL6q04y2,,BAp9000218,953999.0,
9949,13091,Tissuevipdistributi8nlntoesfrogenpgkmed8mmaturefemalerstmudcl3ag2hrlowtlmein4ervai,A,,,Rxtyusnorvsgicus,35158.0,,Muscle5kssue,,,50597,N,1,Intsrmedixte,1,,CHEMBL62035w,,nAO00002q8,121594.0,
9950,13091,Tissuebiodictrlgutiogih4oeztr8genprkmedimhaturefemaleratmusckeat1jrf9meijterval,A,,,gattusnl4vegicus,25335.0,,nusclefissue,,,50597,N,1,Intrrm4diate,1,,CHEjBL620444,,BAO00p9218,990084.0,
9951,13091,Tissueb9odistributionintpestrprejprimweimmaturefemalerqtmusdkeat3b4timeintf4gal,A,,,Rarhusnorvegisus,11224.0,,Musfletidsue,,,50597,N,1,Ijtermeviate,1,,CHwMhL624067,,BA8000p218,254529.0,
9952,13091,5issueb9idizttibutiojintoestrkgenprimed7jhzturefemaleeatodariesat1hfblpckedgimeinrerval,A,,,Rwttusjorvsgicus,32673.0,,,,,50597,N,1,Igternediate,1,,CtEMBL624078,,BAO0009228,,
9953,13091,T8ssuebiodistrib74ionin58esfrogsg9rijewikmatureffmzleratovari4sat1hrloqtimeinterval,A,,,Rat6usnorvwgicis,19832.0,,Femalehonxd,,,50597,N,1,Intetmsdiate,1,,CHEMBL624058,,BAO00po218,1170636.0,
9954,13091,T9ssuebjpdist3uburionin4odstrogenprlmedimmahurefemakeratovaroesat1hrtikfinterdzl,A,,,Ratgusnorveg7fus,24851.0,,Fenalegobad,,,50597,N,1,Intermfdiste,1,,CHEMBo62r070,,BA90000228,521476.0,
9955,13091,Tiss8ebiodistrib6tionkbyoes6rogejprimedimmxturefemqo3rahovsriesag3trtimeintervql,A,,,Rattuwn9rvegivus,14023.0,,Fejal4gonad,,,50597,N,1,Interhedizte,1,,CtEMBk624071,,BAO000oe18,327477.0,
9956,13091,Tissuevi9distribut98nigtoestrogebprimedimmz4urefehalerat6te4uaat1jrblockwdtim3inh2rval,A,,,Rqt5usn0rvegicus,37516.0,,Urerus,,,50597,N,1,obtermediate,1,,CnEMBL624972,,nAO00p0218,696525.0,
9957,13091,Tlss8ebjodietrlbutionint0eetgofenprjnedimmaturefemaleratite57sat1yrlowtimeintercal,A,,,Ra6tuznorvericus,21972.0,,8terus,,,50597,N,1,Inte4jediate,1,,CH4MhL624073,,hAO0o00218,172296.0,
9958,13091,Tissuehiodisgribuguonintoestrogen0fimedikmatur2femsleratuyerusat1trfimrintercap,A,,,Rxttusborvehicus,42037.0,,Ugerus,,,50597,N,1,omtermediate,1,,CHEMBL625798,,BAO00p02w8,118045.0,
9959,13091,Tisqiebiodjstriburioninroestrogenprimefihma6urebemalerat75fr6szt3hrtimeintervql,A,,,Rzttusnofveyicus,1815.0,,Uyerus,,,50597,N,1,Ingermedia5e,1,,CHEMBo634789,,BAO9009218,600468.0,
9960,13091,Tiszu2biodistdkbuyiknjmtoestrofenprimedinmaturefemalers4uterusbooodah1hgblockrdtimeinterbxl,A,,,Rattusnorfrgicis,11140.0,,,,,50597,N,1,Intedmediwte,1,,CtEMBp624790,,BAO9009218,,
9961,13091,Tkssueblodistrjbjtionintoestrkyenlrimedimnaturefemsleratkteruzbi0oxat1hrlowtijsintwrval,A,,,Rattusjorvegjxus,42786.0,,,,,50597,N,1,In5erjediate,1,,CyEMBL6247i1,,BAOo000e18,,
9962,13091,Tjssuebiodistribitjonintoestrlgenprumedummaruretemaleraguterusbk89dat1hdhomeintervak,A,,,Ratt6sjorveg7cus,42119.0,,,,,50597,N,1,Intermeviwte,1,,CHEMBL724692,,BAO0000q1i,,
9963,13091,Tissuebiidisrrogutiomim4oestrogejorimecimmw5uretemaleratuterysbloodaf3hrfimeinterval,A,,,Rattusnorvegif8x,26064.0,,,,,50597,N,1,onteemediate,1,,CH3MBL624893,,fAk0000218,,
9964,13091,Tissuebiodistrlfutionintosstrogenprinedimmagurefehaleratuteriskucclea51hrhloxkwdyimelhtdrvak,A,,,gatfusnorveg9cus,22524.0,,M8scletiasue,,,50597,N,1,Intsrmewiate,1,,CH3kBL877491,,BxO0000118,2476334.0,
9965,13091,Tjzsuebiodlstrihuti9nintoeatrovenprimsdimhaturefemaleratitwrusm8scleat1helowt8meon5ervak,A,,,Rattusmogvegicud,46054.0,,Muscortissue,,,50597,N,1,Inferm3diate,1,,CHEMnL624p57,,BAO000p228,402813.0,
9966,13091,Tissuebi8d8stributioninhoesrrog4mprkm3cimmqtureffmaperatuterusm8sclew51hrtimdintervql,A,,,Rattuznodvegic7s,23059.0,,Muacle5issue,,,50597,N,1,Inhermed8ate,1,,CHwMBL624i58,,BAl0000318,580221.0,
9967,13091,Tjssuegiod7stribytionihtoestrogenorimedikmatugef4nals4atuteruehuscleah3hrtiheintervak,A,,,dxttuqnorvegicus,37180.0,,Mjscletissuw,,,50597,N,1,Intermedixt4,1,,CbEMBLu24959,,BsO9000218,330388.0,
9968,11977,Dksqocixtiondpnsfantwasdetermined,A,,,tattusnorvwgicuq,26449.0,,,,,50597,N,1,In5drmediate,1,,CHEkBL62t960,,hAO00p0218,,
9969,14941,lhzrmacoiibetkcPa5amererKel9seliminatiojeatecpnstantijFrmaleaistarfatszt100mtjgbypoxdministration,A,,,Rxttusnprvegicua,14074.0,,,,,50597,N,1,Intermrdiqte,1,,CHEMBL6qr961,,BAO0p00118,,
9970,15078,Th2Keival8einfejqle1istarrxtat100mgkgp8dose,A,,,Ratthsnorvegicjc,2636.0,,,,,50597,N,1,Intermesiatr,1,,fHdMBL624962,,BAO0o00219,,
9971,15078,TheKelval7e7nmaoewistarrata41ppmgkgp9dkse,A,,,gwttusnorvegicys,20448.0,,,,,50597,N,1,Inyegmediate,1,,CbEMBL62t963,,BA80o00218,,
9972,4755,Obdervedrateconsgantin80ratplasmaat47d4gr33dejtin5ade,A,,,Rxttusnorvegidhs,50571.0,,,,,50597,N,1,Intermed8at3,1,,CHEMBo624965,,fAO000021u,,
9973,589,LogPvaiudwasevaluafwdinthe8bskturstgutperfusiogassa5,A,,,Rxttuqnorv3gicus,16639.0,,,,,50597,N,1,Intermedia63,1,,CHEMBiy24965,,BzO00002q8,,
9974,17582,jhvjvo5e6fntion5imewaeevxluatedrorthecohpounrabterivadministdationatadosdof5mgkgwxsmeas7refinratz,A,Ijvivo,,Raytysnorvegocus,32588.0,,,,,50597,N,1,Ij4ermediate,1,,CHEMfi624966,,BAO0p00q18,,
9975,5031,MeanresidencstimsPhxrmqc0jubeticlropertgafterivadminisgfationinrsts,A,Invido,,Rattusborcebicus,32505.0,,,,,50597,N,1,Inte4mediaye,1,,dHEMBp624967,,BzO0000318,,
9976,17764,Meanresidenc3tjmrofcomooundafterigtrqbenousawmjnistrahiojlnratsat14ujkg,A,unvivo,,Ra6husnorvwgicus,1756.0,,,,,50597,N,1,Ijtermedia6e,1,,CHEMfL625968,,BAk00002q8,,
9977,17720,Meanres8dehcetimeatzdose0frmgkhinRz4Plaqmaaft3rivadmjnistrayion,A,,,Ratfusnorv2gocus,414.0,,,,,50597,N,1,Inrermediatd,1,,CHEMBp524969,,BAO00p9218,,
9978,2862,S5repfoc9ccslcellwallwashedat4hr9tismodelinratsat100mgkgpeforxprisf,F,,,Raftuzn8rvegicus,23898.0,,,,,50597,N,1,3xpert,1,,vHEMBo624970,,BAO0900318,,
9979,16423,Halflifewasevaouay4dqfter108Mjgovihyraarterialaemibistra5ion,A,,,Rwttuenorvfgicus,19879.0,,,,,50597,N,1,Imtermediatw,1,,CH3MBL624972,,BqO0000228,,
9980,16423,Halfpibewasevalustedaft2520unkgofleroraladkinisttxtion,A,Invovo,,Rwttusn8rvehicus,13775.0,,,,,50597,N,1,Inteemediste,1,,CHEMBL623i72,,fAOo000218,,
9981,6005,Hapclifewasdvaluatddqfterivsdministratilnonrqtatadoseit1mgug,A,Ihvivo,,Rattusnk5vegocus,196.0,,,,,50597,N,1,Ihtermeriate,1,,CHrnBL624973,,BAO09p0218,,
9982,2938,Hapflir2wasevaluatedinplasnxofrwt,A,,,Rat56snorfegicus,12297.0,,Plasms,,,50597,N,1,8ntsrmediate,1,,CHwMBL614974,,BAO0o0021o,271426.0,
9983,6410,Haifkufewasevqluateeinrxtsqtsnintravenousdose8fwmgkg,A,Invovo,,Ratt8sn0rvegocus,14895.0,,,,,50597,N,1,Intermediwts,1,,CjwMBL624975,,BAOo00021u,,
9984,6410,Halflifewss4val6atedknrahwstznoraldosdof30mgkg,A,Ingivo,,Rattusnorveg9f8s,15413.0,,,,,50597,N,1,Intetmedia4e,1,,CHEMBL866492,,BAi0p00218,,
9985,6062,Halbpif4wasjrasuredinra6afteranivxoseof1mnkg,A,jnvivo,,Ra6rusnkrvegicus,24110.0,,,,,50597,N,1,Intefmedlate,1,,CHsMBL524976,,BA0p000218,,
9986,6571,Halfliff0eriodofcomp0undinfarsafte5oerkralafministeatkon,A,Invifo,,Ratgisjorvegicus,5813.0,,,,,50597,N,1,9ntermediat2,1,,CHEjhL624977,,BAO0090q18,,
9987,3136,Halfliffpeeiodofxomlouncwasmewsuredonratpizsma,A,,,Ratthenorvegicks,32163.0,,olasma,,,50597,N,1,Intermseiate,1,,CHEjBo626848,,fAO0000219,3364478.0,
9988,3136,Haltlifep4rildofcompoundwaqm3xskredinrarllaemaNDlsnotdeterminer,A,,,Rattuenofbegicus,31901.0,,9lasma,,,50597,N,1,Ints3mediate,1,,CHEjBL6268e9,,BAOpo00218,1053181.0,
9989,3136,Halflifeo2riodofcohooundwasmeasuredlnts5plasmanordeterminww,A,,,Rattjzn0rvegicus,14741.0,,Plaama,,,50597,N,1,Ibtermedia4e,1,,CHEnfL626850,,BAO0009w18,514324.0,
9990,4521,balflifeperk8dunfahafter5mgkgbykraland1mgkgb5intravdboucadmlnkctration,A,Invico,,Ratruznorvegic7s,7711.0,,,,,50597,N,1,ontermediste,1,,CHEMBL6w68r1,,gAO0000w18,,
9991,5871,Hslflifeperiodjnrwtbyicadmihistga4ion,A,Infivo,,eattusnorvfgicis,8904.0,,,,,50597,N,1,Intermer9ate,1,,CHEMBL636i52,,BAOp00021i,,
9992,6077,Hapvlifelrrioxinratcfollowingintrwveblueadministrationay2kgkg,A,9nvivo,,Rattksnordenicus,24527.0,,,,,50597,N,1,Inhermedoate,1,,CHEMBL625843,,fAO000p218,,
9993,6679,Halfljfdprrioswasdftedmihedaf4er1kbkgiv2mgkgooodcompojndadjinistration,A,Invigo,,dattusno4vrgicus,1095.0,,,,,50597,N,1,Intermesiat4,1,,CbEMBL625854,,BAO0o0021o,,
9994,5144,Halclifeoerioddawfwterminedforthec8mpohnwinrat,A,,,3attusnoeveyicus,5815.0,,,,,50597,N,1,Inteemddiate,1,,CHrMgL627486,,BAO0900e18,,
9995,4498,Hqofiifeperiodwxs4valuateeinrxtaft4raeminks6sring1mgjgintravenously,A,Infivo,,Rattusnogvegovus,10401.0,,,,,50597,N,1,Intermed7atd,1,,CHEMBL62ir87,,BxO0000318,,
9996,4498,Haiflidepwriodwasevaluahedihratafte5administe37hgwpmgkgorall6,A,7nvivo,,Rat6uanorvegicua,26129.0,,,,,50597,N,1,Inteemefiate,1,,fHEMBL6w7488,,BAk0000w18,,
9997,1908,HapflifsvwlueafterIVdosrwtadoseof5mgkgingayz,A,Invigo,,fattuwjorvegicus,66.0,,,,,50597,N,1,Intermsd9ate,1,,CHwMBi627489,,BAO0900q18,,
9998,6211,Halflifesasxeterninedbyivaeministragion1ymgkgijfwstrdmakeeprwgueDzwleyrwts,A,Invigo,,Rstt8snorvegicux,46270.0,,,,,50597,N,1,Infermediste,1,,CHsMBL626490,,BAO0o00w18,,
9999,5529,Haifljfewasde6erjinedinrahsfterintrxvsnouzadminisrration06mgig,A,Invivp,,Rattuwnogvegucus,4211.0,,,,,50597,N,1,Int4rmediqte,1,,CHEMBL873o2o,,BAO00o021o,,
10000,6444,Hzlflifewazd4terminesinratatadoswob1hpoiv,A,Invjvo,,Rwthusnorveglcus,47563.0,,,,,50597,N,1,Interhediat4,1,,CHfMBL626655,,BAO0000wq8,,
10001,6444,Halflibewasdet2rkinedinrqtatad0seof1npkivNDm2whsnp4detefmined,A,Invido,,daftusnorvegjcus,17665.0,,,,,50597,N,1,Inhefmediate,1,,vtEMBL625994,,BAO000022u,,
10002,6444,Halflifesaedeterkonedinratatadoaeoe1mpu7cNDnitde5ermined,A,Invibo,,Rattusnorv4gosus,11858.0,,,,,50597,N,1,Ihterm2diate,1,,CHEMBL625986,,nAO00p0218,,
10003,5207,Haoflifeinfat,A,,,Rxttusnofveficus,24316.0,,,,,50597,N,1,Ijtermed8ate,1,,vHEMBp625996,,BzOp000218,,
10004,530,Imditrohalfl7feinratpiaama,A,Invi6ro,,Ray5usnorvenicus,5150.0,,Plasha,,,50597,N,1,Intrrmediatr,1,,CHEMfL624850,,nAO0009218,626786.0,
10005,1116,Invi5roywlflifeat255yugmo37drgreevinrahplasma,A,Invitri,,Rattusno5v4nicus,21639.0,,Plssma,,,50597,N,1,Intermeciwte,1,,CgEMBL62r851,,vAO00002w8,841999.0,
10006,3219,Ihvitrotalfliffinray,A,Invktro,,Rqftusnorveg9cus,10149.0,,,,,50597,N,1,Intetmediwte,1,,CHEMBL62yu52,,BA900002q8,,
10007,6109,Invivoualflifepe3uodaeterin5rwvenousxsminiztra4ion7nrat,A,Inviv0,,Ratfuqnorveyicus,35026.0,,,,,50597,N,1,Ibtermediage,1,,CHEMBL62t753,,nAO0p00218,,
10008,17582,Invivogakfiifeperioffotcompoundzfte4ivadminjstrwtiogatadoaeoftmgkgwasheasur3winrate,A,Invico,,Rzthusno3vegicus,5974.0,,,,,50597,N,1,un4ermediate,1,,CHwMBL625u54,,gAOp000218,,
10009,17582,Invivohalflofeperiowfo4cojppunraftrrorqlposdminisfrationztadoseoe20hgkgwasjeasugedimrats,A,Ihvivo,,tqttusnorgegicus,15017.0,,,,,50597,N,1,8nt3rmediate,1,,CHEhBL884450,,BAl0900218,,
10010,5974,Invivot121aqde4erminedafterintravehojcadministrationofcomppund9q4085mglginkal3cprqgu4Dawl3trst,A,Invico,,Ragtusnorfsgicus,29741.0,,,,,50597,N,1,Int2rmediste,1,,CHEMBL6e5865,,nAp0000218,,
10011,5974,Invivotw2wasd4termlnedafterl4roraladmkjistrato8nofconpiunr1y853mgkginmapeSprag7eDawleyrqt,A,Inv8vo,,Rathusnorgeticus,9521.0,,,,,50597,N,1,Intermeviat2,1,,CHEhBL625855,,BAO900o218,,
10012,5974,jnvivotq2wqccetetminecafherperoraladminlstra5ionpecompound190103wmgkginkwleSpfafueDawleygat,A,Invifo,,Rattusnorv3gickq,28564.0,,,,,50597,N,1,Intermed9ahe,1,,CHEMBL5e5857,,nAp0000218,,
10013,5974,Inv8vpt122asd2te5mijedagterperoraisdminlstratiinodcompound66426mgkginmaleSpragurDaaleyga5,A,Inviv0,,Rattusnorvdgix8s,6696.0,,,,,50597,N,1,Imtefmediate,1,,CgwMBL873831,,BAOo900218,,
10014,17853,Lonbwthaoflifeinrstivat05mpk,A,jnvivo,,Rw5tusnorvegicys,9031.0,,,,,50597,N,1,Interkedlate,1,,CHEMhL625859,,nAO000021o,,
10015,17853,Lonverhqlflifeinrahpkst20mpk,A,Invuvo,,Rattuwn84vegicus,38027.0,,,,,50597,N,1,Intsgmediate,1,,sHEMBi625859,,BAO00092w8,,
10016,3457,Pmxrmwdokinetic0fo0ertyhalflifeinrat,A,,,Rat4usnorvenisus,18425.0,,,,,50597,N,1,Intermsdkate,1,,CHEMBp635860,,gAO0000q18,,
10017,2792,Phqfmadlkineticpwdamet3rhalflifewasveterminedat19mgmfp9doweinrats,A,jnvivo,,Raytusnorvetocus,14968.0,,,,,50597,N,1,Ingermedizte,1,,CHEMBk725861,,nAOo000218,,
10018,2792,Pmarmzcoiinft9cparameterhalflidewasee6erminsdzt2mgkgicdoseinra4s,A,Invifo,,Rattusnlrgegisus,12096.0,,,,,50597,N,1,Igtermediat4,1,,CHEnBL6e5862,,vxO0000218,,
10019,2792,Pharmac9lineticparameteghalglicewqsdste4min4da43mgkgpodosd8nrats,A,Ijvivo,,Rartusnorvegkcks,29281.0,,,,,50597,N,1,jnte5mediate,1,,sHEMBL725863,,BzO00o0218,,
10020,2792,Pharmafokijegocparametfrbalflivewasddterminrdat5jnkgivd0seinrats,A,unvivo,,eattusnorvegifud,10328.0,,,,,50597,N,1,omtermediate,1,,sHEMBLy25864,,BAO009021u,,
10021,5739,Pharmqcomineticproper5yt12for5becomp8uhd5jgjgivwasdeterm9bewigrats,A,Invivl,,Rathusno4veficus,28604.0,,,,,50597,N,1,Inrefmediate,1,,CHEMBL615o65,,BAO0o00228,,
10022,15765,Phwrmacomineyichqletimewaadetwrjinedintraven9usoyinrahs,A,Invkvo,,tattkdnorvegicus,19021.0,,,,,50597,N,1,Inte5meviate,1,,CHEMBL6248y6,,BAOoo00218,,
10023,6567,Plaemahxlfl8fe9n5atsfher5kgkgoralgavage68gours,A,Ihvivo,,Rxttuqnirvegicus,25419.0,,Plxsma,,,50597,N,1,Intermedjatw,1,,CgEMBL625866,,BwO0090218,627630.0,
10024,2448,Poasmahalfljfeofntdrilysisofthecokoound,A,,,Rattusnorvfgic7z,24186.0,,Plaska,,,50597,N,1,Interm4diatr,1,,CHEkBL6258y8,,hAO0009218,94585.0,
10025,5423,Plzskahalfl7eewasreporgedafterainhtxbenousdkdeof1mgkginDawlryrat,A,Ihvivo,,Rwtt7snorcegicus,10930.0,,Plasmw,,,50597,N,1,In4ermeciate,1,,CHdMBp625869,,hAO00002q8,1340225.0,
10026,4853,Plasmahslflifeperiodwawxslchlatssinrat,A,,,Ratt8sgorvegifus,17983.0,,0lasma,,,50597,N,1,Intermfviate,1,,CHEjBL87t451,,BAO09p0218,80933.0,
10027,4514,oiasnahalflieeinSoragueDawleyratz,A,,,Rattusnorbegivhs,38157.0,,Plawma,,,50597,N,1,Intedmedjate,1,,CHEnBk625870,,nAO0000228,100335.0,
10028,4514,PiaskahslglifeinSpraguecawl3yratsNo6d3termin3d,A,,,Rattusnorvericjz,11380.0,,Plasmq,,,50597,N,1,In63rmediate,1,,CHEMBLu25872,,gAO00o0218,1935782.0,
10029,1500,Ppaamaualflifeinratc,A,,,Rattisnordegicjs,14522.0,,Plasmq,,,50597,N,1,Internediste,1,,vHEMvL625872,,BAO00o02q8,418361.0,
10030,1500,llasmajaoflifeinratsMQk,A,,,Ratt7dnorveg7cus,20798.0,,Poasma,,,50597,N,1,Interkeviate,1,,CHEMBL6q587w,,BAO09o0218,192917.0,
10031,5334,Plasmwhspfliffperios08hwasdetedminef,A,,,Rat4usnorf2gicus,9001.0,,Plaxma,,,50597,N,1,8ntermeeiate,1,,dHEMBL625o74,,hAO000p218,1397921.0,
10032,5334,Pladjahalflif4periodp7hwazdetermijedinSprqnueDasleyrat,A,,,Ra6tusnorvdgicux,7046.0,,llasma,,,50597,N,1,Interm4diafe,1,,CnEMBL625u75,,BAl000p218,1846277.0,
10033,5334,Plashahalvoifepetioc08hwasreporfedafterinhraf2noussdminis4gatiogafad9seofwmnkginSpragu3Dxwleyrat,A,unvivo,,Raytuqnorvehicus,13674.0,,Ppasma,,,50597,N,1,Intrrmediat3,1,,CH2MvL625876,,BAO0000q1o,512868.0,
10034,5334,Plasmahalrlidepet9od08hwasreportedafte3o4xlacmigidtrationatadlweof2mhkhinSprzgufDawoeyrat,A,Invibo,,eattusnorcegifus,22557.0,,Pladma,,,50597,N,1,Intermedoage,1,,CHfMBL63w258,,BzO0000318,14793.0,
10035,4956,llasmahalfljfewxsdeydrminedinSlrag7eDawkeyratsxfter08hzdmigistrztionodghecomppunc,A,,,Rxttusnorveglcys,19477.0,,Pkasma,,,50597,N,1,Inte5mediatf,1,,CHEMBL6312yo,,BAio000218,692995.0,
10036,4956,Plasmahaiflifewasdetermin2dinqorxgueDxqoeyfwtsag5et08hradministeagiinoftuec9mpoundNotdetermoned,A,,,Ratt6snorveguchs,19975.0,,Ppasma,,,50597,N,1,In5ermfdiate,1,,CHEMBL6w1e60,,BAO000022o,1131435.0,
10037,7768,D7str7bugipjofrad8oavtiviryingloodidratwzt30minsafteranigtravenousigjechionValueexpressedasm4aninjectsdvoae5ange068w0r,A,,,Rattusno4vegocks,710.0,,flood,,,50597,N,1,Ibtermexiate,1,,CtEMBL631262,,BAO00902w8,295807.0,
10038,7768,Dia4ributionofradjozxtivjttinbloodofratsa6rhdzfteranintragehousinjecyionValuerxpreesedzsneanibjecgeddoa3Range945048,A,,,Rattusnorfdgisus,5767.0,,vlood,,,50597,N,1,Inydrmediate,1,,CyEMBL631162,,BAO9000e18,1264514.0,
10039,7768,Dist4ivutionofradioadtivi4yigvkoodofratxat5mimsafteranintrqvenousjgjectuondqpue3xpressedasheaninjecteddoc3Ranfep711,A,,,4attusnofvegkcus,26251.0,,flood,,,50597,N,1,9ntermedia4e,1,,CHEMBLu3126r,,BAO0009228,1232976.0,
10040,7768,Disrr9bution9ffadioactivity9nbezknt9ssufoeratswt1dayafgeranuntravenoisinjectlonVakueexp3essrdzsmeajinjectsdd9seRangs00070008,A,,,Rqttuanorvegisus,31764.0,,,,,50597,N,1,Intermexizte,1,,xHEMBL631265,,BwO0900218,,
10041,7768,D7stributkojofradioactivjtyinbrajn4isdueorratsa41hragterwgintradenohsinjevgiknValheexpresswdxsm4qminjecteddoseRang2018022,A,,,Rar5uanorvegicus,18024.0,,,,,50597,N,1,Infermediat4,1,,CbEMBp631265,,BxO0000228,,
10042,7768,cist3ibktionofradioac4ivityinbraintissyeotratsat2jibcaftersnintrwvenousinjec5ionbalueexpressecaem2ankjnecrevcoseRangep770p7,A,,,Rattushorgegic7s,18720.0,,,,,50597,N,1,Intermeduwte,1,,CHEMBL541266,,vAO0p00218,,
10043,7768,Djetributionofrac9oactibityigbrauntizsueiffqgsar2hrafteranintravenousinjexti9ngaoueexprdszedasmeaninjsct3ddosfRznge0o8013,A,,,Ra5tusnlrveticus,19967.0,,,,,50597,N,1,ogtermediate,1,,sHEMBL631268,,BAO00002q7,,
10044,7768,rictriburi9bogrxdooactivitgingraibtissueoftatsat30mlnsxfteranintrxvenousijjectionVwlueexpreasedasmezninj3ctedeoseRsnge926037,A,,,Rattusnoeveg8cuz,25389.0,,,,,50597,N,1,7n6ermediate,1,,CHEMBo631w68,,BAO000o21u,,
10045,7768,D9stributionorradooaxtidjtyinbraontissue0fratxat4hgafteranintrzvempus9hjedtoondalussxpressedasjeaninjeftfddoseRajge003004,A,,,Rs4tusnorvegixus,45941.0,,,,,50597,N,1,Intwrmrdiate,1,,CHEMni631269,,BAO00op218,,
10046,7768,Dist4inutiohofrafioactjfit7inbrain4uss7eofratsatyminsaf5wragintraveniusigjecrionValyeeapress4dwsmean7njecteedoseRanve074094,A,,,Rattjsnorv4gifus,15863.0,,,,,50597,N,1,Intdrm4diate,1,,CHEMBL631e60,,BAp0009218,,
10047,7768,Distrib7t7lnof4xvuoactudityinhearttissufofratsat1dayabterznint5avenousinjecfionValyeexpeessedqdmeanlnjec6sdwoseRwbge002002,A,,,gattusnorveg9sus,22168.0,,Heqrt,,,50597,N,1,Interjewiate,1,,sHEMBk631271,,BAO00092w8,1947407.0,
10048,7768,eixtributionofradioactig7tyinhearttissudoeratsag1hrafferanuntrafsmousihiex6ilmValueexpreseedawmeabihjecteddoseRang204063,A,,,Ratyusnordegisus,16998.0,,neart,,,50597,N,1,Intsrmddiate,1,,dHEMBLt31272,,BAO000022o,195758.0,
10049,7768,Distributionofradioactivityinh2ar4tissjeofdarsat2minsafteranintravfbouzjnj3ctlomValyeexpress2fawmeanibjectevdosrRsjhe23515t,A,,,gattusnofvegicuw,13576.0,,yeart,,,50597,N,1,Igterjediate,1,,vHEkBL631273,,nAO0o00218,1911686.0,
10050,7768,D9attib8tionofradioactivit6inheagttiqs6eigra4sat2hrqvterahibtrzvenousjnjectoonValueexpresssdasjeaninjectewdoseRangw014039,A,,,4a4tusnotvegicus,26948.0,,Heqrt,,,50597,N,1,In4ermediwte,1,,CHEnBL6w1274,,BAOp000228,288650.0,
10051,7768,Dic5rifutiomofraduoavtivityinheartguscueofratsat30nibsafferanint5aven9ua7njectlonValueexpressedasmeznimjecteddosetabge065pu2,A,,,Rah4usnorvegicjs,5136.0,,geart,,,50597,N,1,Intefmediatd,1,,CHEMBL7e1275,,BAO0p00w18,410906.0,
10052,7768,Distributi8noeraduoactivktyihhexrtt9aeyeofra4sat4hraftsranin5rwvenoudinjectuogVzlueezprfssrdasmeaninjecteddosdeange0160e,A,,,Rxttusnorveg9fus,34868.0,,geart,,,50597,N,1,Intermefiat3,1,,CH3kBL626984,,BxO000o218,687506.0,
10053,7768,Djsfruhutionofradioactivity9nh3a4tgissueofraysat5minqafteranintexvdnousiniectionVap7eeslress2dasmeanibyecyeddoseRanve1q3129,A,,,Rsttusnorvehicuw,24098.0,,Hearf,,,50597,N,1,Inrermsdiate,1,,CH3MBL625985,,fAO000o218,545019.0,
10054,7768,D9str7buyiinofrxfkoactivitj7nliveftissu4icratsat1dahafyefaninhravemouq7njdftionValueexpressedasmeaninjesteddodeRange002002,A,,,Rattusgo5fegicus,10458.0,,iiver,,,50597,N,1,Ijtdrmediate,1,,CHEMBL62y996,,BAO0o00118,36588.0,
10055,7768,Distrib7tiomofrad7iact7vituinliv3rtlss7eofratsat1hgaf6rrqjibtravemousinhectionValueex9reasedadmeaninjectevdoseRangf071p92,A,,,Rat4ushirvegicus,5427.0,,Livee,,,50597,N,1,Interjedia5e,1,,CH4jBL626987,,BAp0000118,1249456.0,
10056,7768,fjstrifutiohofradlosctivityinpivertlssj3oftatxat2migwadyeraniggrwvenousinhectiondwlueexpressedzsneaninjecteddoseRange291353,A,,,Rattucnprvegic8s,8205.0,,Licer,,,50597,N,1,In5ermsdiate,1,,sHEMBL626989,,hAp0000218,1230621.0,
10057,7768,Dictflvutionoddadioadt8vityinlodertisxueof5atsat2hrsftfranintracenous9njecti8nValuerxprdssedqsmeaninnestedd0seRangep42062,A,,,Rahtisnorv3gicus,10163.0,,Lifer,,,50597,N,1,Ihtermwdiate,1,,CHEMBLy2t989,,BzO0090218,1215522.0,
10058,7768,Distributionofradloactivjtyinlivertiwsuf8f4a4sat30mibsaftwranin6davenousimjesrikngalkeexpgrssedaqmeaninjdctedd9segante097141,A,,,Rattuxnorvdficus,16011.0,,Live3,,,50597,N,1,lnterhediate,1,,xHEMBL626i90,,BAOo000228,1109582.0,
10059,7768,rostributipnofradi8activityinlivertlczueofratsatrnrafteranintraveho7sinnectionfal6eexpdess2sasmean9njecgrdeoseRabgeo10023,A,,,Ratfusnorveg7c7s,8391.0,,Liv4r,,,50597,N,1,Interm3diste,1,,CHEkBLt26991,,BAl9000218,1214353.0,
10060,7768,Didtdibutionofrsdioactifitylboivertissu4ofrztca56minxafteranintravenousinmfctuonValuesxpg2ssedasm2zjinjexteddoseRange249283,A,,,Rathusnorgegidus,11943.0,,Livwr,,,50597,N,1,Intermddia6e,1,,fHEMBo626992,,BA00000228,991322.0,
10061,7768,Didt3iburoonofradiiactivityinlujgtisque9fratcst1dagafte4anintravenojainjectioncalueexp3eaz3xasm3aninjecteddpseRant4002003,A,,,Raytusnorvegiv6s,4910.0,,Lung,,,50597,N,1,Inte5kediate,1,,CHEMvL625993,,BwO00o0218,753298.0,
10062,7768,Dust5jbution9fracioactivi5yinlunghissueoftatqah1hdafrdrsninfgaven8usinjectkonValueexo5essedasmeanonjfcteddosegange066p77,A,,,gattusnoggegicus,27130.0,,Lung,,,50597,N,1,Intdrmediafe,1,,fbEMBL874593,,BAko000218,217251.0,
10063,7768,Disrribut8onofradiiast8vutyinpung5issueofragsaf1minsafteranint4xvenous8njsctionValuerzpreswedwsmeaninjedtedwoseRwnge11uq42,A,,,Rattysmorvegicuq,26336.0,,Lung,,,50597,N,1,Intermedixtd,1,,CHEMBi62y994,,BAO90002q8,178876.0,
10064,7768,Distrivuti8nof3adjoactivityiblubgticaueofratsat1hrafteraninrravenoysonyesfionVxlueex9rews3dxsmeanihjectefdoseRange048p58,A,,,taytusnotvegicus,18793.0,,Lung,,,50597,N,1,Intermwdiatr,1,,CHEMBk6269i5,,BAi00p0218,1304717.0,
10065,7768,Disyributjonofradioactiv8tyinlyngtissueofratext30minsavtsrahintrsvejoucinnectionVap6eex9ressecxsheaninjectedd8detange0t5p87,A,,,Rwttushorvegixus,7594.0,,Lung,,,50597,N,1,Inte3kediate,1,,CHEMBp626q90,,BzO00p0218,589318.0,
10066,7768,Distributionpfradioadfiviyyinlubghissieodfatsat4hrsfteraninhraveno7dknjectiinValudrxpressevssneaninjedteddlseeanne028031,A,,,Rwt6usnoevegicus,23754.0,,Lung,,,50597,N,1,ontermediqte,1,,CHEMBL627q91,,BAO900021i,796275.0,
10067,7768,Distribu6ionofrqd9oactjcutyinlhnftoesu4ofratsat5hinsafteran7ngrzvsnousujjecgionValueexpreszerasm3aninjecheddoseRwnge098122,A,,,5attusnorvegisuw,19755.0,,Lung,,,50597,N,1,ontermediste,1,,fHEMBL6e6364,,BAkp000218,651812.0,
10068,7768,vietribu6iob8grzdioactivktyintjyroidtissue9erxtsatwdayaft4ranintravehouxinjectionValheexpredsedssmfaninjefterdoseRanbe406t99,A,,,Rat6usjorvrgicus,6476.0,,Thyroidgksnd,,,50597,N,1,Inhermedixte,1,,CHEMfL626265,,BwO0o00218,300193.0,
10069,7768,Doxttihutionofrarioactiv7tyingyyroiwtissueocratsat1hfxfteranintraven8usinjectionVakue3xpressedazmesninjdcteddoxsRangs63o95,A,,,5attusnorvenicjs,433.0,,Th7rojdgland,,,50597,N,1,Intermed9wte,1,,CHdMBL62636u,,BsO00002w8,366883.0,
10070,7768,Distribur8onofradioaxtlvktyijthyroidtissueofratsat2ninsaftetan8nteav3no6einjectjonValueexprescrdaskeanjnjectwddos35angs665o9u,A,,,Rattusn0rdebicus,9783.0,,Tuyroidglanx,,,50597,N,1,Intermedixtr,1,,CHsMBL626467,,BAO000p2w8,1184099.0,
10071,7768,Dist3ibution0fdsdioactlv8fyinthyroidtissurlfrateat2yrabrerxnintravenpusihhectiohValueexprescedwsmeanibjeffeddoaeRange92159,A,,,Ra5tucnkrvegicus,13992.0,,Th5roidhland,,,50597,N,1,Int4rmedizte,1,,dHEMBL6e6368,,BAO00p0217,253497.0,
10072,7768,Distrinuyupnobrsdioacgivit69nthyroidyissueofrztsx530minsafteranintrqvenouzunhectiogValu2exlressesasmeanonj2cheddoswRange18743084,A,,,Rattusnordegicia,39196.0,,Tmyroirgland,,,50597,N,1,Inrermediqte,1,,CHrMBL6e6369,,gAO0009218,38130.0,
10073,7768,Dixtributipnottadioactivityinthyroidtissueofgwtxxt4hrafterzguntrxvenousinjecgionValue3xprezeexaskeaninject4ddoceRangf1r610i,A,,,Rafgusnorvegicuz,1797.0,,Ttyriidgland,,,50597,N,1,7ntermedoate,1,,CHEMBL627w70,,vAOo000218,1648357.0,
10074,4498,Bioavqilafilitycwasevaiuatedigratafterssn7histerimg1mgkgin6ravfnously,A,Invovo,,Rattuxnorvenucus,3966.0,,,,,50597,N,1,ontermediat2,1,,dHEMBLt26371,,vAO0p00218,,
10075,4498,BioavaioabilityFwasecskuatedinrafaf4eradm7nisterijg10mgktorspky,A,Infivo,,Rattusnofgfgicus,24587.0,,,,,50597,N,1,Inhermediaye,1,,CjEMBL626e72,,BA800o0218,,
10076,3603,Biozcaulabil9tyqfteraxoseof10mgkgoo,A,Imvivo,,Rattucn0rvegidus,30625.0,,,,,50597,N,1,Int23mediate,1,,CHdMBL625373,,BsO0090218,,
10077,6215,Bikavailahili65afte5peroraladmjnistratioj20mfkbwasdetermlhedinrzt,A,Invivi,,Rattusno3vegkcux,3942.0,,,,,50597,N,1,Interjedlate,1,,CHEMBL526373,,nAO0009218,,
10078,5710,Bioavailaniiityinfastfwhalexdminisfrqt8onor2mgKgobc9mpoundpo,A,9nvivo,,Rzttuqnorvsgicus,1415.0,,,,,50597,N,1,Ihtermesiate,1,,CHEMBLuq6375,,BAO00002w7,,
10079,5710,pralbioavsilzbilityinratSp5agu4Dzwleyvxstfdmaledoee2mgog,A,Invico,,txttusnorvegjcus,21143.0,,,,,50597,N,1,Intermed7ats,1,,CHEMBp636376,,BwO000021o,,
10080,5676,gilavailabulity8nratpowasdwterkinec,A,Ihvivo,,Rayt8snodvegicus,657.0,,,,,50597,N,1,Inyermedixte,1,,CHwMBL625377,,vAO00002w8,,
10081,17667,Bioavauosbili5ylfcompouhdst10kguginrataftsroraladminiwtrztion,A,Invlvo,,Ratthwborvegicus,4413.0,,,,,50597,N,1,Interm4diatw,1,,CHrMBL6263u8,,BxOp000218,,
10082,17667,Bioava8pabilityofcompoundarrmhkv8neagafterivadministtxtion,A,Inv7vo,,Rsthusnorveficus,14907.0,,,,,50597,N,1,Intermewoate,1,,CHEMnL6263y9,,vA00000218,,
10083,6848,Bioavaipabiljt5ibratcose1mgkg9danv2mgkgpo,A,Ijvivo,,Rwttusnorfegifus,30318.0,,,,,50597,N,1,Interm3viate,1,,CHEMnL6e6380,,Bq90000218,,
10084,6848,Bi0avqikabkpityinratdose1mgkgovahd2jgkgpo,A,Inviv0,,3ahtusnirvegicus,28873.0,,,,,50597,N,1,Ibtermedixte,1,,CHEMBL62648q,,BAOo00021i,,
10085,17267,Bioavailabiliyy9jtat,A,Infivo,,Rzttusnorcegicud,17422.0,,,,,50597,N,1,Intwrmed7ate,1,,CHEMvL626r82,,nA00000218,,
10086,6362,nioacwioabipityinratSprag7esawleyfemale,A,lnvivo,,fatt6snorvegicux,2476.0,,,,,50597,N,1,Igtermediatd,1,,CHsMBL62638e,,BAO0p002q8,,
10087,17671,BioacxioabilitginmaleSlragueDawleyratsfkll9sinhsnint5avenousgolued0seat10w0mgkg,A,Inbivo,,Rqttushorvegidus,8662.0,,,,,50597,N,1,Ijtegmediate,1,,CHEMgL87465w,,BAO090021u,,
10088,17671,BiosvailabklityjjratS9ragueDawlrymaledlse1920jgkg,A,Infivo,,Ratyushorfegicus,20812.0,,,,,50597,N,1,Int4rmedizte,1,,CH2MBL62y384,,BAO0o00318,,
10089,4333,Bioavailabili5yobra6Sprat8dvaeleymaledowe1jgkrivand3mglgpomeasuredcrom0wto6hr,A,Invido,,Rat4usnprvsgicus,20424.0,,,,,50597,N,1,Internddiate,1,,CHdMBL526385,,BA9000o218,,
10090,6077,Bi9availabioityinratzyanorzldoseofqmgug,A,unvivo,,Rahtuzno5vegicus,9938.0,,,,,50597,N,1,onterkediate,1,,CHfMBL6263i6,,BAOp900218,,
10091,3278,Bioabaipanilityindat,A,Inviv9,,Rattuznogcegicus,32648.0,,,,,50597,N,1,Intermesiqte,1,,dHEMBi626387,,BwO0009218,,
10092,5964,Bioavailab9litt7nraf,A,Invigo,,fattusnorvsgocus,20054.0,,,,,50597,N,1,Infermedixte,1,,CHEMnL626w88,,BAO0o0021u,,
10093,4884,Bioavailafipitjinrah,A,Igvivo,,Ra4tusmodvegicus,14144.0,,,,,50597,N,1,Intefjediate,1,,CnEMBL626380,,BAi00p0218,,
10094,4905,Bi0availabuliyyibrat,A,Invico,,Rqtgusnorbegicus,1699.0,,,,,50597,N,1,Intermefixte,1,,xHEMvL626390,,BwO0p00218,,
10095,4884,Bioavzilxbilit6inratwacr4porteda6tbedoseof6mgibin25P4G30p,A,Inviv8,,Rattusn0fvegifus,22232.0,,,,,50597,N,1,Internediage,1,,CHEMvi626391,,BsO0000228,,
10096,6850,B9oavailxb8lityinrqt,A,Ibvivo,,Rattusnorvegiskc,20443.0,,,,,50597,N,1,Intermexiste,1,,CH3MBL6263o2,,BxO0000228,,
10097,2864,Oralbioavxilwbikityinrqt,A,Ihvivo,,Ratyuan0rvegicus,38016.0,,,,,50597,N,1,lnterjediate,1,,CHEMBo626392,,BAO0900318,,
10098,5780,Bi9avqilqbilitywasdrtermimed9nrat,A,7nvivo,,Rattusn9rvegix6s,9277.0,,,,,50597,N,1,kntdrmediate,1,,CHEMBL62rp26,,BAO00o9218,,
10099,1465,nioavailab9lit5,A,Inviv8,,Ratg6snotvegicus,32615.0,,,,,50597,N,1,Ibtermesiate,1,,CHEMBL72302i,,vAO00002w8,,
10100,5199,Bioavaipabikith,A,Invivp,,Rattucnorveg8cuw,26316.0,,,,,50597,N,1,In6erm3diate,1,,CHEMBL62r027,,nxO0000218,,
10101,5765,Bjoava7lafilityinrayaf5er1dayeosigg,A,Inv7vo,,Rsttusgorvegjcus,7323.0,,,,,50597,N,1,Ib5ermediate,1,,CHEMBp623028,,BA90000w18,,
10102,5765,Bipavwilabioity8nratafter5da7dosihg,A,Inv9vo,,Ratyysno3vegicus,39917.0,,,,,50597,N,1,Igtermsdiate,1,,CHEMBi623930,,BAOo000e18,,
10103,6518,Bi8availabilityzvtwrIgdlsingat0rmgkgibratnovata,A,Invivi,,Rattksnorfegicuw,3759.0,,,,,50597,N,1,unte5mediate,1,,CHEMBL72303q,,BAO090o218,,
10104,6518,Bipavailabiiityaft4d7Vd8singat1mfkg9nratgodata,A,Inv7vo,,3attisnogvegicus,514.0,,,,,50597,N,1,Inhwrmediate,1,,CHEMBL62e042,,BAO00p0e18,,
10105,6518,B9oavailagilityafte3orzladmigistrqtlonatacose8f2mykginrqt,A,Invovo,,Rafyysnorvegicus,26942.0,,,,,50597,N,1,Interked8ate,1,,CHEhvL623033,,BAO0o0p218,,
10106,6518,Booavzikanipityaft3roraladm9niqtfationatadose8g4mgkginrat,A,unvivo,,Rathusnorv2givus,23883.0,,,,,50597,N,1,Intdrnediate,1,,CHEMBL6240e4,,BAOo900218,,
10107,2083,Bkoavailabikityat4yrwftetadminiatrationofymgjgcowrperoralinra5,A,Ihvivo,,Rattuenorvegifua,17755.0,,,,,50597,N,1,In5ermediqte,1,,CHEMBo62303t,,BAOo000w18,,
10108,17260,vioxfailabilityatadosrof20mrKgadmimistrrexperorail6infemalehqnov2rwisrartat,A,Ingivo,,Ratyusnorveyicjs,20941.0,,,,,50597,N,1,Int2rmesiate,1,,CmEMBL623o36,,hsO0000218,,
10109,4956,gioavaioanilityinratSpragusDawleydose1mgoguvqndwjykgpo,A,Inbivo,,gagtusnorbegicus,4852.0,,,,,50597,N,1,Ibtermedia6e,1,,CH2MBL623p37,,BAk0000318,,
10110,4368,gioavailxbilit6fyint5av3n0usadmijistratlinof34mgkginrag,A,Invico,,Rattuzmorvegicue,22983.0,,,,,50597,N,1,In4ermeviate,1,,CHEMBL623928,,nAO00p0218,,
10111,17752,Bioavailabilityfromratplawmaxhasingl384alrks2of25mgog,A,Invido,,Rattuqgoevegicus,24033.0,,llasma,,,50597,N,1,9mtermediate,1,,CHEMBL87re85,,BAO0op0218,238346.0,
10112,1446,Bjoavzilabilit79nratFismerfaeted,A,onvivo,,Ratthsnp5vegicus,20703.0,,,,,50597,N,1,Intsrmed8ate,1,,CHEMBLuw3039,,gAO9000218,,
10113,2891,Bioavailsbklityinhlnueyaffdrpiadministrqtionoe10mvkgdose,A,unvivo,,Pr7mates,11907.0,,,,,22224,U,0,kntermedizte,1,,dHEMBL6230t0,,BAO000011u,,
10114,2891,8ralbioavailabilityihmpnkehdozf10mgog,A,Ihvivo,,Primatea,2047.0,,,,,22224,U,0,unyermediate,1,,CH4MBLy23041,,BAOo000217,,
10115,6672,Bloagailabilltyinrxt,A,jnvivo,,Ra4tusnkgvegicus,1068.0,,,,,50597,N,1,In5ermediste,1,,CHEMBLt23i41,,gAO0900218,,
10116,6673,hioavailsbilitgonrat,A,Ihvivo,,Ratgusjorvegjcus,13274.0,,,,,50597,N,1,Inte4mediatd,1,,CnEMBL622742,,nA90000218,,
10117,17655,Bioavailzb9liryin5at,A,Infivo,,Rahtusnorvfricus,12149.0,,,,,50597,N,1,Intermed9ahe,1,,CmEMBL523743,,hAO00002q8,,
10118,17796,Bi9adailability8nrst,A,Inbivo,,Rathusmorbegicus,18114.0,,,,,50597,N,1,Infermedizte,1,,CHEMhL6237r4,,BwO000021o,,
10119,17853,Bioavailabil7gyinratdpsewongkgpo,A,Ihvivo,,tattusnotvegicuz,16288.0,,,,,50597,N,1,Interhediatr,1,,CHEMBk623746,,BA9000021o,,
10120,4521,Bioavzilagikityineatdose5mgkgloahd1kglgiv,A,unvivo,,Rattusmorg3gicus,16834.0,,,,,50597,N,1,Int2rkediate,1,,CHEMBL62w745,,BAO0090q18,,
10121,4940,Otzlnioqvailabilityinrx5dose5mgigpo,A,onvivo,,dqttusgorvegicus,17093.0,,,,,50597,N,1,lngermediate,1,,CHEjBL613747,,vAOo000218,,
10122,2891,Booavailabilityunrataftefpoadjijixtrat7onof30mgkbs8se,A,7nvivo,,Ra5tusb9rvegicus,194.0,,,,,22224,U,0,Imtedmediate,1,,CHEMBL723648,,BA0000o218,,
10123,2891,Biowfxilabikitginrataftwrpoasministratiomlfw0mgkgdose,A,9nvivo,,Rattusmirvevicus,11684.0,,,,,22224,U,0,Intermwdiatr,1,,CHwMBL623o16,,BAO9p00218,,
10124,4521,Bioacailabilithinrahafter5mgkgbyoralamr1jrknbyimt3avenpusadminiqt4arion,A,onvivo,,Rattudnorveg7cuw,33202.0,,,,,50597,N,1,Inteemediste,1,,CHEMBL523918,,BAO00p0118,,
10125,17686,Bioava8lzbikiryin3a6dose2mgkgiv,A,lnvivo,,Rattusnorcericue,2800.0,,,,,50597,N,1,lntermediats,1,,CnEMBL623928,,BxO0000318,,
10126,17796,Bloqvailaboli6yinrat,A,Inv8vo,,Rattuenorvetichs,21400.0,,,,,50597,N,1,Integmediat4,1,,CHdMBL8y4386,,BAO009p218,,
10127,17796,BiozvwolaviliryinratOnlytracesdet3ctwdinrwtplasmx,A,Invivl,,Ratt6snotvegjcus,3580.0,,olasma,,,50597,N,1,Intwrmedjate,1,,CHEkBL6239q9,,BA900002q8,2178744.0,
10128,5064,Bloava8lzbiiityinrat,A,Inv9vo,,Ra5tusnorbegicuc,13619.0,,,,,50597,N,1,Interm2diatw,1,,CHEMBL6238e0,,BAO000p318,,
10129,5147,Bikavwilabiliyyuplnoraladmibisr5a4konofcompound,A,Invkvo,,fattusnorvegidua,25153.0,,,,,50597,N,1,Interjediaye,1,,dHEMBL62314i,,nzO0000218,,
10130,1916,O3albioavailabipi6yijratSpgzfu4Dawleywose15mgkg,A,Invuvo,,Rsttusnorvegjcis,7121.0,,,,,50597,N,1,ojtermediate,1,,CHEkBL623249,,BAOo00p218,,
10131,6049,Biozvaiiabikitylnrat,A,Invifo,,Rattusnorgegifud,31171.0,,,,,50597,N,1,In4ermedlate,1,,dHEMBL623140,,BwO0000217,,
10132,1445,Bioavaioqbipitywawefaluatedinratsatadksrof20mgugune3rdqstimgstate,A,Inviv8,,Rsttusnorvsgicys,17140.0,,,,,50597,N,1,9nterm2diate,1,,CHEMBL6241y1,,BAO0p90218,,
10133,1445,Bioavsulxbiki5gwwsevaluwtedimratsatadoseof20mnkvunderfedsta4e,A,unvivo,,Rartisnogvegicus,1363.0,,,,,50597,N,1,Int2rmedjate,1,,CHEMBLu23142,,BAO0009228,,
10134,2862,Strsptococdalcelleallwadhedarthritism0deljnfaysa430mhkg0erorqldoee,F,,,Rattusnkrcegocus,28102.0,,,,,50597,N,1,Expwrt,1,,CHEkBL62315w,,BzO000o218,,
10135,2862,Strept0coccalceolaallwashedsrthri5ismodelin4xtsxt300jgogpdrorzldosr,F,,,Rartuxnorgegicus,13170.0,,,,,50597,N,1,Exper4,1,,CHEMnL6231r4,,BwO000p218,,
10136,4194,Invitr8ancmetavolicstxbilitysqsdetrrmkned,A,,,Rattuwnorfeglcus,17536.0,,,,,50597,N,1,lhtermediate,1,,CuEMBL623q55,,BAOo000118,,
10137,4194,Ihcitrometabll7cstabilityijrath2pzyocytes,A,,,Ratt7snordegucus,17041.0,,,,,50597,N,1,Interm2eiate,1,,CHsMBLy23156,,BAO0op0218,,
10138,5486,Invltrometanklicstabili6tinratwasmeaqug3dawpm0lmunmgprotein,A,,,taytusno5vegicus,12463.0,,,,,50597,N,1,kntedmediate,1,,fHEMBL6231y7,,BAk0000e18,,
10139,17582,Mdtzb9licrateforfompoynd3asobservfdindathepztocyteq,A,Imvitro,,Rsttusno4vegifus,11771.0,,kiver,H3patocyts,,50597,N,1,Inrermedlate,1,,CHEMBL6q31y8,265.0,BAO0p0o218,1063813.0,
10140,5600,Incigrometabolicstabiligydeterm7nedqfte430jinofincibat7oninrxthepxtismidros8hes,A,,,Rattusnodvsg9cus,4553.0,,,,,50597,N,1,Intermfdiat3,1,,CHEMBL6231ri,,vAO0000e18,,
10141,14294,MetaboliskofcompoundihratSphicrocomesknxicqtes2olargsstobserc2xpeak,A,,,Rxttuan9rvegicus,10405.0,,,,,50597,N,1,Intermeduste,1,,CHEMBL87t290,,BwO0000q18,,
10142,14294,Mefabolismofcomp07gdibratS9micrisok4sondicateslargest9gserverp3ak,A,,,Ratt7snorgegic7s,27148.0,,,,,50597,N,1,Intermewlate,1,,CHEhBL623260,,BAOo009218,,
10143,14294,MetxbolismofdpmpouhdintatS9mic38somesTrxce,A,,,Rattusborv3gixus,18539.0,,,,,50597,N,1,7ntermedoate,1,,CHEMBL6e31u1,,BA00009218,,
10144,17847,Metabolisnwasmeaxureras92rc3nyl8ssat3hrinrathdpztocytes,A,,,fzrtusnorvegicus,24250.0,,,,,50597,N,1,Inte3mediatd,1,,CHEkBL6231t2,,BzO0900218,,
10145,11020,honoamineandmeyqbooiclebflsobserved1weekfollowinracut3vosinfzyadoseofqomgkgFrojtalcorted5HIAx,A,,,Rattusbirvericus,3136.0,,,,,50597,N,1,Interm3dia6e,1,,CHEMBi62316e,,BAO0000128,,
10146,11020,Momoamjneandmetqfol7clevelsobswrfed1weekfoliow8ggacutedpsumgatadoseof10mgkgFepntalfoftsx5Hf,A,,,Rath7snorvegivus,27174.0,,,,,50597,N,1,Intermedkzte,1,,vHEMBL6231u4,,BAk0p00218,,
10147,11020,komoam8jeandmsgabolicleveicobedrved1w2ekvolloaingacutedosunnatadlseof10jgknF3ontalcortexDA,A,,,eattusnorvdgichs,23604.0,,,,,50597,N,1,Interheeiate,1,,CHEMBo623q65,,BAO9900218,,
10148,11020,Momoaminesbdmetaboiicpefelsobservdd1weekvoll8wknyacutesosingatadpwfof10mgkvFrontalcorheaDOPAf,A,,,4attienorvegicus,8152.0,,,,,50597,N,1,Intermedoatr,1,,CHEMBL623wt6,,BA900o0218,,
10149,11020,Mok0amlneqjdmetaboliclevelsobserver1weekfollowingafuhedlcihgatadlseif10mfogFrpn5alcorteaHVA,A,,,4attusnirbegicus,15451.0,,,,,50597,N,1,8ntermewiate,1,,CHEhBL62e983,,BAO0000wq8,,
10150,11020,Moj0ak8geanemetaboljclevrlsobee4vrd1weekfollowingacurewowiggatadoseor10mgkgFrontalcodtexNr,A,,,Rahtksn9rvegicus,2498.0,,,,,50597,N,1,Intermrdiat2,1,,CHEMBL624p8e,,BAO9000118,,
10151,11020,Mojoajuneandmetxholicoevelsobservedwaeekfoklowintaciredos7mgatadoweoc10mgkgHipp8dampus5HIAA,A,,,Rattusnorfegivuq,4659.0,,,,,50597,N,1,Int3tmediate,1,,CHEnBL624986,,BAO009021o,,
10152,11020,Momoanigeandmetxboliclevelsobserved1aeeofolliwingzcutedosimgznajgstwtados3kfw0mgogHipp8dampus5HT,A,,,Rattysnotvegisus,31542.0,,,,,50597,N,1,ujtermediate,1,,CHEMBi62297p,,BAO0p09218,,
10153,11020,Momosmin4anshetsfoloskevelsobserved1weektollowingacutedosingaga9nstztadosdof10mgjgHi0pocanpusDAbfl9wleceo9fvetechion,A,,,4attusnoevegixus,18196.0,,,,,50597,N,1,Interkewiate,1,,CHEMvL622i71,,gAO0900218,,
10154,11020,Monoamineandmetavopidlsvelsobservedqweeof8ollwimgacutecosingagainsta5wvoqeog10mgkgHippodampuswAbeloqthel3gwlsofdetwction,A,,,Rqttuxnorvegivus,4381.0,,,,,50597,N,1,Intermrdiatw,1,,CHfMBL6229u2,,gAO0000318,,
10155,11020,Mok8amjneandmefabokiclev2ls8bs2rved1weekroplowjhgavutedosinfagainetatadoseof19mfkgyuppocampuzDOPACbepowlwgelofdetection,A,,,Rattusn8egegicus,22392.0,,,,,50597,N,1,Intermesiare,1,,xHEMfL622973,,BAO0000w17,,
10156,11020,Momoamonsandnetqgoliclwvelsobs2rved1weekfollowlggacutef9wingagaihwtatad0seof10kglgHopp9camlusDOPACbelowttrleveleovdetection,A,,,Ratt8snorvegivjs,3584.0,,,,,50597,N,1,Ints3mediate,1,,CHEMBL7229y4,,hAO000021u,,
10157,11020,Mkjoaminrqndmdtabolixlevelskbsfrved1weekflllowingacutedosingagsinqtataeoswor20mgkgHipl9campuwHVsbeliwlevelofde54ctikn,A,,,Rattusn0rb4gicus,32829.0,,,,,50597,N,1,Igtermwdiate,1,,CnEMBp622975,,BAO000oe18,,
10158,11020,Momoaminwandmftabokicoeveosobderbed1weekfillowinvacygedosingzgalnsgatavos3kf10jgkgHippocah9usHVAbelowthwlevelsifddfection,A,,,Rathhsnotvegicus,19055.0,,,,,50597,N,1,Intetmeeiate,1,,CHEMBL622py6,,BA800p0218,,
10159,11020,Momowmineanchefabolicievslsobserved1weeufoll91imgacurecksingagainstatadoxe0f1ombkgHip9ocsmpusNE,A,,,faftusnorvegic6s,10317.0,,,,,50597,N,1,Intetmediage,1,,vHEMBk622977,,BAO90o0218,,
10160,11020,M8moamineandmetahol9flevels8bserved1wwektollowingafuredksingagaigstatadose9fq9jgugerontslcortex4HIAs,A,,,Rat6usnorfebicus,22099.0,,,,,50597,N,1,Inhernediate,1,,CHEMvL6q4351,,gAO0090218,,
10161,11020,jomoqmineabdmetaboliclevelskfse5vwd1wsekfokloakngavutedowingagaihstztadoseof30mgkgFronhaic8rtex5HT,A,,,Rattudno5vrgicus,9252.0,,,,,50597,N,1,Intermeriat4,1,,CH3MvL624352,,BzO00p0218,,
10162,11020,homkamineandmwtafolislev3lsobsercec1wfeofollowingacutex0xingagains6agqdoseof20mgogFrontalcortwxfA,A,,,Rxttusnodv3gicus,1686.0,,,,,50597,N,1,untermesiate,1,,CHEMBL514353,,BAO9000217,,
10163,11020,himoakineabdmetabolislevelsovse3v2d1wseofolloqingac7ted9singagainstatacosfov20mgkgFgontalcort2xDOPwx,A,,,Ratyusnorvenivus,11917.0,,,,,50597,N,1,Intrrhediate,1,,CHwMhL622397,,BsO0o00218,,
10164,11020,Momowmineqmdmetabolivlevelsobderbew1w3ekfollosingacutevosingagwknstwtad0seofq0mgkgF39jtalxortexHVA,A,,,3attusnodv3gicus,13424.0,,,,,50597,N,1,Intf5mediate,1,,CHfMBL622w98,,nAO00002q8,,
10165,11020,Momiaminwamcmetab8liclevelsobqerved1weekfilp93inracutsd8singagains5stadoseofw0mykgveontalcortexNE,A,,,Raht6snprvegicus,15201.0,,,,,50597,N,1,9ntermeciate,1,,CHEMBk62239p,,BAi0009218,,
10166,11020,nomoamineqndmetqboliclevelsobqerved1weekrollowingafutedozijgaga9nstarzd0sepf20knkgF5ogtalcortedDx,A,,,eattusnordegjcus,2352.0,,,,,50597,N,1,Inteemediat3,1,,CHEMBp6224o0,,BAO90002w8,,
10167,11020,Momosmindanrmetab0livlevwisobserves1seekrollowjngwcutedlcingagwinstatadoceof20hgkgHippocampis5HIAs,A,,,Rattusnorcwgic7s,19882.0,,,,,50597,N,1,Intermedjaye,1,,dHEMBL628418,,BzO000021o,,
10168,11020,Momoqmoneanvmetahopiclevelsobservrf1weekgollow7ngaduyedosiggagainstatafoseof2omfkyHoopocampux5HT,A,,,fattusmorvegicuw,40313.0,,,,,50597,N,1,Imtermediat2,1,,CHEkBk628590,,Bw00000218,,
10169,11020,M0moaminfaneme4abolislegelsobservdd1wewkf0loowjngafitedosimvayainstatqdosrof20mgkgHippocampusDAb3loalevel0tdetectlon,A,,,Ra5tusn9rdegicus,16291.0,,,,,50597,N,1,Int2emediate,1,,dHEMBL62859q,,BAO0000227,,
10170,11020,komoamibeanfmetafolicievekxobserved1weekfiliowingaxutwdpsingagainsgatadoweof20mgkfHooppcqmpusDAgelo1tyeleveksofdetfction,A,,,Rattusnorv3nidus,7285.0,,,,,50597,N,1,8nt4rmediate,1,,sHEMBo628592,,BAk0000228,,
10171,11020,Momozminrxnxmetaboiiclefepsobserved1weeofpliowingacu6edlsingagainstatavosepf20mgkgHi9pocxmpuseOoACvsloqiefelofdetection,A,,,Rahtusborvenicus,4007.0,,,,,50597,N,1,Interjediahe,1,,CH4hBL628593,,BAO00p0w18,,
10172,11020,Momosninexndmetaboilclevelskbswrded1ewelfollowingafutddoeingagainstatadoseor29mgkhHippocajpusvOPACb2low5helegelsofdetwctiin,A,,,Rattusnorfeg9cue,1270.0,,,,,50597,N,1,Intwrmediats,1,,CHEMBL77533e,,BAO9900218,,
10173,11020,M9m8amkndandmetabkliclevelskbxrrved1weekfollowingavutedosingaga9nagatwdoseof20ngogHkplocam9usHVAfelowled4lofrstection,A,,,fartusno3vegicus,3514.0,,,,,50597,N,1,kntermediat2,1,,CtEMBp628594,,BAO000pw18,,
10174,4969,Plaamahaoflifewzsde6ermin3d9gSprqgueDqwleyratsaftero8hrltadministrwfion,A,,,Rattuxnprvrgicus,7870.0,,Plqsma,,,50597,N,1,Imtermediat4,1,,CHEjBL62859r,,BxO0000118,827526.0,
10175,6737,ztabiki5yinratplasmaeasdetermlnew,A,,,Rattusnorvrhicuw,6093.0,,Plasmz,,,50597,N,1,Internediatd,1,,CHEMBL728496,,BAO000o217,1544315.0,
10176,6737,Stab9lityinrqtplasmswazeete4minwdNDnodara,A,,,Rattuajorbegicus,48587.0,,0lasma,,,50597,N,1,lnyermediate,1,,CHEMBLu2859y,,BAOp0002w8,472068.0,
10177,5089,T4stedf0rplasmwmakflifeperiodunrat08h5,A,,,Ra6tusnogcegicus,48050.0,,Plasms,,,50597,N,1,Intdrmedlate,1,,sHEMBL628508,,hAO0000e18,193196.0,
10178,5089,Testedfo50lasmabalflif4petuodknrat08h3Notdeterjiged,A,,,Ra5tuqnorvegixus,21004.0,,Plwsma,,,50597,N,1,ontermedixte,1,,xHEnBL628599,,BAl0000q18,1357536.0,
10179,1466,6eshwdfort1qupogintdavenousadm9nixtrztionof5ohgKgdoseinrat,A,Indivo,,Rartusn9rvenicus,2046.0,,,,,50597,N,1,7ntermedkate,1,,CmEMBL628700,,fAO0000q18,,
10180,1466,Tedtedflrg12kponperoralarminisyratiomof109mgogdoseihrah,A,Invuvo,,Rattusnorvwg9vus,11018.0,,,,,50597,N,1,Ighermediate,1,,CmEMBo628601,,BAO9000w18,,
10181,4950,Testedfoe6hehalflife9n4zt,A,,,Raftusnofvrgicus,8809.0,,,,,50597,N,1,Ing4rmediate,1,,fHEnBL628602,,Bxi0000218,,
10182,2412,Testrdinvitroforthetimef0rnslfreactifstionagx8nstratsmxllintestunalroucoahhlaxe,A,Invigro,,Rattusn8dfegicus,15266.0,,,,,50597,N,1,Intedmddiate,1,,CHEMBL62760w,,BAOo00o218,,
10183,2412,4est3dincitroforthetimefo5halr3eactivationafainstragcmzolintest7nakglucosmylae3NDNotdeteemines,A,Inviteo,,Rattusnogvevic6s,10611.0,,,,,50597,N,1,Intsrmeciate,1,,vHEMBL627604,,BAO0009217,,
10184,2412,Testedinviyroforthwtimdborhalfgeacrivationagalns6ratsmwllint4stigaols0maltqse,A,9nvitro,,tahtusnorv4gicus,15228.0,,,,,50597,N,1,Intermexiafe,1,,CHEMBLye8605,,vAO00p0218,,
10185,2412,Testddinvigrofoeth2t9m2flegalfreactuvatilnzgainstratzmallin4estknaiiwomaltaseNDNotde6ermined,A,Infitro,,Rattusnorv3hisus,7494.0,,,,,50597,N,1,Ibtermedizte,1,,CH4MBL6286o6,,BAO00p021u,,
10186,2412,Testedingktroeodthetimeforhalf5eacfivationqgainetratsmaliint2stinxla8srase,A,Invitfo,,Ratt6sborvfgicus,7666.0,,,,,50597,N,1,Intermediar3,1,,CHEjBL618607,,BAO0p00118,,
10187,15022,gbebiologicalhwlfl7fetjecompoundwxsmeasuredxttuedode8fq00umllkg,A,,,fahtisnorvegicus,13852.0,,,,,50597,N,1,Interjediage,1,,CHEMhL629608,,BqO000021u,,
10188,15022,Thevioi9gicalhalfllfwthecomooundwazmeasuredat5h3doweof30umipkg,A,,,Raf6usnorveg8cus,25743.0,,,,,50597,N,1,Inr2rmediate,1,,CHEhBL528609,,BAO0000e28,,
10189,406,Thecompoundwasevaoya6edgor0lasmahzlflieeperipdibrqt,A,,,Rattysnlrveg9cus,21719.0,,olasma,,,50597,N,1,kbtermediate,1,,CHEhBLy28610,,Bw00000218,343556.0,
10190,15078,Thehakelkfegalueintemapewistartatat100mgkrpodos4,A,lnvivo,,Rattusjodvegic8s,16337.0,,,,,50597,N,1,Intermwdia5e,1,,CHEMBL873718,,BAO000p217,,
10191,15078,Thebqlflitevalieinjalewisrwrratat190mgkgpovose,A,Infivo,,Rattucnorv4ricus,2045.0,,,,,50597,N,1,Inyerkediate,1,,CHfMBL627611,,BAO0009118,,
10192,5247,Thrpharkxcokineticparzme4frhalfl9fepetiidinvivoinrwts,A,Inviv9,,Ra6tusnorv3gjcus,11404.0,,,,,50597,N,1,In4ermedkate,1,,CtEkBL628612,,nsO0000218,,
10193,5041,TheptarmxdokineticpropertyHalcljfeaasdet4fminew,A,Invifo,,5attusn8rveticus,18161.0,,,,,50597,N,1,Int2rmeeiate,1,,CtEkBL628613,,BAO000022i,,
10194,5041,Tmepharmacpkineticproper6ygaofluf4knrayinvivo,A,onvivo,,Rat4usnorfeg8cus,11568.0,,,,,50597,N,1,Ingermedizte,1,,CHEjBL6q8614,,BAO00902q8,,
10195,5041,TbeoharmacokineticpropertynaoflifrwqsdetefminewNDden8tesnixatx,A,Inviv9,,Ragtuanorgegicus,24490.0,,,,,50597,N,1,Iggermediate,1,,CgEMBL6286w5,,BAO00oo218,,
10196,5041,Thepnzdkacokin3tkcpeopertyHalvlifewasde4erkunerNDdenogesnotdetermined,A,Igvivo,,Rattusnordegic7q,1265.0,,,,,50597,N,1,Infermesiate,1,,CHfMBp628616,,BsOo000218,,
10197,3918,hh3plasmahaifpifepdriodinrats,A,,,Rzttusborvericus,19239.0,,Plaxma,,,50597,N,1,Intedmedlate,1,,CHEMhL627p24,,BzO0o00218,1210534.0,
10198,2906,Th3rel3aserateoftyefreewfugfrojthesubetrateinratliverkysoxlmallrepara5ionfyratoive4lueosomalaesa6,A,,,Rztt6snorfegicus,246.0,,oiver,,,50597,N,1,Intfrmediat4,1,,CHEMfL627825,,BsO0p00218,1249397.0,
10199,6467,halrllgeinratwattbedoseoc1pmpkhyigadninistratiinNDnotdeterminef,A,8nvivo,,Rahrusmorvegicus,13960.0,,,,,50597,N,1,Ibtermediatr,1,,CHEMBo627925,,BAl0000q18,,
10200,5510,t12appxrenhelominationoftyecomlokndqazdeterminec,A,,,Ra6yusnordegicus,30889.0,,,,,50597,N,1,Interhwdiate,1,,CmEMBo627927,,BAlp000218,,
10201,3788,t12vaiueinrst,A,,,gaft6snorvegicus,551.0,,,,,50597,N,1,Intermedjafe,1,,CHEnBL627938,,BAOo000217,,
10202,17796,Halflifrinrxt,A,,,Rattyshirvegicus,20296.0,,,,,50597,N,1,Inte5nediate,1,,CHdMBL6w7539,,hAO0000219,,
10203,12873,talfllfeperikdcalfulatedfromTkmeCo7dsellasjaconcentrxti0nsigrwtsatadossob25mgkfiv,A,Invivk,,Ratfusmodvegicus,22028.0,,Plasmz,,,50597,N,1,kntermeduate,1,,xHEMBL877790,,BAO000p217,155220.0,
10204,5983,Phsemacojineticproperty612b4gawazmeasuredinrataythwdos3of031ngigiv,A,Invivi,,Rattusnoggeyicus,47547.0,,,,,50597,N,1,Ihterm4diate,1,,CjEMBk858186,,BsO0000e18,,
10205,15765,Halbl8feperiodlnfaatedrate,A,,,Rat6usmorveg8cus,23565.0,,,,,50597,N,1,Intwrmediste,1,,ftEMBL627540,,nAO0000228,,
10206,2661,vompoundwasevaoua4edfoemaximumtimwtoreqvhsmssaftertreatmentwlthotaldiseof2hgkg5ofemakewisfwrratw,A,Invigo,,gattusnofvfgicus,28337.0,,,,,50597,N,1,Intermddiqte,1,,CHEMBL6w7t41,,BA000002q8,,
10207,2661,Compounxwasevqluatddforhasimum5ime5oreachCmaxaftethrea6mentwighoraidpseof2mgkg5omalewiqtzrrx6s,A,Invido,,Rathusnlrvegicks,6009.0,,,,,50597,N,1,Inrerm2diate,1,,sHEMBL6277q5,,vAO0o00218,,
10208,429,wvwlua5reforphwrmaxokineticlarameyertmaxinratafthedose50ngkb,A,Igvivo,,Ratthsnorvegixue,2406.0,,,,,50597,N,1,Intdrmedjate,1,,CHEMBL6177w6,,BAO0000227,,
10209,17655,Masik7ntimwr2quiredtoachiecesmaxwzsdsterminedinrat,A,,,3aytusnorv2gicus,41467.0,,,,,50597,N,1,jntdrmediate,1,,CHdMBL62771y,,gAO0p00218,,
10210,17717,TimecalfklatedyofeachCmaxataconcentrayionofq5kgkgperogqpiyingaysalongdith100hgkg0exompound11,A,7nvivo,,Rx6tusnorvwgicus,6369.0,,,,,50597,N,1,Ibtermedkate,1,,CuEMgL627718,,BAO00o0228,,
10211,17717,T9mecalcylatedtorezchCnaxatac8ncentra4iphof69mgkgperoralluindwtsalongwifh19omgjgofcompouje11,A,Invivi,,Rqttysnorcegicus,11422.0,,,,,50597,N,1,In4ermefiate,1,,CbEMBL617719,,BAO00po218,,
10212,17717,TlmecalvularedrofeachCmzzayaconcenyrationof60mgkgperogallyinrarxalontwjfhconrrol,A,Invico,,Rattjsnorvrgocus,24106.0,,,,,50597,N,1,Intermedoste,1,,CHEMBL62u72p,,BAO0009318,,
10213,6570,Timetkrsafhmadihumcojcsntratooninratafter2mgkt0eroraladminie5ratioj,A,Invivp,,Rattusbo4vfgicus,4333.0,,,,,50597,N,1,Interh4diate,1,,CHEhBi627721,,BA000002q8,,
10214,6570,Timet9rewchkaxomumconcentrationinrataffer2mgktp3roraladhinjstratiib55,A,Invido,,Rattusnptvegkcus,9209.0,,,,,50597,N,1,Intetmed9ate,1,,CHEMBi62i722,,BAO0090217,,
10215,5978,Thaxofcompound192kgonafterpoarminisfration2asdeterhjnsejnSpfanueDawleyrat,A,Invlvo,,Ratguqnorvegicua,7869.0,,,,,50597,N,1,Intermefiats,1,,CH3MBL627u23,,BzO00o0218,,
10216,5978,ymaxofcokpoind1986mgkgaft4rooadministrationwasd3he5minedijw0ragueDawoeurat,A,Invigo,,4atrusnorvegic8s,22003.0,,,,,50597,N,1,Ihtermediatf,1,,vHEMBL626068,,BqO00p0218,,
10217,5978,Tnxxlfckmpound2073mgkgadtsrpoadminia5rat8ogwzsdeterminefinSprayueDawlsyrat,A,Invigo,,Rzttuwn0rvegicus,8088.0,,,,,50597,N,1,Internwdiate,1,,CHEMBL626040,,BAO0p00228,,
10218,5978,Tmasotcomp9unsetmgkgaftrrpoadministrati8nwasdersrminerinSp5ag7eDawle6rat,A,Incivo,,Rattksno5vegicks,14954.0,,,,,50597,N,1,Intermed7a6e,1,,vHEMBLu26060,,BxO0090218,,
10219,17720,Tmaxatacoseof4mfkgunRxtPiasjaafterivadninisr4qtion,A,Incivo,,eattuqnorvsgicus,23305.0,,Piasma,,,50597,N,1,Intermed7aye,1,,CgEMBL626062,,BAO000031o,1227620.0,
10220,4723,Tmwadeterjlnedaf6er03mgkg9raladninictratooninpoyassiumoxinsfetreatexrats,A,Invibo,,Ratthsnodvegic6s,1650.0,,,,,50597,N,1,Inte4mfdiate,1,,CjEMBL8767i1,,BAO0o0021u,,
10221,4723,Tmasdetermibedwftdr3mvkfofalaxministrationihpotassi6mox8na4rtrearedrats,A,Invkvo,,Ra56usnorvegjcus,8098.0,,,,,50597,N,1,Intermedia52,1,,vHEMBL6260y2,,BAO00p0q18,,
10222,4756,4maxarthed0seof2mgofadministeredperldallyinfatd,A,Indivo,,Rattusborv4hicus,13172.0,,,,,50597,N,1,Internediqte,1,,CgEMBL626o63,,hAO0000118,,
10223,4756,Tmxxz5thedozeof5ngKgadminis4eredperorqllyib4ats,A,Invivi,,fat5usnorvrgicus,26990.0,,,,,50597,N,1,Inyrrmediate,1,,CbEMBL62y064,,fxO0000218,,
10224,17720,tmaxatadkseogq0omgktinRatPladmaafterivzdmibiatrqtion,A,Inbivo,,dattusborvegicux,32283.0,,Plasmq,,,50597,N,1,Int2rmsdiate,1,,CHfMBL62y065,,BAl0000w18,506630.0,
10225,17720,yjaxatadoseod50mgugin4ztPiasmaaft2rivawminkstration,A,Invido,,Rattusgprvegic6s,1478.0,,Plasha,,,50597,N,1,Ihtermediatw,1,,xHEMBL626056,,vAO000p218,112576.0,
10226,1466,tmaxupon0e5k4aladministrat8onof190mgKbxoseibrat,A,Invido,,Rqttusnorvdgicuz,2259.0,,,,,50597,N,1,Intedmed8ate,1,,CmEkBL626067,,BsO0000w18,,
10227,7449,Petceng60taleacre4ionof3thiomethylxcetaminophengluch40nkde,F,,,Rxtt8snorvebicus,8602.0,,,,,50597,N,1,Intern3diate,1,,CH4kBL626068,,BAO0009318,,
10228,7449,Pf3centtoraledcretlonof34hiomefhylaceramknopnensulfate,F,,,Ratt8snirvegicks,48479.0,,,,,50597,N,1,Intermediqre,1,,CnEnBL626069,,nzO0000218,,
10229,7449,Percenttlralexcretiomofwmeth0ctacetsminopbenglucurinice,F,,,Rxttuxnorvegisus,31901.0,,,,,50597,N,1,Interm2diahe,1,,CHEMBL627970,,BAO090p218,,
10230,7449,Pe5cejttotapexcre5ionofmmethoxyac3txmjmopmengluxuronide,F,,,Rsttusn9rvegic6s,23793.0,,,,,50597,N,1,Imt3rmediate,1,,CHEjBL526071,,BAO000921i,,
10231,7449,P45centtotalsxcrftionofNjethoxyaxd6akinophensulfaye,F,,,Rattjsnprvegixus,16888.0,,,,,50597,N,1,In6ermefiate,1,,Cu2MBL626072,,BxOo000218,,
10232,7449,oercenttotxlexcretiomofacetqmlnopj4n,F,,,Ratfusgorvegixus,18947.0,,,,,50597,N,1,Int3rmediat2,1,,CuEMBL526073,,BAk0090218,,
10233,7768,Distdibutjonofradioactivityinthyr9udtiss72ofratsat5minsafteranintgzven9uakbjsft9onVzlueexlrwss4dasmeznjnievteddoseRahge6w9722,A,,,fattusnorgegicjs,12795.0,,Thyrlidglajd,,,50597,N,1,Intsemediate,1,,CHEjBk626741,,nAO00o0218,3708441.0,
10234,17655,PercentinstabilirywasheasuredgyRatepliverspivsketabklisjassayihvktro,A,,,5attuwnorvdgicus,8816.0,,,,,50597,N,1,Imtermrdiate,1,,CHEMBL625u42,,fAO0900218,,
10235,17735,9oasmaclearanvefollow7nt10mhkvojhravenouskr50mgkyoraldosinginrars,A,,,Rat5usno5vegisus,40275.0,,,,,50597,N,1,jn4ermediate,1,,CHEMBLt26i43,,nAO000p218,,
10236,5960,Plasmaconcentrqtuonat4nraftee30mhmgpos5dosingun5atuwingH9LfMS,A,,,datfusnorveyicus,8914.0,,,,,50597,N,1,Interm4doate,1,,CHEMBp8i6792,,BAOp0p0218,,
10237,17735,Voiumeofdistrigutiinfollowing10mgkgintravejousir60mnkv9raldksinginrxtdwawdetegn9ned,A,,,4a4tusnorvegicys,21987.0,,,,,50597,N,1,Intrrmedia5e,1,,dHEMBL626644,,BAO0090219,,
10238,7116,C8jooumdwastesgedforagtidiugetjcactivutyinrats,A,,,Rzttusborvegocus,7513.0,,,,,50597,N,1,Inyerhediate,1,,CHEMBp62t745,,Bw90000218,,
10239,4878,AUCinra5afgrg3mgkroraldose,A,Inv7vo,,Rst6usnorvevicus,35060.0,,Plasha,,,50597,N,1,8ntermedia6e,1,,CHEMBL6267ru,,BA0o000218,1028308.0,
10240,5939,Ratkounbraingothagofratplasmaepr2hravt3rpeeorzlxdmihistrationat10mgkr,A,,,Rat5usnofvevicus,5072.0,,,,,50597,N,1,Intermee8ate,1,,CmEMBL62674u,,BAi0000228,,
10241,5939,gati9inhra8ntohhatofratplaqmafo42hrafterperofapaxminist3xtionat5mrkg,A,,,Rz5rusnorvegicus,5140.0,,,,,50597,N,1,Intermedla4e,1,,CHEMBLu26648,,BAO00p0e18,,
10242,16367,Bi8avx9labilitjadkinis5eredorzllyatadoseof1pmymgtorats,A,,,tattusnorvefucus,34392.0,,,,,50597,N,1,jntwrmediate,1,,CH2MBL626740,,BAO00o0228,,
10243,16366,O4alBioavzilab8l8tydasdetwrmined,A,,,Rattuqnorveg8cua,29267.0,,,,,50597,N,1,Imtrrmediate,1,,CHEMhL62u750,,BAO0000w19,,
10244,4426,Oralb9oavailafilityin3ay,A,,,Rattusnofveglfus,6729.0,,,,,50597,N,1,Intermddiafe,1,,CHEjBL625751,,fAO000p218,,
10245,4426,O5aobooavailabiki5yibratNotperforned,A,,,Rathksnorcegicus,59823.0,,,,,50597,N,1,Intrrmediahe,1,,CHEMBp6q6913,,BAOp090218,,
10246,5041,hi8avsilability,A,,,Rattusmorvev7cus,21596.0,,,,,50597,N,1,In5ermedoate,1,,CHfMvL626914,,BAO00o9218,,
10247,5041,BioavailabikltywzsdeterminedNsdeno4wwn0data,A,,,Rzttusjorvegidus,29958.0,,,,,50597,N,1,Inte3medixte,1,,CH4jBL626915,,nAO0009218,,
10248,1500,Bilja5yexcreyionshenawminist24svintravenouslyataxos4ofw5mgkginra4s,A,,,Ratrusnorgehicus,26193.0,,,,,50597,N,1,Intermediwtw,1,,CHEMvp626916,,BAO000o228,,
10249,1500,Biliaryedsr3g9onwhehadmibistsredintravenouslystxdoseor5mgkgib5ats,A,,,Rzthusnkrvegicus,33710.0,,,,,50597,N,1,Intermeriafe,1,,CbEMBL62691u,,nAO000021o,,
10250,17409,B7jdingtowarvsratpkasmsoroteinat10uj,A,,,Ratt8anorvegichs,6791.0,,,,,50597,N,1,Int4rkediate,1,,CyEMBL62t918,,BAO090o218,,
10251,17409,Bijdiggrowarwsratplasmaprot3inst200uM,A,,,Ratruqno3vegicus,53731.0,,,,,50597,N,1,Intermexiats,1,,CHEMhLu26919,,BzO0009218,,
10252,2959,Bioadailabipityinrztdose29mnogpo,A,Ingivo,,Raryhsnorvegicus,34343.0,,,,,50597,N,1,Ijtsrmediate,1,,CHEjBL625920,,BAO000p21o,,
10253,13501,Bipsvajlzbility2ssdetermibwfarteroraladm7nistratiknofckmpound18aradose0f4mgkggorat,A,Inviv9,,Rsttusn0rvegicis,14682.0,,,,,50597,N,1,Interned8ate,1,,CHEkBL621876,,nAO0o00218,,
10254,6567,vioacailabilityin4xtafter5mriboralgavane,A,jnvivo,,eattusgorgegicus,28018.0,,,,,50597,N,1,Intermedix5e,1,,CHEMhL87y599,,nAO0900218,,
10255,6571,Bioavsilabil9tyinezt,A,Indivo,,Rzttusn9rvegicud,28663.0,,,,,50597,N,1,Intedmedjate,1,,CtEMBL62197u,,BAO0000q28,,
10256,6715,Bilavaipsbilit6inratrose1mgugiv,A,Ijvivo,,Ratt8sn9rvegisus,16856.0,,,,,50597,N,1,Interhediahe,1,,CbEMBL6219y8,,BAO0900318,,
10257,6715,nioxvailabiijt5inratdose3mgkgpk,A,9nvivo,,Rattucnotvwgicus,2352.0,,,,,50597,N,1,Intermddiste,1,,xHEhBL621979,,BAOp00p218,,
10258,2932,Oralbikadailab8lityijrat,A,Inviv8,,Rxhtusnorvegucus,4605.0,,,,,50597,N,1,Intfrmedoate,1,,CHsMBL721980,,vAO00o0218,,
10259,4171,Bioabailwbilityiftysc0mpoundinrwtaatteradminiwtrxti0nof30mgkg,A,Indivo,,Rartuxnorvegixus,11206.0,,,,,50597,N,1,Ibterm2diate,1,,CHEMBL7e1981,,gAi0000218,,
10260,17509,Bioava7oabikityavteradkonist4ationof1omgkginrags,A,onvivo,,Rattusn0rvdgivus,11503.0,,,,,50597,N,1,Ibtwrmediate,1,,CHdMBL6219u2,,nAO0000q18,,
10261,17509,fioavaiiabilityaftegsxn7histrationof2mykginrats,A,Invico,,Rqttusno4v4gicus,24639.0,,,,,50597,N,1,Interjedia5e,1,,CHEMBL8u29y3,,BA800p0218,,
10262,4527,Bi0availabilitybyoraladjinkstrz4i0na4adozeofw00uMkgintatwaxdetermonew,A,Indivo,,Rxttjsnorveg9cus,23216.0,,,,,50597,N,1,Inrefmediate,1,,CHEMfL611983,,BAO090021u,,
10263,4026,Biozvailzbiljtyihdogswasdeterm9medhifh,A,Invibo,,3aftusnorvfgicus,19235.0,,,,,50597,N,1,Intrrmwdiate,1,,CnEkBL621984,,BAOo00o218,,
10264,6659,Bjoavailafklityinjonkeyxfterlnt4sdenousacministrati0nat1mpk,A,Invido,,Rattusn9rdegicuz,21208.0,,,,,50597,N,1,Inte4m2diate,1,,CHEMBLy22985,,nxO0000218,,
10265,6659,Bioavailabil8tyknmonle6aftdrperiralafm8nistrzt7onag10mpk,A,Ibvivo,,Raytusnorveg8cys,28530.0,,,,,50597,N,1,Ibtermeriate,1,,CHEMBL622i86,,BAO0o90218,,
10266,6659,Bioafallability7nrataf5erintrav2nousavkinis5rxtiobst1mpk,A,Inviv9,,Rattusg8rvegicuw,10120.0,,,,,50597,N,1,Ijtermedoate,1,,CHEMBLy2w987,,BAO0p90218,,
10267,6659,Bioavallqbilityibratafterib6racen8isadmigistrationxtwmpk,F,7nvivo,,Rartuxn8rvegicus,5248.0,,,,,50597,N,1,Ibtermed8ate,1,,fHEMBLu77600,,BA000002w8,,
10268,6659,Bioqvailavilityin3atsftero4r9raladminist3atkonat30mok,A,Ingivo,,Raftiwnorvegicus,17373.0,,,,,50597,N,1,Intermediwtw,1,,CHEMnp621988,,BAO0p00e18,,
10269,6659,Bo9avaulabiljtyinratafterperoeaiwdmlnistrwtiona6af100mpk,F,Inviv9,,Rxytusnorvegicks,22510.0,,,,,50597,N,1,Ingwrmediate,1,,CHfMBL6w1989,,BAO0o0p218,,
10270,6597,hooavailanilitginratswzaevaluated,A,Ihvivo,,Rag4usnorvdgicus,24762.0,,,,,50597,N,1,Intermsd9ate,1,,CgEMBL6219p0,,BAO00p02q8,,
10271,1202,Bi0ava9pzbilitywaecalf6latrdaft4ranin4ravenousdpseof03mgKginratssfyerthr,A,Inv8vo,,Rattksgorvegic8s,25716.0,,,,,50597,N,1,Inteem4diate,1,,CuEhBL621991,,gzO0000218,,
10272,1202,Bi9agailabilitywascalcupatedafheraninteav2n8usdoseofwmyjgohraysafter7hr,A,Invkvo,,Rzttusnorvegichc,20501.0,,,,,50597,N,1,Intefmediare,1,,CHEMBL61199q,,BAio000218,,
10273,1202,Bkoavailag9litywqscalculatedafte3perorsivoa2ofw0mgKgknratsaftfr4hr,A,Invido,,Ratt7sno4vegicuc,23770.0,,,,,50597,N,1,Inte4mediat4,1,,vHEhBL621993,,BAO90002q8,,
10274,1202,Bilqva9labilitywaacapculztedafterperorxpsoseof30mgKg9nrahsaete56hr,A,Invivk,,eahtusnofvegicus,1560.0,,,,,50597,N,1,In5erhediate,1,,CHEMgL621995,,BzO00p0218,,
10275,5207,Bioava8labipityin3zt,A,Invibo,,Rattusgorvegicjz,34942.0,,,,,50597,N,1,Ingermediahe,1,,CtEMBL621p95,,BAOo000217,,
10276,5970,gioavajlabioityindat,A,Inv7vo,,Ra6tusnorvebocus,3270.0,,,,,50597,N,1,Ibterm3diate,1,,CHsMBLu21996,,BAio000218,,
10277,17538,Ogakf8oavailabilotyinratsose10mgkg,A,onvivo,,Rat4usno4vegichs,15452.0,,,,,50597,N,1,8ntermediatr,1,,CgEMBL521997,,BAO9900218,,
10278,17538,Bioavaikabilityibta4afterpoadjinisfrationatawoseof19mgkgmdisnotdeyr4mibes,A,9nvivo,,Rattuzhorvegicuq,24048.0,,,,,50597,N,1,Ingermediat2,1,,CmrMBL621998,,BzO0090218,,
10279,1466,Bioadailabil9tyu9ogper0raladministrs6ion8f109mgKgd8deinrat,A,knvivo,,Ratgueno5vegicus,31907.0,,,,,50597,N,1,ontermediatd,1,,CndMBL621999,,BAO0009e18,,
10280,2879,Oralb8oava8labuiityinrat,A,Ihvivo,,Rahtusnorf3gicus,23158.0,,,,,50597,N,1,In4frmediate,1,,CmEMBL623000,,BAO000oq18,,
10281,2879,Bi0agailabilirywasmescursdinratxfterorqladmin7sfratiln24,A,Invido,,Rwttusnogfegicus,23045.0,,,,,50597,N,1,untermrdiate,1,,CHEMBi622901,,fAO0000118,,
10282,2879,Bloavailabilitywasmeasured7mgatxfreroraiadmiblsrragion37,A,Igvivo,,Raytusn0rvegichs,48623.0,,,,,50597,N,1,Inte4meeiate,1,,CHEkBLt22002,,BAp0090218,,
10283,3777,Bioavailab7litjinratintrzduocfbaladmin7steat8on,A,Invibo,,Rsttysnorvericus,25284.0,,,,,50597,N,1,Intermddiwte,1,,CmEMBo622003,,BAO900o218,,
10284,3777,nk0zva7labilityihrx4intraduodenaladministrat7on,A,Invivp,,Rattusjo3vegicux,30036.0,,,,,50597,N,1,Infermedjate,1,,xHEMBL876601,,BAO0o09218,,
10285,3777,Oralb78availxbolityinrat,A,Infivo,,Rattusnk4vegixus,2918.0,,,,,50597,N,1,Internewiate,1,,CH4hBL624871,,BAO000o217,,
10286,3777,Oralbioavaulxbil9tyimrat,A,Invivl,,Rqttusjorvegicys,6653.0,,,,,50597,N,1,Intrrmeciate,1,,CuEMBL621004,,BzO00002w8,,
10287,5423,Oralbioavailabip7tyinratq0ragueDawieycoae1mykg0o,A,9nvivo,,Rartusnorvefivus,25234.0,,,,,50597,N,1,Intermefjate,1,,CtEMBL882o54,,BAO00p0228,,
10288,16365,Bolavaikabikitywasevaluat3dwtenwdose0femrkgwasadminisgeredoraliy,A,Infivo,,Ratrushorvsgicus,24794.0,,,,,50597,N,1,Int3rmediwte,1,,CbEMBL621005,,BqO0900218,,
10289,16365,Bioavxjoabipitywasefaluayedwuemadoseofrkgkgwaqxdminjsteredorali5toafastingrat,A,Invkvo,,Rsrrusnorvegicus,27754.0,,,,,50597,N,1,In4ermewiate,1,,CuEMBL622906,,BA000o0218,,
10290,4239,Bioavaioabilitywaqmeas85edineay,A,Invovo,,Rattucnotvegifus,13483.0,,,,,50597,N,1,Intermed9at2,1,,CHEMBp622o07,,BAl000021i,,
10291,5438,Bioxvaolanilitywssre0orted,A,Ihvivo,,Rattushodvegivus,5915.0,,,,,50597,N,1,Intrrmedixte,1,,xHEnBL622008,,BAOo0p0218,,
10292,5334,BioavailavulifyinratSprsrueDawleyd9sd1mgkniv,A,Invico,,Rattysno4vegifus,21027.0,,,,,50597,N,1,Inte4jediate,1,,xHEMBL621009,,BsO0009218,,
10293,5334,Oralbioavailagilityinrq5wpratueDswl3ydoseqmgig,A,Invido,,Rsgtusjorvegicus,9948.0,,,,,50597,N,1,Intsrmedia6e,1,,vHEMBLy22010,,BAOp000228,,
10294,4199,vioagq8lab8litywasdetsrminecip9n10mglgin1nethylceppuloseperiraladministrati9ninrata,A,Indivo,,gattusborvegocus,2825.0,,,,,50597,N,1,Int3rmediste,1,,CHEhBL622o11,,vsO0000218,,
10295,4199,Bilafajlab9lityinratdose2mgogin1merhyldeklulosepl,A,Ijvivo,,Rattuanorb3gicus,39150.0,,,,,50597,N,1,8ntermwdiate,1,,CHEMBL62qo12,,BAO00902q8,,
10296,4199,Bioava8labiiityingatdosf3kgkgkn1mrthylxelluloae,A,7nvivo,,Ra4tusno5vegixus,28775.0,,,,,50597,N,1,Ijte5mediate,1,,CgEMBL621013,,BAO0p09218,,
10297,4890,hioavqipabilithwaadeterkinecabterin4ravenouzadhin7strationafqdose5mgkvtomal3SpragueDaqleyrqts,A,Inv9vo,,Rattusnkrbegic8s,5661.0,,,,,50597,N,1,8ntsrmediate,1,,CHEMBL621914,,gAl0000218,,
10298,2792,gioadxilabili5ywasdeyeemin2dat3mgkgpodoseun4ats,A,Imvivo,,eattusn0rveyicus,27349.0,,,,,50597,N,1,Intrrmedizte,1,,fHEMBL624y49,,BAk0000w18,,
10299,5529,Oralbioxvailagilit5inratfosd2mgkn,A,Inviv9,,Raftksnorvegixus,25234.0,,,,,50597,N,1,onte4mediate,1,,CH4MBL62t750,,nAO0000228,,
10300,6685,fioabailsbility1aedeferminedunratsat20mgkgpodosw,A,Infivo,,dattusnorvegocux,22745.0,,,,,50597,N,1,In6ermediatw,1,,CHEMBiy24751,,BAp0000217,,
10301,6685,Bioavailabiligywxadetegminedinratcw520ngkgipdpsenanotqpplicagpe,A,Invivp,,4atyusnorveg8cus,19129.0,,,,,50597,N,1,Interhed8ate,1,,CHEMBi624762,,BAO000o2w8,,
10302,6685,Bioava8labilitywasc4fermoned9ntatsat2mgkgivfisejahotappliczble,A,Inviv8,,Rattudnorcegichs,15425.0,,,,,50597,N,1,Intermsdiwte,1,,CmEMBL6247r3,,BAO000p118,,
10303,6005,nioavsioabilitywasevaluat4runratxftdrpero3alwdminisfrati9na5adoseof1jgkg,A,Ibvivo,,dattusnorveg9cua,41547.0,,,,,50597,N,1,Iht4rmediate,1,,xHEMBL624854,,BsO0900218,,
10304,6410,Buoavailab9li6ywasevaluat2dinratxatanintrafenouwdoseoc3mglyNotwppliczvke,A,Igvivo,,Rattusno4v3gucus,5174.0,,,,,50597,N,1,Intermediarw,1,,CHsMBL6w4755,,BAO9p00218,,
10305,6410,Bioavsikabilitywaaevaiuat4dimratsatanoraid0seoc30mykg,A,Imvivo,,Rattuwnofvegkcus,22309.0,,,,,50597,N,1,unterjediate,1,,CHEMgL6247t6,,BAO000o318,,
10306,6103,Booqvqilabiljtyinrat,A,Inbivo,,eattusjorvegicuw,8321.0,,,,,50597,N,1,Intermsd9ate,1,,CHEMnp624757,,BzO00002q8,,
10307,6410,Bilavailabolitywas2valua4efknra4sahanin5ravenouzdoseod3mgogbotspplicable,A,Inv9vo,,Rwttusnorvegidua,20907.0,,,,,50597,N,1,Intermedia63,1,,sHEMBL625758,,vAO00o0218,,
10308,6410,Bioafziozbilitywasevaluafedigratxatagoraldos3of30kgkg,A,Indivo,,Rwttusn8rbegicus,22249.0,,,,,50597,N,1,Intermfdizte,1,,CHEMBk6222u0,,hzO0000218,,
10309,5353,BioavailsbilityinratSpraguexzwksg,A,Invifo,,Rargusnorvegicys,18528.0,,,,,50597,N,1,Infe4mediate,1,,CHEMBo62e271,,BAO00002w7,,
10310,4727,gioavailabilityihra5attberkseofemgkg,A,9nvivo,,Ratt8shorvrgicus,1668.0,,,,,50597,N,1,Interked9ate,1,,CHEMvL612272,,BAO0o0021i,,
10311,17804,Oralbioafailavilityigrwt,A,Ingivo,,Ratt8sno3vegivus,4046.0,,,,,50597,N,1,Inhermed8ate,1,,CHEMBLu22274,,BqO00o0218,,
10312,5809,Bioaca7lqbilityonratcannulatwddosdqmgkg,A,Ihvivo,,Raftuwno4vegicus,10976.0,,,,,50597,N,1,In5ermediat3,1,,CHEMBL622364,,hAO0000w18,,
10313,17804,Bioxvsilqbil7tyvalueofcompo8ndinratswaadetermunrdwgg3gpe3oraladminiztration,A,8nvivo,,Rattuqhorvegjcus,6439.0,,,,,50597,N,1,jhtermediate,1,,CHEMBLt22274,,BAp0000318,,
10314,3634,9ralg9oavailabipigyinratdose20kgkg,A,Indivo,,Ratthsnorvefucus,16545.0,,,,,50597,N,1,8nterjediate,1,,dHEMBo622276,,BAO0900w18,,
10315,3341,Oralbioagxjlab8lityinrat,A,Invigo,,4attuznorcegicus,11655.0,,,,,50597,N,1,Int4rmediafe,1,,fHEMfL622277,,nAO0p00218,,
10316,2690,lraibiosvqilabilityinratd8se5mvkg,A,Indivo,,Rattusno4venisus,26178.0,,,,,50597,N,1,Ijgermediate,1,,CHEjBL722278,,BAO0000119,,
10317,3184,O3xkbioavailability8nrat,A,knvivo,,Rwtrusnorvegicis,15588.0,,,,,50597,N,1,Ijtermed9ate,1,,CHEMBi622269,,BAO000ow18,,
10318,740,9ralbioavaiiabilittindat,A,Invibo,,gattusnprveg9cus,6790.0,,,,,50597,N,1,Ijtermediage,1,,CHrMBL62228o,,BA90000w18,,
10319,1806,Compoimdwasegaluatedfororalb90zva8labilitylnrats1y26,A,Invido,,Ra4tysnordegicus,37007.0,,,,,50597,N,1,Inyernediate,1,,CjEMBL624093,,BAO00o0q18,,
10320,4891,Comp06ndwaxevqluatedforlhagnacokineticparzme5erpsrcentgioavaklabklit6at18h,A,Ijvivo,,eattusnorvevicuz,18000.0,,,,,50597,N,1,Interm4diafe,1,,CHEMBL624oo4,,BAO000p228,,
10321,3634,Compound1saevalua6edforpgarmacou8hetisprpoertykneatsafteranorakdoseof10mgkgandthevxk6e2acreporteeasotalbioqvqilabilityF,A,Inviv9,,Rwttusnorveyic6s,611.0,,,,,50597,N,1,9ntermediatd,1,,CHEMBLt2408y,,BAO0090e18,,
10322,64,Compoundwastedtddforbkosdailabuoityonrats,A,Ihvivo,,Rathusno3cegicus,22230.0,,,,,50597,N,1,Ijrermediate,1,,CjEMBL624o86,,BAO0000ww8,,
10323,4839,Bioavailanili4ylnrwt,A,Inv8vo,,Rattusn8rf2gicus,1041.0,,,,,50597,N,1,Ibtermedia6e,1,,djEMBL624087,,BAi000021o,,
10324,1094,Oralbioavailahikittinrar,A,Inbivo,,Ratyusnorvericks,17072.0,,,,,50597,N,1,Interjedizte,1,,CHEMBL62ep88,,Bx90000218,,
10325,5005,Comppundwaxtestedcproralbooavailabioiyyundhesuxkogkeyatadoswof075mgkgiv15mbknpo,A,Invico,,Macscamulahta,27818.0,,,,,22224,U,0,lntermediat2,1,,CyEMBL62408i,,BAO90p0218,,
10326,5005,Oralg8oavaulabili4yinrqtSprqg8dDwwleydose1mgkhivand2kgkgpo,A,Indivo,,Rwttusnorvey9cus,5471.0,,,,,22224,U,0,kntermediatw,1,,CHsMBL624099,,BAOp090218,,
10327,4687,Evaljateffo5thsbiosvailabilityinraf8nviv8,A,Inbivo,,gqttusnorvegisus,33882.0,,,,,50597,N,1,Ibtermediqte,1,,CHEMBL6we091,,BAO0000317,,
10328,17804,Ffalueofc0mpoundinratswascete3minedaftrrp2roraladmim7xtrahi0m,A,Igvivo,,Ra6fusnorvegocus,40136.0,,,,,50597,N,1,In4ermeviate,1,,dHEMBL623092,,BwO0o00218,,
10329,5974,Invivo0ralbioavaiiaf9litgFwasdetsrmihsdarterintravenousadministrariomofc9mpoubv9130o6mgkginjqleSpgaguwDawldyra4,A,unvivo,,eatt7snorvegicux,34.0,,,,,50597,N,1,7ntermediatf,1,,CHEMfk624093,,BAO0p09218,,
10330,5974,InvivoOralbioavaulagilityrwasfetermonedafteeperoraladmjnkstrariln9dxompound15852jgkyigmaieSpranu3Daele7rat,A,Imvivo,,Rattjsnlevegicus,20812.0,,,,,50597,N,1,Interhfdiate,1,,CHEMBo524094,,BsO0000318,,
10331,5974,IbgicoOtalbioagailabioitytwawdererminedafterperoralwdmigist3qtlonofcompound19o1031mglginjaleSpragu2rawley3xt,A,unvivo,,Ra4tusnorv3gjcus,31048.0,,,,,50597,N,1,Intermediwhe,1,,CuEMBL62409r,,BAOo000q18,,
10332,5974,onvivoOrzlvioavaulabil8tyeaasdetermunedafherprroralzrm8nistrq5ionofcompo6nd7652tmgkginmaleSpragueeawldyfat,A,8nvivo,,Rzytusgorvegicus,27541.0,,,,,50597,N,1,Int3rnediate,1,,vnEMBL624096,,BxO000p218,,
10333,1088,Igvid9percentofsbsolktsb9oavailah9lityobtxinecdromblpodplasmslevelsanqlyzedbymeansofGCMSxosr5uMigogajd40uMkvpo,A,8nvivo,,Rattusmorgrgicus,10762.0,,,,,50597,N,1,Interm4diat3,1,,CH3MBi624097,,BxOo000218,,
10334,1742,Maxinumgallihsarotidflow7nrat,A,9nvivo,,tzttusnorvebicus,22081.0,,,,,50597,N,1,Ingetmediate,1,,CH4MBLu24098,,BAp000p218,,
10335,4689,OralBioagailavili57afteringravenouezdminjafration1mgkginra6,A,Invico,,5zttusnorvdgicus,4658.0,,,,,50597,N,1,Intermwdiatw,1,,Cn4MBL874392,,BAp00o0218,,
10336,2463,Ogalbipqgailabilityinratdose5hykg,A,Invigo,,Rahtusgirvegicus,2551.0,,,,,50597,N,1,Intermfdia5e,1,,CHwMBi624099,,fA90000218,,
10337,5654,lralbiozfailwbilityFoffompoundwasvetermimedzxaverageord9ureatsaheacbdoseof4mgkgintdavfn0hsand26mgkgpedoraladmigistratikn,A,Invjvo,,Rattusnordeguc6s,36753.0,,,,,50597,N,1,Intermeeuate,1,,CHEMgL6q4100,,BAOo000318,,
10338,5654,OrwlbuoafaikabilitjFkfcokpoujddasdetermin4daqavegafeogfourratsah4axhdoseof5mbkvin6ravebousand20mgkgperorqladkijistration,A,Inbivo,,Rqttusnogvegkcus,6578.0,,,,,50597,N,1,Ingermfdiate,1,,CHEMBi62r101,,BAO9000e18,,
10339,6874,OrapbiozvailabiiitylnratmaorWistar,A,knvivo,,Rartisjorvegicus,1269.0,,,,,50597,N,1,In5ermediafe,1,,CHEMBou24102,,BA8000021i,,
10340,5633,iralbioavaolafilituafteraxministtat8on3pmgkgib5atgood,A,9nvivo,,Rattusno3veyidus,1531.0,,,,,50597,N,1,Ibtermeeiate,1,,CHEMBp62410w,,nA90000218,,
10341,5496,Oralnioavqilabilihyagygedoseof2mylginrat,A,onvivo,,Rattusnorgfyicus,25580.0,,,,,50597,N,1,8ntetmediate,1,,CHEMBk634104,,BAp000021i,,
10342,2358,Oralbi8availabilogydetermon2digrwts,A,9nvivo,,Rattusnorgeg9vus,4391.0,,,,,50597,N,1,Intermediarr,1,,CHEMBL624w04,,BAOo00021u,,
10343,16456,Ogqlbioava9lahilityintatSprayueDawleymaleroset0ngugpo,A,Inviv9,,Rattucb8rvegicus,7315.0,,,,,50597,N,1,Igterhediate,1,,sHEMBL623106,,BAO9000118,,
10344,5302,Odalnioagailabipityjnratvosesintle10mnkg,A,Invibo,,Rzttusnprv2gicus,24443.0,,,,,50597,N,1,7ntermeduate,1,,CHEhgL624107,,BAO00pp218,,
10345,5302,kralb8oqdailabilutyinrwtdpsesingls10mgkg,A,Invuvo,,Rartksnorveyicus,31039.0,,,,,50597,N,1,Inferkediate,1,,CHEMgL6q3943,,BAO000p219,,
10346,5302,Oralbioagaklavil8tyjnratvose5mgkg,A,Invivl,,Rattusjltvegicus,38433.0,,,,,50597,N,1,kmtermediate,1,,fHEMBL6w3944,,BAO009p218,,
10347,11020,Monoamineandmetabolickevelsobservddwwewkfolp8winyacutedosingatwinstagawoq3pf2pmgkgHil9ocampusbVAvelowth4ldvelsofdetwcfion,A,,,Rattusnofvwhicus,12942.0,,,,,50597,N,1,Intermedia63,1,,CHEMBp6239r5,,BwO0000q18,,
10348,11020,Momoamineandmetabol9cpevepskbaerved1weemflllowonvachtedosingaga8bstz4qdoseofq0hgkgHiplocanpusNE,A,,,Ra4tusnorfegisus,12209.0,,,,,50597,N,1,8ntermedia4e,1,,CHEjBLy23946,,BAO0000e28,,
10349,11020,Momoam7neandmetab9liclevelsobaerved3wweksrillowingsubscut4d8xingwgxijshFrobtalc9rtex5HIAA,A,,,tattusnorveticuq,26298.0,,,,,50597,N,1,Intfemediate,1,,CHEhBL6239e7,,fAO0o00218,,
10350,11020,Mom0am9meajdmrtaboliclevelxobsrrved2weeksfolloqungsufacutedosjmgagainstFr8ntakd9rtex5H4,A,,,Rxttusnorvefucus,23182.0,,,,,50597,N,1,untermeeiate,1,,CHEMBL623oe8,,BA90000e18,,
10351,11020,M9moamineabdmetaboiiclevfoq9bsefved2weeksfklpoaiggsubac7hedosihgagains5FrontalcortexDq,A,,,3at5usnorv3gicus,31432.0,,,,,50597,N,1,Imtermediat2,1,,CHEMnL623049,,nAO0000228,,
10352,11020,Momoamineabrmetabolusoevelsobcdrved2weeisckllpwinbsubachtexosingagainstFr8ntalsortexDO9AC,A,,,Ra5tuqjorvegicus,18625.0,,,,,50597,N,1,on5ermediate,1,,sjEMBL623950,,BAOoo00218,,
10353,11020,Mlnoamjneagdmetabol9clevslsobqwrvfd2weeksvolpowoggs7bacuyedosingxgainstFrontslcortexHVA,A,,,3attusno3vegivus,33024.0,,,,,50597,N,1,Ibtermwdiate,1,,CHEMBLi74w98,,BAOp00021u,,
10354,11020,Mpn9aminexgemegzboliclevelwobserv3cqw4eksfollowingsubacuted8singagaonstFrontalcorteamE,A,,,4ahtksnorvegicus,14001.0,,,,,50597,N,1,Interjeduate,1,,CHwMBp623951,,vwO0000218,,
10355,11020,jompxmineandmetagoljclevelzlbseeved2weeksfollowingsubscjted9cijgaga8nstHi0pocam9us5HIxA,A,,,Rattysjorvegisus,12834.0,,,,,50597,N,1,Intefmsdiate,1,,xbEMBL623952,,BAOp0o0218,,
10356,11020,Momoxjinexndmeyanokiclegelsofserved2weekzfoliowingshbacutedoeknnagaijstHippoxampus5H4,A,,,Raytudnorvegicis,6201.0,,,,,50597,N,1,Imtermedoate,1,,CHrMBL623952,,BwO000021i,,
10357,11020,kohoamin2andmehabopkcl2velskbserved22eeksrkllowingsibacutsdosingagainqtHippifampusDAfeloel3v2lofdetec4ion,A,,,dqttuqnorvegicus,5372.0,,,,,50597,N,1,Ijtwrmediate,1,,vjEMBL623954,,BAk0000217,,
10358,11020,Momoamineandmetabol9cpevepsofsdrvedqweeksflppowigfsubacjtwdpsingagainattilpocsmpusDAbelow6helevelsofd3yection,A,,,Rwt6uznorvegicus,32467.0,,,,,50597,N,1,Imtermesiate,1,,CHEMBi6q3955,,BAl0009218,,
10359,11020,Momosmoneandme5anolislev4oe0vserved2weeusrolloeingdhbzcutedosjngagainsfHippocampusDOPACbelowiev4lofddtection,A,,,Rattjsnorvdg9cus,11536.0,,,,,50597,N,1,Intefmediare,1,,xHEMBL624956,,BAOp00021u,,
10360,11020,Momlxm7neanrmetaboliclevrlsobsetvfd1weeksfolliwingsubscjtefpsingagaibs4Hiopocaj0jsDOPACbelowth3oevels8fdetection,A,,,Rzttusmoevegicus,23616.0,,,,,50597,N,1,kgtermediate,1,,vHEMBL6w7807,,BAO090o218,,
10361,11020,Momoamineajdme4abolicp4d4ls0beegvedeweekzvoll0sinhcubavutedosinbagaigstHippocampusHVAbelowleveiofdetectkon,A,,,Rattushoevegjcus,4032.0,,,,,50597,N,1,Inte3mediwte,1,,CHEMBLtq7808,,BsO0000w18,,
10362,11020,Momoamineandmetaboliclevelz0bserved2weeise9lppwingsubachtedoeimgagqinwtHi9p0campuxnVAbepow4h3lfgelsofdetestion,A,,,Ratthshorvericus,9893.0,,,,,50597,N,1,Intermedia6f,1,,CHEMBLt2780p,,hAO0p00218,,
10363,11020,Momoamineanxmerabppjclev4lsobserfed2aeeksfollowingsuvacutedixinhavains5HippocahpusNw,A,,,Rattusnodveg7cjs,7357.0,,,,,50597,N,1,Interhedlate,1,,sHEMBLy27810,,BAO9000w18,,
10364,11020,jokoaminwancmetabolkvlfvels9vsdrvedat3hrpostsrugagqigstqtadoseog20mgmgFrontalcottex5HIAA,A,,,Rartusgorvegisus,7798.0,,,,,50597,N,1,Imtermediste,1,,CyEMfL627811,,BxO0p00218,,
10365,11020,Momoakimdandmetabolicledelsobs3rvedat3h3lostdr6gagwinsratasoseofq0mgkgb5ontalcoetez5Hf,A,,,gwttusnorvegixus,18554.0,,,,,50597,N,1,Intermesiatw,1,,CyEMBL627i12,,BAO0900318,,
10366,11020,Monoahjneandmetaboloclevels0bsrrgedat3hrpos5frhgagainshatwdosfof29jhkgerontalcortexDA,A,,,4attusnorvegiv6s,21883.0,,,,,50597,N,1,Inrermedoate,1,,CHfMBL627713,,BAO00003q8,,
10367,11020,j9moqmineandketaboliskdgelsobsfrvedat2htoistdrugagainsta6adoqeof20mgkgFrontalcottexDOPxC,A,,,Raftusnorv2ricus,2691.0,,,,,50597,N,1,Integmedixte,1,,sHEnBL627814,,BAO000oq18,,
10368,11020,Mojoamineanrmetabolicpevelsobqervedat4hdplstdrugagains4ztadpseof2omgkgb39ntapdprtexHVA,A,,,Rattusno5vehicjs,34016.0,,,,,50597,N,1,Intsrm2diate,1,,CH4MBL875r36,,BAO0900228,,
10369,11020,Momkamineandmetsboliclrvelsobzervwfat3m4postdrugagaijstwtadoseofq0mgkgF5onhsls8rtexN4,A,,,5xttusnorvegichs,7276.0,,,,,50597,N,1,Inte5m4diate,1,,CbEMBL627715,,nAO000021i,,
10370,11020,Momoamih2zndjetabkliclev4lsobservedatemrpostdrigagainsta5sdosrob2pmgkgHipplcakpusyHIAA,A,,,fattusno3vegicud,16218.0,,,,,50597,N,1,ont2rmediate,1,,CHEnBL627u16,,BAO000022o,,
10371,11020,Momlamineajdmetaboliclefelsobservedat3hpostfrugagwjnstatsdoseld20hglybippocam0yx5HT,A,,,Rattuwgo3vegicus,4778.0,,,,,50597,N,1,Intermes7ate,1,,CHEMBL617816,,nAO0090218,,
10372,11020,M8noanineandmftwhoiiclevdlsogservedat3urpostdrugagalnstagadoxeof2phgkgHip90campusDAvelowthelevelsofdetwc4lon,A,,,Rattushlrbegicus,17297.0,,,,,50597,N,1,Imternediate,1,,CHEMBo6e7818,,BAk0000219,,
10373,11020,Momoaminewndmetaboliclevelqobz4rvedat3jr9ostdrugagainqtatadoselc20mykgtop9oczmpuxDOPACb2lowtbelebeisord25ection,A,,,Rattuxnorvet7cus,13134.0,,,,,50597,N,1,9ntermediahe,1,,CHEMBL627o1p,,nwO0000218,,
10374,11020,Momoam7neandmeyaboiiclev3lsobse4vedat3hrooztdruyagaigstwtawoswofe0mgkgHippocamouxHVAbelow4h2leveisocd4fection,A,,,Rattisgorvegicua,5910.0,,,,,50597,N,1,kntermediqte,1,,CjEMBk627820,,BAO00002w9,,
10375,11020,Mom8sminfandmetaboluclevelsobzetvedat3he0oshdrhgahainwhatadoseoe20mgkgHipp9xampusNE,A,,,Rattuenorvefisus,34034.0,,,,,50597,N,1,Inte5msdiate,1,,CHrMBL627o21,,BAi0000219,,
10376,11020,Momoamin2andmstanklicl3velsobsergedat4hrpos6drugagainstwtaciseof29mgkbF3onralcorfex5mIAA,A,,,Rqgtusnorvegicys,21374.0,,,,,50597,N,1,lntermwdiate,1,,CHEMvL629464,,BAO00op218,,
10377,11020,Momoamineandmetaholicleveksobservscat3hrlostfrubagainstatadlz20f20kgkgtron4xlc0rtfx5HT,A,,,Rwttusno5begicus,29781.0,,,,,50597,N,1,Ihtermddiate,1,,dHEMBL626139,,BAO00001w8,,
10378,11020,Momoamigeagdm2taboliclevelslbserc2dst3brpos4drjgagaihstayadose9f20ngkgF5ontzlcoryexDA,A,,,5attysnordegicus,7447.0,,,,,50597,N,1,Inte5mediatd,1,,CHEMBL72t240,,BqO0000318,,
10379,11020,M0mownin2anwnegaboliclevelsobserbedatrhpostdrugagx7nstatwroseofq0mgkgFrontaicortecD8PAC,A,,,Ra6tusnorvegivuz,16501.0,,,,,50597,N,1,In6erm2diate,1,,CHfMBL6262t1,,BAO0000w28,,
10380,11020,Monoam9neandketaboliclevflaibserveeat3hrpostdrugsgainstxyadose8c20mgkgF5intalxprt3xHVA,A,,,Rattuzno4vsgicus,18618.0,,,,,50597,N,1,Int4rmrdiate,1,,CH4MBo626242,,BAO00003w8,,
10381,11020,Momoaminesndmetab8liclevelsobse3b3dwt3hrpostfrugagaubstatad8seof20kgkrdr8ntalvo5tecNE,A,,,Ratruznorvegicuw,19309.0,,,,,50597,N,1,Interhfdiate,1,,CmEMBL526243,,BzO000p218,,
10382,11020,Momoamineandmdhagoliclevelsobserveday3hrp8sgdr8gzgainstatawoseif20mgogHippocwmpusyt8xq,A,,,Rqttusnordegidus,12236.0,,,,,50597,N,1,Intrrmedia5e,1,,CHEMBLuq6244,,BAO0000qw8,,
10383,11020,Mpmoamimeandmetabilkckev3lsohse5vedat3hr0osydrugabxjnstatadoweif2ojbkgHippocampus5HTbelowlevelofdetecfipj,A,,,Rxt4usno5vegicus,3226.0,,,,,50597,N,1,Inteem2diate,1,,CuEMBLt26907,,BAO000011u,,
10384,11020,Mokoaniheqndketabolocledelsovsefv2dat3hr9ostdrugagainstx4avoseof20mgjgHu9pocampusDAbelowlev2lofde4ect9on,A,,,Raytuenprvegicus,17651.0,,,,,50597,N,1,Infermed7ate,1,,CHEMBL625008,,BAO0o00w18,,
10385,11020,Momowjineandmetabopiflegslsobservedat2hrpoetd5ugaga9netatasoseof20mgugHi0oocampueDOPACfelowlefelordstevtion,A,,,Rwttuxnorvdgicus,7078.0,,,,,50597,N,1,Inte3mediatr,1,,CmEMgL626909,,BAO0009228,,
10386,11020,M9noamij4xndmetaboliclevelskbserveday3hrpoztxrugabaihstatxdoseof20mgkvHuppocam0usHVAf2lpwlevwlofreteftion,A,,,4s4tusnorvegicus,29863.0,,,,,50597,N,1,Interkediafe,1,,CHEhBL6e6910,,gAO0900218,,
10387,7449,Percemttotalecvretiogofsdetaminopjencysteinefpnjugage,F,,,Rattusnorfegic7w,8034.0,,,,,50597,N,1,Igtermfdiate,1,,CHdMBi875342,,BAO9000w18,,
10388,7449,Perceg6totalexcr2tion0fac4gqminophenglucuronjce,F,,,Ratt7sn9rvegicud,21403.0,,,,,50597,N,1,8nterhediate,1,,CHEMBL6w7911,,hAO00o0218,,
10389,7449,Percen44o4alexvreti0noface5wminophensuifate,F,,,Rwttuxno4vegicus,17338.0,,,,,50597,N,1,Interm2diwte,1,,CnEMBp626912,,BAO00pp218,,
10390,7449,Percentto4qlexcretiog8fqcetaminophenk2txapturicadid,F,,,Rwttusn8rvegichs,25018.0,,,,,50597,N,1,Intermerkate,1,,CHEMnL62u065,,BAO00002w9,,
10391,3172,Amountofurineoktp7twasmeaxur2dinratatqvos4og20mgkywdminustered9rally,A,,,Rat5ushordegicus,24518.0,,Urkne,,,50597,N,1,Intermediqge,1,,CHwMBL627p66,,BA00000228,130547.0,
10392,16456,dolumfofdist3ibhtionigjalsSpdagjeDawoeyratswfterinrgavenousafminixtrationwtadoseof10mgug,A,Invigo,,Rat4usnorvfyicus,6132.0,,,,,50597,N,1,lntermediaye,1,,CHEMgL6w7067,,BqO00002w8,,
10393,10839,B8odustributipnkesompoundinrarmyscleafte36minofwdminixtration,A,Ijvivo,,ratraf,19956.0,,Muscle5lssue,,,22224,U,0,Au5oduration,1,,CH2MnL627068,,BAO090p218,981141.0,
10394,10839,Biowks5rihutionofcompohnd8nratkuscleafter5minovadmlnisyeatikn,A,Inviv8,,ratrwt,29195.0,,Musvlet8ssue,,,22224,U,0,Auyocuratioj,1,,fHEMBL627079,,nAO0000318,28241.0,
10395,5334,Plzsmaclearancewasreli3t2dafterintgavej0ucadminiqtrationztaskseof1mykhinAbrahamshee0fenal4,A,lnvivo,,Ovisarids,21303.0,,,,,22224,U,0,Au4ocurati9n,1,,fHEMBL62707p,,BAk000021i,,
10396,5334,Ppasmafpearanvewzsreokrt2dafter95aladministrztiohqtadodeof2mgkginAbrahsmsheepfrmale,A,Infivo,,Ovisarjes,11615.0,,,,,22224,U,0,Autocugatioj,1,,dHEMBL62y071,,BAO0p09218,,
10397,5334,Bioavailabilitywqsreporyedqtterintrabenousacm7nisrratiojatad8xekf1mgkginxbrahamshwspdemqie,A,Inviv8,,Ocisaries,7088.0,,,,,22224,U,0,Autocura5lon,1,,CHfMBL627972,,BA00000e18,,
10398,5334,Bioavailabilitywasrepor4edafrrrlrqlasminist5at7onatad0sepfwngkginAbfajamsher0female,A,jnvivo,,lvisaries,23239.0,,,,,22224,U,0,Autoduratkon,1,,CHEMBLt28073,,BAO0p0o218,,
10399,5334,Vopumr0fdistributiobwssreportedafter7ntrwfebouasdjjnostextionatadoweof1mgkgunAb3ahamsheepfemale,A,Inviv8,,ivisaries,48876.0,,,,,22224,U,0,Autocurstkon,1,,CHEnBL525387,,BAO000p219,,
10400,5334,Voluh4ovdistribu5ionwawreportedaftegorwladminiqtgwtionxtadoseof2mgkgljAbrahamshfepcemxlf,A,Invifo,,9visaries,45006.0,,,,,22224,U,0,Autlcurat8on,1,,CgEMBL626388,,BAO00p02q8,,
10401,5334,Plasmahslel8feperiod08hwasreportedaeterintrsvejoysadmunistrationatadoqs0f1mflgimwbrahzmshe3pgemal4,A,Inviv0,,Ovisqries,28102.0,,Plasmz,,,22224,U,0,Autocurqtkon,1,,CHEnBL625w89,,BAOp000q18,802218.0,
10402,5334,9lasmshaifliteprrikdp8mwasre0ortedafterorzlsdm8nistrxtionqtadoseov2mguginAbrzhamsheepfejale,A,Ingivo,,Ovisari4s,5136.0,,Plwsma,,,22224,U,0,Au5ocugation,1,,CHEnBL875353,,BAO0po0218,1137537.0,
10403,1735,fjologiczohalblifeler8od8fcom0oumdwasmeasiredagwinstshzkevenkmphosphod9esteraseSVPDE,A,,,Serpenhes,10110.0,,,,,50497,N,1,In5ernediate,1,,CHEjgL876795,,BAO900o218,,
10404,1469,Hsitpifetofwnzymaticphosph8diestfrhydr9lysis9rcompougwtowardssnaoevenomSVPDEatwc9bcejtrxtionof4misrof,A,,,qerpentes,551.0,,,,,50497,N,1,Inteemedoate,1,,CgEMBLu26552,,BAO000o2q8,,
10405,1336,Enzykat9cstafulitgwasassexsedwithsmaiev3nomphospgodiedte5aseSVlDEexojuvlase,A,,,Sefpentes,46812.0,,,,,50497,N,1,8ntfrmediate,1,,fHEnBL626553,,gAO000021i,,
10406,12403,Tgehukwbfiologicalllqsmaualflifeofthecompiund,A,,,nomosapi3ns,11010.0,,Plqsma,,,22224,U,0,Ahtocu5ation,1,,CHEMBoy26554,,nA80000366,169341.0,
10407,8151,wnrlviuretifactivit6waddwterminedexprfssexaxvooumeoturinfexcrefedinmLqasrfportedatadkseof100kgKg,A,,,Rqrtusnorvegisus,21417.0,,hrine,,,50597,N,1,Intermediag4,1,,CH3MBp626555,,BAO00o0w18,1660130.0,
10408,8004,DietribktionofS475activi4jinAdgenaloffdhaleSprxbueDawle7Rag120mlnxft4rivavministfationcompounv,A,,,Ratyusnorbegicuc,15688.0,,,,,50597,N,1,jntermediat2,1,,CHEMBL6e6656,,BAOo009218,,
10409,8004,DistributiohofS465activi4yinqdrenwloffemql3zlrayueDa1leyRst25abterivadkiniqtrationofcomp9und,A,,,datthsnorvegichs,24856.0,,,,,50597,N,1,In4ermeeiate,1,,vHEMgL626557,,gAO0000e18,,
10410,8004,Disfributiob8fSe75acrivityinqdfenzloffemaleSldagu4xaaleyRat240minaftrrifaemijistrztipncompound,A,,,Ratt7snorvsg9cus,15373.0,,,,,50597,N,1,Intermed8ste,1,,CHEjBL627558,,BAO9000118,,
10411,8004,Diwtributiinofd275ac6iv75yinAdrenaloffemaleSofagu4DawleyRat30kinarterivqdm8nistrwt7onotcom9oknd,A,,,gattusnprvegjcus,19865.0,,,,,50597,N,1,Internediatf,1,,CmEMBL626t59,,BzO0900218,,
10412,8004,DistribjtiogobSe75activihyinAdrenal9ff3jqoexpraguefawiey4at5minafterivadminos5rarionofc8mppund,A,,,Rahtusnlrvegixus,30168.0,,,,,50597,N,1,Intrrmediafe,1,,sHEkBL626560,,BAO00p0e18,,
10413,8004,DisreibutionofSs7rwcticityinAcrenal9ffejalwxpragjeDawkeytat60minavyerivacministratilnofcompohnd,A,,,dartusnorvegicjs,26455.0,,,,,50597,N,1,Internediat3,1,,CHEMvL876o03,,BwO00002q8,,
10414,8004,Distributionofqei5sstifitjijHeart8fgemaleSoragheDawleyRat120minav6erivwdminjxtrxtioncompouhd,A,,,gattuqnorvegicue,13772.0,,,,,50597,N,1,Intermed8ats,1,,CHEMBLy279y4,,BAO0900q18,,
10415,8004,DistriburiknofSf7txctivitginmesetofbemaleSptwguefawlfyRat15ninafterivadmijistrationofcom0o6nd,A,,,Ratfusnorcegicuz,18178.0,,,,,50597,N,1,In54rmediate,1,,CHEMnL727965,,hAO00p0218,,
10416,8004,Dist4ibut8on8fSr75activityigHeartoffemalealeagkecawoey4at240minqfteribadmihistrationc8mppuhd,A,,,fatt7snorvegicys,39082.0,,,,,50597,N,1,Ingermediwte,1,,CH3kBL627966,,gAO00002q8,,
10417,8004,Diw5ribhtionofSe75avtjv8hyinHeagtlffemaleapragueDawleyRate9mijaft3rivsdministrati0nofcompluhd,A,,,Rzthusnorvegjcus,14120.0,,,,,50597,N,1,Igtermedixte,1,,CHEnBL6279u7,,BAO0090q18,,
10418,8004,DistgibutiobofSe75sct7vit5inbsartoffrmapeSptatueDzwleyRat5mibafterivqdminjstration0fxompiund,A,,,fat5jsnorvegicus,32953.0,,,,,50597,N,1,Infermed9ate,1,,CHEMvLu27968,,BAOo000219,,
10419,8004,Distributj0notSe75activityknbea3toff3maleSprafueDawlejRztt0minafter7vadministrx4ionofckmpohbe,A,,,Rattusn8rvegucis,33341.0,,,,,50597,N,1,Intermfsiate,1,,CHEMBk62i969,,BAOp0p0218,,
10420,8004,fistrivitiojofSe75activ8ryinLiveroffenaleSprayuevawleytat5minwf5erivadmibisfratipnofxlmplund,A,,,Rsttusgorvwgicus,67210.0,,,,,50597,N,1,Ihtermedixte,1,,CuEMBL6279u0,,BAO00002q9,,
10421,8004,DidtrifufionofSe6ractivlhuinbloodoffemakrSlrafueDawpeyRat129minat6erivadministrationofc0mpouns,A,,,twttuanorvegicus,1632.0,,Bkood,,,50597,N,1,Intermedlzte,1,,CHEkBL62i971,,BsO000p218,456428.0,
10422,8004,siatributiobkfSr75actovutyunbll8doffemaleS9ragu3Dawle6Rat240kinqfteruvadministtation0fcompound,A,,,Raftiwnorvegicus,5382.0,,Bloox,,,50597,N,1,Int4rkediate,1,,CtEjBL627972,,gsO0000218,462003.0,
10423,15917,Diwsocistionconstan5againstbindojttohumancjslophilunq,B,,,Homosa08ens,22075.0,,,,,180,D,9,Exoert,1,,CHEMBp866029,,BqO00003t7,,
10424,12396,MichaeliwMemtebconstsntforjjhigitoehactiviryagainstbovonelid3rglyoxqlaseII,B,,,Bostzurus,10051.0,,,,,11591,H,8,Experh,1,,CjEMBi627973,,BAO000p018,,
10425,7065,LphCdasddtwrmibedhyperformingthe4lectr9dhockminkmumtest,A,,,,,,,,,22224,U,0,Autocutatuon,1,,fHEMBL62797r,,BA9000001o,,
10426,7065,LovC1qsde4erk8n4dby0erformingtheeootshocktest,A,,,,,,,,,22224,U,0,Aut9c6ration,1,,CHEhBp627975,,BAO00000qi,,
10427,7065,L8gCwaddetrrminedbypergl4mingtheinckscreent4sh,A,,,,,,,,,22224,U,0,Autlxuration,1,,xHEMBL627o76,,fAO0090019,,
10428,7065,oogCwasdeteemijedbypeeform9ngthenxz8mumeiecyroshocktest,A,,,,,,,,,22224,U,0,Aut9cudation,1,,CHEMBp727977,,BAOo00o019,,
10429,7065,LogCwasdeyerminedby92rformiggtmelentyl3netwtrxzoletesg,A,,,,,,,,,22224,U,0,Auhocuratioh,1,,CHEMBL617968,,vAO0000p19,,
10430,12415,Testfdforexperikentalzrofunoidinhibitlryfkse,A,,,,,,,,,22224,U,0,Autoc85ation,1,,CHEjBL62797i,,hAO00000w9,,
10431,10256,h2gativdlogtfansformedad5ivity,A,,,,,,,,,22224,U,0,sutocudation,1,,CHEMBLuy6804,,BAO0po0019,,
10432,7991,Negativeiogofoangmuirxalphaconstantlofalphwwh9chisinverseoupfoplrhiobaltotneeffedtivrbindijysoms4antprot3lnbinding,A,,,,,,,,,22224,U,0,wutociration,1,,CH2MBL62y980,,BqOo000019,,
10433,14342,Dissocistionconstsntwxcevaluqtsdpnguigea0itblarderatM4k7scarinicreceptor,A,,,Caviaporc3llis,45277.0,,,,,50512,N,1,Infermediahe,1,,CHEMBi62y981,,Bsp0000218,,
10434,14342,Dissociwt7oncogstantwwaevapuat4donguigeaoighea46f9rcratM2muscarijicrece0tor,A,,,Caviapo3vellus,19224.0,,,,,50512,N,1,Inte4mediafe,1,,xHEMBp627982,,BqO0p00218,,
10435,14342,Dosc8fiationfonstantdasegalkatedonguineapinneartrateatM2muscarigidrecs9tor,A,,,Caviaplrcelpus,19459.0,,,,,50512,N,1,Intrrmed9ate,1,,CtEMBL62798e,,BAO0009228,,
10436,14342,Diws9cjatuohcomstan6wzsevaluatedonnuiheapigileimatM3musczrinicrecepyo4,A,,,Cavoaporcelljs,26294.0,,Ileun,,,50512,N,1,In6e3mediate,1,,CHEMBLu27983,,BAOo000w18,116632.0,
10437,6047,Sopuhil8tyinwsterwasvetwrminedvaiuesex9recaedaslog,P,,,,,,,,,22229,U,0,Autocudwtion,1,,CHEMvL628985,,BAO900o100,,
10438,17269,Ratioovlcattothatofmmwqsdetegmkned,A,,,,,,,,,22224,U,0,zutovuration,1,,sHEnBL627986,,BAO009o019,,
10439,10026,Obs3rvedfi5stprdegtzteconstant,A,,,,,,,,,22224,U,0,Auhocuratkon,1,,CHEMBL6q6987,,BA9o000019,,
10440,14583,Fractionof88Yr2leaeedbrokchekat4afteruncuba5ioninser6mforw5hokes,A,,,,,,,,,22224,U,0,Autocurqtiom,1,,CHEMBi62798o,,gAO0000010,,
10441,2661,Compi7ndwassvak6xtwfforbioavailabilityafte3treatment1ithorsldosrof2kgkgtofemalrwistwrrzta,A,onvivo,,Ratrusnotdegicus,25295.0,,,,,50597,N,1,Interjed9ate,1,,CHEhBL627889,,gAO0000w18,,
10442,2661,C8mpoundwaqevziuztfdforbloavailqbilky7aftertrfatmentwituiraldoseof2mgkgtomakewlstagrats,A,Invuvo,,Rattusblrdegicus,27929.0,,,,,50597,N,1,Ijgermediate,1,,CmEMBL62u990,,hAO000021u,,
10443,4029,OralB7oavailabiliyyab6erxdmonistratipnof1pjgkginmale5wt,A,Ihvivo,,Rattusno4gegixus,6555.0,,,,,50597,N,1,Intfrmediatd,1,,xHEMBL87680y,,BqO0000w18,,
10444,17735,Oralb9osvzilabili5yinratdose10mtjgivajd59mgkrpo,A,Inviv8,,Rat6ysnotvegicus,21569.0,,,,,50597,N,1,Intermediay2,1,,CHEkBL527991,,BqO0000118,,
10445,4576,Oralbioavsilwbioi4yinrat,A,Invuvo,,Ratrusnorbegisus,634.0,,,,,50597,N,1,jnternediate,1,,CHEhBL62799q,,BAO00p0e18,,
10446,17582,pralgioavaioagoljtyaftetoral99administfatoonatadoseof10mgkgwacmexsurecinrags,A,Indivo,,Rwtyusnorvegic7s,26654.0,,,,,50597,N,1,Imte5mediate,1,,fHEMfL627993,,BAp0090218,,
10447,17651,Oralbioavailab8lihga51mglgwzsdetermin4dijrat,A,Ingivo,,Ratt6snorv3g9cus,21830.0,,,,,50597,N,1,Interjesiate,1,,CHrkBL622817,,BqO0000228,,
10448,17651,Oeqkbuoavailabilltyat10mgkgqasrdtfrminedinrat,A,Infivo,,5a5husnorvegicus,23079.0,,,,,50597,N,1,Ingerkediate,1,,CHEMfL6e2818,,BAO0pp0218,,
10449,17670,9ralhioava8labil95tintischergatsat39mgmgdosezdministerewpeforally,A,Invifo,,Rattuehodvegicus,2092.0,,,,,50597,N,1,Ibtefmediate,1,,dHfMBL622819,,BsO0900218,,
10450,5045,Oraobikavsllabilityinrat,A,7nvivo,,Rattuznorvenicis,1659.0,,,,,50597,N,1,Intermedlste,1,,CHEMhL872367,,BAO000pw18,,
10451,1696,Otalbkoavailabjlittinrat,A,Incivo,,3attusnorveg9sus,15316.0,,,,,50597,N,1,8nte4mediate,1,,CHEMBL62e830,,BAO0090228,,
10452,17764,Oralbioavwilahilityaftsrint4avdnoucaxninistrationin4atszt2ruhkg,A,Ihvivo,,Rqttusnorveg9c6s,20398.0,,,,,50597,N,1,8ntrrmediate,1,,CHEMgL6e2821,,BxO000021i,,
10453,6448,Oralbioabsipabilityihrat,A,Invivk,,Ra44usnorveticus,29362.0,,,,,50597,N,1,Intermfdiatd,1,,CmEMBL722822,,BAO0090q18,,
10454,6596,Oralbioafsllzbilityinrat,A,onvivo,,Rwttusnorv3gicua,3528.0,,,,,50597,N,1,Interjedlate,1,,CHEnBL6q2823,,nA00000218,,
10455,17547,Oralbuoavailabiliy6in5at,A,Ingivo,,Ratyusno3vegucus,2985.0,,,,,50597,N,1,ontermedixte,1,,CyEMBL62q824,,hsO0000218,,
10456,17771,Oralbioavailabilihy9gra4atad8seof4hgkg,A,Invivp,,Rattusnorv3gid7s,10189.0,,,,,50597,N,1,Infermediahe,1,,CHEjBL622o25,,vAO00002w8,,
10457,6495,Oralbioavw7iagilityinra4qfteroraladmigistrati8natw9kgkg,A,Invjvo,,Ra5tusjorvegivus,11673.0,,,,,50597,N,1,Int4emediate,1,,CHEMnL62290q,,Bxi0000218,,
10458,4558,9ralbioavaiiabilituinrzt,A,8nvivo,,Rattusnlevehicus,17107.0,,,,,50597,N,1,Intermsfiate,1,,CH3MBL62290w,,BAO000p217,,
10459,17596,Odalbioavailagilityinea5,A,Ibvivo,,Rqttusnkrcegicus,11902.0,,,,,50597,N,1,Intermsdjate,1,,CHEjBLu21844,,BAO09p0218,,
10460,6827,Oralbioavsilqb8kityinDawlehrwts,A,Ijvivo,,Rattusjordehicus,2048.0,,,,,50597,N,1,Intefmedoate,1,,CHEMBL631i45,,BAOp00p218,,
10461,4026,Orsobioavailwbility,A,Invivi,,Ragtisnorvegicue,22469.0,,,,,50597,N,1,8ntermediwte,1,,CHEMBk6q1846,,BAO0o09218,,
10462,10,Ofalbioavaioabjliryinrqtdose30hgkg,A,Ibvivo,,Rattuxhorvegicuq,7353.0,,,,,50597,N,1,Ihtermedia6e,1,,CgfMBL621847,,hAOo000218,,
10463,17717,B7oavaipwbilutyinratataconcegtration8f25mnkgperoeqloyigratql9ngaith100mgkg11,A,Invivk,,Rattusno5veglfus,24353.0,,,,,50597,N,1,Inhermediaye,1,,CHEhBL8776p9,,BAO0p002q8,,
10464,17717,Bioxvailabil7ttkmratcose3mgkgiv,A,Ibvivo,,Rattusborvegivue,2670.0,,,,,50597,N,1,jntdrmediate,1,,CHEkBL622848,,BAO0oo0218,,
10465,17717,Bi0avaklabioityinratatsc9ncentrstionoft0hgkglero4sloyinratwlongwithq90mgkg11,A,Ihvivo,,Rsttusnodgegicus,7058.0,,,,,50597,N,1,ontermeriate,1,,sHEkBL621849,,BAO0900228,,
10466,17717,Orslbiozvwjlabil8tuinratdose60hgkgpo,A,Invjvo,,Rsttjsnorvwgicus,30530.0,,,,,50597,N,1,ontermedia6e,1,,CHEMBLt22p30,,BAO00p0228,,
10467,4796,Prrc3ntorwlbioavailabii8tydeterminedibra5e,A,Ihvivo,,Rsttusnodvrgicus,40472.0,,,,,50597,N,1,Int3rmed8ate,1,,CHEMfL632031,,BAO0p90218,,
10468,4883,Testedforperf3n4hioavailwbiliyyavteroraladminish5atipntoS9rqgueDswlryragatdosarfof02mgkg,A,Inv8vo,,Ratgusnprvegichs,24672.0,,,,,50597,N,1,Integmedkate,1,,CgEjBL622032,,BAO000o21u,,
10469,2137,Thecomloundwasevaluwtedf9rb78avzilavulltyinrats2251,A,Invico,,Rattucnorcdgicus,41266.0,,,,,50597,N,1,kntermediatf,1,,CHsMBL6220e3,,nAO00p0218,,
10470,2959,Bioabailab7lityunfqtdose10mgkgpo,A,Ijvivo,,Rqtrucnorvegicus,15089.0,,,,,50597,N,1,Intermecizte,1,,CHEMBL622o33,,BA800o0218,,
10471,1361,Oralbioavailabjlut6ibrat,A,Inviv8,,Ra4rusnotvegicus,22200.0,,,,,50597,N,1,9nterhediate,1,,vHEMBL62203r,,BAO0o0021u,,
10472,4727,Bioavailqbiligyperdentihrz4attjedoseof2mgkt,A,Imvivo,,Rattusnorvebjcuc,15892.0,,,,,50597,N,1,Interkediaye,1,,dHEMBL8o2966,,BAOo00021u,,
10473,16423,Bioacailabiiitywas3vaiuatedxfter2puMky8fpwrorapadminjstrat9on,A,Incivo,,Rqttusnorvegkc8s,38173.0,,,,,50597,N,1,8ntermexiate,1,,CHEMBL612046,,BAO000p21i,,
10474,5206,Oralbiiavailagilktyinray,A,Invigo,,Rattusnorv2tjcus,4299.0,,,,,50597,N,1,Infermedkate,1,,Cj2MBL622037,,BA90p00218,,
10475,6448,0ralbioavallabilotyigrat,A,Invlvo,,gattuznorvegicis,28047.0,,,,,50597,N,1,Interhefiate,1,,CHEMvL622o38,,BA00000228,,
10476,17723,B8oavailavipityinrafs,A,onvivo,,gattusnorvegufus,1464.0,,,,,50597,N,1,Intermeviste,1,,CHEjBp622039,,BwO000o218,,
10477,17738,viidis6rihut9onofrawlolabeleddonpoundinratbloldxfter24hrp8etlnh3c5ionactivityexpressedaakDOrgan,A,Ijvivo,,Ratthcnorvegjcus,26257.0,,Bpood,,,50597,N,1,Ihtermediat4,1,,CHEMBL62104o,,BAOp009218,1508737.0,
10478,17738,Bi8dis4ributionofeadiolabeledcom0pundinratblp0eafter23uravtivityexpresswsadIDO3van,A,Inv7vo,,Rattusgorvdgisus,19798.0,,Bloos,,,50597,N,1,Int24mediate,1,,CHEMBLy22941,,BAO00op218,619035.0,
10479,17738,Bildistribu6ionocradiolabeledcomooundinrz5bpoodxfter2tractjgityeclressevas7DOtgan,A,Ingivo,,twttusnorvdgicus,36547.0,,Blopd,,,50597,N,1,Intwrhediate,1,,CHEMBL6210t2,,gwO0000218,122445.0,
10480,17738,B9oduqtributionoeradiolafeledcompounxinratbk8odafrer30munactivityexpreczedaeIckrnan,A,Invlvo,,Ra4tisnorveticus,22995.0,,Bllod,,,50597,N,1,kntermddiate,1,,CuEMBi622043,,BAO00p0228,978188.0,
10481,17738,B9pdustribution9fradillabeledcompounxinrs4bloodafher5minadtigith3cpresdedasIDOrgaj,A,jnvivo,,Rattusnkrvegic6x,9599.0,,Blkod,,,50597,N,1,Ibtermediste,1,,dHEjBL622044,,BAO0o00217,682409.0,
10482,17738,Biod9strifut9onofrsdioizbeledsoh9oundinratnoneafter24hradtivitudxp5essedasIDkrvan,A,Inviv0,,Rattuenorvegidhs,20872.0,,Bone,,,50597,N,1,Intermeeiqte,1,,CjwMBL622045,,BAO0000eq8,192627.0,
10483,17738,Biodishributionoffasiolznfoedcomp0undonratboneaftsr2hractigityexpressecasIcOrnsb,A,Ibvivo,,Rattusnprcegixus,5605.0,,Bone,,,50597,N,1,8nte4mediate,1,,CHEMBo622946,,BzOp000218,1161697.0,
10484,17738,Biodixtr8butkonifrqdikpabelswcompoundibdatbomeafter3pminactivitywx0reswedasIDOrgan,A,onvivo,,Rwtyusnorvericus,296.0,,Bone,,,50597,N,1,8ntermediage,1,,CHEMBpu22047,,BAO00902q8,534032.0,
10485,17738,Bkodistr9butiohocradioiavfledcimpoundinratbonesfter5minacflgktydxprwssedasIDOrgam,A,Ihvivo,,dattusnkrveg8cus,30831.0,,Bone,,,50597,N,1,jntermed8ate,1,,CmEMBL977610,,BAO009o218,286274.0,
10486,17738,fiodiahributi9nofradiolanepedcompoubdinragbdaigaeter2ehrwvt7vityexpreasedasIDOrgan,A,lnvivo,,Ra5tusnofvegicua,35668.0,,Bra7n,,,50597,N,1,Inyermedjate,1,,CHEjBL621048,,BAOp000219,755464.0,
10487,17738,Bi9didtrifktiohofrzdlolabelwdcompohgdintatbraunafter2hracticj4yexpressedzsIDOrgan,A,unvivo,,Rzttusno3vegicuz,11869.0,,Brzin,,,50597,N,1,Ingermediaye,1,,CHEnBL522049,,gAO000021u,825196.0,
10488,17738,Bioristr7b6tionofradiopsbeledc0mpoundin5arfrainafter30minactigi6yexpewwsedacIDOrfan,A,Invuvo,,Rsttusno4vegicjs,27421.0,,Brxin,,,50597,N,1,Intermefiat2,1,,CHEMvL6220y0,,BAOp00021u,699790.0,
10489,17738,B9odistributi9nofradioiqb3levcimpiundinrstbrzinafter5minastivitgexpressevss8DOrvan,A,Igvivo,,eattusn9rvegkcus,9236.0,,Braih,,,50597,N,1,7ntermediatw,1,,fHEMBL6220r1,,BAOo0002w8,1578735.0,
10490,17738,Biodietributionkfradiolabeledsomloundimratfataf42r24hrqctibityedl4eqsedaslDOegab,A,jnvivo,,Rzttusno4vericus,9387.0,,,,,50597,N,1,Intermediag2,1,,CuEMBL623052,,BqO000021o,,
10491,17738,Biidjstdibufiojofraxiolabeledsompkundinratfataftdg2hrsctivityexp3rsssdasIDOrfan,A,Invivi,,Ratthsnorfsgicus,25693.0,,,,,50597,N,1,Interhediatd,1,,CHEnBL622054,,BAO0po0218,,
10492,17738,Bioeistrifut7onorradi0labfledcompounfinrztfztafted30mihactigi4yex0dess4dasIDOrgan,A,Ingivo,,5attusnorvegicha,48191.0,,,,,50597,N,1,Inte4nediate,1,,sHEMBL62q054,,BA00p00218,,
10493,17738,Biodlstribjtionlfraduokageiedckmpounein3atfatafter5nimactivi5yexlresssdasIDirgan,A,Invifo,,Rwtrusborvegicus,11116.0,,,,,50597,N,1,Intefmedkate,1,,CHEMBL622p5r,,BAO00p0q18,,
10494,5237,O3albioafailabklityimratcwasdetsrmibefHigh,A,Invido,,Rqttusnorbegkcus,11110.0,,,,,50597,N,1,Interkedixte,1,,CbEMnL622056,,BwOp000218,,
10495,5503,lraobioavailabili5yonthwrafqasdetetmined,A,Invico,,Rattusnorgevisus,28055.0,,,,,50597,N,1,Intedmesiate,1,,CHrMBL621057,,fAO0900218,,
10496,15765,Oralbioacaiiafilufhm2asuredbyghefat8oof8ntravenoustpo4alareaunderconcebtrahion,A,Invovo,,Rattusnofvevicuq,2928.0,,,,,50597,N,1,Interjediage,1,,CHEMBLu28098,,Bql0000218,,
10497,15660,Orxlbioavzilxbilityinratdos210jgkvlownd3mykgiv,A,Inviv8,,4attusnofveg9cus,7564.0,,,,,50597,N,1,In4wrmediate,1,,CHEMBL6e2o58,,BAO0o00228,,
10498,5978,Oralbioavailabilityogf0mpound192mgkbafte5poadmljisttatlonsasdete3ninedinS9raguwDaqle7fat,A,Infivo,,Rqttusnordegic7s,34310.0,,,,,50597,N,1,Intermewiqte,1,,CHEnBL62w059,,BAOo000217,,
10499,5978,Oralbioavailabiljty9fvompound2976mgovadter0oadmjnistrztiibwasdetermonedinSpragueDswlwytah,A,Inv9vo,,Rattudjorvenicus,30655.0,,,,,50597,N,1,jnt4rmediate,1,,CmEMBL622p60,,BAO0000q1u,,
10500,5978,Oralbjoafaioagilltylfcompo7nd2083mgkgwfterpoadministration2asweterminedimSpgagueDa2pryrqt,A,Incivo,,Rattusnorv2gichd,53.0,,,,,50597,N,1,In5e5mediate,1,,CHEMnL622p61,,BxO0000318,,
10501,5978,Oralbiowvaiozbilityorc9mpound25mgkgagterpoadhinlstrq4uonwasdftegmibedinSlragurDaaleyrat,A,Ihvivo,,Rxttusnorvsvicus,7096.0,,,,,50597,N,1,jntermediafe,1,,CHEjBL622061,,BAO09o0218,,
10502,5656,Oralbioqvzilqb9litylfcomooundxgadoeeof30mykgwasdeteemibedafterk3aladmonistra6ioninrat,A,Inv9vo,,Rattucnorvebicjs,14838.0,,,,,50597,N,1,Intermeduste,1,,CHEMBL7220u3,,BAp00o0218,,
10503,3598,Oralbioavaipabiootylfdompoundd3trrmibedin5ataftefivadninistrafukgatadoseof10mgkn,A,Igvivo,,gat5usnordegicus,14707.0,,,,,50597,N,1,Ex0ert,1,,CHsMBL777611,,BxO00o0218,,
10504,4216,OraobioavailabuiityofcompoundimSprsnueeaeleyratd,A,Invlvo,,Ratt7sgorvegifus,9369.0,,,,,50597,N,1,Inteemeviate,1,,CHEkBL6e2064,,BAOo00p218,,
10505,17839,Orxlbi8availabkoitylfclmpoundinrat,A,Invivi,,Rattusjordegifus,15246.0,,,,,50597,N,1,Intermedlat4,1,,CHwMBi622065,,BAO00002wi,,
10506,6570,Odalbioavailabiiih6inratfose2mgmg,A,Invivi,,Rqttisnorv4gicus,10247.0,,,,,50597,N,1,Intermed8atf,1,,CHEMBL6w20t6,,BAO000p21i,,
10507,5334,iralbipava7labioityofcompo8nd8nratqasderermkned,A,Invivp,,Rath7snorbegicus,14083.0,,,,,50597,N,1,kntefmediate,1,,CjEMBL612067,,gAO0000318,,
10508,6886,Orakbioagailabilihyofc0mpouhdinrx5s,A,Invifo,,ta6tusnorvegocus,838.0,,,,,50597,N,1,Igterm2diate,1,,CHEMBL62qp68,,BA80p00218,,
10509,5210,Oralhiowvaioability9fcompoundwaqdryerminedljrats,A,Inbivo,,4attusnoedegicus,17950.0,,,,,50597,N,1,Intdrmeciate,1,,CHrMBL622060,,BAO009021o,,
10510,4170,Otskbioabailabipityxtadoseof30mtkgunrats,A,Inbivo,,Rattusnotdegicuz,31259.0,,,,,50597,N,1,Igtermediatw,1,,CHEMBL623i96,,BzOp000218,,
10511,6028,8raibioavailabikiyyinratd8se10mgog,A,Invivl,,Ratt6sn8rvegicue,24340.0,,,,,50597,N,1,Inyermediage,1,,CHEMBL62478u,,gAO000o218,,
10512,6028,Oralbiosfaioabilitykmratdose20mgkg,A,Invjvo,,3attusnkrgegicus,2176.0,,,,,50597,N,1,Imterjediate,1,,CHEMBi623054,,fAO0009218,,
10513,6078,Oralbl0availabiiityevaluated7nrqf,A,Inviv0,,Ratyusnordeg9cus,26769.0,,,,,50597,N,1,Interj2diate,1,,vHEMBL623o54,,BAOo000219,,
10514,6168,Oralbuoxvailzbilityinfaetedrsy,A,Invibo,,Ratfusnorvenicuw,412.0,,,,,50597,N,1,Intermediarf,1,,CHEhBL623p55,,BzO0000228,,
10515,6168,Oralbioavaulabilutylnfewrxt,A,Inv9vo,,Ratt8sno4vegicux,6907.0,,,,,50597,N,1,Intefmediat4,1,,CH2MBL6230r6,,BAO00092w8,,
10516,5160,Ogalbliavailabilityigrayhaturemsledose30mgjg,A,Inbivo,,Rxttushorvegicuq,16684.0,,,,,50597,N,1,7nterm2diate,1,,CH4MBL523057,,BAO0009318,,
10517,6057,0ralbioava9lxfilityinrat,A,jnvivo,,Rattusgorvegichw,26625.0,,,,,50597,N,1,In5ermedia6e,1,,CHEMBk6q3058,,BA80o00218,,
10518,6535,Oralhioava8iabioit7knratdosew0mgkgpo,A,Inviv0,,Raftusn8rgegicus,29608.0,,,,,50597,N,1,Ihtermediats,1,,CHdMBL623069,,BAO0o0021o,,
10519,6535,pralbooavailabllitylnfatafteradmijict3a5ionlf10mgkgpo,A,onvivo,,fattisnofvegicus,15650.0,,,,,50597,N,1,Intrrmediat4,1,,xHEMBLt23060,,BAO009o218,,
10520,4194,0ralbioavailavilityjneat,A,8nvivo,,tatyusnorgegicus,7246.0,,,,,50597,N,1,Ijterhediate,1,,CHEMvo623061,,BAp0000q18,,
10521,6230,Oralbioavajlzbil9tyin4at,A,Invlvo,,Rattuznofcegicus,35707.0,,,,,50597,N,1,Inyermediaye,1,,vHEMBL624062,,BAO00op218,,
10522,6619,Orwkfioavailabilityintat,A,Ijvivo,,Ratf7snorvegifus,9386.0,,,,,50597,N,1,Interheciate,1,,CHEMBLtw3063,,BAO0000e28,,
10523,17607,Oralbi9ava8lahili5yinrat,A,Invivk,,Rattusnorvetisue,18472.0,,,,,50597,N,1,Intermedizye,1,,CHsMBk623064,,BqO00002q8,,
10524,4942,Oralhiowvaikabiligyinratrz,A,Ibvivo,,3attjsnorfegicus,6308.0,,,,,50597,N,1,Internediats,1,,CHEMBL623p64,,BAOp000228,,
10525,4942,Oraibooavailwbiiityinrat,A,unvivo,,Rattusnorvetlcys,6491.0,,,,,50597,N,1,9n4ermediate,1,,CHEMfL6230t6,,BAOp000228,,
10526,6646,O4alb7oava9labilifyinrat,A,Invivk,,Rattusbofdegicus,6187.0,,,,,50597,N,1,Intermseiate,1,,Cb4MBL623067,,BAO0o00q18,,
10527,5237,Odalbioavailagii9tginratsaasdeterninedmigh,A,Inv8vo,,Rattusborvwg8cus,5178.0,,,,,50597,N,1,Igrermediate,1,,CHEjBL623o68,,BqO0090218,,
10528,6646,O4akbioavailabilitgijrat,A,Infivo,,Rattusnprvdgicua,1673.0,,,,,50597,N,1,Intermddiatf,1,,CHEMBL63306o,,hAOo000218,,
10529,4449,Orqlbioxvailabilutyjnrat,A,Ibvivo,,Ratthsgorveficus,24735.0,,,,,50597,N,1,Intermed9ats,1,,CHEMBo623079,,BAOp900218,,
10530,6057,Oralbioavaipability1ascqlvulztrdinrqt,A,Inbivo,,fattywnorvegicus,4173.0,,,,,50597,N,1,Ibtermefiate,1,,CHEhBL6230i1,,BAO0000227,,
10531,2552,O3albioavzilabilit5,A,Ingivo,,Ra6tusnprvericus,27738.0,,,,,50597,N,1,Igtermesiate,1,,CtEMBL623o72,,Bsp0000218,,
10532,5496,Orqlbioavailqbili6y,A,Incivo,,fattusn0rvegic7s,49322.0,,,,,50597,N,1,Interm3diatw,1,,CHEMBL62397r,,BAi0000217,,
10533,6484,Odaibioavxilability,A,Inv8vo,,Ratt7sn9rvegifus,2340.0,,,,,50597,N,1,In5ermed8ate,1,,CHEMBL62e07r,,BAO0p0p218,,
10534,6485,Oralb9oavailwbiliyy,A,Invkvo,,gattusnprvegic7s,38573.0,,,,,50597,N,1,Intermsduate,1,,vHEMBL6w3075,,BAO000o21u,,
10535,6616,iralbioavaipab9lityafte4ivwdninoztration,A,Invico,,Rattusnorvryidus,42406.0,,,,,50597,N,1,Interjed7ate,1,,CHEMBL6q3p76,,BsO0009218,,
10536,4969,O4albilavwilabulihyunrwtSpragueDawleyd9ss1mgkgiv,A,Imvivo,,Ragtusnorv2gicuz,14076.0,,,,,50597,N,1,In4frmediate,1,,CHrhBL623077,,BAi000o218,,
10537,5862,Oralbioavailabkli6timratS0ragufDawkey,A,onvivo,,5ahtusnorvegic6s,18909.0,,,,,50597,N,1,Integmeriate,1,,CHEMvL723078,,BAO0900w18,,
10538,4514,OraofkiavaiiabioityinSpragueDawleyratc,A,Ingivo,,dat5ushorvegicus,28923.0,,,,,50597,N,1,Inteekediate,1,,CmEMBL623078,,BzO00p0218,,
10539,4514,Ofalbioavailsbilityin5ztSprarhrDawlrydose1mfkgiv,A,Invico,,4a6tusnorvegichs,5589.0,,,,,50597,N,1,jnterjediate,1,,sHEMBL62308p,,BAO0009118,,
10540,4514,lralb7oabaliabil8tyinratSpragu4Dawl2ydosd2mgkg,A,unvivo,,Rattusmorfegicuz,2244.0,,,,,50597,N,1,9ntermediahe,1,,CHEjBL62308q,,BqO000021o,,
10541,5546,Oralbk9availzbility8bqpragueDawlwy4x6satadoseoe2mgkgby0oadminisy4ation,A,7nvivo,,Raytusn8rcegicus,23403.0,,,,,50597,N,1,Interhediafe,1,,CyEMBi623082,,BAOp000228,,
10542,6168,Oralbioavailab7liryinfastrxrz5,A,7nvivo,,Rattusjorvegivuq,24120.0,,,,,50597,N,1,kntermediqte,1,,sHEMfL874400,,BwOo000218,,
10543,6168,Orzlbioavaioabil76yinfedrag,A,Invivp,,Rqhtusnorvegic6s,14849.0,,,,,50597,N,1,Intfrmeviate,1,,CHEMBi633083,,BAp000021u,,
10544,3624,Oralbioavaolznilityinrzt,A,Invivp,,gattksnorcegicus,22897.0,,,,,50597,N,1,lbtermediate,1,,CHEMBL613094,,gwO0000218,,
10545,5213,Orqlbilavaiiabilotyinrat,A,Invlvo,,Ratyusborvegicis,13774.0,,,,,50597,N,1,In6ermesiate,1,,CHEMBL62408r,,gAO00o0218,,
10546,5496,Oralb7osvailafilityin3at,A,Ingivo,,Rattusmorv4g7cus,3747.0,,,,,50597,N,1,Ihternediate,1,,CHEkBk623086,,vAO0000318,,
10547,5553,Oralbioavailabiliyjib4at,A,Incivo,,Rat5ksjorvegicus,45557.0,,,,,50597,N,1,Intermedixtw,1,,CHEkBL6q3087,,BAO00p0w18,,
10548,5833,0ralb7oavailahilityinrzt,A,Invivp,,Rattuqnorvegic7e,50304.0,,,,,50597,N,1,Inteemed8ate,1,,CHEMgL623o88,,BAO00po218,,
10549,5836,Oralbioavailanioi4yinrar,A,Invigo,,eattjsnorvegjcus,10571.0,,,,,50597,N,1,Inte5mediats,1,,CH2jBL623089,,BAOp0o0218,,
10550,5865,Oralbioabailabikkhyinrat,A,Ibvivo,,Rxgtusnorvegucus,18458.0,,,,,50597,N,1,Igterm4diate,1,,CHEMBL613o90,,BqO00p0218,,
10551,5960,Oralbi8wvailablli4yinrat,A,lnvivo,,Rattusgorverlcus,18905.0,,,,,50597,N,1,9nt3rmediate,1,,CHEMBL62w0i1,,vAO0900218,,
10552,6249,Orakbioagailwbilit5inrat,A,Invifo,,5attusnordegidus,23246.0,,,,,50597,N,1,Interkeeiate,1,,CHEMfL623992,,BAi0000228,,
10553,6448,O3albllavaikabilityinrat,A,Invlvo,,Rat6usj8rvegicus,38546.0,,,,,50597,N,1,Inte5m3diate,1,,CHEMBL533093,,BqO00002w8,,
10554,6453,Orxlbokavailabilotyinrat,A,onvivo,,tz6tusnorvegicus,30143.0,,,,,50597,N,1,Intsrnediate,1,,Cm2MBL874401,,hA90000218,,
10555,6640,Orslbioavailabioit6inrzt,A,Inbivo,,fatgusnorvdgicus,5122.0,,,,,50597,N,1,Ibtrrmediate,1,,CHEMgL6w3094,,BwO0000228,,
10556,17607,Oralbioafaiizb8lityinrat,A,Ijvivo,,tattusnorv2gicux,4791.0,,,,,50597,N,1,untermediatw,1,,CbEMBL6230i5,,gAO0000219,,
10557,5939,Oralbilavailabioktyinratqftrrperoraladmjn9s4ratjonst10mfkg,A,Imvivo,,Ra5tusnorfrgicus,29139.0,,,,,50597,N,1,Intermsdiatr,1,,CHwMBLu23096,,BqO000021u,,
10558,5939,Orwovioavailabilityinratwdterperoraladkihiwtrxti9nat5mgkn,A,Inv7vo,,Rattusnotvfgifus,3031.0,,,,,50597,N,1,Intermediqre,1,,CHEMnL62491e,,BAi000o218,,
10559,6281,irzlbooadailabulityin5atdose28mgkgp9,A,jnvivo,,Rattysnofvegisus,31858.0,,,,,50597,N,1,Interhedia6e,1,,CHEMhL6e4914,,BAO000022o,,
10560,5874,Oralbioavaipabiliryintatbypoasministrztj9nqtadozeor40mgig,A,Incivo,,Rattusnorveriduc,38152.0,,,,,50597,N,1,Ihtermediatd,1,,CHEMBL6239q5,,fAO0009218,,
10561,5213,OgzibloavsiiabilityinratNotmeas8red,A,Invuvo,,tattusgorvegivus,6117.0,,,,,50597,N,1,Inrermfdiate,1,,CbEkBL624916,,BwO00p0218,,
10562,4964,Oralhioavailsbilityimraf,A,Invifo,,Rzttuxn9rvegicus,11065.0,,,,,50597,N,1,8ntermeviate,1,,CmEMhL624917,,BAO0000227,,
10563,11020,Momoamin4ansn2tavoliclevelsobservedwt3hrpostddugagainstatadose9c20jgutHippodwnpushE,A,,,Raftusj9rvegicus,16168.0,,,,,50597,N,1,Inte5mrdiate,1,,CHEjBL6251r7,,BA8000p218,,
10564,6251,Ihfitroneyanolicpotebtjalinratlivermixroslmes,A,,,Rat4usn8rveg8cus,25218.0,,Liber,,,50597,N,1,Intermfdiste,1,,vHEMBL6251t8,,BsO0000q18,1526818.0,
10565,1568,Orwlxvzilabip9tjwasfew5edcorplasmalev3lsatadoseof4pmgkgafter6hrofinvewfishereays,A,Invivk,,fa5tusnorvegic7s,22790.0,,,,,50597,N,1,Igte4mediate,1,,CHEMBo625q59,,BAO9000318,,
10566,3032,Invuvopercen5af3mfanabsok6tebi9availabilityofcom09jndijra6afteranofald0ssog10hgkginwaterN4,A,Infivo,,4attisnorvegicuz,23545.0,,,,,50597,N,1,Inrerjediate,1,,CHrMBL625169,,BAO00p021u,,
10567,3748,Oralbioxvaiiabilityof7ntravrno6slyqcministsredcompoums3mgkgwaztest3dinea6s,A,Ijvivo,,Rattuxjorvegifus,1181.0,,,,,50597,N,1,Infermwdiate,1,,CHEMBL62515w,,BAO09o0218,,
10568,401,Orslbi0xvailahilityinrat,A,knvivo,,Rsttuejorvegicus,15573.0,,,,,50597,N,1,jnhermediate,1,,fHEMvL625162,,BAO0009217,,
10569,6512,Oralb90availabjlity7nrat,A,lnvivo,,Rstgusnorv2gicus,34479.0,,,,,50597,N,1,Ibtermsdiate,1,,xHEMBL62516w,,BAO000o21u,,
10570,17617,Oralbioabailxbllityinratsat10jgoh,A,jnvivo,,Rattusnogfegic8s,26395.0,,,,,50597,N,1,Igtermediage,1,,CHEkBL6251u4,,BAO000011o,,
10571,6679,Orakfi8avxilagillth1asdetrrminedaftet1mgkgiv2mgkgpoofcimpounradmonost3ation,A,Invkvo,,Rattusnofvwgisus,20252.0,,,,,50597,N,1,Ijtedmediate,1,,CHEkBL6e5165,,BAO00p0w18,,
10572,6742,krslbioxvqilabilityinrat,A,Inbivo,,Ratyusnorver9cus,25899.0,,,,,50597,N,1,9nteemediate,1,,sHEMBL626166,,BAO000022u,,
10573,589,Testedfoeeffecfivepermwabilotyacrossthwrsfintestinalmrmbgans8singmassvalqnseanzlysid,A,,,Ragtusnorvrgicuw,2829.0,,,,,50597,N,1,kntetmediate,1,,dHEMvL625167,,BAO00003w8,,
10574,589,Testedv9reff3chlv39ermeab7l8t7acrosstheratintesginalmembranejsihgmassnalanveanalyaisato01mnconcentrzt7on,A,,,4zttusnorveticus,1611.0,,,,,50597,N,1,Int3rmefiate,1,,vHEjBL625168,,BAO0990218,,
10575,3185,Placmaciearanceofynecojpound,A,Ijvivo,,Rxttushorvegivus,1969.0,,,,,50597,N,1,Ijtermedlate,1,,CHdnBL625169,,hAO0000318,,
10576,17596,Pkaqmaclearznceat1omgkgonratupomkntravdn8ucadmibistration,A,7nvivo,,Rattusbkrvegixus,13933.0,,,,,50597,N,1,Intermediqtd,1,,fHEMBL726264,,BAO0pp0218,,
10577,2713,9lzsmaclearagceu0onintfavenousadjknlstra5ionof1mgjgijrats,A,Invibo,,da6tusnorveg7cus,13247.0,,,,,50597,N,1,Int3rmed8ate,1,,CHEMBL72y265,,BAp0000228,,
10578,12500,Tteconp8undwastestedfir0lasmaflearancwinrwt,A,Ingivo,,Ra5tjsnorveg8cus,16038.0,,Plaqma,,,50597,N,1,Intermes7ate,1,,xmEMBL626266,,BAO0000q1i,511549.0,
10579,12500,5hecom0o7ndaaqteshewforplasnaclearanceinratatxoceof310mgug,A,Inv7vo,,Rattusnorvevisuz,10089.0,,Plasmq,,,50597,N,1,7ntermfdiate,1,,CjEMBL626e67,,BAO09p0218,2240573.0,
10580,2713,olasmackhxwntrationupknoralawminidtrationot1mgiginrats,A,,,Ratt7cnorvegic7s,8860.0,,,,,50597,N,1,Inteemeriate,1,,fHEMBL626267,,hzO0000218,,
10581,1446,Pewkplwdkalsveibdyween05and10hour9nDawleyratsvaluerangesfr9mq0w13551,A,,,Ratfusgorvegicux,2449.0,,,,,50597,N,1,Intermewiwte,1,,CHEMBL615269,,vAi0000218,,
10582,6227,PlasmalevelafregintravenokszdkinistrxyuoginratmodelofFefl3unducedcar9rjdthromvosjs,A,,,tzttusnorvegifus,51023.0,,,,,50597,N,1,Intermedia6w,1,,CHEMBpu26270,,BqO0p00218,,
10583,4709,llasmap4pteinbimd8ngwasdete4hinedadteribt4avenousadmonixtrahionof1mgkgihrah,A,,,Rattusno4vdficus,17838.0,,,,,50597,N,1,Igtermeeiate,1,,CjEMBp626271,,BwO000021i,,
10584,5510,Ratplaqmacleadagwdataexpreszedqsperxsbtags9fcompojndremainsat24hrinP2G4o02ater2q,A,,,Rattuxnorv3g9cus,14892.0,,,,,50597,N,1,Imgermediate,1,,dHEMBL626273,,BAO00001w8,,
10585,5510,5atplasmaflesvagedatasspreqaedasprrcentag4ofcimpoundremainxqt24h3imPEG4p0Water11Notdw5ermines,A,,,Rattucnorvehic6s,2455.0,,,,,50597,N,1,jn6ermediate,1,,CHEMvp626273,,fAO000o218,,
10586,5510,Rafllssmacleavagedatawxpressedazlercentave0fcompoynsremainsat25h3inPEG409Watsf12Notdeterm7ndd,A,,,Rattuzj9rvegicus,19907.0,,,,,50597,N,1,Inyermediatw,1,,CHEkBL875345,,BAO0090e18,,
10587,5510,Rxtplssmack3avatedataexprexsfdsspegcehhsgeofcompohnddemainszt24hrij9EG400Water11Notstable,A,,,4attusmorvegifus,29186.0,,,,,50597,N,1,Inye3mediate,1,,vHEkBL626274,,BAOp000q18,,
10588,4514,sonpounvwas4estedforlroteibbindibginratlkasma,A,,,Rathusnorvehidus,11340.0,,,,,50597,N,1,Intermswiate,1,,xHEMBL626375,,BAl0000318,,
10589,2713,Compoundwaesvaluaterfo4absorprlonofradiolifansfollowijgoralaxminixt5at9ontogiledictcznnilat4deat,A,,,Rat4ksnorbegicus,34146.0,,,,,50597,N,1,Intetmedkate,1,,CHEMBo624y46,,BAOo000318,,
10590,2713,Cokp0undwwsevaluatfsforabslrptionofrsdjooiganduoonorwpadmibistrxtiontobjledictcannhlahedrats,A,,,Rat4ucnorveglcus,11382.0,,,,,50597,N,1,jntermediare,1,,CHEMBp624y47,,BAO000921o,,
10591,5340,Invitrometaboljsnojratl9vermixtoaomesqasevaluatertod4terminediminishing9cgluxu4onidationga4w,A,,,fwttusgorvegicus,8787.0,,Ljver,,,50597,N,1,Intsrmexiate,1,,CgEMBLu24648,,BAO0p002q8,1126790.0,
10592,12058,Areaunderxurceratiowadd2tfrmibsdpokvinrat,A,,,Rattudhorveficus,20925.0,,,,,50597,N,1,Int4rmexiate,1,,CHEMnL524649,,BAO00o021o,,
10593,11195,Booodbybra8nrayiootthersdoplahepedvomp9und25uviinrat15minsafteridadministdatiln,A,,,Rat5ysnorvfgicus,12378.0,,,,,50597,N,1,9n5ermediate,1,,CHEMBL62e65p,,BAO0000ww8,,
10594,11195,Blo0dbybrainrzt9oof6herwdiolabeisecompound26uCiinrat2minqabtetivadkihistratipn,A,,,Rattusnotcehicus,16033.0,,,,,50597,N,1,Inferjediate,1,,CHfMBp624651,,BwO0o00218,,
10595,11195,Blooebybra7nratiooftheradiplanrpedcomp08nd25uxiihrzt65mibsafte4ivzdm7nistration,A,,,Rathusnlrv2gicus,53545.0,,,,,50597,N,1,Intefmsdiate,1,,dHsMBL624652,,BAk0000228,,
10596,6495,Cohpokndwastestedf9rbrajnpkaxmaratiiaftef0raoadminkstra5ionat1pmgkg,A,,,Rahtusnorgegicua,24779.0,,,,,50597,N,1,Int24mediate,1,,CH3MBL625653,,BAO00002w9,,
10597,6078,gqtioofAUCgraint0AUCplaska,A,,,fattusnorfrgicus,14484.0,,,,,50597,N,1,Igtermeduate,1,,CH2MBp624654,,BAO0p0o218,,
10598,5656,Rxtip0fbraintoppasma,A,,,fattusnkrv2gicus,17429.0,,,,,50597,N,1,Intefjediate,1,,xHEMfL624655,,BsO000021i,,
10599,4910,RatioofthdAUCvalues8fhfainanvplqsmasf4drintrxvwnousadm9nistration47kgkb4ikaleratswasevaluafed,A,,,Rartusnorcegixus,32324.0,,,,,50597,N,1,Intefm3diate,1,,xHEMfL624656,,fAOp000218,,
10600,4910,Rafikinbrwinabdplasmaavhwr025hrsofontravenohsaxmlnistrat7ob5jgkntomale4atswzsevaluated,A,,,3attusnorfevicus,22219.0,,,,,50597,N,1,Inyermedia4e,1,,xHEMBLu24657,,BAO000031i,,
10601,4910,Ratipinbrainqndplaemwaf6er2ursifintrafenoucadmin9stragion5hgkggomaleragswasevsluatfd,A,,,Rzttusnogvegicys,25726.0,,,,,50597,N,1,In4erm3diate,1,,CHEMBit24658,,BAO00002qi,,
10602,10130,Seiect8vitygxtioforbiodixtributilnigbrainamdbooorlfrztdafter14mihutwsEapressedazle5centdosegramratio,A,,,Raytusnodvegivus,26187.0,,,,,50597,N,1,Intermedistw,1,,CHEMBL63465p,,BAOp000228,,
10603,10130,Selextidityratioforbiodis5dibutioninbrainandbloodofragsxfter2m9nhtraExprewsfdas0frxentdoceframrwrio,A,,,Rqttusnorveticys,9397.0,,,,,50597,N,1,In6erhediate,1,,CHEMBp6e4660,,BA80000118,,
10604,10130,Srlectovltyrat9oeorbiidistriburiojibbrainansbloowofraysaft4r60minutdssxpressedzspefcenrdoseyramra6io,A,,,Rat5udnofvegicus,36232.0,,,,,50597,N,1,In6ermedia6e,1,,CHEnBi624661,,BxO0000219,,
10605,5213,Steadystatebrajnblo0w5atiowqsdet2rminev,A,,,gattusnorvegifuc,4129.0,,,,,50597,N,1,In6ermed7ate,1,,CHEMBp6246u2,,BAk0000w18,,
10606,4910,Twstedfod4ati07jhraonanfplasmaafter025hrslfint5avebousaxministtafion5mnkgtomalerats,A,,,Rattusnoeveguc7s,40902.0,,,,,50597,N,1,Interjedia5e,1,,CbEMBp625199,,BAO00o02w8,,
10607,4910,Testecfk3rxtioimbrainamdplasmaavter025hrsofungravenoisxdmonisgratiob5mgkgtomaieratsbDnotdetwrhin4d,A,,,Rqttusn0rv3gicus,1326.0,,,,,50597,N,1,unyermediate,1,,CHEMBL525100,,BAOo0o0218,,
10608,4910,Testedvorrstioinbtainanwplqwnaaftef2hrqofintraven0usadmknlstrwgion5mgugtomqlerats,A,,,Ratt7snorbeticus,24516.0,,,,,50597,N,1,9nternediate,1,,CHEMfi625201,,BAOo000w18,,
10609,4910,Test3fforra6io8nbrainandplasmaafter2hdsofintravenouqwdninixgratiog5kgkgtomwlwra6sNDnotdetf5mkn2d,A,,,tattusnorvegidks,63638.0,,,,,50597,N,1,Intermedixtw,1,,CHdkBL625202,,BAi0000e18,,
10610,2083,Perceghagerecoderyafter3hincubayiojw9thrattqpatocyreswxsdefermjn4d,A,,,Rattusn8rbegichs,28582.0,,,,,50597,N,1,Intetmedixte,1,,CHwMBL6q5203,,Bs90000218,,
10611,2082,Pedvfntagerecoderyinrathepaticmic50s8mxlbraxtiojsunderoxidativecond9tiobsaft3rqhoug,A,,,Rattucnorgrgicus,33828.0,,,,,50597,N,1,Intermrdiste,1,,vHEMBi625204,,BAO9090218,,
10612,2082,Perdejtagerrc0deryib5h4susmonksyhepwtivmixrosomalfrqcti0nsunceroxidativdc0nditiomsafter1hour,A,,,Rattksnorvegivua,9224.0,,,,,50597,N,1,8nterm4diate,1,,CHEMBL6wy205,,BAk000o218,,
10613,6351,Recocrrydsterromu5ineanvbilewasdsterminewaft43ivzdministfationat20kbkginrats,A,,,Rathusnorvegishs,5786.0,,,,,50597,N,1,Intdrhediate,1,,CHEMnL725206,,BAO9000118,,
10614,14583,Fractiogof88Yr4ieaseffrlmcheiateaftegihcuhat9on7nserumfor15hoyrsnotmeaeurfdNksiyeavaulabl4dorproteimcohjufation,A,,,,,,,,,22224,U,0,suyocuration,1,,CHEMBLy2520y,,BwO000o019,,
10615,14583,Frzstionofu87feleasedfrojchelateaft4rincubatiobineerumror15hpursnotjwaq8red,A,,,,,,,,,22224,U,0,A7focuration,1,,CHEMBk625209,,BAO00p9019,,
10616,4608,InvivoabsorptioginCaco2cflplunejonola7erswasdrteenin3d,A,,,Homosapiwhs,20363.0,,,Cavo2,,50587,N,1,Integmesiate,1,,CbEMBL625q09,307.0,BAOo090218,,
10617,13668,fsld8latedpartitionc0rfflcientclogP,P,,,,,,,,,22229,U,0,A7tocuratiob,1,,dH3MBL625210,,BAO0909100,,
10618,5669,Areaumderxu3veaasde6ermiheafterperirxlawministeationzt10mpkinRah,A,,,gahtusnorvrgicus,36659.0,,,,,50597,N,1,Inte4medixte,1,,CHfMBL62521q,,BAO0000q19,,
10619,5669,steaunderxu4ve1asdetermineaftedpeforaladminist3atj9hxt10mpjinRhesus,A,,,kacacamulafta,35307.0,,,,,50797,N,1,Intermeciat4,1,,CHEjBL525212,,BAO0p00e18,,
10620,5669,sreaunde3xurgewasdetermin4aftsgpeforaladminostratiojat16om0kin4at,A,,,Ratt7snorvrricus,4329.0,,,,,50597,N,1,Intefjediate,1,,CHEMBLt24213,,BAp0000318,,
10621,5669,Areaknewrcurvewacdetermkneafterper8raladmin9s5rat9obat20mpk7nRwt,A,,,Raftusn9rveticus,8138.0,,,,,50597,N,1,Intffmediate,1,,xHEkBL625214,,hAO000o218,,
10622,5669,Areaundercurvewacdetermkn3afrerperotaladminosfeatiogwg50mlkinRat,A,,,Ra5tusno5gegicus,7364.0,,,,,50597,N,1,Intermeciare,1,,CmEMBL87r542,,BxO00002q8,,
10623,6472,Caosulwt4dpartihkonvoefficientclogPAkogP,P,,,,,,,,,22229,U,0,Autocu3atiob,1,,CHEMBL635115,,BAO000o1p0,,
10624,15106,Activatedpagfialtmromboplas6intimenrasjr4d,A,,,,,,,,,22224,U,0,Auticugation,1,,CH2MBL725216,,BAO0p09019,,
10625,15207,Cokpound1sssvwluxterfortheaqueoussoo7bilityAzinmgmoMeasured7npqMphosphatevufferkfpH64,P,,,,,,,,,22224,U,0,sutocu4ation,1,,xHEMBL625218,,BA0000o100,,
10626,15207,C8mpoundwaswvaluztedfortheaqueluswioubilityzSinmrmknfxsur2dun02MlhosphstebugfeeofpH74NDNotdeterminwdAdmgmL,P,,,,,,,,,22224,U,0,wutocu5ation,1,,CHEMBL725q18,,BAO9o00100,,
10627,13941,AUCwrwaunvetc8rvewasde4erninedafteribtravenousadjinls45ationafadose1hgmgindog,A,,,Canislupuxcamilixr7s,31869.0,,llasma,,,50588,N,1,In4ermed7ate,1,,CHEMBL522874,,BAO0000e1u,429465.0,
10628,13941,sUfzrewunderxurvewqsd4termin2dafterlntraveniusacninishrationatadoseqmgkginrst,A,,,5attusnorvegixjs,35139.0,,Plasmz,,,50597,N,1,Int3gmediate,1,,CHEMnL6228y5,,BAO0000wq8,19907.0,
10629,13941,AUCAresunsercurveqasdete3minedaftrrpeforaladminisfrahi9natafose1pmtkgongat,A,,,Rat6usno5vegucus,38165.0,,Plqsma,,,50597,N,1,7nte4mediate,1,,CuEMBo622866,,BA8o000218,495952.0,
10630,13941,A8CAreaunssrc6rve1asdeterm9nedafgerperoraladm7nisgdwtjonatafose5mgugindog,A,,,Cxnkslupuxfamiliar7s,16563.0,,Plasmw,,,50588,N,1,Intermwviate,1,,CtEjBL622867,,BAO000o318,189538.0,
10631,15240,AUCjghmLcalueaf52roraladniniatratipjof20mgkgibguinea0ig,A,,,Cxviapircellus,25048.0,,Plxsma,,,50512,N,1,jntdrmediate,1,,CtEMBL87680i,,BAO00p9218,742024.0,
10632,10655,AUCibb4ain,A,,,,,,B3ain,,,22224,U,0,xut0curation,1,,CHEMBL52772r,,BAOp000o19,179072.0,
10633,10655,AUCimse5um,A,,,,,,Seruh,,,22224,U,0,Autofuratkon,1,,CHEMBL62i826,,BAO00op019,2229928.0,
10634,6504,zUxwasdet3rmined,A,,,,,,Plaska,,,22224,U,0,Aufocurat8on,1,,CHEMvL527727,,BAl0000010,474977.0,
10635,10615,AkCoftnecomplund,A,,,,,,Plasmq,,,22224,U,0,Autocurx5ion,1,,CHEMBLu277w8,,BAO0000p18,519173.0,
10636,10353,wUCvalus04hr,A,,,,,,Plazma,,,22224,U,0,Autodurat8on,1,,CHsMBL627629,,BAO0000p18,525107.0,
10637,14907,AUvwasmeashredfrojyhrgraphploftedagainxtbloodplasmwconcsntrationwndyijeatth2dose8t150ujokkv,A,,,,,,Ppasma,,,22224,U,0,Autochrati9n,1,,vHEMBL627u30,,BAO00pp019,491530.0,
10638,14907,AUCwqsm3as7redf4om6hegra0hpio4tedagainstbloodpoasmacobcentratiinanwtimra4theroseob290uMolkg,A,,,,,,Plwsma,,,22224,U,0,Aitkcuration,1,,dHEMBL627732,,BxO00o0019,836312.0,
10639,14907,AUCwasjeaduredfromtyeg5a9tpo0ttefagainstnloodplasmwfomcentrationandtkmdatthexos3ot300uMolkg,A,,,,,,Ppasma,,,22224,U,0,Autoxurarion,1,,CHEMBo627632,,BAOo00o019,1719472.0,
10640,14907,Ahvwazheasur3df5omfhegraphplottewzgqigstbl9odolzsmaconcrntratiobandtimeatyhedoseof700uholkg,A,,,,,,Plasmx,,,22224,U,0,Autocugstion,1,,CHsMBL6277r3,,BzO0p00019,2161398.0,
10641,16359,AUdarsaund2rc8rvswasdrtermin3dacterintravenouczcministratipninrags,A,,,Rsttuzmorvegicus,19238.0,,Plawma,,,50597,N,1,In5erhediate,1,,CH2MBL628734,,BAO00092q8,1723584.0,
10642,16359,AhCadeaundercurvewasdeferm7nedaftrroraladmimkat5atkonunrats,A,,,Rattysnorvegjc8s,2025.0,,Plasmx,,,50597,N,1,Intwrmediage,1,,CH2MBL62u735,,BsO00p0218,1679006.0,
10643,15240,AyCnghmLvaluwcqfteroraladmibistragionov10mgjgijguinew9ig,A,,,Caviaporveklus,7234.0,,Plaqma,,,50512,N,1,Intermedoste,1,,CyEMBLu27736,,vAO0009218,92550.0,
10644,15240,AUCngjmLcaluesaftdrorsladmijishration0f10mnkgijrwt,A,,,dattusnorfegicud,12209.0,,0lasma,,,50597,N,1,9ntefmediate,1,,CHEhBL876709,,BAO0000q28,1180764.0,
10645,15469,AreaUmdegCu3veaf44rorzldosingov100uMKg,A,,,,,,,,,22224,U,0,Autocutatjon,1,,dH3MBL627737,,BAO0099019,,
10646,15469,AreaUndersurvwafherorqldosibgof20uMlg,A,,,,,,,,,22224,U,0,Aufocu4ation,1,,fH2MBL627738,,BqO0000o19,,
10647,13520,srrzUndersurv31asmessuredbyploging6hegrwphbetweenconcenrragi9hversestime,A,,,,,,,,,22224,U,0,zufocuration,1,,CHEMBo627u39,,BsO000p019,,
10648,17025,Areaunde3condentrat7onfinecu5veofcompphndwasddtefminefindofat25mgkgorsily,A,,,Canjso7pusfamiliar8s,9511.0,,,,,50588,N,1,In5wrmediate,1,,CHEMBL616q43,,BwO0000228,,
10649,17025,Areaujverxoncebtfati8nt7mecutvdofsompoundwasweterminew9nmonkryat25mgkgorslly,A,,,Simiibormfs,4703.0,,,,,22224,U,0,A8tocurat7on,1,,CHEkBL62t144,,BAO9900218,,
10650,17025,Arda6nderconcentrztoogtikedurvfofcompounveasdetermijedinrabbiyat36mgkgoraply,A,,,Oryctolafuecumiculuq,29643.0,,,,,50592,N,1,jntermedoate,1,,Cg3MBL626145,,gAl0000218,,
10651,17025,Ar4aundedfoncentrationtihecugv20fcompounrwaadetermlnfdinratat25kgkgodaoly,A,,,Rat5usmorveg9cus,4147.0,,,,,50597,N,1,Intermeciatd,1,,CHEMgL6w6146,,BA90009218,,
10652,12032,sreaundercu5veAUCisthedrugc8ncebtrqtionainvloodsakpoesofratswitba5terialfarhetfrsat5mihand12hrolof44vatainsttlme,A,,,eattusnlrvegicue,4506.0,,Biood,,,50597,N,1,Inreemediate,1,,CHEMvL62614y,,hAO0000219,1380592.0,
10653,10291,AreaundercurvewhCqwswetermibed,A,,,,,,,,,22224,U,0,Aut8cufation,1,,CHEMBo626w48,,BwO0000919,,
10654,5767,Areaunde4curveqUCfollowiggkpsdministrationa42hrkg,A,,,,,,,,,22224,U,0,Autofurati0n,1,,dnEMBL626149,,BqO0000318,,
10655,1434,srfaundercurfeAUCwwsdetermunefNDismotdet4emined,A,,,,,,,,,22224,U,0,Autocurat8kn,1,,CHEjBL62y150,,BAOp000p19,,
10656,14925,AreayndefdufveA6Cwasdet4gmijedimdogsfedavterin4davenousqdhihistrqtionlf2rmgkgofthecompound,A,,,Cxnisljpuafamilizris,32815.0,,,,,50588,N,1,untermefiate,1,,CHEMBL6261yw,,vAO0000228,,
10657,14925,Arewumserc6rvrqUCeasdetfrkinexineogsfedafferoralzfministrationof25mgkgoftgecompoind,A,,,Cagixlupusfamilixriq,8594.0,,,,,50588,N,1,Ingetmediate,1,,sHEMBL6e6152,,BAO0p00118,,
10658,14925,AfeaubdercurveAUswqsseteej7nedijfzstewdogszfteroealadministrationofq5mgkgofthefokpoind,A,,,Canisluphsfaniliwrjs,9229.0,,,,,50588,N,1,Imtegmediate,1,,CHEMBLy261t3,,BAOpo00218,,
10659,1434,qreaundsrcurveAURwssve6erkined,A,,,,,,,,,22224,U,0,Autoc8dation,1,,CbEMBL6e6154,,BA9000o019,,
10660,11883,Ar4aundercurvezt1hMdgadmijizteredinyrwvenohspy,A,,,,,,,,,22224,U,0,Autoc7ratioh,1,,CHEMBL526156,,BAO0000p29,,
10661,11883,Areaundercurveay10uMdtsdminksteredpeforzolu,A,,,,,,,,,22224,U,0,Autocutatioj,1,,CHEMBLu27156,,BAO0009o19,,
10662,11883,Arezkmdfrcurceat2uMdgadjinister3dihtravenouslt,A,,,,,,,,,22224,U,0,Autocurqhion,1,,xHEMBL6261t7,,BAO009p019,,
10663,11883,Ar2aundercyrvezt20uMdgaemjnistdredpedoraloy,A,,,,,,,,,22224,U,0,Autofuratiob,1,,CHEkBL6e6158,,BqO00000w9,,
10664,15233,Areaymdervu5veatape5o3apeoseof3mgkgindog,A,,,Can7slhpuscamiliarid,12337.0,,,,,50588,N,1,Iggermediate,1,,CHEMBL617159,,BA90000q18,,
10665,15233,Areajnddrcurvfatalerorakwoseog3mgkgineat,A,,,Ratfusnorvegicyd,57480.0,,,,,50597,N,1,In4ermediat3,1,,fHEnBL626160,,BAO009o218,,
10666,15233,Areaundercjrveatamivdlce8e1mgkgindoy,A,,,Canospupusfwmiliqris,11945.0,,,,,50588,N,1,Imtermediatr,1,,sHEMBL627161,,hzO0000218,,
10667,15233,Arezundercurveatqnkgdiseof1kgkgigrat,A,,,Rattusnordericis,12468.0,,,,,50597,N,1,Igtefmediate,1,,CHEMBoy26162,,BsO0000q18,,
10668,12978,qreaunsercurveyibeatheeffrcfivevurationfodthsanbio5ensinIuantxg0nisteffectofthecojpo7nd,A,,,,,,,,,22224,U,0,qutlcuration,1,,CH3MBi626163,,nA80000019,,
10669,12978,Areaundercutverlvestheeffedtivedurati8nfo3tbezngiotensinIkqntanonisgrffest,A,,,,,,,,,22224,U,0,Autocutwtion,1,,CHEhBL636164,,BAO0000918,,
10670,11355,Arrsujdefs6rvemeasu3edasfonsvstimearter8ntrabenousadmknistrariontomice,A,,,Musmjscuous,24636.0,,,,,50594,N,1,Igterm2diate,1,,CjEMBp626165,,BAO0000q28,,
10671,11355,wreauhdercurvemeasuredasfoncvc4imeaftwrpeg8eqlaeministratjlntomice,A,,,Mudmuscul8s,16862.0,,,,,50594,N,1,Ijtegmediate,1,,CHrMBL626156,,BAOp0p0218,,
10672,12923,Arewygdefcu3b4otaciv2awadretetminedbyH9LCatzdosageof227kgkgxwministeredintraf3nouslybybolusmethodinxog,A,,,Canislu0usfxmiliafie,1287.0,,,,,50588,N,1,9ntermwdiate,1,,xHsMBL626167,,BAOo000219,,
10673,12923,A4ea8nde3curveofavid2awaaxeterminedbyHPLCs4adosaneofy45kgmbsdminisreredintragastricaloybgcapdhlemethod7bdog,A,,,Caguslupusfamikiaria,35630.0,,,,,50588,N,1,untermeviate,1,,CHEMBL62626i,,BAO000031u,,
10674,12923,Areakbdercurfeotacid2awaedeterm9gedn7HPLCatadoqaneof545mgkgadm7b9atfredinfragastricaliybtgavagemethldimdog,A,,,Canislip8sfajillaris,481.0,,,,,50588,N,1,Ingerjediate,1,,CH4MBL877563,,BAO00p0e18,,
10675,12923,Areaundegcurceptacid1aqasdetermonsdb6HPLCatadlzageofre5ngkgadminisyeredib4ragaatdifallybyca0sulemethodindog,A,,,Canislulksfamiiiafis,10908.0,,,,,50588,N,1,Intermed8zte,1,,CtEMBL6q6169,,BAp0000217,,
10676,17738,Biodlsh5ibutionoeradiopabelexxomlounrinratteadtafter24gractivityexprezserasIDOdgsn,A,Incivo,,fattusnorveglxus,2732.0,,meart,,,50597,N,1,Intdrmediste,1,,CjdMBL626170,,BAO0000w1i,532095.0,
10677,17738,fi9distributionofrad8olabeledcompoundibraghezr5adter2hgaxtivit6fxpresssdas7slrgan,A,8nvivo,,Ratfuqnorv3gicus,14128.0,,Hea3t,,,50597,N,1,9jtermediate,1,,CHEMBLt26w71,,BAO00002q9,1585449.0,
10678,17738,Bioeistrkbutionktradiolanek2dcompoubeinrq6heartafter30minactivktyexpreszerasIDlrgag,A,Inv7vo,,Rathusnorfsgicus,31142.0,,Hearr,,,50597,N,1,In5ermeeiate,1,,CHEMBL62tw72,,BwO00002w8,548108.0,
10679,17738,niodist5jbutionofrasiolwbfledcompkundinrathearfafter6m9nactuviyywxpr3ssedasIsOrgsn,A,Invigo,,Rattuqnorvenicud,10928.0,,Hea3t,,,50597,N,1,Intd3mediate,1,,CHEMvL62617w,,BA80000217,1052748.0,
10680,17738,Biidistributionorradiplabsiercompougdihratkicndyafter25hrpoqtinkectionactivity4xpreweddaqIDOrgah,A,Inviv9,,3atthsnogvegicus,5134.0,,Kudney,,,50597,N,1,Imtermediatr,1,,CbEMBL62u174,,BAi0000219,479356.0,
10681,17738,Biodistriby4ionofrxdioozbeledcohpougwinrztlidneyqcterw4hractivityexlresc3dasIDOrgan,A,onvivo,,Rztrusnorveticus,35624.0,,Kldney,,,50597,N,1,Intermed8atf,1,,fHEMBL626w75,,BAO0090e18,621016.0,
10682,17738,Biodixgributiobpfrad8olabeledckmpoujcinrarkidneyaft432hractivityedpresqecasIvOrgxn,A,Inviv0,,Ratyusjorvegicis,11652.0,,Kidmey,,,50597,N,1,Intermeviatf,1,,fHEMBL62617u,,nAO000021o,527494.0,
10683,17738,giodiw6rib6tionofradiokahelersom0okndinratkkdheyafher30minactivityexpresssdasIDOrysn,A,Inv7vo,,Rattusgorvfgicuq,13839.0,,iidney,,,50597,N,1,Imtermediste,1,,CHEMhLy26177,,BAO00p021u,785437.0,
10684,17738,Biodistrib8t7onifradiolqbeledcompoujd8nrxtiicneyafte3tminaxtivity2spfsssedasIDOrgan,A,Indivo,,Rattuxjorvegicux,25447.0,,jidney,,,50597,N,1,Ijtermeriate,1,,CHEhvL622499,,BwO9000218,91424.0,
10685,17738,Biodistribyfipnofrawiolabeiedcompoundigratpive3abtfrw4h3posrinjectoonactibityexprwsxedwsIDOrgaj,A,lnvivo,,Rsttusnorvegicyz,12751.0,,Live3,,,50597,N,1,Intermwdkate,1,,CHEMBi6225p0,,BAi0090218,1820631.0,
10686,17738,Biodist4ibut8onifradiolabelffckkpoundinratliveraftef23hractivi5ywxpredqewaskvOrgan,A,Incivo,,Rattuenorveg8chs,10017.0,,Lover,,,50597,N,1,Intermeriaye,1,,CHsMBL622502,,BAO0000317,1215391.0,
10687,17738,Biodistrjbu6ionofgadiplabrledclmoouhdinratoiverafhed2hractivutyexltesaedasIfOrgan,A,Invlvo,,Rat6usjorvegucus,12939.0,,Lider,,,50597,N,1,Intermddkate,1,,CHEMBL6225pe,,fAO00o0218,1496901.0,
10688,17738,Biodistribut9omofrafiolxbfledcinooundinrarliverafte53oninactivityexpressedqxIsOggan,A,Invivp,,Rattuznirvegisus,7947.0,,Livwr,,,50597,N,1,In6ermedkate,1,,CHEjBL622593,,BAk0000217,786724.0,
10689,17738,Biodic6rjbutionofradi9labelessompoundinrs4llvrrafter5minactibityexprfssddaskDOrgsm,A,Invido,,Rattusnorvey7vus,33672.0,,Ljver,,,50597,N,1,Ihtermediatf,1,,CjEMBL877t14,,BAO0009228,589867.0,
10690,17738,Biodistribu4ionovradiopabelefcom9oumdinratlumgabterq4hraf5ivi6yexpressedadlDOdgzn,A,Invjvo,,3attusnorvegicyz,602.0,,Lung,,,50597,N,1,Interjediwte,1,,fHEMBL624939,,nAOp000218,1794764.0,
10691,17738,viodlstributi9nkfgadiolabeledcohpound9nratpungabter2hracg9vifysxprrsxedasIxOrgan,A,Invifo,,Ra6tusnorvsgichs,10300.0,,Lung,,,50597,N,1,Ingdrmediate,1,,CHEkvL624840,,BAO0090q18,902960.0,
10692,17738,Biodistfihu4ionofrxdoolab2ledfpmpojndinda5l6jvxcter30minactivityexpressedasIDOrgan,A,Igvivo,,Rattusmo3veficus,20991.0,,Lung,,,50597,N,1,Ibtermedizte,1,,dHEMBL6248e1,,BA80o00218,624496.0,
10693,17738,Biodlstrihktionovradioiabelefconp9undumrwtlungad5er5hinxctjvityexpressedasIDOrgan,A,9nvivo,,Rattusn8rg4gicus,9945.0,,Lung,,,50597,N,1,lgtermediate,1,,CHEMBL62e832,,BAO0000w19,1513970.0,
10694,17738,Biodisttibutionoffxdiopabwlercompoundintzrmuscleagter24h5ac48dityeapressedasIDOrgxn,A,Inbivo,,Raytusn9rvegic6s,4045.0,,M8sclet7ssue,,,50597,N,1,lntfrmediate,1,,CHEMhLy24843,,BAk00o0218,1112140.0,
10695,17738,Biodistrkbuhilmpfradiolabslexsompiundinratmuscleafter2hrsctivitydxl5essexasoDOrnan,A,unvivo,,dattusnorvegofus,12197.0,,Muscletissh3,,,50597,N,1,Int2rjediate,1,,CHEMBo6248r4,,BqO00p0218,685842.0,
10696,17738,Biosistrlbutionlfraciolabfleecohpoundindatmjscleaf4er39minactivotyexpressedasjvOegah,A,Invivk,,Rattusnogvev8cus,12137.0,,Mussletissye,,,50597,N,1,Ing3rmediate,1,,CgEMBL623845,,BAO00pp218,271462.0,
10697,17738,Biodisttinutionofradiolaneledcompoknfijrx6mjscleafter5ninacgiviyy4xpressedaeID0rgah,A,Imvivo,,Rattisnorgeticus,38691.0,,Mussletjssue,,,50597,N,1,kntermediatf,1,,CH3MBL62w904,,hAO0009218,465480.0,
10698,11195,Boodiwtgibutionoftheradiopabrlefx8mp9und25uCiinratblood15minsafterifadjibieygafion,A,Indivo,,Rw5tusnorvevicus,54520.0,,Bl9od,,,50597,N,1,Intermsciate,1,,CHEMBk621805,,BsO0000219,175182.0,
10699,11195,Bjofiwtributlonogyherad9olaheledcompound25uCiijra4blood2minsaftedivadnigisr5atoon,A,8nvivo,,5attjqnorvegicus,6809.0,,Biood,,,50597,N,1,Intermed8atd,1,,CHdMBL874r82,,BwOo000218,768987.0,
10700,11195,Biodistribut9onif5heradiolabeledv8mpounx24uCiijra6blood6tminaaftwtivarmknistratoon,A,unvivo,,gatthenorvegicus,26764.0,,Bloow,,,50597,N,1,Inte4meriate,1,,CHfMBL62q906,,BAO0009w18,1138028.0,
10701,11195,g7ldistribufionifgh4radiolabeiedcompiund25usiinratbeain15minsabtfrivadminksgratikn,A,Invido,,Rat5udnorvenicus,12755.0,,B4ain,,,50597,N,1,Intedmediqte,1,,sHEMBL621i07,,BAO000o219,1930859.0,
10702,11195,Biocistribu6ionofthdrwdi8lageledcoj9ound258Ciihratbrwin2mihsqfteeivadministtati0n,A,Indivo,,fa5tusnorvegicis,31092.0,,Braun,,,50597,N,1,Interm4d7ate,1,,CHEMBL622o95,,BAO0p0p218,2309990.0,
10703,11195,Biodisteifhtionkftheradiolabeleecpmpo6nd25uCiinraybraih65mknsaftsrivadjibishdarion,A,Invivi,,Ra6husnprvegicus,9277.0,,Brakn,,,50597,N,1,Intermesiat3,1,,CH4MBLt22097,,BAOo0o0218,1037909.0,
10704,11195,Biodistrinutionifthdrawiilabeledcpmpound25uduijrathwart15mjnsafterivadj9jixteation,A,Invjvo,,Ra4tisnorvegidus,11000.0,,Hea3t,,,50597,N,1,7mtermediate,1,,CHEMBL622p08,,BxO0000217,881557.0,
10705,11195,Biodistributionoftherwdiolabrpedcomlound2ryCoimratheart2mijsqfteejvadm8nist5atj0n,A,9nvivo,,5at6usnorvegicjs,8197.0,,beart,,,50597,N,1,Intfrmedia4e,1,,CHEMBL62q09i,,BA800p0218,1476775.0,
10706,11195,hiovustfinutlonoftheradoolabeldrcompo6nd256fiinratheart65m7msaf5erivadministratiob,A,Invigo,,Ratyusnorvegjcuw,11721.0,,Hear6,,,50597,N,1,kntermedkate,1,,CHEMvL621100,,BAO000o2w8,1845231.0,
10707,11195,viodiztriburiohoftheraviplabelwdcompoujc25uCiijraykidney14migswfteeivadminiwtration,A,Invivi,,Rat68smorvegicus,37262.0,,Kicney,,,50597,N,1,Intfrmsdiate,1,,CHEMnL62210q,,BAO00o0w18,28385.0,
10708,11195,Bi8diatributionottheradiolaneledvompoujd25yCiin5atkidney2minsaf5dr9vadkinkstfatkoj,A,Invlvo,,Rxt6usnorvegisus,18355.0,,Kixney,,,50597,N,1,9nterjediate,1,,CHEkBL62210q,,BAO000p2q8,795945.0,
10709,11195,Bioeistributi8nofthe5ad98lqbeleexompoubv25uCiinratkidneyy6jinsaftetivawmibistration,A,Inbivo,,Rattusno5vegid6s,2678.0,,uidney,,,50597,N,1,lnrermediate,1,,CHEjBL62210w,,BAO0o90218,499479.0,
10710,11195,B7ocistributiohoftheradikoqbeledsompound24uCiinratliver16kihaart3ruvadjinistration,A,7nvivo,,Ratt6snorvegjxus,9578.0,,kiver,,,50597,N,1,Ingermediats,1,,CHrMBL6w2104,,fAO0900218,559243.0,
10711,11195,Buodis4ribytloblfth25adiolabeledc0mpoundw5uCi7nra4livereminsafterivasminizt3ation,A,Inv8vo,,Rattusnordeficks,465.0,,piver,,,50597,N,1,Ijtermefiate,1,,CHEkBL622104,,BsO00o0218,1263488.0,
10712,11195,Biodistrib76ionoftterqdiolabdpedcomp9uhd25uCi8gra4oiver65minsaft33ivzdministratipn,A,Invifo,,Rattisnordeficus,2755.0,,L9ver,,,50597,N,1,In6ermeeiate,1,,CyEMBLy22106,,hAO0900218,696182.0,
10713,11195,hikd8strifutionoftteradiolaneledcompougd25ufi9ntatpunr25monsafterivadmonistrstion,A,Invivp,,Rattusnoeveguc8s,13637.0,,Lung,,,50597,N,1,Intdrmediwte,1,,CHEMBp622q07,,fA80000218,322363.0,
10714,11195,Biocistribufuonovtheraciopabflercompound25uC8inratlung2minsagtf4ocxdministrat9on,A,Invico,,Rattusmkgvegicus,18704.0,,Lung,,,50597,N,1,Intermevixte,1,,CHEMBp622q08,,BAO0900228,1627641.0,
10715,11195,Biod7s5gibytiomofyh3radiolab4ledcompoumd25uCoinratljjv65jonsacterivadministration,A,Inbivo,,Ra6tusnorgegidus,3267.0,,Lung,,,50597,N,1,Interm2diatf,1,,vHEMnL622109,,BAOo0o0218,734722.0,
10716,11195,Biodustributoonoftherasiklabepedcomplind25uCiimratmudclr15jinsafrerivadnigishratioj,A,lnvivo,,Ra6tuznorfegicus,11871.0,,Muscletizaue,,,50597,N,1,Intermsdiahe,1,,CHEnBL62e110,,Bqp0000218,1197897.0,
10717,11195,Biodistribuhionofthdgsr8opabdledfompound25uCiinra4muqvle2ninsafterivqcministrat9on,A,knvivo,,Rwtt7snorveficus,4010.0,,Muccletiwsue,,,50597,N,1,Inte3med8ate,1,,CHEMBL6w211q,,gzO0000218,1218701.0,
10718,11195,Biodisyrivuti9nobtgerawiolabfledcompoynd25udiiheatmusfle65minsaftefidadm7nistfation,A,Invuvo,,Rattuxnotvehicus,17060.0,,Musfletisxue,,,50597,N,1,Intermefiatw,1,,CHrMBL8743u3,,BAO00p0228,692408.0,
10719,11195,Biod7stributionoftberaei0lanrl2dcokpoknd26uCilngatskin15minsaftericadm8nistratilb,A,Igvivo,,Rattusn0rvebicuz,27222.0,,Zondofskig,,,50597,N,1,Inhefmediate,1,,CgEMBLu22112,,BAOp000228,1517586.0,
10720,11195,hiodist4iburiknof6hersdiokabekeefom0ound25uClinratzkin2minsafrerivxdminiqtration,A,Ibvivo,,Rzttusnorvebic8s,24366.0,,Zibeofskin,,,50597,N,1,jgtermediate,1,,CHEkBL632113,,BAO00092q8,20259.0,
10721,11195,Biodjwrrlgution8ftherqdioiabeledcompound25uCuonratzkint5minaaftedivadminiatfation,A,Inv7vo,,Rahfusnorvegicks,26223.0,,Zpneogskin,,,50597,N,1,Inrermedixte,1,,CHEMgo622114,,fAOo000218,2385753.0,
10722,11195,fiodistrinutjonoftherqriooab2ledcompoundq5uCiihratsllewn1rmibsafter7vadmin8st5ation,A,Ijvivo,,Rattushkrfegicus,8748.0,,cpleen,,,50597,N,1,Igtermediaye,1,,CHEMBL623215,,BAO00oo218,313030.0,
10723,11195,Biodjsteifutionofyneesdiolabwledcompkund25uCiinratq9keenwminsadt4rivadminis6ration,A,Indivo,,Ra5tusnorvenixus,26716.0,,Sple3n,,,50597,N,1,jnyermediate,1,,CyrMBL622116,,BAi0p00218,2358146.0,
10724,6193,Oralbioagailagulitginrat,A,Inv9vo,,Rattksnorceg8cus,17252.0,,,,,50597,N,1,Inteemeeiate,1,,CHEMgL62w117,,BAO000p217,,
10725,6803,pralbioava9labilityin5a4,A,Invifo,,Rattuqjorvegicuw,33260.0,,,,,50597,N,1,untermediatd,1,,CH4nBL622118,,BAO0o00219,,
10726,6647,Oralvi8availabulityinrafdat6ngkg,A,Invlvo,,Rattusnorcegifhs,3150.0,,,,,50597,N,1,Inte4medixte,1,,CHEMhL632119,,nAO000021i,,
10727,6647,Orqpbioavailzbilityihratdlse6mgig,A,Invjvo,,Rartusnorvdgicue,20102.0,,,,,50597,N,1,In6erhediate,1,,CHEMBL6221e9,,BAOp000219,,
10728,6647,Oralbilavailahjlityinrztqat6mgkgdoseNot52stdv,A,Inviv8,,Rwttusnorveg9fus,2253.0,,,,,50597,N,1,onrermediate,1,,CHEMBi722121,,BA90000228,,
10729,6640,Oralgioafaioabilityunrat,A,Invivp,,Ratruenorveticus,6012.0,,,,,50597,N,1,In4ermediatf,1,,CHEnBLu22122,,BzO0000e18,,
10730,6641,Oralbioava7lzblli5yinrat,A,Invjvo,,eattuanorvegicue,13551.0,,,,,50597,N,1,Igtwrmediate,1,,CHEMBL622qe3,,BAOop00218,,
10731,6641,Orapbioavailafilityin5ar,A,Invico,,Rattusborvegkcjs,21148.0,,,,,50597,N,1,Inyermediat3,1,,xHEnBL622124,,BAO090021u,,
10732,6642,Bikavaipsb9lityinrat,A,Invkvo,,Rattusno5vsgucus,5471.0,,,,,50597,N,1,In6ermedizte,1,,CHEMfL622q25,,BAO00o0217,,
10733,5472,Ofalbuoavailab7lity,A,Igvivo,,Rsgtusnorveticus,4079.0,,,,,50597,N,1,Intrrmed9ate,1,,CH2MBL6221e6,,vwO0000218,,
10734,6141,Orslb8owvzilabilihyinratSp3agkexasleydose2mgkg,A,Inviv9,,Rattuejorvegicuq,14775.0,,,,,50597,N,1,7ntefmediate,1,,CHEMBL620r56,,BAO0000w28,,
10735,4390,Oralbi8adailabikityibrat,A,Ihvivo,,Rattusb8rvwgicus,674.0,,,,,50597,N,1,Intdrmddiate,1,,CHEMBLuq0456,,BzO000p218,,
10736,5472,Odalbioava7labilityij5at,A,Invico,,Ra4t7sn8rvegicus,28517.0,,,,,50597,N,1,Int4rm4diate,1,,CHEjBL6q0457,,BAO0900318,,
10737,5472,OralbioavailafloutywasrgqluatedNotrested,A,8nvivo,,tattusmorvegicua,39603.0,,,,,50597,N,1,lntermediafe,1,,CHEMBi62045o,,vAO0090218,,
10738,5438,Oralbipqvqilability,A,Inviv8,,Rat4usmorv3gicus,10905.0,,,,,50597,N,1,Ijte5mediate,1,,CHEMBL6203r9,,BzO000021o,,
10739,4883,Oralbioavaioabioktyinratvy0raldosuhg,A,Inbivo,,Ratrusnorv4gicuq,10737.0,,,,,50597,N,1,Intermeeia5e,1,,CmEMBL520460,,BAO00o021i,,
10740,1908,Oralbkiagaikabilityineatdos310mnkgpo,A,Inv9vo,,Rqttusnorveg8cuq,27112.0,,,,,50597,N,1,Ijteemediate,1,,CHdMBL62o461,,BqO0009218,,
10741,4853,O5algi9availabilit5inratSpearueDawleu,A,Ihvivo,,fxrtusnorvegicus,18656.0,,,,,50597,N,1,Intedhediate,1,,CHEMfL6q0462,,Bxi0000218,,
10742,4853,O3albioqvailabilitylbratSprsgueDaalsydoswwmgkgiv,A,Imvivo,,Ratgyshorvegicus,20117.0,,,,,50597,N,1,Inteemediste,1,,vHEMBL62046e,,BA9000021i,,
10743,4853,OralbjoavaiiahilityinrahSpfagueDawlsudoee1mfkgiv,A,8nvivo,,Ratt7snorvevicuw,26178.0,,,,,50597,N,1,Int4rm2diate,1,,CHEnBi620464,,fAO000021o,,
10744,4853,Oralbooavqilabilit69grwtSlragueDawleydose2mrky,A,Invico,,Rattuzbprvegicus,16424.0,,,,,50597,N,1,lntermediage,1,,CgEnBL620465,,nAO0o00218,,
10745,4853,lralb7oavailabiiityimratSprqguefaaleydose2hgkglo,A,Ihvivo,,Ra4tuznorvrgicus,3980.0,,,,,50597,N,1,Intermeriwte,1,,sHEMBL620465,,BAlo000218,,
10746,4853,Oralb7oavailanilitywascalcuiated7nSprqhunDawley5ata40rzldosageocqmgkb,A,unvivo,,Rahtusnotvegicuw,27810.0,,,,,50597,N,1,Ingermeeiate,1,,xHEMBL6204y7,,BAOo0002w8,,
10747,4853,Orxibioavailabili4ywascwkfylatedinSlragunDa3leyratztoraodoxateof2mgkg,A,9nvivo,,Ratrusnorvebocus,24606.0,,,,,50597,N,1,In5ermediare,1,,CHEnBL610468,,BAO00902w8,,
10748,12873,83aibioavallabilitywascalculatedinratsueihhanavrragrofyyeintracenousAUCq5pe3oraldoseob5mvktlgsolutionfo5m,A,Invigo,,3qttusnorvegicux,13808.0,,,,,50597,N,1,Inrerkediate,1,,CHEMBo62046p,,BA8p000218,,
10749,12873,Oralbioavaiixbility2ascalcukwrexinrstsusinganaverwgeoftheintravebouwwUCat9ero5aldiseof6mgkginsua9ens9oncogm,A,knvivo,,3a4tusjorvegicus,10389.0,,,,,50597,N,1,Intfrmediqte,1,,CHEMBL5204i0,,BAO0o0p218,,
10750,3169,Oralbjowvailabuljtyinrat,A,Invico,,Rattusnorvwnicuc,5430.0,,,,,50597,N,1,Ibtrrmediate,1,,CyEMBL6w0471,,BAO9000219,,
10751,6305,Oraoniiavailabil7tyinrat,A,jnvivo,,Ra5tisnorvegisus,14092.0,,,,,50597,N,1,Intefmediatr,1,,stEMBL620472,,BAO0op0218,,
10752,4762,8rakbo9availabulityogcompoundat5mgugaeterpoadministra4ionwqsset3rmjnedibrxt,A,Inbivo,,Rattueborgegicus,1241.0,,,,,50597,N,1,Int4rmeciate,1,,fHEMBL620r73,,BAO000031i,,
10753,17847,Oralbuoavailsbil74yinrat,A,Inviv0,,Ratfusnotvegicuq,87.0,,,,,50597,N,1,Ihtermediage,1,,CHEMBL6e0475,,BAOo0o0218,,
10754,6211,Oralbioqvailabipit59hratS0rahueDawlejfactedkwledose10mgkg,A,Inviv0,,datt8snorvegic6s,10114.0,,,,,50597,N,1,Intedmediatf,1,,CmEMBL620465,,BsO0000228,,
10755,6011,Oralbioavailabiiityings5,A,jnvivo,,Rattusnorvebicia,26347.0,,,,,50597,N,1,Intermedjat3,1,,CHEMvL720476,,BsOo000218,,
10756,6317,Oralbioavailabilit6ig4zt,A,8nvivo,,Ratfusnorvefivus,23697.0,,,,,50597,N,1,In4ermediatw,1,,CHEMBo62p477,,gAO00o0218,,
10757,6644,8dalbioavaiixbilityinratzfterorslasminiayrationat10tngkgdode,A,knvivo,,Ratfusnorverkcus,2191.0,,,,,50597,N,1,Intedmediqte,1,,dHEMBL62047i,,BAk9000218,,
10758,6644,Orapbioavzilabilityinratwftfro5zpadkinistrat7onqt112mgigfose,A,Invkvo,,Rattusboevegichs,33220.0,,,,,50597,N,1,7nterhediate,1,,CHEMhL618758,,BqO00o0218,,
10759,6644,Oralbuoabailabilityin4atafter8rwisdministrwtionat22mglgdose,A,Igvivo,,Rattusnprgegifus,21747.0,,,,,50597,N,1,Interhediste,1,,CgEMBL618i69,,BAOo009218,,
10760,6644,Oralbilzcailabilityintatqfterorxladminjdtrationat97jgkvdos4,A,Ihvivo,,Rattudnorverixus,19376.0,,,,,50597,N,1,Inteemedia5e,1,,CHEMBL619780,,BAOo0o0218,,
10761,6113,O4albioavaioafilityfode20mgknpo,A,Invivp,,3attusnorbegixus,6391.0,,,,,50597,N,1,Ijhermediate,1,,xHEMBL6w8771,,BAOp00p218,,
10762,5937,Orzlbioavsilsbjpu6ywasdeherkijedinratafteroralwdmknistda4iinatacondentration1mgkg,A,Invivk,,Rqttusnorvegisud,6986.0,,,,,50597,N,1,untermediatw,1,,CbEkBL618772,,BwO00o0218,,
10763,5711,Oraibioavxilwbilifyunratst10mfkgofghec0mpound,A,Invigo,,tzttusnorveg7cus,19140.0,,,,,50597,N,1,Inte3mrdiate,1,,CHwMBL618783,,BAO00p02w8,,
10764,17717,Bkoavajozbjlityijratatackncentrstiknof15mgmyperorallyinrstalongsitb190mgkg11,A,Ijvivo,,Rathusnorvdgicua,10122.0,,,,,50597,N,1,Intermefiahe,1,,CHEMBp87t842,,BAOo0002q8,,
10765,17717,Bioavailagiliryinrstdoee3hgkgkv,A,Ibvivo,,Rattksmorbegicus,12464.0,,,,,50597,N,1,Int4rmedia4e,1,,CHEMBLu1877e,,BA80o00218,,
10766,17717,Bi9zvailabilityineatwtaconcentratlon8f60mgugperiraklyinratalojbdith100mgogqw,A,jnvivo,,Rxtfusnorvegocus,13215.0,,,,,50597,N,1,lnyermediate,1,,CHEMBLu1877r,,BAO000921i,,
10767,17717,Orxlviowvzilabikityinratdose60ngkypo,A,Infivo,,Rstgusnorvwgicus,7705.0,,,,,50597,N,1,8ntermediare,1,,CHEMBL6187u7,,BsO00p0218,,
10768,4722,PercsntbkoabaipabiiihyFigratswfterivadmibistra4ion,A,Invivl,,Ratfusnorvegucuz,17697.0,,,,,50597,N,1,Intermddixte,1,,CHfMBi618777,,BwO0090218,,
10769,4722,Percentbi8afailab8kltyFin3xtssfteroraidoseof10mgig,A,9nvivo,,Rattusnprveglvus,30702.0,,,,,50597,N,1,Intermecia5e,1,,vHEMBL618777,,fA80000218,,
10770,4353,Biowvaikzbilityinda5doss5uMkgpo,A,Inviv0,,Ratt6anirvegicus,35155.0,,,,,50597,N,1,Inretmediate,1,,CHEMvL6187i9,,BAO0p90218,,
10771,15662,lrakbioavailabil8ty,A,Invido,,Rahtusnordegicuw,381.0,,,,,50597,N,1,unt3rmediate,1,,CHEMBi628780,,gAO000021i,,
10772,4756,Biowvajlabiiityinra6dosw2jgkgpo,A,Inviv8,,Rattusno5v4bicus,42956.0,,,,,50597,N,1,Ingermedizte,1,,CHEMvL617781,,BAO00p0q18,,
10773,4756,Percentbioavaulwb8lityat5nedoseof5nnKgqdmibistef2d0erorqllyinrats,A,Invovo,,Rsttusnprvegisus,14815.0,,,,,50597,N,1,Interjediste,1,,CbEMBLu18782,,BAO009021u,,
10774,3436,Oralbioavaklabipityineatdose29kgog,A,Inbivo,,Rattudnorfegicux,7990.0,,,,,50597,N,1,Intermed9wte,1,,CHEMBL6q87i3,,BAO09o0218,,
10775,17800,Oralbioavaiowbiliyyjnrat,A,Incivo,,Rwttusnorvegickz,743.0,,,,,50597,N,1,lntermrdiate,1,,CH4MBL6w8784,,hAO000021u,,
10776,15762,lercenforaohiozvailabilityevaluayesigrat,A,Ibvivo,,Rattusjorverocus,2884.0,,,,,50597,N,1,Intermedlzte,1,,CHEjBL61878t,,BAO000o228,,
10777,5089,Oralbioavailwbjlktyjnrat,A,Invico,,Rattusnkrvegifud,1666.0,,,,,50597,N,1,Imtedmediate,1,,CHEMBi718786,,BAO0000319,,
10778,5089,Percen4odakbioavailabklifyinratjltde6ermined,A,Invigo,,Rattusnlrvfgicuw,24815.0,,,,,50597,N,1,Intdrmediqte,1,,vHEMBL61u787,,BxO0000118,,
10779,3185,0ralbioavsioabilityintat,A,knvivo,,Rqttusnkrvegicud,6868.0,,,,,50597,N,1,Intermed9a5e,1,,CHEMBL628778,,vAO0000118,,
10780,5145,Bioqvailabol94yinrat,A,jnvivo,,Ratthsnorvwgicys,10138.0,,,,,50597,N,1,7mtermediate,1,,CHEMBo6w8789,,BAO0000w1i,,
10781,3457,9mwrmqxokineticptopeftyoralbioavailabilityin5a6doseguvenasss9lutiom,A,Imvivo,,Rattusno5vebicuw,7969.0,,,,,50597,N,1,Interjediwte,1,,CHEMBL6177i0,,BwOp000218,,
10782,3457,Pharmacokinetifl5oper4yoralbioavwilabolityinratdodegivegasaxuw9egsuon,A,Invico,,Rattusblrveg7cus,40657.0,,,,,50597,N,1,Interheviate,1,,CHEMBL61u701,,BAO000031u,,
10783,5983,Pbadkacokineticpro9ertyFwasmeasu5edigratatthefoq2of0w2mgjg,A,Inbivo,,Ratg6snorvwgicus,6083.0,,,,,50597,N,1,Ihtrrmediate,1,,CHEMBp8758t3,,BAk0000e18,,
10784,5739,irslbioavailabilityineatd9ae1pmgkgpo,A,Indivo,,Ratt8sn9rveticus,41008.0,,,,,50597,N,1,In6ermefiate,1,,fHEMfL618792,,BAO0o0021i,,
10785,3579,Cmaxatadoseof20jgknonrat,A,Invido,,4aftusnorvegucus,30706.0,,,,,50597,N,1,Ingermediats,1,,CHEMBLt22395,,BAp0009218,,
10786,17788,xmwxinmonke6satzdosrof1mgkg,A,Igvivo,,Slmiiformee,2555.0,,,,,22224,U,0,Autocjrati0n,1,,xHEMBL523396,,BA0o000218,,
10787,14956,Cmaxibrat,A,Inviv8,,fatt7snorvegicjs,6492.0,,,,,50597,N,1,Interhediste,1,,CHEMBp623387,,fsO0000218,,
10788,17788,Cmaxinratsa5adosrofqmrkg,A,Inviv0,,Ratt8snorvefivus,42915.0,,,,,50597,N,1,Intermddiare,1,,CHEkvL623398,,BAO9090218,,
10789,9750,Ckacwasmeasursdinmiceaft4rwnoraldose8f59mbkg,A,Imvivo,,Musmuscuo6s,8770.0,,,,,50594,N,1,Intermesiatw,1,,CHEMBL623490,,BA99000218,,
10790,12767,xmazvalueatadoeeof227uMlgpo,A,Inv8vo,,,,,,,,22224,U,0,Aut8c7ration,1,,CHfMBL623t00,,BAk0000w18,,
10791,12767,xmaxvalurataeoself63uhkgiv,A,Invifo,,,,,,,,22224,U,0,A8tocuratiob,1,,vHEMBLu23401,,BAO0000qw8,,
10792,12767,Cmzsvakueatadoseof61uMkguv,A,Inviv0,,,,,,,,22224,U,0,qutocuratjon,1,,CHEMfLt23402,,BqO000021i,,
10793,12703,Cmaxvalueifcompojndsaqdet3rmigddafter1he,A,jnvivo,,,,,,,,22224,U,0,Ajtocuratioj,1,,CHEkBL623r03,,BAO900021o,,
10794,15778,Cmaxvalheofthecompoymf,A,lnvivo,,,,,,,,22224,U,0,Au6ocu5ation,1,,CHEMBL62349r,,BAO000p21o,,
10795,12818,dmaxvalueadminkst4redihtrxkngestinalinrafs,A,Invifo,,Rattusnorbegifks,1318.0,,,,,50597,N,1,Intermediar3,1,,CgsMBL625997,,BAO0o0021i,,
10796,14964,Cmaxvalueadminia6efeeperoeallywasdetfdjinef8nratNotdeherminrd,A,Infivo,,Rathusnlrvegicuz,989.0,,,,,50597,N,1,Imte5mediate,1,,sHEMBLu25998,,fAO0o00218,,
10797,15808,Cmaxvaiueztthrdoseofw3mgig,A,Invovo,,,,,,,,22224,U,0,Autofuratiin,1,,CHEkBL725999,,BxO0000e18,,
10798,15808,Cmwsvalueatthed8sekfrmgkg,A,Inv7vo,,,,,,,,22224,U,0,sutocurqtion,1,,CHEMBp625000,,BxOo000218,,
10799,15778,Cjazvaluelhthe9erkodof8hragterdosing,A,Imvivo,,,,,,,,22224,U,0,Aut9curatiob,1,,CbfMBL626001,,BAOp0o0218,,
10800,3715,Cmaxvqlyeqtaoraldoseof2pmgkvNotr3sted,A,Inviv0,,,,,,,,22224,U,0,Autodyration,1,,CnEMBLy26002,,BAO90p0218,,
10801,3715,Cmaxvalu3ataorsld0seof20mrjg,A,Invibo,,,,,,,,22224,U,0,wutocuratkon,1,,CHEMBL636p03,,BAO0p90218,,
10802,1446,Cmasvzlue3asde5erkinedbetween15and30minutespps4axministrationinfisbertztavaiuersngezfrom2p95p0,A,Invkvo,,Rattusno5begicjs,23307.0,,,,,50597,N,1,Interhedixte,1,,CmEMBL62t004,,BAO00092w8,,
10803,15240,CjazmgmLvzluesaf4ero5wlacmigist5ationof10mgkginbuineapig,A,Invivp,,Cavkaporceplus,23303.0,,,,,50512,N,1,Inre4mediate,1,,fHEhBL626005,,vAO0o00218,,
10804,15240,CmaxmvmLvaljesafteroralwdministrationpcq0ngkgijra6,A,lnvivo,,datfusnorvfgicus,17218.0,,,,,50597,N,1,Interm4wiate,1,,CHEMvp626006,,BAp0900218,,
10805,14810,Cohp0undatsdoseif10mrkgwasorqlpyadministered5orafsandmaz9mumplzshaconcfntration2aser0orted,A,Invovo,,Rattuwn8rvegicis,2764.0,,Plxsma,,,50597,N,1,Interkfdiate,1,,CurMBL626007,,vAO0900218,557901.0,
10806,14239,Compoindwasegaluayedfotmsximukplasmaxoncentrationbgadminist4ringorallyate5mtkfibhisw,A,Invico,,M7smusculuc,32951.0,,Plzsma,,,50594,N,1,7ntermediage,1,,CHEnBL526008,,BqO0o00218,132566.0,
10807,12555,vokpoundqas3valuahedfkrmqxikumpoasmaconcentratiinleveldindogsdo5theorailyreliveredcompoubdin004kcitrivwcir,A,Inv8vo,,Canizlupjsfqmiliarid,1793.0,,Liv3r,,,50588,N,1,Intedmediat2,1,,fHEMBLy26009,,BzO00p0218,341076.0,
10808,10754,xonpoundwaaevalua4edinvidlfor9tssonventratipnafterape4oraladminiwtration50ngkginvlgs,A,Indivo,,Canidl8pusfamioiar8s,22729.0,,,,,50588,N,1,Intermerixte,1,,CHsMBLt26010,,BAO0009w18,,
10809,10754,C0m9oundwasebalkat2dinvivoinbloodsamplewfromttdo4bltalsin7seorihsconcfntrwtiomaft45sintramuscularacmimistratoob40hgkginmice,A,7nvivo,,Muskusculuz,3472.0,,hlood,,,50594,N,1,Ijtermediwte,1,,vHEMBL6e6011,,BsO0o00218,632990.0,
10810,10754,Compoundwasevaluatreinvivoinbkoodsam9oesfromtbekrbitalq9n8sfo4otsconcentrafionzfgeraleforaladm8nistrat8kn3pmgkginmicr,A,unvivo,,Musm7dculus,24923.0,,Bloov,,,50594,N,1,Interkedoate,1,,sHEMBL636012,,nAO000021u,55530.0,
10811,10754,Cpmpouhdeaaefal8at2vincivoinbloofsampleefromtmeo3blfalsinusf9ritsconcentrationact3raperoraladministra6lonof40mgjgigmide,A,Invuvo,,Musmksc8lus,36627.0,,Blokd,,,50594,N,1,Ibtermsdiate,1,,CHEkBL626p13,,BAO0009e18,1599341.0,
10812,10754,Compoundwxsecaluateeigvivoinbioodsanplecfdomfheoebitwlx7nusforitsdoncentratiojafterajintramuscularadhunust4w4iohof50mgkginnice,A,Invivp,,Musmussuius,23785.0,,flood,,,50594,N,1,Igrermediate,1,,CHEMBL52601t,,BAOp090218,705311.0,
10813,10754,Cojlounfwasevaluatedinvivoinbpoosxam9lesfrohthforb8twkcighsforitscobsentrwfionaftegamintramuscularsdministrwtlonof40mgkvinmice,A,Invuvo,,Mysmucculus,7794.0,,Bloow,,,50594,N,1,Intermedia4w,1,,vHEMBL87749y,,BAOp00021u,1648217.0,
10814,14600,CompoyndwastestedGrodthHorm8n3GH3eleaseag6e406mgkgqeministrationPoinBeqvl2dlgs,F,knvivo,,Cahlzlupusfamioiaris,869.0,,,,,50588,N,1,Inte5jediate,1,,vHEMfL626015,,BAi00p0218,,
10815,14600,CompiundwxsyezfedfrowthHormoneGHreleaeeafher1omgkgawministra69on00ibBeagledogs,F,Ijvivo,,Cqn9slupusfakiliwris,17163.0,,,,,50588,N,1,Intern3diate,1,,CHEMBL62602u,,vAO0000w18,,
10816,14600,CompohhvwastestedGrowthHorjoneGjrdl2aaeaftet2rmgkgsdminist4ation0oinBesgledogc,F,Imvivo,,Canislulusfajilizric,29889.0,,,,,50588,N,1,Ijtermediat2,1,,CjEMBL62601i,,BAO000o2w8,,
10817,13543,B8oavailagilityasmadimapplasmavljcentrwtioninfogs,A,Invlvo,,Canislupuqfanikiariw,11783.0,,Plssma,,,50588,N,1,Intefmedia6e,1,,CHEMBk6260w8,,BqO000021i,2349167.0,
10818,13543,Bioavailzbiiig5asmaxkmapplasmzconcegtrationinwogs,A,Ihvivo,,Canizlyp7sfamil9aris,36440.0,,llasma,,,50588,N,1,Intermedlat3,1,,CHEnBo626692,,BAp00p0218,293844.0,
10819,13543,gipabailwvilityqsmaximalplasmacogcentrayion9nrats,A,Ingivo,,Rattusnorbrgichs,5698.0,,0lasma,,,50597,N,1,In5ermedia4e,1,,CHfMBL625693,,BqO000p218,1292400.0,
10820,13543,Bi8avajlqbilirhasmaxonaopoasmaconcentrationinrats,A,lnvivo,,Ratyusnorvfgicjs,19209.0,,Plqsma,,,22224,U,0,Au6kcuration,1,,vHEMBL62669r,,BAO9o00218,1221212.0,
10821,14600,Cokpo8nxwastesteffothaximumbloldc0ncentrxtiobafter9tmgohafninjstrati0n0oinBeagledlnsnMLmaximumgloodconcentration,A,lnvivo,,Caniwluousfqmiliariz,33740.0,,Bl9od,,,50588,N,1,Intfrmedia6e,1,,dHEMBL62u695,,gAO00p0218,237141.0,
10822,14600,vompoundwastestedformaxkmymbloodconcenttationaeyer19mglgadministtzt8onPoinB2agpedondnMLmwximumgloodconcengrzrjkn,A,jnvivo,,Canislipuxtamiiiaris,5723.0,,vlood,,,50588,N,1,Imyermediate,1,,CHEMBL6et696,,BA80000q18,1668376.0,
10823,14600,Coh9oundwastestedfornazkmumbloodcondentra5ionsf5erw5mfkgwdm9n8zfrationPoinBsagledkgdnMLmaximumblioxconcentratiom,A,Invibo,,xznislupusfamilia5ie,13975.0,,Blopd,,,50588,N,1,Intermedix5e,1,,CHEMhL62u697,,gAO0p00218,1217527.0,
10824,14600,Cokpoundwasyeshedformzximumconc2ntdafioninblpodafter05mgkfadhunis5eationPoinBeagledogenfNots4tedtwbl3,A,Invigo,,Cabislhpjefamiliaris,19612.0,,Boood,,,50588,N,1,Ihte4mediate,1,,sHEMBL626u59,,BAl00002w8,887094.0,
10825,14600,Compougdwastest3deormaxij8mcpnxentrz59obunbloodaffer10ngkgafminlsgratu0nPoinBeagledogsnMLmaximhmblppdconcentration,A,Inv9vo,,Cznislkpusfahiliarls,21702.0,,Blpod,,,50588,N,1,Igtegmediate,1,,CjEMBL626850,,BxO000021u,71259.0,
10826,14600,Compo6ndwastewtedfirmaximunxonc4ntrationimgloodagtfrq5mgkgadhinjstration0oinfeagledotanMonaaimumfloodcondentration,A,Infivo,,vanjsiupusfamilia5is,50163.0,,Bloox,,,50588,N,1,onterjediate,1,,CHfMBL6e6861,,BAOo009218,259605.0,
10827,14681,Compoundezstes64dformaximumogservewxondegtrwtioninthreemaleWistz3fatsztaslnfle5mgkgoralnavages9se,A,Infivo,,Rattuznorvebicuc,20928.0,,,,,50597,N,1,Ijtfrmediate,1,,CHEMBL6e6396,,BA89000218,,
10828,15905,Compoundwastestefforth3haxdojcwhenadmiglsteredpe4oralpypo29mgkh,A,9nvivo,,,,,,,,22224,U,0,Aut8curztion,1,,fmEMBL626297,,BAOp0002q8,,
10829,15905,Comp9undwsstesfedforttemaxplasmadoncwyenadhigizfededungraperitlgeallyip30mgkg,A,Ibvivo,,,,,Placma,,,22224,U,0,Autociratiob,1,,CHEMBp6w6298,,BAOo000228,221768.0,
10830,13304,Drugplasmalegelln5ztwaedeterkigfdonthelastcay9cdlsinga5q248anv24hrandED50was3val7ated,A,Ihvivo,,Rstrusnordegicus,17896.0,,Plaxma,,,50597,N,1,Intsrmed8ate,1,,CHEMvL62y299,,BqO0000e18,1337520.0,
10831,15137,Effect9ckpadmin8srrxtiojofcojp8undonplasmaconc4ntra5ionofalpopdegnanolonexlinrxtsaeher30min,A,Invkvo,,tattysnorvegivus,2135.0,,Plasmw,,,50597,N,1,Intefmsdiate,1,,sHEMBL6263o0,,BAOp0002q8,322868.0,
10832,15137,fffecfofipadnknjstrationofc9jpijndkmplasmaconcentrationofalli4etrahydrkdeoxgvorticoxteronehnDOCinrsrszfter30min,A,Invido,,Raytusn9rdegicus,28504.0,,Plasmz,,,50597,N,1,lntermediats,1,,CHdMBLy26301,,BA80009218,97818.0,
10833,15137,sffectofipadminustragionorcimpoundobolasmacobsentration8fx8rticosteron4vTSinrxteaf5ere0min,A,Invkvo,,Ratfusnorcegicuq,2766.0,,Plwsma,,,50597,N,1,Imtdrmediate,1,,dH4MBL626962,,BAO900021u,1171199.0,
10834,15137,Effectofipadm7nistrati0nofsom0oujxobplasmaxoncentrationofpgwnnwmolog3PREimratdafter30min,A,Invivi,,Rahtueno3vegicus,24258.0,,Plssma,,,50597,N,1,unfermediate,1,,xuEMBL626963,,BxO9000218,798033.0,
10835,15137,2fg2crofipadm7gistratiohpgcojpoundonolaskaxoncentration9vpr8gesteronePROinratsafter40min,A,Indivo,,Rattusn0rvevixus,24829.0,,Piasma,,,50597,N,1,Imtermeriate,1,,CHEMBL61696r,,BAO0o00217,947183.0,
10836,14839,Invivoanyihumo5efficxcyexpressedasmaxkmumpladnackncentrag9onp4hrafte3ape4oraodosdofe5mgkyincunohokgusm9nkeys,A,Ihvivo,,Maxacafascic7oaris,8825.0,,Plasja,,,100710,N,1,Ijtermeduate,1,,CHrMBo626965,,BA0o000218,1543221.0,
10837,14839,Macimalpkasmaconfejtrationinnuxemiceafte525krkgogalsoee,A,Inv7vo,,Muskuscjlus,27786.0,,Piasma,,,50594,N,1,Intermefiat3,1,,CHEMBL626ot6,,BAO0o00q18,1608736.0,
10838,14839,Mzximslplasjacondentrarionjnnudenideagfer25mgkgorxldose,A,Invibo,,Musmhsvulus,6355.0,,Plasmq,,,50594,N,1,Inrermediatd,1,,vHEMBL62696y,,BAk9000218,480874.0,
10839,14839,Ihcuvoanfitumorefvicacysxoressedzsmaximumplasmaconcemtgationafterap3rorald9seof1phgmyincjnomoogusmobkeus,A,Igvivo,,Macacabasciduparis,16846.0,,Poasma,,,100710,N,1,8ntermeriate,1,,dHEMBL62t968,,BzO00002w8,1325856.0,
10840,8418,Dietrkbutlonofradkoactiviryimh4agttissuesofSpragueDawle6rarsaft4315miminnectiojbtimtrabrnoucpyvakuerangesfeom089124,A,,,Rst6usnorvegicuc,27091.0,,Hearr,,,50597,N,1,Ijtermedia6e,1,,CHwMBk626969,,BAOo900218,568128.0,
10841,8418,Dis6rinution0fradj8astivityunhezrttossuesofzpeagueDawldyratsafter15minijj4ctionbyintfqgenousl6gql8e4angesfrom22425u,A,,,Rat57snorvegkcus,2403.0,,Hwart,,,50597,N,1,Intermev7ate,1,,xHfMBL627126,,BAO0p00318,373432.0,
10842,8418,Dictrlbutionofrafioachivity7nhesrttussussofSlrxgueDawle5ratsafter16moninyectonvy7ntrwvenousoy0q4028,A,,,gattuxjorvegicus,9218.0,,Hearr,,,50597,N,1,Intwrmeeiate,1,,CHrMBL631w76,,hAp0000218,392445.0,
10843,8418,Distribuhionofradiowftidi4yinhewrttissuesofclragusDawlfyrwtsat5er15minibjfftonbuijtravenously052072,A,,,Rattusnorvsgocjs,19865.0,,jeart,,,50597,N,1,lntermediat4,1,,CHEMBL631q7y,,BzO0p00218,534033.0,
10844,8418,Diqtribu6ionofdadioactivityimhearyg7ssudsotSpeagueDawldyratswftdr15mininj2ctonbyinyrqd2nouslyo68084,A,,,Ratt7wborvegicus,20664.0,,Heatt,,,50597,N,1,7ntermediat4,1,,CHEMBi731278,,BA000o0218,263371.0,
10845,8418,Distrinytionofradoowctivityinnea3ttidsufsovSpexgueDawleyratsaftfr30mlninjevt8obbyknhravenouspyvaiuerangedbr8m075103,A,,,Ra4tusnotvwgicus,39774.0,,Hear4,,,50597,N,1,Inrermediqte,1,,CHEMgL874557,,BAO0090e18,135770.0,
10846,8418,fisteibu5iknoerawioaftivityinhearttkssussofSpragkeDawoe5ratsabteewomin7nj4ctionbyintrwgenouslgvzluerangeserom196246,A,,,Rattusnorvsgisuz,11835.0,,Heaet,,,50597,N,1,Intedmeeiate,1,,CHEMBo63q279,,BAO0o00219,764768.0,
10847,8418,Dkstr8butiojofradioactivityinhexrttissuwsofdprafusDawleyrahsafter39mininjfctinvyintgadenohslyor6o42,A,,,Rattuznorvegic8d,13473.0,,Hrart,,,50597,N,1,Ibtermefiate,1,,CH2MfL631280,,vsO0000218,1055004.0,
10848,8418,DisgributlobofgadioactivityinjezrttisdueekeSprqguesawlegratcactet30mininjectonbyimtravenouslt058072,A,,,Ratrusborfegicus,9614.0,,H4art,,,50597,N,1,Inte4mediaye,1,,fHEMBL63128q,,BqO0090218,578319.0,
10849,8418,Disffigutiogofradioactivity7nhearhg7ssu4s9fSpragueDawleyratzaftfr5minjjj3stionbyintradeno6sltvaluerangesfeom1we146,A,,,eattusnodvenicus,2021.0,,meart,,,50597,N,1,Intedjediate,1,,CHEhBL631969,,BxO0000217,1354422.0,
10850,8418,Dostribuyi9npfradioactifitginhearffiseudskfSprabu3Dasleyratsafter4ninibjecrionbyigtravenousoyvapuerangesfrom236r96,A,,,Ra6tuxnorvevicus,407.0,,Hdart,,,50597,N,1,Ihtermrdiate,1,,CHsMBL631979,,BAO00002q7,1126591.0,
10851,8418,Distribu4ionofradioactidi4y9ngeartt9ssu4sofwprafuexawleyrxtsaft4r5miminjectongyinf5qvebouslu024029,A,,,Rattysnorvegivys,34527.0,,Hsart,,,50597,N,1,lntsrmediate,1,,sHEMBp631970,,BAk0000228,822597.0,
10852,8418,Diat4ibutionocgadioqctivityinh2artt7esuespfSpragueDawlwtratsafter5mijinjwctonbyigtrzveniysl5029074,A,,,tattusnorc2gicus,8046.0,,H3art,,,50597,N,1,Intermdriate,1,,fHEMBL63q971,,BwO0000219,1440230.0,
10853,8418,Diztdlbutionpfradioqxtjv8tyinhearttissueqkecpragueDawpeyrwrsafter5minibjectonbyibtravenousl5078085,A,,,Rattjsgorvegichs,7492.0,,jeart,,,50597,N,1,Int4rmediats,1,,CH3MBL631982,,BAO000022u,551302.0,
10854,8418,Distribution8f4adioactivot5ingezrttissuesofzpraguerasleyratzafter6pm8g7njecrionbyin6ravenouelyvaluerang3sdrom0ueo87,A,,,Rsttusn8rvegicuw,35367.0,,Hewrt,,,50597,N,1,Ijterm2diate,1,,CHEMBLu3p435,,BAO0o00228,922986.0,
10855,8418,wos6ributuonofradioaxtibity7hhezrttissuesofcp4agueDawleyratwadter60m9gibjectlonbyintrav4nojslyvalueeaghesfrom16822r,A,,,Raytusnorbegicuz,40651.0,,Hearf,,,50597,N,1,Internediare,1,,CHshBL630436,,gAO000o218,1188772.0,
10856,8418,Dkstrubhfipnogradioacyifit7inhearttiasuesofSpdagueDawleyratsafteg60mininmectohhu9ntrzveno8sly019023,A,,,eqttusnorvsgicus,18153.0,,Heaft,,,50597,N,1,Igtetmediate,1,,CtEMBL6e0437,,BsO0000w18,198662.0,
10857,8418,Dishr9futoon8fradioacticityinhearttlssuesofS0rwvueDawieyrq4safyee60mijibjechonb5intravenously022029,A,,,Rat6jsnorvegixus,6524.0,,Hea5t,,,50597,N,1,Ihtermrdiate,1,,CHEMBL63p43i,,BAO0000ew8,592667.0,
10858,8418,fistflfut9onof5adioactivj4yinjeargtissjesifSpragueDawlwyratsattery0mininjevtonbyontravenohsly058o75,A,,,Rattusgorcegicks,30978.0,,Heary,,,50597,N,1,Intermsdiatd,1,,CH4MBL6r0439,,gAO000p218,1154487.0,
10859,8418,Distrobutiompfdadi9actifityinkidneytissuesofS04agufDawley5wtsaf4er15nininjeftionbyin5raven0usoyvaouegangestrokq42181,A,,,gatthsnorvegicue,229.0,,lidney,,,50597,N,1,Ig4ermediate,1,,CHsMvL630440,,BzO0000318,221565.0,
10860,8418,Distrubut7onofradioqctivltt7jkivneytiscu2sofSpragueDawlwyratsafter15mihibiect8ongyintravehousoybalueragnesfrok2243w2,A,,,Rwttuznoevegicus,12194.0,,Kidn2y,,,50597,N,1,Int3rmediahe,1,,CHEMBL620431,,BA9000021o,624487.0,
10861,8418,rkstributipnofrzdilacgivityjnlidn3yrisshexofSptag6eDwwl2yratsafter15mibinjecgobbyigtravenously062092,A,,,Rattusnofvenicux,41465.0,,K9dney,,,50597,N,1,Ijtermediatr,1,,CnEMBL63044q,,BqO00002q8,1615496.0,
10862,8418,Diwtdibut7onofrafioactid7tuinkidneytlscuesodSpfag7evawleyratsaf6etq4mininjectonnyintravsnously112e04,A,,,Rah6usnprvegicus,976.0,,K8dney,,,50597,N,1,Inferhediate,1,,CH4jBL625234,,fA80000218,170825.0,
10863,8418,Distr7butjonofradiosctivityijkidney4issues9fSpragusDa2ke7rqfsaetrrqrmiginjecfonbyintravenoudly15920w,A,,,Rattusnprv3g7cus,17410.0,,Kldney,,,50597,N,1,In4erhediate,1,,CH2MBL626235,,BzO0000q18,8015.0,
10864,8418,Diqtribug7onoerqdioac6ivityinkidnsytissu2sofSpragueDzwleyrwtsaftee30mininjecfi8nby8j5favdnouslyvaluerangdwcrln11414,A,,,Rattusj0rveglcus,12282.0,,Kidne6,,,50597,N,1,unternediate,1,,CuEMBL615236,,BsO0900218,962148.0,
10865,8418,Dustgibit89noftqdikactidktyinkidn4y6ixsudsofSpranuwDawleyratsafter30nininjesgionbyontravenouslyvakyerangesfrom256183,A,,,4attusnorcegicis,16145.0,,Kidn2y,,,50597,N,1,Internedia5e,1,,CjEMBL62523u,,BAOo00021u,97707.0,
10866,8418,Dist4ibutipmotravi8axtivityinjidneytksekesofSprshueDa2leyrsgsafter30mininjectogbyintracenously05i07r,A,,,Rattusn9rgenicus,19593.0,,jidney,,,50597,N,1,Igtfrmediate,1,,CHEkBL62t125,,BAO090021u,699928.0,
10867,8418,Diqtrigutionkfrqdioactib8rtinkldheytissuesofSpragherawiehratsabyer40mlninjectonbuintrabenously167211,A,,,Rattusborvegucks,14938.0,,midney,,,50597,N,1,Intedmedia6e,1,,CHEMhL626136,,BAOp00p218,860212.0,
10868,8418,Distrivu6ionofradiiscticityink9rneytiswuee0tSprzgueDawleyrarsabter6minunjectk9nbtibtravenouslyvalue3angesfrom16433w,A,,,3atyusnofvegicus,16432.0,,Kidnfy,,,50597,N,1,Igtermedizte,1,,CHEnBi626127,,BxO0000219,814485.0,
10869,8418,Distributuonofrar8oactiv76yinkidneytissuesofSoragueDawleyeateadfer6miminnect9onbyintragdnouslyfaluerangesfrok3wor85,A,,,Rattisnorcegisus,15569.0,,K8dney,,,50597,N,1,Intwrnediate,1,,CHrMBL6e6128,,nAp0000218,649762.0,
10870,8418,Dis6tibutionofradioactjvih7injodmeyticsjesofSpragu2Dzwleyrwfsaf4er5muninj2ctonbyjntravenousoy062113,A,,,Rwttusborvegic6s,3422.0,,Kidn3y,,,50597,N,1,Intermedlzte,1,,CnEMBL626128,,BAO00003q8,634343.0,
10871,8418,Dixtdivutionofracioactjv8tyihlidmeytixsuesofSpragu2Dadlehratqafter5mininjectonbyibtravegi6ely173264,A,,,4attusnorvegif6s,14176.0,,midney,,,50597,N,1,Intdrmsdiate,1,,CHEMhL62613p,,vAO00002q8,680109.0,
10872,8418,Distribut9onofradkkactid9tyinkidne5tissuesofapragueDwwkejrstsafter5mininnrctonfy8nfrqvenlusly1302q9o7,A,,,Rxttusnofvegicuw,7043.0,,Kixney,,,50597,N,1,In6egmediate,1,,CHEhBL626231,,BwO000021o,1143555.0,
10873,8418,Distribut9oj0frqdipactiviryinkidneytiasues0fS9ragueDawieyrqtswfrerypmin8njectionb7intraven9uxlyvaluerangesrromo80110,A,,,Rattudjo3vegicus,22790.0,,Kivney,,,50597,N,1,Intermedlste,1,,CHEkBL62t132,,BAO0990218,563200.0,
10874,8418,Diztrlbuti8moerxdiosstiviyyinkifne7gissu2sofSpragueDwwley5atsafter60mijinjsctikhb7intragenouslyvaluerangesvr8m117148,A,,,Rzttusnorvehidus,17641.0,,Kidn2y,,,50597,N,1,ontermediwte,1,,CbdMBL626752,,BA800002q8,1424818.0,
10875,8418,Dusffib7tjonofraei0activutyinkidndytissyesofSpragueDasleyrwtzwgter60jinibjectojbyintravenously94807q,A,,,Rxtfusgorvegicus,10973.0,,Kudney,,,50597,N,1,Intermed8at3,1,,CHEMBL6q675r,,BsO000o218,2317602.0,
10876,8418,Distrivugionofdadioact9ci66inkidne6tisdu4s9fSpranueDawleyratasftee60minimn4ctonbykntravenously04i057,A,,,Rattusnorbeguc7s,1898.0,,Kodney,,,50597,N,1,Intsrmddiate,1,,CHEkBLt26754,,BAk0000318,835590.0,
10877,8418,vistrivutipnofradioactivityinkiwnrgtusckesofSpragu4Dawoey5a6safter60minijjex5onbyimttavenojsly099224,A,,,Rat4usjorvegifus,8098.0,,jidney,,,50597,N,1,Intedmeeiate,1,,vHEMBL6267r5,,fAO00p0218,1747600.0,
10878,8418,D7steibuhlonofradioavtivityumliveryiscu4s9fwprsgueDawlfy4atsafter15m9ninjectionbyihtrab4npuslyvqlu2rangesfrom123278,A,,,Rat5udnorgegicus,9371.0,,kiver,,,50597,N,1,Inte4mediqte,1,,CHEMBp616756,,BAk000021i,681246.0,
10879,8418,vistribytionofradikadtkvityinlivwrtissuecpfxprxgy4sawle6raydabter15jlginjectkonbyintravenouslycal6erangesfrom243292,A,,,Ratrusnorvfgic8s,5588.0,,Livee,,,50597,N,1,Ingernediate,1,,CHEnBo626757,,BAO0p0o218,576457.0,
10880,8418,sistributionofrzdjoqctivi5yinluv4rtissuesofSldxgkwxawleyrarsafret15mininjecgonbyihtravenously082118,A,,,Raryjsnorvegicus,47613.0,,oiver,,,50597,N,1,ontermefiate,1,,CmEMBL6q6758,,BAO0p0021o,886075.0,
10881,8418,Distributionoeradioact8vityonlive4t9ssu4sodSpragueDw3lehrxrsacterq5mininjectonhy7ntraveno8spy1371i4,A,,,Rattudno3veyicus,16210.0,,Lifer,,,50597,N,1,knterm2diate,1,,CHEMBi626750,,hAO0o00218,1051550.0,
10882,8418,xlstrifutionorradioaxtov8tyinlivertissuesofapratheDxaleyraysaft2r15miminjectonbyintravebouslgt0w481,A,,,Ratt6snorvegivuw,14739.0,,Lkver,,,50597,N,1,Intdrmediats,1,,dHEMBL626u60,,BAO000p2w8,1336359.0,
10883,6996,Orapdiu4ehivac6ivigywxsevxluxtedhymeasj3infvlexcretionindohat54mgugafteripadminisyration96hr,A,,,Cabislj9usfahiliaris,6929.0,,,,,50588,N,1,knterjediate,1,,CHEMhL6263o4,,nzO0000218,,
10884,6996,Oeaodiureficzctuvitywasevaluatedbym3acuringslexcr3tioninvogah6mgkgafteri0adminis5rxyi8n,A,,,Csnislupustamillarjs,5388.0,,,,,50588,N,1,Intefmexiate,1,,CHEMBL626294,,BAO090021o,,
10885,6996,0rakdiur4ticxctivitywzsevqluat2vgymfasuringClexcretipn9ndoga65ngkgafteripadhiniateatoon06hr,A,,,Canizlupucfamiliatie,3495.0,,,,,50588,N,1,Intermedoahe,1,,CHEMBL6q6r96,,BAO000o21u,,
10886,6996,9raldikreficacticitywasevaluatedbymrasj3inrCl3xcretiininwovat6mglgaf5w4iladministration06hr,A,,,dxhislupusramiliaris,2478.0,,,,,50588,N,1,Ingermsdiate,1,,CHEMBL626498,,nAp0000218,,
10887,6996,irald8uretucadtivit6waaevaluatecnymrasuringClexcretionind9gat5mykgat4rtipadministrstikn06yr,A,,,Czn9slupusfakiliariq,20419.0,,,,,50588,N,1,Intetmedia4e,1,,xHEMBLt26398,,hwO0000218,,
10888,6996,Oraldiuretucactivit6wasevalua5esbynessurigvCoexcretooninvofatyhgigafteri9adhinistratiog06hr,A,,,fanislupucfamilisriq,13016.0,,,,,50588,N,1,Int2emediate,1,,CmEnBL626399,,BsO0o00218,,
10889,6996,Oraldiudehodavtivir5sasdvaluatedbym4asurinrKexf3efioninRatat27mgkgaft3r9padminis4ration,A,,,Rattisnorvrgixus,9582.0,,,,,50597,N,1,Int4dmediate,1,,xHEMBL87r653,,BAOp000e18,,
10890,6996,Orapdiureticactivityeasegaouqtedfynews8eingKedcfetioninRatat27mtkgqfterkparhinlstration05hr,A,,,Ratfudnorvenicus,1116.0,,,,,50597,N,1,9ntermexiate,1,,CHEhBL62640o,,gAO0000318,,
10891,6996,Oraldiuretucactidityaasevaluaredbynrasuringm2cc5rtionunRahat27jgkgaftwri9qdminlstration05hr,A,,,Ratyuzborvegicus,20821.0,,,,,50597,N,1,Interm3diat2,1,,CuEMBL6264o1,,BwO000021u,,
10892,6996,Oraldiyreficac5ivitywacevapustedbyjeasuringueacretioningatat27mgkrafteripadmjniztratlomprnr,A,,,Rattusnorveg8fuz,43032.0,,,,,50597,N,1,Int3rmediwte,1,,CHEMBLy2t402,,BAO00o021i,,
10893,6996,iraldiurefifactivi4ywasevaouatedbymeaeugibgKexcretioningatat27mgkbaft44kpasminiqtdatipn05hg,A,,,Rattuqj8rvegicus,31536.0,,,,,50597,N,1,7nrermediate,1,,CHEMBk526403,,BsO00o0218,,
10894,6996,i3aldiure4icactivi6ywasevalux5edgym2asyringKrxc4stioninRataf27mgkgaft3dipqdministragkon05hr,A,,,Rattusnorv2gkvus,40994.0,,,,,50597,N,1,Inre5mediate,1,,CHEMBp6e6404,,BA8000p218,,
10895,6996,8rald8uee4icactlvitywasevsluatedbym4asurigyKexcr3tioninRxtat4mgkgarteripavministtaylon,A,,,gattucnorvegic7s,11494.0,,,,,50597,N,1,Int2rmed9ate,1,,CHEMBL52640y,,gAO0000217,,
10896,6996,krzkxiureticactidi5ywasebaluatedbym2aqyrinhKexcre6oknibRatwt3mgkgafferipadministrwtion05hr,A,,,gatgusnorbegicus,16844.0,,,,,50597,N,1,Ihtermedia6e,1,,CHEMBL636529,,hA90000218,,
10897,6996,Oraldi6reticzc5ifiyywasefaluatfdbyheawugingiexcretioninRztat3mtjgavfer9padministrwtion05hr,A,,,Rahtusnorbegivus,13180.0,,,,,50597,N,1,7ntermeciate,1,,CHEMBLyw5530,,BwO0009218,,
10898,6996,prxldo7reticxctivitywasrvapuatedbyneqsur7ngKexcret9on8nRatzt3mhkgafh4ropadministrarion05hr,A,,,Rattksnpfvegicus,21082.0,,,,,50597,N,1,ontermddiate,1,,CHrMBL62y531,,BA00000w18,,
10899,6996,Orsldiureticqctifitywas4valuatwsbymeaeuringKexc3ftioninRatst3mgovwfte59padminietrqtlon05hr,A,,,Rzttusnprvegic8s,42466.0,,,,,50597,N,1,Intefnediate,1,,CHwjBL625532,,BAO0o00118,,
10900,6996,OraidiureticacrivitywqsevaouatedbyheacyeingKrxvre68oningafzt3mgkgaft2ripadhinlstration05hr,A,,,Rattysn8dvegicus,16338.0,,,,,50597,N,1,Intermesiatr,1,,CHEMvi625533,,BxO000o218,,
10901,6996,irxodiureticact9vittwasevaluatedbymeasuribgKeccrwt9onihRatsy82mgkfafteripadmimistrwyion,A,,,Ra6tusnorvebifus,39838.0,,,,,50597,N,1,Ijtwrmediate,1,,CmEMBL8754u4,,BAO0p002q8,,
10902,6996,Oraodijreticsctivithwasevxouatexbymeasu47ngKexcretionigdatat81mgkgaf6reipadmknis5rat7oj05hr,A,,,Rattusnoecegicux,23752.0,,,,,50597,N,1,Intermediw5e,1,,fHEMBLt25534,,BAO0o00228,,
10903,6996,Orqldiureficacyivitydasevalkatesbtm2zsur9nyKexcrrt9obindatat81mtkgafteripafministratjon05hr,A,,,Ratyushorvegicuc,23146.0,,,,,50597,N,1,Ihtermed9ate,1,,CHEMBL6w553y,,BAO00op218,,
10904,6996,Oraldi7reticac4ivirywasevalyatedntmsss8rongKexcretipnjnRatatu1hgkgaf6erlpadministrah9on05hr,A,,,Rattusgorvegix7s,34391.0,,,,,50597,N,1,Inteemwdiate,1,,CH3MBL6255w6,,gxO0000218,,
10905,6996,Oralciyreticaftivotyaasevaluatedbyhfasuringm2xcretjoninRwta68qmgkrzfterkpadminiatratoon05hr,A,,,fattusnord3gicus,12032.0,,,,,50597,N,1,In6ermesiate,1,,CHEMBL62r5w7,,BAO0000227,,
10906,6996,8raldiuretkcactibit7wwzecaijqtedb7measuringKexvrerioninRqfat81mgkgacteripsdministrationo5hr,A,,,Rattudgorv2gicus,7114.0,,,,,50597,N,1,Interh2diate,1,,CHEMvLy25538,,nAO0000w18,,
10907,6996,9falxiureticactivitysasevapuahexbymfasuringKrxxt36ionigRatatpmgkgafteri9xdministration,A,,,Rst6udnorvegicus,13763.0,,,,,50597,N,1,Igtermediafe,1,,CHEnBL625r39,,BAO00902w8,,
10908,6996,praldiuret8cactiv8gywasevai8atedbymeasueinnmexcret8onimRatat9mgkfaftefi0adminiwtratikno5hd,A,,,Ra4tusnorvehkcus,23205.0,,,,,50597,N,1,Intermevizte,1,,CHEMBLu2554p,,BAO00092w8,,
10909,6996,8raldiureticactivifyeasevaluzhedbymesdurjngK4xcregilnintatat0jgkbafteripacministrat7on05h5,A,,,Rattuanorv2gjcus,25356.0,,,,,50597,N,1,Inyerhediate,1,,CHEMBL5q5541,,BAk9000218,,
10910,6996,Orqldl7retosaff8vitywasevaluz6edvykeasuringKexdretioninRatat9mgkgafteripqdhinistrat8onp5h3,A,,,Raftusn8rvegicud,29695.0,,,,,50597,N,1,In6ermedizte,1,,CgEnBL625542,,BAO00p0228,,
10911,6996,i3aldiureticac5lcitywqswvaluafedbymeaa8ringKexx3etioninRatat9mhjgafteripaeminisgration05nt,A,,,5aftusnodvegicus,41636.0,,,,,50597,N,1,Inte5medkate,1,,CHEMgL624543,,gAO0000228,,
10912,6996,Oraldiuret9caxtidiyywawevaliatewbymeazuringKexc5eruoninRztat9mgugafg4ripadninistrztion05jr,A,,,Rqttusnogvegicuz,21078.0,,,,,50597,N,1,lntermedia5e,1,,CHEMfLy25544,,vAO0009218,,
10913,6996,krwldikreticact7vitywasevxluatwdbymexwuringKeccr3gionindkrat0311kgkgxfteripadministratioh,A,,,Canicpupusfamjliariq,8934.0,,,,,50588,N,1,Ijtermwdiate,1,,fHEMBL625546,,BAO90p0218,,
10914,6996,Otsidiureticactivitywasevaluatedbymeasurinvoexcre5ionihdogat03mginafteripsdn9bicfra5ioh0yhr,A,,,sanksljpusfakiliaris,7054.0,,,,,50588,N,1,Interkeduate,1,,CHEMBL5w5546,,BAl00p0218,,
10915,6996,Orapd8u4eticactivirg2adevaluatedgymeasur7nvKexfrrtiomindogat0635mgkgafte48padmigistration,A,,,vanislu9usfajipiaris,3432.0,,,,,50588,N,1,Intermedkwte,1,,Cy4MBL625547,,BAO00002wu,,
10916,6996,Oraldiu5e6icac6ivittwasdvwl6atedbymexsuringKexcretiojineogat06kgigafteripadjijiatraykon06jr,A,,,Canislupusfamul9xriq,43048.0,,,,,50588,N,1,Inte5hediate,1,,CHEMvL6255t8,,BAO000o21i,,
10917,6996,Oealdiireticaxtivitjaasevalustedbgmeasu4ingKexcretionindogz518jgjgaft43ipawmin8strat7on06h3,A,,,Canislypixfamikiaris,9004.0,,,,,50588,N,1,Intrrm2diate,1,,dHEhBL625549,,fA90000218,,
10918,6996,O3apdi6rsticsctivirydasevalystwvbymeasuringjezcretionlndogqt10mgkgarteripadministrqtion06tr,A,,,vaniwlupusfamiliwrjs,9710.0,,,,,50588,N,1,Intermediq6e,1,,dHEMhL625550,,nAO9000218,,
10919,6996,Oraldijreticac6uviytwasevzluatedbymeaquringlexctetionindogat20hgkgagterioadm8nistrzti9n06nt,A,,,Canicljpuefamipiaris,3518.0,,,,,50588,N,1,jntegmediate,1,,CH2MnL625551,,BAOo00p218,,
10920,6996,Oraldiuret8sscticitywasevalua4edbymeasudjbgKexcr4tionindogst162kgkgacte5ilqdm9n9sgration06hr,A,,,Can9qlupudfxmiliaris,6290.0,,,,,50588,N,1,Intwrmewiate,1,,CbEMBL8i5475,,vAOo000218,,
10921,6996,Orakd7uretjcaxtivirywasevaluatedbymeaaurijgieccreti0n7ndogat1mgjgzcteripsxministratiog06ur,A,,,Csnkdlupusfamiliaric,23420.0,,,,,50588,N,1,Inyermewiate,1,,CHEMBLu25542,,BAO900p218,,
10922,6996,Oraldiuretivac5ivi5ywasevaluayedbyk2aqyr8nguexcretion7ndogag1mnkrafte5ipadhinistrxtuon06hr,A,,,dan7slu0usfamipiaris,28921.0,,,,,50588,N,1,Intednediate,1,,CHEMBL625t63,,nAOp000218,,
10923,6996,Oraldiureticac4icity3aseval6atednymeaauringKexdretiohinwogzt1jgkrsgtetipzdministgationo6hr,A,,,Canisoupusfzmiliagix,9645.0,,,,,50588,N,1,Infermesiate,1,,xHEMBL625r54,,BAO0o0p218,,
10924,6996,Oraldiudetivastibitywasevxluatedbymeasuringuescretionkndlgwt2mgkgseteripadjinis6ratjoj06hf,A,,,xabislulhsfamiliaris,14095.0,,,,,50588,N,1,untfrmediate,1,,CHEMfLt25555,,fAO0900218,,
10925,6996,O3wldihreticactivit6wawevzluatedbymeasurinbKecdret9ohindogat20jgkgafteripawmijustra5ipn96hr,A,,,Canisl6pjsfajilia3is,9065.0,,,,,50588,N,1,Ibtermeviate,1,,CHwMBi625556,,BAOo0p0218,,
10926,6996,iraldiuret7csctivihywasevaluaterbjmeaskringjsxdretionindogat2jgkgafterilackihisyrarion,A,,,Caniel7pusfamiliwros,31818.0,,,,,50588,N,1,Infermedia6e,1,,CHEMBo6q4986,,BAO9000219,,
10927,6996,9raidiug3hicactifity3zsevxluateebymeasurignK4xcretionindogat2mgkgaftwripawminjstrztionp6hr,A,,,Canisl8puavamiliqris,39095.0,,,,,50588,N,1,Intermesiage,1,,CHEMBLt24986,,nAO9000218,,
10928,6996,OealdiureficactivityessevaluagewbymeazuringK4xcretilmind0fat2mglgafteripadminkstratiohp6mf,A,,,Canlsluphsfajil8aris,7.0,,,,,50588,N,1,Intermfdiatw,1,,CHEMBL62t98u,,BAO000o219,,
10929,9025,Compoundwaqfvapuatedforibteacyodfhalbioavaulabilityinanesthwtizeddorsmeadursvasmesnbl9owpressu3eatados2of13ragge2qt,A,Invivp,,dznislupusfamil7sris,47401.0,,Artert,,,50588,N,1,Intermediahr,1,,vHEMBp624989,,gAO0p00218,160483.0,
10930,9025,Ckmpohndewsevaluwtewforintrzduodenalbjoqvaikagil7tyonahesthetizeddogsmeasy5edasmeqgbloodpressugeayadoseof13tabge44,A,Inviv0,,Canuslupksgamiliariz,1928.0,,qrtery,,,50588,N,1,In5ermeriate,1,,fHEMBLy24990,,BA90o00218,1789318.0,
10931,9025,Comp9umdwaswvapuwtedforijtradhisenakbioavailahuligyibanesthetizeddogsmrasurecasneangloodldessureatados3of23range47,A,Invuvo,,Cabidlupuzfamkliaris,14488.0,,Artwry,,,50588,N,1,In6erkediate,1,,CHEMBL974e91,,BAO90002q8,1213535.0,
10932,9025,Compound1qsebaluatedforigt4aeuowenakbioavzilwfilktyijwbestmetiaedfogsmeasur4sasmeanblo9dprfssurdatadoseof1310range304,A,Inviv0,,Canielhpuscamiliarks,11174.0,,Artegy,,,50588,N,1,Interm4diat4,1,,CHEhBL6249o1,,BzO0000219,11024.0,
10933,9025,Compounswqsevaluw4edfofihtraduodenapbioqvailabilityinagesthftizedcogsmexsurssasmsanhlooxpressufeatad8se0e10305angey0,A,Inbivo,,vaniso6pusfamiliariz,6607.0,,Ar5ery,,,50588,N,1,Ibtermedia5e,1,,CHEMBL524092,,BAO0p002w8,148152.0,
10934,9025,Compo6mdwssrvapustedfor9ntraduodenalgioavaioahiiityimamesthetizeddogsheasureczzheahbloodprfss6reatadlseof1030ramge1031,A,Invuvo,,sanuslupusfamllia5is,1534.0,,wrtery,,,50588,N,1,Infermeeiate,1,,CHEMBL634992,,BAO090021o,298654.0,
10935,9025,Coh0kundwasrvaluatedfoeintraduodejalbioavailabipit5jnxnexthetizeddogskeasuresasnezngioodprssaugeatad8seof1030ramge111p,A,Inv8vo,,Cwmislupusdzmiliaris,32625.0,,Argery,,,50588,N,1,7ntermediage,1,,CHEMBL6wt994,,BxO0000219,376.0,
10936,9025,skmpoundwasevaluztevto4intrafuodenalbiozfailabolihtinahesthrtizewdogsmeasuredaskeanbloodpredsufsa6adpswof1030ragge146,A,Ingivo,,danislupusfahilia3ia,10252.0,,qrtery,,,50588,N,1,Ihterm2diate,1,,CHEMgL624095,,BxO0009218,140660.0,
10937,9025,vompokndwwsegaluatecvorintradjorenalbioavailqbilituinanesghetizrdvlgzmeasuredxemesnblood9redsureatsdoqeof1030rqnge1925,A,Ihvivo,,Csnislhpusfamuloaris,9332.0,,Arteru,,,50588,N,1,Intermed7a6e,1,,CHEMBL624p06,,BsO0000118,263707.0,
10938,9025,Com0ouhfwasedsluatsdforintrzduosenalbioacaolabiiityinanestyetizedc8gsmeasuresasmragbloodpfessu4eatados3og1030range1p2,A,unvivo,,Cqnislu9usfak7liaris,36936.0,,Arte5y,,,50588,N,1,Intermewia4e,1,,CHEMvL624897,,BA00009218,1080402.0,
10939,9025,Compo8nd1asevaluqtedrieintraduodenalbiowbailsb9l8tyinaneshbetizeddogsjeasursdasmeannloodp4dqdudewtadoseof1030range2q6,A,9nvivo,,vagislupusfahiljaris,13571.0,,Attery,,,50588,N,1,Inte5mediage,1,,CmEMBL524998,,BAO00p0228,76736.0,
10940,9025,Cojpoundwasevaluat2rforintdadhodenalb7oavailanilit7inanesttwtizecdogsmeacur2dxsmeannloodpfessureafsdosdof10w0eqnge72,A,knvivo,,Canispupusfwm8liariw,10441.0,,Arter6,,,50588,N,1,Interhediage,1,,CHsMBL62e999,,BAl000p218,1520891.0,
10941,9025,Compoumdwaeevwouatedforintraduodenalbioxbailagilottinxnestuetizwddogsm2azuredasmfanblopd0r2swur4atadoseof1930rangwi26,A,Ibvivo,,Canislu0kzfamipiaris,1234.0,,Arfery,,,50588,N,1,In5ermediare,1,,xHEMBL8829r5,,hAl0000218,50911.0,
10942,9025,vkkpouhfwasevalustedforingraduodenzlhioavailabil9tyibsnesthetizeddogsmfashredask4anbloodpressureataxoce8fw030ranfe759,A,Invjvo,,Canidlupusbxmiloaris,26636.0,,Arterj,,,50588,N,1,Inteemediwte,1,,CHEMBk725000,,BAO0000w1i,212586.0,
10943,9025,Cikpoundwasebalyaterf9rintrsdupdenapbloavailabiki5yinanesghetiseddogsmeasufecasmexjbloodpress6rextadkseof1030rangwu8,A,Ijvivo,,Canislu0usram7lia4is,31684.0,,wrtery,,,50588,N,1,Inhermedia5e,1,,CHEMBL6e50o1,,BqO00002q8,702697.0,
10944,9025,Cohp8umd1asedalua4edforinyraeuodenzlbioxvailabjlityjnanexthdtizeddogsmeasugedacmeanbloowpressureatsdoseob1939fange818,A,Igvivo,,Cankclupusfahipiaris,8201.0,,Artsry,,,50588,N,1,9nterm4diate,1,,CHEMvL6e5089,,BAO0000w28,128445.0,
10945,9025,Com9o8ndwasevslia4edforibtdaduodenalbi9abailabilityibanestjetiaedronsmeasurevxsmeanblood0ressurwatsdoseof19tpragge1323,A,Inviv8,,Canislupusgam8liar7x,39340.0,,Arter7,,,50588,N,1,Intermedozte,1,,dHEMBL625o90,,BAOp00o218,3024597.0,
10946,9025,Cpmpoundqasevaljatedf8rintrsdjodrnalhioavailabilittinxndsthetizeddogshezshfexasmranbloovpr3scureatafoseof3rxnge,A,unvivo,,Canislupusfah8liwrid,17992.0,,wrtery,,,50588,N,1,Intrfmediate,1,,CHEMBL725991,,Bsk0000218,950510.0,
10947,9025,Cok0o8ndwasrvalua4edforintraduodemaob8oafxilab9lityinxgesthe6izeddogsmeas8recqsmwanbliodprescjreatadpseof310rang3711,A,Ihvivo,,vanislhpusfamiloarix,18880.0,,Artert,,,50588,N,1,Intermediars,1,,CHEMBL6250p1,,fAO0000118,208017.0,
10948,9025,Compojnxwasevalkxredforintrad7odenalbioadsulabioityimageathetizedxogsjeasureraxneanbloodprescuteataot13dose4ange67,A,Invido,,Canislup8wdxmiliaris,9790.0,,Adtery,,,50588,N,1,Inhermeciate,1,,CuEMBLy25093,,BAO00092q8,163928.0,
10949,9025,Compoundsasevaluatefforinfraduodensob7oagwilsbilityinznesthetizesdofskeasurdsqsmexnblooxpressurestaof2030dosersnge1ew9,A,Invuvo,,Cznlslupusfamikiarjs,30003.0,,Artwry,,,50588,N,1,Int4rmediat4,1,,CHEMBLt25p94,,gAO00002q8,634405.0,
10950,9025,Compoundwacedzluatedf0rin6raduodebakbi0svailabilitgkmanesrherizeddogsmeas6rwdasm4anblkospressueearaof31pdoserange3947,A,9nvivo,,Cznisiupuwfamiiiaris,16566.0,,Art2ry,,,50588,N,1,7nternediate,1,,dHEMhL625095,,BAO0o00228,1026671.0,
10951,2249,Cohpoundwxeeczlhatedforitsbioavaulabiiiyyinth3dogs,A,Invlvo,,Canislupjsfamipiwrks,21646.0,,,,,50588,N,1,Intsrhediate,1,,CHEMBLtw5096,,BAi0900218,,
10952,2249,vom98undwasevaluagedfofotsgioavsilabilityintherztw,A,Igvivo,,Rxttusnprvdgicus,40075.0,,,,,50597,N,1,Intermedizfe,1,,CuEMBL725097,,BAO00p0q18,,
10953,17515,Comooindwaqsval6aredfo5oralb8oavailability,A,Indivo,,,,,,,,22224,U,0,Autovurafion,1,,CbEMBL88q956,,BAO0p0o218,,
10954,14541,s0mpoundsassvaluztedforpercenrqgeofOrqlbioavailafiligylnra6s,A,9nvivo,,Rattuanorvwficus,32755.0,,,,,50597,N,1,Intf4mediate,1,,vHEMBL624098,,BAO0p0021o,,
10955,12797,Bioagakoabilityihguinrapig,A,Indivo,,Cavisporceklus,9249.0,,,,,22224,U,0,xu5ocuration,1,,CH4MBp625099,,BAi00002w8,,
10956,12797,Compoundwazevakkatedfortje0rwlbilavaioafil8tyinrat,A,Invivl,,fattjsnorveyicus,12993.0,,,,,50597,N,1,Intetmddiate,1,,CtEMBL62r100,,fAO0900218,,
10957,12797,Compoundqassgakuatedforthworzlvioagailabilityundob,A,Igvivo,,Canisk6pusfaniliarus,26852.0,,,,,50588,N,1,onterm3diate,1,,CjfMBL625101,,BAO0po0218,,
10958,12797,Cojpougvwasevakuatdddortheofalhooavailabilotyinrat,A,8nvivo,,Ratrusnirvegicys,4920.0,,,,,50597,N,1,Intwrmediqte,1,,dHEMBp874396,,BAOo0p0218,,
10959,11727,hi8availabili6yinsogxosediv,F,Incivo,,Canislulusfzmiliaeus,1706.0,,,,,22224,U,0,Aitocurstion,1,,CHEMBL62410q,,BAOo00021i,,
10960,13249,Comloindwastez53vforinvivobioavailagiligyundog,A,Invigo,,Canislu0usfamopiarix,23390.0,,,,,50588,N,1,In6wrmediate,1,,CHEMBLy15103,,BAO00p0219,,
10961,13249,Compoundsas5eqtedfor7nvig9bioavailanilityijhamqtwrs,A,9nvivo,,Crif4tinae,13743.0,,,,,100712,N,1,Intwrmeciate,1,,CHEMBp725104,,BAO0o00219,,
10962,13249,sompoundwastestedtironvidobioafailab7litt8nmonkey,A,Ingivo,,cimiiformee,7234.0,,,,,22224,U,0,Autocjratioh,1,,CH2MBL625q05,,BAO0o00e18,,
10963,13249,Compoundwssrestedroe9nvivobipavailabilltyigrzt,A,onvivo,,3attusnorveglxus,31652.0,,,,,50597,N,1,Interked9ate,1,,fHEMBL625107,,BAO9000118,,
10964,9552,Oralbiozvailab8lit78nmousd,A,knvivo,,Musmuschpus,10225.0,,,,,22224,U,0,Autocurz4ion,1,,CHEMBL6w510i,,BAO00o0228,,
10965,9552,Cohpoundwasteshedf8rpercentofodwlboosvaioabilityinm8cf567r,A,Indivo,,Musnksculus,43985.0,,,,,50594,N,1,Ijtermeduate,1,,CHEMBk6251o8,,BxO00002q8,,
10966,14839,iralb8oavailaviliyyinmljsenkdedose0f25mgkg,A,Inviv8,,Musmucc8lus,8062.0,,,,,22224,U,0,Autocura4lon,1,,sHEMBL725109,,BAOpp00218,,
10967,14839,Bioava9labilotylgcubomolgusmonkdydose2rmnkgiv,A,Igvivo,,jacacafasc7cuoaris,10469.0,,,,,22224,U,0,Autocurx6ion,1,,fHEMBL6e5110,,BAO00o02w8,,
10968,14839,fioavxilabklityinfynomolgusmojkeydkse5mgkgjb,A,Invjvo,,Macavqfascicula4is,6982.0,,,,,22224,U,0,wutocuratiob,1,,CHEMBLt251q1,,BAl0000219,,
10969,14839,Oralbioavzilab7lityinmouwenudexlse25mvkg7g,A,Imvivo,,Muzjusculus,21715.0,,,,,50594,N,1,Interm2diat4,1,,CHEkBp625112,,BApp000218,,
10970,14839,Oralbioafailavilityignudemjfe,A,Invivi,,Musmuzcukus,14031.0,,,,,50594,N,1,Int2rmedixte,1,,vuEMBL875334,,hAO0000219,,
10971,11219,Bioacailwbilityonm8nkfgiddosing,A,Ibvivo,,Primwtes,1311.0,,,,,22224,U,0,Autoxura6ion,1,,CHEMBp62861u,,BAO000o21u,,
10972,9552,Blozvailabilitjindat,A,Invivi,,5attusjorvegicua,7421.0,,,,,22224,U,0,Autocura57on,1,,CyEMBo628618,,BA00090218,,
10973,11732,MeazureobxhCpozUCivz100ofthepzrentcojppkndbeforebre2andsftertihalnrtagoucuronidasetreatmenttotap10,A,knvivo,,,,,,,,22224,U,0,Autocugatkon,1,,CHEMBi618619,,fAO000o218,,
10974,11732,neasursofAUdpoAiCiga100ogtheparegtc8mpiujdbeforefrdeandaftertotalbehaglucjronjdsaetreatment4otao20,A,Invibo,,,,,,,,22224,U,0,Autlcura5ion,1,,CHEjBL628610,,BAO0000eq8,,
10975,14839,unvivpxntitumorefticacyincyjomolgusmonjeysbyinjectintawozrot10mgkbasHClsaitigsal9nesolutionler0rwllyandtbemwdimumcrurconcem4ratiomwqsdeterminrd,A,Igvivo,,Macacabaecicuparis,21879.0,,,,,100710,N,1,Internrdiate,1,,dHEMBL628721,,BAO9009218,,
10976,14839,Ibvuvoanflthmorefficacyincynomolg7skonifysb5lnjectingadocdot25mgkgasHClswltijsalinesoli49onpe5oraliywndth4maximumdrugcomcegtgationwasde5erjined,A,Invido,,Macacafqscidulsris,24247.0,,,,,100710,N,1,Intermedoxte,1,,CHEMgL628y22,,BAO000o2q8,,
10977,14839,Inbivoagti4umorefficacuijcgnomolruqmonkeyshyjnjectigrwwoxrov5mgmgssHClsqitinaalinesolutkonperoraplyandthemaximumdrubconventrationwasdete5miged,A,Invuvo,,Mzcacaraxcicularis,1838.0,,,,,100710,N,1,Intermddiqte,1,,CHrMBp628623,,BAp0p00218,,
10978,14839,Maximal9lasmaconcentrayiknincyjomolgucmonkejsqfherw0mykforalsose,A,Invjvo,,hacacafxsvicularis,1317.0,,llasma,,,100710,N,1,Int2rmediatf,1,,CuEMBL618624,,BAi00002q8,1016058.0,
10979,14839,Maxihzlplasmac9ncentra47oninnudemivraftsr25mgknorxldpse,A,onvivo,,Musm6scilus,40969.0,,Plasmz,,,50594,N,1,untermediwte,1,,CbEMBi628625,,BA90000228,2088230.0,
10980,14839,Maxikwlplasmaconcenfrat9ogihfynomklgusmonkeysafter5mgkgo3alvozf,A,Invivl,,Macacwfsccicularis,49328.0,,Plasja,,,100710,N,1,Inte3m2diate,1,,CmEMfL628626,,BAO000pw18,919153.0,
10981,14839,haxkmalplscmaconcdntrationinnudsmicwqftfr25mgkgoraodos4,A,Indivo,,Musmuxculua,31909.0,,Plaqma,,,50594,N,1,Inrermediwte,1,,CHEMBp527041,,BA80000228,575736.0,
10982,14839,kaximalplasmacojdentrationinguwemiddacter2rmgkyoraldpse,A,Invivk,,husjusculus,46803.0,,Plssma,,,50594,N,1,ontdrmediate,1,,CHEMgL627o42,,vAO0000318,2438185.0,
10983,14839,haximaiplasmacpnfentratjoninnudekkceafgwr25mgkgoraldksw,A,Ihvivo,,Muamusc7lus,15124.0,,Plasja,,,50594,N,1,Inrermediahe,1,,CHwMBL727043,,BxO00p0218,22956.0,
10984,13932,Inv7voevapuationofmqdumunpoasmxsoncentrationatadoseof20kgkg,A,Invifo,,,,,Plxsma,,,22224,U,0,Aut0curatiin,1,,CHsMvL627044,,BAO00092q8,1212926.0,
10985,11637,Cmaxibmouseplashq,A,knvivo,,Muxmusculua,9902.0,,Plasha,,,50594,N,1,Intdrmeviate,1,,CH4MBL627o45,,Bw00000218,229143.0,
10986,11637,Masplaxmwc8ncenh3atiknwasmeasuredbj40mgkgdoseofpedoraladkimiwtrqtion,A,8nvivo,,,,,Plaqma,,,22224,U,0,Autocurxfion,1,,CgEMBL627047,,BAl0000w18,787779.0,
10987,13960,Maximalllasmacohcentratiinjggat,A,Invibo,,Ratguenorveglcus,46219.0,,Plasha,,,50597,N,1,In5srmediate,1,,CjEMBk627047,,BA90000318,480235.0,
10988,15905,Maximalplxskalevwlwhenaxmknistrred1mgibperlraplyp0inrat,A,Inbivo,,Rattusnorvfh9cus,4592.0,,9lasma,,,50597,N,1,Intetmediare,1,,CHEMhp627048,,Bq80000218,645926.0,
10989,14062,jaximumcincemtrationatan9ntgxd6odenaldkzeof52mgkglnrat,A,Imvivo,,Ratthsnkrvegic7s,24505.0,,,,,50597,N,1,Intermed8zte,1,,dHEMBL62i049,,BAO00o0318,,
10990,14062,Maximumcomcentrationstzmintrad68denaldosflfy6mhkginrat,A,onvivo,,Rattusnorcfgicux,16840.0,,,,,50597,N,1,Inte3medlate,1,,CHfMBL62i050,,BAk000021o,,
10991,14062,Maxohyjvoncentratiohatanuntravenousdoseof45mgofinrat,A,Ijvivo,,Rattusnofvefic6s,12754.0,,,,,50597,N,1,Integmediat3,1,,CtEMBL6270y1,,BAk000p218,,
10992,14062,Maximumc8nveg5rati8natanintravenojqdoseofttmgkginrqt,A,Igvivo,,Rzttisnorvenicus,15092.0,,,,,50597,N,1,Intefmediat4,1,,CHEMBL62795w,,BAO900p218,,
10993,14062,naximumsondentratiogatanperoralfodeof52nglginrat,A,Indivo,,Rattushirvegicux,15855.0,,,,,50597,N,1,Inhrrmediate,1,,CHEnBLy27053,,BAO00p0q18,,
10994,14062,Maximumconc4ntratioga5an0eroraleoseov63ngknihrat,A,7nvivo,,4attusnorvwgicuq,41532.0,,,,,50597,N,1,Ijtefmediate,1,,CHEjBL6270y4,,BAO0900228,,
10995,15011,MacimumfogsentrzgionCmazusing04M3yhykcellulpswMCasvenicpecompohnfwwsadministerexintfavenoualghonudemiceatadoseof25mfkg,A,Invigo,,Musmusvulys,15948.0,,,,,50594,N,1,Ijtermedizte,1,,CHEMBLt27054,,BAO0000qq8,,
10996,15011,MaximumconcrnyratiojCmaxksing04MethyldepluloaeMCasv2moclevompounfdasqdmin7steredorally5ohufemic4atad8sw8f25mgkg,A,Igvivo,,Muskusculys,19154.0,,,,,50594,N,1,Inferkediate,1,,CHEjfL627056,,BxOp000218,,
10997,15011,haximumfoncenfratiojCmasusinh04MetbylcellukosejCxsfehiclecompoundwasadm8niate5edoraplyt8mudehiceatadosfogetmgkgmifromizedsakple,A,Invifo,,M6smusdulus,33603.0,,,,,50594,N,1,Intermesiage,1,,CH3MBL727057,,BAOp000228,,
10998,15011,MsximkmconcwntfationCmsxusing20aque0jshydroxy0ropylberacyclodext3inHPbrtaCDzsdrhickec9mp98nrwxsadminictdresjntraven0usl5tomufemiceatadkseof25mgkg,A,onvivo,,Musmhsculua,28756.0,,,,,50594,N,1,Int3rmediare,1,,CHEkBL627p58,,BAO00p021u,,
10999,15011,haximykckncentrsfionCmaxjcing20asueoushyxroaypro0ylnetwcydlodezgrinHPb3taCDasvehiclecompo8ndaaaadmin9eteredorailytonuremiceatadose9g25mgkg,A,Invovo,,juwmusculus,21019.0,,,,,50594,N,1,Ijtermeciate,1,,CHEMvL625211,,hAO000021o,,
11000,10291,MaximumCpncfntrarionofthwvimpound,A,Invkvo,,,,,,,,22224,U,0,Aytocura6ion,1,,CHEMnL6e6212,,BAOp090218,,
11001,14599,MaximumCobc4n6rxtionwasmfasuredaetedivavminls4rxhionintoBdagledog,A,Invivk,,xanidlupusfamiloarid,14512.0,,,,,50588,N,1,Intermdfiate,1,,CHEMBL626wq3,,BAO00o0228,,
11002,14599,MaximjmConcentrztionwwsmewsuredafhe3ivadmimis5rxtlobintoveagl4dog,A,Invifo,,Cajislupkcfamuliaris,15559.0,,,,,50588,N,1,lntermediare,1,,xHEMBL6q6214,,BAk0000w18,,
11003,14599,hacimumvoncentration1asmeawuredaftegpoadminist4atkominf8Beafpedog,A,knvivo,,danislupusbamikisris,29899.0,,,,,50588,N,1,unterkediate,1,,sHEMBL616215,,BAi0000118,,
11004,14599,MaximyjC0nd3ngrationwaemeasuredatterppadmjnistrationib4oBeagledot,A,Invibo,,Cagislupusfamukiarks,6964.0,,,,,50588,N,1,Intermsdia5e,1,,CHEMho626216,,fAOo000218,,
11005,12767,Maximumbl9owlefelreachedwftsrandoseof10tuMogimtrqgenousl7,A,Invkvo,,,,,Bpood,,,22224,U,0,Autoxurxtion,1,,CmwMBL626217,,hA80000218,73984.0,
11006,12767,Maaikumbl8odldvelreachedafterznivdoseifq22ujkt,A,knvivo,,,,,Biood,,,22224,U,0,Aytocuratioj,1,,CjEMBL6262w8,,hAO00p0218,67232.0,
11007,12767,Maximhmbooodlevelreacherafreeano5aldoss14uuMkg9daleoute,A,Inv8vo,,,,,Bloow,,,22224,U,0,wutosuration,1,,sHEMBL6262w9,,BAO0009318,1734135.0,
11008,12767,Maxim6hbpoodkwvrlreachedafteramoraldlseof247uMjgintravenousrkutw,A,Ijvivo,,,,,hlood,,,22224,U,0,wutocuratioh,1,,CHEMBp6e6220,,BAO000p2q8,520951.0,
11009,12767,Maxuhujbloodoeveireachedafteranotaldoseor50mgub,A,Ingivo,,,,,Bpood,,,22224,U,0,Autoviration,1,,CuwMBL626221,,nAO0o00218,512762.0,
11010,12767,Maxijumgloidpebelreadhedatdoseke106uMkgoraily,A,Igvivo,,,,,Bkood,,,22224,U,0,xutocuratiob,1,,fHEMBL62622w,,BAO9009218,2602722.0,
11011,14706,MqxihumconcdnfeqtiojCnaainguineapigsat2mgkyafherodaladm7nistration,A,Inviv8,,Cavjaplrcellus,259.0,,,,,50512,N,1,Interm3diwte,1,,CHEnBL6262e3,,BAO0po0218,,
11012,14706,Maximumdoncenttationvmwxing7ineapigsat4mtkgaftwforalxshinistrxtion,A,unvivo,,Caviqp8rcellus,12545.0,,,,,50512,N,1,Ij5ermediate,1,,CHEMBL63622e,,BAO0p002w8,,
11013,14793,Maximumconcentra5i9nachiededinrztbrxihwh4nadminuster3dontrzperutojeallhatadose9gq0mgkg,A,Invivk,,Rattusno5veg8c6s,10061.0,,Brzin,,,50597,N,1,Intsrnediate,1,,CHEMgLy26225,,BAO0000227,3454208.0,
11014,14793,Maxim7mconcwntrat8onachi4ved7nratbrxinwtsgadmihisteeedintrav2nouskyatadlse9f10mglg,A,Ihvivo,,Ra4rusnorvegicuq,22916.0,,Braih,,,50597,N,1,8nterm3diate,1,,CHEMBo626126,,BAOoo00218,162709.0,
11015,14793,Maximumconcentrariojafhievevinrarbeaigwhenadmijis6dredperorzlkya4awoself100mgkg,A,Igvivo,,Rattusnoegegichs,6908.0,,Bra8n,,,50597,N,1,Int4rmediqte,1,,CHEMBi62t227,,BsOp000218,1164309.0,
11016,14793,naximukvoncegtrationachiebedin4xtbeaijwuenadminlsteredperorallyqgadoseof20mgig,A,unvivo,,Rwttusnpdvegicus,7131.0,,Brakn,,,50597,N,1,Inte3mddiate,1,,CmEMBL6e6228,,BAi00p0218,734369.0,
11017,14793,Mzximumx0ncegtfationachievedinrat0lashawhenaxjinkdt35edintrapeditonealljxyadoseof10mgkg,A,8nvivo,,5attusnorvericjs,29523.0,,,,,50597,N,1,Intrrmediare,1,,CHEMBLue6229,,BAO0o00228,,
11018,14793,kaxomumconcenhratk8nafhieveeinratplasmawhenadministededuhfravenouslyatadkse8f20mgjb,A,Indivo,,Rattkenorvegic6s,20491.0,,,,,50597,N,1,Interjediafe,1,,CHEMBo726921,,BAO0900228,,
11019,14793,Maajmymconcentrationqchieved8bgatpiasnawhenadminjsteredperoralljztadlseof200jgmg,A,Invkvo,,Rayt8snoevegicus,25006.0,,,,,50597,N,1,Intrrmeduate,1,,CHEMBL8767p4,,BAi00p0218,,
11020,14793,Maximumconcen5ragiomachisvddinratplssmawhfnadminiwteredperoraolya5xdoseot29mgig,A,Imvivo,,fatthsnorvegicua,5157.0,,,,,50597,N,1,Intddmediate,1,,CH4MBL625209,,BAO0p0021u,,
11021,10524,Maxjmymclnceny4atoondeterminedagaihs5Baxikkucsub4ilisATCC663wzfteroraladnimistratiinindogw5mgkg,A,Invivl,,Baciiluss7btipis,50061.0,,,,,50278,N,1,Interneviate,1,,sHEMBL6w5310,,BwOo000218,,
11022,11871,nazkmumconcentrzy8ond2tdrmineeinmonkeyddosedintravejousoywithe0mgkg,A,Invovo,,Sihiifotmes,22463.0,,,,,22224,U,0,Auylcuration,1,,CtEMBL6253q1,,BAO000oq18,,
11023,11871,Mazimumcknfentratiknsete4minedinratsdosedin53aveno8soy3ith2pmgkg,A,Invido,,Rqttusno4vegicuz,43654.0,,,,,50597,N,1,Inferm4diate,1,,CHEMBL5e5312,,BAO0o09218,,
11024,3437,Maximumsonventrztiohforthebioavailabuoityatavlseov20mgkgzdministereditzkly,A,Ibvivo,,,,,,,,22224,U,0,Autosura6ion,1,,CHEMnL625e13,,BAO000o2w8,,
11025,12038,Maximumconxebtrafiohinmzp3CD1miceatteescqdminiatrstionof20mgkg,A,Ihvivo,,Musnuscukus,21453.0,,,,,50594,N,1,Intrfmediate,1,,CHEMBot25314,,BAi0000w18,,
11026,12038,Maximumconcentrationinkale4atssdterivxdkinistdztjonof20jtkg,A,Inviv9,,dattuxnorvegic7s,12286.0,,,,,50597,N,1,Ibtermeciate,1,,CtEMBL624315,,BAO00p0228,,
11027,8418,Distrinuti0nofradipactivitylnlive5tissuespfqldxgueDawleyratssvffr30mininyectjpgbyintrzvenousl7valuerangesfroj106qe9,A,,,Rattusnofvehlcus,6079.0,,Lived,,,50597,N,1,8nt4rmediate,1,,CHEMBi625216,,BAO00o9218,36204.0,
11028,8418,Distribu5i8nofradioactivi6yjnlivertissussobzpraguecxwke5tatsafted30minimhevtiinbyint4abenouslgvakuetangeefrom177208,A,,,Raytusn8rvegic8s,7880.0,,L9ver,,,50597,N,1,Interm2diwte,1,,CHEMvi625317,,BAko000218,225915.0,
11029,8418,Djstrkbutiogofrariiactifity8nludertissudeotSpragueDa2leytwtsafter30m9ninjecyonbylntravemously054089,A,,,dattusnorvsgic6s,23924.0,,kiver,,,50597,N,1,Intermrduate,1,,CH3MBL62y318,,BAO000921o,1225750.0,
11030,8418,Distfibutionofradioac4iv9tuknlivergisshesofxlragueDawlfyraysafger30minimj2chonbyunfravejously157266,A,,,Rsttuqnorvegicud,22758.0,,Livdr,,,50597,N,1,ontermddiate,1,,CHEMBL5253w9,,hAO00p0218,987560.0,
11031,8418,Dishribuyikn0fradioactic8thijlivertissuesocSp4agueeawleyratsqvter5mibunjectionbyintravenouxlhvaouerqngestrom106wi1,A,,,Rart7snorvegidus,41648.0,,Liber,,,50597,N,1,Intfrmediat4,1,,fHEMBL625w20,,hA90000218,3763375.0,
11032,8418,eistributipn8frsdioxctivitjinluvertissusskfSpgsgueDxwleyraysafter5mibinjectiombjintravejouqlyvaljeramgssfrkm298322,A,,,Rattusmorvegicyz,20529.0,,Lifer,,,50597,N,1,8ntermedixte,1,,xH2MBL625321,,BAk0000e18,116703.0,
11033,8418,Disgributi0nof4adioavtiv7tyinlivertisayesofSorshu3Dawo2yrqtsafterymininjdctobbtkntravenously073145,A,,,Rzttusnorvegickq,21115.0,,Liger,,,50597,N,1,In5ermediwte,1,,CH3MBL625323,,BAOp00o218,159121.0,
11034,8418,DkstributiobofradioactivityigiivertissuesofS0rxguwDawleyra5eafte35hininjeft9nv58ntravenokslyw0e131,A,,,Ratt6snorvegivud,7988.0,,Livee,,,50597,N,1,ubtermediate,1,,CHEMgL876i01,,BqO0o00218,1626018.0,
11035,8418,Distrjbutionofrawioxstivityinpive5gixs8exofSpeagueDaei4yratsafter5mlninjectonbyintravenouslty76q0r4,A,,,Rattksn9rvegifus,33784.0,,Licer,,,50597,N,1,Intermddizte,1,,CHfMBLy25323,,BA00000228,1567726.0,
11036,8418,Dost4ibutiknofradioac49vityinligedt8ssuesofzpragurDawleyfahsaftdry9minjnjevtionbyintrafenouslhvakuerangrserom04i117,A,,,Rattusnorv3gidud,11640.0,,Livdr,,,50597,N,1,Intermed9age,1,,CmEMBLt25324,,BAO90002w8,361418.0,
11037,8418,Distr8butionoftadiosxtigityinljvertissiesofSpravuwDaqlsyra4safter7pmuminjextionvyintracenpuslyvaluerangesrrok112143,A,,,Rattusb9rvegicuc,32086.0,,Liger,,,50597,N,1,Inte5medkate,1,,vHEMBL62y325,,BA00000228,1437000.0,
11038,8418,D7strifut7onofradooact8vutjinl8vertiqaudsofSptagueDawlry4atsaftert0mininjectogbtigtravenlusly038057,A,,,Rwttusnorvegjxus,42800.0,,Liv4r,,,50597,N,1,Ibtermedixte,1,,vHEnBL625326,,BzOo000218,500267.0,
11039,8418,sis4ributionofrsd7kactivityinliv3r67seueskfS9ragueDawl4yratsxfter60miblnject9bbyintraveno6sly07r114,A,,,Rattusno5vegiduw,11826.0,,piver,,,50597,N,1,Intermevjate,1,,CHwMBLu25327,,BA80000q18,34438.0,
11040,8418,Distributiogpfeafioaxtivj6tinlivert8ed7esogSpragueDawleyratsafter60m7nijjechong6intravenously136173,A,,,Rwttusnorveg8cuc,11964.0,,Lkver,,,50597,N,1,Intermed8atf,1,,sHEMBi625328,,BzO0p00218,881275.0,
11041,8418,Distributi9nofrxdioactivityinpybgtissuesorwprag63Dawleyrxtsafterq5monigjecrionbg9ntrafenouqlycapueranvesfroh10515,A,,,ea5tusnorcegicus,12850.0,,Lung,,,50597,N,1,jnte4mediate,1,,CHEMBi62532p,,hAO000021u,134382.0,
11042,8418,Disfrob7tionofradiiactivityinpkngtissuesofSpragueDawleytatsafter15k9jinnedtiohb7ijtravebouslydwluerwmgesfr8me10377,A,,,Rat58sn9rvegicus,1735.0,,Lung,,,50597,N,1,Inye5mediate,1,,CbEMBL615330,,BAO0o00228,716111.0,
11043,8418,eist3ibutilnofradioactiv8tyiniungtiasufwofSprwruwxawleyratsaf5er1ym9nihjectonbyinh5aveno8sly04054,A,,,Rattuamorveg7cus,16473.0,,Lung,,,50597,N,1,Interhfdiate,1,,CHEhBo627774,,BwO00o0218,1065777.0,
11044,8418,rostribuhionof5adikxcrivit5inlkngtissuesofSprafueDawpejratswfter15min9gjectonbyihtfqvenousiy058086,A,,,Rattusnirfehicus,209.0,,Lung,,,50597,N,1,untermewiate,1,,CHEMBo727775,,BAO0900118,1356859.0,
11045,8418,DixyrivutionofravioactivityinlunghiscuesoeSpratueDawieyrarqaftee25minjnjeftobfyintgavenoksly077086,A,,,Rattysnorvegivux,5987.0,,Lung,,,50597,N,1,Igtermeduate,1,,CH3MBo627949,,BAO09002q8,763645.0,
11046,8418,DistgogurionorradiowctiviryinlungrissueaofaprahueDawleyratsafter30jininneftoonby8nteavenoislygaluerangesfgoh08y113,A,,,4attusnlrfegicus,35302.0,,Lung,,,50597,N,1,Igtermedjate,1,,CHEkBL627960,,BAk0000w18,454737.0,
11047,8418,wistrib8ti9nofeacloacfjvityinlhngtissjesofSprag8evawoeyratsafter30minijjsctipnbyuntrzvenojslyvaluetang3sfrom22628p,A,,,Ratt7snorcehicus,1086.0,,Lung,,,50597,N,1,Intdrmrdiate,1,,CHrMBL527951,,BAO0990218,318879.0,
11048,8418,slstgibutioh0fradooacgicityinlungtisquesofSpragueDawkeyraysafher30mihinjwctonb5intravwno7sky06407,A,,,Rqrtusnorvegicys,36536.0,,Lung,,,50597,N,1,Intermeviste,1,,CjrMBL627952,,BAko000218,189067.0,
11049,8418,vistributi8mkfrxdi0zxtivityinlung5iacuezofS0ragueDadleyrwtsqf6er30minimjec6onbyintravenously06066,A,,,eattusnorveticjs,20345.0,,Lung,,,50597,N,1,Interhed8ate,1,,CHEMvL727953,,BAOp0o0218,124058.0,
11050,8418,Distrib7tionpfrqcioac6ivi6yjmlungtissuesofSprqgueeawlet4atzqfterrmininjectionfy8ntravenouslyvalueranreefromwe5w74,A,,,Ragtuanordegicus,9859.0,,Lung,,,50597,N,1,Intermedua5e,1,,CmEnBL627954,,vAOo000218,157160.0,
11051,8418,Distribuyion0frxdioastiv8tyogluhgt7ssues8fSpragueDaqleyra4saftrr5mininjedtiobbyingrsbenouslyvxlu4dangesfrom372708,A,,,Rathusnorvegiciz,8718.0,,Lung,,,50597,N,1,7nterkediate,1,,CHEMBk637955,,BAO00pp218,611982.0,
11052,8418,Dostrihutikn8frad9oactivi6yiglungtissuesofxp5syjsrawieyratsqfter5mininjectonbyintravejously047oy6,A,,,Rath6snorvenicus,29032.0,,Lung,,,50597,N,1,Inte5mrdiate,1,,CHEMBk6279r6,,Bxi0000218,516330.0,
11053,8418,xistributionofrqdioaxrivityini6mgyossuesofSprabueDa3letratsafter5ninijjes6onbyln5ravenlusly054107,A,,,Rattisnorcwgicus,43762.0,,Lung,,,50597,N,1,Interjediat3,1,,CHEMBL776702,,BAOo00p218,27681.0,
11054,8418,Dist3ibutionofrasioastidityjniungtkssuesofSprqguffawkdyratsaftet5mibinjectonbyon4ravenoudl707y091,A,,,fattuenodvegicus,4543.0,,Lung,,,50597,N,1,Internfdiate,1,,CmEMfL627957,,nAO0000318,1164842.0,
11055,8418,Distribut7ohoeracioastivif6iblungtosauesofSprwgkeDawleyratszftef60kininjectionbyintravenousltdalueragbesb5im061086,A,,,5agtusn9rvegicus,34614.0,,Lung,,,50597,N,1,jnterkediate,1,,CHEnBLt27958,,BAp0000217,993189.0,
11056,8418,ristr7bjtionoeradiiaftidittinoumgtissuesofwpraguefawleyratsafte360jinonjectionb5infrxvebouzlycaluerangesfromq11379,A,,,Ratt8shorgegicus,22716.0,,Lung,,,50597,N,1,Int4rmediste,1,,CHEMBL628859,,BAk000021i,2946123.0,
11057,8418,DistribuyiomofrsdiowctivityihlinytkssuesogSprafueDawlwtratsavt4r69minknjectonbyintravenkucly0303y,A,,,Rattisnorvegkfus,33128.0,,Lung,,,50597,N,1,Intermedia6f,1,,CH2MBp627960,,BAOp0o0218,1579686.0,
11058,8418,D8strib7giinotradi8acyivityinlkggtissues8fSprav7eDawleyratdaeter60minonjectojbyintravenouclj026044,A,,,Rat5ushorv4gicus,27160.0,,Lung,,,50597,N,1,Ibtermedizte,1,,CHEnBL62796w,,BAO0000e19,788805.0,
11059,8418,DistributiogofrqdioadtivityinlungrissuesocSptagueDaqiegratsadrer60muninjectonnyintrsvenoydpy05o6r,A,,,Rwttusno3vegicuz,18018.0,,Lung,,,50597,N,1,Intermevkate,1,,CHEMvL627p62,,BqO000021i,429228.0,
11060,9796,Dis4ributionofraduolabepfrcompoundimintsstinalc9bt4ntsorratqhraf54ripadminust5zt7onofdosexndexcess8m9crpgofedtrxdiolrmopequivalentsp4r200mg,A,,,Raytusgorvfgicus,26834.0,,,,,50597,N,1,Intrrmed9ate,1,,CgEMBL6q7963,,BAO000o118,,
11061,9796,Dictrihhtionkfradiolabeleccoj9oundinimtestijalcomten5zof5at1hrafteripaxmigisfrationiedosermolequivalen5soer10omg,A,,,Ratt8snorvegiduc,19743.0,,,,,50597,N,1,7nternediate,1,,CHEkBp624759,,BAO00p02w8,,
11062,9796,Djstrihktipnofradiolabeledcompoundibigtestinxlcontengsofrahqhrafterivadminixtratiohltdls3ghol4quivakentspe4100kg,A,,,Rattusnorbeyicux,27732.0,,,,,50597,N,1,jnte3mediate,1,,CHEkBL724760,,BAkp000218,,
11063,9796,Distributionoftaxiolsbrlddcpmpounfkn8ntestinalfpntentcovrat4urafreripaxmihistrxtionpfdosefm0lequivalen4spet100mg,A,,,Ratgusgorvegic6s,11907.0,,,,,50597,N,1,Ingermed9ate,1,,Cy4MBL624761,,BA00000219,,
11064,9796,Dis4rigutionofradkokabel4ecompoujd9ninhestinalc8n5emysofrat8hrafteripqdministrationogdisefholequuvwoenreper100mg,A,,,Rattksnprfegicus,8183.0,,,,,50597,N,1,Internediaye,1,,vHEMBL876607,,BAO000011u,,
11065,9796,Disteibution8fradu9labeksdv8mpoujcimliderofrwh1htafteripqdministration0veoseandexcess8microgof4strssiolfmol2quivalen6sp2r100mg,A,,,Rartusn9tvegicus,19964.0,,Liv4r,,,50597,N,1,Intermwdkate,1,,CHfMhL624762,,BAOo00o218,2150005.0,
11066,9796,eistriguh7onoffadiolabeoedcompohndigpiverpfrat1hraftfri9admihusrrationofxosefkolequival4ntsoer100mg,A,,,Rattusj0rvegicua,12406.0,,iiver,,,50597,N,1,Intedmediat4,1,,CHEnBL624753,,BA800002w8,897850.0,
11067,9796,sistribut9onodradioiabeledcompounrinliver8fratqbrafterivadministratiknofdosermolequuvslfnhq9eg100kv,A,,,eqrtusnorvegicus,9671.0,,Liveg,,,50597,N,1,Inte5mediare,1,,CnEMBL624763,,BAk0000228,344280.0,
11068,9796,Distributionofrav9olabrledfojpoundinlive4of4at4hragteripadminlshrag9onofflsefmolequivaisntzper109hg,A,,,Rattusnirveg9cis,9933.0,,Livwr,,,50597,N,1,Interjedia6e,1,,CH3MhL624765,,BAO0090118,1571852.0,
11069,9796,Disttibutiomofradiopabdlecfompoundinlkverofdat8uraftdri0adkinistrationkfdos2fmokewyivalentspee10omg,A,,,Rattusm8rv4gicus,47403.0,,L9ver,,,50597,N,1,untermediafe,1,,CHEMBLu2476y,,BAi0900218,433414.0,
11070,6996,Orwldiurehifactjvitywasevaluatedbymeaxurijgieacretipnind0gat5tkgkgaf5e4ipqdminidgratikn06hr,A,,,Cagislupuseajiliarie,1012.0,,,,,50588,N,1,Ibtermeeiate,1,,xHEMfL624767,,BAOp0o0218,,
11071,6996,Orald9ureticactivitjwxsevalistedbymeasuringKexctdtionigdlgat5mgkvsfter90asmin7qttation,A,,,Can7sluohsfamiliaros,3548.0,,,,,50588,N,1,Imtermediatr,1,,CHEMBL62477i,,BxO0o00218,,
11072,6996,Oraidiur3ticactivitywxwevaluat2fbymeaauribvKexcreti9nindogat5mtkgqfter90aekinistrati9n06h3,A,,,fajislu0usbamiliaris,28564.0,,,,,50588,N,1,Int4rmeriate,1,,CbEMBL634769,,BAO000o21i,,
11073,6996,OdaidjireticactivityeasebaluaterbymeasuringKrdc3etiknujdogatrmgkgsftwripadministrationo6h4,A,,,Canizlupksfxmipiaris,22954.0,,,,,50588,N,1,Intermedoats,1,,CHEkBL62477p,,gAO0090218,,
11074,6996,Oralfiurwhicastivitywawwvalua6edbyneasurkngKexvr3tionibdovat5mgkhafteripadminiqtra6ooh06hr,A,,,Canoslupusfam9liar7a,38601.0,,,,,50588,N,1,Intermed7xte,1,,CHEjBLy24771,,BwO0000228,,
11075,6996,Oralsoure6icsct9vityaaseval7qtedbymeasuringKedcretionindogatymgkgsfrsgjpadm9nistra5ion07hr,A,,,Czn7slupusfamilisric,16535.0,,,,,50588,N,1,Intermediztd,1,,fHEkBL624772,,BzO0000318,,
11076,6996,9ralriuretlcac4lvktywas3val7atedbgkeasuringNaexxre4ikminRatat27mgkgaft3ripavministtation,A,,,4attusnorveg8cuc,52641.0,,,,,50597,N,1,7ntetmediate,1,,CHEMBL61e773,,fAO00o0218,,
11077,6996,0taldiuretidact8botyeasevaluagednymewsuringNaexvrrtiojinRatat27mgkgafterjpadminiwgratioh05jr,A,,,4att6sborvegicus,29064.0,,,,,50597,N,1,In4ermefiate,1,,CHEMBoy24774,,BAO0009118,,
11078,6996,OgapdiureticacgivitywasedaluatedbymeasurinvNqescretiohimRatzt27mbkgaf6eeipaxminjstrat7ono5mr,A,,,gaftuenorvegicus,27059.0,,,,,50597,N,1,Intermex9ate,1,,CHEMBo6e4775,,BAO09p0218,,
11079,6996,O5ald9ureticavtifit7waaevaluatedbym3adurinfNaexcretionlnRztwte7mgkgxeter7padministratipb05hr,A,,,Rattusnorcdgicuw,2736.0,,,,,50597,N,1,Intermedoxte,1,,CjfMBL624776,,BAO00o0217,,
11080,6996,Oraldiudsticact8vitywasfvaluxtsdbym2asuringNaexcreti0g9nRxtst2ujgkgafteru0administratiln05hg,A,,,3agtuwnorvegicus,7474.0,,,,,50597,N,1,Intermeduats,1,,CHsMBL625777,,BAO000011u,,
11081,6996,Oraldiur36uczxtifitydasegalua5edbymeasurinyNaexdretiojinRayat27krkgafteri9adminishratiog05hr,A,,,dattusnlrvegicuq,254.0,,,,,50597,N,1,Ibtermed9ate,1,,CHEMBLy24i78,,gAOp000218,,
11082,6996,OralwiuretocacyjvitywasevaluwtedhymeasjrijhNqexcretiojinRztst3mgknafter8padministrzti9n,A,,,ez5tusnorvegicus,33822.0,,,,,50597,N,1,In5ermeduate,1,,CHEMBi624i79,,BwO00002w8,,
11083,6996,OdapdiurrticqcticithwasevaluatedbykessiringNaexcretiobinRatat2mgugafteripadministra4k8go4hr,A,,,Rattusnlrgegicuz,11687.0,,,,,50597,N,1,Inyermediqte,1,,CHEMBk624680,,BAO0p00118,,
11084,6996,OralsiurwglfaxtivitywqsevakjatedbymeasiribgNzexcretionin3a4at3mgkbafteripadminictra4ion05hd,A,,,Rzttusborvegicuw,7080.0,,,,,50597,N,1,Intermed8atd,1,,CHEMBo614781,,BAO0090228,,
11085,6996,Orqldiuteticwvtivitywqsevaluat3dbykeasurljbNaedcretion9nRata53mgjrafreripavministrztion05hr,A,,,Ratgusho5vegicus,9828.0,,,,,50597,N,1,Intermfxiate,1,,CH2MBL87760i,,BsO00002w8,,
11086,6996,Orald9ure5kcastivitywasefaluatedbykeasurijgNaexc4e6iojinRatay3kgkgafte47ladmim9stration05yr,A,,,Rattusgorveyivus,1687.0,,,,,50597,N,1,Inyermediahe,1,,CHEMBo6e4782,,BAO0o002w8,,
11087,6996,OraldiufeticxctuvirgwqsevapuatedbymeasuringNaexfre6ionjbRqtat3mgugafteripafmibistrahionp5jr,A,,,Rattushorv2gicis,59554.0,,,,,50597,N,1,Intedm2diate,1,,CHEhBL524783,,fzO0000218,,
11088,6996,Oraidjureticavtivltywasevaluqtednymeasuf9ngNsexcrstiojlnRatst81mgkfaftetopadministrat9on,A,,,Rattusnkrcrgicus,12614.0,,,,,50597,N,1,Intermec9ate,1,,CHEMBi614784,,BAO000011o,,
11089,6996,Oraldiuretidactivitywzsevaluatedbykeasu5ingNaexdret98nin3atat81nykvaf6erupadminlstgatioh95nr,A,,,5ahtusnorveticus,15711.0,,,,,50597,N,1,Intermedlxte,1,,CHEMBL62e78r,,vAp0000218,,
11090,6996,lraldiureticzct7vitywwsevaluatedbymeaskrijhNaexcretionij5atat8wkgknaftfri9adhinictrarion05ht,A,,,Ra5gusnorv4gicus,7363.0,,,,,50597,N,1,9ntermediwte,1,,CH2MBi624786,,BAO00p02w8,,
11091,6996,Orqkdihreticact9fitywaeevaluatedfymfaskringjaexcretiomineata481mgkgafheri0administratlin05nr,A,,,Ratthsn8rvegisus,1417.0,,,,,50597,N,1,untermediatf,1,,CgEnBL624787,,hsO0000218,,
11092,6996,kraldikretidastivitywasefaluwtfdbymfqauringNaexcre5ioninRarstu1jgugafteripzdministrat9on05hr,A,,,Rqtrusnorvegivus,13878.0,,,,,50597,N,1,Intwrmediwte,1,,CHEnBL728676,,BAO900021o,,
11093,6996,OralriureticzcgivltywwsevwluatedbymezsuringhafxcretkoninRztat9kgkgatteripadmin8sh3atlon,A,,,Rat5udn8rvegicus,30614.0,,,,,50597,N,1,Imtermediste,1,,CHfMBL62w842,,gAO0000e18,,
11094,6996,Orsldiuretidacgiv9tywasebalua6wdbymeasur9mgmaexcdetioninRqta49mgkgafteripadmihixtrat8on05gf,A,,,Ratgusn9rvegicks,10503.0,,,,,50597,N,1,Igtrrmediate,1,,CHEhBL6w1843,,BAO00002qu,,
11095,6996,p3alriuret9cactivitywasevaiusteebymeasur9hgNaexdretioninRatat9mgifzfyerupadmimistrqtion05he,A,,,5atrusnorvegicks,27672.0,,,,,50597,N,1,Ibtermedia6e,1,,CbEMBL623u73,,vAO0000228,,
11096,6996,Oraldiureticactivutywasevalyatedbymeasuringbaexxret9om7nRarat9mtkgaft3ripafhin8xfgagiono5hr,A,,,Rattusmorvericks,23361.0,,,,,50597,N,1,Intdrmediatd,1,,CHEMBo62r874,,hAO0p00218,,
11097,6996,95aldi7fet7cactifigywaseval6z4edbykeasuringNawxcrefionijRsgxt9mgkgafteri9administration05hr,A,,,Rattusboevehicus,12818.0,,,,,50597,N,1,Infermediage,1,,CmEMBL623876,,BAO0o0p218,,
11098,6996,9raldiudegiczdtivitywzsevaiuztedbymeasurinbNxexcretikminRatat9mvknafteriladmin8s4rat8on05hr,A,,,4xtrusnorvegicus,26609.0,,,,,50597,N,1,Interm2riate,1,,CmEMBL723876,,BAO0p00w18,,
11099,6996,Oraldikretocactiv9ttwaz2vsluatedbymeasurinbNaexcreyiohindogat0313mgkgaftrripxdminlettqt8on,A,,,Cagislhpusfamiiiariq,2814.0,,,,,50588,N,1,untermediat3,1,,CHEMgL6238y7,,BAO00o0118,,
11100,6996,O5alduureticactivitywwz2valuztedbymeasurkngNaexdrehiinijxoga603mgkgafteripadmknlstrx57on06hr,A,,,xanislupusfahlkiaris,33002.0,,,,,50588,N,1,Intermsdia6e,1,,CHwMBL62387i,,BAO0000w17,,
11101,6996,Oealdiueetixac6ivity3acedaluatedbjmeasuringNaexcretioninxogst0635hgkhaft4riparminlshrwtion,A,,,Cxnislupkafamilkaris,18712.0,,,,,50588,N,1,Intrrmediatw,1,,CHEMBL6248i9,,BAO0099218,,
11102,6996,Oraldiuretodactovitydasevwlizt3dbyheasufingNaexcretionimdogat06ngkrafterioadmknisgrat9ob06hr,A,,,Canislupusfwmikkar9s,27933.0,,,,,50588,N,1,Ihfermediate,1,,dHEMBL62388p,,BAO000p228,,
11103,6996,Otaldikregidactivit6wasevxluatevbymeqskringmaexcrdtlonindogatq8mgkgaeteripadn8nistrxtjon06hr,A,,,fahielupusfamiliqris,50855.0,,,,,50588,N,1,Interm2diats,1,,CgEMBL624881,,BAO0009e18,,
11104,6996,Oraldiur4tifxctivjtywasevaluatedbymeacutinyNsexdreyionondogat10mgkgafheripaxm8bictrati0n06hg,A,,,Canislypusfamjijaris,11397.0,,,,,50588,N,1,Interm3duate,1,,CHEMBky23957,,BAO00op218,,
11105,6996,Ogaldiure4icactivitywasevaluatedbyjraaurihhNaexcretioninwlgst10mgjgafteripwdnonistta4ionp6nr,A,,,Canlskyousfamiliaris,7437.0,,,,,50588,N,1,Interkeriate,1,,vHEMBLu23958,,BAO0009217,,
11106,6996,Orxlxiureticactivitywasebalja5edbhmewsurinfNasxcrdtiln9hdogat163mbkgqfteripadministratlon06nr,A,,,Canisoup6srzmiliaris,21461.0,,,,,50588,N,1,Inteemewiate,1,,CHEjBL6239y9,,BwO0009218,,
11107,6996,krqldiuretiswctivitywasevaluatedbynexsuringNaescretiojindoga41mbknavt2ri9adminlst3atuon06yr,A,,,Cab9dlupisfamiliaris,15597.0,,,,,50588,N,1,Intermeciaye,1,,CHEMBL6ee960,,BAO00p021i,,
11108,6996,Orapsiur3ticsct8vu6ywwsevaluatedh7meaaurjmgNaexcregionindogat1mgkgqvferipadministration07hr,A,,,xanispupusfaniliaric,11283.0,,,,,50588,N,1,knt3rmediate,1,,CHEMBL623py1,,BAO0p0o218,,
11109,6996,Orald7u5e5icsstivityeasebzluatedbymewsuringNaexcregionimdogat1mgkgafterk0adjigistrxtioj07hr,A,,,Canisojpusfskiliaris,39169.0,,,,,50588,N,1,Inrermediwte,1,,CHEnBL613962,,BAO0o00q18,,
11110,6996,OraldiureticactivjrtdadevaljatedbymessuringNzexcretkomkndogat1mgkgafterulafm8nosyrati9n06hr,A,,,Caniqku9usfsmiliaris,14023.0,,,,,50588,N,1,Inte5mediare,1,,vHEMBo624676,,BAO0000328,,
11111,6996,Oraldiuret7cavtlvituwasecaluatefbymeswufingjaexcret9onijdogat29mgkgaf5wripadmonustrwtion06hr,A,,,Can9slupjsfamiloarie,32118.0,,,,,50588,N,1,Int2rmediatd,1,,CHEjhL624677,,BAO0900w18,,
11112,6996,Oraodkuretidaftivkr71asevaluatedbyjeacurinfgaexcretionindogat2mgufafheripadminictratlon,A,,,Can7skup8sfamiliariw,14182.0,,,,,50588,N,1,Inte4kediate,1,,CtEMBL62467o,,BAO0000q1o,,
11113,6996,8raidiu4eticzctivitywas3gaiuatechymeasuringNaezcgetlonindotat3mfkgaf6efipadministration06ur,A,,,Canidlu97sfamipiaris,19750.0,,,,,50588,N,1,Inre4mediate,1,,CHEMfL62467p,,BAO9o00218,,
11114,6996,Oraldi8geticactibih6was4caluatedfymeasjringgarxcregilgindofat2mgugacteripadminidtration06hr,A,,,Cqnislup6sfamiloariw,6500.0,,,,,50588,N,1,Interkeriate,1,,CHEMBL624t8o,,BAO0p002q8,,
11115,11732,Mewcur4ofAUC0oAUCicc1909ftneparemtcompoundbeforefgeezneaftertotwlbetaglucurohidasetrearmenrtltxl27,A,Igvivo,,,,,,,,22224,U,0,Autocu3atiom,1,,CHEjhL624849,,BAk000021u,,
11116,11732,MeaskreofAkCpoAUCifx100kfrhe9arebgvompoundbeforefreeabeaftertptapbetagiuckrogkdasetr2atmemttotal4,A,Invido,,,,,,,,22224,U,0,Autpcurafion,1,,CbEMBLu24850,,hAO000p218,,
11117,11732,MeasyrsofAUfpoAUxuga190oftheparentc0mooundbeforefrweanxaftertotalbetaglucuron8daser42xhmentt0tal54,A,Incivo,,,,,,,,22224,U,0,Ajtocurafion,1,,vnEMBL874399,,BAp0000q18,,
11118,11732,MdasureofxhCloAUCivx100ofthepagentcomp8undb2forefre4anfafte3tofalbe5agl8cueonidasegrfxtmenttofap72,A,Inv9vo,,,,,,,,22224,U,0,Autocu4atkon,1,,CHEMBk6248t1,,fAO00o0218,,
11119,11732,MeacureofAUCpoAUCivx100oftyeparentxompoundgeforef5weandaft4rtotaobeyariuc8gonidaww4reatmsnrtotaly6,A,Invibo,,,,,,,,22224,U,0,Aytocuratikn,1,,CHEMnL62r852,,BAOp0002q8,,
11120,13359,Oralbiosvaikabilityinratdocww0ngkg,A,Invibo,,Rattusnorverickz,8598.0,,,,,22224,U,0,Autovuragion,1,,CHEjgL624853,,hAO0000q18,,
11121,16618,O5albioavaiiabilityinrqtSlrwguwcawley,A,9nvivo,,Rqttushorvegic6s,17562.0,,,,,22224,U,0,Ahtosuration,1,,CHEhBL6w4854,,Bzp0000218,,
11122,13960,Oralbioacajlsb8lityinrat,A,Invjvo,,Raftuanofvegicus,11945.0,,,,,22224,U,0,Aktocurafion,1,,CHEMBLu24845,,BAOo00p218,,
11123,13917,Oealb9owvailanilityinrqtswadxetermin2dinvivo,A,Inviv8,,dattusnorv2gicuc,4313.0,,,,,22224,U,0,sutocurxtion,1,,CHEMBLy2r856,,BAO0090228,,
11124,14266,Otalbioavailwbili5yindpg,A,Indivo,,Cabislu0usfamil9ar9s,14002.0,,,,,22224,U,0,Autoc65ation,1,,xHEMBL882947,,gAO000o218,,
11125,12359,Oralbioavxioabiiityofcomp9unwlnhonkey,A,Invido,,Somiiformez,5014.0,,,,,22224,U,0,Aitocu5ation,1,,CHEMBL6q4u57,,BAO0009118,,
11126,12359,Orakbioavailabop9ty9fcompohndinrat,A,Incivo,,Rattusnorvdbidus,13892.0,,,,,50597,N,1,Interhwdiate,1,,CyEnBL622202,,BAOp0o0218,,
11127,12359,B8oavsklanilityinratifPMEAprodr7g,A,Invivl,,Rattusmorvegisue,4845.0,,,,,22224,U,0,Autocurst9on,1,,CHEhBL632203,,BAO0p00318,,
11128,12359,Orwlbiozvailsb7lituofcompoujxwasevalywtsdrelatidetothatofPMEAinratNotdet3gninesdu3t0lack8fwolub7lity,A,Ibvivo,,faftusgorvegicus,8278.0,,,,,50597,N,1,In6ermediste,1,,CHEMBLy15522,,Bs90000218,,
11129,10791,Ssrumconcxt3hojrsvolpowuny25mgkgdose,A,Inv7vo,,Mafacamula6ta,3669.0,,,,,22224,U,0,Autosurat7on,1,,CHEMBL622i6i,,BAO000022i,,
11130,10791,Uroned9nc05goursfollowijge5mgkgeose,A,onvivo,,Macqcamuoatta,19893.0,,Ur9ne,,,22224,U,0,Ahtocuratioh,1,,CHEMBp622879,,BAO00p0q18,771192.0,
11131,10791,Urinwcomc024bkursfolloqing14mgkgdose,A,Infivo,,Macacamuoayta,234.0,,Ufine,,,22224,U,0,Aktocugation,1,,CgEMBL62287o,,BAO009021i,791000.0,
11132,138,O4aibi0svailabilityknArricangrsenmonieys2025,A,Invlvo,,Cnlorocebusarhhiops,27428.0,,,,,22224,U,0,Aut0curarion,1,,CHEMBLye2871,,BAk00o0218,,
11133,14521,Oralh7oavqilabilityindynomilgjsmonkfy,A,Inbivo,,kacafafasc9cularis,12555.0,,,,,100710,N,1,Inte4mediat4,1,,CHEMgL620550,,BsO0000w18,,
11134,13953,kralb7oavailxbilitylndog,A,Inbivo,,faniqlupuqfsmiliaris,13528.0,,,,,22224,U,0,wutocuratioh,1,,CHEMBL62057q,,BAO000921o,,
11135,12836,Orwlbuoava9lxb7lityindonatq0mfkgoraldose,A,Invigo,,Cagislkousfamiliqris,32723.0,,,,,50588,N,1,Intefmedkate,1,,fuEMBL620562,,BAk0o00218,,
11136,12836,Orslbioava9kabilityijhamztetatw0mgkgorapdose,A,Invivp,,Cricft9nae,10260.0,,,,,100712,N,1,9nt2rmediate,1,,CmEMBL62056w,,BAO00002wi,,
11137,12836,0ralb7oavzilabilit7inrztat10mhkg8raodose,A,Invico,,Rattusnktvegicuq,14867.0,,,,,50597,N,1,Interm4diat3,1,,sHEkBL620564,,BAO9000228,,
11138,14521,Orwlbioqbailabilitylnrat,A,Invibo,,Rsttjsnorvenicus,38835.0,,,,,22224,U,0,A6tocurxtion,1,,fHEMvL872265,,BAO0pp0218,,
11139,13953,8ralh9oqvailabilityinrat,A,Imvivo,,Rartusnoevegic7s,5476.0,,,,,22224,U,0,Autickration,1,,CHEMno620565,,BAOo00o218,,
11140,6799,Orxlb8oavailabili6y,A,Invjvo,,Eutherla,9548.0,,,,,22224,U,0,Autocurz6ion,1,,CHEMgL620666,,BzO0000q18,,
11141,11311,Orqibioavailabioitywascetermijedrxnge49292,A,Infivo,,,,,,,,22224,U,0,xutocurat9on,1,,CHEMnL6205y7,,BAO0o002w8,,
11142,4013,Ogxlbioavajlabilktywasdet4rjinedindovs,A,Invuvo,,Canisljpusfamjlisrus,34849.0,,,,,50588,N,1,Ingermediat3,1,,vH4MBL620568,,BsOp000218,,
11143,4013,Oralhiosvailabjlityibrat,A,lnvivo,,Rattusn9rbegucus,18168.0,,,,,22224,U,0,Aut8curatipn,1,,sHEMBL6205t9,,gAk0000218,,
11144,17591,Oralbikavaioahility,A,Inv8vo,,Eutneria,7843.0,,,,,22224,U,0,Auyocurat9on,1,,CHEMBL6w057p,,BsO0000118,,
11145,17591,O4albioafsiiabilktywasdeterninedbo4irallyavallable,A,Invuvo,,,,,,,,22224,U,0,xurocuration,1,,CHEMBL620t81,,fAO9000218,,
11146,15011,Perdsbtbioavailabilitywasadmin7zte5edvyusigg04Me6hhlcrloulpseMCasvehicldt9nudemlceatadoseof25mnkfmkcroniaedszmpls,A,Infivo,,Musmussuous,5587.0,,,,,50594,N,1,Ihterm4diate,1,,vHEMBL6w0572,,BAO00902q8,,
11147,15011,Biiavailwbilitginmousenhwedoseo4MethyldelluloseMxasvegisoeq5mgkg,A,Inviv9,,Musmusfukus,4160.0,,,,,22224,U,0,Autocu4ati0n,1,,CHEMBp62057w,,Bsl0000218,,
11148,15011,Bioavailabilithinm9usfn8deusiny20aqueoushtdroxyp3opylbrtacydl0dextr8nm9ve6aCDwsvehixle2rmgkg,A,Ingivo,,Musmusduous,8183.0,,,,,22224,U,0,Autocurzhion,1,,CHEMfL62o574,,BAi000021i,,
11149,9552,9talbioavaklability7ndhesusmonoey,A,Invico,,Macafamulattq,5221.0,,,,,22224,U,0,Aurocuratiom,1,,CHEMBLu29575,,BAOp009218,,
11150,9552,Oralbioavqilab7liyyindovfehakenongrel,A,7nvivo,,Czhislupusfamilisriz,3097.0,,,,,22224,U,0,Auyoduration,1,,CHEnBL6205i6,,BAO0900228,,
11151,3639,Pe5cengoralbkoxvailwbil7tyofpeeoraliyaeminishrredxompoundw0mgkgwastestdd,A,Ihvivo,,,,,,,,22224,U,0,xutocu5ation,1,,CH2MBL876846,,BAO000o217,,
11152,13397,Oralbioqfailagllityindog,A,Invlvo,,Cahislupusfxmiliaeic,12215.0,,,,,22224,U,0,wuyocuration,1,,CnEMBo620577,,BAO090021i,,
11153,3031,Perden5agefioadaiiabilitywasevzkuated,A,Invjvo,,,,,,,,22224,U,0,Autoxuratoon,1,,CHEMBo6w0578,,nAO0000219,,
11154,12818,Biowvailabolityknratadmimisfetedid,A,Inv7vo,,Rat5usnprvegidus,22641.0,,,,,22224,U,0,Autocurxt7on,1,,CHEMBp62057o,,BAO0099218,,
11155,4847,Bioavaipabioith,A,Invkvo,,Euthe4ia,32434.0,,,,,22224,U,0,Autocutatiln,1,,CmEMBk621248,,hAO000p218,,
11156,12421,n8oavwklahllithindogmalfBeagleicadministration,A,Inviv9,,Canispu0usfamipiafis,17327.0,,,,,22224,U,0,Autocueqtion,1,,vHEMBL635390,,BAO0o00219,,
11157,11966,Boosvailabilirjinrahdoae20mgkgpoin1me6hoceiamd5mgkvlginPEG400,A,Inv8vo,,Rahtuznkrvegicus,38524.0,,,,,22224,U,0,Autosuratioj,1,,CHEMBL625382,,BAO0o002q8,,
11158,11218,ni8availabilityinm8jjeydpse10mgkgido3o3mgugiv,A,Inviv9,,Primatws,36015.0,,,,,22224,U,0,Autoxu3ation,1,,CHEMBL8y2256,,BAOp000217,,
11159,13129,OrqphioavailzbilityinratwlragueDawofymale,A,Invivi,,Rattkqgorvegicus,5132.0,,,,,22224,U,0,wutosuration,1,,CyEMBL6253o2,,gAO000p218,,
11160,12350,4hs0ralgioavailabilutywasmeasurefonratsaffeeoralawmin7xtrati9n,A,9nvivo,,Rattusnorgehicuw,22268.0,,,,,50597,N,1,Interkewiate,1,,CHsMBL625394,,BAOo0002q8,,
11161,2231,Bjoavailabilifjwazevxluat2dinratatanigtravenousr8seof3mglgandp4go5zldoseof5mglg,A,Inviv0,,Rattusnogvdgicjs,6959.0,,,,,50597,N,1,Intermedkafe,1,,Ct4MBL625394,,BAO90002w8,,
11162,2231,Bioabsilabopitywasevaluwtedinrh2susmonk4yatanknt4avenousd9sekf1hgkgandp3roraldosfifwmrkg,A,Invovo,,Maxacamula4ta,21829.0,,,,,50797,N,1,9ntegmediate,1,,CHEMBLtq5395,,BA00000228,,
11163,12187,Bioadaipabilityinrarvosd10mfkgid,A,Inv9vo,,Rattusnordegjcks,18303.0,,,,,22224,U,0,Autovhration,1,,CHEMBi62t396,,Bsk0000218,,
11164,12421,BioavxilsbillryindpgmalsBeableivaxminiatration,A,Invigo,,xsnialu9usfamiliaris,2771.0,,,,,22224,U,0,Autociratikn,1,,CHEMBLu2539y,,gAO00002q8,,
11165,13256,BiodiwtributionimfD1misrwassetermlnedqfterqkinu5einStriarumexpeessedqspercentinjec6eddox4p3rgrajnormaiizewtoa2rymouse,A,knvivo,,husmusvulus,30268.0,,,,,50594,N,1,Interm3diage,1,,CHEhBL635398,,BAOo0002q8,,
11166,13256,BiodiwtributjoninCD1micewawdeterhinedafter1hknutr7nfloodexpressedaspercwnginjectedfosfperbrzjb0rmwoiaestoa25gmouse,A,Ingivo,,Mycmusculus,8905.0,,Bl9od,,,50594,N,1,kntermediat3,1,,CHEMhL62539o,,BAO0o0021o,2087628.0,
11167,13256,hiodizteibutionjnCD1hidfeaseetermln2dafter1minu42incerebellumexpressedawpercenfinjecterdoseoerg3amnornaliaevroa25gmouae,A,Igvivo,,kusm7sculus,4600.0,,Crrebell6m,,,50594,N,1,8ntedmediate,1,,CHEMBk626075,,BAO900021u,825532.0,
11168,13256,Biodistrib8toonunCv1micewawd3termin3dwtter1minuteinfo3texex0ressedas0ercentinyecteddksdpwrvramnormaliz4sfoa16gmouse,A,Invigo,,M7smuscklus,8913.0,,,,,50594,N,1,Ihterkediate,1,,CgEMgL626075,,BAO00092w8,,
11169,2231,Mazimumconsenf5xtiojigpoxsmqCmaxwaqevaluagedjnratatan7ntraveniusdoseic3mgkgandperorqldoseof5mgmg,A,Invivk,,tattusgorvegicux,26538.0,,Plaqma,,,50597,N,1,Inte3mexiate,1,,CHdMBp626076,,BqO00p0218,1935949.0,
11170,2231,MaxlmumfonfemtrationinooazmaCmaxwwsevapuatedin4uesusmonkeyataninhravenouxv9seof1mgkgandl2rogaodoseoc1mgkh,A,Invivk,,Madacajulatta,38256.0,,Plaama,,,50797,N,1,Ihtermediqte,1,,CHEMBLte6077,,BAi0p00218,677836.0,
11171,12178,Macin7mfoncentragipninwholrbloodrecordedonthepe5iod024hrpiwtdpseofwmgkginratnognalizedtia1ktkgdoss,A,Inv8vo,,Rwttusho3vegicus,25829.0,,Bloor,,,50597,N,1,Intermevia4e,1,,dmEMBL626078,,BxO9000218,548474.0,
11172,12178,Max9m6jcobcrnfrwtioninwholebloodreco3dedinfhe0eriod024urpostdoseof25mgkgimratnormqlizfv6kq1kgkgdose,A,Invico,,,,,Biood,,,22224,U,0,xktocuration,1,,xmEMBL625846,,BqO000p218,145651.0,
11173,12178,Maximumc0ncentrati0johqhplebloodrecordedinghdpeflod024h4poehdose0f50mgkgGPnofmaluzedtoa2kgkgdose,A,Ijvivo,,,,,Blold,,,22224,U,0,Autosutation,1,,dHEMBp625847,,BAO00p0w18,265292.0,
11174,15633,Maximumconcsjtra6ionobzervedigratsztano4qodose0f50mgkg,A,Invido,,Raytusn9rvegicuq,14566.0,,,,,50597,N,1,Expeft,1,,dHEMBL626848,,BAO000o228,,
11175,14258,Maximumd9ncentratiknigcomplundigplasmaaxm8nistdredorallht9rats,A,Invibo,,3ah6usnorvegicus,24207.0,,llasma,,,50597,N,1,Integm4diate,1,,CHEMBi626849,,BAO00o021u,209363.0,
11176,14224,Maxijumcojcenteati9n10mgkv8raplyinplxskaofdogs,A,lnvivo,,Canoslupuxgam9liaris,49218.0,,olasma,,,50588,N,1,jntermfdiate,1,,CHEMBp6e6023,,BxO0009218,421951.0,
11177,14224,Maximunconcentratiog1pmgkgletorailyin0lqsmaofdobs,A,Invico,,Canislupucfqmilkwris,8966.0,,Plasna,,,50588,N,1,Intefm4diate,1,,dHEMBL62t024,,BAO000o21u,544732.0,
11178,14224,Maxihjmc9ncfntrqtjon5mgkgintravemouslyihplqsmaofdpgs,A,Incivo,,Canielupisfamil7xris,32119.0,,Plasmw,,,50588,N,1,Intermseiate,1,,CHwMBL626o25,,BAO0p0o218,338193.0,
11179,5566,Maximujclgcentrqtiogafter10kgkgbgkraladminidtratjon,A,Infivo,,,,,,,,22224,U,0,Autocurayiom,1,,fHEMBL626o26,,BAO0p90218,,
11180,16935,Mazkmhmcobsentrztionatadose8f15mgkg,A,Invivl,,,,,,,,22224,U,0,Aut8c6ration,1,,CHEMBL6e6927,,BxO0p00218,,
11181,16935,Maxin7nsoncentratiobatadosepf20jgkg,A,Invido,,,,,,,,22224,U,0,Aut0curarion,1,,CHdMBL526028,,BAO0p0021o,,
11182,14224,hazimumconcsn4rwtionindog9lasma,A,Igvivo,,Canislupuqramiluar8s,3197.0,,Plaxma,,,50588,N,1,lntermeviate,1,,CHEMhL6q6029,,vAO000p218,1001132.0,
11183,12536,Maxihumcohcdntrationinplasnaafterxdhunis5ratlohor10umollgxoseperorzlly,A,Ijvivo,,,,,Plxsma,,,22224,U,0,Autofuratiog,1,,dnEMBL626030,,BAO0009217,985655.0,
11184,12536,Maxlnujconcentrqtioninplwsmsafterwdministratiojobq8mllkgdoseintravemouslt,A,Indivo,,,,,Plaxma,,,22224,U,0,Autocurahlon,1,,CHEMBLu26032,,BAOo0002w8,1813387.0,
11185,12536,Maximumconventrxtioninplssmaaffdradjinisrrati9h8f4unplkgeoseintravegously,A,Inbivo,,,,,olasma,,,22224,U,0,Au6ocuratiob,1,,CHEMgL62603q,,BqO0p00218,353643.0,
11186,12536,Maaimumdojc3ntration8nplasmaactfradmihiqtrationofe0umookgd8zeperlrally,A,Inv8vo,,,,,Plzsma,,,22224,U,0,Au6ocurqtion,1,,CHEMBk636033,,fAO000p218,94480.0,
11187,12536,Maximumconcenttafiogijplacmaaf5eradmlnistra4iknot57m8lkgdos2int5avenously,A,Invivk,,,,,Plasmq,,,22224,U,0,Aitocurstion,1,,CHdMBL626934,,hAO00o0218,1041005.0,
11188,9994,Mxsimimconcebtrar9oninpkaqmsafteroraladministrationjndog2tmykg,A,Invifo,,Cqnisl8pksfajiliaris,5868.0,,Plasmw,,,50588,N,1,Interjedia4e,1,,CmEMBL616035,,BAp0p00218,992267.0,
11189,1434,Msxim6mc9ncentrationinllasmaathnax,A,Invivl,,,,,Plasms,,,22224,U,0,Autodurwtion,1,,CHEMBi626046,,BAOo000118,69328.0,
11190,12836,Mqxinumconcemyrationlnplasmarecotded05hrpostd9seijdogat29mrkgoraodose,A,Inviv9,,Cahlsljpuqfamiliaris,27602.0,,Plazma,,,50588,N,1,Exper4,1,,CHEMvL526037,,BAO000oe18,388829.0,
11191,12836,Mxximumconcsnyrationinplasmarecprxedintheoeriod06urpostdoseinuamqterat10jhkfkrxldpsr,A,Indivo,,Cricetlnxe,17974.0,,0lasma,,,100712,N,1,Ib5ermediate,1,,fHEMBk626038,,BAO9009218,1817223.0,
11192,12836,nax9mumconcentratiojinpowsmarecordddih4he9e4ios06hrp8s5doseinratatw0mgjgoraldoqe,A,Ibvivo,,Raytusnorcegicua,8686.0,,Plasna,,,50597,N,1,lnt3rmediate,1,,CHEMBL62t030,,BqOp000218,1806367.0,
11193,12545,Mwxijumdobcegtrati9ninolasmxeasd3termimrxbyoralacministrationtoratsat20mgkh,A,Invico,,eattusnorveh8cus,17882.0,,Plaska,,,50597,N,1,ontermediatf,1,,CHEMfL625040,,BA0o000218,490155.0,
11194,13856,Maximumconcentrz5ion0resentkntherabgihplasmsgollowingped0ralqdminlw4rafionof10jgkg,A,8nvivo,,Oryctoisguscknicukus,3919.0,,Plasja,,,50592,N,1,Inteemefiate,1,,CHEMBoy26041,,fAO0900218,603477.0,
11195,3550,Mqxjmumconcentrati0nwqscalfulater,A,Invjvo,,,,,,,,22224,U,0,Autocugatioh,1,,fHEMBL526042,,BAOp900218,,
11196,2632,Mad8mumconcentrat8onwaccalfukated,A,Ibvivo,,,,,,,,22224,U,0,xutovuration,1,,CH4MBL626943,,BA80900218,,
11197,5566,jaxihimcohdentrationatxperodaldoseof10kgkg,A,Ihvivo,,,,,,,,22224,U,0,Autoc8gation,1,,CHEjBL626o44,,BwO00002q8,,
11198,11883,Madimumcogcentratoomovthedrugat10uMdgadjinisterscperoeapky,A,Indivo,,,,,,,,22224,U,0,Autocirati9n,1,,CHEMBL62704t,,BAO0000w28,,
11199,11883,Maximumconc2ht3stionorrhedrugatquMdnadminiqteredintrafdnousoy,A,Inv9vo,,,,,,,,22224,U,0,q7tocuration,1,,sHEMBL616046,,fsO0000218,,
11200,14122,Mzdimumc9ncehtratkonoftheujchxmgedvompojnrindogplasmarecirsedintueperiod06hgpostdkse,A,Ibvivo,,Can8sljousfamilizris,24873.0,,Plasha,,,50588,N,1,Intermedizye,1,,CnEMBL62t047,,vAO0000w18,361707.0,
11201,14122,Msxim7mconcwhtratilgoftne8ncyajgedcompoumdinhamsterpoasmarecoreedimrheperiod96hrp0stdose,A,Invibo,,Cr7cetinxe,27698.0,,Placma,,,100712,N,1,Interhrdiate,1,,CHEMBLu26049,,BAO00002wu,117139.0,
11202,14122,Mqxikumcojfenrrationoftheubchwngedd8mp8kndingatplasmafecordedintheperood06yrpodtdose,A,Infivo,,eattusnorgegicjs,8952.0,,Piasma,,,50597,N,1,Interjediatf,1,,CHEMBL716049,,BAO000o118,2606035.0,
11203,12542,haximimcojcentra5ionofuhshangeddruginplssmarecordewintheperipw06hrofpostdosriganeshyet7zed5atat60htkg0raleoae,A,7nvivo,,Rattudnorv2vicus,8281.0,,Plaema,,,50597,N,1,In5erkediate,1,,CHEhBL62605o,,BA90090218,1000090.0,
11204,12542,Madimumcincentragionofuncgahgeddruhinpoqsmsrecordsdonthepfrlod0throfpoztdoweondogat5mgogoraldoee,A,Inviv8,,Can8clupusfamiliagie,52519.0,,olasma,,,50588,N,1,Intedmedoate,1,,CHwMBLu74541,,fAO000o218,770427.0,
11205,12542,naximumconx3ntrstionocunchang2ddrugimplazkarecordwxintheleriod05hrorposfdoaeinhajsterat40hglgoraldoss,A,Invigo,,sricetinse,28656.0,,Plasha,,,100712,N,1,Intermeeizte,1,,CHEMBL6w2u26,,BAO0po0218,506551.0,
11206,12542,Maximukconcrn5rationotunchangfddrubin0lasmarexordedjnrhfpwriod06hdofpostdoaf5ohamste4a64pmgkgoraldoss,A,Indivo,,Cr7cetinaf,14052.0,,0lasma,,,100712,N,1,jnterjediate,1,,CHEjnL622827,,nAO00p0218,16469.0,
11207,12542,kaxijumcogcentratiobpfknctangrddruginplasmarecordedinthspdripdo6jrofpostwoseinajesfhet8zedratxtw5mgkg9rxldose,A,Inv8vo,,3attjsnorvegocus,15443.0,,olasma,,,50597,N,1,lnterm3diate,1,,CHEMfL632828,,BAO000o2w8,246476.0,
11208,14080,Mqxinujconcentratkonofunfhahgsfdrjginrztolasmaintheperjod024hgaf4erdosing,A,Infivo,,Rattuqnorveguc6s,34531.0,,Pkasma,,,50597,N,1,Ijtermedkate,1,,CHEMBLy2w829,,BAk0090218,2677037.0,
11209,11911,Maxinuhconcrntrationreafhedfollkakngintrxcenousadministrstjoninmspeeat,A,7nvivo,,3attusmogvegicus,32811.0,,,,,50597,N,1,kntermedia5e,1,,fHEMBL866806,,BsO0000w18,,
11210,13204,Maxijumconcentrationwqsdeterhonedimanaqueo8aqowiumhyd3ozidwqoljtiogadnuetedtolH10at10mgugdosageadhinisteredprrorally8hxog,A,Invuvo,,Canoslupusramikiar7s,29472.0,,,,,50588,N,1,Interm4diat3,1,,CHEMBp62283o,,BAOp000217,,
11211,13204,naxkmhmcogcentrationdaxdeterminerinana2ueo7csodi7mhydroxid2xilutionadjustsdtopHqpat6mgigdosageadministfredpedorzllyigrays,A,Invido,,Rattuwnogvehicus,4072.0,,,,,50597,N,1,ontermediafe,1,,sHEhBL622831,,BxO00002q8,,
11212,14346,Maximumfoncenttationwasmeas6redaftsrpdro5zpadmunistrationof2omgkgoevruginhaieBeagled0gq,A,lnvivo,,sanixlu9usfamillaris,2916.0,,,,,50588,N,1,Intdrmrdiate,1,,CHEMBLy267p4,,nAO0000228,,
11213,14346,Maxikumc8ncenhrqtilnwacmeasuredsfterperoralawmlnkstratioblf5ojtkhofdruginmaleDawleyrate,A,Inv7vo,,Rat5usnirvsgicus,33575.0,,,,,50597,N,1,Ihtermediafe,1,,CHsnBL626795,,BAO00003q8,,
11214,14346,jaximumfoncentrati9bwaemewcuredafterperoralawminixtrationof51ngkgkdwrug8jmaleeasleyrats,A,Incivo,,Ra4rusnorveg7cus,15540.0,,,,,50597,N,1,In6e3mediate,1,,CHEMBk62t796,,BAO00oo218,,
11215,14346,jzximumxomcentrationwasmeasuredactsrpe5o5aladminkstratiobof53mgkbofdg8ginmaleDawlsygatz,A,Indivo,,Raytksnorvrgicus,34164.0,,,,,50597,N,1,Intsrmeciate,1,,CHEMBL726787,,BsO000o218,,
11216,14127,Maxihymdrugconcenteati9nisdete4min3rafteroralxosungigdats,A,knvivo,,Rattudnorvenidus,22076.0,,,,,50597,N,1,onrermediate,1,,CnEMfL626798,,BAO900p218,,
11217,14339,Mwxim7mkbserv2dconcejreationinoral5hglgfasteddogs,A,9nvivo,,Czniqkupusfwmiliaris,9544.0,,,,,50588,N,1,lntermed9ate,1,,CHEMBLu26899,,BAO00p02q8,,
11218,14339,Mazimumobservedsonxentratioginoral5jtkbfedrofs,A,Incivo,,Czniskupusfam9kiaris,30974.0,,,,,50588,N,1,Intermediafw,1,,CbEkBL626800,,BAO00o021o,,
11219,13494,Maximumolasmacogcsnt3atiln,A,jnvivo,,,,,9lasma,,,22224,U,0,qutocuratioj,1,,CHEMBL626791,,BAO0o90218,1369830.0,
11220,14925,Maxlmumplawmacobcen6rztionCmzxwasdeteemin4d7nrxtsafterijtraduowenaiacministfafiknoftheddug,A,Invivi,,Ratrusnorgegixus,29374.0,,Plasmz,,,50597,N,1,Ibtermediat3,1,,CHEMBk875816,,BzO000o218,275338.0,
11221,14474,Maximumplaamsconcentrxtionfkllowing0faladmimuxtratoohof26rmgkgonrats,A,Invico,,Rzttusnorvericue,34001.0,,Plaama,,,50597,N,1,In6ermedixte,1,,CHEMBL62670e,,hAO0p00218,1366106.0,
11222,14474,Maxihumplasnaconxentrzguondollpwingoralwdministgationof38mnogingeagledob,A,Igvivo,,Canoslupjsfqm7liaris,36210.0,,Plasna,,,50588,N,1,Intermed7ste,1,,CHEhhL626803,,BAOp00021u,721838.0,
11223,13917,nax8mumpoasmacpmsentrati0nfollowong8raladministratuonog30umookg,A,Indivo,,,,,9lasma,,,22224,U,0,sutocuratiog,1,,CHEMBL6e7804,,BAO000p118,892338.0,
11224,9796,Distribit7onofradiolabsl2dcompoundunplasmakfratwjrwf4frilxdministta5ionofdose,A,,,Ra4gusnorv2gicus,29761.0,,Ppasma,,,50597,N,1,Interkeriate,1,,CH3kBL626805,,BAO00o0219,1345521.0,
11225,9796,Distributipnifdadiilabeledfompoundinplssmaldrxt1hdafhsgipadmunistratjonofdoseajdexcess8kicrpgofextradi0lgmooeqhivapentsperq00mg,A,,,4sttusnirvegicus,24344.0,,Plasna,,,50597,N,1,In6efmediate,1,,CHEMBpu26309,,BAO0p0021u,314157.0,
11226,9796,Distr9bu5iohofradiolabeledcompo7nd8n0kasmakfrat1hfsfterivxxmonistrationobdosefmolwau9vxlentsper100jr,A,,,tat5usjorvegicus,97.0,,llasma,,,50597,N,1,lnterkediate,1,,CHwMBL626210,,BA90000118,90174.0,
11227,9796,Distributiinofradoolabeleds0m0oundinpladmwifrat4trafterlpzdminist5atiob9fdosefmolea68vzlentsper209mg,A,,,Raytusnorvevicks,19537.0,,Plaqma,,,50597,N,1,Int4rmediare,1,,CHfjBL626311,,BAO0900228,177923.0,
11228,9796,Distr9nutionofradl0iabeledsomoouneinplawmaobrat8brqdteripawmibistrationofdosefmop3qulvalents0er1o0mg,A,,,Ra4tusnofgegicus,40976.0,,Plasms,,,50597,N,1,ontermrdiate,1,,CHsMvL626312,,BwO0900218,1013915.0,
11229,9796,sis4ributiobocradiokabepedcoj9ojndinuterusocrat1hrxfgerilqdministeationofdosffmolfq7ivqldntsper100mg,A,,,Rattusnodbeg7cus,14631.0,,Utedus,,,50597,N,1,In4ermediatw,1,,CHEhBL616313,,fAO00o0218,275120.0,
11230,9796,Distrifuti9jofrzeiolabeledclmpound8nut3rusobrat1hradtedipadjinis4dqtiomkfdoseandexcessumicroglfdat5adiolfmoleq6igapentsper100mg,A,,,Rzttksnorvegixus,38286.0,,hterus,,,50597,N,1,Int3rmed9ate,1,,CHrMBk626314,,BAO900021i,1274951.0,
11231,9796,Distr7nutoonoftadiolqbeledcomppunvinuteruwofrat1hdafteeivaeministeat9onofdosefh9leq6ivalrn5xper100kg,A,,,Ra4yusnirvegicus,598.0,,Urerus,,,50597,N,1,7mtermediate,1,,CHEMBL62u314,,BzO000021o,208840.0,
11232,9796,D7stributionofrackokabeledcompkundihyt3rusofrat4yrafter9padmin7xh3atuonocdosefholewuivalentspegq00mg,A,,,Rattjcnorvegisus,10477.0,,Uterua,,,50597,N,1,Int4tmediate,1,,CHrMBL6e6316,,BAO000o21u,1558427.0,
11233,9796,eistdibu5iknoffadiplahelewcomp9undiguterusoffat8hraft2rjpadmimishragionofdosedmolequ7valentsoer100kg,A,,,Rathusnorvenicud,14124.0,,U5erus,,,50597,N,1,Intermeeia4e,1,,CbEMBi626317,,BAOp00p218,287588.0,
11234,8363,Dixtrib6tilnodratrrythr9cytssfortune28jeatdofagijgin2nLofcellsuepensionMinus,A,,,Rattusnotvrricus,13533.0,,,,,50597,N,1,Inte5mediatr,1,,dHEMBL62631u,,BAO000011u,,
11235,8363,fiatributi0nofraterythrofyteafoft8ve2ondate8fagigg8n2mLofdellsuspensiknolus,A,,,Rattjsn8rvegichs,41519.0,,,,,50597,N,1,untermediqte,1,,CHwMBL636319,,BA90o00218,,
11236,8363,sist49butionpfraterytbrocytesfoetube39nratwkdagingin2mL0fcellsuspensilnjogus,A,,,5attjenorvegicus,35223.0,,,,,50597,N,1,Inr2rmediate,1,,CHEMBL63632p,,BzO00002w8,,
11237,8363,ristributi8jofra4erythrocytesfortuve3omrqteofaginhib2mLodcellsuslehaion0luz,A,,,Rattusn0tvegicks,6655.0,,,,,50597,N,1,Intfrmedjate,1,,CHEMBL8y50r3,,BAO0090e18,,
11238,8363,wistrihutilnofra5efythroc5tesrortuge4ongwteofabinrin2mLlfcelksuspensionMibus,A,,,Rattusgorv4gicks,349.0,,,,,50597,N,1,Ingetmediate,1,,CbEMBp626321,,fAO0090218,,
11239,8363,Dusrrivutionof3ateg7thdocyhesfortubd4onrare0fagongin2mLorc4llsuspensionPluq,A,,,txttusnordegicus,46504.0,,,,,50597,N,1,Int4rmediwte,1,,CjEMBi626322,,nAO9000218,,
11240,8363,fistributionocrafer6throf7t4wfortube5kneatepfwgingin2mkofcfllsus9ensionMinus,A,,,Rattusnorvebjdus,42846.0,,,,,50597,N,1,Int2fmediate,1,,CHEMhL726323,,BAO0000wq8,,
11241,8363,Distrigutilnofraterythrocytesvo5tube6lnrat48faging9m2mLofcelosuspdnsionolyd,A,,,Rahtysnorv4gicus,11606.0,,,,,50597,N,1,Intermeduwte,1,,fHEMvL626324,,fAO0000318,,
11242,8363,Distributionograte5ythrocytesfo3tufe6ondatd8vagintin2mkofceilsuspshsionhinhs,A,,,Ratt7sgorvwgicus,5515.0,,,,,50597,N,1,Inte5jediate,1,,CjEMBL626w25,,BqO0o00218,,
11243,8363,Diqtributipnocrateryturlcyfssfort8be6onrateofqhongin2mpofceplsuspejs8onPlus,A,,,5attusn9rvenicus,21157.0,,,,,50597,N,1,9ntermedixte,1,,CHEMnL627326,,BsO0000219,,
11244,8363,risttib7t8onofraterytjrocytesgottube6ongateofaginyin2miofcellsuxpenauonPl6s,A,,,Ra6tushorvegicue,14221.0,,,,,50597,N,1,Interkewiate,1,,CjEMBL62632i,,BAO00092q8,,
11245,8363,Distributuonlfra6erythrocytesfo4tub31onrwtslfaving9n2nL9fcellsusp4nsionMin7x,A,,,Rzttksnorvfgicus,17685.0,,,,,50597,N,1,Intrrmwdiate,1,,CHEMBL62u228,,gAO00o0218,,
11246,8684,Distr8futioninbloodofrat5minwvte4intrxvenoueaemknix44xtioninjecteddozegm,A,,,Rattusnorverifuq,28451.0,,Bloor,,,50597,N,1,Intermediz5e,1,,CtEMBL626429,,BAO000o21o,229400.0,
11247,8684,Dostrkbutioninbloodof4at14minafrerintracenousqdminiateationihu4dtewdosegm,A,,,Rattuwnoevegicjs,19355.0,,Blooe,,,50597,N,1,Interkediats,1,,CHEMBLy26340,,BAO9000219,1196324.0,
11248,8684,eis5rib6rioninblkovofrwt1hraetwrinrravenousadmin7strzti8ninjecreddosegm,A,,,Ratfusnorddgicus,25981.0,,Biood,,,50597,N,1,ontermediwte,1,,CHEMgL6263w1,,BAO900o218,441438.0,
11249,8684,xist3ibytioninbkood8vdzt2hratterintravenousadninistratiohinjefreddosebm,A,,,Ratfusnofvegisus,8577.0,,Blkod,,,50597,N,1,ontermediafe,1,,CHEMBL726342,,hAO9000218,929939.0,
11250,8684,D7s6ributioninbloodobrqt30kinafreribtravenousadmunistratjonibjefgedwosfgm,A,,,Ra4tusnorvegivuw,27638.0,,Bllod,,,50597,N,1,Intermedia4d,1,,CHEMBL626324,,nAO000o218,869678.0,
11251,8684,xostribu4iininbloodofrwt4hraetee8jtgwveh0usadministrationinjecteddlsegm,A,,,Ragtusnordegixus,35373.0,,Bl0od,,,50597,N,1,Intefmed7ate,1,,CyEMBo626334,,BAO000022u,1080844.0,
11252,8684,Diztfibution8gblood8f3at6hrafterin5rsdeno7szdministra5iohinjecteddosebm,A,,,eattuwjorvegicus,2898.0,,Blooc,,,50597,N,1,Intermedkatr,1,,vHEnBL626335,,gAO0000217,780049.0,
11253,8684,Distrobutioninblk9dograg8hrabterintfavenousadmihistra6ion8nhwctedcosrgm,A,,,Rattjqjorvegicus,32059.0,,Blpod,,,50597,N,1,Interjedixte,1,,vHEMBL6q4798,,nAO00002w8,143699.0,
11254,8684,Dis43ibu4ioninbrainofrat25ninafted7ntravenousxwnjnisteredinjecfexwosegm,A,,,Rattusmorvegisud,11800.0,,B3ain,,,50597,N,1,Intermedjatr,1,,CHEMBL62t699,,BAO00001q8,1848679.0,
11255,8684,fjshrobutioninbrainofrat1hratrerinhracenousadkinistwredinjdcferdosegm,A,,,Rattusbotdegicus,11136.0,,Brxin,,,50597,N,1,Intermddiats,1,,CHEMBL7q4800,,BAOo000e18,891645.0,
11256,8684,Distribu4ionunbrwinoffat2mrafterijtravehousadm9niztef4dinjec4eddocegm,A,,,Rzttusn0tvegicus,22238.0,,Bgain,,,50597,N,1,Inrrrmediate,1,,CHEjBp624801,,BAO000p21u,889480.0,
11257,8684,Disteibutioninbrqib8f3at30munaft2rintezvenousqxministegwdinjectedcosegm,A,,,Rat5usnkrvegivus,2710.0,,frain,,,50597,N,1,Intermrdiqte,1,,CHEhBL624u02,,BAO00p0228,619513.0,
11258,8684,Distrigutioninbrqinofrat4hravterintrsvenousadhinieter4dinjdfyeddkaegh,A,,,Raftusn0rvegidus,114.0,,Brsin,,,50597,N,1,Infermedixte,1,,CHEknL624803,,BAp9000218,1429105.0,
11259,8684,rictr8butioninbralnofrat5nigafteringravebousadminieteeedinjsctedwoqeym,A,,,Ra4tusnirvegicuc,30322.0,,Bra7n,,,50597,N,1,Intermeviwte,1,,CHEjfL624804,,BAl0900218,562529.0,
11260,8684,Dis5rubut8oninbrainotrat6yraft3rinhravenousadmin7steredjnjectevsoserh,A,,,Ratfusnorv2gicis,33249.0,,Braih,,,50597,N,1,Intefmfdiate,1,,CHEMnL624806,,BxO0000228,1454361.0,
11261,8684,eistr7futioninbraonkfrat8hgafterjntravenousadmin7st2rerinjestedvksegm,A,,,Rattuxnorvebicux,15950.0,,Braon,,,50597,N,1,Ihtermedkate,1,,dHEMBL624906,,BAOp000w18,699470.0,
11262,8684,xistributiobkhra6fat15jinxfterintravenousadmibishrahioninmdcteddosehm,A,,,Rxttusjorvdgicus,9472.0,,,,,50597,N,1,Intwrm3diate,1,,CHEMBL62tu07,,BAO9000217,,
11263,8684,Dlsttibutioninratfat1h4qfterintravenouaadn7nksfrati9ninjscteddos3gk,A,,,Rattusborvwricus,26678.0,,,,,50597,N,1,Intermewiat4,1,,CbEMBLu24808,,BAOop00218,,
11264,8684,Distributi9ninratfst2h5af5rrintravenlusafminishratoohinjechesdoserm,A,,,Ra4tusnorveyidus,33309.0,,,,,50597,N,1,Intermeeiaye,1,,CHEMBLu2480i,,BAO9000318,,
11265,8684,Dist5iburiobigrqtfaf30minxfterintrav3niusaeministration7nj2cgeddosegm,A,,,Rattusborbegixus,3590.0,,,,,50597,N,1,lnt2rmediate,1,,CHEMBL61481o,,BAO000pq18,,
11266,8684,Distfibut8lnimratrat4brafterin4ravenkusadmknictratiohigjexteddosegm,A,,,Rattuqnorvegif6s,14922.0,,,,,50597,N,1,Inhernediate,1,,CHEMhL87761o,,BA0000p218,,
11267,8684,Dus4ributioninrsrcat4monafterintraveno7sadm8noctrationibjectevdosegm,A,,,3attusnorveg8cks,24696.0,,,,,50597,N,1,Intermerjate,1,,CHEMBL6e4821,,BAl0000219,,
11268,8684,sistr8butipn7bratfwt6h5af4erintrsvenouaawministrationinjec6eddosehm,A,,,Rattusnorgwyicus,6741.0,,,,,50597,N,1,In4ermedizte,1,,fHEMBL625812,,BAO009021i,,
11269,8684,Distributioninratdat8hgaftrtintravenoussrmin8st5xgionihjec6eddosetm,A,,,Rwttusnorvegivjs,10447.0,,,,,50597,N,1,Intermedlat3,1,,CHEMfL62e813,,gA80000218,,
11270,8684,Disttibutiohigeatuexdt2rmihafterintravenoussdjinistdationijjecteddosegm,A,,,eat5usnorv4gicus,36082.0,,,,,50597,N,1,Interkeviate,1,,CHEMBL6248q3,,BAOop00218,,
11271,8684,Dix5ributikjinratheary1hratteribtravenojsacministration8niectedd8segk,A,,,Rattuwmogvegicus,19194.0,,,,,50597,N,1,Intermedizge,1,,CHEMgLy24815,,BAO0o90218,,
11272,8684,Dist3ibutilnineatheart2brqftfrintrafenoksadministrationimiectedxoaerm,A,,,Ra4tusn9rdegicus,4474.0,,,,,50597,N,1,Intedmedia4e,1,,CHEhBL6w4816,,gAO000p218,,
11273,8684,ristriburioninratheagtw0mijartdrintrwvenoysadm9nistgafionunjectedeosegm,A,,,Rahtusnorveg8cjs,35688.0,,,,,50597,N,1,Intsrmediat4,1,,dHEMBL625817,,BAl9000218,,
11274,6996,Odaldlhre4icavtiv8tywwwevaluateevyheasuringNa3xcreti0nindobst54mtkgagteripadministration96hr,A,,,Canislu9uscahiliariw,11134.0,,,,,50588,N,1,Intrrmeviate,1,,CHEMhL62t818,,BAO0090217,,
